PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rajasekaran, D; Zierow, S; Syed, M; Bucala, R; Bhandari, V; Lolis, EJ				Rajasekaran, Deepa; Zierow, Swen; Syed, Mansoor; Bucala, Richard; Bhandari, Vineet; Lolis, Elias J.			Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment	FASEB JOURNAL			English	Article						covalent inhibitor; 4-IPP	D-DOPACHROME TAUTOMERASE; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURE; CYSTIC-FIBROSIS; CYTOKINE; HOMOLOG; MODEL; GENE; DISCOVERY; CD74	We report a new inflammatory activity for extracellular d-dopachrome tautomerase (D-DT), the recruitment of neutrophils to the lung on D-DT intratracheal installation of C57BL/6J mice with an EC50 of 5.6 g. We also find that D-DT and macrophage migration inhibitory factor (MIF) have additive effects in neutrophil recruitment. Although the tautomerase site of D-DT and its homologue MIF are biophysically very different, 4-iodo-6-phenylpyrimidine (4-IPP) forms a covalent bond with Pro-1 of both proteins, resulting in a 6-phenylpyrimidine (6-PP) adduct. Recruitment of neutrophils to the lung for the 6-PP adducts of D-DT and MIF are reduced by approximate to 50% relative to the apo proteins, demonstrating that an unmodified Pro-1 is important for this activity, but there is no cooperativity in inhibition of the proteins together. The differences in the binding mode of the 6-PP adduct for D-DT was determined by crystallographic studies at 1.13 angstrom resolution and compared to the structure of the MIF-6-PP complex. There are major differences in the location of the 6-PP adduct to the D-DT and MIF active sites that provide insight into the lack of cooperativity by 4-IPP and into tuning the properties of the covalent inhibitors of D-DT and MIF that are necessary for the development of therapeutic small molecules against neutrophil damage from lung infections such as Pseudomonas aeruginosa in cystic fibrosis and immunocompromised patients.Rajasekaran, D., Zierow, S., Syed, M., Bucala, R., Bhandari, V., Lolis, E. J. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.	[Rajasekaran, Deepa; Zierow, Swen; Lolis, Elias J.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Syed, Mansoor; Bhandari, Vineet] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Bucala, Richard] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA; [Bucala, Richard; Lolis, Elias J.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Lolis, EJ (corresponding author), 333 Cedar St, New Haven, CT 06510 USA.	elias.lolis@yale.edu	Bhandari, Vineet/AAS-3365-2020; syed, mansoor ali/I-6957-2018; syed, Mansoor ali/G-8986-2013	syed, Mansoor ali/0000-0003-2697-7832; Lolis, Elias/0000-0002-7902-7868	U.S. National Institutes of Health [AI065029, AI082295, AR049610]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082295, R01AI065029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors are grateful to Wibke Schulte and Melanie Merk for the data in Fig. 1C, D on the comparative effects of ISO-1 and 4IPP on MIF and DDT tautomerase activity. The authors thank the staff at the X25 beamline of the National Synchrotron Light Source (Brookhaven National Laboratory, Upton, NY, USA) for assistance in data collection and the Yale School of Medicine Keck Biotechnology Research Laboratory for mass spectrometry. This Work was supported by the U.S. National Institutes of Health, R01 grants AI065029, AI082295, and AR049610.	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Almrud JJ, 2002, BIOCHEMISTRY-US, V41, P12010, DOI 10.1021/bi020271h; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218; Bhandari V, 2012, AM J RESP CELL MOL, V46, P668, DOI 10.1165/rcmb.2011-0074OC; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho Y, 2011, CHEM BIOL, V18, P1089, DOI 10.1016/j.chembiol.2011.07.011; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; Crichlow GV, 2012, BIOCHEMISTRY-US, V51, P7506, DOI 10.1021/bi3005494; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan CP, 2013, P NATL ACAD SCI USA, V110, P10994, DOI 10.1073/pnas.1221817110; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Hare AA, 2010, BIOORG MED CHEM LETT, V20, P5811, DOI 10.1016/j.bmcl.2010.07.129; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Jorgensen WL, 2011, BIOORG MED CHEM LETT, V21, P4545, DOI 10.1016/j.bmcl.2011.05.127; Jorgensen WL, 2010, BIOORG MED CHEM LETT, V20, P7033, DOI 10.1016/j.bmcl.2010.09.118; Kobold S, 2014, ONCOTARGET, V5, P103, DOI 10.18632/oncotarget.1560; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Makita H, 1998, AM J RESP CRIT CARE, V158, P573, DOI 10.1164/ajrccm.158.2.9707086; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean LR, 2010, BIOORG MED CHEM LETT, V20, P1821, DOI 10.1016/j.bmcl.2010.02.009; McLean LR, 2009, BIOORG MED CHEM LETT, V19, P6717, DOI 10.1016/j.bmcl.2009.09.106; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ODH G, 1993, BIOCHEM BIOPH RES CO, V197, P619, DOI 10.1006/bbrc.1993.2524; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Stamps SL, 1998, BIOCHEMISTRY-US, V37, P10195, DOI 10.1021/bi9806955; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Swope MD, 1999, REV PHYSIOL BIOCH P, V139, P1, DOI 10.1007/BFb0033647; Sydnor ERM, 2011, CLIN MICROBIOL REV, V24, P141, DOI 10.1128/CMR.00027-10; Takahashi K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-33; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C	57	47	48	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4961	4971		10.1096/fj.14-256636	http://dx.doi.org/10.1096/fj.14-256636			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25016026	Green Published			2022-12-25	WOS:000344050900032
J	Adham, M; Stoker, SD; Wildeman, MA; Rachmadi, L; Gondhowiardjo, S; Atmakusumah, D; Gatot, D; Fles, R; Greijer, AE; Hermani, B; Middeldorp, JM; Tan, IB				Adham, Marlinda; Stoker, Sharon D.; Wildeman, Maarten A.; Rachmadi, Lisnawati; Gondhowiardjo, Soehartati; Atmakusumah, Djumhana; Gatot, Djayadiman; Fles, Renske; Greijer, Astrid E.; Hermani, Bambang; Middeldorp, Jaap M.; Tan, I. Bing			Current Status of Cancer Care for Young Patients with Nasopharyngeal Carcinoma in Jakarta, Indonesia	PLOS ONE			English	Article							CHILDREN; RADIOTHERAPY; MANAGEMENT	Background: Nasopharyngeal carcinoma (NPC) is endemic in Indonesia and 20% of the patients are diagnosed before the age of 31. This study evaluates presentation and treatment outcome of young patients in Jakarta, in a tertiary referral centre. Methods: Forty-nine patients under the age of 31, diagnosed with NPC between July 2004 and January 2007, were evaluated. Baseline data included histological type, stage of disease and presenting symptoms. We intended to follow all patients after diagnosis to reveal treatment outcome and overall survival (OS). Results: All but two patients had advanced stage disease (94%), 7 (14%) had distant metastasis. The median interval between start of complaints and diagnosis was 9 months. Forty-two patients were planned for curative intent treatment. Eleven patients (26%) never started treatment, 2 patients did not complete treatment and 3 patients did not return after finishing treatment. Four patients died before radiation could start. Three patients died within 4 months after treatment. Nine patients (21%) had a complete response. Due to the high number of patients who were lost to follow-up (LFU), OS was analyzed as follows: a best-case (patients censored at last contact) and a worst-case scenario (assuming that patients who did not finish treatment or had disease at last contact would have died). The 2-year OS for patients without distant metastases was 39-71%. Conclusion: Treatment outcome for young patients with NPC in this institute was poor. Improvement can be achieved when NPC is diagnosed at an earlier stage and when there is better treatment compliance.	[Adham, Marlinda; Rachmadi, Lisnawati; Gondhowiardjo, Soehartati; Atmakusumah, Djumhana; Hermani, Bambang] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Gatot, Djayadiman] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, Med Oncol Pediat Dept, Jakarta, Indonesia; [Stoker, Sharon D.; Wildeman, Maarten A.; Fles, Renske; Tan, I. Bing] Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Greijer, Astrid E.; Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Tan, I. Bing] Gadjah Mada Univ, Ear Nose & Throat Dept, Yogyakarta, Indonesia; [Wildeman, Maarten A.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands; [Tan, I. Bing] Univ Amsterdam, Acad Med Ctr, Dept Oral & Maxillofacial Surg, NL-1105 AZ Amsterdam, Netherlands	University of Indonesia; University of Indonesia; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Gadjah Mada University; University of Amsterdam; Academic Medical Center Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Tan, IB (corresponding author), Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands.	I.tan@nki.nl		Adham, Marlinda/0000-0003-2461-9628; Middeldorp, Jaap Michiel/0000-0002-0765-4125	Dutch Cancer Society [KWF-VUmc IN2006-21]	Dutch Cancer Society(KWF Kankerbestrijding)	This study was sponsored by a grant of the Dutch Cancer Society, project number KWF-VUmc IN2006-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Akimoto T, 1997, JPN J CLIN ONCOL, V27, P240, DOI 10.1093/jjco/27.4.240; Ayan I, 2003, LANCET ONCOL, V4, P13, DOI 10.1016/S1470-2045(03)00956-2; Ayan I, 1996, INT J RADIAT ONCOL, V35, P485, DOI 10.1016/0360-3016(96)00018-1; Buehrlen M, 2012, CANCER-AM CANCER SOC, V118, P4892, DOI 10.1002/cncr.27395; Cheuk DKL, 2011, CANCER-AM CANCER SOC, V117, P197, DOI 10.1002/cncr.25376; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Downing NL, 2009, INT J RADIAT ONCOL, V75, P1064, DOI 10.1016/j.ijrobp.2008.12.030; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fles R, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-81; Gondhowiardjo Sa, 2008, Biomed Imaging Interv J, V4, pe42, DOI 10.2349/biij.4.3.e42; Ho KY, 2008, J OTOLARYNGOL-HEAD N, V37, P362, DOI 10.2310/7070.2008.0071; Hutajulu SH, 2012, THESIS; Ji Ming-fang, 2011, Chin J Cancer, V30, P120; Kimman M, 2012, ASIAN PAC J CANCER P, V13, P411, DOI 10.7314/APJCP.2012.13.2.411; Laskar S, 2004, INT J RADIAT ONCOL, V58, P189, DOI 10.1016/S0360-3016(03)00773-9; Lee A. W. M., 1997, Hong Kong Medical Journal, V3, P355; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Mertens R, 2005, CANCER-AM CANCER SOC, V104, P1083, DOI 10.1002/cncr.21258; Ozyar E, 2006, RADIOTHER ONCOL, V81, P39, DOI 10.1016/j.radonc.2006.08.019; Platek ME, 2012, HEAD NECK-J SCI SPEC, V35, P684; Satriana S, 2012, SOCIAL PROTECTION AS; Slotman BJ, 2005, RADIOTHER ONCOL, V75, P349, DOI 10.1016/j.radonc.2004.12.005; Stoker SD, 2014, PLOS ONE, V23; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Wildeman MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032756; Wildeman MA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-190; Wolden SL, 2000, INT J RADIAT ONCOL, V46, P859, DOI 10.1016/S0360-3016(99)00493-9	31	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102353	10.1371/journal.pone.0102353	http://dx.doi.org/10.1371/journal.pone.0102353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019625	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600072
J	Kushnir, VA; Yu, Y; Barad, DH; Weghofer, A; Himaya, E; Lee, HJ; Wu, YG; Shohat-Tal, A; Lazzaroni-Tealdi, E; Gleicher, N				Kushnir, Vitaly A.; Yu, Yao; Barad, David H.; Weghofer, Andrea; Himaya, Eric; Lee, Ho-Joon; Wu, Yan-Guang; Shohat-Tal, Aya; Lazzaroni-Tealdi, Emanuela; Gleicher, Norbert			Utilizing FMR1 Gene Mutations as Predictors of Treatment Success in Human In Vitro Fertilization	PLOS ONE			English	Article							OVARIAN AGING PATTERNS; SIZED CGG REPEAT; INTERMEDIATE; RESERVE; DONORS	Context: Mutations of the fragile X mental retardation 1 (FMR1) gene are associated with distinct ovarian aging patterns. Objective: To confirm in human in vitro fertilization (IVF) that FMR1 affects outcomes, and to determine whether this reflects differences in ovarian aging between FMR1 mutations, egg/embryo quality or an effect on implantation. Design, Setting, Patients: IVF outcomes were investigated in a private infertility center in reference to patients' FMR1 mutations based on a normal range of CGG(n=26-34) and sub-genotypes high (CGG(n>34)) and low (CGG(<26)). The study included 3 distinct sections and study populations: (i) A generalized mixed-effects model of morphology (777 embryos, 168 IVF cycles, 125 infertile women at all ages) investigated whether embryo quality is associated with FMR1; (ii) 1041 embryos in 149 IVF cycles in presumed fertile women assessed whether the FMR1 gene is associated with aneuploidy; (iii) 352 infertile patients (< age 38; in 1st IVF cycles) and 179 donor-recipient cycles, assessed whether the FMR1 gene affects IVF pregnancy chances via oocyte/embryo quality or non-oocyte maternal factors. Interventions: Standardized IVF protocols. Main Outcome Measures: Morphologic embryo quality, ploidy and pregnancy rates. Results: (i) Embryo morphology was reduced in presence of a low FMR1 allele (P = 0.032). In absence of a low allele, the odds ratio (OR) of chance of good (vs. fair/poor) embryos was 1.637. (ii) FMR1 was not associated with aneuploidy, though aneuploidy increased with female age. (iii) Recipient pregnancy rates were neither associated with donor age or donor FMR1. In absence of a low FMR1 allele, OR of clinical pregnancy (vs. chemical or no pregnancy) was 2.244 in middle-aged infertility patients. Conclusions: A low FMR1 allele (CGG(<26)) is associated with significantly poorer morphologic embryo quality and pregnancy chance. As women age, low FMR1 alleles affect IVF pregnancy chances by reducing egg/embryo quality by mechanisms other than embryo aneuploidy.	[Kushnir, Vitaly A.; Yu, Yao; Barad, David H.; Weghofer, Andrea; Lee, Ho-Joon; Wu, Yan-Guang; Shohat-Tal, Aya; Lazzaroni-Tealdi, Emanuela; Gleicher, Norbert] Ctr Human Reprod, New York, NY 10021 USA; [Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Weghofer, Andrea] Univ Vienna, Sch Med, Dept Obstet & Gynecol, Vienna, Austria; [Himaya, Eric] McGill Univ, Gatineau Hosp, Quebec City, PQ, Canada	University of Vienna; McGill University	Kushnir, VA (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.	vkushnir@thechr.com	Barad, David/AAF-4332-2021; Yu, Yao/O-3224-2016		Foundation for Reproductive Medicine and Center for Human Reproduction	Foundation for Reproductive Medicine and Center for Human Reproduction	This work was supported by Foundation for Reproductive Medicine and Center for Human Reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Ferder I, 2013, REPRODUCTION, V145, P335, DOI 10.1530/REP-12-0305; Fragouli E, 2012, SEMIN REPROD MED, V30, P289, DOI 10.1055/s-0032-1313908; Gleicher N, 2012, HUM REPROD, V27, P2; Gleicher N, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-80; Gleicher N, 2013, HUM REPROD, V28, P1084, DOI 10.1093/humrep/det033; Gleicher N, 2012, J ASSIST REPROD GEN, V29, P1159, DOI 10.1007/s10815-012-9871-2; Gleicher N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-77; Gleicher N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033638; Gleicher N, 2012, J AUTOIMMUN, V38, pJ74, DOI 10.1016/j.jaut.2011.05.016; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-140; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher NN, 2012, HUM REPROD, V27, P2241, DOI 10.1093/humrep/des161; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; Kushnir VA, 2013, FERTIL STERIL, V100, pS114, DOI 10.1016/j.fertnstert.2013.07.1656; Lledo B, 2012, HUM REPROD, V27, P609, DOI 10.1093/humrep/der415; Sen A, 2014, NAT REV ENDOCRINOL, V10, P37, DOI 10.1038/nrendo.2013.212; Setti AS, 2011, EUR J OBSTET GYN R B, V159, P364, DOI 10.1016/j.ejogrb.2011.07.031	23	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102274	10.1371/journal.pone.0102274	http://dx.doi.org/10.1371/journal.pone.0102274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019151	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600058
J	Marti, H; Koschwanez, M; Pesch, T; Blenn, C; Borel, N				Marti, Hanna; Koschwanez, Maria; Pesch, Theresa; Blenn, Christian; Borel, Nicole			Water-Filtered Infrared A Irradiation in Combination with Visible Light Inhibits Acute Chlamydial Infection	PLOS ONE			English	Article							ENDOCERVICAL EPITHELIAL-CELLS; TRACHOMATIS INFECTION; HELA-CELLS; HOST-CELLS; EXPRESSION; SECRETION; CYTOKINE; RESISTANCE; PERSISTENCE; ACTIVATION	New therapeutic strategies are needed to overcome drawbacks in treatment of infections with intracellular bacteria. Chlamydiaceae are Gram-negative bacteria implicated in acute and chronic diseases such as abortion in animals and trachoma in humans. Water-filtered infrared A (wIRA) is short wavelength infrared radiation with a spectrum ranging from 780 to 1400 nm. In clinical settings, wIRA alone and in combination with visible light (VIS) has proven its efficacy in acute and chronic wound healing processes. This is the first study to demonstrate that wIRA irradiation combined with VIS (wIRA/VIS) diminishes recovery of infectious elementary bodies (EBs) of both intra-and extracellular Chlamydia (C.) in two different cell lines (Vero, HeLa) regardless of the chlamydial strain (C. pecorum, C. trachomatis serovar E) as shown by indirect immunofluorescence and titration by subpassage. Moreover, a single exposure to wIRA/VIS at 40 hours post infection (hpi) led to a significant reduction of C. pecorum inclusion frequency in Vero cells and C. trachomatis in HeLa cells, respectively. A triple dose of irradiation (24, 36, 40 hpi) during the course of C. trachomatis infection further reduced chlamydial inclusion frequency in HeLa cells without inducing the chlamydial persistence/stress response, as ascertained by electron microscopy. Irradiation of host cells (HeLa, Vero) neither affected cell viability nor induced any molecular markers of cytotoxicity as investigated by Alamar blue assay and Western blot analysis. Chlamydial infection, irradiation, and the combination of both showed a similar release pattern of a subset of pro-inflammatory cytokines (MIF/GIF, Serpin E1, RANTES, IL-6, IL-8) and chemokines (IL-16, IP-10, ENA-78, MIG, MIP-1 alpha/beta) from host cells. Initial investigation into the mechanism indicated possible thermal effects on Chlamydia due to irradiation. In summary, we demonstrate a non-chemical reduction of chlamydial infection using the combination of water-filtered infrared A and visible light.	[Marti, Hanna; Koschwanez, Maria; Borel, Nicole] Univ Zurich Vetsuisse, Inst Vet Pathol, Zurich, Switzerland; [Pesch, Theresa; Blenn, Christian] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Zurich; University of Zurich	Borel, N (corresponding author), Univ Zurich Vetsuisse, Inst Vet Pathol, Zurich, Switzerland.	n.borel@access.uzh.ch	Borel, Nicole/GPP-1073-2022; Marti, Hanna/AAA-3955-2021; Borel, Nicole/M-6204-2016	Borel, Nicole/0000-0002-1556-9262; Marti, Hanna/0000-0002-8398-4708; Borel, Nicole/0000-0002-1556-9262	Dr. Erwin Braun Foundation, Basel, Switzerland	Dr. Erwin Braun Foundation, Basel, Switzerland	This work was financially supported by the Dr. Erwin Braun Foundation, Basel, Switzerland, awarded to Christian Blenn and Nicole Borel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA., 2010, PATHOGENESIS BACTERI, P575; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Borel N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-201; Buckner LR, 2013, CYTOKINE, V63, P151, DOI 10.1016/j.cyto.2013.04.022; Burton MJ, 2011, INFECT IMMUN, V79, P4977, DOI 10.1128/IAI.05718-11; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chancey ST, 2012, FUTURE MICROBIOL, V7, P959, DOI [10.2217/fmb.12.63, 10.2217/FMB.12.63]; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cunha LD, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00076; Dean D, 2013, EMERG INFECT DIS, V19, P1948, DOI 10.3201/eid1912.130656; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Dessus-Babus S, 2000, CELL MICROBIOL, V2, P317, DOI 10.1046/j.1462-5822.2000.00058.x; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Di Paolo NC, 2014, METHODS MOL BIOL, V1089, P133, DOI 10.1007/978-1-62703-679-5_10; Dreses-Werringloer U, 2003, ANTIMICROB AGENTS CH, V47, P2316, DOI 10.1128/AAC.47.7.2316-2318.2003; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Ermolaeva SA, 2012, J MED MICROBIOL, V61, P793, DOI 10.1099/jmm.0.038117-0; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; GALASSO GJ, 1961, J IMMUNOL, V86, P382; Gervassi A, 2004, INFECT IMMUN, V72, P7231, DOI 10.1128/IAI.72.12.7231-7239.2004; Guseva NV, 2007, INFECT IMMUN, V75, P553, DOI 10.1128/IAI.01517-06; Hammerschlag MR, 2012, EXPERT OPIN PHARMACO, V13, P545, DOI 10.1517/14656566.2012.658776; Hartel M, 2006, BRIT J SURG, V93, P952, DOI 10.1002/bjs.5429; Hoffmann G, 2007, GMS KRANKENHHYG INTE, V2, pDoc54; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Jung T, 2010, FREE RADICAL BIO MED, V48, P153, DOI 10.1016/j.freeradbiomed.2009.10.036; KAHANE S, 1992, FEMS MICROBIOL LETT, V97, P25; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kutlin A, 2005, ANTIMICROB AGENTS CH, V49, P903, DOI 10.1128/AAC.49.3.903-907.2005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Rank RG, 2010, INFECT IMMUN, V78, P536, DOI 10.1128/IAI.00772-09; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Schachter J., 1999, CHLAMYDIA, P156; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schieke SM, 2002, J INVEST DERMATOL, V119, P1323, DOI 10.1046/j.1523-1747.2002.19630.x; Schoborg RV, 2011, MICROBES INFECT, V13, P649, DOI 10.1016/j.micinf.2011.03.004; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Shah A, 2002, INT J HYPERTHER, V18, P534, DOI 10.1080/02656730210157843; Suchland RJ, 2005, ANTIMICROB AGENTS CH, V49, P1120, DOI 10.1128/AAC.49.3.1120-1126.2005; Tormakangas L, 2010, INFECT IMMUN, V78, P2714, DOI 10.1128/IAI.01456-09; Wasson CJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-176; Wright J, 2013, MED CLIN N AM, V97, P667, DOI 10.1016/j.mcna.2013.02.006; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102239	10.1371/journal.pone.0102239	http://dx.doi.org/10.1371/journal.pone.0102239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019934	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000339618600056
J	Shao, HW; Ou, YS; Wang, T; Shen, H; Wu, FL; Zhang, WF; Tao, CL; Yuan, Y; Bo, HB; Wang, H; Huang, SL				Shao, Hongwei; Ou, Yusheng; Wang, Teng; Shen, Han; Wu, Fenglin; Zhang, Wenfeng; Tao, Changli; Yuan, Yin; Bo, Huaben; Wang, Hui; Huang, Shulin			Differences in TCR-V beta Repertoire and Effector Phenotype between Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes Increase with Age	PLOS ONE			English	Article							T-CELL GENERATION; IMMUNE-SYSTEM; GENE USAGE; MELANOMA; CD8; CD4(+); CANCER; MICROENVIRONMENT; DIVERSITY; SEQUENCES	Tumor infiltrating lymphocytes (TIL) reflect the host's anti-tumor immune response, and can be a valuable predictor of prognosis. However, many properties of TIL are not fully understood. In the present study, TCR-V beta repertoires of cancer patients were primarily analyzed by flow cytometry. Abnormally expressed TCR-V beta subfamilies were generally found in both TIL and peripheral blood lymphocytes (PBL) of each patient. Of note, increased patient age was associated with increasingly biased TCR-V beta repertoire in TIL but not in PBL, and the dispersion degree of the differences of TCR-V beta subfamilies between TIL and PBL correlated positively with age (P = 0.007). Utilizing immunoscope analysis, we identified the age-related reduction in TCR-V beta diversity, but polyclonal pattern was predominant in significantly expanded TCR-V beta subfamilies. In addition, we found that older patients possessed a decreased ratio of CD8(+)CD62L(+) non-effector cells in TIL compared to PBL, implying age-related increase of CD8(+)CD62L(-) effector cells in TIL. The colocalization analysis of CD8 and CD3, however, suggested the suppressed activity of these effector cells in tumor microenvironment. These findings further elucidate the properties of TIL, showing an increasing difference between TIL and PBL with age, which may provide insight for the development of effective immunotherapies for cancer patients of different ages.	[Shao, Hongwei; Ou, Yusheng; Wang, Teng; Shen, Han; Wu, Fenglin; Zhang, Wenfeng; Tao, Changli; Yuan, Yin; Bo, Huaben; Wang, Hui; Huang, Shulin] Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou, Guangdong, Peoples R China; [Shao, Hongwei; Ou, Yusheng; Wang, Teng; Shen, Han; Wu, Fenglin; Zhang, Wenfeng; Tao, Changli; Yuan, Yin; Bo, Huaben; Wang, Hui; Huang, Shulin] Guangdong Pharmaceut Univ, Sch Biosci & Biopharmaceut, Guangzhou, Guangdong, Peoples R China; [Huang, Shulin] Southern Med Univ, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Southern Medical University - China	Huang, SL (corresponding author), Guangdong Prov Key Lab Biotechnol Drug Candidates, Guangzhou, Guangdong, Peoples R China.	shulhuang@sina.com	shao, hongwei/GWC-1808-2022; shen, han/AAQ-5341-2021	Shen, Han/0000-0003-0366-4403	National Natural Science Foundation of China [31100664, 31300737, 81303292]; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2009ZX09103-708]; Natural Science Foundation of Guangdong Province [10151022401000024]; Faculty Development and Research Funds of GDPU	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Special Project for "Significant New Drugs Development''; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Faculty Development and Research Funds of GDPU	This work was supported by the National Natural Science Foundation of China (No. 31100664, 31300737, 81303292), National Major Scientific and Technological Special Project for "Significant New Drugs Development'' (No. 2009ZX09103-708), Natural Science Foundation of Guangdong Province (No. 10151022401000024), and a grant from Faculty Development and Research Funds of GDPU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380; Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005; Blohm U, 2002, J IMMUNOL, V169, P5522, DOI 10.4049/jimmunol.169.10.5522; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; Demotte N, 2002, EUR J IMMUNOL, V32, P1688, DOI 10.1002/1521-4141(200206)32:6<1688::AID-IMMU1688>3.0.CO;2-9; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Dudley ME, 2013, J CLIN ONCOL, V31, P2152, DOI 10.1200/JCO.2012.46.6441; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Echchakir H, 1999, INT J CANCER, V81, P205, DOI 10.1002/(SICI)1097-0215(19990412)81:2<205::AID-IJC7>3.0.CO;2-M; FERRADINI L, 1992, CANCER RES, V52, P4649; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gebhard DH, 1999, J INFECT DIS, V180, P1503, DOI 10.1086/315089; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; HOLMES EC, 1985, ANN SURG, V202, P335, DOI 10.1097/00000658-198509000-00010; IOANNIDES CG, 1991, J IMMUNOL, V146, P1700; KUDOH S, 1995, CANCER IMMUNOL IMMUN, V41, P175, DOI 10.1007/s002620050216; Lyons GE, 2006, CANCER RES, V66, P11455, DOI 10.1158/0008-5472.CAN-06-2379; Nagorsen D, 2003, CLIN CANCER RES, V9, P4296; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Nishimura MI, 1998, J IMMUNOTHER, V21, P352, DOI 10.1097/00002371-199809000-00003; Rezvany MR, 2003, BLOOD, V101, P1063, DOI 10.1182/blood-2002-03-0746; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Sainz-Perez A, 2012, CANCER RES, V72, P3557, DOI 10.1158/0008-5472.CAN-12-0277; SALVI S, 1995, CANCER RES, V55, P3374; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Selin LK, 2004, SEMIN IMMUNOL, V16, P335, DOI 10.1016/j.smim.2004.08.014; SENSI M, 1995, IMMUNOL TODAY, V16, P588, DOI 10.1016/0167-5699(95)80082-4; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Steinmann G G, 1986, Curr Top Pathol, V75, P43; Thor Straten Per, 2004, J Transl Med, V2, P11; Voss Stephan, 1993, P411; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; Wong JL, 2013, CANCER RES, V73, P4653, DOI 10.1158/0008-5472.CAN-12-4366; Wu FL, 2013, CANCER LETT, V339, P195, DOI 10.1016/j.canlet.2013.06.009; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yannelli JR, 1996, INT J CANCER, V65, P413, DOI 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#; Yu R, 2005, EUR J IMMUNOL, V35, P1754, DOI 10.1002/eji.200425866; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102327	10.1371/journal.pone.0102327	http://dx.doi.org/10.1371/journal.pone.0102327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019226	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600068
J	Zhao, MH; Kwon, JW; Liang, S; Kim, SH; Li, YH; Oh, JS; Kim, NH; Cui, XS				Zhao, Ming-Hui; Kwon, Jung-Woo; Liang, Shuang; Kim, Seon-Hyang; Li, Ying-Hua; Oh, Jeong-Su; Kim, Nam-Hyung; Cui, Xiang-Shun			Zinc Regulates Meiotic Resumption in Porcine Oocytes via a Protein Kinase C-Related Pathway (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							MATURATION-PROMOTING FACTOR; PIG OOCYTES; CELL-CYCLE; GERMINAL VESICLE; MOUSE OOCYTES; CUMULUS CELLS; MEIOSIS-II; ACTIVATION; FERTILIZATION; GONADOTROPINS	Zinc is an extremely important trace element that plays important roles in several biological processes. However, the function of zinc in meiotic division of porcine oocytes is unknown. In this study, we investigated the role of zinc during meiotic resumption in in vitro matured porcine oocytes. During meiotic division, a massive release of zinc was observed. The level of free zinc in the cytoplasm significantly increased during maturation. Depletion of zinc using N, N, N', N'-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN), a Zn2+ chelator, blocked meiotic resumption in a dose dependent manner. The level of phosphorylated mitogen activated protein kinase (MAPK) and p34(cdc2) kinase activity were reduced when zinc was depleted. Moreover, zinc depletion reduced the levels of phosphorylated protein kinase C (PKC) substrates in a dose dependent manner. Real-time PCR analysis showed that expression of the MAPK-and maturation promoting factor related genes C-mos, CyclinB1, and Cdc2 was downregulated following zinc depletion. Treatment with the PKC agonist phorbol 12-myristate 13-acetate (PMA) increased phosphorylation of PKC substrates and MAPK and increased p34(cdc2) kinase activity. This rescued the meiotic arrest, even in the presence of TPEN. Activation of PKC by PMA increased the level of zinc in the cytoplasm. These data demonstrate that zinc is required for meiotic resumption in porcine oocytes, and this appears to be regulated via a PKC related pathway.	[Zhao, Ming-Hui; Kwon, Jung-Woo; Liang, Shuang; Kim, Seon-Hyang; Li, Ying-Hua; Kim, Nam-Hyung; Cui, Xiang-Shun] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Zhao, Ming-Hui; Kwon, Jung-Woo; Liang, Shuang; Kim, Seon-Hyang; Kim, Nam-Hyung; Cui, Xiang-Shun] Brain Korea 21 Ctr Bioresource Dev, Cheongju, South Korea; [Oh, Jeong-Su] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Genet Engn, Suwon, South Korea	Chungbuk National University; Sungkyunkwan University (SKKU)	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.	nhkim@chungbuk.ac.kr; xscui@chungbuk.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ00909801, PJ009594]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by grants from the Next-Generation BioGreen 21 Program (PJ00909801 and PJ009594), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avazeri N, 2004, J CELL SCI, V117, P4969, DOI 10.1242/jcs.01375; Bernhardt ML, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097253; Bernhardt ML, 2011, BIOL REPROD, V84, P526, DOI 10.1095/biolreprod.110.086488; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Chen WY, 2000, MOL REPROD DEV, V56, P74, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;74::AID-MRD9&gt;3.0.CO;2-6; COSKUN S, 1995, MOL REPROD DEV, V42, P311, DOI 10.1002/mrd.1080420308; Doree M, 2002, J CELL SCI, V115, P2461; Endo T, 2006, REPRODUCTION, V131, P439, DOI 10.1530/rep.1.00924; Fan HY, 2004, BIOL REPROD, V70, P1178, DOI 10.1095/biolreprod.103.024737; Fan HY, 2003, BIOL REPROD, V68, P968, DOI 10.1095/biolreprod.102.008839; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; HEDBERG KK, 1994, J CELL PHYSIOL, V158, P337, DOI 10.1002/jcp.1041580216; HUNTER RHF, 1966, J REPROD FERTIL, V12, P525, DOI 10.1530/jrf.0.0120525; INOUE M, 1995, ZYGOTE, V3, P265, DOI 10.1017/S0967199400002665; Kim AM, 2011, ACS CHEM BIOL, V6, P716, DOI 10.1021/cb200084y; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kong BY, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099390; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LEFEVRE B, 1992, J EXP ZOOL, V264, P206, DOI 10.1002/jez.1402640213; Li YH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109850; Lisle RS, 2013, REPRODUCTION, V145, P381, DOI 10.1530/REP-12-0338; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Meinecke B, 2003, ZYGOTE, V11, P7, DOI 10.1017/S0967199403001023; MOTLIK J, 1976, J EXP ZOOL, V198, P155, DOI 10.1002/jez.1401980205; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PROCHAZKA R, 1989, CELL DIFFER DEV, V27, P175, DOI 10.1016/0922-3371(89)90698-9; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; Shoujo A, 2000, J MAMM OVA RES, V17, P35; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sun QY, 1997, DEV GROWTH DIFFER, V39, P523, DOI 10.1046/j.1440-169X.1997.t01-2-00014.x; Tian X, 2012, ENDOCRINOLOGY, V153, P873, DOI 10.1210/en.2011-1599; Viveiros MM, 2001, DEV BIOL, V235, P330, DOI 10.1006/dbio.2001.0311; Yu BZ, 2004, CELL BIOCHEM FUNCT, V22, P291, DOI 10.1002/cbf.1103; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031	40	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102097	10.1371/journal.pone.0102097	http://dx.doi.org/10.1371/journal.pone.0102097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019390	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600045
J	Bladowska, J; Knysz, B; Zimny, A; Malyszczak, K; Koltowska, A; Szewczyk, P; Gasiorowski, J; Furdal, M; Sasiadek, MJ				Bladowska, Joanna; Knysz, Brygida; Zimny, Anna; Malyszczak, Krzysztof; Koltowska, Anna; Szewczyk, Pawel; Gasiorowski, Jacek; Furdal, Michal; Sasiadek, Marek J.			Value of Perfusion-Weighted MR Imaging in the Assessment of Early Cerebral Alterations in Neurologically Asymptomatic HIV-1-Positive and HCV-Positive Patients	PLOS ONE			English	Article							HEPATITIS-C; BLOOD-FLOW; EMISSION-TOMOGRAPHY; HIV; METABOLISM; INFECTION; THERAPY; RISK	Background and Purpose: Asymptomatic central nervous system (CNS) involvement occurs in the early stage of the human immunodeficiency virus (HIV) infection. It has been documented that the hepatitis C virus (HCV) can replicate in the CNS. The aim of the study was to evaluate early disturbances in cerebral microcirculation using magnetic resonance (MR) perfusion-weighted imaging (PWI) in asymptomatic HIV-1-positive and HCV-positive patients, as well as to assess the correlation between PWI measurements and the clinical data. Materials and Methods: Fifty-six patients: 17 HIV-1-positive non-treated, 18 HIV-1-positive treated with combination antiretroviral therapy (cART), 7 HIV-1/HCV-positive non-treated, 14 HCV-positive before antiviral therapy and 18 control subjects were enrolled in the study. PWI was performed with a 1.5T MR unit using dynamic susceptibility contrast (DSC) method. Cerebral blood volume (CBV) measurements relative to cerebellum (rCBV) were evaluated in the posterior cingulated region (PCG), basal ganglia (BG), temporoparietal (TPC) and frontal cortices (FC), as well as in white matter of frontoparietal areas. Correlations of rCBV values with immunologic data and liver histology activity index (HAI) were analyzed. Results: Significantly lower rCBV values were found in the right TPC and left FC as well as in PCG in HIV-1-positive naiive (p = 0.009; p = 0.020; p = 0.012), HIV-1 cART treated (p = 0.007; p = 0.009; p = 0.033), HIV-1/HCV-positive (p = 0.007; p = 0.027; p = 0.045) and HCV-positive patients (p = 0.010; p = 0.005; p = 0.045) compared to controls. HIV-1-positive cART treated and HIV-1/HCV-positive patients demonstrated lower rCBV values in the right FC (p = 0.009; p = 0.032, respectively) and the left TPC (p = 0.036; p = 0.005, respectively), while HCV-positive subjects revealed lower rCBV values in the left TPC region (p = 0.003). We found significantly elevated rCBV values in BG in HCV-positive patients (p = 0.0002; p, 0.0001) compared to controls as well as to all HIV-1-positive subjects. There were no significant correlations of rCBV values and CD4 T cell count or HAI score. Conclusions: PWI examination enables the assessment of HIV-related as well as HCV-related early cerebral dysfunction in asymptomatic subjects. HCV-infected patients seem to reveal the most pronounced perfusion changes.	[Bladowska, Joanna; Zimny, Anna; Koltowska, Anna; Szewczyk, Pawel; Sasiadek, Marek J.] Wroclaw Med Univ, Chair Radiol, Dept Gen Radiol Intervent Radiol & Neuroradiol, Wroclaw, Poland; [Knysz, Brygida; Gasiorowski, Jacek] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immune Defic, Wroclaw, Poland; [Malyszczak, Krzysztof] Wroclaw Med Univ, Dept Psychiat, Div Psychotherapy & Psychosomat Med, Wroclaw, Poland; [Furdal, Michal] Reg Specialist Hosp, Dept Cardiol, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University	Bladowska, J (corresponding author), Wroclaw Med Univ, Chair Radiol, Dept Gen Radiol Intervent Radiol & Neuroradiol, Wroclaw, Poland.	asia.bladowska@gmail.com	Małyszczak, Krzysztof/ABD-5670-2021	Małyszczak, Krzysztof/0000-0001-6295-2742; Koltowska, Anna/0000-0003-2508-9817; Knysz, Brygida/0000-0003-2605-1079; Sasiadek, Marek/0000-0003-3627-118X	Wroclaw Medical University [ST-146]	Wroclaw Medical University	Supported by Wroclaw Medical University Grant ST-146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; Bladowska J, 2013, J HEPATOL, V59, P651, DOI 10.1016/j.jhep.2013.05.008; Bladowska J, 2013, EUR J RADIOL, V82, P686, DOI 10.1016/j.ejrad.2012.11.029; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; Byrnes V, 2012, J HEPATOL, V56, P549, DOI 10.1016/j.jhep.2011.09.015; Carvalho RJ, 2012, WORLD J GASTROENTERO, V18, P188, DOI 10.3748/wjg.v18.i2.188; CATAFAU AM, 1994, J NUCL MED, V35, P1041; Chang L, 2000, NEUROLOGY, V54, P389, DOI 10.1212/WNL.54.2.389; Clifford DB, 2005, J NEUROVIROL, V11, P67, DOI 10.1080/13550280500513762; Gruis KL, 2003, ARCH NEUROL-CHICAGO, V60, P877, DOI 10.1001/archneur.60.6.877; Gutierrez J, 2013, NEUROPATHOLOGY, V33, P256, DOI 10.1111/j.1440-1789.2012.01358.x; HARRIS GJ, 1994, AIDS, V8, P495, DOI 10.1097/00002030-199404000-00012; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Laskus T, 2005, AIDS, V19, pS140, DOI 10.1097/01.aids.0000192083.41561.00; Lee MH, 2010, STROKE, V41, P2894, DOI 10.1161/STROKEAHA.110.598136; Lentz MR, 2009, NEUROLOGY, V72, P1465, DOI 10.1212/WNL.0b013e3181a2e90a; Li CX, 2011, NEUROIMAGE, V58, P286, DOI 10.1016/j.neuroimage.2011.05.068; Liner Kevin J 2nd, 2010, Curr HIV/AIDS Rep, V7, P85, DOI 10.1007/s11904-010-0042-8; Monaco S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/236148; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Rottenberg DA, 1996, J NUCL MED, V37, P1133; Rumboldt Z, 2008, NEUROIMAG CLIN N AM, V18, P85, DOI 10.1016/j.nic.2007.12.006; TALBOT PR, 1994, EUR J NUCL MED, V21, P503; Tanaka M, 1995, Ann Nucl Med, V9, P43; Towgood KJ, 2013, HUM BRAIN MAPP, V34, P2484, DOI 10.1002/hbm.22078; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; Vivithanaporn P, 2012, J NEUROL SCI, V312, P45, DOI 10.1016/j.jns.2011.08.025; von Giesen HJ, 2000, ARCH NEUROL-CHICAGO, V57, P1601, DOI 10.1001/archneur.57.11.1601; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wenserski F, 2003, RADIOLOGY, V228, P185, DOI 10.1148/radiol.2281010683; Zimny A, 2010, MED SCI MONIT S1, V16, P5	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102214	10.1371/journal.pone.0102214	http://dx.doi.org/10.1371/journal.pone.0102214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013963	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400076
J	Heimiller, J; Sridharan, V; Huntley, J; Wesley, CS; Singh, R				Heimiller, Joseph; Sridharan, Vinod; Huntley, Jim; Wesley, Cedric S.; Singh, Ravinder			Drosophila Polypyrimidine Tract-Binding Protein (DmPTB) Regulates Dorso-Ventral Patterning Genes in Embryos	PLOS ONE			English	Article							ALTERNATIVE 3'-SPLICE-SITE SELECTION; IN-VIVO; CELL FATE; NOTCH; RNA; PTB; EXPRESSION; DIFFERENTIATION; COMPLEXES; MORPHOGEN	The Drosophila polypyrimidine tract-binding protein (dmPTB or hephaestus) plays an important role during embryogenesis. A loss of function mutation, heph(03429), results in varied defects in embryonic developmental processes, leading to embryonic lethality. However, the suite of molecular functions that are disrupted in the mutant remains unknown. We have used an unbiased high throughput sequencing approach to identify transcripts that are misregulated in this mutant. Misregulated transcripts show evidence of significantly altered patterns of splicing (exon skipping, 5' and 3' splice site switching), alternative 5' ends, and mRNA level changes (up and down regulation). These findings are independently supported by reverse-transcription-polymerase chain reaction (RT-PCR) analysis and in situ hybridization. We show that a group of genes, such as Zerknullt, z600 and screw are among the most upregulated in the mutant and have been functionally linked to dorso-ventral patterning and/or dorsal closure processes. Thus, loss of dmPTB function results in specific misregulated transcripts, including those that provide the missing link between the loss of dmPTB function and observed developmental defects in embryogenesis. This study provides the first comprehensive repertoire of genes affected in vivo in the heph mutant in Drosophila and offers insight into the role of dmPTB during embryonic development.	[Heimiller, Joseph; Sridharan, Vinod; Singh, Ravinder] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Huntley, Jim] Univ Colorado, BioFrontiers Next Gen Sequencing Facil, Boulder, CO 80309 USA; [Wesley, Cedric S.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wesley, Cedric S.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Singh, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	rsingh@colorado.edu	Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020		University of Colorado Boulder; National Institutes of Health [HD062928]; Butcher Foundation award	University of Colorado Boulder; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Butcher Foundation award	The Butcher Foundation award, Departmental funds (R. S.), and National Institutes of Health - HD062928 (CSW). Article processing charge was funded by the University of Colorado Boulder Libraries Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashburner M, 1989, DROSOPHILA, p2v; Bejsovec A, 2013, MOL REPROD DEV, V80, P882, DOI 10.1002/mrd.22228; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Clerte C, 2006, RNA, V12, P457, DOI 10.1261/rna.2178406; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Cruz C, 2009, GENETICS, V183, P1005, DOI 10.1534/genetics.109.107748; Dansereau DA, 2002, DEVELOPMENT, V129, P5553, DOI 10.1242/dev.00153; Davis MB, 2002, MECH DEVELOP, V111, P143, DOI 10.1016/S0925-4773(01)00595-0; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Kafasla P, 2012, BIOCHEM SOC T, V40, P815, DOI 10.1042/BST20120044; Kankel MW, 2007, GENETICS, V177, P2493, DOI 10.1534/genetics.107.080994; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; LIN CH, 1995, RNA, V1, P234; McDermott SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069978; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Perez I, 1997, RNA, V3, P764; Ratnaparkhi GS, 2006, DEVELOPMENT, V133, P4409, DOI 10.1242/dev.02643; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robida M, 2010, P NATL ACAD SCI USA, V107, P12570, DOI 10.1073/pnas.1007935107; Robida MD, 2003, EMBO J, V22, P2924, DOI 10.1093/emboj/cdg301; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SCHULZ RA, 1989, DEV BIOL, V136, P211, DOI 10.1016/0012-1606(89)90143-7; Shepherd A, 2010, DEV DYNAM, V239, P1220, DOI 10.1002/dvdy.22262; Shepherd AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008063; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Stein D, 1998, DEVELOPMENT, V125, P2159; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Tremmel DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067789; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wesley CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021876; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e98585	10.1371/journal.pone.0098585	http://dx.doi.org/10.1371/journal.pone.0098585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014769	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400003
J	Mabuto, T; Latka, MH; Kuwane, B; Churchyard, GJ; Charalambous, S; Hoffmann, CJ				Mabuto, Tonderai; Latka, Mary H.; Kuwane, Bulelani; Churchyard, Gavin J.; Charalambous, Salome; Hoffmann, Christopher J.			Four Models of HIV Counseling and Testing: Utilization and Test Results in South Africa	PLOS ONE			English	Article							CLUSTER-RANDOMIZED-TRIAL; SERVICES; HOME; INTERVENTION; PREVENTION; MEN; KNOWLEDGE; PROGRAM; LINKAGE; UGANDA	Background: HIV Counseling and Testing (HCT) is the point-of-entry for pathways of HIV care and prevention. However, HCT is not reaching many who are HIV infected and this may be related to the HCT provision model. We describe HCT utilization and HIV diagnosis using four models of HCT delivery: clinic-based, urban mobile, rural mobile, and stand-alone. Methods: Using cross-sectional data from routine HCT provided in South Africa, we described client characteristics and HIV test results from information collected during service delivery between January 2009 and June 2012. Results: 118,358 clients received services at clinic-based units, 18,597; stand-alone, 28,937; urban mobile, 38,840; and rural mobile, 31,984. By unit, clients were similar in terms of median age (range 28-31), but differed in sex distribution, employment status, prior testing, and perceived HIV risk. Urban mobile units had the highest proportion of male clients (52%). Rural mobile units reached the highest proportion of clients with no prior HCT (61%) and reporting no perceived HIV risk (64%). Overall, 10,862 clients (9.3%) tested HIV-positive. Conclusions: Client characteristics varied by HCT model. Importantly, rural and urban mobile units reached more men, first-time testers, and clients who considered themselves to be at low risk for HIV.	[Mabuto, Tonderai; Latka, Mary H.; Kuwane, Bulelani; Churchyard, Gavin J.; Charalambous, Salome; Hoffmann, Christopher J.] Aurum Inst, Johannesburg, South Africa; [Latka, Mary H.; Churchyard, Gavin J.; Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin J.] London Sch Hyg & Trop Med, London WC1, England; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University	Hoffmann, CJ (corresponding author), Aurum Inst, Johannesburg, South Africa.	choffmann@jhmi.edu		Hoffmann, Christopher/0000-0002-9422-0519; Charalambous, Salome/0000-0001-7143-1009; Churchyard, Gavin/0000-0002-4269-3699	PEPFAR [U2GPS000811]; SATBAT [U2RTW007370/3]; National Institutes of Health [K23AI083099]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI083099] Funding Source: NIH RePORTER	PEPFAR; SATBAT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The HIV counseling and testing described in this analysis was supported by a PEPFAR Cooperative Agreement number U2GPS000811. TM was partially supported by SATBAT U2RTW007370/3. CJH was partially supported by a National Institutes of Health grant award K23AI083099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Baral SD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18768; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Doherty T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3481; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Hutchinson PL, 2006, AIDS CARE, V18, P446, DOI 10.1080/09540120500213511; Joint United Nations Programme on HIV/AIDS, 2013, GETT ZER HIV E SO AF; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Kranzer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025244; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marum E, 2012, JAIDS-J ACQ IMM DEF, V60, pS63, DOI 10.1097/QAI.0b013e31825f313b; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Maughan-Brown B, 2014, AIDS BEHAV, V18, P958, DOI 10.1007/s10461-013-0636-4; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Metro Trading Company, 2012, ANN REPORT; Mulogo EM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-54; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Shisana O, 2014, S AFRICAN NATL HIV P; South African National Department of Health, 2010, NAT HIV COUNS TEST P; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; Vu L, 2013, SEX TRANSM INFECT, V89, P659, DOI 10.1136/sextrans-2013-051065; World Health Organization, 2012, SERV DEL APPR HIV TE	33	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102267	10.1371/journal.pone.0102267	http://dx.doi.org/10.1371/journal.pone.0102267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013938	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400083
J	Singer, P; Helic, D; Taraghi, B; Strohmaier, M				Singer, Philipp; Helic, Denis; Taraghi, Behnam; Strohmaier, Markus			Detecting Memory and Structure in Human Navigation Patterns Using Markov Chain Models of Varying Order	PLOS ONE			English	Article							WEB; INFERENCE; USERS	One of the most frequently used models for understanding human navigation on the Web is the Markov chain model, where Web pages are represented as states and hyperlinks as probabilities of navigating from one page to another. Predominantly, human navigation on the Web has been thought to satisfy the memoryless Markov property stating that the next page a user visits only depends on her current page and not on previously visited ones. This idea has found its way in numerous applications such as Google's PageRank algorithm and others. Recently, new studies suggested that human navigation may better be modeled using higher order Markov chain models, i.e., the next page depends on a longer history of past clicks. Yet, this finding is preliminary and does not account for the higher complexity of higher order Markov chain models which is why the memoryless model is still widely used. In this work we thoroughly present a diverse array of advanced inference methods for determining the appropriate Markov chain order. We highlight strengths and weaknesses of each method and apply them for investigating memory and structure of human navigation on the Web. Our experiments reveal that the complexity of higher order models grows faster than their utility, and thus we confirm that the memoryless model represents a quite practical model for human navigation on a page level. However, when we expand our analysis to a topical level, where we abstract away from specific page transitions to transitions between topics, we find that the memoryless assumption is violated and specific regularities can be observed. We report results from experiments with two types of navigational datasets (goal-oriented vs. free form) and observe interesting structural differences that make a strong argument for more contextual studies of human navigation in future work.	[Singer, Philipp; Strohmaier, Markus] GESIS Leibniz Inst Social Sci, Cologne, Germany; [Helic, Denis] Graz Univ Technol, Knowledge Technol Inst, A-8010 Graz, Austria; [Taraghi, Behnam] Graz Univ Technol, Inst Informat Syst & Comp Media, A-8010 Graz, Austria; [Strohmaier, Markus] Univ Koblenz Landau, Inst Web Sci & Technol, Koblenz, Germany	Leibniz Institut fur Sozialwissenschaften (GESIS); Graz University of Technology; Graz University of Technology; University of Koblenz & Landau	Singer, P (corresponding author), GESIS Leibniz Inst Social Sci, Cologne, Germany.	philipp.singer@gesis.org		Helic, Denis/0000-0003-0725-7450	DFG [STR 1191/3-2]; FWF Austrian Science Fund [P24866]	DFG(German Research Foundation (DFG)); FWF Austrian Science Fund(Austrian Science Fund (FWF))	This research was in part funded by the DFG German Science Fund research project "Pragmatics and Semantics in Social Tagging Systems II" (STR 1191/3-2) as well as the FWF Austrian Science Fund research project "Navigability of Decentralized Information Networks" (P24866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson CR, 2001, P 17 INT JOINT C ART, P79; [Anonymous], ENCY COGNITIVE SCI; Baigorri A, 2009, ARXIV09100264; BARTLETT MS, 1951, P CAMB PHILOS SOC, V47, P86, DOI 10.1017/S0305004100026402; Bestavros A., 1995, Proceedings of the 1995 ACM CIKM International Conference on Information and Knowledge Management, P403, DOI 10.1145/221270.221653; Borges J, 2000, LECT NOTES COMPUT SC, V1836, P92; Borges J, 2007, IEEE T KNOWL DATA EN, V19, P441, DOI 10.1109/TKDE.2007.1012; Box George E.P., 2011, BAYESIAN INFERENCE S, V40; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cadez I, 2003, DATA MIN KNOWL DISC, V7, P399, DOI 10.1023/A:1024992613384; CATLEDGE LD, 1995, COMPUT NETWORKS ISDN, V27, P1065, DOI 10.1016/0169-7552(95)00043-7; Chierichetti F, 2012, P 21 INT C WORLD WID; Csiszar I, 2000, ANN STAT, V28, P1601; Deshpande M., 2004, ACM T INTERNET TECHN, V4, P163, DOI DOI 10.1145/990301.990304; Durbin R., 1998, BIOL SEQUENCE ANAL P; GATES P, 1976, J APPL METEOROL, V15, P1145, DOI 10.1175/1520-0450(1976)015<1145:OMCMTS>2.0.CO;2; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; Huberman BA, 1998, NOVELTY SOCIAL SEARC; Huelsenbeck JP, 2007, GENETICS, V175, P1787, DOI 10.1534/genetics.106.061317; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KATZ RW, 1981, TECHNOMETRICS, V23, P243, DOI 10.2307/1267787; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kumar Ravi, 2010, P 19 INT C WORLD WID, P561, DOI DOI 10.1145/1772690.1772748; Lempel R, 2000, COMPUT NETW, V33, P387, DOI 10.1016/S1389-1286(00)00034-7; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; MacKay D.J.C., 1992, THESIS CALTECH; MacKay D. J. C., 2003, INFORM THEORY INFERE; Morrison DE, 2006, SIGNIFICANCE TEST CO; Murray I, 2005, NOTE EVIDENCE BAYESI; Perkowitz M, 1997, INT JOINT CONF ARTIF, P16; Pirolli P. L. T., 1999, World Wide Web, V2, P29, DOI 10.1023/A:1019288403823; Pitkow J, 1999, P 2 C USENIX S INT T, V2; Rendle S., 2010, P 19 INT C WORLD WID, P811, DOI DOI 10.1145/1772690.1772773; Rosvall M, 2013, ARXIV13054807; Royall R., 1997, STAT EVIDENCE LIKELI, V71; Sarukkai RR, 2000, COMPUT NETW, V33, P377, DOI 10.1016/S1389-1286(00)00044-X; Scaria AT, 2014, LAST CLICK WHY USERS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sen R, 2003, J COMPUT GRAPH STAT, V12, P143, DOI 10.1198/1061860031275; Singer P, 2014, PATH TOOLS, DOI [10.5281/zenodo.10229, DOI 10.5281/ZENODO.10229]; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Stigler S.M., 2002, STAT TABLE HIST STAT; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Strelioff CC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011106; TONG H, 1975, J APPL PROBAB, V12, P488, DOI 10.2307/3212863; Wang C, 2012, SCI REPORTS; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; West R., 2012, WWW, P619, DOI DOI 10.1145/2187836.2187920; West R, 2012, ICWSM; West R, 2009, 21ST INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-09), PROCEEDINGS, P1598; Xing DS, 2004, INFORM SOFTWARE TECH, V46, P55, DOI 10.1016/S0950-5849(03)00109-5; Zukerman I, 1999, CISM COURSES LECT, P275	55	48	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102070	10.1371/journal.pone.0102070	http://dx.doi.org/10.1371/journal.pone.0102070			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013937	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400062
J	Floderer, M; Prchal-Murphy, M; Vizzardelli, C				Floderer, Melanie; Prchal-Murphy, Michaela; Vizzardelli, Caterina			Dendritic Cell-Secreted Lipocalin2 Induces CD8(+) T-Cell Apoptosis, Contributes to T-Cell Priming and Leads to a T(H)1 Phenotype	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-PHASE PROTEIN; IMMUNE-RESPONSES; INDOLEAMINE 2,3-DIOXYGENASE; CANCER; ACTIVATION; IRON; IMMUNOTHERAPY; SUPPRESSION; EXPRESSION	Lipocalin 2 (LCN2), which is highly expressed by dendritic cells (DCs) when treated with dexamethasone (Dex) and lipopolysaccharide (LPS), plays a key role in the defence against bacteria and is also involved in the autocrine apoptosis of T-cells. However, the function of LCN2 when secreted by DCs is unknown: this is a critical gap in our understanding of the regulation of innate and adaptive immune systems. Tolerance, stimulation and suppression are functions of DCs that facilitate the fine-tuning of the immune responses and which are possibly influenced by LCN2 secretion. We therefore examined the role of LCN2 in DC/T-cell interaction. WT or Lcn2(-/-) bone marrow-derived DCs were stimulated with LPS or LPS+IFN-gamma with and without Dex and subsequently co-cultured with T-cells from ovalbumin-specific TCR transgenic (OT-I and OT-II) mice. We found that CD8(+) T-cell apoptosis was highly reduced when Lcn2(-/-) DCs were compared with WT. An in vivo CTL assay, using LPS-treated DCs, showed diminished killing ability in mice that had received Lcn2(-/-) DCs compared with WT DCs. As a consequence, we analysed T-cell proliferation and found that LCN2 participates in T-cell-priming in a dose-dependent manner and promotes a T(H)1 microenvironment. DC-secreted LCN2, whose function has previously been unknown, may in fact have an important role in regulating the balance between T(H)1 and T(H)2. Our results yield insights into DC-secreted LCN2 activity, which could play a pivotal role in cellular immune therapy and in regulating immune responses.	[Floderer, Melanie; Vizzardelli, Caterina] St Anna Childrens Canc Res Inst, Lab Tumour Immunol, Vienna, Austria; [Prchal-Murphy, Michaela] Univ Vet Med Vienna, Dept Biomed Sci, Inst Pharmacol & Toxicol, Vienna, Austria	Saint Anna Children's Hospital; University of Veterinary Medicine Vienna	Vizzardelli, C (corresponding author), St Anna Childrens Canc Res Inst, Lab Tumour Immunol, Vienna, Austria.	caterina.vizzardelli@ccri.at		Vizzardelli, Caterina/0000-0001-9262-6710	St. Anna Kinderkrebsforschung	St. Anna Kinderkrebsforschung	This work was supported by St. Anna Kinderkrebsforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2009, J LEUKOCYTE BIOL, V85, P243, DOI 10.1189/jlb.0608374; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer M, 1999, IMMUNOLOGY, V97, P699, DOI 10.1046/j.1365-2567.1999.00811.x; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Devireddy LR, CELL, V141, P1006; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Felzmann T, 2005, CANCER IMMUNOL IMMUN, V54, P769, DOI 10.1007/s00262-004-0637-2; Felzmann T, 2002, ONKOLOGIE, V25, P456, DOI 10.1159/000067441; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Granucci F, 2008, CELL MOL LIFE SCI, V65, P1683, DOI 10.1007/s00018-008-8009-2; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harden JL, 2012, IMMUNOL INVEST, V41, P738, DOI 10.3109/08820139.2012.676122; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Huttner KG, 2005, CANCER IMMUNOL IMMUN, V54, P67, DOI 10.1007/s00262-004-0571-3; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; Luger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054879; Matyszak MK, 2000, EUR J IMMUNOL, V30, P1233, DOI 10.1002/(SICI)1521-4141(200004)30:4<1233::AID-IMMU1233>3.0.CO;2-F; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nava S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052301; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; Reilly PT, 2013, ONCOGENE, V32, P1233, DOI 10.1038/onc.2012.159; Ryon J, 2002, BIOCHEM J, V367, P271, DOI 10.1042/BJ20020026; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Volchenkov R, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4294; von Bergwelt-Baildon MS, 2006, BLOOD, V108, P228, DOI 10.1182/blood-2005-08-3507; Warszawska JM, 2013, J CLIN INVEST, V123, P3363, DOI 10.1172/JCI67911; Yacoub Mona-Rita, 2012, Inflammation & Allergy Drug Targets, V11, P285; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhou F, 2013, IMMUNOL RES; Zhou F, 2012, EUR J IMMUNOL, V42, P1449, DOI 10.1002/eji.201141733; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175	55	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101881	10.1371/journal.pone.0101881	http://dx.doi.org/10.1371/journal.pone.0101881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010215	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800049
J	Wolny, E; Braszewska-Zalewska, A; Hasterok, R				Wolny, Elzbieta; Braszewska-Zalewska, Agnieszka; Hasterok, Robert			Spatial Distribution of Epigenetic Modifications in Brachypodium distachyon Embryos during Seed Maturation and Germination	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; REPETITIVE ELEMENTS; DNA HYPOMETHYLATION; CHROMATIN; DORMANCY; HETEROCHROMATIN; ENDOSPERM; DEMETHYLATION; ESTABLISHMENT	Seed development involves a plethora of spatially and temporally synchronised genetic and epigenetic processes. Although it has been shown that epigenetic mechanisms, such as DNA methylation and chromatin remodelling, act on a large number of genes during seed development and germination, to date the global levels of histone modifications have not been studied in a tissue-specific manner in plant embryos. In this study we analysed the distribution of three epigenetic markers, i.e. H4K5ac, H3K4me2 and H3K4me1 in 'matured', 'dry' and 'germinating' embryos of a model grass, Brachypodium distachyon (Brachypodium). Our results indicate that the abundance of these modifications differs considerably in various organs and tissues of the three types of Brachypodium embryos. Embryos from matured seeds were characterised by the highest level of H4K5ac in RAM and epithelial cells of the scutellum, whereas this modification was not observed in the coleorhiza. In this type of embryos H3K4me2 was most evident in epithelial cells of the scutellum. In 'dry' embryos H4K5ac was highest in the coleorhiza but was not present in the nuclei of the scutellum. H3K4me1 was the most elevated in the coleoptile but absent from the coleorhiza, whereas H3K4me2 was the most prominent in leaf primordia and RAM. In embryos from germinating seeds H4K5ac was the most evident in the scutellum but not present in the coleoptile, similarly H3K4me1 was the highest in the scutellum and very low in the coleoptile, while the highest level of H3K4me2 was observed in the coleoptile and the lowest in the coleorhiza. The distinct patterns of epigenetic modifications that were observed may be involved in the switch of the gene expression profiles in specific organs of the developing embryo and may be linked with the physiological changes that accompany seed desiccation, imbibition and germination.	[Wolny, Elzbieta; Braszewska-Zalewska, Agnieszka; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Hasterok, R (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	robert.hasterok@us.edu.pl	Hasterok, Robert/A-1629-2008	Wolny, Elzbieta/0000-0001-7588-4830; Braszewska, Agnieszka/0000-0003-0997-8753; Hasterok, Robert/0000-0001-6667-2721	Polish National Science Centre [2012/04/A/NZ3/00572, 2011/01/B/NZ3/00177]	Polish National Science Centre	The authors acknowledge financial support from the Polish National Science Centre (grants no. 2012/04/A/NZ3/00572 and 2011/01/B/NZ3/00177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriotis VME, 2010, NEW PHYTOL, V187, P791, DOI 10.1111/j.1469-8137.2010.03311.x; Angelovici R, 2010, TRENDS PLANT SCI, V15, P211, DOI 10.1016/j.tplants.2010.01.003; Ariizumi T, 2013, PLANT PHYSIOL, V162, P2125, DOI 10.1104/pp.113.219451; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Benoit M, 2013, GENE, V526, P39, DOI 10.1016/j.gene.2013.01.060; Bentsink Leonie, 2008, Arabidopsis Book, V6, pe0119, DOI 10.1199/tab.0119; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BINO RJ, 1993, ANN BOT-LONDON, V72, P181, DOI 10.1006/anbo.1993.1097; Braszewska-Zalewska A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26711; Braszewska-Zalewska A, 2012, GENOME, V55, P68, DOI [10.1139/G11-076, 10.1139/g11-076]; Braszewska-Zalewska A, 2010, GENOME, V53, P203, DOI [10.1139/g09-088, 10.1139/G09-088]; Braszewska-Zalewska AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069204; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; COMAI L, 1990, P NATL ACAD SCI USA, V87, P2671, DOI 10.1073/pnas.87.7.2671; DELTOUR R, 1985, J CELL SCI, V75, P43; Douet J, 2008, PLANT CELL PHYSIOL, V49, P1783, DOI 10.1093/pcp/pcn152; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fischer C, 1996, PLANT J, V9, P659, DOI 10.1046/j.1365-313X.1996.9050659.x; Fischer-Iglesias C, 2001, PLANT J, V26, P115, DOI 10.1046/j.1365-313x.2001.01013.x; Fransz P, 2011, PLANT J, V66, P4, DOI 10.1111/j.1365-313X.2011.04526.x; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Guillon F, 2012, J EXP BOT, V63, P739, DOI 10.1093/jxb/err298; Guillon F, 2011, J EXP BOT, V62, P1001, DOI 10.1093/jxb/erq332; Gutierrez L, 2007, TRENDS PLANT SCI, V12, P294, DOI 10.1016/j.tplants.2007.06.003; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Hsieh TF, 2005, ANNU REV PLANT BIOL, V56, P327, DOI 10.1146/annurev.arplant.56.032604.144118; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kapazoglou A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-172; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Lauria M, 2004, PLANT CELL, V16, P510, DOI 10.1105/tpc.017780; Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Mathieu O, 2003, PLANT CELL, V15, P2929, DOI 10.1105/tpc.017467; Muller K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051532; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; North H, 2010, PLANT J, V61, P971, DOI 10.1111/j.1365-313X.2009.04095.x; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Opanowicz M, 2011, J EXP BOT, V62, P735, DOI 10.1093/jxb/erq309; Osborne DJ, 2002, DESICCATION SURVIVAL, P350; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; STEEDMAN HF, 1957, NATURE, V179, P1345, DOI 10.1038/1791345a0; Tessadori F, 2007, J CELL SCI, V120, P1200, DOI 10.1242/jcs.000026; Tessadori F, 2007, PLANT J, V50, P848, DOI 10.1111/j.1365-313X.2007.03093.x; Tessadori F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000638; van Zanten M, 2013, EPIGENETIC MEMORY CO, P261; van Zanten M, 2012, PLANT SIGNAL BEHAV, V7, P338, DOI 10.4161/psb.19281; van Zanten M, 2011, P NATL ACAD SCI USA, V108, P20219, DOI 10.1073/pnas.1117726108; Vicente-Carbajosa J, 2005, INT J DEV BIOL, V49, P645, DOI 10.1387/ijdb.052046jc; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang H, 2009, MOL PLANT, V2, P610, DOI 10.1093/mp/ssp027; Zhang L, 2012, PLANT MOL BIOL, V79, P285, DOI 10.1007/s11103-012-9912-3; Zhang L, 2011, PHYSIOL PLANTARUM, V143, P287, DOI 10.1111/j.1399-3054.2011.01496.x; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zheng J, 2012, NEW PHYTOL, V193, P605, DOI 10.1111/j.1469-8137.2011.03969.x	66	17	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101246	10.1371/journal.pone.0101246	http://dx.doi.org/10.1371/journal.pone.0101246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006668	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600032
J	Le Goff, G; Goodman, SM; Elguero, E; Robert, V				Le Goff, Gilbert; Goodman, Steven M.; Elguero, Eric; Robert, Vincent			Survey of the Mosquitoes (Diptera: Culicidae) of Mayotte	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; INDIAN-OCEAN; COMOROS ARCHIPELAGO; MALARIA VECTOR; ISLAND; IDENTIFICATION; BIODIVERSITY; REUNION; EPIDEMIOLOGY; TRANSMISSION	A transversal survey of immature mosquitoes was conducted on Mayotte Island (France) in the Comoros Archipelago, western Indian Ocean, with the aim to inventory the Culicidae and to document inter-species relationships in different habitats. In total 420 habitats were sampled for larvae and/or pupae mosquitoes, resulting in more than 6,000 specimens. Forty species belonging to 15 genera were collected, with eight taxa integrated for the first time to the Mayotte mosquito list. The most frequently recorded species were Stegomyia aegypti, St. albopicta, Anopheles gambiae and Eretmapodites subsimplicipes, the first three species being known vectors of viruses and parasites transmitted to humans. Mean species richness in habitats ranged from 1.00 to 3.29, with notable differences between habitats. For example, water-filled axils of banana leaves, tree-holes and crab-holes had low species richness, while cut bamboo, water pools, abandoned tires and marsh and swamp water had notably higher species richness. Twenty-seven mosquito species belonging to 12 genera were routinely collected (in >= 20% of at least one type of larval habitat) suggesting that multiple species play a role in the biocenosis of these aquatic habitats. Multispecies association was observed in 52% of the habitats. The co-occurrence of up to six species belonging to five genera was recorded in a single habitat. The mosquitoes of Mayotte show notable biogeographical affinities to those of Madagascar, as compared to the African continent. These two potential source areas are nearly equidistant from Mayotte, which in turn indicates biased dispersal from east to west. Our findings suggest that with relatively short-term intensive sampling in different habitats, it is possible to approach exhaustive species inventories based on collection of larvae. Mayotte, with its modest elevation range and land surface, has a notable species richness of mosquitoes with 45 well-documented species belonging to 15 genera.	[Le Goff, Gilbert; Elguero, Eric; Robert, Vincent] Univ Montpellier, Inst Rech Dev, CNRS 5290, IRD 224, F-34059 Montpellier, France; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Field Museum of Natural History (Chicago)	Robert, V (corresponding author), Univ Montpellier, Inst Rech Dev, CNRS 5290, IRD 224, F-34059 Montpellier, France.	vincent.robert@ird.fr		ROBERT, Vincent/0000-0003-1738-1842; Le Goff, Gilbert/0000-0001-9913-8736	Institut de Recherche pour le Developpement (IRD); Agence Regionale de Sante-Ocean Indien	Institut de Recherche pour le Developpement (IRD); Agence Regionale de Sante-Ocean Indien	Funding for this work was provided by the Institut de Recherche pour le Developpement (IRD) and Agence Regionale de Sante-Ocean Indien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TYP ECH COMM ENTR MA; Ayala D, 2006, ACTA TROP, V97, P292, DOI 10.1016/j.actatropica.2005.12.002; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Basset Y, 2001, PLANT ECOL, V153, P87, DOI 10.1023/A:1017581406101; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; BOISIER P, 1994, ANN SOC BELG MED TR, V74, P217; Bousses P., 2013, Bulletin de la Societe de Pathologie Exotique, V106, P113, DOI 10.1007/s13149-013-0288-7; Brunhes J, 1997, ANN SOC ENTOMOL FR, V33, P173; BRUNHES J, 1978, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V109, P193; BRUNHES J, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P131; BRUNHES J, 1971, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V9, P335; BRUNHES J, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P153; Brunhes J, 1995, FAUNE MADAGASCAR, V85; BRYGOO E. R., 1955, BULL SOC PATHOL EXOT, V48, P833; Carpentier M, 2006, UNIVERS MAORE, V5, P28; Chauvet G, 1967, MISSION ENTOMOLOGIQU; Clements A. N., 1992, BIOL MOSQUITOES, V1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; da Cunha Ramos H, 2004, FAUNE MADAGASCAR, V91; DAVIDSON G, 1964, Riv Malariol, V43, P167; DIAMOND JM, 1985, NATURE, V315, P538, DOI 10.1038/315538a0; Didham RK, 2013, INSECT CONSERV DIVER, V6, P1, DOI 10.1111/icad.12022; Edwards F. W., 1920, Bulletin of Entomological Research London, V11, DOI 10.1017/S0007485300044539; Edwards F. W., 1935, Bull cnt Res London, V26, P127, DOI 10.1017/S0007485300038116; Edwards FW, 1912, B ENTOMOL RES, V3, P1; Elissa N, 2005, J AM MOSQUITO CONTR, V21, P472, DOI 10.2987/8756-971X(2006)21[472:ROAFAI]2.0.CO;2; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Erwin T.L., 1983, Bulletin of the Entomological Society of America, V29, P14; Erwin T. L., 1983, Tropical rain forest: ecology and management. Special Publication Number 2 of the British Ecological Society, P59; Fattorini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062118; Garcia FH, 2012, ZOOTAXA, P1; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; Gillies MT, 1987, FAUNE MADAGASCAR; GILLOT PY, 1994, EARTH PLANET SC LETT, V122, P291, DOI 10.1016/0012-821X(94)90003-5; Girod R, 2004, PARASITE, V11, P74; Goodman SM, 2010, ACTA CHIROPTEROL, V12, P117, DOI 10.3161/150811010X504635; Greenacre M., 2007, CORRES ANAL PRACTICE; Grjebine A., 1956, Naturaliste Malgache Tananarive, V8, P160; Grjebine A, 1966, FAUNE MADAGASCAR; Hamilton AJ, 2013, OECOLOGIA, V171, P357, DOI 10.1007/s00442-012-2434-5; HARBACH R E, 1981, Mosquito Systematics, V13, P201; Harbach R.E., 1980, TAXONOMISTS GLOSSARY; Harbach RE, 2014, MOSQUITO TAXONOMIC I; Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, V2nd; HUANG Y-M, 1979, Mosquito Systematics, V11, P221; Huang YM, 2004, ZOOTAXA, P1; HUNT RH, 1986, J MED ENTOMOL, V23, P655, DOI 10.1093/jmedent/23.6.655; INSEE, 2012, INSEE MAYOTTE INFOS, V61, P1; Janzen D. H., 2000, Biodiversity, V1, P7; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Janzen DH, 1996, ASC NEWSLETTER, V24, P49; Johanson KA, 2009, ZOOTAXA, P1; JULVEZ J, 1987, B SOC PATHOL EXOT, V80, P505; JULVEZ J, 1994, ANN SOC ENTOMOL FR, V30, P391; Julvez J, 1998, B SOC PATHOL EXOT, V91, P99; Julvez L, 1988, B SOC PATHOL EXOT, V81, P847; Jury MR., 2003, NATURAL HIST MADAGAS, P75; LAVERGNE J., 1950, Revue Coloniale de Medecine et de Chirurgie, V22, P134; Le Goff G, 2013, PARASITE, V20, DOI 10.1051/parasite/2013030; Le Goff G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-207; Leong PTJM, 2003, PARASITE, V10, P273, DOI 10.1051/parasite/2003103273; Leponce Maurice, 2010, Abc Taxa, V8, P18; Lernout T, 2011, East Afr J Public Health, V8, P155; Louette M, 1999, ANN SCI ZOOLOGIQUES, V284, P1; LOUNIBOS LP, 1980, B ENTOMOL RES, V70, P309, DOI 10.1017/S0007485300007598; Lourenco Wilson R., 2009, Boletin de la SEA, V44, P35; Marsden CD, 2013, EVOL APPL, V6, P706, DOI 10.1111/eva.12056; Mattingly P. F., 1955, Bulletin of Entomological Research London, V46, P69, DOI 10.1017/S0007485300030777; MCCARTHY D. D., 1943, East African Medical Journal, V20, P293; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Nichols BJ, 2007, SOUTHEAST NAT, V6, P27, DOI 10.1656/1528-7092(2007)6[27:TSATBI]2.0.CO;2; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; PAULIAN RENAUD, 1964, BULL SOC ENTOMOL FRANCE, V69, P167; PETRARCA V, 1990, Parassitologia (Rome), V32, P371; Randrianambinintsoa FJ, 2013, PARASITE, V20, DOI 10.1051/parasite/2013005; Receveur M C, 2004, Bull Soc Pathol Exot, V97, P265; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; Reinert JF, 2009, EUROPEAN MOSQUITO B, P68; Reinert John F., 1999, Contributions of the American Entomological Institute, V31, P1; Renault P, 2012, MED MALADIES INFECT, V42, P93, DOI 10.1016/j.medmal.2011.12.002; Robert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-31; Rocha S, 2005, BELG J ZOOL, V135, P39; SABATINELLI G, 1994, PARASITE, V1, P71, DOI 10.1051/parasite/1994011071; Sabatinelli G., 1988, Parassitologia (Rome), V30, P178; Sabatinelli G., 1988, Parassitologia (Rome), V30, P176; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service M, 1993, MOSQUITO ECOLOGY FIE; Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018; Sissoko D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014141; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; SUBRA R, 1975, TROPENMED PARASITOL, V26, P48; Subra R, 1973, CAHIER ORSTOM, V11, P225; Theobald FV, 1910, MONOGRAPH CULICIDAE, VV; Theobald FV, 1911, NOVAE CULICIDAE 1, P9; Tsy JMLP, 2003, MALARIA J, V2; Ventrillon E., 1905, Archives de Parasitologie, Vix, P441; Ventrillon E, 1906, B MUS HIST NAT BELG, V11, P427; Yoshimura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033325; Zeller HG, 1998, B SOC PATHOL EXOT, V91, P56	102	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100696	10.1371/journal.pone.0100696	http://dx.doi.org/10.1371/journal.pone.0100696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004163	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700011
J	Pouplin, T; Phuong, PN; Toi, PV; Pouplin, JN; Farrar, J				Pouplin, Thomas; Pham Nguyen Phuong; Pham Van Toi; Julie Nguyen Pouplin; Farrar, Jeremy			Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets	PLOS ONE			English	Article							TUBERCULOSIS; CHILDREN; PHARMACOKINETICS; BIOAVAILABILITY	Setting: In most developing countries, paediatric tuberculosis is treated with split tablets leading to potential inaccuracy in the dose delivery and drug exposure. There is no data on the quality of first-line drugs content in split fixed-dose combination tablets. Objective: To determine Isoniazid, Pyrazinamide and Rifampicin content uniformity in split FDC tablets used in the treatment of childhood tuberculosis. Design: Drug contents of 15 whole tablets, 30 half tablets and 36 third tablets were analysed by high performance liquid chromatography. The content uniformity was assessed by comparing drug content measured in split portions with their expected amounts and the quality of split portions was assessed applying qualitative specifications for whole tablets. Results: All whole tablets measurements fell into the USP proxy for the three drugs. But a significant number of half and third portions was found outside the tolerated variation range and the split formulation failed the requirements for content uniformity. To correct for the inaccuracy of splitting the tablets into equal portions, a weight-adjustment strategy was used but this did not improve the findings. Conclusion: In split tablets the content of the three drugs is non-uniform and exceeded the USP recommendations. There is an absolute need to make child-friendly formulations available for the treatment of childhood tuberculosis.	[Pouplin, Thomas; Pham Nguyen Phuong; Pham Van Toi; Julie Nguyen Pouplin] Mahidol Univ, Fac Trop Med, Mahidol Univ Oxford Trop Med Res Programme, Bangkok, Thailand; [Farrar, Jeremy] Wellcome Trust Major Overseas Programme, Oxford Univ Clin Res Unit Vietnam, Ctr Trop Med, Ho Chi Minh City, Vietnam; [Pouplin, Thomas; Farrar, Jeremy] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England	Mahidol University; University of Oxford	Pouplin, T (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Univ Oxford Trop Med Res Programme, Bangkok, Thailand.	thomas@tropmedres.ac	Farrar, Jeremy J./HGA-7610-2022	PHAM VAN, TOI/0000-0002-6496-5464; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust Major Oversea Program, Vietnam [089276/B/09/Z]	Wellcome Trust Major Oversea Program, Vietnam	This work was supported by the Wellcome Trust Major Oversea Program, Vietnam (Grant 089276/B/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MON 905 UNIFORMITY D, V905; Donald PR, 2007, INT J TUBERC LUNG D, V11, P1162; Donald PR, 2011, TUBERCULOSIS, V91, P196, DOI 10.1016/j.tube.2011.02.004; Ellard GA, 1999, INT J TUBERC LUNG D, V3, pS301; Enarson PM, 2005, INT J TUBERC LUNG D, V9, P727; European Medicines Agency, 2008, ICH Q4B ANN 6 UN DOS; Graham SM, 2006, ANTIMICROB AGENTS CH, V50, P407, DOI 10.1128/AAC.50.2.407-413.2006; Graham SM, 2011, PAEDIATR RESPIR REV, V12, P22, DOI 10.1016/j.prrv.2010.09.005; Hill SW, 2009, J MANAGE CARE PHARM, V15, P253, DOI 10.18553/jmcp.2009.15.3.253; KOUP JR, 1986, THER DRUG MONIT, V8, P17, DOI 10.1097/00007691-198603000-00004; Nahirya-Ntege P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036186; Schaaf HS, 2005, ARCH DIS CHILD, V90, P614, DOI 10.1136/adc.2004.052175; Singh S, 2001, INT J PHARMACEUT, V228, P5, DOI 10.1016/S0378-5173(01)00754-2; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Thee S, 2009, INT J TUBERC LUNG D, V13, P1106; UNICEF/WHO, 2010, SOURC PRIC SEL MED C	16	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102047	10.1371/journal.pone.0102047	http://dx.doi.org/10.1371/journal.pone.0102047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004128	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700101
J	Xiang, XC; Deng, L; Zhang, JL; Zhang, XD; Lei, TJ; Luan, GX; Yang, CL; Xiao, ZX; Li, Q; Li, QT				Xiang, Xiaocong; Deng, Li; Zhang, Jingli; Zhang, Xudong; Lei, Tingjun; Luan, Guangxin; Yang, Chunlei; Xiao, Zhi-Xiong; Li, Qian; Li, Qintong			A Distinct Expression Pattern of Cyclin K in Mammalian Testes Suggests a Functional Role in Spermatogenesis	PLOS ONE			English	Article							RNA-POLYMERASE-II; CELL SELF-RENEWAL; EMBRYONIC STEM-CELLS; TERMINAL DOMAIN; IN-VIVO; KINASE; PLURIPOTENCY; TRANSCRIPTION; GERMLINE; CDK9	Germ cell and embryonic stem cells are inextricably linked in many aspects. Remarkably both can generate all somatic cell types in organisms. Yet the molecular regulation accounting for these similarities is not fully understood. Cyclin K was previously thought to associate with CDK9 to regulate gene expression. However, we and others have recently shown that its cognate interacting partners are CDK12 and CDK13 in mammalian cells. We further demonstrated that cyclin K is essential for embryonic stem cell maintenance. In this study, we examined the expression of cyclin K in various murine and human tissues. We found that cyclin K is highly expressed in mammalian testes in a developmentally regulated manner. During neonatal spermatogenesis, cyclin K is highly expressed in gonocytes and spermatogonial stem cells. In adult testes, cyclin K can be detected in spermatogonial stem cells but is absent in differentiating spermatogonia, spermatids and spermatozoa. Interestingly, the strongest expression of cyclin K is detected in primary spermatocytes. In addition, we found that cyclin K is highly expressed in human testicular cancers. Knockdown of cyclin K in a testicular cancer cell line markedly reduces cell proliferation. Collectively, we suggest that cyclin K may be a novel molecular link between germ cell development, cancer development and embryonic stem cell maintenance.	[Xiang, Xiaocong; Deng, Li; Zhang, Xudong; Lei, Tingjun; Luan, Guangxin; Yang, Chunlei; Xiao, Zhi-Xiong; Li, Qintong] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China; [Xiang, Xiaocong; Deng, Li; Zhang, Xudong; Lei, Tingjun; Luan, Guangxin; Yang, Chunlei; Xiao, Zhi-Xiong; Li, Qintong] Sichuan Univ, Coll Life Sci, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Jingli; Li, Qian] 363 Hosp, Aviat Ind Corp China, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Aviation Industry Corporation of China (AVIC)	Li, QT (corresponding author), Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Ctr Growth Metab & Aging, Chengdu 610064, Sichuan, Peoples R China.	liqintong@scu.edu.cn		Li, Qintong/0000-0002-8447-9770	National Basic Research Program of China/973 [2011CB504200, 2012CB910700]; National Natural Science Foundation of China [31171260, 81261120399, 81330054, J1103518]; Science and Technology Department of Sichuan Province [2013JQ0041]	National Basic Research Program of China/973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan Province	Financial support is provided by grants from the National Basic Research Program of China/973 (2011CB504200 and 2012CB910700), the National Natural Science Foundation of China (31171260, 81261120399, 81330054, and J1103518), and the Science and Technology Department of Sichuan Province (2013JQ0041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Dai Q, 2012, J BIOL CHEM, V287, P25344, DOI 10.1074/jbc.M111.321760; De Rooij DG, 2000, J ANDROL, V21, P776; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanatsu-Shinohara M, 2013, ANNU REV CELL DEV BI, V29, P163, DOI 10.1146/annurev-cellbio-101512-122353; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Ko TK, 2001, J CELL SCI, V114, P2591; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Leitch HG, 2013, DEVELOPMENT, V140, P2495, DOI 10.1242/dev.091603; Leroy X, 2002, J HISTOCHEM CYTOCHEM, V50, P283, DOI 10.1177/002215540205000216; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singh SR, 2011, J CELL MOL MED, V15, P468, DOI 10.1111/j.1582-4934.2010.01242.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	34	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101539	10.1371/journal.pone.0101539	http://dx.doi.org/10.1371/journal.pone.0101539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004108	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700037
J	Ryu, J; Kaul, Z; Yoon, AR; Liu, Y; Yaguchi, T; Na, Y; Ahn, HM; Gao, R; Choi, IK; Yun, CO; Kaul, SC; Wadhwa, R				Ryu, Jihoon; Kaul, Zeenia; Yoon, A-Rum; Liu, Ye; Yaguchi, Tomoko; Na, Youjin; Ahn, Hyo Min; Gao, Ran; Choi, Il-Kyu; Yun, Chae-Ok; Kaul, Sunil C.; Wadhwa, Renu			Identification and Functional Characterization of Nuclear Mortalin in Human Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; TUMOR-SUPPRESSOR P53; HNRNP K-PROTEIN; HSP70 FAMILY; CANCER-CELLS; CYTOPLASMIC SEQUESTRATION; GLUCOSE DEPRIVATION; PARKINSONS-DISEASE; COLORECTAL-CANCER; LEUKEMIA-CELLS	The Hsp70 family protein mortalin is an essential chaperone that is frequently enriched in cancer cells and exists in various subcellular sites, including the mitochondrion, plasma membrane, endoplasmic reticulum, and cytosol. Although the molecular mechanisms underlying its multiple subcellular localizations are not yet clear, their functional significance has been revealed by several studies. In this study, we examined the nuclear fractions of human cells and found that the malignantly transformed cells have more mortalin than the normal cells. We then generated a mortalin mutant that lacked a mitochondrial targeting signal peptide. It was largely localized in the nucleus, and, hence, is called nuclear mortalin (mot-N). Functional characterization of mot-N revealed that it efficiently protects cancer cells against endogenous and exogenous oxidative stress. Furthermore, compared with the full-length mortalin overexpressing cancer cells, mot-N derivatives showed increased malignant properties, including higher proliferation rate, colony forming efficacy, motility, and tumor forming capacity both in in vitro and in vivo assays. We demonstrate that mot-N promotes carcinogenesis and cancer cell metastasis by inactivation of tumor suppressor protein p53 functions and by interaction and functional activation of telomerase and heterogeneous ribonucleoprotein K (hnRNP-K) proteins.	[Ryu, Jihoon; Kaul, Zeenia; Liu, Ye; Yaguchi, Tomoko; Ahn, Hyo Min; Gao, Ran; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan; [Ryu, Jihoon; Kaul, Zeenia; Liu, Ye; Yaguchi, Tomoko; Ahn, Hyo Min; Gao, Ran; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Dept Biotechnol DBT, Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan; [Ryu, Jihoon; Yoon, A-Rum; Na, Youjin; Ahn, Hyo Min; Choi, Il-Kyu; Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Kaul, Zeenia] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Hanyang University; University System of Ohio; Ohio State University	Yun, CO (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, 222 Wangsimni Ro, Seoul 133791, South Korea.	chaeok@hanyang.ac.kr; s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Yun, Chae-Ok/P-3698-2015; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; Gao, Ran/0000-0001-8712-429X; Liu, Ye/0000-0002-4845-6643; Yun, Chae-Ok/0000-0002-9466-4531	Japanese Society for the Promotion of Science, Japan; Ministry of Knowledge Economy [10030051]; Korea Science Engineering Foundation [2010-0029220, 2013K1A1A2A02050188, 2013M3A9D3045879]	Japanese Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by grants-in-aid for scientific research (Kakenhi) from the Japanese Society for the Promotion of Science, Japan (to S. C. K.); by Ministry of Knowledge Economy Grant 10030051 (to C.-O. Y.); and by Korea Science Engineering Foundation Grants 2010-0029220, 2013K1A1A2A02050188, and 2013M3A9D3045879 (to C.-O. Y.).	Ando K, 2014, GASTRIC CANCER, V17, P255, DOI 10.1007/s10120-013-0279-1; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Chen J, 2014, INT J ONCOL, V44, P247, DOI 10.3892/ijo.2013.2161; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Flachbartova Z, 2013, ACTA VIROL, V57, P2, DOI 10.4149/av_2013_01_3; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Gestl EE, 2012, BIOCHEM BIOPH RES CO, V423, P411, DOI 10.1016/j.bbrc.2012.05.139; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; He ZY, 2010, WORLD J GASTROENTERO, V16, P4670, DOI 10.3748/wjg.v16.i37.4670; Hope NR, 2011, HUM PATHOL, V42, P393, DOI 10.1016/j.humpath.2010.08.006; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kaul SC, 1998, ONCOGENE, V17, P907, DOI 10.1038/sj.onc.1202017; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Li Hong-Yan, 2011, Shengli Xuebao, V63, P69; Li LP, 2011, PROTEOMICS, V11, P429, DOI 10.1002/pmic.200900819; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Mizukoshi E, 2001, BIOCHEM BIOPH RES CO, V280, P1203, DOI 10.1006/bbrc.2001.4225; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostrowski J, 2003, BRIT J CANCER, V89, P1493, DOI 10.1038/sj.bjc.6601250; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; Papanikolaou V, 2009, INT J ONCOL, V35, P1141, DOI 10.3892/ijo_00000430; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Pilzer D, 2010, INT J CANCER, V126, P1428, DOI 10.1002/ijc.24888; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Rozenberg P, 2013, INT J CANCER, V133, P514, DOI 10.1002/ijc.28029; Sataranatarajan K, 2008, CELL SIGNAL, V20, P969, DOI 10.1016/j.cellsig.2008.01.016; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2002, CANCER RES, V62, P4434; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wu PK, 2013, MOL CELL BIOL, V33, P4051, DOI 10.1128/MCB.00021-13; Xu J, 1999, ONCOL RES, V11, P429; Yang L, 2011, J MOL BIOL, V414, P654, DOI 10.1016/j.jmb.2011.09.009; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Yoo JY, 2010, J GENE MED, V12, P586, DOI 10.1002/jgm.1471	50	44	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24832	24844		10.1074/jbc.M114.565929	http://dx.doi.org/10.1074/jbc.M114.565929			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012652	Green Published, hybrid			2022-12-25	WOS:000341985300010
J	Navarro, A; Fos, S; Laguna, E; Duran, D; Rey, L; Rubio-Sanz, L; Imperial, J; Ruiz-Argueso, T				Navarro, Albert; Fos, Simon; Laguna, Emilio; Duran, David; Rey, Luis; Rubio-Sanz, Laura; Imperial, Juan; Ruiz-Argueeso, Tomas			Conservation of Endangered Lupinus mariae-josephae in Its Natural Habitat by Inoculation with Selected, Native Bradyrhizobium Strains	PLOS ONE			English	Article							GENETIC DIVERSITY; SOILS; REGION; DIVERSIFICATION; POPULATIONS; SERRADELLA; NODULATION; FABACEAE; ALBUS	Lupinus mariae-josephae is a recently discovered endemism that is only found in alkaline-limed soils, a unique habitat for lupines, from a small area in Valencia region (Spain). In these soils, L. mariae-josephae grows in just a few defined patches, and previous conservation efforts directed towards controlled plant reproduction have been unsuccessful. We have previously shown that L. mariae-josephae plants establish a specific root nodule symbiosis with bradyrhizobia present in those soils, and we reasoned that the paucity of these bacteria in soils might contribute to the lack of success in reproducing plants for conservation purposes. Greenhouse experiments using L. mariae-josephae trap-plants showed the absence or near absence of L. mariae-josephae-nodulating bacteria in "terra rossa'' soils of Valencia outside of L. mariae-josephae plant patches, and in other "terra rossa'' or alkaline red soils of the Iberian Peninsula and Balearic Islands outside of the Valencia L. mariae-josephae endemism region. Among the bradyrhizobia able to establish an efficient symbiosis with L. mariae-josephae plants, two strains, LmjC and LmjM3 were selected as inoculum for seed coating. Two planting experiments were carried out in consecutive years under natural conditions in areas with edapho-climatic characteristics identical to those sustaining natural L. mariae-josephae populations, and successful reproduction of the plant was achieved. Interestingly, the successful reproductive cycle was absolutely dependent on seedling inoculation with effective bradyrhizobia, and optimal performance was observed in plants inoculated with LmjC, a strain that had previously shown the most efficient behavior under controlled conditions. Our results define conditions for L. mariae-josephae conservation and for extension to alkaline-limed soil habitats, where no other known lupine can thrive.	[Navarro, Albert; Fos, Simon; Laguna, Emilio] Generalitat Valenciana, Conselleria Infraestruct Terr & Medio Ambiente, Serv Vida Silvestre, VAERSA,CIEF, Valencia, Spain; [Duran, David; Rey, Luis; Rubio-Sanz, Laura; Imperial, Juan; Ruiz-Argueeso, Tomas] Univ Politecn Madrid, CBGP, Pozuelo De Alarcon, Madrid, Spain; [Duran, David; Rey, Luis; Rubio-Sanz, Laura; Imperial, Juan; Ruiz-Argueeso, Tomas] Univ Politecn Madrid, Dept Biotecnol ETSI Agronomos, Pozuelo De Alarcon, Madrid, Spain; [Rubio-Sanz, Laura] Univ Politecn Madrid, Escuela Ingenieros Tecn Agr, Madrid, Spain; [Imperial, Juan] CSIC, Madrid, Spain	Center for Forestry Research & Experimentation (CIEF); Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Ruiz-Argueso, T (corresponding author), Univ Politecn Madrid, CBGP, Campus Montegancedo, Pozuelo De Alarcon, Madrid, Spain.	t.ruizargueso@upm.es	imperial, Juan/G-3925-2015; Rey, Luis/A-3389-2014; Ruiz-Argueso, TOMAS-ANDRES/I-1803-2015; Lumbreras, Emilio Laguna/H-9518-2015; Wendt, David Duran/A-2031-2019	imperial, Juan/0000-0002-5002-6458; Rey, Luis/0000-0003-3477-6942; Ruiz-Argueso, TOMAS-ANDRES/0000-0001-9118-3065; Lumbreras, Emilio Laguna/0000-0002-9674-2767; Wendt, David Duran/0000-0003-3940-3395; Fos Martin, Simon/0000-0003-0976-5459; Laura, Rubio-Sanz/0000-0003-4144-4428	FBBVA [BIOCON08-078]; Comunidad de Madrid [Microambiente S2009/AMB-1551]; MICINN (MICROGEN) [Consolider Ingenio 2010 CSD2009-00006, CGL2011-26932]	FBBVA(BBVA Foundation); Comunidad de Madrid(Comunidad de Madrid); MICINN (MICROGEN)	This research was supported by FBBVA (BIOCON08-078) and Comunidad de Madrid (Microambiente S2009/AMB-1551) to TRA and by MICINN (MICROGEN, Consolider Ingenio 2010 CSD2009-00006, and CGL2011-26932) to JI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilella A, 2010, COLECCION BIODIVERSI, V18; Ainouche A, 2004, PLANT SYST EVOL, V246, P211, DOI 10.1007/s00606-004-0149-8; Ainouche AK, 1999, AM J BOT, V86, P590, DOI 10.2307/2656820; Allison L.E., 1965, METHODS SOIL ANAL, P1379, DOI DOI 10.2134/AGRONMONOGR9.2.C40; AMARGER N, 1983, AGRONOMIE, V3, P995, DOI 10.1051/agro:19831008; Botha WJ, 2002, BIOL FERT SOILS, V36, P335, DOI 10.1007/s00374-002-0540-y; Duran D, 2013, SYST APPL MICROBIOL, V36, P128, DOI 10.1016/j.syapm.2012.10.008; Eastwood R. J., 2008, Lupins for health and wealth. Proceedings of the 12th International Lupin Conference, Fremantle, Western Australia, 14-18 September 2008, P346; Fos S., 2006, TOLL NEGRE, V8, P21; Gladstones J. S., 1998, P1; Ramirez-Bahena MH, 2012, SYST APPL MICROBIOL, V35, P334, DOI 10.1016/j.syapm.2012.05.003; Howieson John G., 1998, P149; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Jarabo-Lorenzo A, 2003, SYST APPL MICROBIOL, V26, P611, DOI 10.1078/072320203770865927; Kerley SJ, 2000, PLANT SOIL, V218, P197, DOI 10.1023/A:1014967720952; Laguna E, 2004, BIOL CONSERV, V119, P421, DOI 10.1016/j.biocon.2004.01.001; Mahe F, 2011, GENET RESOUR CROP EV, V58, P101, DOI 10.1007/s10722-010-9580-6; Merino E, 2008, J GEOL, V116, P62, DOI 10.1086/524675; Muhs DR, 2010, QUATERNARY SCI REV, V29, P2518, DOI 10.1016/j.quascirev.2010.04.013; Navarro Peris A.J., 2006, FLORA MONTIBERICA, P59; Pascual Higinio, 2004, Anales del Jardin Botanico de Madrid, V61, P69; RUIZARGUESO T, 1979, ANN INIA SERIE PRODU, V11, P127; Sanchez-Canizares C, 2011, SYST APPL MICROBIOL, V34, P207, DOI 10.1016/j.syapm.2010.11.020; Somasegaran P., 1994, HDB RHIZOBIA, DOI [10.1007/978-1-4613-8375-8, DOI 10.1007/978-1-4613-8375-8]; Stepkowski T, 2005, APPL ENVIRON MICROB, V71, P7041, DOI 10.1128/AEM.71.11.7041-7052.2005; Stepkowski T, 2011, SYST APPL MICROBIOL, V34, P368, DOI 10.1016/j.syapm.2011.03.002; TANG C, 1995, AUST J EXP AGR, V35, P87, DOI 10.1071/EA9950087; TANG CX, 1993, PLANT SOIL, V152, P269, DOI 10.1007/BF00029097; TORRENT J, 1986, GEODERMA, V37, P57, DOI 10.1016/0016-7061(86)90043-1; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Yaalon DH, 1997, CATENA, V28, P157, DOI 10.1016/S0341-8162(96)00035-5	31	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102205	10.1371/journal.pone.0102205	http://dx.doi.org/10.1371/journal.pone.0102205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019379	Green Accepted, Green Published, gold			2022-12-25	WOS:000339618600053
J	Ray, JG; Redelmeier, DA; Urquia, ML; Guttmann, A; McDonald, SD; Vermeulen, MJ				Ray, Joel G.; Redelmeier, Donald A.; Urquia, Marcelo L.; Guttmann, Astrid; McDonald, Sarah D.; Vermeulen, Marian J.			Risk of Cerebral Palsy among the Offspring of Immigrants	PLOS ONE			English	Article							INTRAUTERINE GROWTH; GESTATIONAL-AGE; BIRTH; PREECLAMPSIA; PREVALENCE; CHILDREN; PLACENTA; FEATURES; INFANTS; LESIONS	Background: Cerebral palsy (CP) has a multifactorial etiology, and placental vascular disease may be one major risk factor. The risk of placental vascular disease may be lower among some immigrant groups. We studied the association between immigrant status and the risk of CP. Methods: We conducted a population-based retrospective cohort study of all singleton and twin livebirths in Ontario between 2002-2008, and who survived >= 28 days after birth. Each child was assessed for CP up to age 4 years, based on either a single inpatient or >= 2 outpatient pediatric diagnoses of CP. Relative to non-immigrants (n = 566,668), the risk of CP was assessed for all immigrants (n = 177,390), and further evaluated by World region of origin. Cox proportional hazard ratios (aHR) were adjusted for maternal age, income, diabetes mellitus, obesity, tobacco use, Caesarean delivery, year of delivery, physician visits, twin pregnancy, preterm delivery, as well as small-and large-for-gestational age birthweight. Results: There were 1346 cases of CP, with a lower rate among immigrants (1.45 per 1000) than non-immigrants (1.92 per 1000) (aHR 0.77, 95% confidence interval [CI] 0.67 to 0.88). Mothers from East Asia and the Pacific (aHR 0.54, 95% CI 0.39 to 0.77) and the Caribbean (aHR 0.58, 95% CI 0.37 to 0.93) were at a significantly lower risk of having a child with CP. Whether further adjusting for preeclampsia, gestational hypertension, placental abruption or placental infraction, or upon using a competing risk analysis that further accounted for stillbirth and neonatal death, these results did not change. Conclusions: Immigration and ethnicity appear to attenuate the risk of CP, and this effect is not fully explained by known risk factors.	[Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada; [Ray, Joel G.; Vermeulen, Marian J.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Redelmeier, Donald A.] Univ Toronto, Inst Clin Evaluat Sci, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Urquia, Marcelo L.] St Michaels Hosp, Inst Clin Evaluat Sci, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Inst Clin Evaluat Sci, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Inst Clin Evaluat Sci, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Diagnost Imaging, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Div Maternal Fetal Med, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; McMaster University	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	rayj@smh.ca		Urquia, Marcelo/0000-0002-8289-8090	OFCP Research Fund, Ontario Federation for Cerebral Palsy	OFCP Research Fund, Ontario Federation for Cerebral Palsy	This work was funded by OFCP Research Fund, Ontario Federation for Cerebral Palsy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Becher JC, 2006, BJOG-INT J OBSTET GY, V113, P310, DOI 10.1111/j.1471-0528.2006.00852.x; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; Blair E, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.022; Bolen J C, 2000, MMWR CDC Surveill Summ, V49, P1; EVANS P, 1985, ARCH DIS CHILD, V60, P940, DOI 10.1136/adc.60.10.940; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gee EM, 2004, CAN J AGING, V23, pS61; Greenwood C, 2005, ARCH DIS CHILD-FETAL, V90, P141, DOI 10.1136/adc.2004.052860; Grobman WA, 2013, AM J OBSTET GYNECOL, V209; Hawkins F., 1972, CANADA IMMIGRATION P; Hecht JL, 2008, PATHOLOGY, V40, P372, DOI 10.1080/00313020802035865; Hemming K, 2008, ARCH DIS CHILD-FETAL, V93, pF121, DOI 10.1136/adc.2007.121129; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Janik MDC, 2013, J PEDIATR-US, V163, P1307, DOI 10.1016/j.jpeds.2013.06.062; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Kraus FT, 1999, HUM PATHOL, V30, P759, DOI 10.1016/S0046-8177(99)90136-3; Kumazaki K, 2002, PEDIATRICS, V109, P650, DOI 10.1542/peds.109.4.650; Kustec S, 2004, CITIZENSHIP IMMIGRAT; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Neff JM, 2002, AMBUL PEDIATR, V2, P71, DOI 10.1367/1539-4409(2002)002<0071:IACCWC>2.0.CO;2; Newstead J, 2007, Expert Rev Cardiovasc Ther, V5, P283, DOI 10.1586/14779072.5.2.283; Perlman JM, 1997, PEDIATRICS, V99, P851, DOI 10.1542/peds.99.6.851; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ray JG, 2007, CAN MED ASSOC J, V176, P1419, DOI 10.1503/cmaj.061680; Ray JG, 2005, J OBSTET GYNAECOL CA, V27, P1095, DOI 10.1016/S1701-2163(16)30391-7; Ray JG, 2012, J OBSTET GYNAECOL CA, V34, P159, DOI 10.1016/S1701-2163(16)35159-3; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; Redline RW, 1998, ARCH PATHOL LAB MED, V122, P1091; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Rouse DJ, 2008, NEW ENGL J MED, V359, P895, DOI 10.1056/NEJMoa0801187; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1097, DOI 10.1016/0002-9378(95)91333-5; SALAFIA CM, 1991, AM J OBSTET GYNECOL, V165, P934, DOI 10.1016/0002-9378(91)90443-U; Salihu HM, 2008, SEMIN PERINATOL, V32, P232, DOI 10.1053/j.semperi.2008.04.002; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Strand KM, 2013, BMJ-BRIT MED J, V347, pf4089, DOI DOI 10.1136/BMJ.F4089; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Urquia ML, 2010, BJOG-INT J OBSTET GY, V117, P591, DOI 10.1111/j.1471-0528.2010.02523.x; Urquia ML, 2012, J OBSTET GYNAECOL CA, V34, P348, DOI 10.1016/S1701-2163(16)35215-X; Wu YW, 2011, PEDIATRICS, V127, pE674, DOI 10.1542/peds.2010-1656	42	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102275	10.1371/journal.pone.0102275	http://dx.doi.org/10.1371/journal.pone.0102275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019202	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600059
J	Sinibaldi, E; Argiolas, A; Puleo, GL; Mazzolai, B				Sinibaldi, Edoardo; Argiolas, Alfredo; Puleo, Gian Luigi; Mazzolai, Barbara			Another Lesson from Plants: The Forward Osmosis-Based Actuator	PLOS ONE			English	Article							POLYMER; WATER; PRINCIPLES; SELECTION; SYSTEMS; PHYSICS; DESIGN; GROWTH; ROOTS; POWER	Osmotic actuation is a ubiquitous plant-inspired actuation strategy that has a very low power consumption but is capable of generating effective movements in a wide variety of environmental conditions. In light of these features, we aimed to develop a novel, low-power-consumption actuator that is capable of generating suitable forces during a characteristic actuation time on the order of a few minutes. Based on the analysis of plant movements and on osmotic actuation modeling, we designed and fabricated a forward osmosis-based actuator with a typical size of 10 mm and a characteristic time of 2-5 minutes. To the best of our knowledge, this is the fastest osmotic actuator developed so far. Moreover, the achieved timescale can be compared to that of a typical plant cell, thanks to the integrated strategy that we pursued by concurrently addressing and solving design and material issues, as paradigmatically explained by the bioinspired approach. Our osmotic actuator produces forces above 20 N, while containing the power consumption (on the order of 1 mW). Furthermore, based on the agreement between model predictions and experimental observations, we also discuss the actuator performance (including power consumption, maximum force, energy density and thermodynamic efficiency) in relation to existing actuation technologies. In light of the achievements of the present study, the proposed osmotic actuator holds potential for effective exploitation in bioinspired robotics systems.	[Sinibaldi, Edoardo; Argiolas, Alfredo; Puleo, Gian Luigi; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Pontedera, Italy; [Argiolas, Alfredo] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna	Sinibaldi, E (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Pontedera, Italy.	edoardo.sinibaldi@iit.it; barbara.mazzolai@iit.it	Mazzolai, Barbara/I-8876-2016; Sinibaldi, Edoardo/AAV-9599-2021	Mazzolai, Barbara/0000-0003-0722-8350; Sinibaldi, Edoardo/0000-0002-9755-3431	European Community [293431]	European Community(European Commission)	This work was supported by the European Community's 7th Framework Programme under the Grant Agreement No. 293431 of the PLANTOID project (www.plantoidproject.eu; http://cordis.europa.eu/fp7/ict/fet-open/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alici G, 2011, SENSOR ACTUAT B-CHEM, V157, P72, DOI 10.1016/j.snb.2011.03.028; Anjanappa M., 1994, Smart Materials and Structures, V3, P83, DOI 10.1088/0964-1726/3/2/001; [Anonymous], 2010, CELLULAR MAT NATURE; Atkins P., 2006, PHYS CHEM; Bartlett PA, 2001, SENSOR ACTUAT A-PHYS, V91, P133, DOI 10.1016/S0924-4247(01)00475-7; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bell DJ, 2005, J MICROMECH MICROENG, V15, pS153, DOI 10.1088/0960-1317/15/7/022; Benard WL, 1998, J MICROELECTROMECH S, V7, P245, DOI 10.1109/84.679390; Bengough AG, 1997, PLANT SOIL, V189, P155, DOI 10.1023/A:1004240706284; Bigue JPL, 2013, IEEE-ASME T MECH, V18, P169, DOI 10.1109/TMECH.2011.2164930; Biso M, 2011, CARBON, V49, P2253, DOI 10.1016/j.carbon.2011.01.057; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Chang T, 2001, IEEE T CONTR SYST T, V9, P69, DOI 10.1109/87.896747; Cheng ZY, 2001, SENSOR ACTUAT A-PHYS, V90, P138, DOI 10.1016/S0924-4247(01)00496-4; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; CHOU CP, 1994, IEEE INT CONF ROBOT, P281, DOI 10.1109/ROBOT.1994.350977; Cianchetti M, 2009, SENSOR ACTUAT B-CHEM, V142, P288, DOI 10.1016/j.snb.2009.08.039; Cinquin P, 2005, US patent, Patent No. [0158841 A1, 0158841]; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Darwin C., 1875, INSECTIVOROUS PLANTS; Darwin C. R, 1880, POWER MOVEMENTS PLAN; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; FLEURATLESSARD P, 1988, BIOL REV, V63, P1, DOI 10.1111/j.1469-185X.1988.tb00467.x; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Forterre Y, 2013, J EXP BOT, V64, P4745, DOI 10.1093/jxb/ert230; FOUGERE F, 1991, PLANT PHYSIOL, V96, P1228, DOI 10.1104/pp.96.4.1228; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Fu YQ, 2004, SENSOR ACTUAT A-PHYS, V112, P395, DOI 10.1016/j.sna.2004.02.019; Gilroy S, 2008, PLANT TROPISMS, P1; Grunwald A, 2008, SENSOR ACTUAT A-PHYS, V144, P161, DOI 10.1016/j.sna.2007.12.034; Harrington MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1336; Herrlich S, 2012, ADV DRUG DELIVER REV, V64, P1617, DOI 10.1016/j.addr.2012.02.003; HILL BS, 1981, Q REV BIOPHYS, V14, P173, DOI 10.1017/S0033583500002249; Holmes DP, 2007, ADV MATER, V19, P3589, DOI 10.1002/adma.200700584; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Hunter I., 1992, ROBOT REV, P299, DOI [10.5555/146312, DOI 10.5555/146312]; Hunter I. W., 1992, Technical Digest. IEEE Solid-State Sensor and Actuator Workshop (Cat. No.92TH0403-X), P178, DOI 10.1109/SOLSEN.1992.228297; Jordan T, 2000, 209861 NASACR; Joyeux M, 2011, FRONT LIFE SCI, V5, P71, DOI 10.1080/21553769.2012.708907; Kaneto K, 2007, SMART MATER STRUCT, V16, pS250, DOI 10.1088/0964-1726/16/2/S08; Knipfer T, 2010, NEW PHYTOL, V187, P159, DOI 10.1111/j.1469-8137.2010.03240.x; Kornbluh R, 1998, IEEE INT CONF ROBOT, P2147, DOI 10.1109/ROBOT.1998.680638; Kusaka M, 2003, J COMPOS MATER, DOI [10.1177/0021998302040565, DOI 10.1177/0021998302040565]; Lee H, 2010, SOFT MATTER, V6, P4342, DOI 10.1039/c0sm00092b; Lenouvel F, 2009, US patent, Patent No. [0120082 A1, 0120082]; Li YH, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065013; Madden JD, 2003, IEEE J OCEANIC ENG, P706; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Maitland DJ, 2000, US patent, Patent No. [US006102917A, 006102917]; Malone E, 2006, RAPID PROTOTYPING J, V12, P244, DOI 10.1108/13552540610707004; Martone PT, 2010, INTEGR COMP BIOL, V50, P888, DOI 10.1093/icb/icq122; Mazzolai B, 2011, IEEE-ASME T MECH, V16, P201, DOI 10.1109/TMECH.2009.2038997; Najem J, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/9/094026; Nakamura Y, 1997, PROC IEEE MICR ELECT, P262, DOI 10.1109/MEMSYS.1997.581821; Paik IH, 2006, SMART MATER STRUCT, V15, P1476, DOI 10.1088/0964-1726/15/5/037; Pelrine R, 2000, MAT SCI ENG C-BIO S, V11, P89, DOI 10.1016/S0928-4931(00)00128-4; Piyasena ME, 2009, SENSOR ACTUAT B-CHEM, V141, P263, DOI 10.1016/j.snb.2009.05.014; Plante JS, 2007, SENSOR ACTUAT A-PHYS, V137, P96, DOI 10.1016/j.sna.2007.01.017; Poppinga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045735; Priya S, 2005, JPN J APPL PHYS 2, V44, pL104, DOI 10.1143/JJAP.44.L104; Shahinpoor M, 2001, SMART MATER STRUCT, V10, P819, DOI 10.1088/0964-1726/10/4/327; Shenoy DK, 2002, SENSOR ACTUAT A-PHYS, V96, P184, DOI 10.1016/S0924-4247(01)00793-2; Shimizu K, 2013, J BIOSCI BIOENG, V115, P115, DOI 10.1016/j.jbiosc.2012.08.024; Sinibaldi E, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/025002; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Spinks G, 2005, PROC SPIE, V5759, P314, DOI 10.1117/12.598407; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sundaresan VB, 2008, SENSOR ACTUAT B-CHEM, V131, P384, DOI 10.1016/j.snb.2007.11.057; Thrasher M. A., 1994, Smart Materials and Structures, V3, P226, DOI 10.1088/0964-1726/3/2/019; Timoshenko S., 1964, THEORY PLATES SHELLS, V2; ULANOWICZ RE, 1995, ECOL MODEL, V79, P49, DOI 10.1016/0304-3800(94)00032-D; Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292; Wang CM, 2012, LAB CHIP, V12, P1710, DOI 10.1039/c2lc40059f; Zupan M, 2002, ADV ENG MATER, V4, P933, DOI 10.1002/adem.200290009	76	31	31	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102461	10.1371/journal.pone.0102461	http://dx.doi.org/10.1371/journal.pone.0102461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020043	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600083
J	Romandini, M; Peresani, M; Laroulandie, V; Metz, L; Pastoors, A; Vaquero, M; Slimak, L				Romandini, Matteo; Peresani, Marco; Laroulandie, Veronique; Metz, Laure; Pastoors, Andreas; Vaquero, Manuel; Slimak, Ludovic			Convergent Evidence of Eagle Talons Used by Late Neanderthals in Europe: A Further Assessment on Symbolism	PLOS ONE			English	Article							HISTORICAL STRUCTURE; CULTURAL SHIFTS; MOULA-GUERCY; FUMANE CAVE; MIDDLE; DIVERSITY; ARDECHE; BP	To contribute to have a better understanding of the symbolic or not use of certain items by Neanderthals, this work presents new evidence of the deliberate removal of raptor claws occurred in Mediterranean Europe during the recent phases of the Mousterian. Rio Secco Cave in the north-east of Italy and Mandrin Cave in the Middle Rhone valley have recently produced two golden eagle pedal phalanges from contexts not younger than 49.1-48.0 ky cal BP at Rio Secco and dated around 50.0 ky cal BP at Mandrin. The bones show cut-marks located on the proximal end ascribable to the cutting of the tendons and the incision of the cortical organic tissues. Also supported by an experimental removal of large raptor claws, our reconstruction explains that the deliberate detachment occurred without damaging the claw, in a way comparable at a general level with other Mousterian contexts across Europe. After excluding that these specimens met the nutritional requirements for human subsistence, we discuss the possible implications these findings perform in our current knowledge of the European Middle Palaeolithic context.	[Romandini, Matteo; Peresani, Marco] Univ Ferrara, Dipartimento Studi Umanistici, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Laroulandie, Veronique] Univ Bordeaux, CNRS, PACEA UMR5199, Talence, France; [Metz, Laure] Univ Aix Marseille, UMR LAMPEA 7269, Aix En Provence, France; [Pastoors, Andreas] Neanderthal Museum, Mettmann, Germany; [Vaquero, Manuel] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Slimak, Ludovic] Univ Toulouse 2, CNRS, UMR 5608, Toulouse, France	University of Ferrara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Peresani, M (corresponding author), Univ Ferrara, Dipartimento Studi Umanistici, Sez Sci Preistor & Antropol, Corso Ercole Este 32, I-44100 Ferrara, Italy.	marco.peresani@unife.it; slimak@univ-tlse2.fr	Vaquero, Manuel/W-1405-2019; Peresani, Marco/X-1343-2019; Slimak, Ludovic/AAG-7890-2020; Laroulandie, Véronique/AAD-6860-2019	Vaquero, Manuel/0000-0001-6572-8543; Laroulandie, Véronique/0000-0002-9745-6578; Metz, Laure/0000-0003-0304-5645; Peresani, Marco/0000-0001-6562-6336	Administration of the Clauzetto Municipality; Friuli Venezia Giulia Region; Ecomuseo delle Dolomiti Friulane "Lis Aganis"; BIM Tagliamento Consortium; Pordenone Province; Fondazione CRUP; Buzzi Unicem Spa; Albino Armani winegrover; Fantinel winegrovers; French Rhone-Alpes Regional Archaeological Service (SRA-DRAC) from Lyon; Committee and Research Exploration of the National Geographic Society [9222-11]	Administration of the Clauzetto Municipality; Friuli Venezia Giulia Region(Regione Friuli Venezia Giulia); Ecomuseo delle Dolomiti Friulane "Lis Aganis"; BIM Tagliamento Consortium; Pordenone Province; Fondazione CRUP; Buzzi Unicem Spa; Albino Armani winegrover; Fantinel winegrovers; French Rhone-Alpes Regional Archaeological Service (SRA-DRAC) from Lyon(Region Auvergne-Rhone-Alpes); Committee and Research Exploration of the National Geographic Society(National Geographic Society)	Financial support to Rio Secco Research Project is provided by the Administration of the Clauzetto Municipality and the Friuli Venezia Giulia Region and a group of public institutions (Ecomuseo delle Dolomiti Friulane "Lis Aganis", BIM Tagliamento Consortium, Pordenone Province), Foundations (Fondazione CRUP) and private companies (Buzzi Unicem Spa, Albino Armani winegrover, Fantinel winegrovers). Grotte Mandrin researches were conducted with the full financial support of the French Rhone-Alpes Regional Archaeological Service (SRA-DRAC) from Lyon. The experimental butchering was supported by the Committee and Research Exploration of the National Geographic Society (Grant 9222-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; Blasco R, 2013, QUATERNARY SCI REV, V70, P124, DOI 10.1016/j.quascirev.2013.03.008; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2010, CR PALEVOL, V9, P171, DOI 10.1016/j.crpv.2010.05.004; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Defleur A, 1999, SCIENCE, V286, P128, DOI 10.1126/science.286.5437.128; Dibble Harold L., 2009, Paleoanthropology, V2009, P182; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Gaudzinski-Windheuser S, 2009, VERTEBR PALEOBIOL PA, P99, DOI 10.1007/978-1-4020-9699-0_7; Gourichon L, 1994, THESIS U LUMIERE LYO; Granger JM, 1997, CR ACAD SCI II A, V325, P537, DOI 10.1016/S1251-8050(97)89874-6; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Kuhn SL, 2004, ISRAELI J PREHIST SO, V34, P5; Kuhn SL, 2009, J HUM EVOL, V56, P87, DOI 10.1016/j.jhevol.2008.07.014; Laroulandie V., 2000, THESIS U BORDEAUX BO; Laroulandie V., 2010, GRONINGEN ARCHAEOLOG, V12, P219; Laroulandie V., 2004, APPROCHES FONCTIONNE, P387; Lenssen-Erz T, 2012, ROCK ART RES INST MO, P47; Mallye JB, 2013, PALEO, V24, P235; Maslow A.H., 1954, MOTIVATION PERSONALI; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Mourer-Chauvire C, 1975, ISSUES GEOLOGICAL LA, V64; Mourer-Chauvire C., 1989, BAUME GIGNY JURA 27, P121; Mussini C, 2012, TRANSITIONS RUPTURE, VI, P133; Peresani M, J FIELD ARC IN PRESS; Peresani M, 2014, J ANTHROPOL SCI, V92, P1; Peresani M, 2012, ANTIQUITY PROJECT GA, V86, P332; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Rendu W, 2013, P NATL ACAD SCI USA, V108, P3888; Romandini M., 2013, EUR ASS STUD HUM EV, P189; Simmons T, 1998, INT J OSTEOARCHAEOL, V8, P79, DOI 10.1002/(SICI)1099-1212(199803/04)8:2<79::AID-OA386>3.0.CO;2-I; Slimak L, GALLIA PREH IN PRESS; Slimak L., 2004, THESIS U PROVENCE; Slimak L, 2008, J ARCHAEOL SCI, V35, P2204, DOI 10.1016/j.jas.2008.02.005; Slimak L, 2007, CR PALEVOL, V6, P301, DOI 10.1016/j.crpv.2007.02.004; Slimak L, 2006, CR PALEVOL, V5, P909, DOI 10.1016/j.crpv.2006.05.002; Soressi M., 2008, SOCIETE PREHISTORIQU, P95; Soressi M, 2007, NEANDERTALIENS BIOL, P297; Street M, 2013, MONOGRAPHIEN ROMISCH, V104; Talamo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095376; Valensi P, 2012, QUATERN INT, V252, P48, DOI 10.1016/j.quaint.2011.07.028; White R, 2002, GALLIA PREHISTOIRE S, VXXXIV, P257; White T.D., 1992, PREHISTORIC CANNIBAL; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	49	88	89	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101278	10.1371/journal.pone.0101278	http://dx.doi.org/10.1371/journal.pone.0101278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK9RG	25010346	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800018
J	Wheelhouse, N; Coyle, C; Barlow, PG; Mitchell, S; Greub, G; Baszler, T; Rae, MT; Longbottom, D				Wheelhouse, Nick; Coyle, Christopher; Barlow, Peter G.; Mitchell, Stephen; Greub, Gilbert; Baszler, Tim; Rae, Mick T.; Longbottom, David			Waddlia chondrophila Infects and Multiplies in Ovine Trophoblast Cells Stimulating an Inflammatory Immune Response	PLOS ONE			English	Article							ABORTED BOVINE FETUS; REAL-TIME PCR; CHLAMYDIA-TRACHOMATIS; HUMAN MACROPHAGES; NEOSPORA-CANINUM; GENE; NOD1; INTERLEUKIN-8; RICKETTSIA; RECEPTOR	Background: Waddlia chondrophila (W. chondrophila) is an emerging abortifacient organism which has been identified in the placentae of humans and cattle. The organism is a member of the order Chlamydiales, and shares many similarities at the genome level and in growth studies with other well-characterised zoonotic chlamydial abortifacients, such as Chlamydia abortus (C. abortus). This study investigates the growth of the organism and its effects upon pro-inflammatory cytokine expression in a ruminant placental cell line which we have previously utilised in a model of C. abortus pathogenicity. Methodology/Principal Findings: Using qPCR, fluorescent immunocytochemistry and electron microscopy, we characterised the infection and growth of W. chondrophila within the ovine trophoblast AH-1 cell line. Inclusions were visible from 6 h post-infection (p.i.) and exponential growth of the organism could be observed over a 60 h time-course, with significant levels of host cell lysis being observed only after 36 h p.i. Expression of CXCL8, TNF-alpha, IL-1 alpha and IL-1 beta were determined 24 h p.i. A statistically significant response in the expression of CXCL8, TNF-alpha and IL-1 beta could be observed following active infection with W. chondrophila. However a significant increase in IL-1 beta expression was also observed following the exposure of cells to UV-killed organisms, indicating the stimulation of multiple innate recognition pathways. Conclusions/Significance: W. chondrophila infects and grows in the ruminant trophoblast AH-1 cell line exhibiting a complete chlamydial replicative cycle. Infection of the trophoblasts resulted in the expression of pro-inflammatory cytokines in a dose-dependent manner similar to that observed with C. abortus in previous studies, suggesting similarities in the pathogenesis of infection between the two organisms.	[Wheelhouse, Nick; Longbottom, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Coyle, Christopher; Barlow, Peter G.; Rae, Mick T.] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland; [Mitchell, Stephen] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, CRIB, Lausanne, Switzerland; [Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland; [Baszler, Tim] Washington State Univ, Coll Vet Med, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA	Moredun Research Institute; Edinburgh Napier University; University of Edinburgh; University of Lausanne; Washington State University	Wheelhouse, N (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	nick.wheelhouse@moredun.ac.uk	Longbottom, David/GWZ-8448-2022; Greub, Gilbert GG/K-5804-2017; Barlow, Peter/O-4078-2019	Longbottom, David/0000-0003-0086-8443; Greub, Gilbert GG/0000-0001-9529-3317; Barlow, Peter/0000-0002-6516-9312; Wheelhouse, Nick/0000-0002-2803-0055; Molodiuc, Veaceslav/0000-0002-3014-4203	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Edinburgh Napier University Research Excellence Award; Biotechnology and Biological Sciences Research Council (BBSRC); Zoetis [BB/J015083/1]; Biotechnology and Biological Sciences Research Council [BB/J015083/1] Funding Source: researchfish; BBSRC [BB/J015083/1] Funding Source: UKRI	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Edinburgh Napier University Research Excellence Award; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, http://www.scotland.gov.uk/), an Edinburgh Napier University Research Excellence Award, and through the Industrial partnership award awarded by the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk/) and Zoetis (grant no. BB/J015083/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkallah M, 2013, VET MICROBIOL, V164, P101, DOI 10.1016/j.vetmic.2013.01.036; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Baud D, 2014, EMERG INFECT DIS, V20, P460, DOI 10.3201/eid2003.131019; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; Crawford T. B., 1989, P 8 C VET HEM DIS ST, P121; Croxatto A, 2010, MICROBIOL-SGM, V156, P340, DOI 10.1099/mic.0.034546-0; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; Fach SJ, 2007, VIRAL IMMUNOL, V20, P119, DOI 10.1089/vim.2006.0056; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Haldorson GJ, 2006, EXP PARASITOL, V112, P172, DOI 10.1016/j.exppara.2005.11.004; Henning K, 2002, VET MICROBIOL, V85, P285, DOI 10.1016/S0378-1135(01)00510-7; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; Kebbi-Beghdadi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028605; Kebbi-Beghdadi C, 2011, FEMS IMMUNOL MED MIC, V63, P339, DOI 10.1111/j.1574-695X.2011.00856.x; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Lienard J, 2011, J CLIN MICROBIOL, V49, P2637, DOI 10.1128/JCM.00114-11; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Rurangirwa FR, 1999, INT J SYST BACTERIOL, V49, P577, DOI 10.1099/00207713-49-2-577; Smeed Jennifer A, 2007, BMC Vet Res, V3, P18, DOI 10.1186/1746-6148-3-18; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wheelhouse N, 2009, J REPROD IMMUNOL, V80, P49, DOI 10.1016/j.jri.2008.12.003	28	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102386	10.1371/journal.pone.0102386	http://dx.doi.org/10.1371/journal.pone.0102386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010668	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800098
J	Gao, J; Lv, F; Li, J; Wu, ZY; Qi, J				Gao, Jia; Lv, Fang; Li, Jia; Wu, Zongyong; Qi, Jun			Serum Cytokeratin 19 Fragment, CK19-2G2, as a Newly Identified Biomarker for Lung Cancer	PLOS ONE			English	Article							POLYPEPTIDE-SPECIFIC-ANTIGEN; MARKERS; CYFRA-21-1	Background: CK19-2G2, a new fragment of cytokeratin 19, is a potential tumor marker for diagnosing lung cancer. The preoperative level of serum CK19-2G2 has been demonstrated to be associated with tumor metastasis and survival of breast cancer patients. This study investigated the postoperative dynamic changes in serum CK19-2G2 levels and its clinical significance in lung cancer patients. Materials and Methods: Preoperative serum CK19-2G2 levels were measured in 630 lung cancer patients and were compared with individuals with benign pulmonary diseases (n = 134) and healthy volunteers (n = 263). In 352 cases, the patients underwent surgery. In these patients, in addition to preoperative assays, serum CK19-2G2 was also monitored at 1 week and 1 month after the operation. Results: The preoperative baseline levels of serum CK19-2G2 was significantly higher in lung cancer patients than patients with benign diseases and healthy controls (P < 0.001). The postoperative levels of CK19-2G2 declined significantly within 1 week after tumor resection. Hereafter, a further decrease was observed in the patients who underwent palliative operations, while for the patients in the radical resection group, their CK19-2G2 levels stabilized. Conclusion: CK19-2G2 may be a candidate marker for diagnosing and monitoring a patient's response to lung cancer treatment. In addition, CK19-2G2 may be an indicator for micrometastases in lung cancer patients.	[Gao, Jia; Li, Jia; Wu, Zongyong; Qi, Jun] Chinese Acad Med Sci, Canc Inst & Hosp, Clin Lab, Beijing 100730, Peoples R China; [Gao, Jia; Lv, Fang; Li, Jia; Wu, Zongyong; Qi, Jun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lv, Fang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Qi, J (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Clin Lab, Beijing 100730, Peoples R China.	qijun5610@163.com			Capital Medical Development Research Fund	Capital Medical Development Research Fund	This study was supported by the Capital Medical Development Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Ettinger David S, 2006, J Natl Compr Canc Netw, V4, P548; Gao Jia, 2008, Zhonghua Zhongliu Zazhi, V30, P930; Kong YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057092; Ku NO, 2001, J BIOL CHEM, V276, P26792, DOI 10.1074/jbc.M103315200; Liang ZK, 2013, CLIN LAB, V59, P551, DOI 10.7754/Clin.Lab.2012.120511; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nisman B, 1998, CANCER-AM CANCER SOC, V82, P1850, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R; OSBORN M, 1982, CELL, V31, P303, DOI 10.1016/0092-8674(82)90122-2; PUJOL JL, 1993, CANCER RES, V53, P61; Rydlander L, 1996, EUR J BIOCHEM, V241, P309, DOI 10.1111/j.1432-1033.1996.00309.x; Sheard MA, 2002, J CELL BIOCHEM, V85, P670, DOI 10.1002/jcb.10173; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	13	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101979	10.1371/journal.pone.0101979	http://dx.doi.org/10.1371/journal.pone.0101979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006982	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600085
J	Moscoso, M; Esteban-Torres, M; Menendez, M; Garcia, E				Moscoso, Miriam; Esteban-Torres, Maria; Menendez, Margarita; Garcia, Ernesto			In Vitro Bactericidal and Bacteriolytic Activity of Ceragenin CSA-13 against Planktonic Cultures and Biofilms of Streptococcus pneumoniae and Other Pathogenic Streptococci	PLOS ONE			English	Article							CATIONIC STEROID COMPOUNDS; PSEUDOMONAS-AERUGINOSA; CELL-WALL; PNEUMOCOCCAL STRAINS; EXTRACELLULAR-DNA; ENZYME-ACTIVITY; WILD-TYPE; ACID; TOLERANCE; AUTOLYSIN	Ceragenin CSA-13, a cationic steroid, is here reported to show a concentration-dependent bactericidal/bacteriolytic activity against pathogenic streptococci, including multidrug-resistant Streptococcus pneumoniae. The autolysis promoted by CSA-13 in pneumococcal cultures appears to be due to the triggering of the major S. pneumoniae autolysin LytA, an N-acetylmuramoyl-L-alanine amidase. CSA-13 also disintegrated pneumococcal biofilms in a very efficient manner, although at concentrations slightly higher than those required for bactericidal activity on planktonic bacteria. CSA-13 has little hemolytic activity which should allow testing its antibacterial efficacy in animal models.	[Moscoso, Miriam; Esteban-Torres, Maria; Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain; [Moscoso, Miriam; Esteban-Torres, Maria; Menendez, Margarita; Garcia, Ernesto] CIBER Enfermedades Resp CIBERES, Mallorca, Illes Balears, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Garcia, E (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	e.garcia@cib.csic.es	Esteban-Torres, Maria/AAA-8621-2020; Menendez, Margarita/M-1795-2014; Esteban-Torres, María/AAT-6046-2020	Menendez, Margarita/0000-0002-3267-4443; Esteban-Torres, María/0000-0001-8433-5729; Moscoso, Miriam/0000-0001-8977-3269; Partearroyo Lacaba, Olvido/0000-0002-1692-4481	Direccion General de Investigacion Cientifica y Tecnica [SAF2009-10824, BFU2009-10052, BFU2012-36825, SAF2012-39444-C02-01]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	This work was supported by Direccion General de Investigacion Cientifica y Tecnica (grant numbers SAF2009-10824, BFU2009-10052, BFU2012-36825, and SAF2012-39444-C02-01) and Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), which is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Berron S, 2005, J CLIN MICROBIOL, V43, P1694, DOI 10.1128/JCM.43.4.1694-1698.2005; Bozkurt-Guzel C, 2011, CHEMOTHERAPY, V57, P505, DOI 10.1159/000335588; Bucki R, 2007, J ANTIMICROB CHEMOTH, V60, P535, DOI 10.1093/jac/dkm218; Burnside K, 2011, J BIOL CHEM, V286, P44197, DOI 10.1074/jbc.M111.313486; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chin JN, 2007, ANTIMICROB AGENTS CH, V51, P1268, DOI 10.1128/AAC.01325-06; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Coates H, 2008, OTOLARYNG HEAD NECK, V138, P778, DOI 10.1016/j.otohns.2007.02.009; Diez-Martinez R, 2013, ANTIMICROB AGENTS CH, V57, P5355, DOI 10.1128/AAC.01372-13; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Domenech M, 2012, MICROB BIOTECHNOL, V5, P455, DOI 10.1111/j.1751-7915.2011.00294.x; Dufour D, 2013, J BACTERIOL, V195, P105, DOI 10.1128/JB.00926-12; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RM, 2008, DRUG NEWS PERSPECT, V21, P307, DOI 10.1358/dnp.2008.21.6.1246829; GARCIABUSTOS JF, 1987, J BIOL CHEM, V262, P15400; GOPPELTSTRUEBE M, 1995, CANCER CHEMOTH PHARM, V35, P519, DOI 10.1007/s002800050271; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; HOLTJE JV, 1975, P NATL ACAD SCI USA, V72, P1690, DOI 10.1073/pnas.72.5.1690; HOLTJE JV, 1976, J BIOL CHEM, V251, P4199; HORNE D, 1977, ANTIMICROB AGENTS CH, V11, P888, DOI 10.1128/AAC.11.5.888; HORNE D, 1977, J BACTERIOL, V132, P704, DOI 10.1128/JB.132.2.704-717.1977; Isogai E, 2009, ORAL MICROBIOL IMMUN, V24, P170, DOI 10.1111/j.1399-302X.2008.00464.x; Jensen PO, 2010, FEMS IMMUNOL MED MIC, V59, P292, DOI 10.1111/j.1574-695X.2010.00706.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Lai XZ, 2008, ACCOUNTS CHEM RES, V41, P1233, DOI 10.1021/ar700270t; Leszczynska K, 2011, J APPL MICROBIOL, V110, P229, DOI 10.1111/j.1365-2672.2010.04874.x; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; LIU HH, 1985, J INFECT DIS, V152, P365, DOI 10.1093/infdis/152.2.365; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Llull D, 2007, ANTIMICROB AGENTS CH, V51, P1844, DOI 10.1128/AAC.01428-06; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lopez R, 2004, PNEUMOCCOCUS, P75; LOPEZ R, 1990, FEMS MICROBIOL LETT, V66, P317, DOI 10.1016/0378-1097(90)90305-A; LUND E, 1978, METHOD MICROBIOL, V12, P241; Maestro Beatriz, 2007, Recent Pat Antiinfect Drug Discov, V2, P188, DOI 10.2174/157489107782497290; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Medrano FJ, 1996, J BIOL CHEM, V271, P29152, DOI 10.1074/jbc.271.46.29152; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2010, MOL MICROBIOL, V77, P1052, DOI 10.1111/j.1365-2958.2010.07271.x; MOSSER JL, 1970, J BIOL CHEM, V245, P287; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Nagant C, 2012, J APPL MICROBIOL, V112, P1173, DOI 10.1111/j.1365-2672.2012.05297.x; Nagant C, 2013, MICROBIOLOGYOPEN, V2, P318, DOI 10.1002/mbo3.77; Nagant C, 2010, APPL MICROBIOL BIOT, V88, P251, DOI 10.1007/s00253-010-2748-3; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; OTTOLENGHI E, 1962, J EXP MED, V116, P491, DOI 10.1084/jem.116.4.491; Papazafiri P, 2005, CANCER CHEMOTH PHARM, V56, P261, DOI 10.1007/s00280-004-0935-6; Polat ZA, 2011, J OCUL PHARMACOL TH, V27, P1, DOI 10.1089/jop.2010.0041; Pollard JE, 2012, J ANTIMICROB CHEMOTH, V67, P2665, DOI 10.1093/jac/dks276; RONDA C, 1988, MOL GEN GENET, V215, P53, DOI 10.1007/BF00331302; Sambrook J, 2001, MOL CLONING LAB MANU; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; Soriano F, 2008, J ANTIMICROB CHEMOTH, V62, P1234, DOI 10.1093/jac/dkn392; Sung H, 2006, J CLIN MICROBIOL, V44, P3524, DOI 10.1128/JCM.00558-06; TOMASZ A, 1975, BIOCHEM BIOPH RES CO, V65, P1311, DOI 10.1016/S0006-291X(75)80373-1; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; [UNICEF WHO], 2006, PNEUM FORG KILL CHIL; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682	63	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101037	10.1371/journal.pone.0101037	http://dx.doi.org/10.1371/journal.pone.0101037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006964	Green Published, gold			2022-12-25	WOS:000339040600027
J	Sharma, K; Bayrakcismith, R; Tumursukh, L; Johansson, O; Sevger, P; McCarthy, T; Mishra, C				Sharma, Koustubh; Bayrakcismith, Rana; Tumursukh, Lkhagvasumberel; Johansson, Orjan; Sevger, Purevsuren; McCarthy, Tom; Mishra, Charudutt			Vigorous Dynamics Underlie a Stable Population of the Endangered Snow Leopard Panthera uncia in Tost Mountains, South Gobi, Mongolia	PLOS ONE			English	Article							TIGER DENSITIES; RECAPTURE; DISPERSAL; ABUNDANCE; TIGRIS; PARAMETERS; PANNA; INDIA	Population monitoring programmes and estimation of vital rates are key to understanding the mechanisms of population growth, decline or stability, and are important for effective conservation action. We report, for the first time, the population trends and vital rates of the endangered snow leopard based on camera trapping over four years in the Tost Mountains, South Gobi, Mongolia. We used robust design multi-season mark-recapture analysis to estimate the trends in abundance, sex ratio, survival probability and the probability of temporary emigration and immigration for adult and young snow leopards. The snow leopard population remained constant over most of the study period, with no apparent growth (lambda = 1.08+-20.25). Comparison of model results with the "known population'' of radio-collared snow leopards suggested high accuracy in our estimates. Although seemingly stable, vigorous underlying dynamics were evident in this population, with the adult sex ratio shifting from being male-biased to female-biased (1.67 to 0.38 males per female) during the study. Adult survival probability was 0.82 (SE+-0.08) and that of young was 0.83 (SE+-0.15) and 0.77 (SE+-0.2) respectively, before and after the age of 2 years. Young snow leopards showed a high probability of temporary emigration and immigration (0.6, SE +-0.19 and 0.68, SE +-0.32 before and after the age of 2 years) though not the adults (0.02 SE+-0.07). While the current female-bias in the population and the number of cubs born each year seemingly render the study population safe, the vigorous dynamics suggests that the situation can change quickly. The reduction in the proportion of male snow leopards may be indicative of continuing anthropogenic pressures. Our work reiterates the importance of monitoring both the abundance and population dynamics of species for effective conservation.	[Sharma, Koustubh; Tumursukh, Lkhagvasumberel; Johansson, Orjan; Sevger, Purevsuren; Mishra, Charudutt] Snow Leopard Trust, Seattle, WA 98103 USA; [Sharma, Koustubh; Mishra, Charudutt] Nat Conservat Fdn, Mysore, Karnataka, India; [Bayrakcismith, Rana; Johansson, Orjan; McCarthy, Tom] Panthera, New York, NY USA; [Tumursukh, Lkhagvasumberel; Sevger, Purevsuren] Snow Leopard Conservat Fdn, Ulaanbaatar, Mongolia; [Johansson, Orjan] Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Uppsala, Sweden	Swedish University of Agricultural Sciences	Sharma, K (corresponding author), Snow Leopard Trust, Seattle, WA 98103 USA.	koustubhsharma@gmail.com			Whitley Fund For Nature; BBC Wildlife Fund; Kolmarden Zoo; AZA Conservation Endowment Fund; Disney, Worldwide Conservation Fund; David Shepherd Wildlife Foundation; Columbus Zoo and Aquarium; Nysether Family Foundation; Cheyenne Mountain zoos; Woodland Park Zoo	Whitley Fund For Nature; BBC Wildlife Fund; Kolmarden Zoo; AZA Conservation Endowment Fund; Disney, Worldwide Conservation Fund; David Shepherd Wildlife Foundation; Columbus Zoo and Aquarium; Nysether Family Foundation; Cheyenne Mountain zoos; Woodland Park Zoo	The authors are grateful to the Whitley Fund For Nature, BBC Wildlife Fund, Kolmarden Zoo, AZA Conservation Endowment Fund, Disney, Worldwide Conservation Fund, David Shepherd Wildlife Foundation, Woodland Park Zoo, Columbus Zoo and Aquarium, Nysether Family Foundation and Cheyenne Mountain zoos for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme G.A., 2004, ECOL J, V6, P1; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caro TM, 2003, ANIM CONSERV, V6, P171, DOI 10.1017/S1367943003003214; Chundawat RS, 2009, PANNAS LAST TIGER; Cooch E., 2008, PROGRAM MARK GENTLE; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Goodrich JM, 2008, J ZOOL, V276, P323, DOI 10.1111/j.1469-7998.2008.00458.x; Gopal R, 2010, ORYX, V44, P383, DOI 10.1017/S0030605310000529; Gour DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066956; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; Johansson O, 2013, J WILDLIFE DIS, V49, P338, DOI 10.7589/2012-02-049; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kendall WL, 2001, BIOMETRICS, V57, P1113, DOI 10.1111/j.0006-341X.2001.01113.x; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kerley LL, 2003, J MAMMAL, V84, P288, DOI 10.1644/1545-1542(2003)084<0288:RPOWFA>2.0.CO;2; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Maffei L, 2005, J TROP ECOL, V21, P349, DOI 10.1017/S0266467405002397; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; McCarthy KP, 2008, J WILDLIFE MANAGE, V72, P1826, DOI 10.2193/2008-040; McCarthy T, 2003, SNOW LEOPARD SURVIVA; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Nichols James D., 2002, P121; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Shehzad W, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0UMAL.P0NE.0032104; Silver S, 2004, WILDL CONSERV; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Vangen KM, 2001, CAN J ZOOL, V79, P1641, DOI 10.1139/cjz-79-9-1641; Wallace R. B., 2003, Mastozoologia Neotropical, V10, P133; Williams B. K., 2002, ANAL MANAGEMENT ANIM	41	43	47	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101319	10.1371/journal.pone.0101319	http://dx.doi.org/10.1371/journal.pone.0101319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006879	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000339040600034
J	Hwang, SH; Cho, HK; Park, SH; Lee, W; Lee, HJ; Lee, DC; Oh, JH; Park, SH; Kim, TG; Sohn, HJ; Kang, JM; Kim, SW				Hwang, Se Hwan; Cho, Hye Kyung; Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin; Lee, Dong Chang; Oh, Jeong Hoon; Park, Sun Hwa; Kim, Tai-Gyu; Sohn, Hyun-Jung; Kang, Jun Myung; Kim, Sung Won			Toll like Receptor 3 & 4 Responses of Human Turbinate Derived Mesenchymal Stem Cells: Stimulation by Double Stranded RNA and Lipopolysaccharide	PLOS ONE			English	Article							STROMAL CELLS; MULTIPOTENT	Background and objectives: Multipotent mesenchymal stromal cells (MSCs) represent a promising cell-based therapy for a number of inflammatory or autoimmune diseases. Herein, Toll like receptor (TLR) expression by MSCs and their immune regulatory roles are investigated. In this study, we investigated the influence of TLR on the immune response, proliferation, and differentiation potential of human turbinated MSC (hTMSC) cultures in vitro. Subjects and Methods: After isolating hTMSCs from discarded inferior turbinate tissue, FACS analysis was used to assess the expression of TLRs such as TLR2, TLR3, TLR4, and TLR5 in hTMSCs and cell proliferation was assessed using a cell counting kit (CCK)-8. Cytokine and chemokine secretions were analyzed with multiplex immunoassays for IL-1 alpha, IL-1 beta, IL-4, IL-6, IL-8, IL-10, IL-12, IP-10 (CXCL10), RANTES (CCL5), TNF-alpha, GM-CSF, and IFN-gamma. The differentiation potential of hTMSCs was evaluated in the osteogenic, chondogenic, and adipogeinc media and analyzed by histology and gene expression related to differentiation. Results: FACS analysis revealed that TLR3 and TLR4 expression consisted of a relatively high percentage of the surface proteins expressed by hTMSCs. The proliferation of hTMSCs was influenced and significantly increased by the presence of TLR4 agonists. In particular, hTMSCs produced a set of cytokines and chemokines and the expression of IL-6, IL-8, IL-12, IP-10 (CXCL10), RANTES (CCL5), TNF-alpha, and GM-CSF were up-regulated in response to the TLR4 agonist LPS. The osteogenic and adipogeinc differentiation potential of hTMSCs was not affected by TLR agonists. Conclusions: We conclude that TLR4 stimulation affects TLR expression, proliferation, and the immunomodulation potential of hTMSCs. Understanding the mechanism behind TLR's influence on hTMSCs and their immunomodulating properties would be useful for providing a novel target to exploit in the improvement of stem cell-based therapeutic strategies.	[Hwang, Se Hwan; Lee, Dong Chang; Oh, Jeong Hoon; Park, Sun Hwa; Kang, Jun Myung; Kim, Sung Won] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Cho, Hye Kyung] Gachon Univ, Grad Sch Med, Dept Pediat, Inchon, South Korea; [Park, Sang Hi; Lee, WeonSun; Lee, Hee Jin] Catholic Univ Korea, Inst Clin Med Res, Coll Med, Seoul, South Korea; [Park, Sun Hwa; Kim, Sung Won] Catholic Univ Korea, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Kim, Tai-Gyu; Sohn, Hyun-Jung] Catholic Univ Korea, Catholic Hematopoiet Stem Cell Bank, Coll Med, Seoul, South Korea; [Kim, Tai-Gyu] Catholic Univ Korea, Dept Microbiol & Immunol, Coll Med, Seoul, South Korea	Catholic University of Korea; Gachon University; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kang, JM (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	entkjm@catholic.ac.kr; kswent@catholic.ac.kr		Hwang, Se Hwan/0000-0002-2838-7820	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2014R1A2A2A01004325]; Ministry of Education, Science and Technology [2010-0011249]; Research Fund of Seoul St. Mary's Hospital; Catholic Medical Center Research Foundation; Otorhinolaryngology Alumni Fund of the Catholic University of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Research Fund of Seoul St. Mary's Hospital; Catholic Medical Center Research Foundation; Otorhinolaryngology Alumni Fund of the Catholic University of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by by the Ministry of Science, ICT and Future Planning (2014R1A2A2A01004325) and the Ministry of Education, Science and Technology (2010-0011249), Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea, Catholic Institute of Cell Therapy in 2013, the Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program year of 2013, 2012 Research Fund for the Colleague of Catholic University Medical College, the financial support of the Catholic Medical Center Research Foundation made in the program year of 2013, and the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Chen PM, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-49; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2012, OTOLARYNG HEAD NECK, V147, P568, DOI 10.1177/0194599812447172; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Law S, 2013, AM J STEM CELLS, V2, P22; Liang S, 2007, CHINESE MED J-PEKING, V120, P1685, DOI 10.1097/00029330-200710010-00008; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Najar M, 2012, STEM CELL REV REP, V8, P1188, DOI 10.1007/s12015-012-9408-1; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Park HJ, 2012, ACTA OTO-LARYNGOL, V132, pS58, DOI 10.3109/00016489.2012.659756; Raicevic G, 2012, TISSUE ENG PT A, V18, P1410, DOI [10.1089/ten.tea.2011.0434, 10.1089/ten.TEA.2011.0434]; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Seo S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806891; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Wang XB, 2012, EXP CELL RES, V318, P196, DOI 10.1016/j.yexcr.2011.11.001; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088	21	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101558	10.1371/journal.pone.0101558	http://dx.doi.org/10.1371/journal.pone.0101558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004159	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700038
J	Morais, DB; Barros, MS; Paula, TAR; Freitas, MBD; Gomes, MLM; Matta, SLP				Morais, Danielle B.; Barros, Mirlaine S.; Paula, Tarcizio A. R.; Freitas, Mariella B. D.; Gomes, Marcos L. M.; Matta, Sergio L. P.			Evaluation of the Cell Population of the Seminiferous Epithelium and Spermatic Indexes of the Bat Sturnira lilium (Chiroptera: Phyllostomidae)	PLOS ONE			English	Article							MONTANE ATLANTIC FOREST; HISTOMORPHOMETRIC EVALUATION; SPERMATOGENIC EFFICIENCY; SYNAPTONEMAL COMPLEX; TESTIS MORPHOMETRY; MOLOSSUS-MOLOSSUS; CYCLE LENGTH; DURATION; MAMMALIA; BRAZIL	Due to the scarcity of information about patterns of spermatogenesis in bats, this study aimed to provide information on the testicular activity of the bat Sturnira lilium along the annual seasons. Thus, a series of morphometrical and stereological analyses were made using the testes of adult S. lilium in order to achieve a better understanding of the sperm production dynamics. Light and transmission electron microscopy analyses were performed in testicular fragments of animals captured during dry and rainy seasons. The testes followed the pattern of organization described for other mammals, and there were no morphological differences between organs collected either in dry or in rainy seasons. Each tubular cross-section in stage 1 was made of 0.5 type-A spermatogonia, 4.4 primary spermatocytes in preleptotene/leptotene, 3.7 in zygotene, 11.9 in pachytene, 35.6 round spermatids and 8.5 Sertoli cells. The mitotic and meiotic indexes were 15.4 and 2.9 cells, respectively, while the spermatogenesis yield was 68.7 cells. The testicular sperm reserves was 37.61 x 10(6) cells, and daily sperm production per gram of testis averaged 209.68 x 10(6) cells, both highest averages occurring in the rainy season. S. lilium male bats have a continuous reproductive pattern, high spermatogenesis yield and low support capacity by the Sertoli cells.	[Morais, Danielle B.] Univ Fed Rio Grande do Norte, Dept Morphol, BR-59072970 Natal, RN, Brazil; [Barros, Mirlaine S.; Freitas, Mariella B. D.] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [Paula, Tarcizio A. R.] Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil; [Gomes, Marcos L. M.; Matta, Sergio L. P.] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Matta, SLP (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	smatta@ufv.br	Gomes, Marcos/L-5734-2019; Freitas, Mariella B/H-9512-2015	Gomes, Marcos/0000-0003-4397-4609; Freitas, Mariella/0000-0001-5132-242X; Morais, Danielle/0000-0003-3277-1857	FAPEMIG - Research Foundation of the State of Minas Gerais; CAPES - Coordination for the Improvement of Higher Level Personnel	FAPEMIG - Research Foundation of the State of Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES - Coordination for the Improvement of Higher Level Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: FAPEMIG - Research Foundation of the State of Minas Gerais, http://www.fapemig.br; and CAPES - Coordination for the Improvement of Higher Level Personnel, http://www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Almeida FFL, 2006, BIOL REPROD, V75, P792, DOI 10.1095/biolreprod.106.053835; Altringham J D, 1996, BATS BIOL BEHAV, P2; Amann R.P., 1970, TESTIS, V1, P433, DOI DOI 10.1016/B978-0-12-386601-1.50013-5; AMANN RP, 1962, J DAIRY SCI, V45, P774, DOI 10.3168/jds.S0022-0302(62)89487-9; Baker J. R., 1938, P161; Balarini MK, 2012, THERIOGENOLOGY, V77, P873, DOI 10.1016/j.theriogenology.2011.09.011; Beguelini MR, 2011, MICRON, V42, P586, DOI 10.1016/j.micron.2011.02.004; Beguelini MR, 2009, J MORPHOL, V270, P943, DOI 10.1002/jmor.10731; Bernardi I. P., 2011, THESIS FEDERAL U PAR; BERNDTSON WE, 1977, J ANIM SCI, V44, P818, DOI 10.2527/jas1977.445818x; Bittencourt V. L., 2004, Revista Brasileira de Reproducao Animal, V28, P108; Bittencourt VL, 2007, REV CERES, V54, P329; Blanco-Rodriguez J, 1998, INT J ANDROL, V21, P236; Caldeira Bianca Cabral, 2010, Rev. Ceres, V57, P569; Costa KLC, 2011, ANIM REPROD SCI, V127, P202, DOI 10.1016/j.anireprosci.2011.07.016; Costa DS, 2007, ANIM REPROD SCI, V98, P322, DOI 10.1016/j.anireprosci.2006.03.014; Costa GMJ, 2008, THERIOGENOLOGY, V70, P1136, DOI 10.1016/j.theriogenology.2008.06.035; Costa GMJ, 2010, J ANDROL, V31, P489, DOI 10.2164/jandrol.109.009787; Couto D, 2005, ACTA ZOOL-STOCKHOLM, V86, P111, DOI 10.1111/j.1463-6395.2005.00191.x; Crichton E. G., 2000, LIFE HIST REPROD STR, P364; de Barros JBG, 2007, ANIM REPROD SCI, V102, P350, DOI 10.1016/j.anireprosci.2007.04.002; de Azevedo MHF, 2010, ANIM REPROD SCI, V118, P83, DOI 10.1016/j.anireprosci.2009.05.018; Franca LR, 2003, BIOL REPROD, V68, P1554, DOI 10.1095/biolreprod.102.010652; Franca LR, 1998, MALE REPROD MULTIDIS, V197, P219; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; GOLFARI L., 1975, ZONEAMENTO ECOLOGICO; Guiao-Leite F. L., 2003, Revista Brasileira de Reproducao Animal, V27, P21; HAPPOLD DCD, 1990, J ZOOL, V222, P557, DOI 10.1111/j.1469-7998.1990.tb06014.x; HEIDEMAN PD, 1994, BIOL REPROD, V50, P607, DOI 10.1095/biolreprod50.3.607; HERNANDEZ CS, 1986, SOUTHWEST NAT, V31, P331, DOI 10.2307/3671837; Johnson L, 2000, ANIM REPROD SCI, V60, P471, DOI 10.1016/S0378-4320(00)00108-1; Kaku-Oliveira Nathalia Y., 2010, Chiroptera Neotropical, V16, P22; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Kimura M, 2003, J ANDROL, V24, P185; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Leal MC, 2006, BIOL REPROD, V74, P616, DOI 10.1095/biolreprod.105.048074; MARINHOFILHO JS, 1991, J TROP ECOL, V7, P59, DOI 10.1017/S0266467400005083; Mascarenhas RM, 2006, REV CERES, V53, P107; MCGUCKIN MA, 1987, AUST J BIOL SCI, V40, P203; Mello MAR, 2009, CAN J ZOOL, V87, P239, DOI 10.1139/Z09-010; Mello MAR, 2008, J MAMMAL, V89, P485, DOI 10.1644/06-MAMM-A-411R.1; Melo FCSA, 2010, BIOL RES, V43, P445, DOI [/S0716-97602010000400009, 10.4067/S0716-97602010000400009]; Miranda D. C., 2012, THESIS FEDERAL U VIC; Morais DB, 2013, ANIM REPROD SCI, V140, P268, DOI 10.1016/j.anireprosci.2013.06.003; Morais DB, 2013, J ANAT, V222, P372, DOI 10.1111/joa.12016; Morais DB, 2012, ASIAN PAC J REPROD, V1, P303, DOI DOI 10.1016/S2305-0500(13)60097-4; Oliveira RL, 2009, GEN COMP ENDOCR, V161, P283, DOI 10.1016/j.ygcen.2009.01.019; Orsi Antonio Marcos, 1993, Revista Brasileira de Biologia, V53, P583; Passos Fernando C., 2003, Rev. Bras. Zool., V20, P511, DOI 10.1590/S0101-81752003000300024; Paula T.A.R., 2002, BIOSCI J, V18, P121; Paula TAR, 1999, TISSUE CELL, V31, P327, DOI 10.1054/tice.1999.0039; REIS N. R., 2007, SUBFAMILIA STERNODER; ROOSENRU.EC, 1973, J REPROD FERTIL, V35, P339; Russell L. D., 1993, SERTOLI CELL; RUSSELL LD, 1984, J REPROD FERTIL, V70, P635, DOI 10.1530/jrf.0.0700635; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Saidapur S. K., 1992, Indian Journal of Experimental Biology, V30, P1037; Sazima M, 2003, ANN BOT-LONDON, V92, P725, DOI 10.1093/aob/mcg190; SINGWI MS, 1983, ACTA ANAT, V116, P136; TADDEI V A, 1976, Boletim de Zoologia, V1, P313; Wilson D.E., 1979, Texas Tech University Museum Special Publications, P317; Xie Wen-Jun, 2012, Yichuan, V34, P167, DOI 10.3724/SP.J.1005.2012.00167; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Zhengwei Y, 1997, J Androl, V18, P681; Zortea M, 2008, BIODIVERS CONSERV, V17, P1	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101759	10.1371/journal.pone.0101759	http://dx.doi.org/10.1371/journal.pone.0101759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003782	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700062
J	Ponnuchamy, R; Bonhomme, V; Prasad, S; Das, L; Patel, P; Gaucherel, C; Pragasam, A; Anupama, K				Ponnuchamy, Raja; Bonhomme, Vincent; Prasad, Srinivasan; Das, Lipi; Patel, Prakash; Gaucherel, Cedric; Pragasam, Arunachalam; Anupama, Krishnamurthy			Honey Pollen: Using Melissopalynology to Understand Foraging Preferences of Bees in Tropical South India	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; CONSERVATION; FORESTS; RESTORATION; POLLINATION; FREQUENCY; GRADIENT; PLANTS; TREES	The aim of the study was to use melissopalynology to delineate the foraging preferences of bees in tropical environs. This was done by comparing pollen spectra obtained from the same hives every three months for three years at four sampling locations (in two sites) within a confined landscape mosaic. If melissopalynology is highly replicable, the spatial variation of the pollen spectrum from the honey samples would be much more than the temporal (inter-annual) variations. In other words, given the three factors, Month, Year and Location, honey pollen from different Locations, in a given Year and Month, would be much less similar than samples from different Years, in a given Location and Month. We then determined how the factors, Month, Year and Location, influenced the pollen influx of honey. The pollen analyses of the 42 honey samples collected during the three years yielded 80 pollen taxa/types: 72 dicotyledonous and 8 monocotyledonous, encompassing 41 botanical families spread into seven life forms namely, trees, shrubs, epiphytes, herbs, climbers, grasses, and sedges. Our results showed that pollen spectra were equally comparable between Locations and between Months and Years; the importance of this result is that it helped to demonstrate the complexity of ecological/environmental phenomena involved in the process of foraging by bees in a heterogeneous and complex landscape.	[Ponnuchamy, Raja; Bonhomme, Vincent; Prasad, Srinivasan; Gaucherel, Cedric; Anupama, Krishnamurthy] UMIFRE 21 CNRS MAEE USR 3330, French Inst Pondicherry, Dept Ecol, Pondicherry, India; [Pragasam, Arunachalam] Kanchi Mamunivar Ctr Postgrad Studies, Dept Bot, Pondicherry, India; [Das, Lipi; Patel, Prakash] Sri Aurobindo Int Ctr Educ, Pondicherry, India	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Kanchi Mamunivar Government Institute for Post graduate Studies & Research	Anupama, K (corresponding author), UMIFRE 21 CNRS MAEE USR 3330, French Inst Pondicherry, Dept Ecol, Pondicherry, India.	anupama.k@ifpindia.org		Vincent, Bonhomme/0000-0002-2742-6349	French Institute of Pondicherry	French Institute of Pondicherry	Ms. Sieglind D'Arcy provided financial support through a donation that helped provide a Doctoral fellowship to the first author ( RP). She had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other funding is available for this project. Publication fee has been provided by The French Institute of Pondicherry.	Aronne G, 2010, PLANT BIOSYST, V144, P833, DOI 10.1080/11263504.2010.514125; Baldock KCR, 2011, ECOLOGY, V92, P687, DOI 10.1890/10-1110.1; Bawa KS, 2003, AM J BOT, V90, P877, DOI 10.3732/ajb.90.6.877; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bhargava HR., 2009, APIACTA, V44, P14; Bilisik A, 2008, GRANA, V47, P70, DOI 10.1080/00173130801923976; Bogdanov S, 2007, J APICULT RES, V46, P269, DOI 10.1080/00218839.2007.11101407; Borchert R, 2004, GLOBAL ECOL BIOGEOGR, V13, P409, DOI 10.1111/j.1466-822X.2004.00111.x; Bryant V. M., 2001, PALYNOLOGY, V25, P11, DOI DOI 10.1080/01916122.2001.9989554; Champion H. G., 1968, REVISED SURVEY FORES, P404; Corbella E, 2008, CHIL J AGR RES, V68, P102, DOI 10.4067/S0718-58392008000100010; Corlett RT, 2004, BIOL REV, V79, P497, DOI 10.1017/S1464793103006341; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; ERDTMAN G., 1960, SVENSK BOT TIDSKR, V54, P561; Erdtman G., 1969, HDB PALYNOLOGY MORPH; Faegri K., 1898, J BIOGEOGR, V12, P238; Grim EC, 1987, TILIA TILIA GRAPH; HERRERA CM, 1995, ECOLOGY, V76, P218, DOI 10.2307/1940644; Herrero B, 2002, CAN J PLANT SCI, V82, P75, DOI 10.4141/P00-187; Huang T. C., 1972, POLLEN FLORA TAIWAN; JATO MV, 1994, GRANA, V33, P260, DOI 10.1080/00173139409429008; Jens MO, 2008, ECOLOGY, V89, P1573, DOI DOI 10.1890/07-0451.1; JHANSI P, 1994, APIDOLOGIE, V25, P289, DOI 10.1051/apido:19940303; Jones Gretchen D., 1992, Palynology, V16, P63, DOI 10.1080/01916122.1992.9989407; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Maurizio A., 1975, HONEY A COMPREHENSIV, P240; Meher-Homji VM, 1966, INDIAN GEOGRAPHICAL, V41, P9; Meher- Homji VM, 1974, J ECOLOGY ENV SCI, V1, P19; MOAR NT, 1985, NEW ZEAL J AGR RES, V28, P39, DOI 10.1080/00288233.1985.10426997; Montenegro Gloria, 2010, Braz. J. Bot., V33, P615, DOI 10.1590/S0100-84042010000400010; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nair PKK, 1964, J INDIAN BOT SOC, V43, P171; Nascimento DL, 2012, EXTREME EFFECTS SEAS, V2012, DOI [10.1155/2012/267361, DOI 10.1155/2012/267361]; Nayar TS., 1990, POLLEN FLORA MAHARAS; OKSANEN FJ, 2011, VEGAN COMMUNITY ECOL; Oldroyd BP, 2009, APIDOLOGIE, V40, P296, DOI 10.1051/apido/2009021; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Parthasarathy N, 2008, TROP CONSERV SCI, V1, P89, DOI 10.1177/194008290800100203; Pragasam A., 2013, CHECK LIST, V9, P555, DOI 10.15560/9.3.555; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Ramanujam C.C.K., 1992, Geophytology, V22, P261; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Rivera G, 2001, TREE PHYSIOL, V21, P201, DOI 10.1093/treephys/21.4.201; Sajwani A, 2007, PALYNOLOGY, V31, P63, DOI 10.2113/gspalynol.31.1.63; Sajwani A, 2014, PALYNOLOGY, V38, P207, DOI 10.1080/01916122.2013.871652; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Selva Singh Richard P, 2011, INDIAN FOR, V137, P962; SHARMA M, 1970, Grana, V10, P35, DOI 10.1080/00173137009429855; SIVARAJ N, 1989, VEGETATIO, V79, P85, DOI 10.1007/BF00044851; Song XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049545; Thomas SG, 2009, TROP ECOL, V50, P79; Tissot C., 1994, POLLEN WET EVERGREEN; Todd FE, 1942, J ECON ENTOMOL, V35, P728, DOI 10.1093/jee/35.5.728; Vasanthy G., 1976, POLLEN S INDIAN HILL; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Waters R, 1915, J AGR, V11, P213; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Wodehouse RP., 1959, POLLEN GRAINS THEIR	59	21	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101618	10.1371/journal.pone.0101618	http://dx.doi.org/10.1371/journal.pone.0101618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004103	Green Published, gold			2022-12-25	WOS:000339242700046
J	DebRoy, A; Vogel, SM; Soni, D; Sundivakkam, PC; Malik, AB; Tiruppathi, C				DebRoy, Auditi; Vogel, Stephen M.; Soni, Dheeraj; Sundivakkam, Premanand C.; Malik, Asrar B.; Tiruppathi, Chinnaswamy			Cooperative Signaling via Transcription Factors NF-kappa B and AP1/c-Fos Mediates Endothelial Cell STIM1 Expression and Hyperpermeability in Response to Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 Transcription Factor (AP-1); Calcium; Endothelium; Gene Regulation; NF-B Transcription Factor; p38 MAPK; Permeability; Sepsis; Thrombin	PROTEASE-ACTIVATED RECEPTOR-1; RESPIRATORY-DISTRESS-SYNDROME; TRPC1 EXPRESSION; MAPK PATHWAYS; SEVERE SEPSIS; CA2+ INFLUX; ENTRY; ORAI1; INFLAMMATION; THROMBIN	Background: STIM1 activates store-operated Ca2+ entry (SOCE). The transcriptional regulation of STIM1 during sepsis is not known. Results: STIM1 expression occurs downstream of TLR4 via activation of NF-B and p38-mediated c-Fos expression in endothelial cells. Conclusion: Cooperative signaling of NF-B and p38 MAPK downstream of TLR4 is essential for STIM1 expression during sepsis. Significance: Selective p38 inhibitors may represent a potential therapeutic strategy to prevent sepsis-mediated lung vascular leaks. Stromal interacting molecule 1 (STIM1) regulates store-operated Ca2+ entry (SOCE). Here we show that STIM1 expression in endothelial cells (ECs) is increased during sepsis and, therefore, contributes to hyperpermeability. LPS induced STIM1 mRNA and protein expression in human and mouse lung ECs. The induced STIM1 expression was associated with augmented SOCE as well as a permeability increase in both in vitro and in vivo models. Because activation of both the NF-B and p38 MAPK signaling pathways downstream of TLR4 amplifies vascular inflammation, we studied the influence of these two pathways on LPS-induced STIM1 expression. Inhibition of either NF-B or p38 MAPK activation by pharmacological agents prevented LPS-induced STIM1 expression. Silencing of the NF-B proteins (p65/RelA or p50/NF-B1) or the p38 MAPK isoform p38 prevented LPS-induced STIM1 expression and increased SOCE in ECs. In support of these findings, we found NF-B and AP1 binding sites in the 5-regulatory region of human and mouse STIM1 genes. Further, we demonstrated that LPS induced time-dependent binding of the transcription factors NF-B (p65/RelA) and AP1 (c-Fos/c-Jun) to the STIM1 promoter. Interestingly, silencing of c-Fos, but not c-Jun, markedly reduced LPS-induced STIM1 expression in ECs. We also observed that silencing of p38 prevented c-Fos expression in response to LPS in ECs, suggesting that p38 signaling mediates the expression of c-Fos. These results support the proposal that cooperative signaling of both NF-B and AP1 (via p38) amplifies STIM1 expression in ECs and, thereby, contributes to the lung vascular hyperpermeability response during sepsis.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tiruppathi, C (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC868, 835 S Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu	Soni, Dheeraj/P-5496-2017	Soni, Dheeraj/0000-0002-5555-2051; Malik, Asrar/0000-0002-8205-7128	National Institutes of Health Grant [P01HL077806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL077806 (Project 3).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Baghai-Ravary R., 2006, ADV SEPSIS, V5, P42; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Fazal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059965; Ferreiro I, 2010, J BIOL CHEM, V285, P31819, DOI 10.1074/jbc.M110.155846; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Huang QJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-18; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Kandasamy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063465; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Lowry JL, 2013, J BIOL CHEM, V288, P4174, DOI 10.1074/jbc.M112.436022; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mayer R.J., 2006, DRUG DISCOV TODAY TH, V3, P49; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sehnert B, 2013, P NATL ACAD SCI USA, V110, P16556, DOI 10.1073/pnas.1218219110; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Tiruppathi C, 2014, NAT IMMUNOL, V15, P239, DOI 10.1038/ni.2823; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020	51	40	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24188	24201		10.1074/jbc.M114.570051	http://dx.doi.org/10.1074/jbc.M114.570051			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016017	Green Published, hybrid			2022-12-25	WOS:000341505600017
J	Hart, BL; Hart, LA; Thigpen, AP; Willits, NH				Hart, Benjamin L.; Hart, Lynette A.; Thigpen, Abigail P.; Willits, Neil H.			Long-Term Health Effects of Neutering Dogs: Comparison of Labrador Retrievers with Golden Retrievers	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; RISK-FACTORS; GONADECTOMY; CANCER; TUMORS; BREED; CATS; AGE; ASSOCIATIONS; ANIMALS	Our recent study on the effects of neutering (including spaying) in Golden Retrievers in markedly increasing the incidence of two joint disorders and three cancers prompted this study and a comparison of Golden and Labrador Retrievers. Veterinary hospital records were examined over a 13-year period for the effects of neutering during specified age ranges: before 6 mo., and during 6-11 mo., year 1 or years 2 through 8. The joint disorders examined were hip dysplasia, cranial cruciate ligament tear and elbow dysplasia. The cancers examined were lymphosarcoma, hemangiosarcoma, mast cell tumor, and mammary cancer. The results for the Golden Retriever were similar to the previous study, but there were notable differences between breeds. In Labrador Retrievers, where about 5 percent of gonadally intact males and females had one or more joint disorders, neutering at <6 mo. doubled the incidence of one or more joint disorders in both sexes. In male and female Golden Retrievers, with the same 5 percent rate of joint disorders in intact dogs, neutering at <6 mo. increased the incidence of a joint disorder to 4-5 times that of intact dogs. The incidence of one or more cancers in female Labrador Retrievers increased slightly above the 3 percent level of intact females with neutering. In contrast, in female Golden Retrievers, with the same 3 percent rate of one or more cancers in intact females, neutering at all periods through 8 years of age increased the rate of at least one of the cancers by 3-4 times. In male Golden and Labrador Retrievers neutering had relatively minor effects in increasing the occurrence of cancers. Comparisons of cancers in the two breeds suggest that the occurrence of cancers in female Golden Retrievers is a reflection of particular vulnerability to gonadal hormone removal.	[Hart, Benjamin L.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Hart, Lynette A.; Thigpen, Abigail P.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Willits, Neil H.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hart, BL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	blhart@ucdavis.edu	Fiumefreddo, Andrea/T-2977-2019; Hart, Lynette/L-4833-2019	Hart, Lynette/0000-0002-7133-6535; hart, benjamin/0000-0003-2342-6058	Canine Health Foundation [01488-A]; Center for Companion Animal Health University of California, Davis [2009-54-F/M]	Canine Health Foundation; Center for Companion Animal Health University of California, Davis(University of California System)	This work was supported by the Canine Health Foundation (#01488-A) and the Center for Companion Animal Health University of California, Davis (# 2009-54-F/M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin K, 2010, J AM ANIM HOSP ASSOC, V46, P285, DOI 10.5326/0460285; Beauvais W, 2012, J SMALL ANIM PRACT, V53, P314, DOI 10.1111/j.1748-5827.2011.01220.x; CONCANNON PW, 1993, J REP FER S, P3; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; COX DR, 1972, J R STAT SOC B, V34, P187; de la Riva GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055937; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Dobson Jane M, 2013, ISRN Vet Sci, V2013, P941275, DOI 10.1155/2013/941275; Duerr FM, 2007, JAVMA-J AM VET MED A, V231, P1688, DOI 10.2460/javma.231.11.1688; Duval JM, 1999, J AM VET MED ASSOC, V215, P811; Fields MJ, 2004, BIOL REPROD, V71, P1412, DOI 10.1095/biolreprod.104.027201; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Hart BL, 2001, J AM VET MED ASSOC, V219, P51, DOI 10.2460/javma.2001.219.51; Hart BL, 1988, PERFECT PUPPY CHOOSE; Hoffman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061082; Kasstrom H, 1975, Acta Radiol Suppl, V344, P135; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; PRYMAK C, 1988, J AM VET MED ASSOC, V193, P706; Reichler IM, 2008, VET DERMATOL, V19, P77, DOI 10.1111/j.1365-3164.2008.00652.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Sallander M, 2001, ACTA VET SCAND, V42, P71, DOI 10.1186/1751-0147-42-71; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; Trevejo R, 2011, JAVMA-J AM VET MED A, V238, P898, DOI 10.2460/javma.238.7.898; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Villamil JA, 2009, J CANCER EPIDEMIOL, V2009, DOI [10.1155/2009/591753, 10.1155/2009/747803]; Ware WA, 1999, J VET INTERN MED, V13, P95, DOI 10.1892/0891-6640(1999)013&lt;0095:CTID&gt;2.3.CO;2; White CR, 2011, J AM ANIM HOSP ASSOC, V47, P210, DOI 10.5326/JAAHA-MS-5621; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Zink MC, 2014, JAVMA-J AM VET MED A, V244, P309, DOI 10.2460/javma.244.3.309	33	66	66	2	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102241	10.1371/journal.pone.0102241	http://dx.doi.org/10.1371/journal.pone.0102241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020045	gold, Green Published			2022-12-25	WOS:000339618600057
J	Guan, XM; Bidlack, FB; Stokes, N; Bartlett, JD				Guan, Xiaomu; Bidlack, Felicitas B.; Stokes, Nicole; Bartlett, John D.			E-Cadherin Can Replace N-Cadherin during Secretory-Stage Enamel Development	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; VASCULAR MORPHOGENESIS; RAT INCISOR; AMELOBLASTS; EXPRESSION; LEADS; AMELOGENESIS; JUNCTIONS; ADHESION	Background: N-cadherin is a cell-cell adhesion molecule and deletion of N-cadherin in mice is embryonic lethal. During the secretory stage of enamel development, E-cadherin is down-regulated and N-cadherin is specifically up-regulated in ameloblasts when groups of ameloblasts slide by one another to form the rodent decussating enamel rod pattern. Since N-cadherin promotes cell migration, we asked if N-cadherin is essential for ameloblast cell movement during enamel development. Methodology/Principal Findings: The enamel organ, including its ameloblasts, is an epithelial tissue and for this study a mouse strain with N-cadherin ablated from epithelium was generated. Enamel from wild-type (WT) and N-cadherin conditional knockout (cKO) mice was analyzed. mu CT and scanning electron microscopy showed that thickness, surface structure, and prism pattern of the cKO enamel looked identical to WT. No significant difference in hardness was observed between WT and cKO enamel. Interestingly, immunohistochemistry revealed the WT and N-cadherin cKO secretory stage ameloblasts expressed approximately equal amounts of total cadherins. Strikingly, E-cadherin was not normally down-regulated during the secretory stage in the cKO mice suggesting that E-cadherin can compensate for the loss of N-cadherin. Previously it was demonstrated that bone morphogenetic protein-2 (BMP2) induces E- and N-cadherin expression in human calvaria osteoblasts and we show that the N-cadherin cKO enamel organ expressed significantly more BMP2 and significantly less of the BMP antagonist Noggin than did WT enamel organ. Conclusions/Significance: The E- to N-cadherin switch at the secretory stage is not essential for enamel development or for forming the decussating enamel rod pattern. E- cadherin can substitute for N-cadherin during these developmental processes. Bmp2 expression may compensate for the loss of N-cadherin by inducing or maintaining E-cadherin expression when E- cadherin is normally down-regulated. Notably, this is the first demonstration of a natural endogenous increase in E-cadherin expression due to N-cadherin ablation in a healthy developing tissue.	[Guan, Xiaomu; Bidlack, Felicitas B.; Bartlett, John D.] Dept Mineralized Tissue Biol, Cambridge, MA 02142 USA; [Guan, Xiaomu; Bidlack, Felicitas B.; Bartlett, John D.] Harvard Univ, Sch Dent Med, Forsyth Inst, Cambridge, MA 02138 USA; [Stokes, Nicole] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Howard Hughes Medical Institute; Rockefeller University	Bartlett, JD (corresponding author), Dept Mineralized Tissue Biol, Cambridge, MA 02142 USA.	jbartlett@forsyth.org	Bartlett, John/L-9832-2017	Bartlett, John/0000-0003-2052-6299; Bidlack, Felicitas/0000-0001-8105-223X	National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01DE016276]; National Institutes of Health [1S10RR027553-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016276] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Research reported in this publication was supported by National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number R01DE016276 (JDB). The Forsyth Institute micro-CT Core is partly supported by National Institutes of Health grant 1S10RR027553-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012703; Brieher WM, 2013, CURR OPIN CELL BIOL, V25, P39, DOI 10.1016/j.ceb.2012.10.010; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Cheng L, 2011, J BIOL CHEM, V286, P20478, DOI 10.1074/jbc.M111.218560; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Guan X, 2013, J DENT RES, V92, P1123, DOI 10.1177/0022034513506581; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Johansson JK, 2010, GENESIS, V48, P374, DOI 10.1002/dvg.20628; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Libusova L, 2010, DEVELOPMENT, V137, P2297, DOI 10.1242/dev.048488; Luo Y, 2001, DEVELOPMENT, V128, P459; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; NISHIKAWA S, 1988, EUR J CELL BIOL, V47, P222; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piven OO, 2011, EXP BIOL MED, V236, P816, DOI 10.1258/ebm.2011.010362; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Radice GL, 2013, PROG MOL BIOL TRANSL, V116, P263, DOI 10.1016/B978-0-12-394311-8.00012-1; REITH EJ, 1973, ARCH ORAL BIOL, V18, P445, DOI 10.1016/0003-9969(73)90170-2; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; RISNES S, 1979, ARCH ORAL BIOL, V24, P299, DOI 10.1016/0003-9969(79)90092-X; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102153	10.1371/journal.pone.0102153	http://dx.doi.org/10.1371/journal.pone.0102153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014356	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400072
J	Guimier, A; Ferrand, S; Pierron, G; Couturier, J; Janoueix-Lerosey, I; Combaret, V; Mosseri, V; Thebaud, E; Gambart, M; Plantaz, D; Marabelle, A; Coze, C; Rialland, X; Fasola, S; Lapouble, E; Freneaux, P; Peuchmaur, M; Michon, J; Delattre, O; Schleiermacher, G				Guimier, Anne; Ferrand, Sandrine; Pierron, Gaelle; Couturier, Jerome; Janoueix-Lerosey, Isabelle; Combaret, Valerie; Mosseri, Veronique; Thebaud, Estelle; Gambart, Marion; Plantaz, Dominique; Marabelle, Aurelien; Coze, Carole; Rialland, Xavier; Fasola, Sylvie; Lapouble, Eve; Freneaux, Paul; Peuchmaur, Michel; Michon, Jean; Delattre, Olivier; Schleiermacher, Gudrun			Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN	PLOS ONE			English	Article							ACTIVATING MUTATIONS; GENE AMPLIFICATION; SOLID TUMORS; ALK KINASE; ARRAY-CGH; MDM2; EXPRESSION; AMPLICONS; PATTERN; CANCER	Background: Somatically acquired genomic alterations with MYCN amplification (MNA) are key features of neuroblastoma (NB), the most common extra-cranial malignant tumour of childhood. Little is known about the frequency, clinical characteristics and outcome of NBs harbouring genomic amplification(s) distinct from MYCN. Methods: Genomic profiles of 1100 NBs from French centres studied by array-CGH were re-examined specifically to identify regional amplifications. Patients were included if amplifications distinct from the MYCN locus were seen. A subset of NBs treated at Institut Curie and harbouring MNA as determined by array-CGH without other amplification was also studied. Clinical and histology data were retrospectively collected. Results: In total, 56 patients were included and categorised into 3 groups. Group 1 (n = 8) presented regional amplification(s) without MNA. Locus 12q13-14 was a recurrent amplified region (4/8 cases). This group was heterogeneous in terms of INSS stages, primary localisations and histology, with atypical clinical features. Group 2 (n = 26) had MNA as well as other regional amplifications. These patients shared clinical features of those of a group of NBs MYCN amplified (Group 3, n = 22). Overall survival for group 1 was better than that of groups 2 and 3 (5 year OS: 87.5%+/- 11% vs 34.9%+/- 7%, log-rank p<0.05). Conclusion: NBs harbouring regional amplification(s) without MNA are rare and seem to show atypical features in clinical presentation and genomic profile. Further high resolution genetic explorations are justified in this heterogeneous group, especially when considering these alterations as predictive markers for targeted therapy.	[Guimier, Anne; Michon, Jean; Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Ferrand, Sandrine; Pierron, Gaelle; Couturier, Jerome; Lapouble, Eve] Inst Curie, Unite Genet Somat, Paris, France; [Janoueix-Lerosey, Isabelle; Delattre, Olivier; Schleiermacher, Gudrun] INSERM, Inst Curie, U830, Lab Genet & Biol Canc, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translationnelle, F-69373 Lyon, France; [Mosseri, Veronique] Inst Curie, Serv Biostat, Paris, France; [Thebaud, Estelle] CHU Nantes, Serv Hematooncol Pediat, F-44035 Nantes 01, France; [Gambart, Marion] CHU Toulouse, Serv Hematooncol Pediat, Toulouse, France; [Plantaz, Dominique] CHU Grenoble, Serv Hematooncol Pediat, F-38043 Grenoble, France; [Marabelle, Aurelien] Ctr Lutte Canc Leon Berard, Inst Hematol & Oncol Pediat, Lyon, France; [Coze, Carole] Aix Marseille Univ, Marseille, France; [Coze, Carole] Hop Enfants La Timone, APHM, Serv Hematooncol Pediat, Marseille, France; [Rialland, Xavier] CHU Angers, Serv Hematooncol Pediat, Angers, France; [Fasola, Sylvie] Hop Trousseau, Serv Hematooncol Pediat, F-75571 Paris, France; [Freneaux, Paul] Inst Curie, Anat Pathol Lab, Paris, France; [Peuchmaur, Michel] Hop Univ Robert Debre, AP HP, Serv Pathol, Paris, France; [Peuchmaur, Michel] Univ Paris 07, Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Nantes Universite; CHU de Nantes; CHU de Toulouse; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Schleiermacher, G (corresponding author), Inst Curie, Dept Pediat, Paris, France.	gudrun.schleiermacher@curie.net	GAMBART, Marion/AAR-4551-2020; Schleiermacher, Gudrun/AAN-4711-2021; marabelle, aurelien/AAP-3791-2021; Janoueix-Lerosey, Isabelle/G-1758-2018	Schleiermacher, Gudrun/0000-0002-0133-5879; marabelle, aurelien/0000-0002-5816-3019; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Guimier, Anne/0000-0002-4759-0621; delattre, olivier/0000-0002-8730-2276	Annenberg foundation; Institut National de la Sante et de la Recherche Medicale; Ligue Nationale contre le Cancer (Equipe labellisee);  [PHRC AOM 02014];  [PHRC IC2007-09]	Annenberg foundation; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); ; 	This study was partly supported by the Annenberg foundation. This work was also supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Ligue Nationale contre le Cancer (Equipe labellisee) and the PHRC AOM 02014 and PHRC IC2007-09. The construction of the BAC/PAC array was supported by grants from the Carte d'Identite des Tumeurs program of the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Berner JM, 1996, GENE CHROMOSOME CANC, V17, P254, DOI 10.1002/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2; Bielle F, 2012, AM J SURG PATHOL, V36, P1141, DOI 10.1097/PAS.0b013e31825a6895; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Carr J, 2007, CANCER GENET CYTOGEN, V172, P127, DOI 10.1016/j.cancergencyto.2006.08.012; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; CORVI R, 1995, ONCOGENE, V10, P1081; Fix A, 2004, GENE CHROMOSOME CANC, V40, P266, DOI 10.1002/gcc.20041; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mejia-Guerrero S, 2010, GENE CHROMOSOME CANC, V49, P518, DOI 10.1002/gcc.20761; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2003, GENE CHROMOSOME CANC, V36, P242, DOI 10.1002/gcc.10166; Mosse YP, 2007, GENE CHROMOSOME CANC, V46, P936, DOI 10.1002/gcc.20477; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Reifenberger G, 1996, CANCER RES, V56, P5141; Rubie H, 1997, J CLIN ONCOL, V15, P1171, DOI 10.1200/JCO.1997.15.3.1171; Ryan SL, 2012, ACTA NEUROPATHOL, V123, P501, DOI 10.1007/s00401-011-0923-y; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2012, BRIT J CANCER, V107, P1418, DOI 10.1038/bjc.2012.375; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Schwab M, 1999, SEMIN CANCER BIOL, V9, P319, DOI 10.1006/scbi.1999.0126; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Su WT, 2004, CANCER GENET CYTOGEN, V154, P131, DOI 10.1016/j.cancergencyto.2004.02.009; Tomioka N, 2008, ONCOGENE, V27, P441, DOI 10.1038/sj.onc.1210661; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Wang LL, 2013, CANCER-AM CANCER SOC, V119, P3718, DOI 10.1002/cncr.28251; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51	42	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101990	10.1371/journal.pone.0101990	http://dx.doi.org/10.1371/journal.pone.0101990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013904	Green Submitted, gold, Green Published			2022-12-25	WOS:000339378400051
J	Halasa, T; Boklund, A				Halasa, Tariq; Boklund, Anette			The Impact of Resources for Clinical Surveillance on the Control of a Hypothetical Foot-and-Mouth Disease Epidemic in Denmark	PLOS ONE			English	Article							CONTROL STRATEGIES; SIMULATION-MODEL; VACCINATION; SPREAD	The objectives of this study were to assess whether current surveillance capacity is sufficient to fulfill EU and Danish regulations to control a hypothetical foot-and-mouth disease (FMD) epidemic in Denmark, and whether enlarging the protection and/or surveillance zones could minimize economic losses. The stochastic spatial simulation model DTU-DADS was further developed to simulate clinical surveillance of herds within the protection and surveillance zones and used to model spread of FMD between herds. A queuing system was included in the model, and based on daily surveillance capacity, which was 450 herds per day, it was decided whether herds appointed for surveillance would be surveyed on the current day or added to the queue. The model was run with a basic scenario representing the EU and Danish regulations, which includes a 3 km protection and 10 km surveillance zone around detected herds. In alternative scenarios, the protection zone was enlarged to 5 km, the surveillance zone was enlarged to 15 or 20 km, or a combined enlargement of the protection and surveillance zones was modelled. Sensitivity analysis included changing surveillance capacity to 200, 350 or 600 herds per day, frequency of repeated visits for herds in overlapping surveillance zones from every 14 days to every 7, 21 and 30 days, and the size of the zones combined with a surveillance capacity increased to 600 herds per day. The results showed that the default surveillance capacity is sufficient to survey herds on time. Extra resources for surveillance did not improve the situation, but fewer resources could result in larger epidemics and costs. Enlarging the protection zone was a better strategy than the basic scenario. Despite that enlarging the surveillance zone might result in shorter epidemic duration, and lower number of affected herds, it resulted frequently in larger economic losses.	[Halasa, Tariq; Boklund, Anette] Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Copenhagen, Denmark	Technical University of Denmark	Halasa, T (corresponding author), Tech Univ Denmark, Natl Vet Inst, Epidemiol Sect, Copenhagen, Denmark.	tahbh@vet.dtu.dk	Boklund, Anette/HGE-8502-2022	Boklund, Anette/0000-0001-6359-3403; Halasa, Tariq/0000-0003-1112-0254	Danish Veterinary Authorities	Danish Veterinary Authorities	This study was funded by the Danish Veterinary Authorities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I., 2002, FOOT MOUTH DIS 2001; [Anonymous], 2003, OFF J EUR UNION L, V306, P46; Backer JA, 2012, PREV VET MED, V107, P27, DOI 10.1016/j.prevetmed.2012.05.012; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Boklund A, 2013, PREV VET MED, V111, P206, DOI 10.1016/j.prevetmed.2013.05.008; Boklund A, 2009, PREV VET MED, V90, P180, DOI 10.1016/j.prevetmed.2009.04.008; Cox SJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008051; Danish Contingency Plan, 2004, MUND OG KLOV BER OP, V19, P2860; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Halasa T, 2013, PREV VET MED, V112, P194, DOI 10.1016/j.prevetmed.2013.09.003; Halasa T, 2011, PREV VET MED, V98, P1, DOI 10.1016/j.prevetmed.2010.08.005; Halasa T, 2014, PLOS ONE, DOI [10.1371/journalpone.0092521., DOI 10.1371/JOURNALPONE.0092521]; Hutber AM, 2006, RES VET SCI, V81, P31, DOI 10.1016/j.rvsc.2005.09.014; Junker F., 2009, OECD FOOD AGR FISHER, DOI [10.1787/18156797, DOI 10.1787/221275827814]; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Martinez-Lopez B, 2010, PREV VET MED, V96, P19, DOI 10.1016/j.prevetmed.2010.05.015; Pendell D. L., 2007, Journal of Agricultural and Applied Economics, V39, P19; Perez AM, 2004, PREV VET MED, V65, P217, DOI 10.1016/j.prevetmed.2004.08.002; R Core Team, 2016, R FDN STAT COMP; Velthuis AGJ, 2007, PREV VET MED, V82, P262, DOI 10.1016/j.prevetmed.2007.05.023; Ward MP, 2009, PREV VET MED, V88, P286, DOI 10.1016/j.prevetmed.2008.12.006	23	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102480	10.1371/journal.pone.0102480	http://dx.doi.org/10.1371/journal.pone.0102480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014351	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400097
J	Widmann, M; Pleiss, J				Widmann, Michael; Pleiss, Juergen			Protein Variants Form a System of Networks: Microdiversity of IMP Metallo-Beta-Lactamases	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANCIENT GENES; SCHEME	Genome and metagenome sequencing projects support the view that only a tiny portion of the total protein microdiversity in the biosphere has been sequenced yet, while the vast majority of existing protein variants is still unknown. By using a network approach, the microdiversity of 42 metallo-beta-lactamases of the IMP family was investigated. In the networks, the nodes are formed by the variants, while the edges correspond to single mutations between pairs of variants. The 42 variants were assigned to 7 separate networks. By analyzing the networks and their relationships, the structure of sequence space was studied and existing, but still unknown, functional variants were predicted. The largest network consists of 10 variants with IMP-1 in its center and includes two ubiquitous mutations, V67F and S262G. By relating the corresponding pairs of variants, the networks were integrated into a single system of networks. The largest network also included a quartet of variants: IMP-1, two single mutants, and the respective double mutant. The existence of quartets indicates that if two mutations resulted in functional enzymes, the double mutant may also be active and stable. Therefore, quartet construction from triplets was applied to predict 15 functional variants. Further functional mutants were predicted by applying the two ubiquitous mutations in all networks. In addition, since the networks are separated from each other by 10-15 mutations on average, it is expected that a subset of the theoretical intermediates are functional, and therefore are supposed to exist in the biosphere. Finally, the network analysis helps to distinguish between epistatic and additive effects of mutations; while the presence of correlated mutations indicates a strong interdependency between the respective positions, the mutations V67F and S262G are ubiquitous and therefore background independent.	[Widmann, Michael; Pleiss, Juergen] Univ Stuttgart, Inst Tech Biochem, D-70174 Stuttgart, Germany	University of Stuttgart	Pleiss, J (corresponding author), Univ Stuttgart, Inst Tech Biochem, D-70174 Stuttgart, Germany.	Juergen.Pleiss@itb.uni-stuttgart.de			Deutsche Forschungsgemeinschaft [FOR1296]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MW and JP are grateful to the Deutsche Forschungsgemeinschaft (FOR1296) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dryden DTF, 2008, J R SOC INTERFACE, V5, P953, DOI 10.1098/rsif.2008.0085; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; Gabor E, 2012, J MOL BIOL, V418, P16, DOI 10.1016/j.jmb.2012.02.015; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Holmes B, 2004, NEW SCI, V184, P6; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Maughan H, 2002, MOL BIOL EVOL, V19, P1637, DOI 10.1093/oxfordjournals.molbev.a004227; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Nakhleh L, 2005, 2005 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P93, DOI 10.1109/CSB.2005.47; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Oelschlaeger P, 2008, J INORG BIOCHEM, V102, P2043, DOI 10.1016/j.jinorgbio.2008.05.007; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; Page MGP, 2010, ANTIMICROB AGENTS CH, V54, P2291, DOI 10.1128/AAC.01525-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Widmann M, 2012, ANTIMICROB AGENTS CH, V56, P3481, DOI 10.1128/AAC.00255-12; Wright GD, 2012, TRENDS MICROBIOL, V20, P157, DOI 10.1016/j.tim.2012.01.002	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101813	10.1371/journal.pone.0101813	http://dx.doi.org/10.1371/journal.pone.0101813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013948	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400037
J	Wyllie, AL; Chu, MLJN; Schellens, MHB; Gastelaars, JVE; Jansen, MD; van der Ende, A; Bogaert, D; Sanders, EAM; Trzcinski, K				Wyllie, Anne L.; Chu, Mei Ling J. N.; Schellens, Marielle H. B.; Gastelaars, Jody van Engelsdorp; Jansen, Marc D.; van der Ende, Arie; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof			Streptococcus pneumoniae in Saliva of Dutch Primary School Children	PLOS ONE			English	Article							PNEUMOCOCCAL CARRIAGE; MULTIPLEX PCR; CONJUGATE VACCINE; INVASIVE DISEASE; SEROTYPES; COLONIZATION; COMPETITION; VIRULENCE; REPLACEMENT; STRAINS	While nasopharyngeal sampling is the gold standard for the detection of Streptococcus pneumoniae carriage, historically seen, saliva sampling also seems highly sensitive for pneumococcal detection. We investigated S. pneumoniae carriage in saliva from fifty schoolchildren by conventional and molecular methods. Saliva was first culture-enriched for pneumococci, after which, DNA was extracted from all bacterial growth and tested by quantitative-PCR (qPCR) for pneumococcus-specific genes lytA and piaA. Next, serotype composition of the samples was determined by serotype-specific qPCRs, conventional-PCRs (cPCR) and sequencing of cPCR amplicons. Although only 2 (4%) of 50 samples were positive by conventional diagnostic culture, 44 (88%) were positive for pneumococci by qPCR. In total, we detected the presence of at least 81 pneumococcal strains representing 20 serotypes in samples from 44 carriers with 23 carriers (52%) positive for multiple (up to 6) serotypes. The number of serotypes detected per sample correlated with pneumococcal abundance. This study shows that saliva could be used as a tool for future pneumococcal surveillance studies. Furthermore, high rates of pneumococcal carriage and co-carriage of multiple pneumococcal strains together with a large number of serotypes in circulation suggests a ubiquitous presence of S. pneumoniae in saliva of school-aged children. Our results also suggest that factors promoting pneumococcal carriage within individual hosts may weaken competitive interactions between S. pneumoniae strains.	[Wyllie, Anne L.; Chu, Mei Ling J. N.; Schellens, Marielle H. B.; Gastelaars, Jody van Engelsdorp; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof] Univ Med Ctr Utrecht, Wilhelminas Children Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands; [Jansen, Marc D.] Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Trzcinski, K (corresponding author), Univ Med Ctr Utrecht, Wilhelminas Children Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands.	K.Trzcinski@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; Wyllie, Anne/0000-0001-6015-0279; Bogaert, Debby/0000-0003-2651-7000; van der Ende, Arie/0000-0003-1298-3086; Jansen, Marc/0000-0001-7567-8519	Wilhelmina Children's Hospital of the University Medical Centre Utrecht	Wilhelmina Children's Hospital of the University Medical Centre Utrecht	This study was supported by internal funds from Wilhelmina Children's Hospital of the University Medical Centre Utrecht. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auranen K, 2013, VACCINE, V32, P159, DOI 10.1016/j.vaccine.2013.06.105; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Benton KA, 1997, INFECT IMMUN, V65, P1237, DOI 10.1128/IAI.65.4.1237-1244.1997; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Griffith F., 1927, J HYG LOND, V64, P129; GUNDEL M., 1933, Zeitschrift fur Hygiene und Infektionskrankheiten, V114, P678, DOI 10.1007/BF02183676; Heffron R, 1979, PNEUMOCOCCUS CARRIER, P342; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Krone CL, 2013, LANCET RESP MED, V2600, P1; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; Mehtala J, 2013, EPIDEMIOLOGY, V24, P522, DOI 10.1097/EDE.0b013e318294be89; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Rosenau MJ, 1926, AM J HYG, V6, P463, DOI 10.1093/oxfordjournals.aje.a120022; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Verhagen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089541; Walsh RL, 2011, MBIO, V2, DOI 10.1128/mBio.00092-11; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; White B, 1938, ISOLATION PNEUMOCOCC, P30; White B, 1938, CARRIER STATE BIOL P, P230	41	59	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102045	10.1371/journal.pone.0102045	http://dx.doi.org/10.1371/journal.pone.0102045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013895	Green Submitted, gold, Green Published			2022-12-25	WOS:000339378400058
J	Andries, K; Villellas, C; Coeck, N; Thys, K; Gevers, T; Vranckx, L; Lounis, N; de Jong, BC; Koul, A				Andries, Koen; Villellas, Cristina; Coeck, Nele; Thys, Kim; Gevers, Tom; Vranckx, Luc; Lounis, Nacer; de Jong, Bouke C.; Koul, Anil			Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline	PLOS ONE			English	Article							DRUG-RESISTANCE; ATP SYNTHASE; EFFLUX; INHIBITOR; EMERGENCE; VERAPAMIL; TMC207; 1ST	Bedaquiline (BDQ), an ATP synthase inhibitor, is the first drug to be approved for treatment of multi-drug resistant tuberculosis in decades. In vitro resistance to BDQ was previously shown to be due to target-based mutations. Here we report that non-target based resistance to BDQ, and cross-resistance to clofazimine (CFZ), is due to mutations in Rv0678, a transcriptional repressor of the genes encoding the MmpS5-MmpL5 efflux pump. Efflux-based resistance was identified in paired isolates from patients treated with BDQ, as well as in mice, in which it was confirmed to decrease bactericidal efficacy. The efflux inhibitors verapamil and reserpine decreased the minimum inhibitory concentrations of BDQ and CFZ in vitro, but verapamil failed to increase the bactericidal effect of BDQ in mice and was unable to reverse efflux-based resistance in vivo. Cross-resistance between BDQ and CFZ may have important clinical implications.	[Andries, Koen; Villellas, Cristina; Thys, Kim; Gevers, Tom; Vranckx, Luc; Lounis, Nacer; Koul, Anil] Janssen Pharmaceut, Dept Infect Dis, B-2340 Beerse, Belgium; [Coeck, Nele; de Jong, Bouke C.] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Johnson & Johnson; Janssen Pharmaceuticals; Institute of Tropical Medicine (ITM)	Andries, K (corresponding author), Janssen Pharmaceut, Dept Infect Dis, B-2340 Beerse, Belgium.	kandries@its.jnj.com	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675	Janssen; Baekeland PhD scholarship from the Flemish Institute for Scientific Technology [IWT 130308]	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Baekeland PhD scholarship from the Flemish Institute for Scientific Technology	BdJ received funds from Janssen for drug susceptibility testing on isolates from clinical studies on bedaquiline. NC is funded by a Baekeland PhD scholarship from the Flemish Institute for Scientific Technology (IWT 130308). The funder provided support in the form of salaries for NC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cohen J, 2013, SCIENCE, V339, P130, DOI 10.1126/science.339.6116.130; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Gupta S, 2014, ANTIMICROB AGENTS CH, V58, P574, DOI 10.1128/AAC.01462-13; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14; Huitric E, 2010, ANTIMICROB AGENTS CH, V54, P1022, DOI 10.1128/AAC.01611-09; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Segala E, 2012, ANTIMICROB AGENTS CH, V56, P2326, DOI 10.1128/AAC.06154-11; Williams K, 2012, ANTIMICROB AGENTS CH, V56, P3114, DOI 10.1128/AAC.00384-12; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	24	228	242	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102135	10.1371/journal.pone.0102135	http://dx.doi.org/10.1371/journal.pone.0102135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010492	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800074
J	Boyd, NF; Li, Q; Melnichouk, O; Huszti, E; Martin, LJ; Gunasekara, A; Mawdsley, G; Yaffe, MJ; Minkin, S				Boyd, Norman F.; Li, Qing; Melnichouk, Olga; Huszti, Ella; Martin, Lisa J.; Gunasekara, Anoma; Mawdsley, Gord; Yaffe, Martin J.; Minkin, Salomon			Evidence That Breast Tissue Stiffness Is Associated with Risk of Breast Cancer	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MAMMOGRAPHIC DENSITY; QUANTITATIVE-ANALYSIS; ELASTOGRAPHY; PROGRESSION; ARCHITECTURE; MALIGNANCY; SYMMETRY	Background: Evidence from animal models shows that tissue stiffness increases the invasion and progression of cancers, including mammary cancer. We here use measurements of the volume and the projected area of the compressed breast during mammography to derive estimates of breast tissue stiffness and examine the relationship of stiffness to risk of breast cancer. Methods: Mammograms were used to measure the volume and projected areas of total and radiologically dense breast tissue in the unaffected breasts of 362 women with newly diagnosed breast cancer (cases) and 656 women of the same age who did not have breast cancer (controls). Measures of breast tissue volume and the projected area of the compressed breast during mammography were used to calculate the deformation of the breast during compression and, with the recorded compression force, to estimate the stiffness of breast tissue. Stiffness was compared in cases and controls, and associations with breast cancer risk examined after adjustment for other risk factors. Results: After adjustment for percent mammographic density by area measurements, and other risk factors, our estimate of breast tissue stiffness was significantly associated with breast cancer (odds ratio = 1.21, 95% confidence interval = 1.03, 1.43, p = 0.02) and improved breast cancer risk prediction in models with percent mammographic density, by both area and volume measurements. Conclusion: An estimate of breast tissue stiffness was associated with breast cancer risk and improved risk prediction based on mammographic measures and other risk factors. Stiffness may provide an additional mechanism by which breast tissue composition is associated with risk of breast cancer and merits examination using more direct methods of measurement.	[Boyd, Norman F.; Li, Qing; Melnichouk, Olga; Huszti, Ella; Martin, Lisa J.; Minkin, Salomon] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Gunasekara, Anoma; Mawdsley, Gord; Yaffe, Martin J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Boyd, NF (corresponding author), Ontario Canc Inst, Campbell Family Inst Breast Canc Res, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	boyd@uhnres.utoronto.ca		Shestakovska, Olga/0000-0002-4175-4680; Mawdsley, Gord/0000-0001-6957-8060	Canadian Breast Cancer Research Alliance; Ontario Ministry of Health and Long Term Care; Lau Chair in Breast Cancer Research; Tory Chair in Cancer Research	Canadian Breast Cancer Research Alliance; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Lau Chair in Breast Cancer Research; Tory Chair in Cancer Research	This work was supported by a grant from the Canadian Breast Cancer Research Alliance and by the Ontario Ministry of Health and Long Term Care. Dr. Boyd was supported by the Lau Chair in Breast Cancer Research and Dr. Yaffe by the Tory Chair in Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Boyd N, 2009, CANCER EPIDEM BIOMAR, V18, P1754, DOI 10.1158/1055-9965.EPI-09-0107; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2010, JNCI-J NATL CANCER I, V102, P1224, DOI 10.1093/jnci/djq239; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Byng JW, 1996, EUR J CANCER PREV, V5, P319, DOI 10.1097/00008469-199610000-00003; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250; Hennessey S, 2014, CANCER CAUSE CONTROL, V25, P491, DOI 10.1007/s10552-014-0351-0; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Lorenzen J, 2002, ROFO-FORTSCHR RONTG, V174, P830, DOI 10.1055/s-2002-32690; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Pawluczyk O, 2003, MED PHYS, V30, P352, DOI 10.1118/1.1539038; Pawluczyk O, 2001, MED PHYS, V28, P438, DOI 10.1118/1.1359244; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P43, DOI 10.1158/1055-9965.EPI-06-0738; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wojcinski S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-159; Wojcinski S, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-35; Yaffe MJ, 2009, MED PHYS, V36, P5437, DOI 10.1118/1.3250863; Zangani D, 1999, DIFFERENTIATION, V64, P91, DOI 10.1046/j.1432-0436.1999.6420091.x	26	84	86	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100937	10.1371/journal.pone.0100937	http://dx.doi.org/10.1371/journal.pone.0100937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010427	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800008
J	Folias, AE; Penaranda, C; Su, AL; Bluestone, JA; Hebrok, M				Folias, Alexandra E.; Penaranda, Cristina; Su, Anthony L.; Bluestone, Jeffrey A.; Hebrok, Matthias			Aberrant Innate Immune Activation following Tissue Injury Impairs Pancreatic Regeneration	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; DUCTAL ADENOCARCINOMA; MACROPHAGES; CELLS; MICE; INFLAMMATION; KIDNEY; CANCER; REPAIR; RISK	Normal tissue architecture is disrupted following injury, as resident tissue cells become damaged and immune cells are recruited to the site of injury. While injury and inflammation are critical to tissue remodeling, the inability to resolve this response can lead to the destructive complications of chronic inflammation. In the pancreas, acinar cells of the exocrine compartment respond to injury by transiently adopting characteristics of progenitor cells present during embryonic development. This process of de-differentiation creates a window where a mature and stable cell gains flexibility and is potentially permissive to changes in cellular fate. How de-differentiation can turn an acinar cell into another cell type (such as a pancreatic beta-cell), or a cell with cancerous potential (as in cases of deregulated Kras activity) is of interest to both the regenerative medicine and cancer communities. While it is known that inflammation and acinar de-differentiation increase following pancreatic injury, it remains unclear which immune cells are involved in this process. We used a combination of genetically modified mice, immunological blockade and cellular characterization to identify the immune cells that impact pancreatic regeneration in an in vivo model of pancreatitis. We identified the innate inflammatory response of macrophages and neutrophils as regulators of pancreatic regeneration. Under normal conditions, mild innate inflammation prompts a transient de-differentiation of acinar cells that readily dissipates to allow normal regeneration. However, non-resolving inflammation developed when elevated pancreatic levels of neutrophils producing interferon-c increased iNOS levels and the pro-inflammatory response of macrophages. Pancreatic injury improved following in vivo macrophage depletion, iNOS inhibition as well as suppression of iNOS levels in macrophages via interferon-c blockade, supporting the impairment in regeneration and the development of chronic inflammation arises from aberrant activation of the innate inflammatory response. Collectively these studies identify targetable inflammatory factors that can be used to influence the development of non-resolving inflammation and pancreatic regeneration following injury.	[Folias, Alexandra E.; Penaranda, Cristina; Su, Anthony L.; Bluestone, Jeffrey A.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94115 USA.	mhebrok@diabetes.ucsf.edu		Su, Anthony/0000-0002-5280-6423; Penaranda, Cristina/0000-0002-2595-2863	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation [3-2011-95]; Ruth L. Kirschstein National Research Service Award [5 T32 DK07418]; NIH [R21 AI107328-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107328, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Leona M. and Harry B. Helmsley Charitable Trust (http://helmsleytrust.org/) supported work in the laboratory of M.H. A.E.F. was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation (3-2011-95; http://jdrf.org/) and the Ruth L. Kirschstein National Research Service Award (5 T32 DK07418; https://www.nidcd.nih.gov/). An NIH Exploratory/Developmental Research Grant Award (R21 AI107328-01A1; http://nih.gov/) supported work in the laboratory of J.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Frossard JL, 2011, J CLIN PATHOL, V64, P387, DOI 10.1136/jcp.2010.088500; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gandolfo MT, 2009, KIDNEY INT, V76, P717, DOI 10.1038/ki.2009.259; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GU DL, 1993, DEVELOPMENT, V118, P33; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Kinsey GR, 2010, KIDNEY INT, V77, P771, DOI 10.1038/ki.2010.12; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Ray A, 2010, J VIS EXP; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Saeki K, 2012, GASTROENTEROLOGY, V142, P1010, DOI 10.1053/j.gastro.2011.12.054; Sakai Y, 2003, GASTROENTEROLOGY, V124, P725, DOI 10.1053/gast.2003.50099; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Sandoval D, 1996, GASTROENTEROLOGY, V111, P1081, DOI 10.1016/S0016-5085(96)70077-X; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Viebahn CS, 2010, J HEPATOL, V53, P500, DOI 10.1016/j.jhep.2010.04.010	46	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102125	10.1371/journal.pone.0102125	http://dx.doi.org/10.1371/journal.pone.0102125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010227	Green Published, gold			2022-12-25	WOS:000338763800072
J	Yi, ZA; Stunz, LL; Lin, WW; Bishop, GA				Yi, Zuoan; Stunz, Laura L.; Lin, Wai Wai; Bishop, Gail A.			TRAF3 Regulates Homeostasis of CD8(+) Central Memory T Cells	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED FACTOR-3; B-INDUCING KINASE; PROTECTIVE IMMUNITY; DENDRITIC CELLS; ROLES; TOLERANCE; NAIVE	Our laboratory reported previously that TNF receptor associated factor 3 (TRAF3) is a positive regulator of TCR signaling and T cell function. In the current study, we present new findings that reveal differential roles for TRAF3 in the regulation of CD4(+) and CD8(+) T cells. In response to TCR stimulation in vitro, TRAF3 has greater impact in CD4+ T cells than in CD8(+) T cells. However, T cell-specific TRAF3 deficient mice (CD4(Cre) TRAF3(flox/flox); T-TRAF3(-/-)) have a greater number of CD4(+)CD44(hi) effector/memory T cells than littermate control (LMC) mice, possibly due to an inefficient suppressive effect of TRAF3 deficient Foxp3(+) regulatory T cells. In contrast, CD(8+)CD44(hi)CD62L(hi) central memory (Tcm) cells are markedly reduced in T-TRAF3(-/-) mice in comparison to LMC mice, although CD(8+)CD44(hi)CD62L(low) effector memory T (Tem) cells and naive T cells (CD(8+)CD44(low) CD62L(hi)) do not show significant differences in number. Importantly, TRAF3-deficient Tcm cells exhibit defective homeostasis due to impaired IL-15 signaling. These results indicate that the involvement of TRAF3 in IL-15 mediated signaling to T cells plays a previously unappreciated and critical role in CD(8+)Tcm cell regulation and maintenance.	[Yi, Zuoan; Stunz, Laura L.; Lin, Wai Wai; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Lin, Wai Wai; Bishop, Gail A.] Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Bishop, Gail A.] VA Med Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Bishop, GA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Institutes of Health [P30CA086862, AI28847, T32 AI007260]; Veterans Administration Senior RCS Award; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260, R29AI028847, R01AI028847, R56AI028847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Senior RCS Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health (nih.gov): P30CA086862 (GAB), AI28847 (GAB), T32 AI007260 (ZY); Veterans Administration Senior RCS Award (Va.gov) (GAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Amsen D, 2013, ADV EXP MED BIOL, V785, P107, DOI 10.1007/978-1-4614-6217-0_12; Bishop GA, 2007, IMMUNOL RES, V39, P22, DOI 10.1007/s12026-007-0068-1; Bishop GA, 2013, J IMMUNOL, V191, P3483, DOI 10.4049/jimmunol.1390048; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Chang JH, 2014, J EXP MED, V211, P137, DOI 10.1084/jem.20131019; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hildebrand JM, 2011, IMMUNOL REV, V244, P55, DOI 10.1111/j.1600-065X.2011.01055.x; Hofmann J, 2011, J EXP MED, V208, P1917, DOI 10.1084/jem.20110128; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murray SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076216; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Rowe AM, 2013, J IMMUNOL, V191, P3663, DOI 10.4049/jimmunol.1301328; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Xie P, 2011, J LEUKOCYTE BIOL, V90, P1149, DOI 10.1189/jlb.0111044; Xie P, 2011, J IMMUNOL, V186, P143, DOI 10.4049/jimmunol.1000290; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yi ZA, 2014, CYTOKINE GROWTH F R, V25, P147, DOI 10.1016/j.cytogfr.2013.12.002; Yi ZA, 2013, J EXP MED, V210, P1079, DOI 10.1084/jem.20122135; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	35	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102120	10.1371/journal.pone.0102120	http://dx.doi.org/10.1371/journal.pone.0102120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010048	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800070
J	Hass, M; Luttermann, C; Meyers, G				Hass, Maria; Luttermann, Christine; Meyers, Gregor			Feline Calicivirus Can Tolerate Gross Changes of Its Minor Capsid Protein Expression Levels Induced by Changing Translation Reinitiation Frequency or Use of a Separate VP2-Coding mRNA	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; TRACT-BINDING-PROTEIN; RIBOSOME ENTRY SITE; OPEN READING FRAME; TERMINATION-REINITIATION; COUPLED TRANSLATION; SUBGENOMIC RNA; INTERNAL INITIATION; CDNA CONSTRUCTS; VP2 PROTEIN	Caliciviruses use reinitiation of translation governed by a 'termination upstream ribosomal binding site' (TURBS) for expression of their minor capsid protein VP2. Mutation analysis allowed to identify sequences surrounding the translational start/stop site of the feline calicivirus (FCV) that fine tune reinitiation frequency. A selection of these changes was introduced into the infectious FCV cDNA clone to check the influence of altered VP2 levels on virus replication. In addition, full length constructs were established that displayed a conformation, in which VP2 expression occurred under control of a duplicated subgenomic promoter. Viable viruses recovered from such constructs revealed a rather broad range of VP2 expression levels but comparable growth kinetics showing that caliciviruses can tolerate gross changes of the VP2 expression level.	[Hass, Maria; Luttermann, Christine; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany.	gregor.meyers@fli.bund.de	Luttermann, Christine/L-5440-2019	Luttermann, Christine/0000-0002-6977-9900	Deutsche Forschungsgemeinschaft [1367/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant Me 1367/3 from the Deutsche Forschungsgemeinschaft: http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian G, 2000, EMBO J, V19, P2681, DOI 10.1093/emboj/19.11.2681; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Clarke I., 2012, CALICIVIRIDAE, P977; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Gould PS, 2014, RNA, V20, P373, DOI 10.1261/rna.041574.113; Gould PS, 2007, J VIROL, V81, P8488, DOI 10.1128/JVI.00457-07; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Karakasiliotis I, 2006, J GEN VIROL, V87, P3339, DOI 10.1099/vir.0.82153-0; Karakasiliotis I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009562; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Li H, 2011, J VIROL, V85, P7343, DOI 10.1128/JVI.00364-11; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P145; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; Machin A, 2001, J BIOL CHEM, V276, P27787, DOI 10.1074/jbc.M100707200; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Meyers G, 2000, VIROLOGY, V276, P349, DOI 10.1006/viro.2000.0545; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; Morales M, 2004, J BIOL CHEM, V279, P17013, DOI 10.1074/jbc.M313674200; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; Neill JD, 2002, VIRUS RES, V87, P89, DOI 10.1016/S0168-1702(02)00086-2; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Powell ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016822; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439; Reusken CBEM, 2003, J GEN VIROL, V84, P1761, DOI 10.1099/vir.0.19063-0; REYNOLDS JE, 1995, EMBO J, V14, P6010, DOI 10.1002/j.1460-2075.1995.tb00289.x; Ryabova L, 2004, BIOCHEM SOC T, V32, P592, DOI 10.1042/BST0320592; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; SCHAFFER FL, 1980, J GEN VIROL, V47, P215, DOI 10.1099/0022-1317-47-1-215; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Sosnovtsev SV, 2000, VIROLOGY, V277, P193, DOI 10.1006/viro.2000.0579; Sosnovtsev SV, 2005, J VIROL, V79, P4012, DOI 10.1128/JVI.79.7.4012-4024.2005; Sosnovtsev SV, 1998, J VIROL, V72, P3051, DOI 10.1128/JVI.72.4.3051-3059.1998; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Thumfart JO, 2002, J VIROL, V76, P6398, DOI 10.1128/JVI.76.12.6398-6407.2002; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102254	10.1371/journal.pone.0102254	http://dx.doi.org/10.1371/journal.pone.0102254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007260	Green Published, gold			2022-12-25	WOS:000339040600110
J	Lindholm, ME; Huss, M; Solnestam, BW; Kjellqvist, S; Lundeberg, J; Sundberg, CJ				Lindholm, Malene E.; Huss, Mikael; Solnestam, Beata W.; Kjellqvist, Sanela; Lundeberg, Joakim; Sundberg, Carl J.			The human skeletal muscle transcriptome: sex differences, alternative splicing, and tissue homogeneity assessed with RNA sequencing	FASEB JOURNAL			English	Article						gene expression profiling; biopsy; isoform; splice variant; novel transcript	GENE-EXPRESSION; MESSENGER-RNA; LIPOPROTEIN-LIPASE; EXERCISE; PHOSPHORYLATION; METABOLISM; ACTIVATION; MECHANISMS; REGULATORS; ATROPHY	Human skeletal muscle health is important for quality of life and several chronic diseases, including type II diabetes, heart disease, and cancer. Skeletal muscle is a tissue widely used to study mechanisms behind different diseases and adaptive effects of controlled interventions. For such mechanistic studies, knowledge about the gene expression profiles in different states is essential. Since the baseline transcriptome has not been analyzed systematically, the purpose of this study was to provide a deep reference profile of female and male skeletal muscle. RNA sequencing data were analyzed from a large set of 45 resting human muscle biopsies. We provide extensive information on the skeletal muscle transcriptome, including 5 previously unannotated protein-coding transcripts. Global transcriptional tissue homogeneity was strikingly high, within both a specific muscle and the contralateral leg. We identified >23,000 known isoforms and found >5000 isoforms that differ between the sexes. The female and male transcriptome was enriched for genes associated with oxidative metabolism and protein catabolic processes, respectively. The data demonstrate remarkably high tissue homogeneity and provide a deep and extensive baseline reference for the human skeletal muscle transcriptome, with regard to alternative splicing, novel transcripts, and sex differences in functional ontology.	[Lindholm, Malene E.; Sundberg, Carl J.] Karolinska Inst, Dept Physiol & Pharmacol, Solna, Sweden; [Huss, Mikael; Kjellqvist, Sanela] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Stockholm, Sweden; [Solnestam, Beata W.; Lundeberg, Joakim] Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Solna, Sweden	Karolinska Institutet; Stockholm University; Royal Institute of Technology	Lindholm, ME (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Von Eulers Vag 8, S-17177 Stockholm, Sweden.	malene.lindholm@ki.se	Sundberg, Carl Johan/B-9356-2013; Lindholm, Malene/E-5125-2017	Lindholm, Malene/0000-0002-5763-7833; Huss, Mikael/0000-0003-0839-2451	Swedish National Centre for Research in Sports; Wallenberg Advanced Bioinformatics Infrastructure; Karolinska Institutet	Swedish National Centre for Research in Sports; Wallenberg Advanced Bioinformatics Infrastructure; Karolinska Institutet(Karolinska Institutet)	The authors thank Eva-Karin Gidlund and Susanna Appel (Karolinska Institutet) for assistance with physiological testing and biopsy handling and Science for Life Laboratory (SciLifeLab, Stockholm, Sweden), National Genomics Infrastructure (SciLifeLab), and Uppmax (Uppsala University, Uppsala, Sweden) for providing massive parallel sequencing and computational infrastructure. This work was supported by the Swedish National Centre for Research in Sports and the Wallenberg Advanced Bioinformatics Infrastructure. M.E.L has a PhD training grant from Karolinska Institutet.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Chopard A, 2009, PHYSIOL GENOMICS, V38, P291, DOI 10.1152/physiolgenomics.00036.2009; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje; Dalla Libera L, 2009, J APPL PHYSIOL, V107, P549, DOI 10.1152/japplphysiol.00280.2009; Gordon PM, 2012, J APPL PHYSIOL, V112, P443, DOI 10.1152/japplphysiol.00860.2011; Guerra B, 2011, J APPL PHYSIOL, V110, P1708, DOI 10.1152/japplphysiol.00091.2011; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; KAIPAINEN A, 1993, J EXP MED, V178, P2077, DOI 10.1084/jem.178.6.2077; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khal J, 2005, INT J BIOCHEM CELL B, V37, P2196, DOI 10.1016/j.biocel.2004.10.017; Kiens B, 2004, J APPL PHYSIOL, V97, P1209, DOI 10.1152/japplphysiol.01278.2003; Kjellqvist S, 2013, MOL CELL PROTEOMICS, V12, P407, DOI 10.1074/mcp.M112.021873; Kohn TA, 2007, J ANAT, V210, P8, DOI 10.1111/j.1469-7580.2007.00661.x; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Koval JA, 1998, AM J PHYSIOL-ENDOC M, V274, pE304, DOI 10.1152/ajpendo.1998.274.2.E304; Kraniou Y, 2000, J APPL PHYSIOL, V88, P794, DOI 10.1152/jappl.2000.88.2.794; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Kurtovic S, 2011, MOL MED, V17, P665, DOI 10.2119/molmed.2011.00018; Larrouy D, 2008, AM J CLIN NUTR, V88, P125, DOI 10.1093/ajcn/88.1.125; LEXELL J, 1985, J APPL PHYSIOL, V59, P1228, DOI 10.1152/jappl.1985.59.4.1228; LEXELL J, 1989, ACTA PHYSIOL SCAND, V136, P561, DOI 10.1111/j.1748-1716.1989.tb08702.x; LIN L, 1988, CLIN PHYSIOL, V8, P391, DOI 10.1111/j.1475-097X.1988.tb00282.x; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Liu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-659; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Maher AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006335; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; Martens H, 2001, CHEMOMETR INTELL LAB, V58, P151, DOI 10.1016/S0169-7439(01)00157-5; Melia MJ, 2013, BRAIN, V136, P1508, DOI 10.1093/brain/awt074; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Noguchi S, 2003, HUM MOL GENET, V12, P595, DOI 10.1093/hmg/ddg065; Norrbom J, 2011, AM J PHYSIOL-ENDOC M, V301, pE1092, DOI 10.1152/ajpendo.00119.2011; Olsson AH, 2011, MOL GENET METAB, V103, P275, DOI 10.1016/j.ymgme.2011.03.017; POLGAR J, 1973, J NEUROL SCI, V19, P307, DOI 10.1016/0022-510X(73)90094-4; Punkt K, 1998, ACTA HISTOCHEM, V100, P37, DOI 10.1016/S0065-1281(98)80005-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Reardon KA, 2001, MUSCLE NERVE, V24, P893, DOI 10.1002/mus.1086.abs; Roepstorff C, 2006, AM J PHYSIOL-ENDOC M, V291, pE1106, DOI 10.1152/ajpendo.00097.2006; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Seip RL, 1998, EXERCISE SPORT SCI R, V26, P191; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Stranneheim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021910; Su WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-273; Thompson JR, 2013, J SURG RES, V185, P206, DOI 10.1016/j.jss.2013.05.054; Timmons JA, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-19; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang M, 2010, J INT MED RES, V38, P769; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	68	46	46	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4571	4581		10.1096/fj.14-255000	http://dx.doi.org/10.1096/fj.14-255000			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25016029	Bronze			2022-12-25	WOS:000342222700032
J	Helm, JR; Bentley, M; Thorsen, KD; Wang, T; Foltz, L; Oorschot, V; Klumperman, J; Hay, JC				Helm, Jared R.; Bentley, Marvin; Thorsen, Kevin D.; Wang, Ting; Foltz, Lauren; Oorschot, Viola; Klumperman, Judith; Hay, Jesse C.			Apoptosis-linked Gene-2 (ALG-2)/Sec31 Interactions Regulate Endoplasmic Reticulum (ER)-to-Golgi Transport A POTENTIAL EFFECTOR PATHWAY FOR LUMINAL CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Endoplasmic Reticulum (ER); Golgi; Membrane Trafficking; Secretion; Vesicles; Endoplasmic Reticulum to Golgi Transport	INTRACELLULAR MEMBRANE TRAFFICKING; GOLGI INTERMEDIATE COMPARTMENT; UNFOLDED PROTEIN RESPONSE; COPII VESICLE FUSION; P24 PROTEINS; EXIT SITES; MAMMALIAN-CELLS; CARGO RECEPTORS; CA2+-DEPENDENT MANNER; SECRETORY PATHWAY	Background: Whether ER to Golgi transport requires calcium, the source of calcium, and its mechanism is unknown. Results: A requirement for luminal calcium is demonstrated, and evidence is presented for a molecular effector pathway. Conclusion: Luminal calcium may regulate transport by activating these protein interactions. Significance: The described calcium effector pathway may lead to greater insight into calcium action at multiple transport steps. Luminal calcium released from secretory organelles has been suggested to play a regulatory role in vesicle transport at several steps in the secretory pathway; however, its functional roles and effector pathways have not been elucidated. Here we demonstrate for the first time that specific luminal calcium depletion leads to a significant decrease in endoplasmic reticulum (ER)-to-Golgi transport rates in intact cells. Ultrastructural analysis revealed that luminal calcium depletion is accompanied by increased accumulation of intermediate compartment proteins in COPII buds and clusters of unfused COPII vesicles at ER exit sites. Furthermore, we present several lines of evidence suggesting that luminal calcium affected transport at least in part through calcium-dependent interactions between apoptosis-linked gene-2 (ALG-2) and the Sec31A proline-rich region: 1) targeted disruption of ALG-2/Sec31A interactions caused severe defects in ER-to-Golgi transport in intact cells; 2) effects of luminal calcium and ALG-2/Sec31A interactions on transport mutually required each other; and 3) Sec31A function in transport required luminal calcium. Morphological phenotypes of disrupted ALG-2/Sec31A interactions were characterized. We found that ALG-2/Sec31A interactions were not required for the localization of Sec31A to ER exit sites per se but appeared to acutely regulate the stability and trafficking of the cargo receptor p24 and the distribution of the vesicle tether protein p115. These results represent the first outline of a mechanism that connects luminal calcium to specific protein interactions regulating vesicle trafficking machinery.	[Hay, Jesse C.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Hay, Jesse C.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Oorschot, Viola; Klumperman, Judith] Univ Med Ctr Utrecht, Cell Microscopy Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	University of Montana System; University of Montana; University of Montana System; University of Montana; Utrecht University; Utrecht University Medical Center	Hay, JC (corresponding author), Univ Montana, Div Biol Sci, 32 Campus Dr,HS104, Missoula, MT 59812 USA.	jesse.hay@umontana.edu	Wang, Ting/GSN-9679-2022	Bentley, Marvin/0000-0002-1754-0332; Foltz, Lauren/0000-0002-7141-8493	National Institutes of Health [GM106323, NS067834]; University of Montana Center for Structural and Functional Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Montana Center for Structural and Functional Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM106323 (to J. C. H.) and Fellowship NS067834 (to J. R. H.). This work was also supported by the University of Montana Center for Structural and Functional Neuroscience.	Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025; Ahluwalia JP, 2001, J BIOL CHEM, V276, P34148, DOI 10.1074/jbc.M105398200; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Bartoszewski S, 2004, MECH DEVELOP, V121, P1259, DOI 10.1016/j.mod.2004.05.006; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Contreras I, 2004, PLANT CELL PHYSIOL, V45, P1779, DOI 10.1093/pcp/pch200; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Higashio H, 2002, BIOCHEM BIOPH RES CO, V296, P568, DOI 10.1016/S0006-291X(02)00923-3; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Maki M., 2007, CALCIUM BIND PROTEIN, V2, P4; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MASON MJ, 1991, J BIOL CHEM, V266, P20856; Micaroni M, 2012, ADV EXP MED BIOL, V740, P439, DOI 10.1007/978-94-007-2888-2_18; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Rotter J, 2002, J CELL SCI, V115, P1049; Sato M, 2002, BIOCHEM BIOPH RES CO, V296, P560, DOI 10.1016/S0006-291X(02)00922-1; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trahey Meg, 2010, F1000 Biol Rep, V2, P47; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200	75	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23609	23628		10.1074/jbc.M114.561829	http://dx.doi.org/10.1074/jbc.M114.561829			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006245	hybrid, Green Published			2022-12-25	WOS:000341505000030
J	Rajabi, HN; Takahashi, C; Ewen, ME				Rajabi, Hasan N.; Takahashi, Chiaki; Ewen, Mark E.			Retinoblastoma Protein and MyoD Function Together to Effect the Repression of Fra-1 and in Turn Cyclin D1 during Terminal Cell Cycle Arrest Associated with Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Gene Regulation; Myogenesis; Transcription Enhancer; Transcription Factor; Fra-1; MyoD; pRb; Terminal Cell Cycle Arrest	SKELETAL-MUSCLE DIFFERENTIATION; GENE-EXPRESSION; KINASE-ACTIVITY; MYOBLAST DIFFERENTIATION; SUPPRESSES APOPTOSIS; C-FOS; RB; ACTIVATION; TRANSCRIPTION; RAS	Background: Repression of cyclin D1 is required for terminal cell cycle arrest associated with myogenesis. Results: pRb and MyoD function together to block induction of Fra-1 and in turn cyclin D1. Conclusion: MyoD and pRb cooperate to effect transcriptional repression during myogenesis. Significance: The findings reveal a link between MyoD, pRb, Fra-1, and cyclin D1, the latter three of which are often deregulated in cancer. The acquisition of skeletal muscle-specific function and terminal cell cycle arrest represent two important features of the myogenic differentiation program. These cellular processes are distinct and can be separated genetically. The lineage-specific transcription factor MyoD and the retinoblastoma protein pRb participate in both of these cellular events. Whether and how MyoD and pRb work together to effect terminal cell cycle arrest is uncertain. To address this question, we focused on cyclin D1, whose stable repression is required for terminal cell cycle arrest and execution of myogenesis. MyoD and pRb are both required for the repression of cyclin D1; their actions, however, were found not to be direct. Rather, they operate to regulate the immediate early gene Fra-1, a critical player in mitogen-dependent induction of cyclin D1. Two conserved MyoD-binding sites were identified in an intronic enhancer of Fra-1 and shown to be required for the stable repression of Fra-1 and, in turn, cyclin D1. Localization of MyoD alone to the intronic enhancer of Fra-1 in the absence of pRb was not sufficient to elicit a block to Fra-1 induction; pRb was also recruited to the intronic enhancer in a MyoD-dependent manner. These observations suggest that MyoD and pRb work together cooperatively at the level of the intronic enhancer of Fra-1 during terminal cell cycle arrest. This work reveals a previously unappreciated link between a lineage-specific transcription factor, a tumor suppressor, and a proto-oncogene in the control of an important facet of myogenic differentiation.	[Rajabi, Hasan N.; Takahashi, Chiaki; Ewen, Mark E.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Ewen, Mark E.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Harvard University; Dana-Farber Cancer Institute; Kanazawa University; Tufts Medical Center	Ewen, ME (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St,5609, Boston, MA 02111 USA.	mewen@tuftsmedicalcenter.org			National Institutes of Health [R01 CA065842]; Department of Defense Breast Cancer Research Program Fellowship [DAMD17-01-1-0224]; NATIONAL CANCER INSTITUTE [R01CA065842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA065842 (to M. E. E.). This work was also supported by Department of Defense Breast Cancer Research Program Fellowship DAMD17-01-1-0224 (to H. N. R.).	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Saavedra HI, 2002, CELL GROWTH DIFFER, V13, P215; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Schreiber M, 1997, ONCOGENE, V15, P1171, DOI 10.1038/sj.onc.1201460; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SHAPIRO GI, 1995, CANCER RES, V55, P6200; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Tiainen M, 1996, CELL GROWTH DIFFER, V7, P1039; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; TROUCHE D, 1993, NATURE, V363, P79, DOI 10.1038/363079a0; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhu J, 1998, BIOINFORMATICS, V14, P25, DOI 10.1093/bioinformatics/14.1.25; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	69	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23417	23427		10.1074/jbc.M113.532572	http://dx.doi.org/10.1074/jbc.M113.532572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006242	Green Published, hybrid			2022-12-25	WOS:000341505000016
J	Condette, CJ; Khorsi-Cauet, H; Morliere, P; Zabijak, L; Reygner, J; Bach, V; Gay-Queheillard, J				Condette, Claire Joly; Khorsi-Cauet, Hafida; Morliere, Patrice; Zabijak, Luciane; Reygner, Julie; Bach, Veronique; Gay-Queheillard, Jerome			Increased Gut Permeability and Bacterial Translocation after Chronic Chlorpyrifos Exposure in Rats	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; TIGHT JUNCTION; BARRIER FUNCTION; DISRUPTION; EPITHELIUM; DAMAGE; MODEL; TIME; OXON	The epithelium's barrier function is crucial for maintaining homeostasis and preventing the passage of food antigens and luminal bacteria. This function is essentially subserved by tight junctions (TJs), multiprotein complexes located in the most apical part of the lateral membrane. Some gastrointestinal disease states are associated with elevated intestinal permeability to macromolecules. In a study on rats, we determined the influence of chronic, daily ingestion of chlorpyrifos (CPF, a pesticide that crosses the placental barrier) during pre- and postnatal periods on intestinal permeability and TJ characteristics in the pups. Fluorescein isothiocyanate (FITC)-dextran was used as a marker of paracellular transport and mucosal barrier dysfunction. Pups were gavaged with FITC-dextran solution and blood samples were collected every 30 min for 400 min and analyzed spectrofluorimetrically. At sacrifice, different intestinal segments were resected and prepared for analysis of the transcripts (qPCR) and localization (using immunofluorescence) of ZO-1, occludin and claudins (scaffolding proteins that have a role in the constitution of TJs). In rats that had been exposed to CPF in utero and after birth, we observed a progressive increase in FITC-dextran passage across the epithelial barrier from 210 to 325 min at day 21 after birth (weaning) but not at day 60 (adulthood). At both ages, there were significant changes in intestinal TJ gene expression, with downregulation of ZO-1 and occludin and upregulation of claudins 1 and 4. In some intestinal segments, there were changes in the cellular localization of ZO-1 and claudin 4 immunostaining. Lastly, bacterial translocation to the spleen was also observed. The presence of CPF residues in food may disturb epithelial homeostasis in rats. Changes in TJ protein expression and localization may be involved in gut barrier dysfunction in this model. Uncontrolled passage of macromolecules and bacteria across the intestinal epithelium may be a risk factor for digestive inflammatory diseases.	[Condette, Claire Joly; Khorsi-Cauet, Hafida; Reygner, Julie; Bach, Veronique; Gay-Queheillard, Jerome] Jules Verne Univ Picardy, Fac Med, Peritox Lab, Ineris EA4285 UMI01, Amiens, France; [Morliere, Patrice] Jules Verne Univ Picardy, Fac Med, INSERMU1088, Amiens, France; [Morliere, Patrice] Amiens Univ Hosp, Human Biol Ctr, Biochem Lab, Amiens, France; [Zabijak, Luciane] Jules Verne Univ Picardy, EA4666, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Gay-Queheillard, J (corresponding author), Jules Verne Univ Picardy, Fac Med, Peritox Lab, Ineris EA4285 UMI01, Amiens, France.	jerome.gay@u-picardie.fr	Khorsi-Cauet, Hafida/AFO-7669-2022; Bach, Veronique/AAD-5958-2022		French Ministry of Research; Picardy Regional Council	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Picardy Regional Council(Region Hauts-de-France)	Sources of financial support: The French Ministry of Research and the Picardy Regional Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 2011, NUTRIENTS, V3, P104, DOI 10.3390/nu3010104; Bolles HG, 1999, J AGR FOOD CHEM, V47, P1817, DOI 10.1021/jf980962d; Boudry G, 2011, PEDIATR RES, V69, P4, DOI 10.1203/PDR.0b013e3181fc9d13; Cameron HL, 2007, NEUROGASTROENT MOTIL, V19, P47, DOI 10.1111/j.1365-2982.2006.00845.x; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Carroll IM, 2013, WORLD J GASTROENTERO, V19, P7531, DOI 10.3748/wjg.v19.i43.7531; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; COCHRAN RC, 1995, FOOD CHEM TOXICOL, V33, P165, DOI 10.1016/0278-6915(94)00124-7; Cook TJ, 2003, TOXICOLOGY, V184, P125, DOI 10.1016/S0300-483X(02)00555-3; De Lisle RC, 2013, CELL TISSUE RES; Du MH, 2013, WORLD J GASTROENTERO, V19, P5988, DOI 10.3748/wjg.v19.i36.5988; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Fries W, 1999, LAB INVEST, V79, P49; Gearhart DA, 2007, TOXICOL APPL PHARM, V218, P20, DOI 10.1016/j.taap.2006.10.008; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Gibson PR, 1996, INFLAMM BOWEL DIS, V2, P279, DOI 10.1002/ibd.3780020412; Grigoryan H, 2009, TOXICOL APPL PHARM, V240, P143, DOI 10.1016/j.taap.2009.07.015; Grootjans J, 2010, WORLD J GASTRO SURG, V2, P61, DOI 10.4240/wjgs.v2.i3.61; Hamada K, 2013, CANCER CHEMOTH PHARM, V72, P757, DOI 10.1007/s00280-013-2238-2; Hamada K, 2010, CANCER CHEMOTH PHARM, V66, P1031, DOI 10.1007/s00280-010-1253-9; Jarvinen KM, 2013, PEDIAT ALLERG IMM-UK, V24, P589, DOI 10.1111/pai.12106; Joly C, 2013, ENVIRON SCI POLLUT R, V20, P2726, DOI 10.1007/s11356-012-1283-4; Joly Condette C, J PEDIAT GASTR UNPUB; Lennette E., 1985, MANUAL CLIN MICROBIO, Vfourth; Liu J, 2002, TOXICOL APPL PHARM, V178, P102, DOI 10.1006/taap.2001.9326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Medina M, 2014, GUT, V63, P116, DOI 10.1136/gutjnl-2012-304119; Maurissen JPJ, 2000, TOXICOL SCI, V57, P250, DOI 10.1093/toxsci/57.2.250; Mazzon E, 2002, GUT, V51, P507, DOI 10.1136/gut.51.4.507; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Tirelli V, 2007, TOXICOL IN VITRO, V21, P308, DOI 10.1016/j.tiv.2006.08.015; Yajima M, 2001, J PEDIATR GASTR NUTR, V33, P592, DOI 10.1097/00005176-200111000-00015; Yeh TH, 2011, BIOMATERIALS, V32, P6164, DOI 10.1016/j.biomaterials.2011.03.056; Yu Q, 2012, J DAIRY SCI, V95, P5580, DOI 10.3168/jds.2012-5540; Zhang Y, 2012, BIOCHEM BIOPH RES CO, V428, P321, DOI 10.1016/j.bbrc.2012.10.056	37	65	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102217	10.1371/journal.pone.0102217	http://dx.doi.org/10.1371/journal.pone.0102217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019507	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600054
J	Faisal, MN; Hoffmann, J; El-Kholy, S; Kallsen, K; Wagner, C; Bruchhaus, I; Fink, C; Roeder, T				Faisal, Muhammad N.; Hoffmann, Julia; El-Kholy, Samar; Kallsen, Kimberley; Wagner, Christina; Bruchhaus, Iris; Fink, Christine; Roeder, Thomas			Transcriptional Regionalization of the Fruit Fly's Airway Epithelium	PLOS ONE			English	Article							TRACHEAL SYSTEM; DROSOPHILA; EXPRESSION; ASTHMA; GENES; MORPHOGENESIS; ACTIVATION; OCTOPAMINE; BEHAVIOR; GROWTH	Although airway epithelia are primarily devoted to gas exchange, they have to fulfil a number of different tasks including organ maintenance and the epithelial immune response to fight airborne pathogens. These different tasks are at least partially accomplished by specialized cell types in the epithelium. In addition, a proximal to distal gradient mirroring the transition from airflow conduction to real gas exchange, is also operative. We analysed the airway system of larval Drosophila melanogaster with respect to region-specific expression in the proximal to distal axis. The larval airway system is made of epithelial cells only. We found differential expression between major trunks of the airways and more distal ones comprising primary, secondary and terminal ones. A more detailed analysis was performed using DNA-microarray analysis to identify cohorts of genes that are either predominantly expressed in the dorsal trunks or in the primary/secondary/terminal branches of the airways. Among these differentially expressed genes are especially those involved in signal transduction. Wnt-signalling associated genes for example are predominantly found in secondary/terminal airways. In addition, some G-protein coupled receptors are differentially expressed between both regions of the airways, exemplified by those activated by octopamine or tyramine, the invertebrate counterparts of epinephrine and norepinephrine. Whereas the OAMB is predominantly found in terminal airway regions, the oct beta bR has higher expression levels in dorsal trunks. In addition, we observed a significant association of both, genes predominantly expressed in dorsal trunks or in primary to terminal branches branches with those regulated by hypoxia. Taken together, this observed differential expression is indicative for a proximal to distal transcriptional regionalization presumably reflecting functional differences in these parts of the fly's airway system.	[Faisal, Muhammad N.; Hoffmann, Julia; El-Kholy, Samar; Kallsen, Kimberley; Fink, Christine; Roeder, Thomas] Univ Kiel, Dept Mol Physiol, Kiel, Germany; [Kallsen, Kimberley; Wagner, Christina] Res Ctr Borstel, Prior Area Allergy & Asthma, Borstel, Germany; [Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, D-20359 Hamburg, Germany; [Roeder, Thomas] ARCN, German Ctr Lung Res DZL, Lubeck, Germany	University of Kiel; Forschungszentrum Borstel; Bernhard Nocht Institut fur Tropenmedizin	Roeder, T (corresponding author), Univ Kiel, Dept Mol Physiol, Kiel, Germany.	troeder@zoologie.uni-kiel.de	Wagner, Christina/M-7796-2018; Roeder, Thomas/B-9016-2011; faisal, M/GQB-4757-2022; Fink, Christine/ABF-7102-2021	Roeder, Thomas/0000-0002-3489-3834; Fink, Christine/0000-0003-0083-2168; Faisal, Muhammad/0000-0001-6448-9325	German Research Foundation [SFB TR22]	German Research Foundation(German Research Foundation (DFG))	We would like to thank the German Research Foundation for financial support (SFB TR22 Teilprojekt A7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-265; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Cardoso WV, 2000, DEV DYNAM, V219, P121, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1053>3.3.CO;2-8; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Clark AC, 2004, J NEUROSCI, V24, P4283, DOI 10.1523/JNEUROSCI.4938-03.2004; Costantino BFB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000102; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Gervais L, 2011, DEVELOPMENT, V138, P1269, DOI 10.1242/dev.059188; Hashimoto S, 2012, J CELL SCI, V125, P932, DOI 10.1242/jcs.092734; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Kida H, 2008, AM J PATHOL, V172, P1542, DOI 10.2353/ajpath.2008.071052; LIEDTKE CM, 1989, AM J PHYSIOL, V257, pL125, DOI 10.1152/ajplung.1989.257.2.L125; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Pitsouli C, 2010, DEVELOPMENT, V137, P3615, DOI 10.1242/dev.056408; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Roeder T, 2002, MICROSC RES TECHNIQ, V56, P237, DOI 10.1002/jemt.10027; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Roeder T, 2012, ADV EXP MED BIOL, V710, P37, DOI 10.1007/978-1-4419-5638-5_5; Roeder T, 2009, AM J RESP CRIT CARE, V179, P979, DOI 10.1164/rccm.200811-1777PP; Ruhle H, 1932, Z WISS ZOOL ABT A, V141, P159; Salathe Matthias, 2002, Journal of Allergy and Clinical Immunology, V110, pS275, DOI 10.1067/mai.2002.129412; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Terakado M, 2011, AM J PHYSIOL-LUNG C, V300, pL56, DOI 10.1152/ajplung.00159.2010; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Wagner C, 2009, FASEB J, V23, P2045, DOI 10.1096/fj.08-114223; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Wegener C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r131; Whitten J, 1957, Q J MICROSC SCI, V98; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102534	10.1371/journal.pone.0102534	http://dx.doi.org/10.1371/journal.pone.0102534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020150	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600092
J	Baraz, R; Cisterne, A; Saunders, PO; Hewson, J; Thien, M; Weiss, J; Basnett, J; Bradstock, KF; Bendall, LJ				Baraz, Rana; Cisterne, Adam; Saunders, Philip O.; Hewson, John; Thien, Marilyn; Weiss, Jocelyn; Basnett, Jordan; Bradstock, Kenneth F.; Bendall, Linda J.			mTOR Inhibition by Everolimus in Childhood Acute Lymphoblastic Leukemia Induces Caspase-Independent Cell Death	PLOS ONE			English	Article							5'-UNTRANSLATED REGION; PROGRAMMED NECROSIS; RAD001 EVEROLIMUS; MAMMALIAN TARGET; ER STRESS; B-LINEAGE; APOPTOSIS; RAPAMYCIN; AUTOPHAGY; ACTIVATION	Increasingly, anti-cancer medications are being reported to induce cell death mechanisms other than apoptosis. Activating alternate death mechanisms introduces the potential to kill cells that have defects in their apoptotic machinery, as is commonly observed in cancer cells, including in hematological malignancies. We, and others, have previously reported that the mTOR inhibitor everolimus has pre-clinical efficacy and induces caspase-independent cell death in acute lymphoblastic leukemia cells. Furthermore, everolimus is currently in clinical trial for acute lymphoblastic leukemia. Here we characterize the death mechanism activated by everolimus in acute lymphoblastic leukemia cells. We find that cell death is caspase-independent and lacks the morphology associated with apoptosis. Although mitochondrial depolarization is an early event, permeabilization of the outer mitochondrial membrane only occurs after cell death has occurred. While morphological and biochemical evidence shows that autophagy is clearly present it is not responsible for the observed cell death. There are a number of features consistent with paraptosis including morphology, caspase-independence, and the requirement for new protein synthesis. However in contrast to some reports of paraptosis, the activation of JNK signaling was not required for everolimus-induced cell death. Overall in acute lymphoblastic leukemia cells everolimus induces a cell death that resembles paraptosis.	[Baraz, Rana; Cisterne, Adam; Saunders, Philip O.; Hewson, John; Thien, Marilyn; Weiss, Jocelyn; Basnett, Jordan; Bendall, Linda J.] Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW, Australia; [Bradstock, Kenneth F.] Westmead Hosp, Dept Haematol, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Bendall, LJ (corresponding author), Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW, Australia.	linda.bendall@sydney.edu.au	Cisterne, Adam/HGA-8311-2022		Leukemia and Lymphoma Society of the USA [6105-08]; University of Sydney; National Health and Medical Research Council (NHMRC) [1042305]; Cancer Institute NSW [12/CDF/2-03]	Leukemia and Lymphoma Society of the USA(Leukemia and Lymphoma Society); University of Sydney(University of Sydney); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	This work has been supported by grant funding from the Leukemia and Lymphoma Society of the USA (No. 6105-08), PS was supported by a University of Sydney Postgraduate Award and LB by fellowships from the National Health and Medical Research Council (NHMRC, No. 1042305) and Cancer Institute NSW (No. 12/CDF/2-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Bendall LJ, 2005, CANCER RES, V65, P3290, DOI 10.1158/0008-5472.CAN-04-3402; Bertrand FE, 2005, LEUKEMIA, V19, P98, DOI 10.1038/sj.leu.2403560; Boumber Y, 2012, FINAL REPORT PHASE 1; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Brown VI, 2003, P NATL ACAD SCI USA, V100, P15113, DOI 10.1073/pnas.2436348100; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Crazzolara R, 2009, AUTOPHAGY, V5, P727, DOI 10.4161/auto.5.5.8507; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Das G., 2012, COLD SPRING HARB PER, V4; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Higgins GC, 2012, FREE RADICAL BIO MED, V53, P1960, DOI 10.1016/j.freeradbiomed.2012.08.586; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kantarjian HM, 2000, J CLIN ONCOL, V18, P547, DOI 10.1200/JCO.2000.18.3.547; Khan NI, 2008, LEUKEMIA LYMPHOMA, V49, P710, DOI 10.1080/10428190701861660; Kolesnichenko M, 2012, CELL CYCLE, V11, P2391, DOI 10.4161/cc.20683; Ling YH, 2011, CLIN CANCER RES, V17, P5353, DOI 10.1158/1078-0432.CCR-10-1948; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Pospelova TV, 2012, CELL CYCLE, V11, P2402, DOI 10.4161/cc.20882; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; SALVARIS E, 1992, LEUKEMIA RES, V16, P655, DOI 10.1016/0145-2126(92)90016-Z; Saunders P. O., 2012, ONCOGENE; Saunders P, 2011, HAEMATOL-HEMATOL J, V96, P69, DOI 10.3324/haematol.2010.026997; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Sun QR, 2010, J CELL PHYSIOL, V222, P421, DOI 10.1002/jcp.21982; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Teachey DT, 2008, BLOOD, V112, P2020, DOI 10.1182/blood-2008-02-137141; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Tseng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036006; WADA M, 1993, BLOOD, V82, P3163; Wang G, 2012, INT J NANOMED, V7, P271, DOI 10.2147/IJN.S26935; Wang L, 2004, LEUKEMIA RES, V28, P733, DOI 10.1016/j.leukres.2003.10.033; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226	46	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102494	10.1371/journal.pone.0102494	http://dx.doi.org/10.1371/journal.pone.0102494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014496	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400098
J	Rojas, JM; Moreno, H; Valcarcel, F; Pena, L; Sevilla, N; Martin, V				Rojas, Jose M.; Moreno, Hector; Valcarcel, Felix; Pena, Lourdes; Sevilla, Noemi; Martin, Veronica			Vaccination with Recombinant Adenoviruses Expressing the Peste des Petits Ruminants Virus F or H Proteins Overcomes Viral Immunosuppression and Induces Protective Immunity against PPRV Challenge in Sheep	PLOS ONE			English	Article							RINDERPEST VIRUS; RESPONSES; VECTORS; ANTIBODY; GOATS; IMMUNIZATION; INDUCTION; INFECTION; EFFICACY; VACCINES	Peste des petits ruminants (PPR) is a highly contagious disease of small ruminants caused by the Morbillivirus peste des petits ruminants virus (PPRV). Two recombinant replication-defective human adenoviruses serotype 5 (Ad5) expressing either the highly immunogenic fusion protein (F) or hemagglutinin protein (H) from PPRV were used to vaccinate sheep by intramuscular inoculation. Both recombinant adenovirus vaccines elicited PPRV-specific B- and T-cell responses. Thus, neutralizing antibodies were detected in sera from immunized sheep. In addition, we detected a significant antigen specific T-cell response in vaccinated sheep against two different PPRV strains, indicating that the vaccine induced heterologous T cell responses. Importantly, no clinical signs and undetectable virus shedding were observed after virulent PPRV challenge in vaccinated sheep. These vaccines also overcame the T cell immunosuppression induced by PPRV in control animals. The results indicate that these adenovirus constructs could be a promising alternative to current vaccine strategies for the development of PPRV DIVA vaccines.	[Rojas, Jose M.; Moreno, Hector; Valcarcel, Felix; Pena, Lourdes; Sevilla, Noemi; Martin, Veronica] Ctr Invest Sanidad Anim CISA INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Martin, V (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain.	veronica.martin@inia.es	Martin, Veronica/M-9641-2019; Rojas, José M/J-7406-2012; Valcarcel, Felix/Y-3386-2019; Moreno, Hector/AAA-6283-2020; Martín, Verónica/H-2776-2015; Sevilla, Noemi/K-8648-2014; Rojas, José Manuel/X-2903-2019	Martin, Veronica/0000-0003-1486-1656; Rojas, José M/0000-0002-4055-3967; Valcarcel, Felix/0000-0001-5609-0496; Martín, Verónica/0000-0003-1486-1656; Sevilla, Noemi/0000-0003-0118-0376; Rojas, José Manuel/0000-0002-4055-3967; Moreno, Hector/0000-0002-2615-8514	Ministerio de Ciencia e Innovacion [RyC-2010-06516, AGL-2011-25025, AGL2009-07353, RTA2010-00094-C03-03]; NADIR Integrating Activities 7th EU program [228394]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NADIR Integrating Activities 7th EU program	This work was funded by grant numbers RyC-2010-06516 and AGL-2011-25025 (VM); AGL2009-07353 (NS) and RTA2010-00094-C03-03 (FV) from Ministerio de Ciencia e Innovacion (http://www.mineco.gob.es/portal/site/mineco/idi) and 228394-NADIR Integrating Activities 7th EU program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2012, VIRUS RES, V167, P43, DOI 10.1016/j.virusres.2012.03.018; Babiuk LA, 2000, J BIOTECHNOL, V83, P105, DOI 10.1016/S0168-1656(00)00314-X; Baron MD, 2011, BIOLOGY OF PARAMYXOVIRUSES, P293; BARRETT T, 1989, VIROLOGY, V170, P11, DOI 10.1016/0042-6822(89)90346-2; Berhe G, 2003, J VIROL, V77, P1571, DOI 10.1128/JVI.77.2.1571-1577.2003; Butler D, 2013, NATURE, V499, P264, DOI 10.1038/499264a; CHARLTON KM, 1992, ARCH VIROL, V123, P169, DOI 10.1007/BF01317147; Chen WY, 2010, VACCINE, V28, P4742, DOI 10.1016/j.vaccine.2010.04.102; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Cruz PE, 2006, BIOTECHNOL PROGR, V22, P568, DOI 10.1021/bp050294y; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; DHAR D, 1990, PHYS REV LETT, V64, P1613, DOI 10.1103/PhysRevLett.64.1613; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; El Harrak M, 2012, J CLIN MICROBIOL, V50, P3738, DOI 10.1128/JCM.01785-12; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Ferreira TB, 2005, J BIOTECHNOL, V119, P272, DOI 10.1016/j.jbiotec.2005.03.009; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Herbert R, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-24; Hu RL, 2007, VACCINE, V25, P5301, DOI 10.1016/j.vaccine.2007.05.024; Hu RL, 2006, MICROBES INFECT, V8, P1090, DOI 10.1016/j.micinf.2005.11.007; Jaiswal S, 2003, J VIROL, V77, P12907, DOI 10.1128/JVI.77.23.12907-12913.2003; Lameiro MH, 2006, J BIOTECHNOL, V126, P152, DOI 10.1016/j.jbiotec.2006.04.030; Lefevre P C, 1990, Rev Sci Tech, V9, P935; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Liu Y, 2008, VACCINE, V26, P5368, DOI 10.1016/j.vaccine.2008.08.001; Lund BT, 2000, J GEN VIROL, V81, P2137, DOI 10.1099/0022-1317-81-9-2137; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Mayr GA, 1999, VIROLOGY, V263, P496, DOI 10.1006/viro.1999.9940; Munir M., 2012, SEROLOGICAL DIAGNOSI, DOI DOI 10.5772/36464; Ozkul A, 2002, EMERG INFECT DIS, V8, P708; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; PREVEC L, 1989, J GEN VIROL, V70, P429, DOI 10.1099/0022-1317-70-2-429; PREVEC L, 1990, J INFECT DIS, V161, P27, DOI 10.1093/infdis/161.1.27; Qin JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037170; Rajak KK, 2005, COMP IMMUNOL MICROB, V28, P287, DOI 10.1016/j.cimid.2005.08.002; Riyesh Thachamvally, 2011, Virologica Sinica, V26, P324, DOI 10.1007/s12250-011-3205-x; Rojas JM, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-30; Rojas JM, 2014, VACCINE, V32, P393, DOI 10.1016/j.vaccine.2013.11.033; Saravanan P, 2008, BIOLOGICALS, V36, P1, DOI 10.1016/j.biologicals.2007.03.005; Schneider-Schaulies J, 2008, ADV VIRUS RES, V71, P173, DOI 10.1016/S0065-3527(08)00004-3; Sen A, 2010, EXPERT REV VACCINES, V9, P785, DOI [10.1586/erv.10.74, 10.1586/ERV.10.74]; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Sun Y, 2010, RES VET SCI, V88, P77, DOI 10.1016/j.rvsc.2009.06.005; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; TAYLOR WP, 1979, RES VET SCI, V27, P321, DOI 10.1016/S0034-5288(18)32800-5; Truong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087145; Wang Y, 2013, VET IMMUNOL IMMUNOP, V154, P1, DOI 10.1016/j.vetimm.2013.05.002	47	41	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101226	10.1371/journal.pone.0101226	http://dx.doi.org/10.1371/journal.pone.0101226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013961	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400022
J	Zhang, DZ; Lau, KM; Chan, ESY; Wang, G; Szeto, CC; Wong, K; Choy, RKW; Ng, CF				Zhang, Ding-Zuan; Lau, Kin-Mang; Chan, Eddie S. Y.; Wang, Gang; Szeto, Cheuk-Chun; Wong, Kenneth; Choy, Richard K. W.; Ng, Chi-Fai			Cell-Free Urinary MicroRNA-99a and MicroRNA-125b Are Diagnostic Markers for the Non-Invasive Screening of Bladder Cancer	PLOS ONE			English	Article							FREE DNA; TUMOR; PROLIFERATION; BIOMARKERS; EXPRESSION; GROWTH; GENES; SERUM; RISK	Background: Evidence implicated the diagnostic significance of microRNAs in whole urine/urine sediments in urothelial carcinoma of the bladder (UCB). However, the contaminated blood cells in patients with haematouria significantly altered the expression profiles of urinary microRNA, influencing the test accuracy. Methods: MicroRNA profiles of the urine supernatants of UCB patients and controls without any malignancy and profiles of malignant and corresponding normal mucosa tissues from the patients were determined by microRNA microarray and compared to identify differentially expressed microRNAs. The differential expression was verified in the tissues of an independent patient cohort by RT-qPCR. The diagnostic significance of selected microRNAs as biomarkers in the urine supernatant was investigated in the expanded cohorts. Results: MicroRNA-99a and microRNA-125b were down-regulated in the urine supernatants of UCB patients. The degree of down-regulation was associated with the tumor grade. A diagnostic model was developed using a combined index of the levels of microRNA-99a and microRNA-125b in the urine supernatant with a sensitivity of 86.7%, a specificity of 81.1% and a positive predicted value (PPV) of 91.8%. Discriminating between high-and low-grade UCB, the model using the level of microRNA-125b alone exhibited a sensitivity of 81.4%, a specificity of 87.0% and a PPV of 93.4%. Conclusions: The results revealed a unique microRNA expression signature in the urine supernatants of UCB patients for the development of molecular diagnostic tests. An effective cell-free urinary microRNA-based model was developed using a combined index of the levels of microRNA-99a and microRNA-125b to detect UCB with good discriminating power, high sensitivity and high specificity.	[Zhang, Ding-Zuan; Chan, Eddie S. Y.; Ng, Chi-Fai] Chinese Univ Hong Kong, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China; [Lau, Kin-Mang] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Wang, Gang; Szeto, Cheuk-Chun] Chinese Univ Hong Kong, Dept Med & Therapeut, Div Nephrol, Hong Kong, Hong Kong, Peoples R China; [Wong, Kenneth; Choy, Richard K. W.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Ng, CF (corresponding author), Chinese Univ Hong Kong, Dept Surg, Div Urol, Hong Kong, Hong Kong, Peoples R China.	ngcf@surgery.cuhk.edu.hk	Chi-fai, NG/AAV-8270-2021; Szeto, Cheuk Chun/N-4954-2015; Choy, Richard/AAW-8230-2020; Ng, Chi-Fai/E-5134-2011	Szeto, Cheuk Chun/0000-0002-8898-8505; Choy, Richard/0000-0002-3616-6200; Ng, Chi-Fai/0000-0002-1723-9646; Lau, Kin-Mang/0000-0001-5888-1937	Chinese University of Hong Kong [2009.1.096]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was supported by the Direct Grant for Research (2009.1.096), The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Chang HW, 2007, INT J BIOL MARKER, V22, P287, DOI 10.1177/172460080702200408; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman GD, 1996, CANCER EPIDEM BIOMAR, V5, P993; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hansel DE, 2010, AM J PATHOL, V176, P3062, DOI 10.2353/ajpath.2010.090872; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mostofi F, 1999, HISTOLOGICAL TYPING; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Parker J, 2011, THESCIENTIFICWORLDJO, V11, P1103, DOI 10.1100/tsw.2011.104; Satge D, 2009, UROL INT, V82, P296, DOI 10.1159/000209361; Schroeder GL, 2004, J UROLOGY, V172, P1123, DOI 10.1097/01.ju.0000134347.14643.ab; Snowdon J, 2012, CUAJ-CAN UROL ASSOC, V15, P1; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Szarvas T, 2007, ONCOL REP, V18, P405; Timberg G, 1997, SCAND J UROL NEPHROL, V31, P337, DOI 10.3109/00365599709030616; Tzai TS, 2003, UROLOGY, V62, P378, DOI 10.1016/S0090-4295(03)00344-3; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zancan M, 2005, INT J BIOL MARKER, V20, P134, DOI 10.1177/172460080502000209; Zhao AH, 2012, J GENET GENOMICS, V39, P29, DOI 10.1016/j.jgg.2011.12.003	35	191	192	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100793	10.1371/journal.pone.0100793	http://dx.doi.org/10.1371/journal.pone.0100793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014919	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400011
J	Cao, HP; Deterding, LJ; Blackshear, PJ				Cao, Heping; Deterding, Leesa J.; Blackshear, Perry J.			Identification of a Major Phosphopeptide in Human Tristetraprolin by Phosphopeptide Mapping and Mass Spectrometry	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA; GENE-EXPRESSION; RECOMBINANT TRISTETRAPROLIN; TTP; BINDING; MOUSE; PHOSPHORYLATION; DEADENYLATION	Tristetraprolin/zinc finger protein 36 (TTP/ZFP36) binds and destabilizes some pro-inflammatory cytokine mRNAs. TTP-deficient mice develop a profound inflammatory syndrome due to excessive production of pro-inflammatory cytokines. TTP expression is induced by various factors including insulin and extracts from cinnamon and green tea. TTP is highly phosphorylated in vivo and is a substrate for several protein kinases. Multiple phosphorylation sites are identified in human TTP, but it is difficult to assign major vs. minor phosphorylation sites. This study aimed to generate additional information on TTP phosphorylation using phosphopeptide mapping and mass spectrometry (MS). Wild-type and site-directed mutant TTP proteins were expressed in transfected human cells followed by in vivo radiolabeling with [P-32]-orthophosphate. Histidine-tagged TTP proteins were purified with Ni-NTA affinity beads and digested with trypsin and lysyl endopeptidase. The digested peptides were separated by C-18 column with high performance liquid chromatography. Wild-type and all mutant TTP proteins were localized in the cytosol, phosphorylated extensively in vivo and capable of binding to ARE-containing RNA probes. Mutant TTP with S-90 and S-93 mutations resulted in the disappearance of a major phosphopeptide peak. Mutant TTP with an S-197 mutation resulted in another major phosphopeptide peak being eluted earlier than the wildtype. Additional mutations at S-186, S-296 and T-271 exhibited little effect on phosphopeptide profiles. MS analysis identified the peptide that was missing in the S-90 and S-93 mutant protein as LGPELSPSPTSPTATSTTPSR (corresponding to amino acid residues 83-103 of human TTP). MS also identified a major phosphopeptide associated with the first zinc-finger region. These analyses suggest that the tryptic peptide containing S-90 and S-93 is a major phosphopeptide in human TTP.	[Cao, Heping] ARS, USDA, So Reg Res Ctr, New Orleans, LA 70124 USA; [Deterding, Leesa J.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, New Orleans, LA 70124 USA.	Heping.Cao@ars.usda.gov	Blackshear, Perry J./C-6206-2019; Cao, Heping/AAC-1666-2021	Blackshear, Perry J./0000-0002-9561-8529; Cao, Heping/0000-0002-0958-1468	United States Department of Agriculture-Agriculture Research Service Quality and Utilization of Agricultural Products Research Program 306 [CRIS 6435-41000-102-00D]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080, ZIAES103206] Funding Source: NIH RePORTER	United States Department of Agriculture-Agriculture Research Service Quality and Utilization of Agricultural Products Research Program 306; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by United States Department of Agriculture-Agriculture Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-102-00D and the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Cao HP, 2008, PROTEIN J, V27, P163, DOI 10.1007/s10930-007-9119-7; Cao H, 2008, BIOTECHNOL PROGR, V24, P326, DOI 10.1021/bp070269n; Cao H, 2008, J NUTR, V138, P833, DOI 10.1093/jn/138.5.833; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2011, J AGR FOOD CHEM, V59, P2739, DOI 10.1021/jf103527x; Cao HP, 2009, BIOTECHNOL PROGR, V25, P461, DOI 10.1002/btpr.121; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Deterding LJ, 1998, J BIOL CHEM, V273, P12863, DOI 10.1074/jbc.273.21.12863; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Dvorak CMT, 2005, VET IMMUNOL IMMUNOP, V105, P301, DOI 10.1016/j.vetimm.2005.02.006; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; KANEDA N, 1992, GENE, V118, P289, DOI 10.1016/0378-1119(92)90202-Z; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Ming XF, 2001, MOL CELL BIOL, V21, P5778, DOI 10.1128/MCB.21.17.5778-5789.2001; Phillips K, 2004, P NATL ACAD SCI USA, V101, P2011, DOI 10.1073/pnas.0400148101; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Suswam EA, 2013, J NEURO-ONCOL, V113, P195, DOI 10.1007/s11060-013-1112-8; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Twizere JC, 2003, J NATL CANCER I, V95, P1846, DOI 10.1093/jnci/djg118; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, P499	46	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100977	10.1371/journal.pone.0100977	http://dx.doi.org/10.1371/journal.pone.0100977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010646	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800010
J	Padmaraj, D; Pande, R; Miller, JH; Wosik, J; Zagozdzon-Wosik, W				Padmaraj, Divya; Pande, Rohit; Miller, John H., Jr.; Wosik, Jarek; Zagozdzon-Wosik, Wanda			Mitochondrial Membrane Studies Using Impedance Spectroscopy with Parallel pH Monitoring	PLOS ONE			English	Article							INTERNAL MEMBRANES; BIOLOGICAL CELLS; ELECTRIC-FIELDS; PROTON GRADIENT; OUTER-MEMBRANE; MODEL; FCCP; CANCER; SIMULATION; GENERATION	A biological microelectromechanical system (BioMEMS) device was designed to study complementary mitochondrial parameters important in mitochondrial dysfunction studies. Mitochondrial dysfunction has been linked to many diseases, including diabetes, obesity, heart failure and aging, as these organelles play a critical role in energy generation, cell signaling and apoptosis. The synthesis of ATP is driven by the electrical potential across the inner mitochondrial membrane and by the pH difference due to proton flux across it. We have developed a tool to study the ionic activity of the mitochondria in parallel with dielectric measurements (impedance spectroscopy) to gain a better understanding of the properties of the mitochondrial membrane. This BioMEMS chip includes: 1) electrodes for impedance studies of mitochondria designed as two-and four-probe structures for optimized operation over a wide frequency range and 2) ion-sensitive field effect transistors for proton studies of the electron transport chain and for possible monitoring other ions such as sodium, potassium and calcium. We have used uncouplers to depolarize the mitochondrial membrane and disrupt the ionic balance. Dielectric spectroscopy responded with a corresponding increase in impedance values pointing at changes in mitochondrial membrane potential. An electrical model was used to describe mitochondrial sample's complex impedance frequency dependencies and the contribution of the membrane to overall impedance changes. The results prove that dielectric spectroscopy can be used as a tool for membrane potential studies. It can be concluded that studies of the electrochemical parameters associated with mitochondrial bioenergetics may render significant information on various abnormalities attributable to these organelles.	[Padmaraj, Divya; Pande, Rohit; Wosik, Jarek; Zagozdzon-Wosik, Wanda] Univ Houston, Elect & Comp Engn Dept, Houston, TX 77004 USA; [Padmaraj, Divya; Pande, Rohit; Miller, John H., Jr.; Wosik, Jarek] Univ Houston, Texas Ctr Superconduct, Houston, TX USA; [Miller, John H., Jr.] Univ Houston, Dept Phys, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston	Zagozdzon-Wosik, W (corresponding author), Univ Houston, Elect & Comp Engn Dept, Houston, TX 77004 USA.	wwosik@uh.edu	Miller, John J/GZG-5663-2022	Miller, John/0000-0001-9329-5810	NIH: NHLBI [R21CA133153]; NIH: NCI [R21CA133153, 3 R21 CA133153-03S1]; State of Texas through the Texas Center for Superconductivity at the University of Houston; Norman Hackerman Advanced Research Program; NATIONAL CANCER INSTITUTE [R21CA133153] Funding Source: NIH RePORTER	NIH: NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH: NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); State of Texas through the Texas Center for Superconductivity at the University of Houston; Norman Hackerman Advanced Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge support by grant R21CA133153 (NIH: NHLBI & NCI) and by ARRA supplement 3 R21 CA133153-03S1 (NIH: NCI). Additional support was provided by the State of Texas through the Texas Center for Superconductivity at the University of Houston and the Norman Hackerman Advanced Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Chung WY, 2006, MICROELECTRON J, V37, P1105, DOI 10.1016/j.mejo.2006.05.001; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200; Ellappan P, 2005, J ELECTROSTAT, V63, P297, DOI 10.1016/j.elstat.2004.11.007; Feeney CJ, 2003, J NEUROSCI METH, V125, P13, DOI 10.1016/S0165-0270(03)00027-X; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; FRICKE HUGO, 1933, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOL, V1, P117; Gowrishankar TR, 2003, P NATL ACAD SCI USA, V100, P3203, DOI 10.1073/pnas.0636434100; GRATTAROLA M, 1993, IEEE T BIO-MED ENG, V40, P35, DOI 10.1109/10.204769; HEYTLER PG, 1962, BIOCHEM BIOPH RES CO, V7, P272, DOI 10.1016/0006-291X(62)90189-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jack J, 1983, ELECT CURRENT FLOW E; Kadenbach B, 2011, MITOCHONDRION, V11, P700, DOI 10.1016/j.mito.2011.06.001; Kadenbach B, 2010, BBA-GEN SUBJECTS, V1800, P205, DOI 10.1016/j.bbagen.2009.04.019; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Lemeshko VV, 2002, BIOPHYS J, V82, P684, DOI 10.1016/S0006-3495(02)75431-3; Lin JH, 2005, P ANN INT IEEE EMBS, P7608, DOI 10.1109/IEMBS.2005.1616273; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Morgan H, 2007, J PHYS D APPL PHYS, V40, P61, DOI 10.1088/0022-3727/40/1/S10; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Padmaraj D, 2011, BIOSENS BIOELECTRON, V29, P13, DOI 10.1016/j.bios.2011.06.050; Park KS, 2002, PFLUG ARCH EUR J PHY, V443, P344, DOI 10.1007/s004240100703; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Prodan E, 2008, BIOPHYS J, V95, P4174, DOI 10.1529/biophysj.108.137042; Schoenbach KH, 2004, P IEEE, V92, P1122, DOI 10.1109/JPROC.2004.829009; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Talbot J, 2007, J PHYSIOL-LONDON, V579, P783, DOI 10.1113/jphysiol.2006.126383; To MS, 2010, ARCH BIOCHEM BIOPHYS, V495, P152, DOI 10.1016/j.abb.2010.01.004; Tomaszewski D., 2007, J TELECOMMUNICATIONS, V2007, P55; Treuer L, 1998, MOL PHARM, V53, P734; Vajrala V, 2008, BIOPHYS J, V94, P2043, DOI 10.1529/biophysj.107.114611; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; Yao CG, 2008, IEEE T BIO-MED ENG, V55, P1792, DOI 10.1109/TBME.2008.919887; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	42	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101793	10.1371/journal.pone.0101793	http://dx.doi.org/10.1371/journal.pone.0101793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010497	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800041
J	Ruberti, C; Barizza, E; Bodner, M; La Rocca, N; De Michele, R; Carimi, F; Lo Schiavo, F; Zottini, M				Ruberti, Cristina; Barizza, Elisabetta; Bodner, Martina; La Rocca, Nicoletta; De Michele, Roberto; Carimi, Francesco; Lo Schiavo, Fiorella; Zottini, Michela			Mitochondria Change Dynamics and Morphology during Grapevine Leaf Senescence	PLOS ONE			English	Article							CELL-DEATH; ARABIDOPSIS; LEAVES; GROWTH; EMBRYOGENESIS; CHLOROPLASTS; SEQUENCE; REVEALS; GENOME; ASSAYS	Leaf senescence is the last stage of development of an organ and is aimed to its ordered disassembly and nutrient reallocation. Whereas chlorophyll gradually degrades during senescence in leaves, mitochondria need to maintain active to sustain the energy demands of senescing cells. Here we analysed the motility and morphology of mitochondria in different stages of senescence in leaves of grapevine (Vitis vinifera), by stably expressing a GFP (green fluorescent protein) reporter targeted to these organelles. Results show that mitochondria were less dynamic and markedly changed morphology during senescence, passing from the elongated, branched structures found in mature leaves to enlarged and sparse organelles in senescent leaves. Progression of senescence in leaves was not synchronous, since changes in mitochondria from stomata were delayed. Mitochondrial morphology was also analysed in grapevine cell cultures. Mitochondria from cells at the end of their growth curve resembled those from senescing leaves, suggesting that cell cultures might represent a useful model system for senescence. Additionally, senescence-associated mitochondrial changes were observed in plants treated with high concentrations of cytokinins. Overall, morphology and dynamics of mitochondria might represent a reliable senescence marker for plant cells.	[Ruberti, Cristina; Barizza, Elisabetta; Bodner, Martina; La Rocca, Nicoletta; Lo Schiavo, Fiorella; Zottini, Michela] Univ Padua, Dipartimento Biol, Padua, Italy; [De Michele, Roberto; Carimi, Francesco] CNR, Ist Biosci & Biorisorse, IBBR, Palermo, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Zottini, M (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	michela.zottini@unipd.it	De Michele, Roberto/Z-4760-2019; Carimi, Francesco/E-2954-2016; La Rocca, Nicoletta/AAA-2241-2021; Zottini, Michela/Y-3763-2019; Bodner, Martina/AAK-2971-2020; Carimi, Francesco/GYU-0312-2022; Ruberti, Cristina/AAC-2135-2019; Ruberti, Cristina/W-5132-2018	De Michele, Roberto/0000-0002-8987-6599; Carimi, Francesco/0000-0002-7700-9527; La Rocca, Nicoletta/0000-0003-4866-5952; Bodner, Martina/0000-0002-2753-9052; Ruberti, Cristina/0000-0002-9013-1412; zottini, michela/0000-0001-8930-2969	University of Padova (PRAT); Veneto Region Innovation Grants [Mis. 124 PSR Veneto]; Vigoni-DAAD Project; Italian Ministry for University and Research (MIUR) [PON01 -02286];  [PRIN200920094CEKT4]	University of Padova (PRAT); Veneto Region Innovation Grants; Vigoni-DAAD Project; Italian Ministry for University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); 	This work was supported by University of Padova (PRAT 2012), Veneto Region Innovation Grants (Mis. 124 PSR Veneto), Vigoni-DAAD Project, by the Italian Ministry for University and Research (MIUR), Projec (PON01 -02286) 'Tecnologie e processi per il miglioramento della shelf-life dei prodotti del comparto agroalimentare attraverso l'uso di film edibili innovativi a base pectinica' and by the grant PRIN200920094CEKT4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2003, ANAL BIOCHEM, V314, P555; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Carimi F, 2005, PLANT CELL ENVIRON, V28, P1171, DOI 10.1111/j.1365-3040.2005.01355.x; Carimi F, 2005, IN VITRO CELL DEV-PL, V41, P249, DOI 10.1079/IVP2004617; Carimi F, 2004, PLANT SCI, V166, P963, DOI 10.1016/j.plantsci.2003.12.016; Carimi F, 2003, PLANTA, V216, P413, DOI 10.1007/s00425-002-0862-x; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; De Michele R, 2009, PLANT SIGNAL BEHAV, V4, P1; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; De Michele R, 2014, INT J BIOCHEM CELL B, V48, P39, DOI 10.1016/j.biocel.2013.12.014; De Michele R, 2013, ELIFE, V2, DOI 10.7554/eLife.00800; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Duby G, 2001, PLANT J, V27, P539, DOI 10.1046/j.1365-313X.2001.01098.x; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Keech O, 2007, PLANT CELL ENVIRON, V30, P1523, DOI 10.1111/j.1365-3040.2007.01724.x; Keech O, 2010, PLANT PHYSIOL, V154, P1710, DOI 10.1104/pp.110.163402; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Logan DC, 2010, SEMIN CELL DEV BIOL, V21, P550, DOI 10.1016/j.semcdb.2009.12.010; Loro G, 2012, PLANT J, V71, P1, DOI 10.1111/j.1365-313X.2012.04968.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NITSCH JP, 1969, SCIENCE, V163, P85, DOI 10.1126/science.163.3862.85; OZUNA R, 1985, PLANT PHYSIOL, V79, P7, DOI 10.1104/pp.79.1.7; Piotrowska A, 2009, ACTA PHYSIOL PLANT, V31, P573, DOI 10.1007/s11738-008-0267-y; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; SIEDOW JN, 2000, BIOCH MOL BIOL PLANT, P676; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Vlckova A, 2006, PHYSIOL PLANTARUM, V126, P257, DOI 10.1111/j.1399-3054.2006.00593.x; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; ZEIGER E, 1982, SCIENCE, V218, P680, DOI 10.1126/science.218.4573.680; Zhao RM, 2000, PLANT CELL, V12, P535, DOI 10.1105/tpc.12.4.535; Zottini M, 2008, PLANT CELL REP, V27, P845, DOI 10.1007/s00299-008-0510-4; Zottini M, 2006, NEW PHYTOL, V172, P239, DOI 10.1111/j.1469-8137.2006.01830.x	39	22	25	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102012	10.1371/journal.pone.0102012	http://dx.doi.org/10.1371/journal.pone.0102012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009991	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800058
J	Wu, BB; Wang, GQ; Wu, J; Fu, Q; Liu, CM				Wu, Binbin; Wang, Guoqiang; Wu, Jin; Fu, Qing; Liu, Changming			Sources of Heavy Metals in Surface Sediments and an Ecological Risk Assessment from Two Adjacent Plateau Reservoirs	PLOS ONE			English	Article							QUALITY GUIDELINES; GUIZHOU PROVINCE; RIVER SEDIMENTS; WATER; POLLUTION; GROUNDWATER; MERCURY; CONTAMINATION; GEOCHEMISTRY; SOUTHWEST	The concentrations of heavy metals (mercury (Hg), cadmium (Cd), lead (Pb), chromium (Cr), copper (Cu) and arsenic (As)) in surface water and sediments were investigated in two adjacent drinking water reservoirs (Hongfeng and Baihua Reservoirs) on the Yunnan-Guizhou Plateau in Southwest China. Possible pollution sources were identified by spatial and statistical analyses. For both reservoirs, Cd was most likely from industrial activities, and As was from lithogenic sources. For the Hongfeng Reservoir, Pb, Cr and Cu might have originated from mixed sources (traffic pollution and residual effect of former industrial practices), and the sources of Hg included the inflows, which were different for the North (industrial activities) and South (lithogenic origin) Lakes, and atmospheric deposition resulting from coal combustion. For the Baihua Reservoir, the Hg, Cr and Cu were primarily derived from industrial activities, and the Pb originated from traffic pollution. The Hg in the Baihua Reservoir might also have been associated with coal combustion pollution. An analysis of ecological risk using sediment quality guidelines showed that there were moderate toxicological risks for sediment-dwelling organisms in both reservoirs, mainly from Hg and Cr. Ecological risk analysis using the Hakanson index suggested that there was a potential moderate to very high ecological risk to humans from fish in both reservoirs, mainly because of elevated levels of Hg and Cd. The upstream Hongfeng Reservoir acts as a buffer, but remains an important source of Cd, Cu and Pb and a moderately important source of Cr, for the downstream Baihua Reservoir. This study provides a replicable method for assessing aquatic ecosystem health in adjacent plateau reservoirs.	[Wu, Binbin; Wang, Guoqiang; Wu, Jin; Liu, Changming] Beijing Normal Univ, Coll Water Sci, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China; [Fu, Qing] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Beijing Normal University; Chinese Research Academy of Environmental Sciences	Wang, GQ (corresponding author), Beijing Normal Univ, Coll Water Sci, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China.	wanggq@bnu.edu.cn	WU, JIN/AAE-9081-2019	Wang, Guoqiang/0000-0002-3976-1056	Beijing Higher Education Young Elite Teacher Project [YETP0275]; Program for New Century Excellent Talents in University [NCET-12-0058]; Fundamental Research Funds for the Central Universities [2012LZD10]	Beijing Higher Education Young Elite Teacher Project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Beijing Higher Education Young Elite Teacher Project (Grant No. YETP0275), the Program for New Century Excellent Talents in University (Grant No. NCET-12-0058) and the Fundamental Research Funds for the Central Universities (Grant No. 2012LZD10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, WATER SA, V31, P95; Bai JH, 2011, ECOL MODEL, V222, P301, DOI 10.1016/j.ecolmodel.2009.12.002; Bai JH, 2009, STOCH ENV RES RISK A, V23, P341, DOI 10.1007/s00477-008-0219-5; [白占国 Bai Zhanguo], 2002, [地球化学, Geochimica], V31, P113; Bhavsar Satyendra P., 2010, Integrated Environmental Assessment and Management, V6, P641, DOI 10.1002/ieam.102; Chabukdhara M, 2012, CHEMOSPHERE, V87, P945, DOI 10.1016/j.chemosphere.2012.01.055; Farkas A, 2007, CHEMOSPHERE, V68, P761, DOI 10.1016/j.chemosphere.2006.12.099; Feng XB, 2010, ENVIRON SCI TECHNOL, V44, P3363, DOI 10.1021/es9039488; Feng XB, 2009, ENVIRON POLLUT, V157, P2970, DOI 10.1016/j.envpol.2009.06.002; Feng XB, 2009, ENVIRON POLLUT, V157, P2594, DOI 10.1016/j.envpol.2009.05.024; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hakanson L., 1983, PRINCIPLES LAKE SEDI; Han GL, 2004, CHEM GEOL, V204, P1, DOI 10.1016/j.chemgeo.2003.09.009; [何邵麟 He Shaolin], 2012, [物探与化探, Geophysical and Geochemical Exploration], V36, P273; HE T, 2007, BIOGEOCHEMICAL CYCLI; He TR, 2008, ENVIRON POLLUT, V154, P56, DOI 10.1016/j.envpol.2007.11.013; Huang XF, 2008, STUDIES CHARACTERIST; Huang XianFei, 2008, Research of Environmental Sciences, V21, P18; Ingersoll CG, 1996, J GREAT LAKES RES, V22, P602, DOI 10.1016/S0380-1330(96)70984-X; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Lang YC, 2006, APPL GEOCHEM, V21, P887, DOI 10.1016/j.apgeochem.2006.03.005; Larrose A, 2010, APPL GEOCHEM, V25, P1912, DOI 10.1016/j.apgeochem.2010.10.007; LARSEN B, 1989, MAR POLLUT BULL, V20, P556, DOI 10.1016/0025-326X(89)90356-1; Li XD, 2000, APPL GEOCHEM, V15, P567, DOI 10.1016/S0883-2927(99)00072-4; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Liu F, 2011, ENVIRON CHEM, V30, P440; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Liu Y, 2007, WATER SA, V33, P305; Long ER, 2006, ENVIRON SCI TECHNOL, V40, P1726, DOI 10.1021/es058012d; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; NEPA: National Environmental Protection Agency (Presently known as MEP; Ministry of Environmental Protection), 1994, ATL SOIL ENV BACKGR; Persaud D, 1993, GUIDELINES PROTECTIO, P27; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Smith SL, 1996, J GREAT LAKES RES, V22, P624, DOI 10.1016/S0380-1330(96)70985-1; Sophocleous M, 2002, HYDROGEOL J, V10, P52, DOI 10.1007/s10040-001-0170-8; State Environmental Protection Administration (SEPA), 2000, REP STAT ENV CHIN; Swartz RC, 1999, ENVIRON TOXICOL CHEM, V18, P780, DOI 10.1002/etc.5620180426; [田林锋 Tian Linfeng], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P885; Uluturhan E, 2007, WATER RES, V41, P1185, DOI 10.1016/j.watres.2006.11.044; Wang B, 2005, B ENVIRON CONTAM TOX, V74, P227, DOI 10.1007/s00128-004-0574-y; Wang FS, 2011, APPL GEOCHEM, V26, pS375, DOI 10.1016/j.apgeochem.2011.03.065; Wang FS, 2011, ATMOS ENVIRON, V45, P3827, DOI 10.1016/j.atmosenv.2011.04.014; Wang Y, 2001, J HYDROL, V246, P223, DOI 10.1016/S0022-1694(01)00376-6; Word JQ, 2005, USE OF SEDIMENT: QUALITY GUIDELINES AND RELATED TOOLS FOR THE ASSESSMENT OF CONTAMINATED SEDIMENTS, P121; Yan HY, 2008, SCI TOTAL ENVIRON, V407, P497, DOI 10.1016/j.scitotenv.2008.08.043; Yi YJ, 2011, ENVIRON POLLUT, V159, P2575, DOI 10.1016/j.envpol.2011.06.011; [曾艳 Zeng Yan], 2010, [地球与环境, Earth and Environment], V38, P470; Zhu ZM, 2013, J HAZARD MATER, V246, P189, DOI 10.1016/j.jhazmat.2012.12.024	50	75	77	5	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102101	10.1371/journal.pone.0102101	http://dx.doi.org/10.1371/journal.pone.0102101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010771	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800068
J	Barua, S; Chadman, KK; Kuizon, S; Buenaventura, D; Stapley, NW; Ruocco, F; Begum, U; Guariglia, SR; Brown, WT; Junaid, MA				Barua, Subit; Chadman, Kathryn K.; Kuizon, Salomon; Buenaventura, Diego; Stapley, Nathan W.; Ruocco, Felicia; Begum, Umme; Guariglia, Sara R.; Brown, W. Ted; Junaid, Mohammed A.			Increasing Maternal or Post-Weaning Folic Acid Alters Gene Expression and Moderately Changes Behavior in the Offspring	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTER-1; GENOMIC DNA METHYLATION; NEURAL-TUBE DEFECTS; MOUSE MODEL; BIPOLAR DISORDER; UNITED-STATES; FOLATE STATUS; QUANTAL SIZE; MICE; VGLUT1	Background: Studies have indicated that altered maternal micronutrients and vitamins influence the development of newborns and altered nutrient exposure throughout the lifetime may have potential health effects and increased susceptibility to chronic diseases. In recent years, folic acid (FA) exposure has significantly increased as a result of mandatory FA fortification and supplementation during pregnancy. Since FA modulates DNA methylation and affects gene expression, we investigated whether the amount of FA ingested during gestation alters gene expression in the newborn cerebral hemisphere, and if the increased exposure to FA during gestation and throughout the lifetime alters behavior in C57BL/6J mice. Methods: Dams were fed FA either at 0.4 mg or 4 mg/kg diet throughout the pregnancy and the resulting pups were maintained on the diet throughout experimentation. Newborn pups brain cerebral hemispheres were used for microarray analysis. To confirm alteration of several genes, quantitative RT-PCR (qRT-PCR) and Western blot analyses were performed. In addition, various behavior assessments were conducted on neonatal and adult offspring. Results: Results from microarray analysis suggest that the higher dose of FA supplementation during gestation alters the expression of a number of genes in the newborns' cerebral hemispheres, including many involved in development. QRT-PCR confirmed alterations of nine genes including down-regulation of Cpn2, Htr4, Zfp353, Vgll2 and up-regulation of Xist, Nkx6-3, Leprel1, Nfix, Slc17a7. The alterations in the expression of Slc17a7 and Vgll2 were confirmed at the protein level. Pups exposed to the higher dose of FA exhibited increased ultrasonic vocalizations, greater anxiety-like behavior and hyperactivity. These findings suggest that although FA plays a significant role in mammalian cellular machinery, there may be a loss of benefit from higher amounts of FA. Unregulated high FA supplementation during pregnancy and throughout the life course may have lasting effects, with alterations in brain development resulting in changes in behavior.	[Barua, Subit; Kuizon, Salomon; Junaid, Mohammed A.] New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, Staten Isl, NY 10314 USA; [Chadman, Kathryn K.; Buenaventura, Diego; Stapley, Nathan W.; Ruocco, Felicia; Begum, Umme] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Guariglia, Sara R.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Brown, W. Ted] New York State Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY 10314 USA; [Junaid, Mohammed A.] CUNY, Grad Ctr, Staten Isl, NY USA; [Junaid, Mohammed A.] CUNY Coll Staten Isl, Staten Isl, NY USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Columbia University; Institute for Basic Research in Developmental Disabilities; City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY)	Junaid, MA (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Dev Biochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	mohammed.junaid@opwdd.ny.gov	Brown, William/GXN-2777-2022	, Kathryn/0000-0002-2307-7225; Buenaventura, Diego/0000-0002-5430-1357	March of Dimes Research Foundation [12-FY12-170]; New York State Office for People with Developmental Disabilities	March of Dimes Research Foundation(March of Dimes); New York State Office for People with Developmental Disabilities	This study was supported by grant 12-FY12-170 from March of Dimes Research Foundation to KKC WTB MAJ and Institutional Funds from the New York State Office for People with Developmental Disabilities to KKC and MAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achon M, 1999, J NUTR, V129, P1204, DOI 10.1093/jn/129.6.1204; Balschun D, 2010, CEREB CORTEX, V20, P684, DOI 10.1093/cercor/bhp133; Barua S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-3; Callaerts-Vegh Z, 2013, BEHAV BRAIN RES, V245, P13, DOI 10.1016/j.bbr.2013.01.042; Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009; Chadman KK, 2011, PHARMACOL BIOCHEM BE, V97, P586, DOI 10.1016/j.pbb.2010.09.012; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Choumenkovitch SF, 2002, J NUTR, V132, P2792, DOI 10.1093/jn/132.9.2792; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dietrich M, 2005, J AM COLL NUTR, V24, P266, DOI 10.1080/07315724.2005.10719474; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gilabert-Juan J, 2012, NEUROSCI LETT, V530, P97, DOI 10.1016/j.neulet.2012.09.032; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Hamilton SM, 2011, BEHAV BRAIN RES, V218, P29, DOI 10.1016/j.bbr.2010.11.026; HEID MK, 1992, J NUTR, V122, P888, DOI 10.1093/jn/122.4.888; Heng YH, 2012, CEREB CORTEX, V24, P261; Hu VW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019067; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Johnson CW, 2011, DEV BIOL, V357, P269, DOI 10.1016/j.ydbio.2011.06.034; Junaid MA, 2011, BIOCHEM BIOPH RES CO, V412, P688, DOI 10.1016/j.bbrc.2011.08.027; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Mikael LG, 2013, BIRTH DEFECTS RES A, V97, P47, DOI 10.1002/bdra.23092; Miller JW, 2013, LANCET, V381, P974, DOI 10.1016/S0140-6736(13)60110-5; Muris P, 1998, J ANXIETY DISORD, V12, P387, DOI 10.1016/S0887-6185(98)00022-X; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Ohtsuki T, 2002, MOL PSYCHIATR, V7, P954, DOI 10.1038/sj.mp.4001133; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; Pickell L, 2011, BIRTH DEFECTS RES A, V91, P8, DOI 10.1002/bdra.20754; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Roy S, 2012, BRAIN DEV-JPN, V34, P64, DOI 10.1016/j.braindev.2011.01.002; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sie KKY, 2013, MOL NUTR FOOD RES, V57, P677, DOI 10.1002/mnfr.201200186; Silberberg G, 2010, AM J MED GENET B, V153B, P1318, DOI 10.1002/ajmg.b.31112; Simon R, 2007, CANCER INFORM, V3, P11; Sittig LJ, 2012, GENES BRAIN BEHAV, V11, P193, DOI 10.1111/j.1601-183X.2011.00749.x; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Stanger O, 2002, CURR DRUG METAB, V3, P211, DOI 10.2174/1389200024605163; Stapley NW, 2013, NEUROSCI LETT, V549, P120, DOI 10.1016/j.neulet.2013.06.032; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; Sweeney MR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-41; Sweeney MR, 2005, BRIT J NUTR, V94, P727, DOI 10.1079/BJN20051572; Vawter MP, 2007, AM J MED GENET B, V144B, P728, DOI 10.1002/ajmg.b.30454; Vincent JB, 2009, AM J MED GENET B, V150B, P817, DOI 10.1002/ajmg.b.30903; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	57	55	58	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101674	10.1371/journal.pone.0101674	http://dx.doi.org/10.1371/journal.pone.0101674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006883	Green Published, gold			2022-12-25	WOS:000339040600056
J	Chen, HL; Wu, SP; Lu, R; Zhang, YG; Zheng, YY; Sun, J				Chen, Honglei; Wu, Shaoping; Lu, Rong; Zhang, Yong-guo; Zheng, Yuanyuan; Sun, Jun			Pulmonary Permeability Assessed by Fluorescent-Labeled Dextran Instilled Intranasally into Mice with LPS-Induced Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EVANS BLUE-DYE; ALBUMIN CLEARANCE; VASCULAR LEAKAGE; NEUTROPHIL; JUNCTIONS; PROGRESS; MARKER; ALPHA	Background: Several different methods have been used to assess pulmonary permeability in response to acute lung injury (ALI). However, these methods often involve complicated procedures and algorithms that are difficult to precisely control. The purpose of the current study is to establish a feasible method to evaluate alterations in lung permeability by instilling fluorescently labeled dextran (FITC-Dextran) intranasally. Methods/Principal Findings: For the mouse model of direct ALI, lipopolysaccharide (LPS) was administered intranasally. FITC-Dextran was instilled intranasally one hour before the mice were euthanized. Plasma fluorescence intensities from the LPS group were significantly higher than in the control group. To determine the reliability and reproducibility of the procedure, we also measured the lung wet-to-dry weight ratio, the protein concentration of the bronchoalveolar lavage fluid, tight and adherens junction markers and pathological changes. Consistent results were observed when the LPS group was compared with the control group. Simultaneously, we found that the concentration of plasma FITC-Dextran was LPS dose-dependent. The concentration of plasma FITC-Dextran also increased with initial intranasal FITC-Dextran doses. Furthermore, increased fluorescence intensity of plasma FITC-Dextran was found in the intraperitoneally LPS-induced ALI model. Conclusion/Significance: In conclusion, the measurement of FITC-Dextran in plasma after intranasal instillation is a simple, reliable, and reproducible method to evaluate lung permeability alterations in vivo. The concentration of FITC-Dextran in the plasma may be useful as a potential peripheral biomarker of ALI in experimental clinical studies.	[Chen, Honglei; Wu, Shaoping; Lu, Rong; Zhang, Yong-guo; Zheng, Yuanyuan; Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA	Rush University	Sun, J (corresponding author), Rush Univ, Dept Biochem, Chicago, IL 60612 USA.	jun_sun@rush.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	NIDDK [KO1 DK075386, 1R03DK089010-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075386, R03DK089010] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIDDK (KO1 DK075386 and 1R03DK089010-01) to Jun Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett N, 2011, CRIT CARE CLIN, V27, P661, DOI 10.1016/j.ccc.2011.04.001; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; Grommes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038917; Hoff J, 2000, LAB ANIMAL, V29, P47; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Maus U, 2001, AM J RESP CRIT CARE, V164, P406, DOI 10.1164/ajrccm.164.3.2009055; Mayeux PR, 1997, J TOXICOL ENV HEALTH, V51, P415, DOI 10.1080/00984109708984034; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Zhang YG, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23118; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	21	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101925	10.1371/journal.pone.0101925	http://dx.doi.org/10.1371/journal.pone.0101925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007191	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600080
J	Porwollik, S; Santiviago, CA; Cheng, P; Long, F; Desai, P; Fredlund, J; Srikumar, S; Silva, CA; Chu, WP; Chen, X; Canals, R; Reynolds, MM; Bogomolnaya, L; Shields, C; Cui, P; Guo, JB; Zheng, Y; Endicott-Yazdani, T; Yang, HJ; Maple, A; Ragoza, Y; Blondel, CJ; Valenzuela, C; Andrews-Polymenis, H; McClelland, M				Porwollik, Steffen; Santiviago, Carlos A.; Cheng, Pui; Long, Fred; Desai, Prerak; Fredlund, Jennifer; Srikumar, Shabarinath; Silva, Cecilia A.; Chu, Weiping; Chen, Xin; Canals, Rocio; Reynolds, M. Megan; Bogomolnaya, Lydia; Shields, Christine; Cui, Ping; Guo, Jinbai; Zheng, Yi; Endicott-Yazdani, Tiana; Yang, Hee-Jeong; Maple, Aimee; Ragoza, Yury; Blondel, Carlos J.; Valenzuela, Camila; Andrews-Polymenis, Helene; McClelland, Michael			Defined Single-Gene and Multi-Gene Deletion Mutant Collections in Salmonella enterica sv Typhimurium	PLOS ONE			English	Article							CONDITIONALLY ESSENTIAL GENES; HIGH-THROUGHPUT; GENOME; INSERTION; INFECTION; MUTAGENESIS; SEQUENCE; LIBRARY; FITNESS; PROTEIN	We constructed two collections of targeted single gene deletion (SGD) mutants and two collections of targeted multi-gene deletion (MGD) mutants in Salmonella enterica sv Typhimurium 14028s. The SGD mutant collections contain (1), 3517 mutants in which a single gene is replaced by a cassette containing a kanamycin resistance (Kan(R)) gene oriented in the sense direction (SGD-K), and (2), 3376 mutants with a chloramphenicol resistance gene (Cam(R)) oriented in the antisense direction (SGD-C). A combined total of 3773 individual genes were deleted across these SGD collections. The MGD collections contain mutants bearing deletions of contiguous regions of three or more genes and include (3), 198 mutants spanning 2543 genes replaced by a Kan(R) cassette (MGD-K), and (4), 251 mutants spanning 2799 genes replaced by a Cam(R) cassette (MGD-C). Overall, 3476 genes were deleted in at least one MGD collection. The collections with different antibiotic markers permit construction of all viable combinations of mutants in the same background. Together, the libraries allow hierarchical screening of MGDs for different phenotypic followed by screening of SGDs within the target MGD regions. The mutants of these collections are stored at BEI Resources (www.beiresources.org) and publicly available.	[Porwollik, Steffen; Cheng, Pui; Long, Fred; Desai, Prerak; Fredlund, Jennifer; Srikumar, Shabarinath; Silva, Cecilia A.; Chu, Weiping; Chen, Xin; Canals, Rocio; McClelland, Michael] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Santiviago, Carlos A.; Silva, Cecilia A.; Blondel, Carlos J.; Valenzuela, Camila] Univ Chile, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Reynolds, M. Megan; Bogomolnaya, Lydia; Shields, Christine; Cui, Ping; Guo, Jinbai; Zheng, Yi; Endicott-Yazdani, Tiana; Yang, Hee-Jeong; Maple, Aimee; Ragoza, Yury; Andrews-Polymenis, Helene] Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA	University of California System; University of California Irvine; Universidad de Chile; Texas A&M University System; Texas A&M University College Station	Andrews-Polymenis, H (corresponding author), Texas A&M Univ, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77843 USA.	handrews@medicine.tamhsc.edu; mmcclell@uci.edu	Blondel, Carlos/X-7380-2019; Desai, Prerak/ABF-8529-2020; Silva, Cecilia A./E-1382-2015; Chen, Xin/ABA-3794-2020; Blondel, Carlos J/B-1287-2010; Valenzuela, Camila/ADU-5264-2022; Santiviago, Carlos/N-9991-2018	Blondel, Carlos/0000-0002-7099-6347; Silva, Cecilia A./0000-0003-1945-7767; Blondel, Carlos J/0000-0002-7099-6347; Valenzuela, Camila/0000-0002-5642-6188; Santiviago, Carlos/0000-0002-7043-7908; Bogomolnaya, Lydia/0000-0001-7041-1815; Srikumar, Shabarinath/0000-0003-3775-2831; McClelland, Michael/0000-0003-1788-9347; Yang, Hee-Jeong/0000-0002-7351-8404; Canals, Rocio/0000-0001-7079-7690	NIH [R01AI075093, R21AI083964, R01AI083646, R56AI077645]; NIAID [HHSN272200900040C]; Binational Agricultural Research Development Fund; Center for Produce Safety at UC Davis; AFRI CSRESS United States Department of Agriculture [2009-03579]; FONDECYT [1110172, 1140754]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083646, R21AI083964, R56AI077645, R01AI075093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Binational Agricultural Research Development Fund; Center for Produce Safety at UC Davis; AFRI CSRESS United States Department of Agriculture; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part under NIH grant R01AI075093, and NIAID Contract No. HHSN272200900040C. The authors also acknowledge support from NIH grants R21AI083964, R01AI083646, R56AI077645, the Binational Agricultural Research Development Fund, the Center for Produce Safety at UC Davis, AFRI CSRESS United States Department of Agriculture grant 2009-03579, and FONDECYT grants 1110172 and 1140754. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Polymenis HL, 2004, J BACTERIOL, V186, P2619, DOI 10.1128/JB.186.9.2619-2628.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barquist L, 2013, NUCLEIC ACIDS RES, V41, P4549, DOI 10.1093/nar/gkt148; Baumler AJ, 1996, INFECT IMMUN, V64, P61; Bolle C, 2013, PLANT J, V75, P157, DOI 10.1111/tpj.12197; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Canals R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-212; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Gallagher LA, 2013, MBIO, V4, DOI 10.1128/mBio.00604-13; Goodman AL, 2011, NAT PROTOC, V6, P1969, DOI 10.1038/nprot.2011.417; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Huang TT, 2013, CARCINOGENESIS, DOI 10.1093/carcin/bgt112 23568951; IZAT AL, 1990, POULTRY SCI, V69, P1876, DOI 10.3382/ps.0691876; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Katribe E, 2009, J BACTERIOL, V191, P2843, DOI 10.1128/JB.01223-08; Khatiwara A, 2012, APPL ENVIRON MICROB, V78, P3098, DOI 10.1128/AEM.06865-11; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mulleder M, 2012, NAT BIOTECHNOL, V30, P1176, DOI 10.1038/nbt.2442; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Pezoa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063917; Pickard D, 2013, J BACTERIOL, V195, P1320, DOI 10.1128/JB.01632-12; Reynolds MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015800; Sabbagh SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036643; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Skurnik D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003582; Swearingen MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036043; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Varshney GK, 2013, NUCLEIC ACIDS RES, V41, pD861, DOI 10.1093/nar/gks946; WALDROUP AL, 1993, POULTRY SCI, V72, P643, DOI 10.3382/ps.0720643; Wang Y, 2009, COLD SPRING HARB PRO, V2009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zheng Y, 2013, MOL MICROBIOL, V89, P403, DOI 10.1111/mmi.12284	54	87	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99820	10.1371/journal.pone.0099820	http://dx.doi.org/10.1371/journal.pone.0099820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007190	Green Published, gold			2022-12-25	WOS:000339040600009
J	Stanton, DWG; Hart, J; Galbusera, P; Helsen, P; Shephard, J; Kumpel, NF; Wang, JL; Ewen, JG; Bruford, MW				Stanton, David W. G.; Hart, John; Galbusera, Peter; Helsen, Philippe; Shephard, Jill; Kuempel, Noelle F.; Wang, Jinliang; Ewen, John G.; Bruford, Michael W.			Distinct and Diverse: Range-Wide Phylogeography Reveals Ancient Lineages and High Genetic Variation in the Endangered Okapi (Okapia johnstoni)	PLOS ONE			English	Article							POPULATION-GENETICS; COMPREHENSIVE ANALYSIS; CLIMATE-CHANGE; MITOCHONDRIAL; EVOLUTION; CONSERVATION; HISTORY; POLYMORPHISM; EXPANSION; REFUGIA	The okapi is an endangered, evolutionarily distinctive even-toed ungulate classified within the giraffidae family that is endemic to the Democratic Republic of Congo. The okapi is currently under major anthropogenic threat, yet to date nothing is known about its genetic structure and evolutionary history, information important for conservation management given the species' current plight. The distribution of the okapi, being confined to the Congo Basin and yet spanning the Congo River, also makes it an important species for testing general biogeographic hypotheses for Congo Basin fauna, a currently understudied area of research. Here we describe the evolutionary history and genetic structure of okapi, in the context of other African ungulates including the giraffe, and use this information to shed light on the biogeographic history of Congo Basin fauna in general. Using nuclear and mitochondrial DNA sequence analysis of mainly non-invasively collected samples, we show that the okapi is both highly genetically distinct and highly genetically diverse, an unusual combination of genetic traits for an endangered species, and feature a complex evolutionary history. Genetic data are consistent with repeated climatic cycles leading to multiple Plio-Pleistocene refugia in isolated forests in the Congo catchment but also imply historic gene flow across the Congo River.	[Stanton, David W. G.; Bruford, Michael W.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hart, John] Lukuru Fdn, Projet Tshuapa Lomami Lualaba TL2, Kinshasa, DEM REP CONGO; [Galbusera, Peter; Helsen, Philippe; Shephard, Jill] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Kuempel, Noelle F.] Zool Soc London, Conservat Programmes, London, England; [Wang, Jinliang; Ewen, John G.] Zool Soc London, Inst Zool, London NW1 4RY, England	Cardiff University; Zoological Society of London; Zoological Society of London	Stanton, DWG (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	stantondw@cardiff.ac.uk	Bruford, Michael/Y-7463-2019; Helsen, Philippe/K-8660-2018; Galbusera, Peter HA/D-2188-2014; Bruford, Michael W/D-3750-2009	Bruford, Michael/0000-0001-6357-6080; Galbusera, Peter HA/0000-0001-9516-8196; Bruford, Michael W/0000-0001-6357-6080; Stanton, David/0000-0002-9753-3166; Shephard, Jill/0000-0002-4418-9891	UK Natural Environment Research Council (NERC); ZSL (ZSL as NERC CASE industry partner and via an Erasmus Darwin Barlow Expedition grant); GIC (the Okapi Conservation Project); US Fish and Wildlife Service; UK's Darwin Initiative; Mohamed bin Zayed Species Conservation Fund	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ZSL (ZSL as NERC CASE industry partner and via an Erasmus Darwin Barlow Expedition grant); GIC (the Okapi Conservation Project); US Fish and Wildlife Service(US Fish & Wildlife Service); UK's Darwin Initiative; Mohamed bin Zayed Species Conservation Fund	This project was jointly funded by the UK Natural Environment Research Council (NERC) and ZSL (ZSL as NERC CASE industry partner and via an Erasmus Darwin Barlow Expedition grant). The authors also acknowledge the financial support provided by GIC (the Okapi Conservation Project), the US Fish and Wildlife Service, the UK's Darwin Initiative and the Mohamed bin Zayed Species Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken N, 2004, MOL ECOL, V13, P1423, DOI 10.1111/j.1365-294X.2004.02159.x; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Anka Z, 2009, TECTONOPHYSICS, V470, P42, DOI 10.1016/j.tecto.2008.04.009; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Born C, 2011, MOL ECOL, V20, P131, DOI 10.1111/j.1365-294X.2010.04919.x; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; BRAGA J, 1995, CR ACAD SCI II, V320, P1025; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clifford SL, 2004, MOL ECOL, V13, P1551, DOI 10.1111/j.1365-294X.2004.02140.x; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Cowling SA, 2008, GLOBAL CHANGE BIOL, V14, P827, DOI 10.1111/j.1365-2486.2007.01524.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; deBonis L, 1997, PALAEONTOLOGY, V40, P121; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dietrich WO, 1942, PALAEONTOGR ABT A, V94, P3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Frankham R., 2002, INTRO CONSERVATION G; GENTRY AW, 1990, J HUM EVOL, V19, P529, DOI 10.1016/0047-2484(90)90063-H; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton AC, 1975, PLANT ECOL, V30, P99; Harris J.M., 1991, P93; Harris John M., 2010, P797; HART JA, 1989, SYM ZOOL S, V61, P31; Hart JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044271; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; IUCN, 2008, IUCN 2013 IUCN RED L; Johnston AR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-120; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059660; Kennis J, 2011, ZOOL J LINN SOC-LOND, V163, P983, DOI 10.1111/j.1096-3642.2011.00733.x; Lankester E. R., 1901, Proceedings of the Zoological Society of London, Vii, P279; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIVINGSTONE DA, 1975, ANNU REV ECOL SYST, V6, P249, DOI 10.1146/annurev.es.06.110175.001341; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; Lorenzen ED, 2010, J BIOGEOGR, V37, P571, DOI 10.1111/j.1365-2699.2009.02207.x; MAGLIO VJ, 1973, T AM PHILOS SOC, V63, P5; Mallon D, 2013, IUCN 2013 IUCN RED L; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Mboumba JF, 2011, J ZOOL SYST EVOL RES, V49, P77, DOI 10.1111/j.1439-0469.2010.00579.x; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Nixon S., 2008, CONSERVATION STATUS; Pickles RSA, 2011, MOL PHYLOGENET EVOL, V61, P616, DOI 10.1016/j.ympev.2011.08.017; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Querouil S, 2003, MOL PHYLOGENET EVOL, V28, P24, DOI 10.1016/S1055-7903(03)00027-7; Rambaut A., 2007, TRACER V1 5; Rohland N, 2005, MOL BIOL EVOL, V22, P2435, DOI 10.1093/molbev/msi244; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stuart C., 2017, STUARTS FIELD GUIDE; Uchida A, 1996, TRENDS ECOL EVOL, V11, P163, DOI 10.1016/0169-5347(96)10007-0; Van der Made J, 2012, ESTUD GEOL-MADRID, V67, P613; Van Hooft WF, 2002, MOL ECOL, V11, P267, DOI 10.1046/j.1365-294X.2002.01429.x; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	74	13	13	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101081	10.1371/journal.pone.0101081	http://dx.doi.org/10.1371/journal.pone.0101081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007188	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000339040600029
J	de Jong, PA; Hellings, WE; Takx, RAP; Isgum, I; van Herwaarden, JA; Mali, WPTM				de Jong, Pim A.; Hellings, Willem E.; Takx, Richard A. P.; Isgum, Ivana; van Herwaarden, Joost A.; Mali, Willem P. Th M.			Computed Tomography of Aortic Wall Calcifications in Aortic Dissection Patients	PLOS ONE			English	Article							HUMAN THORACIC AORTA; ARTERIAL CALCIFICATION; CARDIOVASCULAR EVENTS; RISK-FACTORS; ATHEROSCLEROSIS; ARTERIOSCLEROSIS; MANAGEMENT; STENOSIS; BONE; CT	Objectives: To investigate the frequency of aortic calcifications at the outer edge of the false lumen and the frequency of fully circular aortic calcifications in a consecutive series of patients with aortic dissection who underwent contrast-enhanced CT. Methods: The study population compromised of 69 consecutive subjects aged 60 years and older with a contrast-enhanced CT scan demonstrating an aortic dissection. All CT scans were evaluated for the frequency of aortic calcifications at the outer edge of the false lumen and the frequency of fully circular aortic calcifications by two experienced observers. Between observer reliability was evaluated by using Cohen's Kappa. Differences between groups were tested using unpaired T test and Chi-square test. Results: Presumed media calcifications were observed in 22 (32%) patients of 60 years and older and were found more frequently in chronic aortic dissection (N = 12/23, 52%) than in acute aortic dissection (N = 10/46, 22%). Conclusion: As the intima has been torn away by the aortic dissection it is highly likely that CT scans can visualize the calcifications in the tunica media of the aorta.	[de Jong, Pim A.; Takx, Richard A. P.; Mali, Willem P. Th M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Hellings, Willem E.; van Herwaarden, Joost A.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Isgum, Ivana] Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	pimdejong@gmail.com	de Jong, Pim A/G-7220-2014; Takx, Richard/T-2852-2019; Isgum, Ivana/H-8659-2014	de Jong, Pim A/0000-0003-4840-6854; Takx, Richard/0000-0003-2252-3040; van Herwaarden, Joost/0000-0003-1165-5179; Isgum, Ivana/0000-0003-1869-5034				Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Blumenthal Herman T., 1944, AMER JOUR PATH, V20, P665; Dweck MR, 2013, EUR HEART J, V34, P1567, DOI 10.1093/eurheartj/eht034; ELLIOTT RJ, 1994, CALCIFIED TISSUE INT, V54, P268, DOI 10.1007/BF00295949; GOEBEL FD, 1983, DIABETOLOGIA, V24, P347; HACHIYA J, 1993, J COMPUT ASSIST TOMO, V17, P374, DOI 10.1097/00004728-199305000-00006; HICKLER RB, 1990, CLIN CARDIOL, V13, P317, DOI 10.1002/clc.4960130504; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Iribarren C, 2007, J INTERN MED, V261, P235, DOI 10.1111/j.1365-2796.2007.01768.x; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; Jacobs PC, 2011, EUR RADIOL, V21, P1577, DOI 10.1007/s00330-011-2112-8; Jeffcoate WJ, 2009, DIABETOLOGIA, V52, P2478, DOI 10.1007/s00125-009-1521-6; Juraszek A, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-110; KANNEL WB, 1972, J PEDIATR-US, V80, P544, DOI 10.1016/S0022-3476(72)80049-0; Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311; LACHMAN AS, 1977, AM J MED, V63, P615, DOI 10.1016/0002-9343(77)90207-8; LINDBOM A, 1950, Acta Radiol Suppl, V80, P1; MCCULLAGH KG, 1975, ATHEROSCLEROSIS, V21, P37, DOI 10.1016/0021-9150(75)90093-3; MEEMA HE, 1986, RADIOLOGY, V158, P671, DOI 10.1148/radiology.158.3.3945736; Monckeberg JG, 1903, VIRCHOWS ARCH A, V171, P141; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; ORR DP, 1978, INVEST RADIOL, V13, P110, DOI 10.1097/00004424-197803000-00002; REID JM, 1982, THORAX, V37, P902, DOI 10.1136/thx.37.12.902; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Subbotin VM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-41; Tohno S, 1998, CELL MOL BIOL, V44, P1253; Tohno Y, 1996, BIOL TRACE ELEM RES, V54, P23, DOI 10.1007/BF02785317; Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010.abs; Willoteaux S, 2004, EUR RADIOL, V14, P1999, DOI 10.1007/s00330-004-2441-y; Yamada S, 2014, EUR J RADIOL, V83, P957, DOI 10.1016/j.ejrad.2014.02.009	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102036	10.1371/journal.pone.0102036	http://dx.doi.org/10.1371/journal.pone.0102036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003993	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700100
J	Rondeau, G; Abedinpour, P; Desai, P; Baron, VT; Borgstrom, P; Welsh, J				Rondeau, Gaelle; Abedinpour, Parisa; Desai, Prerak; Baron, Veronique T.; Borgstrom, Per; Welsh, John			Effects of Different Tissue Microenvironments on Gene Expression in Breast Cancer Cells	PLOS ONE			English	Article							RAT MAMMARY-TUMORS; ENDOPLASMIC-RETICULUM; MODEL; METASTASIS; MICE; DYNAMICS; STRESS	In metastasis, circulating tumor cells penetrate the walls of blood vessels and enter the metastatic target tissue, thereby becoming exposed to novel and relatively unsupportive microenvironments. In the new microenvironments, the tumor cells often remain in a dormant state indefinitely and must adapt before they are able to successfully colonize the tissue. Very little is known about this adaptive process. We studied temporal changes in gene expression when breast cancer cells adapt to survive and grow on brain, bone marrow, and lung tissue maintained in an in vivo culture system, as models of the metastatic colonization of these tissues. We observed the transient activation of genes typically associated with homeostasis and stress during the initial stages of adaptation, followed by the activation of genes that mediate more advanced functions, such as elaboration of cell morphology and cell division, as the cells adapted to thrive in the host tissue microenvironment. We also observed the temporary induction of genes characteristic of the host tissue, which was particularly evident when tumor cells were grown on brain tissue. These early transient gene expression events suggest potential points of therapeutic intervention that are not evident in data from well-established tumors.	[Rondeau, Gaelle; Abedinpour, Parisa; Desai, Prerak; Baron, Veronique T.; Borgstrom, Per; Welsh, John] Vaccine Res Inst San Diego, San Diego, CA 92121 USA		Welsh, J (corresponding author), Vaccine Res Inst San Diego, San Diego, CA 92121 USA.	jwelsh@sdibr.org	Desai, Prerak/ABF-8529-2020		California Breast Cancer Research Program [151B-0133]; DOD [W81XWH-09-1-0280]; NCI [1R21CA133638]; NATIONAL CANCER INSTITUTE [R21CA133638] Funding Source: NIH RePORTER	California Breast Cancer Research Program; DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the California Breast Cancer Research Program (151B-0133), the DOD (W81XWH-09-1-0280), and the NCI (1R21CA133638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Astolfi A, 2005, AM J PATHOL, V166, P1205, DOI 10.1016/S0002-9440(10)62339-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benosman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064256; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brochner CB, 2012, J HISTOCHEM CYTOCHEM, V60, P188, DOI 10.1369/0022155411433331; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chan MM, 2007, INT J CANCER, V121, P474, DOI 10.1002/ijc.22684; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cuadros C, 2003, CANCER RES, V63, P5895; DULBECCO R, 1988, P NATL ACAD SCI USA, V85, P8659, DOI 10.1073/pnas.85.22.8659; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Frost GI, 2005, MICROVASC RES, V69, P1, DOI 10.1016/j.mvr.2004.10.001; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Han HX, 2011, ACTA PHARMACOL SIN, V32, P1327, DOI 10.1038/aps.2011.106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiuchi Y, 2012, AM J MED GENET B, V159B, P30, DOI 10.1002/ajmg.b.31249; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnston J, 2010, TRANSGENIC RES, V19, P1017, DOI 10.1007/s11248-010-9376-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khoo MLM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019025; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kobayashi K, 2003, DEVELOPMENT, V130, P5179, DOI 10.1242/dev.00732; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lombard Z, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-30; Lu X, 2009, CELL CYCLE, V8, P3804, DOI 10.4161/cc.8.23.10104; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Miles RR, 2000, ENDOCRINOLOGY, V141, P4533, DOI 10.1210/en.141.12.4533; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Overgaard K, 1999, J PHYSIOL-LONDON, V518, P215, DOI 10.1111/j.1469-7793.1999.0215r.x; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; R Core Team, 2012, R LANG ENV STAT COMP; Rojas P, 2007, MOL PSYCHIATR, V12, P756, DOI 10.1038/sj.mp.4001993; Saadat L, 2010, GLIA, V58, P391, DOI 10.1002/glia.20930; Sabrautzki S, 2012, MAMM GENOME, V23, P416, DOI 10.1007/s00335-012-9397-z; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Velasco J, 2010, OSTEOPOROSIS INT, V21, P109, DOI 10.1007/s00198-009-0931-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhang P, 2011, ARTERIOSCL THROM VAS, V31, P890, DOI 10.1161/ATVBAHA.110.215640	57	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101160	10.1371/journal.pone.0101160	http://dx.doi.org/10.1371/journal.pone.0101160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004123	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700019
J	Sala, R; Nguyen, QD; Patel, CBK; Mann, D; Steinke, JHG; Vilar, R; Aboagye, EO				Sala, Roberta; Quang-De Nguyen; Patel, Chirag B. K.; Mann, David; Steinke, Joachim H. G.; Vilar, Ramon; Aboagye, Eric O.			Phosphorylation Status of Thymidine Kinase 1 Following Antiproliferative Drug Treatment Mediates 3 '-Deoxy-3 '-[F-18]-Fluorothymidine Cellular Retention	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; BREAST-CANCER; 3'-DEOXY-3'-FLUOROTHYMIDINE PET; MITOTIC PHOSPHORYLATION; PROLIFERATION; TUMOR; CELLS; DEGRADATION; VALIDATION	Background: 3'-Deoxy-3'-[F-18]-fluorothymidine ([F-18] FLT) is being investigated as a Positron Emission Tomography (PET) proliferation biomarker. The mechanism of cellular [F-18] FLT retention has been assigned primarily to alteration of the strict transcriptionally regulated S-phase expression of thymidine kinase 1 (TK1). This, however, does not explain how anticancer agents acting primarily through G2/M arrest affect [F-18] FLT uptake. We investigated alternative mechanisms of [F-18] FLT cellular retention involving post-translational modification of TK1 during mitosis. Methods: [F-18] FLT cellular retention was assessed in cell lines having different TK1 expression. Drug-induced phosphorylation of TK1 protein was evaluated by MnCl2-phos-tag gel electrophoresis and correlated with [F-18] FLT cellular retention. We further elaborated the amino acid residues involved in TK1 phosphorylation by transient transfection of FLAG-pCMV2 plasmids encoding wild type or mutant variants of TK1 into TK1 negative cells. Results: Baseline [F-18] FLT cellular retention and TK1 protein expression were associated. S-phase and G2/M phase arrest caused greater than two-fold reduction in [F-18] FLT cellular retention in colon cancer HCT116 cells (p<0.001). G2/M cell cycle arrest increased TK1 phosphorylation as measured by induction of at least one phosphorylated form of the protein on MnCl2-phos-tag gels. Changes in [F-18] FLT cellular retention reflected TK1 phosphorylation and not expression of total protein, in keeping with the impact of phosphorylation on enzyme catalytic activity. Both Ser13 and Ser231 were shown to be involved in the TK1 phosphorylation-modulated [F-18] FLT cellular retention; although the data suggested involvement of other amino-acid residues. Conclusion: We have defined a regulatory role of TK1 phosphorylation in mediating [F-18] FLT cellular retention and hence reporting of antiproliferative activity, with implications especially for drugs that induce a G2/M cell cycle arrest.	[Sala, Roberta; Quang-De Nguyen; Aboagye, Eric O.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Comprehens Canc Imaging Ctr, London, England; [Patel, Chirag B. K.; Steinke, Joachim H. G.; Vilar, Ramon] Univ London Imperial Coll Sci Technol & Med, Dept Chem, Inst Chem Biol, London SW7 2AY, England; [Mann, David] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London; Imperial College London; Imperial College London	Aboagye, EO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Comprehens Canc Imaging Ctr, London, England.	eric.aboagye@imperial.ac.uk	Vilar, Ramon/U-3746-2019	Vilar, Ramon/0000-0003-2992-199X; ABOAGYE, Eric/0000-0003-2276-6771	Cancer Research UK - Engineering and Physical Sciences Research Council grant [C2536/A10337]; UK Medical Research Council [MC_US_A652_0030]; EPSRC [EP/K039946/1] Funding Source: UKRI; Cancer Research UK [10337] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K039946/1] Funding Source: researchfish	Cancer Research UK - Engineering and Physical Sciences Research Council grant; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by Cancer Research UK - Engineering and Physical Sciences Research Council grant (in association with the Medical Research Council and Department of Health (England)) grant C2536/A10337. EOA's laboratory receives core funding from the UK Medical Research Council (MC_US_A652_0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Barthel H, 2003, CANCER RES, V63, P3791; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Brockenbrough J Scott, 2011, J Nucl Med, V52, P1181, DOI 10.2967/jnumed.111.089482; Chan F, 2007, MOL CANCER THER, V6, P3147, DOI 10.1158/1535-7163.MCT-07-2156; CHANG ZF, 1994, J BIOL CHEM, V269, P21249; Chang ZF, 1998, J BIOL CHEM, V273, P12095, DOI 10.1074/jbc.273.20.12095; CHANG ZF, 1993, J BIOL CHEM, V268, P1266; Contractor K, 2012, BIOMARK MED, V6, P231, DOI [10.2217/BMM.12.11, 10.2217/bmm.12.11]; Contractor KB, 2011, CLIN CANCER RES, V17, P7664, DOI 10.1158/1078-0432.CCR-11-0783; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dittmann H, 2002, EUR J NUCL MED MOL I, V29, P1462, DOI 10.1007/s00259-002-0925-z; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Ke PY, 2003, BIOCHEM J, V370, P265, DOI 10.1042/BJ20021335; Kenny LM, 2009, CLIN CANCER RES, V15, P6649, DOI 10.1158/1078-0432.CCR-09-1213; Kenny LM, 2005, CANCER RES, V65, P10104, DOI 10.1158/0008-5472.CAN-04-4297; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2005, J SEP SCI, V28, P155, DOI 10.1002/jssc.200401833; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Leyton J, 2008, MOL CANCER THER, V7, P3112, DOI 10.1158/1535-7163.MCT-08-0264; Leyton J, 2006, CANCER RES, V66, P7621, DOI 10.1158/0008-5472.CAN-05-3962; Li CL, 2004, BIOCHEM BIOPH RES CO, V313, P587, DOI 10.1016/j.bbrc.2003.11.147; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058938; Merrick KA, 2011, MOL CELL, V42, P624, DOI 10.1016/j.molcel.2011.03.031; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MUNCHPETERSEN B, 1993, J BIOL CHEM, V268, P15621; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Muzi M, 2005, J NUCL MED, V46, P274; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Rasey JS, 2002, J NUCL MED, V43, P1210; Alexander S, 2007, SEMIN NUCL MED, V37, P429, DOI 10.1053/j.semnuclmed.2007.08.001; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SCHLOSSER CA, 1981, P NATL ACAD SCI-BIOL, V78, P1119, DOI 10.1073/pnas.78.2.1119; Seitz U, 2002, EUR J NUCL MED MOL I, V29, P1174, DOI 10.1007/s00259-002-0851-0; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 2003, J NUCL MED, V44, P1432; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Shields AF, 2006, MOL IMAGING BIOL, V8, P141, DOI 10.1007/s11307-006-0039-2; Smith G, 2012, NUCL MED BIOL, V39, P652, DOI 10.1016/j.nucmedbio.2011.12.002; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; Toyohara J, 2002, NUCL MED BIOL, V29, P281, DOI 10.1016/S0969-8051(02)00286-X; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102; Wells P, 2004, BBA-REV CANCER, V1705, P91, DOI 10.1016/j.bbcan.2004.09.007; XU YZ, 1993, J BIOL CHEM, V268, P22363; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	54	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101366	10.1371/journal.pone.0101366	http://dx.doi.org/10.1371/journal.pone.0101366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003822	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700026
J	Robertson, WE; Rose, KL; Hudson, BG; Vanacore, RM				Robertson, Wesley E.; Rose, Kristie L.; Hudson, Billy G.; Vanacore, Roberto M.			Supramolecular Organization of the alpha 121-alpha 565 Collagen IV Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; DIFFERENTIAL EXPRESSION; STRUCTURAL BASIS; ALPORT SYNDROME; CHAINS; IDENTIFICATION; ALPHA-5; COL4A1; KIDNEY; GENES	Collagen IV is a family of 6 chains (alpha 1-alpha 6), that form triple-helical protomers that assemble into supramolecular networks. Two distinct networks with chain compositions of alpha 121 and alpha 345 have been established. These oligomerize into separate alpha 121 and alpha 345 networks by a homotypic interaction through their trimeric noncollagenous (NC1) domains, forming alpha 121 and alpha 345 NC1 hexamers, respectively. These are stabilized by novel sulfilimine (-S=N-) cross-links, a covalent cross-link that forms between Met(93) and Hyl(211) at the trimer-trimer interface. A third network with a composition of alpha 1256 has been proposed, but its supramolecular organization has not been established. In this study we investigated the supramolecular organization of this network by determining the chain identity of sulfilimine-cross-linked NC1 domains derived from the alpha 1256 NC1 hexamer. High resolution mass spectrometry analyses of peptides revealed that sulfilimine bonds specifically cross-link alpha 1 to alpha 5 and alpha 2 to alpha 6 NC1 domains, thus providing the spatial orientation between interacting alpha 121 and alpha 565 trimers. Using this information, we constructed a three-dimensional homology model in which the alpha 565 trimer shows a good chemical and structural complementarity to the alpha 121 trimer. Our studies provide the first chemical evidence for an alpha 565 protomer and its heterotypic interaction with the alpha 121 protomer. Moreover, our findings, in conjunction with our previous studies, establish that the six collagen IV chains are organized into three canonical protomers alpha 121, alpha 345, and alpha 565 forming three distinct networks: alpha 121, alpha 345, and alpha 121-alpha 565, each of which is stabilized by sulfilimine bonds between their C-terminal NC1 domains.	[Robertson, Wesley E.; Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Rose, Kristie L.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Rose, Kristie L.] Vanderbilt Univ, Med Ctr, Mass Spectrometry Res Ctr, Prote Lab, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Vanacore, RM (corresponding author), Vanderbilt Univ, Dept Med, 1161 21st Ave S,B-3113 MCN, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100; Robertson, Wesley/0000-0001-9812-8288	National Institutes of Health [S10 RR027714]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mohamed Rafi and Parvin Todd for technical expertise. We are also very grateful to Salisha Hill and Hayes McDonald from the Vanderbilt Mass Spectrometry Center for assistance with MS analysis of some of our samples. We thank Suraj Adhikary for helpful comments with molecular modeling. The LTQ Orbitrap Velos mass spectrometer used in these studies was purchased with funds from National Institutes of Health Grant S10 RR027714 awarded to the Vanderbilt proteomics shared resource.	Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Hino S, 1996, PEDIATR NEPHROL, V10, P742, DOI 10.1007/s004670050206; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; KASHTAN CE, 1990, PEDIATR NEPHROL, V4, P523, DOI 10.1007/BF00869840; Kashtan CE, 2010, NEPHROL DIAL TRANSPL, V25, P3554, DOI 10.1093/ndt/gfq271; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Lyons O T A, 2007, Ann Vasc Surg, V21, P816, DOI 10.1016/j.avsg.2007.06.004; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Seki T, 1998, HISTOCHEM CELL BIOL, V110, P359, DOI 10.1007/s004180050296; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008	35	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25601	25610		10.1074/jbc.M114.571844	http://dx.doi.org/10.1074/jbc.M114.571844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25006246	Green Published, hybrid			2022-12-25	WOS:000342130800021
J	Okamura, A; Koyanagi, S; Dilxiat, A; Kusunose, N; Chen, JJ; Matsunaga, N; Shibata, S; Ohdo, S				Okamura, Ayako; Koyanagi, Satoru; Dilxiat, Adila; Kusunose, Naoki; Chen, Jia Jun; Matsunaga, Naoya; Shibata, Shigenobu; Ohdo, Shigehiro			Bile Acid-regulated Peroxisome Proliferator-activated Receptor-alpha (PPAR alpha) Activity Underlies Circadian Expression of Intestinal Peptide Absorption Transporter PepT1/Slc15a1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; NUCLEAR RECEPTOR; DIURNAL RHYTHM; COTRANSPORTER; METABOLISM; PACEMAKER; BIOLOGY; PEPT-1; CLOCK	Digested proteins are mainly absorbed as small peptides composed of two or three amino acids. The intestinal absorption of small peptides is mediated via only one transport system: the proton-coupled peptide transporter-1 (PepT1) encoded from the soluble carrier protein Slc15a1. In mammals, intestinal expression of PepT1/Slc15a1 oscillates during the daily feeding cycle. Although the oscillation in the intestinal expression of PepT1/Slc15a1 is suggested to be controlled by molecular components of circadian clock, we demonstrated here that bile acids regulated the oscillation of PepT1/Slc15a1 expression through modulating the activity of peroxisome proliferator-activated receptor alpha (PPAR alpha). Nocturnally active mice mainly consumed their food during the dark phase. PPAR alpha activated the intestinal expression of Slc15a1 mRNA during the light period, and protein levels of PepT1 peaked before the start of the dark phase. After food intake, bile acids accumulated in intestinal epithelial cells. Intestinal accumulated bile acids interfered with recruitment of co-transcriptional activator CREB-binding protein/p300 on the promoter region of Slc15a1 gene, thereby suppressing PPAR alpha-mediated transactivation of Slc15a1. The time-dependent suppression of PPAR alpha-mediated transactivation by bile acids caused an oscillation in the intestinal expression of PepT1/Slc15a1 during the daily feeding cycle that led to circadian changes in the intestinal absorption of small peptides. These findings suggest a molecular clock-independent mechanism by which bile acid-regulated PPAR alpha activity governs the circadian expression of intestinal peptide transporter.	[Okamura, Ayako; Koyanagi, Satoru; Dilxiat, Adila; Kusunose, Naoki; Chen, Jia Jun; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Fukuoka 8128582, Japan; [Shibata, Shigenobu] Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Tokyo 1628480, Japan	Kyushu University; Waseda University	Ohdo, S (corresponding author), Kyushu Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Japan Society for the Promotion of Science [25136716, 25253038, 25670079, 26670317]; Grants-in-Aid for Scientific Research [26670317, 26861456] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 25136716 (to S. O.), Grant-in-aid for Scientific Research (A) 25253038 (to S. O.), Grant-in-aid for Challenging Exploratory Research 25670079 (to S. O.), and 26670317 (to S. K.) from the Japan Society for the Promotion of Science.	Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Ashida K, 2002, AM J PHYSIOL-GASTR L, V282, pG617, DOI 10.1152/ajpgi.00344.2001; Berlioz F, 2000, J PHARMACOL EXP THER, V294, P466; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Feillet CA, 2006, J PHYSIOL-PARIS, V100, P252, DOI 10.1016/j.jphysparis.2007.05.002; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gangopadhyay A, 2002, AM J PHYSIOL-GASTR L, V283, pG133, DOI 10.1152/ajpgi.00445.2001; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Herrera-Ruiz D, 2003, J PHARM SCI-US, V92, P691, DOI 10.1002/jps.10303; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MATTHEWS DM, 1975, PHYSIOL REV, V55, P537, DOI 10.1152/physrev.1975.55.4.537; Meredith D, 2006, J MEMBRANE BIOL, V213, P79, DOI 10.1007/s00232-006-0876-6; Nielsen CU, 2001, AM J PHYSIOL-GASTR L, V281, pG191, DOI 10.1152/ajpgi.2001.281.1.G191; Ogihara H, 1996, BIOCHEM BIOPH RES CO, V220, P848, DOI 10.1006/bbrc.1996.0493; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Pan XY, 2003, J PHARMACOL EXP THER, V307, P626, DOI 10.1124/jpet.103.055939; Ripperger JA, 2000, GENE DEV, V14, P679; Ritskes-Hoitinga M., 2004, LAB MOUSE, P463; Saito H, 2008, AM J PHYSIOL-GASTR L, V295, pG395, DOI 10.1152/ajpgi.90317.2008; Shimakura J, 2006, AM J PHYSIOL-GASTR L, V291, pG851, DOI 10.1152/ajpgi.00171.2006; Son DO, 2004, BIOFACTORS, V21, P395, DOI 10.1002/biof.552210177	35	31	34	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25296	25305		10.1074/jbc.M114.577023	http://dx.doi.org/10.1074/jbc.M114.577023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25016014	hybrid, Green Published			2022-12-25	WOS:000341985300048
J	Seo, YA; Lee, S; Hennigar, SR; Kelleher, SL				Seo, Young Ah; Lee, Sooyeon; Hennigar, Stephen R.; Kelleher, Shannon L.			Prolactin (PRL)-stimulated Ubiquitination of ZnT2 Mediates a Transient Increase in Zinc Secretion Followed by ZnT2 Degradation in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mammary Gland; Prolactin; Protein Degradation; Secretion; Ubiquitination; Zinc Transporter; ZnT2	KAPPA-B-ALPHA; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; GENE-EXPRESSION; BINDING-SITE; PRL RECEPTOR; IN-VIVO; TRANSPORTER; PROTEIN; INTERNALIZATION	Background: ZnT2 regulates zinc export from mammary cells. Results: Prolactin stimulates ZnT2 ubiquitination, targeting ZnT2 to vesicles and activating zinc accumulation to transiently enhance zinc secretion dependent upon Lys(4)/Lys(6), after which ZnT2 is degraded. Conclusion: Prolactin is a critical regulator of transient ZnT2-mediated zinc secretion. Significance: This work provides insight into post-translational hormonal mechanisms that regulate zinc transport. The zinc transporter ZnT2 imports zinc into secretory vesicles and regulates zinc export from the mammary epithelial cell. Mutations in ZnT2 substantially impair zinc secretion into milk. The lactogenic hormone prolactin (PRL) transcriptionally increases ZnT2 expression through the Jak2/STAT5 signaling pathway, increasing zinc accumulation in secretory vesicles and zinc secretion. Herein, we report that PRL post-translationally stimulated ZnT2 ubiquitination, which altered ZnT2 trafficking and augmented vesicular zinc accumulation and secretion from mammary epithelial cells in a transient manner. Ubiquitination then down-regulated zinc secretion by stimulating degradation of ZnT2. Mutagenesis of two N-terminal lysine residues (K4R and K6R) inhibited ZnT2 ubiquitination, vesicular zinc accumulation and secretion, and protein degradation. These findings establish that PRL post-translationally regulates ZnT2-mediated zinc secretion in a multifactorial manner, first by enhancing zinc accumulation in vesicles to transiently enhance zinc secretion and then by activating ubiquitin-dependent ZnT2 degradation. This provides insight into novel mechanisms through which ZnT2 and zinc transport is tightly regulated in mammary epithelial cells.	[Lee, Sooyeon; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Cell & Mol Physiol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Surg, Hershey, PA 17033 USA; [Seo, Young Ah; Lee, Sooyeon; Hennigar, Stephen R.; Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Seo, Young Ah] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Seo, Young Ah] Harvard Univ, Sch Publ Hlth, Dept Complex Dis & Nutr, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kelleher, SL (corresponding author), 500 Univ Dr, Hershey, PA USA.	slk39@psu.edu	Seo, Young Ah/AAT-5022-2020	Seo, Young Ah/0000-0003-3884-0665; Lee, Sooyeon/0000-0002-1076-3314	National Institutes of Health [R01 HD058614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD058614 (to S. L. K.).	Al-Sakkaf KA, 1997, J MOL ENDOCRINOL, V19, P347, DOI 10.1677/jme.0.0190347; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; De Domenico I, 2009, P NATL ACAD SCI USA, V106, P3800, DOI 10.1073/pnas.0900453106; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Goupille O, 2000, MOL CELL ENDOCRINOL, V159, P133, DOI 10.1016/S0303-7207(99)00197-5; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Isasa Marta, 2012, Methods Mol Biol, V910, P337, DOI 10.1007/978-1-61779-965-5_15; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jahn GA, 1997, BIOL REPROD, V57, P894, DOI 10.1095/biolreprod57.4.894; Jantarajit W, 2007, AM J PHYSIOL-ENDOC M, V293, pE372, DOI 10.1152/ajpendo.00142.2007; Kelleher SL, 2012, J CELL PHYSIOL, V227, P1761, DOI 10.1002/jcp.22900; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lkhider M, 2001, J CELL SCI, V114, P1883; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; McManaman JL, 2000, ARCH BIOCHEM BIOPHYS, V373, P318, DOI 10.1006/abbi.1999.1573; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Moore H.-P. H., 2002, Archives of Physiology and Biochemistry, V110, P16, DOI 10.1076/apab.110.1.16.903; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; OLLIVIERBOUSQUET M, 1978, CELL TISSUE RES, V187, P25, DOI 10.1007/BF00220616; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PICCOLETTI R, 1994, BIOCHEM J, V303, P429, DOI 10.1042/bj3030429; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Selvaraj NG, 2000, MOL ENDOCRINOL, V14, P2054, DOI 10.1210/me.14.12.2054; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Swaminathan G, 2008, J ENDOCRINOL, V196, pR1, DOI 10.1677/JOE-07-0554; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Winklehner-Jennewein P, 1998, GENE, V217, P127, DOI 10.1016/S0378-1119(98)00380-1	54	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23653	23661		10.1074/jbc.M113.531145	http://dx.doi.org/10.1074/jbc.M113.531145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016022	hybrid, Green Published			2022-12-25	WOS:000341505000033
J	Tavares, CDJ; Ferguson, SB; Giles, DH; Wang, QT; Wellmann, RM; O'Brien, JP; Warthaka, M; Brodbelt, JS; Ren, PY; Dalby, KN				Tavares, Clint D. J.; Ferguson, Scarlett B.; Giles, David H.; Wang, Qiantao; Wellmann, Rebecca M.; O'Brien, John P.; Warthaka, Mangalika; Brodbelt, Jennifer S.; Ren, Pengyu; Dalby, Kevin N.			The Molecular Mechanism of Eukaryotic Elongation Factor 2 Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Calcium; Calmodulin (CaM); Phosphorylation; Translation; CaMK-III; Thr-348; eEF-2; eEF-2K; Phosphate-binding Pocket	CALMODULIN-DEPENDENT PHOSPHORYLATION; MR 100,000 SUBSTRATE; FACTOR-II KINASE; PROTEIN-SYNTHESIS; ALPHA-KINASES; IDENTIFICATION; SITE; PURIFICATION; TRANSLATION; AUTOPHAGY	Background: Eukaryotic elongation factor 2 kinase (eEF-2K) regulates protein translation elongation rates. Results: eEF-2K activation involves a two-step process of calmodulin binding and rapid Thr-348 autophosphorylation. Conclusion: Activation of eEF-2K involves two distinct allosteric steps, both of which potentially induce a conformational change. Significance: This mechanism provides a framework for understanding how eEF-2K integrates inputs from multiple upstream signaling pathways. Calmodulin (CaM)-dependent eukaryotic elongation factor 2 kinase (eEF-2K) impedes protein synthesis through phosphorylation of eukaryotic elongation factor 2 (eEF-2). It is subject to complex regulation by multiple upstream signaling pathways, through poorly described mechanisms. Precise integration of these signals is critical for eEF-2K to appropriately regulate protein translation rates. Here, an allosteric mechanism comprising two sequential conformations is described for eEF-2K activation. First, Ca2+/CaM binds eEF-2K with high affinity (K-d(CaM)(app) = 24 +/- 5 nm) to enhance its ability to autophosphorylate Thr-348 in the regulatory loop (R-loop) by > 10(4)-fold (k(auto) = 2.6 +/- 0.3 s(-1)). Subsequent binding of phospho-Thr-348 to a conserved basic pocket in the kinase domain potentially drives a conformational transition of the R-loop, which is essential for efficient substrate phosphorylation. Ca2+/CaM binding activates autophosphorylated eEF-2K by allosterically enhancing k(cat)(app) for peptide substrate phosphorylation by 10(3)-fold. Thr-348 autophosphorylation results in a 25-fold increase in the specificity constant (k(cat)(app)/K-m(Pep-S)(app)), with equal contributions from k(cat)(app) and K-m(Pep-S)(app), suggesting that peptide substrate binding is partly impeded in the unphosphorylated enzyme. In cells, Thr-348 autophosphorylation appears to control the catalytic output of active eEF-2K, contributing more than 5-fold to its ability to promote eEF-2 phosphorylation. Fundamentally, eEF-2K activation appears to be analogous to an amplifier, where output volume may be controlled by either toggling the power switch (switching on the kinase) or altering the volume control (modulating stability of the active R-loop conformation). Because upstream signaling events have the potential to modulate either allosteric step, this mechanism allows for exquisite control of eEF-2K output.	[Tavares, Clint D. J.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Cell & Mol Biol, Austin, TX 78712 USA; [Tavares, Clint D. J.; Ferguson, Scarlett B.; Giles, David H.; Wang, Qiantao; Wellmann, Rebecca M.; Warthaka, Mangalika; Dalby, Kevin N.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Wang, Qiantao; Ren, Pengyu] Univ Texas Austin, Cockrell Sch Engn, Dept Biomed Engn, Austin, TX 78712 USA; [O'Brien, John P.; Brodbelt, Jennifer S.] Univ Texas Austin, Coll Nat Sci, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Tavares, CDJ (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, 107 W Dean Keeton,Biomed Engn Bldg, Austin, TX 78712 USA.	clinttavares@utexas.edu; dalby@austin.utexas.edu	Dalby, Kevin N/A-1905-2013; Ren, Pengyu/Q-6872-2017	Dalby, Kevin N/0000-0001-9272-5129; Ren, Pengyu/0000-0002-5613-1910	National Institutes of Health [GM59802, R21 GM099028, GM106137]; Welch Foundation [F-1390, F-1155]; Robert A. Welch Foundation [F-1691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802, R01GM106137, R21GM099028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM59802 (to K. N. D.). This work was also supported by Welch Foundation Grant F-1390 (to K. N. D.).; Supported by Welch Foundation Grant F-1155 and National Institutes of Health Grant R21 GM099028.; Supported by Robert A. Welch Foundation Grant F-1691 and National Institutes of Health Grant GM106137.	Abramczyk O, 2011, PROTEIN EXPRES PURIF, V79, P237, DOI 10.1016/j.pep.2011.05.005; BAGAGLIO DM, 1994, CELL GROWTH DIFFER, V5, P1403; BAGAGLIO DM, 1993, CANCER RES, V53, P2260; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Crawley SW, 2008, BBA-PROTEINS PROTEOM, V1784, P908, DOI 10.1016/j.bbapap.2008.03.001; Crawley SW, 2011, J BIOL CHEM, V286, P2607, DOI 10.1074/jbc.M110.177014; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Kristelly R, 2003, ACTA CRYSTALLOGR D, V59, P1859, DOI 10.1107/S0907444903018067; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Meloche S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003163; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MITSUI K, 1993, J BIOL CHEM, V268, P13422; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; Pigott CR, 2012, BIOCHEM J, V442, P105, DOI 10.1042/BJ20111536; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tavares CDJ, 2012, BIOCHEMISTRY-US, V51, P2232, DOI 10.1021/bi201788e; Tekedereli I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041171; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wiseman SL, 2013, J BIOL CHEM, V288, P17803, DOI 10.1074/jbc.M113.477182; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213	61	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23901	23916		10.1074/jbc.M114.577148	http://dx.doi.org/10.1074/jbc.M114.577148			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012662	hybrid, Green Published			2022-12-25	WOS:000341505000056
J	Li, H; Hu, D; Fan, HM; Zhang, Y; LeSage, GD; Caudle, Y; Stuart, C; Liu, ZM; Yin, DL				Li, Hui; Hu, Dan; Fan, Huimin; Zhang, Ying; LeSage, Gene D.; Caudle, Yi; Stuart, Charles; Liu, Zhongmin; Yin, Deling			beta-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (TLR4)-triggered Inflammatory Signaling via Targeting p38 MAPK and Interleukin 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-10 PRODUCTION; ACTIVATED MACROPHAGES; PROTEIN; CELLS; BETA-ARRESTIN-2; TRANSDUCTION; MIGRATION; SCAFFOLD; PATHWAYS; GLYCOPROTEIN	The control of IL-10 production in Toll-like receptor (TLR) signals remains to be elucidated. Here, we report that beta-arrestin 2 positively regulates TLR-triggered IL-10 production in a p38 mitogen-activated protein kinase (MAPK)-dependent mechanism. In vitro studies with cells including peritoneal macrophages and HEK293/TLR4 cells have demonstrated that beta-arrestin 2 forms complexes with p38 and facilitates p38 activation after lipopolysaccharide (LPS) stimulation. Deficiency of beta-arrestin 2 and inhibition of p38 MAPK activity both ameliorate TLR4-stimulated IL-10 response. Additionally, in vivo experiments show that mice lacking beta-arrestin 2 produce less amount of IL-10, and are more susceptible to LPS-induced septic shock which is further enhanced by blocking IL-10 signal. These results reveal a novel mechanism by which beta-arrestin 2 negatively regulates TLR4-mediated inflammatory reactions.	[Li, Hui; Hu, Dan; LeSage, Gene D.; Caudle, Yi; Stuart, Charles; Yin, Deling] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA; [Hu, Dan] Wuhan Univ, Dept Neurol, Renmin Hosp, Wuhan 430060, Peoples R China; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Cardiovasc & Thorac Surg, Shanghai 200120, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	East Tennessee State University; Wuhan University; Tongji University; Johns Hopkins University	Liu, ZM (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Cardiovasc & Thorac Surg, Shanghai 200120, Peoples R China.	zhongmin_liu@sina.com; yin@etsu.edu		Yin, Deling/0000-0003-3215-7566	National Institutes of Health [NIDA020120, NIGM094740]; National Natural Science Foundation of China [81370433]; Fundamental Research Funds for the Central Universities of China [121020]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported in part by Research Grants NIDA020120 and NIGM094740 from the National Institutes of Health (to D. Y.). This work was also supported in part by the National Natural Science Foundation of China (81370433) (to Z. L.). This work was also supported in part by the Fundamental Research Funds for the Central Universities of China (121020) (to D. H.).	Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Dai H, 2012, J NEUROIMMUNOL, V245, P1, DOI 10.1016/j.jneuroim.2012.01.005; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Hofmann SR, 2012, CLIN IMMUNOL, V145, P69, DOI 10.1016/j.clim.2012.07.012; Katholnig K, 2013, J IMMUNOL, V190, P1519, DOI 10.4049/jimmunol.1202683; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Komori H, 2012, J BIOL CHEM, V287, P30688, DOI 10.1074/jbc.M112.353771; Koscso B, 2012, J IMMUNOL, V188, P445, DOI 10.4049/jimmunol.1101224; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Ley S, 2013, ONCOGENE, V32, P631, DOI 10.1038/onc.2012.77; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P7235, DOI 10.1167/iovs.12-10587; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Morris GE, 2012, AM J PHYSIOL-CELL PH, V302, pC723, DOI [10.1152/ajpcell.00202.2011, 10.1152/ajpcell.00202.2011.]; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Porter KJ, 2010, J CELL PHYSIOL, V225, P406, DOI 10.1002/jcp.22289; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seregin SS, 2010, VIRUS RES, V147, P123, DOI 10.1016/j.virusres.2009.10.023; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Xia R, 2010, J INTERF CYTOK RES, V30, P155, DOI 10.1089/jir.2009.0017; Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428	40	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23075	23085		10.1074/jbc.M114.591495	http://dx.doi.org/10.1074/jbc.M114.591495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25012660	Green Published, hybrid			2022-12-25	WOS:000341017200045
J	Attucks, OC; Jasmer, KJ; Hannink, M; Kassis, J; Zhong, ZP; Gupta, S; Victory, SF; Guzel, M; Polisetti, DR; Andrews, R; Mjalli, AMM; Kostura, MJ				Attucks, Otis C.; Jasmer, Kimberly J.; Hannink, Mark; Kassis, Jareer; Zhong, Zhenping; Gupta, Suparna; Victory, Sam F.; Guzel, Mustafa; Polisetti, Dharma Rao; Andrews, Robert; Mjalli, Adnan M. M.; Kostura, Matthew J.			Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity	PLOS ONE			English	Article							TRANSCRIPTION REPRESSOR BACH1; OXIDATIVE STRESS; MYOCARDIAL PROTECTION; CYSTEINE RESIDUES; GENETIC ABLATION; NRF2 ACTIVATION; BINDING-SITES; UP-REGULATION; ACID-ESTERS; MICE	Oxidative stress is generated by reactive oxygen species (ROS) produced in response to metabolic activity and environmental factors. Increased oxidative stress is associated with the pathophysiology of a broad spectrum of inflammatory diseases. Cellular response to excess ROS involves the induction of antioxidant response element (ARE) genes under control of the transcriptional activator Nrf2 and the transcriptional repressor Bach1. The development of synthetic small molecules that activate the protective anti-oxidant response network is of major therapeutic interest. Traditional small molecules targeting ARE-regulated gene activation (e.g., bardoxolone, dimethyl fumarate) function by alkylating numerous proteins including Keap1, the controlling protein of Nrf2. An alternative is to target the repressor Bach1. Bach1 has an endogenous ligand, heme, that inhibits Bach1 binding to ARE, thus allowing Nrf2-mediated gene expression including that of heme-oxygenase-1 (HMOX1), a well described target of Bach1 repression. In this report, normal human lung fibroblasts were used to screen a collection of synthetic small molecules for their ability to induce HMOX1. A class of HMOX1-inducing compounds, represented by HPP-4382, was discovered. These compounds are not reactive electrophiles, are not suppressed by N-acetyl cysteine, and do not perturb either ROS or cellular glutathione. Using RNAi, we further demonstrate that HPP-4382 induces HMOX1 in an Nrf2-dependent manner. Chromatin immunoprecipitation verified that HPP-4382 treatment of NHLF cells reciprocally coordinated a decrease in binding of Bach1 and an increase of Nrf2 binding to the HMOX1 E2 enhancer. Finally we show that HPP-4382 can inhibit Bach1 activity in a reporter assay that measures transcription driven by the human HMOX1 E2 enhancer. Our results suggest that HPP-4382 is a novel activator of the antioxidant response through the modulation of Bach1 binding to the ARE binding site of target genes.	[Attucks, Otis C.; Kassis, Jareer; Zhong, Zhenping; Gupta, Suparna; Victory, Sam F.; Guzel, Mustafa; Polisetti, Dharma Rao; Andrews, Robert; Mjalli, Adnan M. M.; Kostura, Matthew J.] TransTech Pharma LLC, High Point, NC 27265 USA; [Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO USA; [Hannink, Mark] Univ Missouri, Life Sci Ctr, Columbia, MO USA; [Jasmer, Kimberly J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kostura, MJ (corresponding author), TransTech Pharma LLC, High Point, NC 27265 USA.	matthew.j.kostura@gmail.com	Jasmer, Kimberly/V-2522-2019	Jasmer, Kimberly/0000-0002-8669-428X; Kostura, Matthew/0000-0001-7940-7492; Guzel, Prof. Mustafa/0000-0002-1423-0435	High Point Pharmaceuticals LLC.	High Point Pharmaceuticals LLC.	The research described in this manuscript was funded by High Point Pharmaceuticals LLC. The funder did have a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Botros FT, 2005, KIDNEY INT, V68, P2745, DOI 10.1111/j.1523-1755.2005.00745.x; Burgess A, 2010, HYPERTENSION, V56, P1124, DOI 10.1161/HYPERTENSIONAHA.110.151423; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Elmarakby AA, 2012, AM J PHYSIOL-RENAL, V302, pF791, DOI 10.1152/ajprenal.00472.2011; Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149; Harusato A, 2011, FREE RADICAL RES, V45, P717, DOI 10.3109/10715762.2011.574287; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; Iida A, 2009, TOHOKU J EXP MED, V217, P223, DOI 10.1620/tjem.217.223; Inoue M, 2011, J CLIN BIOCHEM NUTR, V48, P161, DOI 10.3164/jcbn.09-122GFR; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Johns DG, 2009, EUR J PHARMACOL, V606, P109, DOI 10.1016/j.ejphar.2008.12.030; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kondo K, 2013, AM J PHYSIOL-ENDOC M, V305, pE641, DOI 10.1152/ajpendo.00120.2013; Kruger AL, 2006, J PHARMACOL EXP THER, V319, P1144, DOI 10.1124/jpet.106.107482; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Stec DE, 2008, AM J HYPERTENS, V21, P189, DOI 10.1038/ajh.2007.29; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tanimoto T, 2009, FREE RADICAL BIO MED, V46, P1119, DOI 10.1016/j.freeradbiomed.2009.01.017; Vanella L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt176; Vera T, 2008, HYPERTENSION, V52, P660, DOI 10.1161/HYPERTENSIONAHA.108.114884; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Watari Y, 2008, HYPERTENS RES, V31, P783, DOI 10.1291/hypres.31.783; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x; Yore MM, 2011, PLOS ONE, DOI [10.1371/journal.pone0022862, DOI 10.1371/J0URNAL.P0NE0022862]; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	51	31	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101044	10.1371/journal.pone.0101044	http://dx.doi.org/10.1371/journal.pone.0101044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019514	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600010
J	Gao, JJ; Yan, Q; Liu, S; Yang, XS				Gao, Jiujiao; Yan, Qiu; Liu, Shuai; Yang, Xuesong			Knockdown of EpCAM Enhances the Chemosensitivity of Breast Cancer Cells to 5-fluorouracil by Downregulating the Antiapoptotic Factor Bcl-2	PLOS ONE			English	Article							MAPK SIGNALING PATHWAYS; IN-VITRO; FAMILY; GROWTH; EXPRESSION; APOPTOSIS; PROTEINS; SURVIVAL; ARREST	Resistance to fluoropyrimidine-based chemotherapy is the main reason for the failure of cancer treatment, and drug resistance is associated with an inability of tumor cells to undergo apoptosis in response to treatment. Alterations in the expression of epithelial cell adhesion molecule (EpCAM) affect the sensitivity or resistance of tumor cells to anticancer treatment and the activity of intracellular signaling pathways. However, the role of EpCAM in the induction of apoptosis in breast cancer cells remains unclear. Here, we investigated the effect of EpCAM gene knockdown on chemosensitivity to 5-fluorouracil (5-FU) in MCF-7 cells and explored the underlying mechanisms. Our results showed that knockdown of EpCAM promoted apoptosis, inhibited cell proliferation and caused cell-cycle arrest. EpCAM knockdown enhanced the cytotoxic effect of 5-FU, promoting apoptosis by downregulating the expression of the anti-apoptotic protein Bcl-2 and upregulating the expression of the pro-apoptotic proteins Bax, and caspase3 via the ERK1/2 and JNK MAPK signaling pathways in MCF-7 cells. These results indicate that knockdown of EpCAM may have a tumor suppressor effect and suggest EpCAM as a potential target for the treatment of breast cancer.	[Gao, Jiujiao; Yan, Qiu; Liu, Shuai; Yang, Xuesong] Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Peoples R China	Dalian Medical University	Yang, XS (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Peoples R China.	yxmsnow@126.com			Major State basic Research Development Program of China [2012CB822103]; National Natural Science Foundation of China [30800195, 31070729, 31270866]; National Natural Science Foundation of Liaoning Province [2013023046]	Major State basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Liaoning Province	This work was supported by grants from the Major State basic Research Development Program of China (2012CB822103), the National Natural Science Foundation of China (No.: 30800195, 31070729 and 31270866) and the National Natural Science Foundation of Liaoning Province (NO.2013023046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyagari VN, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-61; Barille-Nion S, 2012, ANTICANCER RES, V32, P4225; Bugalho A, 2013, CLIN LUNG CANC; Chow LWC, 2013, EXPERT OPIN INV DRUG, V22, P299, DOI 10.1517/13543784.2013.766715; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Fan Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004131; Ferguson JE, 2014, J MED FOOD; Flatmark K, 2013, INT J CANCER, V133, P1497, DOI 10.1002/ijc.28158; Fu Q, 2013, J ZHEJIANG UNIV-SC B, V14, P8, DOI 10.1631/jzus.B1200189; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Geng M, 2013, INT J CLIN EXP PATHO, V6, P2554; Geng ZM, 2013, ONCOL REP, V30, P793, DOI 10.3892/or.2013.2539; Gostner JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-45; Hall C, 2013, CLIN GENITOURIN CANC, V11, P10, DOI 10.1016/j.clgc.2012.09.002; Hardwick JM, 2012, TRENDS CELL BIOL, V22, P318, DOI 10.1016/j.tcb.2012.03.005; He LC, 2013, TOXICOLOGY, V312, P36, DOI 10.1016/j.tox.2013.07.013; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Liljefors M, 2004, INT J ONCOL, V25, P703; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lund K, 2014, MABS, V6; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Ni J, 2013, INT J BIOCHEM CELL B, V45, P2736, DOI 10.1016/j.biocel.2013.09.008; Nunna S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087703; Ogawa K, 2014, ANN SURG ONCOL, V21, P1314, DOI 10.1245/s10434-013-3430-7; Ohno S, 2013, BREAST CANC RES TREA; Qu C, 2013, MOL CELL BIOCH; Russo F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-56; Sorrentino MF, 2012, CARDIOL J, V19, P453, DOI 10.5603/CJ.2012.0084; Takahashi K, 2013, INT J ONCOL, V43, P1985, DOI 10.3892/ijo.2013.2135; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Yang D, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-105	37	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102590	10.1371/journal.pone.0102590	http://dx.doi.org/10.1371/journal.pone.0102590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019346	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600095
J	Jin, YZ; Zhang, C; Liu, W; Qi, HY; Chen, H; Cao, SX				Jin, Yazhong; Zhang, Chong; Liu, Wei; Qi, Hongyan; Chen, Hao; Cao, Songxiao			The Cinnamyl Alcohol Dehydrogenase Gene Family in Melon (Cucumis melo L.): Bioinformatic Analysis and Expression Patterns	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; LOBLOLLY-PINE; CAD GENES; LIGNIFICATION; PLANT; PROMOTER; ETHYLENE; SORGHUM	Cinnamyl alcohol dehydrogenase (CAD) is a key enzyme in lignin biosynthesis. However, little was known about CADs in melon. Five CAD-like genes were identified in the genome of melons, namely CmCAD1 to CmCAD5. The signal peptides analysis and CAD proteins prediction showed no typical signal peptides were found in all CmCADs and CmCAD proteins may locate in the cytoplasm. Multiple alignments implied that some motifs may be responsible for the high specificity of these CAD proteins, and may be one of the key residues in the catalytic mechanism. The phylogenetic tree revealed seven groups of CAD and melon CAD genes fell into four main groups. CmCAD1 and CmCAD2 belonged to the bona fide CAD group, in which these CAD genes, as representative from angiosperms, were involved in lignin synthesis. Other CmCADs were distributed in group II, V and VII, respectively. Semi-quantitative PCR and real time qPCR revealed differential expression of CmCADs, and CmCAD5 was expressed in different vegetative tissues except mature leaves, with the highest expression in flower, while CmCAD2 and CmCAD5 were strongly expressed in flesh during development. Promoter analysis revealed several motifs of CAD genes involved in the gene expression modulated by various hormones. Treatment of abscisic acid (ABA) elevated the expression of CmCADs in flesh, whereas the transcript levels of CmCAD1 and CmCAD5 were induced by auxin (IAA); Ethylene induced the expression of CmCADs, while 1-MCP repressed the effect, apart from CmCAD4. Taken together, these data suggested that CmCAD4 may be a pseudogene and that all other CmCADs may be involved in the lignin biosynthesis induced by both abiotic and biotic stresses and in tissue-specific developmental lignification through a CAD genes family network, and CmCAD2 may be the main CAD enzymes for lignification of melon flesh and CmCAD5 may also function in flower development.	[Jin, Yazhong; Zhang, Chong; Liu, Wei; Qi, Hongyan; Chen, Hao; Cao, Songxiao] Shenyang Agr Univ, Key Lab Protected Hort, Educ Minist, Shenyang, Liaoning, Peoples R China; [Jin, Yazhong; Zhang, Chong; Liu, Wei; Qi, Hongyan; Chen, Hao; Cao, Songxiao] Shenyang Agr Univ, Dept Hort, Shenyang, Liaoning, Peoples R China; [Jin, Yazhong] Heilongjiang Bayi Agr Univ, Coll Agr, Daqing, Heilong Jiang, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University; Heilongjiang Bayi Agricultural University	Qi, HY (corresponding author), Shenyang Agr Univ, Key Lab Protected Hort, Educ Minist, Shenyang, Liaoning, Peoples R China.	hyqiaaa@126.com			National Natural Science Foundation of China [31272154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (31272154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-100; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Bedon F, 2009, PLANT CELL REP, V28, P787, DOI 10.1007/s00299-009-0688-0; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Boudet AM, 2000, PLANT PHYSIOL BIOCH, V38, P81, DOI 10.1016/S0981-9428(00)00166-2; Bukh C, 2012, J EXP BOT, V63, P6223, DOI 10.1093/jxb/ers275; Chantreau M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-159; Cheng H, 2013, MOL BIOL REP, V40, P707, DOI 10.1007/s11033-012-2111-0; Damiani I, 2005, PLANT MOL BIOL, V59, P753, DOI 10.1007/s11103-005-0947-6; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Domon JM, 2013, PHYTOCHEMISTRY, V85, P51, DOI 10.1016/j.phytochem.2012.09.001; Frost CJ, 2008, NEW PHYTOL, V178, P835, DOI 10.1111/j.1469-8137.2008.02420.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; GALLIANO H, 1993, PLANT MOL BIOL, V23, P145, DOI 10.1007/BF00021427; GOFFNER D, 1992, PLANTA, V188, P48, DOI [10.1007/BF01160711, 10.1007/BF00198938]; Guo DM, 2010, J MOL EVOL, V71, P202, DOI 10.1007/s00239-010-9378-3; HALPIN C, 1994, PLANT J, V6, P339, DOI 10.1046/j.1365-313X.1994.06030339.x; Hirano K, 2012, PLANT CELL REP, V31, P91, DOI 10.1007/s00299-011-1142-7; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Jordi G. M., 2012, PNAS, P12054; Kaur H, 2012, PLANT PHYSIOL, V159, P1545, DOI 10.1104/pp.112.196717; Kim SJ, 2004, P NATL ACAD SCI USA, V101, P1455, DOI 10.1073/pnas.0307987100; Kim SJ, 2007, PHYTOCHEMISTRY, V68, P1957, DOI 10.1016/j.phytochem.2007.02.032; Kim YH, 2010, PLANT CELL REP, V29, P779, DOI 10.1007/s00299-010-0864-2; Latreche K, 2011, PHYSIOL MOL PLANT P, V76, P144, DOI 10.1016/j.pmpp.2011.08.001; LAUVERGEAT V, 1995, BIOCHEMISTRY-US, V34, P12426, DOI 10.1021/bi00038a041; Li XJ, 2009, PLANT MOL BIOL, V69, P685, DOI 10.1007/s11103-008-9448-8; Ma QH, 2010, J EXP BOT, V61, P2735, DOI 10.1093/jxb/erq107; MACKAY JJ, 1995, MOL GEN GENET, V247, P537, DOI 10.1007/BF00290344; MCKIE JH, 1993, BIOCHIM BIOPHYS ACTA, V1202, P61, DOI 10.1016/0167-4838(93)90063-W; OMALLEY DM, 1992, PLANT PHYSIOL, V98, P1364, DOI 10.1104/pp.98.4.1364; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Saathoff AJ, 2012, APPL BIOCHEM BIOTECH, V168, P1086, DOI 10.1007/s12010-012-9843-0; Saathoff AJ, 2011, BIOENERG RES, V4, P120, DOI 10.1007/s12155-010-9106-2; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Saidi MN, 2013, PLANT SCI, V211, P8, DOI 10.1016/j.plantsci.2013.06.008; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Shan LL, 2008, PLANTA, V227, P1243, DOI 10.1007/s00425-008-0696-2; Singh RK, 2010, PHYTOCHEMISTRY, V71, P1485, DOI 10.1016/j.phytochem.2010.05.024; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Tesniere C, 2004, J EXP BOT, V55, P2235, DOI 10.1093/jxb/erh244; Tobias CM, 2005, PLANTA, V220, P678, DOI 10.1007/s00425-004-1385-4; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tronchet M, 2010, MOL PLANT PATHOL, V11, P83, DOI [10.1111/j.1364-3703.2009.00578.X, 10.1111/j.1364-3703.2009.00578.x]; Verries C, 2004, PLANT SCI, V167, P1067, DOI 10.1016/j.plantsci.2004.06.003; Wang YY, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-251; Youn B, 2006, ORG BIOMOL CHEM, V4, P1687, DOI 10.1039/b601672c; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007; Zhang LB, 2010, FOOD CHEM, V123, P32, DOI 10.1016/j.foodchem.2010.03.122	53	24	26	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101730	10.1371/journal.pone.0101730	http://dx.doi.org/10.1371/journal.pone.0101730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019207	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600025
J	Kylaniemi, MK; Kaukonen, R; Myllyviita, J; Rasool, O; Lahesmaa, R				Kylaniemi, Minna K.; Kaukonen, Riina; Myllyviita, Johanna; Rasool, Omid; Lahesmaa, Riitta			The Regulation and Role of c-FLIP in Human Th Cell Differentiation	PLOS ONE			English	Article							NF-KAPPA-B; INHIBITORY PROTEIN EXPRESSION; INTERFERON-GAMMA; UP-REGULATION; LYMPHOCYTE-ACTIVATION; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; SUBUNIT EXPRESSION; GENE-EXPRESSION; DEATH	The early differentiation of T helper (Th) cells is a tightly controlled and finely balanced process, which involves several factors including cytokines, transcription factors and co-stimulatory molecules. Recent studies have shown that in addition to the regulation of apoptosis, caspase activity is also needed for Th cell proliferation and activation and it might play a role in Th cell differentiation. The isoforms of the cellular FLICE inhibitory protein (c-FLIP) are regulators of CASPASE-8 activity and the short isoform, c-FLIPS, has been shown to be up-regulated by IL-4, the Th2 driving cytokine. In this work, we have studied the expression and functional role of three c-FLIP isoforms during the early Th cell differentiation. Only two of the isoforms, c-FLIPS and c-FLIPL, were detected at the protein level although c-FLIPR was expressed at the mRNA level. The knockdown of c-FLIPL led to enhanced Th1 differentiation and elevated IL-4 production by Th2 cells, whereas the knockdown of c-FLIPS diminished GATA3 expression and IL-4 production by Th2 cells. In summary, our results provide new insight into the role of c-FLIP proteins in the early differentiation of human Th cells.	[Kylaniemi, Minna K.; Kaukonen, Riina; Myllyviita, Johanna; Rasool, Omid; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Kylaniemi, Minna K.; Kaukonen, Riina; Myllyviita, Johanna; Rasool, Omid; Lahesmaa, Riitta] Abo Akad Univ, Turku, Finland; [Kylaniemi, Minna K.] Abo Akad Univ, Natl Doctoral Programme Informat & Struct Biol, Turku, Finland	University of Turku; Abo Akademi University; Abo Akademi University	Lahesmaa, R (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.	riitta.lahesmaa@btk.fi		Kylaniemi, Minna/0000-0001-7374-9862	Centre of Excellence in Molecular Systems Immunology and Physiology Research [250114]; The Academy of Finland; European Union [201106]; The Sigrid Juselius Foundation; Hospital District of Southwest Finland; Waldemar von Frenckell's foundation	Centre of Excellence in Molecular Systems Immunology and Physiology Research; The Academy of Finland(Academy of Finland); European Union(European Commission); The Sigrid Juselius Foundation(Sigrid Juselius Foundation); Hospital District of Southwest Finland; Waldemar von Frenckell's foundation	This work was sponsored by the Centre of Excellence in Molecular Systems Immunology and Physiology Research, no. 250114, The Academy of Finland, European Union FP7 Grant Systems Biology of T cell activation in health and disease, no. 201106, The Sigrid Juselius Foundation (www.sigridjuselius.fi), Hospital District of Southwest Finland, Waldemar von Frenckell's foundation (http://www.foundationweb.net/frenckell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dohrman A, 2005, J IMMUNOL, V175, P311, DOI 10.4049/jimmunol.175.1.311; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Hinshaw-Makepeace J, 2008, EUR J IMMUNOL, V38, P54, DOI 10.1002/eji.200636956; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; Kirchhoff S, 2000, J IMMUNOL, V165, P6293, DOI 10.4049/jimmunol.165.11.6293; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lund RJ, 2003, EUR J IMMUNOL, V33, P1105, DOI 10.1002/eji.200323899; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Rautajoki KJ, 2007, MOL CELL PROTEOMICS, V6, P238, DOI 10.1074/mcp.M600290-MCP200; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehra S, 2005, J IMMUNOL, V174, P3440, DOI 10.4049/jimmunol.174.6.3440; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tai TS, 2004, CELL DEATH DIFFER, V11, P69, DOI 10.1038/sj.cdd.4401316; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tripathi P, 2012, IMMUNOL CELL BIOL, V90, P676, DOI 10.1038/icb.2011.87; Tseveleki V, 2004, J IMMUNOL, V173, P6619, DOI 10.4049/jimmunol.173.11.6619; Ueffing N, 2008, BLOOD, V112, P690, DOI 10.1182/blood-2008-02-141382; Ueffing N, 2009, BLOOD, V114, P572, DOI 10.1182/blood-2009-02-204230; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wu WF, 2004, J IMMUNOL, V172, P4724, DOI 10.4049/jimmunol.172.8.4724; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; Zhang J, 2009, INT J BIOCHEM CELL B, V41, P1678, DOI 10.1016/j.biocel.2009.02.008; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	63	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102022	10.1371/journal.pone.0102022	http://dx.doi.org/10.1371/journal.pone.0102022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019384	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600036
J	Raveendran, VV; Smith, DD; Tan, XY; Sweeney, ME; Reed, GA; Flynn, CA; Tawfik, OW; Milne, G; Dileepan, KN				Raveendran, Vineesh V.; Smith, Donald D.; Tan, Xiaoyu; Sweeney, Matthew E.; Reed, Gregory A.; Flynn, Colleen A.; Tawfik, Ossama W.; Milne, Ginger; Dileepan, Kottarappat N.			Chronic Ingestion of H1-Antihistamines Increase Progression of Atherosclerosis in Apolipoprotein E-/- Mice	PLOS ONE			English	Article							ARTERY ENDOTHELIAL-CELLS; APOE-DEFICIENT MICE; E-NULL MICE; LESION FORMATION; THROMBOXANE A(2); MAST-CELLS; HISTAMINE; EXPRESSION; ATHEROGENESIS; PERMEABILITY	Although increased serum histamine levels and H1R expression in the plaque are seen in atherosclerosis, it is not known whether H1R activation is a causative factor in the development of the disease, or is a host defense response to atherogenic signals. In order to elucidate how pharmacological inhibition of histamine receptor 1 (H1R) signaling affects atherogenesis, we administered either cetirizine (1 and 4 mg/kg. b.w) or fexofenadine (10 and 40 mg/kg. b.w) to ApoE(-/-) mice maintained on a high fat diet for three months. Mice ingesting a low dose of cetirizine or fexofenadine had significantly higher plaque coverage in the aorta and cross-sectional lesion area at the aortic root. Surprisingly, the higher doses of cetirizine or fexofenadine did not enhance atherosclerotic lesion coverage over the controls. The low dose of fexofenadine, but not cetirizine, increased serum LDL cholesterol. Interestingly, the expression of iNOS and eNOS mRNA was increased in aortas of mice on high doses of cetirizine or fexofenadine. This may be a compensatory nitric oxide (NO)-mediated vasodilatory mechanism that accounts for the lack of increase in the progression of atherosclerosis. Although the administration of cetirizine did not alter blood pressure between the groups, there was a positive correlation between blood pressure and lesion/media ratio at the aortic root in mice receiving the low dose of cetirizine. However, this association was not observed in mice treated with the high dose of cetirizine or either doses of fexofenadine. The macrophages or T lymphocytes densities were not altered by low doses of H1-antihistamines, whereas, high doses decreased the number of macrophages but not T lymphocytes. The number of mast cells was decreased only in mice treated with low dose of fexofenadine. These results demonstrate that chronic ingestion of low therapeutic doses of cetirizine or fexofenadine enhance progression of atherosclerosis.	[Raveendran, Vineesh V.; Smith, Donald D.; Tan, Xiaoyu; Sweeney, Matthew E.; Dileepan, Kottarappat N.] Univ Kansas, Med Ctr, Dept Med, Div Allergy Clin Immunol & Rheumatol, Kansas City, KS 66103 USA; [Reed, Gregory A.; Flynn, Colleen A.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Tawfik, Ossama W.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Milne, Ginger] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Vanderbilt University	Dileepan, KN (corresponding author), Univ Kansas, Med Ctr, Dept Med, Div Allergy Clin Immunol & Rheumatol, Kansas City, KS 66103 USA.	kdileepan@kumc.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X	National Institutes of Health [R01-HL070101, 3R01-HL070101-04S1]; Joseph and Elizabeth Carey Arthritis Fund; Audrey E. Smith Medical Research Fund from KU Endowment Association; Department of Internal Medicine Research Office; Research Institute at the University of Kansas Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph and Elizabeth Carey Arthritis Fund; Audrey E. Smith Medical Research Fund from KU Endowment Association; Department of Internal Medicine Research Office; Research Institute at the University of Kansas Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01-HL070101 and 3R01-HL070101-04S1, the Joseph and Elizabeth Carey Arthritis Fund and the Audrey E. Smith Medical Research Fund from KU Endowment Association and Department of Internal Medicine Research Office, and Lied Grant from the Research Institute at the University of Kansas Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON JB, 1994, HUM PATHOL, V25, P154, DOI 10.1016/0046-8177(94)90271-2; Benarroch EE, 2010, NEUROLOGY, V75, P1472, DOI 10.1212/WNL.0b013e3181f884b1; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; CHALDAKOV GN, 1995, HUM PATHOL, V26, P1286, DOI 10.1016/0046-8177(95)90209-0; Church DS, 2011, WORLD ALLERGY ORGAN, V4, pS22, DOI 10.1097/WOX.0b013e3181f385d9; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Deml KF, 2009, MOL PHARMACOL, V76, P1019, DOI 10.1124/mol.109.058651; Flynn CA, 2011, RAPID COMMU IN PRESS; GILL DS, 1989, METABOLISM, V38, P243, DOI 10.1016/0026-0495(89)90082-6; HARMAN D, 1969, J ATHEROSCLER RES, V10, P77, DOI 10.1016/S0368-1319(69)80084-0; Jin H, 2006, EUR J PHARMACOL, V529, P136, DOI 10.1016/j.ejphar.2005.10.060; Jutel A, 2006, CHEM IMMUNOL ALLERGY, V91, P174; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Leurs R, 2002, CLIN EXP ALLERGY, V32, P489, DOI 10.1046/j.0954-7894.2002.01314.x; Li Y, 2001, MICROVASC RES, V61, P253, DOI 10.1006/mvre.2001.2304; Ludewig B, 2004, P NATL ACAD SCI USA, V101, P11529, DOI 10.1073/pnas.0404612101; OWENS GK, 1979, ATHEROSCLEROSIS, V34, P365, DOI 10.1016/0021-9150(79)90061-3; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Raveendran VV, 2011, IMMUNOLOGY, V132, P578, DOI 10.1111/j.1365-2567.2010.03403.x; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Sakata Y, 1996, AM J CARDIOL, V77, P1121, DOI 10.1016/S0002-9149(96)00147-6; Smith DD, 2010, J PHYSIOL PHARMACOL, V61, P309; Smith DD, 2012, AM J PHYSIOL-HEART C, V302, pH2612, DOI 10.1152/ajpheart.00879.2011; TAKAGISHI T, 1995, AM J PATHOL, V146, P981; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Tan X, 2007, J IMMUNOL, V179, P7899, DOI 10.4049/jimmunol.179.11.7899; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; Villablanca A, 2004, ARTERIOSCL THROM VAS, V24, P1055, DOI 10.1161/01.ATV.0000130467.65290.d4; Vimala Raveendran V, 2014, AM J PHYSIOL-GASTR L; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Yarnal J R, 1975, J Am Osteopath Assoc, V74, P561; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102165	10.1371/journal.pone.0102165	http://dx.doi.org/10.1371/journal.pone.0102165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020133	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600050
J	Adelman, MW; Kurbatova, E; Wang, YF; Leonard, MK; White, N; McFarland, DA; Blumberg, HM				Adelman, Max W.; Kurbatova, Ekaterina; Wang, Yun F.; Leonard, Michael K.; White, Nancy; McFarland, Deborah A.; Blumberg, Henry M.			Cost Analysis of a Nucleic Acid Amplification Test in the Diagnosis of Pulmonary Tuberculosis at an Urban Hospital with a High Prevalence of TB/HIV	PLOS ONE			English	Article							SKIN-TEST CONVERSION; MYCOBACTERIUM-TUBERCULOSIS; UNITED-STATES; INFECTION; RISK	Introduction: The Centers for Disease Control and Prevention has recommended using a nucleic acid amplification test NAAT) for diagnosing pulmonary tuberculosis (TB) but there is a lack of data on NAAT cost-effectiveness. Methods: We conducted a prospective cohort study that included all patients with an AFB smear-positive respiratory specimen at Grady Memorial Hospital in Atlanta, GA, USA between January 2002 and June 2008. We determined the sensitivity, specificity, and positive and negative predictive value of a commercially available and FDA-approved NAAT (amplified MTD, Gen-Probe) compared to the gold standard of culture. A cost analysis was performed and included costs related to laboratory tests, hospital charges, anti-TB medications, and contact investigations. Average cost per patient was calculated under two conditions: (1) using a NAAT on all AFB smear-postive respiratory specimens and (2) not using a NAAT. One-way sensitivity analyses were conducted to determine sensitivity of cost difference to reasonable ranges of model inputs. Results: During a 6 1/2 year study period, there were 1,009 patients with an AFB smear-positive respiratory specimen at our public urban hospital. We found the NAAT to be highly sensitive (99.6%) and specific (99.1%) on AFB smear-positive specimens compared to culture. Overall, the positive predictive value (PPV) of an AFB smear-positive respiratory specimen for culture-confirmed TB was 27%. The PPV of an AFB smear-positive respiratory specimen for culture-confirmed TB was significantly higher for HIV-uninfected persons compared to those who were HIV-seropositive (152/271 [56%] vs. 85/445 [19%]; RR = 2.94, 95% CI 2.36-3.65, p<0.001). The cost savings of using the NAAT was $2,003 per AFB smear-positive case. Conclusions: Routine use of the NAAT on AFB smear-positive respiratory specimens was highly cost-saving in our setting at a U.S. urban public hospital with a high prevalence of TB and HIV because of the low PPV of an AFB smear for culture-confirmed TB.	[Adelman, Max W.] Emory Univ, Sch Med, Atlanta, GA USA; [Kurbatova, Ekaterina; Leonard, Michael K.; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Kurbatova, Ekaterina; McFarland, Deborah A.; Blumberg, Henry M.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Wang, Yun F.] Grady Mem Hosp, Clin Microbiol Lab, Atlanta, GA USA; [Wang, Yun F.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [White, Nancy; Blumberg, Henry M.] Grady Mem Hosp, Dept Epidemiol, Atlanta, GA USA; [Blumberg, Henry M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Rollins School Public Health	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.	henry.m.blumberg@emory.edu	McFarland, Deborah A/P-1907-2018; Adelman, Max/HHZ-5271-2022; Blumberg, Henry/W-2156-2019	McFarland, Deborah A/0000-0002-0019-5165; Adelman, Max/0000-0002-9277-6046; Blumberg, Henry/0000-0002-3110-2443	Georgia Department of Public Health [PH-10100210-88]; National Institutes of Health (NIH) National Center for Advancing Translational Sciences [UL1TR000454, TL1TR000456]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, TL1TR000456] Funding Source: NIH RePORTER	Georgia Department of Public Health; National Institutes of Health (NIH) National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Georgia Department of Public Health (Contract PH-10100210-88) and by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (UL1TR000454 and TL1TR000456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, UPD GUID US NUCL AC; [Anonymous], 2005, GUID INV CONT PERS I; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; BLUMBERG HM, 1995, ANN INTERN MED, V122, P658, DOI 10.7326/0003-4819-122-9-199505010-00003; Blumberg HM, 1998, CLIN INFECT DIS, V27, P826, DOI 10.1086/514963; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Dowdy DW, 2003, J CLIN MICROBIOL, V41, P948, DOI 10.1128/JCM.41.3.948-953.2003; Guerra RL, 2008, J CLIN MICROBIOL, V46, P3811, DOI 10.1128/JCM.01682-08; Hughes R, 2012, RESP MED, V106, P300, DOI 10.1016/j.rmed.2011.10.005; Larsen NM, 2002, CLIN INFECT DIS, V35, P796, DOI 10.1086/342333; Leonard MK, 2006, AM J INFECT CONTROL, V34, P69, DOI 10.1016/j.ajic.2005.09.003; Millman AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079669; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; Park PH, 2013, INT J TUBERC LUNG D, V17, P759, DOI 10.5588/ijtld.12.0739; Parrish NM, 2011, J CLIN MICROBIOL, V49, P772, DOI 10.1128/JCM.02451-10; Sotir MJ, 1999, CLIN INFECT DIS, V29, P1138, DOI 10.1086/313453; Sprinson JE, 2003, INT J TUBERC LUNG D, V7, pS363; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; Wright PW, 1998, J CLIN MICROBIOL, V36, P1046, DOI 10.1128/JCM.36.4.1046-1049.1998	20	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100649	10.1371/journal.pone.0100649	http://dx.doi.org/10.1371/journal.pone.0100649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014783	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400010
J	Chatani, E; Tsuchisaka, Y; Masuda, Y; Tsenkova, R				Chatani, Eri; Tsuchisaka, Yutaro; Masuda, Yuki; Tsenkova, Roumiana			Water Molecular System Dynamics Associated with Amyloidogenic Nucleation as Revealed by Real Time Near Infrared Spectroscopy and Aquaphotomics	PLOS ONE			English	Article							INSULIN; FIBRILLATION; HYDRATION; CLUSTERS; FIBRILS; BETA(2)-MICROGLOBULIN; MECHANISM; KINETICS; VIEW	The formation of amyloid fibrils proceeds via a nucleation-dependent mechanism in which nucleation phase is generally associated with a high free energy resulting in the rate-limiting step. On the basis of this kinetic feature, the nucleation is one of the most crucial phases controlling the pathogenesis of amyloidoses, but little is known about the details of how protein molecules and surrounding environment vary at this stage. Here, we applied near infrared (NIR) spectral monitoring of water structural changes in real time during the nucleation-dependent fibrillation of insulin. Whilst multivariate spectral analysis in the 2050-2350 nm spectral region indicated cross-beta formation, characteristic transformations of water structure have been detected in the spectral region 1300-1600 nm corresponding to the first overtone of water OH stretching vibrations. Furthermore, specific water spectral patterns (aquagrams) related to different water molecular conformations have been found along the course of protein nucleation and aggregation. Right in the beginning, dissociation of hydrogen-bonded network in bulk water and coinstantaneous protein and ion hydration were observed, followed by water hydrogen-bonded networks development, presumably forcing the nucleation. These specific transformations of water spectral pattern could be used further as a biomarker for early non-invasive diagnosis of amyloidoses prior to explosive amplification and deposits of amyloid fibrils.	[Chatani, Eri; Masuda, Yuki] Kobe Univ, Dept Chem, Grad Sch Sci, Kobe, Hyogo, Japan; [Tsuchisaka, Yutaro; Tsenkova, Roumiana] Kobe Univ, Dept Environm Informat & Bioprod Engn, Grad Sch Agr Sci, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Chatani, E (corresponding author), Kobe Univ, Dept Chem, Grad Sch Sci, Kobe, Hyogo, Japan.	chatani@crystal.kobe-u.ac.jp; rtsen@kobe-u.ac.jp	Tsenkova, Roumiana/ABB-7980-2021	Tsenkova, Roumiana/0000-0002-9733-7587	MEXT KAKENHI [25440071]; Naito Foundation; Kobe University Innovation Center	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation(Naito Memorial Foundation); Kobe University Innovation Center	This work was supported, in part, by MEXT KAKENHI Grant Number 25440071, Grant from the Naito Foundation for E.C., and Kobe University Innovation Center Grant for R.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; [Anonymous], 2001, NEAR INFRARED TECHNO; Baftizadeh F, 2012, J AM CHEM SOC, V134, P3886, DOI 10.1021/ja210826a; Bekard IB, 2009, BIOPHYS J, V97, P2521, DOI 10.1016/j.bpj.2009.07.064; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Brovchenko I, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/155105; Chatani E, 2005, BBA-PROTEINS PROTEOM, V1753, P64, DOI 10.1016/j.bbapap.2005.08.002; Chatani E, 2014, J BIOL CHEM, V289, P10399, DOI 10.1074/jbc.M113.520874; Chong SH, 2012, P NATL ACAD SCI USA, V109, P7636, DOI 10.1073/pnas.1120646109; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Hazy E, 2011, BIOPHYS J, V101, P2260, DOI 10.1016/j.bpj.2011.08.052; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Jinendra B, 2010, BIOCHEM BIOPH RES CO, V397, P685, DOI 10.1016/j.bbrc.2010.06.007; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kinoshita K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00856; Krone MG, 2008, J AM CHEM SOC, V130, P11066, DOI 10.1021/ja8017303; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Maeda H., 1995, J NEAR INFRARED SPEC, V3, P191, DOI [10.1255/jnirs.69, DOI 10.1255/JNIRS.69]; Miyazawa M., 1998, J NEAR INFRARED SPEC, V6, P253, DOI [10.1255/jnirs.204, DOI 10.1255/JNIRS.204]; Murayama K, 2002, BIOPOLYMERS, V67, P394, DOI 10.1002/bip.10142; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Ozaki Y, 2002, APPL CHEM; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Robert P, 1999, APPL SPECTROSC, V53, P226, DOI 10.1366/0003702991946361; SADLER AJ, 1984, ANAL BIOCHEM, V138, P44, DOI 10.1016/0003-2697(84)90766-8; Sasahara K, 2005, J MOL BIOL, V352, P700, DOI 10.1016/j.jmb.2005.07.033; Takeuchi M, 2009, J NEAR INFRARED SPEC, V17, P373, DOI 10.1255/jnirs.843; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Tsenkova R, 2001, J ANIM SCI, V79, P2550; Tsenkova R., 2010, SPECTROSC EUR, V22, P6; Tsenkova RN, 2004, BIOCHEM BIOPH RES CO, V325, P1005, DOI 10.1016/j.bbrc.2004.10.135; Tsenkova R, 2009, J NEAR INFRARED SPEC, V17, P303, DOI 10.1255/jnirs.869; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Walton JH, 2011, BIOPHYS J, V100, P2302, DOI 10.1016/j.bpj.2011.03.029; Weber JM, 2000, SCIENCE, V287, P2461, DOI 10.1126/science.287.5462.2461; Wei DQ, 1997, J CHEM PHYS, V106, P6086, DOI 10.1063/1.473607; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wu Y, 2000, BBA-MOL CELL RES, V1497, P27, DOI 10.1016/S0167-4889(00)00043-4; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Yuan B, 2003, APPL SPECTROSC, V57, P1223, DOI 10.1366/000370203769699072	47	38	40	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101997	10.1371/journal.pone.0101997	http://dx.doi.org/10.1371/journal.pone.0101997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013915	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400053
J	del Campo, M; Sagredo, A; del Campo, L; Villalobo, A; Ferrer, M				del Campo, Marta; Sagredo, Ana; del Campo, Lara; Villalobo, Antonio; Ferrer, Mercedes			Time-Dependent Effect of Orchidectomy on Vascular Nitric Oxide and Thromboxane A(2) Release. Functional Implications to Control Cell Proliferation through Activation of the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							ACETYLCHOLINE-INDUCED RELAXATION; ARTERY SMOOTH-MUSCLE; PROTEIN-KINASE; ENDOTHELIAL DYSFUNCTION; MESENTERIC-ARTERIES; SEX-HORMONES; INCREASES; TESTOSTERONE; PROSTANOIDS; ANDROGENS	This study analyzes whether the release of nitric oxide (NO) and thromboxane A(2) (TXA(2)) depends on the time lapsed since gonadal function is lost, and their correlation with the proliferation of vascular smooth muscle cells (VSMC) mediated by the epidermal growth factor receptor (EGFR). For this purpose, aortic and mesenteric artery segments from control and 6-weeks or 5-months orchidectomized rats were used to measure NO and TXA(2) release. The results showed that the basal and acetylcholine (ACh)-induced NO release were decreased 6 weeks post-orchidectomy both in aorta and mesenteric artery, but were recovered 5 months thereafter up to levels similar to those found in arteries from control rats. The basal and ACh-induced TXA(2) release increased in aorta and mesenteric artery 6 weeks post-orchidectomy, and was maintained at high levels 5 months thereafter. Since we previously observed that orchidectomy, which decreased testosterone level, enlarged the muscular layer of mesenteric arteries, the effect of testosterone on VSMC proliferation was analyzed. The results showed that treatment of cultured VSMC with testosterone downregulated mitogenic signaling pathways initiated by the ligand-dependent activation of the EGFR. In contrast, the EGFR pathways were constitutively active in mesenteric arteries of long-term orchidectomized rats. Thus, the exposure of mesenteric arteries from control rats to epidermal growth factor (EGF) induced the activation of EGFR signaling pathways. However, the addition of EGF to arteries from orchidectomized rats failed to induce a further activation of these pathways. In conclusion, this study shows that the release of NO depends on the time lapsed since the gonadal function is lost, while the release of TXA(2) is already increased after short periods post-orchidectomy. The alterations in these signaling molecules could contribute to the constitutive activation of the EGFR and its downstream signaling pathways after long period post-orchidectomy enhancing the proliferation of the vascular muscular layer.	[del Campo, Marta; Sagredo, Ana; del Campo, Lara; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [del Campo, Lara; Ferrer, Mercedes] Hosp La Paz, Inst Invest Sanit IdIPAZ, Madrid, Spain; [del Campo, Marta; Villalobo, Antonio] CSIC, Inst Invest Biomed, Madrid, Spain; [del Campo, Marta; Villalobo, Antonio] Univ Autonoma Madrid, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.	mercedes.ferrer@uam.es	Villalobo, Antonio/K-2902-2017; Parra, Mercedes Ferrer/AAE-1746-2020; del Campo Milan, Marta/K-5405-2016; Villalobo, Antonio/O-9621-2019; Ferrer, Mercedes/E-3556-2018; del Campo Milán, Lara/ABD-4219-2021; del Campo, Lara/A-8317-2015	Parra, Mercedes Ferrer/0000-0002-4670-7146; del Campo Milan, Marta/0000-0003-2808-3699; Villalobo, Antonio/0000-0002-4200-374X; del Campo Milán, Lara/0000-0002-0394-116X; del Campo, Lara/0000-0002-0394-116X	Fondo de Investigaciones Sanitarias [PI1100406]; Fondo Europeo de Desarrollo Regional; Secretaria de Estado de Investigacion, Desarrollo e Innovacion [SAF2011-23494]; Consejeria de Educacion de la Comunidad de Madrid [S2011/BMD-2349]; European Commission [PITN-GA-2011-289033]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional(European Commission); Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Consejeria de Educacion de la Comunidad de Madrid; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants to M.F. from the Fondo de Investigaciones Sanitarias (PI1100406) and Fondo Europeo de Desarrollo Regional, and grants to A.V. from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (SAF2011-23494), the Consejeria de Educacion de la Comunidad de Madrid (S2011/BMD-2349), and the European Commission (contract PITN-GA-2011-289033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Atochin DN, 2010, PFLUG ARCH EUR J PHY, V460, P965, DOI 10.1007/s00424-010-0867-4; Ba ZF, 2001, ARCH SURG-CHICAGO, V136, P1158, DOI 10.1001/archsurg.136.10.1158; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2005, J VASC RES, V42, P526, DOI 10.1159/000088342; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2006, J ENDOCRINOL, V190, P771, DOI 10.1677/joe.1.06887; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Cao Jian, 2010, Chinese Medical Sciences Journal, V25, P44; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cutini PH, 2012, J STEROID BIOCHEM, V132, P322, DOI 10.1016/j.jsbmb.2012.08.001; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo L, 2013, CLIN SCI, V124, P719, DOI 10.1042/CS20120700; Estrada C, 1997, BIOCHEM J, V326, P369, DOI 10.1042/bj3260369; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; Fernandez-Martinez AB, 2013, BBA-MOL CELL RES, V1833, P2029, DOI 10.1016/j.bbamcr.2013.04.013; Ferrer M, 1998, ENDOTHELIUM-NEW YORK, V6, P133, DOI 10.3109/10623329809072200; Formoso G, 2006, MOL ENDOCRINOL, V20, P1153, DOI 10.1210/me.2005-0266; Gallet C, 2003, BIOCHEM J, V371, P733, DOI 10.1042/BJ20021030; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; Gonzales RJ, 2004, AM J PHYSIOL-HEART C, V286, pH552, DOI 10.1152/ajpheart.00663.2003; Gonzales RJ, 2005, AM J PHYSIOL, V286, P552; Guder G, 2010, HEART, V96, P504, DOI 10.1136/hrt.2009.181065; Jones TH, 2010, TRENDS ENDOCR REV, V24, P313; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; Matz RL, 2000, BRIT J PHARMACOL, V131, P303, DOI 10.1038/sj.bjp.0703568; MORINELLI TA, 1994, J BIOL CHEM, V269, P5693; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Myers SI, 1996, PROSTAG LEUKOTR ESS, V54, P403, DOI 10.1016/S0952-3278(96)90023-X; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Perusquia M, 2012, VASC PHARMACOL, V56, P176, DOI 10.1016/j.vph.2012.01.008; Perusquia M, 2010, AM J PHYSIOL-HEART C, V298, pH1301, DOI 10.1152/ajpheart.00753.2009; Sagredo A, 2011, JOINT M EUR SOC MICR; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Shimokawa H, 1998, J Atheroscler Thromb, V4, P118; Simoncini T, 2003, ENDOCRINOLOGY, V144, P3449, DOI 10.1210/en.2003-0044; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Villalobo A, 2007, DYN CELL BIOL, V1, P60; Wang Y, 2014, J ATHEROSCLER THROMB, V21, P204, DOI 10.5551/jat.19448; Wynne FL, 2003, J ENDOCRINOL INVEST, V26, P181, DOI 10.1007/BF03345150; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Yu J, 2012, BIOCHEM BIOPH RES CO, V424, P538, DOI 10.1016/j.bbrc.2012.06.151	51	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102523	10.1371/journal.pone.0102523	http://dx.doi.org/10.1371/journal.pone.0102523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013941	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400101
J	Finlay, MC; Ahmed, AK; Sugrue, A; Bhar-Amato, J; Quarta, G; Pantazis, A; Ciaccio, EJ; Syrris, P; Sen-Chowdhry, S; Ben-Simon, R; Chow, AW; Lowe, MD; Segal, OR; McKenna, WJ; Lambiase, PD				Finlay, Malcolm C.; Ahmed, Akbar K.; Sugrue, Alan; Bhar-Amato, Justine; Quarta, Giovanni; Pantazis, Antonis; Ciaccio, Edward J.; Syrris, Petros; Sen-Chowdhry, Srijita; Ben-Simon, Ron; Chow, Anthony W.; Lowe, Martin D.; Segal, Oliver R.; McKenna, William J.; Lambiase, Pier D.			Dynamic Conduction and Repolarisation Changes in Early Arrhythmogenic Right Ventricular Cardiomyopathy versus Benign Outflow Tract Ectopy Demonstrated by High Density Mapping & Paced Surface ECG Analysis	PLOS ONE			English	Article							T-WAVE; MUTATIONS; DYSPLASIA/CARDIOMYOPATHY; ABNORMALITIES; ELECTROGRAMS; TACHYCARDIA; DISEASE; STIMULATION; RESTITUTION; VALIDATION	The concealed phase of arrhythmogenic right ventricular cardiomyopathy (ARVC) may initially manifest electrophysiologically. No studies have examined dynamic conduction/repolarization kinetics to distinguish benign right ventricular outflow tract ectopy (RVOT ectopy) from ARVC's early phase. We investigated dynamic endocardial electrophysiological changes that differentiate early ARVC disease expression from RVOT ectopy. Methods: 22 ARVC (12 definite based upon family history and mutation carrier status, 10 probable) patients without right ventricular structural anomalies underwent high-density non-contact mapping of the right ventricle. These were compared to data from 14 RVOT ectopy and 12 patients with supraventricular tachycardias and normal hearts. Endocardial & surface ECG conduction and repolarization parameters were assessed during a standard S1-S2 restitution protocol. Results: Definite ARVC without RV structural disease could not be clearly distinguished from RVOT ectopy during sinus rhythm or during steady state pacing. Delay in Activation Times at coupling intervals just above the ventricular effective refractory period (VERP) increased in definite ARVC (43 +/- 20 ms) more than RVOT ectopy patients (36 +/- 14 ms, p = 0.03) or Normals (25 +/- 16 ms, p = 0.008) and a progressive separation of the repolarisation time curves between groups existed. Repolarization time increases in the RVOT were also greatest in ARVC (definite ARVC: 18620 ms; RVOT ectopy: 5 +/- 14, Normal: 1 +/- 18, p, 0.05). Surface ECG correlates of these intracardiac measurements demonstrated an increase of greater than 48 ms in stimulus to surface ECG J-point pre-ERP versus steady state, with an 88% specificity and 68% sensitivity in distinguishing definite ARVC from the other groups. This technique could not distinguish patients with genetic predisposition to ARVC only (probable ARVC) from controls. Conclusions: Significant changes in dynamic conduction and repolarization are apparent in early ARVC before detectable RV structural abnormalities, and were present to a lesser degree in probable ARVC patients. Investigation of dynamic electrophysiological parameters may be useful to identify concealed ARVC in patients without disease pedigrees by using endocardial electrogram or paced ECG parameters.	[Finlay, Malcolm C.; Ahmed, Akbar K.; Sugrue, Alan; Bhar-Amato, Justine; Quarta, Giovanni; Pantazis, Antonis; Syrris, Petros; Sen-Chowdhry, Srijita; Ben-Simon, Ron; Chow, Anthony W.; Lowe, Martin D.; Segal, Oliver R.; McKenna, William J.; Lambiase, Pier D.] UCL, Inst Cardiovasc Sci, London, England; [Ciaccio, Edward J.] Columbia Univ, Dept Med, New York, NY USA	University of London; University College London; Columbia University	Lambiase, PD (corresponding author), UCL, Inst Cardiovasc Sci, London, England.	pier.lambiase@uclh.nhs.uk	Sugrue, Alan/AAN-8589-2021; Lambiase, Pier/L-8534-2019; SYRRIS, PETROS/C-1703-2008; McKenna, William J/C-3243-2008; Finlay, Malcolm/Q-2363-2015	Lambiase, Pier/0000-0002-9055-9267; SYRRIS, PETROS/0000-0002-2363-8758; McKenna, William J/0000-0001-7994-2460; Finlay, Malcolm/0000-0001-6403-9340	Heart Research UK [RG2582]; Wellcome Trust Research Training Fellowship; British Heart Foundation Project [BHF-PG/05/112]; University College London Hospital Biomedicine National Institute of Health Research, Educational Grant; St Jude Medical and the Stephen Lyness Research Fund;  [WT093879MA]; British Heart Foundation [FS/10/011/27881] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10230] Funding Source: researchfish	Heart Research UK; Wellcome Trust Research Training Fellowship(Wellcome Trust); British Heart Foundation Project(British Heart Foundation); University College London Hospital Biomedicine National Institute of Health Research, Educational Grant; St Jude Medical and the Stephen Lyness Research Fund; ; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Heart Research UK, Grant no. RG2582; http://www. heartresearch. org. uk/(to JB); Wellcome Trust Research Training Fellowship, Grant no. WT093879MA; http://www. wellcome. ac. uk/(to MF); British Heart Foundation Project, Grant no. BHF-PG/05/112; www. bhf. org. uk (to PL); University College London Hospital Biomedicine National Institute of Health Research, Educational Grant, St Jude Medical and the Stephen Lyness Research Fund (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avella A, 2010, HEART RHYTHM, V7, P828, DOI 10.1016/j.hrthm.2010.01.016; Cerrone M., 2013, CIRCULATION; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Ciaccio EJ, 2000, CIRCULATION, V102, P464; Corrado D, 2008, J AM COLL CARDIOL, V51, P731, DOI 10.1016/j.jacc.2007.11.027; Corrado D, 2010, CIRCULATION, V122, P1144, DOI 10.1161/CIRCULATIONAHA.109.913871; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763; Delmar M, 2012, PEDIATR CARDIOL, V33, P975, DOI 10.1007/s00246-012-0257-0; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; FRANZ MR, 1987, CIRCULATION, V75, P379, DOI 10.1161/01.CIR.75.2.379; Gomes J, 2012, EUR HEART J, V33, P1942, DOI 10.1093/eurheartj/ehr472; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Haqqani HM, 2012, CIRC-ARRHYTHMIA ELEC, p[6, 1123]; Imai K., 2009, ZELIG EVERYONES STAT; Kawara T, 2001, CIRCULATION, V104, P3069, DOI 10.1161/hc5001.100833; Lambiase PD, 2009, CIRCULATION, V120, P106, DOI 10.1161/CIRCULATIONAHA.108.771401; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Pinheiro J., 2019, NLME LINEAR NONLINEA; Potse M, 2007, ANATOL J CARDIOL, V7, P164; Potse M, 2009, AM J PHYSIOL-HEART C, V297, pH792, DOI 10.1152/ajpheart.00064.2009; Quarta G, 2010, HEART, V96, P516, DOI 10.1136/hrt.2009.182949; Saffitz JE, 2009, HEART RHYTHM, V6, pS62, DOI 10.1016/j.hrthm.2009.03.003; Santangeli P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P632, DOI 10.1161/CIRCEP.110.958116; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Schilling RJ, 1998, CIRCULATION, V98, P887, DOI 10.1161/01.CIR.98.9.887; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Syrris P, 2006, CIRCULATION, V113, P356, DOI 10.1161/CIRCULATIONAHA.105.561654; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Tandri H, 2009, HEART RHYTHM, V6, P769, DOI 10.1016/j.hrthm.2009.02.031; Team RCD, 2010, R LANG ENV STAT COMP; THERNEAU TM, 2010, RPART RECURSIVE PART, P1; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Yue AM, 2004, CIRCULATION, V110, P1343, DOI 10.1161/01.CIR.0000141734.43393.BE	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e99125	10.1371/journal.pone.0099125	http://dx.doi.org/10.1371/journal.pone.0099125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014132	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400005
J	Jagadapillai, R; Mellen, NM; Sachleben, LR; Gozal, E				Jagadapillai, Rekha; Mellen, Nicholas M.; Sachleben, Leroy R., Jr.; Gozal, Evelyne			Ceftriaxone Preserves Glutamate Transporters and Prevents Intermittent Hypoxia-Induced Vulnerability to Brain Excitotoxic Injury	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; ISCHEMIC TOLERANCE; STROKE; ASTROCYTES; INDUCTION; MECHANISM; RELEASE; DISEASE; EXPRESSION; CULTURES	Hypoxia alters cellular metabolism and although the effects of sustained hypoxia (SH) have been extensively studied, less is known about chronic intermittent hypoxia (IH), commonly associated with cardiovascular morbidity and stroke. We hypothesize that impaired glutamate homeostasis after chronic IH may underlie vulnerability to stroke-induced excitotoxicity. P16 organotypic hippocampal slices, cultured for 7 days were exposed for 7 days to IH (alternating 2 min 5% O-2 - 15 min 21% O-2), SH (5% O-2) or RA (21% O-2), then 3 glutamate challenges. The first and last exposures were intended as a metabolic stimulus (200 mu M glutamate, 15 min); the second emulated excitotoxicity (10 mM glutamate, 10 min). GFAP, MAP2, and EAAT1, EAAT2 glutamate transporters expression were assessed after exposure to each hypoxic protocol. Additionally, cell viability was determined at baseline and after each glutamate challenge, in presence or absence of ceftriaxone that increases glutamate transporter expression. GFAP and MAP2 decreased after 7 days IH and SH. Long-term IH but not SH decreased EAAT1 and EAAT2. Excitotoxic glutamate challenge decreased cell viability and the following 200 mu M exposure further increased cell death, particularly in IH-exposed slices. Ceftriaxone prevented glutamate transporter decrease and improved cell viability after IH and excitotoxicity. We conclude that IH is more detrimental to cell survival and glutamate homeostasis than SH. These findings suggest that impaired regulation of extracellular glutamate levels is implicated in the increased brain susceptibility to excitotoxic insult after long-term IH.	[Jagadapillai, Rekha; Mellen, Nicholas M.; Sachleben, Leroy R., Jr.; Gozal, Evelyne] Univ Louisville, Dept Pediat, KCHRI, Louisville, KY 40292 USA; [Gozal, Evelyne] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Mellen, Nicholas M.; Gozal, Evelyne] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Gozal, E (corresponding author), Univ Louisville, Dept Pediat, KCHRI, Louisville, KY 40292 USA.	evelyne.gozal@louisville.edu			University of Louisville Department of Pediatrics Pilot Research Grant (PRG) Program;  [NIH-RR15576];  [NIH-RR031159]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031159, P20RR015576] Funding Source: NIH RePORTER	University of Louisville Department of Pediatrics Pilot Research Grant (PRG) Program; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH-RR15576, NIH-RR031159 grants and by the University of Louisville Department of Pediatrics Pilot Research Grant (PRG) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Martinez-Garcia MA, 2009, AM J RESP CRIT CARE, V180, P36, DOI 10.1164/rccm.200808-1341OC; Arnaud C, 2011, AM J RESP CRIT CARE, V184, P724, DOI 10.1164/rccm.201012-2033OC; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Calvin AD, 2009, NAT CLIN PRACT CARD, V6, P90, DOI 10.1038/ncpcardio1418; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dronne MA, 2007, BRAIN RES, V1138, P231, DOI 10.1016/j.brainres.2006.12.062; Foster GE, 2007, EXP PHYSIOL, V92, P51, DOI 10.1113/expphysiol.2006.035204; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; Gong SJ, 2012, NEUROCHEM RES, V37, P527, DOI 10.1007/s11064-011-0639-3; Gozal E, 2005, AM J PHYSIOL-CELL PH, V288, pC535, DOI 10.1152/ajpcell.00270.2004; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Kato M, 2009, CIRC J, V73, P1363, DOI 10.1253/circj.CJ-09-0364; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Lavie L, 2005, NEUROL CLIN, V23, P1059, DOI 10.1016/j.ncl.2005.05.005; Lavie L, 2009, EUR RESPIR J, V33, P1467, DOI 10.1183/09031936.00086608; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu YX, 2012, GLIA, V60, P112, DOI 10.1002/glia.21252; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan S, 2009, POSTGRAD MED J, V85, P693, DOI 10.1136/thx.2008.105577; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 2001, NEUROSCI LETT, V307, P151, DOI 10.1016/S0304-3940(01)01937-1; Serebrovskaya TV, 2008, EXP BIOL MED, V233, P627, DOI 10.3181/0710-MR-267; Shi YF, 2009, SLEEP MED, V10, P717, DOI 10.1016/j.sleep.2008.08.006; Somers V K, 1992, Clin Auton Res, V2, P171, DOI 10.1007/BF01818958; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Vega C, 2006, J NEUROCHEM, V97, P872, DOI 10.1111/j.1471-4159.2006.03790.x; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1352, DOI 10.1038/sj.jcbfm.9600441; Zheng SR, 2011, NEPHRON EXP NEPHROL, V119, pE21, DOI 10.1159/000327586	48	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100230	10.1371/journal.pone.0100230	http://dx.doi.org/10.1371/journal.pone.0100230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014412	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400007
J	Lange, Y; Ye, J; Steck, TL				Lange, Yvonne; Ye, Jin; Steck, Theodore L.			Essentially All Excess Fibroblast Cholesterol Moves from Plasma Membranes to Intracellular Compartments	PLOS ONE			English	Article							NONVESICULAR STEROL TRANSPORT; CULTURED HUMAN-FIBROBLASTS; ENDOPLASMIC-RETICULUM; FOAM CELLS; HOMEOSTASIS; MOVEMENT; PHOSPHOLIPIDS; PROTEINS; BINDING; PHOSPHATIDYLCHOLINE	It has been shown that modestly increasing plasma membrane cholesterol beyond its physiological set point greatly increases the endoplasmic reticulum and mitochondrial pools, thereby eliciting manifold feedback responses that return cell cholesterol to its resting state. The question arises whether this homeostatic mechanism reflects the targeting of cell surface cholesterol to specific intracellular sites or its general equilibration among the organelles. We now show that human fibroblast cholesterol can be increased as much as two-fold from 2-hydroxypropyl-beta-cyclodextrin without changing the size of the cell surface pool. Rather, essentially all of the added cholesterol disperses rapidly among cytoplasmic membranes, increasing their overall cholesterol content by as much as five-fold. We conclude that the level of plasma membrane cholesterol is normally at capacity and that even small increments above this physiological set point redistribute essentially entirely to intracellular membranes, perhaps down their chemical activity gradients.	[Lange, Yvonne; Ye, Jin] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Steck, Theodore L.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Rush University; University of Chicago	Lange, Y (corresponding author), Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA.	ylange@rush.edu	Lange, Yvonne/A-7794-2009; Steck, Theodore/GWM-4373-2022	Steck, Theodore/0000-0002-8391-9244	Commonwealth Scientific and Industrial Research Organisation (CSIRO); CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program, Marine Biodiversity Hub; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R55HL028448, R01HL028448] Funding Source: NIH RePORTER	Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program, Marine Biodiversity Hub; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship. HP was supported by a CSIRO Office of the Executive Chief Postdoctoral Award. BDB's time on this paper was supported by the Australia Governments' National Environmental Research Program, Marine Biodiversity Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2007, BIOPHYS J, V92, P1125, DOI 10.1529/biophysj.106.088427; Bach D, 2003, BBA-BIOMEMBRANES, V1610, P187, DOI 10.1016/S0005-2736(03)00017-8; Brown AJ, 2012, EUR J LIPID SCI TECH, V114, P617, DOI 10.1002/ejlt.201100295; Brzustowicz MR, 2002, BIOPHYS J, V82, P285, DOI 10.1016/S0006-3495(02)75394-0; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; ECHEVARRIA F, 1990, J BIOL CHEM, V265, P8484; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Johnson BB, 2012, BIOCHEMISTRY-US, V51, P3373, DOI 10.1021/bi3003132; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lange Y, 1999, J LIPID RES, V40, P2264; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2013, BIOCHEMISTRY-US, V52, P6950, DOI 10.1021/bi400862q; Lange Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030051; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Lange Y, 2009, BIOCHEMISTRY-US, V48, P8505, DOI 10.1021/bi900951r; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Lopez CA, 2013, SCI REPORTS, V3, P1; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; MURPHY RF, 1984, CYTOMETRY, V5, P275, DOI 10.1002/cyto.990050310; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Pitchiaya S, 2013, METHODS, V63, P188, DOI 10.1016/j.ymeth.2013.05.028; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; SLOTTE JP, 1992, BIOCHIM BIOPHYS ACTA, V1123, P326, DOI 10.1016/0005-2760(92)90014-M; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Steck TL, 1970, METHOD CANCER RES, V5, P93; TANGIRALA RK, 1994, J LIPID RES, V35, P93; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wustner D, 2012, CURR PHARM BIOTECHNO, V13, P303, DOI 10.2174/138920112799095301; Wustner D, 2002, J BIOL CHEM, V277, P30325, DOI 10.1074/jbc.M202626200; Ziblat R, 2010, J AM CHEM SOC, V132, P9920, DOI 10.1021/ja103975g; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	52	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e98482	10.1371/journal.pone.0098482	http://dx.doi.org/10.1371/journal.pone.0098482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014655	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400002
J	Leuenberger, T; Pfueller, CF; Luessi, F; Bendix, I; Paterka, M; Prozorovski, T; Treue, D; Luenstedt, S; Herz, J; Siffrin, V; Infante-Duarte, C; Zipp, F; Waiczies, S				Leuenberger, Tina; Pfueller, Caspar F.; Luessi, Felix; Bendix, Ivo; Paterka, Magdalena; Prozorovski, Timour; Treue, Denise; Luenstedt, Sarah; Herz, Josephine; Siffrin, Volker; Infante-Duarte, Carmen; Zipp, Frauke; Waiczies, Sonia			Modulation of Dendritic Cell Immunobiology via Inhibition of 3-Hydroxy-3-Methylglutaryl-CoA (HMG-CoA) Reductase	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; REGULATORY T-CELLS; HEMATOPOIETIC PROGENITOR CELLS; STEADY-STATE; IN-VITRO; SIMVASTATIN TREATMENT; INTERFERON BETA-1A; CONTROLLED-TRIAL; ATORVASTATIN; TOLERANCE	The maturation status of dendritic cells determines whether interacting T cells are activated or if they become tolerant. Previously we could induce T cell tolerance by applying a 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor (HMGCRI) atorvastatin, which also modulates MHC class II expression and has therapeutic potential in autoimmune disease. Here, we aimed at elucidating the impact of this therapeutic strategy on T cell differentiation as a consequence of alterations in dendritic cell function. We investigated the effect of HMGCRI during differentiation of peripheral human monocytes and murine bone marrow precursors to immature DC in vitro and assessed their phenotype. To examine the stimulatory and tolerogenic capacity of these modulated immature dendritic cells, we measured proliferation and suppressive function of CD4+ T cells after stimulation with the modulated immature dendritic cells. We found that an HMGCRI, atorvastatin, prevents dendrite formation during the generation of immature dendritic cells. The modulated immature dendritic cells had a diminished capacity to take up and present antigen as well as to induce an immune response. Of note, the consequence was an increased capacity to differentiate naive T cells towards a suppressor phenotype that is less sensitive to proinflammatory stimuli and can effectively inhibit the proliferation of T effector cells in vitro. Thus, manipulation of antigen-presenting cells by HMGCRI contributes to an attenuated immune response as shown by promotion of T cells with suppressive capacities.	[Leuenberger, Tina; Luessi, Felix; Paterka, Magdalena; Siffrin, Volker; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Rhine Main Neurosci Network Rmn2, Dept Neurol,Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany; [Leuenberger, Tina; Paterka, Magdalena; Luenstedt, Sarah; Siffrin, Volker; Zipp, Frauke] Max Delbrueck Ctr Mol Med Berlin Buch, Berlin, Germany; [Pfueller, Caspar F.] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Bendix, Ivo; Herz, Josephine] Univ Hosp Essen, Dept Pediat Neonatol 1, Essen, Germany; [Prozorovski, Timour] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany; [Treue, Denise] Charite, Inst Pathol, D-13353 Berlin, Germany; [Infante-Duarte, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Waiczies, Sonia] Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany	Johannes Gutenberg University of Mainz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Luessi, F (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Rhine Main Neurosci Network Rmn2, Dept Neurol,Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany.	luessi@uni-mainz.de	Siffrin, Volker/AAR-3632-2021; Waiczies, Sonia/H-4181-2012; Zipp, Frauke/C-9968-2015	Waiczies, Sonia/0000-0002-9916-9572; Zipp, Frauke/0000-0002-1231-1928; Infante Duarte, Carmen/0000-0003-3005-351X; Siffrin, Volker/0000-0002-1532-2868; Treue, Denise/0000-0002-0657-5505; Bendix, Ivo/0000-0002-9751-3640	Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR 43, SFB 650, GRK1258]; Johannes Gutenberg-University Mainz (JGU)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Johannes Gutenberg-University Mainz (JGU)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) to F. Z. (SFB-TRR 43 and SFB 650) and to T. L. and J. H. (GRK1258), and the Johannes Gutenberg-University Mainz (JGU) to F. L. (MAIFOR-grant and grant from the "Inneruniversitare Forschungsforderung (Stufe I)''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Chataway J, 2014, LANCET; Cools N, 2007, J LEUKOCYTE BIOL, V82, P1365, DOI 10.1189/jlb.0307166; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hugues S, 2010, SEMIN IMMUNOPATHOL, V32, P227, DOI 10.1007/s00281-010-0211-2; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; Johansson SM, 2008, IMMUNOLOGY, V123, P491, DOI 10.1111/j.1365-2567.2007.02714.x; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Kamm CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086663; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laman JD, 1997, IMMUNOL TODAY, V18, P272, DOI 10.1016/S0167-5699(97)80022-9; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Legge KL, 2002, J EXP MED, V196, P217, DOI 10.1084/jem.20011061; Li XL, 2013, MOL CELL NEUROSCI, V56, P85, DOI 10.1016/j.mcn.2013.03.005; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Rudick RA, 2009, NEUROLOGY, V72, P1989, DOI 10.1212/WNL.0b013e3181a92b96; Scheffold A, 2007, NAT IMMUNOL, V8, P1285, DOI 10.1038/ni1207-1285; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sorensen PS, 2011, LANCET NEUROL, V10, P691, DOI 10.1016/S1474-4422(11)70144-2; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Togha M, 2010, MULT SCLER J, V16, P848, DOI 10.1177/1352458510369147; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Waiczies S, 2005, J IMMUNOL, V174, P5630, DOI 10.4049/jimmunol.174.9.5630; Waiczies S, 2007, J IMMUNOL, V179, P6024, DOI 10.4049/jimmunol.179.9.6024; Weber MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-29; Xu H, 2014, J NEUROIMMUNOL, V269, P28, DOI 10.1016/j.jneuroim.2014.02.002; Yates SF, 2007, J IMMUNOL, V179, P967, DOI 10.4049/jimmunol.179.2.967; Yilmaz A, 2004, ATHEROSCLEROSIS, V172, P85, DOI 10.1016/j.atherosclerosis.2003.10.002; Yilmaz A, 2006, J LEUKOCYTE BIOL, V79, P529, DOI 10.1189/jlb.0205064; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang Y, 1999, BLOOD, V93, P1208, DOI 10.1182/blood.V93.4.1208.404k05_1208_1220; Zhang Y, 1997, BLOOD, V90, P4842, DOI 10.1182/blood.V90.12.4842.4842_4842_4853	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100871	10.1371/journal.pone.0100871	http://dx.doi.org/10.1371/journal.pone.0100871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013913	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000339378400014
J	Okumura, K; Saito, M; Isogai, E; Aoto, Y; Hachiya, T; Sakakibara, Y; Katsuragi, Y; Hirose, S; Kominami, R; Goitsuka, R; Nakamura, T; Wakabayashi, Y				Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Aoto, Yoshimasa; Hachiya, Tsuyoshi; Sakakibara, Yasubumi; Katsuragi, Yoshinori; Hirose, Satoshi; Kominami, Ryo; Goitsuka, Ryo; Nakamura, Takuro; Wakabayashi, Yuichi			Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis	PLOS ONE			English	Article							MALIGNANT PROGRESSION; GENE-EXPRESSION; INITIATION; PROMOTION; CANCER; PROTEINS; TUMORS; CARCINOGENESIS; NEUROBLASTOMA; CARCINOMAS	Previous studies have shown that Meis1 plays an important role in blood development and vascular homeostasis, and can induce blood cancers, such as leukemia. However, its role in epithelia remains largely unknown. Here, we uncover two roles for Meis1 in the epidermis: as a critical regulator of epidermal homeostasis in normal tissues and as a proto-oncogenic factor in neoplastic tissues. In normal epidermis, we show that Meis1 is predominantly expressed in the bulge region of the hair follicles where multipotent adult stem cells reside, and that the number of these stem cells is reduced when Meis1 is deleted in the epidermal tissue of mice. Mice with epidermal deletion of Meis1 developed significantly fewer DMBA/TPA-induced benign and malignant tumors compared with wild-type mice, suggesting that Meis1 plays a role in both tumor development and malignant progression. This is consistent with the observation that Meis1 expression increases as tumors progress from benign papillomas to malignant carcinomas. Interestingly, we found that Meis1 localization was altered to neoplasia development. Instead of being localized to the stem cell region, Meis1 is localized to more differentiated cells in tumor tissues. These findings suggest that, during the transformation from normal to neoplastic tissues, a functional switch occurs in Meis1.	[Okumura, Kazuhiro; Saito, Megumi; Isogai, Eriko; Wakabayashi, Yuichi] Chiba Canc Ctr, Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, Chiba 2608717, Japan; [Aoto, Yoshimasa; Hachiya, Tsuyoshi; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Bioinfomat Lab, Yokohama, Kanagawa 223, Japan; [Katsuragi, Yoshinori; Hirose, Satoshi; Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata, Japan; [Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Biol Sci, Div Dev & Aging, Noda, Chiba 278, Japan; [Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan	Chiba Cancer Center; Keio University; Niigata University; Tokyo University of Science; Japanese Foundation for Cancer Research	Wakabayashi, Y (corresponding author), Chiba Canc Ctr, Res Inst, Dept Carcinogenesis Res, Div Expt Anim Res, 666-2 Nitonacho, Chiba 2608717, Japan.	yuichi_wakabayashi@chiba-cc.jp	Hachiya, Tsuyoshi/AAM-8691-2021; Hirose, Satoshi/CAF-1500-2022	Hachiya, Tsuyoshi/0000-0002-5274-3266; Hirose, Satoshi/0000-0001-7825-501X	MEXT's program under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [23241066] Funding Source: KAKEN	MEXT's program under the Special Coordination Funds for Promoting Science and Technology at Niigata University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT's program "Promotion of Environmental Improvement for Independence of Young Researchers'' under the Special Coordination Funds for Promoting Science and Technology at Niigata University, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Amornphimoltham P, 2008, CLIN CANCER RES, V14, P8094, DOI 10.1158/1078-0432.CCR-08-0703; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Darwiche N, 2007, ONCOGENE, V26, P6885, DOI 10.1038/sj.onc.1210491; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fernandez P, 2004, ONCOGENE, V23, P5084, DOI 10.1038/sj.onc.1207665; Geerts D, 2005, CANCER LETT, V228, P43, DOI 10.1016/j.canlet.2005.01.047; GLICK AB, 1994, GENE DEV, V8, P2429, DOI 10.1101/gad.8.20.2429; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hirayama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089885; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Indra AK, 2000, HORM RES, V54, P296, DOI 10.1159/000053275; Jones TA, 2000, EUR J CANCER, V36, P2368, DOI 10.1016/S0959-8049(00)00332-4; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Maeda R, 2001, ONCOGENE, V20, P1329, DOI 10.1038/sj.onc.1204250; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Matsumoto T, 2003, CANCER RES, V63, P4819; Morris RJ, 1997, CANCER RES, V57, P3436; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; MORRIS RJ, 1986, CANCER RES, V46, P3061; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Niessen MT, 2013, J CELL BIOL, V202, P887, DOI 10.1083/jcb.201307001; Okumura K, 2012, CARCINOGENESIS, V33, P2260, DOI 10.1093/carcin/bgs250; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Rundhaug JE, 1997, MOL CARCINOGEN, V20, P125, DOI 10.1002/(SICI)1098-2744(199709)20:1<125::AID-MC14>3.0.CO;2-3; Rundhaug JE, 2007, MOL CARCINOGEN, V46, P981, DOI 10.1002/mc.20340; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Spieker N, 2001, GENOMICS, V71, P214, DOI 10.1006/geno.2000.6408; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wilker E, 2005, MOL CARCINOGEN, V44, P137, DOI 10.1002/mc.20132; YUSPA SH, 1994, J INVEST DERMATOL, V103, pS90, DOI 10.1111/1523-1747.ep12399255	51	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102111	10.1371/journal.pone.0102111	http://dx.doi.org/10.1371/journal.pone.0102111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013928	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400067
J	Vosselman, MJ; Vijgen, GHEJ; Kingma, BRM; Brans, B; Lichtenbelt, WDV				Vosselman, Maarten J.; Vijgen, Guy H. E. J.; Kingma, Boris R. M.; Brans, Boudewijn; Lichtenbelt, Wouter D. van Marken			Frequent Extreme Cold Exposure and Brown Fat and Cold-Induced Thermogenesis: A Study in a Monozygotic Twin	PLOS ONE			English	Article							ADIPOSE-TISSUE ACTIVITY; NONSHIVERING THERMOGENESIS; ADAPTIVE THERMOGENESIS; UNCOUPLING PROTEIN-1; ADULT HUMANS; MILD COLD; TEMPERATURE; DECREASE; GENES; FINNS	Introduction: Mild cold acclimation is known to increase brown adipose tissue (BAT) activity and cold-induced thermogenesis (CIT) in humans. We here tested the effect of a lifestyle with frequent exposure to extreme cold on BAT and CIT in a Dutch man known as 'the Iceman', who has multiple world records in withstanding extreme cold challenges. Furthermore, his monozygotic twin brother who has a 'normal' sedentary lifestyle without extreme cold exposures was measured. Methods: The Iceman (subject A) and his brother (subject B) were studied during mild cold (13 degrees C) and thermoneutral conditions (31 degrees C). Measurements included BAT activity and respiratory muscle activity by [F-18]FDG-PET/CT imaging and energy expenditure through indirect calorimetry. In addition, body temperatures, cardiovascular parameters, skin perfusion, and thermal sensation and comfort were measured. Finally, we determined polymorphisms for uncoupling protein-1 and beta 3-adrenergic receptor. Results: Subjects had comparable BAT activity (A: 1144 SUVtotal and B: 1325 SUVtotal), within the range previously observed in young adult men. They were genotyped with the polymorphism for uncoupling protein-1 (G/G). CIT was relatively high (A: 40.1% and B: 41.9%), but unlike during our previous cold exposure tests in young adult men, here both subjects practiced a g-Tummo like breathing technique, which involves vigorous respiratory muscle activity. This was confirmed by high [F-18]FDG-uptake in respiratory muscle. Conclusion: No significant differences were found between the two subjects, indicating that a lifestyle with frequent exposures to extreme cold does not seem to affect BAT activity and CIT. In both subjects, BAT was not higher compared to earlier observations, whereas CIT was very high, suggesting that g-Tummo like breathing during cold exposure may cause additional heat production by vigorous isometric respiratory muscle contraction. The results must be interpreted with caution given the low subject number and the fact that both participants practised the g-Tummo like breathing technique.	[Vosselman, Maarten J.; Kingma, Boris R. M.; Lichtenbelt, Wouter D. van Marken] Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Brans, Boudewijn] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands; [Vijgen, Guy H. E. J.] Erasmus MC, Dept Surg GV, Rotterdam, Netherlands	Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Lichtenbelt, WDV (corresponding author), Sch Nutr Toxicol & Metab NUTRIM, Dept Human Biol, Maastricht, Netherlands.	markenlichtenbelt@maastrichtuniversity.nl	Kingma, Boris/AAK-4492-2020	Kingma, Boris/0000-0001-5961-0215; Vijgen, Guy/0000-0002-6011-753X	Netherlands Organization for Scientific Research [TOP 91209037]; EU [HEALTH-F2-2011-278373]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	This work is partly financed by the Netherlands Organization for Scientific Research (TOP 91209037 to W.D.vM.L.), and by the EU FP7 project DIABAT (HEALTH-F2-2011-278373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens E, 2006, THERMAL AND MOISTURE TRANSPORT IN FIBROUS MATERIALS, P560, DOI 10.1533/9781845692261.3.560; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; DAVIS TR, 1961, J APPL PHYSIOL, V16, P1011, DOI 10.1152/jappl.1961.16.6.1011; Esterbauer H, 1998, J LIPID RES, V39, P834; Kildeso J, 1999, SCAND J WORK ENV HEA, V25, P361, DOI 10.5271/sjweh.446; Kingma BRM, 2011, ACTA PHYSIOL, V203, P419, DOI 10.1111/j.1748-1716.2011.02336.x; Kox M, 2012, PSYCHOSOM MED, V74, P489, DOI 10.1097/PSY.0b013e3182583c6d; Kozhevnikov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058244; Lichtenbelt WDV, 2002, AM J PHYSIOL-ENDOC M, V282, pE1077, DOI 10.1152/ajpendo.00020.2001; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Nagai N, 2011, INT J OBESITY, V35, P1050, DOI 10.1038/ijo.2010.261; Peters R M, 1969, Ann Thorac Surg, V7, P51; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Tiwari AK, 2009, J DIABETES COMPLICAT, V23, P102, DOI 10.1016/j.jdiacomp.2007.10.003; Valve R, 1998, DIABETOLOGIA, V41, P357, DOI 10.1007/s001250050915; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; van Ooijen AMJ, 2005, BRIT J NUTR, V93, P387, DOI 10.1079/BJN20041362; van Rooijen BD, 2013, INVEST RADIOL, V48, P708, DOI 10.1097/RLI.0b013e31829363b8; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125	29	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101653	10.1371/journal.pone.0101653	http://dx.doi.org/10.1371/journal.pone.0101653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014028	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400029
J	Fernandez-Banares, F; Carrasco, A; Garcia-Puig, R; Rosinach, M; Gonzalez, C; Alsina, M; Loras, C; Salas, A; Viver, JM; Esteve, M				Fernandez-Banares, Fernando; Carrasco, Anna; Garcia-Puig, Roger; Rosinach, Merce; Gonzalez, Clarisa; Alsina, Montserrat; Loras, Carme; Salas, Antonio; Viver, Josep M.; Esteve, Maria			Intestinal Intraepithelial Lymphocyte Cytometric Pattern Is More Accurate than Subepithelial Deposits of Anti-Tissue Transglutaminase IgA for the Diagnosis of Celiac Disease in Lymphocytic Enteritis	PLOS ONE			English	Article							GLUTEN-SENSITIVE ENTEROPATHY; FLOW-CYTOMETRY; HELICOBACTER-PYLORI; T-LYMPHOCYTES; ANTIBODIES; CHILDREN; MUCOSA; CELLS; ANTIGLIADIN; DUODENOSIS	Background & Aims: An increase in CD3+TCR gamma delta+ and a decrease in CD3- intraepithelial lymphocytes (IEL) is a characteristic flow cytometric pattern of celiac disease (CD) with atrophy. The aim was to evaluate the usefulness of both CD IEL cytometric pattern and anti-TG2 IgA subepithelial deposit analysis (CD IF pattern) for diagnosing lymphocytic enteritis due to CD. Methods: Two-hundred and five patients (144 females) who underwent duodenal biopsy for clinical suspicion of CD and positive celiac genetics were prospectively included. Fifty had villous atrophy, 70 lymphocytic enteritis, and 85 normal histology. Eight patients with non-celiac atrophy and 15 with lymphocytic enteritis secondary to Helicobacter pylori acted as control group. Duodenal biopsies were obtained to assess both CD IEL flow cytometric (complete or incomplete) and IF patterns. Results: Sensitivity of IF, and complete and incomplete cytometric patterns for CD diagnosis in patients with positive serology (Marsh 1+3) was 92%, 85 and 97% respectively, but only the complete cytometric pattern had 100% specificity. Twelve seropositive and 8 seronegative Marsh 1 patients had a CD diagnosis at inclusion or after gluten free-diet, respectively. CD cytometric pattern showed a better diagnostic performance than both IF pattern and serology for CD diagnosis in lymphocytic enteritis at baseline (95% vs 60% vs 60%, p = 0.039). Conclusions: Analysis of the IEL flow cytometric pattern is a fast, accurate method for identifying CD in the initial diagnostic biopsy of patients presenting with lymphocytic enteritis, even in seronegative patients, and seems to be better than anti-TG2 intestinal deposits.	[Fernandez-Banares, Fernando; Carrasco, Anna; Rosinach, Merce; Loras, Carme; Viver, Josep M.; Esteve, Maria] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Gastroenterol, CIBERehd, Terrassa, Barcelona, Spain; [Garcia-Puig, Roger] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Pediat, Terrassa, Barcelona, Spain; [Gonzalez, Clarisa; Salas, Antonio] Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Pathol, CIBERehd, Terrassa, Barcelona, Spain; [Alsina, Montserrat] CATLAB, Dept Immunol, Viladecavalls, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario Mutua Terrassa; University of Barcelona	Fernandez-Banares, F (corresponding author), Univ Barcelona, Hosp Univ Mutua Terrassa, Dept Gastroenterol, CIBERehd, Terrassa, Barcelona, Spain.	ffbanares@mutuaterrassa.es		Carrasco, Anna/0000-0001-8810-1583; Fernandez-Banares, Fernando/0000-0002-1489-504X; ESTEVE, MARIA/0000-0001-7716-0027; ESTEVE, MARIA/0000-0002-3178-7008; LORAS ALASTRUEY, CARME/0000-0002-4035-3316	Instituto de Salud Carlos III (Ministry of Health, Spain) [PI10/00892]	Instituto de Salud Carlos III (Ministry of Health, Spain)(Instituto de Salud Carlos IIISpanish Government)	The study was sponsored by a grant from the Instituto de Salud Carlos III (PI10/00892, Ministry of Health, Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz I, 2010, ALIMENT PHARM THER, V32, P1392, DOI 10.1111/j.1365-2036.2010.04477.x; Calleja S, 2011, DIGEST DIS SCI, V56, P2042, DOI 10.1007/s10620-010-1534-5; Camarero C, 2000, ACTA PAEDIATR, V89, P285, DOI 10.1080/080352500750028410; Carroccio A, 2006, CLIN CHEM, V52, P1175, DOI 10.1373/clinchem.2005.061366; Catassi C, 2010, AM J MED, V123, P691, DOI 10.1016/j.amjmed.2010.02.019; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; CHORZELSKI TP, 1984, BRIT J DERMATOL, V111, P395, DOI 10.1111/j.1365-2133.1984.tb06601.x; Eiras P, 1998, CYTOMETRY, V34, P95, DOI 10.1002/(SICI)1097-0320(19980415)34:2<95::AID-CYTO6>3.0.CO;2-B; Farre C., 2002, THESIS U BARCELONA; Forne M, 2000, AM J GASTROENTEROL, V95, P2200, DOI 10.1111/j.1572-0241.2000.02303.x; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jarvinen TT, 2003, AM J GASTROENTEROL, V98, P1332, DOI 10.1016/S0002-9270(03)00230-2; Kakar S, 2003, AM J GASTROENTEROL, V98, P2027, DOI 10.1016/S0002-9270(03)00542-2; Kokkonen J, 2000, SCAND J GASTROENTERO, V35, P1137, DOI 10.1080/003655200750056592; Koskinen O, 2010, J CLIN GASTROENTEROL, V44, P483, DOI 10.1097/MCG.0b013e3181b64557; KUTLU T, 1993, GUT, V34, P208, DOI 10.1136/gut.34.2.208; Leon F, 2003, GASTROENTEROLOGY, V125, P345, DOI 10.1016/S0016-5085(03)00886-2; Leon F, 2011, J IMMUNOL METHODS, V363, P177, DOI 10.1016/j.jim.2010.09.002; Lindfors K, 2011, INT REV IMMUNOL, V30, P185, DOI 10.3109/08830185.2011.595854; Maglio M, 2011, DIGEST LIVER DIS, V43, P604, DOI 10.1016/j.dld.2011.01.015; MAKI M, 1991, GUT, V32, P1412, DOI 10.1136/gut.32.11.1412; Marine M, 2011, ALIMENT PHARM THER, V33, P477, DOI 10.1111/j.1365-2036.2010.04543.x; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Olivencia Palomar Pilar, 2008, Gastroenterol Hepatol, V31, P555, DOI 10.1157/13128293; Rosinach M, 2012, DIGEST LIVER DIS, V44, P643, DOI 10.1016/j.dld.2012.03.006; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Salmi TT, 2010, DIGEST LIVER DIS, V42, P28, DOI 10.1016/j.dld.2009.04.004; Santaolalla R, 2008, ALIMENT PHARM THER, V27, P820, DOI 10.1111/j.1365-2036.2008.03652.x; SAVILAHTI E, 1990, PEDIATR RES, V28, P579, DOI 10.1203/00006450-199012000-00005; Tosco A, 2013, CLIN EXP IMMUNOL, V171, P69, DOI 10.1111/j.1365-2249.2012.04673.x; Tosco A, 2008, J PEDIATR GASTR NUTR, V47, P293, DOI 10.1097/MPG.0b013e3181677067; TREJDOSIEWICZ LK, 1991, CLIN EXP IMMUNOL, V84, P440; Tursi A, 2001, AM J GASTROENTEROL, V96, P1507; Verbeek WHM, 2008, AM J GASTROENTEROL, V103, P3152, DOI 10.1111/j.1572-0241.2008.02213.x; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15; Wahab PJ, 2001, AM J GASTROENTEROL, V96, P1464, DOI 10.1111/j.1572-0241.2001.03812.x; Walker MM, 2011, HISTOPATHOLOGY, V59, P166, DOI 10.1111/j.1365-2559.2010.03680.x	39	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101249	10.1371/journal.pone.0101249	http://dx.doi.org/10.1371/journal.pone.0101249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010214	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800017
J	Josowitz, R; Lu, J; Falce, C; D'Souza, SL; Wu, M; Cohen, N; Dubois, NC; Zhao, Y; Sobie, EA; Fishman, GI; Gelb, BD				Josowitz, Rebecca; Lu, Jia; Falce, Christine; D'Souza, Sunita L.; Wu, Meng; Cohen, Ninette; Dubois, Nicole C.; Zhao, Yong; Sobie, Eric A.; Fishman, Glenn I.; Gelb, Bruce D.			Identification and Purification of Human Induced Pluripotent Stem Cell-Derived Atrial-Like Cardiomyocytes Based on Sarcolipin Expression	PLOS ONE			English	Article							MATURATION; PHARMACOLOGY; SELECTION; PROTEIN; MUSCLE	The use of human stem cell-derived cardiomyocytes to study atrial biology and disease has been restricted by the lack of a reliable method for stem cell-derived atrial cell labeling and purification. The goal of this study was to generate an atrial-specific reporter construct to identify and purify human stem cell-derived atrial-like cardiomyocytes. We have created a bacterial artificial chromosome (BAC) reporter construct in which fluorescence is driven by expression of the atrial-specific gene sarcolipin (SLN). When purified using flow cytometry, cells with high fluorescence specifically express atrial genes and display functional calcium handling and electrophysiological properties consistent with atrial cardiomyocytes. Our data indicate that SLN can be used as a marker to successfully monitor and isolate hiPSC-derived atrial-like cardiomyocytes. These purified cells may find many applications, including in the study of atrial-specific pathologies and chamber-specific lineage development.	[Josowitz, Rebecca; Wu, Meng; Dubois, Nicole C.; Zhao, Yong; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Lu, Jia; Fishman, Glenn I.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA; [Falce, Christine; Sobie, Eric A.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [D'Souza, Sunita L.; Dubois, Nicole C.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Wu, Meng; Cohen, Ninette; Zhao, Yong; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Fishman, Glenn I.] NYU, Sch Med, Dept Med, New York, NY USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai	Gelb, BD (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	bruce.gelb@mssm.edu	Wu, Meng/J-8515-2016	Wu, Meng/0000-0001-5512-9651; Fishman, Glenn/0000-0002-2366-8527	Empire State Stem Cell Fund through New York State Department of Health [NYSTEM N08T-020, NYSTEM N11G-032]; National Institutes of Health [R01 HL113499, R01 HL105983, R01 HL076230]; American Heart Association [12PRE12060254]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105983, R01HL076230, R01HL113499] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM N08T-020, http://stemcell.ny.gov/) to BDG; National Institutes of Health (R01 HL113499, https://www.nhlbi.nih.gov/) to BDG; American Heart Association (12PRE12060254, https://my.americanheart.org) to RJ; Empire State Stem Cell Fund through New York State Department of Health (NYSTEM N11G-032, http://stemcell.ny.gov/) to GIF; National Institutes of Health (R01 HL105983, https://www.nhlbi.nih.gov/) to GIF; and National Institutes of Health (R01 HL076230, https://www.nhlbi.nih.gov/) to EAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bootman MD, 2011, BBA-MOL CELL RES, V1813, P922, DOI 10.1016/j.bbamcr.2011.01.030; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Don CW, 2013, J CELL MOL MED, V17, P1355, DOI 10.1111/jcmm.12147; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Hatem SN, 2010, J MOL CELL CARDIOL, V48, P90, DOI 10.1016/j.yjmcc.2009.08.029; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Small EM, 2004, TRENDS CARDIOVAS MED, V14, P13, DOI 10.1016/j.tcm.2003.09.005; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; VARRO A, 1993, ACTA PHYSIOL SCAND, V149, P133, DOI 10.1111/j.1748-1716.1993.tb09605.x; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Willems E, 2011, CIRC RES, V109, P360, DOI 10.1161/CIRCRESAHA.111.249540; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558	31	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101316	10.1371/journal.pone.0101316	http://dx.doi.org/10.1371/journal.pone.0101316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010565	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800020
J	Mizukami, T; Momose, H; Kuramitsu, M; Takizawa, K; Araki, K; Furuhata, K; Ishii, KJ; Hamaguchi, I; Yamaguchi, K				Mizukami, Takuo; Momose, Haruka; Kuramitsu, Madoka; Takizawa, Kazuya; Araki, Kumiko; Furuhata, Keiko; Ishii, Ken J.; Hamaguchi, Isao; Yamaguchi, Kazunari			System Vaccinology for the Evaluation of Influenza Vaccine Safety by Multiplex Gene Detection of Novel Biomarkers in a Preclinical Study and Batch Release Test	PLOS ONE			English	Article							IMMUNE-RESPONSE; TOXICITY; PATTERNS; VIRUS	Vaccines are beneficial and universal tools to prevent infectious disease. Thus, safety of vaccines is strictly evaluated in the preclinical phase of trials and every vaccine batch must be tested by the National Control Laboratories according to the guidelines published by each country. Despite many vaccine production platforms and methods, animal testing for safety evaluation is unchanged thus far. We recently developed a systems biological approach to vaccine safety evaluation where identification of specific biomarkers in a rat pre-clinical study evaluated the safety of vaccines for pandemic H5N1 influenza including Irf7, Lgals9, Lgalsbp3, Cxcl11, Timp1, Tap2, Psmb9, Psme1, Tapbp, C2, Csf1, Mx2, Zbp1, Ifrd1, Trafd1, Cxcl9, beta 2m, Npc1, Ngfr and Ifi47. The current study evaluated whether these 20 biomarkers could evaluate the safety, batch-to-batch and manufacturer-to-manufacturer consistency of seasonal trivalent influenza vaccine using a multiplex gene detection system. When we evaluated the influenza HA vaccine (HAv) from four different manufactures, the biomarker analysis correlated to findings from conventional animal use tests, such as abnormal toxicity test. In addition, sensitivity of toxicity detection and differences in HAvs were higher and more accurate than with conventional methods. Despite a slight decrease in body weight caused by HAv from manufacturer B that was not statistically significant, our results suggest that HAv from manufacturer B is significantly different than the other HAvs tested with regard to Lgals3bp, Tapbp, Lgals9, Irf7 and C2 gene expression in rat lungs. Using the biomarkers confirmed in this study, we predicted batch-to-batch consistency and safety of influenza vaccines within 2 days compared with the conventional safety test, which takes longer. These biomarkers will facilitate the future development of new influenza vaccines and provide an opportunity to develop in vitro methods of evaluating batch-to-batch consistency and vaccine safety as an alternative to animal testing.	[Mizukami, Takuo; Momose, Haruka; Kuramitsu, Madoka; Takizawa, Kazuya; Araki, Kumiko; Furuhata, Keiko; Hamaguchi, Isao; Yamaguchi, Kazunari] Natl Inst Infect Dis, Dept Safety Res Blood & Biol, Lab Blood & Vaccine safety, Tokyo, Japan; [Ishii, Ken J.] Natl Inst Biomed Innovat NIBIO, Lab Adjuvant Innovat, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, WPI Immunol Frontier Res Ctr WPI IFREC, Lab Vaccine Sci, Osaka, Japan	National Institute of Infectious Diseases (NIID); Osaka University	Hamaguchi, I (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol, Lab Blood & Vaccine safety, Tokyo, Japan.	130hama@nih.go.jp	Ishii, Ken J/B-1685-2012; Mizukami, Takuo/F-9248-2016	Ishii, Ken J/0000-0002-6728-3872; Mizukami, Takuo/0000-0001-6105-6049	Ministry of Health, Labor, and Welfare of Japan [201132001, 201208036]; Grants-in-Aid for Scientific Research [25860798] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from Ministry of Health, Labor, and Welfare of Japan (201132001 and 201208036, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Ato M, 2013, VACCINE, V31, P2184, DOI 10.1016/j.vaccine.2013.02.016; Baylor NW., 2012, VACCINES EXPERT CONS, V6th, P1427; Brennan FR, 2005, VACCINE, V23, P3210, DOI 10.1016/j.vaccine.2004.11.072; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Couch Robert B., 1997, Journal of Infectious Diseases, V176, pS38, DOI 10.1086/514173; Even-Or O, 2013, EXPERT REV VACCINES, V12, P1095, DOI 10.1586/14760584.2013.825445; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Hamaguchi I, 2008, VACCINE, V26, P4686, DOI 10.1016/j.vaccine.2008.06.086; Hamaguchi I, 2007, VACCINE, V25, P3355, DOI 10.1016/j.vaccine.2006.12.059; KUROKAWA M, 1961, JPN J MED SCI BIOL, V14, P249, DOI 10.7883/yoken1952.14.249; Mizukami T, 2008, VACCINE, V26, P2270, DOI 10.1016/j.vaccine.2008.02.031; Mizukami T, 2009, BIOLOGICALS, V37, P8, DOI 10.1016/j.biologicals.2008.07.007; Momose H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/361841; Momose H, 2010, JPN J INFECT DIS, V63, P25; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Offit PA, 2012, VACCINES, P1464; Plotkin SL, 2012, VACCINES, P1; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Verdier F, 2001, VACCINE, V20, pS21, DOI 10.1016/S0264-410X(01)00308-5; Wang IM, 2012, MICROB BIOTECHNOL, V5, P177, DOI 10.1111/j.1751-7915.2011.00317.x; WHO, 2020, PAND INFL RISK MAN W; Wolf JJ, 2010, METHODS MOL BIOL, V626, P29, DOI 10.1007/978-1-60761-585-9_3; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Wood JM., 1998, TXB INFLUENZA, P317; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101835	10.1371/journal.pone.0101835	http://dx.doi.org/10.1371/journal.pone.0101835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010690	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800044
J	Rabeony, H; Petit-Paris, I; Garnier, J; Barrault, C; Pedretti, N; Guilloteau, K; Jegou, JF; Guillet, G; Huguier, V; Lecron, JC; Bernard, FX; Morel, F				Rabeony, Hanitriniaina; Petit-Paris, Isabelle; Garnier, Julien; Barrault, Christine; Pedretti, Nathalie; Guilloteau, Karline; Jegou, Jean-Francois; Guillet, Gerard; Huguier, Vincent; Lecron, Jean-Claude; Bernard, Francois-Xavier; Morel, Franck			Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1 alpha, TNF alpha and Oncostatin M	PLOS ONE			English	Article							CYTOKINE PRODUCTION; T-LYMPHOCYTES; EXPRESSION; PSORIASIS; EPIDERMIS; PERTURBATION; MECHANISMS; DEFENSE; DISEASE; GENES	Keratinocyte differentiation program leading to an organized epidermis plays a key role in maintaining the first line of defense of the skin. Epidermal integrity is regulated by a tight communication between keratinocytes and leucocytes, particularly under cytokine control. Imbalance of the cytokine network leads to inflammatory diseases such as psoriasis. Our attempt to model skin inflammation showed that the combination of IL-17A, IL-22, IL-1 alpha, OSM and TNF alpha (Mix M5) synergistically increases chemokine and antimicrobial-peptide expression, recapitulating some features of psoriasis. Other characteristics of psoriasis are acanthosis and down-regulation of keratinocyte differentiation markers. Our aim was to characterize the specific roles of these cytokines on keratinocyte differentiation, and to compare with psoriatic lesion features. All cytokines decrease keratinocyte differentiation markers, but IL-22 and OSM were the most powerful, and the M5 strongly synergized the effects. In addition, IL-22 and OSM induced epidermal hyperplasia in vitro and M5 induced epidermal thickening and decreased differentiation marker expression in a mouse model, as observed in human psoriatic skin lesions. This study highlights the precise role of cytokines in the skin inflammatory response. IL-22 and OSM more specifically drive epidermal hyperplasia and differentiation loss while IL-1 alpha, IL-17A and TNF alpha were more involved in the activation of innate immunity.	[Rabeony, Hanitriniaina; Petit-Paris, Isabelle; Guilloteau, Karline; Jegou, Jean-Francois; Lecron, Jean-Claude; Bernard, Francois-Xavier; Morel, Franck] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, Equipe Accueil 4331, Poitiers, France; [Petit-Paris, Isabelle; Lecron, Jean-Claude] Ctr Hosp Univ Poitiers, Lab Immunol & Inflammat, Poitiers, France; [Garnier, Julien; Barrault, Christine; Pedretti, Nathalie; Bernard, Francois-Xavier] BIOalternatives, Gencay, France; [Guillet, Gerard] Ctr Hosp Univ Poitiers, Serv Dermatol, Poitiers, France; [Huguier, Vincent] Ctr Hosp Univ Poitiers, Serv Chirurg Plast, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Morel, F (corresponding author), Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, Equipe Accueil 4331, Poitiers, France.	f.morel@univ-poitiers.fr	Morel, Franck/AAI-4274-2021	Morel, Franck/0000-0003-3812-9304; LECRON, Jean-Claude/0000-0003-3990-5213; Rabeony, Hanitriniaina/0000-0001-6470-0514; Jegou, Jean-Francois/0000-0002-9703-5976	Poitiers University Hospital (PHRC); "La Ligue contre le cancer"; "Association Nationale de Recherche et de la Technologie"; "le conseil regional de la region Poitou-Charentes"	Poitiers University Hospital (PHRC); "La Ligue contre le cancer"(Ligue nationale contre le cancer); "Association Nationale de Recherche et de la Technologie"; "le conseil regional de la region Poitou-Charentes"(Region Nouvelle-Aquitaine)	This study was supported by grants from a clinical research program from Poitiers University Hospital (PHRC), "La Ligue contre le cancer", "Association Nationale de Recherche et de la Technologie" and from "le conseil regional de la region Poitou-Charentes". H. Rabeony is supported by "le conseil regional de la region Poitou-Charentes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 1999, J IMMUNOL, V162, P494; Bernard Francois-Xavier, 2012, J Allergy (Cairo), V2012, P718725, DOI 10.1155/2012/718725; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kupetsky EA, 2013, CYTOKINE, V61, P704, DOI 10.1016/j.cyto.2012.12.027; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	30	71	76	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101937	10.1371/journal.pone.0101937	http://dx.doi.org/10.1371/journal.pone.0101937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010647	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800053
J	Rohrl, C; Eigner, K; Fruhwurth, S; Stangl, H				Roehrl, Clemens; Eigner, Karin; Fruhwuerth, Stefanie; Stangl, Herbert			Bile Acids Reduce Endocytosis of High-Density Lipoprotein (HDL) in HepG2 Cells	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; SELECTIVE LIPID UPTAKE; SR-BI; SCAVENGER RECEPTOR; NUCLEAR RECEPTOR; PARTICLE UPTAKE; SECRETION; IDENTIFICATION; EXPRESSION	High-density lipoprotein (HDL) transports lipids to hepatic cells and the majority of HDL-associated cholesterol is destined for biliary excretion. Cholesterol is excreted into the bile directly or after conversion to bile acids, which are also present in the plasma as they are effectively reabsorbed through the enterohepatic cycle. Here, we provide evidence that bile acids affect HDL endocytosis. Using fluorescent and radiolabeled HDL, we show that HDL endocytosis was reduced in the presence of high concentrations of taurocholate, a natural non-cell-permeable bile acid, in human hepatic HepG2 and HuH7 cells. In contrast, selective cholesteryl-ester (CE) uptake was increased. Taurocholate exerted these effects extracellularly and independently of HDL modification, cell membrane perturbation or blocking of endocytic trafficking. Instead, this reduction of endocytosis and increase in selective uptake was dependent on SR-BI. In addition, cell-permeable bile acids reduced HDL endocytosis by farnesoid X receptor (FXR) activation: chenodeoxycholate and the non-steroidal FXR agonist GW4064 reduced HDL endocytosis, whereas selective CE uptake was unaltered. Reduced HDL endocytosis by FXR activation was independent of SR-BI and was likely mediated by impaired expression of the scavenger receptor cluster of differentiation 36 (CD36). Taken together we have shown that bile acids reduce HDL endocytosis by transcriptional and non-transcriptional mechanisms. Further, we suggest that HDL endocytosis and selective lipid uptake are not necessarily tightly linked to each other.	[Roehrl, Clemens; Eigner, Karin; Fruhwuerth, Stefanie; Stangl, Herbert] Med Univ Vienna, Dept Med Chem, Ctr Pathobiochem & Genet, Vienna, Austria	Medical University of Vienna	Stangl, H (corresponding author), Med Univ Vienna, Dept Med Chem, Ctr Pathobiochem & Genet, Vienna, Austria.	herbert.stangl@meduniwien.ac.at	Stangl, Herbert/AAT-4379-2021; Stangl, Herbert/R-9441-2019	Stangl, Herbert/0000-0002-7288-7320; Rohrl, Clemens/0000-0002-1192-0748	Austrian Science Fund (FWF) [P25763-B13, P22838-B13]; DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Institute of Medical Chemistry at the Medical University of Vienna; Austrian Science Fund (FWF) [P 22838] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Institute of Medical Chemistry at the Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are funded by the Austrian Science Fund (FWF) projects: P25763-B13 (to Clemens Rohrl) and P22838-B13 (to Herbert Stangl). Stefanie Fruhwurth is a recipient of a DOC-fFORTE-fellowship of the Austrian Academy of Sciences at the Institute of Medical Chemistry at the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ANGELIN B, 1982, J CLIN INVEST, V70, P724, DOI 10.1172/JCI110668; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Camarota LM, 2004, J BIOL CHEM, V279, P27599, DOI 10.1074/jbc.M402946200; Chao F, 2010, ATHEROSCLEROSIS, V213, P443, DOI 10.1016/j.atherosclerosis.2010.09.016; Claudel T, 2002, J CLIN INVEST, V109, P961; Dikkers A, 2010, WORLD J GASTROENTERO, V16, P5936, DOI 10.3748/wjg.v16.i47.5936; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; GLOMSET JA, 1968, J LIPID RES, V9, P155; Goffinet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095807; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hambruch E, 2012, J PHARMACOL EXP THER, V343, P556, DOI 10.1124/jpet.112.196519; Harder CJ, 2006, J LIPID RES, V47, P492, DOI 10.1194/jlr.M500444-JLR200; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Kovacs WJ, 2009, J BIOL CHEM, V284, P7232, DOI 10.1074/jbc.M809064200; Krieger M, 1986, Methods Enzymol, V129, P227; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Li F, 1996, BIOCHEMISTRY-US, V35, P6657, DOI 10.1021/bi952313q; Li GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035895; LIANG D, 1993, HEPATOLOGY, V18, P1162; Liu B, 2002, J BIOL CHEM, V277, P34125, DOI 10.1074/jbc.M204265200; Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Malerod L, 2005, BIOCHEM BIOPH RES CO, V336, P1096, DOI 10.1016/j.bbrc.2005.08.237; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Meyer JM, 2013, CURR OPIN LIPIDOL, V24, P386, DOI 10.1097/MOL.0b013e3283638042; Nieland TJF, 2005, BBA-MOL CELL BIOL L, V1734, P44, DOI 10.1016/j.bbalip.2005.02.007; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; PLESNER L, 1995, INT REV CYTOL, V158, P141; Rohrl C, 2013, BBA-MOL CELL BIOL L, V1831, P1626, DOI [10.1016/j.bbalip.2013.07.014, 10.1016/j.bbalip2013.07.014]; Rohrl C, 2012, CURR PHARM BIOTECHNO, V13, P331, DOI 10.2174/138920112799095338; Rohrl C, 2010, HISTOCHEM CELL BIOL, V133, P261, DOI 10.1007/s00418-009-0672-3; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996; Serhan N, 2013, BBA-MOL CELL BIOL L, V1831, P719, DOI 10.1016/j.bbalip.2012.12.006; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sirvent A, 2004, J LIPID RES, V45, P2110, DOI 10.1194/jlr.M400221-JLR200; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3086, DOI 10.1073/pnas.83.10.3086; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899	43	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102026	10.1371/journal.pone.0102026	http://dx.doi.org/10.1371/journal.pone.0102026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010412	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800062
J	Spencer, M; Yang, L; Adu, A; Finlin, BS; Zhu, BB; Shipp, LR; Rasouli, N; Peterson, CA; Kern, PA				Spencer, Michael; Yang, Lin; Adu, Akosua; Finlin, Brian S.; Zhu, Beibei; Shipp, Lindsey R.; Rasouli, Neda; Peterson, Charlotte A.; Kern, Philip A.			Pioglitazone Treatment Reduces Adipose Tissue Inflammation through Reduction of Mast Cell and Macrophage Number and by Improving Vascularity	PLOS ONE			English	Article							INSULIN SENSITIVITY; SKELETAL-MUSCLE; FATTY-ACIDS; OBESITY; ADIPONECTIN; ACTIVATION; METFORMIN; THIAZOLIDINEDIONES; EXPRESSION; SECRETION	Context and Objective: Adipose tissue in insulin resistant subjects contains inflammatory cells and extracellular matrix components. This study examined adipose pathology of insulin resistant subjects who were treated with pioglitazone or fish oil. Design, Setting and Participants: Adipose biopsies were examined from nine insulin resistant subjects before/after treatment with pioglitazone 45 mg/day for 12 weeks and also from 19 subjects who were treated with fish oil (1,860 mg EPA, 1,500 mg DHA daily). These studies were performed in a clinical research center setting. Results: Pioglitazone treatment increased the cross-sectional area of adipocytes by 18% (p = 0.01), and also increased capillary density without affecting larger vessels. Pioglitazone treatment decreased total adipose macrophage number by 26%, with a 56% decrease in M1 macrophages and an increase in M2 macrophages. Mast cells were more abundant in obese versus lean subjects, and were decreased from 24 to 13 cells/mm(2) (p = 0.02) in patients treated with pioglitazone, but not in subjects treated with FO. Although there were no changes in total collagen protein, pioglitazone increased the amount of elastin protein in adipose by 6-fold. Conclusion: The PPAR gamma agonist pioglitazone increased adipocyte size yet improved other features of adipose, increasing capillary number and reducing mast cells and inflammatory macrophages. The increase in elastin may better permit adipocyte expansion without triggering cell necrosis and an inflammatory reaction.	[Spencer, Michael; Adu, Akosua; Finlin, Brian S.; Zhu, Beibei; Shipp, Lindsey R.; Kern, Philip A.] Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA; [Spencer, Michael; Adu, Akosua; Finlin, Brian S.; Zhu, Beibei; Shipp, Lindsey R.; Kern, Philip A.] Univ Kentucky, Barnstable Brown Diabet & Obes Ctr, Lexington, KY USA; [Yang, Lin] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Peterson, Charlotte A.] Univ Kentucky, Coll Hlth Sci, Lexington, KY USA; [Rasouli, Neda] Univ Colorado, Div Endocrinol, Denver, CO 80202 USA; [Rasouli, Neda] Eastern Colorado Vet Hlth Care Syst, Denver, CO USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Colorado System; University of Colorado Denver	Kern, PA (corresponding author), Univ Kentucky, Dept Med, Div Endocrinol, Lexington, KY 40506 USA.	philipkern@uky.edu	Adu, Akosua/AAY-3285-2021	Adu, Akosua/0000-0001-9615-970X; Rasouli, Neda/0000-0003-1269-3580	VA Merit grant; CTSA grant [UL1TR000117]; COBRE [P20RR021954];  [DK80327];  [DK71349]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080327, R01DK071349] Funding Source: NIH RePORTER	VA Merit grant; CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); COBRE; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: DK80327 (P. K.), DK71349 (C. P. and P. K.), A VA Merit grant (N.R.), CTSA grant UL1TR000117, and COBRE P20RR021954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Bodles AM, 2006, J LIPID RES, V47, P2080, DOI 10.1194/jlr.M600235-JLR200; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Ciaraldi TP, 2002, DIABETES, V51, P30, DOI 10.2337/diabetes.51.1.30; Consoli A, 2005, LUPUS, V14, P794, DOI 10.1191/0961203305lu2223oa; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Di Cataldo S, 2010, COMPUT METH PROG BIO, V100, P1, DOI 10.1016/j.cmpb.2010.02.002; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Divoux A, 2012, J CLIN ENDOCR METAB, V97, pE1677, DOI 10.1210/jc.2012-1532; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Gupta AK, 2009, J DIABETES COMPLICAT; Itoh M, 2007, ARTERIOSCLER THROMB; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Koenen TB, 2009, J CLIN ENDOCR METAB, V94, P4453, DOI 10.1210/jc.2009-0517; Koppaka S, 2013, DIABETES, V62, P1843, DOI 10.2337/db12-0868; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee BC, 2013, BIOCH BIOPHYS ACTA; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; McLaughlin TM, 2010, OBESITY, V18, P926, DOI 10.1038/oby.2009.380; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Mula J, 2013, J APPL PHYSIOL, V114, P148, DOI 10.1152/japplphysiol.01022.2012; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Rasouli N, 2006, AM J PHYSIOL-ENDOC M, V290, pE42, DOI 10.1152/ajpendo.00240.2005; Rasouli N, 2005, AM J PHYSIOL-ENDOC M, V288, pE930, DOI 10.1152/ajpendo.00522.2004; Rasouli N, 2006, AM J PHYSL ENDOCRINO; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rasouli N, 2007, AM J PHYSIOL-ENDOC M, V292, pE359, DOI 10.1152/ajpendo.00221.2006; Rasouli N, 2012, PHARMACOGENET GENOM, V22, P484, DOI 10.1097/FPC.0b013e328352a72e; Shadid S, 2003, DIABETES CARE, V26, P3148, DOI 10.2337/diacare.26.11.3148; Smith SR, 2006, ADIPOCYTES, V2, P11; Smolle J, 1996, ANAL QUANT CYTOL, V18, P323; Spencer M, 2013, DIABETES, V62, P1709, DOI 10.2337/db12-1042; Spencer M, 2011, J CLIN ENDOCR METAB, V96, pE1990, DOI 10.1210/jc.2011-1567; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Teranishi T, 2007, METABOLISM, V56, P1418, DOI 10.1016/j.metabol.2007.06.005; Tonelli J, 2004, DIABETES, V53, P1621, DOI 10.2337/diabetes.53.6.1621; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Unal R, 2010, J CLIN ENDOCRINOL ME; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P14, DOI 10.1016/j.bbadis.2010.12.012	51	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102190	10.1371/journal.pone.0102190	http://dx.doi.org/10.1371/journal.pone.0102190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010722	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800078
J	Wang, SM; Chen, IC; Liao, YT; Liu, CC				Wang, Shih-Min; Chen, I-Chun; Liao, Yu-Ting; Liu, Ching-Chuan			The Clinical Correlation of Regulatory T Cells and Cyclic Adenosine Monophosphate in Enterovirus 71 Infection	PLOS ONE			English	Article							SELECTIVE PHOSPHODIESTERASE INHIBITORS; 71-INDUCED PULMONARY-EDEMA; BRAIN-STEM ENCEPHALITIS; CARDIOPULMONARY BYPASS; CYTOKINE PRODUCTION; UP-REGULATION; MILRINONE; LYMPHOCYTES; CHILDREN; KEY	Background: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. Objective: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. Study Design: Patients < 18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. Results: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4(+)CD25(+)Foxp3(+) and CD4(+)Foxp3(+) T cells compared with patients with HFMD or BE. The expression frequency of CD4(-)CD8(-) was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4(+)Foxp3(+) increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. Conclusions: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.	[Wang, Shih-Min] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Emergency Med, Tainan, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ & Hosp, Coll Med, Dept Pediat, Tainan, Taiwan; [Wang, Shih-Min; Liao, Yu-Ting; Liu, Ching-Chuan] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chen, I-Chun] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Wang, SM (corresponding author), Natl Cheng Kung Univ & Hosp, Coll Med, Dept Emergency Med, Tainan, Taiwan.	pedwang@mail.ncku.edu.tw; liucc@mail.ncku.edu.tw			National Science Council, Taiwan [NSC 98-2314-B-006-002-MY3, NSC 101-2314-B-006-014-MY3]; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	This study was supported by grants from the National Science Council, Taiwan (NSC 98-2314-B-006-002-MY3, NSC 101-2314-B-006-014-MY3); and the Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Carulli G, 2004, ACTA HAEMATOL-BASEL, V111, P163, DOI 10.1159/000076526; Chi CY, 2013, CRIT CARE MED, V41, P1754, DOI 10.1097/CCM.0b013e31828a2a85; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Dekkers BGJ, 2013, PHARMACOL THERAPEUT, V137, P248, DOI 10.1016/j.pharmthera.2012.10.006; Fu Dan, 2009, Zhonghua Er Ke Za Zhi, V47, P829; Glavas NA, 2001, P NATL ACAD SCI USA, V98, P6319, DOI 10.1073/pnas.101131098; Hayashida N, 1999, ANN THORAC SURG, V68, P1661, DOI 10.1016/S0003-4975(99)00716-X; Hentschel T, 2007, ANESTHESIOLOGY, V106, P124, DOI 10.1097/00000542-200701000-00021; HOWELL RE, 1995, J PHARMACOL EXP THER, V275, P703; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; La Cava A, 2008, AUTOIMMUN REV, V8, P83, DOI 10.1016/j.autrev.2008.08.002; Lamarche Y, 2005, J THORAC CARDIOV SUR, V130, P83, DOI 10.1016/j.jtcvs.2004.09.011; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mathiot ND, 2001, AIDS RES HUM RETROV, V17, P977, DOI 10.1089/088922201750290096; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SCHMIDT J, 1995, IMMUNOPHARMACOLOGY, V30, P191, DOI 10.1016/0162-3109(95)00022-L; Shipley JB, 1996, AM J MED SCI, V311, P286, DOI 10.1097/00000441-199606000-00011; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; STROBER S, 1989, J IMMUNOL, V143, P1118; Szczypka M, 2010, PHARMACOL REP, V62, P1148, DOI 10.1016/S1734-1140(10)70377-7; Vendetti S, 2002, J IMMUNOL, V169, P6231, DOI 10.4049/jimmunol.169.11.6231; Vendetti S, 2006, J LEUKOCYTE BIOL, V80, P880, DOI 10.1189/jlb.0106072; Wang SM, 2012, EUR J CLIN MICROBIOL, V31, P1219, DOI 10.1007/s10096-011-1432-6; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2014, EXPERT REV ANTI-INFE, V12, P447, DOI 10.1586/14787210.2014.895666; Wang SM, 2005, PEDIATR PULM, V39, P219, DOI 10.1002/ppul.20157; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Yang KD, 2001, J INFECT DIS, V183, P850, DOI 10.1086/319255; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102025	10.1371/journal.pone.0102025	http://dx.doi.org/10.1371/journal.pone.0102025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010330	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800061
J	Bastos, EP; Brentani, H; Pasini, FS; Silva, ART; Torres, CH; Puga, RD; Olivieri, EHR; Piovezani, AR; Pereira, CAD; Machado-Lima, A; Carraro, DM; Brentani, MM				Bastos, Elen Pereira; Brentani, Helena; Pasini, Fatima Solange; Silva, Aderbal Ruy T.; Torres, Cesar Henrique; Puga, Renato David; Ribeiro Olivieri, Eloisa Helena; Piovezani, Amanda Rusiska; de Braganca Pereira, Carlos Alberto; Machado-Lima, Ariane; Carraro, Dirce Maria; Brentani, Maria Mitzi			MicroRNAs Discriminate Familial from Sporadic Non-BRCA1/2 Breast Carcinoma Arising in Patients <= 35 Years	PLOS ONE			English	Article							CANCER PATIENTS; MESSENGER-RNA; GENE-EXPRESSION; YOUNG; WOMEN; SURVIVAL; MUTATIONS; TARGETS; TUMORS; CELLS	The influence of genetic factors may contribute to the poor prognosis of breast cancer (BC) at a very young age. However BRCA1/2 mutations could not explain the majority of cases arising in these patients. MicroRNAs (miRs) have been implicated in biological processes associated with BC. Therefore, we investigated differences in miRs expression between tumors from young patients (<= 35 years) with sporadic or familial history and non-carriers of BRCA1/2 mutations. Thirty-six young Brazilian patients were divided into 2 groups: sporadic (NF-BC) or familial breast cancer (F-BC). Most of the samples were classified as luminal A and B and the frequency of subtypes did not differ between familial or sporadic cases. Using real time qPCR and discriminant function analysis, we identified 9 miRs whose expression levels rather than miR identity can discriminate between both patient groups. Candidate predicted targets were determined by combining results from miRWalk algorithms with mRNA expression profiles (n = 91 differently expressed genes). MiR/mRNA integrated analysis identified 91 candidate genes showing positive or negative correlation to at least 1 of the 9 miRs. Co-expression analysis of these genes with 9 miRs indicated that 49 differentially co-expressed miR-gene interactions changes in F-BC tumors as compared to those of NF-BC tumors. Out of 49, 17 (34.6%) of predicted miR-gene interactions showed an inverse correlation suggesting that miRs act as post-transcriptional regulators, whereas 14 (28.6%) miR-gene pairs tended to be co-expressed in the same direction indicating that the effects exerted by these miRs pointed to a complex level of target regulation. The remaining 18 pairs were not predicted by our criteria suggesting involvement of other regulators. MiR-mRNA co-expression analysis allowed us to identify changes in the miR-mRNA regulation that were able to distinguish tumors from familial and sporadic young BC patients non-carriers of BRCA mutations.	[Bastos, Elen Pereira; Pasini, Fatima Solange; Brentani, Maria Mitzi] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 24 24, Oncol & Radiol Dept, Sao Paulo, Brazil; [Brentani, Helena; Silva, Aderbal Ruy T.; Torres, Cesar Henrique] Univ Sao Paulo, Sch Med, Inst & Dept Psychiat, Clin Pathol Lab,Lab Med Invest LIM 23 23, Sao Paulo, Brazil; [Puga, Renato David] HIAE, Clin Res Ctr, Sao Paulo, Brazil; [Ribeiro Olivieri, Eloisa Helena; Carraro, Dirce Maria] AC Camargo Canc Ctr, Res Ctr CIPE, Lab Genom & Mol Biol, Sao Paulo, Brazil; [Piovezani, Amanda Rusiska; de Braganca Pereira, Carlos Alberto] Univ Sao Paulo, Math & Stat Inst, Sao Paulo, Brazil; [Machado-Lima, Ariane] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo	Bastos, EP (corresponding author), Univ Sao Paulo, Sch Med, Lab Med Invest LIM 24 24, Oncol & Radiol Dept, Sao Paulo, Brazil.	elenbastos@hotmail.com	Machado-Lima, Ariane/F-4245-2012; carraro, dirce/C-9179-2009; Pasini, Fatima/D-8966-2012; Pasini, Fatima Solange/AAA-2283-2019; Faria, Carolina Pereira de Morais/HHT-0142-2022; Brentani, Maria Mitzi/E-8017-2012; Brentani, Helena/G-6839-2011; Lima, Ariane Machado/O-1772-2019; Ruy T. Silva, Aderbal/K-6503-2012; Pereira, Carlos Alberto de Braganca/O-5022-2015	Machado-Lima, Ariane/0000-0002-5719-338X; carraro, dirce/0000-0001-5667-1418; Pasini, Fatima Solange/0000-0002-0361-7781; Brentani, Helena/0000-0001-5192-4682; Lima, Ariane Machado/0000-0002-5719-338X; Ruy T. Silva, Aderbal/0000-0003-1158-5617; Pereira, Carlos Alberto de Braganca/0000-0001-6315-7484	FAPESP [2009/10088-7]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by FAPESP (2009/10088-7) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CH, 2012, HUM PATHOL, V43, P40, DOI 10.1016/j.humpath.2010.03.015; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brinton LA, 2008, JNCI-J NATL CANCER I, V100, P1643, DOI 10.1093/jnci/djn344; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cancello G, 2013, BREAST, V22, P1046, DOI 10.1016/j.breast.2013.08.006; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carraro DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057581; CHU G, 2001, SAM SIGNIFICANCE ANA; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Dimitrakakis C, 2013, OBSTET GYNECOL, V121, P1235, DOI 10.1097/AOG.0b013e318291ef9a; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; El Saghir NS, 2006, BMC CANCER, V20, P6; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Fernandez-Ramires R, 2011, INT J CANCER, V128, P2635, DOI 10.1002/ijc.25603; Ferracin M, 2011, SEMIN ONCOL, V38, P764, DOI 10.1053/j.seminoncol.2011.08.005; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Garrido P, 2013, ENDOCRINOLOGY, V154, P1979, DOI 10.1210/en.2012-1558; Haffty BG, 2009, ANN ONCOL, V20, P1653, DOI 10.1093/annonc/mdp051; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Hung TC, 2013, J AM CHEM SOC, V135, P5934, DOI 10.1021/ja312210c; Kashimoto K, 2012, CANCER SCI, V103, P2021, DOI 10.1111/j.1349-7006.2012.02407.x; Keegan THM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3556; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lieblein JC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-302; Lin CH, 2011, J CLIN PATHOL, V64, P781, DOI 10.1136/jclinpath-2011-200064; Liu SL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002751; Lv Xiao-Bin, 2011, Chin J Cancer, V30, P821, DOI 10.5732/cjc.011.10289; Madaras L, 2013, PATHOL ONCOL RES, V19, P723, DOI 10.1007/s12253-013-9635-z; Estal RM, 2013, BREAST CANCER RES TR, V142, P19, DOI 10.1007/s10549-013-2723-7; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Paluch-Shimon S, 2011, AM J CLIN ONCOL-CANC, V34, P219, DOI 10.1097/COC.0b013e3181d6b500; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62; Peng RJ, 2011, BREAST, V20, P568, DOI 10.1016/j.breast.2011.07.012; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Silva ART, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048751; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tanic M, 2013, BRIT J CANCER, V109, P2724, DOI 10.1038/bjc.2013.612; Tichy JR, 2013, J NATL COMPR CANC NE, V11, P1060, DOI 10.6004/jnccn.2013.0128; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; van Miltenburg MH, 2013, ONCOGENE IN PRESS, DOI [10.1038/onc.2013.219, DOI 10.1038/ONC.2013.219]; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Wagner Kay-Uwe, 2011, J Carcinog, V10, P32, DOI 10.4103/1477-3163.90677; Wang C, 2012, J CANCER RES CLIN, V138, P2127, DOI 10.1007/s00432-012-1288-x; Yoshitaka T, 2013, J ORTHOP RES, V31, P1992, DOI 10.1002/jor.22457	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101656	10.1371/journal.pone.0101656	http://dx.doi.org/10.1371/journal.pone.0101656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006670	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600053
J	Huang, Y; Shi, JQ; Tao, ZS; Zhang, LD; Liu, Q; Wang, XF; Yang, Q; Liu, GH; Wang, HZ				Huang, Yi; Shi, Jiaqin; Tao, Zhangsheng; Zhang, Lida; Liu, Qiong; Wang, Xinfa; Yang, Qing; Liu, Guihua; Wang, Hanzhong			Microarray Expression Analysis of the Main Inflorescence in Brassica napus	PLOS ONE			English	Article							GENE-EXPRESSION; ALLELIC VARIATION; ARABIDOPSIS-THALIANA; ARCHITECTURE; RICE; DIVERSITY; PROFILES; GENOME; QTL	The effect of the number of pods on the main inflorescence (NPMI) on seed yield in Brassica napus plants grown at high density is a topic of great economic and scientific interest. Here, we sought to identify patterns of gene expression that determine the NPMI during inflorescence differentiation. We monitored gene expression profiles in the main inflorescence of two B. napus F-6 RIL pools, each composed of nine lines with a low or high NPMI, and their parental lines, Zhongshuang 11 (ZS11) and 73290, using a Brassica 90K elements oligonucleotide array. We identified 4,805 genes that were differentially expressed (>= 1.5 fold-change) between the low- and high-NPMI samples. Of these, 82.8% had been annotated and 17.2% shared no significant homology with any known genes. About 31 enriched GO clusters were identified amongst the differentially expressed genes (DEGs), including those involved in hormone responses, development regulation, carbohydrate metabolism, signal transduction, and transcription regulation. Furthermore, 92.8% of the DEGs mapped to chromosomes that originated from B. rapa and B. oleracea, and 1.6% of the DEGs co-localized with two QTL intervals (PMI10 and PMI11) known to be associated with the NPMI. Overexpression of BnTPI, which co-localized with PMI10, in Arabidopsis suggested that this gene increases the NPMI. This study provides insight into the molecular factors underlying inflorescence architecture, NPMI determination and, consequently, seed yield in B. napus.	[Huang, Yi; Shi, Jiaqin; Tao, Zhangsheng; Liu, Qiong; Wang, Xinfa; Yang, Qing; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China; [Zhang, Lida] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Liu, Qiong] Hubei Univ, Sch Life Sci & Technol, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Shanghai Jiao Tong University; Hubei University	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	wanghz@oilcrops.cn			Hubei Provincial Key Natural Science Foundation [2011CDA073]; National High-tech RD Program [2012AA101107]; National System of Modern Technology for Rapeseed Industry in China [CARS-13]; Hubei Agricultural Science and Technology Innovation Center	Hubei Provincial Key Natural Science Foundation; National High-tech RD Program; National System of Modern Technology for Rapeseed Industry in China; Hubei Agricultural Science and Technology Innovation Center	This work was financially supported by grants from the Hubei Provincial Key Natural Science Foundation (No.: 2011CDA073), National High-tech R&D Program (No.: 2012AA101107), The National System of Modern Technology for Rapeseed Industry in China (No.: CARS-13), and Hubei Agricultural Science and Technology Innovation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abied M, 2012, PLANT J, V71, P787, DOI 10.1111/j.1365-313X.2012.05032.x; Benlloch R, 2007, ANN BOT-LONDON, V100, P659, DOI 10.1093/aob/mcm146; Carlsson J, 2007, PLANT J, V49, P452, DOI 10.1111/j.1365-313X.2006.02975.x; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Harder LD, 2013, ANN BOT-LONDON, V112, P1477, DOI 10.1093/aob/mcs252; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Huang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-256; Iwata T, 2012, NEW PHYTOL, V193, P196, DOI 10.1111/j.1469-8137.2011.03892.x; Jansen L, 2013, PLANT BIOTECHNOL J, V11, P1092, DOI 10.1111/pbi.12104; Jefferson RA, 1987, EMBO J, V6, P39001; Jiang YQ, 2010, PLANT CELL REP, V29, P327, DOI 10.1007/s00299-010-0824-x; Kawamura K, 2011, THEOR APPL GENET, V122, P661, DOI 10.1007/s00122-010-1476-5; Koes R, 2008, TRENDS PLANT SCI, V13, P1, DOI 10.1016/j.tplants.2007.11.004; Koia JH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-240; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Larson SR, 2013, J HERED, V104, P678, DOI 10.1093/jhered/est033; Liu C, 2013, DEV CELL, V24, P612, DOI 10.1016/j.devcel.2013.02.013; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; MacAlister CA, 2012, NAT GENET, V44, P1393, DOI 10.1038/ng.2465; Oono Y, 2013, PLANT MOL BIOL, V83, P523, DOI 10.1007/s11103-013-0106-4; Park SJ, 2014, CURR OPIN PLANT BIOL, V17, P70, DOI 10.1016/j.pbi.2013.11.006; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Rodriguez-Suarez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019885; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sun MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047037; Teo ZWN, 2014, TRENDS PLANT SCI, V19, P158, DOI 10.1016/j.tplants.2013.11.001; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Yan F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-58; Zhu YN, 2012, THEOR APPL GENET, V124, P515, DOI 10.1007/s00122-011-1725-2; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	37	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102024	10.1371/journal.pone.0102024	http://dx.doi.org/10.1371/journal.pone.0102024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007212	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600087
J	Klailova, M; Lee, PC				Klailova, Michelle; Lee, Phyllis C.			Wild Western Lowland Gorillas Signal Selectively Using Odor	PLOS ONE			English	Article							OLFACTORY DISCRIMINATION; REPRODUCTIVE SUCCESS; SCENT-MARKING; BODY ODOR; BEHAVIOR; SKIN; TESTOSTERONE; STRATEGIES; QUALITY; GLAND	Mammals communicate socially through visual, auditory and chemical signals. The chemical sense is the oldest sense and is shared by all organisms including bacteria. Despite mounting evidence for social chemo-signaling in humans, the extent to which it modulates behavior is debated and can benefit from comparative models of closely related hominoids. The use of odor cues in wild ape social communication has been only rarely explored. Apart from one study on wild chimpanzee sniffing, our understanding is limited to anecdotes. We present the first study of wild gorilla chemo-communication and the first analysis of olfactory signaling in relation to arousal levels and odor strength in wild apes. If gorilla scent is used as a signaling mechanism instead of only a sign of arousal or stress, odor emission should be context specific and capable of variation as a function of the relationships between the emitter and perceiver(s). Measured through a human pungency scale, we determined the factors that predicted extreme levels of silverback odor for one wild western lowland gorilla (Gorilla gorilla gorilla) group silverback. Extreme silverback odor was predicted by the presence and intensity of inter-unit interactions, silverback anger, distress and long-calling auditory rates, and the absence of close proximity between the silverback and mother of the youngest infant. Odor strength also varied according to the focal silverback's strategic responses during high intensity inter-unit interactions. Silverbacks appear to use odor as a modifiable form of communication; where odor acts as a highly flexible, context dependent signaling mechanism to group members and extragroup units. The importance of olfaction to ape social communication may be especially pertinent in Central African forests where limited visibility may necessitate increased reliance on other senses.	[Klailova, Michelle; Lee, Phyllis C.] Univ Stirling, Sch Nat Sci, Evolut & Res Grp, Div Psychol, Stirling FK9 4LA, Scotland; [Klailova, Michelle] Univ Lisbon, Inst Super Ciencias Sociais Polit, Ctr Adm Polit Publ, Dept Antropol, P-1699 Lisbon, Portugal; [Klailova, Michelle] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	University of Stirling; Universidade de Lisboa; University of Oxford	Klailova, M (corresponding author), Univ Stirling, Sch Nat Sci, Evolut & Res Grp, Div Psychol, Stirling FK9 4LA, Scotland.	mk29@stir.ac.uk		Lee, Phyllis/0000-0002-4296-3513	Fundacao Para a Ciencia e Tecnologia, Bolsa de Pos-Doutoramento, Portugal; Division of Psychology, Behaviour and Evolution Research Group, School of Natural Sciences, University of Stirling, Stirling; Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, UK; Toronto Zoo, Canada; Panton Trust, UK	Fundacao Para a Ciencia e Tecnologia, Bolsa de Pos-Doutoramento, Portugal; Division of Psychology, Behaviour and Evolution Research Group, School of Natural Sciences, University of Stirling, Stirling; Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, UK; Toronto Zoo, Canada; Panton Trust, UK	This work received funding from Fundacao Para a Ciencia e Tecnologia, Bolsa de Pos-Doutoramento, Portugal (http://www.fct.pt); Division of Psychology, Behaviour and Evolution Research Group, School of Natural Sciences, University of Stirling, Stirling (http://www.stir.ac.uk); Wildlife Conservation Research Unit, Department of Zoology, University of Oxford, UK (http://www.wildcru.org); The Toronto Zoo, Canada (http://www.torontozoo.com); and The Panton Trust, UK (http://opencharities.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; Adolph D, 2010, PHYSIOL BEHAV, V101, P666, DOI 10.1016/j.physbeh.2010.08.004; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2007, BBC NEWS GORILLA NOV; Blackman TM, 1947, AM J PHYS ANTHROP-NE, V5, P283, DOI 10.1002/ajpa.1330050303; Breuer T, 2012, J HUM EVOL, V62, P466, DOI 10.1016/j.jhevol.2012.01.006; Caillaud D, 2008, AM J PHYS ANTHROPOL, V135, P379, DOI 10.1002/ajpa.20754; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; Cousins D, 1990, MAGNIFICIENT GORILLA; DIXSON A. F., 1981, NATURAL HIST GORILLA; DONISTHORPE J. H., 1958, S AFRICAN JOUR SCI, V54, P195; DORAN DM, 2001, MOUNTAIN GORILLAS 3, P123, DOI DOI 10.1017/CBO9780511661631.006; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; ELLIS RA, 1962, AM J PHYS ANTHROPOL, V20, P79, DOI 10.1002/ajpa.1330200210; Elsenberg J.F., 1972, Annual Rev Ecol Syst, V3, P1; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; FOSSEY D, 1983, GORILLAS MIST; GILBERT AN, 1986, J COMP PSYCHOL, V100, P262, DOI 10.1037/0735-7036.100.3.262; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Grammer K, 2005, EUR J OBSTET GYN R B, V118, P135, DOI 10.1016/j.ejogrb.2004.08.010; HARCOURT AH, 2001, MOUNTAIN GORILLAS 3, P241; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Hedwig D, 2014, BEHAVIOUR, V151, P1091, DOI 10.1163/1568539X-00003175; Hepper P, 2008, CHEM SIGNAL, V11, P103, DOI 10.1007/978-0-387-73945-8_9; Hepper PG, 2012, PRIMATES, V53, P121, DOI 10.1007/s10329-011-0291-1; Hepper PG, 2010, CHEM SENSES, V35, P263, DOI 10.1093/chemse/bjq015; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; Jeffery KJ, 2007, INTEGR ZOOL, V2, P111, DOI 10.1111/j.1749-4877.2007.00050.x; KING JE, 1974, J HUM EVOL, V3, P435, DOI 10.1016/0047-2484(74)90003-7; Klailova M, 2011, THESIS U STIRLING SC; Laska M, 2005, CHEM SENSES, V30, P505, DOI 10.1093/chemse/bji043; Macfie EJ, 2010, BEST PRACTICE GUIDEL; Matsumoto-Oda A, 2007, PRIMATES, V48, P81, DOI 10.1007/s10329-006-0006-1; MONTAGNA W, 1963, AM J PHYS ANTHROPOL, V21, P189, DOI 10.1002/ajpa.1330210211; MOORE AJ, 1995, ANIM BEHAV, V50, P191, DOI 10.1006/anbe.1995.0231; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; MULLERSCHWARZE D, 1984, J CHEM ECOL, V10, P1707, DOI 10.1007/BF00987357; Murray AK, 2013, THESIS U LIVERPOOL E; Oeda R, 2002, ANTHROPOL SCI, V110, P140; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Parnell RJ, 2002, AM J PRIMATOL, V56, P193, DOI 10.1002/ajp.1074; Parnell RJ, 2001, NATURE, V412, P294, DOI 10.1038/35085631; Rijksen HD, 1978, THESIS NETHERLANDS; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Robbins MM, 1997, AM J PRIMATOL, V43, P51, DOI 10.1002/(SICI)1098-2345(1997)43:1<51::AID-AJP4>3.0.CO;2-X; Roberts SC, 2011, ARCH SEX BEHAV, V40, P1111, DOI 10.1007/s10508-011-9803-8; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Salvador A, 2005, NEUROSCI BIOBEHAV R, V29, P195, DOI 10.1016/j.neubiorev.2004.07.004; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; Saxton TK, 2008, CHEM SIGNAL, V11, P111, DOI 10.1007/978-0-387-73945-8_10; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Setchell JM, 2010, BIOESSAYS, V32, P940, DOI 10.1002/bies.201000066; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Stephan H, 1970, THE PRIMATE BRAIN, P289; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Struthers EJ, 1996, MAD WISC 16 C INT PR, P762; Wells DL, 2007, APPL ANIM BEHAV SCI, V106, P155, DOI 10.1016/j.applanim.2006.07.010; Williams RJP, 1981, P R SOC LONDON, V213, P361; Wyatt T, 2003, PHEROMONES ANIMAL BE, P408; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x; [No title captured]	66	18	18	35	370	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99554	10.1371/journal.pone.0099554	http://dx.doi.org/10.1371/journal.pone.0099554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006973	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600007
J	Natsuka, S; Masuda, M; Sumiyoshi, W; Nakakita, S				Natsuka, Shunji; Masuda, Mayumi; Sumiyoshi, Wataru; Nakakita, Shin-ichi			Improved Method for Drawing of a Glycan Map, and the First Page of Glycan Atlas, Which Is a Compilation of Glycan Maps for a Whole Organism	PLOS ONE			English	Article							N-LINKED GLYCANS; PERFORMANCE LIQUID-CHROMATOGRAPHY; SUGAR CHAINS; STRUCTURAL-ANALYSIS; OLIGOSACCHARIDES; IDENTIFICATION; GLYCOPROTEINS; IGM	Glycan Atlas is a set of glycan maps over the whole body of an organism. The glycan map that includes data of glycan structure and quantity displays micro-heterogeneity of the glycans in a tissue, an organ, or cells. The two-dimensional glycan mapping is widely used for structure analysis of N-linked oligosaccharides on glycoproteins. In this study we developed a comprehensive method for the mapping of both N- and O-glycans with and without sialic acid. The mapping data of 150 standard pyridylaminated glycans were collected. The empirical additivity rule which was proposed in former reports was able to adapt for this extended glycan map. The adapted rule is that the elution time of pyridylamino glycans on high performance liquid chromatography (HPLC) is expected to be the simple sum of the partial elution times assigned to each monosaccharide residue. The comprehensive mapping method developed in this study is a powerful tool for describing the micro-heterogeneity of the glycans. Furthermore, we prepared 42 pyridylamino (PA-) glycans from human serum and were able to draw the map of human serum N- and O-glycans as an initial step of Glycan Atlas editing.	[Natsuka, Shunji; Masuda, Mayumi] Niigata Univ, Fac Sci, Dept Biol, Niigata 95021, Japan; [Sumiyoshi, Wataru; Nakakita, Shin-ichi] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan	Niigata University; Kagawa University	Natsuka, S (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Niigata 95021, Japan.	natsuka@bio.sc.niigata-u.ac.jp	Natsuka, Shunji/L-9330-2018	Natsuka, Shunji/0000-0003-1726-8946	Mizutani Foundation for Glycosciences	Mizutani Foundation for Glycosciences	This work was supported by the Mizutani Foundation for Glycosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAPMAN A, 1979, J BIOL CHEM, V254, P816; CUMMING DA, 1987, BIOCHEMISTRY-US, V26, P6655, DOI 10.1021/bi00395a015; HASE S, 1987, ANAL BIOCHEM, V167, P321, DOI 10.1016/0003-2697(87)90171-0; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; HASE S, 1990, ANAL BIOCHEM, V184, P135, DOI 10.1016/0003-2697(90)90025-5; HASE S, 1985, J BIOCHEM-TOKYO, V98, P863, DOI 10.1093/oxfordjournals.jbchem.a135366; HASE S, 1982, J BIOCHEM-TOKYO, V91, P735, DOI 10.1093/oxfordjournals.jbchem.a133748; Kuraya N, 1996, ANAL BIOCHEM, V233, P205, DOI 10.1006/abio.1996.0029; LEE YC, 1990, ANAL BIOCHEM, V188, P259, DOI 10.1016/0003-2697(90)90603-7; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; Natsuka S, 1998, METH MOL B, V76, P101; Natsuka S, 2006, J BIOCHEM, V140, P87, DOI 10.1093/jb/mvj131; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; SHIBUYA N, 1988, ARCH BIOCHEM BIOPHYS, V267, P676, DOI 10.1016/0003-9861(88)90076-8; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; YAMAMOTO S, 1989, J BIOCHEM-TOKYO, V105, P547, DOI 10.1093/oxfordjournals.jbchem.a122703; Yanagida K, 1998, J CHROMATOGR A, V800, P187, DOI 10.1016/S0021-9673(97)01109-6	18	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102219	10.1371/journal.pone.0102219	http://dx.doi.org/10.1371/journal.pone.0102219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006806	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600106
J	Onoa, B; Schneider, AR; Brooks, MD; Grob, P; Nogales, E; Geissler, PL; Niyogi, KK; Bustamante, C				Onoa, Bibiana; Schneider, Anna R.; Brooks, Matthew D.; Grob, Patricia; Nogales, Eva; Geissler, Phillip L.; Niyogi, Krishna K.; Bustamante, Carlos			Atomic Force Microscopy of Photosystem II and Its Unit Cell Clustering Quantitatively Delineate the Mesoscale Variability in Arabidopsis Thylakoids	PLOS ONE			English	Article							GRANA MEMBRANES; SUPRAMOLECULAR ORGANIZATION; MACRO-ORGANIZATION; PROTEINS; MACROSTRUCTURE; ACCLIMATION; ARRANGEMENT; COMPLEXES; SOFTWARE; SPINACH	Photoautotrophic organisms efficiently regulate absorption of light energy to sustain photochemistry while promoting photoprotection. Photoprotection is achieved in part by triggering a series of dissipative processes termed non-photochemical quenching (NPQ), which depend on the re-organization of photosystem (PS) II supercomplexes in thylakoid membranes. Using atomic force microscopy, we characterized the structural attributes of grana thylakoids from Arabidopsis thaliana to correlate differences in PSII organization with the role of SOQ1, a recently discovered thylakoid protein that prevents formation of a slowly reversible NPQ state. We developed a statistical image analysis suite to discriminate disordered from crystalline particles and classify crystalline arrays according to their unit cell properties. Through detailed analysis of the local organization of PSII supercomplexes in ordered and disordered phases, we found evidence that interactions among light-harvesting antenna complexes are weakened in the absence of SOQ1, inducing protein rearrangements that favor larger separations between PSII complexes in the majority (disordered) phase and reshaping the PSII crystallization landscape. The features we observe are distinct from known protein rearrangements associated with NPQ, providing further support for a role of SOQ1 in a novel NPQ pathway. The particle clustering and unit cell methodology developed here is generalizable to multiple types of microscopy and will enable unbiased analysis and comparison of large data sets.	[Onoa, Bibiana; Nogales, Eva; Geissler, Phillip L.; Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Schneider, Anna R.; Geissler, Phillip L.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Brooks, Matthew D.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Brooks, Matthew D.; Grob, Patricia; Nogales, Eva; Niyogi, Krishna K.; Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Brooks, Matthew D.; Geissler, Phillip L.; Niyogi, Krishna K.; Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Nogales, Eva; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Geissler, Phillip L.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	carlosb@berkeley.edu		Grob, Patricia/0000-0002-8330-8961; Bustamante, Carlos/0000-0002-2970-0073; Brooks, Matthew D./0000-0002-6081-6103	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, US Department of Energy; National Science Foundation Graduate Research Fellowship; Howard Hughes Medical; Institute and the Gordon and Betty Moore Foundation [GBMF3070]; National Science Foundation [MCB-1158555, CHE-7178966]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Howard Hughes Medical(Howard Hughes Medical Institute); Institute and the Gordon and Betty Moore Foundation; National Science Foundation(National Science Foundation (NSF))	BO MDB KKN CB EN and PLG were supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, Office of Science, US Department of Energy (Field work proposal SISGRKN). ARS was supported by National Science Foundation Graduate Research Fellowship. KKN CB EN PG were supported by Howard Hughes Medical. KKN was supported by the Institute and the Gordon and Betty Moore Foundation Grant GBMF3070. PLG was supported by National Science Foundation grants No. MCB-1158555 and CHE-7178966 "Functional Significance of Ultrastructural Changes in Photosynthesis Membranes for the Repair of Damaged Photosystem II". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Brooks MD, 2013, P NATL ACAD SCI USA, V110, pE2733, DOI 10.1073/pnas.1305443110; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Hankamer B, 2005, ADV PHOTO RESPIRAT, V22, P403; Hastie T., 2009, UNSUPERVISED LEARNIN; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; Keys AS, 2011, J COMPUT PHYS, V230, P6438, DOI 10.1016/j.jcp.2011.04.017; Keys AS, 2011, ANNU REV CONDEN MA P, V2, P263, DOI 10.1146/annurev-conmatphys-062910-140526; Kirchhoff H, 2004, BIOCHEMISTRY-US, V43, P9204, DOI 10.1021/bi0494626; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Morosinotto T, 2010, J BIOENERG BIOMEMBR, V42, P37, DOI 10.1007/s10863-009-9261-3; Muh F, 2012, BBA-BIOENERGETICS, V1817, P1446, DOI 10.1016/j.bbabio.2012.02.016; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; POWELL MJD, 1993, MATH APPL, V275, P51; Ruban AV, 2003, NATURE, V421, P648, DOI 10.1038/nature01344; Schneider AR, 2013, BIOPHYS J, V105, P1161, DOI 10.1016/j.bpj.2013.06.052; Schneider AR, 2013, ZENODO, DOI [10.5281/zenodo.10533, DOI 10.5281/ZENODO.10533]; SEMENOVA GA, 1995, CAN J BOT, V73, P1676, DOI 10.1139/b95-181; Sznee K, 2011, J BIOL CHEM, V286, P39164, DOI 10.1074/jbc.M111.284844; Tax DMJ, 2008, PATTERN RECOGN LETT, V29, P1565, DOI 10.1016/j.patrec.2008.03.010; van Oort B, 2011, PHYS CHEM CHEM PHYS, V13, P12614, DOI 10.1039/c1cp20331b; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	42	20	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101470	10.1371/journal.pone.0101470	http://dx.doi.org/10.1371/journal.pone.0101470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007326	gold, Green Published			2022-12-25	WOS:000339040600038
J	Palusinska-Szysz, M; Kania, M; Turska-Szewczuk, A; Danikiewicz, W; Russa, R; Fuchs, B				Palusinska-Szysz, Marta; Kania, Magdalena; Turska-Szewczuk, Anna; Danikiewicz, Witold; Russa, Ryszard; Fuchs, Beate			Identification of Unusual Phospholipid Fatty Acyl Compositions of Acanthamoeba castellanii	PLOS ONE			English	Article							P-31 NMR-SPECTROSCOPY; BIOLOGY; LIPIDS; BIOSYNTHESIS; PATHOGENESIS; SPP.	Acanthamoeba are opportunistic protozoan pathogens that may lead to sight-threatening keratitis and fatal granulomatous encephalitis. The successful prognosis requires early diagnosis and differentiation of pathogenic Acanthamoeba followed by aggressive treatment regimen. The plasma membrane of Acanthamoeba consists of 25% phospholipids (PL). The presence of C20 and, recently reported, 28- and 30-carbon fatty acyl residues is characteristic of amoeba PL. A detailed knowledge about this unusual PL composition could help to differentiate Acanthamoeba from other parasites, e.g. bacteria and develop more efficient treatment strategies. Therefore, the detailed PL composition of Acanthamoeba castellanii was investigated by P-31 nuclear magnetic resonance spectroscopy, thin-layer chromatography, gas chromatography, high performance liquid chromatography and liquid chromatography-mass spectrometry. Normal and reversed phase liquid chromatography coupled with mass spectrometric detection was used for detailed characterization of the fatty acyl composition of each detected PL. The most abundant fatty acyl residues in each PL class were octadecanoyl (18:0), octadecenoyl (18:1 Delta 9) and hexadecanoyl (16:0). However, some selected PLs contained also very long fatty acyl chains: the presence of 28- and 30-carbon fatty acyl residues was confirmed in phosphatidylethanolamine (PE), phosphatidylserine, phosphatidic acid and cardiolipin. The majority of these fatty acyl residues were also identified in PE that resulted in the following composition: 28:1/20:2, 30:2/18:1, 28:0/20:2, 30:2/20:4 and 30:3/20:3. The PL of amoebae are significantly different in comparison to other cells: we describe here for the first time unusual, very long chain fatty acids with Delta(5)-unsaturation (30:3(5,21,24)) and 30:2(21,24) localized exclusively in specific phospholipid classes of A. castellanii protozoa that could serve as specific biomarkers for the presence of these microorganisms.	[Palusinska-Szysz, Marta; Turska-Szewczuk, Anna; Russa, Ryszard] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Lublin, Poland; [Kania, Magdalena; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem, Mass Spectrometry Grp, Warsaw, Poland; [Fuchs, Beate] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany	Maria Curie-Sklodowska University; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Leipzig University	Fuchs, B (corresponding author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04109 Leipzig, Germany.	Beate.Fuchs@medizin.uni-leipzig.de	Danikiewicz, Witold/H-2257-2016	Danikiewicz, Witold/0000-0003-0484-2689; Palusinska-Szysz, Marta/0000-0001-8540-3084; Turska-Szewczuk, Anna/0000-0002-2975-9593	Deutsche Forschungsgemeinschaft (German Research Council) DFG [FU 771/1-2]	Deutsche Forschungsgemeinschaft (German Research Council) DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (German Research Council) DFG: FU 771/1-2 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAND RN, 1959, J GEN MICROBIOL, V21, P80, DOI 10.1099/00221287-21-1-80; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOCHNER BR, 1981, ANAL BIOCHEM, V117, P81, DOI 10.1016/0003-2697(81)90695-3; Brindley N, 2009, EXP PARASITOL, V121, P254, DOI 10.1016/j.exppara.2008.11.009; Croft SL, 2003, MOL BIOCHEM PARASIT, V126, P165, DOI 10.1016/S0166-6851(02)00283-9; Fuchs B, 2012, MINI-REV MED CHEM, V12, P74, DOI 10.2174/138955712798868931; Fuchs B, 2007, CHEM PHYS LIPIDS, V150, P229, DOI 10.1016/j.chemphyslip.2007.08.005; Kates M, 1986, TECHNIQUES LIPIDOLOG, P232; Khan NA, 2001, CURR MICROBIOL, V43, P391, DOI 10.1007/s002840010325; Khan NA, 2006, FEMS MICROBIOL REV, V30, P564, DOI 10.1111/j.1574-6976.2006.00023.x; KORN ED, 1964, J BIOL CHEM, V239, P396; KUNSMAN JE, 1970, J BACTERIOL, V103, P104, DOI 10.1128/JB.103.1.104-110.1970; Lam SM, 2013, J GENET GENOMICS, V40, P375, DOI 10.1016/j.jgg.2013.06.007; Larsen A, 2005, MODERN METHODS LIPID; LITCHFIELD C, 1980, LIPIDS, V15, P200, DOI 10.1007/BF02540971; LONDON E, 1979, J LIPID RES, V20, P408; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; McBride J, 2007, J ANTIMICROB CHEMOTH, V60, P521, DOI 10.1093/jac/dkm245; Palusinska-Szysz M, 2009, ACTA PROTOZOOL, V48, P63; Pearce JM, 2000, MAGN RESON MED, V44, P215, DOI 10.1002/1522-2594(200008)44:2<215::AID-MRM8>3.0.CO;2-N; Rod'kina SA, 2005, RUSS J MAR BIOL, V31, P49; Sayanova O, 2006, J BIOL CHEM, V281, P36533, DOI 10.1074/jbc.M605158200; Schiller J, 2004, PROG LIPID RES, V43, P449, DOI 10.1016/j.plipres.2004.08.001; SCHILLER J, 2002, MED SCI MONITOR, V8, P205; Schiller J, 2000, ENCY ANAL CHEM, P559; Schiller J, 2007, CURR ANAL CHEM, V3, P283, DOI 10.2174/157341107782109635; Schiller J, 2007, FRONT BIOSCI-LANDMRK, V12, P2568, DOI 10.2741/2255; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-112; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; SMITH JD, 1993, PROG LIPID RES, V32, P47, DOI 10.1016/0163-7827(93)90004-G; ULSAMER AG, 1969, J CELL BIOL, V43, P105, DOI 10.1083/jcb.43.1.105; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Xu GY, 1996, MICROCHEM J, V53, P29, DOI 10.1006/mchj.1996.0005	33	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e01243	10.1371/journal.pone.0101243	http://dx.doi.org/10.1371/journal.pone.0101243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007336	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600031
J	Li, QG; Zhuo, CH; Cai, GX; Zheng, HT; Li, DW; Cai, SJ				Li, Qingguo; Zhuo, Changhua; Cai, Guoxiang; Zheng, Hongtu; Li, Dawei; Cai, SanJun			Pathological Features and Survival Outcomes of Young Patients with Operable Colon Cancer: Are They Homogeneous?	PLOS ONE			English	Article							COLORECTAL-CANCER; OLDER PATIENTS; ADULTS; ADENOCARCINOMA; PROGNOSIS; AGE; ADOLESCENTS; CARCINOMA; DIAGNOSIS; RATES	Objective: To compare the pathological features and survival outcomes at different age subgroups of young patients with colon cancer. Methods: Using Surveillance, Epidemiology, and End Results (SEER) population-based data, we identified 2,861 young patients with colon cancer diagnosed between 1988 and 2005 treated with surgery. Patients were divided into four groups: group 1 (below 25 years), group 2 (26-30 years), group 3 (31-35 years) and group 4 (36-40 years). Five-year cancer specific survival data were obtained. Kaplan-Meier methods were adopted and multivariable Cox regression models were built for the analysis of long-term survival outcomes and risk factors. Results: There were significant different among four groups in pathological grading, histological type, AJCC stage, current standard (>= 12 lymph nodes retrieval), mean number of lymph nodes examined and positive lymph nodes (p<0.001). The 5-year cause specific survival was 71.0% in group 1, 75.1% in group 2, 80.6% in group 3 and 82.5% in group 4, which had significant difference in both univariate (P = 0.002) and multivariate analysis (P = 0.041). Conclusions: Young patients with colon cancer at age 18-40 years are essentially a heterogeneous group. Patients at age 31-35, 36-40 subgroups have more favorable clinicopathologic characteristics and better cancer specific survival than below 30 years.	[Li, Qingguo; Zhuo, Changhua; Cai, Guoxiang; Zheng, Hongtu; Li, Dawei; Cai, SanJun] Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Li, Qingguo; Zhuo, Changhua; Cai, Guoxiang; Zheng, Hongtu; Li, Dawei; Cai, SanJun] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Li, DW (corresponding author), Fudan Univ, Dept Colorectal Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	18918298120@163.com; caisanjun_sh@163.com	ZHUO, CHANGHUA/H-7592-2012	ZHUO, CHANGHUA/0000-0002-5900-9048	National Natural Science Foundation of China [81001055, 81101586]; Shanghai Pujiang Program [13PJD008]; National High Technology Research and Development Program (863 Program) [2012AA02A506]; Shanghai Shenkang Program [SHDC12012120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Shenkang Program	This study was supported by grants from the National Natural Science Foundation of China (No. 81001055; 81101586), Shanghai Pujiang Program (No. 13PJD008), National High Technology Research and Development Program (863 Program, No. 2012AA02A506) and Shanghai Shenkang Program (No. SHDC12012120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Ben-Ishay O, 2013, ISR MED ASSOC J, V15, P284; Cusack JC, 1996, J AM COLL SURGEONS, V183, P105; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035021; Golan T, 2013, CANCER-AM CANCER SOC, V119, P3084, DOI 10.1002/cncr.28143; Gondos A, 2013, INT J CANCER, V133, P2207, DOI 10.1002/ijc.28231; Kam M H, 2004, Colorectal Dis, V6, P191, DOI 10.1111/j.1463-1318.2004.00596.x; Kaplan MA, 2013, J PEDIAT HEMATOL ONC, V35, P83, DOI 10.1097/MPH.0b013e31827e7f20; Karsten B, 2008, AM SURGEON, V74, P973; Li M, 2011, J SURG RES, V167, P231, DOI 10.1016/j.jss.2010.10.040; Li Q, 2014, PLOS ONE, V9; MARBLE K, 1992, J SURG ONCOL, V51, P179, DOI 10.1002/jso.2930510311; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Neufeld D, 2009, TECH COLOPROCTOL, V13, P201, DOI 10.1007/s10151-009-0501-7; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2003, AM SURGEON, V69, P866; Schellerer VS, 2012, INT J COLORECTAL DIS, V27, P71, DOI 10.1007/s00384-011-1291-8; TAYLOR MC, 1988, CAN J SURG, V31, P150; You YN, 2012, ARCH INTERN MED, V172, P287, DOI 10.1001/archinternmed.2011.602	20	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102004	10.1371/journal.pone.0102004	http://dx.doi.org/10.1371/journal.pone.0102004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003760	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700098
J	Panda, AC; Sahu, I; Kulkarni, SD; Martindale, JL; Abdelmohsen, K; Vindu, A; Joseph, J; Gorospe, M; Seshadri, V				Panda, Amaresh C.; Sahu, Itishri; Kulkarni, Shardul D.; Martindale, Jennifer L.; Abdelmohsen, Kotb; Vindu, Arya; Joseph, Jomon; Gorospe, Myriam; Seshadri, Vasudevan			miR-196b-Mediated Translation Regulation of Mouse Insulin2 via the 5 ' UTR	PLOS ONE			English	Article							MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; MICRORNA EXPRESSION; GLUCOSE; REPRESSION; RESISTANCE; PANCREAS; ISLETS; GENES; HUR	The 5' and the 3' untranslated regions (UTR) of the insulin genes are very well conserved across species. Although microRNAs (miRNAs) are known to regulate insulin secretion process, direct regulation of insulin biosynthesis by miRNA has not been reported. Here, we show that mouse microRNA miR-196b can specifically target the 5'UTR of the long insulin2 splice isoform. Using reporter assays we show that miR-196b specifically increases the translation of the reporter protein luciferase. We further show that this translation activation is abolished when Argonaute 2 levels are knocked down after transfection with an Argonaute 2-directed siRNA. Binding of miR-196b to the target sequence in insulin 5'UTR causes the removal of HuD (a 5'UTR-associated translation inhibitor), suggesting that both miR-196b and HuD bind to the same RNA element. We present data suggesting that the RNA-binding protein HuD, which represses insulin translation, is displaced by miR-196b. Together, our findings identify a mechanism of post-transcriptional regulation of insulin biosynthesis.	[Panda, Amaresh C.; Sahu, Itishri; Kulkarni, Shardul D.; Vindu, Arya; Joseph, Jomon; Seshadri, Vasudevan] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Panda, Amaresh C.; Martindale, Jennifer L.; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Seshadri, V (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	seshadriv@nccs.res.in	Joseph, Jomon/C-1397-2009; Martindale, Jennifer Luethy/AAD-1963-2022; Kulkarni, S/AAO-8388-2020; Vindu, Arya/GQP-2981-2022; Abdelmohsen, Kotb/AAX-4191-2020; Kulkarni, Shardul/AAD-2205-2020; Panda, Amaresh C./H-5459-2019	Martindale, Jennifer Luethy/0000-0002-3234-6861; Abdelmohsen, Kotb/0000-0001-6240-5810; Kulkarni, Shardul/0000-0003-3814-4432; Panda, Amaresh C./0000-0003-3189-8995; Joseph, Jomon/0000-0002-3042-6286; Sahu, Itishri/0000-0002-6069-656X; Vindu, Arya/0000-0001-8711-2037	Department of Biotechnology, India [BT/PR14109/BRB/10/812/2010]; intramural grant from National Centre for Cell Science, India; Council for scientific and industrial research, India; National Institute on Aging - Intramural Research Program, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000394] Funding Source: NIH RePORTER	Department of Biotechnology, India(Department of Biotechnology (DBT) India); intramural grant from National Centre for Cell Science, India; Council for scientific and industrial research, India(Council of Scientific & Industrial Research (CSIR) - India); National Institute on Aging - Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant (BT/PR14109/BRB/10/812/2010) from Department of Biotechnology, India, and intramural grant from National Centre for Cell Science, India, to VS. AV and SDK are supported by a fellowship from Council for scientific and industrial research, India. KA, JLM, and MG were supported by the National Institute on Aging - Intramural Research Program, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P472, DOI 10.1093/abbs/gmp035; ITOH N, 1978, FEBS LETT, V93, P343, DOI 10.1016/0014-5793(78)81136-3; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ling HY, 2009, CLIN EXP PHARM PHYSL; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Minn AH, 2005, MOL ENDOCRINOL, V19, P794, DOI 10.1210/me.2004-0119; Muralidharan B, 2007, FEBS LETT, V581, P4103, DOI 10.1016/j.febslet.2007.07.050; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Panda AC, 2013, INT J MOL SCI, V14, P19202, DOI 10.3390/ijms140919202; Panda AC, 2010, FEBS LETT, V584, P1169, DOI 10.1016/j.febslet.2010.02.020; Phua SLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025689; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WESSELLS NK, 1968, DEV BIOL, V17, P413, DOI 10.1016/0012-1606(68)90073-0; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7	32	25	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101084	10.1371/journal.pone.0101084	http://dx.doi.org/10.1371/journal.pone.0101084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003985	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700018
J	Santalla, M; Valverde, CA; Harnichar, E; Lacunza, E; Aguilar-Fuentes, J; Mattiazzi, A; Ferrero, P				Santalla, Manuela; Valverde, Carlos A.; Harnichar, Ezequiel; Lacunza, Ezequiel; Aguilar-Fuentes, Javier; Mattiazzi, Alicia; Ferrero, Paola			Aging and CaMKII Alter Intracellular Ca2+ Transients and Heart Rhythm in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN-KINASE-II; CARDIAC-HYPERTROPHY; RYANODINE RECEPTOR; PHOSPHORYLATION; AGE; ARRHYTHMIAS; INHIBITION; MUTATIONS; LOAD	Aging is associated to disrupted contractility and rhythmicity, among other cardiovascular alterations. Drosophila melanogaster shows a pattern of aging similar to human beings and recapitulates the arrhythmogenic conditions found in the human heart. Moreover, the kinase CaMKII has been characterized as an important regulator of heart function and an arrhythmogenic molecule that participate in Ca2+ handling. Using a genetically engineered expressed Ca2+ indicator, we report changes in cardiac Ca2+ handling at two different ages. Aging prolonged relaxation, reduced spontaneous heart rate (HR) and increased the occurrence of arrhythmias, ectopic beats and asystoles. Alignment between Drosophila melanogaster and human CaMKII showed a high degree of conservation and indicates that relevant phosphorylation sites in humans are also present in the fruit fly. Inhibition of CaMKII by KN-93 (CaMKII-specific inhibitor), reduced HR without significant changes in other parameters. By contrast, overexpression of CaMKII increased HR and reduced arrhythmias. Moreover, it increased fluorescence amplitude, maximal rate of rise of fluorescence and reduced time to peak fluorescence. These results suggest that CaMKII in Drosophila melanogaster acts directly on heart function and that increasing CaMKII expression levels could be beneficial to improve contractility.	[Santalla, Manuela; Valverde, Carlos A.; Harnichar, Ezequiel; Mattiazzi, Alicia; Ferrero, Paola] Univ Nacl La Plata, Fac Med, CONICET La Plata, Ctr Invest Cardiovasc, La Plata, Buenos Aires, Argentina; [Santalla, Manuela; Ferrero, Paola] Univ Nacl Noroeste Buenos Aires, Dept Ciencias Basicas & Expt, Buenos Aires, DF, Argentina; [Lacunza, Ezequiel] Univ Nacl La Plata, Ctr Invest Inmunol Basicas & Aplicadas, CONICET La Plata, Fac Med, La Plata, Buenos Aires, Argentina; [Aguilar-Fuentes, Javier] Univ Autonoma Chiapas, Ctr Mesoamer Estudios Salud Publ & Desastres, Lab Epigenet Neurodesarrollo & Neurobiol Mol, Tapachula, Chiapas, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Universidad Autonoma de Chiapas	Ferrero, P (corresponding author), Univ Nacl La Plata, Fac Med, CONICET La Plata, Ctr Invest Cardiovasc, La Plata, Buenos Aires, Argentina.	pferrero@unnoba.edu.ar	Mattiazzi, Alicia/L-1512-2019	Mattiazzi, Alicia/0000-0002-5166-5606; Ferrero, Paola/0000-0002-5582-642X; Harnichar, Alejandro Ezequiel/0000-0002-1308-9097; Santalla, Manuela/0000-0002-3590-9586	UNNOBA (SIB); CONICET [PIP-2010-00318]; PIP [2139]; MinCyT [PICT 1903]	UNNOBA (SIB); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); PIP; MinCyT	This work was supported by grants of UNNOBA (SIB 2013) and CONICET (PIP-2010-00318) to PF and PIP 2139 and MinCyT, PICT 1903, to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Anderson ME, 2009, J CLIN INVEST, V119, P1082, DOI 10.1172/JCI39262; Ashpole NM, 2012, J BIOL CHEM, V287, P19856, DOI 10.1074/jbc.M111.322537; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bodmer R., 2004, BIOTECHNIQUES, DOI [10.2144/04371st01, DOI 10.2144/04371ST01]; Cain BS, 1998, J AM COLL CARDIOL, V32, P458, DOI 10.1016/S0735-1097(98)00233-2; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; CHO KO, 1991, NEURON, V7, P439, DOI 10.1016/0896-6273(91)90296-C; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Desai-Shah M., 2010, OPEN PHYSL J, V3, P16; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x; Ferrero P, 2007, J MOL CELL CARDIOL, V43, P281, DOI 10.1016/j.yjmcc.2007.05.022; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Gonano LA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P947, DOI 10.1161/CIRCEP.111.964908; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Lin N, 2011, CIRC RES, V108, P1306, DOI 10.1161/CIRCRESAHA.110.238105; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Maier LS, 2012, ADV EXP MED BIOL, V740, P685, DOI 10.1007/978-94-007-2888-2_30; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; MundinaWeilenmann C, 1996, J BIOL CHEM, V271, P33561, DOI 10.1074/jbc.271.52.33561; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Said M, 2008, AM J PHYSIOL-HEART C, V295, pH1669, DOI 10.1152/ajpheart.00010.2008; Said M, 2011, J MOL CELL CARDIOL, V51, P936, DOI 10.1016/j.yjmcc.2011.08.010; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; Tang M, 2013, CIRC-CARDIOVASC GENE, V6, P472, DOI 10.1161/CIRCGENETICS.113.000253; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vogler G, 2009, JOVE-J VIS EXP; Wang Z, 1998, J NEUROCHEM, V71, P378; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wessells R, 2009, AGING CELL, V8, P542, DOI 10.1111/j.1474-9726.2009.00504.x; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	43	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101871	10.1371/journal.pone.0101871	http://dx.doi.org/10.1371/journal.pone.0101871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003749	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700079
J	Wei, KF; Chen, YH; Lin, YN; Pan, YT				Wei, Kaifa; Chen, Yanhui; Lin, Yina; Pan, Yutian			Genetic Dynamic Analysis of the Influenza A H5N1 NS1 Gene in China	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL-3-KINASE PI3K; PHOSPHOINOSITIDE 3-KINASE; AIRBORNE TRANSMISSION; HEMAGGLUTININ GENE; STRUCTURAL BASIS; BETA-INTERFERON; RNA-BINDING; VIRUS; PROTEIN; VIRULENCE	The direct precursors of the A/Goose/Guangdong/1/1996 (GS/GD) virus lineage and its reassortants have been established geographically and ecologically. To investigate the variation and evolutionary dynamics of H5N1 viruses, whole-genome viral sequences (n = 164) were retrieved from the NCBI Influenza Virus Resource. Here, we present phylogenetic evidence for intrasubtype reassortments among H5N1 viruses isolated from China during 1996-2012. On the basis of phylogenetic analysis, we identified four major groups and further classified the reassortant viruses into three subgroups. Putative mosaic structures were mostly found in the viral ribonucleoprotein (vRNP) complexes and 91.0% (10/11) mosaics were obtained from terrestrial birds. Sequence variability and selection pressure analyses revealed that both surface glycoproteins (HA and NA) and nonstructural protein 1 (NS1) have higher dN/dS ratio and variability than other internal proteins. Furthermore, we detected 47 positively selected sites in genomic segments with the exception of PB2 and M1 genes. Hemagglutinin (HA) and neuraminidase (NA) are considered highly variable due to host immune pressure, however, it is not known what drives NS1 variability. Therefore, we performed a thorough analysis of the genetic variation and selective pressure of NS1 protein (462 available NS1 sequences). We found that most of positively selected sites and variable amino acids were located in the C-terminal effector domain (ED) of NS1. In addition, we focused on the NS1-RNA and NS1-protein interactions that were involved in viral replication mechanisms and host immune response. Transcriptomic analysis of H5N1-infected monkey lungs showed that certain PI3K-related genes were up-regulated.	[Wei, Kaifa; Lin, Yina] Minnan Normal Univ, Sch Biol Sci & Biotechnol, Zhangzhou, Peoples R China; [Chen, Yanhui] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Pan, Yutian] Minnan Normal Univ, Engn Technol Ctr Mushroom Ind, Zhangzhou, Peoples R China	MinNan Normal University; Tsinghua University; MinNan Normal University	Wei, KF (corresponding author), Minnan Normal Univ, Sch Biol Sci & Biotechnol, Zhangzhou, Peoples R China.	kaifa-wei@163.com; xmpyt@sina.com						AGUADE M, 1989, GENETICS, V122, P607; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Carrillo B, 2014, J VIROL, V88, P4113, DOI 10.1128/JVI.03692-13; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan SF, 2013, J VIROL, V87, P4861, DOI 10.1128/JVI.02608-12; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; Lam TTY, 2013, INFECT GENET EVOL, V18, P367, DOI 10.1016/j.meegid.2013.03.015; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li WZ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-36; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Li Y, 2008, J BIOL CHEM, V283, P23397, DOI 10.1074/jbc.M802737200; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuda M, 2010, BIOCHEM BIOPH RES CO, V395, P312, DOI 10.1016/j.bbrc.2010.03.166; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Munir M, 2011, J GEN VIROL, V92, P2111, DOI 10.1099/vir.0.031716-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Neverov AD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004037; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubio L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00151; Shi WF, 2008, SCI CHINA SER C, V51, P987, DOI 10.1007/s11427-008-0131-8; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; SIMONSEN KL, 1995, GENETICS, V141, P413; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Wang J, 2008, J Virol, V82, P3405, DOI 10.1128/JVI.02468-07; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Wei KF, 2013, VET MICROBIOL, V167, P383, DOI 10.1016/j.vetmic.2013.09.030; Wei KF, 2013, CHINESE J CANCER RES, V25, P430, DOI 10.3978/j.issn.1000-9604.2013.08.13; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang DG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-170; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	77	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101384	10.1371/journal.pone.0101384	http://dx.doi.org/10.1371/journal.pone.0101384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003973	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700027
J	Wang, H; Leinwand, LA; Anseth, KS				Wang, Huan; Leinwand, Leslie A.; Anseth, Kristi S.			Roles of transforming growth factor-beta 1 and OB-cadherin in porcine cardiac valve myofibroblast differentiation	FASEB JOURNAL			English	Article						aortic valve fibrosis; genome-wide transcription; alpha-smooth muscle actin	GROWTH-FACTOR-BETA; TGF-BETA; TISSUE-REPAIR; EMERGING ROLE; MATRIX; FIBROBLASTS; FIBROSIS; CELLS; HEART; MECHANISMS	Calcific aortic stenosis is a common disease, and some of its early causes are the activation and differentiation of resident fibroblasts to myofibroblasts in response to transforming growth factor beta 1 (TGF-beta 1). The aim of this study was to understand how TGF-beta 1 and its downstream effector, OB-cadherin [cadherin 11 (CDH11)], regulate porcine myofibroblast phenotypes. Based on whole-genome microarrays, 95 and 107 genes are up-and down-regulated at both the early (8 h) and the late (24 h) time points of TGF-beta 1 treatment. Gene functions related to cell adhesion, skeletal system development, and extracellular matrix are up-regulated by TGF-beta 1, whereas oxidation-reduction and steroid metabolic process are down-regulated. Notably, one of the cell adhesion molecules, CDH11, is up-regulated by similar to 2-fold through both the Smad2/3 and the ERK pathways elicited by TGF-beta 1. CDH11 mediates cell-cell contacts in both valvular fibroblasts and myofibroblasts. Knockdown of CDH11 by small interfering RNA increases the myofibroblast phenotype, including an similar to 2-fold increase in alpha-smooth muscle actin (alpha-SMA) expression and stress fiber formation. In contrast, increased binding of CDH11 through antibody treatment inhibits alpha-SMA expression. This study presents gene functional changes in response to TGF-beta 1 at the systems level and supports an inhibitory role of CDH11 in myofibroblast differentiation.	[Wang, Huan; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Wang, Huan; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wang, Huan; Leinwand, Leslie A.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Anseth, KS (corresponding author), Howard Hughes Med Inst, 3415 Colorado Ave,JSCBB A315,596UCB, Boulder, CO 80303 USA.	kristi.anseth@colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810; WANG, HUAN/0000-0002-3857-5737	U.S. National Institutes of Health [R01 HL089260, R01 GM29090]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors appreciate scientific discussions with Dr. Nicholas Farina and Dr. Bradley Olwin regarding microarray analysis and thank Dr. Bradley Olwin for generously sharing software resources. The authors also thank Dr. Michael Brenner (Brigham and Women's Hospital, Boston, MA, USA) for generously sharing CDH11 antibodies. This work was supported by the U.S. National Institutes of Health (grants R01 HL089260 and R01 GM29090) and the Howard Hughes Medical Institute.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Blaauboer ME, 2011, BIOCHEM BIOPH RES CO, V404, P23, DOI 10.1016/j.bbrc.2010.11.033; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chang SK, 2010, IMMUNOL REV, V233, P256, DOI 10.1111/j.0105-2896.2009.00854.x; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Conte E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024663; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Follonier L, 2008, J CELL SCI, V121, P3305, DOI 10.1242/jcs.024521; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hutcheson JD, 2013, ARTERIOSCL THROM VAS, V33, P114, DOI 10.1161/ATVBAHA.112.300278; Hutcheson JD, 2012, J MOL CELL CARDIOL, V53, P707, DOI 10.1016/j.yjmcc.2012.08.012; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1; Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Li L, 2012, ONCOGENE, V31, P3901, DOI 10.1038/onc.2011.541; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Pittet P, 2008, J CELL SCI, V121, P877, DOI 10.1242/jcs.024877; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Verhoekx JSN, 2013, J INVEST DERMATOL, V133, P2664, DOI 10.1038/jid.2013.219; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069667; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969; Wang J, 2003, AM J PHYSIOL-HEART C, V285, pH1871, DOI 10.1152/ajpheart.00387.2003; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	52	29	29	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4551	4562		10.1096/fj.14-254623	http://dx.doi.org/10.1096/fj.14-254623			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25008089	Green Published			2022-12-25	WOS:000342222700030
J	Tamura, S; Matsumoto, N; Takeba, R; Fujiki, Y				Tamura, Shigehiko; Matsumoto, Naomi; Takeba, Ryota; Fujiki, Yukio			AAA Peroxins and Their Recruiter Pex26p Modulate the Interactions of Peroxins Involved in Peroxisomal Protein Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Peroxisome; Protein Complex; Protein Targeting; Scaffold Protein; AAA Peroxins; Pex14p; Pex26p; Protein Import	SIGNAL TYPE-1 RECEPTOR; BIOGENESIS DISORDERS; MEMBRANE-PROTEIN; PTS1 RECEPTOR; CONSERVED CYSTEINE; CELL MUTANTS; PEX14P; PEX5P; MATRIX; COMPLEMENTATION	Background: Pex26p and AAA peroxins are required for the peroxisome biogenesis. Results: Pex26p directly binds to Pex14p and acts as a scaffold protein to specify the molecular target of AAA peroxins. Conclusion: AAA peroxins modulate the interaction between Pex26p and Pex14p on peroxisome membrane. Significance: Functional modulation by Pex26p and AAA peroxins of the interaction between peroxins makes important contribution to peroxisome biogenesis. Pex1p and Pex6p are required for the relocation of the import receptor Pex5p from the peroxisomal membrane to the cytosol. We herein show that mammalian Pex26p directly binds to Pex14p, the initial docking receptor of Pex5p, and interacts with Pex5p via Pex14p. The binding affinity of Pex26p to Pex14p is altered by Pex5p. Further evidence suggests that the N-terminal region in Pex26p acts as a scaffold protein to recruit Pex14pPex5p complex together with Pex1pPex6p complexes on peroxisomes. Pex26p binding to Pex14p was suppressed by overexpression of Pex1p and Pex6p in an ATP-dependent manner, whereas Pex14p was not competed out by Pex1p and Pex6p from Pex26p mutant defective in peroxisomal matrix protein import. These results suggested that peroxisome biogenesis requires Pex1p- and Pex6p-regulated dissociation of Pex14p from Pex26p. Pex1p homo-oligomer directly binds to Pex5p as assessed by a surface plasmon resonance-based assay. Moreover, cytosolic Pex1p is likely to maintain the functional oligomer of Pex5p. Taken together, in the peroxisomal protein import, AAA peroxins modulate the interaction between Pex26p and Pex14p on peroxisome membrane as well as Pex5p oligomer in the cytosol.	[Fujiki, Yukio] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Tamura, Shigehiko] Kyushu Univ, Fac Arts & Sci, Fukuoka 8128581, Japan; [Tamura, Shigehiko; Matsumoto, Naomi; Takeba, Ryota] Kyushu Univ, Grad Sch Syst Life Sci, Grad Sch, Fukuoka 8128581, Japan	Kyushu University; Kyushu University; Kyushu University	Fujiki, Y (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp	Matsumoto, Naomi/AAD-3468-2022; Matsumoto, Naomi/AFL-4833-2022		Global Center of Excellence (GCOE) program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Science and Technology Agency of Japan; Takeda Science Foundation; Japan Foundation for Applied Enzymology;  [21570116];  [24570134];  [20370039];  [24247038];  [25116717];  [25112518];  [26116007]	Global Center of Excellence (GCOE) program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; ; ; ; ; ; ; 	This work was supported in part by Grants-in-aid for Scientific Research 21570116 and 24570134 (to S. T.) and 20370039, 24247038, 25116717, 25112518, and 26116007 (to Y. F.); by the Global Center of Excellence (GCOE) program and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by a CREST (Core Research for Evolutional Science and Technology) grant (to Y. F.) from the Science and Technology Agency of Japan, and grants (to Y. F.) from Takeda Science Foundation and Japan Foundation for Applied Enzymology.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Beyer A, 1997, PROTEIN SCI, V6, P2043; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Fujiki Y, 1997, BBA-MOL BASIS DIS, V1361, P235, DOI 10.1016/S0925-4439(97)00051-3; Furuki S, 2006, J BIOL CHEM, V281, P1317, DOI 10.1074/jbc.M510044200; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Itoh R, 2006, J BIOL CHEM, V281, P10196, DOI 10.1074/jbc.M600158200; Johnson MA, 2001, YEAST, V18, P621, DOI 10.1002/yea.711; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Komori M, 1999, FEBS LETT, V457, P397, DOI 10.1016/S0014-5793(99)01087-X; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Matsumoto N, 2003, AM J HUM GENET, V73, P233, DOI 10.1086/377004; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nashiro C, 2011, TRAFFIC, V12, P774, DOI 10.1111/j.1600-0854.2011.01182.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2001, J BIOL CHEM, V276, P2858, DOI 10.1074/jbc.M007730200; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; Tamura S, 2001, BIOCHEM J, V357, P417, DOI 10.1042/0264-6021:3570417; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Thoms S, 2012, J MED GENET, V49, P314, DOI 10.1136/jmedgenet-2012-100899; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Weller S, 2005, AM J HUM GENET, V76, P987, DOI 10.1086/430637; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	42	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24336	24346		10.1074/jbc.M114.588038	http://dx.doi.org/10.1074/jbc.M114.588038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016021	Green Published, hybrid			2022-12-25	WOS:000341505600029
J	Halpern, KB; Vana, T; Walker, MD				Halpern, Keren Bahar; Vana, Tal; Walker, Michael D.			Paradoxical Role of DNA Methylation in Activation of FoxA2 Gene Expression during Endoderm Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; DNA Methylation; Polycomb; Transcription; Transcription Enhancer; Endoderm	EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; TRANSCRIPTION FACTORS; MOLECULAR-BASIS; HUMAN GENOME; BETA-CELLS; IN-VIVO; MOUSE; SEQUENCE; MICE	Background: The transcription factor FoxA2 is a key mediator of endoderm development and pancreas gene expression. Results: DNA methylation is paradoxically associated with active expression of the FoxA2 gene. Conclusion: Developmental control genes such as FoxA2 may be regulated by a novel genetic mechanism. Significance: Clarification of this mechanism may provide a better understanding of how developmental pathways are activated. The transcription factor FoxA2 is a master regulator of endoderm development and pancreatic beta cell gene expression. To elucidate the mechanisms underlying the activation of the FoxA2 gene during differentiation, we have compared the epigenetic status of undifferentiated human embryonic stem cells (hESCs), hESC-derived early endoderm stage cells (CXCR4+ cells), and pancreatic islet cells. Unexpectedly, a CpG island in the promoter region of the FoxA2 gene displayed paradoxically high levels of DNA methylation in expressing tissues (CXCR4+, islets) and low levels in nonexpressing tissues. This CpG island region was found to repress reporter gene expression and bind the Polycomb group protein SUZ12 and the DNA methyltransferase (DNMT)3b preferentially in undifferentiated hESCs as compared with CXCR4+ or islets cells. Consistent with this, activation of FoxA2 gene expression, but not CXCR4 or SOX17, was strongly inhibited by 5-aza-2-deoxycytidine and by knockdown of DNMT3b. We hypothesize that in nonexpressing tissues, the lack of DNA methylation allows the binding of DNA methyltransferases and repressing proteins, such as Polycomb group proteins; upon differentiation, DNMT activation leads to CpG island methylation, causing loss of repressor protein binding. These results suggest a novel and unexpected role for DNA methylation in the activation of FoxA2 gene expression during differentiation.	[Halpern, Keren Bahar; Vana, Tal; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Rehovot, Israel.	m.walker@weizmann.ac.il			Juvenile Diabetes Research Foundation; Israel Science Foundation; Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute	This work was supported by grants from the Juvenile Diabetes Research Foundation, the Israel Science Foundation, and the Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute (to M. D. W.).	ANG SL, 1993, DEVELOPMENT, V119, P1301; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Niesen MI, 2005, J BIOL CHEM, V280, P38914, DOI 10.1074/jbc.M504633200; Nishizaki Y, 2001, MECH DEVELOP, V102, P57, DOI 10.1016/S0925-4773(01)00281-7; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; PANI L, 1992, MOL CELL BIOL, V12, P552, DOI 10.1128/MCB.12.2.552; POLLACK Y, 1980, P NATL ACAD SCI-BIOL, V77, P6463, DOI 10.1073/pnas.77.11.6463; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sharivkin R, 2012, MOL CELL PROTEOMICS, V11, P586, DOI 10.1074/mcp.M111.016840; Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Varghese S, 2007, CANCER RES, V67, P9371, DOI 10.1158/0008-5472.CAN-07-0674; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	45	60	62	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23882	23892		10.1074/jbc.M114.573469	http://dx.doi.org/10.1074/jbc.M114.573469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016019	Green Published, hybrid			2022-12-25	WOS:000341505000054
J	Conde-Jaldon, M; Montes-Cano, MA; Garcia-Lozano, JR; Ortiz-Fernandez, L; Ortego-Centeno, N; Gonzalez-Leon, R; Espinosa, G; Grana-Gil, G; Sanchez-Burson, J; Gonzalez-Gay, MA; Barnosi-Marin, AC; Solans, R; Fanlo, P; Carballeira, MR; Camps, T; Castaneda, S; Martin, J; Gonzalez-Escribano, MF				Conde-Jaldon, Marta; Antonio Montes-Cano, Marco; Raul Garcia-Lozano, Jose; Ortiz-Fernandez, Lourdes; Ortego-Centeno, Norberto; Gonzalez-Leon, Rocio; Espinosa, Gerard; Grana-Gil, Genaro; Sanchez-Burson, Juan; Angel Gonzalez-Gay, Miguel; Celia Barnosi-Marin, Ana; Solans, Roser; Fanlo, Patricia; Rodriguez Carballeira, Monica; Camps, Teresa; Castaneda, Santos; Martin, Javier; Francisca Gonzalez-Escribano, Maria			Epistatic Interaction of ERAP1 and HLA-B in Behcet Disease: A Replication Study in the Spanish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MHC CLASS-I; ANKYLOSING-SPONDYLITIS SUSCEPTIBILITY; GENETIC ASSOCIATION; ENDOPLASMIC-RETICULUM; CHINESE POPULATION; LOCI; IDENTIFICATION; PSORIASIS; AMINOPEPTIDASE	Behcet's disease (BD) is a multifactorial disorder associated with the HLA region. Recently, the ERAP1 gene has been proposed as a susceptibility locus with a recessive model and with epistatic interaction with HLA-B51. ERAP1 trims peptides in the endoplasmic reticulum to optimize their length for MHC-I binding. Polymorphisms in this gene have been related with the susceptibility to other immune-mediated diseases associated to HLA class I. Our aim was, the replication in the Spanish population of the association described in the Turkish population between ERAP1 (rs17482078) and BD. Additionally, in order to improve the understanding of this association we analyzed four additional SNPs (rs27044, rs10050860, rs30187 and rs2287987) associated with other diseases related to HLA class I and the haplotype blocks in this gene region. According to our results, frequencies of the homozygous genotypes for the minor alleles of all the SNPs were increased among patients and the OR values were higher in the subgroup of patients with the HLA-B risk factors, although differences were not statistically significant. Moreover, the presence of the same mutation in both chromosomes increased the OR values from 4.51 to 10.72 in individuals carrying the HLA-B risk factors. Therefore, although they were not statistically significant, our data were consistent with an association between ERAP1 and BD as well as with an epistatic interaction between ERAP1 and HLA-B in the Spanish population.	[Conde-Jaldon, Marta; Antonio Montes-Cano, Marco; Raul Garcia-Lozano, Jose; Ortiz-Fernandez, Lourdes; Francisca Gonzalez-Escribano, Maria] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Serv Inmunol,IBiS, Seville, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Serv Med Interna, Granada, Spain; [Gonzalez-Leon, Rocio] Hosp Univ Virgen del Rocio, Serv Med Interna, Seville, Spain; [Espinosa, Gerard] Hosp Clin Barcelona, Serv Enfermedades Autoinmunes, Barcelona, Spain; [Grana-Gil, Genaro] CHU A Coruna, Serv Reumatol, La Coruna, Spain; [Sanchez-Burson, Juan] Hosp Valme, Serv Reumatol, Seville, Spain; [Angel Gonzalez-Gay, Miguel] Hosp Marques de Valdecilla, Serv Reumatol, Santander, Spain; [Celia Barnosi-Marin, Ana] Hosp Torrecardenas, Serv Med Interna, Almeria, Spain; [Solans, Roser] Hosp Valle De Hebron, Serv Med Interna, Barcelona, Spain; [Fanlo, Patricia] Hosp Virgen del Camino, Serv Med Interna, Pamplona, Spain; [Rodriguez Carballeira, Monica] Hosp Univ Mutua Terrassa, Med Interna Unitat Malalties Autoimmunes & Sistem, Barcelona, Spain; [Camps, Teresa] Hosp Carlos Haya, Serv Med Interna, Malaga, Spain; [Castaneda, Santos] Hosp Princesa, Serv Reumatol, Madrid, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario San Cecilio; Virgen del Rocio University Hospital; University of Barcelona; Hospital Clinic de Barcelona; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Valme; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Torrecardenas; Hospital Universitari Vall d'Hebron; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Mutua Terrassa; Hospital Carlos Haya; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Montes-Cano, MA (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Serv Inmunol,IBiS, Seville, Spain.	marcoa.montes.sspa@juntadeandalucia.es	Ortiz-Fernández, Lourdes/AAA-6647-2020; Carballeir, Monica Rodriguez/AAQ-8337-2021; Martin, Javier/B-8141-2008; Espinosa, Gerard/AAV-2751-2020; Ortiz-Fernández, Lourdes/GOJ-7451-2022; González-Gay, Miguel A./B-2306-2008; Martín, Javier/AAV-5209-2021; Centeno, Norberto Ortego/C-4793-2019; IBIS, EPIDEMIOLOGIA/O-8791-2015; Martín, María/HDL-9512-2022; Espinosa, Gerard/J-2603-2016; González-Escribano, María Francisca/X-5554-2019; Ortiz-Fernández, Lourdes/C-3937-2015	Ortiz-Fernández, Lourdes/0000-0002-0247-4280; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Martin, Javier/0000-0002-2202-0622; Espinosa, Gerard/0000-0003-1336-0163; González-Gay, Miguel A./0000-0002-7924-7406; Centeno, Norberto Ortego/0000-0003-2325-0937; Espinosa, Gerard/0000-0003-1336-0163; Ortiz-Fernández, Lourdes/0000-0002-0247-4280	Fondo de Investigaciones Sanitarias [10/1701]; Fondos FEDER; Plan Andaluz de Investigacion [CTS-0197, CTS-180]; Red Enfermedades Inflamatorias y Reumaticas [RD08/0075/0013]; Consejeria de Salud de la Junta de Andalucia [0260/08];  [FI11/00547]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fondos FEDER(European Commission); Plan Andaluz de Investigacion; Red Enfermedades Inflamatorias y Reumaticas; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); 	This work was supported by Fondo de Investigaciones Sanitarias (10/1701), Fondos FEDER, Plan Andaluz de Investigacion (CTS-0197 and CTS-180), Red Enfermedades Inflamatorias y Reumaticas (RD08/0075/0013) and Consejeria de Salud de la Junta de Andalucia (0260/08). LOF is the recipient of a fellowship (FI11/00547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Montes-Cano MA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4328; Bettencourt BF, 2013, RHEUMATOLOGY, V52, P2168, DOI 10.1093/rheumatology/ket269; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen R, 2012, RHEUMATOL INT, V32, P909, DOI 10.1007/s00296-010-1712-y; Choi CB, 2010, ANN RHEUM DIS, V69, P582, DOI 10.1136/ard.2008.105296; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Fei YP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2695; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Kadi A, 2013, ANN RHEUM DIS, V72, P608, DOI 10.1136/annrheumdis-2012-201783; Karasneh J, 2005, ARTHRITIS RHEUM-US, V52, P1836, DOI 10.1002/art.21060; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kone-Paut I, 1999, J PEDIATR-US, V135, P89, DOI 10.1016/S0022-3476(99)70333-1; Lee YH, 2011, INFLAMM RES, V60, P999, DOI 10.1007/s00011-011-0374-x; Lysell J, 2013, J INVEST DERMATOL, V133, P411, DOI 10.1038/jid.2012.280; Maksymowych WP, 2009, ARTHRITIS RHEUM, V60, P1317, DOI 10.1002/art.24467; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pazar B, 2010, J RHEUMATOL, V37, P379, DOI 10.3899/jrheum.090806; Pimentel-Santos FM, 2009, CLIN EXP RHEUMATOL, V27, P800; Reeves E, 2013, J IMMUNOL, V191, P35, DOI 10.4049/jimmunol.1300598; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SILMAN AJ, 1990, LANCET, V335, P1078; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436	41	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102100	10.1371/journal.pone.0102100	http://dx.doi.org/10.1371/journal.pone.0102100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019531	Green Published, gold			2022-12-25	WOS:000339618600046
J	Yin, J; Wang, LM; Tang, WF; Wang, X; Lv, L; Shao, AZ; Shi, YJ; Ding, GW; Chen, SC; Gu, HY				Yin, Jun; Wang, Liming; Tang, Weifeng; Wang, Xu; Lv, Lu; Shao, Aizhong; Shi, Yijun; Ding, Guowen; Chen, Suocheng; Gu, Haiyong			RANK rs1805034 T > C Polymorphism Is Associated with Susceptibility of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; B LIGAND RANKL; INHIBITS PROSTATE-CANCER; BONE-MINERAL DENSITY; BREAST-CANCER; RECEPTOR ACTIVATOR; CELL FUNCTION; ZOLEDRONIC ACID; TUMOR-GROWTH; OSTEOPROTEGERIN	Esophageal cancer remains the sixth leading cause of cancer associated death and eighth most common cancer worldwide. Genetic factors, such as single nucleotide polymorphisms (SNPs), may contribute to the carcinogenesis of esophageal cancer. Here, we conducted a hospital based case-control study to evaluate the genetic susceptibility of functional SNPs on the development of esophageal cancer. A total of 629 esophageal squamous cell carcinoma (ESCC) cases and 686 controls were enrolled for this study. The OPG rs3102735 T>C, rs2073618 G>C, RANK rs1805034 T>C, RANKL rs9533156 T>C and rs2277438 A>G were determined by ligation detection reaction method. Our findings suggested that RANK rs1805034 T>C is associated with the susceptibility of ESCC, which is more evident in male and elder (>= 63) patients. Our study provides the first evidence that functional polymorphisms RANK rs1805034 T>C may be an indicator for individual susceptibility to ESCC. However, further larger studies among different ethnic populations are warranted to verify our conclusion.	[Yin, Jun; Tang, Weifeng; Wang, Xu; Lv, Lu; Shao, Aizhong; Shi, Yijun; Ding, Guowen; Chen, Suocheng; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Wang, Liming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Chemotherapy, Inst Canc, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	yin912@126.com; chensuocheng@sina.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81370001, 81101889, 81000028, 81300037]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; "333" Elitist Training Program of Jiangsu [BRA2013135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); "333" Elitist Training Program of Jiangsu	This study was supported in part by National Natural Science Foundation of China (81370001, 81101889, 81000028, 81300037), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), The "333" Elitist Training Program of Jiangsu (BRA2013135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Assmann G, 2010, J RHEUMATOL, V37, P900, DOI 10.3899/jrheum.091110; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bonifaci N, 2011, BREAST CANCER RES TR, V129, P947, DOI 10.1007/s10549-011-1546-7; Brown JM, 2001, UROLOGY, V57, P611, DOI 10.1016/S0090-4295(00)01122-5; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chu LW, 2010, CANCER EPIDEM BIOMAR, V19, P1848, DOI 10.1158/1055-9965.EPI-10-0101; Chung PYJ, 2010, J BONE MINER RES, V25, P2316, DOI 10.1002/jbmr.162; DESTEFANI E, 1993, EUR J CANCER, V29A, P763, DOI 10.1016/S0959-8049(05)80363-6; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng XS, 2014, ASIAN PAC J CANCER P, V15, P1981, DOI 10.7314/APJCP.2014.15.5.1981; Fisher JL, 2006, CANCER RES, V66, P3620, DOI 10.1158/0008-5472.CAN-05-3119; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Good CR, 2002, J SURG ONCOL, V79, P174, DOI 10.1002/jso.10067; Hsu YH, 2006, HUM GENET, V118, P568, DOI 10.1007/s00439-005-0062-4; Huang CH, 2011, RHEUMATOLOGY, V50, P359, DOI 10.1093/rheumatology/keq306; Huang L, 2002, J CLIN PATHOL, V55, P877, DOI 10.1136/jcp.55.11.877; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jorgensen HL, 2004, J BONE MINER METAB, V22, P132, DOI 10.1007/s00774-003-0461-3; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Katz J, 2011, INT J ORAL MAX SURG, V40, P605, DOI 10.1016/j.ijom.2011.02.002; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee CH, 2007, EUR J CANCER, V43, P1188, DOI 10.1016/j.ejca.2007.01.039; McGonigle JS, 2009, ANGIOGENESIS, V12, P35, DOI 10.1007/s10456-008-9127-z; Ney JT, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-40; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pitocco D, 2009, DIABETES CARE, V32, P1694, DOI 10.2337/dc09-0243; Quinn JE, 2005, PROSTATE CANCER P D, V8, P253, DOI 10.1038/sj.pcan.4500815; Rhee EJ, 2010, ENDOCR J, V57, P541, DOI 10.1507/endocrj.K10E-015; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Taylor PR, 2003, J NATL CANCER I, V95, P1414, DOI 10.1093/jnci/djg044; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Whang PG, 2005, J ORTHOP RES, V23, P1475, DOI 10.1016/j.orthres.2005.05.004; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080570; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685; Zhang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021835	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101705	10.1371/journal.pone.0101705	http://dx.doi.org/10.1371/journal.pone.0101705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019155	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600024
J	Boczek, T; Lisek, M; Ferenc, B; Kowalski, A; Stepinski, D; Wiktorska, M; Zylinska, L				Boczek, Tomasz; Lisek, Malwina; Ferenc, Bozena; Kowalski, Antoni; Stepinski, Dariusz; Wiktorska, Magdalena; Zylinska, Ludmila			Plasma Membrane Ca2+-ATPase Isoforms Composition Regulates Cellular pH Homeostasis in Differentiating PC12 Cells in a Manner Dependent on Cytosolic Ca2+ Elevations	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; ASCITES TUMOR MITOCHONDRIA; CYCLOSPORINE-A; CALCIUM-TRANSPORT; BRAIN; INHIBITION; NEURONS; DEPOLARIZATION; ACTIVATION; INTRAMITOCHONDRIAL	Plasma membrane Ca2+-ATPase (PMCA) by extruding Ca2+ outside the cell, actively participates in the regulation of intracellular Ca2+ concentration. Acting as Ca2+/H+ counter-transporter, PMCA transports large quantities of protons which may affect organellar pH homeostasis. PMCA exists in four isoforms (PMCA1-4) but only PMCA2 and PMCA3, due to their unique localization and features, perform more specialized function. Using differentiated PC12 cells we assessed the role of PMCA2 and PMCA3 in the regulation of intracellular pH in steady-state conditions and during Ca2+ overload evoked by 59 mM KCl. We observed that manipulation in PMCA expression elevated pH(mito) and pH(cyto) but only in PMCA2-downregulated cells higher mitochondrial pH gradient (Delta pH) was found in steady-state conditions. Our data also demonstrated that PMCA2 or PMCA3 knock-down delayed Ca2+ clearance and partially attenuated cellular acidification during KCl-stimulated Ca2+ influx. Because SERCA and NCX modulated cellular pH response in neglectable manner, and all conditions used to inhibit PMCA prevented KCl-induced pH drop, we considered PMCA2 and PMCA3 as mainly responsible for transport of protons to intracellular milieu. In steady-state conditions, higher TMRE uptake in PMCA2-knockdown line was driven by plasma membrane potential (Psi(p)). Nonetheless, mitochondrial membrane potential (Psi(m)) in this line was dissipated during Ca2+ overload. Cyclosporin and bongkrekic acid prevented Psi(m) loss suggesting the involvement of Ca2+-driven opening of mitochondrial permeability transition pore as putative underlying mechanism. The findings presented here demonstrate a crucial role of PMCA2 and PMCA3 in regulation of cellular pH and indicate PMCA membrane composition important for preservation of electrochemical gradient.	[Boczek, Tomasz; Lisek, Malwina; Ferenc, Bozena; Kowalski, Antoni; Zylinska, Ludmila] Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland; [Kowalski, Antoni] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Stepinski, Dariusz] Univ Lodz, Dept Cytophysiol, PL-90131 Lodz, Poland; [Wiktorska, Magdalena] Med Univ Lodz, Dept Mol Cell Mech, Lodz, Poland	Medical University Lodz; Aarhus University; University of Lodz; Medical University Lodz	Boczek, T (corresponding author), Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland.	tomasz.boczek@umed.lodz.pl	Zylinska, Ludmila/A-1205-2008; Zylinska, Ludmila/ABE-9113-2020	Zylinska, Ludmila/0000-0002-3876-8942; Zylinska, Ludmila/0000-0002-3876-8942; Lisek, Malwina/0000-0003-3438-2396; Boczek, Tomasz/0000-0002-7654-9011; Kowalski, Antoni/0000-0002-0936-7373; Wiktorska, Magdalena/0000-0001-7346-0380	Medical University of Lodz [503/6-086-02/503-01]; National Science Centre [UMO-2012/05/D/NZ4/02982]	Medical University of Lodz; National Science Centre(National Science Centre, Poland)	This work was supported by Medical University of Lodz grant no. 503/6-086-02/503-01 and, in part, by National Science Centre grant (to TB) based on decision UMO-2012/05/D/NZ4/02982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; BENHAM CD, 1992, J PHYSIOL-LONDON, V455, P567, DOI 10.1113/jphysiol.1992.sp019316; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Boczek T, 2012, CELL CALCIUM, V52, P433, DOI 10.1016/j.ceca.2012.08.002; Boczek T, 2012, MOL CELL BIOCHEM, V360, P89, DOI 10.1007/s11010-011-1047-3; BOGUCKA K, 1995, BBA-BIOENERGETICS, V1228, P261, DOI 10.1016/0005-2728(94)00188-B; Bolshakov AP, 2008, CELL CALCIUM, V43, P602, DOI 10.1016/j.ceca.2007.10.005; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Burette A, 2007, J COMP NEUROL, V500, P1127, DOI 10.1002/cne.21237; Carafoli E, 2000, CALCIUM HOMEOSTASIS; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Csordas G, 2003, J BIOL CHEM, V278, P42273, DOI 10.1074/jbc.M305248200; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Fakira Amanda Kathleen, 2010, World J Biol Chem, V1, P103, DOI 10.4331/wjbc.v1.i5.103; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; Haak LL, 2002, J NEUROCHEM, V80, P405, DOI 10.1046/j.0022-3042.2001.00727.x; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HANSFORD RG, 1967, BIOCHEM BIOPH RES CO, V27, P686, DOI 10.1016/S0006-291X(67)80090-1; HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084; Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8; Holton Mary Louisa, 2010, World J Biol Chem, V1, P201, DOI 10.4331/wjbc.v1.i6.201; Jacobson J, 2002, J CELL SCI, V115, P1175; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kip SN, 2006, HIPPOCAMPUS, V16, P20, DOI 10.1002/hipo.20129; Krohn AJ, 1999, J NEUROSCI, V19, P7394, DOI 10.1523/JNEUROSCI.19-17-07394.1999; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; Lehotsky J, 2002, FRONT BIOSCI, V7, P53; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; Mata AM, 2005, BRAIN RES REV, V49, P398, DOI 10.1016/j.brainresrev.2004.11.004; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MORENOSANCHEZ R, 1988, BIOCHEM J, V256, P403, DOI 10.1042/bj2560403; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; NICHOLLS DG, 1978, BIOCHEM J, V170, P511, DOI 10.1042/bj1700511; O'Reilly CM, 2004, AM J PHYSIOL-CELL PH, V286, pC1139, DOI 10.1152/ajpcell.00371.2003; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Perry SW, 2005, J IMMUNOL, V174, P4333, DOI 10.4049/jimmunol.174.7.4333; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Pitter JG, 2002, CELL CALCIUM, V31, P97, DOI 10.1054/ceca.2001.0264; Poburko D, 2012, PFLUG ARCH EUR J PHY, V464, P19, DOI 10.1007/s00424-012-1106-y; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Pytlowany M, 2008, ACTA BIOCHIM POL, V55, P339, DOI 10.18388/abp.2008_3081; REYNOLDS EE, 1982, BIOCHEMISTRY-US, V21, P4795, DOI 10.1021/bi00262a042; ROMAN I, 1981, MEMBRANE BIOCHEM, V4, P1, DOI 10.3109/09687688109065419; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schuchmann S, 2000, J NEUROPHYSIOL, V83, P1710, DOI 10.1152/jn.2000.83.3.1710; Souayah N, 2008, EXP NEUROL, V214, P341, DOI 10.1016/j.expneurol.2008.09.002; STAHL WL, 1992, MOL BRAIN RES, V16, P223, DOI 10.1016/0169-328X(92)90229-5; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; VILLALOBO A, 1980, J BIOL CHEM, V255, P2457; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; ZACHARIAS DA, 1995, MOL BRAIN RES, V28, P263, DOI 10.1016/0169-328X(94)00215-Z; Zaidi A, 1998, NEUROBIOL AGING, V19, P487, DOI 10.1016/S0197-4580(98)00078-5; Zhdanov AV, 2010, BBA-BIOENERGETICS, V1797, P1627, DOI 10.1016/j.bbabio.2010.06.006; Zylinska L, 2007, ANN NY ACAD SCI, V1099, P254, DOI 10.1196/annals.1387.008	75	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102352	10.1371/journal.pone.0102352	http://dx.doi.org/10.1371/journal.pone.0102352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014339	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400088
J	Higo, N; Ogawa, K; Minemura, J; Xu, BJ; Nozawa, T; Ogata, T; Ara, K; Yano, K; Miyake, Y				Higo, Naoki; Ogawa, Ken-ichiro; Minemura, Juichi; Xu, Bujie; Nozawa, Takayuki; Ogata, Taiki; Ara, Koji; Yano, Kazuo; Miyake, Yoshihiro			Interpersonal Similarity between Body Movements in Face-To-Face Communication in Daily Life	PLOS ONE			English	Article								Individuals are embedded in social networks in which they communicate with others in their daily lives. Because smooth face-to-face communication is the key to maintaining these networks, measuring the smoothness of such communication is an important issue. One indicator of smoothness is the similarity of the body movements of the two individuals concerned. A typical example noted in experimental environments is the interpersonal synchronization of body movements such as nods and gestures during smooth face-to-face communication. It should therefore be possible to estimate quantitatively the smoothness of face-to-face communication in social networks through measurement of the synchronization of body movements. However, this is difficult because social networks, which differ from disciplined experimental environments, are open environments for the face-to-face communication between two individuals. In such open environments, their body movements become complicated by various external factors and may follow unstable and nonuniform patterns. Nevertheless, we consider there to be some interaction during face-to-face communication that leads to the interpersonal synchronization of body movements, which can be seen through the interpersonal similarity of body movements. The present study aims to clarify such interaction in terms of body movements during daily face-to-face communication in real organizations of more than 100 people. We analyzed data on the frequency of body movement for each individual during face-to-face communication, as measured by a wearable sensor, and evaluated the degree of interpersonal similarity of body movements between two individuals as their frequency difference. Furthermore, we generated uncorrelated data by resampling the data gathered and compared these two data sets statistically to distinguish the effects of actual face-to-face communication from those of the activities accompanying the communication. Our results confirm an interpersonal similarity of body movements between two individuals in face-to-face communication, for all the organizations studied, and suggest that some body interaction is behind this similarity.	[Higo, Naoki; Ogawa, Ken-ichiro; Minemura, Juichi; Xu, Bujie; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Nozawa, Takayuki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Ogata, Taiki] Univ Tokyo, Ctr Engn, Kashiwa, Chiba, Japan; [Ara, Koji; Yano, Kazuo] Hitachi Ltd, Ctr Res Lab, Tokyo, Japan	Tokyo Institute of Technology; Tohoku University; University of Tokyo; Hitachi Limited	Ogawa, K (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	ogawa@dis.titech.ac.jp	Nozawa, Takayuki/Y-9610-2019	Nozawa, Takayuki/0000-0001-6300-4373; Ogata, Taiki/0000-0002-0590-598X	Homo Contribuens Research and Development Institute [0004]	Homo Contribuens Research and Development Institute	This work was supported, in part, by the Homo Contribuens Research and Development Institute (Grant No. 0004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Akitomi T., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P814, DOI 10.1109/PASSAT/SocialCom.2011.65; Ara Koji, 2011, 2011 16th Asia and South Pacific Design Automation Conference, ASP-DAC 2011, P567, DOI 10.1109/ASPDAC.2011.5722254; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; CONDON WS, 1967, J PSYCHIAT RES, V5, P221, DOI 10.1016/0022-3956(67)90004-0; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Condon WS., 1971, PERCEPTION LANGUAGE, P150; Daibo I, 1982, SOC PSYCH 22 INT C P, P188; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Mattarazzo JD, 1972, INTERVIEW RES ITS AN; Mehrabian A., 1971, SILENT MESSAGE; Ono E, 2012, 2012 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P912, DOI 10.1109/SII.2012.6427358; Paradiso JA, 2010, PERS UBIQUIT COMPUT, V14, P137, DOI 10.1007/s00779-009-0239-2; Pentland A, 2010, AM SCI, V98, P204, DOI 10.1511/2010.84.203; Pentland AP, 2010, HONEST SIGNALS WE SH; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Tsuji S., 2009, 6 INT C NETW SENS SY, P1, DOI DOI 10.1109/INSS.2009.5409930; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176	23	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102019	10.1371/journal.pone.0102019	http://dx.doi.org/10.1371/journal.pone.0102019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014021	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400056
J	Hijaz, F; Killiny, N				Hijaz, Faraj; Killiny, Nabil			Collection and Chemical Composition of Phloem Sap from Citrus sinensis L. Osbeck (Sweet Orange)	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; AMINO-ACID-COMPOSITION; GREENING DISEASE; TCA CYCLE; METABOLISM; JUICES; DERIVATIZATION; MYOINOSITOL; BACTERIUM; COMPLEX	Through utilizing the nutrient-rich phloem sap, sap feeding insects such as psyllids, leafhoppers, and aphids can transmit many phloem-restricted pathogens. On the other hand, multiplication of phloem-limited, uncultivated bacteria such as Candidatus Liberibacter asiaticus (CLas) inside the phloem of citrus indicates that the sap contains all the essential nutrients needed for the pathogen growth. The phloem sap composition of many plants has been studied; however, to our knowledge, there is no available data about citrus phloem sap. In this study, we identified and quantified the chemical components of phloem sap from pineapple sweet orange. Two approaches (EDTA enhanced exudation and centrifugation) were used to collect phloem sap. The collected sap was derivatized with methyl chloroformate (MCF), N-methyl-N-[tert-butyl dimethylsilyl]-trifluroacetamide (MTBSTFA), or trimethylsilyl (TMS) and analyzed with GC-MS revealing 20 amino acids and 8 sugars. Proline, the most abundant amino acid, composed more than 60% of the total amino acids. Tryptophan, tyrosine, leucine, isoleucine, and valine, which are considered essential for phloem sap-sucking insects, were also detected. Sucrose, glucose, fructose, and inositol were the most predominant sugars. In addition, seven organic acids including succinic, fumaric, malic, maleic, threonic, citric, and quinic were detected. All compounds detected in the EDTA-enhanced exudate were also detected in the pure phloem sap using centrifugation. The centrifugation technique allowed estimating the concentration of metabolites. This information expands our knowledge about the nutrition requirement for citrus phloem-limited bacterial pathogen and their vectors, and can help define suitable artificial media to culture them.	[Hijaz, Faraj; Killiny, Nabil] Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL 33850 USA	State University System of Florida; University of Florida	Killiny, N (corresponding author), Univ Florida, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL 33850 USA.	nabilkilliny@ufl.edu		Hijaz, Faraj/0000-0002-8079-161X; Killiny, Nabil/0000-0002-3895-6943	citrus research and development foundation [00085011]	citrus research and development foundation	This work was supported by grant (contract # 00085011) from citrus research and development foundation to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid G, 2009, GENE, V439, P1, DOI 10.1016/j.gene.2009.03.007; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Bursell E., 1981, P135; BYRNE DN, 1990, J INSECT PHYSIOL, V36, P433, DOI 10.1016/0022-1910(90)90061-J; CANDY DJ, 1967, BIOCHEM J, V103, P666, DOI 10.1042/bj1030666; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; Castle WS, 2013, INCIDENCE HLB COMMER; Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010; Chen WP, 2010, J CHROMATOGR B, V878, P2199, DOI 10.1016/j.jchromb.2010.06.027; Chen XT, 2009, INT J FOOD SCI NUTR, V60, P116, DOI 10.1080/09637480802695649; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; DADD RH, 1967, J INSECT PHYSIOL, V13, P763, DOI 10.1016/0022-1910(67)90125-4; DERENOBALES M, 1987, TRENDS BIOCHEM SCI, V12, P364, DOI 10.1016/0968-0004(87)90167-8; Dinant S, 2010, CR BIOL, V333, P504, DOI 10.1016/j.crvi.2010.03.008; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Gholami M, 2004, ACTA HORTIC, P143, DOI 10.17660/ActaHortic.2004.640.16; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gou Zhiheng, 2012, Zoological Research, V33, pE75, DOI 10.3724/SP.J.1141.2012.E05-06E75; Graham JH, 2008, P M INT RES C HUANGL; Guelette BS, 2012, J EXP BOT, V63, P3603, DOI 10.1093/jxb/ers028; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Ham TaeHo, 2012, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V57, P144, DOI 10.7740/kjcs.2012.57.2.144; Hasib A, 2001, SCI ALIMENT, V21, P555, DOI 10.3166/sda.21.555-562; Hunter Wayne B., 1999, International Journal of Ecology and Environmental Sciences, V25, P259; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Karadeniz Feryal, 2004, Turkish Journal of Agriculture and Forestry, V28, P267; Komor E, 1996, J EXP BOT, V47, P1155, DOI 10.1093/jxb/47.Special_Issue.1155; Lee HS, 2000, J LIQ CHROMATOGR R T, V23, P2123, DOI 10.1081/JLC-100100476; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Madey E, 2002, PLANTA, V214, P625, DOI 10.1007/s004250100649; Merchant A, 2010, J EXP BOT, V61, P1785, DOI 10.1093/jxb/erq045; MOORE S, 1968, J BIOL CHEM, V243, P6281; Nation J. L., 2002, INSECT PHYSL BIOCH, DOI DOI 10.1017/CBO9781107415324.004; Nour V, 2010, NOT BOT HORTI AGROBO, V38, P44; Nowak H, 2010, OECOLOGIA, V163, P973, DOI 10.1007/s00442-010-1652-y; OHSHIMA T, 1990, PLANT CELL PHYSIOL, V31, P735; Parker JK, 2014, PHYTOPATHOLOGY, V104, P15, DOI 10.1094/PHYTO-05-13-0119-R; Raveh E, 2005, SCI HORTIC-AMSTERDAM, V103, P317, DOI 10.1016/j.scienta.2004.06.007; Rennenberg H, 1996, J EXP BOT, V47, P1491, DOI 10.1093/jxb/47.10.1491; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Smart KF, 2010, NAT PROTOC, V5, P1709, DOI 10.1038/nprot.2010.108; Sobolevsky TG, 2003, J SEP SCI, V26, P1474, DOI 10.1002/jssc.200301492; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Thompson SN, 1995, BBA-GEN SUBJECTS, V1245, P376, DOI 10.1016/0304-4165(95)00107-7; Valle EM, 1998, PLANT CELL PHYSIOL, V39, P458, DOI 10.1093/oxfordjournals.pcp.a029391; van Bel AJE, 2008, J EXP BOT, V59, P261, DOI 10.1093/jxb/erm294; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Vinuelas J, 2011, MOL MICROBIOL, V81, P1271, DOI 10.1111/j.1365-2958.2011.07760.x; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Waterfield N, 2010, CURR BIOL, V20, pR13, DOI 10.1016/j.cub.2009.11.018; ZYREN J, 1985, J ASSOC OFF ANA CHEM, V68, P672	56	106	109	5	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101830	10.1371/journal.pone.0101830	http://dx.doi.org/10.1371/journal.pone.0101830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014027	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400039
J	Liang, Z; Xie, Y; Dominguez, JA; Breed, ER; Yoseph, BP; Burd, EM; Farris, AB; Davidson, NO; Coopersmith, CM				Liang, Zhe; Xie, Yan; Dominguez, Jessica A.; Breed, Elise R.; Yoseph, Benyam P.; Burd, Eileen M.; Farris, Alton B.; Davidson, Nicholas O.; Coopersmith, Craig M.			Intestine-Specific Deletion of Microsomal Triglyceride Transfer Protein Increases Mortality in Aged Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GUT EPITHELIAL APOPTOSIS; PSEUDOMONAS-AERUGINOSA; IMPROVES SURVIVAL; BARRIER FUNCTION; MURINE MODEL; MUCOSAL BARRIER; CECAL LIGATION; SEVERE SEPSIS; MUCUS LAYER	Background: Mice with conditional, intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO) exhibit a complete block in chylomicron assembly together with lipid malabsorption. Young (8-10 week) Mttp-IKO mice have improved survival when subjected to a murine model of Pseudomonas aeruginosa-induced sepsis. However, 80% of deaths in sepsis occur in patients over age 65. The purpose of this study was to determine whether age impacts outcome in Mttp-IKO mice subjected to sepsis. Methods: Aged (20-24 months) Mttp-IKO mice and WT mice underwent intratracheal injection with P. aeruginosa. Mice were either sacrificed 24 hours post-operatively for mechanistic studies or followed seven days for survival. Results: In contrast to young septic Mttp-IKO mice, aged septic Mttp-IKO mice had a significantly higher mortality than aged septic WT mice (80% vs. 39%, p = 0.005). Aged septic Mttp-IKO mice exhibited increased gut epithelial apoptosis, increased jejunal Bax/Bcl-2 and Bax/Bcl-XL ratios yet simultaneously demonstrated increased crypt proliferation and villus length. Aged septic Mttp-IKO mice also manifested increased pulmonary myeloperoxidase levels, suggesting increased neutrophil infiltration, as well as decreased systemic TNF alpha compared to aged septic WT mice. Conclusions: Blocking intestinal chylomicron secretion alters mortality following sepsis in an age-dependent manner. Increases in gut apoptosis and pulmonary neutrophil infiltration, and decreased systemic TNF alpha represent potential mechanisms for why intestine-specific Mttp deletion is beneficial in young septic mice but harmful in aged mice as each of these parameters are altered differently in young and aged septic WT and Mttp-IKO mice.	[Liang, Zhe; Breed, Elise R.; Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA; [Liang, Zhe; Breed, Elise R.; Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Xie, Yan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Dominguez, Jessica A.] Bastyr Univ Calif, Dept Basic Sci, San Diego, CA USA; [Burd, Eileen M.; Farris, Alton B.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University; Washington University (WUSTL); Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA.	cmcoop3@emory.edu	Breed, Elise/G-2547-2017; Farris, Alton Brad/S-6041-2017	Breed, Elise/0000-0001-6468-8463; Farris, Alton Brad/0000-0001-5534-7763; Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health [GM072808, GM104323, GM095442, GM66202, HL-38180, DK-56260, DK-52574]; Shock Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM104323, T32GM095442, R01GM066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shock Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from National Institutes of Health (GM072808, GM104323, GM095442, GM66202, HL-38180, DK-56260, DK-52574) and the Shock Society Early Career Investigator Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Babrowski T, 2013, SURGERY, V153, P36, DOI 10.1016/j.surg.2012.06.022; Badami CD, 2008, SHOCK, V30, P680, DOI 10.1097/SHK.0b013e318173edd1; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Cao ZY, 2014, J PROTEOME RES, V13, P422, DOI 10.1021/pr400814s; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087; Chang M, 2012, SHOCK, V37, P297, DOI 10.1097/SHK.0b013e318240b59b; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Chen MM, 2014, EXP GERONTOL, VS0531-5565, DOI [10.1016/j.ex-ger.2013.12.010, DOI 10.1016/J.EX-GER.2013.12.010]; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Deitch EA, 2011, SHOCK, V36, P177, DOI 10.1097/SHK.0b013e3182205c30; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dominguez JA, 2013, CRIT CARE MED, V41, pE275, DOI 10.1097/CCM.0b013e31828a44ed; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Dominguez JA, 2010, CRIT CARE CLIN, V26, P549, DOI 10.1016/j.ccc.2010.04.005; Drechsler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051457; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Fang JF, 2010, SHOCK, V34, P291, DOI 10.1097/SHK.0b013e3181ceef5e; Fink D, 2011, J TRAUMA, V71, P1575, DOI 10.1097/TA.0b013e31821cb7e5; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; Fishman JE, 2013, AM J PHYSIOL-GASTR L, V304, pG57, DOI 10.1152/ajpgi.00170.2012; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Geng YX, 2013, INFLAMMATION, V36, P670, DOI 10.1007/s10753-012-9591-x; Gomez CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/475139; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Lanza-Jacoby S, 2003, J ENDOTOXIN RES, V9, P341, DOI 10.1179/096805103225002782; Lu Q, 2011, J TRAUMA, V70, P630, DOI 10.1097/TA.0b013e3181e1221b; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; McConnell KW, 2010, CRIT CARE MED, V38, P223, DOI 10.1097/CCM.0b013e3181b4a76b; Mittal A, 2010, SHOCK, V34, P140, DOI 10.1097/SHK.0b013e3181cd8631; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; MURACA M, 1993, J HEPATOL, V17, P141, DOI 10.1016/S0168-8278(05)80028-5; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Osuchowski MF, 2012, J IMMUNOL, V189, P4648, DOI 10.4049/jimmunol.1201806; Ott J, 2011, PROSTAG LEUKOTR ESS, V85, P267, DOI 10.1016/j.plefa.2011.04.011; Peltz ED, 2009, SURGERY, V146, P347, DOI 10.1016/j.surg.2009.02.022; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Qin XF, 2008, SHOCK, V29, P372, DOI 10.1097/shk.0b013e3181453f4e; Qiu P, 2011, EXPERT OPIN INV DRUG, V20, P1555, DOI 10.1517/13543784.2011.623125; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Romanowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030119; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Sambol JT, 2009, J APPL PHYSIOL, V106, P57, DOI 10.1152/japplphysiol.90937.2008; Sarin EL, 2004, J TRAUMA, V57, P950, DOI 10.1097/01.TA.0000149493.95859.6C; Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Tucsek Z, 2013, J GERONTOL A-BIOL, V68, P652, DOI 10.1093/gerona/gls232; Turnbull IR, 2004, SHOCK, V22, P364, DOI 10.1097/01.shk.0000142552.77473.7d; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Watkins AC, 2008, J TRAUMA, V64, P126, DOI 10.1097/TA.0b013e3181574a8a; Williams AE, 2014, AM J PHYSIOL-LUNG C, V306, pL217, DOI 10.1152/ajplung.00311.2013; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2012, ARTERIOSCL THROM VAS, V32, P1624, DOI 10.1161/ATVBAHA.112.246066; Yamamoto K, 2002, AM J PATHOL, V161, P1805, DOI 10.1016/S0002-9440(10)64457-4; Yang JX, 2013, SURGERY, V153, P52, DOI 10.1016/j.surg.2012.04.002; Yoseph BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062792; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	81	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101828	10.1371/journal.pone.0101828	http://dx.doi.org/10.1371/journal.pone.0101828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010671	gold, Green Published			2022-12-25	WOS:000338763800043
J	Roorkiwal, M; von Wettberg, EJ; Upadhyaya, HD; Warschefsky, E; Rathore, A; Varshney, RK				Roorkiwal, Manish; von Wettberg, Eric J.; Upadhyaya, Hari D.; Warschefsky, Emily; Rathore, Abhishek; Varshney, Rajeev K.			Exploring Germplasm Diversity to Understand the Domestication Process in Cicer spp. Using SNP and DArT Markers	PLOS ONE			English	Article							PLANT GENETIC-RESOURCES; CROP IMPROVEMENT; CHICKPEA; DISCOVERY; GENOMICS	To estimate genetic diversity within and between 10 interfertile Cicer species (94 genotypes) from the primary, secondary and tertiary gene pool, we analysed 5,257 DArT markers and 651 KASPar SNP markers. Based on successful allele calling in the tertiary gene pool, 2,763 DArT and 624 SNP markers that are polymorphic between genotypes from the gene pools were analyzed further. STRUCTURE analyses were consistent with 3 cultivated populations, representing kabuli, desi and pea-shaped seed types, with substantial admixture among these groups, while two wild populations were observed using DArT markers. AMOVA was used to partition variance among hierarchical sets of landraces and wild species at both the geographical and species level, with 61% of the variation found between species, and 39% within species. Molecular variance among the wild species was high (39%) compared to the variation present in cultivated material (10%). Observed heterozygosity was higher in wild species than the cultivated species for each linkage group. Our results support the Fertile Crescent both as the center of domestication and diversification of chickpea. The collection used in the present study covers all the three regions of historical chickpea cultivation, with the highest diversity in the Fertile Crescent region. Shared alleles between different gene pools suggest the possibility of gene flow among these species or incomplete lineage sorting and could indicate complicated patterns of divergence and fusion of wild chickpea taxa in the past.	[Roorkiwal, Manish; Upadhyaya, Hari D.; Rathore, Abhishek; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [von Wettberg, Eric J.; Warschefsky, Emily] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [von Wettberg, Eric J.; Warschefsky, Emily] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Miami, FL USA	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); State University System of Florida; Florida International University	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	von Wettberg, Eric/C-1115-2016; Updhayaya, Hari/C-4858-2014; Roorkiwal, Manish/E-9822-2011; Varshney, Rajeev K/C-5295-2014; Warschefsky, Emily/AAA-6146-2019	von Wettberg, Eric/0000-0002-2724-0317; Updhayaya, Hari/0000-0002-5166-6844; Roorkiwal, Manish/0000-0001-6595-281X; Varshney, Rajeev K/0000-0002-4562-9131; Warschefsky, Emily/0000-0003-3894-6662	Australian Indo Strategic Research Fund (AISRF) of Ministry of Science Technology; CGIAR Generation Challenge Programme (GCP), Mexico; HHMI [52006924]; USDA-NIFA-Hispanic Serving Institutions Grant [2011-38422-30804]; Fairchild Challenge of Fairchild Tropical Botanic Garden	Australian Indo Strategic Research Fund (AISRF) of Ministry of Science Technology(Australian GovernmentDepartment of Industry, Innovation and Science); CGIAR Generation Challenge Programme (GCP), Mexico; HHMI(Howard Hughes Medical Institute); USDA-NIFA-Hispanic Serving Institutions Grant; Fairchild Challenge of Fairchild Tropical Botanic Garden	This study was funded by grants from Australian Indo Strategic Research Fund (AISRF) of Ministry of Science & Technology and CGIAR Generation Challenge Programme (GCP), Mexico. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. Thanks are also due to several colleagues at ICRISAT and partners in collaborating centres. EvW received support from HHMI award #52006924 to FIU's discipline-based education research group, and USDA-NIFA-Hispanic Serving Institutions Grant 2011-38422-30804 to FIU's agroecology program. EW is supported by the Fairchild Challenge of Fairchild Tropical Botanic Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2003, FUNCT PLANT BIOL, V30, P1081, DOI 10.1071/FP03084; Abbo S, 2009, Q REV BIOL, V84, P29, DOI 10.1086/596462; Akibode S, 2011, GLOBAL REGIONAL TREN; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Berger J, 2003, CROP SCI, V43, P1076, DOI 10.2135/cropsci2003.1076; Berger JD, 2011, EUPHYTICA, V180, P1, DOI 10.1007/s10681-011-0391-4; Berger JD, 2013, CROP PASTURE SCI, V64, P300, DOI 10.1071/CP13023; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dempewolf H, 2014, AGROECOL SUST FOOD, V38, P369, DOI 10.1080/21683565.2013.870629; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; EXCOFFIER L, 1992, GENETICS, V131, P479; Fu Yong-Bi, 2006, Plant Genetic Resources Characterization and Utilization, V4, P87, DOI [10.1079/PGR2005100, 10.1079/PGR2006116]; Gepts P, 2004, PLANT PHYSIOL, V134, P1295, DOI 10.1104/pp.103.038885; Gepts P, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P1; Gowda CLL, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.05.0016; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Haussmann B. I. G., 2004, Plant Genetic Resources Characterization and Utilization, V2, P3, DOI 10.1079/PGR200430; Hillman G., 1975, P PREHIST SOC, V41, P70; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kassa MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039563; Lachance J, 2013, BIOESSAYS, V35, P780, DOI 10.1002/bies.201300014; LADIZINSKY G, 1985, ECON BOT, V39, P191, DOI 10.1007/BF02907844; LADIZINSKY G, 1976, THEOR APPL GENET, V48, P197, DOI 10.1007/BF00527371; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mallikarjuna N, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: LEGUME CROPS AND FORAGES, P63, DOI 10.1007/978-3-642-14387-8_4; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Miflin B, 2000, J EXP BOT, V51, P1, DOI 10.1093/jexbot/51.342.1; Millan T, 2006, EUPHYTICA, V147, P81, DOI 10.1007/s10681-006-4261-4; MORENO MT, 1978, EUPHYTICA, V27, P465, DOI 10.1007/BF00043173; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rao V. R., 2002, PLANT CELL TISSUE OR, V68, P1, DOI DOI 10.1023/A:1013359015812; Roorkiwal M, 2013, PLANT GEN, V6, P1, DOI DOI 10.3835/PLANTGENOME2013.05.0017; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Saxena RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088568; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Singh M, 2013, ELSEV INSIGHT, P1; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; VANDERMAESEN LJG, 1987, CHICKPEA, P139; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Yadav SS, 2007, CHICKPEA BREEDING AND MANAGEMENT, P1, DOI 10.1079/9781845932138.000; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	53	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102016	10.1371/journal.pone.0102016	http://dx.doi.org/10.1371/journal.pone.0102016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010059	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800059
J	Yoshii, H; Yanagihara, K; Imaseki, H; Hamano, T; Yamanishi, H; Inagaki, M; Sakai, Y; Sugiura, N; Kurihara, O; Sakai, K				Yoshii, Hiroshi; Yanagihara, Kouta; Imaseki, Hitoshi; Hamano, Tsuyoshi; Yamanishi, Hirokuni; Inagaki, Masayo; Sakai, Yasuhiro; Sugiura, Nobuyuki; Kurihara, Osamu; Sakai, Kazuo			Methodology Using a Portable X-Ray Fluorescence Device for On-Site and Rapid Evaluation of Heavy-Atom Contamination in Wounds: A Model Study for Application to Plutonium Contamination	PLOS ONE			English	Article							IN-VIVO; WHOLE-BLOOD; XRF MEASUREMENT; IRON; BONE; LEAD; ZN; FE; CU	Workers decommissioning the Fukushima-Daiichi nuclear power plant damaged from the Great East Japan Earthquake and resulting tsunami are at risk of injury with possible contamination from radioactive heavy atoms including actinides, such as plutonium. We propose a new methodology for on-site and rapid evaluation of heavy-atom contamination in wounds using a portable X-ray fluorescence (XRF) device. In the present study, stable lead was used as the model contaminant substitute for radioactive heavy atoms. First, the wound model was developed by placing a liquid blood phantom on an epoxy resin wound phantom contaminated with lead. Next, the correlation between the concentration of contaminant and the XRF peak intensity was formulated considering the thickness of blood exiting the wound. Methods to determine the minimum detection limit (MDL) of contaminants at any maximal equivalent dose to the wound by XRF measurement were also established. For example, in this system, at a maximal equivalent dose of 16.5 mSv to the wound and blood thickness of 0.5 mm, the MDL value for lead was 1.2 ppm (3.1 nmol). The radioactivity of Pu-239 corresponding to 3.1 nmol is 1.7 kBq, which is lower than the radioactivity of Pu-239 contaminating puncture wounds in previous severe accidents. In conclusion, the established methodology could be beneficial for future development of a method to evaluate plutonium contamination in wounds. Highlights: Methodology for evaluation of heavy-atom contamination in a wound was established. A portable Xray fluorescence device enables on-site, rapid and direct evaluation. This method is expected to be used for evaluation of plutonium contamination in wounds.	[Yoshii, Hiroshi; Yanagihara, Kouta; Imaseki, Hitoshi; Hamano, Tsuyoshi; Kurihara, Osamu; Sakai, Kazuo] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 260, Japan; [Yanagihara, Kouta; Sakai, Yasuhiro] Toho Univ, Dept Phys, Fac Sci, Funabashi, Chiba 274, Japan; [Yamanishi, Hirokuni; Inagaki, Masayo] Kinki Univ, Atom Energy Res Inst, Higashiosaka, Osaka 577, Japan; [Sugiura, Nobuyuki] Nucl Safety Res Assoc, Radiat Environm Effects Res Ctr, Minato Ku, Shinbashi, Tokyo, Japan	National Institutes for Quantum Science & Technology; Toho University; Japan Atomic Energy Agency; Kindai University (Kinki University)	Yoshii, H (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 260, Japan.	yoshii@nirs.go.jp						BORJESSON J, 1995, PHYS MED BIOL, V40, P413, DOI 10.1088/0031-9155/40/3/006; Bradley DA, 2000, J RADIOANAL NUCL CH, V244, P213, DOI 10.1023/A:1006757424682; Carbaugh EH, 2010, HEALTH PHYS, V99, P483, DOI 10.1097/HP.0b013e3181d96381; CHRISTOFFERSSON JO, 1983, PHYS MED BIOL, V28, P1135, DOI 10.1088/0031-9155/28/10/005; Deslattes RD, 2003, REV MOD PHYS, V75, P35, DOI 10.1103/RevModPhys.75.35; Estevam M, 2013, HEALTH PHYS, V104, P132, DOI 10.1097/HP.0b013e3182667721; Fleming DEB, 2007, PHYS MED BIOL, V52, pN459, DOI 10.1088/0031-9155/52/19/N04; GENICOT JL, 1995, APPL RADIAT ISOTOPES, V46, P199, DOI 10.1016/0969-8043(94)00115-G; Gherase MR, 2010, APPL RADIAT ISOTOPES, V68, P743, DOI 10.1016/j.apradiso.2009.09.037; Helmer OM, 1934, J BIOL CHEM, V104, P157; ICRP, 2007, ANN ICRP, V37, P98; International Atomic Energy Agency, 2005, SER MED PROBL ALW HA, P53; IYENGAR GV, 1987, BIOL TRACE ELEM RES, V12, P263, DOI 10.1007/BF02796686; Jenkins R, 1999, XRAY FLUORESCENCE SP, p[153, 175]; King LS, 1942, J EXP MED, V76, P325, DOI 10.1084/jem.76.4.325; Moreno MA, 1999, SCI TOTAL ENVIRON, V229, P209, DOI 10.1016/S0048-9697(99)00074-1; National Council on Radiation protection and Measurement, 2006, 156 NCRP, P118; Nie HL, 2006, PHYS MED BIOL, V51, P351, DOI 10.1088/0031-9155/51/2/011; Nie HL, 2004, PHYS MED BIOL, V49, pN325, DOI 10.1088/0031-9155/49/19/N02; Nie LH, 2011, PHYS MED BIOL, V56, pN39, DOI 10.1088/0031-9155/56/3/N01; O'Meara JM, 1998, APPL RADIAT ISOTOPES, V49, P713, DOI 10.1016/S0969-8043(97)00091-2; O'Meara JM, 2000, APPL RADIAT ISOTOPES, V53, P639, DOI 10.1016/S0969-8043(00)00244-X; Saha GB, 1993, PHYS RADIOBIOLOGY NU, P11; Schadilov AE, 2010, HEALTH PHYS, V99, P560, DOI 10.1097/HP.0b013e3181c34989; Teng WF, 2008, BIOL TRACE ELEM RES, V121, P243, DOI 10.1007/s12011-007-8047-x; TRUDNOWSKI RJ, 1974, CLIN CHEM, V20, P615	26	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101966	10.1371/journal.pone.0101966	http://dx.doi.org/10.1371/journal.pone.0101966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010749	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800055
J	Li, RH; Li, X; Ning, SW; Ye, JR; Han, L; Kang, CS; Li, X				Li, Ronghong; Li, Xiang; Ning, Shangwei; Ye, Jingrun; Han, Lei; Kang, Chunsheng; Li, Xia			Identification of a Core miRNA-Pathway Regulatory Network in Glioma by Therapeutically Targeting miR-181d, miR-21, miR-23b, beta-Catenin, CBP, and STAT3	PLOS ONE			English	Article							MALIGNANT GLIOMAS; WNT/BETA-CATENIN; DOWN-REGULATION; CANCER CELLS; IN-VIVO; MICRORNA; GLIOBLASTOMA; EXPRESSION; GENES; PROGRESSION	The application of microRNAs (miRNAs) in the therapeutics of glioma and other human diseases is an area of intense interest. However, it's still a great challenge to interpret the functional consequences of using miRNAs in glioma therapy. Here, we examined paired deep sequencing expression profiles of miRNAs and mRNAs from human glioma cell lines after manipulating the levels of miRNAs miR-181d, -21, and -23b, as well as transcriptional regulators beta-catenin, CBP, and STAT3. An integrated approach was used to identify functional miRNA-pathway regulatory networks (MPRNs) responding to each manipulation. MiRNAs were identified to regulate glioma related biological pathways collaboratively after manipulating the level of either post-transcriptional or transcriptional regulators, and functional synergy and crosstalk was observed between different MPRNs. MPRNs responsive to multiple interventions were found to occupy central positions in the comprehensive MPRN (cMPRN) generated by integrating all the six MPRNs. Finally, we identified a core module comprising 14 miRNAs and five pathways that could predict the survival of glioma patients and represent potential targets for glioma therapy. Our results provided novel insight into miRNA regulatory mechanisms implicated in therapeutic interventions and could offer more inspiration to miRNA-based glioma therapy.	[Li, Ronghong; Li, Xiang; Ning, Shangwei; Ye, Jingrun; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Han, Lei; Kang, Chunsheng] Tianjin Med Univ, Lab Neurooncol,Dept Neurosurg, Tianjin Neurol Inst,Gen Hosp, Lab Neurotrauma Variat & Regenerat,Minist Educ, Tianjin, Peoples R China; [Han, Lei; Kang, Chunsheng] Tianjin Municipal Govt, Tianjin, Peoples R China	Harbin Medical University; Tianjin Medical University	Kang, CS (corresponding author), Tianjin Med Univ, Lab Neurooncol,Dept Neurosurg, Tianjin Neurol Inst,Gen Hosp, Lab Neurotrauma Variat & Regenerat,Minist Educ, Tianjin, Peoples R China.	kang97061@gmail.com; lixia@hrbmu.edu.cn	Ye, jingrun/GSJ-2822-2022; li, xia/HHZ-7468-2022; Kang, Chunsheng/AAM-5979-2021	Kang, Chunsheng/0000-0002-3255-3369	National High Technology Research and Development Program of China (863 Program) [2014AA021102]; National Natural Science Foundation of China [81272792, 61073136, 81171122, 61170154]; Undergraduate Innovation Funds of Harbin Medical University [YJSCX2012-206HLJ]; Foundation of Tianjin Municipal Science and Technology commission [12ZCDZSY17300]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Undergraduate Innovation Funds of Harbin Medical University; Foundation of Tianjin Municipal Science and Technology commission	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2014AA021102), the National Natural Science Foundation of China (81272792, 61073136, 81171122 and 61170154), the Undergraduate Innovation Funds of Harbin Medical University (YJSCX2012-206HLJ), and Foundation of Tianjin Municipal Science and Technology commission (12ZCDZSY17300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Burel-Vandenbos F, 2013, NEURO-ONCOLOGY, V15, P1278, DOI 10.1093/neuonc/not094; Carcagno AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021938; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen LC, 2012, NEURO-ONCOLOGY, V14, P1026, DOI 10.1093/neuonc/nos122; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; de Oliveira RL, 2011, MOL ASPECTS MED, V32, P71, DOI 10.1016/j.mam.2011.04.001; Dong CG, 2012, INT J ONCOL, V41, P1005, DOI 10.3892/ijo.2012.1542; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Han ZQ, 2009, CARCINOGENESIS, V30, P2014, DOI 10.1093/carcin/bgp249; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hui Wang, 2013, PLoS One, V8, pe54932, DOI 10.1371/journal.pone.0054932; Hutchins AP, 2013, NUCLEIC ACIDS RES, V41, P2155, DOI 10.1093/nar/gks1300; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Jia WT, 2010, INT J BIOCHEM CELL B, V42, P2019, DOI 10.1016/j.biocel.2010.09.003; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lazovic J, 2012, NEURO-ONCOLOGY, V14, P1465, DOI 10.1093/neuonc/nos258; Lerebours F, 2013, INT J CANCER, V133, P1614, DOI 10.1002/ijc.28171; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moller HG, 2013, MOL NEUROBIOL, V47, P131, DOI 10.1007/s12035-012-8349-7; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Nichane M, 2010, EMBO J, V29, P55, DOI 10.1038/emboj.2009.313; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Pio G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S8; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Plate KH, 2012, ACTA NEUROPATHOL, V124, P763, DOI 10.1007/s00401-012-1066-5; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez FJ, 2012, J NEUROPATH EXP NEUR, V71, P789, DOI 10.1097/NEN.0b013e3182656ef8; Rukov JL, 2011, TRENDS MOL MED, V17, P412, DOI 10.1016/j.molmed.2011.04.003; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Shahab SW, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-33; Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3; Skuli N, 2006, CANCER RES, V66, P482, DOI 10.1158/0008-5472.CAN-05-2299; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang XF, 2012, J CANCER RES CLIN, V138, P573, DOI 10.1007/s00432-011-1114-x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Xu J, 2013, ONCOGENE, V32, P976, DOI 10.1038/onc.2012.121; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yang QQ, 2011, BIOINFORMATICS, V27, P3329, DOI 10.1093/bioinformatics/btr556; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zhang AL, 2013, J NEURO-ONCOL, V112, P179, DOI 10.1007/s11060-013-1061-2; Zhang JX, 2011, NEURO-ONCOLOGY, V13, P600, DOI 10.1093/neuonc/nor034; Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zhao LQ, 2012, CARCINOGENESIS, V33, P2220, DOI 10.1093/carcin/bgs235; Zhao SG, 2013, CANCER LETT, V333, P253, DOI 10.1016/j.canlet.2013.01.039; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	77	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101903	10.1371/journal.pone.0101903	http://dx.doi.org/10.1371/journal.pone.0101903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007077	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600079
J	Singh, N; Eeda, SS; Gudapati, BK; Reddy, S; Kanade, P; Shantha, GPS; Rani, PK; Chakrabarti, S; Khanna, RC				Singh, Nakul; Eeda, Shiva Shankar; Gudapati, Bala Krishna; Reddy, Srinivasa; Kanade, Pushkar; Shantha, Ghanshyam Palamaner Subash; Rani, Padmaja Kumari; Chakrabarti, Subhabrata; Khanna, Rohit C.			Prevalence and Causes of Blindness and Visual Impairment and Their Associated Risk Factors, in Three Tribal Areas of Andhra Pradesh, India	PLOS ONE			English	Article							RAPID ASSESSMENT; AVOIDABLE BLINDNESS; CATARACT-SURGERY; OLDER-ADULTS; DISTRICT; PAKISTAN; VISION; NEPAL	Objective: To assess the prevalence of blindness and visual impairment (VI), their associated causes and underlying risk factors in three tribal areas of Andhra Pradesh, India and compare this data in conjunction with data from other countries with low and middle income settings. Methods: Using a validated Rapid Assessment of Avoidable Blindness methodology, a two stage sampling survey was performed in these areas involving probability proportionate to size sampling and compact segment sampling methods. Blindness, VI and severe visual impairment (SVI) were defined as per the WHO guidelines and Indian definitions. Results: Based on a prior enumeration, 7281 (97.1%) subjects were enrolled (mean age = 61.0+/27.9 years). Based on the presenting visual acuity (PVA), the prevalences of VI, SVI and blindness were 16.9% (95% CI: 15.7-18.1), 2.9% (95% CI: 2.5-3.4), and 2.3% (95% CI: 1.9-2.7), respectively. When based on the Pinhole corrected visual acuity (PCVA), the prevalences were lower in VI (6.2%, 95% CI: 5.4-6.9), SVI (1.5%, 95% CI: 1.2-1.9) and blindness (2.1%, 95% CI: 1.7-2.5). Refractive error was the major cause of VI (71.4%), whereas, cataract was the major cause of SVI and blindness (70.3%). Based on the PVA, the odds ratio (OR) of blindness increased in the age groups of 60-69 years (OR = 3.8, 95% CI: 2.8, 5.1), 70-79 years (OR = 10.6, 95% CI: 7.2, 15.5) and 80 years and above (OR = 30.7, 95% CI: 19.2, 49). The ORs were relatively higher in females (OR = 1.3, 95% CI: 1.0, 1.6) and illiterate subjects (OR = 4.3, 95% CI: 2.2, 8.5), but lower in those wearing glasses (OR = 0.2, 95% CI: 0.1, 0.4). Conclusions: This is perhaps the first study to assess the prevalence of blindness and VI in these tribal regions and the majority of the causes of blindness and SVI were avoidable (88.5%). These findings may be useful for planning eye care services in these underserved regions.	[Singh, Nakul] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Eeda, Shiva Shankar; Gudapati, Bala Krishna; Reddy, Srinivasa] Andhra Pradesh Right Sight Soc, Hyderabad, Andhra Pradesh, India; [Eeda, Shiva Shankar; Gudapati, Bala Krishna; Reddy, Srinivasa] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Kanade, Pushkar] St Vincent Charity Med Ctr, Cleveland, OH USA; [Shantha, Ghanshyam Palamaner Subash] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Shantha, Ghanshyam Palamaner Subash] Wright Ctr Grad Med Educ, Dept Internal Med, Scranton, PA 18510 USA; [Rani, Padmaja Kumari; Chakrabarti, Subhabrata; Khanna, Rohit C.] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India; [Rani, Padmaja Kumari; Khanna, Rohit C.] LV Prasad Eye Inst, GPR Int Ctr Adv Rural Eye Care, Allen Foster Res Ctr Community Eye Hlth, Hyderabad, Andhra Pradesh, India	Harvard University; Harvard T.H. Chan School of Public Health; University of New South Wales Sydney; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Khanna, RC (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Banjara Hills, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org	pallerla, srinivasa r/F-4575-2014; Chakrabarti, Subhabrata/F-2468-2015	pallerla, srinivasa r/0000-0001-9126-1676; Chakrabarti, Subhabrata/0000-0003-3717-4963	Department for International Development (DFID) UK; Rose Traveling Fellowship	Department for International Development (DFID) UK; Rose Traveling Fellowship	Department for International Development (DFID) UK funded the study. The sponsor or funding organization had no role in the design or conduct of this research. In addition, Nakul Singh was supported by the Rose Traveling Fellowship, administered through the Harvard School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2005, OPHTHAL EPIDEMIOL, V12, P19, DOI 10.1080/09286580490921304; Anjum KM, 2006, BRIT J OPHTHALMOL, V90, P135, DOI 10.1136/bjo.2005.078527; Casson RJ, 2007, OPHTHALMOLOGY, V114, P2302, DOI 10.1016/j.ophtha.2007.02.004; Dulal S, 2012, NEPAL J OPHTHALMOL, V4, P282, DOI http://dx.doi.org/10.3126/nepjoph.v4i2.6545; Guruprasad BS, 2013, OPHTHAL EPIDEMIOL, V20, P89, DOI 10.3109/09286586.2012.759597; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Khandekar R, 2011, OMAN J OPHTHALMOLOGY, V4, P129; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070120; Marmamula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055924; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Neena J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002867; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Sapkota YD, 2006, BRIT J OPHTHALMOL, V90, P411, DOI 10.1136/bjo.2005.082503; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; Shaikh Sajida Parveen, 2005, J Coll Physicians Surg Pak, V15, P145; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; StataCorp, 2009, STAT STAT SOFTW REL; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	23	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100644	10.1371/journal.pone.0100644	http://dx.doi.org/10.1371/journal.pone.0100644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007075	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600015
J	Vossius, C; Lotto, E; Lyanga, S; Mduma, E; Msemo, G; Perlman, J; Ersdal, HL				Vossius, Corinna; Lotto, Editha; Lyanga, Sara; Mduma, Estomih; Msemo, Georgina; Perlman, Jeffrey; Ersdal, Hege L.			Cost-Effectiveness of the "Helping Babies Breathe'' Program in a Missionary Hospital in Rural Tanzania	PLOS ONE			English	Article							CHILD-MORTALITY; COUNTRIES	Objective: The Helping Babies Breathe'' (HBB) program is an evidence-based curriculum in basic neonatal care and resuscitation, utilizing simulation-based training to educate large numbers of birth attendants in low-resource countries. We analyzed its cost-effectiveness at a faith-based Haydom Lutheran Hospital (HLH) in rural Tanzania. Methods: Data about early neonatal mortality and fresh stillbirth rates were drawn from a linked observational study during one year before and one year after full implementation of the HBB program. Cost data were provided by the Tanzanian Ministry of Health and Social Welfare (MOHSW), the research department at HLH, and the manufacturer of the training material Laerdal Global Health. Findings: Costs per life saved were USD 233, while they were USD 4.21 per life year gained. Costs for maintaining the program were USD 80 per life saved and USD 1.44 per life year gained. Costs per disease adjusted life year (DALY) averted ranged from International Dollars (ID; a virtual valuta corrected for purchasing power world-wide) 12 to 23, according to how DALYs were calculated. Conclusion: The HBB program is a low-cost intervention. Implementation in a very rural faith-based hospital like HLH has been highly cost-effective. To facilitate further global implementation of HBB a cost-effectiveness analysis including government owned institutions, urban hospitals and district facilities is desirable for a more diverse analysis to explore cost-driving factors and predictors of enhanced cost-effectiveness.	[Vossius, Corinna; Ersdal, Hege L.] Stavanger Univ Hosp, SAFER Stavanger Acute Med Fdn Educ & Res, Stavanger, Norway; [Lotto, Editha; Lyanga, Sara; Mduma, Estomih; Ersdal, Hege L.] Haydom Lutheran Hosp, Res Inst, Haydom, Tanzania; [Msemo, Georgina] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Perlman, Jeffrey] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Stavanger University Hospital; Cornell University	Vossius, C (corresponding author), Stavanger Univ Hosp, SAFER Stavanger Acute Med Fdn Educ & Res, Stavanger, Norway.	c.vossius@hotmail.com			Laerdal Foundation for Acute Medicine [40023]; municipaility of Stavanger, Norway; research department of Haydom Lutheran Hospital, Tanzania	Laerdal Foundation for Acute Medicine; municipaility of Stavanger, Norway; research department of Haydom Lutheran Hospital, Tanzania	The study was partly funded by the Laerdal Foundation for Acute Medicine (grant number 40023; http://www.laerdal.com/no/doc/311/Laerdals-Fond-for-Akuttmedisin), that provided travel expenses for Corinna Vossius and Hege L. Ersdal and a reserach grant for Hege L. Ersdal. Further, the research was funded by the municipaility of Stavanger, Norway and the research department of Haydom Lutheran Hospital, Tanzania. No funding bodies had any role in study design, data collection, decision or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Ersdal HL, 2012, RESUSCITATION, V83, P869, DOI 10.1016/j.resuscitation.2011.12.011; Ersdal HL, 2012, PEDIATRICS, V129, pE1238, DOI 10.1542/peds.2011-3134; Ersdal HL, 2013, PAS 2013; Johns B, 2003, PROGRAMME COSTS EC E; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Manasyan A, 2011, PEDIATRICS, V127, pE1176, DOI 10.1542/peds.2010-2158; Mduma E, 2013, PAS 2013; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Save The Children, 2009, SIT AN NEWB HLTH TAN; UN, 1994, INT C POP DEV 5 13 S, P5; UNICEF, 2004, STAT WORLDS CHILDR R; UNICEF, 2011, UNICEF REP 2011 LEV; United Nations, 2013, BREAKTHR INN CAN SAV; United Nations Department of Economic and Social Affairs (UN DESA), 2011, POP DIV WORLD POP PR; WHO, 2009, NAT ROADM STRAT PLAN; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2005, CHOOS INT AR COST EF; World Health Organization, 2005, CHOSS INT ARE COST E; World Health Organization, 2006, WORK HLTH; World Health Organization, 2005, WORLD HLTH REP 2005	25	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102080	10.1371/journal.pone.0102080	http://dx.doi.org/10.1371/journal.pone.0102080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006802	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600092
J	Rosenberg, MS				Rosenberg, Michael S.			Contextual Cross-Referencing of Species Names for Fiddler Crabs (Genus Uca): An Experiment in Cyber-Taxonomy	PLOS ONE			English	Article							OCYPODIDAE	Cyber-taxonomy of name usage has focused primarily on producing authoritative lists of names or cross-linking names and data across disparate databases. A feature missing from much of this work is the recording and analysis of the context in which a name was used-context which can be critical for understanding not only what name an author used, but to which currently recognized species they actually refer. An experiment on recording contextual information associated with name usage was conducted for the fiddler crabs (genus Uca). Data from approximately one quarter of all publications that mention fiddler crabs, including 95% of those published prior to 1924 and 67% of those published prior to 1976, have currently been recorded in a database. Approaches and difficulties in recording and analyzing the context of name use are discussed. These results are not meant to be a full solution, rather to highlight problems which have not been previously investigated and may act as a springboard for broader approaches and discussion. Some data on the accessibility of the literature, including in particular electronic forms of publication, are also presented.	[Rosenberg, Michael S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Rosenberg, Michael S.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Rosenberg, MS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	msr@asu.edu	Rosenberg, Michael S/A-4621-2008	Rosenberg, Michael S/0000-0001-7882-2467				BOTT R, 1973, Senckenbergiana Biologica, V54, P311; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; FIELDER DR, 1971, COMP BIOCHEM PHYSIOL, V39, P291, DOI 10.1016/0305-0491(71)90172-6; Franz NM, 2013, SYST BIODIVERS, V11, P209, DOI 10.1080/14772000.2013.806371; George R.W., 1982, Records of the Western Australian Museum Supplement, V14, P1; Gould A.A., 1841, REPORT INVERTEBRA MA; Hess W., 1865, ARCH NATURGESCH, VXXXI, P127; Hoffmann CK, 1874, CRUSTACEA; Holthuis L.B., 1979, Bulletin of Zoological Nomenclature, V35, P248; Huber R, 2009, COMPUT GEOSCI-UK, V35, P862, DOI 10.1016/j.cageo.2008.02.016; Kennedy JB, 2005, LECT NOTES COMPUT SC, V3615, P80; KING DS, 1969, NATURE, V221, P955, DOI 10.1038/221955a0; Kingsley JS, 1880, P ACAD NAT SCI PHILA, P135; LINNAEUS C, 1758, SYSTEMA NATURAE; MACNAE W, 1966, AUST J BOT, V14, P67, DOI 10.1071/BT9660067; MARCGRAVI G., 1648, HIST NATURALIS BRASI, P1; Miller J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-87; Nabout JC, 2010, IHERINGIA SER ZOOL, V100, P463, DOI 10.1590/S0073-47212010000400019; NOVAK A, 1974, Proceedings of the Biological Society of Washington, V87, P313; Page RDM, 2013, PEERJ, V1, DOI 10.7717/peerj.190; Rao K. R., 1968, Proceedings of the Louisiana Academy of Sciences, V31, P27; Rathbun M. J., 1897, P BIOL SOC WASH, V11, P153; Rathbun Mary J., 1914, Proceedings of the United States National Museum Smithsonian Institution Washington, V47; Rosenberg MS, 2013, ZOOTAXA, V3716, P494; Rumphius G.E., 1705, AMBOINSCHE RARITEITK; Shih HT, 2009, HYDROBIOLOGIA, V635, P373, DOI 10.1007/s10750-009-9930-6; Tavares Marcos S., 1993, V8, P7; VERNBERG FJ, 1966, PHYSIOL ZOOL, V39, P36, DOI 10.1086/physzool.39.1.30152765; VERWEY J., 1930, TREUBIA, V12, P167	29	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101704	10.1371/journal.pone.0101704	http://dx.doi.org/10.1371/journal.pone.0101704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004097	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700055
J	Widjaja, D; Caicedo, A; Vlemincx, E; Van Diest, I; Van Huffel, S				Widjaja, Devy; Caicedo, Alexander; Vlemincx, Elke; Van Diest, Ilse; Van Huffel, Sabine			Separation of Respiratory Influences from the Tachogram: A Methodological Evaluation	PLOS ONE			English	Article							RSA COMPONENT EXTRACTION; SINUS ARRHYTHMIA; BAROREFLEX GAIN; VARIABILITY; SIGNALS; MODEL; PCA	The variability of the heart rate (HRV) is widely studied as it contains information about the activity of the autonomic nervous system (ANS). However, HRV is influenced by breathing, independently of ANS activity. It is therefore important to include respiratory information in HRV analyses in order to correctly interpret the results. In this paper, we propose to record respiratory activity and use this information to separate the tachogram in two components: one which is related to breathing and one which contains all heart rate variations that are unrelated to respiration. Several algorithms to achieve this have been suggested in the literature, but no comparison between the methods has been performed yet. In this paper, we conduct two studies to evaluate the methods' performances to accurately decompose the tachogram in two components and to assess the robustness of the algorithms. The results show that orthogonal subspace projection and an ARMAX model yield the best performances over the two comparison studies. In addition, a real-life example of stress classification is presented to demonstrate that this approach to separate respiratory information in HRV studies can reveal changes in the heart rate variations that are otherwise masked by differing respiratory patterns.	[Widjaja, Devy; Caicedo, Alexander; Van Huffel, Sabine] Katholieke Univ Leuven, Dept Elect Engn, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium; [Widjaja, Devy; Caicedo, Alexander; Van Huffel, Sabine] IMinds, Med Informat Technol Dept, Leuven, Belgium; [Vlemincx, Elke; Van Diest, Ilse] Katholieke Univ Leuven, Fac Psychol & Educ Sci Hlth Psychol, Leuven, Belgium	KU Leuven; IMEC; KU Leuven	Widjaja, D (corresponding author), Katholieke Univ Leuven, Dept Elect Engn, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium.	devy.widjaja@esat.kuleuven.be	Dorado, Alexander Caicedo/ABG-9304-2020	Dorado, Alexander Caicedo/0000-0002-2073-8008; Van Diest, Ilse/0000-0002-0048-774X	Research Council KUL [CoE PFV/10/002 (OPTEC), GOA/10/09 MaNet]; FWO [G.0427.10N, G.0108.11, G.0869.12N, G.0A5513N]; IWT [TBM 080658-MRI, TBM 110697-NeoGuard]; IWT PhD Grant; iMinds Medical Information Technologies: SBO; ICON NXT_Sleep; Flanders Care Demonstratieproject Tele-Rehab III; Belgian Federal Science Policy Office [IUAP P7/19]; Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; EU RECAP 209G within INTERREG IVB NWE programme, EU MC ITN TRANSACT [316679]; ERC Advanced Grant BIOTENSORS [339804]; ERASMUS EQR Community service engineer [539642-LLP-1-2013]	Research Council KUL(KU Leuven); FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IWT PhD Grant; iMinds Medical Information Technologies: SBO; ICON NXT_Sleep; Flanders Care Demonstratieproject Tele-Rehab III; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; EU RECAP 209G within INTERREG IVB NWE programme, EU MC ITN TRANSACT; ERC Advanced Grant BIOTENSORS; ERASMUS EQR Community service engineer	Research supported by Research Council KUL: CoE PFV/10/002 (OPTEC), GOA/10/09 MaNet, PhD/Postdoc grants; FWO: PhD/Postdoc grants, G.0427.10N (Integrated EEG-fMRI), G.0108.11 (Compressed Sensing), G.0869.12N (Tumor imaging), G.0A5513N (Deep brain stimulation); IWT: PhD/Postdoc grants, TBM 080658-MRI (EEG-fMRI), TBM 110697-NeoGuard, D. Widjaja is supported by an IWT PhD Grant; iMinds Medical Information Technologies: SBO 2014, ICON NXT_Sleep; Flanders Care Demonstratieproject Tele-Rehab III (2012-2014); Belgian Federal Science Policy Office IUAP P7/19 (DYSCO,'Dynamical systems, control and optimization', 2012-2017); Belgian Foreign Affairs-Development Cooperation: VLIR UOS programs; EU RECAP 209G within INTERREG IVB NWE programme, EU MC ITN TRANSACT 2012 (no 316679), ERC Advanced Grant BIOTENSORS (no 339804), ERASMUS EQR Community service engineer (no 539642-LLP-1-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataee P, 2012, IEEE ENG MED BIO, P3805, DOI 10.1109/EMBC.2012.6346796; Bailon R, 2007, P ANN INT IEEE EMBS, P6675; Bakshi BR, 1998, AICHE J, V44, P1596, DOI 10.1002/aic.690440712; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; BASELLI G, 1988, IEEE T BIO-MED ENG, V35, P1033, DOI 10.1109/10.8688; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; BIANCHI AM, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P121, DOI 10.1109/IEMBS.1994.412075; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Caicedo A, 2013, IEEE ENG MED BIO, P2032, DOI 10.1109/EMBC.2013.6609930; Caicedo A, 2012, IEEE ENG MED BIO, P6153, DOI 10.1109/EMBC.2012.6347398; Camm AJ, 1996, EUR HEART J, V17, P354; Choi J, 2011, IEEE SENS J, V11, P2649, DOI 10.1109/JSEN.2011.2150746; Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Grossman P, 2006, BIOMED SCI INSTRUM, V42, P193; Hayano J, 1996, CIRCULATION, V94, P842, DOI 10.1161/01.CIR.94.4.842; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Lewis GF, 2012, BIOL PSYCHOL, V89, P349, DOI 10.1016/j.biopsycho.2011.11.009; MERRI M, 1990, IEEE T BIO-MED ENG, V37, P99, DOI 10.1109/10.43621; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patton DJ, 1996, AM J PHYSIOL-HEART C, V270, pH1240, DOI 10.1152/ajpheart.1996.270.4.H1240; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Ritz T, 2006, PSYCHOSOM MED, V68, P617, DOI 10.1097/01.psy.0000228010.96408.ed; Seidel H, 1995, MODELLING DYNAMICS B, P205, DOI DOI 10.1007/978-3-642-79290-8_11; Taelman J, 2011, EUR J APPL PHYSIOL, V111, P1497, DOI 10.1007/s00421-010-1776-0; Tiinanen S, 2009, COMPUT CARDIOL, V36, P161; Tiinanen S, 2008, IEEE T BIO-MED ENG, V55, P51, DOI 10.1109/TBME.2007.897840; Tiinanen S, 2010, COMPUT CARDIOL CONF, V37, P73; Vlemincx E, 2013, INT J PSYCHOPHYSIOL, V87, P147, DOI 10.1016/j.ijpsycho.2012.12.002; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Widjaja D, 2012, 7 INT WORKSH BIOS IN, P299; Widjaja D, 2013, IEEE ENG MED BIO, P6123, DOI 10.1109/EMBC.2013.6610950; Yasuma F, 2004, CHEST, V125, P683, DOI 10.1378/chest.125.2.683	36	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101713	10.1371/journal.pone.0101713	http://dx.doi.org/10.1371/journal.pone.0101713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004139	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700056
J	Yokota, M; Kobayashi, Y; Morita, J; Suzuki, H; Hashimoto, Y; Sasaki, Y; Akiyoshi, K; Moriyama, K				Yokota, Masako; Kobayashi, Yukiho; Morita, Jumpei; Suzuki, Hiroyuki; Hashimoto, Yoshihide; Sasaki, Yoshihiro; Akiyoshi, Kazunari; Moriyama, Keiji			Therapeutic Effect of Nanogel-Based Delivery of Soluble FGFR2 with S252W Mutation on Craniosynostosis	PLOS ONE			English	Article							FACTOR RECEPTOR-2 FGFR2; APERT-SYNDROME; MOUSE MODEL; SUSTAINED-RELEASE; IMMUNE-RESPONSES; BONE-DEVELOPMENT; CROUZON-SYNDROME; CALVARIAL BONE; GENE CAUSE; DIFFERENTIATION	Apert syndrome is an autosomal dominantly inherited disorder caused by missense mutations in fibroblast growth factor receptor 2 (FGFR2). Surgical procedures are frequently required to reduce morphological and functional defects in patients with Apert syndrome; therefore, the development of noninvasive procedures to treat Apert syndrome is critical. Here we aimed to clarify the etiological mechanisms of craniosynostosis in mouse models of Apert syndrome and verify the effects of purified soluble FGFR2 harboring the S252W mutation (sFGFR2IIIc(S252W)) on calvarial sutures in Apert syndrome mice in vitro. We observed increased expression of Fgf10, Esrp1, and Fgfr2IIIb, which are indispensable for epidermal development, in coronal sutures in Apert syndrome mice. Purified sFGFR2IIIc(S252W) exhibited binding affinity for fibroblast growth factor (Fgf)2 but also formed heterodimers with FGFR2IIIc, FGFR2IIIc(S252W), and FGFR2IIIb(S252W). Administration of sFGFR2IIIc(S252W) also inhibited Fgf2-dependent proliferation, phosphorylation of intracellular signaling molecules, and mineralization of FGFR2(S252W)-overexpressing MC3T3-E1 osteoblasts. sFGFR2IIIc(S252W) complexed with nanogels maintained the patency of coronal sutures, whereas synostosis was observed where the nanogel without sFGFR2(S252W) was applied. Thus, based on our current data, we suggest that increased Fgf10 and Fgfr2IIIb expression may induce the onset of craniosynostosis in patients with Apert syndrome and that the appropriate delivery of purified sFGFR2IIIc(S252W) could be effective for treating this disorder.	[Yokota, Masako; Kobayashi, Yukiho; Morita, Jumpei; Suzuki, Hiroyuki; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Maxillofacial Neck Reconstruct, Dept Maxillofacial Reconstruct & Funct, Tokyo, Japan; [Kobayashi, Yukiho; Suzuki, Hiroyuki; Sasaki, Yoshihiro; Akiyoshi, Kazunari; Moriyama, Keiji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto, Japan; [Hashimoto, Yoshihide; Akiyoshi, Kazunari] Japan Sci & Technol Agcy, ERATO, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; Japan Science & Technology Agency (JST)	Kobayashi, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Maxillofacial Neck Reconstruct, Dept Maxillofacial Reconstruct & Funct, Tokyo, Japan.	yukiho-kobayashi.mort@tmd.ac.jp	HASHIMOTO, YOSHIHIDE/S-3056-2017; Moriyama, Keiji/AAC-3193-2019	HASHIMOTO, YOSHIHIDE/0000-0003-0537-8291; Moriyama, Keiji/0000-0003-0580-4510	Japan Society for the Promotion of Science, as well as the Global Center of Excellence Program at the Tokyo Medical and Dental University (TMDU), Japan [23390471, 23792418]	Japan Society for the Promotion of Science, as well as the Global Center of Excellence Program at the Tokyo Medical and Dental University (TMDU), Japan	This study was financially supported by a Grant-in-aid for Scientific Research (No. 23390471 to KM, http://www.jsps.go.jp/english/index.html) and Young Scientists (No. 23792418 to YK, http://www.jsps.go.jp/english/index.html) from Japan Society for the Promotion of Science, as well as the Global Center of Excellence Program at the Tokyo Medical and Dental University (TMDU), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behr B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070240; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chevrel G, 2002, ANN RHEUM DIS, V61, P730, DOI 10.1136/ard.61.8.730; Fong KD, 2004, PLAST RECONSTR SURG, V113, P2037, DOI 10.1097/01.PRS.0000121182.01199.C1; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Fujioka-Kobayashi M, 2012, BIOMATERIALS, V33, P7613, DOI 10.1016/j.biomaterials.2012.06.075; Hajihosseini MK, 2001, P NATL ACAD SCI USA, V98, P3855, DOI 10.1073/pnas.071586898; Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760; Holmes G, 2009, DEV BIOL, V328, P273, DOI 10.1016/j.ydbio.2009.01.026; Ikuta Y, 2002, BLOOD, V99, P3717, DOI 10.1182/blood.V99.10.3717; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Kageyama S, 2008, CANCER SCI, V99, P601, DOI 10.1111/j.1349-7006.2007.00705.x; Kitano S, 2006, CLIN CANCER RES, V12, P7397, DOI 10.1158/1078-0432.CCR-06-1546; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lamoureux F, 2008, MOL CANCER THER, V7, P3389, DOI 10.1158/1535-7163.MCT-08-0497; Lomri A, 1998, J CLIN INVEST, V101, P1310; Matsumoto K, 2002, SCAND J PLAST RECONS, V36, P368, DOI 10.1080/028443102321096375; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Morita J, 2014, DEV DYNAM, V243, P560, DOI 10.1002/dvdy.24099; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Przylepa KA, 1996, NAT GENET, V13, P492, DOI 10.1038/ng0896-492; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Rice DPC, 1999, EUR J ORAL SCI, V107, P265, DOI 10.1046/j.0909-8836.1999.eos107406.x; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; Rice DPC, 2000, DEVELOPMENT, V127, P1845; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008; Shen K, 2009, ORTHOD CRANIOFAC RES, V12, P254, DOI 10.1111/j.1601-6343.2009.01460.x; Shimizu T, 2008, BIOCHEM BIOPH RES CO, V367, P330, DOI 10.1016/j.bbrc.2007.12.112; Shimoda A, 2012, COLLOID SURFACE B, V99, P38, DOI 10.1016/j.colsurfb.2011.09.025; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Suzuki H, 2012, J CELL PHYSIOL, V227, P3267, DOI 10.1002/jcp.24021; Tanimoto Y, 2004, J BIOL CHEM, V279, P45926, DOI 10.1074/jbc.M404824200; TROWELL OA, 1954, EXP CELL RES, V6, P246, DOI 10.1016/0014-4827(54)90169-X; Veistinen L, 2009, J EXP ZOOL PART B, V312B, P351, DOI 10.1002/jez.b.21276; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Watanabe K, 2011, BIOMATERIALS, V32, P5900, DOI 10.1016/j.biomaterials.2011.04.058; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Yang F, 2008, BONE, V43, P55, DOI 10.1016/j.bone.2008.02.008; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	46	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101693	10.1371/journal.pone.0101693	http://dx.doi.org/10.1371/journal.pone.0101693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003957	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700054
J	Zolnerciks, JK; Akkaya, BG; Snippe, M; Chiba, P; Seelig, A; Linton, KJ				Zolnerciks, Joseph K.; Akkaya, Begum G.; Snippe, Marjolein; Chiba, Peter; Seelig, Anna; Linton, Kenneth J.			The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycle	FASEB JOURNAL			English	Article						ABC transporter molecular mechanism; drug efflux pump; MDR1; membrane protein; primary active transport	P-GLYCOPROTEIN REVEALS; CASSETTE TRANSPORTER; CRYSTAL-STRUCTURE; MALTOSE TRANSPORTER; MONOCLONAL-ANTIBODY; GLUTAMATE RESIDUES; ALTERNATING ACCESS; PLASMA-MEMBRANE; HIGH-AFFINITY; LIVING CELLS	For a primary active pump, such as the human ATP-binding-cassette (ABC) transporter ABCB1, coupling of drug-binding by the two transmembrane domains (TMDs) to the ATP catalytic cycle of the two nucleotide-binding domains (NBDs) is fundamental to the transport mechanism, but is poorly understood at the biochemical level. Structure data suggest that signals are transduced through intracellular loops of the TMDs that slot into grooves on the NBDs. At the base of these grooves is the Q loop. We therefore mutated the eponymous glutamine in one or both NBD Q loops and measured the effect on conformation and function by using a conformation-sensitive antibody (UIC2) and a fluorescent drug (Bodipy-verapamil), respectively. We showed that the double mutant is trapped in the inward-open state, which binds the drug, but cannot couple to the ATPase cycle. Our data also describe marked redundancy within the transport mechanism, because single-Q-loop mutants are functional for Bodipy-verapamil transport. This result allowed us to elucidate transduction pathways from twin drug-binding cavities to the Q loops using point mutations to favor one cavity over the other. Together, the data show that the Q loop is the central flexion point where the aspect of the drug-binding cavities is coupled to the ATP catalytic cycle.	[Zolnerciks, Joseph K.; Akkaya, Begum G.; Snippe, Marjolein; Linton, Kenneth J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Chiba, Peter] Med Univ Vienna, Inst Med Chem, Vienna, Austria; [Seelig, Anna] Univ Basel, Biophys Chem Biozentrum, Basel, Switzerland	University of London; Queen Mary University London; Medical University of Vienna; University of Basel	Linton, KJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, 4 Newark St, London E1 2AT, England.	k.j.linton@qmul.ac.uk	Chiba, Peter/ABA-7347-2020	Chiba, Peter/0000-0003-4465-5263	Medical Research Council UK; Federation of European Biological Societies (FEBS) short-term fellowship; Queen Mary, University of London; Medical Research Council [MC_U120088463] Funding Source: researchfish; MRC [MC_U120088463] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Federation of European Biological Societies (FEBS) short-term fellowship; Queen Mary, University of London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank T. Ritchie for practical investigations and intellectual contribution to the manuscript, M. Zwick and C. Esposito for assistance with the cytosensor experiments and valuable discussions, and T. Stockner for use of his homology model of ABCB1. This work was supported by the Medical Research Council UK and a Federation of European Biological Societies (FEBS) short-term fellowship to J.K.Z. B.G.A. is funded by Queen Mary, University of London.	Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033; Blott EJ, 1999, EMBO J, V18, P6800, DOI 10.1093/emboj/18.23.6800; Cakil YD, 2014, MOL PHARMACOL, V85, P420, DOI 10.1124/mol.113.088526; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; Gaudet R, 2001, TECHNOL REV, V104, P20; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P147, DOI 10.1016/S0925-4439(97)00025-2; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Parveen Z, 2011, MOL PHARMACOL, V79, P443, DOI 10.1124/mol.110.067611; Pleban K, 2005, MOL PHARMACOL, V67, P365, DOI 10.1124/mol.104.006973; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rothnie A, 2001, EUR BIOPHYS J BIOPHY, V30, P430, DOI 10.1007/s002490100156; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Stockner T, 2009, FEBS J, V276, P964, DOI 10.1111/j.1742-4658.2008.06832.x; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; Taylor AM, 2001, BRIT J PHARMACOL, V134, P1609, DOI 10.1038/sj.bjp.0704400; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; WALTER C, 1992, FEBS LETT, V303, P41, DOI 10.1016/0014-5793(92)80473-T; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhou Y, 1999, ARCH BIOCHEM BIOPHYS, V367, P74, DOI 10.1006/abbi.1999.1221; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	55	33	34	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4335	4346		10.1096/fj.13-245639	http://dx.doi.org/10.1096/fj.13-245639			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25016028	Green Submitted			2022-12-25	WOS:000342222700013
J	Vassilopoulos, A; Xiao, CY; Chisholm, C; Chen, WP; Xu, XL; Lahusen, TJ; Bewley, C; Deng, CX				Vassilopoulos, Athanassios; Xiao, Cuiying; Chisholm, Cristine; Chen, Weiping; Xu, Xiaoling; Lahusen, Tyler J.; Bewley, Carole; Deng, Chu-Xia			Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cancer Stem Cells; Cytoskeleton; Drug Resistance; Tumor Metastases; PI3K Signaling	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; STEM-CELLS; INITIATING CELLS; ERM PROTEINS; IDENTIFICATION; RESISTANCE; PATHWAY; PHOSPHORYLATION; CYTOSKELETON	Background: Metastasis is a serious problem that claims the lives of breast cancer patients. Results: Rapamycin and cisplatin synergistically inhibit CSC-mediated primary and metastatic cancer growth by blocking mTOR signaling and cytoskeletal remodeling. Conclusion: Cancer stem cells are involved in both primary and metastatic cancer growth of Brca1 tumors through distinct signaling pathways. Significance: Targeting cancer stem cell-specific pathways may reveal new therapeutic strategies. Drug resistance and cancer metastasis are two major problems in cancer research. During a course of therapeutic treatment in Brca1-associated tumors, we found that breast cancer stem cells (CSCs) exhibit an intrinsic ability to metastasize and acquire drug resistance through distinct signaling pathways. Microarray analysis indicated that the cytoskeletal remodeling pathway was differentially regulated in CSCs, and this was further evidenced by the inhibitory role of reagents that impair this pathway in the motility of cancer cells. We showed that cisplatin treatment, although initially inhibiting cancer growth, preventing metastasis through blocking cytoskeletal remodeling, and retarding CSC motility, eventually led to drug resistance associated with a marked increase in the number of CSCs. This event was at least partially attributed to the activation of PI3K signaling, and it could be significantly inhibited by co-treatment with rapamycin. These results provide strong evidence that cytoskeletal rearrangement and PI3K/AKT signaling play distinct roles in mediating CSC mobility and viability, respectively, and blocking both pathways synergistically may inhibit primary and metastatic cancer growth.	[Vassilopoulos, Athanassios; Xiao, Cuiying; Chisholm, Cristine; Xu, Xiaoling; Lahusen, Tyler J.; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Microarray Core Facil, NIH, Bethesda, MD 20892 USA; [Bewley, Carole] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deng, CX (corresponding author), Bldg 10,Rm 9N105,10 Ctr Dr, Bethesda, MD 20814 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016; Chen, Wei/GZK-7348-2022	Bewley, Carole/0000-0003-2203-0852	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056009, ZIADK031135, ZIADK056011] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIDDK.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albert S, 2010, EXPERT OPIN INV DRUG, V19, P919, DOI 10.1517/13543784.2010.499121; Anders C, 2008, ONCOLOGY-NY, V22, P1233; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dine J, 2013, CANCER METAST REV, V32, P25, DOI 10.1007/s10555-012-9403-7; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Jain P, 2011, FRONT BIOSCI-LANDMRK, V16, P1824, DOI 10.2741/3824; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Lam L, 2009, BREAST CANCER RES TR, V118, P605, DOI 10.1007/s10549-008-0231-y; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Metaferia BB, 2007, J AM CHEM SOC, V129, P2434, DOI 10.1021/ja068538d; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tassone P, 2009, CANCER BIOL THER, V8, P648, DOI 10.4161/cbt.8.7.7968; Vassilopoulos A, 2014, ONCOGENE, V33, P5477, DOI 10.1038/onc.2013.516; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Xiang T, 2011, ONCOGENE, V30, P2443, DOI 10.1038/onc.2010.603; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	49	20	20	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24202	24214		10.1074/jbc.M114.567552	http://dx.doi.org/10.1074/jbc.M114.567552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006250	Green Published, hybrid			2022-12-25	WOS:000341505600018
J	Leung, A; Parks, BW; Du, J; Trac, C; Setten, R; Chen, Y; Brown, K; Lusis, AJ; Natarajan, R; Schones, DE				Leung, Amy; Parks, Brian W.; Du, Juan; Trac, Candi; Setten, Ryan; Chen, Yin; Brown, Kevin; Lusis, Aldons J.; Natarajan, Rama; Schones, Dustin E.			Open Chromatin Profiling in Mice Livers Reveals Unique Chromatin Variations Induced by High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Diet; Gene Regulation; Liver Metabolism; Metabolic Disease; Gene-environment Interaction	TRANSCRIPTION FACTOR; GENE; ENHANCERS; OBESITY; MUSCLE; SITES; SEQ	Background: Metabolic diseases result from a combination of multiple genetic and environmental factors. Results: High fat diet leads to chromatin remodeling in mice liver tissue in a strain-dependent manner. Conclusion: Diet can induce changes in the epigenome thereby contributing to metabolic disease. Significance: Environmental factors can contribute to complex disease progression through modifications to chromatin. Metabolic diseases result from multiple genetic and environmental factors. We report here that one manner in which environmental factors can contribute to metabolic disease progression is through modification to chromatin. We demonstrate that high fat diet leads to chromatin remodeling in the livers of C57BL/6J mice, as compared with mice fed a control diet, and that these chromatin changes are associated with changes in gene expression. We further show that the regions of greatest variation in chromatin accessibility are targeted by liver transcription factors, including HNF4, CCAAT/enhancer-binding protein (CEBP/), and FOXA1. Repeating the chromatin and gene expression profiling in another mouse strain, DBA/2J, revealed that the regions of greatest chromatin change are largely strain-specific and that integration of chromatin, gene expression, and genetic data can be used to characterize regulatory regions. Our data indicate dramatic changes in the epigenome due to diet and demonstrate strain-specific dynamics in chromatin remodeling.	[Leung, Amy; Natarajan, Rama] City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, Duarte, CA 91010 USA; [Du, Juan; Trac, Candi; Brown, Kevin; Schones, Dustin E.] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Du, Juan; Setten, Ryan; Chen, Yin; Natarajan, Rama; Schones, Dustin E.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Parks, Brian W.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of California System; University of California Los Angeles	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91016 USA.	rnatarajan@coh.org; dschones@coh.org		Setten, Ryan/0000-0002-0956-7084	National Cancer Institute of the National Institutes of Health [P30CA33572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864, K22HL101950, R01HL106089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094311, T32DK007571, R01DK065073] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Kirti Bhatt for assistance with staining and other members of the Schones and Natarajan laboratories for helpful discussions and comments. Research reported in this publication included work performed in the Pathology and Integrative Genomics Cores of the City of Hope supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Funkat A, 2004, J NUTR, V134, P3264, DOI 10.1093/jn/134.12.3264; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hall RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089279; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hosseini M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003570; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keating ST, 2012, J CARDIOVASC TRANSL, V5, P399, DOI 10.1007/s12265-012-9380-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mair M, 2011, FRONT BIOSCI-LANDMRK, V16, P2794, DOI 10.2741/3886; Martinez MJ, 2007, BIOINFORMATICS, V23, P21, DOI 10.1093/bioinformatics/btl531; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Reddy MA, 2011, CARDIOVASC RES, V90, P421, DOI 10.1093/cvr/cvr024; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2005, BIOINFORMATICS, V21, pI403, DOI 10.1093/bioinformatics/bti1043; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Widiker S, 2010, J APPL GENET, V51, P193, DOI 10.1007/BF03195727; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	43	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23557	23567		10.1074/jbc.M114.581439	http://dx.doi.org/10.1074/jbc.M114.581439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006255	Green Published, hybrid			2022-12-25	WOS:000341505000026
J	Fuhrmann, A; Li, JL; Chien, S; Engler, AJ				Fuhrmann, Alexander; Li, Julie; Chien, Shu; Engler, Adam J.			Cation Type Specific Cell Remodeling Regulates Attachment Strength	PLOS ONE			English	Article							INTEGRIN-MEDIATED ADHESION; QUANTITATIVE MEASUREMENTS; DIVALENT-CATIONS; BINDING; FIBRONECTIN; AFFINITY; MATRIX; FIBROBLASTS; MAGNESIUM; DYNAMICS	Single-molecule experiments indicate that integrin affinity is cation-type-dependent, but in spread cells integrins are engaged in complex focal adhesions (FAs), which can also regulate affinity. To better understand cation-type-dependent adhesion in fully spread cells, we investigated attachment strength by application of external shear. While cell attachment strength is indeed modulated by cations, the regulation of integrin-mediated adhesion is also exceedingly complex, cell specific, and niche dependent. In the presence of magnesium only, fibroblasts and fibrosarcoma cells remodel their cytoskeleton to align in the direction of applied shear in an alpha(5)-integrin/fibronectin-dependent manner, which allows them to withstand higher shear. In the presence of calcium or on collagen in modest shear, fibroblasts undergo piecewise detachment but fibrosarcoma cells exhibit increased attachment strength. These data augment the current understanding of force-mediated detachment by suggesting a dynamic interplay in situ between cell adhesion and integrins depending on local niche cation conditions.	[Fuhrmann, Alexander; Li, Julie; Chien, Shu; Engler, Adam J.] Univ Calif San Diego, Dept Bioengn, Inst Engn Med, La Jolla, CA 92093 USA; [Chien, Shu] Univ Calif San Diego, Dept Med, Inst Engn Med, La Jolla, CA 92093 USA; [Chien, Shu; Engler, Adam J.] Sanford Consortium Regenerat Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Engler, AJ (corresponding author), Univ Calif San Diego, Dept Bioengn, Inst Engn Med, La Jolla, CA 92093 USA.	aengler@ucsd.edu	Engler, Adam/AAF-4016-2019	Engler, Adam/0000-0003-1642-5380	 [DP02OD006460];  [U54CA143803];  [BC121670P1]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006460] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DP02OD006460, U54CA143803, BC121670P1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2012, BIOCHEM BIOPH RES CO, V421, P245, DOI 10.1016/j.bbrc.2012.03.145; Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; Boettiger D, 2007, METHOD ENZYMOL, V426, P1, DOI 10.1016/S0076-6879(07)26001-X; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chen JB, 2010, J CELL PHYSIOL, V223, P68, DOI 10.1002/jcp.22010; Chen Y, 2013, P NATL ACAD SCI USA, V110, pE2352, DOI 10.1073/pnas.1221637110; CONFORTI G, 1994, CELL ADHES COMMUN, V1, P279, DOI 10.3109/15419069409097260; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Elineni KK, 2011, BIOPHYS J, V101, P2903, DOI 10.1016/j.bpj.2011.11.013; Engler AJ, 2009, J CELL SCI, V122, P1647, DOI 10.1242/jcs.040824; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Gabriele E, 1997, CELL GROWTH DIFFER, V8, P1339; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lange T S, 1995, Exp Dermatol, V4, P130, DOI 10.1111/j.1600-0625.1995.tb00236.x; LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271; Lee AM, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4748811; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Lomakina EB, 2004, BIOPHYS J, V86, P1223, DOI 10.1016/S0006-3495(04)74196-X; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MARTZ E, 1980, J CELL BIOL, V84, P584, DOI 10.1083/jcb.84.3.584; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Noria S, 2004, AM J PATHOL, V164, P1211, DOI 10.1016/S0002-9440(10)63209-9; Patterson KC, 2013, BIOPHYS J, V105, P40, DOI 10.1016/j.bpj.2013.05.052; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Schinagl RM, 1999, J ORTHOP RES, V17, P121, DOI 10.1002/jor.1100170118; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; SELTZER MH, 1970, CANCER RES, V30, P615; Sherwood L, 2004, HUMAN PHYSL CELLS SY; Spillmann C, 2002, ANN BIOMED ENG, V30, P1002, DOI 10.1114/1.1511241; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; TAKEICHI M, 1974, DEV BIOL, V39, P336; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535	44	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102424	10.1371/journal.pone.0102424	http://dx.doi.org/10.1371/journal.pone.0102424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014042	Green Published, gold			2022-12-25	WOS:000339378400095
J	Wei, W; Xin, HH; Roy, B; Dai, JB; Miao, YG; Gao, GJ				Wei, Wei; Xin, Huhu; Roy, Bhaskar; Dai, Junbiao; Miao, Yungen; Gao, Guanjun			Heritable Genome Editing with CRISPR/Cas9 in the Silkworm, Bombyx mori	PLOS ONE			English	Article							GUIDED CAS9 NUCLEASE; CAENORHABDITIS-ELEGANS; TARGETED MUTAGENESIS; HUMAN-CELLS; URIC-ACID; RNA; DROSOPHILA; SYSTEMS; GENES; TRANSFORMATION	We report the establishment of an efficient and heritable gene mutagenesis method in the silkworm Bombyx mori using modified type II clustered regularly interspaced short palindromic repeats (CRISPR) with an associated protein (Cas9) system. Using four loci Bm-ok, BmKMO, BmTH, and Bmtan as candidates, we proved that genome alterations at specific sites could be induced by direct microinjection of specific guide RNA and Cas9-mRNA into silkworm embryos. Mutation frequencies of 16.7-35.0% were observed in the injected generation, and DNA fragments deletions were also noted. Bm-ok mosaic mutants were used to test for mutant heritability due to the easily determined translucent epidermal phenotype of Bm-ok-disrupted cells. Two crossing strategies were used. In the first, injected Bm-ok moths were crossed with wild-type moths, and a 28.6% frequency of germline mutation transmission was observed. In the second strategy, two Bm-ok mosaic mutant moths were crossed with each other, and 93.6% of the offsprings appeared mutations in both alleles of Bm-ok gene (compound heterozygous). In summary, the CRISPR/Cas9 system can act as a highly specific and heritable gene-editing tool in Bombyx mori.	[Wei, Wei; Roy, Bhaskar; Dai, Junbiao; Gao, Guanjun] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Xin, Huhu; Miao, Yungen] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China	Tsinghua University; Zhejiang University	Miao, YG (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	miaoyg@zju.edu.cn; gaogu@mail.tsinghua.edu.cn	Dai, Junbiao/AAB-8328-2021	Dai, Junbiao/0000-0002-5299-4700	National Natural Science Foundation of China [31171278, 31271542, 31372374/C1703]; National Basic Research Program of China [2012CB114601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (31171278, 31271542, 31372374/C1703) and the National Basic Research Program of China (2012CB114601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BUCKNER JS, 1990, J INSECT PHYSIOL, V36, P219, DOI 10.1016/0022-1910(90)90106-P; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daimon T, 2014, DEV GROWTH DIFFER, V56, P14, DOI 10.1111/dgd.12096; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; KIKKAWA H, 1953, ADV GENET, V5, P107, DOI 10.1016/S0065-2660(08)60407-1; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tamura Toshiki, 2007, Journal of Insect Biotechnology and Sericology, V76, P155; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xiao A, 2014, BIOINFORMATICS; Yamao M, 1999, GENE DEV, V13, P511, DOI 10.1101/gad.13.5.511; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao AC, 2012, INSECT SCI, V19, P172, DOI 10.1111/j.1744-7917.2011.01422.x	32	60	74	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101210	10.1371/journal.pone.0101210	http://dx.doi.org/10.1371/journal.pone.0101210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013902	Green Submitted, gold, Green Published			2022-12-25	WOS:000339378400021
J	Creason, AL; Vandeputte, OM; Savory, EA; Davis, EW; Putnam, ML; Hu, ED; Swader-Hines, D; Mol, A; Baucher, M; Prinsen, E; Zdanowska, M; Givan, SA; El Jaziri, M; Loper, JE; Mahmud, T; Chang, JH				Creason, Allison L.; Vandeputte, Olivier M.; Savory, Elizabeth A.; Davis, Edward W., II; Putnam, Melodie L.; Hu, Erdong; Swader-Hines, David; Mol, Adeline; Baucher, Marie; Prinsen, Els; Zdanowska, Magdalena; Givan, Scott A.; El Jaziri, Mondher; Loper, Joyce E.; Mahmud, Taifo; Chang, Jeff H.			Analysis of Genome Sequences from Plant Pathogenic Rhodococcus Reveals Genetic Novelties in Virulence Loci	PLOS ONE			English	Article							TRANSFER-RNA; ISOPRENOID BIOSYNTHESIS; CYTOKININ BIOSYNTHESIS; FASCIANS; IDENTIFICATION; PATHWAY; PROTEIN; EVOLUTION; SELECTION; AGROBACTERIUM	Members of Gram-positive Actinobacteria cause economically important diseases to plants. Within the Rhodococcus genus, some members can cause growth deformities and persist as pathogens on a wide range of host plants. The current model predicts that phytopathogenic isolates require a cluster of three loci present on a linear plasmid, with the fas operon central to virulence. The Fas proteins synthesize, modify, and activate a mixture of growth regulating cytokinins, which cause a hormonal imbalance in plants, resulting in abnormal growth. We sequenced and compared the genomes of 20 isolates of Rhodococcus to gain insights into the mechanisms and evolution of virulence in these bacteria. Horizontal gene transfer was identified as critical but limited in the scale of virulence evolution, as few loci are conserved and exclusive to phytopathogenic isolates. Although the fas operon is present in most phytopathogenic isolates, it is absent from phytopathogenic isolate A21d2. Instead, this isolate has a horizontally acquired gene chimera that encodes a novel fusion protein with isopentyltransferase and phosphoribohydrolase domains, predicted to be capable of catalyzing and activating cytokinins, respectively. Cytokinin profiling of the archetypal D188 isolate revealed only one activate cytokinin type that was specifically synthesized in a fas-dependent manner. These results suggest that only the isopentenyladenine cytokinin type is synthesized and necessary for Rhodococcus phytopathogenicity, which is not consistent with the extant model stating that a mixture of cytokinins is necessary for Rhodococcus to cause leafy gall symptoms. In all, data indicate that only four horizontally acquired functions are sufficient to confer the trait of phytopathogenicity to members of the genetically diverse clade of Rhodococcus.	[Creason, Allison L.; Savory, Elizabeth A.; Davis, Edward W., II; Putnam, Melodie L.; Hu, Erdong; Swader-Hines, David; Loper, Joyce E.; Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Creason, Allison L.; Davis, Edward W., II; Loper, Joyce E.; Mahmud, Taifo; Chang, Jeff H.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Vandeputte, Olivier M.; Mol, Adeline; Baucher, Marie; El Jaziri, Mondher] Univ Libre Bruxelles, Lab Biotechnol Vegetale, Gosselies, Belgium; [Prinsen, Els; Zdanowska, Magdalena] Univ Antwerp, Dept Biol, Lab Plant Growth & Dev, B-2020 Antwerp, Belgium; [Givan, Scott A.] Univ Missouri, Informat Res Core Facil, Columbia, MO USA; [Loper, Joyce E.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR USA; [Mahmud, Taifo] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Chang, Jeff H.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Universite Libre de Bruxelles; University of Antwerp; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); Oregon State University; Oregon State University	Chang, JH (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	changj@science.oregonstate.edu	Prinsen, Els/M-8973-2016; Mahmud, Taifo/A-1492-2015	Prinsen, Els/0000-0003-4320-1585; Mahmud, Taifo/0000-0001-9639-526X; Givan, Scott/0000-0002-0630-8589; Davis, Edward/0000-0003-1229-4272; Creason, Allison/0000-0001-5724-1276; Chang, Jeff/0000-0002-1833-0695; Savory, Elizabeth/0000-0002-6016-9962; Baucher, Marie/0000-0002-2404-8573; Loper, Joyce/0000-0003-3501-5969	Agricultural Research Foundation; USDA (United States Department of Agriculture) NIFA (National Institute of Food and Agriculture) [2013-67012-21139]; Provost's Distinguished Graduate Fellowship by Oregon State University; National Science Foundation [DGE-1314109]; Society of American Florists; USDA-ARS (Agricultural Research Service); FRS-FNRS; Fonds David et Alice Van Buuren (Belgium)	Agricultural Research Foundation; USDA (United States Department of Agriculture) NIFA (National Institute of Food and Agriculture); Provost's Distinguished Graduate Fellowship by Oregon State University; National Science Foundation(National Science Foundation (NSF)); Society of American Florists; USDA-ARS (Agricultural Research Service); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds David et Alice Van Buuren (Belgium)	This work is supported by a grant from the Agricultural Research Foundation awarded to JHC. EAS is supported by USDA (United States Department of Agriculture) NIFA (National Institute of Food and Agriculture) post-doctoral fellowship #2013-67012-21139. EWD is supported by a Provost's Distinguished Graduate Fellowship awarded by Oregon State University. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1314109 to EWD. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors(s) and do not necessarily reflect the views of the National Science Foundation. This work is also supported in part by the Society of American Florists and a cooperative agreement with USDA-ARS (Agricultural Research Service) awarded to MLP. OMV is a Post-doctoral Researcher of the FRS-FNRS (Fonds de la Recherche Scientifique, Belgium) and supported by grants from FRS-FNRS and the Fonds David et Alice Van Buuren (Belgium). MB is a Senior Research Associate of the FRS-FNRS (Fonds de la Recherche Scientifique, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AKIYOSHI DE, 1987, J BACTERIOL, V169, P4242, DOI 10.1128/jb.169.9.4242-4248.1987; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell KS, 1998, J APPL MICROBIOL, V85, P195; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Chen HP, 2012, APPL ENVIRON MICROB, V78, P7798, DOI 10.1128/AEM.02120-12; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cornelis K, 2001, MOL PLANT MICROBE IN, V14, P599, DOI 10.1094/MPMI.2001.14.5.599; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; CRESPI M, 1992, EMBO J, V11, P795, DOI 10.1002/j.1460-2075.1992.tb05116.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; EINSET JW, 1977, BIOCHEM BIOPH RES CO, V79, P1117, DOI 10.1016/0006-291X(77)91121-4; Francis I, 2012, MOL PLANT MICROBE IN, V25, P637, DOI 10.1094/MPMI-08-11-0215; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gurtler V, 2004, FEMS MICROBIOL REV, V28, P377, DOI 10.1016/j.femsre.2004.01.001; Herbig A, 2012, BIOINFORMATICS, V28, pI7, DOI 10.1093/bioinformatics/bts217; Hjerde E, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00055-13; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jeon WB, 2006, PROTEINS, V65, P1051, DOI 10.1002/prot.21166; Joshi MV, 2007, MOL PLANT MICROBE IN, V20, P751, DOI 10.1094/MPMI-20-7-0751; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Konishi M, 2014, MAR BIOTECHNOL, V16, P484, DOI 10.1007/s10126-014-9568-x; Krall L, 2002, FEBS LETT, V527, P315, DOI 10.1016/S0014-5793(02)03258-1; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Maes T, 2001, MOL MICROBIOL, V42, P13, DOI 10.1046/j.1365-2958.2001.02615.x; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MATSUBARA S, 1968, PLANT PHYSIOL, V43, P451, DOI 10.1104/pp.43.3.451; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Na KS, 2005, J BIOSCI BIOENG, V99, P378, DOI 10.1263/jbb.99.378; Parmley JL, 2007, J MOL EVOL, V64, P646, DOI 10.1007/s00239-006-0207-7; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Pertry I, 2009, P NATL ACAD SCI USA, V106, P929, DOI 10.1073/pnas.0811683106; Pertry I, 2010, MOL PLANT MICROBE IN, V23, P1164, DOI 10.1094/MPMI-23-9-1164; Putnam ML, 2007, PLANT DIS, V91, P1064, DOI 10.1094/PDIS-91-9-1064; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; R Core Team, 2021, R LANG ENV STAT COMP; Rajaonson S, 2011, ENVIRON MICROBIOL, V13, P1236, DOI 10.1111/j.1462-2920.2011.02424.x; RATHBONE MP, 1972, PLANTA, V108, P93, DOI 10.1007/BF00386072; Redig P, 1996, PLANT PHYSIOL, V112, P141, DOI 10.1104/pp.112.1.141; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Sakakibara H, 2005, P NATL ACAD SCI USA, V102, P9972, DOI 10.1073/pnas.0500793102; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekine M, 2006, ENVIRON MICROBIOL, V8, P334, DOI 10.1111/j.1462-2920.2005.00899.x; Soisson SM, 1997, SCIENCE, V276, P421, DOI 10.1126/science.276.5311.421; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stes E, 2011, ANNU REV PHYTOPATHOL, V49, P69, DOI 10.1146/annurev-phyto-072910-095217; Sugawara H, 2008, P NATL ACAD SCI USA, V105, P2734, DOI 10.1073/pnas.0707374105; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; Temmerman W, 2000, J BACTERIOL, V182, P5832, DOI 10.1128/JB.182.20.5832-5840.2000; Vandeputte O, 2005, APPL ENVIRON MICROB, V71, P1169, DOI 10.1128/AEM.71.3.1169-1177.2005; Vereecke D, 2002, J BACTERIOL, V184, P1112, DOI 10.1128/jb.184.4.1112-1120.2002; Vereecke D, 2000, PLANTA, V210, P241, DOI 10.1007/PL00008131; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; von Bargen K, 2009, FEMS MICROBIOL REV, V33, P870, DOI 10.1111/j.1574-6976.2009.00181.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yanai I, 2002, GENOME BIOL, V3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101	92	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101996	10.1371/journal.pone.0101996	http://dx.doi.org/10.1371/journal.pone.0101996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010934	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800057
J	Eletsky, A; Michalska, K; Houliston, S; Zhang, Q; Daily, MD; Xu, XH; Cui, H; Yee, A; Lemak, A; Wu, B; Garcia, M; Burnet, MC; Meyer, KM; Aryal, UK; Sanchez, O; Ansong, C; Xiao, R; Acton, TB; Adkins, JN; Montelione, GT; Joachimiak, A; Arrowsmith, CH; Savchenko, A; Szyperski, T; Cort, JR				Eletsky, Alexander; Michalska, Karolina; Houliston, Scott; Zhang, Qi; Daily, Michael D.; Xu, Xiaohui; Cui, Hong; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Burnet, Meagan C.; Meyer, Kristen M.; Aryal, Uma K.; Sanchez, Octavio; Ansong, Charles; Xiao, Rong; Acton, Thomas B.; Adkins, Joshua N.; Montelione, Gaetano T.; Joachimiak, Andrzej; Arrowsmith, Cheryl H.; Savchenko, Alexei; Szyperski, Thomas; Cort, John R.			Structural and Functional Characterization of DUF1471 Domains of Salmonella Proteins SrfN, YdgH/SssB, and YahO	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; SOLUTION NMR STRUCTURE; VIRULENCE FACTORS; RESONANCE ASSIGNMENTS; MULTIDIMENSIONAL NMR; QUALITY ASSESSMENT; BIOFILM FORMATION; RCS PHOSPHORELAY; STRESS-RESPONSE; FORCE-FIELD	Bacterial species in the Enterobacteriaceae typically contain multiple paralogues of a small domain of unknown function (DUF1471) from a family of conserved proteins also known as YhcN or BhsA/McbA. Proteins containing DUF1471 may have a single or three copies of this domain. Representatives of this family have been demonstrated to play roles in several cellular processes including stress response, biofilm formation, and pathogenesis. We have conducted NMR and X-ray crystallographic studies of four DUF1471 domains from Salmonella representing three different paralogous DUF1471 subfamilies: SrfN, YahO, and SssB/YdgH (two of its three DUF1471 domains: the N-terminal domain I (residues 21-91), and the C-terminal domain III (residues 244-314)). Notably, SrfN has been shown to have a role in intracellular infection by Salmonella Typhimurium. These domains share less than 35% pairwise sequence identity. Structures of all four domains show a mixed alpha+beta fold that is most similar to that of bacterial lipoprotein RcsF. However, all four DUF1471 sequences lack the redox sensitive cysteine residues essential for RcsF activity in a phospho-relay pathway, suggesting that DUF1471 domains perform a different function(s). SrfN forms a dimer in contrast to YahO and SssB domains I and III, which are monomers in solution. A putative binding site for oxyanions such as phosphate and sulfate was identified in SrfN, and an interaction between the SrfN dimer and sulfated polysaccharides was demonstrated, suggesting a direct role for this DUF1471 domain at the host-pathogen interface.	[Eletsky, Alexander; Zhang, Qi; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Michalska, Karolina; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; [Houliston, Scott; Xu, Xiaohui; Cui, Hong; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Houliston, Scott; Xu, Xiaohui; Cui, Hong; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Daily, Michael D.; Burnet, Meagan C.; Meyer, Kristen M.; Aryal, Uma K.; Sanchez, Octavio; Ansong, Charles; Adkins, Joshua N.; Cort, John R.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08855 USA; [Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Savchenko, Alexei] Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Michalska, Karolina; Xu, Xiaohui; Cui, Hong; Joachimiak, Andrzej; Savchenko, Alexei] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Eletsky, Alexander; Houliston, Scott; Zhang, Qi; Yee, Adelinda; Lemak, Alexander; Wu, Bin; Garcia, Maite; Xiao, Rong; Acton, Thomas B.; Montelione, Gaetano T.; Arrowsmith, Cheryl H.; Szyperski, Thomas] Northeast Struct Genom Consortium, Piscataway, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; United States Department of Energy (DOE); Argonne National Laboratory; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory	Cort, JR (corresponding author), Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA.	john.cort@pnnl.gov		Zhang, Qi/0000-0002-7482-0875; Arrowsmith, Cheryl/0000-0002-4971-3250; Montelione, Gaetano/0000-0002-9440-3059; Joachimiak, Andrzej/0000-0003-2535-6209	US National Institutes of Health [NIAID Y1-AI-8401, NIGMS PSI-Biology GM094623, GM094597, GM094585]; Natural Sciences and Engineering Research Council of Canada [372475-10]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI008401, R01AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094623, U54GM094597, U54GM094585] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the US National Institutes of Health (nih.gov) grants NIAID Y1-AI-8401 (J.N.A.) and NIGMS PSI-Biology GM094623 (J.N.A.), GM094597 (G.T.M. and T.S., NESG), and GM094585 (A.J., MCSG), the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) grant 372475-10 (C.H.A), and the U.S. Department of Energy, Office of Biological and Environmental Research (science.energy.gov), contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; [Anonymous], PYMOL MOL GRAPHICS S; Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cort JR, 2008, J MOL BIOL, V382, P692, DOI 10.1016/j.jmb.2008.07.022; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eletsky Alexander, 2012, Journal of Structural and Functional Genomics, V13, P1, DOI 10.1007/s10969-011-9121-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gutmanas A, 2002, J BIOMOL NMR, V24, P191, DOI 10.1023/A:1021609314308; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; Jansson M, 1996, J BIOMOL NMR, V7, P131; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lopez CA, 2009, J CHEM THEORY COMPUT, V5, P3195, DOI 10.1021/ct900313w; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Manes NP, 2007, MOL CELL PROTEOMICS, V6, P717, DOI 10.1074/mcp.M600282-MCP200; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Osborne SE, 2009, P NATL ACAD SCI USA, V106, P3982, DOI 10.1073/pnas.0811669106; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rogov VV, 2011, J BIOL CHEM, V286, P18775, DOI 10.1074/jbc.M111.230185; Rossi P, 2010, J BIOMOL NMR, V46, P11, DOI 10.1007/s10858-009-9386-z; Rudd KE, 1998, ELECTROPHORESIS, V19, P536, DOI 10.1002/elps.1150190413; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salazar JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057272; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki M, 2008, J BIOL CHEM, V283, P25936, DOI 10.1074/jbc.M803773200; Wang SY, 2010, APPL ENVIRON MICROB, V76, P5013, DOI 10.1128/AEM.00823-10; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Weber MM, 2010, MICROBIOL-SGM, V156, P139, DOI 10.1099/mic.0.031468-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; Yoon H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-100; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10; Zhang XS, 2008, ISME J, V2, P615, DOI 10.1038/ismej.2008.24; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	74	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101787	10.1371/journal.pone.0101787	http://dx.doi.org/10.1371/journal.pone.0101787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010333	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800039
J	de Boer, M; Ramrattan, MA; Boeker, EB; Kuks, PFM; Boermeester, MA; Lie-A-Huen, L				de Boer, Monica; Ramrattan, Maya A.; Boeker, Eveline B.; Kuks, Paul F. M.; Boermeester, Marja A.; Lie-A-Huen, Loraine			Quality of Pharmaceutical Care in Surgical Patients	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; VULNERABLE ELDERS; MEDICATION ERRORS; HOSPITAL-CARE; TRIGGER TOOL; HEALTH-CARE; INDICATORS; PHARMACISTS; AGREEMENT; HARM	Background: Surgical patients are at risk for preventable adverse drug events (ADEs) during hospitalization. Usually, preventable ADEs are measured as an outcome parameter of quality of pharmaceutical care. However, process measures such as QIs are more efficient to assess the quality of care and provide more information about potential quality improvements. Objective: To assess the quality of pharmaceutical care of medication-related processes in surgical wards with quality indicators, in order to detect targets for quality improvements. Methods: For this observational cohort study, quality indicators were composed, validated, tested, and applied on a surgical cohort. Three surgical wards of an academic hospital in the Netherlands (Academic Medical Centre, Amsterdam) participated. Consecutive elective surgical patients with a hospital stay longer than 48 hours were included from April until June 2009. To assess the quality of pharmaceutical care, the set of quality indicators was applied to 252 medical records of surgical patients. Results: Thirty-four quality indicators were composed and tested on acceptability and content- and face-validity. The selected 28 candidate quality indicators were tested for feasibility and 'sensitivity to change'. This resulted in a final set of 27 quality indicators, of which inter-rater agreements were calculated (kappa 0.92 for eligibility, 0.74 for pass-rate). The quality of pharmaceutical care was assessed in 252 surgical patients. Nearly half of the surgical patients passed the quality indicators for pharmaceutical care (overall pass rate 49.8%). Improvements should be predominantly targeted to medication care related processes in surgical patients with gastro-intestinal problems (domain pass rate 29.4%). Conclusions: This quality indicator set can be used to measure quality of pharmaceutical care and detect targets for quality improvements. With these results medication safety in surgical patients can be enhanced.	[de Boer, Monica; Ramrattan, Maya A.; Kuks, Paul F. M.; Lie-A-Huen, Loraine] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, NL-1105 AZ Amsterdam, Netherlands; [Boeker, Eveline B.; Boermeester, Marja A.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Boer, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.deboer@amc.nl		Boermeester, Marja/0000-0003-3890-8105	Dutch Organization for Health Research and Development [170882706]	Dutch Organization for Health Research and Development	This work was supported by funding of ZonMw, The Dutch Organization for Health Research and Development [grant number 170882706]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SURG SAF CHECKL; Arora VM, 2007, J AM GERIATR SOC, V55, P1705, DOI 10.1111/j.1532-5415.2007.01444.x; Boeker EB, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-364; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Boer M, 2013, J EVAL CLIN PRACT, V19, P1073, DOI 10.1111/jep.12033; de Boer M, 2013, INT J CLIN PHARM-NET, V35, P744, DOI 10.1007/s11096-013-9797-5; De Vos M, 2009, INT J QUAL HEALTH C, V21, P119, DOI 10.1093/intqhc/mzn059; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Evans SM, 2009, INTERN MED J, V39, P648, DOI 10.1111/j.1445-5994.2008.01733.x; Handler Steven M, 2010, Ann Longterm Care, V18, P17; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; Kristensen S, 2009, INT J QUAL HEALTH C, V21, P169, DOI 10.1093/intqhc/mzp015; Kucukarslan SN, 2003, ARCH INTERN MED, V163, P2014, DOI 10.1001/archinte.163.17.2014; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lawrence M., 1997, EUR J GEN PRACT, V3, P103, DOI DOI 10.3109/13814789709160336; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; McGory ML, 2009, ANN SURG, V250, P338, DOI 10.1097/SLA.0b013e3181ae575a; Meyer-Massetti C, 2011, AM J HEALTH-SYST PH, V68, P227, DOI 10.2146/ajhp100019; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; Rozich JD, 2003, QUAL SAF HEALTH CARE, V12, P194, DOI 10.1136/qhc.12.3.194; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P489, DOI 10.1093/intqhc/13.6.489; Rubin HR, 2001, INT J QUAL HEALTH C, V13, P469, DOI 10.1093/intqhc/13.6.469; Seynaeve S, 2011, AM J CRIT CARE, V20, pE131, DOI 10.4037/ajcc2011818; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Singh R, 2009, QUAL SAF HEALTH CARE, V18, P199, DOI 10.1136/qshc.2007.024406; Takata GS, 2008, PEDIATRICS, V121, pE927, DOI 10.1542/peds.2007-1779; van Doormaal JE, 2009, QUAL SAF HEALTH CARE, V18, P22, DOI 10.1136/qshc.2007.023812; Verdaasdonk EGG, 2009, SURG ENDOSC, V23, P715, DOI 10.1007/s00464-008-0044-4; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Wierenga PC, 2011, DRUG AGING, V28, P295, DOI 10.2165/11587700-000000000-00000	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101573	10.1371/journal.pone.0101573	http://dx.doi.org/10.1371/journal.pone.0101573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006676	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600046
J	Mosesson, Y; Voichek, Y; Barkai, N				Mosesson, Yaron; Voichek, Yoav; Barkai, Naama			Divergence and Selectivity of Expression-Coupled Histone Modifications in Budding Yeasts	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME-WIDE; SACCHAROMYCES-CEREVISIAE; SAGA COMPLEX; TRANSCRIPTIONAL ELONGATION; H3 ACETYLATION; METHYLATION; NUCLEOSOME; CHROMATIN; RECRUITMENT	Various histone modifications are widely associated with gene expression, but their functional selectivity at individual genes remains to be characterized. Here, we identify widespread differences between genome-wide patterns of two prominent marks, H3K9ac and H3K4me3, in budding yeasts. As well as characteristic gene profiles, relative modification levels vary significantly amongst genes, irrespective of expression. Interestingly, we show that these differences couple to contrasting features: higher methylation to essential, periodically expressed, 'DPN' (Depleted Proximal Nucleosome) genes, and higher acetylation to non-essential, responsive, 'OPN' (Occupied Proximal Nucleosome) genes. Thus, H3K4me3 may generally associate with expression stability, and H3K9ac, with variability. To evaluate this notion, we examine their association with expression divergence between the closely related species, S. cerevisiae and S. paradoxus. Although individually well conserved at orthologous genes, changes between modifications are mostly uncorrelated, indicating largely non-overlapping regulatory mechanisms. Notably, we find that inter-species differences in methylation, but not acetylation, are well correlated with expression changes, thereby proposing H3K4me3 as a candidate regulator of expression divergence. Taken together, our results suggest distinct evolutionary roles for expression-linked modifications, wherein H3K4me3 may contribute to stabilize average expression, whilst H3K9ac associates with more indirect aspects such as responsiveness.	[Mosesson, Yaron; Voichek, Yoav; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il		Voichek, Yoav/0000-0001-8460-7018	ERC; Israel Science Foundation; Helen and Martin Kimmel award for Innovative Investigations	ERC(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel award for Innovative Investigations	This work was supported by the ERC, the Israel Science Foundation, and the Helen and Martin Kimmel award for Innovative Investigations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson DR, 2011, CURR OPIN GENET DEV, V21, P591, DOI 10.1016/j.gde.2011.07.010; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Maltby VE, 2012, P NATL ACAD SCI USA, V109, P18505, DOI 10.1073/pnas.1202070109; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Nagarajan M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000913; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Protacio RU, 2000, MOL CELL BIOL, V20, P8866, DOI 10.1128/MCB.20.23.8866-8878.2000; Radman-Livaja M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002811; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Stein AB, 2011, J CLIN INVEST, V121, P2641, DOI 10.1172/JCI44641; Thompson DA, 2009, FEBS LETT, V583, P3959, DOI 10.1016/j.febslet.2009.11.032; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tirosh I, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.20; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zhang ZQ, 2004, TRENDS GENET, V20, P403, DOI 10.1016/j.tig.2004.07.006; Zhou BO, 2011, J BIOL CHEM, V286, P34770, DOI 10.1074/jbc.M111.273128	60	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101538	10.1371/journal.pone.0101538	http://dx.doi.org/10.1371/journal.pone.0101538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007273	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600044
J	Quintela, M; Johansson, MP; Kristjansson, BK; Barreiro, R; Laurila, A				Quintela, Maria; Johansson, Magnus P.; Kristjansson, Bjarni K.; Barreiro, Rodolfo; Laurila, Anssi			AFLPs and Mitochondrial Haplotypes Reveal Local Adaptation to Extreme Thermal Environments in a Freshwater Gastropod	PLOS ONE			English	Article							GRAYLING THYMALLUS-THYMALLUS; ADAPTIVE GENETIC-DIVERGENCE; MULTILOCUS GENOTYPE DATA; DETECT CANDIDATE LOCI; CYTOCHROME-C-OXIDASE; POPULATION-STRUCTURE; LITTORINA-SAXATILIS; NATURAL-SELECTION; SPATIAL-ANALYSIS; GENOME-SCAN	The way environmental variation shapes neutral and adaptive genetic variation in natural populations is a key issue in evolutionary biology. Genome scans allow the identification of the genetic basis of local adaptation without previous knowledge of genetic variation or traits under selection. Candidate loci for divergent adaptation are expected to show higher F-ST than neutral loci influenced solely by random genetic drift, migration and mutation. The comparison of spatial patterns of neutral markers and loci under selection may help disentangle the effects of gene flow, genetic drift and selection among populations living in contrasting environments. Using the gastropod Radix balthica as a system, we analyzed 376 AFLP markers and 25 mtDNA COI haplotypes for candidate loci and associations with local adaptation among contrasting thermal environments in Lake Myvatn, a volcanic lake in northern Iceland. We found that 2% of the analysed AFLP markers were under directional selection and 12% of the mitochondrial haplotypes correlated with differing thermal habitats. The genetic networks were concordant for AFLP markers and mitochondrial haplotypes, depicting distinct topologies at neutral and candidate loci. Neutral topologies were characterized by intense gene flow revealed by dense nets with edges connecting contrasting thermal habitats, whereas the connections at candidate loci were mostly restricted to populations within each thermal habitat and the number of edges decreased with temperature. Our results suggest microgeographic adaptation within Lake Myvatn and highlight the utility of genome scans in detecting adaptive divergence.	[Quintela, Maria; Barreiro, Rodolfo] Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain; [Quintela, Maria; Johansson, Magnus P.; Laurila, Anssi] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Kristjansson, Bjarni K.] Holar Univ Coll, Dept Aquaculture & Fish Biol, Sauoarkrokur, Iceland	Universidade da Coruna; Uppsala University	Quintela, M (corresponding author), Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain.	m.quintelas@udc.es	Barreiro, Rodolfo/B-1005-2008; Kristjánsson, Bjarni K./B-4349-2013	Barreiro, Rodolfo/0000-0002-6049-5215; Kristjánsson, Bjarni K./0000-0001-6984-5771	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this study was provided by the Swedish Research Council (to AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baumann H, 2011, P ROY SOC B-BIOL SCI, V278, P2265, DOI 10.1098/rspb.2010.2479; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Blier PU, 2001, J COMP PHYSIOL B, V171, P247, DOI 10.1007/s003600000169; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Coutellec-Vreto MA, 1998, EVOLUTION, V52, P1635, DOI [10.2307/2411337, 10.1111/j.1558-5646.1998.tb02244.x]; Dalesman S, 2007, ECOLOGY, V88, P2462, DOI 10.1890/07-0403.1; Dalesman S, 2007, FRESHWATER BIOL, V52, P2134, DOI 10.1111/j.1365-2427.2007.01843.x; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Einarsson A, 2004, AQUAT ECOL, V38, P111, DOI 10.1023/B:AECO.0000032091.58691.45; EINARSSON A, 1982, FRESHWATER BIOL, V12, P63, DOI 10.1111/j.1365-2427.1982.tb00603.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Gebremedhin B, 2009, ANIM CONSERV, V12, P89, DOI 10.1111/j.1469-1795.2009.00238.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; HALL T, 1999, BIOEDIT 7 0 9 0; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Junge C, 2011, HEREDITY, V106, P460, DOI 10.1038/hdy.2010.160; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; Kavanagh KD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-350; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kingsolver JG, 2009, EVOLUTION, V63, P537, DOI 10.1111/j.1558-5646.2008.00568.x; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; KIRBY RR, 1994, BIOL J LINN SOC, V53, P255; Koskinen MT, 2002, ECOL LETT, V5, P193, DOI 10.1046/j.1461-0248.2002.00302.x; Kristmannsdottir H, 2004, AQUAT ECOL, V38, P115, DOI 10.1023/B:AECO.0000032067.47495.71; Kuo ESL, 2009, MAR ECOL PROG SER, V388, P137, DOI 10.3354/meps08102; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Lowry DB, 2010, BIOL LETTERS, V6, P502, DOI 10.1098/rsbl.2009.0969; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; MANTEL N, 1967, CANCER RES, V27, P209; Minor ES, 2007, ECOL APPL, V17, P1771, DOI 10.1890/06-1073.1; Morelissen B, 2007, J EXP MAR BIOL ECOL, V348, P162, DOI 10.1016/j.jembe.2007.04.006; NIEWIAROWSKI PH, 1993, ECOLOGY, V74, P1992, DOI 10.2307/1940842; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Nunes VL, 2011, MOL ECOL, V20, P193, DOI 10.1111/j.1365-294X.2010.04936.x; Okland J., 1990, LAKES SNAILS ENV GAS; Pardo LM, 2005, MAR ECOL PROG SER, V296, P229, DOI 10.3354/meps296229; Parsons KE, 1997, EVOLUTION, V51, P784, DOI 10.1111/j.1558-5646.1997.tb03661.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Ribeiro AM, 2011, EVOLUTION, V65, P3499, DOI 10.1111/j.1558-5646.2011.01397.x; Richter-Boix A, 2011, MOL ECOL, V20, P1582, DOI 10.1111/j.1365-294X.2011.05025.x; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Schwartz MK, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P165, DOI 10.1007/978-4-431-87771-4_9; SINERVO B, 1989, OECOLOGIA, V78, P411, DOI 10.1007/BF00379118; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sokolova IM, 2001, MAR BIOL, V139, P113; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Stinchcombe JR, 2007, HEREDITY; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Trussell GC, 2000, EVOLUTION, V54, P151, DOI 10.1111/j.0014-3820.2000.tb00016.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Welter-Schulte F, 2009, SPECIES SUMMARY OMPH; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; YAMADA SB, 1989, MAR BIOL, V103, P403, DOI 10.1007/BF00397275; Yeaman S, 2006, P ROY SOC B-BIOL SCI, V273, P1587, DOI 10.1098/rspb.2006.3498; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	108	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101821	10.1371/journal.pone.0101821	http://dx.doi.org/10.1371/journal.pone.0101821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007329	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600068
J	Sim, JH; Himmel, NJ; Redd, SK; Pulous, FE; Rogers, RT; Black, LN; Hong, SM; von Bergen, TN; Blount, MA				Sim, Jae H.; Himmel, Nathaniel J.; Redd, Sara K.; Pulous, Fadi E.; Rogers, Richard T.; Black, Lauren N.; Hong, Seongun M.; von Bergen, Tobias N.; Blount, Mitsi A.			Absence of PKC-Alpha Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; RENAL COLLECTING DUCT; INDUCED AQUAPORIN-2 TRAFFICKING; ENHANCER-BINDING PROTEIN; KINASE-C-ALPHA; PRINCIPAL CELLS; DOWN-REGULATION; URINE CONCENTRATION; UREA TRANSPORTER; HYPERCALCEMIC RATS	Lithium, an effective antipsychotic, induces nephrogenic diabetes insipidus (NDI) in similar to 40% of patients. The decreased capacity to concentrate urine is likely due to lithium acutely disrupting the cAMP pathway and chronically reducing urea transporter (UT-A1) and water channel (AQP2) expression in the inner medulla. Targeting an alternative signaling pathway, such as PKC-mediated signaling, may be an effective method of treating lithium-induced polyuria. PKC-alpha null mice (PKC alpha KO) and strain-matched wild type (WT) controls were treated with lithium for 0, 3 or 5 days. WT mice had increased urine output and lowered urine osmolality after 3 and 5 days of treatment whereas PKC alpha KO mice had no change in urine output or concentration. Western blot analysis revealed that AQP2 expression in medullary tissues was lowered after 3 and 5 days in WT mice; however, AQP2 was unchanged in PKC alpha KO. Similar results were observed with UT-A1 expression. Animals were also treated with lithium for 6 weeks. Lithium-treated WT mice had 19-fold increased urine output whereas treated PKC alpha KO animals had a 4-fold increase in output. AQP2 and UT-A1 expression was lowered in 6 week lithium-treated WT animals whereas in treated PKC alpha KO mice, AQP2 was only reduced by 2-fold and UT-A1 expression was unaffected. Urinary sodium, potassium and calcium were elevated in lithium-fed WT but not in lithium-fed PKC alpha KO mice. Our data show that ablation of PKC alpha preserves AQP2 and UT-A1 protein expression and localization in lithium-induced NDI, and prevents the development of the severe polyuria associated with lithium therapy.	[Sim, Jae H.; Himmel, Nathaniel J.; Redd, Sara K.; Pulous, Fadi E.; Rogers, Richard T.; Black, Lauren N.; Hong, Seongun M.; von Bergen, Tobias N.; Blount, Mitsi A.] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Blount, Mitsi A.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University; Emory University	Blount, MA (corresponding author), Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA 30322 USA.	mabloun@emory.edu	Himmel, Nathaniel J./AAC-2463-2020	Himmel, Nathaniel J./0000-0001-7876-6960; Sim, Jae/0000-0002-3851-5689; Redd, Sara/0000-0002-2422-8937; Pulous, Fadi/0000-0002-0794-8078	American Society of Nephrology Medical Student Scholar Grant [K01-DK082733, R03-DK091501]; Satellite Dialysis - Norman S. Coplon Extramural Grant Program; Emory University Research Committee; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082733, R03DK091501] Funding Source: NIH RePORTER	American Society of Nephrology Medical Student Scholar Grant; Satellite Dialysis - Norman S. Coplon Extramural Grant Program; Emory University Research Committee; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the following sources: American Society of Nephrology Medical Student Scholar Grant (J.H.S.), K01-DK082733 (M.A.B.), R03-DK091501 (M.A.B.), Satellite Dialysis - Norman S. Coplon Extramural Grant Program (M.A.B.), and support from the Emory University Research Committee (M. A. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount MA, 2008, AM J PHYSIOL-RENAL, V295, pF295, DOI 10.1152/ajprenal.00102.2008; Blount MA, 2010, AM J PHYSIOL-RENAL, V298, pF601, DOI 10.1152/ajprenal.00424.2009; Boone M, 2010, NEPHROL DIAL TRANSPL, V25, P48, DOI 10.1093/ndt/gfp409; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Chen GP, 2006, J BIOL CHEM, V281, P27436, DOI 10.1074/jbc.M605525200; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Christensen BM, 2011, J AM SOC NEPHROL, V22, P253, DOI 10.1681/ASN.2010070734; de Groot T, 2014, J AM SOC NEPHROL, V25, P501, DOI 10.1681/ASN.2013090988; Earm JH, 1998, J AM SOC NEPHROL, V9, P2181; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Grandjean EM, 2009, CNS DRUGS, V23, P331, DOI 10.2165/00023210-200923040-00005; Grunfeld JP, 2009, NAT REV NEPHROL, V5, P270, DOI 10.1038/nrneph.2009.43; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hryciw DH, 2005, AM J PHYSIOL-RENAL, V288, pF1227, DOI 10.1152/ajprenal.00428.2003; Jeon US, 2007, AM J PHYSIOL-RENAL, V293, pF408, DOI 10.1152/ajprenal.00502.2006; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kishore BK, 2013, AM J PHYSIOL-RENAL, V304, pF1139, DOI 10.1152/ajprenal.00718.2012; Klein JD, 2012, PFLUG ARCH EUR J PHY, V464, P561, DOI 10.1007/s00424-012-1157-0; LAU K, 1978, AM J PHYSIOL, V234, pE294, DOI 10.1152/ajpendo.1978.234.3.E294; Li CL, 2003, AM J PHYSIOL-RENAL, V284, pF1066, DOI 10.1152/ajprenal.00090.2002; Li YD, 2006, J AM SOC NEPHROL, V17, P1063, DOI 10.1681/ASN.2005080884; Lim SW, 2007, J AM SOC NEPHROL, V18, P421, DOI 10.1681/ASN.2006060664; Mann L, 2008, INT J NEUROPSYCHOPH, V11, P533, DOI 10.1017/S1461145707008395; Naruse M, 1997, J AM SOC NEPHROL, V8, P517; Nielsen J, 2008, P NATL ACAD SCI USA, V105, P3634, DOI 10.1073/pnas.0800001105; Olesen ETB, 2013, J AM SOC NEPHROL, V24, P169, DOI 10.1681/ASN.2012020217; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Procino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033145; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Rao R, 2005, AM J PHYSIOL-RENAL, V288, pF642, DOI 10.1152/ajprenal.00287.2004; Rao R, 2012, CURR OPIN NEPHROL HY, V21, P541, DOI 10.1097/MNH.0b013e32835571d4; Rej S, 2012, J GERIATR PSYCH NEUR, V25, P51, DOI 10.1177/0891988712436690; Renkema KY, 2009, J AM SOC NEPHROL, V20, P1705, DOI 10.1681/ASN.2008111195; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; SAMADIAN T, 1993, HISTOL HISTOPATHOL, V8, P139; Sands Jeff M, 2011, Trans Am Clin Climatol Assoc, V122, P82; Sands JM, 1998, AM J PHYSIOL-RENAL, V274, pF978, DOI 10.1152/ajprenal.1998.274.5.F978; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Stone K A, 1999, J Am Board Fam Pract, V12, P43; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Thomsen K, 2006, NEPHROL DIAL TRANSPL, V21, P869, DOI 10.1093/ndt/gfk029; Timmer RT, 1999, J AM SOC NEPHROL, V10, P666; Valenti G, 2000, J AM SOC NEPHROL, V11, P1873, DOI 10.1681/ASN.V11101873; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; von Bergen TN, 2012, AM J PHYSIOL-RENAL, V303, pF900, DOI 10.1152/ajprenal.00547.2011; Vossenkamper A, 2007, AM J PHYSIOL-CELL PH, V293, pC1129, DOI 10.1152/ajpcell.00628.2006; Wang WD, 2002, AM J PHYSIOL-RENAL, V283, pF1313, DOI 10.1152/ajprenal.00040.2002; Wang Y, 2013, AM J PHYSIOL-RENAL, V304, pF233, DOI 10.1152/ajprenal.00484.2012; WILSON DM, 1993, AM J CLIN PATHOL, V100, P419, DOI 10.1093/ajcp/100.4.419; YAMAKI M, 1991, AM J PHYSIOL, V261, pF505, DOI 10.1152/ajprenal.1991.261.3.F505; Yao LJ, 2004, AM J PHYSIOL-RENAL, V287, pF299, DOI 10.1152/ajprenal.00274.2003; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zhang Y, 2013, AM J PHYSIOL-RENAL, V305, pF407, DOI 10.1152/ajprenal.00464.2012; Zhang Y, 2008, AM J PHYSIOL-RENAL, V295, pF1715, DOI 10.1152/ajprenal.90311.2008; Zhao H, 2012, ACTA PHARMACOL SIN, V33, P230, DOI 10.1038/aps.2011.160	59	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101753	10.1371/journal.pone.0101753	http://dx.doi.org/10.1371/journal.pone.0101753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006961	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600064
J	Tobe, T; Yen, H; Takahashi, H; Kagayama, Y; Ogasawara, N; Oshima, T				Tobe, Toru; Yen, Hilo; Takahashi, Hiroki; Kagayama, Yoko; Ogasawara, Naotake; Oshima, Taku			Antisense Transcription Regulates the Expression of the Enterohemorrhagic Escherichia coli Virulence Regulatory Gene ler in Response to the Intracellular Iron Concentration	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT LEE; PATHOGENICITY ISLAND; DNA-DAMAGE; SMALL RNAS; LOCUS; O157-H7; SEQUENCE; K-12; HOMEOSTASIS; TRANSPORT	Enteric pathogens, such as enterohemorrhagic E. coli (EHEC) O157:H7, encounter varying concentrations of iron during their life cycle. In the gastrointestinal tract, the amount of available free iron is limited because of absorption by host factors. EHEC and other enteric pathogens have developed sophisticated iron-responsive systems to utilize limited iron resources, and these systems are primarily regulated by the Fur repressor protein. The iron concentration could be a signal that controls gene expression in the intestines. In this study, we explored the role of iron in LEE (locus for enterocyte effacement) virulence gene expression in EHEC. In contrast to the expression of Fur-regulated genes, the expression of LEE genes was greatly reduced in fur mutants irrespective of the iron concentration. The expression of the ler gene, the LEE-encoded master regulator, was affected at a post-transcription step by fur mutation. Further analysis showed that the loss of Fur affected the translation of the ler gene by increasing the intracellular concentration of free iron, and the transcription of the antisense strand was necessary for regulation. The results indicate that LEE gene expression is closely linked to the control of intracellular free iron homeostasis.	[Tobe, Toru] Osaka Univ, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan; [Yen, Hilo] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Suita, Osaka, Japan; [Takahashi, Hiroki] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Kagayama, Yoko; Ogasawara, Naotake; Oshima, Taku] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara 6300101, Japan	Osaka University; Osaka University; Chiba University; Nara Institute of Science & Technology	Tobe, T (corresponding author), Osaka Univ, Dept Biomed Informat, Grad Sch Med, Suita, Osaka, Japan.	torutobe@sahs.med.osaka-u.ac.jp	Takahashi, Hiroki/M-9169-2015	Takahashi, Hiroki/0000-0001-5627-1035	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590389]; Institute for Fermentation Osaka; Biotechnology and Biological Sciences Research Council [BB/H531586/1] Funding Source: researchfish; BBSRC [BB/H531586/1] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation Osaka(Institute for Fermentation (IFO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grant 22590389 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a grant from the Institute for Fermentation Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Ahmad R, 2009, PROTEINS, V75, P373, DOI 10.1002/prot.22247; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054; CALDERWOOD SB, 1987, J BACTERIOL, V169, P4759, DOI 10.1128/jb.169.10.4759-4764.1987; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEGRANDIS S, 1987, J BACTERIOL, V169, P4313, DOI 10.1128/jb.169.9.4313-4319.1987; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gottesman S, 2010, COLD SPRING HARBOR P, V3; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523; HANTKE K, 1981, MOL GEN GENET, V182, P288, DOI 10.1007/BF00269672; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Jacques JF, 2006, MOL MICROBIOL, V62, P1181, DOI 10.1111/j.1365-2958.2006.05439.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Salvail H, 2010, P NATL ACAD SCI USA, V107, P15223, DOI 10.1073/pnas.1007805107; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Tobe T, 2005, MOL MICROBIOL, V58, P320, DOI 10.1111/j.1365-2958.2005.04828.x	38	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101582	10.1371/journal.pone.0101582	http://dx.doi.org/10.1371/journal.pone.0101582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006810	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600047
J	Dong, B; Han, RM; Wang, GX; Cao, X				Dong, Bin; Han, Ruiming; Wang, Guoxiang; Cao, Xun			O-2, pH, and Redox Potential Microprofiles around Potamogeton malaianus Measured Using Microsensors	PLOS ONE			English	Article							SUBMERGED MACROPHYTE; BOUNDARY-LAYERS; LAKE TAIHU; OXYGEN; EPIPHYTE; PHOTOSYNTHESIS; SHALLOW; PERIPHYTON; ALGAE; PHYTOPLANKTON	This study aimed to elucidate the effects of periphyton on the microprofiles of oxygen (O-2), pH, and oxidation-reduction potential around the stems and leaves of a submerged macrophyte Potamogeton malaianus and on the plant growth in the eutrophic shallow Taihu Lake, China. The microprofiles were measured using a motorized microprofiling system equipped with microsensors. The leaf age of the macrophyte and periphyton exerted significant effects on the microprofiles of O-2, pH, and oxidation-reduction potential. O-2 concentration and pH increased whereas the oxidation-reduction potential decreased with decreasing distance to the stem/leaf surface. The fluctuation amplitudes of O-2, pH, and oxidation-reduction potential were the largest in the microprofiles of mature leaves and the lowest in senescent leaves. The periphyton increased the thickness of the broad diffusive boundary layer and fluctuation amplitudes of O-2, pH, and oxidation-reduction potential. When the periphyton was removed, the thickness of the broad diffusive boundary layer in the microprofiles of stems, senescent leaves, and mature leaves reduced by 29.0%, 49.72%, and 70.34%, and the O-2, pH, and oxidation-reduction potential fluctuation amplitudes also declined accordingly. Our results suggest that a thick periphyton exerted negative effects on the growth of macrophytes by providing extensive shading and creating a barrier that hindered the transport of dissolved substances such as O-2, and led to premature decline in macrophytes in the eutrophic Taihu Lake. The consequent implications can help to elucidate the control mechanism of the broad diffusive boundary layer around macrophytes on nutrient cycling in eutrophic waters and to better understand the role of this layer in the Taihu Lake and other similar eutrophic waters.	[Dong, Bin; Han, Ruiming; Wang, Guoxiang; Cao, Xun] Nanjing Normal Univ, Sch Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China; [Dong, Bin] Linyi Univ, Sch Resource & Environm, Linyi, Peoples R China	Nanjing Normal University; Linyi University	Wang, GX (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China.	wangguoxiang@njnu.edu.cn			National Natural Science Foundation of China [41173078]; National Water Pollution Control and Management Technology Major Projects [2012ZX07101-008-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Water Pollution Control and Management Technology Major Projects	This study was supported by the National Natural Science Foundation of China (41173078), National Water Pollution Control and Management Technology Major Projects (2012ZX07101-008-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon M, 2007, FRESHWATER BIOL, V52, P1762, DOI 10.1111/j.1365-2427.2007.01807.x; Asaeda T, 2004, ENVIRON EXP BOT, V52, P225, DOI 10.1016/j.envexpbot.2004.02.001; Boros G, 2011, HYDROBIOLOGIA, V665, P117, DOI 10.1007/s10750-011-0609-4; Cai XL, 2013, J BASIC MICROB, V53, P828, DOI 10.1002/jobm.201200220; China EPA, 2002, MON AN METH WAT WAST; Demarty M, 2009, CAN J FISH AQUAT SCI, V66, P1522, DOI 10.1139/F09-099; Dong Bin, 2013, Hupo Kexue, V25, P359; Fang F, 2013, J APPL PHYCOL, V25, P1; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; Hart DD, 2013, FRESHWATER BIOL, V58, P1588, DOI 10.1111/fwb.12147; He Feng, 2002, Acta Hydrobiologica Sinica, V26, P421; Herrmann M, 2011, APPL ENVIRON MICROB, V77, P1896, DOI 10.1128/AEM.02879-10; Ji Haiting, 2013, Hupo Kexue, V25, P163; Jones JI, 2000, AQUAT BOT, V67, P191; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; Korschgen CE, 1997, AQUAT BOT, V58, P1, DOI 10.1016/S0304-3770(97)00014-4; Li YL, 2013, PLANT SOIL, V365, P115, DOI 10.1007/s11104-012-1378-1; Liboriussen L, 2003, FRESHWATER BIOL, V48, P418, DOI 10.1046/j.1365-2427.2003.01018.x; [刘伟龙 LIU WeiLong], 2007, [生态学报, Acta Ecologica Sinica], V27, P3324; Ozkan K, 2010, FRESHWATER BIOL, V55, P463, DOI 10.1111/j.1365-2427.2009.02297.x; PHILLIPS GL, 1978, AQUAT BOT, V4, P103, DOI 10.1016/0304-3770(78)90012-8; PIP E, 1984, Hydrobiological Bulletin, V18, P109, DOI 10.1007/BF02257050; Pomazkina G, 2012, LIMNOLOGICAL REV, V12, P19, DOI DOI 10.2478/v10194-011-0041-1; [钱宝 Qian Bao], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P295; Qin BQ, 2006, SCI CHINA SER C, V49, P597, DOI 10.1007/s11427-006-2025-y; Qin BQ, 2013, CHINESE SCI BULL, V58, P961, DOI 10.1007/s11434-012-5560-x; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Revsbech NP, 1999, BIOL FERT SOILS, V29, P379, DOI 10.1007/s003740050568; ROGERS KH, 1981, MICROBIAL ECOL, V7, P351, DOI 10.1007/BF02341430; Romanow M, 2011, OCEANOL HYDROBIOL ST, V40, P64, DOI 10.2478/s13545-011-0042-3; SANDJENSEN K, 1985, MAR BIOL, V89, P55, DOI 10.1007/BF00392877; SANDJENSEN K, 1987, LIMNOL OCEANOGR, V32, P452, DOI 10.4319/lo.1987.32.2.0452; SANDJENSEN K, 1989, AQUAT BOT, V34, P5, DOI 10.1016/0304-3770(89)90048-X; SANDJENSEN K, 1990, FOLIA GEOBOT PHYTOTX, V25, P315, DOI 10.1007/BF02913033; Santegoeds CM, 1998, BIODEGRADATION, V9, P159, DOI 10.1023/A:1008302622946; Schreiber L, 2005, NEW PHYTOL, V166, P589, DOI 10.1111/j.1469-8137.2005.01343.x; Schreiber U, 1997, PLANT CELL PHYSIOL, V38, P945, DOI 10.1093/oxfordjournals.pcp.a029256; SIMPSON PS, 1986, AQUAT BOT, V24, P1, DOI 10.1016/0304-3770(86)90112-9; Song Yu-zhi, 2007, Yingyong Shengtai Xuebao, V18, P928; Song Yuzhi, 2010, Hupo Kexue, V22, P935; Spilling K, 2010, J PHYCOL, V46, P1350, DOI 10.1111/j.1529-8817.2010.00894.x; Stevens CL, 1997, HYDROBIOLOGIA, V346, P119, DOI 10.1023/A:1002914015683; Toth VR, 2013, AQUAT SCI, V75, P523, DOI 10.1007/s00027-013-0297-4; Vermaire JC, 2013, J PALEOLIMNOL, V50, P447, DOI 10.1007/s10933-013-9737-3; Wahl A, 2005, GALVANOTECHTNIK, V96, P1820; Wang WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098457; Wang YongPing, 2013, China Environmental Science, V33, P132; Wang ZJ, 2013, BIORESOURCE TECHNOL, V132, P387, DOI 10.1016/j.biortech.2012.11.026; Wang Zhi, 2013, China Environmental Science, V33, P328; Wieland A, 2006, FEMS MICROBIOL ECOL, V55, P195, DOI 10.1111/j.1574-6941.2005.00031.x; Xie D, 2013, CHEMOSPHERE, V93, P1301, DOI [10.1016/j.chemosphere.2013.07.008, 10.1016/j.chemosphere.2013.04.098]; Zhao DY, 2013, CAN J MICROBIOL, V59, P237, DOI 10.1139/cjm-2012-0554	52	10	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101825	10.1371/journal.pone.0101825	http://dx.doi.org/10.1371/journal.pone.0101825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004129	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700073
J	Kiwelu, IE; Novitsky, V; Kituma, E; Margolin, L; Baca, J; Manongi, R; Sam, N; Shao, J; McLane, MF; Kapiga, SH; Essex, M				Kiwelu, Ireen E.; Novitsky, Vladimir; Kituma, Elimsaada; Margolin, Lauren; Baca, Jeannie; Manongi, Rachel; Sam, Noel; Shao, John; McLane, Mary F.; Kapiga, Saidi H.; Essex, M.			HIV-1 pol Diversity among Female Bar and Hotel Workers in Northern Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; REVERSE-TRANSCRIPTASE; TYPE-1 SUBTYPES; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; CROSS-RESISTANCE; MBEYA REGION; CLADE-C; PROTEASE	A national ART program was launched in Tanzania in October 2004. Due to the existence of multiple HIV-1 subtypes and recombinant viruses co-circulating in Tanzania, it is important to monitor rates of drug resistance. The present study determined the prevalence of HIV-1 drug resistance mutations among ART-naive female bar and hotel workers, a high-risk population for HIV-1 infection in Moshi, Tanzania. A partial HIV-1 pol gene was analyzed by single-genome amplification and sequencing in 45 subjects (622 pol sequences total; median number of sequences per subject, 13; IQR 5-20) in samples collected in 2005. The prevalence of HIV-1 subtypes A1, C, and D, and inter-subtype recombinant viruses, was 36%, 29%, 9% and 27%, respectively. Thirteen different recombination patterns included D/A1/D, C/A1, A1/C/A1, A1/U/A1, C/U/A1, C/A1, U/D/U, D/A1/D, A1/C, A1/C, A2/C/A2, CRF10_CD/C/CRF10_CD and CRF35_AD/A1/CRF35_AD. CRF35_AD was identified in Tanzania for the first time. All recombinant viruses in this study were unique, suggesting ongoing recombination processes among circulating HIV-1 variants. The prevalence of multiple infections in this population was 16% (n=7). Primary HIV-1 drug resistance mutations to RT inhibitors were identified in three (7%) subjects (K65R plus Y181C; N60D; and V106M). In some subjects, polymorphisms were observed at the RT positions 41, 69, 75, 98, 101, 179, 190, and 215. Secondary mutations associated with NNRTIs were observed at the RT positions 90 (7%) and 138 (6%). In the protease gene, three subjects (7%) had M46I/L mutations. All subjects in this study had HIV-1 subtype-specific natural polymorphisms at positions 36, 69, 89 and 93 that are associated with drug resistance in HIV-1 subtype B. These results suggested that HIV-1 drug resistance mutations and natural polymorphisms existed in this population before the initiation of the national ART program. With increasing use of ARV, these results highlight the importance of drug resistance monitoring in Tanzania.	[Kiwelu, Ireen E.; Kituma, Elimsaada; Manongi, Rachel; Sam, Noel; Shao, John] Tumaini Univ, Kilimanjaro Christian Med Ctr & Coll, Moshi, Tanzania; [Kiwelu, Ireen E.; Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; McLane, Mary F.; Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kapiga, Saidi H.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kituma, Elimsaada; Manongi, Rachel; Sam, Noel; Kapiga, Saidi H.] Kilimanjaro Reprod Hlth Program, Moshi, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Essex, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	shao, jianfu/N-2447-2018	shao, jianfu/0000-0002-6632-8207; Kapiga, Saidi/0000-0003-1753-4060	International Partnership for Microbicides; NIH Fogarty International Center AIDS International Training and Research Program [D43 TW000004]; Fogarty International Center Scholars and Fellows Program; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER	International Partnership for Microbicides; NIH Fogarty International Center AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center Scholars and Fellows Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the International Partnership for Microbicides (SHK), the NIH Fogarty International Center AIDS International Training and Research Program grant D43 TW000004 (IEK), and the Fogarty International Center Scholars and Fellows Program (IEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ao TTH, 2011, AIDS BEHAV, V15, P330, DOI 10.1007/s10461-010-9849-y; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Apetrei C, 1998, J VIROL, V72, P3534, DOI 10.1128/JVI.72.5.3534-3538.1998; Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Becker-Pergola G, 2000, AIDS RES HUM RETROV, V16, P807, DOI 10.1089/088922200308800; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Birk M, 1998, AIDS, V12, P2369, DOI 10.1097/00002030-199818000-00005; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Brindeiro R, 1999, ANTIMICROB AGENTS CH, V43, P1674, DOI 10.1128/AAC.43.7.1674; Chan DJ, 2009, CURR HIV RES, V7, P231, DOI 10.2174/157016209787581463; de Oliveira T, 2006, REGA HIV 1 SUBTYPING; Deeks SG, 2008, PLOS MED, V5, P1014, DOI 10.1371/journal.pmed.0050164; Descamps D, 1998, AIDS, V12, P1109; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson JW, 1999, AIDS, V13, pS189; Eshleman SH, 2002, AIDS RES HUM RETROV, V18, P507, DOI 10.1089/088922202317406655; Grossman Z, 2001, AIDS, V15, P1453, DOI 10.1097/00002030-200108170-00001; GU ZX, 1995, J GEN VIROL, V76, P2601, DOI 10.1099/0022-1317-76-10-2601; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hickman M, 1999, SEX TRANSM INFECT, V75, P385, DOI 10.1136/sti.75.6.385; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; *HIV, HIV SEQ DAT; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; HolmHansen C, 1996, APMIS, V104, P459, DOI 10.1111/j.1699-0463.1996.tb00742.x; Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kahle EM, 2014, JAIDS-J ACQ IMM DEF, V65, pE90, DOI 10.1097/QAI.0b013e3182a2db02; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kantor R, 2004, J CLIN VIROL, V29, P152, DOI 10.1016/S1386-6532(03)00115-X; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kasang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023091; Kijak GH, 2004, AIDS REV, V6, P54; Kiwelu IE, 2005, AIDS RES HUM RETROV, V21, P897, DOI 10.1089/aid.2005.21.897; Kiwelu IE, 2003, AIDS RES HUM RETROV, V19, P57, DOI 10.1089/08892220360473970; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Koulinska IN, 2001, AIDS RES HUM RETROV, V17, P423, DOI 10.1089/088922201750102508; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martinez-Picado J, 2000, VIROLOGY, V275, P318, DOI 10.1006/viro.2000.0527; Mosha F, 2011, AIDS RES HUM RETROV, V27, P377, DOI 10.1089/aid.2010.0113; National AIDS Control Programme, 2007, HIV AIDS STI SURV RE; Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298; Nucleotide Blast, BLAST BAS LOG AL SEA; Nyombi BM, 2008, AIDS RES HUM RETROV, V24, P761, DOI 10.1089/aid.2007.0311; Nyombi Balthazar M, 2008, AIDS Res Ther, V5, P13, DOI 10.1186/1742-6405-5-13; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; Perno CF, 2001, J INFECT DIS, V184, P983, DOI 10.1086/323604; Piantadosi A, 2008, AIDS RES HUM RETROV, V24, P1221, DOI 10.1089/aid.2008.0100; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Quesnel-Vallieres M, 2011, EMERG INFECT DIS, V17, P271, DOI 10.3201/eid1702.100629; Rambaut A, 2009, FIGTREE V1 3 1; Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rusine J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; Shafer RW, 2008, AIDS REV, V10, P67; Shekelle Paul, 2007, Evid Rep Technol Assess (Full Rep), P1; SIWKA W, 1994, AIDS RES HUM RETROV, V10, P1753, DOI 10.1089/aid.1994.10.1753; Soheilli ZS, 2009, AIDS RES HUM RETROV, V25, P123, DOI 10.1089/aid.2008.0199; Somi GR, 2008, ANTIVIR THER, V13, P77; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vandamme AM, 2011, AIDS REV, V13, P77; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Whitman S, 2000, ARCH INTERN MED, V160, P365, DOI 10.1001/archinte.160.3.365; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	83	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102258	10.1371/journal.pone.0102258	http://dx.doi.org/10.1371/journal.pone.0102258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003939	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000339242700117
J	Ming, Y; Hu, XN; Song, Y; Liu, ZG; Li, JB; Gao, RF; Zhang, YY; Mei, H; Guo, TW; Xiao, L; Wang, BC; Wu, CD; Xiao, XQ				Ming, Yue; Hu, Xiangnan; Song, Ying; Liu, Zhiguo; Li, Jibin; Gao, Rufei; Zhang, Yuyao; Mei, Hu; Guo, Tingwang; Xiao, Ling; Wang, Bochu; Wu, Chaodong; Xiao, Xiaoqiu			CMHX008, a Novel Peroxisome Proliferator-Activated Receptor gamma Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo	PLOS ONE			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; MYOCARDIAL-INFARCTION; ANTIDIABETIC THIAZOLIDINEDIONE; SELECTIVE MODULATOR; ROSIGLITAZONE; OBESITY; SENSITIZATION; METABOLISM; MECHANISMS	The peroxisome proliferator-activated receptor gamma (PPAR gamma) plays an important role in adipocyte differentiation and insulin sensitivity. Its ligand rosiglitazone has anti-diabetic effect but is frequently accompanied with some severe unwanted effects. The aim of the current study was to compare the anti-diabetic effect of CMHX008, a novel thiazolidinedione-derivative, with rosiglitazone. A luciferase assay was used to evaluate in vitro PPAR gamma activation. 3T3-L1 cells were used to examine adipocyte differentiation. High fat diet (HFD) mice were used to examine in vivo insulin sensitivity. The mRNA levels were evaluated by real-time RT-PCR. Serum biochemical and hormonal variables were assessed using a clinical chemistry analyser. CMHX008 displayed a moderate PPAR gamma agonist activity, and promoted 3T3-L1 preadipocyte differentiation with lower activity than rosiglitazone. CMHX008 regulated the expression of PPAR gamma target genes in a different manner from rosiglitazone. CMHX008 increased the expression and secretion of adiponectin with the similar efficacy as rosiglitazone, but only 25% as potent as rosiglitazone for the induction of adipocyte fatty acid binding protein. Treatment of CMHX008 and rosiglitazone protected mice from high fat diet (HFD)-induced glucose intolerance, hyperinsulinemia and inflammation. CMHX008 reduced the mRNA expression of M1 macrophage markers, and significantly increased the expressions of M2 markers. In conclusion, CMHX008 shared the comparable insulin-sensitizing effects as rosiglitazone with lower adipogenic capacity and might potentially be developed into an effective agent for the treatment of diabetes and metabolic disorders.	[Ming, Yue; Liu, Zhiguo; Gao, Rufei; Zhang, Yuyao; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China; [Hu, Xiangnan] Chongqing Med Univ, Coll Pharm, Chongqing, Peoples R China; [Song, Ying; Gao, Rufei; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine, Chongqing, Peoples R China; [Li, Jibin] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Nutr & Food Hyg, Chongqing, Peoples R China; [Mei, Hu; Guo, Tingwang; Xiao, Ling; Wang, Bochu] Chongqing Univ, Coll Bioengn, Chongqing 630044, Peoples R China; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing University; Texas A&M University System; Texas A&M University College Station	Xiao, XQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China.	xiaoxq@cqmu.edu.cn	Xiao, Xiaoqiu/K-7672-2019; Li, Jibin/ABF-6006-2021; Wang, Bo/AAU-1329-2021	Xiao, Xiaoqiu/0000-0002-4568-8772; Li, Jibin/0000-0001-9160-4093; Wang, Bo/0000-0001-8947-8526	National Program on Key Basic Research Project of China [2012CB517505]; National Natural Science Foundation of China [81270947]; Doctoral Fund of Ministry of Education of China [20115503110008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095828] Funding Source: NIH RePORTER	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Program on Key Basic Research Project of China (http://www.most.gov.cn, 2012CB517505, to Xiaoqiu Xiao), National Natural Science Foundation of China (http://www.nsfc.gov.cn, 81270947, to Xiaoqiu Xiao) and Doctoral Fund of Ministry of Education of China (http://www.moe.edu.cn, 20115503110008, to Xiaoqiu Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, MINI-REV MED CHEM, V12, P87, DOI 10.2174/138955712798995048; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bhalla K, 2011, J BIOL CHEM, V286, P41626, DOI 10.1074/jbc.M111.257915; Brun RP, 1997, J ENDOCRINOL, V155, P217, DOI 10.1677/joe.0.1550217; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Dunn FL, 2011, J DIABETES COMPLICAT, V25, P151, DOI 10.1016/j.jdiacomp.2010.06.006; Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Halade GV, 2011, PHARMACOL RES, V63, P300, DOI 10.1016/j.phrs.2010.12.012; Hemmeryckx B, 2013, EUR J PHARMACOL, V700, P23, DOI 10.1016/j.ejphar.2012.11.062; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kubo M, 2014, J PHARMACOL SCI, V124, P276, DOI 10.1254/jphs.13236FP; Kubo M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00275; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lu CJ, 2013, CEREBROVASC DIS, V36, P145, DOI 10.1159/000353679; MacDonald MR, 2011, DIABETES CARE, V34, P1394, DOI 10.2337/dc10-2398; Mendez R, 2013, AM J TRANSL RES, V5, P224; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Misra P, 2003, J PHARMACOL EXP THER, V306, P763, DOI 10.1124/jpet.103.049791; Mitka M, 2013, JAMA-J AM MED ASSOC, V310, P246, DOI 10.1001/jama.2013.8141; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Nugent C, 2001, MOL ENDOCRINOL, V15, P1729, DOI 10.1210/me.15.10.1729; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Takasawa K, 2008, ENDOCR J, V55, P767, DOI 10.1507/endocrj.K08E-018; Taygerly JP, 2013, BIOORGAN MED CHEM, V21, P979, DOI 10.1016/j.bmc.2012.11.058; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200	51	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102102	10.1371/journal.pone.0102102	http://dx.doi.org/10.1371/journal.pone.0102102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004107	Green Submitted, gold, Green Published			2022-12-25	WOS:000339242700109
J	Ceraudo, E; Galanth, C; Carpentier, E; Banegas-Font, I; Schonegge, AM; Alvear-Perez, R; Iturrioz, X; Bouvier, M; Llorens-Cortes, C				Ceraudo, Emilie; Galanth, Cecile; Carpentier, Eric; Banegas-Font, Inmaculada; Schonegge, Anne-Marie; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Bouvier, Michel; Llorens-Cortes, Catherine			Biased Signaling Favoring G(i) over beta-Arrestin Promoted by an Apelin Fragment Lacking the C-terminal Phenylalanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Cell Signaling; Extracellular Signal-regulated Kinase (ERK); G Protein; G Protein-coupled Receptor (GPCR); Mitogen-activated Protein Kinase (MAPK); Pertussis Toxin; Apelin; Apelin Receptor	RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; ENDOGENOUS LIGAND APELIN; HUMAN APJ RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; FUNCTIONAL SELECTIVITY; CONFORMATIONAL-CHANGES; CARDIAC CONTRACTILITY; ERK1/2 ACTIVATION; REGULATED KINASES	Background: Apelin receptor represents a therapeutic target for cardiovascular diseases. Results: Apelin 17 activates ERK1/2 in a -arrestin-dependent and G protein-dependent manner, whereas apelin 17 with deleted C-terminal phenylalanine only signals through the G protein. Conclusion: Biased signaling promoted by an apelin fragment lacking the C-terminal phenylalanine is favoring G(i) over -arrestin. Significance: Apelin receptor -arrestin signaling may account for apelin hypotensive activity. Apelin plays a prominent role in body fluid and cardiovascular homeostasis. We previously showed that the C-terminal Phe of apelin 17 (K17F) is crucial for triggering apelin receptor internalization and decreasing blood pressure (BP) but is not required for apelin binding or G(i) protein coupling. Based on these findings, we hypothesized that the important role of the C-terminal Phe in BP decrease may be as a G(i)-independent but -arrestin-dependent signaling pathway that could involve MAPKs. For this purpose, we have used apelin fragments K17F and K16P (K17F with the C-terminal Phe deleted), which exhibit opposite profiles on apelin receptor internalization and BP. Using BRET-based biosensors, we showed that whereas K17F activates G(i) and promotes -arrestin recruitment to the receptor, K16P had a much reduced ability to promote -arrestin recruitment while maintaining its G(i) activating property, revealing the biased agonist character of K16P. We further show that both -arrestin recruitment and apelin receptor internalization contribute to the K17F-stimulated ERK1/2 activity, whereas the K16P-promoted ERK1/2 activity is entirely G(i)-dependent. In addition to providing new insights on the structural basis underlying the functional selectivity of apelin peptides, our study indicates that the -arrestin-dependent ERK1/2 activation and not the G(i)-dependent signaling may participate in K17F-induced BP decrease.	[Ceraudo, Emilie; Galanth, Cecile; Banegas-Font, Inmaculada; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Llorens-Cortes, Catherine] INSERM, U1050, Lab Cent Neuropeptides Regulat Body Fluid Homeost, F-75005 Paris, France; [Ceraudo, Emilie; Galanth, Cecile; Banegas-Font, Inmaculada; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Llorens-Cortes, Catherine] Coll France, Ctr Interdisciplinary Res Biol, F-75005 Paris, France; [Ceraudo, Emilie; Galanth, Cecile; Banegas-Font, Inmaculada; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Llorens-Cortes, Catherine] CNRS, UMR 7241, F-75005 Paris, France; [Carpentier, Eric; Schonegge, Anne-Marie; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Carpentier, Eric; Schonegge, Anne-Marie; Bouvier, Michel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3T 1J4, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Universite de Montreal	Llorens-Cortes, C (corresponding author), Coll France, CIRB, INSERM, U1050, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	c.llorens-cortes@college-de-france.fr	Llorens-Cortès, catherine/AAL-3893-2021; Bouvier, Michel/H-2758-2014; Llorens-Cortes, Catherine/E-5839-2016; ITURRIOZ, Xavier/Q-4406-2017; Iturrioz, Xavier/AAS-3555-2020	Llorens-Cortès, catherine/0000-0002-7667-0401; Bouvier, Michel/0000-0003-1128-0100; Llorens-Cortes, Catherine/0000-0002-7667-0401; ITURRIOZ, Xavier/0000-0001-7143-8323; Iturrioz, Xavier/0000-0001-7143-8323; Banegas Font, Inmaculada/0000-0002-1910-3726	Institut National de la Sante et de la Recherche Medicale; College de France; Agence Nationale pour la Recherche Physique et Chimie du Vivant; Fondation pour la Recherche Medicale; Cardiovasculaires-Obesite-Rein-Diabete from Region Ile-de-France	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); College de France; Agence Nationale pour la Recherche Physique et Chimie du Vivant(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Cardiovasculaires-Obesite-Rein-Diabete from Region Ile-de-France	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the College de France and the Agence Nationale pour la Recherche Physique et Chimie du Vivant. This work was also supported by funds from the Fondation pour la Recherche Medicale (to I. B.-F.) and the Cardiovasculaires-Obesite-Rein-Diabete from Region Ile-de-France (to E. C.).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Blanchard A, 2013, J CLIN ENDOCR METAB, V98, P2084, DOI 10.1210/jc.2012-3794; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Brailoiu GC, 2002, NEUROSCI LETT, V327, P193, DOI 10.1016/S0304-3940(02)00411-1; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Iturrioz X, 2010, J BIOL CHEM, V285, P32627, DOI 10.1074/jbc.M110.127167; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P1095, DOI 10.1046/j.1365-2826.2003.01102.x; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xu TR, 2008, BIOCHEM J, V413, P51, DOI 10.1042/BJ20080685; Zhou NM, 2003, VIROLOGY, V307, P22, DOI 10.1016/S0042-6822(02)00021-1; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522	65	56	59	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24599	24610		10.1074/jbc.M113.541698	http://dx.doi.org/10.1074/jbc.M113.541698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012663	hybrid, Green Published			2022-12-25	WOS:000341505600050
J	Simhadri, S; Peterson, S; Patel, DS; Huo, YY; Cai, H; Bowman-Colin, C; Miller, S; Ludwig, T; Ganesan, S; Bhaumik, M; Bunting, SF; Jasin, M; Xia, B				Simhadri, Srilatha; Peterson, Shaun; Patel, Dharm S.; Huo, Yanying; Cai, Hong; Bowman-Colin, Christian; Miller, Shoreh; Ludwig, Thomas; Ganesan, Shridar; Bhaumik, Mantu; Bunting, Samuel F.; Jasin, Maria; Xia, Bing			Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; DNA Damage Response; Homologous Recombination; Meiosis; Spermatogenesis; BRCA2; FANCN; Fanconi Anemia; PALB2; Male Infertility	RAD51 FILAMENT FORMATION; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; FANCONI-ANEMIA; DNA-REPAIR; MOUSE MEIOSIS; PALB2; BRCA2; CANCER; SPERMATOGENESIS	Background: BRCA1 and PALB2 interact with each other to promote homologous recombination and DNA double strand break repair. Results: Mice with abrogated PALB2-BRCA1 interaction show male fertility defect. Conclusion: PALB2 and BRCA1 function together to ensure normal male meiosis. Significance: This work demonstrates the importance of the PALB2-BRCA1 interaction in vivo and reveals a novel role of PALB2 in sex chromosome synapsis. PALB2 links BRCA1 and BRCA2 in homologous recombinational repair of DNA double strand breaks (DSBs). Mono-allelic mutations in PALB2 increase the risk of breast, pancreatic, and other cancers, and biallelic mutations cause Fanconi anemia (FA). Like Brca1 and Brca2, systemic knock-out of Palb2 in mice results in embryonic lethality. In this study, we generated a hypomorphic Palb2 allele expressing a mutant PALB2 protein unable to bind BRCA1. Consistent with an FA-like phenotype, cells from the mutant mice showed hypersensitivity and chromosomal breakage when treated with mitomycin C, a DNA interstrand crosslinker. Moreover, mutant males showed reduced fertility due to impaired meiosis and increased apoptosis in germ cells. Interestingly, mutant meiocytes showed a significant defect in sex chromosome synapsis, which likely contributed to the germ cell loss and fertility defect. Our results underscore the in vivo importance of the PALB2-BRCA1 complex formation in DSB repair and male meiosis.	[Simhadri, Srilatha; Huo, Yanying; Cai, Hong; Ganesan, Shridar; Bhaumik, Mantu; Xia, Bing] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Simhadri, Srilatha; Huo, Yanying; Cai, Hong; Xia, Bing] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08901 USA; [Miller, Shoreh; Bhaumik, Mantu] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Ganesan, Shridar] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA; [Peterson, Shaun; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, Sloan Kettering Inst, New York, NY 10065 USA; [Patel, Dharm S.; Bunting, Samuel F.] Rutgers State Univ, Sch Arts & Sci, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bowman-Colin, Christian] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ludwig, Thomas] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Harvard University; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University	Xia, B (corresponding author), Rutgers Canc Inst New Jersey, Dept Radiat Oncol, 195 Little Albany St, New Brunswick, NJ 08903 USA.	xiabi@cinj.rutgers.edu	Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585; HUO, YANYING/0000-0003-4747-4951; Peterson, Shaun/0000-0002-0906-8939; Patel, Dharm/0000-0003-1804-838X	NCI CCSG Grant [P30CA072720]; Robert Wood Johnson Foundation [67038]; NATIONAL CANCER INSTITUTE [R00CA160574, R01CA138804, R01CA169182, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339, R01GM105421] Funding Source: NIH RePORTER	NCI CCSG Grant; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Florent le Masson for valuable technical assistance, Scott Keeney for critical comments on the manuscript, and Reena Shakya for helpful discussions. We thank the Transgenic and Knockout Mouse Shared Resource of the Rutgers Cancer Institute of New Jersey, which is supported by an NCI CCSG Grant (P30CA072720) and by a Robert Wood Johnson Foundation grant to the Child Health Institute of New Jersey (Grant 67038).	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bakker ST, 2013, DIS MODEL MECH, V6, P40, DOI 10.1242/dmm.009795; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bouwman P, 2011, J PATHOL, V224, P10, DOI 10.1002/path.2861; Bowman-Colin C, 2013, P NATL ACAD SCI USA, V110, P8632, DOI 10.1073/pnas.1305362110; Buisson R, 2012, NUCLEIC ACIDS RES, V40, P10312, DOI 10.1093/nar/gks807; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Cressman VL, 1999, MOL CELL BIOL, V19, P7061; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hayakawa T, 2010, J CELL SCI, V123, P1124, DOI 10.1242/jcs.060178; HEYTING C, 1991, METHOD CELL BIOL, V35, P177; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Hunter N., 2007, TOPICS CURRENT GENET; Huo YY, 2013, CANCER DISCOV, V3, P894, DOI 10.1158/2159-8290.CD-13-0011; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kolas NK, 2005, CHROMOSOMA, V114, P92, DOI 10.1007/s00412-005-0334-8; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oliver AW, 2009, EMBO REP, V10, P990, DOI 10.1038/embor.2009.126; Rantakari P, 2010, HUM MOL GENET, V19, P3021, DOI 10.1093/hmg/ddq207; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Sy SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/jbc.C109.023937; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tischkowitz M, 2011, J PATHOL, V224, P301, DOI 10.1002/path.2903; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhang F, 2012, J CELL SCI, V125, P6049, DOI 10.1242/jcs.111872; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	51	48	49	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24617	24629		10.1074/jbc.M114.566141	http://dx.doi.org/10.1074/jbc.M114.566141			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016020	hybrid, Green Published			2022-12-25	WOS:000341505600052
J	Ballesteros, Y; Polidori, C; Tormos, J; Banos-Picon, L; Asis, JD				Ballesteros, Yolanda; Polidori, Carlo; Tormos, Jose; Banos-Picon, Laura; Daniel Asis, Josep			Complex-to-Predict Generational Shift between Nested and Clustered Organization of Individual Prey Networks in Digger Wasps	PLOS ONE			English	Article							STIZUS-CONTINUUS HYMENOPTERA; GRASSHOPPER-HUNTING WASP; INTRASPECIFIC COMPETITION; RESOURCE USE; NICHE WIDTH; DIET SPECIALIZATION; PONERINE ANT; SEA OTTERS; FEEDING SPECIALIZATION; SPECIES COEXISTENCE	Although diet has traditionally been considered to be a property of the species or populations as a whole, there is nowadays extensive knowledge that individual specialization is widespread among animal populations. Nevertheless, the factors determining the shape of interactions within food webs remain largely undiscovered, especially in predatory insects. We used an aggregation of the digger wasp Bembix merceti to 1) analyse patterns of individual prey use across three flying seasons in a network-based context; and 2) test the effect of four potential factors that might explain network topologies (wasp mass, nest spatial distribution, simultaneous nest-provisioning, prey availability). Inter-individual diet variation was found in all three years, under different predator-prey network topologies: Individuals arranged in dietary clusters and displayed a checkerboard pattern in 2009, but showed nestedness in 2008 and 2010. Network topologies were not fully explained by the tested factors. Larger females consumed a higher proportion of the total number of prey species captured by the population as a whole, in such a way that nested patterns may arise from mass-dependent prey spectrum width. Conversely, individuals with similar body mass didn't form clusters. Nested patterns seemed to be associated with a greater availability of the main prey species (a proxy for reduced intra-specific competition). Thus, according with theory, clusters seemed to appear when competition increased. On the other hand, the nests of the individuals belonging to a given cluster were not more closely located, and neither did individuals within a cluster provision their nests simultaneously. Thus, a female-female copying behaviour during foraging was unlikely. In conclusion, wasp populations can maintain a considerable individual variation across years under different food web organizations. The tested factors only partially accounted for the shift in network properties, and new analyses should be carried out to elucidate how diet network topologies arise in wasp populations.	[Ballesteros, Yolanda; Tormos, Jose; Banos-Picon, Laura; Daniel Asis, Josep] Univ Salamanca, Fac Biol, Dept Zool, E-37008 Salamanca, Spain; [Polidori, Carlo] Museo Nacl Ciencias Nat CSIC, Dept Biodiversidad & Biol Evolut, Madrid, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Ballesteros, Y (corresponding author), Univ Salamanca, Fac Biol, Dept Zool, E-37008 Salamanca, Spain.	ballesteros.y@outlook.com	Baños-Picón, Laura/A-7675-2017; Asís, Josep D/K-5623-2014; Polidori, Carlo/G-4382-2010; Tormos, José/K-5643-2014	Baños-Picón, Laura/0000-0003-0500-8231; Asís, Josep D/0000-0001-8134-1875; Polidori, Carlo/0000-0003-4834-0752; Tormos, José/0000-0002-0568-4486	Junta de Castilla y Leon [SA094A09, SA010A06]; MICINN [CGL2010-16730]; Universidad de Salamanca-Santander Bank grant; post-doctoral contract within the Program JAE-Doc "Junta para la Ampliacion de Estudios''; Spanish Research Council (CSIC); FSE	Junta de Castilla y Leon(Junta de Castilla y Leon); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Universidad de Salamanca-Santander Bank grant; post-doctoral contract within the Program JAE-Doc "Junta para la Ampliacion de Estudios''; Spanish Research Council (CSIC); FSE(European Social Fund (ESF))	This work was supported by the Projects SA094A09 and SA010A06 (Junta de Castilla y Leon) and CGL2010-16730 (MICINN). YB was funded by a Universidad de Salamanca-Santander Bank grant. CP was funded by a post-doctoral contract within the Program JAE-Doc "Junta para la Ampliacion de Estudios,'' funded by the Spanish Research Council (CSIC) and the FSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBOGBA C, 1992, INSECT SOC, V39, P455, DOI 10.1007/BF01240629; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Araujo MS, 2010, OIKOS, V119, P81, DOI 10.1111/j.1600-0706.2009.17624.x; Asis JD, 2011, BEHAVIOUR, V148, P191, DOI 10.1163/000579510X551651; ASIS JD, 1988, ENTOMOL NEWS, V99, P199; Asis JD, 2004, J NAT HIST, V38, P1799, DOI 10.1080/0022293031000156295; Asis JD, 2014, ETHOLOGY, V120, P340, DOI 10.1111/eth.12208; Ballesteros Y, 2012, ANN SOC ENTOMOL FR, V48, P281, DOI 10.1080/00379271.2012.10697777; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2009, EVOL ECOL RES, V11, P1217; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Cantor M, 2013, OIKOS, V122, P1085, DOI 10.1111/j.1600-0706.2012.00070.x; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; Diamond J.M., 1975, P342; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Durell SEALD, 2000, BIOL REV, V75, P503; ENDO T, 1994, ECOL RES, V9, P225, DOI 10.1007/BF02347498; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Evans HE., 2007, SAND WASPS NATURAL H; GOSSCUSTARD JD, 1988, J ANIM ECOL, V57, P827, DOI 10.2307/5095; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; GWYNNE DT, 1983, ANN ENTOMOL SOC AM, V76, P434, DOI 10.1093/aesa/76.3.434; Hagbery J, 2012, NATURWISSENSCHAFTEN, V99, P821, DOI 10.1007/s00114-012-0964-7; Heino J, 2005, FRESHWATER BIOL, V50, P567, DOI 10.1111/j.1365-2427.2005.01346.x; Kendall BE, 2003, CONSERV BIOL, V17, P1170, DOI 10.1046/j.1523-1739.2003.02411.x; Krasnov BR, 2005, ECOGRAPHY, V28, P475, DOI 10.1111/j.0906-7590.2005.04238.x; Lankau RA, 2009, AM NAT, V174, pE40, DOI 10.1086/600083; Leadbeater E, 2008, P ROY SOC B-BIOL SCI, V275, P1669, DOI 10.1098/rspb.2008.0270; LEWIS AC, 1986, SCIENCE, V232, P863, DOI 10.1126/science.232.4752.863; Lichstein JW, 2007, AM NAT, V170, P807, DOI 10.1086/522937; Lomnicki A., 1988, POPULATION ECOLOGY I, DOI 10.12987/9780691209616; Masello JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067714; Moleon M, 2012, J ANIM ECOL, V81, P1154, DOI 10.1111/j.1365-2656.2012.02006.x; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Nieh James C., 2009, P266; Okuyama T, 2008, ECOL RES, V23, P665, DOI 10.1007/s11284-007-0425-5; Partridge L., 1985, P207; PERSSON L, 1985, OECOLOGIA, V67, P338, DOI 10.1007/BF00384938; PIELOU EC, 1972, J THEOR BIOL, V34, P337, DOI 10.1016/0022-5193(72)90166-X; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Polidori C, 2005, EUR J ENTOMOL, V102, P801, DOI 10.14411/eje.2005.111; Polidori C, 2011, PREDATION HYMENOPTER, P101; Polidori C, 2008, ANIM BEHAV, V75, P1651, DOI 10.1016/j.anbehav.2007.10.018; Polidori C, 2013, OIKOS, V122, P385, DOI 10.1111/j.1600-0706.2012.20387.x; Polidori C, 2012, POPUL ECOL, V54, P443, DOI 10.1007/s10144-012-0322-9; Polidori C, 2010, BIOL J LINN SOC, V99, P544, DOI 10.1111/j.1095-8312.2009.01397.x; Polidori C, 2009, J NAT HIST, V43, P2985, DOI 10.1080/00222930903383511; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; Poulin R, 2002, INT J PARASITOL, V32, P1235, DOI 10.1016/S0020-7519(02)00109-1; Provencher JF, 2012, MAR ECOL PROG SER, V454, P171, DOI 10.3354/meps09299; Punzo F, 2005, J NEW YORK ENTOMOL S, V113, P222, DOI 10.1664/0028-7199(2005)113[0222:EAHBOT]2.0.CO;2; Raveret-Richter M., 2000, ANNU REV ENTOMOL, V45, P121, DOI [10.1146/annurev.ento.45.1.121, DOI 10.1146/ANNUREV.ENTO.45.1.121]; Santoro D, 2011, J ANIM ECOL, V80, P1123, DOI 10.1111/j.1365-2656.2011.01874.x; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; SCHATZ B, 1995, SOCIOBIOLOGY, V26, P269; Schatz B, 1999, J INSECT BEHAV, V12, P641, DOI 10.1023/A:1020927703689; SMITH TB, 1990, ECOLOGY, V71, P1246, DOI 10.2307/1938261; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Svanback R, 2008, OIKOS, V117, P114, DOI 10.1111/j.2007.0030-1299.16267.x; Swanson BO, 2003, ECOLOGY, V84, P1441, DOI 10.1890/02-0353; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Ulrich W, 2004, OIKOS, V107, P603, DOI 10.1111/j.0030-1299.2004.12981.x; WERNER TK, 1987, P NATL ACAD SCI USA, V84, P5506, DOI 10.1073/pnas.84.15.5506	77	3	3	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102325	10.1371/journal.pone.0102325	http://dx.doi.org/10.1371/journal.pone.0102325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019164	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600067
J	Duong, T; Kim, J; Ruley, HE; Jo, D				Duong, Tam; Kim, Jaetaek; Ruley, H. Earl; Jo, Daewoong			Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals	PLOS ONE			English	Article							PROTECTS DOPAMINERGIC-NEURONS; UBIQUITIN LIGASE ACTIVITY; NUCLEAR IMPORT INHIBITOR; MOUSE MODEL; ANTITUMOR-ACTIVITY; MOLECULAR-MECHANISMS; INDUCED TOXICITY; ALPHA-SYNUCLEIN; L-DOPA; DELIVERY	Parkinson's disease (PD) is a neurodegenerative disorder of complex etiology characterized by the selective loss of dopaminergic neurons, particularly in the substantia nigra. Parkin, a tightly regulated E3 ubiquitin ligase, promotes the survival of dopaminergic neurons in both PD and Parkinsonian syndromes induced by acute exposures to neurotoxic agents. The present study assessed the potential of cell-permeable parkin (CP-Parkin) as a neuroprotective agent. Cellular uptake and tissue penetration of recombinant, enzymatically active parkin was markedly enhanced by the addition of a hydrophobic macromolecule transduction domain (MTD). The resulting CP-Parkin proteins (HPM13 and PM10) suppressed dopaminergic neuronal toxicity in cells and mice exposed to 6-hydroxydopamine (6-OHDH) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). These included enhanced survival and dopamine expression in cultured CATH. a and SH-SY5Y neuronal cells; and protection against MPTP-induced damage in mice, notably preservation of tyrosine hydroxylase-positive cells with enhanced dopamine expression in the striatum and midbrain, and preservation of gross motor function. These results demonstrate that CP-Parkin proteins can compensate for intrinsic limitations in the parkin response and provide a therapeutic strategy to augment parkin activity in vivo.	[Duong, Tam; Jo, Daewoong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea; [Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 156756, South Korea; [Ruley, H. Earl] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Jo, Daewoong] ProCell Therapeut Inc, ProCell R&D Inst, Seoul, South Korea	Chonnam National University; Chung Ang University; Chung Ang University Hospital; Vanderbilt University	Jo, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37212 USA.	dae-woong.jo@vanderbilt.edu	Kim, Jaetaek/AAE-7147-2020	Kim, Jaetaek/0000-0001-5247-0408	Ministry of Education, Science and Technology, Republic of Korea [KRF-2006-331-E00102]	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant of the Rising Professor Support Program (KRF-2006-331-E00102 to D.J.) of Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.	Ahn EH, 2013, FREE RADICAL BIO MED, V55, P36, DOI 10.1016/j.freeradbiomed.2012.11.008; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093; Haobam R, 2005, BEHAV BRAIN RES, V163, P159, DOI 10.1016/j.bbr.2005.04.011; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jeong HJ, 2012, MOL CELLS, V33, P471, DOI 10.1007/s10059-012-2255-8; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Joshi RL, 2011, FEBS LETT, V585, P1573, DOI 10.1016/j.febslet.2011.05.006; Kim DW, 2010, FREE RADICAL BIO MED, V48, P969, DOI 10.1016/j.freeradbiomed.2010.01.023; Kim MJ, 2012, BIOCHIMIE, V94, P2448, DOI 10.1016/j.biochi.2012.07.005; Kim MJ, 2010, J NEUROL SCI, V298, P64, DOI 10.1016/j.jns.2010.08.016; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lee YP, 2012, FEBS J, V279, P1929, DOI 10.1111/j.1742-4658.2012.08574.x; Lim J, 2013, BIOMATERIALS, V34, P6261, DOI 10.1016/j.biomaterials.2013.05.011; Lim J, 2013, CLIN CANCER RES, V19, P680, DOI 10.1158/1078-0432.CCR-12-2692; Lim J, 2012, MOL THER, V20, P1540, DOI 10.1038/mt.2012.102; Lim J, 2011, CANCER RES, V71, P7216, DOI 10.1158/0008-5472.CAN-11-2015; Lipski J, 2011, PROG NEUROBIOL, V94, P389, DOI 10.1016/j.pneurobio.2011.06.005; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200; Liu XY, 2000, J BIOL CHEM, V275, P16774; Liu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000093; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Luthra PM, 2009, J NEUROSCI METH, V178, P284, DOI 10.1016/j.jneumeth.2008.12.019; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Masserano JM, 1996, MOL PHARMACOL, V50, P1309; Moore DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013235; Nagel F, 2008, J NEUROCHEM, V105, P853, DOI 10.1111/j.1471-4159.2007.05204.x; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Ramamoorthy A, 2007, BIOCHEMISTRY-US, V46, P965, DOI 10.1021/bi061895g; Rosen KM, 2006, J BIOL CHEM, V281, P12809, DOI 10.1074/jbc.M512649200; Sohn EJ, 2012, BBA-GEN SUBJECTS, V1820, P1647, DOI 10.1016/j.bbagen.2012.06.012; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095; Surmeier DJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009290; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Trempe JF, 2013, SCIENCE; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Walden H, 2012, CELL MOL LIFE SCI, V69, P3053, DOI 10.1007/s00018-012-0978-5; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0	53	5	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102517	10.1371/journal.pone.0102517	http://dx.doi.org/10.1371/journal.pone.0102517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019626	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600089
J	Hofstra, JM; Coenen, MJH; Schijvenaars, MMVAP; Berden, JHM; van der Vlag, J; Hoefsloot, LH; Knoers, NVAM; Wetzels, JFM; Nijenhuis, T				Hofstra, Julia M.; Coenen, Marieke J. H.; Schijvenaars, Mascha M. V. A. P.; Berden, Jo H. M.; van der Vlag, Johan; Hoefsloot, Lies H.; Knoers, Nine V. A. M.; Wetzels, Jack F. M.; Nijenhuis, Tom			TRPC6 Single Nucleotide Polymorphisms and Progression of Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; RECEPTOR; ACTIVATION; ASSOCIATION; COMPLEMENT; EXPRESSION; MUTATION; ANTIGEN; MARKERS	Background: Activating mutations in the Transient Receptor Potential channel C6 (TRPC6) cause autosomal dominant focal segmental glomerular sclerosis (FSGS). TRPC6 expression is upregulated in renal biopsies of patients with idiopathic membranous glomerulopathy (iMN) and animal models thereof. In iMN, disease progression is characterized by glomerulosclerosis. In addition, a context-dependent TRPC6 overexpression was recently suggested in complement-mediated podocyte injury in e. g. iMN. Hence, we hypothesized that genetic variants in TRPC6 might affect susceptibility to development or progression of iMN. Methods & Results: Genomic DNA was isolated from blood samples of 101 iMN patients and 292 controls. By direct sequencing of the entire TRPC6 gene, 13 single nucleotide polymorphisms (SNPs) were identified in the iMN cohort, two of which were causing an amino acid substitution (rs3802829; Pro15Ser and rs36111323, Ala404Val). No statistically significant differences in genotypes or allele frequencies between patients and controls were observed. Clinical outcome in patients was determined (remission n = 26, renal failure n = 46, persistent proteinuria n = 29, follow-up median 80 months {range 51-166}). The 13 identified SNPs showed no association with remission or renal failure. There were no differences in genotypes or allele frequencies between patients in remission and progressors. Conclusions: Our data suggest that TRPC6 polymorphisms do not affect susceptibility to iMN, or clinical outcome in iMN.	[Hofstra, Julia M.; Berden, Jo H. M.; van der Vlag, Johan; Wetzels, Jack F. M.; Nijenhuis, Tom] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Coenen, Marieke J. H.; Schijvenaars, Mascha M. V. A. P.; Hoefsloot, Lies H.; Knoers, Nine V. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Nijenhuis, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands.	Tom.Nijenhuis@Radboudumc.nl	Hofstra, Julia/A-4171-2015; Wetzels, Jack F.M./A-1720-2014; Coenen, Marieke/A-2159-2010; Van der Vlag, Johan/E-4636-2010; Schijvenaars, Mascha/P-8712-2015; Nijenhuis, Tom/L-4547-2015; Nijenhuis, Tom/ABE-5194-2021; Berden, J.H.M./H-8009-2014	Wetzels, Jack F.M./0000-0002-0650-6921; Coenen, Marieke/0000-0001-8796-2031; Van der Vlag, Johan/0000-0001-7843-5918; Nijenhuis, Tom/0000-0002-4375-7236; Nijenhuis, Tom/0000-0002-4375-7236; 	Dutch Kidney Foundation [OW08, KJPB 07.0001]; Genzyme Renal Innovations Program (GRIP); Dutch Diabetes Fund [2009.80.118]	Dutch Kidney Foundation; Genzyme Renal Innovations Program (GRIP)(Sanofi-AventisGenzyme Corporation); Dutch Diabetes Fund	Financial support was provided by a Dutch Kidney Foundation grant (OW08) for J.M.H and J.F. M. W., a Kolff Career Stimulation Grant from the Dutch Kidney Foundation (KJPB 07.0001), a grant from the Genzyme Renal Innovations Program (GRIP) and a Ruby Diabetes Research Grant from the Dutch Diabetes Fund (2009.80.118) for T.N. http://www. nierstichting.nl http://www.genzyme.com/Responsibility/Grants-and-Giving.aspx http://www.diabetesfonds.nl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Branten AJW, 2005, J AM SOC NEPHROL, V16, P169, DOI 10.1681/ASN.2004040287; BROOKS RC, 1989, J BIOL CHEM, V264, P20147; Chen WC, 2010, RENAL FAILURE, V32, P666, DOI 10.3109/0886022X.2010.485289; Cheng WR, 2011, NEPHROL DIAL TRANSPL, V26, P2544, DOI 10.1093/ndt/gfq768; Coenen MJH, 2013, J AM SOC NEPHROL, V24, P677, DOI 10.1681/ASN.2012070730; Debiec H, 2011, NEW ENGL J MED, V364, P689, DOI 10.1056/NEJMc1011678; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; GLASSOCK RJ, 1992, NEPHROL DIAL TRANSPL, V7, P64; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Heeringa SF, 2007, NEPHROL DIAL TRANSPL, V22, P2201, DOI 10.1093/ndt/gfm188; Hofstra JM, 2012, NETH J MED, V70, P109; Hofstra JM, 2013, NAT REV NEPHROL, V9, P443, DOI 10.1038/nrneph.2013.125; Hofstra JM, 2013, NEPHROL DIAL TRANSPL, V28, P1830, DOI 10.1093/ndt/gfs572; Hofstra JM, 2012, NEPHROL DIAL TRANSPL, V27, P6, DOI 10.1093/ndt/gfr371; JONES DB, 1957, AM J PATHOL, V33, P313; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; Kistler AD, 2013, J BIOL CHEM, V288, P36598, DOI 10.1074/jbc.M113.488122; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Ma H, 2013, SEMIN NEPHROL, V33, P531, DOI 10.1016/j.semnephrol.2013.08.004; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ronco P, 2012, NAT REV NEPHROL, V8, P203, DOI 10.1038/nrneph.2012.35; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Sonneveld R, 2013, AM J PATHOL, V182, P1196, DOI 10.1016/j.ajpath.2012.12.011; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; van den Brand JAJG, 2012, CLIN J AM SOC NEPHRO, V7, P1242, DOI 10.2215/CJN.00670112; van den Brand JAJG, 2011, CLIN J AM SOC NEPHRO, V6, P2846, DOI 10.2215/CJN.04020411; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhang H, 2009, EXP BIOL MED, V234, P1029, DOI 10.3181/0901-RM-11	36	4	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102065	10.1371/journal.pone.0102065	http://dx.doi.org/10.1371/journal.pone.0102065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019165	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600042
J	Mian, C; Ceccato, F; Barollo, S; Watutantrige-Fernando, S; Albiger, N; Regazzo, D; de Lazzari, P; Pennelli, G; Rotondi, S; Nacamulli, D; Pelizzo, MR; Jaffrain-Rea, ML; Grimaldi, F; Occhi, G; Scaroni, C				Mian, Caterina; Ceccato, Filippo; Barollo, Susi; Watutantrige-Fernando, Sara; Albiger, Nora; Regazzo, Daniela; de Lazzari, Paola; Pennelli, Gianmaria; Rotondi, Sandra; Nacamulli, Davide; Pelizzo, Maria Rosa; Jaffrain-Rea, Marie-Lise; Grimaldi, Franco; Occhi, Gianluca; Scaroni, Carla			AHR Over-Expression in Papillary Thyroid Carcinoma: Clinical and Molecular Assessments in a Series of Italian Acromegalic Patients with a Long-Term Follow-Up	PLOS ONE			English	Article							PITUITARY-ADENOMA PREDISPOSITION; INTERACTING PROTEIN MUTATIONS; HYDROCARBON RECEPTOR AHR; CANCER INCIDENCE; AIP MUTATIONS; PREVALENCE; MORTALITY; NEOPLASMS; CONSENSUS; DISEASES	Aim: Acromegaly reportedly carries an increased risk of malignant and benign thyroid tumors, with a prevalence of thyroid cancer of around 3-7%. Germline mutations in the aryl-hydrocarbon receptor (AHR) interacting protein (AIP) have been identified in familial forms of acromegaly. The molecular and endocrine relationships between follicular thyroid growth and GH-secreting pituitary adenoma have yet to be fully established. Our aim was to study the prevalence of differentiated thyroid cancer (DTC) in acromegaly, focusing on the role of genetic events responsible for the onset of thyroid cancer. Methods: Germline mutations in the AIP gene were assessed in all patients; BRAF and H-N-K RAS status was analyzed by direct sequencing in thyroid specimens, while immunohistochemistry was used to analyze the protein expression of AIP and AHR. A set of PTCs unrelated to acromegaly was also studied. Results: 12 DTCs (10 papillary and 2 follicular carcinomas) were identified in a cohort of 113 acromegalic patients. No differences in GH/IGF-1 levels or disease activity emerged between patients with and without DTC, but the former were older and more often female. BRAF V600E was found in 70% of the papillary thyroid cancers; there were no RAS mutations. AIP protein expression was similar in neoplastic and normal cells, while AHR protein was expressed more in PTCs carrying BRAF mutations than in normal tissue, irrespective of acromegaly status. Conclusions: The prevalence of DTC in acromegaly is around 11% and endocrinologists should bear this in mind, especially when examining elderly female patients with uninodular goiter. The DTC risk does not seem to correlate with GH/IGF-1 levels, while it may be associated with BRAF mutations and AHR over-expression. Genetic or epigenetic events probably play a part in promoting thyroid carcinoma.	[Mian, Caterina; Ceccato, Filippo; Barollo, Susi; Watutantrige-Fernando, Sara; Albiger, Nora; Regazzo, Daniela; de Lazzari, Paola; Nacamulli, Davide; Occhi, Gianluca; Scaroni, Carla] Univ Hosp Padua, Dept Med, Endocrinol Unit, Padua, Italy; [Pennelli, Gianmaria] Univ Hosp Padua, Dept Med, Pathol Unit 2, Padua, Italy; [Rotondi, Sandra; Jaffrain-Rea, Marie-Lise] Univ Aquila, Dept Clin & Biotechnol Sci, I-67100 Laquila, Italy; [Pelizzo, Maria Rosa] Univ Hosp Padua, Dept Surg, Surg Pathol Unit, Padua, Italy; [Jaffrain-Rea, Marie-Lise] Univ Aquila, Dept Neurol Sci, Neuromed Inst, I-67100 Laquila, Italy; [Grimaldi, Franco] Univ Hosp Santa Maria Misericordia, Endocrinol & Metab Unit, Udine, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; University of L'Aquila; University of Padua; Azienda Ospedaliera - Universita di Padova; University of L'Aquila; Hospital Santa Maria della Misericordia	Mian, C (corresponding author), Univ Hosp Padua, Dept Med, Endocrinol Unit, Padua, Italy.	caterina.mian@unipd.it	Ceccato, Filippo/K-1316-2018; Dagdelen, Selcuk/A-9432-2017; Occhi, Gianluca/AAJ-1125-2020; Regazzo, Daniela/X-3139-2019; Jaffrain-Rea, Marie-Lise/D-1129-2009; Occhi, Gianluca/S-5872-2019; Grimaldi, Franco/AAK-5748-2020; Rea, Marie Lise Jaffrain/AAK-9443-2021; Pennelli, Gianmaria/J-9937-2016; Scaroni, Carla/G-3853-2017	Ceccato, Filippo/0000-0003-1456-8716; Dagdelen, Selcuk/0000-0002-0513-1750; Regazzo, Daniela/0000-0002-1942-7202; Jaffrain-Rea, Marie-Lise/0000-0002-5916-8997; Occhi, Gianluca/0000-0003-4065-4677; Rea, Marie Lise Jaffrain/0000-0002-5916-8997; Pennelli, Gianmaria/0000-0003-0210-165X; Scaroni, Carla/0000-0001-9396-3815; MIAN, CATERINA/0000-0003-2615-8001; Watutantrige Fernando, Sara/0000-0001-7056-0423				Baldys-Waligorska A, 2010, ENDOKRYNOL POL, V61, P29; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; dos Santos MCC, 2013, PITUITARY, V16, P109, DOI 10.1007/s11102-012-0383-y; Ceccato F, 2011, J ENDOCRINOL INVEST, V34, P353, DOI [10.1007/BF03347459, 10.3275/7145]; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Colao A, 2007, J CLIN ENDOCR METAB, V92, P3854, DOI 10.1210/jc.2006-2551; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dagdelen S, 2014, PITUITARY, V17, P299, DOI 10.1007/s11102-013-0501-5; Duong Cuong V, 2012, Endocr Relat Cancer, V19, P805, DOI 10.1530/ERC-12-0251; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernando SW, 2013, EUR J CLIN NUTR, V67, P366, DOI 10.1038/ejcn.2013.44; Gasperi M, 2002, J ENDOCRINOL INVEST, V25, P240, DOI 10.1007/BF03343997; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; Gullu BE, 2010, PITUITARY, V13, P242, DOI 10.1007/s11102-010-0224-9; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Herrmann BL, 2004, EXP CLIN ENDOCR DIAB, V112, P225, DOI 10.1055/s-2004-817967; Jaffrain-Rea ML, 2013, ENDOCR-RELAT CANCER, V20, P753, DOI 10.1530/ERC-12-0322; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; Jenkins PJ, 2006, CLIN ENDOCRINOL, V64, P115, DOI 10.1111/j.1365-2265.2005.02404.x; Kurimoto M, 2008, ENDOCR J, V55, P67, DOI 10.1507/endocrj.K07E-010; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Melmed S, 2013, PITUITARY, V16, P294, DOI 10.1007/s11102-012-0420-x; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; MINUTO F, 1989, J CLIN ENDOCR METAB, V68, P621, DOI 10.1210/jcem-68-3-621; Occhi G, 2010, EUR J ENDOCRINOL, V163, P369, DOI 10.1530/EJE-10-0327; ONODA N, 1992, EUR J CANCER, V28A, P1904, DOI 10.1016/0959-8049(92)90033-X; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Pardi E, 2013, J CLIN ENDOCR METAB, V98, P2800, DOI 10.1210/jc.2012-4029; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Pennelli G, 2011, THYROID, V21, P1393, DOI 10.1089/thy.2011.0120; Popovic V, 1998, CLIN ENDOCRINOL, V49, P441, DOI 10.1046/j.1365-2265.1998.00536.x; Raitila A, 2007, ENDOCR-RELAT CANCER, V14, P901, DOI 10.1677/ERC-07-0025; Raitila A, 2009, J ENDOCRINOL INVEST, V32, P426, DOI 10.1007/BF03346480; Reiners C, 2014, NAT REV ENDOCRINOL, V10, P69, DOI 10.1038/nrendo.2013.247; Roger P, 1998, J CLIN ENDOCR METAB, V66, P1158; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; Tita P, 2005, CLIN ENDOCRINOL, V63, P161, DOI 10.1111/j.1365-2265.2005.02316.x; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Watutantrige-Fernando S, 2018, THYROID, V28, P96, DOI 10.1089/thy.2017.0248	39	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101560	10.1371/journal.pone.0101560	http://dx.doi.org/10.1371/journal.pone.0101560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019383	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600018
J	Vidal, BD; Ghiraldini, FG; Mello, MLS				Vidal, Benedicto de Campos; Ghiraldini, Flavia Gerelli; Mello, Maria Luiza S.			Changes in Liver Cell DNA Methylation Status in Diabetic Mice Affect Its FT-IR Characteristics	PLOS ONE			English	Article							CYTOSINE METHYLATION; INFRARED-SPECTRA; LASER-RAMAN; BINDING; SITES	Background: Lower levels of cytosine methylation have been found in the liver cell DNA from non-obese diabetic (NOD) mice under hyperglycemic conditions. Because the Fourier transform-infrared (FT-IR) profiles of dry DNA samples are differently affected by DNA base composition, single-stranded form and histone binding, it is expected that the methylation status in the DNA could also affect its FT-IR profile. Methodology/Principal Findings: The DNA FT-IR signatures obtained from the liver cell nuclei of hyperglycemic and normoglycemic NOD mice of the same age were compared. Dried DNA samples were examined in an IR microspectroscope equipped with an all-reflecting objective (ARO) and adequate software. Conclusions/Significance: Changes in DNA cytosine methylation levels induced by hyperglycemia in mouse liver cells produced changes in the respective DNA FT-IR profiles, revealing modifications to the vibrational intensities and frequencies of several chemical markers, including v(as) -CH3 stretching vibrations in the 5-methylcytosine methyl group. A smaller band area reflecting lower energy absorbed in the DNA was found in the hyperglycemic mice and assumed to be related to the lower levels of -CH3 groups. Other spectral differences were found at 1700-1500 cm(-1) and in the fingerprint region, and a slight change in the DNA conformation at the lower DNA methylation levels was suggested for the hyperglycemic mice. The changes that affect cytosine methylation levels certainly affect the DNA-protein interactions and, consequently, gene expression in liver cells from the hyperglycemic NOD mice.	[Vidal, Benedicto de Campos; Ghiraldini, Flavia Gerelli; Mello, Maria Luiza S.] Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Mello, MLS (corresponding author), Univ Campinas Unicamp, Inst Biol, Dept Struct & Funct Biol, Sao Paulo, Brazil.	mlsmello@unicamp.br	Vidal, Benedicto/I-3227-2012; de Campos Vidal, Benedicto/ABH-6617-2020; Mello, Maria Luiza Silveira/D-9158-2012	Vidal, Benedicto/0000-0003-1629-5619; de Campos Vidal, Benedicto/0000-0003-0285-1653; Mello, Maria Luiza Silveira/0000-0003-1629-5619	Sao Paulo State Research Foundation (FAPESP) [201050015-6]; Brazilian National Council for Research and Development (CNPq) [301943/2009-5, 475261/2012-7]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grant no. 201050015-6 from the Sao Paulo State Research Foundation (FAPESP) and grants no. 301943/2009-5 and 475261/2012-7 from the Brazilian National Council for Research and Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Anastassopoulou J, 2009, VIB SPECTROSC, V51, P270, DOI 10.1016/j.vibspec.2009.07.005; Arakawa H, 2001, BIOPHYS J, V81, P1580, DOI 10.1016/S0006-3495(01)75812-2; Banyay M, 2002, J MOL BIOL, V324, P667, DOI 10.1016/S0022-2836(02)01104-X; Bird B, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-8; Colucci F, 1997, P NATL ACAD SCI USA, V94, P8670, DOI 10.1073/pnas.94.16.8670; Damasceno NB, 2013, 59 C BRAS GEN AG LIN, P57; Eglinton G, 1970, INTRO SPECTROSCOPY M, V1, p[129, 139]; Flett MSC, 1970, INTRO SPECTROSCOPIC, V1, P109; Fox JJ, 1940, PROC R SOC LON SER-A, V175, P0208, DOI 10.1098/rspa.1940.0053; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P673, DOI 10.1107/S0365110X53001939; Ghiraldini FG, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-19; Ghiraldini FG, 2012, CYTOM PART A, V81A, P755, DOI 10.1002/cyto.a.22102; Ghiraldini FG, 2013, MOL BIOL CELL, V24, P2467, DOI 10.1091/mbc.E13-04-0186; Hembram KPSS, 2009, MAT SCI ENG C-BIO S, V29, P1093, DOI 10.1016/j.msec.2008.09.021; Kelly JG, 2011, J BIOPHOTONICS, V4, P345, DOI 10.1002/jbio.201000085; Kurtz DM, 2000, J LIPID RES, V41, P2063; KYOGOKU Y, 1961, J MOL BIOL, V3, P741, DOI 10.1016/S0022-2836(61)80078-8; MATHLOUTHI M, 1986, CARBOHYD RES, V146, P1, DOI 10.1016/0008-6215(86)85019-4; Mello MLS, 2014, MICRON, V61, P49, DOI 10.1016/j.micron.2014.02.003; Mello MLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043169; MOHAN S, 1993, ASIAN J CHEM, V5, P243; Mukai T, 2006, LIVER INT, V26, P1006, DOI 10.1111/j.1478-3231.2006.01322.x; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; REDI CA, 1990, CHROMOSOMA, V99, P11, DOI 10.1007/BF01737284; Reusch W, 1999, VIRTUAL TEXT ORGANIC; Shimanouchi T., 1964, ADVANCES CHEMICAL PH, V7, P435; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Vargason JM, 2000, NAT STRUCT BIOL, V7, P758; Vargason JM, 2001, P NATL ACAD SCI USA, V98, P7265, DOI 10.1073/pnas.121176898; Vargason JM, 2002, THESIS OREGON STATE; Vidal BD, 2011, MICRON, V42, P283, DOI 10.1016/j.micron.2010.09.010; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yang PY, 2012, APOPTOSIS, V17, P154, DOI 10.1007/s10495-011-0666-1; Yang Y, 2003, DIABETOLOGIA, V46, P1447, DOI 10.1007/s00125-003-1218-1; Yugami H, 1996, SOLID STATE IONICS, V85, P319, DOI 10.1016/0167-2738(96)00076-8; Zelig U, 2011, BBA-GEN SUBJECTS, V1810, P827, DOI 10.1016/j.bbagen.2011.06.010	38	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102295	10.1371/journal.pone.0102295	http://dx.doi.org/10.1371/journal.pone.0102295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019512	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600062
J	Zhang, Y; Peng, L; Kan, HD; Xu, JM; Chen, RJ; Liu, Y; Wang, WB				Zhang, Yue; Peng, Li; Kan, Haidong; Xu, Jianming; Chen, Renjie; Liu, Yuan; Wang, Weibing			Effects of Meteorological Factors on Daily Hospital Admissions for Asthma in Adults: A Time-Series Analysis	PLOS ONE			English	Article							DIURNAL TEMPERATURE-RANGE; CLIMATE-CHANGE; AIR-POLLUTION; CHILDHOOD ASTHMA; COLD TEMPERATURE; HEAT WAVES; MORTALITY; PREVALENCE; SYMPTOMS; DISEASE	Background: There is limited evidence for the impacts of meteorological changes on asthma hospital admissions in adults in Shanghai, China. Objectives: To quantitatively evaluate the short-term effects of daily mean temperature on asthma hospital admissions. Methods: Daily hospital admissions for asthma and daily mean temperatures between January 2005 and December 2012 were analyzed. After controlling for secular and seasonal trends, weather, air pollution and other confounding factors, a Poisson generalized additive model (GAM) combined with a distributed lag non-linear model were used to explore the associations between temperature and hospital admissions for asthma. Results: During the study periods, there were 15,678 hospital admissions for asthma by residents of Shanghai, an average 5.6 per day. Pearson correlation analysis found a significant negative correlation (r = -0.174, P<0.001) between asthma hospitalizations and daily mean temperature (DMT). The DMT effect on asthma increased below the median DMT, with lower temperatures associated with a higher risk of hospital admission for asthma. Generally, the cold effect appeared to be relatively acute, with duration lasting several weeks, while the hot effect was short-term. The relative risk of asthma hospital admissions associated with cold temperature (the 25th percentile of temperature relative to the median temperature) was 1.20 (95% confidence interval [CI], 1.01 similar to 1.41) at lag0-14. However, warmer temperatures were not associated with asthma hospital admissions. Conclusions: Cold temperatures may trigger asthmatic attacks. Effective strategies are needed to protect populations at risk from the effects of cold.	[Zhang, Yue; Kan, Haidong; Chen, Renjie; Liu, Yuan; Wang, Weibing] Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhang, Yue; Kan, Haidong; Chen, Renjie; Liu, Yuan; Wang, Weibing] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Kan, Haidong; Wang, Weibing] Fudan Univ, Fudan Tyndall Ctr, Shanghai 200433, Peoples R China; [Peng, Li; Xu, Jianming] Shanghai Ctr Urban Environm Meteorol, Shanghai, Peoples R China; [Peng, Li; Xu, Jianming] Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, WB (corresponding author), Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	wwb@fudan.edu.cn	Kan, Haidong/AGU-0328-2022		Global Environment Change Research in Fudan University [EZH1829007/003]; Chinese Meteorological Administration [GYHY201206027]; Chinese National Science Foundation [30800937]; program of Key Discipline Construction of Public Health of Shanghai [12GWZX0101]	Global Environment Change Research in Fudan University; Chinese Meteorological Administration; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); program of Key Discipline Construction of Public Health of Shanghai	This study was funded by the Global Environment Change Research in Fudan University (Grant No. EZH1829007/003), the Chinese Meteorological Administration (Grant No. GYHY201206027), Chinese National Science Foundation (30800937) and the program of Key Discipline Construction of Public Health of Shanghai (Grant No. 12GWZX0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, AM J EMERG MED, V27, P153, DOI 10.1016/j.ajem.2008.01.013; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Amoah A S, 2012, Ghana Med J, V46, P23; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Beggs PJ, 2010, INT J ENV RES PUB HE, V7, P3006, DOI 10.3390/ijerph7083006; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; Buckley JP, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-55; Cao JS, 2009, SCI TOTAL ENVIRON, V407, P5531, DOI 10.1016/j.scitotenv.2009.07.021; Chan-Yeung M, 2002, EUR RESPIR J, V19, P853, DOI 10.1183/09031936.02.00250602; Chen RJ, 2010, J HAZARD MATER, V181, P234, DOI 10.1016/j.jhazmat.2010.05.002; D'Amato G, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-12; D'Amato G, 2011, MULTIDISCIP RESP MED, V6, P28, DOI 10.1186/2049-6958-6-1-28; Donaldson GC, 1999, EUR RESPIR J, V13, P844, DOI 10.1034/j.1399-3003.1999.13d25.x; Epton MJ, 1997, THORAX, V52, P528, DOI 10.1136/thx.52.6.528; Europe WHOROf, 2006, AIR QUAL GUID GLOB U; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Grineski SE, 2011, ENVIRON RES, V111, P1148, DOI 10.1016/j.envres.2011.06.007; Guo YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042232; Guo YM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-36; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Hajat S, 2002, INT J EPIDEMIOL, V31, P825, DOI 10.1093/ije/31.4.825; Hales S, 1998, ENVIRON HEALTH PERSP, V106, P607, DOI 10.2307/3434236; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; Li MC, 2011, J ALLERGY CLIN IMMUN, V128, P626, DOI 10.1016/j.jaci.2011.04.032; Lim YH, 2012, SCI TOTAL ENVIRON, V417, P55, DOI 10.1016/j.scitotenv.2011.12.048; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Makinen TM, 2009, RESP MED, V103, P456, DOI 10.1016/j.rmed.2008.09.011; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Michelozzi P, 2006, J EPIDEMIOL COMMUN H, V60, P417, DOI 10.1136/jech.2005.040857; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051567; Son J-Y, 2014, INT J BIOMETEOROL, P1; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Vutcovici M, 2014, INT J BIOMETEOROL, V58, P843, DOI 10.1007/s00484-013-0664-9; Wang MZ, 2013, SCI TOTAL ENVIRON, V456, P370, DOI 10.1016/j.scitotenv.2013.03.023; WHO, 2005, AIR QUAL GUID GLOB U; Xu ZW, 2013, OCCUP ENVIRON MED, V70, P730, DOI 10.1136/oemed-2013-101538; Xu ZW, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-12; Yang J, 2012, ENV HLTH, V11, P1; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279	46	52	54	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102475	10.1371/journal.pone.0102475	http://dx.doi.org/10.1371/journal.pone.0102475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019158	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600085
J	Brust, H; Lehmann, T; D'Hulst, C; Fettke, J				Brust, Henrike; Lehmann, Tanja; D'Hulst, Christophe; Fettke, Joerg			Analysis of the Functional Interaction of Arabidopsis Starch Synthase and Branching Enzyme Isoforms Reveals that the Cooperative Action of SSI and BEs Results in Glucans with Polymodal Chain Length Distribution Similar to Amylopectin	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; AMYLOSE-EXTENDER MUTATION; BIOSYNTHETIC-ENZYMES; MAIZE ENDOSPERM; RICE ENDOSPERM; ESCHERICHIA-COLI; RESERVE STARCH; WHEAT STARCHES; LEAF STARCH; ZEA-MAYS	Starch synthase (SS) and branching enzyme (BE) establish the two glycosidic linkages existing in starch. Both enzymes exist as several isoforms. Enzymes derived from several species were studied extensively both in vivo and in vitro over the last years, however, analyses of a functional interaction of SS and BE isoforms are missing so far. Here, we present data from in vitro studies including both interaction of leaf derived and heterologously expressed SS and BE isoforms. We found that SSI activity in native PAGE without addition of glucans was dependent on at least one of the two BE isoforms active in Arabidopsis leaves. This interaction is most likely not based on a physical association of the enzymes, as demonstrated by immunodetection and native PAGE mobility analysis of SSI, BE2, and BE3. The glucans formed by the action of SSI/BEs were analysed using leaf protein extracts from wild type and be single mutants (Atbe2 and Atbe3 mutant lines) and by different combinations of recombinant proteins. Chain length distribution (CLD) patterns of the formed glucans were irrespective of SSI and BE isoforms origin and still independent of assay conditions. Furthermore, we show that all SS isoforms (SSI-SSIV) were able to interact with BEs and form branched glucans. However, only SSI/BEs generated a polymodal distribution of glucans which was similar to CLD pattern detected in amylopectin of Arabidopsis leaf starch. We discuss the impact of the SSI/BEs interplay for the CLD pattern of amylopectin.	[Brust, Henrike; Lehmann, Tanja; Fettke, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [D'Hulst, Christophe] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	University of Potsdam; Universite de Lille - ISITE; Universite de Lille	Brust, H (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	henbrust@uni-potsdam.de	D'HULST, Christophe/B-2072-2012; D'Hulst, Christophe/AAX-2809-2020; Brust, Henrike/AAM-7193-2021	D'HULST, Christophe/0000-0002-5556-9099; D'Hulst, Christophe/0000-0002-5556-9099; Fettke, Joerg/0000-0003-0137-7611				Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Bertoft E, 2004, CARBOHYD POLYM, V57, P211, DOI 10.1016/j.carbpol.2004.04.015; Bertoft E, 2011, INT J BIOL MACROMOL, V49, P441, DOI 10.1016/j.ijbiomac.2011.04.014; Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Broberg S, 2000, CARBOHYD POLYM, V43, P285, DOI 10.1016/S0144-8617(00)00152-1; Brust H., 2013, Journal of Applied Glycoscience, V60, P3, DOI 10.5458/jag.jag.JAG-2012_018; BURTON RA, 1995, PLANT J, V7, P3, DOI 10.1046/j.1365-313X.1995.07010003.x; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; Chauhan F, 2013, STARCH-STARKE, V65, P191, DOI 10.1002/star.201200132; Commuri PD, 2001, PLANT J, V25, P475, DOI 10.1046/j.1365-313x.2001.00955.x; Crofts N, 2012, PLANT SCI, V193, P62, DOI 10.1016/j.plantsci.2012.05.006; Cuevas RP, 2010, CARBOHYD POLYM, V81, P120, DOI 10.1016/j.carbpol.2010.02.004; Delvalle D, 2005, PLANT J, V43, P398, DOI 10.1111/j.1365-313X.2005.02462.x; Dumez S, 2006, PLANT CELL, V18, P2694, DOI 10.1105/tpc.105.037671; Fettke J, 2012, ESSENTIAL REV EXPT B, V5, P309; Fettke J, 2012, J EXP BOT, V63, P3011, DOI 10.1093/jxb/ers014; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fujita N., 2008, Journal of Applied Glycoscience, V55, P167, DOI 10.5458/jag.55.167; Fujita N, 2007, PLANT PHYSIOL, V144, P2009, DOI 10.1104/pp.107.102533; Gao M, 1997, PLANT PHYSIOL, V114, P69, DOI 10.1104/pp.114.1.69; Gerard C, 2000, CARBOHYD RES, V326, P130, DOI 10.1016/S0008-6215(00)00025-2; Gomand SV, 2010, FOOD HYDROCOLLOID, V24, P307, DOI 10.1016/j.foodhyd.2009.10.008; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; Hanashiro I, 1996, CARBOHYD RES, V283, P151, DOI 10.1016/0008-6215(95)00408-4; HANASHIRO I, 2004, J APPL GLYCOSCI, V51, P217; HAWKER JS, 1974, ARCH BIOCHEM BIOPHYS, V160, P530, DOI 10.1016/0003-9861(74)90430-5; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; Kalinga DN, 2013, STARCH-STARKE, V65, P791, DOI 10.1002/star.201200240; Keeling PL, 2010, ANNU REV FOOD SCI T, V1, P271, DOI 10.1146/annurev.food.102308.124214; Konik-Rose C, 2007, THEOR APPL GENET, V115, P1053, DOI 10.1007/s00122-007-0631-0; Franco CML, 2010, BRAZ ARCH BIOL TECHN, V53, P443, DOI 10.1590/S1516-89132010000200025; Li ZY, 2011, J EXP BOT, V62, P5217, DOI 10.1093/jxb/err239; Lin QH, 2012, PLANT PHYSIOL, V158, P679, DOI 10.1104/pp.111.189704; Liu FS, 2012, BIOCHEM J, V448, P373, DOI 10.1042/BJ20120573; Liu FS, 2012, J EXP BOT, V63, P1167, DOI 10.1093/jxb/err341; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; McMaugh SJ, 2014, J EXP BOT, V65, P2189, DOI 10.1093/jxb/eru095; Morell MK, 2003, PLANT J, V34, P172, DOI 10.1046/j.1365-313X.2003.01712.x; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; PEAT S, 1952, J CHEM SOC, P4546; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; POLLOCK C, 1980, ARCH BIOCHEM BIOPHYS, V204, P578, DOI 10.1016/0003-9861(80)90070-3; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Sawada T, 2009, PLANT CELL PHYSIOL, V50, P1062, DOI 10.1093/pcp/pcp058; Senoura T, 2004, BIOSCI BIOTECH BIOCH, V68, P1949, DOI 10.1271/bbb.68.1949; Stitt M, 1989, METHOD ENZYMOL, V174, P971; Szydlowski N, 2011, J EXP BOT, V62, P4547, DOI 10.1093/jxb/err172; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Tetlow IJ, 2012, STARCH ORIGINS STRUC, V5, P115; Tetlow IJ, 2012, ESSENTIAL REV EXPT B, V5, P144; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Vrinten PL, 2012, CARBOHYD POLYM, V89, P1250, DOI 10.1016/j.carbpol.2012.04.029; WAFFENSCHMIDT S, 1987, ANAL BIOCHEM, V165, P337, DOI 10.1016/0003-2697(87)90278-8; Yamamori M, 2000, THEOR APPL GENET, V101, P21, DOI 10.1007/s001220051444; Yandeau-Nelson MD, 2011, PLANT PHYSIOL, V156, P479, DOI 10.1104/pp.111.174094; Yasui T, 2005, STARCH-STARKE, V57, P521, DOI 10.1002/star.200500426; Yasushi YB, 2002, CARBOHYD POLYM, V47, P159; Yoo SH, 2002, CARBOHYD POLYM, V49, P297, DOI 10.1016/S0144-8617(01)00338-1; Zhang XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-96; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zhang XL, 2004, PLANT MOL BIOL, V54, P865, DOI 10.1007/s11103-004-0312-1	75	24	25	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102364	10.1371/journal.pone.0102364	http://dx.doi.org/10.1371/journal.pone.0102364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014622	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400090
J	Talukder, ZI; Gong, L; Hulke, BS; Pegadaraju, V; Song, QJ; Schultz, Q; Qi, LL				Talukder, Zahirul I.; Gong, Li; Hulke, Brent S.; Pegadaraju, Venkatramana; Song, Qijian; Schultz, Quentin; Qi, Lili			A High-Density SNP Map of Sunflower Derived from RAD-Sequencing Facilitating Fine-Mapping of the Rust Resistance Gene R-12	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FERTILITY RESTORATION GENE; HELIANTHUS-ANNUUS L.; SEGREGATION DISTORTION LOCI; MARKER-ASSISTED SELECTION; QUANTITATIVE TRAIT LOCI; CONSENSUS LINKAGE MAP; SCLEROTINIA-SCLEROTIORUM; DOWNY MILDEW; DNA MARKERS	A high-resolution genetic map of sunflower was constructed by integrating SNP data from three F-2 mapping populations (HA 89/RHA 464, B-line/RHA 464, and CR 29/RHA 468). The consensus map spanned a total length of 1443.84 cM, and consisted of 5,019 SNP markers derived from RAD tag sequencing and 118 publicly available SSR markers distributed in 17 linkage groups, corresponding to the haploid chromosome number of sunflower. The maximum interval between markers in the consensus map is 12.37 cM and the average distance is 0.28 cM between adjacent markers. Despite a few shortdistance inversions in marker order, the consensus map showed high levels of collinearity among individual maps with an average Spearman's rank correlation coefficient of 0.972 across the genome. The order of the SSR markers on the consensus map was also in agreement with the order of the individual map and with previously published sunflower maps. Three individual and one consensus maps revealed the uneven distribution of markers across the genome. Additionally, we performed fine mapping and marker validation of the rust resistance gene R12, providing closely linked SNP markers for marker-assisted selection of this gene in sunflower breeding programs. This high resolution consensus map will serve as a valuable tool to the sunflower community for studying marker-trait association of important agronomic traits, marker assisted breeding, map-based gene cloning, and comparative mapping.	[Talukder, Zahirul I.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Gong, Li] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; [Hulke, Brent S.; Qi, Lili] USDA ARS, No Crop Sci Lab, Fargo, ND 58105 USA; [Pegadaraju, Venkatramana; Schultz, Quentin] BioDiagnostics Inc, River Falls, WI USA; [Song, Qijian] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA	North Dakota State University Fargo; North Dakota State University Fargo; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Qi, LL (corresponding author), USDA ARS, No Crop Sci Lab, Fargo, ND 58105 USA.	lili.qi@ars.usda.gov	Qi, LI/AAF-3389-2019; Hulke, Brent/GZG-4449-2022	Talukder, Zahirul/0000-0002-7429-5329	National Sunflower Association-SNP Consortium; public-private partnership between the non-profit National Sunflower Association; public researchers at United States Department of Agriculture (USDA); USDA-ARS CRIS Project [5442-21000-039-00D]	National Sunflower Association-SNP Consortium; public-private partnership between the non-profit National Sunflower Association; public researchers at United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); USDA-ARS CRIS Project(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by the National Sunflower Association-SNP Consortium, a public-private partnership between the non-profit National Sunflower Association, public researchers at United States Department of Agriculture (USDA), and private seed companies, and the USDA-ARS CRIS Project No. 5442-21000-039-00D. Venkatramana Pegadaraju and Quentin Schultz have competing commercial interests as employees of BioDiagnostics, Inc., a for-profit company that has provided some financial assistance to this project and also has a commercial interest in the data generated with the chip because it increases the value of their services to their customers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bachlava E, 2011, THEOR APPL GENET, V122, P1211, DOI 10.1007/s00122-010-1525-0; BERRY ST, 1995, THEOR APPL GENET, V91, P195, DOI 10.1007/BF00220877; Bert PF, 2004, THEOR APPL GENET, V109, P865, DOI 10.1007/s00122-004-1701-1; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Bohra A, 2012, THEOR APPL GENET, V125, P1325, DOI 10.1007/s00122-012-1916-5; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Cloutier S, 2012, THEOR APPL GENET, V125, P685, DOI 10.1007/s00122-012-1860-4; FAO, 2010, FAO AGR HDB; Faris JD, 1998, GENETICS, V149, P319; Feng JH, 2008, THEOR APPL GENET, V117, P241, DOI 10.1007/s00122-008-0769-4; Fusari CM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-7; Galeano CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028135; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Gedil MA, 2001, GENOME, V44, P213, DOI 10.1139/gen-44-2-213; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Gong L, 2013, THEOR APPL GENET, V126, P93, DOI 10.1007/s00122-012-1962-z; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Herve D, 2001, J EXP BOT, V52, P1857, DOI 10.1093/jexbot/52.362.1857; Hulke BS, 2010, J PLANT REGIST, V4, P249, DOI 10.3198/jpr2010.02.0114crg; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Isobe S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-57; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Jan CC, 1998, THEOR APPL GENET, V96, P15, DOI 10.1007/s001220050703; Kane NC, 2011, BOTANY, V89, P429, DOI [10.1139/B11-032, 10.1139/b11-032]; Khan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047864; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kumar LS, 1999, BIOTECHNOL ADV, V17, P143, DOI 10.1016/S0734-9750(98)00018-4; Lawson WR, 1998, MOL BREEDING, V4, P227, DOI 10.1023/A:1009667112088; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Li X, 2010, GENOME, V53, P939, DOI 10.1139/G10-054; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu Z, 2012, THEOR APPL GENET, V125, P121, DOI 10.1007/s00122-012-1820-z; Liu Z, 2012, MOL BREEDING, V29, P275, DOI 10.1007/s11032-011-9563-0; Lombard V, 2001, THEOR APPL GENET, V103, P491, DOI 10.1007/s001220100560; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Micic Z, 2005, THEOR APPL GENET, V110, P1490, DOI 10.1007/s00122-005-1984-x; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Mulpuri S, 2009, THEOR APPL GENET, V119, P795, DOI 10.1007/s00122-009-1089-z; Oliveros JC, 2007, VENNY INTERACTIVE TO; Pan QC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052777; Pegadaraju V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-556; Qi LL, 2012, MOL BREEDING, V30, P745, DOI 10.1007/s11032-011-9659-6; Qi LL, 2012, THEOR APPL GENET, V125, P921, DOI 10.1007/s00122-012-1883-x; Qi LL, 2011, THEOR APPL GENET, V123, P351, DOI 10.1007/s00122-011-1588-6; Qi LL, 2011, PHYTOPATHOLOGY, V101, P241, DOI 10.1094/PHYTO-06-10-0162; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Remington DL, 1999, THEOR APPL GENET, V98, P1279, DOI 10.1007/s001220051194; RIESEBERG LH, 1993, HEREDITY, V70, P285, DOI 10.1038/hdy.1993.41; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Ronicke S, 2005, PHYTOPATHOLOGY, V95, P834, DOI 10.1094/PHYTO-95-0834; Schnabel U, 2008, PLANT BREEDING, V127, P587, DOI 10.1111/j.1439-0523.2008.01516.x; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Talukder ZI, 2014, THEOR APPL GENET, V127, P193, DOI 10.1007/s00122-013-2210-x; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Varshney RK, 2006, TRENDS BIOTECHNOL, V24, P490, DOI 10.1016/j.tibtech.2006.08.006; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wills DM, 2007, GENETICS, V176, P2589, DOI 10.1534/genetics.107.075333; Xu Y, 1997, MOL GEN GENET, V253, P535, DOI 10.1007/s004380050355; Yu JK, 2003, CROP SCI, V43, P367, DOI 10.2135/cropsci2003.0367; Yue B, 2008, PHYTOPATHOLOGY, V98, P926, DOI 10.1094/PHYTO-98-8-0926; Yue B, 2010, PLANT BREEDING, V129, P24, DOI 10.1111/j.1439-0523.2009.01661.x; Zhu CS, 2007, THEOR APPL GENET, V114, P295, DOI 10.1007/s00122-006-0432-x	74	57	58	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e98628	10.1371/journal.pone.0098628	http://dx.doi.org/10.1371/journal.pone.0098628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014030	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400004
J	Fairhall, SL; Albi, A; Melcher, D				Fairhall, Scott L.; Albi, Angela; Melcher, David			Temporal Integration Windows for Naturalistic Visual Sequences	PLOS ONE			English	Article							UNIVERSAL CONSTANT; RECEPTIVE WINDOWS; MOTION; SEGMENTATION; PERCEPTION; HIERARCHY; COGNITION; SPEECH	There is increasing evidence that the brain possesses mechanisms to integrate incoming sensory information as it unfolds over time-periods of 2-3 seconds. The ubiquity of this mechanism across modalities, tasks, perception and production has led to the proposal that it may underlie our experience of the subjective present. A critical test of this claim is that this phenomenon should be apparent in naturalistic visual experiences. We tested this using movie-clips as a surrogate for our day-to-day experience, temporally scrambling them to require (re-) integration within and beyond the hypothesized 2-3 second interval. Two independent experiments demonstrate a step-wise increase in the difficulty to follow stimuli at the hypothesized 2-3 second scrambling condition. Moreover, only this difference could not be accounted for by low-level visual properties. This provides the first evidence that this 2-3 second integration window extends to complex, naturalistic visual sequences more consistent with our experience of the subjective present.	[Fairhall, Scott L.; Albi, Angela; Melcher, David] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	University of Trento	Fairhall, SL (corresponding author), Univ Trento, Ctr Mind Brain Sci, Trento, Italy.	Scott.fairhall@unitn.it	Fairhall, Scott/AAT-9126-2021; Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X	European Research Council under the European Union/ERC [313658]	European Research Council under the European Union/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 313658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058149; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; ELBERT T, 1991, PSYCHOPHYSIOLOGY, V28, P648, DOI 10.1111/j.1469-8986.1991.tb01009.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Howell DC., 2012, STAT METHODS PSYCHOL; Kagerer FA, 2002, NEUROPSYCHOLOGIA, V40, P357, DOI 10.1016/S0028-3932(01)00111-7; Kiss M, 2008, ACTA NEUROBIOL EXP, V68, P204; Kolers P. A., 1972, ASPECTS MOTION PERCE; Kortum P, 2010, HUM FACTORS, V52, P105, DOI 10.1177/0018720810366020; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; MacDorman K. F., 2006, SUBJECTIVE RATINGS R, P25; Mach E., 1965, MACH BANDS QUANTITAT, P253; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; Melcher D, 2003, NAT NEUROSCI, V6, P877, DOI 10.1038/nn1098; Messaris P., 1994, VISUAL LITERACY IMAG; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Occelli V, 2011, PSYCHON B REV, V18, P429, DOI 10.3758/s13423-011-0070-4; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poppel E, 2009, PHILOS T R SOC B, V364, P1887, DOI 10.1098/rstb.2009.0015; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Salt Barry, 1983, FILM STYLE TECHNOLOG; SCHLEIDT M, 1987, NATURWISSENSCHAFTEN, V74, P289, DOI 10.1007/BF00366417; Vandenbroucke ARE, 2011, NEUROPSYCHOLOGIA, V49, P1559, DOI 10.1016/j.neuropsychologia.2010.12.044; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; VOLLRATH M, 1992, NATURWISSENSCHAFTEN, V79, P479, DOI 10.1007/BF01139205; Wang HX, 2012, J VISION, V12, DOI [10.1167/12.1.16, 10.1167/12.6.26]; Wertheimer Max, 1912, EXPT STUDIEN SEHEN B; Wutz A, 2014, J NEUROSCI, V34, P1554, DOI 10.1523/JNEUROSCI.3187-13.2014; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9; Zacks Jeffrey M., 2011, ART SENSES, P435	35	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102248	10.1371/journal.pone.0102248	http://dx.doi.org/10.1371/journal.pone.0102248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010517	Green Published, gold			2022-12-25	WOS:000338763800085
J	Garijo, R; Hernandez-Alonso, P; Rivas, C; Diallo, JS; Sanjuan, R				Garijo, Raquel; Hernandez-Alonso, Pablo; Rivas, Carmen; Diallo, Jean-Simon; Sanjuan, Rafael			Experimental Evolution of an Oncolytic Vesicular Stomatitis Virus with Increased Selectivity for p53-Deficient Cells	PLOS ONE			English	Article							RNA VIRUS; INNATE IMMUNITY; INFECTED-CELLS; BREAST-CANCER; LEADER RNA; HOST; ADAPTATION; VIROTHERAPY; P53; GLYCOPROTEIN	Experimental evolution has been used for various biotechnological applications including protein and microbial cell engineering, but less commonly in the field of oncolytic virotherapy. Here, we sought to adapt a rapidly evolving RNA virus to cells deficient for the tumor suppressor gene p53, a hallmark of cancer cells. To achieve this goal, we established four independent evolution lines of the vesicular stomatitis virus (VSV) in p53-knockout mouse embryonic fibroblasts (p53-/- MEFs) under conditions favoring the action of natural selection. We found that some evolved viruses showed increased fitness and cytotoxicity in p53-/- cells but not in isogenic p53+/+ cells, indicating gene-specific adaptation. However, full-length sequencing revealed no obvious or previously described genetic changes associated with oncolytic activity. Half-maximal effective dose (EC50) assays in mouse p53-positive colon cancer (CT26) and p53-deficient breast cancer (4T1) cells indicated that the evolved viruses were more effective against 4T1 cells than the parental virus or a reference oncolytic VSV (M Delta 51), but showed no increased efficacy against CT26 cells. In vivo assays using 4T1 syngeneic tumor models showed that one of the evolved lines significantly delayed tumor growth compared to mice treated with the parental virus or untreated controls, and was able to induce transient tumor suppression. Our results show that RNA viruses can be specifically adapted typical cancer features such as p53 inactivation, and illustrate the usefulness of experimental evolution for oncolytic virotherapy.	[Garijo, Raquel; Hernandez-Alonso, Pablo; Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Garijo, Raquel; Diallo, Jean-Simon] Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON, Canada; [Rivas, Carmen] Ctr Nacl Biotecnol, Dept Biol Mol & Celular, Madrid, Spain; [Rivas, Carmen] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Santiago De Compostela, Spain; [Rivas, Carmen] Univ Santiago de Compostela, IDIS, Santiago De Compostela, Spain; [Sanjuan, Rafael] Univ Valencia, Dept Genet, Valencia, Spain	University of Valencia; University of Ottawa; Ottawa Hospital Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Valencia	Sanjuan, R (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain.	rafael.sanjuan@uv.es	Sanjuan, Rafael/A-4248-2015; Rivas, Carmen/AAB-6278-2019; Hernandez-Alonso, Pablo/Q-1090-2018; Rivas, Carmen/L-3162-2017; Diallo, Jean-Simon/G-4465-2017	Rivas, Carmen/0000-0002-0518-7199; Hernandez-Alonso, Pablo/0000-0002-9977-8976; Rivas, Carmen/0000-0002-0518-7199; Diallo, Jean-Simon/0000-0002-4862-2795; Sanjuan, Rafael/0000-0002-1844-545X	Spanish Ministerio de Economia y Competitividad [BFU2011-25271]; European Research Council [ERC-2011-StG- 281191-VIRMUT]; Terry Fox Research Institute [201201TFF-271514-TFF-AYDP-29782]; Lotte & John Hecht Memorial Foundation Innovation of the Canadian Cancer Society [2012-701460]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Terry Fox Research Institute; Lotte & John Hecht Memorial Foundation Innovation of the Canadian Cancer Society	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (www.mineco.es; BFU2011-25271) and the European Research Council (erc.europa.eu; ERC-2011-StG- 281191-VIRMUT) to R. S., and from the Terry Fox Research Institute (www.tfri.ca; 201201TFF-271514-TFF-AYDP-29782) and The Lotte & John Hecht Memorial Foundation Innovation of the Canadian Cancer Society (www.msfhr.org; 2012-701460) to J-S.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, INFECT GENET EVOL, V8, P806, DOI 10.1016/j.meegid.2008.07.010; Alemany R, 2013, CLIN TRANSL ONCOL, V15, P182, DOI 10.1007/s12094-012-0951-7; Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Bull JJ, 2001, ANNU REV ECOL SYST, V32, P183, DOI 10.1146/annurev.ecolsys.32.081501.114020; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cuevas JM, 2009, J EVOLUTION BIOL, V22, P2041, DOI 10.1111/j.1420-9101.2009.01817.x; Cuevas JM, 2002, GENETICS, V162, P533; DaPoian AT, 1996, P NATL ACAD SCI USA, V93, P8268, DOI 10.1073/pnas.93.16.8268; Diallo JS, 2010, MOL THER, V18, P1123, DOI 10.1038/mt.2010.67; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Ebert O, 2005, CANCER GENE THER, V12, P350, DOI 10.1038/sj.cgt.7700794; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Faul EJ, 2009, VIRUSES-BASEL, V1, P832, DOI 10.3390/v1030832; Furio V, 2012, J VIROL, V86, P12228, DOI 10.1128/JVI.00755-12; Gao YH, 2006, J VIROL, V80, P8603, DOI 10.1128/JVI.00142-06; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; GRINNELL BW, 1983, J VIROL, V48, P88, DOI 10.1128/JVI.48.1.88-101.1983; Hastie E, 2012, J GEN VIROL, V93, P2529, DOI 10.1099/vir.0.046672-0; Heiber JF, 2011, J VIROL, V85, P10440, DOI 10.1128/JVI.05408-11; Hunt KK, 2007, GENE THERAPY CANC; Janelle V, 2011, J VIROL, V85, P6513, DOI 10.1128/JVI.02484-10; Jha BK, 2013, MOL THER, V21, P1749, DOI 10.1038/mt.2013.112; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; KURILLA MG, 1982, P NATL ACAD SCI-BIOL, V79, P5240, DOI 10.1073/pnas.79.17.5240; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Marcos-Villar L, 2013, CELL CYCLE, V12, P2809, DOI 10.4161/cc.25868; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Novella IS, 2004, J MOL BIOL, V342, P1415, DOI 10.1016/j.jmb.2004.08.003; Oldstone MBA, 2010, VIRUS PLAGUES HIST; Pagan I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000786; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Rainwater-Lovett K, 2007, J GEN VIROL, V88, P2042, DOI 10.1099/vir.0.82644-0; Remold SK, 2008, MOL BIOL EVOL, V25, P1138, DOI 10.1093/molbev/msn059; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Simon D., 2013, EVOLUTIONARY OPTIMIZ; Socha RD, 2013, FEBS J, V280, P5582, DOI 10.1111/febs.12354; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Turner PE, 2000, GENETICS, V156, P1465; Uil TG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1258; Walker JD, 2011, J VIROL, V85, P7363, DOI 10.1128/JVI.00098-11; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Wollmann G, 2005, J VIROL, V79, P6005, DOI 10.1128/JVI.79.10.6005-6022.2005; Wollmann G, 2013, J VIROL, V87, P6644, DOI 10.1128/JVI.03311-12; Wu L, 2008, HUM GENE THER, V19, P635, DOI 10.1089/hum.2007.163; Yan W, 2003, J VIROL, V77, P2640, DOI 10.1128/JVI.77.4.2640-2650.2003; Zhang Z, 2012, CANCER GENE THER, V19, P630, DOI 10.1038/cgt.2012.41	57	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102365	10.1371/journal.pone.0102365	http://dx.doi.org/10.1371/journal.pone.0102365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010337	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800094
J	Palmyre, A; Lee, J; Ryklin, G; Camarata, T; Selig, MK; Duchemin, AL; Nowak, P; Arnaout, MA; Drummond, IA; Vasilyev, A				Palmyre, Aurelien; Lee, Jeongeun; Ryklin, Gennadiy; Camarata, Troy; Selig, Martin K.; Duchemin, Anne-Laure; Nowak, Paul; Arnaout, M. Amin; Drummond, Iain A.; Vasilyev, Aleksandr			Collective Epithelial Migration Drives Kidney Repair after Acute Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CELL-MIGRATION; ZEBRAFISH; MORPHOGENESIS; REGENERATION; GENES	Acute kidney injury (AKI) is a common and significant medical problem. Despite the kidney's remarkable regenerative capacity, the mortality rate for the AKI patients is high. Thus, there remains a need to better understand the cellular mechanisms of nephron repair in order to develop new strategies that would enhance the intrinsic ability of kidney tissue to regenerate. Here, using a novel, laser ablation-based, zebrafish model of AKI, we show that collective migration of kidney epithelial cells is a primary early response to acute injury. We also show that cell proliferation is a late response of regenerating kidney epithelia that follows cell migration during kidney repair. We propose a computational model that predicts this temporal relationship and suggests that cell stretch is a mechanical link between migration and proliferation, and present experimental evidence in support of this hypothesis. Overall, this study advances our understanding of kidney repair mechanisms by highlighting a primary role for collective cell migration, laying a foundation for new approaches to treatment of AKI.	[Palmyre, Aurelien; Lee, Jeongeun; Camarata, Troy; Duchemin, Anne-Laure; Arnaout, M. Amin; Drummond, Iain A.; Vasilyev, Aleksandr] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Selig, Martin K.; Vasilyev, Aleksandr] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lee, Jeongeun; Ryklin, Gennadiy; Nowak, Paul; Vasilyev, Aleksandr] NYIT COM, Dept Biomed Sci, Old Westbury, NY USA; [Arnaout, M. Amin] Harvard Univ, Sch Med, Dept Dev & Regenerat Biol, Boston, MA USA; [Drummond, Iain A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; New York Institute Technology; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vasilyev, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.	avasilye@nyit.edu		Palmyre, Aurelien/0000-0002-5470-4367; Duchemin, Anne-Laure/0000-0002-2897-0821; Camarata, Troy/0000-0002-7628-2716	HSCI Pilot Grant [K08DK082782, R03DK097443];  [DK053093];  [DK071041];  [DK070263];  [DK088327];  [DK48549];  [DK007540]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071041, T32DK007540, R01DK070263, R03DK097443, K08DK082782, R01DK048549, R01DK053093, R01DK088327] Funding Source: NIH RePORTER	HSCI Pilot Grant; ; ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	K08DK082782, R03DK097443, HSCI Pilot Grant (A. V.); DK053093, DK071041, DK070263 (I. A. D.), and DK088327, DK48549 and DK007540 (M. A. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Blanco MT, 2012, J CELL SCI, V125, P5984, DOI 10.1242/jcs.109066; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; Cosentino C. C., 2010, J VIS EXP; Cosentino CC, 2013, J AM SOC NEPHROL, V24, P943, DOI 10.1681/ASN.2012111055; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Esson ML, 2002, ANN INTERN MED, V137, P744, DOI 10.7326/0003-4819-137-9-200211050-00010; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Hellman NE, 2010, P NATL ACAD SCI USA, V107, P18499, DOI 10.1073/pnas.1005998107; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Johnson CS, 2011, JOVE-J VIS EXP, DOI 10.3791/2845; Korzh V, 2011, ZEBRAFISH, V8, P23, DOI 10.1089/zeb.2011.0689; Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rodriguez-Diaz A, 2008, HFSP J, V2, P220, DOI 10.2976/1.2955565; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Takakura A, 2009, HUM MOL GENET, V18, P2523, DOI 10.1093/hmg/ddp147; TOBACK FG, 1992, KIDNEY INT, V41, P226, DOI 10.1038/ki.1992.32; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vasilyev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039992; Vasilyev Aleksandr, 2012, Methods Mol Biol, V886, P55, DOI 10.1007/978-1-61779-851-1_6; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Yasuda H, 2010, THER APHER DIAL, V14, P541, DOI 10.1111/j.1744-9987.2010.00826.x	35	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101304	10.1371/journal.pone.0101304	http://dx.doi.org/10.1371/journal.pone.0101304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010471	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800019
J	Jiang, QJ; Ding, SF; Wu, JX; Liu, X; Wu, ZG				Jiang, Qijun; Ding, Shifang; Wu, Jianxiang; Liu, Xing; Wu, Zonggui			Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BONE-MARROW; ANGIOGENESIS; GROWTH; SYSTEM; NEOANGIOGENESIS; CATECHOLAMINES; AKT/ENOS; STRESS; VEGF	Objective: During several pathological processes such as cancer progression, thermal injury, wound healing and hindlimb ischemia, the mobilization of endothelial progenitor cells (EPCs) mobilization was enhanced with an increase of sympathetic nerve activity and norepinephrine (NE) secretion, yet the cellular and molecular mechanisms involved in the effects of NE on EPCs has less been investigated. Methods and Results: EPCs from BMs, peripheral circulation and spleens, the VEGF concentration in BM, skeletal muscle, peripheral circulation and spleen and angiogenesis in ischemic gastrocnemius were quantified in mice with hindlimbs ischemia. Systemic treatment of NE significantly increased EPCs number in BM, peripheral circulation and spleen, VEGF concentration in BM and skeletal muscle and angiogenesis in ischemic gastrocnemius in mice with hind limb ischemia, but did not affair VEGF concentration in peripheral circulation and spleen. EPCs isolated from healthy adults were cultured with NE in vitro to evaluate proliferation potential, migration capacity and phosphorylations of Akt and eNOS signal moleculars. Treatment of NE induced a significant increase in number of EPCs in the S-phase in a dose-dependent manner, as well as migrative activity of EPCs in vitro (p<0.05). The co-treatment of Phentolamine, I127, LY294002 and L-NAME with NE blocked the effects of NE on EPCs proliferation and migration. Treatment with NE significantly increased phosphorylation of Akt and eNOS of EPCs. Addition of phentolamine and I127 attenuated the activation of Akt/eNOS pathway, but metoprolol could not. Pretreatment of mice with either Phentolamine or I127 significantly attenuated the effects of NE on EPCs in vivo, VEGF concentration in BM, skeletal muscle and angiogenesis in ischemic gastrocnemius, but Metoprolol did not. Conclusion: These results unravel that sympathetic nervous system regulate EPCs mobilization and their pro-angiogenic capacity via alpha adrenoceptor, beta 2 adrenoceptor and meanwhile Akt/eNOS signaling pathway.	[Jiang, Qijun; Ding, Shifang] Wuhan Gen Hosp Guangzhou Mil, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Jiang, Qijun; Wu, Jianxiang; Liu, Xing; Wu, Zonggui] Second Mil Med Univ, Changzheng Hosp, Dept Cardiol, Shanghai, Peoples R China	Naval Medical University	Ding, SF (corresponding author), Wuhan Gen Hosp Guangzhou Mil, Dept Cardiol, Wuhan, Hubei, Peoples R China.	DingSFMD@gmail.com			Major National Basic Research Development Program of People's Republic of China [2005CB523309]	Major National Basic Research Development Program of People's Republic of China	This work was supported by the Major National Basic Research Development Program of People's Republic of China (2005CB523309). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; Erami C, 2005, AM J PHYSIOL-HEART C, V289, pH744, DOI 10.1152/ajpheart.00129.2005; Fox A, 2008, BRIT J SURG, V95, P244, DOI 10.1002/bjs.5913; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; Lee SH, 2013, ARTERIOSCL THROM VAS, V33, P2407, DOI 10.1161/ATVBAHA.113.301931; Liang C, 2009, BRIT J PHARMACOL, V158, P1865, DOI 10.1111/j.1476-5381.2009.00450.x; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Peng XQ, 2003, HYPERTENSION, V41, P378, DOI 10.1161/01.HYP.0000049624.99844.3D; Qijun J, 2013, MED HYPOTHESES, V80, P778; Ramcharan SK, 2013, EUR J CLIN INVEST, V43, P801, DOI 10.1111/eci.12108; Recalde A, 2012, ARTERIOSCL THROM VAS, V32, P643, DOI 10.1161/ATVBAHA.111.244392; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sun CB, 2009, BASIC RES CARDIOL, V104, P42, DOI 10.1007/s00395-008-0738-8; Sun CK, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt181; Tabarowski Z, 1996, ACTA HISTOCHEM, V98, P453, DOI 10.1016/S0065-1281(96)80013-4; Tanaka R, 2013, DIABETES, V62, P3207, DOI 10.2337/db12-1621; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Turgeon J, 2013, ATHEROSCLEROSIS, V229, P295, DOI 10.1016/j.atherosclerosis.2013.05.020; Zhang H, 2004, AM J PHYSIOL-HEART C, V287, pH2106, DOI 10.1152/ajpheart.00290.2004	29	27	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101774	10.1371/journal.pone.0101774	http://dx.doi.org/10.1371/journal.pone.0101774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007164	gold, Green Published, Green Submitted			2022-12-25	WOS:000339040600066
J	Peugnet, P; Wimel, L; Duchamp, G; Sandersen, C; Camous, S; Guillaume, D; Dahirel, M; Dubois, C; Jouneau, L; Reigner, F; Berthelot, V; Chaffaux, S; Tarrade, A; Serteyn, D; Chavatte-Palmer, P				Peugnet, Pauline; Wimel, Laurence; Duchamp, Guy; Sandersen, Charlotte; Camous, Sylvaine; Guillaume, Daniel; Dahirel, Michele; Dubois, Cedric; Jouneau, Luc; Reigner, Fabrice; Berthelot, Valerie; Chaffaux, Stephane; Tarrade, Anne; Serteyn, Didier; Chavatte-Palmer, Pascale			Enhanced or Reduced Fetal Growth Induced by Embryo Transfer into Smaller or Larger Breeds Alters Post-Natal Growth and Metabolism in Pre-Weaning Horses	PLOS ONE			English	Article							CATCH-UP GROWTH; INSULIN SENSITIVITY; PLACENTAL RESTRICTION; BIRTH-WEIGHT; DEVELOPMENTAL ORIGINS; PRENATAL EXPOSURE; GLUCOSE-TOLERANCE; THYROID-HORMONE; MATERNAL SIZE; BODY-WEIGHT	In equids, placentation is diffuse and nutrient supply to the fetus is determined by uterine size. This correlates with maternal size and affects intra-uterine development and subsequent post-natal growth, as well as insulin sensitivity in the newborn. Long-term effects remain to be described. In this study, fetal growth was enhanced or restricted through ET using pony (P), saddlebred (S) and draft (D) horses. Control P-P (n = 21) and S-S (n = 28) pregnancies were obtained by AI. Enhanced and restricted pregnancies were obtained by transferring P or S embryos into D mares (P-D, n = 6 and S-D, n = 8) or S embryos into P mares (S-P, n = 6), respectively. Control and experimental foals were raised by their dams and recipient mothers, respectively. Weight gain, growth hormones and glucose homeostasis were investigated in the foals from birth to weaning. Fetal growth was enhanced in P-D and these foals remained consistently heavier, with reduced T-3 concentrations until weaning compared to P-P. P-D had lower fasting glucose from days 30 to 200 and higher insulin secretion than P-P after IVGTT on day 3. Euglycemic clamps in the immediate post-weaning period revealed no difference in insulin sensitivity between P-D and P-P. Fetal growth was restricted in S-P and these foals remained consistently lighter until weaning compared to S-D, with elevated T-3 concentrations in the newborn compared to S-S. S-P exhibited higher fasting glycemia than S-S and S-D from days 30 to 200. They had higher maximum increment in plasma glucose than S-D after IVGTT on day 3 and clamps on day 200 demonstrated higher insulin sensitivity compared to S-D. Neither the restricted nor the enhanced fetal environment affected IGF-1 concentrations. Thus, enhanced and restricted fetal and post-natal environments had combined effects that persisted until weaning. They induced different adaptive responses in post-natal glucose metabolism: an early insulin-resistance was induced in enhanced P-D, while S-P developed increased insulin sensitivity.	[Peugnet, Pauline; Camous, Sylvaine; Dahirel, Michele; Jouneau, Luc; Chaffaux, Stephane; Tarrade, Anne; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France; [Peugnet, Pauline; Camous, Sylvaine; Dahirel, Michele; Jouneau, Luc; Chaffaux, Stephane; Tarrade, Anne; Chavatte-Palmer, Pascale] ENVA, Maisons Alfort, France; [Wimel, Laurence; Dubois, Cedric] IFCE, Stn Expt Valade, Chamberet, France; [Duchamp, Guy; Reigner, Fabrice] INRA, UE1293, F-37380 Nouzilly, France; [Sandersen, Charlotte; Serteyn, Didier] Univ Liege, CORD, Fac Med Vet, Clin Equine, Liege, Belgium; [Guillaume, Daniel] INRA, UMR85, F-37380 Nouzilly, France; [Guillaume, Daniel] CNRS, UMR7247, Nouzilly, France; [Guillaume, Daniel] Univ Tours, Tours, France; [Guillaume, Daniel] IFCE, Nouzilly, France; [Berthelot, Valerie] INRA, Modelisat Syst Appl Ruminants UMR791, Paris, France; [Berthelot, Valerie] AgroParis Tech, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Liege; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Chavatte-Palmer, P (corresponding author), INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France.	pascale.chavatte@jouy.inra.fr	Chavatte-Palmer, Pascale/K-7349-2012; Jouneau, Luc/AAC-4711-2020	Chavatte-Palmer, Pascale/0000-0002-4581-6092; Couturier-Tarrade, Anne/0000-0003-1559-5476; Sandersen, charlotte/0000-0002-3404-2757	Institut Francais du Cheval et de l'Equitation (IFCE) under the "FOETALIM''; INRA Dept of Physiology and Breeding Systems	Institut Francais du Cheval et de l'Equitation (IFCE) under the "FOETALIM''; INRA Dept of Physiology and Breeding Systems	This work was funded through a grant from the Institut Francais du Cheval et de l'Equitation (IFCE) under the grant name "FOETALIM'' and through funding from INRA Dept of Physiology and Breeding Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2004, REPRODUCTION, V127, P67, DOI 10.1530/rep.1.00024; Allen WR, 2002, REPRODUCTION, V123, P445, DOI 10.1530/rep.0.1230445; Ansari T, 1998, PILOT INVESTIGATIONS, P15; Arnaud G, 2000, NOTATION ETAT CORPOR; Bamford NJ, 2013, DOMEST ANIM IN PRESS; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Ben XM, 2001, CHINESE MED J-PEKING, V114, P636; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Berg EL, 2007, J ANIM SCI, V85, P1660, DOI 10.2527/jas.2006-771; Buff PR, 2002, J ANIM SCI, V80, P2942; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cymbaluk NF, 1996, DOMEST ANIM ENDOCRIN, V13, P197, DOI 10.1016/0739-7240(96)00014-8; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; De Blasio MJ, 2007, ENDOCRINOLOGY, V148, P1350, DOI 10.1210/en.2006-0653; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; DOREAU M, 1989, LIVEST PROD SCI, V22, P213, DOI 10.1016/0301-6226(89)90057-2; Elliott C, 2009, THERIOGENOLOGY, V71, P683, DOI 10.1016/j.theriogenology.2008.09.041; Firshman AM, 2007, EQUINE VET J, V39, P567, DOI 10.2746/042516407X238512; Forhead AJ, 2000, J PHYSIOL-LONDON, V526, P167, DOI 10.1111/j.1469-7793.2000.00167.x; Forhead AJ, 2004, J ENDOCRINOL, V181, P459, DOI 10.1677/joe.0.1810459; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; FOWDEN AL, 1984, EQUINE VET J, V16, P286, DOI 10.1111/j.2042-3306.1984.tb01928.x; Frank N, 2014, EQUINE VET J, V46, P103, DOI 10.1111/evj.12169; Frank N, 2010, J VET INTERN MED, V24, P467, DOI 10.1111/j.1939-1676.2010.0503.x; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Geor R, 2009, VET IMMUNOL IMMUNOP, V129, P151, DOI 10.1016/j.vetimm.2008.11.012; Giussani DA, 2003, J PHYSIOL-LONDON, V547, P67, DOI 10.1113/jphysiol.2002.027409; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Heidler B, 2004, THERIOGENOLOGY, V61, P883, DOI 10.1016/S0093-691X(03)00279-6; Hemkemeyer SA, 2014, HUM REPROD, V29, P220, DOI 10.1093/humrep/det411; HESSDUDAN F, 1994, EQUINE VET J, V26, P134, DOI 10.1111/j.2042-3306.1994.tb04352.x; Hoffman RM, 2003, J ANIM SCI, V81, P2333; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; IRVINE CHG, 1975, J REPROD FERTIL, P709; Jakimiuk AJ, 2003, GYNECOL ENDOCRINOL, V17, P311, DOI 10.1080/713603295; JEFFCOTT LB, 1986, EQUINE VET J, V18, P97, DOI 10.1111/j.2042-3306.1986.tb03556.x; Johnson PJ, 2002, VET CLIN N AM-EQUINE, V18, P271, DOI 10.1016/S0749-0739(02)00006-8; Kawai M, 1997, BIOCHEM BIOPH RES CO, V240, P798, DOI 10.1006/bbrc.1997.7750; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Larsen PR, 1998, WILLIAMS TXB ENDOCRI, P389; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Malinowski K, 1996, J ANIM SCI, V74, P1936; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; McMullen S, 2009, P NUTR SOC, V68, P306, DOI 10.1017/S0029665109001396; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ogilvy-Stuart AL, 2002, ARCH DIS CHILD-FETAL, V87, P165, DOI 10.1136/fn.87.3.F165; Ohkawa N, 2010, ACTA PAEDIATR, V99, P37, DOI 10.1111/j.1651-2227.2009.01516.x; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Panzani S, 2012, THERIOGENOLOGY, V77, P1167, DOI 10.1016/j.theriogenology.2011.10.023; Pardo CE, 2013, ANIMAL, V7, P1884, DOI 10.1017/S1751731113001419; Poore KR, 2003, J PHYSIOL-LONDON, V547, P107, DOI 10.1113/jphysiol.2002.024349; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Powell DM, 2002, EQUINE VET J, V34, P81; Radin MJ, 2009, VET CLIN PATH, V38, P136, DOI 10.1111/j.1939-165X.2009.00133.x; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rijnen KEPM, 2003, AM J VET RES, V64, P1260, DOI 10.2460/ajvr.2003.64.1260; Romagnoli U, 2007, ANIM REPROD SCI, V97, P180, DOI 10.1016/j.anireprosci.2006.02.004; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Rossdale PD, 2002, EQUINE VET EDUC, V14, P98, DOI 10.1111/j.2042-3292.2002.tb00148.x; ROSSDALE PD, 1976, P ROY SOC MED, V69, P631, DOI 10.1177/003591577606900901; Sainsbury A, 2012, OBES REV, V13, P234, DOI 10.1111/j.1467-789X.2011.00948.x; Salazar-Ortiz J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-130; Salimei E, 2002, REPROD NUTR DEV, V42, P65, DOI 10.1051/rnd:2002007; SILVER M, 1991, J REPROD FERTIL, P619; Slebodzinski AB, 1998, REPROD NUTR DEV, V38, P235, DOI 10.1051/rnd:19980303; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Symonds ME, 2010, ANIMAL, V4, P1075, DOI 10.1017/S1751731110000479; Thomas C R, 2001, Int J Exp Diabetes Res, V2, P113, DOI 10.1155/EDR.2001.113; Thomas L, 2001, J ENDOCRINOL, V169, P465, DOI 10.1677/joe.0.1690465; Vander Heyden L, 2013, VET REC, V172, P68, DOI 10.1136/vr.101034; Vick MM, 2006, REPROD FERT DEVELOP, V18, P609, DOI 10.1071/RD06016; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; Wang C, 2005, ENDOCRINE, V27, P75, DOI 10.1385/ENDO:27:1:075; Watkins A J, 2010, J Dev Orig Health Dis, V1, P87, DOI 10.1017/S2040174409990195; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	83	33	33	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102044	10.1371/journal.pone.0102044	http://dx.doi.org/10.1371/journal.pone.0102044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006665	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600090
J	Pickering, JW; Endre, ZH				Pickering, John W.; Endre, Zoltan H.			Acute Kidney Injury Urinary Biomarker Time-Courses	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; LINE RENAL-FUNCTION; CARDIAC-SURGERY; CREATININE; AKI; ESTABLISHMENT; PERFORMANCE; ADAPTATION; KINETICS; ABLATION	Factors which modify the excretion profiles of acute kidney injury biomarkers are difficult to measure. To facilitate biomarker choice and interpretation we modelled key modifying factors: extent of hyperfiltration or reduced glomerular filtration rate, structural damage, and reduced nephron number. The time-courses of pre-formed, induced (upregulated), and filtered biomarker concentrations were modelled in single nephrons, then combined to construct three multiple-nephron models: a healthy kidney with normal nephron number, a non-diabetic hyperfiltering kidney with reduced nephron number but maintained total glomerular filtration rate, and a chronic kidney disease kidney with reduced nephron number and reduced glomerular filtration rate. Time-courses for each model were derived for acute kidney injury scenarios of structural damage and/or reduced nephron number. The model predicted that pre-formed biomarkers would respond quickest to injury with a brief period of elevation, which would be easily missed in clinical scenarios. Induced biomarker time-courses would be influenced by biomarker-specific physiology and the balance between insult severity (which increased single nephron excretion), the number of remaining nephrons (reduced total excretion), and the extent of glomerular filtration rate reduction (increased concentration). Filtered biomarkers have the longest time-course because plasma levels increased following glomerular filtration rate decrease. Peak concentration and profile depended on the extent of damage to the reabsorption mechanism and recovery rate. Rapid recovery may be detected through a rapid reduction in urinary concentration. For all biomarkers, impaired hyperfiltration substantially increased concentration, especially with chronic kidney disease. For clinical validation of these model-derived predictions the clinical biomarker of choice will depend on timing in relation to renal insult and interpretation will require the pre-insult nephron number (renal mass) and detection of hyperfiltration.	[Pickering, John W.] Univ Otago, Dept Med, Christchurch, New Zealand; [Endre, Zoltan H.] Univ New S Wales, Prince Wales Clin Sch, Dept Nephrol, Sydney, NSW, Australia	University of Otago; University of New South Wales Sydney	Pickering, JW (corresponding author), Univ Otago, Dept Med, Christchurch, New Zealand.	john.pickering@otago.ac.nz	Pickering, John/ABC-8089-2021; Pickering, John W/A-9453-2009; Endre, Zoltan/A-3331-2009	Pickering, John/0000-0001-9475-0344; Pickering, John W/0000-0001-9475-0344; Endre, Zoltan/0000-0002-4782-8695	Royal Society of New Zealand [UOO1020]; University of Otago Research Grant	Royal Society of New Zealand(Royal Society of New Zealand); University of Otago Research Grant	1. Marsden Grant UOO1020 administered by the Royal Society of New Zealand. 2. University of Otago Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON L, 1995, SCAND J CLIN LAB INV, V55, P577, DOI 10.3109/00365519509110257; Bakonska-Pacon E, 2003, BIOL SPORT, V20, P69; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Bonventre JV, 2009, NEPHROL DIAL TRANSPL, V24, P3265, DOI 10.1093/ndt/gfp010; BRENNER BM, 1985, AM J PHYSIOL, V249, pF324, DOI 10.1152/ajprenal.1985.249.3.F324; Cullen MR, 2012, ANN CLIN BIOCHEM, V49, P190, DOI 10.1258/acb.2011.011105; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Han M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-25; Han WK, 2009, CLIN J AM SOC NEPHRO, V4, P873, DOI 10.2215/CJN.04810908; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; KAUFMAN JM, 1975, CIRC RES, V36, P286, DOI 10.1161/01.RES.36.2.286; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Krawczeski CD, 2011, J AM COLL CARDIOL, V58, P2301, DOI 10.1016/j.jacc.2011.08.017; McIlroy DR, 2010, CLIN J AM SOC NEPHRO, V5, P211, DOI 10.2215/CJN.04240609; Metcalfe W, 2007, NEPHROL DIAL TRANSPL, V22, P26, DOI 10.1093/ndt/gfm446; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Molnar AO, 2012, CLIN J AM SOC NEPHRO, V7, P1749, DOI 10.2215/CJN.13421211; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Nejat M, 2012, NEPHROL DIAL TRANSPL, V27, P96, DOI 10.1093/ndt/gfr222; Pennemans V, 2013, CLIN CHEM LAB MED, V51, P1795, DOI 10.1515/cclm-2013-0157; Pickering JW, 2013, BLOOD PURIFICAT, V35, P295, DOI 10.1159/000351542; Pickering JW, 2013, CRIT CARE, V17, DOI 10.1186/cc11931; Pickering JW, 2009, LANCET, V373, P1318, DOI 10.1016/S0140-6736(09)60751-0; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Westhuyzen J, 2003, NEPHROL DIAL TRANSPL, V18, P543, DOI 10.1093/ndt/18.3.543	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101288	10.1371/journal.pone.0101288	http://dx.doi.org/10.1371/journal.pone.0101288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006799	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600033
J	Higashi, K; Imamura, M; Fudo, S; Uemura, T; Saiki, R; Hoshino, T; Toida, T; Kashiwagi, K; Igarashi, K				Higashi, Kyohei; Imamura, Masataka; Fudo, Satoshi; Uemura, Takeshi; Saiki, Ryotaro; Hoshino, Tyuji; Toida, Toshihiko; Kashiwagi, Keiko; Igarashi, Kazuei			Identification of Functional Amino Acid Residues Involved in Polyamine and Agmatine Transport by Human Organic Cation Transporter 2	PLOS ONE			English	Article							ORNITHINE-DECARBOXYLASE; RECOGNITION SITE; PROTEIN; PUTRESCINE; EXCRETION; ANTIPORTER; SPERMIDINE; CADAVERINE; PERMEASE; OCT2	Polyamine (putrescine, spermidine and spermine) and agmatine uptake by the human organic cation transporter 2 (hOCT2) was studied using HEK293 cells transfected with pCMV6-XL4/hOCT2. The Km values for putrescine and spermidine were 7.50 and 6.76 mM, and the Vmax values were 4.71 and 2.34 nmol/min/mg protein, respectively. Spermine uptake by hOCT2 was not observed at pH 7.4, although it inhibited both putrescine and spermidine uptake. Agmatine was also taken up by hOCT2, with Km value: 3.27 mM and a Vmax value of 3.14 nmol/min/mg protein. Amino acid residues involved in putrescine, agmatine and spermidine uptake by hOCT2 were Asp(427), Glu(448), Glu(456), Asp(475), and Glu(516). In addition, Glu(524) and Glu(530) were involved in putrescine and spermidine uptake activity, and Glu(528) and Glu(540) were weakly involved in putrescine uptake activity. Furthermore, Asp(551) was also involved in the recognition of spermidine. These results indicate that the recognition sites for putrescine, agmatine and spermidine on hOCT2 strongly overlap, consistent with the observation that the three amines are transported with similar affinity and velocity. A model of spermidine binding to hOCT2 was constructed based on the functional amino acid residues.	[Higashi, Kyohei; Imamura, Masataka; Fudo, Satoshi; Uemura, Takeshi; Saiki, Ryotaro; Hoshino, Tyuji; Toida, Toshihiko; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Saiki, Ryotaro; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chiba, Japan; [Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba, Japan	Chiba University; Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan.	iga16077@faculty.chiba-u.jp		Igarashi, Kazuei/0000-0003-3751-3187; Higashi, Kyohei/0000-0002-2622-4825; Fudo, Satoshi/0000-0001-9925-5131	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Fujita M, 2012, P NATL ACAD SCI USA, V109, P6343, DOI 10.1073/pnas.1121406109; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; Higashi K, 2004, J BIOCHEM, V136, P533, DOI 10.1093/jb/mvh150; Higashi K, 2008, J BACTERIOL, V190, P872, DOI 10.1128/JB.01505-07; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; KAKINUMA Y, 1987, ARCH BIOCHEM BIOPHYS, V259, P171, DOI 10.1016/0003-9861(87)90483-8; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pelis RM, 2007, AM J PHYSIOL-RENAL, V292, pF1583, DOI 10.1152/ajprenal.00496.2006; Pelis RM, 2006, J BIOL CHEM, V281, P35272, DOI 10.1074/jbc.M606561200; Sala-Rabanal M, 2013, MOL PHARMACEUT, V10, P1450, DOI 10.1021/mp400024d; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Tachihara K, 2005, J BIOL CHEM, V280, P12637, DOI 10.1074/jbc.M410778200; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Terui Y, 2014, AMINO ACIDS, V46, P661, DOI 10.1007/s00726-013-1517-x; Tomitori H, 2012, AMINO ACIDS, V42, P733, DOI 10.1007/s00726-011-0989-9; Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1028, DOI 10.1016/j.bbrc.2005.01.064; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Winter TN, 2011, MOL PHARMACEUT, V8, P133, DOI 10.1021/mp100180a; Yokoo S, 2008, DRUG METAB DISPOS, V36, P2299, DOI 10.1124/dmd.108.023168; Zhang XH, 2005, J BIOL CHEM, V280, P34813, DOI 10.1074/jbc.M506342200	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102234	10.1371/journal.pone.0102234	http://dx.doi.org/10.1371/journal.pone.0102234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019617	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600055
J	Faller, J; Scherer, R; Costa, U; Opisso, E; Medina, J; Muller-Putz, GR				Faller, Josef; Scherer, Reinhold; Costa, Ursula; Opisso, Eloy; Medina, Josep; Mueller-Putz, Gernot R.			A Co-Adaptive Brain-Computer Interface for End Users with Severe Motor Impairment	PLOS ONE			English	Article							EEG; COMMUNICATION; PATIENT; IMAGERY; RHYTHMS	Co-adaptive training paradigms for event-related desynchronization (ERD) based brain-computer interfaces (BCI) have proven effective for healthy users. As of yet, it is not clear whether co-adaptive training paradigms can also benefit users with severe motor impairment. The primary goal of our paper was to evaluate a novel cue-guided, co-adaptive BCI training paradigm with severely impaired volunteers. The co-adaptive BCI supports a non-control state, which is an important step toward intuitive, self-paced control. A secondary aim was to have the same participants operate a specifically designed self-paced BCI training paradigm based on the auto-calibrated classifier. The co-adaptive BCI analyzed the electroencephalogram from three bipolar derivations (C3, Cz, and C4) online, while the 22 end users alternately performed right hand movement imagery (MI), left hand MI and relax with eyes open (non-control state). After less than five minutes, the BCI auto-calibrated and proceeded to provide visual feedback for the MI task that could be classified better against the non-control state. The BCI continued to regularly recalibrate. In every calibration step, the system performed trial-based outlier rejection and trained a linear discriminant analysis classifier based on one auto-selected logarithmic band-power feature. In 24 minutes of training, the co-adaptive BCI worked significantly (p = 0.01) better than chance for 18 of 22 end users. The self-paced BCI training paradigm worked significantly (p = 0.01) better than chance in 11 of 20 end users. The presented co-adaptive BCI complements existing approaches in that it supports a non-control state, requires very little setup time, requires no BCI expert and works online based on only two electrodes. The preliminary results from the self-paced BCI paradigm compare favorably to previous studies and the collected data will allow to further improve self-paced BCI systems for disabled users.	[Faller, Josef; Scherer, Reinhold; Mueller-Putz, Gernot R.] Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria; [Costa, Ursula; Opisso, Eloy; Medina, Josep] UAB, Neurorehab Univ Inst, Guttmann Inst, Barcelona, Spain; [Opisso, Eloy; Medina, Josep] Germans Trias & Pujol Found, Hlth Sci Res Inst, Barcelona, Spain	Graz University of Technology; Autonomous University of Barcelona	Scherer, R (corresponding author), Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria.	reinhold.scherer@tugraz.at	Faller, Josef/ABG-2374-2020	Faller, Josef/0000-0001-7814-9292; Scherer, Reinhold/0000-0003-3407-9709; Muller-Putz, Gernot/0000-0002-0087-3720	FP7 EU Research Project BrainAble [247447]; FP7 EU Research Project BackHome [288566]	FP7 EU Research Project BrainAble; FP7 EU Research Project BackHome	This work was supported by the FP7 EU Research Projects BrainAble (No. 247447; http://www.brainable.org/) and BackHome (No. 288566; http://www.backhome-fp7.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-34; Billinger M., 2012, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5_17, DOI 10.1007/978-3-642-29746-5_17]; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Blankertz B., 2006, CLIN NEUROPHYSIOL, V113, P108, DOI DOI 10.1109/MSP.2008.4408441; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Conradi J., 2009, INT J BIOELECTROMAGN, V11, P65; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Daly I, 2013, CLIN NEUROPHYSIOL, V124, P1787, DOI 10.1016/j.clinph.2013.02.118; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Faller J, 2013, I IEEE EMBS C NEUR E, P977, DOI 10.1109/NER.2013.6696099; Faller J, 2012, 34 ANN INT C IEEE EN; Faller J, 2013, P BCI M 2013 AS CA U; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Friedrich EVC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076214; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Grosse-Wentrup M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025004; Jatzev S, 2008, P 4 INT BCI WORKSH T; Kreilinger A, 2013, IEEE INTELL SYST APP, V28, P28; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kus R, 2012, IEEE T NEUR SYS REH, V20, P823, DOI 10.1109/TNSRE.2012.2214789; Leeb R, 2013, ARTIF INTELL MED, V59, P121, DOI 10.1016/j.artmed.2013.08.004; Lotte F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00568; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Millan JD, 2004, ARTIF INTELL, V159, P241, DOI 10.1016/j.artint.2004.05.008; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Obermaier B, 2003, IEEE T NEUR SYS REH, V11, P422, DOI 10.1109/TNSRE.2003.816866; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Pfurtscheller G, 2009, Comput Intell Neurosci, P104180, DOI 10.1155/2009/104180; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pichiorri F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025020; Pokorny C, 2013, ARTIF INTELL MED, V59, P81, DOI 10.1016/j.artmed.2013.07.003; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Rohm M, 2013, P 4 TOBI WORKSH 2013, P19; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Scherer Reinhold, 2007, Comput Intell Neurosci, P79826, DOI 10.1155/2007/79826; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	48	35	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101168	10.1371/journal.pone.0101168	http://dx.doi.org/10.1371/journal.pone.0101168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014055	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400019
J	Lu, JJ; Tan, DY; Baskin, JM; Baskin, CC				Lu, Juan J.; Tan, Dun Y.; Baskin, Jerry M.; Baskin, Carol C.			Germination Season and Watering Regime, but Not Seed Morph, Affect Life History Traits in a Cold Desert Diaspore-Heteromorphic Annual	PLOS ONE			English	Article							WEED DIPLOTAXIS ERUCOIDES; ARABIDOPSIS-THALIANA; PHENOTYPIC PLASTICITY; EVOLUTIONARY ECOLOGY; NATURAL-SELECTION; FLOWERING TIME; BRASSICACEAE; RESPONSES; DATE; CHARACTERS	Seed morph, abiotic conditions and time of germination can affect plant fitness, but few studies have tested their combined effects on plasticity of plant life history traits. Thus, we tested the hypothesis that seed morph, germination season and watering regime influence phenotypic expression of post-germination life history traits in the diaspore-heteromorphic cold desert winter annual/spring ephemeral Diptychocarpus strictus. The two seed morphs were sown in watered and non-watered plots in late summer, and plants derived from them were watered or not-watered throughout the study. Seed morph did not affect phenology, growth and morphology, survival, dry mass accumulation and allocation or silique and seed production. Seeds in watered plots germinated in autumn (AW) and spring (SW) but only in spring for non-watered plots (SNW). A high percentage of AW, SW and SNW plants survived and reproduced, but flowering date and flowering period of autumn- vs. spring-germinated plants differed. Dry mass also differed with germination season/watering regime (AW > SW > SNW). Number of siliques and seeds increased with plant size (AW > SW > SNW), whereas percent dry mass allocated to reproduction was higher in small plants: SNW > SW > AW. Thus, although seed morph did not affect the expression of life history traits, germination season and watering regime significantly affected phenology, plant size and accumulation and allocation of biomass to reproduction. Flexibility throughout the life cycle of D. strictus is an adaptation to the variation in timing and amount of rainfall in its cold desert habitat.	[Lu, Juan J.; Tan, Dun Y.; Baskin, Jerry M.; Baskin, Carol C.] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Grassland Resources & Ecol, Urumqi, Peoples R China; [Lu, Juan J.; Tan, Dun Y.; Baskin, Jerry M.; Baskin, Carol C.] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Minist Educ, Key Lab Western Arid Reg Grassland Resources & Ec, Urumqi, Peoples R China; [Baskin, Jerry M.; Baskin, Carol C.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Xinjiang Agricultural University; Xinjiang Agricultural University; University of Kentucky; University of Kentucky	Tan, DY (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Grassland Resources & Ecol, Urumqi, Peoples R China.	tandunyan@163.com; ccbask0@uky.edu			National Science Foundation of China [31160093, U1130301, 41361011]; Chinese Ministry of Education [213038A]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Science Foundation of China (31160093, U1130301, 41361011) and the Key Project of Chinese Ministry of Education (No. 213038A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZX, 1995, FLORA XINJIANGENSIS, V2, P171; Angert AL, 2010, AM J BOT, V97, P405, DOI 10.3732/ajb.0900242; ARONSON J, 1993, OECOLOGIA, V93, P336, DOI 10.1007/BF00317875; BASKIN JM, 1984, B TORREY BOT CLUB, V111, P329, DOI 10.2307/2995914; BASKIN JM, 1972, AM MIDL NAT, V88, P318, DOI 10.2307/2424357; CHEPLICK GP, 1992, J ECOL, V80, P567, DOI 10.2307/2260699; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Dubois J, 2012, ANN BOT-LONDON, V110, P1245, DOI 10.1093/aob/mcs203; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Lu JJ, 2012, OIKOS, V121, P357, DOI 10.1111/j.1600-0706.2011.19800.x; Lu JJ, 2010, ANN BOT-LONDON, V105, P999, DOI 10.1093/aob/mcq041; Mandak B, 2005, FLORA, V200, P516, DOI 10.1016/j.flora.2005.06.003; Mandak Bohumil, 1997, Preslia (Prague), V69, P129; MARKS M, 1981, OIKOS, V36, P326, DOI 10.2307/3544630; Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807; Penfield S, 2012, PHILOS T R SOC B, V367, P291, DOI 10.1098/rstb.2011.0186; Sans FX, 1997, CAN J BOT, V75, P86, DOI 10.1139/b97-011; SANS FX, 1994, CAN J BOT, V72, P10, DOI 10.1139/b94-003; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sokal R. R., 2012, BIOMETRY; SZAREK SR, 1982, AM MIDL NAT, V108, P338, DOI 10.2307/2425494; VANROOYEN MW, 1992, J ARID ENVIRON, V22, P51, DOI 10.1016/S0140-1963(18)30656-6; VENABLE DL, 1985, AM NAT, V126, P577, DOI 10.1086/284440; VENABLE DL, 1987, ECOLOGY, V68, P65, DOI 10.2307/1938805; Venable DL, 1985, J ECOL, V73, P113; Wang XQ, 2006, CHINESE SCI BULL, V51, P110, DOI 10.1007/s11434-006-8214-z; [魏文寿 Wei Wenshou], 2003, [中国沙漠, Journal of Desert Research], V23, P101; Zhou DW, 2005, CAN J BOT, V83, P28, DOI [10.1139/b04-148, 10.1139/B04-148]	31	29	34	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102018	10.1371/journal.pone.0102018	http://dx.doi.org/10.1371/journal.pone.0102018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013967	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400055
J	Morimoto, N; de Leon, MSP; Zollikofer, CPE				Morimoto, Naoki; de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.			Phenotypic Variation in Infants, Not Adults, Reflects Genotypic Variation among Chimpanzees and Bonobos	PLOS ONE			English	Article							Q(ST)-F-ST COMPARISONS; GENE FLOW; LOCOMOTOR BEHAVIOR; STABILIZING SELECTION; POPULATION-STRUCTURE; DIAPHYSEAL STRUCTURE; QUANTITATIVE TRAIT; NATURAL-SELECTION; PAN-PANISCUS; G MATRIX	Studies comparing phenotypic variation with neutral genetic variation in modern humans have shown that genetic drift is a main factor of evolutionary diversification among populations. The genetic population history of our closest living relatives, the chimpanzees and bonobos, is now equally well documented, but phenotypic variation among these taxa remains relatively unexplored, and phenotype-genotype correlations are not yet documented. Also, while the adult phenotype is typically used as a reference, it remains to be investigated how phenotype-genotye correlations change during development. Here we address these questions by analyzing phenotypic evolutionary and developmental diversification in the species and subspecies of the genus Pan. Our analyses focus on the morphology of the femoral diaphysis, which represents a functionally constrained element of the locomotor system. Results show that during infancy phenotypic distances between taxa are largely congruent with non-coding (neutral) genotypic distances. Later during ontogeny, however, phenotypic distances deviate from genotypic distances, mainly as an effect of heterochronic shifts between taxon-specific developmental programs. Early phenotypic differences between Pan taxa are thus likely brought about by genetic drift while late differences reflect taxon-specific adaptations.	[Morimoto, Naoki] Kyoto Univ, Grad Sch Sci, Lab Phys Anthropol, Kyoto, Japan; [de Leon, Marcia S. Ponce; Zollikofer, Christoph P. E.] Univ Zurich, Inst Anthropol, Zurich, Switzerland	Kyoto University; University of Zurich	Morimoto, N (corresponding author), Kyoto Univ, Grad Sch Sci, Lab Phys Anthropol, Kyoto, Japan.	morimoto@anthro.zool.kyoto-u.ac.jp; zolli@aim.uzh.ch		Morimoto, Naoki/0000-0002-8367-4777	Swiss National Science Foundation [3100A0-109344/1]; Japan Society for Promotion of Science [251133]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Swiss National Science Foundation (no. 3100A0-109344/1) and Japan Society for Promotion of Science Research Fellowship for Young Scientists (no. 251133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Betti L, 2010, AM J PHYS ANTHROPOL, V141, P76, DOI 10.1002/ajpa.21115; Bolter DR, 2011, AM J PHYS ANTHROPOL, V145, P647, DOI 10.1002/ajpa.21517; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bourne GH, 1971, CHIMPANZEE, V4; Bourne GH, 1969, CHIMPANZEE, V1; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Carlson K, 2008, INT J PRIMATOL, V29, P1401, DOI 10.1007/s10764-008-9297-y; Carlson KJ, 2006, J HUM EVOL, V50, P394, DOI 10.1016/j.jhevol.2005.10.004; Carlson KJ, 2005, AM J PHYS ANTHROPOL, V127, P312, DOI 10.1002/ajpa.20124; Carlson KJ, 2008, INTEGR COMP BIOL, V48, P385, DOI 10.1093/icb/icn066; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Champneys F, 1871, J Anat Physiol, V6, P176; Chapuis E, 2008, GENETICS, V180, P2151, DOI 10.1534/genetics.108.092452; Charmantier A, 2006, P ROY SOC B-BIOL SCI, V273, P225, DOI 10.1098/rspb.2005.3294; Collard M, 2000, P NATL ACAD SCI USA, V97, P5003, DOI 10.1073/pnas.97.9.5003; Crass E, 1952, THESIS U WISCONSIN; de Leon MSP, 2007, VERTEBR PALEOBIOL PA, P71; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Doran D. M., 1996, GREAT APE SOC; Doran DM, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P14, DOI 10.1017/CBO9780511606397.004; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Edelaar P, 2011, MOL ECOL, V20, P4830, DOI 10.1111/j.1365-294X.2011.05333.x; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Geiger M, 2013, J EVOLUTIONARY BIOL, V20, P12279; Gonder MK, 2006, INT J PRIMATOL, V27, P1103, DOI 10.1007/s10764-006-9063-y; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunz P, 2005, DEV PRIMATOL; Gunz P, 2012, J HUM EVOL, V62, P300, DOI 10.1016/j.jhevol.2011.11.013; Haller BC, 2014, EVOLUTION, V68, P483, DOI 10.1111/evo.12275; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Hawks J, 2013, ANNU REV ANTHROPOL, V42, P433, DOI 10.1146/annurev-anthro-092412-155548; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Kalinowski ST, 2002, MOL ECOL, V11, P1263, DOI 10.1046/j.1365-294X.2002.01520.x; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Koyabu D, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-21; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Lesser KJ, 2006, AGING CELL, V5, P293, DOI 10.1111/j.1474-9726.2006.00219.x; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; LYNCH M, 1989, EVOLUTION, V43, P1, DOI 10.1111/j.1558-5646.1989.tb04203.x; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Martin G, 2008, GENETICS, V180, P2135, DOI 10.1534/genetics.107.080820; McGrew MC, 1996, GREAT APE SOC; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 1997, EVOLUTION, V51, P946, DOI 10.1111/j.1558-5646.1997.tb03675.x; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Morgan TJ, 2005, HEREDITY, V94, P518, DOI 10.1038/sj.hdy.6800652; Morimoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041980; Morimoto N, 2011, ANAT REC, V294, P1433, DOI 10.1002/ar.21424; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Palagi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052767; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penin X, 2002, AM J PHYS ANTHROPOL, V118, P50, DOI 10.1002/ajpa.10044; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Puymerail L, 2013, COMPTES RENDUS PALEV; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Relethford JH, 1997, HUM BIOL, V69, P443; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2007, BIOESSAYS, V29, P1185, DOI 10.1002/bies.20678; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; Saether SA, 2007, J EVOLUTION BIOL, V20, P1563, DOI 10.1111/j.1420-9101.2007.01328.x; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Sanchez M, 2012, EMBRYOS IN DEEP TIME: THE ROCK RECORD OF BIOLOGICAL DEVELOPMENT, P1, DOI 10.1525/california/9780520271937.001.0001; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Shaw KL, 2011, GENETICA, V139, P649, DOI 10.1007/s10709-011-9562-4; SHEA BT, 1983, AM J PHYS ANTHROPOL, V62, P275, DOI 10.1002/ajpa.1330620307; SHEA BT, 1983, SCIENCE, V222, P521, DOI 10.1126/science.6623093; SIGMON BA, 1974, J HUM EVOL, V3, P161, DOI 10.1016/0047-2484(74)90197-3; Slate J, 2013, EVOLUTION, V67, P1251, DOI 10.1111/evo.12060; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Smith HF, 2007, AM J PHYS ANTHROPOL, V134, P312, DOI 10.1002/ajpa.20671; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Specht M, 2007, VISUAL COMPUT, V23, P743, DOI 10.1007/s00371-007-0156-1; SPITZE K, 1993, GENETICS, V135, P367; STERN JT, 1972, AM J PHYS ANTHROPOL, V36, P315, DOI 10.1002/ajpa.1330360303; Storz JF, 2002, MOL ECOL, V11, P2537, DOI 10.1046/j.1365-294X.2002.01636.x; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; von Cramon-Taubadel N, 2009, EVOL ANTHROPOL, V18, P237, DOI 10.1002/evan.20233; Wagner GP, 1996, GENETICS, V143, P617; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wilson LAB, 2011, J EXP ZOOL PART B, V316B, P50, DOI 10.1002/jez.b.21380; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wright S., 1978, EVOLUTION GENETICS P, V4; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI; Zollikofer CPE, 2001, HOM EVOLUT CLIMAT CH, V2, P50	123	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102074	10.1371/journal.pone.0102074	http://dx.doi.org/10.1371/journal.pone.0102074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013970	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339378400064
J	Li, MY; Wetzel-Strong, SE; Hua, XY; Tilley, SL; Oswald, E; Krummel, MF; Caron, KM				Li, Manyu; Wetzel-Strong, Sarah E.; Hua, Xiaoyang; Tilley, Stephen L.; Oswald, Erin; Krummel, Matthew F.; Caron, Kathleen M.			Deficiency of RAMP1 Attenuates Antigen-Induced Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; ACTIVITY MODIFYING PROTEINS; CALCITONIN-GENE; HYDROPS-FETALIS; RECEPTOR; EXPRESSION; LACKING; ASTHMA; POTENT; CELLS	Asthma is a chronic inflammatory disease affecting the lung, characterized by breathing difficulty during an attack following exposure to an environmental trigger. Calcitonin gene-related peptide (CGRP) is a neuropeptide that may have a pathological role in asthma. The CGRP receptor is comprised of two components, which include the G-protein coupled receptor, calcitonin receptor-like receptor (CLR), and receptor activity-modifying protein 1 (RAMP1). RAMPs, including RAMP1, mediate ligand specificity in addition to aiding in the localization of receptors to the cell surface. Since there has been some controversy regarding the effect of CGRP on asthma, we sought to determine the effect of CGRP signaling ablation in an animal model of asthma. Using gene-targeting techniques, we generated mice deficient for RAMP1 by excising exon 3. After determining that these mice are viable and overtly normal, we sensitized the animals to ovalbumin prior to assessing airway resistance and inflammation after methacholine challenge. We found that mice lacking RAMP1 had reduced airway resistance and inflammation compared to wildtype animals. Additionally, we found that a 50% reduction of CLR, the G-protein receptor component of the CGRP receptor, also ameliorated airway resistance and inflammation in this model of allergic asthma. Interestingly, the loss of CLR from the smooth muscle cells did not alter the airway resistance, indicating that CGRP does not act directly on the smooth muscle cells to drive airway hyperresponsiveness. Together, these data indicate that signaling through RAMP1 and CLR plays a role in mediating asthma pathology. Since RAMP1 and CLR interact to form a receptor for CGRP, our data indicate that aberrant CGRP signaling, perhaps on lung endothelial and inflammatory cells, contributes to asthma pathophysiology. Finally, since RAMP-receptor interfaces are pharmacologically tractable, it may be possible to develop compounds targeting the RAMP1/CLR interface to assist in the treatment of asthma.	[Li, Manyu; Wetzel-Strong, Sarah E.; Caron, Kathleen M.] Univ N Carolina, Dept Cell Biol, Chapel Hill, NC 27599 USA; [Li, Manyu; Wetzel-Strong, Sarah E.; Caron, Kathleen M.] Univ N Carolina, Dept Physiol, Chapel Hill, NC USA; [Caron, Kathleen M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Hua, Xiaoyang; Tilley, Stephen L.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA; [Oswald, Erin; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco	Caron, KM (corresponding author), Univ N Carolina, Dept Cell Biol, Chapel Hill, NC 27599 USA.	kathleen_Caron@med.unc.edu	Hua, Xiaoyang/T-5252-2019	Caron, Kathleen/0000-0002-7033-9232; Wetzel-Strong, Sarah/0000-0001-5560-2330; Hua, Xiaoyang/0000-0001-6414-7712	National Institutes of Health/National Heart Lung and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases [HD060860, DK99156];  [2U19A1077439-06];  [P01 HL024136]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060860] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099156] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health/National Heart Lung and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases HD060860 and DK99156 to KMC, as well as 2U19A1077439-06 and P01 HL024136 to MFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2011, NATL HLTH STAT REPOR, V1-14; Aoki-Nagase T, 2002, AM J PHYSIOL-LUNG C, V283, pL963, DOI 10.1152/ajplung.00130.2002; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bonner K, 2013, J ALLERGY CLIN IMMUN, V132, P942, DOI 10.1016/j.jaci.2013.04.015; Bonner K, 2010, J ALLERGY CLIN IMMUN, V126, P1277, DOI 10.1016/j.jaci.2010.08.013; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dakhama A, 2002, AM J RESP CRIT CARE, V165, P1137, DOI 10.1164/ajrccm.165.8.2109058; Fraser NJ, 1999, MOL PHARMACOL, V55, P1054, DOI 10.1124/mol.55.6.1054; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; Kay AB, 2007, ALLERGY, V62, P495, DOI 10.1111/j.1398-9995.2007.01342.x; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Potaczek DP, 2013, PEDIAT ALLERG IMM-UK, V24, P441, DOI 10.1111/pai.12083; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Salvatore CA, 2008, J PHARMACOL EXP THER, V324, P416, DOI 10.1124/jpet.107.130344; Simms J, 2009, BIOCHEMISTRY-US, V48, P198, DOI 10.1021/bi801869n; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Stapleton CM, 2005, AM J PHYSIOL-LUNG C, V289, pL144, DOI 10.1152/ajplung.00348.2004; Tang YM, 1998, J NEUROIMMUNOL, V84, P207, DOI 10.1016/S0165-5728(97)00257-9; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Toru H, 1996, INT IMMUNOL, V8, P1367; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Wetzel-Strong SE, 2014, DEV DYNAM, V243, P243, DOI 10.1002/dvdy.24065; Wootten D, 2013, BRIT J PHARMACOL, V168, P822, DOI 10.1111/j.1476-5381.2012.02202.x; Yamamoto H, 2007, J APPL PHYSIOL, V102, P2361, DOI 10.1152/japplphysiol.00615.2006	35	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102356	10.1371/journal.pone.0102356	http://dx.doi.org/10.1371/journal.pone.0102356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010197	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800093
J	Hiratani, N; Fukai, T				Hiratani, Naoki; Fukai, Tomoki			Interplay between Short- and Long-Term Plasticity in Cell-Assembly Formation	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; IRREGULAR PERSISTENT ACTIVITY; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; MEMORY RETENTION; WORKING-MEMORY; AMYLOID-BETA; SPIKE; NETWORKS; MODULATION	Various hippocampal and neocortical synapses of mammalian brain show both short-term plasticity and long-term plasticity, which are considered to underlie learning and memory by the brain. According to Hebb's postulate, synaptic plasticity encodes memory traces of past experiences into cell assemblies in cortical circuits. However, it remains unclear how the various forms of long-term and short-term synaptic plasticity cooperatively create and reorganize such cell assemblies. Here, we investigate the mechanism in which the three forms of synaptic plasticity known in cortical circuits, i.e., spike-timing-dependent plasticity (STDP), short-term depression (STD) and homeostatic plasticity, cooperatively generate, retain and reorganize cell assemblies in a recurrent neuronal network model. We show that multiple cell assemblies generated by external stimuli can survive noisy spontaneous network activity for an adequate range of the strength of STD. Furthermore, our model predicts that a symmetric temporal window of STDP, such as observed in dopaminergic modulations on hippocampal neurons, is crucial for the retention and integration of multiple cell assemblies. These results may have implications for the understanding of cortical memory processes.	[Hiratani, Naoki; Fukai, Tomoki] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan; [Fukai, Tomoki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Hiratani, Naoki; Fukai, Tomoki] RIKEN, Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Fukai, Tomoki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science; RIKEN; Japan Science & Technology Agency (JST)	Fukai, T (corresponding author), Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan.	tfukai@riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638	Junior Research Associate Program of RIKEN;  [22115013]	Junior Research Associate Program of RIKEN; 	This work was partly supported by Grants-in-Aid for Scientific Research on Innovative Areas (no. 22115013, http://www.jsps.go.jp/english/e-grants/index.html). NH was supported by Junior Research Associate Program of RIKEN (http://www.riken.jp/en/careers/programs/jra/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Barbieri F, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.005.2007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Billings G, 2009, J NEUROPHYSIOL, V101, P2775, DOI 10.1152/jn.91007.2008; Bush D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000839; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Cheetham CEJ, 2010, J NEUROSCI, V30, P12566, DOI 10.1523/JNEUROSCI.2544-10.2010; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Del Giudice P, 2001, NEUROCOMPUTING, V38, P1175, DOI 10.1016/S0925-2312(01)00557-4; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; El Boustani S, 2012, J NEUROSCI, V32, P194, DOI 10.1523/JNEUROSCI.2496-11.2012; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Fukai T, 2001, BIOL CYBERN, V85, P107, DOI 10.1007/PL00007998; Gilson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025339; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00023; Gilson M, 2010, BIOL CYBERN, V103, P365, DOI 10.1007/s00422-010-0405-7; Gilson M, 2009, BIOL CYBERN, V101, P427, DOI 10.1007/s00422-009-0346-1; Hansel D, 2013, J NEUROSCI, V33, P133, DOI 10.1523/JNEUROSCI.3455-12.2013; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hiratani N, 2013, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00102; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Itami C, 2012, J NEUROSCI, V32, P15000, DOI 10.1523/JNEUROSCI.2506-12.2012; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Klampfl S, 2013, J NEUROSCI, V33, P11515, DOI 10.1523/JNEUROSCI.5044-12.2013; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marro J, 2007, NEURAL NETWORKS, V20, P230, DOI 10.1016/j.neunet.2006.11.005; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Romani S, 2006, J COMPUT NEUROSCI, V20, P201, DOI 10.1007/s10827-006-6308-x; Sandi C, 2011, TRENDS NEUROSCI, V34, P165, DOI 10.1016/j.tins.2011.01.006; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Tan DP, 2006, P NATL ACAD SCI USA, V103, P5125, DOI 10.1073/pnas.0601043103; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; York LC, 2009, J COMPUT NEUROSCI, V27, P607, DOI 10.1007/s10827-009-0172-4; Zenke F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003330; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; Zheng PS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002848	59	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101535	10.1371/journal.pone.0101535	http://dx.doi.org/10.1371/journal.pone.0101535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007209	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600043
J	Noratto, GD; Garcia-Mazcorro, JF; Markel, M; Martino, HS; Minamoto, Y; Steiner, JM; Byrne, D; Suchodolski, JS; Mertens-Talcott, SU				Noratto, Giuliana D.; Garcia-Mazcorro, Jose F.; Markel, Melissa; Martino, Hercia S.; Minamoto, Yasushi; Steiner, Joerg M.; Byrne, David; Suchodolski, Jan S.; Mertens-Talcott, Susanne U.			Carbohydrate-Free Peach (Prunus persica) and Plum (Prunus domestica) Juice Affects Fecal Microbial Ecology in an Obese Animal Model	PLOS ONE			English	Article							EUTERPE-OLERACEA MART.; DIET-INDUCED OBESITY; GUT MICROBIOTA; IN-VITRO; INTESTINAL MICROBIOTA; BACTERIAL MICROBIOTA; TEA POLYPHENOLS; METABOLIC-FATE; RIBOSOMAL-RNA; RED WINE	Background: Growing evidence shows the potential of nutritional interventions to treat obesity but most investigations have utilized non-digestible carbohydrates only. Peach and plum contain high amounts of polyphenols, compounds with demonstrated anti-obesity effects. The underlying process of successfully treating obesity using polyphenols may involve an alteration of the intestinal microbiota. However, this phenomenon is not well understood. Methodology/Principal Findings: Obese Zucker rats were assigned to three groups (peach, plum, and control, n = 10 each), wild-type group was named lean (n = 10). Carbohydrates in the fruit juices were eliminated using enzymatic hydrolysis. Fecal samples were obtained after 11 weeks of fruit or control juice administration. Real-time PCR and 454-pyrosequencing were used to evaluate changes in fecal microbiota. Over 1,500 different Operational Taxonomic Units at 97% similarity were detected in all rats. Several bacterial groups (e. g. Lactobacillus and members of Ruminococcacea) were found to be more abundant in the peach but especially in the plum group (plum juice contained 3 times more total polyphenolics compared to peach juice). Principal coordinate analysis based on Unifrac-based unweighted distance matrices revealed a distinct separation between the microbiota of control and treatment groups. These changes in fecal microbiota occurred simultaneously with differences in fecal short-chain acids concentrations between the control and treatment groups as well as a significant decrease in body weight in the plum group. Conclusions: This study suggests that consumption of carbohydrate-free peach and plum juice has the potential to modify fecal microbial ecology in an obese animal model. The separate contribution of polyphenols and non-polyphenols compounds (vitamins and minerals) to the observed changes is unknown.	[Noratto, Giuliana D.; Martino, Hercia S.; Mertens-Talcott, Susanne U.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Garcia-Mazcorro, Jose F.] Univ Autonoma Nuevo Leon, Fac Med Vet & Zootecnia, Nuevo Leon, Mexico; [Markel, Melissa; Minamoto, Yasushi; Steiner, Joerg M.; Suchodolski, Jan S.] Texas A&M Univ, Gastrointestinal Lab, College Stn, TX USA; [Byrne, David] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Mertens-Talcott, Susanne U.] Texas A&M Univ, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Universidad Autonoma de Nuevo Leon; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mertens-Talcott, SU (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.	SMTalcott@tamu.edu	Noratto, Giuliana/AAS-8959-2020; Byrne, David/AAF-6262-2021; Garcia-Mazcorro, Jose F./O-5799-2018	Garcia-Mazcorro, Jose F./0000-0001-6047-4361; Stampini Duarte Martino, Hercia/0000-0002-8565-8439; Noratto, Giuliana/0000-0003-1831-7172; Suchodolski, Jan/0000-0002-2176-6932; Mertens-Talcott, Susanne/0000-0003-2828-4044	Vegetable and Fruit Improvement Center at Texas AM University; National Counsel of Technological and Scientific Development (CNPq-Brazil) [200382/2011-0]; CONACYT (Mexico) through the National System of Researchers program	Vegetable and Fruit Improvement Center at Texas AM University; National Counsel of Technological and Scientific Development (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONACYT (Mexico) through the National System of Researchers program	This research was supported by the Vegetable and Fruit Improvement Center (http://vfic.tamu.edu/) at Texas A&M University. Hercia S. Martino thanks the National Counsel of Technological and Scientific Development (CNPq-Brazil) for the scholarship (reference number: 200382/2011-0). Jose F Garcia-Mazcorro is financially supported by CONACYT (Mexico) through the National System of Researchers (SNI, for initials in Spanish) program (http://www.conacyt.mx/index.php/el-conacyt/sistema-nacional-de-investigadores). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 1998, J APPL MICROBIOL, V84, P439, DOI 10.1046/j.1365-2672.1998.00363.x; Albrecht M, 2004, J MED FOOD, V7, P274, DOI 10.1089/1096620041938704; Bialonska D, 2010, INT J FOOD MICROBIOL, V140, P175, DOI 10.1016/j.ijfoodmicro.2010.03.038; Bolca S, 2013, CURR OPIN BIOTECH, V24, P220, DOI 10.1016/j.copbio.2012.09.009; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiva-Blanch G, 2012, J BERRY RES, V2, P63, DOI 10.3233/JBR-2012-028; Coccia A, 2012, INT J FOOD SCI TECH, V47, P1620, DOI 10.1111/j.1365-2621.2012.03012.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Cueva C, 2013, FEMS MICROBIOL ECOL, V83, P792, DOI 10.1111/1574-6941.12037; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hidalgo M, 2012, J AGR FOOD CHEM, V60, P3882, DOI 10.1021/jf3002153; Holvoet P, 2008, Verh K Acad Geneeskd Belg, V70, P193; Hunter DC, 2012, PHYTOCHEMICALS NUTRA, P225; Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Jellinger Paul S, 2007, Clin Cornerstone, V8 Suppl 7, pS30, DOI 10.1016/S1098-3597(07)80019-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Lacombe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067497; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Mertens-Talcott SU, 2008, J AGR FOOD CHEM, V56, P7796, DOI 10.1021/jf8007037; Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Muhling M, 2008, ISME J, V2, P379; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Niswender KD, 2011, POSTGRAD MED, V123, P27, DOI 10.3810/pgm.2011.07.2301; Pacheco-Palencia LA, 2008, J AGR FOOD CHEM, V56, P3593, DOI 10.1021/jf8001608; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Dorsten FA, 2010, MOL NUTR FOOD RES, V54, P897, DOI 10.1002/mnfr.200900212; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885	61	32	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101723	10.1371/journal.pone.0101723	http://dx.doi.org/10.1371/journal.pone.0101723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007331	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000339040600061
J	Zou, X; Wang, HJ; Cai, LL; Li, KL; Zhang, W; Ding, Y; Si, QJ				Zou, Xiao; Wang, Haijun; Cai, Lili; Li, Kailiang; Zhang, Wei; Ding, Yu; Si, Quanjin			Effects of Serum Lipid Smoothness on the Progression and Vulnerability of Atherosclerotic Plaques in Rabbits	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; MATRIX METALLOPROTEINASES; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; INFLAMMATION; RUPTURE; LOX-1; CELLS; RISK	Objective: We aimed to explore the effects of lipid smoothness on the progression and vulnerability of atherosclerotic plaques. Approach: 24 rabbits were divided into three groups randomly. Group 1 was given standard chow diet; group 2 was fed with cholesterol-rich diet; for group 3, subjects were planned to take cholesterol-rich diet at the first phase for 12 weeks and during the second phase, low-fat and cholesterol-rich diet was then applied alternately every three weeks till the end of the experiment. Lipid profiles, inflammatory factors, endothelium functions, pathological and histological changes were examined. Expressions of matrix metalloproteinase-9 and lectin-like oxidized LDL receptor-1 were measured by immunohistochemical staining. Results: According to data collected during the whole experiment, lipid smoothness index of group 3 was the lowest. Compared with group 2, statistics of the group 3 indicated that: the development of plaques progressed faster; the plaque area and plaque thickness (53.53[22.6]% vs 33.90[24.91]%, 800.38[98.25]mu m vs 675.00[109.67]mu m) were higher while the fibrous cap thickness (103.50[45.66]mu m vs 295.83[97.90] mm) was lower; hs-CRP (0.53[0.07] mg/dL vs 0.45[0.06] mg/dL), interleukin-18 (186.01[8.41]ng/L vs 158.08[2.37]ng/L), OX-LDL (177.15[5.93]mu g/L vs 139.57[2.35] mu g/L) and endothelin-1 (164.66[9.54] ng/L vs 131.52[4.39]ng/L) were higher while nitric-oxide (22.41[1.69]mu mol/L vs 27.23[1.36]mu mol/L) was lower; expressions of matrix metalloproteinase-9 (IOD: 37375.87[5634.52] vs 20956.57[4616.93]) and lectin-like oxidized LDL receptor-1 (IOD: 45213.04[16653.81] vs 21921.68[6142.32]) were higher. Conclusions: Lipids fluctuation could accelerate the progression and vulnerability of atherosclerotic plaques through worsening arterial endothelium dysfunction and inflammatory reactions.	[Zou, Xiao; Wang, Haijun; Li, Kailiang; Zhang, Wei; Ding, Yu; Si, Quanjin] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol 1, Beijing, Peoples R China; [Cai, Lili] Chinese Peoples Liberat Army Gen Hosp, Clin Lab Nanlou, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Si, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol 1, Beijing, Peoples R China.	quanjin2004@sohu.com						Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Calabro P, 2009, SEMIN IMMUNOPATHOL, V31, P79, DOI 10.1007/s00281-009-0149-4; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hayashida K, 2002, FEBS LETT, V511, P133, DOI 10.1016/S0014-5793(01)03297-5; Heo SH, 2011, J CLIN NEUROL, V7, P69, DOI 10.3988/jcn.2011.7.2.69; Itabe H, 1998, PROG LIPID RES, V37, P181, DOI 10.1016/S0163-7827(98)00009-5; Juhel C, 2000, BRIT J NUTR, V83, P549; Li D, 2010, CIRC-CARDIOVASC IMAG, V3, P464, DOI 10.1161/CIRCIMAGING.109.896654; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Li TT, 2011, TOHOKU J EXP MED, V225, P23, DOI 10.1620/tjem.225.23; Libby P, 2005, J AM COLL CARDIOL, V45, P1600, DOI 10.1016/j.jacc.2005.02.058; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Mauriello A, 2005, J AM COLL CARDIOL, V45, P1585, DOI 10.1016/j.jacc.2005.01.054; Moreno PR, 2002, CIRCULATION, V105, P923, DOI 10.1161/hc0802.104291; Nadzhafov RN, 2010, KARDIOLOGIIA, V50, P88; Ortiz AF, 1999, REV ESP CARDIOL, V52, P3; Rai S, 2009, INT J EXP PATHOL, V90, P598, DOI 10.1111/j.1365-2613.2009.00668.x; Razavian M, 2011, J NUCL MED, V52, P1795, DOI 10.2967/jnumed.111.092379; Ross JS, 2001, ANN NY ACAD SCI, V947, P271; Silva D, 2012, REV PORT CARDIOL, V31, P733, DOI 10.1016/j.repc.2012.02.018; Silvello D, 2013, BIOMARKERS; Steinberg D, 2005, MOL NUTR FOOD RES, V49, P995, DOI 10.1002/mnfr.200500081; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wilbert-Lampen U, 2007, ENDOTHELIUM-J ENDOTH, V14, P65, DOI 10.1080/10623320701346585; Wu G, 2013, CHEM PHARM BULL, V61, P121, DOI 10.1248/cpb.c12-00462; Yu MM, 2010, INT J CARDIOL, V145, P57, DOI 10.1016/j.ijcard.2009.04.018; Yu Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/506159; Zhao SH, 2008, THROMB RES, V123, P281, DOI 10.1016/j.thromres.2008.04.011	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e93686	10.1371/journal.pone.0093686	http://dx.doi.org/10.1371/journal.pone.0093686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007151	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600001
J	Patel, SA; Narayan, KMV; Ali, MK; Mehta, NK				Patel, Shivani A.; Narayan, K. M. Venkat; Ali, Mohammed K.; Mehta, Neil K.			Interstate Variation in Modifiable Risk Factors and Cardiovascular Mortality in the United States	PLOS ONE			English	Article							LEADING CAUSES; HEART-DISEASE; HEALTH; PREVALENCE; VALIDITY; DEATHS; IMPACT	Objective: We investigated the role of state-level differences in modifiable cardiovascular (CV) risk factors in contributing to state disparities in cardiovascular mortality rates in the US. Methods: Adults aged 45-74 in 2010 were examined. We constructed a CV risk index summarizing state-level exposure to current smoking, obesity, physical inactivity, alcohol abstinence, hypertension, elevated cholesterol, and diabetes using the Behavioral Risk Factor Surveillance System. Outcomes were cardiovascular, coronary heart disease, and stroke mortality. Linear regression was used to estimate associations between the CV risk index and mortality outcomes. Models accounted for state-level socioeconomic characteristics and other potential confounders. Results: Risk factors were highly correlated at the state-level (Cronbach's alpha 0.85 (men) and 0.92 (women). Each + 1SD difference in the cardiovascular risk index was associated with higher adjusted cardiovascular mortality rates by 41.0 (95% CI = 26.3, 55.7) and 33.3 (95% CI = 24.4, 42.2) deaths per 100,000 for men and women, respectively. The index accounted for 8% (men) and 11% (women) of the variation in state-level cardiovascular mortality. Comparable associations were also observed for coronary heart disease and stroke mortality. Conclusions: CV risk factors were highly correlated at the state-level and were independently associated with state CV mortality, suggesting the utility of generalized CV risk reduction.	[Patel, Shivani A.; Narayan, K. M. Venkat; Ali, Mohammed K.; Mehta, Neil K.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Patel, SA (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	s.a.patel@emory.edu	Narayan, K.M. Venkat/J-9819-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Patel, Shivani/0000-0003-0082-5857; Ali, Mohammed/0000-0001-7266-2503	Robert Wood Johnson Foundation [70769]; NATIONAL INSTITUTE ON AGING [R01AG040212] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Robert Wood Johnson Foundation (http://www.rwjf.org; grant #: 70769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; Byers T, 1998, PREV MED, V27, P311, DOI 10.1006/pmed.1998.0303; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Ford ES, 2005, OBES RES, V13, P118, DOI 10.1038/oby.2005.15; Hahn R A, 1998, MMWR CDC Surveill Summ, V47, P35; Howard G, 2009, PREV MED, V49, P129, DOI 10.1016/j.ypmed.2009.03.004; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Li CY, 2012, PREV MED, V54, P381, DOI 10.1016/j.ypmed.2012.04.003; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Yoon PW, 2014, MMWR-MORBID MORTAL W, V63, P369; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	21	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101531	10.1371/journal.pone.0101531	http://dx.doi.org/10.1371/journal.pone.0101531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL6KZ	25003975	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700036
J	Penn, LA; Qian, M; Zhang, EH; Ng, E; Shao, YZ; Berwick, M; Lazovich, D; Polsky, D				Penn, Lauren A.; Qian, Meng; Zhang, Enhan; Ng, Elise; Shao, Yongzhao; Berwick, Marianne; Lazovich, DeAnn; Polsky, David			Development of a Melanoma Risk Prediction Model Incorporating MC1R Genotype and Indoor Tanning Exposure: Impact of Mole Phenotype on Model Performance	PLOS ONE			English	Article							DIVERGENT PATHWAY HYPOTHESIS; GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; BREAST-CANCER RISK; CUTANEOUS MELANOMA; IDENTIFYING INDIVIDUALS; MELANOCYTIC NEVI; PROSTATE-CANCER; FAMILY-HISTORY; SUN EXPOSURE	Background: Identifying individuals at increased risk for melanoma could potentially improve public health through targeted surveillance and early detection. Studies have separately demonstrated significant associations between melanoma risk, melanocortin receptor (MC1R) polymorphisms, and indoor ultraviolet light (UV) exposure. Existing melanoma risk prediction models do not include these factors; therefore, we investigated their potential to improve the performance of a risk model. Methods: Using 875 melanoma cases and 765 controls from the population-based Minnesota Skin Health Study we compared the predictive ability of a clinical melanoma risk model (Model A) to an enhanced model (Model F) using receiver operating characteristic (ROC) curves. Model A used self-reported conventional risk factors including mole phenotype categorized as "none'', "few'', "some'' or "many'' moles. Model F added MC1R genotype and measures of indoor and outdoor UV exposure to Model A. We also assessed the predictive ability of these models in subgroups stratified by mole phenotype (e.g. nevus-resistant ("none'' and "few'' moles) and nevus-prone ("some'' and "many'' moles)). Results: Model A (the reference model) yielded an area under the ROC curve (AUC) of 0.72 (95% CI = 0.69, 0.74). Model F was improved with an AUC = 0.74 (95% CI = 0.71-0.76, p<0.01). We also observed substantial variations in the AUCs of Models A & F when examined in the nevus-prone and nevus-resistant subgroups. Conclusions: These results demonstrate that adding genotypic information and environmental exposure data can increase the predictive ability of a clinical melanoma risk model, especially among nevus-prone individuals.	[Penn, Lauren A.; Ng, Elise; Polsky, David] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10012 USA; [Qian, Meng; Zhang, Enhan; Shao, Yongzhao] NYU, Sch Med, Dept Populat Hlth & Environm Med, New York, NY USA; [Berwick, Marianne] Univ New Mexico, Ctr Canc, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Lazovich, DeAnn] Univ Minnesota, Sch Publ Hlth, Masonic Med Ctr, Div Epidemiol & Community Hlth, Minneapolis, MN USA	New York University; New York University; University of New Mexico; University of Minnesota System; University of Minnesota Twin Cities	Polsky, D (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10012 USA.	David.Polsky@nyumc.org	Polsky, David/AAO-6254-2020	Polsky, David/0000-0001-9554-5289; Berwick, Marianne/0000-0001-5062-2180	Live4Life foundation; Marc Jacobs Campaign; American Cancer Society [RSGPB-04-083-01-CCE]; National Cancer Institute [5R01CA106807]; NATIONAL CANCER INSTITUTE [R01CA106807, P30CA016087] Funding Source: NIH RePORTER	Live4Life foundation; Marc Jacobs Campaign; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following sources of funding: 1. Live4Life foundation; 2. Marc Jacobs Campaign to Support Melanoma Research; 3. American Cancer Society (RSGPB-04-083-01-CCE); and 4. The National Cancer Institute (5R01CA106807). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boniol M, 2012, CUTANEOUS MELANOMA A, V345, pe8503; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Chatterjee N, 2011, CANCER EPIDEM BIOMAR, V20, P3, DOI 10.1158/1055-9965.EPI-10-1022; Cho E, 2005, J CLIN ONCOL, V23, P2669, DOI 10.1200/JCO.2005.11.108; Cust AE, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-406; Elfakir A, 2010, J INVEST DERMATOL, V130, P1107, DOI 10.1038/jid.2009.366; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085642; Fargnoli MC, 2010, EUR J CANCER, V46, P1413, DOI 10.1016/j.ejca.2010.01.027; Fears TR, 2006, J CLIN ONCOL, V24, P3590, DOI 10.1200/JCO.2005.04.1277; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Fortes C, 2010, EUR J CANCER PREV, V19, P393, DOI 10.1097/CEJ.0b013e32833b492f; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Gimotty PA, 2007, J CLIN ONCOL, V25, P1129, DOI 10.1200/JCO.2006.08.1463; Guy GP, 2013, JAMA INTERN MED, V173, P1920, DOI 10.1001/jamainternmed.2013.10013; Hill VK, 2013, ANNU REV GENOM HUM G, V14, P257, DOI 10.1146/annurev-genom-091212-153429; Ibarrola-Villava M, 2012, EUR J CANC; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Katalinic A, 2012, CANCER; Kricker A, 2005, CANCER EPIDEM BIOMAR, V14, P2427, DOI 10.1158/1055-9965.EPI-05-0265; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P437, DOI 10.1158/1055-9965.EPI-11-1038; MacInnis RJ, 2011, GENET EPIDEMIOL, V35, P549, DOI 10.1002/gepi.20605; Mar V, 2011, AUSTRALAS J DERMATOL, V52, P109, DOI 10.1111/j.1440-0960.2010.00727.x; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Newton-Bishop JA, 2010, CANCER EPIDEM BIOMAR, V19, P2043, DOI 10.1158/1055-9965.EPI-10-0233; Olsen CM, 2009, INT J CANCER, V124, P937, DOI 10.1002/ijc.24011; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Ranucci M, 2010, EUR J CARDIO-THORAC, V37, P724, DOI 10.1016/j.ejcts.2009.08.033; Ries L MD, 2008, SEER CANC STAT REV 1; Sestini P, 2011, NEW ENGL J MED, V365, P2037, DOI 10.1056/NEJMc1110293; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; Stefanaki I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055712; Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439; Udayakumar D, 2009, GENOME MED, V1, DOI 10.1186/gm95; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Whiteman DC, 2010, EXPERT REV ANTICANC, V10, P615, DOI 10.1586/ERA.10.42; Whiteman DC, 2005, CANCER EPIDEM BIOMAR, V14, P761, DOI 10.1158/1055-9965.EPI-14-4-ED; Whiteman DC, 2005, J AM ACAD DERMATOL, V52, P40, DOI 10.1016/j.jaad.2004.07.053; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Wong SS, 2012, J INVEST DERMATOL, V132, P1452, DOI 10.1038/jid.2011.473	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101507	10.1371/journal.pone.0101507	http://dx.doi.org/10.1371/journal.pone.0101507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003831	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700035
J	Parker, BL; Shepherd, NE; Trefely, S; Hoffman, NJ; White, MY; Engholm-Keller, K; Hambly, BD; Larsen, MR; James, DE; Cordwell, SJ				Parker, Benjamin L.; Shepherd, Nicholas E.; Trefely, Sophie; Hoffman, Nolan J.; White, Melanie Y.; Engholm-Keller, Kasper; Hambly, Brett D.; Larsen, Martin R.; James, David E.; Cordwell, Stuart J.			Structural Basis for Phosphorylation and Lysine Acetylation Cross-talk in a Kinase Motif Associated with Myocardial Ischemia and Cardioprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; PERMEABILITY TRANSITION; GCN5-MEDIATED ACETYLATION; ARGININE METHYLATION; HISTONE H3; SIRT1; IDENTIFICATION; REPERFUSION; GLUCOSE	Myocardial ischemia and cardioprotection by ischemic preconditioning induce signal networks aimed at survival or cell death if the ischemic period is prolonged. These pathways are mediated by protein post-translational modifications that are hypothesized to cross-talk with and regulate each other. Phosphopeptides and lysine-acetylated peptides were quantified in isolated rat hearts subjected to ischemia or ischemic pre-conditioning, with and without splitomicin inhibition of lysine deacetylation. We show lysine acetylation (acetyl-Lys)-dependent activation of AMP-activated protein kinase, AKT, andPKA kinases during ischemia. Phosphorylation and acetyl-Lys sites mapped onto tertiary structures were proximal in >50% of proteins investigated, yet they were mutually exclusive in 50 ischemic pre-conditioning-and/or ischemia-associated peptides containing the KXXS basophilic protein kinase consensus motif. Modifications in this motif were modeled in the C terminus of muscle-type creatine kinase. Acetyl-Lys increased proximal dephosphorylation by 10-fold. Structural analysis of modified muscle-type creatine kinase peptide variants by two-dimensional NMR revealed stabilization via a lysine-phosphate salt bridge, which was disrupted by acetyl-Lys resulting in backbone flexibility and increased phosphatase accessibility.	[Parker, Benjamin L.; Hambly, Brett D.; Cordwell, Stuart J.] Univ Sydney, Sch Med Sci, Discipline Pathol, Sydney, NSW 2006, Australia; [Parker, Benjamin L.; Trefely, Sophie; Hoffman, Nolan J.; James, David E.] Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Parker, Benjamin L.; Hoffman, Nolan J.; James, David E.] Garvan Inst Med Res, Biol Mass Spectrometry Unit, Darlinghurst, NSW 2010, Australia; [Shepherd, Nicholas E.; White, Melanie Y.; Cordwell, Stuart J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [White, Melanie Y.; Engholm-Keller, Kasper; Hambly, Brett D.; James, David E.; Cordwell, Stuart J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Sydney; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of Sydney; University of Sydney; University of Southern Denmark	Cordwell, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Hub Bldg D17, Sydney, NSW 2006, Australia.	stuart.cordwell@sydney.edu.au	Trefely, Sophie/AAL-9434-2020; Shepherd, Nicholas/H-6781-2016; Hambly, Brett D/B-1965-2009; Engholm-Keller, Kasper/B-7623-2018; Larsen, Martin Rossel/F-1411-2015	Shepherd, Nicholas/0000-0001-6234-4456; Hambly, Brett D/0000-0002-5988-562X; Engholm-Keller, Kasper/0000-0001-5988-2632; Larsen, Martin Rossel/0000-0001-6203-0123; Cordwell, Stuart/0000-0002-0995-0171; Hoffman, Nolan/0000-0001-5168-7082; White, Melanie/0000-0003-2571-2816; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia [571002]; Lundbeck Foundation Junior Group Leader Fellowship; LTQ-Orbitrap Velos; Danish Natural Science Research Council [09-06-5989]; University of Sydney Medical Alumni; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lundbeck Foundation Junior Group Leader Fellowship; LTQ-Orbitrap Velos; Danish Natural Science Research Council(Danish Natural Science Research Council); University of Sydney Medical Alumni; Australian Research Council(Australian Research Council)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 571002 (to S. J. C. and B. D. H.), the Lundbeck Foundation Junior Group Leader Fellowship and LTQ-Orbitrap Velos (to M. R. L.), and the Danish Natural Science Research Council Grant 09-06-5989 (to M. R. L.).; Supported by a postgraduate award from the University of Sydney Medical Alumni.; Recipients of Australian Research Council Discovery Early Career Researcher Awards.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Barnett ME, 2007, CELL SIGNAL, V19, P1820, DOI 10.1016/j.cellsig.2007.05.014; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carr SM, 2011, EMBO J, V30, P317, DOI 10.1038/emboj.2010.311; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Diviani D, 2011, AM J PHYSIOL-HEART C, V301, pH1742, DOI 10.1152/ajpheart.00569.2011; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; Engholm-Keller K, 2012, J PROTEOMICS, V75, P5749, DOI 10.1016/j.jprot.2012.08.007; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Ho PC, 2008, CELL SIGNAL, V20, P1911, DOI 10.1016/j.cellsig.2008.07.001; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; KARMAZYN M, 1993, CARDIOVASC RES, V27, P2079, DOI 10.1093/cvr/27.11.2079a; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KIRCHBERGER MA, 1972, J MOL CELL CARDIOL, V4, P673, DOI 10.1016/0022-2828(72)90120-4; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kubota K, 2009, NAT BIOTECHNOL, V27, P933, DOI 10.1038/nbt.1566; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Liu B, 1996, CIRC RES, V79, P940, DOI 10.1161/01.RES.79.5.940; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lynn EG, 2008, FEBS LETT, V582, P2857, DOI 10.1016/j.febslet.2008.07.016; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MARTIN DB, 1962, J BIOL CHEM, V237, P1787; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OLIVER MF, 1994, LANCET, V343, P155, DOI 10.1016/S0140-6736(94)90939-3; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; Rigbolt KTG, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.007450; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SODIPALLARES D, 1962, AM J CARDIOL, V9, P166, DOI 10.1016/0002-9149(62)90035-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Yu YH, 2009, P NATL ACAD SCI USA, V106, P11606, DOI 10.1073/pnas.0905165106; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	104	37	37	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25890	25906		10.1074/jbc.M114.556035	http://dx.doi.org/10.1074/jbc.M114.556035			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25008320	hybrid, Green Published			2022-12-25	WOS:000342130800045
J	Golubkov, VS; Prigozhina, NL; Zhang, Y; Stoletov, K; Lewis, JD; Schwartz, PE; Hoffman, RM; Strongin, AY				Golubkov, Vladislav S.; Prigozhina, Natalie L.; Zhang, Yong; Stoletov, Konstantin; Lewis, John D.; Schwartz, Phillip E.; Hoffman, Robert M.; Strongin, Alex Y.			Protein-tyrosine Pseudokinase 7 (PTK7) Directs Cancer Cell Motility and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Polarity; Matrix Metalloproteinase (MMP); Metastasis; Migration; Protein Kinase	TYPE-1 MATRIX-METALLOPROTEINASE; OFF-TRACK; EXTRACELLULAR-MATRIX; KINASE FAMILY; LEADING-EDGE; LUNG-CANCER; MEMBRANE; RECEPTOR; POLARITY; MT1-MMP	Background: In embryonic development, PTK7 regulates orientation of cells in a tissue plane. Results: PTK7 controls cellular protrusions and, as a result, directional cell motility and metastasis in fibrosarcoma HT1080 cells. Conclusion: Both PTK7 expression and proteolysis contribute to efficient cell motility and metastasis. Significance: PTK7 is a potential diagnostic biomarker with predictive value and a promising drug target in cancer. It is well established that widely expressed PTK7 is essential for vertebrate tissue morphogenesis. In cancer, the functionality of PTK7 is selectively regulated by membrane type-1 matrix metalloproteinase (MT1-MMP), ADAMs (a disintegrin domain and metalloproteinases), and -secretase proteolysis. Here, we established that the full-length membrane PTK7, its Chuzhoi mutant with the two functional MT1-MMP cleavage sites, and its L622D mutant with the single inactivated MT1-MMP cleavage site differentially regulate cell motility in a two-dimensional versus three-dimensional environment. We also demonstrated that in polarized cancer cells, the levels of PTK7 expression and proteolysis were directly linked to the structure and kinetics of cell protrusions, including lamellipodia and invadopodia. In the functionally relevant and widely accepted animal models of metastasis, mouse and chick embryo models, both the overexpression and knock-out of PTK7 in HT1080 cells abrogated metastatic dissemination. Our analysis of human tissue specimens confirmed intensive proteolysis of PTK7 in colorectal cancer tumors, but not in matching normal tissue. Our results provide convincing evidence that both PTK7 expression and proteolysis, rather than the level of the cellular full-length PTK7 alone, contribute to efficient directional cell motility and metastasis in cancer.	[Golubkov, Vladislav S.; Prigozhina, Natalie L.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Stoletov, Konstantin; Lewis, John D.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2E1, Canada; [Schwartz, Phillip E.] Prot Biotechnol Inc, Ramona, CA 92065 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Sanford Burnham Prebys Medical Discovery Institute; Anti Cancer Inc; University of Alberta; University of California System; University of California San Diego	Golubkov, VS (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	vgolubkov@sanfordburnham.org; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; Stoletov, Konstantin/0000-0002-7384-2917	National Institutes of Health Grants [R01CA83017, R01CA157328, R01DE022757, R03DA033979]; Alberta Innovates [201201250] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033979] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Innovates; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA83017, R01CA157328, and R01DE022757 (to A. Y. S.) and R03DA033979 (to V. S. G.).	Andreeva A., 2014, DEV CELL; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baudrier-Regnier A, 2000, CANCER GENET CYTOGEN, V119, P80, DOI 10.1016/S0165-4608(99)00215-0; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Fazilaty H, 2014, CLIN EXP METASTAS, V31, P595, DOI 10.1007/s10585-014-9642-9; Gartner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084472; Golubkov VS, 2012, J BIOL CHEM, V287, P42009, DOI 10.1074/jbc.M112.371153; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kim JH, 2014, ONCOL REP, V31, P2708, DOI 10.3892/or.2014.3164; Kimura H, 2010, J CELL BIOCHEM, V109, P58, DOI 10.1002/jcb.22379; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lhoumeau AC, 2011, CELL CYCLE, V10, P1233, DOI 10.4161/cc.10.8.15368; Liu YS, 2014, MOL CELL PROTEOMICS, V13, P1753, DOI 10.1074/mcp.M114.038273; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martin KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4119; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Munoz-Soriano V, 2012, CURR GENOMICS, V13, P609, DOI 10.2174/138920212803759721; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Piao Z, 2001, GENE CHROMOSOME CANC, V30, P113, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1069>3.3.CO;2-Y; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Shin WS, 2013, CANCER SCI, V104, P1120, DOI 10.1111/cas.12194; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Su YA, 2010, J CANCER, V1, P38; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	59	43	44	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24238	24249		10.1074/jbc.M114.574459	http://dx.doi.org/10.1074/jbc.M114.574459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006253	hybrid, Green Published			2022-12-25	WOS:000341505600021
J	Vajjhala, PR; Kaiser, S; Smith, SJ; Ong, QR; Soh, SL; Stacey, KJ; Hill, JM				Vajjhala, Parimala R.; Kaiser, Sebastian; Smith, Sarah J.; Ong, Qi-Rui; Soh, Stephanie L.; Stacey, Katryn J.; Hill, Justine M.			Identification of Multifaceted Binding Modes for Pyrin and ASC Pyrin Domains Gives Insights into Pyrin Inflammasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Death Domain; Inflammation; Innate Immunity; Mutagenesis; Pattern Recognition Receptor (PRR); Protein Complex; Protein-Protein Interaction; Familial Mediterranean Fever; Inflammasome; Pyrin	FAMILIAL MEDITERRANEAN FEVER; CIRCULAR-DICHROISM; AUTOINFLAMMATORY DISORDER; CRYSTAL-STRUCTURE; PROTEIN DOMAIN; APOPTOSIS; NMR; MUTATIONS; DISEASES; COMPLEX	Background: Pyrin, ASC, and procaspase-1 associate to form an inflammasome that mediates inflammatory responses. Results: Multiple binding sites on the pyrin domains of ASC and pyrin mediate their interaction. Conclusion: Interaction between pyrin and ASC via multiple sites drives ASC clustering to form an inflammasome. Significance: These findings provide insight into the interaction modes of pyrin domains and inflammasome assembly. Inflammasomes are macromolecular complexes that mediate inflammatory and cell death responses to pathogens and cellular stress signals. Dysregulated inflammasome activation is associated with autoinflammatory syndromes and several common diseases. During inflammasome assembly, oligomerized cytosolic pattern recognition receptors recruit procaspase-1 and procaspase-8 via the adaptor protein ASC. Inflammasome assembly is mediated by pyrin domains (PYDs) and caspase recruitment domains, which are protein interaction domains of the death fold superfamily. However, the molecular details of their interactions are poorly understood. We have studied the interaction between ASC and pyrin PYDs that mediates ASC recruitment to the pyrin inflammasome, which is implicated in the pathogenesis of familial Mediterranean fever. We demonstrate that both the ASC and pyrin PYDs have multifaceted binding modes, involving three sites on pyrin PYD and two sites on ASC PYD. Molecular docking of pyrin-ASC PYD complexes showed that pyrin PYD can simultaneously interact with up to three ASC PYDs. Furthermore, ASC PYD can self-associate and interact with pyrin, consistent with previous reports that pyrin promotes ASC clustering to form a proinflammatory complex. Finally, the effects of familial Mediterranean fever-associated mutations, R42W and A89T, on structural and functional properties of pyrin PYD were investigated. The R42W mutation had a significant effect on structure and increased stability. Although the R42W mutant exhibited reduced interaction with ASC, it also bound less to the pyrin B-box domain responsible for autoinhibition and hence may be constitutively active. Our data give new insights into the binding modes of PYDs and inflammasome architecture.	[Vajjhala, Parimala R.; Kaiser, Sebastian; Smith, Sarah J.; Ong, Qi-Rui; Soh, Stephanie L.; Stacey, Katryn J.; Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Vajjhala, PR (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	p.vajjhala@uq.edu.au	Hill, Justine M/C-5781-2009	Stacey, Katryn/0000-0002-3992-7802	Australian National Health and Medical Research Council [511227]; R. D. Wright Biomedical Career Development Award [401748]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); R. D. Wright Biomedical Career Development Award	This work was supported by the Australian National Health and Medical Research Council through Project Grant 511227 and R. D. Wright Biomedical Career Development Award 401748 (to J. M. H.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 1997, CELL, V90, P797; ARNOLD GE, 1992, BIOCHEMISTRY-US, V31, P7948, DOI 10.1021/bi00149a028; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Ben-Chetrit E, 2009, ARTHRIT CARE RES, V61, P1447, DOI 10.1002/art.24458; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; de Jesus AA, 2013, CLIN IMMUNOL, V147, P155, DOI 10.1016/j.clim.2013.03.016; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Eliezer D, 2003, STRUCTURE, V11, P1190, DOI 10.1016/j.str.2003.09.008; Federici S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00351; French FMF Consortium, 1997, NAT GENET, V17, P25; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hesker PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051105; Hill Justine A., 2008, V426, P437, DOI 10.1007/978-1-60327-058-8_29; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Masters SL, 2013, CLIN IMMUNOL, V147, P223, DOI 10.1016/j.clim.2012.12.006; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schmid F. X., 1997, PROTEIN STRUCTURE PR, P293; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Su MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067843; Tidow N, 2000, BLOOD, V95, P1451, DOI 10.1182/blood.V95.4.1451.004k52_1451_1455; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2013, J BIOL CHEM, V288, P11378, DOI 10.1074/jbc.M112.448795; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	69	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23504	23519		10.1074/jbc.M114.553305	http://dx.doi.org/10.1074/jbc.M114.553305			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006247	Green Published, hybrid			2022-12-25	WOS:000341505000022
J	Takagi, M; Nishiyama, Y; Taguchi, A; Imamoto, N				Takagi, Masatoshi; Nishiyama, Yuko; Taguchi, Atsuko; Imamoto, Naoko			Ki67 Antigen Contributes to the Timely Accumulation of Protein Phosphatase 1 gamma on Anaphase Chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD-ASSOCIATED DOMAIN; POSITIVE BREAST-CANCER; KI-67 ANTIGEN; CELL-PROLIFERATION; MITOTIC EXIT; ANTIBODY KI-67; CYCLE; CHROMATIN; MITOSIS; AURORA	Ki67 is a protein widely used as cell-proliferation marker, with its cellular functions being hardly unveiled. In this paper, we present the direct interaction between Ki67 and PP1 gamma, a protein phosphatase showing characteristic accumulation on anaphase chromosomes via the canonical PP1-binding motif within Ki67. In cells depleted of Ki67, PP1 gamma is targeted to anaphase chromosomes less efficiently. Additionally, overexpression of Ki67, but not a mutant form without the ability to bind PP1 gamma, induced ectopic localization of PP1 gamma on metaphase chromosomes. These observations demonstrate that Ki67 is one factor that defines the cellular behavior of PP1 gamma in anaphase. To explore the specific roles of the subset of PP1 gamma recruited on chromosome via its interaction with Ki67 (PP1 gamma-Ki67), endogenous Ki67 was replaced with a Ki67 mutant deficient in its ability to interact with PP1 gamma. Although no obvious defects in the progression of mitosis were observed, the timing of dephosphorylation of the mutant Ki67 in anaphase was delayed, indicating that Ki67 itself is one of the substrates of PP1 gamma -Ki67.	[Takagi, Masatoshi; Nishiyama, Yuko; Taguchi, Atsuko; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	RIKEN	Takagi, M (corresponding author), RIKEN, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mtakagi@riken.jp; nimamoto@riken.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science KAKENHI [24657124]; RIKEN Incentive Research Fund	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Incentive Research Fund	This work was supported by RIKEN Special Project Funding for Basic Science in Cellular System Project Research (to N.I.), and Japan Society for the Promotion of Science KAKENHI Grant Number 24657124 and RIKEN Incentive Research Fund (to M.T.).	Ali HR, 2012, BRIT J CANCER, V106, P1798, DOI 10.1038/bjc.2012.167; Ali HR, 2012, J PATHOL, V226, P97, DOI 10.1002/path.2976; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bridger JM, 1998, CHROMOSOME RES, V6, P13, DOI 10.1023/A:1009210206855; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Chamousset D, 2010, MOL BIOL CELL, V21, P4212, DOI 10.1091/mbc.E10-04-0287; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; GAUTIER T, 1992, CHROMOSOMA, V101, P502, DOI 10.1007/BF00352473; Gerdes J, 1990, Semin Cancer Biol, V1, P199; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Gunawardena SR, 2008, J BIOL CHEM, V283, P398, DOI 10.1074/jbc.M706708200; HERNANDEZVERDUN D, 1994, BIOESSAYS, V16, P179, DOI 10.1002/bies.950160308; Kametaka A, 2002, GENES CELLS, V7, P1231, DOI 10.1046/j.1365-2443.2002.00596.x; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kill IR, 1996, J CELL SCI, V109, P1253; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; MacCallum DE, 2000, J PATHOL, V190, P537; MacCallum DE, 1999, EXP CELL RES, V252, P186, DOI 10.1006/excr.1999.4600; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Saiwaki T, 2005, EXP CELL RES, V308, P123, DOI 10.1016/j.yexcr.2005.04.010; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Starborg M, 1996, J CELL SCI, V109, P143; Sueishi M, 2000, J BIOL CHEM, V275, P28888, DOI 10.1074/jbc.M003879200; Takagi M, 1999, J CELL SCI, V112, P2463; Takagi M, 2001, J BIOL CHEM, V276, P25386, DOI 10.1074/jbc.M102227200; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2012, NUCLEUS-AUSTIN, V3, P138, DOI 10.4161/nucl.19267; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	41	29	31	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22877	22887		10.1074/jbc.M114.556647	http://dx.doi.org/10.1074/jbc.M114.556647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25012651	hybrid, Green Published			2022-12-25	WOS:000341017200029
J	Avsaroglu, B; Bronk, G; Gordon-Messer, S; Ham, J; Bressan, DA; Haber, JE; Kondev, J				Avsaroglu, Baris; Bronk, Gabriel; Gordon-Messer, Susannah; Ham, Jungoh; Bressan, Debra A.; Haber, James E.; Kondev, Jane			Effect of Chromosome Tethering on Nuclear Organization in Yeast	PLOS ONE			English	Article							GENOME ORGANIZATION; CHROMATIN FIBER; GENE-EXPRESSION; DYNAMICS; REVEALS; DNA; TERRITORIES; FLEXIBILITY; PRINCIPLES; PERIPHERY	Interphase chromosomes in Saccharomyces cerevisiae are tethered to the nuclear envelope at their telomeres and to the spindle pole body (SPB) at their centromeres. Using a polymer model of yeast chromosomes that includes these interactions, we show theoretically that telomere attachment to the nuclear envelope is a major determinant of gene positioning within the nucleus only for genes within 10 kb of the telomeres. We test this prediction by measuring the distance between the SPB and the silent mating locus (HML) on chromosome III in wild-type and mutant yeast strains that contain altered chromosome-tethering interactions. In wild-type yeast cells we find that disruption of the telomere tether does not dramatically change the position of HML with respect to the SPB, in agreement with theoretical predictions. Alternatively, using a mutant strain with a synthetic tether that localizes an HML-proximal site to the nuclear envelope, we find a significant change in the SPB-HML distance, again as predicted by theory. Our study quantifies the importance of tethering at telomeres on the organization of interphase chromosomes in yeast, which has been shown to play a significant role in determining chromosome function such as gene expression and recombination.	[Avsaroglu, Baris; Bronk, Gabriel; Kondev, Jane] Brandeis Univ, Dept Phys, Waltham, MA 02254 USA; [Gordon-Messer, Susannah; Ham, Jungoh; Bressan, Debra A.; Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Gordon-Messer, Susannah; Ham, Jungoh; Bressan, Debra A.; Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Gordon-Messer, Susannah] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Brandeis University; Brandeis University; Brandeis University; Brandeis University	Avsaroglu, B (corresponding author), Brandeis Univ, Dept Phys, Waltham, MA 02254 USA.	baris@brandeis.edu			NSF grants [MRSEC 0820492, DMR-1206146]; NIH grant [GM20056]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R37GM020056] Funding Source: NIH RePORTER	NSF grants(National Science Foundation (NSF)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grants MRSEC 0820492 and DMR-1206146, and by the NIH grant GM20056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Albert B, 2013, J CELL BIOL, V202, P201, DOI 10.1083/jcb.201208186; Albert B, 2012, BBA-GENE REGUL MECH, V1819, P468, DOI 10.1016/j.bbagrm.2011.12.010; Alberts B, 2002, MOL BIOL CELL; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bassett A, 2009, CURR OPIN GENET DEV, V19, P159, DOI 10.1016/j.gde.2009.02.010; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Belmont AS, 1989, CHROMOSOMA; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Brickner Jason H, 2004, PLoS Biol, V2, pe342; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Bystricky K, 2009, MOL CELL BIOL, V29, P835, DOI 10.1128/MCB.01009-08; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cockell MM, 1999, CURR BIOL, V9, pR575, DOI 10.1016/S0960-9822(99)80359-5; Cremer T, 2006, EUR J HISTOCHEM, V50, P161; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Gehlen LR, 2006, J PHYS-CONDENS MAT, V18, pS245, DOI 10.1088/0953-8984/18/14/S09; GEHLEN LR, 2012, DO NOT DISTRIBUTE, V3, P370; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hajjoul H, 2013, GENOME RES, V23, P1829, DOI 10.1101/gr.157008.113; Hoze N, 2013, MOL BIOL CELL, V24, P1791, DOI 10.1091/mbc.E13-01-0031; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Marvin ME, 2009, GENETICS, V183, P453, DOI 10.1534/genetics.109.106682; Marvin ME, 2009, GENETICS, V183, P441, DOI 10.1534/genetics.109.106674; Marvin ME, 2009, GENETICS, V183, p1SI; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; PETERLIN A, 1953, NATURE, V171, P259, DOI 10.1038/171259b0; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Rabl C, 1885, MORPHOL JB, V10, P214; Rippe K, 2012, GENOME ORGANIZATION AND FUNCTION IN THE CELL NUCLEUS, P1; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Tjong H, 2012, GENOME RES, V22, P1295, DOI 10.1101/gr.129437.111; Tokuda N, 2012, BIOPHYS J, V102, P296, DOI 10.1016/j.bpj.2011.12.005; UCHIDA M, 2011, QUANTITATIVE ANAL YE, V28, P227; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Wong H, 2012, CURR BIOL, V22, P1881, DOI 10.1016/j.cub.2012.07.069; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zimmer C, 2011, J CELL BIOL, V192, P723, DOI 10.1083/jcb.201010058; Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686	84	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102474	10.1371/journal.pone.0102474	http://dx.doi.org/10.1371/journal.pone.0102474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020108	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600084
J	Cui, YY; Xu, H; Wu, HH; Qi, J; Shi, J; Li, YQ				Cui, Yuan-Yuan; Xu, Hao; Wu, Huang-Hui; Qi, Jian; Shi, Juan; Li, Yun-Qing			Spatio-Temporal Expression and Functional Involvement of Transient Receptor Potential Vanilloid 1 in Diabetic Mechanical Allodynia in Rats	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; IMMUNOHISTOCHEMICALLY IDENTIFIED NEURONS; PRIMARY SENSORY NEURONS; SPINAL NERVE LIGATION; CAPSAICIN RECEPTOR; INFLAMMATORY PAIN; THERMAL HYPERALGESIA; NEUROPATHIC PAIN; DRG NEURONS; TRPV1	Diabetic neuropathic pain (DNP) is one of the most common clinical manifestations of diabetes mellitus (DM), which is characterized by prominent mechanical allodynia (DMA). However, the molecular mechanism underlying it has not fully been elucidated. In this study, we examined the spatio-temporal expression of a major nociceptive channel protein transient receptor potential vanilloid 1 (TRPV1) and analyzed its functional involvement by intrathecal (i.t.) application of TRPV1 antagonists in streptozocin (STZ)-induced DMA rat models. Western blot and immunofluorescent staining results showed that TRPV1 protein level was significantly increased in the soma of the dorsal root ganglion (DRG) neurons on 14 days after STZ treatment (DMA 14 d), whereas those in spinal cord and skin (mainly from the central and peripheral processes of DRG neurons) had already been enhanced on DMA 7 d to peak on DMA 14 d. qRT-PCR experiments confirmed that TRPV1 mRNA level was significantly up-regulated in the DRG on DMA 7 d, indicating a preceding translation of TRPV1 protein in the soma but preferential distribution of this protein to the processes under the DMA conditions. Cell counting assay based on double immunostaining suggested that increased TRPV1-immunoreactive neurons were likely to be small-sized and CGRP-ergic. Finally, single or multiple intrathecal applications of non-specific or specific TRPV1 antagonists, ruthenium red and capsazepine, at varying doses, effectively alleviated DMA, although the effect of the former was more prominent and long-lasting. These results collectively indicate that TRPV1 expression dynamically changes during the development of DMA and this protein may play important roles in mechanical nociception in DRG neurons, presumably through facilitating the release of CGRP.	[Cui, Yuan-Yuan; Xu, Hao; Qi, Jian; Shi, Juan; Li, Yun-Qing] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Cui, Yuan-Yuan; Xu, Hao; Qi, Jian; Shi, Juan; Li, Yun-Qing] Fourth Mil Med Univ, Preclin Sch Med, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Cui, Yuan-Yuan] Xian Med Univ, Inst Basic Med Sci, Xian, Peoples R China; [Cui, Yuan-Yuan] Xian Med Univ, Lab Cell Biol & Translat Med, Xian, Peoples R China; [Wu, Huang-Hui] Fujian Med Univ, Fuzhou Gen Hosp, Dept Anesthesiol, Fuzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University; Xi'an Medical University; Fujian Medical University	Shi, J (corresponding author), Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China.	shixjuan@fmmu.edu.cn; deptanat@fmmu.edu.cn			National Natural Science Foundation of China [30971123, 31010103909, 31071012, 81371239]; Shaanxi Provincial Education Department [2013JK0757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Education Department	National Natural Science Foundation of China (Nos. 30971123, 31010103909, 31071012, 81371239) and Scientific Research Program Funded by Shaanxi Provincial Education Department (Program No. 2013JK0757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Bennett DLH, 2001, NEUROSCIENTIST, V7, P13, DOI 10.1177/107385840100700105; Bishnoi M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-52; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ciura S, 2006, J NEUROSCI, V26, P9069, DOI 10.1523/JNEUROSCI.0877-06.2006; Daly D, 2007, J PHYSIOL-LONDON, V583, P663, DOI 10.1113/jphysiol.2007.139147; De Petrocellis Luciano, 2013, Recent Pat CNS Drug Discov, V8, P180; Engle MP, 2012, J COMP NEUROL, V520, P1663, DOI 10.1002/cne.23005; Gerke MB, 2002, ANAT RECORD, V268, P105, DOI 10.1002/ar.10144; Hammond DL, 2004, J COMP NEUROL, V475, P575, DOI 10.1002/cne.20209; Hara T, 2013, PAIN, V154, P882, DOI 10.1016/j.pain.2013.02.023; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Holzer P, 2009, DIGEST DIS, V27, P24, DOI 10.1159/000268118; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Ivanusic JJ, 2009, J COMP NEUROL, V517, P276, DOI 10.1002/cne.22160; Jakkamsetti V, 2013, NEURON, V80, P72, DOI 10.1016/j.neuron.2013.07.020; Kasama S, 2007, EUR J NEUROSCI, V25, P2956, DOI 10.1111/j.1460-9568.2007.05584.x; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Ma WY, 2005, PAIN, V113, P386, DOI 10.1016/j.pain.2004.11.018; Mandadi S, 2008, CURR NEUROPHARMACOL, V6, P21, DOI 10.2174/157015908783769680; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morioka N, 2002, J NEUROCHEM, V80, P989, DOI 10.1046/j.0022-3042.2002.00722.x; Morrow Thomas J, 2004, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0918s29; Murthy Kalyani, 2005, Endocr Pract, V11, P331; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Pabbidi RM, 2008, MOL PHARMACOL, V73, P995, DOI 10.1124/mol.107.041707; Palazzo E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-66; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Pierre MS, 2009, EXP BRAIN RES, V196, P31, DOI 10.1007/s00221-009-1808-3; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; Sekino Y, 2014, EUR J PAIN, V18, P639, DOI 10.1002/j.1532-2149.2013.00412.x; Shinoda M, 2008, J PAIN, V9, P687, DOI 10.1016/j.jpain.2008.02.007; Smart D, 2001, EUR J PHARMACOL, V417, P51, DOI 10.1016/S0014-2999(01)00901-3; Sugimoto Y, 2013, J PHARMACOL SCI, V123, P256, DOI 10.1254/jphs.13088FP; Sun W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039647; Tang ZY, 2009, J NEUROTRAUM, V26, P289, DOI 10.1089/neu.2008.0506; Tominaga M, 2000, JPN J PHARMACOL, V83, P20, DOI 10.1254/jjp.83.20; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Ugawa S, 2005, MOL BRAIN RES, V136, P125, DOI 10.1016/j.molbrainres.2005.01.010; Veves A, 2008, PAIN MED, V9, P660, DOI 10.1111/j.1526-4637.2007.00347.x; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Wu HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092374; Xiao LZ, 2013, PAIN MED, V14, P276, DOI 10.1111/pme.12017; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	52	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102052	10.1371/journal.pone.0102052	http://dx.doi.org/10.1371/journal.pone.0102052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020137	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600041
J	Sellami, H; Znazen, A; Sellami, A; Mnif, H; Louati, N; Ben Zarrouk, S; Keskes, L; Rebai, T; Gdoura, R; Hammami, A				Sellami, Hanen; Znazen, Abir; Sellami, Afifa; Mnif, Hela; Louati, Nour; Ben Zarrouk, Soumaya; Keskes, Leila; Rebai, Tarek; Gdoura, Radhouane; Hammami, Adnene			Molecular Detection of Chlamydia trachomatis and Other Sexually Transmitted Bacteria in Semen of Male Partners of Infertile Couples in Tunisia: The Effect on Semen Parameters and Spermatozoa Apoptosis Markers	PLOS ONE			English	Article							REAL-TIME PCR; UREAPLASMA-UREALYTICUM INFECTIONS; ASYMPTOMATIC MALE PARTNERS; POLYMERASE-CHAIN-REACTION; SPERM DNA FRAGMENTATION; EJACULATED HUMAN SPERM; MYCOPLASMA-HOMINIS; GENITAL-TRACT; MITOCHONDRIAL-FUNCTION; CHROMATIN INTEGRITY	This study was undertaken to determine the prevalence of Chlamydia trachomatis, Mycoplasmas, and Ureaplasmas in semen samples of the male partners of infertile couples and to investigate whether Chlamydia trachomatis could initiate apoptosis in human spermatozoa. A total of 85 males partners of infertile couples undergoing routine semen analysis according to World Health Organization guidelines were included. Specimens were examined for the presence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Ureaplasma parvum by Real time PCR (qPCR). Semen specimens were analysed for the appearance of apoptotic markers (sperm DNA fragmentation, activated caspase 3 levels, mitochondrial membrane potential (Delta Psi m)) using flow cytometry. C. trachomatis, N. gonorrhoeae, U. urealyticum, M genitalium were detected in semen samples of 13 (15.2%), 5 (5.8%), 5 (5.8%) and 3 (3.5%) male partners of infertile couples, respectively. M. hominis and U. parvum were detected in semen sample of only one patient (1.1%). The semen of infertile men positive for C. trachomatis showed lower mean of semen count and lower rapid progressive motility (category [a]) of spermatozoa compared to uninfected men with statistically significances (p = 0.02 and p = 0.04, respectively). Flow cytometry analyses demonstrated a significant increase of the mean rate of semen with low Delta Psi m and caspase 3 activation of infertile men positive for C. trachomatis compared to uninfected men (p = 0.006 and p = 0.001, respectively). DNA fragmentation was also increased in sperm of infertile men positive for C. trachomatis compared to uninfected men but without statistical significances (p = 0.62). Chlamydial infection was associated to loss of Delta Psi m and caspase 3activation. Thus, C. trachomatis infection could be incriminated in apoptosis induction of spermatozoa. These effects may explain the negative direct impact of C. trachomatis infection on sperm fertilizing ability.	[Sellami, Hanen; Znazen, Abir; Hammami, Adnene] Habib Bourguiba Univ Hosp Sfax, Dept Microbiol & Res Lab Microorganismes & Pathol, Sfax, Tunisia; [Sellami, Afifa; Ben Zarrouk, Soumaya; Keskes, Leila; Rebai, Tarek] Univ Sfax, Fac Med Sfax, Histol Embryol Res Unit, Sfax, Tunisia; [Mnif, Hela; Louati, Nour] Sfax Reg Ctr Blood Transfus, Sfax, Tunisia; [Gdoura, Radhouane] Univ Sfax, Sci Fac Sfax, Unit Res Toxicol Microbiol Environm & Hlth, Sfax, Tunisia	Universite de Sfax; Hopital Habib Bourguiba; Universite de Sfax; Universite de Sfax; Universite de Sfax	Znazen, A (corresponding author), Habib Bourguiba Univ Hosp Sfax, Dept Microbiol & Res Lab Microorganismes & Pathol, Sfax, Tunisia.	abir.znazen@rns.tn	Gdoura, Radhouane/AAD-6486-2022; Gdoura, Radhouane/I-6865-2018	Gdoura, Radhouane/0000-0003-1140-3780; SELLAMI, Hanen/0000-0001-5479-1707; Keskes, Leila/0000-0002-8420-139X	research laboratory "MPH'' Habib Bourguiba University Hospital of Sfax Tunisia	research laboratory "MPH'' Habib Bourguiba University Hospital of Sfax Tunisia	The work was financed by the research laboratory "MPH'' Habib Bourguiba University Hospital of Sfax Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusarah EA, 2013, DIAGN MICR INFEC DIS, V77, P283, DOI 10.1016/j.diagmicrobio.2013.05.018; Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Al-Mously N, 2009, FERTIL STERIL, V92, P1606, DOI 10.1016/j.fertnstert.2008.08.128; Al-Sweih NA, 2012, J ANDROL, V33, P1323, DOI 10.2164/jandrol.111.013821; BORNMAN MS, 1990, ANDROLOGIA, V22, P118; Cengiz T., 1997, International Urology and Nephrology, V29, P687, DOI 10.1007/BF02552187; CUSTO GM, 1989, ARCH ANDROLOGY, V23, P243, DOI 10.3109/01485018908986847; Motrich RD, 2006, J INFECTION, V53, P175, DOI 10.1016/j.jinf.2005.11.007; Datcu R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-480; de Barbeyrac B, 2006, EUR J OBSTET GYN R B, V129, P46, DOI 10.1016/j.ejogrb.2006.02.014; DEJONG Z, 1990, EUR UROL, V18, P127; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Domes T, 2012, FERTIL STERIL, V97, P299, DOI 10.1016/j.fertnstert.2011.11.024; Eggert-Kruse W, 2003, FERTIL STERIL, V80, P660, DOI 10.1016/S0015-0282(03)00761-1; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; GALDIERO F, 1994, FEMS MICROBIOL LETT, V115, P197, DOI 10.1016/0378-1097(94)90013-2; Gallegos G, 2008, FERTIL STERIL, V90, P328, DOI 10.1016/j.fertnstert.2007.06.035; Garner DL, 1999, MOL REPROD DEV, V53, P222, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;222::AID-MRD11&gt;3.0.CO;2-L; Gdoura R, 2008, J ANDROL, V29, P198, DOI 10.2164/jandrol.107.003566; Gdoura R, 2001, EUR J CONTRACEP REPR, V6, P102, DOI 10.1080/713604209; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Gewies A, 2003, BRIT J CANCER, V89, P1574, DOI 10.1038/sj.bjc.6601297; GORCZYCA W, 1993, EXP CELL RES, V207, P202, DOI 10.1006/excr.1993.1182; Gravance CG, 2000, THERIOGENOLOGY, V53, P1691, DOI 10.1016/S0093-691X(00)00308-3; Habermann B, 1999, J EUR ACAD DERMATOL, V12, P25, DOI 10.1016/S0926-9959(98)00092-0; Hamdad-Daoudi F, 2004, J MED MICROBIOL, V53, P985, DOI 10.1099/jmm.0.45641-0; Hjelmevoll SO, 2006, J MOL DIAGN, V8, P574, DOI 10.2353/jmoldx.2006.060024; Hosseinzadeh S, 2003, J MED MICROBIOL, V52, P193, DOI 10.1099/jmm.0.04836-0; Hosseinzadeh S, 2001, HUM REPROD, V16, P293, DOI 10.1093/humrep/16.2.293; Hosseinzadeh S, 2004, J ANDROL, V25, P104; Hosseinzadeh S, 2000, INFECT IMMUN, V68, P4872, DOI 10.1128/IAI.68.9.4872-4876.2000; Idahl A, 2004, HUM REPROD, V19, P1121, DOI 10.1093/humrep/deh155; Jakiel Grzegorz, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P61; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jalal H, 2013, INT J MOL EPIDEMIOL, V4, P167; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Keck C, 1998, HUM REPROD UPDATE, V4, P891, DOI 10.1093/humupd/4.6.891; Knox CL, 2003, FERTIL STERIL, V80, P921, DOI 10.1016/S0015-0282(03)01125-7; La Vignera S, 2011, INT J ANDROL, V34, pE330, DOI 10.1111/j.1365-2605.2011.01200.x; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Liu JJ, 2014, UROLOGY, V83, P795, DOI 10.1016/j.urology.2013.11.009; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Ochsendorf FR, 1999, J EUR ACAD DERMATOL, V12, P143, DOI 10.1111/j.1468-3083.1999.tb01005.x; Paasch U, 2004, FERTIL STERIL, V81, P802, DOI 10.1016/j.fertnstert.2003.09.030; Paasch U, 2003, J ANDROL, V24, P246; Paavonen J, 1999, HUM REPROD UPDATE, V5, P433, DOI 10.1093/humupd/5.5.433; Pajovic B, 2013, ANDROLOGIA, V45, P266, DOI 10.1111/and.12004; Pannekoek Y, 2000, J MED MICROBIOL, V49, P697, DOI 10.1099/0022-1317-49-8-697; Pascual A, 2010, INT J MICROBIOL, V2010; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Reichart M, 2000, BIOL REPROD, V63, P1041, DOI 10.1095/biolreprod63.4.1041; Rosemond A, 2006, PATHOL BIOL, V54, P125, DOI 10.1016/j.patbio.2005.09.004; Rowe P.J., 2000, WHO MANUAL STANDARDI; Rybar R, 2012, ANDROLOGIA, V44, P410, DOI 10.1111/j.1439-0272.2011.01198.x; Sakkas D, 1999, EXP CELL RES, V251, P350, DOI 10.1006/excr.1999.4586; Sakkas Denny, 2003, Reprod Biomed Online, V7, P428; Satta A, 2006, HUM REPROD, V21, P134, DOI 10.1093/humrep/dei269; Schuffner A, 2002, J ANDROL, V23, P194; Schulz M, 2010, FERTIL STERIL, V94, P619, DOI 10.1016/j.fertnstert.2009.01.140; Sellami H, 2011, J ANDROL, V32, P86, DOI 10.2164/jandrol.109.009183; Shen HM, 2002, HUM REPROD, V17, P1266, DOI 10.1093/humrep/17.5.1266; Taylor SL, 2004, MOL HUM REPROD, V10, P825, DOI 10.1093/molehr/gah099; Vancutsem E, 2011, J MOL DIAGN, V13, P206, DOI 10.1016/j.jmoldx.2010.10.007; Veznik Z, 2004, ACTA OBSTET GYN SCAN, V83, P656, DOI 10.1111/j.0001-6349.2004.00542.x; Vigil P, 2002, ANDROLOGIA, V34, P155, DOI 10.1046/j.1439-0272.2002.00472.x; Villegas J, 2005, APOPTOSIS, V10, P105, DOI 10.1007/s10495-005-6065-8; VOGELS WHM, 1993, J CLIN MICROBIOL, V31, P1103, DOI 10.1128/JCM.31.5.1103-1107.1993; Wang Y, 2006, ASIAN J ANDROL, V8, P562, DOI 10.1111/j.1745-7262.2006.00190.x; Weidner W, 1996, INFECTION, V24, P309, DOI 10.1007/BF01743366; Weng SL, 2002, MOL HUM REPROD, V8, P984, DOI 10.1093/molehr/8.11.984; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Witkin SS, 2002, BEST PRACT RES CL OB, V16, P865, DOI 10.1053/beog.2002.0326; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yoshida T, 2002, J CLIN MICROBIOL, V40, P105, DOI 10.1128/JCM.40.1.105-110.2002	76	41	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e98903	10.1371/journal.pone.0098903	http://dx.doi.org/10.1371/journal.pone.0098903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019616	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600001
J	Xu, TD; Wu, X; Chen, QP; Zhu, SS; Liu, Y; Pan, DF; Chen, XH; Li, DY				Xu, Tongda; Wu, Xin; Chen, Qiuping; Zhu, Shasha; Liu, Yang; Pan, Defeng; Chen, Xiaohu; Li, Dongye			The Anti-Apoptotic and Cardioprotective Effects of Salvianolic Acid A on Rat Cardiomyocytes following Ischemia/Reperfusion by DUSP-Mediated Regulation of the ERK1/2/JNK Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MAP KINASE PHOSPHATASES; MYOCARDIAL-ISCHEMIA; SIGNALING PATHWAYS; CELL-SURVIVAL; C-JUN; INHIBITION; ERK; PROTECTS; CANCER	The purpose of this study was to observe the effects of salvianolic acid A (SAA) pretreatment on the myocardium during ischemia/reperfusion (I/R) and to illuminate the interrelationships among dual specificity protein phosphatase (DUSP) 2/4/16, ERK1/2 and JNK pathways during myocardial I/R, with the ultimate goal of elucidating how SAA exerts cardioprotection against I/R injury (IRI). Wistar rats were divided into the following six groups: control group (CON), I/R group, SAA+I/R group, ERK1/2 inhibitor PD098059+I/R group (PD+I/R), PD+SAA+I/R group, and JNK inhibitor SP600125+I/R group (SP+I/R). The cardioprotective effects of SAA on the myocardium during I/R were investigated with a Langendorff device. Heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), maximum rate of ventricular pressure rise and fall (+/- dp/dt(max)), myocardial infarction areas (MIA), lactate dehydrogenase (LDH), and cardiomyocytes apoptosis were monitored. To determine the crosstalk betwee JNK and ERK1/2 via DUSP2/4/16 with SAA pretreatment, siRNA-DUSP2/4/16 were performed. The expression levels of Bcl-2, Bax, caspase 3, p-JNK, p-ERK1/2 and DUSP2/4/16 in cardiomyocytes were assayed by Western blot. Our results showed that LDH, MIA and cell apoptosis were decreased, and various parameters of heart function were improved by SAA pretreatment and SP application. In the I/R group, the expression levels of p-ERK1/2 and DUSP4/16 were not significantly different compared with the CON group, however, the protein expression levels of p-ERK1/2, Bcl-2 and DUSP4/16 were higher, while p-JNK, Bax, caspase 3 and DUSP2 levels were reduced among the SAA+I/R, PD+SAA+I/R and SP+I/R groups. The above indices were not significantly different between the SAA+I/R and SP+I/R groups. Compared with the SAA+I/R group, p-ERK1/2 was increased and p-JNK was decreased in the SAA+si-DUSP2+I/R, however, p-ERK was downregulated and p-JNK was upregulated in SAA+si-DUSP4+I/R group. SAA exerts an anti-apoptotic role against myocardial IRI by inhibiting DUSP2-mediated JNK dephosphorylation and activating DUSP4/16-mediated ERK1/2 phosphorylation.	[Xu, Tongda; Wu, Xin; Chen, Qiuping; Zhu, Shasha; Liu, Yang; Pan, Defeng; Li, Dongye] Xuzhou Med Coll, Res Inst Cardiovasc Dis, Xuzhou, Jiangsu, Peoples R China; [Xu, Tongda; Chen, Xiaohu; Li, Dongye] Nanjing Tradit Chinese Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University	Chen, XH (corresponding author), Nanjing Tradit Chinese Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China.	chenxiaohu2001@aliyun.com; ldy@xzmc.edu.cn	李, 东野/AAY-6410-2020; 李, 东/GYA-4703-2022	Xu, Tongda/0000-0002-5594-3992	Ministry of Education of China [20123237110006]	Ministry of Education of China(Ministry of Education, China)	This work was supported by Doctoral Fund of Ministry of Education of China (Grant No. 20123237110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Fan H, 2012, EVID-BASED COMPL ALT, V2012, DOI DOI 10.1155/2012/508938; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Fey D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00355; Hu XL, 2013, ARCH DERMATOL RES, V305, P433, DOI 10.1007/s00403-013-1334-9; Hu ZY, 2009, CLIN EXP PHARMACOL P, V36, P776, DOI 10.1111/j.1440-1681.2009.05138.x; Jiang BH, 2009, PLANTA MED, V75, P1286, DOI 10.1055/s-0029-1185669; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Krstic A, 2012, J BIOL REG HOMEOS AG, V26, P641; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Ottani A, 2010, EUR J PHARMACOL, V637, P124, DOI 10.1016/j.ejphar.2010.03.052; Pan HJ, 2011, J CARDIOVASC PHARM, V58, P535, DOI 10.1097/FJC.0b013e31822de355; Qiao ZY, 2011, MOLECULES, V16, P10002, DOI 10.3390/molecules161210002; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sun Q, 2009, EXP BIOL MED, V234, P1212, DOI 10.3181/0812-RM-349; Tao JP, 2011, AM J PHYSIOL-HEART C, V301, pH1471, DOI 10.1152/ajpheart.00097.2011; Verma YK, 2013, APOPTOSIS, V18, P212, DOI 10.1007/s10495-012-0780-8; Wang XY, 2011, J ETHNOPHARMACOL, V135, P662, DOI 10.1016/j.jep.2011.03.070; Wang XJ, 2005, J ETHNOPHARMACOL, V97, P441, DOI 10.1016/j.jep.2004.11.036; Wei XL, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-37; Wiejak J, 2012, CELL SIGNAL, V24, P1690, DOI 10.1016/j.cellsig.2012.04.016; Yin XL, 2011, AM J CHINESE MED, V39, P853, DOI 10.1142/S0192415X11009251; Yue TL, 2005, DIABETES, V54, P554, DOI 10.2337/diabetes.54.2.554; Zhai CL, 2012, ACTA PHARMACOL SIN, V33, P1477, DOI 10.1038/aps.2012.112	32	63	71	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102292	10.1371/journal.pone.0102292	http://dx.doi.org/10.1371/journal.pone.0102292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019380	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600061
J	Lange, M; Fiedler, M; Bankwitz, D; Osburn, W; Viazov, S; Brovko, O; Zekri, AR; Khudyakov, Y; Nassal, M; Pumpens, P; Pietschmann, T; Timm, J; Roggendorf, M; Walker, A				Lange, Milena; Fiedler, Melanie; Bankwitz, Dorothea; Osburn, William; Viazov, Sergei; Brovko, Olena; Zekri, Abdel-Rahman; Khudyakov, Yury; Nassal, Michael; Pumpens, Paul; Pietschmann, Thomas; Timm, Joerg; Roggendorf, Michael; Walker, Andreas			Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies	PLOS ONE			English	Article							HEPADNAVIRUS CORE PROTEINS; THERAPEUTIC VACCINES; CELL ENTRY; DISPLAY; INFECTION; ANTIGEN; EPITOPES; CARRIER; SURFACE; MIMOTOPES	Hepatitis C virus (HCV) infection is still a serious global health burden. Despite improved therapeutic options, a preventative vaccine would be desirable especially in undeveloped countries. Traditionally, highly conserved epitopes are targets for antibody-based prophylactic vaccines. In HCV-infected patients, however, neutralizing antibodies are primarily directed against hypervariable region I (HVRI) in the envelope protein E2. HVRI is the most variable region of HCV, and this heterogeneity contributes to viral persistence and has thus far prevented the development of an effective HVRI-based vaccine. The primary goal of an antibody-based HCV vaccine should therefore be the induction of cross-reactive HVRI antibodies. In this study we approached this problem by presenting selected cross-reactive HVRI variants in a highly symmetric repeated array on capsid-like particles (CLPs). SplitCore CLPs, a novel particulate antigen presentation system derived from the HBV core protein, were used to deliberately manipulate the orientation of HVRI and therefore enable the presentation of conserved parts of HVRI. These HVRI-CLPs induced high titers of cross-reactive antibodies, including neutralizing antibodies. The combination of only four HVRI CLPs was sufficient to induce antibodies cross-reactive with 81 of 326 (24.8%) naturally occurring HVRI peptides. Most importantly, HVRI CLPs with AS03 as an adjuvant induced antibodies with a 10-fold increase in neutralizing capability. These antibodies were able to neutralize infectious HCVcc isolates and 4 of 19 (21%) patient-derived HCVpp isolates. Taken together, these results demonstrate that the induction of at least partially cross-neutralizing antibodies is possible. This approach might be useful for the development of a prophylactic HCV vaccine and should also be adaptable to other highly variable viruses.	[Lange, Milena; Fiedler, Melanie; Viazov, Sergei; Brovko, Olena; Timm, Joerg; Roggendorf, Michael; Walker, Andreas] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Bankwitz, Dorothea; Pietschmann, Thomas] TWINCORE, Div Expt Virol, Hannover, Germany; [Osburn, William] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Zekri, Abdel-Rahman] Natl Canc Inst, Virol & Immunol Unit, Cairo, Egypt; [Khudyakov, Yury] Ctr Dis Control & Prevent, Atlanta, GA USA; [Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med 2, Freiburg, Germany; [Pumpens, Paul] Latvian Biomed Res & Study Ctr, Dept Recombinant Biotechnol, Riga, Latvia	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research; Johns Hopkins University; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Centers for Disease Control & Prevention - USA; University of Freiburg; Latvian Biomedical Research & Study Centre	Walker, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	Andreas.Walker@uni-due.de	Pietschmann, Thomas/E-9241-2015; Zekri, Abdel-Rahman N/A-3768-2008; Pumpens, Paul/A-2163-2008; Nassal, Michael/U-4529-2019; Timm, Jörg/P-7652-2019	Pietschmann, Thomas/0000-0001-5138-6239; Nassal, Michael/0000-0003-2204-9158; Timm, Jörg/0000-0001-7799-3045; Pietschmann, Thomas/0000-0001-6789-4422; Zekri, Abdel-Rahman/0000-0003-3939-0416; Walker, Andreas/0000-0002-8736-0863	Deutsche Forschungsgemeinschaft [Fi768/6-1, KFO 117/2]; German federal ministry of education and research; YEAL-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German federal ministry of education and research(Federal Ministry of Education & Research (BMBF)); YEAL-Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de; grant number Fi768/6-1 within the Priority program KFO 117/2) and the German federal ministry of education and research (www.bmbf.de; grant number EGY08/068). ML received a scholarship from the YEAL-Stiftung (http://www.yael-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameiss K, 2010, VACCINE, V28, P6704, DOI 10.1016/j.vaccine.2010.07.083; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Barnes E, SCI TRANSL MED, V4; Barouch DH, NATURE; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Belnap DM, 2003, P NATL ACAD SCI USA, V100, P10884, DOI 10.1073/pnas.1834404100; BICHKO V, 1993, MOL IMMUNOL, V30, P221, DOI 10.1016/0161-5890(93)90051-C; Billaud JN, 2007, VACCINE, V25, P1593, DOI 10.1016/j.vaccine.2006.11.013; Billaud JN, 2005, J VIROL, V79, P13656, DOI 10.1128/JVI.79.21.13656-13666.2005; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 2006, J MOL BIOL, V356, P812, DOI 10.1016/j.jmb.2005.11.053; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Campo DS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00267; Conaty S, 2004, VACCINE, V22, P3214, DOI 10.1016/j.vaccine.2003.08.050; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Fournillier A, 2013, J INFECT DIS, V208, P1008, DOI 10.1093/infdis/jit267; Geldmacher A, 2005, VACCINE, V23, P3973, DOI 10.1016/j.vaccine.2005.02.025; Gregson AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001556; Guan M, 2012, J BIOL CHEM, V287, P35631, DOI 10.1074/jbc.M112.382341; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; HERZENBERG LA, 1980, NATURE, V285, P664, DOI 10.1038/285664a0; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; KUMAR U, 1994, GASTROENTEROLOGY, V106, P1072, DOI 10.1016/0016-5085(94)90770-6; Law JLM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059776; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Meunier JC, 2011, J INFECT DIS, V204, P1186, DOI 10.1093/infdis/jir511; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Mondelli MU, 2003, J BIOSCIENCES, V28, P305, DOI 10.1007/BF02970149; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Puntoriero G, 1998, EMBO J, V17, P3521, DOI 10.1093/emboj/17.13.3521; Ray R, 2010, J INFECT DIS, V202, P862, DOI 10.1086/655902; Roccasecca R, 2001, Int Rev Immunol, V20, P289, DOI 10.3109/08830180109043040; Roccasecca R, 2001, MOL IMMUNOL, V38, P485, DOI 10.1016/S0161-5890(01)00084-0; Sallberg M, 2002, INTERVIROLOGY, V45, P350, DOI 10.1159/000067928; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Skamel C, 2006, J BIOL CHEM, V281, P17474, DOI 10.1074/jbc.M513571200; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; Vieyres G, 2011, J GEN VIROL, V92, P494, DOI 10.1099/vir.0.028092-0; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Walker A, 2011, NATURE SCI REPORTS, V1; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Walker A, 2008, J BIOL CHEM, V283, P33508, DOI 10.1074/jbc.M805211200; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zibert A, 1997, J VIROL, V71, P4123, DOI 10.1128/JVI.71.5.4123-4127.1997; ZIBERT A, 1995, VIROLOGY, V208, P653, DOI 10.1006/viro.1995.1196; Zucchelli S, 2001, HEPATOLOGY, V33, P692, DOI 10.1053/jhep.2001.22175	75	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102235	10.1371/journal.pone.0102235	http://dx.doi.org/10.1371/journal.pone.0102235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014219	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400079
J	Lee, JH; Choi, SS; Kim, HW; Xiong, WC; Min, CK; Lee, SJ				Lee, Jae Ho; Choi, Sung Sook; Kim, Hae Won; Xiong, Wen Cheng; Min, Churl K.; Lee, Sang Jin			Neogenin as a Receptor for Early Cell Fate Determination in Preimplantation Mouse Embryos	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; STEM-CELLS; TROPHECTODERM; BLASTOMERES; EXPRESSION; NETRIN-1; TEAD4; DCC; SPECIFICATION; APOPTOSIS	The first cell lineage determination in embryos takes place when two cell populations are set apart, each differentiating into the trophectoderm (TE) and inner cell mass (ICM), respectively. It is widely believed that position/polarity cues play a key role in triggering this differentiation, but it remains unclear how extracellular cues are transduced into cell fate determination. Here, we provide evidence that supports that neogenin is implicated in relaying extracellular cues into the first cell fate determination in preimplantation mouse embryos. A polarized and transient distribution of neogenin was manifested in early blastomeres. Neogenin up-regulation by its overexpression accelerated ICM development in the blastocyst concomitant with the activation of the ICM-specific transcription factors Oct3/4, Sox2, and Nanog while its depletion by small hairpin RNAs (shRNAs) caused a developmental abnormality of poorly endowed ICM accompanied by the deactivation of Oct3/4, Sox2, and Nanog. Treatment with netrin-1 among neogenin ligands further impaired both embryonic development and ICM formation while repulsive guidance molecule c (RGMc) led to opposite consequences, enhancing ICM formation. From this study, we propose a model whereby neogenin interprets its own expression level to control the first cell fate determination in response to extracellular cues.	[Lee, Jae Ho; Kim, Hae Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Lee, Jae Ho; Kim, Hae Won] Dankook Univ, WCU Res Ctr, Cheonan, South Korea; [Choi, Sung Sook] Sahmyook Univ, Dept Pharmacol, Seoul, South Korea; [Kim, Hae Won] Dankook Univ, Sch Dent, Dept Dent Biomat, Cheonan, South Korea; [Xiong, Wen Cheng] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA; [Min, Churl K.] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Lee, Sang Jin] Sahmyook Univ, Dept Anim Biotechnol, Seoul, South Korea	Dankook University; Dankook University; Sahmyook University; Dankook University; University System of Georgia; Augusta University; Ajou University; Sahmyook University	Min, CK (corresponding author), Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea.	minc@ajou.ac.kr; leesj@syu.ac.kr	Knowles, Jonathan Campbell/B-9019-2008	Knowles, Jonathan Campbell/0000-0003-3917-3446	Sahmyook University Research Fund; Priority Research Centers Program [2009-0093829]; World Class University Program [R31-10069]	Sahmyook University Research Fund; Priority Research Centers Program; World Class University Program	This work was supported by a grant of the 2012 Sahmyook University Research Fund to S.J.L.; and the Priority Research Centers Program (Grant No. 2009-0093829) and World Class University Program (Grant No. R31-10069) to H.W.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cole SJ, 2007, INT J BIOCHEM CELL B, V39, P1569, DOI 10.1016/j.biocel.2006.11.009; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; FLEMING TP, 1985, J EMBRYOL EXP MORPH, V89, P175; Ilic D, 1997, J CELL SCI, V110, P401; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Milla LA, 2014, INT J CANCER, V134, P21, DOI 10.1002/ijc.28330; Morris SA, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130104; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Roperch JP, 2008, CANCER RES, V68, P8231, DOI 10.1158/0008-5472.CAN-08-1483; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Severyn CJ, 2009, BIOCHEM J, V422, P393, DOI 10.1042/BJ20090978; Son TW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.94; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tajbakbsh S, 2009, ANNU REV CELL DEV BI, V25, P671, DOI 10.1146/annurev.cellbio.24.110707.175415; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016; ZIOMEK CA, 1982, DEV BIOL, V91, P440, DOI 10.1016/0012-1606(82)90050-1	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101989	10.1371/journal.pone.0101989	http://dx.doi.org/10.1371/journal.pone.0101989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013897	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400050
J	Zekavati, A; Nasir, A; Alcaraz, A; Aldrovandi, M; Marsh, P; Norton, JD; Murphy, JJ				Zekavati, Anna; Nasir, Asghar; Alcaraz, Amor; Aldrovandi, Maceler; Marsh, Phil; Norton, John D.; Murphy, John J.			Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells	PLOS ONE			English	Article							LYMPHOCYTIC-LEUKEMIA CELLS; EARLY RESPONSE GENE; EXPRESSION PROFILES; INDUCE APOPTOSIS; TRISTETRAPROLIN; NUCLEOLIN; FAMILY; DIFFERENTIATION; STABILIZATION; INVOLVEMENT	The human ZFP36 zinc finger protein family consists of ZFP36, ZFP36L1, and ZFP36L2. These proteins regulate various cellular processes, including cell apoptosis, by binding to adenine uridine rich elements in the 3' untranslated regions of sets of target mRNAs to promote their degradation. The pro-apoptotic and other functions of ZFP36 family members have been implicated in the pathogenesis of lymphoid malignancies. To identify candidate mRNAs that are targeted in the proapoptotic response by ZFP36L1, we reverse-engineered a gene regulatory network for all three ZFP36 family members using the 'maximum information coefficient' (MIC) for target gene inference on a large microarray gene expression dataset representing cells of diverse histological origin. Of the three inferred ZFP36L1 mRNA targets that were identified, we focussed on experimental validation of mRNA for the pro-survival protein, BCL2, as a target for ZFP36L1. RNA electrophoretic mobility shift assay experiments revealed that ZFP36L1 interacted with the BCL2 adenine uridine rich element. In murine BCL1 leukemia cells stably transduced with a ZFP36L1 ShRNA lentiviral construct, BCL2 mRNA degradation was significantly delayed compared to control lentiviral expressing cells and ZFP36L1 knockdown in different cell types (BCL1, ACHN, Ramos), resulted in increased levels of BCL2 mRNA levels compared to control cells. 3' untranslated region luciferase reporter assays in HEK293T cells showed that wild type but not zinc finger mutant ZFP36L1 protein was able to downregulate a BCL2 construct containing the BCL2 adenine uridine rich element and removal of the adenine uridine rich core from the BCL2 3' untranslated region in the reporter construct significantly reduced the ability of ZFP36L1 to mediate this effect. Taken together, our data are consistent with ZFP36L1 interacting with and mediating degradation of BCL2 mRNA as an important target through which ZFP36L1 mediates its pro-apoptotic effects in malignant B-cells.	[Zekavati, Anna; Nasir, Asghar; Aldrovandi, Maceler; Murphy, John J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Alcaraz, Amor; Murphy, John J.] Univ Westminster, Dept Biomed Sci, London W1R 8AL, England; [Marsh, Phil] Kings Coll London, Div Endocrinol, London WC2R 2LS, England; [Norton, John D.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of London; King's College London; University of Westminster; University of London; King's College London; University of Essex	Murphy, JJ (corresponding author), Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England.	j.murphy@westminster.ac.uk	Aldrovandi, Maceler/D-4322-2014	Aldrovandi, Maceler/0000-0002-4386-0719	government of Pakistan PhD Studentship	government of Pakistan PhD Studentship	AN was supported by a government of Pakistan PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Baou M, 2009, LEUKEMIA, V23, P986, DOI 10.1038/leu.2008.340; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA QF, 1995, ONCOGENE, V10, P487; MA QF, 1994, ONCOGENE, V9, P3329; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MURPHY JJ, 1990, BIOCHIM BIOPHYS ACTA, V1049, P261; Nasir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052187; Ning ZQ, 1996, EUR J IMMUNOL, V26, P2356, DOI 10.1002/eji.1830261013; NING ZQ, 1995, BIOCHEM BIOPH RES CO, V215, P23, DOI 10.1006/bbrc.1995.2429; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pospisilova H, 2007, LEUKEMIA, V21, P2079, DOI 10.1038/sj.leu.2404739; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Renault TT, 2013, ANN NY ACAD SCI, V1285, P59, DOI 10.1111/nyas.12045; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rounbehler RJ, 2012, CELL, V150, P563, DOI 10.1016/j.cell.2012.06.033; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Treguer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054550; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040	44	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102625	10.1371/journal.pone.0102625	http://dx.doi.org/10.1371/journal.pone.0102625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014217	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400105
J	Allen, ML; Elbroch, LM; Wilmers, CC; Wittmer, HU				Allen, Maximilian L.; Elbroch, L. Mark; Wilmers, Christopher C.; Wittmer, Heiko U.			Trophic Facilitation or Limitation? Comparative Effects of Pumas and Black Bears on the Scavenger Community	PLOS ONE			English	Article							GUILD; FOOD; YELLOWSTONE; COMPETITION; PREDATION; CARCASSES; CARRION; PREY	Scavenging is a widespread behaviour and an important process influencing food webs and ecological communities. Large carnivores facilitate the movement of energy across trophic levels through the scavenging and decomposition of their killed prey, but competition with large carnivores is also likely to constrain acquisition of carrion by scavengers. We used an experimental approach based on motion-triggered video cameras at black-tailed deer (Odocoileus hemionus columbianus) carcasses to measure the comparative influences of two large carnivores in the facilitation and limitation of carrion acquisition by scavengers. We found that pumas (Puma concolor) and black bears (Ursus americanus) had different effects on their ecological communities. Pumas, as a top-level predator, facilitated the consumption of carrion by scavengers, despite significantly reducing their observed sum feeding times (165.7 min +/- 21.2 SE at puma kills 264.3 min +/- 30.1 SE at control carcasses). In contrast, black bears, as the dominant scavenger in the system, limited consumption of carrion by scavengers as evidenced by the observed reduction of scavenger species richness recorded at carcasses where they were present (mean = 2.33 +/- 0.28 SE), compared to where they were absent (mean = 3.28 +/- 0.23 SE). Black bears also had large negative effects on scavenger sum feeding times (88.5 min +/- 19.8 SE at carcasses where bears were present, 372.3 min +/- 50.0 SE at carcasses where bears were absent). In addition, we found that pumas and black bears both increased the nestedness (a higher level of order among species present) of the scavenger community. Our results suggest that scavengers have species-specific adaptions to exploit carrion despite large carnivores, and that large carnivores influence the structure and composition of scavenger communities. The interactions between large carnivores and scavengers should be considered in future studies of food webs and ecological communities.	[Allen, Maximilian L.; Wittmer, Heiko U.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Elbroch, L. Mark] Panthera, New York, NY USA; [Wilmers, Christopher C.] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA	Victoria University Wellington; University of California System; University of California Santa Cruz	Allen, ML (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	Maximilian.Allen@vuw.ac.nz	Allen, Maximilian/ABG-9307-2020; Wittmer, Heiko U/D-4172-2015	Allen, Maximilian/0000-0001-8976-889X; Wittmer, Heiko U/0000-0002-8861-188X	University of California Davis; California Department of Fish and Wildlife; Victoria University of Wellington tuition scholarship	University of California Davis(University of California System); California Department of Fish and Wildlife; Victoria University of Wellington tuition scholarship	The University of California Davis, and the California Department of Fish and Wildlife generously provided financial support for the project. M. Allen was supported by a Victoria University of Wellington tuition scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2014, CAN J ZOOL, V92, P397, DOI 10.1139/cjz-2013-0284; Allen M.L., 2014, THESIS VICTORIA U WE; ANGERBJORN A, 1991, J ANIM ECOL, V60, P705, DOI 10.2307/5307; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Bates D., 2015, LINEAR MIXED EFFECTS, V67, P1, DOI 10.18637/jss.v067.i01; Begon M., 2009, ECOLOGY INDIVIDUALS; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cortes-Avizanda A, 2012, ECOLOGY, V93, P2570, DOI 10.1890/12-0221.1; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Elbroch LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053595; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Houston DC, 1995, SERENGETI DYNAMICS E, P263; Hunter JS, 2007, AFR J ECOL, V45, P275, DOI 10.1111/j.1365-2028.2006.00702.x; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; MATHEWS NE, 1988, CAN J ZOOL, V66, P1241, DOI 10.1139/z88-179; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; Murphy KM, 1998, URSUS-SERIES, V10, P55; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; R Core Team, 2021, R LANG ENV STAT COMP; Ruth Toni K., 2010, P163; SCHWARTZ CC, 1991, WILDLIFE MONOGR, P1; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Selva N, 2007, P ROY SOC B-BIOL SCI, V274, P1101, DOI 10.1098/rspb.2006.0232; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sokal R.R., 1987, INTRO BIOSTATISTICS, V2nd; Svoboda NJ, 2011, URSUS, V22, P91, DOI 10.2192/URSUS-D-10-00024.1; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; WATSON J, 1992, J ANIM ECOL, V61, P543, DOI 10.2307/5609; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	41	43	44	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102257	10.1371/journal.pone.0102257	http://dx.doi.org/10.1371/journal.pone.0102257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010629	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800086
J	Chrol-Cannon, J; Jin, YC				Chrol-Cannon, Joseph; Jin, Yaochu			On the Correlation between Reservoir Metrics and Performance for Time Series Classification under the Influence of Synaptic Plasticity	PLOS ONE			English	Article							COMPUTATION; CHAOS; EDGE	Reservoir computing provides a simpler paradigm of training recurrent networks by initialising and adapting the recurrent connections separately to a supervised linear readout. This creates a problem, though. As the recurrent weights and topology are now separated from adapting to the task, there is a burden on the reservoir designer to construct an effective network that happens to produce state vectors that can be mapped linearly into the desired outputs. Guidance in forming a reservoir can be through the use of some established metrics which link a number of theoretical properties of the reservoir computing paradigm to quantitative measures that can be used to evaluate the effectiveness of a given design. We provide a comprehensive empirical study of four metrics; class separation, kernel quality, Lyapunov's exponent and spectral radius. These metrics are each compared over a number of repeated runs, for different reservoir computing set-ups that include three types of network topology and three mechanisms of weight adaptation through synaptic plasticity. Each combination of these methods is tested on two time-series classification problems. We find that the two metrics that correlate most strongly with the classification performance are Lyapunov's exponent and kernel quality. It is also evident in the comparisons that these two metrics both measure a similar property of the reservoir dynamics. We also find that class separation and spectral radius are both less reliable and less effective in predicting performance.	[Chrol-Cannon, Joseph; Jin, Yaochu] Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England	University of Surrey	Jin, YC (corresponding author), Univ Surrey, Dept Comp, Guildford GU2 5XH, Surrey, England.	yaochu.jin@surrey.ac.uk	Jin, Yaochu/B-3776-2012; Jin, Yaochu/GRY-7004-2022	Jin, Yaochu/0000-0003-1100-0631; Jin, Yaochu/0000-0003-1100-0631	Engineering and Physical Sciences Research Council through University of Surrey	Engineering and Physical Sciences Research Council through University of Surrey	JCC was supported by Engineering and Physical Sciences Research Council's Doctoral Training Grant through University of Surrey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chrol-Cannon J, 2014, BIOSYSTEMS; Chrol-Cannon J., 2012, 2012 INT JOINT C NEU, P1; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Gibbons TE, 2010, IEEE IJCNN; Goodman E, 2006, IEEE IJCNN, P3848; Hebb Donald O., 1949, ORG BEHAV; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jaeger H, 2005, IEEE IJCNN, P1460; Jaeger H, 2007, 10 JAC U BREM; Jaeger H., 2002, 152 GMD GERM NAT RES; Jaeger H., 2001, TECH REP 148, V148; Joshi P, 2009, LECT NOTES COMPUT SC, V5768, P239, DOI 10.1007/978-3-642-04274-4_25; Kudo M, 1999, PATTERN RECOGN LETT, V20, P1103, DOI 10.1016/S0167-8655(99)00077-X; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Lukosevicius M, 2012, KUNSTL INTELL, V26, P365, DOI 10.1007/s13218-012-0204-5; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Norton D, 2010, NEUROCOMPUTING, V73, P2893, DOI 10.1016/j.neucom.2010.08.005; Norton D, 2006, IEEE IJCNN, P4243; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Xue FZ, 2013, NEUROCOMPUTING, V122, P324, DOI 10.1016/j.neucom.2013.06.019; Yin J, 2012, IEEE T AUTON MENT DE, V4, P273, DOI 10.1109/TAMD.2012.2182765	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101792	10.1371/journal.pone.0101792	http://dx.doi.org/10.1371/journal.pone.0101792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010415	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800040
J	Hennessy, E; O'Callaghan, J; Mooij, MJ; Legendre, C; Camacho-Vanegas, O; Camacho, SC; Adams, C; Martignetti, JA; O'Gara, F				Hennessy, Emma; O'Callaghan, Julie; Mooij, Marlies J.; Legendre, Claire; Camacho-Vanegas, Olga; Camacho, Sandra C.; Adams, Claire; Martignetti, John A.; O'Gara, Fergal			The Impact of Simvastatin on Pulmonary Effectors of Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; KRUPPEL-LIKE FACTOR-2; COA REDUCTASE INHIBITORS; TUMOR-SUPPRESSOR GENE; EPITHELIAL-CELLS; IN-VITRO; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA	The statin family of cholesterol-lowering drugs is known to have pleiotropic properties which include anti-inflammatory and immunomodulatory effects. Statins exert their pleiotropic effects by altering expression of human immune regulators including pro-inflammatory cytokines. Previously we found that statins modulate virulence phenotypes of the human pathogen Pseudomonas aeruginosa, and sought to investigate if simvastatin could alter the host response to this organism in lung epithelial cells. Simvastatin increased the expression of the P. aeruginosa target genes KLF2, KLF6, IL-8 and CCL20. Furthermore, both simvastatin and P. aeruginosa induced alternative splicing of KLF6. The novel effect of simvastatin on wtKLF6 expression was found to be responsible for induction of the KLF6 regulated genes CCL20 and iNOS. Simvastatin also increased the adhesion of P. aeruginosa to host cells, without altering invasion or cytotoxicity. This study demonstrated that simvastatin had several novel effects on the pulmonary cellular immune response.	[Hennessy, Emma; O'Callaghan, Julie; Mooij, Marlies J.; Legendre, Claire; Adams, Claire; O'Gara, Fergal] Natl Univ Ireland, Sch Microbiol, BIOMERIT Res Ctr, Cork, Ireland; [Camacho-Vanegas, Olga; Camacho, Sandra C.; Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [O'Gara, Fergal] Curtin Univ, Sch Biomed Sci, Perth, WA 6845, Australia	University College Cork; Icahn School of Medicine at Mount Sinai; Curtin University	O'Gara, F (corresponding author), Natl Univ Ireland, Sch Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	f.ogara@ucc.ie		O'Gara, Fergal/0000-0002-2659-0673; Hennessy, Emma/0000-0003-0511-0797; Claire, LEGENDRE/0000-0003-0248-1111	European Commission [607786, CP-TP-312184, 311975, 287589, 256596]; Science Foundation Ireland [SSPC-2, 07/IN.1/B948, 12/TIDA/B2411, 12/TIDA/B2405, 09/RFP/BMT2350]; Department of Agriculture and Food (FIRM/RSF/CoFoRD) [FIRM 08/RDC/629]; Irish Research Council for Science, Engineering and Technology [PD/2011/2414, RS/2010/2413]; Health Research Board [RP/2006/271, RP/2007/290, HRA/2009/146]; Environmental Protection Agency [EPA2006-PhD-S-21, EPA2008-PhD-S-2]; Marine Institute [C2CRA 2007/082]; Higher Education Authority of Ireland [PRTLI4]; Society For General Microbiology President's Fund for Research Visits	European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture and Food (FIRM/RSF/CoFoRD); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; Environmental Protection Agency(United States Environmental Protection Agency); Marine Institute; Higher Education Authority of Ireland; Society For General Microbiology President's Fund for Research Visits	This research was supported in part by grants awarded by the European Commission (http://ec.europa.eu/index_en.htm)(FP7-PEOPLE-2013-ITN, 607786; FP7-KBBE-2012-6, CP-TP-312184; FP7-KBBE-2012-6, 311975; OCEAN 2011-2, 287589; Marie Curie 256596), Science Foundation Ireland (www.sfi.ie)(SSPC-2; 07/IN.1/B948; 12/TIDA/B2411; 12/TIDA/B2405; 09/RFP/BMT2350), the Department of Agriculture and Food (www.agriculture.gov.ie/) (FIRM/RSF/CoFoRD; FIRM 08/RDC/629), the Irish Research Council for Science, Engineering and Technology (www.research.ie/) (PD/2011/2414; RS/2010/2413), the Health Research Board (www.hrb.ie)(RP/2006/271; RP/2007/290; HRA/2009/146), the Environmental Protection Agency (www.epa.ie) (EPA2006-PhD-S-21; EPA2008-PhD-S-2), the Marine Institute (https://www.marine.ie) (Beaufort award C2CRA 2007/082) Teagasc (www.teagasc.ie) (Walsh Fellowship 2013), the Higher Education Authority of Ireland (www.hea.ie)(PRTLI4) and the Society For General Microbiology President's Fund for Research Visits (www.sgm.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bove PF, 2006, FREE RADICAL BIO MED, V41, P515, DOI 10.1016/j.freeradbiomed.2006.05.011; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284; Dach K, 2009, INFECT IMMUN, V77, P5583, DOI 10.1128/IAI.00121-09; Darling KEA, 2003, INFECT IMMUN, V71, P2341, DOI 10.1128/IAI.71.5.2341-2349.2003; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Difeo A, 2008, CANCER RES, V68, P965, DOI 10.1158/0008-5472.CAN-07-2604; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Dulak J, 2005, CURR CANCER DRUG TAR, V5, P579, DOI 10.2174/156800905774932824; Edwards LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027030; Erkkila L, 2005, ANTIMICROB AGENTS CH, V49, P3959, DOI 10.1128/AAC.49.9.3959-3962.2005; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hennessy E, 2013, J ANTIBIOT, V66, P99, DOI 10.1038/ja.2012.95; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Iwata A, 2012, CLIN EXP IMMUNOL, V168, P234, DOI 10.1111/j.1365-2249.2012.04564.x; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jendrossek V, 2001, INFECT IMMUN, V69, P2675, DOI 10.1128/IAI.69.4.2675-2683.2001; Jouneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022655; Khan MA, 2008, INFECT IMMUN, V76, P1410, DOI 10.1128/IAI.01141-07; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; Kim TG, 2011, EXP DERMATOL, V20, P855, DOI 10.1111/j.1600-0625.2011.01343.x; Kouroumichakis I, 2011, EUR J INTERN MED, V22, P125, DOI 10.1016/j.ejim.2010.12.004; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; LAW RE, 1992, MOL CELL BIOL, V12, P103, DOI 10.1128/MCB.12.1.103; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; LEONARD S, 1990, J BIOL CHEM, V265, P5157; Li CB, 2012, CLIN EXP PHARMACOL P, V39, P759, DOI 10.1111/j.1440-1681.2012.05730.x; Lin TJ, 2003, INFECT IMMUN, V71, P365, DOI 10.1128/IAI.71.1.365-373.2003; Mahabeleshwar GH, 2011, IMMUNITY, V34, P715, DOI 10.1016/j.immuni.2011.04.014; Masamura K, 2003, ARTERIOSCL THROM VAS, V23, P512, DOI 10.1161/01.ATV.0000060461.64771.F0; MASSION PP, 1994, J CLIN INVEST, V93, P26, DOI 10.1172/JCI116954; Matsuda N, 2006, J PHARMACOL EXP THER, V319, P1348, DOI 10.1124/jpet.106.109785; McGuffie EM, 1998, INFECT IMMUN, V66, P2607, DOI 10.1128/IAI.66.6.2607-2613.1998; Mermis JD, 2012, CURR INFECT DIS REP, V14, P484, DOI 10.1007/s11908-012-0277-1; Mgbemena V, 2013, CELL IMMUNOL, V283, P1, DOI 10.1016/j.cellimm.2013.06.002; Mgbemena V, 2012, J IMMUNOL, V189, P606, DOI 10.4049/jimmunol.1102742; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; O'Grady E, 2007, NAT REV MICROBIOL, V5, P337, DOI 10.1038/nrmicro1641; O'Grady EP, 2006, INFECT IMMUN, V74, P5893, DOI 10.1128/IAI.00489-06; Parihar SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075490; Park JH, 2005, BBA-GENE STRUCT EXPR, V1732, P82, DOI 10.1016/j.bbaexp.2006.01.002; Parker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059932; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Quist-Paulsen P, 2010, CURR OPIN CARDIOL, V25, P399, DOI 10.1097/HCO.0b013e3283398e53; Sauvonnet N, 2002, J BIOL CHEM, V277, P25133, DOI 10.1074/jbc.M203239200; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tuomisto TT, 2008, CARDIOVASC RES, V78, P175, DOI 10.1093/cvr/cvn007; Urtasun R, 2012, ALCOHOL CLIN EXP RES, V36, P1851, DOI 10.1111/j.1530-0277.2012.01798.x; Vetter D, 2012, HEPATOLOGY, V56, P1361, DOI 10.1002/hep.25810; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Yea S, 2008, GASTROENTEROLOGY, V134, P1521, DOI 10.1053/j.gastro.2008.02.015; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	65	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102200	10.1371/journal.pone.0102200	http://dx.doi.org/10.1371/journal.pone.0102200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010049	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800081
J	Parkes-Ratanshi, R; Elbireer, A; Mbambu, B; Mayanja, F; Coutinho, A; Merry, C				Parkes-Ratanshi, Rosalind; Elbireer, Ali; Mbambu, Betty; Mayanja, Faridah; Coutinho, Alex; Merry, Concepta			Ebola Outbreak Response; Experience and Development of Screening Tools for Viral Haemorrhagic Fever (VHF) in a HIV Center of Excellence Near to VHF Epicentres	PLOS ONE			English	Article							UGANDA; MARBURG; DIAGNOSIS; VIRUS; TIME	Introduction: There have been 3 outbreaks of viral hemorrhagic fever (VHF) in Uganda in the last 2 years. VHF often starts with non-specific symptoms prior to the onset of haemorrhagic signs. HIV clinics in VHF outbreak countries such as Uganda see large numbers of patients with HIV 1/2 infection presenting with non-specific symptoms every day. Whilst there are good screening tools for general health care facilities expecting VHF suspects, we were unable to find tools for use in HIV or other non-acute clinics. Methods: We designed tools to help with communication to staff, infection control and screening of HIV patients with nonspecific symptoms in a large HIV clinic during the outbreaks in Uganda. We describe our experiences in using these tools in 2 Ebola Virus Disease outbreaks in Uganda. Results: During the Ebola Virus Disease (EVD) outbreaks, enhanced infection control and communication procedures were implemented within 24 hours of the WHO/Ministry of Health announcement of the outbreaks. During course of these outbreaks the clinic saw 12,544 patients with HIV 1/2 infection, of whom 3,713 attended without an appointment, suggesting new symptoms. Of these 4 were considered at risk of EVD and seen with full infection procedures; 3 were sent home after further investigation. One patient was referred to the National Referral Hospital VHF unit, but discharged on the same day. One additional VHF suspect was identified outside of a VHF outbreak; he was transferred to the National Referral Hospital and placed in isolation within 2 hours of arriving at the HIV clinic. Discussion: Use of simple screening tools can be helpful in managing large numbers of symptomatic patients attending for routine and non-routine medical care (including HIV care) within a country experiencing a VHF outbreak, and can raise medical staff awareness of VHF outside of the epidemics.	[Parkes-Ratanshi, Rosalind; Elbireer, Ali; Mbambu, Betty; Mayanja, Faridah; Coutinho, Alex; Merry, Concepta] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Elbireer, Ali] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Merry, Concepta] Univ Ireland Trinity Coll, Dublin, Ireland; [Merry, Concepta] Northwestern Univ, Chicago, IL 60611 USA	Johns Hopkins University; Trinity College Dublin; Northwestern University	Parkes-Ratanshi, R (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	rratanshi@idi.co.ug	Parkes-Ratanshi, Rosalind/AAR-5409-2020; Merry, Concepta/AAM-7887-2021	Parkes-Ratanshi, Rosalind/0000-0001-9297-1311; Elbireer, Ali/0000-0002-2513-3497				Bitekyerezo M, 2002, TROP DOCT, V32, P10, DOI 10.1177/004947550203200107; Borchert M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-357; Control CfD, 2009, EB HEM FEV INF PACK; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Green A, 2012, LANCET, V380, P1726, DOI 10.1016/S0140-6736(12)61973-4; Hewlett Bonnie L, 2005, J Transcult Nurs, V16, P289, DOI 10.1177/1043659605278935; Jeffs B, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506775598914; Kinsman J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-15; Locsin RC, 2002, J ADV NURS, V37, P173, DOI 10.1046/j.1365-2648.2002.02069.x; Mbonye Anthony K, 2010, Int J Adolesc Med Health, V22, P257, DOI 10.1515/IJAMH.2010.22.2.257; Mupere E, 2001, Afr Health Sci, V1, P60; Mwesiga A, 2011, PAN AFR MED J, V9; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; Raabe VN, 2010, T ROY SOC TROP MED H, V104, P48, DOI 10.1016/j.trstmh.2009.07.011; Roddy P, 2009, T ROY SOC TROP MED H, V103, P200, DOI 10.1016/j.trstmh.2008.09.001; Roddy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052986; SANCHEZ A, 1995, EMERG INFECT DIS, V1, P96, DOI 10.3201/eid0103.950307; Shoemaker T, 2012, EMERG INFECT DIS, V18, P1480, DOI 10.3201/eid1809.111536; UNAIDS, 2013, UG AIDSINFO; Wakeham K, 2010, J PALLIAT MED, V13, P375, DOI 10.1089/jpm.2009.0259; WHO CfDCa, 1998, INF CONTR VIR HAEM F	22	20	22	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100333	10.1371/journal.pone.0100333	http://dx.doi.org/10.1371/journal.pone.0100333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007269	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600010
J	Sanchez-Alvarez, M; Finger, F; Arias-Garcia, MD; Bousgouni, V; Pascual-Vargas, P; Bakal, C				Sanchez-Alvarez, Miguel; Finger, Fabian; Arias-Garcia, Maria del Mar; Bousgouni, Vicky; Pascual-Vargas, Patricia; Bakal, Chris			Signaling Networks Converge on TORC1-SREBP Activity to Promote Endoplasmic Reticulum Homeostasis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MTOR COMPLEX 1; CELL-GROWTH; CAENORHABDITIS-ELEGANS; TRANSLATIONAL CONTROL; SREBP PATHWAY; STRESS; DROSOPHILA; GENE; BIOSYNTHESIS	The function and capacity of the endoplasmic reticulum (ER) is determined by multiple processes ranging from the local regulation of peptide translation, translocation, and folding, to global changes in lipid composition. ER homeostasis thus requires complex interactions amongst numerous cellular components. However, describing the networks that maintain ER function during changes in cell behavior and environmental fluctuations has, to date, proven difficult. Here we perform a systems-level analysis of ER homeostasis, and find that although signaling networks that regulate ER function have a largely modular architecture, the TORC1-SREBP signaling axis is a central node that integrates signals emanating from different sub-networks. TORC1-SREBP promotes ER homeostasis by regulating phospholipid biosynthesis and driving changes in ER morphology. In particular, our network model shows TORC1-SREBP serves to integrate signals promoting growth and G1-S progression in order to maintain ER function during cell proliferation.	[Sanchez-Alvarez, Miguel; Finger, Fabian; Arias-Garcia, Maria del Mar; Bousgouni, Vicky; Pascual-Vargas, Patricia; Bakal, Chris] Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bakal, C (corresponding author), Inst Canc Res, Chester Beatty Labs, Div Canc Biol, London, England.	cbakal@icr.ac.uk	SÁNCHEZ-ÁLVAREZ, MIGUEL/AAA-4507-2019	SÁNCHEZ-ÁLVAREZ, MIGUEL/0000-0001-5287-1420; Finger, Fabian/0000-0002-0763-6250; Mar Arias-Garcia, M/0000-0003-0130-1107; Bakal, Chris/0000-0002-0413-6744	Biotechnology and Biological Sciences Research Council [BB/I002510/1]; BBSRC [BB/I002510/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council: Grant BB/I002510/1. CB is a Research Career Development Fellow of the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Glimcher LH, 2010, ANN RHEUM DIS, V69, P67, DOI 10.1136/ard.2009.119388; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Henry KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012732; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Thibault G, 2012, MOL CELL, V48, P16, DOI 10.1016/j.molcel.2012.08.016; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101164	10.1371/journal.pone.0101164	http://dx.doi.org/10.1371/journal.pone.0101164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007267	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600030
J	Zelaya, JE; Goenezen, S; Dargon, PT; Azarbal, AF; Rugonyi, S				Zelaya, Jaime E.; Goenezen, Sevan; Dargon, Phong T.; Azarbal, Amir-Farzin; Rugonyi, Sandra			Improving the Efficiency of Abdominal Aortic Aneurysm Wall Stress Computations	PLOS ONE			English	Article							HUMAN CAROTID BIFURCATION; FINITE-ELEMENT-ANALYSIS; INTRALUMINAL THROMBUS; COMPUTED-TOMOGRAPHY; RUPTURE RISK; MECHANICS; THICKNESS; BEHAVIOR; ATHEROGENESIS; PREDICTION	An abdominal aortic aneurysm is a pathological dilation of the abdominal aorta, which carries a high mortality rate if ruptured. The most commonly used surrogate marker of rupture risk is the maximal transverse diameter of the aneurysm. More recent studies suggest that wall stress from models of patient-specific aneurysm geometries extracted, for instance, from computed tomography images may be a more accurate predictor of rupture risk and an important factor in AAA size progression. However, quantification of wall stress is typically computationally intensive and time-consuming, mainly due to the nonlinear mechanical behavior of the abdominal aortic aneurysm walls. These difficulties have limited the potential of computational models in clinical practice. To facilitate computation of wall stresses, we propose to use a linear approach that ensures equilibrium of wall stresses in the aneurysms. This proposed linear model approach is easy to implement and eliminates the burden of nonlinear computations. To assess the accuracy of our proposed approach to compute wall stresses, results from idealized and patient-specific model simulations were compared to those obtained using conventional approaches and to those of a hypothetical, reference abdominal aortic aneurysm model. For the reference model, wall mechanical properties and the initial unloaded and unstressed configuration were assumed to be known, and the resulting wall stresses were used as reference for comparison. Our proposed linear approach accurately approximates wall stresses for varying model geometries and wall material properties. Our findings suggest that the proposed linear approach could be used as an effective, efficient, easy-to-use clinical tool to estimate patient-specific wall stresses.	[Zelaya, Jaime E.; Rugonyi, Sandra] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Goenezen, Sevan] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Dargon, Phong T.; Azarbal, Amir-Farzin] Oregon Hlth & Sci Univ, Dept Surg, Div Vasc Surg, Portland, OR 97201 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Oregon Health & Science University	Rugonyi, S (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	rugonyis@ohsu.edu	Rugonyi, Sandra/AAF-9269-2020		NSF [DBI-1052688]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Advancing Translational Sciences (NCATS) NIH [TL1TR000129]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000129] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1052688] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Oregon Clinical and Translational Research Institute (OCTRI); National Center for Advancing Translational Sciences (NCATS) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the NSF DBI-1052688 grant and a grant from the Oregon Clinical and Translational Research Institute (OCTRI), National Center for Advancing Translational Sciences (NCATS) NIH TL1TR000129. The content is solely the responsibility of the authors and does not necessarily represent the official views of grant giving bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atar E, 2006, AM J ROENTGENOL, V186, P386, DOI 10.2214/AJR.04.0449; Bathe K-J, 1996, FINITE ELEMENT PROCE, P291; Bauchau OA, 2009, STRUCTURAL ANAL APPL, P117; DARLING RC, 1977, CIRCULATION, V56, P161; de Putter S, 2007, J BIOMECH, V40, P1081, DOI 10.1016/j.jbiomech.2006.04.019; Di Achille P, 2011, J BIOMECH, V44, P2418, DOI 10.1016/j.jbiomech.2011.06.029; Di Martino ES, 2003, ANN BIOMED ENG, V31, P804, DOI 10.1114/1.1581880; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; FUNG YC, 1991, ANN BIOMED ENG, V19, P237, DOI 10.1007/BF02584301; Gee MW, 2010, INT J NUMER METH BIO, V26, P52, DOI 10.1002/cnm.1236; Geest JPV, 2006, J BIOMECH, V39, P1324, DOI 10.1016/j.jbiomech.2005.03.003; HE CM, 1994, J VASC SURG, V20, P6, DOI 10.1016/0741-5214(94)90169-4; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Humphrey JD, 2012, J BIOMECH, V45, P805, DOI 10.1016/j.jbiomech.2011.11.021; Kaazempur-Mofrad MR, 2003, J ENG MATH, V47, P299, DOI 10.1023/B:ENGI.0000007974.82115.16; Li ZY, 2010, CIRCULATION, V122, P1815, DOI 10.1161/CIRCULATIONAHA.110.939819; Lu J, 2007, J BIOMECH, V40, P693, DOI 10.1016/j.jbiomech.2006.01.015; Martufi G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127256; McGloughlin TM, 2010, ARTERIOSCL THROM VAS, V30, P1687, DOI 10.1161/ATVBAHA.110.204529; Molacek J, 2011, ANN VASC SURG, V25, P1036, DOI 10.1016/j.avsg.2011.05.034; Mower WR, 1997, J VASC SURG, V26, P602, DOI 10.1016/S0741-5214(97)70058-2; Nicholls SC, 1998, J VASC SURG, V28, P884, DOI 10.1016/S0741-5214(98)70065-5; Polzer S, 2013, MED ENG PHYS, V35, P1282, DOI 10.1016/j.medengphy.2013.01.008; Rachev A, 2003, CISM COURSES LECT, P221; Rachev A, 2003, J BIOMECH, V36, P661, DOI 10.1016/S0021-9290(02)00444-X; Raghavan ML, 2006, ANN BIOMED ENG, V34, P1414, DOI 10.1007/s10439-006-9115-7; Raghavan ML, 2006, J BIOMECH, V39, P3010, DOI 10.1016/j.jbiomech.2005.10.021; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Raut SS, 2013, J BIOMECH ENG, V135; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Rodriguez JF, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898830; Roy D, 2012, COMPUT MATH METHOD M, V2012, P1; Scotti CM, 2008, COMPUT METHOD BIOMEC, V11, P301, DOI 10.1080/10255840701827412; Shum J, 2010, MED PHYS, V37, P638, DOI 10.1118/1.3284976; Speelman L, 2009, J BIOMECH, V42, P1713, DOI 10.1016/j.jbiomech.2009.04.020; Speelman L, 2010, J VASC SURG, V51, P19, DOI 10.1016/j.jvs.2009.08.075; STRINGFELLOW MM, 1987, J SURG RES, V42, P425, DOI 10.1016/0022-4804(87)90178-8; Taber LA, 2001, J BIOMECH ENG-T ASME, V123, P528, DOI 10.1115/1.1412451; Teutelink A, 2007, J ENDOVASC THER, V14, P44, DOI 10.1583/06-1976.1; Thubrikar MJ, 2001, ANN VASC SURG, V15, P355, DOI 10.1007/s100160010080; Tong J, 2011, EUR J VASC ENDOVASC, V42, P207, DOI 10.1016/j.ejvs.2011.02.017; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Vorp DA, 2007, J BIOMECH, V40, P1887, DOI 10.1016/j.jbiomech.2006.09.003; Wang DHJ, 2002, J VASC SURG, V36, P598, DOI 10.1067/mva.2002.126087; Younis HF, 2004, BIOMECH MODEL MECHAN, V3, P17, DOI 10.1007/s10237-004-0046-7	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101353	10.1371/journal.pone.0101353	http://dx.doi.org/10.1371/journal.pone.0101353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007052	Green Published, gold			2022-12-25	WOS:000339040600035
J	Zhao, SQ; Zhou, L; Niu, GM; Li, Y; Zhao, DZ; Zeng, HY				Zhao, Shengqiang; Zhou, Lei; Niu, Gengming; Li, Yan; Zhao, Dezheng; Zeng, Huiyan			Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways	FASEB JOURNAL			English	Article						angiogenesis; IGF-1R; VEGFR2; KDR; phosphorylation	NITRIC-OXIDE SYNTHASE; NGFI-B NUR77; ENDOTHELIAL-CELLS; GENE-EXPRESSION; ANGIOGENESIS; VEGF; INSULIN; KINASE; PERMEABILITY; TR3/NUR77	Angiogenesis is a hallmark of many diseases, including cancer, ischemic heart disease, inflammation, and others. It is well known that vascular endothelial growth factor (VEGF) is the most important angiogenic factor. Recently, we demonstrated that orphan nuclear receptor TR3 (mouse Nur77 and rat NGFI-B) plays critical roles in tumor growth and angiogenesis induced by VEGF-A in vitro and in vivo. However, the signaling pathways that mediate the expression of TR3 induced by VEGF are still not completely understood. Here we reported that 3 TR3 transcript variants (TR3-TVs) are expressed at differential levels, and regulated differentially in endothelial cells. While the expression of TR3-TV1 is relatively low, the expression of TR3-TV2 is up-regulated markedly, and the expression of TR3-TV3 is up-regulated moderately in endothelial cells induced by VEGF-A. The kinetics of the induction of these TR3-TVs is different. We also found that several signaling pathways, including calcium-PLC-PKC-PKD1 pathway, NF-kappa B pathway, and MAP kinase (ERK, p38, and JNK) pathways are important for VEGF-A-induced TR3-TV2 and TR3-TV3 mRNA induction. More important, we found that VEGF-A or VEGF-E, but not VEGF-B, nor placenta growth factor (PlGF), induces the phosphorylation of insulin-like growth factor-1 receptor (IGF-1R) and the interaction of VEGF receptor 2/kinase insert domain receptor (VEGFR2/KDR) with IGF-1R, which mediates the expression of TR3-TV2, but not TR3-TV3. Taking together, we demonstrate that TR3-TVs are differentially regulated by VEGF-A and identify a novel signaling pathway by which VEGF-A and VEGF-E, but neither VEGF-B, nor PlGF, induce the interaction of VEGFR2/KDR with IGF-1R, resulting in IGF-1R transactivation to induce the high level expression of TR3-TV2. Our data not only elucidate the signaling pathways by which TR3-TVs are regulated, but extend the molecular mechanism, by which VEGF-A-induced angiogenesis. These studies should permit the development of screening assays for compounds that inhibit VEGF signaling.	[Zhao, Shengqiang; Zhou, Lei; Niu, Gengming; Li, Yan; Zhao, Dezheng; Zeng, Huiyan] Harvard Univ, Sch Med, Ctr Vasc Biol Res Div Mol, Boston, MA 02215 USA; [Zhao, Shengqiang; Zhou, Lei; Niu, Gengming; Li, Yan; Zhao, Dezheng; Zeng, Huiyan] Harvard Univ, Sch Med, Div Mol & Vasc Biol, Boston, MA 02215 USA; [Zhao, Dezheng] Harvard Univ, Sch Med, Div Gastroenterol, Dept Med,Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhao, Shengqiang; Li, Yan] Shandong Univ, Prov Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China; [Zhou, Lei] Xi An Jiao Tong Univ, Sch Med, Dept Hepatobiliary Surg, Xian 710049, Peoples R China; [Zhou, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Gen Surg, Xian 710049, Peoples R China; [Niu, Gengming] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Shandong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Fudan University	Zeng, HY (corresponding author), Harvard Univ, Sch Med, Ctr Vasc Biol Res Div Mol, 99 Brookline Ave RN270F, Boston, MA 02215 USA.	hzeng@bidmc.harvard.edu	NIU, NIU/AAA-1523-2022		U.S. National Institutes of Health [R01CA133235, R01DK095873, R21DK080970]; American Cancer Society [RSG CSM 113297]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA133235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095873, R21DK080970] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Pengfei Cui and Taiyang Ye for their technical assistance. This work was supported by U.S. National Institutes of Health grants R01CA133235 (H.Z.), R01DK095873 (D.Z.), and R21DK080970 (D.Z.); American Cancer Society grant RSG CSM 113297 (D.Z.); and scholarships from the China Scholarship Council (S.Z., L.Z., G.N., Y.L.).	Abe Mayumi, 2001, Angiogenesis, V4, P289, DOI 10.1023/A:1016018617152; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bandoh S, 1997, J NEUROENDOCRINOL, V9, P3, DOI 10.1046/j.1365-2826.1997.00571.x; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Bid HK, 2012, MOL CANCER THER, V11, P649, DOI 10.1158/1535-7163.MCT-11-0575; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; DeYoung RA, 2003, J BIOL CHEM, V278, P47104, DOI 10.1074/jbc.M307496200; Folkman J, 1997, EXS, V79, P1; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, SCI AM, V275, P150, DOI 10.1038/scientificamerican0996-150; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gilbert F, 2006, BIOL PSYCHIAT, V60, P538, DOI 10.1016/j.biopsych.2006.04.023; Hayashi K, 1996, MOL CELL ENDOCRINOL, V123, P205, DOI 10.1016/S0303-7207(96)03909-3; HEDVAT CV, 1995, MOL ENDOCRINOL, V9, P1692, DOI 10.1210/me.9.12.1692; Jacobs CM, 2004, J BIOL CHEM, V279, P50097, DOI 10.1074/jbc.M409145200; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Katagiri Y, 1997, J BIOL CHEM, V272, P31278, DOI 10.1074/jbc.272.50.31278; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; NAKAOHAYASHI J, 1992, ATHEROSCLEROSIS, V92, P141, DOI 10.1016/0021-9150(92)90273-J; Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200; Qin LL, 2013, BLOOD, V121, P2154, DOI 10.1182/blood-2012-07-443903; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SCEARCE LM, 1993, J BIOL CHEM, V268, P8855; SCHMID C, 1995, CELL BIOL INT, V19, P445, DOI 10.1006/cbir.1995.1088; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; WATSON MA, 1990, DEVELOPMENT, V110, P173; WILLIAMS GT, 1993, MOL CELL BIOL, V13, P6124, DOI 10.1128/MCB.13.10.6124; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108	39	16	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4524	4533		10.1096/fj.13-248401	http://dx.doi.org/10.1096/fj.13-248401			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25016027	Green Published			2022-12-25	WOS:000342222700028
J	Furrow, RE				Furrow, Robert E.			Epigenetic Inheritance, Epimutation, and the Response to Selection	PLOS ONE			English	Article							DNA METHYLATION; POPULATIONS; EVOLUTION	There has been minimal theoretical exploration of the role of epigenetic variation in the response to natural selection. Using a population genetic model, I derive formulae that characterize the response of epigenetic variation to selection over multiple generations. Unlike genetic models in which mutation rates are assumed to be low relative to the strength of selection, the response to selection decays quickly due to a rapid lowering of parent-offspring epiallelic correlation. This effect is separate from the slowing response caused by a reduction in epigenetic variation. These results suggest that epigenetic variation may be less responsive to natural selection than is genetic variation, even in cases where levels of heritability appear similar.	Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Furrow, RE (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	rfurrow@stanford.edu		Furrow, Robert/0000-0001-5732-5613				Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Cropley JE, 2012, P ROY SOC B-BIOL SCI, V279, P2347, DOI 10.1098/rspb.2011.2646; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Day T, 2011, AM NAT, V178, pE18, DOI 10.1086/660911; Geoghegan JL, 2012, THEOR POPUL BIOL, V81, P232, DOI 10.1016/j.tpb.2011.08.001; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Hirsch S, 2012, Cold Spring Harb Symp Quant Biol, V77, P97, DOI 10.1101/sqb.2013.77.014605; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Jablonka E, 1998, TRENDS ECOL EVOL, V13, P206, DOI 10.1016/S0169-5347(98)01344-5; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Klironomos FD, 2013, BIOESSAYS, V35, P571, DOI 10.1002/bies.201200169; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Liu S, 2012, MOL GENET GENOMICS, V287, P643, DOI 10.1007/s00438-012-0704-x; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Silveira AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003437; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Stumpf MPH, 2002, P NATL ACAD SCI USA, V99, P15234, DOI 10.1073/pnas.232546899; Tal O, 2010, GENETICS, V184, P1037, DOI 10.1534/genetics.109.112466; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x	29	17	18	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101559	10.1371/journal.pone.0101559	http://dx.doi.org/10.1371/journal.pone.0101559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019291	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600017
J	Wrenshall, LE; Clabaugh, SE; Cool, DR; Arumugam, P; Grunwald, WC; Smith, DR; Liu, GC; Miller, JD				Wrenshall, Lucile E.; Clabaugh, Suzanne E.; Cool, David R.; Arumugam, Prakash; Grunwald, William C.; Smith, Deandra R.; Liu, Gino C.; Miller, John D.			Identification of a Cytotoxic Form of Dimeric Interleukin-2 in Murine Tissues	PLOS ONE			English	Article							CELL-DEATH; MELANOMA-CELLS; LYMPHOCYTES-T; CROSS-LINKING; IL-2; OLIGODENDROCYTES; TRANSGLUTAMINASE; EXPRESSION; HEPARANASE; RECEPTOR	Interleukin-2 (IL-2) is a multi-faceted cytokine, known for promoting proliferation, survival, and cell death depending on the cell type and state. For example, IL-2 facilitates cell death only in activated T cells when antigen and IL-2 are abundant. The availability of IL-2 clearly impacts this process. Our laboratory recently demonstrated that IL-2 is retained in blood vessels by heparan sulfate, and that biologically active IL-2 is released from vessel tissue by heparanase. We now demonstrate that heparanase digestion also releases a dimeric form of IL-2 that is highly cytotoxic to cells expressing the IL-2 receptor. These cells include "traditional'' IL-2 receptor-bearing cells such as lymphocytes, as well as those less well known for IL-2 receptor expression, such as epithelial and smooth muscle cells. The morphologic changes and rapid cell death induced by dimeric IL-2 imply that cell death is mediated by disruption of membrane permeability and subsequent necrosis. These findings suggest that IL-2 has a direct and unexpectedly broad influence on cellular homeostatic mechanisms in both immune and non-immune systems.	[Wrenshall, Lucile E.; Clabaugh, Suzanne E.; Arumugam, Prakash; Liu, Gino C.; Miller, John D.] Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Cool, David R.; Grunwald, William C.] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Smith, Deandra R.] Univ Nebraska, Eppley Inst Res Canc, Omaha, NE 68182 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; University of Nebraska System	Wrenshall, LE (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA.	lucile.wrenshall@wright.edu			Miami Valley Hospital Foundation; NIH [R21 HL102589-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102589] Funding Source: NIH RePORTER	Miami Valley Hospital Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the following: 1. Miami Valley Hospital Foundation www.mvhfoundation.org; 2. NIH grant #R21 HL102589-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CONRADT HS, 1988, BIOCHEM BIOPH RES CO, V150, P97, DOI 10.1016/0006-291X(88)90491-3; deGaldeano AG, 1996, TUMOR BIOL, V17, P155, DOI 10.1159/000217978; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; EITAN S, 1992, P NATL ACAD SCI USA, V89, P5442, DOI 10.1073/pnas.89.12.5442; EITAN S, 1993, SCIENCE, V261, P106, DOI 10.1126/science.8100369; EIZENBERG O, 1995, EMBO J, V14, P1136, DOI 10.1002/j.1460-2075.1995.tb07097.x; Gerritsma JSJ, 1997, J AM SOC NEPHROL, V8, P1510; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Harrison RL, 2006, ADV VIRUS RES, V68, P159, DOI 10.1016/S0065-3527(06)68005-6; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Koul S, 2014, AM J PHYSL RENAL PHY; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Miller JD, 2008, IMMUNOL CELL BIOL, V86, P192, DOI 10.1038/sj.icb.7100128; Miller JD, 2012, IMMUNOL CELL BIOL, V90, P159, DOI 10.1038/icb.2011.45; Murthy SNP, 2000, P NATL ACAD SCI USA, V97, P44, DOI 10.1073/pnas.97.1.44; Pillet AH, 2008, EUR CYTOKINE NETW, V19, P49, DOI 10.1684/ecn.2008.0120; Reinecker H, HUMAN INTESTINAL EPI; RIMOLDI D, 1993, ANTICANCER RES, V13, P555; Snow AL, 2010, IMMUNOL REV, V236, P68, DOI 10.1111/j.1600-065X.2010.00917.x; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Zambricki E, 2005, AM J TRANSPLANT, V5, P2623, DOI 10.1111/j.1600-6143.2005.01075.x; Zheng LX, 1998, J IMMUNOL, V160, P763; ZURAWSKI SM, 1993, EMBO J, V12, P5113, DOI 10.1002/j.1460-2075.1993.tb06206.x	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102191	10.1371/journal.pone.0102191	http://dx.doi.org/10.1371/journal.pone.0102191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019288	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600052
J	Zhu, JE; Wu, XR; Yuan, SJ; Qian, D; Nan, Q; An, LZ; Xiang, Y				Zhu, Jingen; Wu, Xiaorong; Yuan, Shunjie; Qian, Dong; Nan, Qiong; An, Lizhe; Xiang, Yun			Annexin5 Plays a Vital Role in Arabidopsis Pollen Development via Ca2+-Dependent Membrane Trafficking	PLOS ONE			English	Article							ACTIN-BINDING PROTEINS; TUBE TIP GROWTH; PLANT ANNEXINS; F-ACTIN; DIFFERENTIAL EXPRESSION; PROTEOMIC ANALYSIS; BREFELDIN-A; ENDOPLASMIC-RETICULUM; PHOSPHOLIPID-BINDING; POLARIZED GROWTH	The regulation of pollen development and pollen tube growth is a complicated biological process that is crucial for sexual reproduction in flowering plants. Annexins are widely distributed from protists to higher eukaryotes and play multiple roles in numerous cellular events by acting as a putative "linker" between Ca2+ signaling, the actin cytoskeleton and the membrane, which are required for pollen development and pollen tube growth. Our recent report suggested that downregulation of the function of Arabidopsis annexin 5 (Ann5) in transgenic Ann5-RNAi lines caused severely sterile pollen grains. However, little is known about the underlying mechanisms of the function of Ann5 in pollen. This study demonstrated that Ann5 associates with phospholipid membrane and this association is stimulated by Ca2+ in vitro. Brefeldin A (BFA) interferes with endomembrane trafficking and inhibits pollen germination and pollen tube growth. Both pollen germination and pollen tube growth of Ann5-overexpressing plants showed increased resistance to BFA treatment, and this effect was regulated by calcium. Overexpression of Ann5 promoted Ca2+-dependent cytoplasmic streaming in pollen tubes in vivo in response to BFA. Lactrunculin (LatB) significantly prohibited pollen germination and tube growth by binding with high affinity to monomeric actin and preferentially targeting dynamic actin filament arrays and preventing actin polymerization. Overexpression of Ann5 did not affect pollen germination or pollen tube growth in response to LatB compared with wild-type, although Ann5 interacts with actin filaments in a manner similar to some animal annexins. In addition, the sterile pollen phenotype could be only partially rescued by Ann5 mutants at Ca2+-binding sites when compared to the complete recovery by wild-type Ann5. These data demonstrated that Ann5 is involved in pollen development, germination and pollen tube growth through the promotion of endomembrane trafficking modulated by calcium. Our results provide reliable molecular mechanisms that underlie the function of Ann5 in pollen.	[Zhu, Jingen; Wu, Xiaorong; Yuan, Shunjie; Qian, Dong; Nan, Qiong; An, Lizhe; Xiang, Yun] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China	Lanzhou University	Xiang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	xiangy@lzu.edu.cn	; Yang, Xiaoming/GRJ-9483-2022	Xiang, Yun/0000-0002-5178-0700; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2014CB954200-03]; National Natural Science Foundation of China [30800079, 31270326]; Program for New Century Excellent Talents in University [NCET-13-0264]; Natural Science Foundation for Distinguished Yong Scholars of Gansu Province [2013GS10064]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation for Distinguished Yong Scholars of Gansu Province	This work was supported by the National Basic Research Program (2014CB954200-03), the National Natural Science Foundation of China (30800079 and 31270326), the Program for New Century Excellent Talents in University (NCET-13-0264), and the Natural Science Foundation for Distinguished Yong Scholars of Gansu Province (2013GS10064) to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Arboledas D, 1997, FEBS LETT, V416, P217, DOI 10.1016/S0014-5793(97)01207-6; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Bai SY, 2010, J EXP BOT, V61, P1089, DOI 10.1093/jxb/erp373; Bassani M, 2004, PLANT MOL BIOL, V56, P367, DOI 10.1007/s11103-004-3474-y; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7970, DOI 10.1021/bi00246a014; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bianco L, 2009, J PROTEOMICS, V72, P586, DOI 10.1016/j.jprot.2008.11.019; BLACKBOURN HD, 1992, PLANT PHYSIOL, V99, P864, DOI 10.1104/pp.99.3.864; BOUSTEAD CM, 1989, FEBS LETT, V244, P456, DOI 10.1016/0014-5793(89)80582-4; Breton G, 2000, PLANT CELL PHYSIOL, V41, P177, DOI 10.1093/pcp/41.2.177; Buitink J, 2006, PLANT J, V47, P735, DOI 10.1111/j.1365-313X.2006.02822.x; Cai G, 2009, J EXP BOT, V60, P495, DOI 10.1093/jxb/ern321; Calvert CM, 1996, PLANT CELL, V8, P333, DOI 10.1105/tpc.8.2.333; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Cantero A, 2006, PLANT PHYSIOL BIOCH, V44, P13, DOI 10.1016/j.plaphy.2006.02.002; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Cheung AY, 2001, SCIENCE, V293, P1441, DOI 10.1126/science.1065051; CLARK GB, 1992, PLANTA, V187, P1, DOI 10.1007/BF00201617; Clark GB, 2005, PLANTA, V220, P621, DOI 10.1007/s00425-004-1374-7; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Clark Greg, 2005, Gravit Space Biol Bull, V18, P113; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dabitz N, 2005, BIOCHEMISTRY-US, V44, P16292, DOI 10.1021/bi0516226; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Filipenko NR, 2001, J BIOL CHEM, V276, P5310, DOI 10.1074/jbc.M009710200; Fu Y, 2010, J INTEGR PLANT BIOL, V52, P131, DOI 10.1111/j.1744-7909.2010.00922.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gorecka KM, 2007, PLANT CELL PHYSIOL, V48, P792, DOI 10.1093/pcp/pcm046; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Helling D, 2006, PLANT CELL, V18, P3519, DOI 10.1105/tpc.106.047373; Hepler PK, 2012, TRENDS PLANT SCI, V17, P32, DOI 10.1016/j.tplants.2011.10.007; Hill WG, 2003, J GEN PHYSIOL, V121, P413, DOI 10.1085/jgp.200308803; Hofmann A, 2002, PROTEIN SCI, V11, P2033, DOI 10.1110/ps.4770102; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7; Hu SQ, 2000, PLANT J, V24, P127, DOI 10.1046/j.1365-313x.2000.00852.x; Huh SM, 2010, PLANT CELL PHYSIOL, V51, P1499, DOI 10.1093/pcp/pcq111; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; Jacob R, 2004, J BIOL CHEM, V279, P3680, DOI 10.1074/jbc.C300503200; Jia HL, 2013, J BIOL CHEM, V288, P32277, DOI 10.1074/jbc.M113.483594; KACHAR B, 1988, J CELL BIOL, V106, P1545, DOI 10.1083/jcb.106.5.1545; Konopka-Postupolska D, 2007, PROTOPLASMA, V230, P203, DOI 10.1007/s00709-006-0234-7; Konrad KR, 2011, CURR OPIN PLANT BIOL, V14, P721, DOI 10.1016/j.pbi.2011.09.005; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Proust J, 1999, PLANT MOL BIOL, V39, P361, DOI 10.1023/A:1006199814795; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Roy SJ, 1999, PLANT J, V19, P379, DOI 10.1046/j.1365-313X.1999.00515.x; RUTTEN TLM, 1993, EUR J CELL BIOL, V61, P247; Santoni V, 1998, PLANT J, V16, P633, DOI 10.1046/j.1365-313x.1998.00335.x; Scheuring D, 2011, PLANT CELL, V23, P3463, DOI 10.1105/tpc.111.086918; Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; SMALLWOOD M, 1990, BIOCHEM J, V270, P157, DOI 10.1042/bj2700157; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Staiger CJ, 2010, J EXP BOT, V61, P1969, DOI 10.1093/jxb/erq012; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Verchot-Lubicz J, 2010, PROTOPLASMA, V240, P99, DOI 10.1007/s00709-009-0088-x; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; WENG XW, 1993, PROTEIN SCI, V2, P448; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yamamoto Y, 2003, PLANT CELL PHYSIOL, V44, P1192, DOI 10.1093/pcp/pcg147; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Zhang CH, 2002, PROTOPLASMA, V219, P59, DOI 10.1007/s007090200006; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349; Zhao LN, 2013, PLANT CELL, V25, P649, DOI 10.1105/tpc.112.103184; Zhu JG, 2014, MOL PLANT, V7, P751, DOI 10.1093/mp/sst171	83	34	37	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102407	10.1371/journal.pone.0102407	http://dx.doi.org/10.1371/journal.pone.0102407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019283	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600078
J	Furugaki, K; Cui, L; Kunisawa, Y; Osada, K; Shinkai, K; Tanaka, M; Kataoka, K; Nakano, K				Furugaki, Kouichi; Cui, Lin; Kunisawa, Yumi; Osada, Kensuke; Shinkai, Kentaro; Tanaka, Masao; Kataoka, Kazunori; Nakano, Kenji			Intraperitoneal Administration of a Tumor-Associated Antigen SART3, CD40L, and GM-CSF Gene-Loaded Polyplex Micelle Elicits a Vaccine Effect in Mouse Tumor Models	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; COLONY-STIMULATING FACTOR; CANCER-PATIENTS; DENDRITIC CELLS; PERITONEAL DISSEMINATION; SART3-DERIVED PEPTIDES; PEGYLATED POLYPLEX; PANCREATIC-CANCER; IMMUNE ACTIVATION; BLOCK-COPOLYMER	Polyplex micelles have demonstrated biocompatibility and achieve efficient gene transfection in vivo. Here, we investigated a polyplex micelle encapsulating genes encoding the tumor-associated antigen squamous cell carcinoma antigen recognized by T cells-3 (SART3), adjuvant CD40L, and granulocyte macrophage colony-stimulating factor (GM-CSF) as a DNA vaccine platform in mouse tumor models with different types of major histocompatibility antigen complex (MHC). Intraperitoneally administrated polyplex micelles were predominantly found in the lymph nodes, spleen, and liver. Compared with mock controls, the triple gene vaccine significantly prolonged the survival of mice harboring peritoneal dissemination of CT26 colorectal cancer cells, of which long-term surviving mice showed complete rejection when re-challenged with CT26 tumors. Moreover, the DNA vaccine inhibited the growth and metastasis of subcutaneous CT26 and Lewis lung tumors in BALB/c and C57BL/6 mice, respectively, which represent different MHC haplotypes. The DNA vaccine highly stimulated both cytotoxic T lymphocyte and natural killer cell activities, and increased the infiltration of CD11c(+) DCs and CD4(+)/CD8a(+) T cells into tumors. Depletion of CD4(+) or CD8a(+) T cells by neutralizing antibodies deteriorated the anti-tumor efficacy of the DNA vaccine. In conclusion, a SART3/CD40L+GM-CSF gene-loaded polyplex micelle can be applied as a novel vaccine platform to elicit tumor rejection immunity regardless of the recipient MHC haplotype.	[Furugaki, Kouichi; Cui, Lin; Kunisawa, Yumi; Nakano, Kenji] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Furugaki, Kouichi; Shinkai, Kentaro; Tanaka, Masao] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 812, Japan; [Osada, Kensuke; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Tokyo, Japan; [Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol, Tokyo, Japan	Kyushu University; Kyushu University; University of Tokyo; University of Tokyo	Nakano, K (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan.	kenakano@med.kyushu-u.ac.jp	Osada, Kensuke/V-3322-2017; Kataoka, Kazunori/K-7108-2012	Osada, Kensuke/0000-0001-9557-6851; Kataoka, Kazunori/0000-0002-8591-413X	Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Special Coordination Funds for Promoting Science and Technology (from Japan)	Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology (from Japan)	This work was supported in part by Grants-in-Aid for Scientific Research (to K.N.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) and by the Special Coordination Funds for Promoting Science and Technology (SCF funding program Grants-in-Aid for Scientific Research from Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BM, 2012, CANCER LETT, V325, P155, DOI 10.1016/j.canlet.2012.07.012; Barth RJ, 2010, CLIN CANCER RES, V16, P5548, DOI 10.1158/1078-0432.CCR-10-2138; Berzofsky JA, 2012, SEMIN ONCOL, V39, P348, DOI 10.1053/j.seminoncol.2012.02.002; Chen QX, 2012, BIOMATERIALS, V33, P4722, DOI 10.1016/j.biomaterials.2012.03.017; Ciupitu AMT, 1998, J EXP MED, V187, P685, DOI 10.1084/jem.187.5.685; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Dessureault S, 2005, J SURG RES, V125, P173, DOI 10.1016/j.jss.2004.11.036; Furugaki K, 2010, BLOOD, V115, P653, DOI 10.1182/blood-2007-08-109009; Harada K, 2000, JPN J CANCER RES, V91, P239, DOI 10.1111/j.1349-7006.2000.tb00937.x; HIRANO K, 1985, J PHARM SCI, V74, P915, DOI 10.1002/jps.2600740902; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; Ito M, 2000, INT J CANCER, V88, P633, DOI 10.1002/1097-0215(20001115)88:4<633::AID-IJC18>3.3.CO;2-E; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0; Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306; Kumagai M, 2012, J CONTROL RELEASE, V160, P542, DOI 10.1016/j.jconrel.2012.03.021; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Lazoura E, 2005, CURR MED CHEM, V12, P1481, DOI 10.2174/0929867054039017; Le DT, 2012, CANCER RES, V72, P3439, DOI 10.1158/0008-5472.CAN-11-3912; LU L, 1994, J EXP MED, V179, P1823, DOI 10.1084/jem.179.6.1823; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Mackiewicz J, 2009, EUR J PHARMACOL, V625, P84, DOI 10.1016/j.ejphar.2009.09.069; Minami T, 2007, CANCER IMMUNOL IMMUN, V56, P689, DOI 10.1007/s00262-006-0216-9; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Ohgidani M, 2013, J CONTROL RELEASE, V167, P238, DOI 10.1016/j.jconrel.2013.02.006; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Shevchenko I, 2013, INT J CANCER, V133, P98, DOI 10.1002/ijc.27990; Slingluff CL, 2010, J IMMUNOTHER, V33, P630, DOI 10.1097/CJI.0b013e3181e311ac; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Takahashi N, 2012, CANCER SCI, V103, P150, DOI 10.1111/j.1349-7006.2011.02106.x; Tongu M, 2013, CANCER IMMUNOL IMMUN, V62, P383, DOI 10.1007/s00262-012-1343-0; Uchida S, 2012, MOL THER, V20, P1196, DOI 10.1038/mt.2012.20; Un K, 2010, HUM GENE THER, V21, P65, DOI 10.1089/hum.2009.106; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Wang Y, 2002, BLOOD, V100, P569, DOI 10.1182/blood.V100.2.569; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang D, 1999, CANCER RES, V59, P4056; Zarei S, 2009, BLOOD, V113, P6658, DOI 10.1182/blood-2008-06-161075; Zhang M, 2005, GENE THER, V12, P1049, DOI 10.1038/sj.gt.3302490	43	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101854	10.1371/journal.pone.0101854	http://dx.doi.org/10.1371/journal.pone.0101854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013909	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400044
J	McGuffey, JE; Wei, B; Bernert, JT; Morrow, JC; Xia, BY; Wang, LQ; Blount, BC				McGuffey, James E.; Wei, Binnian; Bernert, John T.; Morrow, John C.; Xia, Baoyun; Wang, Lanqing; Blount, Benjamin C.			Validation of a LC-MS/MS Method for Quantifying Urinary Nicotine, Six Nicotine Metabolites and the Minor Tobacco Alkaloids-Anatabine and Anabasine-in Smokers' Urine	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PRESSURE CHEMICAL-IONIZATION; ELECTROSPRAY-IONIZATION; HUMAN PLASMA; ANALYTE RESPONSE; ION SUPPRESSION; MS-MS; BIOMARKERS; LC/MS/MS; COTININE	Tobacco use is a major contributor to premature morbidity and mortality. The measurement of nicotine and its metabolites in urine is a valuable tool for evaluating nicotine exposure and for nicotine metabolic profiling-i.e., metabolite ratios. In addition, the minor tobacco alkaloids-anabasine and anatabine-can be useful for monitoring compliance in smoking cessation programs that use nicotine replacement therapy. Because of an increasing demand for the measurement of urinary nicotine metabolites, we developed a rapid, low-cost method that uses isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) for simultaneously quantifying nicotine, six nicotine metabolites, and two minor tobacco alkaloids in smokers' urine. This method enzymatically hydrolyzes conjugated nicotine (primarily glucuronides) and its metabolites. We then use acetone pretreatment to precipitate matrix components (endogenous proteins, salts, phospholipids, and exogenous enzyme) that may interfere with LC-MS/MS analysis. Subsequently, analytes (nicotine, cotinine, hydroxycotinine, norcotinine, nornicotine, cotinine N-oxide, nicotine 1'-N-oxide, anatabine, and anabasine) are chromatographically resolved within a cycle time of 13.5 minutes. The optimized assay produces linear responses across the analyte concentrations typically found in urine collected from daily smokers. Because matrix ion suppression may influence accuracy, we include a discussion of conventions employed in this procedure to minimize matrix interferences. Simplicity, low cost, low maintenance combined with high mean metabolite recovery (76-99%), specificity, accuracy (0-10% bias) and reproducibility (2-9% C.V.) make this method ideal for large high through-put studies.	[McGuffey, James E.; Wei, Binnian; Bernert, John T.; Morrow, John C.; Xia, Baoyun; Wang, Lanqing; Blount, Benjamin C.] Ctr Dis Control & Prevent, Tobacco & Volatiles Branch, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	McGuffey, JE (corresponding author), Ctr Dis Control & Prevent, Tobacco & Volatiles Branch, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	jem4@cdc.gov	; Wei, Binnian/H-2746-2014	Wei, Binnian/0000-0001-8076-1202; Wei, Binnian/0000-0003-0465-9964	U.S. Food and Drug Administration Center for Tobacco Products; Centers for Disease Control and Prevention	U.S. Food and Drug Administration Center for Tobacco Products; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded through an interagency agreement between the U.S. Food and Drug Administration Center for Tobacco Products and the Centers for Disease Control and Prevention. The FDA had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. The authors are employed by the CDC, who provided all elements involved in the study design, data collection, analysis, and preparation of the manuscript for publication.	Alzweiri M, 2008, TALANTA, V74, P1060, DOI 10.1016/j.talanta.2007.07.037; Annesley TM, 2000, J AM SOC SPECTRUN, P942; ANSTALL HB, 1965, CLIN CHEM, V11, P741; Ashri NY, 2011, BIOANALYSIS, V3, P2003, DOI [10.4155/BIO.11.201, 10.4155/bio.11.201]; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Benowitz NL, 1999, J PHARMACOL EXP THER, V291, P1196; Benowitz NL, 2002, J NATL CANCER I, V94, P108, DOI 10.1093/jnci/94.2.108; Berg JZ, 2010, J PHARMACOL EXP THER, V332, P202, DOI 10.1124/jpet.109.159855; Bernert JT, 2005, J ANAL TOXICOL, V29, P814, DOI 10.1093/jat/29.8.814; Bloor WR, 1929, J BIOL CHEM, V82, P273; Boyd EM, 1935, J BIOL CHEM, V110, P61; Buhrman DL, 1996, J AM SOC MASS SPECTR, V7, P1099, DOI 10.1016/S1044-0305(96)00072-4; Choi BK, 2001, J CHROMATOGR A, V907, P337, DOI 10.1016/S0021-9673(00)01052-9; Constantopoulos TL, 1999, J AM SOC MASS SPECTR, V10, P625, DOI 10.1016/S1044-0305(99)00031-8; Dams R, 2003, J AM SOC MASS SPECTR, V14, P1290, DOI 10.1016/S1044-0305(03)00574-9; Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424; Ebbert JO, 2007, NICOTINE TOB RES, V9, P43, DOI 10.1080/14622200601078285; Fan Z, 2008, CHROMATOGRAPHIA, V68, P623, DOI 10.1365/s10337-008-0729-9; Hecht SS, 2010, CHEM RES TOXICOL, V23, P1001, DOI 10.1021/tx100056m; Hoofnagle AN, 2006, AM J CLIN PATHOL, V126, P880, DOI 10.1309/LQ8U3UL956ET324X; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; HUTCHINSON J, 1998, J CHROMATOGR B, V708, P87; Jacob P, 2002, CANCER EPIDEM BIOMAR, V11, P1668; King R, 2000, J AM SOC MASS SPECTR, V11, P942, DOI 10.1016/S1044-0305(00)00163-X; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; Liang HR, 2003, RAPID COMMUN MASS SP, V17, P2815, DOI 10.1002/rcm.1268; Little JL, 2006, J CHROMATOGR B, V833, P219, DOI 10.1016/j.jchromb.2006.02.011; Malaiyandi V, 2006, CANCER EPIDEM BIOMAR, V15, P1812, DOI 10.1158/1055-9965.EPI-05-0723; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matuszewski BK, 1998, ANAL CHEM, V70, P882, DOI 10.1021/ac971078+; Mei H, 2003, RAPID COMMUN MASS SP, V17, P97, DOI 10.1002/rcm.876; Miller EI, 2010, J CHROMATOGR B, V878, P725, DOI 10.1016/j.jchromb.2009.12.018; Muller C, 2002, J CHROMATOGR B, V773, P47, DOI 10.1016/S1570-0232(02)00142-3; Nakajima Miki, 2005, Drug Metab Pharmacokinet, V20, P227, DOI 10.2133/dmpk.20.227; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Polson C, 2003, J CHROMATOGR B, V785, P263, DOI 10.1016/S1570-0232(02)00914-5; Rainville PD, 2012, J PHARMACEUT BIOMED, V59, P138, DOI 10.1016/j.jpba.2011.10.021; Rangiah K, 2011, BIOANALYSIS, V3, P745, DOI 10.4155/BIO.11.42; Schuhmacher J, 2003, RAPID COMMUN MASS SP, V17, P1950, DOI 10.1002/rcm.1139; Shin HS, 2002, J CHROMATOGR B, V769, P177, DOI 10.1016/S1570-0232(02)00007-7; Sinclair RG, 1942, J BIOL CHEM, V142, P659; Taylor JK, 1987, QUALITY ASSURANCE CH; Tomlinson AJ, 2003, RAPID COMMUN MASS SP, V17, P909, DOI 10.1002/rcm.1001; Wang S, 2007, J PHARMACEUT BIOMED, V43, P701, DOI 10.1016/j.jpba.2006.08.010; Xia YQ, 2009, RAPID COMMUN MASS SP, V23, P2125, DOI 10.1002/rcm.4121; Xu X, 2004, CLIN CHEM, V50, P2323, DOI 10.1373/clinchem.2004.038489	46	44	45	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101816	10.1371/journal.pone.0101816	http://dx.doi.org/10.1371/journal.pone.0101816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013964	gold, Green Published			2022-12-25	WOS:000339378400038
J	Backes, C; Leidinger, P; Keller, A; Hart, M; Meyer, T; Meese, E; Hecksteden, A				Backes, Christina; Leidinger, Petra; Keller, Andreas; Hart, Martin; Meyer, Tim; Meese, Eckart; Hecksteden, Anne			Blood Born miRNAs Signatures that Can Serve as Disease Specific Biomarkers Are Not Significantly Affected by Overall Fitness and Exercise	PLOS ONE			English	Article							CIRCULATING MICRORNA; GENE-EXPRESSION; PERIPHERAL-BLOOD; CANCER-DIAGNOSIS; AEROBIC EXERCISE; LUNG-CANCER; PROFILES; SERUM; HEALTH; CELLS	Blood born micro(mi) RNA expression pattern have been reported for various human diseases with signatures specific for diseases. To evaluate these biomarkers, it is mandatory to know possible changes of miRNA signatures in healthy individuals under different physiological conditions. We analyzed the miRNA expression in peripheral blood of elite endurance athletes and moderatly active controls. Blood drawing was done before and after exhaustive exercise in each group. After Benjamini-Hochberg adjustment we did not find any miRNA with significant p-values when comparing miRNA expression between the different groups. We found, however, 24 different miRNAs with an expression fold change of minimum 1.5 in at least one of the comparisons (athletes before vs after exercise, athletes before exercise vs controls and athletes after exercise vs controls). The observed changes are not significant in contrast to the expression changes of the blood born miRNA expression reported for many human diseases. These data support the idea of disease associated miRNA patterns useful as biomarkers that are not readily altered by physiological conditions.	[Backes, Christina; Leidinger, Petra; Hart, Martin; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, Homburg, Germany; [Keller, Andreas] Univ Saarland, Dept Clin Bioinformat, Saarbrucken, Germany; [Meyer, Tim; Hecksteden, Anne] Univ Saarland, Inst Sports & Prevent Med, Saarbrucken, Germany	Saarland University; Saarland University; Saarland University	Backes, C (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, Homburg, Germany.	c.backes@mx.uni-saarland.de	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895	DFG	DFG(German Research Foundation (DFG))	This work was supported in part by DFG grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Buttner P, 2007, J APPL PHYSIOL, V102, P26, DOI 10.1152/japplphysiol.00066.2006; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; ElSharawy A, 2012, AGING CELL, V11, P607, DOI 10.1111/j.1474-9726.2012.00824.x; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gotte M, 2010, Minerva Ginecol, V62, P559; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hochberg Y, 1988, BIOMETRIKA, V75, P185, DOI DOI 10.1093/BIOMET/75.4.800; Keller A, 2011, NAT METH; Keller A, 2014, MULT SCLER J, V20, P295, DOI 10.1177/1352458513496343; Keller A, 2011, RNA BIOL, V8, P506, DOI 10.4161/rna.8.3.14994; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lawrie CH, 2013, BLOOD REV, V27, P143, DOI 10.1016/j.blre.2013.04.002; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li SC, 2013, MODERN PATHOL, V26, P685, DOI 10.1038/modpathol.2012.216; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Pritchard CC, 2011, CANC PREV RES PHILA; Radom-Aizik S, 2008, J APPL PHYSIOL, V104, P236, DOI 10.1152/japplphysiol.00872.2007; Radom-Aizik S, 2012, CTS-CLIN TRANSL SCI, V5, P32, DOI 10.1111/j.1752-8062.2011.00384.x; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Ratert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039309; Schmitt J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-379; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Yin Yu, 2010, Zhonghua Nan Ke Xue, V16, P599	40	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102183	10.1371/journal.pone.0102183	http://dx.doi.org/10.1371/journal.pone.0102183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010680	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800077
J	Oliveira, AB; Fatore, FM; Paulovich, FV; Oliveira, ON; Leite, VBP				Oliveira, Antonio B., Jr.; Fatore, Francisco M.; Paulovich, Fernando V.; Oliveira, Osvaldo N., Jr.; Leite, Vitor B. P.			Visualization of Protein Folding Funnels in Lattice Models	PLOS ONE			English	Article							FREE-ENERGY LANDSCAPE; POTENTIAL-ENERGY; TRANSITION-STATE; DYNAMICS; KINETICS; PATHWAYS; DETERMINES; MECHANISMS; SURFACE	Protein folding occurs in a very high dimensional phase space with an exponentially large number of states, and according to the energy landscape theory it exhibits a topology resembling a funnel. In this statistical approach, the folding mechanism is unveiled by describing the local minima in an effective one-dimensional representation. Other approaches based on potential energy landscapes address the hierarchical structure of local energy minima through disconnectivity graphs. In this paper, we introduce a metric to describe the distance between any two conformations, which also allows us to go beyond the one-dimensional representation and visualize the folding funnel in 2D and 3D. In this way it is possible to assess the folding process in detail, e. g., by identifying the connectivity between conformations and establishing the paths to reach the native state, in addition to regions where trapping may occur. Unlike the disconnectivity maps method, which is based on the kinetic connections between states, our methodology is based on structural similarities inferred from the new metric. The method was developed in a 27-mer protein lattice model, folded into a 3x3x3 cube. Five sequences were studied and distinct funnels were generated in an analysis restricted to conformations from the transition-state to the native configuration. Consistent with the expected results from the energy landscape theory, folding routes can be visualized to probe different regions of the phase space, as well as determine the difficulty in folding of the distinct sequences. Changes in the landscape due to mutations were visualized, with the comparison between wild and mutated local minima in a single map, which serves to identify different trapping regions. The extension of this approach to more realistic models and its use in combination with other approaches are discussed.	[Oliveira, Antonio B., Jr.; Leite, Vitor B. P.] Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Paulo, Brazil; [Fatore, Francisco M.; Paulovich, Fernando V.] Univ Sao Paulo, Inst Ciencias Matemat & Comp, Sao Paulo, Brazil; [Oliveira, Osvaldo N., Jr.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Leite, VBP (corresponding author), Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Paulo, Brazil.	vleite@sjrp.unesp.br	Paulovich, Fernando/G-1329-2010; Oliveira, Osvaldo N./A-1714-2008	Paulovich, Fernando/0000-0002-2316-760X; Oliveira, Osvaldo N./0000-0002-5399-5860; Oliveira Junior, Antonio Bento/0000-0003-1955-3556	FAPESP (Brazil); CNPq (Brazil); CAPES (Brazil); nBioNet network (Brazil)	FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); nBioNet network (Brazil)	This work was supported by FAPESP, CNPq, CAPES and nBioNet network (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, J CHEM PHYS, V101, P6052, DOI 10.1063/1.467320; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Becker OM, 1997, J MOL STRUC-THEOCHEM, V398, P507, DOI 10.1016/S0166-1280(97)00080-8; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chahine J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.168101; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Choi S.S., 2010, J SYST CYBERN INFORM, V8, P43; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Cox T. F., 2010, MULTIDIMENSIONAL SCA; Dickson A, 2013, J AM CHEM SOC, V135, P4729, DOI 10.1021/ja311077u; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dima RI, 1999, P NATL ACAD SCI USA, V96, P4904, DOI 10.1073/pnas.96.9.4904; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doye JPK, 1999, J CHEM PHYS, V111, P8417, DOI 10.1063/1.480217; Doye JPK, 1999, J CHEM PHYS, V110, P6896, DOI 10.1063/1.478595; Evans DA, 2003, J CHEM PHYS, V119, P9947, DOI 10.1063/1.1616515; Garstecki P, 1999, PHYS REV E, V60, P3219, DOI 10.1103/PhysRevE.60.3219; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Klimov DK, 1998, J CHEM PHYS, V109, P4119, DOI 10.1063/1.477012; Krivov SV, 2002, J CHEM PHYS, V117, P10894, DOI 10.1063/1.1517606; Kurnik M, 2012, P NATL ACAD SCI USA, V109, P5705, DOI 10.1073/pnas.1118640109; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lee CL, 2003, J CHEM PHYS, V118, P959, DOI 10.1063/1.1527672; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Levinthal C., 1968, EXTRAIT J CHIMIE PHY, V65; Miller MA, 1999, J CHEM PHYS, V111, P6610, DOI 10.1063/1.480011; Miller MA, 1999, PHYS REV E, V60, P3701, DOI 10.1103/PhysRevE.60.3701; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Noe F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714539; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Otzen DE, 1999, P NATL ACAD SCI USA, V96, P11746, DOI 10.1073/pnas.96.21.11746; Potoyan DA, 2011, J AM CHEM SOC, V133, P7405, DOI 10.1021/ja1111964; Prada-Gracia D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000415; Rao F, 2004, J MOL BIOL, V342, P299, DOI 10.1016/j.jmb.2004.06.063; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; SOCCI ND, 1995, J CHEM PHYS, V103, P4732, DOI 10.1063/1.470610; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tejada E., 2003, Information Visualization, V2, P218, DOI 10.1057/palgrave.ivs.9500054; Thirumalai D, 2010, ANNU REV BIOPHYS, V39, P159, DOI 10.1146/annurev-biophys-051309-103835; Wales D., 2003, ENERGY LANDSCAPES AP; Wales DJ, 2006, J PHYS CHEM B, V110, P20765, DOI 10.1021/jp0680544; Wales DJ, 2006, INT REV PHYS CHEM, V25, P237, DOI 10.1080/01442350600676921; Wales DJ, 2012, PHILOS T R SOC A, V370, P2877, DOI 10.1098/rsta.2011.0208; Wales DJ, 2010, CURR OPIN STRUC BIOL, V20, P3, DOI 10.1016/j.sbi.2009.12.011; Wales DJ, 2004, J CHEM PHYS, V121, P10284, DOI 10.1063/1.1810471; Wales DJ, 2004, MOL PHYS, V102, P891, DOI 10.1080/00268970410001703363; Wales DJ, 1998, NATURE, V394, P758, DOI 10.1038/29487; Wales DJ, 2002, MOL PHYS, V100, P3285, DOI 10.1080/00268970210162691; Wang J, 2012, P NATL ACAD SCI USA, V109, P15763, DOI 10.1073/pnas.1212842109; Ware C., 2001, INFORM DESIGN J, V10; Zheng WW, 2013, J PHYS CHEM B, V117, P12769, DOI 10.1021/jp401911h; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119	59	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100861	10.1371/journal.pone.0100861	http://dx.doi.org/10.1371/journal.pone.0100861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010343	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800007
J	Bose, A; Majot, AT; Bidwai, AP				Bose, Anasua; Majot, Adam T.; Bidwai, Ashok P.			The Ser/Thr Phosphatase PP2A Regulatory Subunit Widerborst Inhibits Notch Signaling	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; CASEIN KINASE-II; DROSOPHILA CIRCADIAN CLOCK; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE EXPRESSION; CELL FATE DECISIONS; OF-SPLIT COMPLEX; LATERAL-INHIBITION; NEURAL DEVELOPMENT; SENSORY ORGAN	Drosophila Enhancer of split M8, an effector of Notch signaling, is regulated by protein kinase CK2. The phosphatase PP2A is thought to play an opposing (inhibitory) role, but the identity of the regulatory subunit was unknown. The studies described here reveal a role for the PP2A regulatory subunit widerborst (wdb) in three developmental contexts; the bristle, wing and the R8 photoreceptors of the eye. wdb overexpression elicits bristle and wing defects akin to reduced Notch signaling, whereas hypomorphic mutations in this PP2A subunit elicit opposite effects. We have also evaluated wdb functions using mutations in Notch and E(spl) that affect the eye. We find that the eye and R8 defects of the well-known N-spl mutation are enhanced by a hypomorphic allele of wdb, whereas they are strongly rescued by wdb overexpression. Similarly, ectopic wdb rescues the eye and R8 defects of the E(spl) D mutation, which affects the m8 gene. In addition, wdb overexpression also rescues the bristle defects of ectopically expressed M8, or the eye and R8 defects of its CK2 phosphomimetic variant M8-S159D. The latter finding suggests that PP2A may target M8 at highly conserved residues in the vicinity of the CK2 site, whose phosphorylation controls repression of Atonal and the R8 fate. Together, the studies identify PP2A-Wdb as a participant in Notch signaling, and suggest that M8 activity is controlled by phosphorylation and dephosphorylation. The conservation of the phosphorylation sites between Drosophila E(spl) and the HES/HER proteins from mammals, reptiles, amphibians, birds and fish raises the prospect that this mode of regulation is widespread.	[Bose, Anasua; Majot, Adam T.; Bidwai, Ashok P.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Bidwai, AP (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	abidwai@wvu.edu		Bidwai, Ashok/0000-0002-4297-5629	National Institutes of Health (NIH) [EY015718]; Eberly Family Foundation [3V-235]; NATIONAL EYE INSTITUTE [R01EY015718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eberly Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (NIH) (EY015718) and a grant from the Eberly Family Foundation (3V-235). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Bae SK, 2000, DEVELOPMENT, V127, P2933; Baker NE, 2004, DEV CELL, V7, P632, DOI 10.1016/j.devcel.2004.10.010; Banreti A, 2012, AUTOPHAGY, V8, P623, DOI 10.4161/auto.19081; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blau J, 2003, NAT NEUROSCI, V6, P208, DOI 10.1038/nn0303-208; Bose A, 2006, MECH DEVELOP, V123, P649, DOI 10.1016/j.mod.2006.07.003; Brand M, 1990, DEV GENES EVOL, V198, P275, DOI DOI 10.1007/BF00377394; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bray SJ, 1997, PERSPECT DEV NEUROBI, V4, P313; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CAMPOS AR, 1987, EMBO J, V6, P425, DOI 10.1002/j.1460-2075.1987.tb04772.x; Campos-Ortega JA, 1998, INT J DEV BIOL, V42, P291; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Dambly-Chaudiere C, 1998, INT J DEV BIOL, V42, P269; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deCelis JF, 1996, DEVELOPMENT, V122, P2719; DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Duvall LB, 2011, CURR BIOL, V21, pR305, DOI 10.1016/j.cub.2011.04.005; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; GHYSEN A, 1979, DEV BIOL, V70, P438, DOI 10.1016/0012-1606(79)90037-X; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Hannus M, 2002, DEVELOPMENT, V129, P3493; Heitzler P, 1996, DEVELOPMENT, V122, P161; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; Kahali B, 2010, GENESIS, V48, P44, DOI 10.1002/dvg.20581; Kahali B, 2009, GENESIS, V47, P456, DOI 10.1002/dvg.20521; Karandikar UC, 2004, MECH DEVELOP, V121, P273, DOI 10.1016/j.mod.2004.01.008; Kiefer JC, 2005, DEV DYNAM, V234, P808, DOI 10.1002/dvdy.20522; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; KNUST E, 1992, GENETICS, V132, P505; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Kunttas-Tatli E, 2009, GENESIS, V47, P647, DOI 10.1002/dvg.20543; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lubensky DK, 2011, P NATL ACAD SCI USA, V108, P11145, DOI 10.1073/pnas.1015302108; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Modolell J, 1998, INT J DEV BIOL, V42, P275; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nagel AC, 1999, DEV GENET, V25, P168, DOI 10.1002/(SICI)1520-6408(1999)25:2<168::AID-DVG11>3.0.CO;2-0; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; PREISS A, 1988, EMBO J, V7, P3917, DOI 10.1002/j.1460-2075.1988.tb03278.x; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; SCHRONS H, 1992, GENETICS, V132, P481; SCHWEISGUTH F, 1995, DEVELOPMENT, V121, P1875; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Seugnet L, 2011, CURR BIOL; SHEPARD SB, 1989, GENETICS, V122, P429; SIMPSON P, 1990, DEVELOPMENT, V109, P509; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Sun H., 2007, TRANSL ONCOGENOM, V2, P105; Sun Y, 1998, DEVELOPMENT, V125, P3731; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Trott RL, 2001, J BIOL CHEM, V276, P2159, DOI 10.1074/jbc.M005996200; Vilas-Boas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015459; Wech I, 1999, DEV GENES EVOL, V209, P370, DOI 10.1007/s004270050266; White NM, 2000, DEVELOPMENT, V127, P1681; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wu MN, 2011, CURR BIOL, V21, pR397, DOI 10.1016/j.cub.2011.04.014; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; ZIEMER A, 1988, GENETICS, V119, P63	100	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101884	10.1371/journal.pone.0101884	http://dx.doi.org/10.1371/journal.pone.0101884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006677	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600076
J	Hodges, JL; Vilchez, SM; Asmussen, H; Whitmore, LA; Horwitz, AR				Hodges, Jennifer L.; Vilchez, Samuel Martin; Asmussen, Hannelore; Whitmore, Leanna A.; Horwitz, Alan Rick			alpha-Actinin-2 Mediates Spine Morphology and Assembly of the Post-Synaptic Density in Hippocampal Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALPHA-ACTININ; DENDRITIC SPINES; NMDA RECEPTOR; AMPA RECEPTORS; MENTAL-RETARDATION; MASS-SPECTROMETRY; PROTEIN; DYNAMICS; SYNAPSE	Dendritic spines are micron-sized protrusions that constitute the primary post-synaptic sites of excitatory neurotransmission in the brain. Spines mature from a filopodia-like protrusion into a mushroom-shaped morphology with a post-synaptic density (PSD) at its tip. Modulation of the actin cytoskeleton drives these morphological changes as well as the spine dynamics that underlie learning and memory. Several PSD molecules respond to glutamate receptor activation and relay signals to the underlying actin cytoskeleton to regulate the structural changes in spine and PSD morphology. alpha-Actinin-2 is an actin filament cross-linker, which localizes to dendritic spines, enriched within the post-synaptic density, and implicated in actin organization. We show that loss of alpha-actinin-2 in rat hippocampal neurons creates an increased density of immature, filopodia-like protrusions that fail to mature into a mushroom-shaped spine during development. alpha-Actinin-2 knockdown also prevents the recruitment and stabilization of the PSD in the spine, resulting in failure of synapse formation, and an inability to structurally respond to chemical stimulation of the N-methyl-D-aspartate (NMDA)-type glutamate receptor. The Ca2+-insensitive EF-hand motif in alpha-actinin-2 is necessary for the molecule's function in regulating spine morphology and PSD assembly, since exchanging it for the similar but Ca2+-sensitive domain from alpha-actinin-4, another alpha-actinin isoform, inhibits its function. Furthermore, when the Ca2+-insensitive domain from alpha-actinin-2 is inserted into alpha-actinin-4 and expressed in neurons, it creates mature spines. These observations support a model whereby alpha-actinin-2, partially through its Ca2+-insensitive EF-hand motif, nucleates PSD formation via F-actin organization and modulates spine maturation to mediate synaptogenesis.	[Hodges, Jennifer L.; Vilchez, Samuel Martin; Asmussen, Hannelore; Whitmore, Leanna A.; Horwitz, Alan Rick] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia	Hodges, JL (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	jlh3ke@virginia.edu; horwitz@virginia.edu	Martin-Vilchez, Samuel/AFV-2112-2022	Martin-Vilchez, Samuel/0000-0003-0557-7653	National Institutes of Health (NIH) [GM23244, T32-GM008136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R37GM023244, R01GM023244] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant (GM23244) and by the Cell and Molecular Biology training grant from the NIH (T32-GM008136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Benson DL, 2012, HIPPOCAMPUS, V22, P954, DOI 10.1002/hipo.20872; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Dunah AW, 2000, MOL BRAIN RES, V79, P77, DOI 10.1016/S0169-328X(00)00102-9; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Hoe HS, 2009, BIOCHEM BIOPH RES CO, V384, P55, DOI 10.1016/j.bbrc.2009.04.069; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kay L, 2011, NAT NEUROSCI, V14, P688, DOI 10.1038/nn.2826; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002	61	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101770	10.1371/journal.pone.0101770	http://dx.doi.org/10.1371/journal.pone.0101770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007055	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600065
J	Lahouaoui, H; Coutanson, C; Cooper, HM; Bennis, M; Dkhissi-Benyahya, O				Lahouaoui, Hasna; Coutanson, Christine; Cooper, Howard M.; Bennis, Mohamed; Dkhissi-Benyahya, Ouria			Clock Genes and Behavioral Responses to Light Are Altered in a Mouse Model of Diabetic Retinopathy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SUPRACHIASMATIC NUCLEUS; ENTRAINMENT FUNCTION; CIRCADIAN RESPONSES; VISUAL DYSFUNCTION; INS2(AKITA) MOUSE; MELANOPSIN; EXPRESSION; RAT; APOPTOSIS	There is increasing evidence that melanopsin-expressing ganglion cells (ipRGCs) are altered in retinal pathologies. Using a streptozotocin-induced (STZ) model of diabetes, we investigated the impact of diabetic retinopathy on non-visual functions by analyzing ipRGCs morphology and light-induced c-Fos and Period 1-2 clock genes in the central clock (SCN). The ability of STZ-diabetic mice to entrain to light was challenged by exposure animals to 1) successive light/dark (LD) cycle of decreasing or increasing light intensities during the light phase and 2) 6-h advance of the LD cycle. Our results show that diabetes induces morphological changes of ipRGCs, including soma swelling and dendritic varicosities, with no reduction in their total number, associated with decreased c-Fos and clock genes induction by light in the SCN at 12 weeks post-onset of diabetes. In addition, STZ-diabetic mice exhibited a reduction of overall locomotor activity, a decrease of circadian sensitivity to light at low intensities, and a delay in the time to re-entrain after a phase advance of the LD cycle. These novel findings demonstrate that diabetes alters clock genes and behavioral responses of the circadian timing system to light and suggest that diabetic patients may show an increased propensity for circadian disturbances, in particular when they are exposed to chronobiological challenges.	[Lahouaoui, Hasna; Coutanson, Christine; Cooper, Howard M.; Dkhissi-Benyahya, Ouria] INSERM, Stem Cell & Brain Res Inst, Dept Chronobiol, U846, F-69500 Bron, France; [Lahouaoui, Hasna; Coutanson, Christine; Cooper, Howard M.; Dkhissi-Benyahya, Ouria] Univ Lyon 1, UMR S 846, F-69365 Lyon, France; [Lahouaoui, Hasna; Bennis, Mohamed] Univ Cadi Ayyad, Lab Pharmacol Neurobiol & Behav, URAC 37, Marrakech, Morocco	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cadi Ayyad University of Marrakech	Dkhissi-Benyahya, O (corresponding author), INSERM, Stem Cell & Brain Res Inst, Dept Chronobiol, U846, F-69500 Bron, France.	ouria.benyahya@inserm.fr	Dkhissi-Benyahya, Ouria/M-5665-2014; COOPER, HOWARD/M-7304-2014	Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; 	Rhone-Alpes CMIRA; GDRI-Neuro (CNRST/INSERM/CNRS); CNRST-INSERM; ARC Handicap Vieillissement Neurosciences	Rhone-Alpes CMIRA(Region Auvergne-Rhone-Alpes); GDRI-Neuro (CNRST/INSERM/CNRS); CNRST-INSERM; ARC Handicap Vieillissement Neurosciences	This research was supported by Rhone-Alpes CMIRA, GDRI-Neuro (CNRST/INSERM/CNRS), CNRST-INSERM PA/RN/2013, ARC Handicap Vieillissement Neurosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2004, INVEST OPHTH VIS SCI, V45, P2760, DOI 10.1167/iovs.03-1392; Akimov NP, 2012, BEHAV BRAIN RES, V226, P601, DOI 10.1016/j.bbr.2011.09.030; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Challet E, 1999, AM J PHYSIOL-REG I, V276, pR1063, DOI 10.1152/ajpregu.1999.276.4.R1063; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Davidson E, 2009, EXP DIABETES RES, DOI 10.1155/2009/431980; de Faria JML, 2002, BRIT J OPHTHALMOL, V86, P725; de Zavalia N, 2011, J NEUROCHEM, V117, P904, DOI 10.1111/j.1471-4159.2011.07260.x; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Dkhissi-Benyahya O, 2013, CELL MOL LIFE SCI, V70, P3435, DOI 10.1007/s00018-013-1338-9; Dollet A, 2010, CHRONOBIOL INT, V27, P768, DOI 10.3109/07420521003695704; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Esquiva G, 2013, INVEST OPHTH VIS SCI, V54, P4605, DOI 10.1167/iovs.13-12120; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Fernandez DC, 2013, CHRONOBIOL INT, V30, P583, DOI 10.3109/07420528.2012.754453; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; Gastinger MJ, 2001, INVEST OPHTH VIS SCI, V42, P2679; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hall AC, 1997, J BIOL RHYTHM, V12, P388, DOI 10.1177/074873049701200501; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Jackson GR, 2003, NEUROL CLIN, V21, P709, DOI 10.1016/S0733-8619(02)00107-X; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Kirwin SJ, 2011, INVEST OPHTH VIS SCI, V52, P7654, DOI 10.1167/iovs.10-6609; Kirwin SJ, 2009, INVEST OPHTH VIS SCI, V50, P5396, DOI 10.1167/iovs.09-3474; Kumar S, 2011, EXP EYE RES, V92, P164, DOI 10.1016/j.exer.2011.01.005; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Oishi K, 2004, THROMB RES, V114, P129, DOI 10.1016/j.thromres.2004.05.011; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Shimazoe T, 1999, JPN J PHARMACOL, V80, P85, DOI 10.1254/jjp.80.85; Shimazoe T, 2000, JPN J PHARMACOL, V83, P355, DOI 10.1254/jjp.83.355; SHIMOMURA Y, 1990, PHYSIOL BEHAV, V47, P1153, DOI 10.1016/0031-9384(90)90366-C; Shirao Y, 1998, PROG RETIN EYE RES, V17, P59, DOI 10.1016/S1350-9462(97)00005-0; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; VARMA SD, 1974, EXP EYE RES, V19, P577, DOI 10.1016/0014-4835(74)90095-5; VELASCO A, 1988, CHRONOBIOL INT, V5, P127, DOI 10.3109/07420528809079553; Wang HZ, 2008, CHINESE MED J-PEKING, V121, P1015, DOI 10.1097/00029330-200806010-00010; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yamanouchi S, 1997, NEUROSCI LETT, V227, P103, DOI 10.1016/S0304-3940(97)00324-8; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504	60	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101584	10.1371/journal.pone.0101584	http://dx.doi.org/10.1371/journal.pone.0101584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006976	gold, Green Published, Green Submitted			2022-12-25	WOS:000339040600048
J	Baudet, A; Morisset, C; d'Athis, P; Maillefert, JF; Casillas, JM; Ornetti, P; Laroche, D				Baudet, Audrey; Morisset, Claire; d'Athis, Philippe; Maillefert, Jean-Francis; Casillas, Jean-Marie; Ornetti, Paul; Laroche, Davy			Cross-Talk Correction Method for Knee Kinematics in Gait Analysis Using Principal Component Analysis (PCA): A New Proposal	PLOS ONE			English	Article							JOINT KINEMATICS; 3-DIMENSIONAL KINEMATICS; AXIS MISALIGNMENT; ANATOMICAL FRAME; FORMAL METHODS; MOVEMENT; MOTION; STANDARDIZATION; CALIBRATION; DEFINITION	Background: In 3D gait analysis, the knee joint is usually described by the Eulerian way. It consists in breaking down the motion between the articulating bones of the knee into three rotations around three axes: flexion/extension, abduction/adduction and internal/external rotation. However, the definition of these axes is prone to error, such as the "cross-talk'' effect, due to difficult positioning of anatomical landmarks. This paper proposes a correction method, principal component analysis (PCA), based on an objective kinematic criterion for standardization, in order to improve knee joint kinematic analysis. Methods: The method was applied to the 3D gait data of two different groups (twenty healthy subjects and four with knee osteoarthritis). Then, this method was evaluated with respect to three main criteria: (1) the deletion of knee joint angle cross-talk (2) the reduction of variance in the varus/valgus kinematic profile (3) the posture trial varus/valgus deformation matching the X-ray value for patients with knee osteoarthritis. The effect of the correction method was tested statistically on variabilities and cross-talk during gait. Results: Cross-talk was lower (p<0.05) after correction (the correlation between the flexion-extension and varus-valgus kinematic profiles being annihilated). Additionally, the variance in the kinematic profile for knee varus/valgus and knee flexion/extension was found to be lower and higher (p<0.05), respectively, after correction for both the left and right side. Moreover, after correction, the posture trial varus/valgus angles were much closer to x-ray grading. Conclusion: The results show that the PCA correction applied to the knee joint eliminates the cross-talk effect, and does not alter the radiological varus/valgus deformation for patients with knee osteoarthritis. These findings suggest that the proposed correction method produces new rotational axes that better fit true knee motion.	[Baudet, Audrey; Morisset, Claire; Casillas, Jean-Marie; Laroche, Davy] Dijon Univ Hosp, Ctr Invest Clin INSERM 1432, Dijon, France; [Morisset, Claire; Maillefert, Jean-Francis; Casillas, Jean-Marie; Ornetti, Paul; Laroche, Davy] INSERM, U1093, Dijon, France; [d'Athis, Philippe] Dijon Univ Hosp, Dept Med Informat, Dijon, France; [Maillefert, Jean-Francis; Casillas, Jean-Marie; Ornetti, Paul] Univ Burgundy, Dijon, France; [Maillefert, Jean-Francis; Ornetti, Paul] Dijon Univ Hosp, Dept Rheumatol, Dijon, France; [Casillas, Jean-Marie] Dijon Univ Hosp, Dept Phys Med, Dijon, France	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Laroche, D (corresponding author), Dijon Univ Hosp, Ctr Invest Clin INSERM 1432, Dijon, France.	davy.laroche@chu-dijon.fr	Laroche, Davy/K-4298-2015	Laroche, Davy/0000-0003-1599-4258; Casillas, Jean-Marie/0000-0003-0962-4699; Morisset, Christophe/0000-0001-5801-6724				Baker R, 1999, HUM MOVEMENT SCI, V18, P655, DOI 10.1016/S0167-9457(99)00027-5; Ball KA, 2008, J BIOMECH, V41, P1599, DOI 10.1016/j.jbiomech.2008.02.033; BLANKEVOORT L, 1988, J BIOMECH, V21, P705, DOI 10.1016/0021-9290(88)90280-1; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Cheze L, 2000, J BIOMECH, V33, P1695, DOI 10.1016/S0021-9290(00)00146-9; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Della Croce U, 1999, MED BIOL ENG COMPUT, V37, P155, DOI 10.1007/BF02513282; Della Croce U, 2003, MED ENG PHYS, V25, P425, DOI 10.1016/S1350-4533(03)00032-8; Donati M, 2007, GAIT POSTURE, V26, P179, DOI 10.1016/j.gaitpost.2007.04.009; Ehrig RM, 2007, J BIOMECH, V40, P2150, DOI 10.1016/j.jbiomech.2006.10.026; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; Freeman MAR, 2005, J BIOMECH, V38, P197, DOI 10.1016/j.jbiomech.2004.02.006; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ishii Y, 1997, CLIN ORTHOP RELAT R, P144; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Laroche D, 2011, OSTEOARTHR CARTILAGE, V19, P194, DOI 10.1016/j.joca.2010.10.024; Marin F, 2003, HUM MOVEMENT SCI, V22, P285, DOI 10.1016/S0167-9457(03)00036-8; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Moglo KE, 2005, J BIOMECH, V38, P1075, DOI 10.1016/j.jbiomech.2004.05.033; Most E, 2004, J BIOMECH, V37, P1743, DOI 10.1016/j.jbiomech.2004.01.025; Noonan KJ, 2003, J PEDIATR ORTHOPED, V23, P279, DOI 10.1097/00004694-200305000-00001; Pearson K, 1901, LINES PLANES CLOSEST; Piazza SJ, 2000, J BIOMECH, V33, P1029, DOI 10.1016/S0021-9290(00)00056-7; RAMAKRISHNAN HK, 1991, J BIOMECH, V24, P969, DOI 10.1016/0021-9290(91)90175-M; Ramsey DK, 1999, CLIN BIOMECH, V14, P595, DOI 10.1016/S0268-0033(99)00015-7; Reinschmidt C, 1997, GAIT POSTURE, V6, P98, DOI 10.1016/S0966-6362(97)01110-7; Rivest LP, 2005, J BIOMECH, V38, P1604, DOI 10.1016/j.jbiomech.2004.07.031; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Sangeux M, 2014, GAIT POSTURE, V40, P20, DOI 10.1016/j.gaitpost.2014.01.024; Schache AG, 2006, GAIT POSTURE, V24, P100, DOI 10.1016/j.gaitpost.2005.08.002; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Szczerbik E, 2011, ACTA BIOENG BIOMECH, V13, P43; TUPLING SJ, 1987, MED BIOL ENG COMPUT, V25, P527, DOI 10.1007/BF02441745; Upadhyaya S, 2013, APCBEE PROC, V7, P27, DOI 10.1016/j.apcbee.2013.08.007; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; WOLTRING HJ, 1994, J BIOMECH, V27, P1399, DOI 10.1016/0021-9290(94)90191-0; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	43	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102098	10.1371/journal.pone.0102098	http://dx.doi.org/10.1371/journal.pone.0102098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003974	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700108
J	Yu, DW; Zhang, SF; Du, WH; Zhang, JX; Fan, ZX; Hao, HS; Liu, Y; Zhao, XM; Qin, T; Zhu, HB				Yu, Dawei; Zhang, Shoufeng; Du, Weihua; Zhang, Jinxia; Fan, Zongxing; Hao, Haisheng; Liu, Yan; Zhao, Xueming; Qin, Tong; Zhu, Huabin			Expression of Intracellular Interferon-Alpha Confers Antiviral Properties in Transfected Bovine Fetal Fibroblasts and Does Not Affect the Full Development of SCNT Embryos	PLOS ONE			English	Article							MOUTH-DISEASE; GENE-EXPRESSION; I INTERFERONS; GAMMA; ACTIVATION; VITRO; LEADS	Foot-and-mouth disease, one of the most significant diseases of dairy herds, has substantial effects on farm economics, and currently, disease control measures are limited. In this study, we constructed a vector with a human interferon-alpha (hIFN-alpha) (without secretory signal sequence) gene cassette containing the immediate early promoter of human cytomegalovirus. Stably transfected bovine fetal fibroblasts were obtained by G418 selection, and hIFN-alpha transgenic embryos were produced by somatic cell nuclear transfer (SCNT). Forty-six transgenic embryos were transplanted into surrogate cows, and five cows (10.9%) became pregnant. Two male cloned calves were born. Expression of hIFN-alpha was detected in transfected bovine fetal fibroblasts, transgenic SCNT embryos, and different tissues from a transgenic SCNT calf at two days old. In transfected bovine fetal fibroblasts, expression of intracellular IFN-alpha induced resistance to vesicular stomatitis virus infection, increased apoptosis, and induced the expression of double-stranded RNA-activated protein kinase gene (PKR) and the 2'-5'-oligoadenylate synthetase gene (29-59 OAS), which are IFN-inducible genes with antiviral activity. Analysis by qRT-PCR showed that the mRNA expression levels of PKR, 29-59 OAS, and P53 were significantly increased in wild-type bovine fetal fibroblasts stimulated with extracellular recombinant human IFN-alpha-2b, showing that intracellular IFN-alpha induces biological functions similar to extracellular IFN-alpha. In conclusion, expression of intracellular hIFN-alpha conferred antiviral properties in transfected bovine fetal fibroblasts and did not significantly affect the full development of SCNT embryos. Thus, IFN-alpha transgenic technology may provide a revolutionary way to achieve elite breeding of livestock.	[Yu, Dawei; Du, Weihua; Fan, Zongxing; Hao, Haisheng; Liu, Yan; Zhao, Xueming; Qin, Tong; Zhu, Huabin] Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China; [Zhang, Shoufeng; Zhang, Jinxia] Acad Mil Med Sci, Inst Mil Vet, Changchun, Peoples R China; [Yu, Dawei] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Academy of Military Medical Sciences - China; China Agricultural University	Du, WH (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China.	dwh@iascaas.net.cn	Yu, Dawei/J-3492-2013	Yu, Dawei/0000-0002-1105-4077	Agricultural Science and Technology Innovation Program [ASTIP-IAS06]; State Major Project of Transgenic [2009ZX08007-007B]	Agricultural Science and Technology Innovation Program; State Major Project of Transgenic	This work was partially supported by grants from the Agricultural Science and Technology Innovation Program (ASTIP-IAS06 to WHD), State Major Project of Transgenic (2009ZX08007-007B to WHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CMI, 2001, J INTERF CYTOK RES, V21, P399, DOI 10.1089/107999001750277871; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Chen WZ, 2006, J VIROL, V80, P3559, DOI 10.1128/JVI.80.7.3559-3566.2006; Fujisawa M, 1998, ARCH ANDROLOGY, V40, P211, DOI 10.3109/01485019808987944; Grubman Marvin J, 2003, Expert Rev Anti Infect Ther, V1, P579, DOI 10.1586/14787210.1.4.579; Haneji T, 2013, INT J ONCOL, V42, P1904, DOI 10.3892/ijo.2013.1911; HEKMAN ACP, 1988, J BIOL CHEM, V263, P12151; Isakari Y, 2007, INT J PHARMACEUT, V338, P157, DOI 10.1016/j.ijpharm.2007.01.042; Knowles NJ, 2001, VET REC, V148, P258; Laible G, 2009, COMP IMMUNOL MICROB, V32, P123, DOI 10.1016/j.cimid.2007.11.012; Li L, 2014, J BIOTECHNOL, V171, P17, DOI 10.1016/j.jbiotec.2013.11.022; Malireddi RKS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00077; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Oritani K, 2001, CYTOKINE GROWTH F R, V12, P337, DOI 10.1016/S1359-6101(01)00009-0; Park JH, 2013, CLIN EXP VACCINE RES, V2, P8, DOI 10.7774/cevr.2013.2.1.8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Satie AP, 2011, J BIOL CHEM, V286, P23280, DOI 10.1074/jbc.M111.229120; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shin-Ya M, 2005, BIOCHEM BIOPH RES CO, V329, P1139, DOI 10.1016/j.bbrc.2005.02.088; Takahashi M, 2003, J REPROD DEVELOP, V49, P297; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Vajta G, 2003, BIOL REPROD, V68, P571, DOI 10.1095/biolreprod.102.008771; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Will A, 1996, J IMMUNOL, V157, P4576; Zhang JX, 2007, J DAIRY SCI, V90, P5218, DOI 10.3168/jds.2007-0301; Zhang JinXia, 2008, Chinese Journal of Veterinary Science, V28, P1433	30	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e94444	10.1371/journal.pone.0094444	http://dx.doi.org/10.1371/journal.pone.0094444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004008	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700001
J	Noda, C; Kimura, H; Arasaki, K; Matsushita, M; Yamamoto, A; Wakana, Y; Inoue, H; Tagaya, M				Noda, Chikano; Kimura, Hana; Arasaki, Kohei; Matsushita, Mitsuru; Yamamoto, Akitsugu; Wakana, Yuichi; Inoue, Hiroki; Tagaya, Mitsuo			Valosin-containing Protein-interacting Membrane Protein (VIMP) Links the Endoplasmic Reticulum with Microtubules in Concert with Cytoskeleton-linking Membrane Protein (CLIMP)-63	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER-associated Degradation; Membrane Protein; Microtubule; Tubulin; CLIMP-63; VIMP	SYNTAXIN 5; ER; ORGANIZATION; COMPARTMENT; RELEASE; NETWORK	Background: The distribution and morphology of the mammalian endoplasmic reticulum (ER) are regulated by microtubules (MTs). Results: Valosin-containing protein (VCP)-interacting membrane protein (VIMP) interacts with both MTs and the rough ER-localized cytoskeleton-linking membrane protein (CLIMP)-63. Its overexpression or depletion affects ER structure. Conclusion: VIMP links the ER and MTs. Significance: VIMP not only recruits VCP to the ER but also regulates ER shape. The distribution and morphology of the endoplasmic reticulum (ER) in mammalian cells depend on both dynamic and static interactions of ER membrane proteins with microtubules (MTs). Cytoskeleton-linking membrane protein (CLIMP)-63 is exclusively localized in sheet-like ER membranes, typical structures of the rough ER, and plays a pivotal role in the static interaction with MTs. Our previous study showed that the 42-kDa ER-residing form of syntaxin 5 (Syn5L) regulates ER structure through the interactions with both CLIMP-63 and MTs. Here, we extend our previous study and show that the valosin-containing protein/p97-interacting membrane protein (VIMP)/SelS is also a member of the family of proteins that shape the ER by interacting with MTs. Depletion of VIMP causes the spreading of the ER to the cell periphery and affects an MT-dependent process on the ER. Although VIMP can interact with CLIMP-63 and Syn5L, it does not interact with MT-binding ER proteins (such as Reep1) that shape the tubular smooth ER, suggesting that different sets of MT-binding ER proteins are used to organize different ER subdomains.	[Noda, Chikano; Kimura, Hana; Arasaki, Kohei; Matsushita, Mitsuru; Wakana, Yuichi; Inoue, Hiroki; Tagaya, Mitsuo] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Life Sci, Hachioji, Tokyo 1920392, Japan; [Yamamoto, Akitsugu] Nagahama Inst Bio Sci & Technol, Fac Biosci, Nagahama, Shiga 5260829, Japan	Tokyo University of Pharmacy & Life Sciences	Tagaya, M (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tagaya@toyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24657141, 25291029]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 24657141 and 25291029 (to M. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gao HY, 2009, EXP CELL RES, V315, P1157, DOI 10.1016/j.yexcr.2009.01.027; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Iinuma T, 2009, J CELL SCI, V122, P1680, DOI 10.1242/jcs.036103; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; LEE C, 1989, J CELL BIOL, V109, P2045, DOI 10.1083/jcb.109.5.2045; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Miyazaki K, 2012, J CELL SCI, V125, P5658, DOI 10.1242/jcs.105304; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Tagaya M, 1996, J BIOL CHEM, V271, P466, DOI 10.1074/jbc.271.1.466; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	36	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24304	24313		10.1074/jbc.M114.571372	http://dx.doi.org/10.1074/jbc.M114.571372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25008318	Green Published, hybrid			2022-12-25	WOS:000341505600026
J	Sizemore, GM; Sizemore, ST; Seachrist, DD; Keri, RA				Sizemore, Gina M.; Sizemore, Steven T.; Seachrist, Darcie D.; Keri, Ruth A.			GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Migration; Cytoskeleton; Extracellular Signal-regulated Kinase (ERK); GABA Receptor	GAMMA-AMINOBUTYRIC-ACID; COLON-CARCINOMA CELLS; MOLECULAR PHENOTYPE; TUMOR-CELLS; PCR ASSAY; EXPRESSION; METASTASIS; INVASION; MARKERS; PHOSPHORYLATION	Background:GABRP correlates with the basal-like breast cancer (BLBC)/triple negative subtype, but its function in this disease is poorly understood. Results: Silencing GABRP in BLBC cells decreases migration, BLBC-associated cytokeratins and ERK1/2 activation. Conclusion: A GABRP-ERK1/2-cytokeratin axis maintains BLBC migration. Significance: GABRP is a component of a cell-surface receptor, thus, targeting this signaling axis may have therapeutic potential in BLBC. Breast cancer is a heterogeneous disease comprised of distinct subtypes predictive of patient outcome. Tumors of the basal-like subtype have a poor prognosis due to inherent aggressiveness and the lack of targeted therapeutics. Basal-like tumors typically lack estrogen receptor-, progesterone receptor and HER2/ERBB2, or in other words they are triple negative (TN). Continued evaluation of basal-like breast cancer (BLBC) biology is essential to identify novel therapeutic targets. Expression of the pi subunit of the GABA(A) receptor (GABRP) is associated with the BLBC/TN subtype, and herein, we reveal its expression also correlates with metastases to the brain and poorer patient outcome. GABRP expression in breast cancer cell lines also demonstrates a significant correlation with the basal-like subtype suggesting that GABRP functions in the initiation and/or progression of basal-like tumors. To address this postulate, we stably silenced GABRP in two BLBC cell lines, HCC1187 and HCC70 cells. Decreased GABRP reduces in vitro tumorigenic potential and migration concurrent with alterations in the cytoskeleton, specifically diminished cellular protrusions and expression of the BLBC-associated cytokeratins, KRT5, KRT6B, KRT14, and KRT17. Silencing GABRP also decreases phosphorylation of extracellular regulated kinase 1/2 (ERK1/2) in both cell lines and selective inhibition of ERK1/2 similarly decreases the basal-like cytokeratins as well as migration. Combined, these data reveal a GABRP-ERK1/2-cytokeratin axis that maintains the migratory phenotype of basal-like breast cancer. GABRP is a component of a cell surface receptor, thus, these findings suggest that targeting this new signaling axis may have therapeutic potential in BLBC.	[Sizemore, Gina M.; Sizemore, Steven T.; Seachrist, Darcie D.; Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet, Sch Med, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Sizemore, Gina/ABI-7542-2020; Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	Dept. of Defense Grants [W81XWH-09-1-0696, W81XWH-11-1-0185]; Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703] Funding Source: NIH RePORTER	Dept. of Defense Grants; Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Dept. of Defense Grants W81XWH-09-1-0696 (to S. T. S.) and W81XWH-11-1-0185 (to R. A. K.) and by the Case Comprehensive Cancer Center P30 CA043703 (to R. A. K.).	Abdul M, 2008, ACTA ONCOL, V47, P1546, DOI 10.1080/02841860801961265; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Azuma H, 2003, CANCER RES, V63, P8090; Backus J, 2005, J MOL DIAGN, V7, P327, DOI 10.1016/S1525-1578(10)60561-2; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Fowler CJ, 2004, TRENDS PHARMACOL SCI, V25, P59, DOI 10.1016/j.tips.2003.12.001; Gaedcke J, 2007, MODERN PATHOL, V20, P864, DOI 10.1038/modpathol.3800830; Garib V, 2005, EUR J ANAESTH, V22, P609, DOI 10.1017/S026502150500102X; Garib V, 2002, ACTA ANAESTH SCAND, V46, P836, DOI 10.1034/j.1399-6576.2002.460714.x; Haeseler G, 2008, BRIT J PHARMACOL, V155, P265, DOI 10.1038/bjp.2008.255; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Inamoto T, 2007, CANCER INVEST, V25, P574, DOI 10.1080/07357900701522471; Johnson SK, 2005, J PANCREAS, V6, P136; Joseph J, 2002, CANCER RES, V62, P6467; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu Y, 2008, WORLD J GASTROENTERO, V14, P7175, DOI 10.3748/wjg.14.7175; Luck AA, 2008, CLIN ONCOL-UK, V20, P40, DOI 10.1016/j.clon.2007.10.002; Mazurkiewicz M, 1999, J EXP CLIN CANC RES, V18, P247; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Miao YF, 2010, BIOMED PHARMACOTHER, V64, P583, DOI 10.1016/j.biopha.2010.03.006; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Neman J, 2014, P NATL ACAD SCI USA, V111, P984, DOI 10.1073/pnas.1322098111; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quezada M, 2006, FERTIL STERIL, V86, P1750, DOI 10.1016/j.fertnstert.2006.05.033; Rakha EA, 2011, CLIN ONCOL-UK, V23, P587, DOI 10.1016/j.clon.2011.03.013; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reinholz MM, 2005, CLIN CANCER RES, V11, P3722, DOI 10.1158/1078-0432.CCR-04-1483; Sadeghi H, 2010, AM J PHYSIOL-ENDOC M, V298, pE889, DOI 10.1152/ajpendo.00577.2009; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Taylor AP, 2010, BRIT J CANCER, V103, P82, DOI 10.1038/sj.bjc.6605746; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zafrakas M, 2006, INT J CANCER, V118, P1453, DOI 10.1002/ijc.21517; Zehentner BK, 2006, MOL DIAGN THER, V10, P41, DOI 10.1007/BF03256441; Zehentner BK, 2002, CLIN CHEM, V48, P1225; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040797	55	43	43	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24102	24113		10.1074/jbc.M114.593582	http://dx.doi.org/10.1074/jbc.M114.593582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012653	Green Published, hybrid			2022-12-25	WOS:000341505600010
J	Foulquier, E; Pompeo, F; Freton, C; Cordier, B; Grangeasse, C; Galinier, A				Foulquier, Elodie; Pompeo, Frederique; Freton, Celine; Cordier, Baptiste; Grangeasse, Christophe; Galinier, Anne			PrkC-mediated Phosphorylation of Overexpressed YvcK Protein Regulates PBP1 Protein Localization in Bacillus subtilis mreB Mutant Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Bacillus; Cell Wall; Gluconeogenesis; Morphogenesis; Protein Phosphorylation	MYCOBACTERIUM-TUBERCULOSIS; SER/THR KINASE; DIVISION; GROWTH; BIOSYNTHESIS; BACTERIA; SYSTEM; IDENTIFICATION; MORPHOGENESIS; SPECIFICITY	Background: The YvcK protein is essential for Bacillus subtilis growth on gluconeogenic conditions; its overproduction rescues an mreB mutant. Results: PrkC phosphorylates YvcK; this phosphorylation is not required for growth on gluconeogenic conditions but is necessary for mreB rescue. Conclusion: YvcK phosphorylation is specifically involved in B. subtilis morphogenesis. Significance: This phosphorylation-based regulatory mechanism could be widespread in bacteria. The YvcK protein has been shown to be necessary for growth under gluconeogenic conditions in Bacillus subtilis. Amazingly, its overproduction rescues growth and morphology defects of the actin-like protein MreB deletion mutant by restoration of PBP1 localization. In this work, we observed that YvcK was phosphorylated at Thr-304 by the protein kinase PrkC and that phosphorylated YvcK was dephosphorylated by the cognate phosphatase PrpC. We show that neither substitution of this threonine with a constitutively phosphorylated mimicking glutamic acid residue or a phosphorylation-dead mimicking alanine residue nor deletion of prkC or prpC altered the ability of B. subtilis to grow under gluconeogenic conditions. However, we observed that a prpC mutant and a yvcK mutant were more sensitive to bacitracin compared with the WT strain. In addition, the bacitracin sensitivity of strains in which YvcK Thr-304 was replaced with either an alanine or a glutamic acid residue was also affected. We also analyzed rescue of the mreB mutant strain by overproduction of YvcK in which the phosphorylation site was substituted. We show that YvcK T304A overproduction did not rescue the mreB mutant aberrant morphology due to PBP1 mislocalization. The same observation was made in an mreB prkC double mutant overproducing YvcK. Altogether, these data show that YvcK may have two distinct functions: 1) in carbon source utilization independent of its phosphorylation level and 2) in cell wall biosynthesis and morphogenesis through its phosphorylation state.	[Foulquier, Elodie; Pompeo, Frederique; Freton, Celine; Cordier, Baptiste; Galinier, Anne] Aix Marseille Univ, Lab Chim Bacterienne, UMR 7283, Inst Microbiol Mediterranee,CNRS, F-13009 Marseille, France; [Freton, Celine; Grangeasse, Christophe] Univ Lyon, UMR 5086, CNRS, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Galinier, A (corresponding author), Aix Marseille Univ, Lab Chim Bacterienne, UMR 7283, Inst Microbiol Mediterranee,CNRS, F-13009 Marseille, France.	galinier@imm.cnrs.fr	Pompeo, Frederique/Q-5772-2017	Cordier, Baptiste/0000-0002-6042-9787; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; Agence Nationale de la Recherche (P-loop); Aix-Marseille Universite; Agence Nationale de la Recherche (PiBaKi)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (P-loop)(French National Research Agency (ANR)); Aix-Marseille Universite; Agence Nationale de la Recherche (PiBaKi)(French National Research Agency (ANR))	This work was supported by CNRS, the Agence Nationale de la Recherche (P-loop and PiBaKi), and Aix-Marseille Universite.	Absalon C, 2009, MICROBIOL-SGM, V155, P932, DOI 10.1099/mic.0.022475-0; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Bird TH, 2011, ARCH MICROBIOL, V193, P451, DOI 10.1007/s00203-011-0676-y; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Foulquier E, 2011, MOL MICROBIOL, V80, P309, DOI 10.1111/j.1365-2958.2011.07587.x; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gilmour MW, 2003, MOL MICROBIOL, V49, P105, DOI 10.1046/j.1365-2958.2003.03551.x; Gorke B, 2005, MICROBIOL-SGM, V151, P3777, DOI 10.1099/mic.0.28172-0; Graupner M, 2002, BIOCHEMISTRY-US, V41, P3754, DOI 10.1021/bi011937v; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Jers C, 2010, MOL MICROBIOL, V77, P287, DOI 10.1111/j.1365-2958.2010.07227.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Obuchowski M, 2000, J BACTERIOL, V182, P5634, DOI 10.1128/JB.182.19.5634-5638.2000; Pietack N, 2010, J MOL MICROB BIOTECH, V18, P129, DOI 10.1159/000308512; Pompeo F, 2012, J BIOL CHEM, V287, P20830, DOI 10.1074/jbc.M112.340331; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Scheffers DJ, 2004, J BACTERIOL, V186, P5153, DOI 10.1128/jb.186.15.5153-5156.2004; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; STORM DR, 1973, J BIOL CHEM, V248, P3940; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	38	30	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23662	23669		10.1074/jbc.M114.562496	http://dx.doi.org/10.1074/jbc.M114.562496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012659	Green Published, hybrid			2022-12-25	WOS:000341505000034
J	Lin, TF; Lin, IW; Chen, SC; Wu, HH; Yang, CS; Fang, HY; Chiu, MM; Jeng, CJ				Lin, Ting-Feng; Lin, I-Wen; Chen, Shu-Ching; Wu, Hao-Han; Yang, Chi-Sheng; Fang, Hsin-Yu; Chiu, Mei-Miao; Jeng, Chung-Jiuan			The Subfamily-specific Assembly of Eag and Erg K+ Channels Is Determined by Both the Amino and the Carboxyl Recognition Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; SUBUNIT STOICHIOMETRY; TERMINAL REGION; C-TERMINUS; SHAKER; TETRAMERIZATION; LOCALIZATION; PROTEIN; DISTAL; MOUSE	A functional voltage-gated K+ (Kv) channel comprises four pore-forming alpha-subunits, and only members of the same Kv channel subfamily may co-assemble to form heterotetramers. The ether-a-go-go family of Kv channels (KCNH) encompasses three distinct subfamilies: Eag (Kv10), Erg (Kv11), and Elk (Kv12). Members of different ether-a-go-go subfamilies, such as Eag and Erg, fail to form heterotetramers. Although a short stretch of amino acid sequences in the distal C-terminal section has been implicated in subfamily-specific subunit assembly, it remains unclear whether this region serves as the sole and/or principal subfamily recognition domain for Eag and Erg. Here we aim to ascertain the structural basis underlying the subfamily specificity of ether-a-go-go channels by generating various chimeric constructs between rat Eag1 and human Erg subunits. Biochemical and electrophysiological characterizations of the subunit interaction properties of a series of different chimeric and truncation constructs over the C terminus suggested that the putative C-terminal recognition domain is dispensable for subfamily-specific assembly. Further chimeric analyses over the N terminus revealed that the N-terminal region may also harbor a subfamily recognition domain. Importantly, exchanging either the N-terminal or the C-terminal domain alone led to a virtual loss of the intersubfamily assembly boundary. By contrast, simultaneously swapping both recognition domains resulted in a reversal of subfamily specificity. Our observations are consistent with the notion that both the N-terminal and the C-terminal recognition domains are required to sustain the subfamily-specific assembly of rat Eag1 and human Erg.	[Lin, Ting-Feng; Lin, I-Wen; Wu, Hao-Han; Yang, Chi-Sheng; Fang, Hsin-Yu; Chiu, Mei-Miao; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 12212, Taiwan; [Jeng, Chung-Jiuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei 12212, Taiwan; [Chen, Shu-Ching] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10051, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Jeng, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, 155,Sect 2,Li Non St, Taipei 12212, Taiwan.	cjjeng@ym.edu.tw		Chen, Shu-Ching/0000-0001-9112-1526; Lin, Ting-Feng/0000-0003-0261-8309	National Science Council, Taiwan [NSC101-2320-B-010-038-MY3]; Aim for the Top University Plan, Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan, Ministry of Education, Taiwan	This work was supported by research grants from the National Science Council, Taiwan (Grant NSC101-2320-B-010-038-MY3) and from the Aim for the Top University Plan, Ministry of Education, Taiwan.	Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chen IH, 2011, J BIOL CHEM, V286, P27183, DOI 10.1074/jbc.M111.233825; Choe CU, 2006, HUM MOL GENET, V15, P2888, DOI 10.1093/hmg/ddl230; Chuang CC, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-23; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Gong QM, 2004, J MOL CELL CARDIOL, V37, P1225, DOI 10.1016/j.yjmcc.2004.10.002; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hille B., 2001, ION CHANNELS EXCITAB, P131; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; LeesMiller JP, 1997, CIRC RES, V81, P719; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; London B, 1997, CIRC RES, V81, P870; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Sahoo N, 2010, FEBS LETT, V584, P3896, DOI 10.1016/j.febslet.2010.07.063; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	43	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22815	22834		10.1074/jbc.M114.574814	http://dx.doi.org/10.1074/jbc.M114.574814			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25008323	hybrid, Green Published			2022-12-25	WOS:000341017200025
J	Fink, G; Sudfeld, CR; Danaei, G; Ezzati, M; Fawzi, WW				Fink, Guenther; Sudfeld, Christopher R.; Danaei, Goodarz; Ezzati, Majid; Fawzi, Wafaie W.			Scaling-Up Access to Family Planning May Improve Linear Growth and Child Development in Low and Middle Income Countries	PLOS ONE			English	Article							TEENAGE MOTHERHOOD; HEALTH SURVEYS; MATERNAL AGE; BIRTH COHORT; OUTCOMES; PREGNANCY; INFANT; FERTILITY; MORTALITY; CONTRACEPTION	Background: A large literature has indicated a robust association between birth spacing and child survival, but evidence on the association of birth timing with physical growth in low and middle income countries (LMICs) remains limited. Methods and Results: Data from 153 cross-sectional Demographic and Health Surveys (DHS) across 61 LMICs conducted between 1990 and 2011 were combined to assess the association of birth timing with child stunting (height-for-age z-score <-2). A total of 623,789 children of birth order 1-5 contributed to the maternal age analysis, while the birth spacing dataset consisted of 584,226 children of birth order 2 and higher. Compared to 27-34 year old mothers, maternal age under 18 years was associated with a relative stunting risk of 1.35 (95% CI: 1.29-1.40) for firstborn children, whereas the relative risk was 1.24 (95% CI: 1.19-1.29) for mothers aged 18-19 years. The association of young maternal age with stunting was significantly greater for urban residents and those in the top 50% of household wealth. Birth intervals less than 12 months and 12-23 months had relative risks for stunting of 1.09 (95% CI: 1.06-1.12) and 1.06 (95% CI: 1.05-1.06) as compared to a 24-35 month inter-pregnancy interval, respectively. The strength of both teenage pregnancy and short birth interval associations showed substantial variation across WHO region. We estimate that 8.6% (6.9-10.3%) of stunted cases in the South Asian DHS sample would have been averted by jointly eliminating teen pregnancies and birth intervals less than 24 months, while only 3.6% (1.5-5.7%) of stunting cases would have prevented in the Middle East and North Africa sample. Conclusions: Postponing the age of first birth and increasing inter-pregnancy intervals has the potential to significantly reduce the prevalence of stunting and improve child development in LMICs.	[Fink, Guenther; Sudfeld, Christopher R.; Danaei, Goodarz; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Epidemiol, London, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Dept Biostat, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; Imperial College London	Fink, G (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	gfink@hsph.harvard.edu	Sudfeld, Christopher/AAW-3856-2021; Danaei, Goodarz/B-6085-2008	Sudfeld, Christopher/0000-0002-3203-3638; 	Grand Challenges Canada through the Saving Brains Project; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056] Funding Source: researchfish	Grand Challenges Canada through the Saving Brains Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by Grand Challenges Canada through the Saving Brains Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari R., 2003, ADULTHOOD EXPLORING, P62; Alam N, 2000, J BIOSOC SCI, V32, P229, DOI 10.1017/S0021932000002297; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Alvergne A, 2013, AM J HUM BIOL, V25, P107, DOI 10.1002/ajhb.22348; Bloom DE, 2010, URB DEV MULT PERSP; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Coyne CA, 2013, TWIN RES HUM GENET, V16, P679, DOI 10.1017/thg.2013.23; Guimarae AMDN, 2013, REV SAUDE PUBL, V47, P11, DOI 10.1590/S0034-89102013000100003; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Finlay JE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000226; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gupta N, 2008, EUR J OBSTET GYN R B, V137, P165, DOI 10.1016/j.ejogrb.2007.06.013; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; ICF International, 2012, DEM HLTH SURV SAMPL; Kar BR, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-31; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Mayor S, 2004, BRIT MED J, V328, P1152, DOI 10.1136/bmj.328.7449.1152-a; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Raj A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4258; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Rutstein SO, 2008, 41 DHS; Scally G, 2002, INT J EPIDEMIOL, V31, P554, DOI 10.1093/ije/31.3.554; SENDEROWITZ J, 1985, POPUL BULL, V40, P1; Shaw M, 2006, SOC SCI MED, V62, P2526, DOI 10.1016/j.socscimed.2005.10.007; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; StataCorp, 2011, STAT STAT SOFTW REL; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Stewart CP, 2007, MATERN CHILD NUTR, V3, P174, DOI 10.1111/j.1740-8709.2007.00097.x; UNICEF, 1990, STRAT IMPR NUTR CHIL; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; WHO, 2006, ANTR SOFTW ASS GROWT; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World B., 2012, WORLD BANK SE4ALL DA; World Health Organization, 2011, WHO GUID PREV EARL P; Yen S, 2013, PEDIATR ANN, V42, P21, DOI 10.3928/00904481-20130128-08; Zabin LS, 1998, STUD FAMILY PLANN, V29, P210, DOI 10.2307/172160; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102391	10.1371/journal.pone.0102391	http://dx.doi.org/10.1371/journal.pone.0102391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25020132	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600075
J	Papadimitropoulos, A; Piccinini, E; Brachat, S; Braccini, A; Wendt, D; Barbero, A; Jacobi, C; Martin, I				Papadimitropoulos, Adam; Piccinini, Elia; Brachat, Sophie; Braccini, Alessandra; Wendt, David; Barbero, Andrea; Jacobi, Carsten; Martin, Ivan			Expansion of Human Mesenchymal Stromal Cells from Fresh Bone Marrow in a 3D Scaffold-Based System under Direct Perfusion	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; EX-VIVO; PROGENITOR CELLS; CULTURE; DIFFERENTIATION; GROWTH; PROLIFERATION; NICHE	Mesenchymal stromal/stem cell (MSC) expansion in conventional monolayer culture on plastic dishes (2D) leads to progressive loss of functionality and thus challenges fundamental studies on the physiology of skeletal progenitors, as well as translational applications for cellular therapy and molecular medicine. Here we demonstrate that 2D MSC expansion can be entirely bypassed by culturing freshly isolated bone marrow nucleated cells within 3D porous scaffolds in a perfusion-based bioreactor system. The 3D-perfusion system generated a stromal tissue that could be enzymatically treated to yield CD45- MSC. As compared to 2D-expanded MSC (control), those derived from 3D-perfusion culture after the same time (3 weeks) or a similar extent of proliferation (7-8 doublings) better maintained their progenitor properties, as assessed by a 4.3-fold higher clonogenicity and the superior differentiation capacity towards all typical mesenchymal lineages. Transcriptomic analysis of MSC from 5 donors validated the robustness of the process and indicated a reduced inter-donor variability and a significant upregulation of multipotency-related gene clusters following 3D-perfusion-as compared to 2D-expansion. Interestingly, the differences in functionality and transcriptomics between MSC expanded in 2D or under 3D-perfusion were only partially captured by cytofluorimetric analysis using conventional surface markers. The described system offers a multidisciplinary approach to study how factors of a 3D engineered niche regulate MSC function and, by streamlining conventional labor-intensive processes, is prone to automation and scalability within closed bioreactor systems.	[Papadimitropoulos, Adam; Piccinini, Elia; Braccini, Alessandra; Wendt, David; Barbero, Andrea; Martin, Ivan] Univ Basel, Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, Basel, Switzerland; [Papadimitropoulos, Adam; Piccinini, Elia; Braccini, Alessandra; Wendt, David; Barbero, Andrea; Martin, Ivan] Univ Basel, Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Biomed, Basel, Switzerland; [Brachat, Sophie; Jacobi, Carsten] Novartis Inst Biomed Res, Basel, Switzerland	University of Basel; University of Basel; Novartis	Martin, I (corresponding author), Univ Basel, Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, Basel, Switzerland.	ivan.martin@usb.ch	Martin, Ivan/K-9286-2016	Lemire-Brachat, Sophie/0000-0002-3398-8225; Barbero, Andrea/0000-0001-5252-789X; Martin, Ivan/0000-0001-6493-0432	Novartis AG, Basel, Switzerland; European Union (OPHIS) [FP7-NMP-2009-SMALL-3-246373]; Novartis AG	Novartis AG, Basel, Switzerland; European Union (OPHIS); Novartis AG	The authors would like to acknowledge Novartis AG, Basel, Switzerland and the European Union (OPHIS; #FP7-NMP-2009-SMALL-3-246373) for financial support. The funding organization (Novartis AG) provided financial support i) in the form of authors' salaries (SBrachat and CJacobi) where their specific roles have been articulated in the 'author contributions' section and ii) for the research materials.	Almeida-Porada G, 2000, BLOOD, V95, P3620, DOI 10.1182/blood.V95.11.3620.011k02_3620_3627; Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Augello A, 2010, EUR CELLS MATER, V20, P121; Baksh D, 2005, BLOOD, V106, P3012, DOI 10.1182/blood-2005-01-0433; Baksh D, 2003, EXP HEMATOL, V31, P723, DOI 10.1016/S0301-472X(03)00106-1; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bocelli-Tyndall C, 2009, ANN RHEUM DIS, V68, P1352, DOI 10.1136/ard.2008.094003; Bocelli-Tyndall C, 2010, ARTHRITIS RHEUM-US, V62, P3815, DOI 10.1002/art.27736; Braccini A, 2005, STEM CELLS, V23, P1066, DOI 10.1634/stemcells.2005-0002; Chen X, 2006, STEM CELLS, V24, P2052, DOI 10.1634/stemcells.2005-0591; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Di Maggio N, 2012, STEM CELLS, V30, P1455, DOI 10.1002/stem.1106; Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041; Diederichs S, 2009, BIOTECHNOL PROGR, V25, P1762, DOI 10.1002/btpr.258; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Eipers PG, 2000, EXP HEMATOL, V28, P815, DOI 10.1016/S0301-472X(00)00183-1; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Louca D, 2013, SCI REP-UK, V3, DOI [10.1038/srep02047, 10.1038/srep02128]; Martin I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008558; Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muraglia A, 2000, J CELL SCI, V113, P1161; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reichardt Anne, 2013, Open Biomed Eng J, V7, P50, DOI 10.2174/1874120701307010050; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scaglione S, 2006, BIOTECHNOL BIOENG, V93, P181, DOI 10.1002/bit.20677; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759; Yang Y, 2007, BIOMATERIALS, V28, P3110, DOI 10.1016/j.biomaterials.2007.03.015; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Zhang ZL, 2009, BONE MARROW TRANSPL, V43, P69, DOI 10.1038/bmt.2008.260; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	60	63	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102359	10.1371/journal.pone.0102359	http://dx.doi.org/10.1371/journal.pone.0102359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020062	gold, Green Submitted, Green Published			2022-12-25	WOS:000339618600074
J	Roy, V; Iken, K; Archambault, P				Roy, Virginie; Iken, Katrin; Archambault, Philippe			Environmental Drivers of the Canadian Arctic Megabenthic Communities	PLOS ONE			English	Article							BEAUFORT SEA; BARENTS SEA; MEGAFAUNAL ASSEMBLAGES; EPIBENTHIC MEGAFAUNA; BENTHIC ECOLOGY; ORGANIC-MATTER; WATER POLYNYA; CHUKCHI SEAS; NORTH WATER; CARBON FLUX	Environmental gradients and their influence on benthic community structure vary over different spatial scales; yet, few studies in the Arctic have attempted to study the influence of environmental gradients of differing spatial scales on megabenthic communities across continental-scales. The current project studied for the first time how megabenthic community structure is related to several environmental factors over 2000 km of the Canadian Arctic, from the Beaufort Sea to northern Baffin Bay. Faunal trawl samples were collected between 2007 and 2011 at 78 stations from 30 to 1000 m depth and patterns in biomass, density, richness, diversity, and taxonomic composition were examined in relation to indirect/spatial gradients (e.g., depth), direct gradients (e. g., bottom oceanographic variables), and resource gradients (e. g., food supply proxies). Six benthic community types were defined based on their biomass-based taxonomic composition. Their distribution was significantly, but moderately, associated with large-scale (100-1000 km) environmental gradients defined by depth, physical water properties (e.g., bottom salinity), and meso-scale (10-100 km) environmental gradients defined by substrate type (hard vs. soft) and sediment organic carbon content. We did not observe a strong decline of bulk biomass, density and richness with depth or a strong increase of those community characteristics with food supply proxies, contrary to our hypothesis. We discuss how local-to meso-scale environmental conditions, such as bottom current regimes and polynyas, sustain biomass-rich communities at specific locations in oligotrophic and in deep regions of the Canadian Arctic. This study demonstrates the value of considering the scales of variability of environmental gradients when interpreting their relevance in structuring of communities.	[Roy, Virginie; Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Iken, Katrin] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA	University of Quebec; University of Alaska System; University of Alaska Fairbanks	Roy, V (corresponding author), Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada.	virginie.m.roy@gmail.com		Archambault, Philippe/0000-0001-5986-6149	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche nature et technologies du Quebec (FQRNT); Institut des sciences de la mer de Rimouski (ISMER) through Post Graduate Scholarships; Canadian Healthy Oceans Network (CHONe); Quebec-Ocean; ArcticNet; CHONe	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche nature et technologies du Quebec (FQRNT); Institut des sciences de la mer de Rimouski (ISMER) through Post Graduate Scholarships; Canadian Healthy Oceans Network (CHONe); Quebec-Ocean; ArcticNet; CHONe	Financial support was received by the Natural Sciences and Engineering Research Council of Canada (NSERC), by Fonds de recherche nature et technologies du Quebec (FQRNT), by Institut des sciences de la mer de Rimouski (ISMER) through Post Graduate Scholarships to VR and by stipends from the Canadian Healthy Oceans Network (CHONe) and Quebec-Ocean, and through grants to PA from ArcticNet and CHONe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WG, 1995, J GEOPHYS RES-OCEANS, V100, P4411, DOI 10.1029/94JC01982; Ambrose WG, 2001, MAR BIOL, V139, P937; [Anonymous], 2010, SEA IC CLIM ATL NO C; Appeltans W., 2013, **NON-TRADITIONAL**; Ardyna M, 2011, MAR ECOL PROG SER, V442, P37, DOI 10.3354/meps09378; Arrigo KR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018978; Bailey JNL, 2013, MAR GEOL, V341, P1, DOI 10.1016/j.margeo.2013.04.017; Barber DG, 2007, ELSEV OCEANOGR SERIE, V74, P1, DOI 10.1016/S0422-9894(06)74001-6; Belanger S, 2013, BIOGEOSCIENCES, V10, P4087, DOI 10.5194/bg-10-4087-2013; Belt ST, 2013, ORG GEOCHEM, V62, P33, DOI 10.1016/j.orggeochem.2013.07.002; Bergmann M, 2011, MAR BIOL RES, V7, P525, DOI 10.1080/17451000.2010.535834; Blanchard AL, 2014, DEEP-SEA RES PT II, V102, P132, DOI 10.1016/j.dsr2.2013.09.022; Blanchard AL, 2013, CONT SHELF RES, V67, P67, DOI 10.1016/j.csr.2013.04.031; Blanchard AL, 2013, CONT SHELF RES, V67, P52, DOI 10.1016/j.csr.2013.04.021; Bluhm BA, 2009, AQUAT BIOL, V7, P269, DOI 10.3354/ab00198; Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Carroll ML, 2012, POLAR BIOL, V35, P1259, DOI 10.1007/s00300-012-1171-x; Carroll ML, 2008, DEEP-SEA RES PT II, V55, P2340, DOI 10.1016/j.dsr2.2008.05.022; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cochrane SKJ, 2009, J SEA RES, V61, P222, DOI 10.1016/j.seares.2009.01.003; Conlan K, 2013, J MARINE SYST, V127, P76, DOI 10.1016/j.jmarsys.2013.07.013; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Curtis M.A., 1975, Polar Record, VNo. 111, P595; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Darnis G, 2012, CLIMATIC CHANGE, V115, P179, DOI 10.1007/s10584-012-0483-8; Denisenko SG, 2003, MAR ECOL PROG SER, V258, P109, DOI 10.3354/meps258109; DFO, 2009, 2009056 DFO CAN SCI; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Eleftheriou A., 2005, METHODS STUDY MARINE, V3rd ed, DOI DOI 10.1111/maec.12189; FISSEL DB, 1982, ARCTIC, V35, P180; Forest A, 2013, BIOGEOSCIENCES, V10, P2833, DOI 10.5194/bg-10-2833-2013; Forest A, 2011, PROG OCEANOGR, V91, P410, DOI 10.1016/j.pocean.2011.05.002; Goni MA, 2013, J GEOPHYS RES-OCEANS, V118, P4017, DOI 10.1002/jgrc.20286; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Grebmeier Jacqueline M., 1995, Coastal and Estuarine Studies, V49, P231; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; GREBMEIER JM, 1995, J GEOPHYS RES-OCEANS, V100, P4439, DOI 10.1029/94JC02198; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; HAGERMAN L, 1988, MAR ECOL PROG SER, V47, P55, DOI 10.3354/meps047055; Hamel D, 2002, DEEP-SEA RES PT II, V49, P5277, DOI 10.1016/S0967-0645(02)00190-X; Hannah CG, 2009, ARCTIC, V62, P83; Hargrave BT, 2002, DEEP-SEA RES PT II, V49, P5227, DOI 10.1016/S0967-0645(02)00187-X; Holte B, 1998, POLAR BIOL, V19, P375, DOI 10.1007/s003000050262; Howell SEL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004730; Howell SEL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037681; JENKS GF, 1971, ANN ASSOC AM GEOGR, V61, P217, DOI 10.1111/j.1467-8306.1971.tb00779.x; Jones DOB, 2007, MAR BIOL RES, V3, P191, DOI 10.1080/17451000701455287; Jorgensen LL, 1999, POLAR BIOL, V22, P395, DOI 10.1007/s003000050435; Kenchington E, 2011, 2011071 DFO CAN SCI, V2011; Klages M, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P139; Klein B, 2002, DEEP-SEA RES PT II, V49, P4983, DOI 10.1016/S0967-0645(02)00174-1; Kuzyk ZZA, 2009, MAR GEOL, V264, P190, DOI 10.1016/j.margeo.2009.05.006; LABARBERA M, 1984, AM ZOOL, V24, P71; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Link H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074077; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; Lubinsky I, 1972, THESIS MCGILL U MONT; Magen C, 2010, ESTUAR COAST SHELF S, V86, P31, DOI 10.1016/j.ecss.2009.09.009; Mayer M, 1996, MAR ECOL PROG SER, V143, P151, DOI 10.3354/meps143151; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McLaughlin F.A., 2004, SEA 14, P1211; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Melling H, 2001, ATMOS OCEAN, V39, P301, DOI 10.1080/07055900.2001.9649683; Metaxas A, 2001, CAN J FISH AQUAT SCI, V58, P86, DOI 10.1139/cjfas-58-1-86; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Morata N, 2008, MAR ECOL PROG SER, V371, P47, DOI 10.3354/meps07677; O'Brien MC, 2006, CONT SHELF RES, V26, P41, DOI 10.1016/j.csr.2005.09.007; Piepenburg D, 1997, MAR ECOL PROG SER, V147, P63, DOI 10.3354/meps147063; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg D, 1996, MAR BIOL, V125, P321, DOI 10.1007/BF00346313; Piepenburg D, 1996, POLAR BIOL, V16, P431, DOI 10.1007/BF02390425; Piepenburg D, 1997, J MARINE SYST, V10, P467, DOI 10.1016/S0924-7963(96)00050-4; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANG ENV STAT COMP; Ravelo AM, 2013, DEEP SEA RES 2, DOI [10.1016/j.dsr2.2013.07.017i, DOI 10.1016/J.DSR2.2013.07.017I]; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Riaux-Gobin C, 1993, HDB METHODS AQUATIC, P369, DOI DOI 10.1201/9780203752746-43; Rozanska M, 2009, MAR ECOL PROG SER, V386, P43, DOI 10.3354/meps08092; Sallon A, 2011, POLAR BIOL, V34, P1989, DOI 10.1007/s00300-011-1055-5; Schmid MK, 2006, PROG OCEANOGR, V71, P314, DOI 10.1016/j.pocean.2006.09.002; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Snelgrove P. V. R, 2001, ENCY OCEAN SCI, P748; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Soreide JE, 2013, MAR BIOL RES, V9, P831, DOI 10.1080/17451000.2013.775457; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stein R, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P169; Stein R., 2004, ORGANIC CARBON CYCLE, P24, DOI DOI 10.1007/978-3-642-18912-8_7; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; THOMSON DH, 1982, ARCTIC, V35, P61; Tremblay JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048825; Tremblay JE, 2007, ELSEV OCEANOGR SERIE, V74, P239, DOI 10.1016/S0422-9894(06)74008-9; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wassmann P, 1998, HYDROBIOLOGIA, V363, P29; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; Wei CL, 2012, DEEP-SEA RES PT I, V69, P82, DOI 10.1016/j.dsr.2012.07.008; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wetzel MA, 2005, HELGOLAND MAR RES, V59, P206, DOI 10.1007/s10152-005-0220-z; Williams WJ, 2008, J MAR RES, V66, P645, DOI 10.1357/002224008787536808; Zajac RN, 1998, HYDROBIOLOGIA, V375-76, P227, DOI 10.1023/A:1017032200173	114	46	47	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100900	10.1371/journal.pone.0100900	http://dx.doi.org/10.1371/journal.pone.0100900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019385	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600009
J	Dominguez, F; Moreno-Moya, JM; Lozoya, T; Romero, A; Martinez, S; Monterde, M; Gurrea, M; Ferri, B; Nunez, MJ; Simon, C; Pellicer, A				Dominguez, Francisco; Manuel Moreno-Moya, Juan; Lozoya, Teresa; Romero, Ainhoa; Martinez, Sebastian; Monterde, Mercedes; Gurrea, Marta; Ferri, Blanca; Jose Nunez, Maria; Simon, Carlos; Pellicer, Antonio			Embryonic miRNA Profiles of Normal and Ectopic Pregnancies	PLOS ONE			English	Article							HUMAN FALLOPIAN-TUBE; MICRORNA EXPRESSION; MUC1; EPIGENETICS; TARGETS	Our objective was to investigate the miRNA profile of embryonic tissues in ectopic pregnancies (EPs) and controlled abortions (voluntary termination of pregnancy; VTOP). Twenty-three patients suffering from tubal EP and twenty-nine patients with a normal ongoing pregnancy scheduled for a VTOP were recruited. Embryonic tissue samples were analyzed by miRNA microarray and further validated by real time PCR. Microarray studies showed that four miRNAs were differentially downregulated (hsa-mir-196b, hsa-mir-30a, hsa-mir-873, and hsa-mir-337-3p) and three upregulated (hsa-mir-1288, hsa-mir-451, and hsa-mir-223) in EP compared to control tissue samples. Hsa-miR-196, hsa-miR-223, and hsa-miR-451 were further validated by real time PCR in a wider population of EP and control samples. We also performed a computational analysis to identify the gene targets and pathways which might be modulated by these three differentially expressed miRNAs. The most significant pathways found were the mucin type O-glycan biosynthesis and the ECM-receptor-interaction pathways. We also checked that the dysregulation of these three miRNAs was able to alter the expression of the gene targets in the embryonic tissues included in these pathways such as GALNT13 and ITGA2 genes. In conclusion, analysis of miRNAs in ectopic and eutopic embryonic tissues shows different expression patterns that could modify pathways which are critical for correct implantation, providing new insights into the understanding of ectopic implantation in humans.	[Dominguez, Francisco; Manuel Moreno-Moya, Juan; Martinez, Sebastian; Simon, Carlos; Pellicer, Antonio] Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain; [Lozoya, Teresa; Romero, Ainhoa; Monterde, Mercedes; Gurrea, Marta; Ferri, Blanca; Jose Nunez, Maria; Pellicer, Antonio] Hosp Univ LaFe, Valencia, Spain; [Dominguez, Francisco] INCLIVA Biomed Res, Valencia, Spain		Dominguez, F (corresponding author), Fdn IVI, Inst Univ IVI, INCLIVA, Valencia, Spain.	francisco.dominguez@ivi.es	Pellicer, Antonio/AAA-6005-2020; Simon, Carlos/G-2186-2014; Dominguez, Francisco/AAA-7260-2020; MARTINEZ, ANTONIO PELLICER/C-4832-2015	Pellicer, Antonio/0000-0002-8254-863X; Simon, Carlos/0000-0003-0902-9531; Dominguez, Francisco/0000-0002-7620-8081; 	Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme - FEDER [CP13/00075]	Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme - FEDER	FD's participation in this work was supported by the Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme (CP13/00075) co-founded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe W, 2013, HUM REPROD; Al-Azemi M, 2009, HUM REPROD, V24, P2582, DOI 10.1093/humrep/dep233; Altmae S, 2012, REPROD SCI; [Anonymous], 1995, JAMA, V273, P533; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bozdag G, 2011, J OBSTET GYNAECOL, V31, P666, DOI 10.3109/01443615.2011.594916; Brown JK, 2011, CURR OPIN OBSTET GYN, V23, P221, DOI 10.1097/GCO.0b013e3283481212; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041080; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fylstra D L, 1998, Obstet Gynecol Surv, V53, P320, DOI 10.1097/00006254-199805000-00024; Gilabert-Estelles J, 2012, CURR MED CHEM, V19, P2406, DOI 10.2174/092986712800269362; Horne AW, 2009, J CLIN ENDOCR METAB, V94, P5146, DOI 10.1210/jc.2009-1476; Jackson Richard J, 2007, Sci STKE, V2007, pre1, DOI 10.1126/stke.3672007re1; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li ZJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1681; Lozoya T, 2014, PLOS ONE, V31, P9; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Manfe V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059390; Moreno-Moya JM, 2014, MOL HUM REPROD, V20, P550, DOI 10.1093/molehr/gau010; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Refaat B, 2012, FERTIL STERIL, V97, P1115, DOI 10.1016/j.fertnstert.2012.02.035; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Salih SM, 2004, AM J OBSTET GYNECOL, V190, P1404, DOI 10.1016/j.ajog.2004.01.066; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Shaw JLV, 2010, HUM REPROD UPDATE, V16, P432, DOI 10.1093/humupd/dmp057; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wilkins-Haug L, 2009, CURR OPIN OBSTET GYN, V21, P201, DOI 10.1097/GCO.0b013e32832d7b95	34	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102185	10.1371/journal.pone.0102185	http://dx.doi.org/10.1371/journal.pone.0102185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013942	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400075
J	Waltz, X; Baillot, M; Connes, P; Bocage, B; Renaudeau, D				Waltz, Xavier; Baillot, Michelle; Connes, Philippe; Bocage, Bruno; Renaudeau, David			Effects of Hydration Level and Heat Stress on Thermoregulatory Responses, Hematological and Blood Rheological Properties in Growing Pigs	PLOS ONE			English	Article							HIGH-TEMPERATURE	Heat stress is one of the major limiting factors of production efficiency in the swine industry. The aims of the present study were 1) to observe if hemorheological and hematological parameters could be associated to physiological acclimation during the first days of heat stress exposure and 2) to determine if water restriction could modulate the effect of thermal heat stress on physiological, hematological and hemorheological parameters. Twelve Large White male pigs were divided into an ad libitum and a water restricted group. All pigs were submitted to one week at 24 degrees C (D-7 to D-1). Then, at D0, temperature was progressively increased until 32 degrees C and maintained during one week (D1 to D7). We performed daily measurements of water and feed intake. Physiological (i.e., skin temperature, rectal temperature, respiratory rate), hematological and hemorheological parameters were measured on D-6, D-5, D0, D1, D2 and D7. Water restriction had no effect on physiological, hematological and hemorheological parameters. The first days of heat stress caused an increase in the three physiological parameters followed by a reduction of these parameters suggesting a successful acclimation of pigs to heat stress. We showed an increase in hematocrit, red blood cell aggregation and red blood cell aggregation strength during heat stress. Further, we observed an important release of reticulocytes, an increase of red blood cell deformability and a reduction of feed intake and blood viscosity under heat stress. This study suggests that physiological acute adaptation to heat stress is accompanied by large hematological and hemorheological changes.	[Waltz, Xavier; Connes, Philippe] UMR Inserm 1134, F-97159 Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Connes, Philippe] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Baillot, Michelle; Connes, Philippe] Univ Antilles Guyane, Dept Physiol, Lab ACTES, EA 3596, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex, Paris, France; [Connes, Philippe] Inst Univ France, Paris, France; [Bocage, Bruno; Renaudeau, David] INRA, UR 143, Unite Rech Zootech, Petit Bourg, France; [Renaudeau, David] INRA, UMR 1348, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; Institut Universitaire de France; INRAE; INRAE	Connes, P (corresponding author), UMR Inserm 1134, F-97159 Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Connes, Philippe/J-7835-2019; WALTZ, Xavier/M-3606-2016	Connes, Philippe/0000-0002-9232-0268; WALTZ, Xavier/0000-0002-0838-290X; Philippe, Connes/0000-0001-8449-7998	INRA (PigChange project); INRA (PigChange project)	INRA (PigChange project); INRA (PigChange project)	The present study has been funded by INRA (PigChange project 2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Collin A, 2001, EXP PHYSIOL, V86, P83, DOI 10.1113/eph8602102; Collin A, 2001, ANIM SCI, V72, P519, DOI 10.1017/S1357729800052048; Grau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056759; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Jung F, 2011, CLIN HEMORHEOL MICRO, V48, P129, DOI 10.3233/CH-2011-1392; Mount L. E., 1975, Livestock Production Science, V2, P381, DOI 10.1016/0301-6226(75)90121-9; Pearce SC, 2013, J ANIM SCI, V91, P2108, DOI 10.2527/jas.2012-5738; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Rampling MW, 2004, BIORHEOLOGY, V41, P91; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Renaudeau D, 2010, J ANIM SCI, V88, P3715, DOI 10.2527/jas.2009-2169; Renaudeau D, 2006, ANIM RES, V55, P209, DOI 10.1051/animres:2006012; Simmonds MJ, 2013, J GERIATR CARDIOL, V10, P291, DOI 10.3969/j.issn.1671-5411.2013.03.010; Tikhomirova IA, 2011, CLIN HEMORHEOL MICRO, V49, P295, DOI 10.3233/CH-2011-1480; Uyuklu M, 2009, CLIN HEMORHEOL MICRO, V41, P269, DOI 10.3233/CH-2009-1178; WALTZ X, 2013, CLIN HEMORHEOL MICRO; Zhou WT, 1999, J THERM BIOL, V24, P193, DOI 10.1016/S0306-4565(99)00011-X	18	8	9	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102537	10.1371/journal.pone.0102537	http://dx.doi.org/10.1371/journal.pone.0102537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013960	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400102
J	Guo, TC; Johansson, DX; Haugland, O; Liljestrom, P; Evensen, O				Guo, Tz-Chun; Johansson, Daniel X.; Haugland, Oyvind; Liljestrom, Peter; Evensen, Oystein			A 6K-Deletion Variant of Salmonid Alphavirus Is Non-Viable but Can Be Rescued through RNA Recombination	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SEMLIKI-FOREST-VIRUS; PANCREAS DISEASE VIRUS; FARMED ATLANTIC SALMON; SINDBIS VIRUS; SLEEPING-DISEASE; RAINBOW-TROUT; SALAR L.; ONCORHYNCHUS-MYKISS; MEMBRANE-PROTEINS	Pancreas disease (PD) of Atlantic salmon is an emerging disease caused by Salmonid alphavirus (SAV) which mainly affects salmonid aquaculture in Western Europe. Although genome structure of SAV has been characterized and each individual viral protein has been identified, the role of 6K protein in viral replication and infectivity remains undefined. The 6K protein of alphaviruses is a small and hydrophobic protein which is involved in membrane permeabilization, protein processing and virus budding. Because these common features are shared across many viral species, they have been named viroporins. In the present study, we applied reverse genetics to generate SAV3 6K-deleted (Delta 6K) variant and investigate the role of 6K protein. Our findings show that the 6K-deletion variant of salmonid alphavirus is non-viable. Despite viral proteins of Delta 6K variant are detected in the cytoplasm by immunostaining, they are not found on the cell surface. Further, analysis of viral proteins produced in Delta 6K cDNA clone transfected cells using radioimmunoprecipitation (RIPA) and western blot showed a protein band of larger size than E2 of wild-type SAV3. When Delta 6K cDNA was co-transfected with SAV3 helper cDNA encoding the whole structural genes including 6K, the infectivity was rescued. The development of CPE after co-transfection and resolved genome sequence of rescued virus confirmed full-length viral genome being generated through RNA recombination. The discovery of the important role of the 6K protein in virus production provides a new possibility for the development of antiviral intervention which is highly needed to control SAV infection in salmonids.	[Guo, Tz-Chun; Haugland, Oyvind; Evensen, Oystein] Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Johansson, Daniel X.; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Norwegian University of Life Sciences; Karolinska Institutet	Evensen, O (corresponding author), Norwegian Univ Life Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	oystein.evensen@nmbu.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Liljestrom, Peter/0000-0002-2132-0981	Norwegian Research Council [182035, 183204]; Swedish Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was carried out with financial support to OE from the Norwegian Research Council, projects no. 182035 Immunisation strategies against viral pathogens of Atlantic salmon and no. 183204 Indo-Norwegian platform on fish and shellfish vaccine development, and from the Swedish Research Council to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine AF, 2007, J MEMBRANE BIOL, V215, P37, DOI 10.1007/s00232-007-9003-6; ATKINS GJ, 1979, J GEN VIROL, V45, P201, DOI 10.1099/0022-1317-45-1-201; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Fringuelli E, 2008, J FISH DIS, V31, P811, DOI 10.1111/j.1365-2761.2008.00944.x; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; GIRON DJ, 1969, APPL MICROBIOL, V18, P584, DOI 10.1128/AEM.18.4.584-588.1969; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Graham DA, 2007, DIS AQUAT ORGAN, V74, P191, DOI 10.3354/dao074191; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2010, CURR OPIN INVEST DR, V11, P175; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; Herath T, 2009, ICELAND AGR SCI, V22, P19; Hill KR, 1997, J VIROL, V71, P2693, DOI 10.1128/JVI.71.4.2693-2704.1997; Hjortaas MJ, 2013, J FISH DIS, V36, P71, DOI 10.1111/j.1365-2761.2012.01445.x; Hodneland K, 2005, DIS AQUAT ORGAN, V66, P113, DOI 10.3354/dao066113; Hofmann K., 1993, BIOL CHEM H-S, P374; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Karlsen M, 2014, J GEN VIROL, V95, P52, DOI 10.1099/vir.0.057455-0; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; LILJESTROM P, 1991, J VIROL, V65, P4107; LILJESTROM P, 1991, J VIROL, V65, P147; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEWY A, 1995, J VIROL, V69, P469, DOI 10.1128/JVI.69.1.469-475.1995; Madan V, 2005, VIROLOGY, V332, P307, DOI 10.1016/j.virol.2004.11.001; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Melton JV, 2002, J BIOL CHEM, V277, P46923, DOI 10.1074/jbc.M207847200; Miller J, 2001, PERCEPT PSYCHOPHYS, V63, P1399, DOI 10.3758/BF03194551; Moriette C, 2006, J VIROL, V80, P4088, DOI 10.1128/JVI.80.8.4088-4098.2006; Moriette C, 2005, J GEN VIROL, V86, P3119, DOI 10.1099/vir.0.81030-0; Nordstrom EKL, 2005, J GEN VIROL, V86, P349, DOI 10.1099/vir.0.80481-0; Petterson E, 2013, J GEN VIROL, V94, P1945, DOI 10.1099/vir.0.052563-0; RAJU R, 1995, J VIROL, V69, P7391, DOI 10.1128/JVI.69.12.7391-7401.1995; Rheme C, 2005, EXP PHYSIOL, V90, P45, DOI 10.1113/expphysiol.2004.028142; Ronn R, 2008, CURR TOP MED CHEM, V8, P533, DOI 10.2174/156802608783955647; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; SaMJS Schlesinger, 2001, FUNDAMENTAL VIROLOGY; Sanz MA, 2005, PROTEIN REV, V1, P233; Sanz MA, 2001, J VIROL, V75, P7778, DOI 10.1128/JVI.75.16.7778-7784.2001; SCHLESINGER MJ, 1993, VIROLOGY, V193, P424, DOI 10.1006/viro.1993.1139; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; StGelais C, 2007, ANTIVIR RES, V76, P48, DOI 10.1016/j.antiviral.2007.05.001; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Taksdal T, 2007, J FISH DIS, V30, P545, DOI 10.1111/j.1365-2761.2007.00845.x; WEISS BG, 1991, J VIROL, V65, P4017, DOI 10.1128/JVI.65.8.4017-4025.1991; Weston J, 2002, J VIROL, V76, P6155, DOI 10.1128/JVI.76.12.6155-6163.2002; Weston JH, 1999, VIROLOGY, V256, P188, DOI 10.1006/viro.1999.9654; Xu C, 2010, J VIROL, V84, P8903, DOI 10.1128/JVI.00851-10	52	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100184	10.1371/journal.pone.0100184	http://dx.doi.org/10.1371/journal.pone.0100184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009976	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800003
J	Kong, XJ; Liu, JH				Kong, Xiangjin; Liu, Junhai			Influence of Alumina Binder Content on Catalytic Performance of Ni/HZSM-5 for Hydrodeoxygenation of Cyclohexanone	PLOS ONE			English	Article							PTSNNA/ZSM-5 CATALYST	The influence of the amount of alumina binders on the catalytic performance of Ni/HZSM-5 for hydrodeoxygenation of cyclohexanone was investigated in a fixed-bed reactor. N-2 sorption, X-ray diffraction, H-2-chemisorption and temperature-programmed desorption of ammonia were used to characterize the catalysts. It can be observed that the Ni/HZSM-5 catalyst bound with 30 wt.% alumina binder exhibited the best catalytic performance. The high catalytic performance may be due to relatively good Ni metal dispersion, moderate mesoporosity, and proper acidity of the catalyst.	[Kong, Xiangjin; Liu, Junhai] Liaocheng Univ, Sch Chem & Chem Engn, Shandong Prov Key Lab Chem Energy Storage & Novel, Liaocheng, Peoples R China	Liaocheng University	Kong, XJ (corresponding author), Liaocheng Univ, Sch Chem & Chem Engn, Shandong Prov Key Lab Chem Energy Storage & Novel, Liaocheng, Peoples R China.	kongxjin@163.com; jhliu@lcu.edu.cn			Doctoral Foundation of Liaocheng University [318051329]	Doctoral Foundation of Liaocheng University	This work is supported by Doctoral Foundation of Liaocheng University (Under Grant No.318051329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ F, 1994, J MOL CATAL, V92, P67, DOI 10.1016/0304-5102(94)00052-2; Consul JMD, 2006, J MOL CATAL A-CHEM, V246, P33, DOI 10.1016/j.molcata.2005.10.011; Du XB, 2014, CATAL COMMUN, V45, P109, DOI 10.1016/j.catcom.2013.10.042; Duan YZ, 2012, MICROPOR MESOPOR MAT, V161, P33, DOI 10.1016/j.micromeso.2012.05.016; Jin F, 2009, IND ENG CHEM RES, V48, P1873, DOI 10.1021/ie8014457; Kim SD, 2006, APPL CATAL A-GEN, V309, P139, DOI 10.1016/j.apcata.2006.05.008; Kong XJ, 2014, APPL CATAL A-GEN, V476, P34, DOI 10.1016/j.apcata.2014.02.011; Kong XJ, 2013, CHEMCATCHEM, V5, P2009, DOI 10.1002/cctc.201200824; Liu H, 2008, IND ENG CHEM RES, V47, P8142, DOI 10.1021/ie800693t; Liu SA, 2011, APPL CATAL A-GEN, V400, P99, DOI 10.1016/j.apcata.2011.04.020; Sanchez P, 2007, J MOL CATAL A-CHEM, V273, P109, DOI 10.1016/j.molcata.2007.03.076; Sun XY, 2010, APPL CATAL A-GEN, V377, P134, DOI 10.1016/j.apcata.2010.01.029; Zhang YW, 2006, IND ENG CHEM RES, V45, P2213, DOI 10.1021/ie051166h	13	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101744	10.1371/journal.pone.0101744	http://dx.doi.org/10.1371/journal.pone.0101744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009974	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800036
J	Rendleman, J; Antipin, Y; Reva, B; Adaniel, C; Przybylo, JA; Dutra-Clarke, A; Hansen, N; Heguy, A; Huberman, K; Borsu, L; Paltiel, O; Ben-Yehuda, D; Brown, JR; Freedman, AS; Sander, C; Zelenetz, A; Klein, RJ; Shao, YZ; Lacher, M; Vijai, J; Offit, K; Kirchhoff, T				Rendleman, Justin; Antipin, Yevgeniy; Reva, Boris; Adaniel, Christina; Przybylo, Jennifer A.; Dutra-Clarke, Ana; Hansen, Nichole; Heguy, Adriana; Huberman, Kety; Borsu, Laetitia; Paltiel, Ora; Ben-Yehuda, Dina; Brown, Jennifer R.; Freedman, Arnold S.; Sander, Chris; Zelenetz, Andrew; Klein, Robert J.; Shao, Yongzhao; Lacher, Mortimer; Vijai, Joseph; Offit, Kenneth; Kirchhoff, Tomas			Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; B-CELL LYMPHOMA; TELANGIECTASIA-MUTATED GENE; DOUBLE-STRAND BREAKS; FOLLICULAR LYMPHOMA; ATM MUTATIONS; CANCER SUSCEPTIBILITY; XRCC1 POLYMORPHISMS; CHINESE POPULATION	Molecular and genetic evidence suggests that DNA repair pathways may contribute to lymphoma susceptibility. Several studies have examined the association of DNA repair genes with lymphoma risk, but the findings from these reports have been inconsistent. Here we provide the results of a focused analysis of genetic variation in DNA repair genes and their association with the risk of non-Hodgkin's lymphoma (NHL). With a population of 1,297 NHL cases and 1,946 controls, we have performed a two-stage case/control association analysis of 446 single nucleotide polymorphisms (SNPs) tagging the genetic variation in 81 DNA repair genes. We found the most significant association with NHL risk in the ATM locus for rs227060 (OR = 1.27, 95% CI: 1.13-1.43, p = 6.77x10(-5)), which remained significant after adjustment for multiple testing. In a subtype-specific analysis, associations were also observed for the ATM locus among both diffuse large B-cell lymphomas (DLBCL) and small lymphocytic lymphomas (SLL), however there was no association observed among follicular lymphomas (FL). In addition, our study provides suggestive evidence of an interaction between SNPs in MRE11A and NBS1 associated with NHL risk (OR = 0.51, 95% CI: 0.34-0.77, p = 0.0002). Finally, an imputation analysis using the 1,000 Genomes Project data combined with a functional prediction analysis revealed the presence of biologically relevant variants that correlate with the observed association signals. While the findings generated here warrant independent validation, the results of our large study suggest that ATM may be a novel locus associated with the risk of multiple subtypes of NHL.	[Rendleman, Justin; Adaniel, Christina; Shao, Yongzhao; Kirchhoff, Tomas] NYU, NYU Sch Med, New York, NY 10012 USA; [Antipin, Yevgeniy; Reva, Boris; Przybylo, Jennifer A.; Dutra-Clarke, Ana; Hansen, Nichole; Heguy, Adriana; Huberman, Kety; Borsu, Laetitia; Sander, Chris; Zelenetz, Andrew; Klein, Robert J.; Lacher, Mortimer; Vijai, Joseph; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Paltiel, Ora; Ben-Yehuda, Dina] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel; [Brown, Jennifer R.; Freedman, Arnold S.] Harvard Univ, Dana Farber Canc Ctr, Boston, MA 02115 USA	New York University; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; Harvard University; Dana-Farber Cancer Institute	Kirchhoff, T (corresponding author), NYU, NYU Sch Med, New York, NY 10012 USA.	Tomas.Kirchhoff@nyumc.org	Rendleman, Justin/ABI-2137-2020; Klein, Robert/ABI-7857-2020; Reva, Boris/AAB-8932-2022; Heguy, Adriana/GPP-3907-2022; Joseph, Vijai/J-9158-2013	Klein, Robert/0000-0003-3539-5391; Joseph, Vijai/0000-0002-7933-151X; Kirchhoff, Tomas/0000-0002-9055-2364; Rendleman, Justin/0000-0001-8152-7127	Leukemia and Lymphoma Society [TRP 6202-09]; Lymphoma Foundation; Filomena M. D'Agostino Foundation; Okonow-Lipton Fund; National Institutes of Health [K23 CA115682]; Anbinder Fund; NATIONAL CANCER INSTITUTE [P30CA008748, K23CA115682, P30CA016087] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lymphoma Foundation; Filomena M. D'Agostino Foundation; Okonow-Lipton Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anbinder Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by Translational Research Grant from Leukemia and Lymphoma Society (TRP 6202-09, awarded to Tomas Kirchhoff). Funding support was also provided by the Lymphoma Foundation and the Filomena M. D'Agostino Foundation (both to Kenneth Offit). Further support was also provided by the Okonow-Lipton Fund (Jennifer R. Brown) and the National Institutes of Health (K23 CA115682, Jennifer R. Brown). Jennifer R. Brown is a Scholar of the American Society of Hematology as well as a Scholar in Clinical Research of the Leukemia and Lymphoma Society. MSKCC Sequenom facility is supported by the Anbinder Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baris S, 2009, PEDIATR HEMAT ONCOL, V26, P467, DOI [10.1080/08880010903096201, 10.3109/08880010903096201]; Bassaganyas L, 2013, LEUKEMIA, V27, P2376, DOI 10.1038/leu.2013.127; Bednarski JJ, 2012, ADV IMMUNOL, V116, P175, DOI 10.1016/B978-0-12-394300-2.00006-5; Berndt SI, 2013, NAT GENET; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bullrich F, 1999, CANCER RES, V59, P24; Camacho E, 2002, BLOOD, V99, P238, DOI 10.1182/blood.V99.1.238; Chang ET, 2005, J NATL CANCER I, V97, P1466, DOI 10.1093/jnci/dji293; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; de Miranda NFCC, 2011, ANN NY ACAD SCI, V1246, P50, DOI 10.1111/j.1749-6632.2011.06322.x; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Economopoulou P, 2011, LEUKEMIA LYMPHOMA, V52, P567, DOI 10.3109/10428194.2010.551155; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Gallagher DJ, 2010, CLIN CANCER RES, V16, P2819, DOI 10.1158/1078-0432.CCR-10-0028; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gronbaek K, 2002, BLOOD, V100, P1430, DOI 10.1182/blood-2002-02-0382; Gumy-Pause F, 2004, LEUKEMIA, V18, P238, DOI 10.1038/sj.leu.2403221; Hill DA, 2006, BLOOD, V108, P3161, DOI 10.1182/blood-2005-01-026690; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kals M, 2005, YEAST, V22, P213, DOI 10.1002/yea.1204; Kanehisa M, 2000, POSTGENOME INFORMATI; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Kim IS, 2010, CANCER GENET CYTOGEN, V196, P31, DOI 10.1016/j.cancergencyto.2009.08.008; Kirchhoff T, 2009, CANCER EPIDEM BIOMAR, V18, P2468, DOI 10.1158/1055-9965.EPI-09-0151; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kumar V, 2011, J HUM GENET, V56, P436, DOI 10.1038/jhg.2011.35; Liu J, 2009, CANCER GENET CYTOGEN, V191, P67, DOI 10.1016/j.cancergencyto.2009.01.015; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Nieters A, 2012, BLOOD, V120, P4645, DOI 10.1182/blood-2012-05-427989; Olshen AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-14; Ostrer H, 2013, HUM GENET, V132, P119, DOI 10.1007/s00439-012-1235-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Schaffner C, 2000, P NATL ACAD SCI USA, V97, P2773, DOI 10.1073/pnas.050400997; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Schuetz JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-117; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Shen M, 2007, HAEMATOLOGICA, V92, P1180, DOI 10.3324/haematol.11324; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Shen M, 2010, BRIT J HAEMATOL, V151, P239, DOI 10.1111/j.1365-2141.2010.08364.x; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Siddiqui Rina, 2004, Curr Oncol Rep, V6, P380, DOI 10.1007/s11912-004-0064-8; Sipahimalani P, 2007, INT J CANCER, V121, P1967, DOI 10.1002/ijc.22888; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Smedby KE, 2006, CANCER EPIDEM BIOMAR, V15, P258, DOI 10.1158/1055-9965.EPI-05-0583; Stankovic T, 2002, BLOOD, V99, P300, DOI 10.1182/blood.V99.1.300; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tan DEK, 2013, NAT GENET, V45, P804, DOI 10.1038/ng.2666; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Worrillow L, 2009, CANCER EPIDEMIOL, V33, P257, DOI 10.1016/j.canep.2009.08.002; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	69	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101685	10.1371/journal.pone.0101685	http://dx.doi.org/10.1371/journal.pone.0101685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010664	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800032
J	Hoffmann, J; Symul, L; Shostak, A; Fischer, T; Naef, F; Brunner, M				Hoffmann, Julia; Symul, Laura; Shostak, Anton; Fischer, Tamas; Naef, Felix; Brunner, Michael			Non-Circadian Expression Masking Clock-Driven Weak Transcription Rhythms in U2OS Cells	PLOS ONE			English	Article							REV-ERB; GENE-EXPRESSION; PROTEIN; REVEALS; OSCILLATIONS; COMPONENT; TARGET; MOUSE; LOOP; LIMB	U2OS cells harbor a circadian clock but express only a few rhythmic genes in constant conditions. We identified 3040 binding sites of the circadian regulators BMAL1, CLOCK and CRY1 in the U2OS genome. Most binding sites even in promoters do not correlate with detectable rhythmic transcript levels. Luciferase fusions reveal that the circadian clock supports robust but low amplitude transcription rhythms of representative promoters. However, rhythmic transcription of these potentially clock-controlled genes is masked by non-circadian transcription that overwrites the weaker contribution of the clock in constant conditions. Our data suggest that U2OS cells harbor an intrinsically rather weak circadian oscillator. The oscillator has the potential to regulate a large number of genes. The contribution of circadian versus non-circadian transcription is dependent on the metabolic state of the cell and may determine the apparent complexity of the circadian transcriptome.	[Hoffmann, Julia; Shostak, Anton; Fischer, Tamas; Brunner, Michael] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany; [Symul, Laura; Naef, Felix] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Brunner, M (corresponding author), Heidelberg Univ, Biochem Ctr, Heidelberg, Germany.	michael.brunner@bzh.uni-heidelberg.de	Fischer, Tamas/A-7729-2016; Symul, Laura/O-9586-2017	Fischer, Tamas/0000-0002-7996-4042; Symul, Laura/0000-0001-9286-0590; Brunner, Michael/0000-0001-9798-3047; Shostak, Anton/0000-0002-9621-741X; Naef, Felix/0000-0001-9786-3037	CycliX; Swiss National Science Foundation; Ecole Polytechique Federale de Lausanne (EPFL)	CycliX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechique Federale de Lausanne (EPFL)	LS and FN were funded by CycliX, a grant from the Swiss SystemsX.ch (www.systemsx.ch) initiative evaluated by the Swiss National Science Foundation, and by the Ecole Polytechique Federale de Lausanne (EPFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102238	10.1371/journal.pone.0102238	http://dx.doi.org/10.1371/journal.pone.0102238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007071	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600108
J	Huang, JC; Wei, SY; Chen, SC; Chang, JM; Hung, CC; Su, HM; Hwang, SJ; Chen, HC				Huang, Jiun-Chi; Wei, Shu-Yi; Chen, Szu-Chia; Chang, Jer-Ming; Hung, Chi-Chih; Su, Ho-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			P Wave Dispersion and Maximum P Wave Duration Are Associated with Renal Outcomes in Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ATRIAL-FIBRILLATION; FUNCTION DECLINE; MORTALITY RISK; DYSFUNCTION; PROGRESSION; CREATININE; PREDICTION; DIALYSIS; IMPACT	P wave parameters measured by 12-lead electrocardiogram (ECG) are commonly used as a noninvasive tool to evaluate left atrial enlargement. This study was designed to assess whether P wave parameters were associated with renal outcomes in chronic kidney disease (CKD) patients. This longitudinal study enrolled 439 patients with CKD stages 3-5. Renal end points were defined as the commencement of dialysis or death. Change in renal function was measured using the estimated glomerular filtration rate (eGFR) slope. We measured two ECG P wave parameters corrected for heart rate, i.e., corrected P wave dispersion and corrected maximum P wave duration. The values of P wave dispersion and maximum P wave duration were 88.8 +/- 21.7 ms and 153.3 +/- 21.7 ms, respectively. During the follow-up period (mean, 25.2 months), 95 patients (21.6%) started hemodialysis and 30 deaths (6.8%) were recorded. Multivariate Cox regression analysis identified that increased P wave dispersion [hazard ratio (HR), 1.020; 95% confidence interval (CI), 1.009-1.032; P < 0.001] and maximum P wave duration (HR, 1.013; 95% CI, 1.003-1.024; P = 0.012) were associated with progression to renal end points. Furthermore, increased P wave dispersion (unstandardized coefficient beta = -0.016; P = 0.037) and maximum P wave duration (unstandardized coefficient beta = -0.014; P = 0.040) were negatively associated with the eGFR slope. We demonstrated that increased P wave dispersion and maximum P wave duration were associated with progression to the renal end points of dialysis or death and faster renal function decline in CKD patients. Screening CKD patients on the basis of P wave dispersion and maximum P wave duration may help identify patients at high risk for worse renal outcomes.	[Huang, Jiun-Chi; Chen, Szu-Chia; Chang, Jer-Ming; Hung, Chi-Chih; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Huang, Jiun-Chi; Chen, Szu-Chia; Chang, Jer-Ming; Su, Ho-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming; Hung, Chi-Chih; Su, Ho-Ming] Kaohsiung Med Univ, Fac Med, Coll Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan; [Wei, Shu-Yi] Kaohsiung Municipal United Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wei, Shu-Yi] Yuh Ing Jr Coll Hlth Care Management, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Su, HM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	cobeshm@seed.net.tw	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860; Su, Ho-Ming/0000-0003-0247-3250				ALPERT MA, 1989, ARCH INTERN MED, V149, P1161, DOI 10.1001/archinte.149.5.1161; Bazett HC, 1920, J PHYSIOL-LONDON, V53, P320, DOI 10.1113/jphysiol.1920.sp001881; Birkbeck JP, 2006, J ELECTROCARDIOL, V39, P225, DOI 10.1016/j.jelectrocard.2005.06.109; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; BUXTON AE, 1981, CHEST, V80, P68, DOI 10.1378/chest.80.1.68; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2012, EXP DIABETES RES, DOI 10.1155/2012/789325; Chen SC, 2011, HYPERTENS RES, V34, P1052, DOI 10.1038/hr.2011.95; Dagli N, 2008, CLIN RES CARDIOL, V97, P98, DOI 10.1007/s00392-007-0587-8; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Furukawa M, 2011, NEPHRON CLIN PRACT, V117, pC341, DOI 10.1159/000321512; Glowinska Irena, 2008, Pol Arch Med Wewn, V118, P404; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunduz H, 2005, TEX HEART I J, V32, P163; Kovesdy CP, 2010, J AM SOC NEPHROL, V21, P1814, DOI 10.1681/ASN.2010090954; Koz C, 2008, SOUTH MED J, V101, P246, DOI 10.1097/SMJ.0b013e3181647071; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Magnani JW, 2011, AM J CARDIOL, V107, P917, DOI 10.1016/j.amjcard.2010.10.075; Mataradzija A, 2010, BOSNIAN J BASIC MED, V10, pS44; Paoletti E, 2011, NEPHROL DIAL TRANSPL, V26, P670, DOI 10.1093/ndt/gfq409; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Ritz E, 2006, AM J MED, V119, p31S, DOI 10.1016/j.amjmed.2006.01.012; Ritz E, 2006, SAUDI J KIDNEY DIS T, V17, P481; Ronco C, 2010, CONTRIB NEPHROL, V164, P33, DOI 10.1159/000313718; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042815; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Truong QA, 2011, J ELECTROCARDIOL, V44, P257, DOI 10.1016/j.jelectrocard.2010.04.011; Veves A, 1998, DIABETES, V47, P457, DOI 10.2337/diabetes.47.3.457; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Yilmaz R, 2004, ANN NONINVAS ELECTRO, V9, P330, DOI 10.1111/j.1542-474X.2004.94568.x; Yjrn DH, 2007, YONSEI MED J, V48, P810, DOI 10.3349/ymj.2007.48.5.810	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101962	10.1371/journal.pone.0101962	http://dx.doi.org/10.1371/journal.pone.0101962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006682	gold, Green Published, Green Submitted			2022-12-25	WOS:000339040600083
J	Chagnon-Choquet, J; Fontaine, J; Poudrier, J; Roger, M				Chagnon-Choquet, Josiane; Fontaine, Julie; Poudrier, Johanne; Roger, Michel		Montreal Primary HIV Infect Grp; Slow Progressor Study Grp	IL-10 and Lymphotoxin-alpha Expression Profiles within Marginal Zone-Like B-Cell Populations Are Associated with Control of HIV-1 Disease Progression	PLOS ONE			English	Article							LYMPHOCYTE STIMULATOR BLYS; AIDS-LIKE DISEASE; DENDRITIC CELLS; TRANSGENIC MICE; CD4(+); BAFF; INFECTION; RESPONSES; EFFECTOR; INCREASE	Understanding how the immune system facilitates or controls HIV-1 disease progression has important implications for the design of effective interventions. We report that although B-cell dysregulations associated with HIV-1 disease progression are accompanied by an overall decrease in the percentage of total blood B-cells, we observe an increase in relative frequencies of cells presenting characteristics of both transitional immature and first-line marginal zone (MZ) B-cell populations, we designated as precursor MZ-like B-cells. B-cells with similar attributes have been associated with IL-10 expression and "regulatory" potential. As such, the relative frequencies of precursor MZ-like B-cells expressing IL-10 are increased in the blood of viremic HIV-1-infected individuals when compared to HIV-negative subjects. Importantly, in aviremic HIV-1 Elite-Controllers (EC), we found unaltered relative percentages of precursor MZ-like B-cells which presented normal IL-10 expression patterns. Furthermore, EC had increased relative frequencies of blood MZ-like B-cells expressing LT-alpha. Thus in contrast to viremic HIV-1-infected individuals, EC present MZ-like B-cell populations which IL-10 and LT-alpha expression profiles may favour homeostasis of immune responses and lymphoid microenvironments.	[Chagnon-Choquet, Josiane; Fontaine, Julie; Poudrier, Johanne; Roger, Michel] CRCHUM, Lab Immunogenet, Montreal, PQ, Canada; [Chagnon-Choquet, Josiane; Fontaine, Julie; Poudrier, Johanne; Roger, Michel] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Poudrier, J (corresponding author), CRCHUM, Lab Immunogenet, Montreal, PQ, Canada.	johanne.poudrier@crchum.qc.ca; michel.roger@ssss.gouv.qc.ca			Canadian Institutes of Health Research (CIHR) [CHR-126633]; Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS); Fondation Gabriel Marquis; Alberta Innovates [201201140] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS); Fondation Gabriel Marquis; Alberta Innovates	This work was supported by grant # CHR-126633 from the Canadian Institutes of Health Research (CIHR) and by the Reseau SIDA from the Fonds de Recherche du Quebec en Sante (FRQS). Josiane Chagnon-Choquet holds a Studentship from the Fondation Gabriel Marquis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Borrow P, 2011, CURR OPIN HIV AIDS, V6, P353, DOI 10.1097/COH.0b013e3283495996; Cagigi A, 2008, BLOOD, V112, P4401, DOI 10.1182/blood-2008-02-140426; Calmon-Hamaty F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3376; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Dosenovic P, 2012, J IMMUNOL, V188, P6018, DOI 10.4049/jimmunol.1200466; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Fontaine J, 2009, J INFECT DIS, V199, P1007, DOI 10.1086/597278; Gray D, 2010, EUR J IMMUNOL, V40, P2677, DOI 10.1002/eji.201040961; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hassler S, 2006, BLOOD, V108, P1941, DOI 10.1182/blood-2006-04-019679; Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001; Lindh E, 2008, P NATL ACAD SCI USA, V105, P18466, DOI 10.1073/pnas.0808205105; Liu Z, 2011, TRENDS IMMUNOL, V32, P388, DOI 10.1016/j.it.2011.06.004; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; MacPherson G, 1999, IMMUNOL REV, V172, P325, DOI 10.1111/j.1600-065X.1999.tb01376.x; Malaspina A, 2007, BLOOD, V109, P2086, DOI 10.1182/blood-2006-06-031385; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mercier F, 2008, CLIN EXP IMMUNOL, V152, P72, DOI 10.1111/j.1365-2249.2008.03610.x; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Poudrier J, 2003, J VIROL, V77, P11733, DOI 10.1128/JVI.77.21.11733-11744.2003; Poudrier J, 2001, IMMUNITY, V15, P173, DOI 10.1016/S1074-7613(01)00177-7; Poudrier J., 2012, CLIN DEV IMMUNOL, V2012, DOI [10.1155/2012/592187, DOI 10.1155/2012/592187]; Poudrier J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002154; Pujanauski LM, 2013, P NATL ACAD SCI USA, V110, P1422, DOI 10.1073/pnas.1213713110; Rodriguez B, 2003, AIDS, V17, P1983, DOI 10.1097/00002030-200309050-00018; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Stohl W, 2002, CLIN IMMUNOL, V104, P115, DOI 10.1006/clim.2002.5238; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Varin MM, 2010, AUTOIMMUN REV, V9, P604, DOI 10.1016/j.autrev.2010.05.006; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2012, BLOOD, V120, P4992, DOI 10.1182/blood-2012-07-440776; Yates NL, 2013, MUCOSAL IMMUNOL, V6, P692, DOI 10.1038/mi.2012.107; Yehudai D, 2012, SCAND J IMMUNOL, V76, P371, DOI 10.1111/j.1365-3083.2012.02752.x; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101949	10.1371/journal.pone.0101949	http://dx.doi.org/10.1371/journal.pone.0101949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003989	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700091
J	Edmondson, JL; O'Sullivan, OS; Inger, R; Potter, J; McHugh, N; Gaston, KJ; Leake, JR				Edmondson, Jill L.; O'Sullivan, Odhran S.; Inger, Richard; Potter, Jonathan; McHugh, Nicola; Gaston, Kevin J.; Leake, Jonathan R.			Urban Tree Effects on Soil Organic Carbon	PLOS ONE			English	Article							FRAXINUS-EXCELSIOR; BIOMASS; STOCKS; ECOSYSTEMS; MECHANISMS; NITROGEN; CLIMATE; MATTER; SHADE; GRASS	Urban trees sequester carbon into biomass and provide many ecosystem service benefits aboveground leading to worldwide tree planting schemes. Since soils hold similar to 75% of ecosystem organic carbon, understanding the effect of urban trees on soil organic carbon (SOC) and soil properties that underpin belowground ecosystem services is vital. We use an observational study to investigate effects of three important tree genera and mixed-species woodlands on soil properties (to 1 m depth) compared to adjacent urban grasslands. Aboveground biomass and belowground ecosystem service provision by urban trees are found not to be directly coupled. Indeed, SOC enhancement relative to urban grasslands is genus-specific being highest under Fraxinus excelsior and Acer spp., but similar to grasslands under Quercus robur and mixed woodland. Tree cover type does not influence soil bulk density or C:N ratio, properties which indicate the ability of soils to provide regulating ecosystem services such as nutrient cycling and flood mitigation. The trends observed in this study suggest that genus selection is important to maximise long-term SOC storage under urban trees, but emerging threats from genus-specific pathogens must also be considered.	[Edmondson, Jill L.; O'Sullivan, Odhran S.; Potter, Jonathan; McHugh, Nicola; Leake, Jonathan R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Inger, Richard; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Sheffield; University of Exeter	Edmondson, JL (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	j.edmondson@sheffield.ac.uk	Inger, Richard/D-3445-2009	Inger, Richard/0000-0003-1660-3706; Edmondson, Jill/0000-0002-3623-4816; Gaston, Kevin J./0000-0002-7235-7928; Leake, Jonathan/0000-0001-8364-7616	U.K. Engineering and Physical Sciences Research Council Sustainable Urban Environments Thematic grants [EP/F007604/1, EP/I002154/1]	U.K. Engineering and Physical Sciences Research Council Sustainable Urban Environments Thematic grants	This work was supported by the U.K. Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/) Sustainable Urban Environments Thematic grants EP/F007604/1 and EP/I002154/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari H, 2002, ENVIRON POLLUT, V116, pS119, DOI 10.1016/S0269-7491(01)00264-0; Armson D, 2012, URBAN FOR URBAN GREE, V11, P245, DOI 10.1016/j.ufug.2012.05.002; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bradley RI, 2005, SOIL USE MANAGE, V21, P363, DOI 10.1079/SUM2005351; Carey P.D., 2008, COUNTRYSIDE SURVEY U; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; Day Susan D., 2010, Arboriculture & Urban Forestry, V36, P193; DEFRA, 2013, CHAL MAN PLAN; DEFRA, 2014, BIG TREE PLANT; Dungait JAJ, 2012, SCI TOTAL ENVIRON, V434, P39, DOI 10.1016/j.scitotenv.2012.04.029; Edmondson JL, 2014, SCI TOTAL ENVIRON, V472, P444, DOI 10.1016/j.scitotenv.2013.11.025; Edmondson JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00963; Edmondson JL, 2011, BIOL LETTERS, V7, P771, DOI 10.1098/rsbl.2011.0260; Forestry Commission, BLEED CANK HORS CHES; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Gaston KJ, 2013, J APPL ECOL, V50, P830, DOI 10.1111/1365-2664.12087; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hamada S, 2010, URBAN FOR URBAN GREE, V9, P15, DOI 10.1016/j.ufug.2009.10.002; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jouraeva VA, 2002, ENVIRON POLLUT, V120, P331, DOI 10.1016/S0269-7491(02)00121-5; Kerr G, 2004, FOREST ECOL MANAG, V188, P225, DOI 10.1016/j.foreco.2003.07.016; Krull ES, 2003, FUNCT PLANT BIOL, V30, P207, DOI 10.1071/FP02085; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Leicester City Council, POP LEIC 1801 2011; Lemoine D, 2001, ANN FOR SCI, V58, P723, DOI 10.1051/forest:2001159; Maleki K., 2011, Annals of Environmental Science, V5, P13; Maskell L., 2013, DISTRIBUTION ASH TRE; McHale M. R., 2009, Urban Ecosystems, V12, P95, DOI 10.1007/s11252-009-0081-3; McPherson E. G., 1997, Urban Ecosystems, V1, P49, DOI 10.1023/A:1014350822458; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2012, URBAN FOR URBAN GREE, V11, P21, DOI 10.1016/j.ufug.2011.11.005; Nowak David J., 2008, Arboriculture & Urban Forestry, V34, P347; Pouyat Richard V., 2009, Urban Ecosystems, V12, P45, DOI 10.1007/s11252-008-0059-6; R Core Team, 2012, R LANG ENV STAT COMP; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Snorrason Arnor, 2006, Icelandic Agricultural Sciences, V19, P15; Tallis M, 2011, LANDSCAPE URBAN PLAN, V103, P129, DOI 10.1016/j.landurbplan.2011.07.003; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Tiwary A, 2009, INTEGRATED TOOL ASSE; Tree Health and Plant Biosecurity Taskforce, 2013, TREE HLTH PLANT BIOS; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Zianis D., 2005, Silva Fennica Monographs, P1	46	20	25	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101872	10.1371/journal.pone.0101872	http://dx.doi.org/10.1371/journal.pone.0101872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003872	gold, Green Published, Green Accepted			2022-12-25	WOS:000339242700080
J	Shi, YZ; Xiang, YT; Wu, SL; Zhang, N; Zhou, J; Bai, Y; Wang, S; Wang, YL; Zhao, XQ; Ungvari, GS; Chiu, HFK; Wang, YJ; Wang, CX				Shi, Yu-Zhi; Xiang, Yu-Tao; Wu, Shuo-Lin; Zhang, Ning; Zhou, Juan; Bai, Ying; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Ungvari, Gabor S.; Chiu, Helen F. K.; Wang, Yong-Jun; Wang, Chun-Xue			The Relationship between Frontal Lobe Lesions, Course of Post-Stroke Depression, and 1-year Prognosis in Patients with First-Ever Ischemic Stroke	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; ANTIDEPRESSANT THERAPY; CELL-DEATH; FOLLOW-UP; LOCATION; SYMPTOMS; METAANALYSIS; MECHANISMS; PREVENTION; CIRCUITS	Background and Purpose: Most studies on post-stroke depression (PSD) have focused on a certain time point after stroke instead of the time course of PSD. The aim of this study was to determine the relationship between frontal lobe lesions, course of PSD over a year following the stroke onset, and the 1-year prognosis in patients with first-ever ischemic stroke. Methods: A total of 1067 patients from the prospective cohort study on the incidence and outcome of patients with post stroke depression in China who were diagnosed with first-ever ischemic stroke and attended 4 follow-up visits at 14 +/- 2 days, 3 months, 6 months, and 1 year after stroke onset, were enrolled in the study. PSD was diagnosed according to DSM-IV. The course of PSD was divided into the following two categories: persistent/recurrent depression and no/transient depression. Patients with any ischemic lesion responsible for the indexed stroke event located in the frontal lobe were defined as patients with frontal lobe lesions. Modified Rankin Scale (mRS) >= 2 at 1-year was considered to be poor prognosis. Results: There were 109 patients with and 958 patients without frontal lobe lesions that formed the frontal lobe (FL) and no-frontal lobe (NFL) groups, respectively. After adjusting for confounding variables, frontal lobe lesion was significantly associated with persistent/recurrent PSD (OR 2.025, 95% CI 1.039-3.949). Overall, 32.7% of patients in the FL group had poor prognosis at 1-year compared with 22.7% in the NFL group (P = 0.021). Compared with no/transient depression, persistent/recurrent depression was found to be an independent predictor of poor prognosis at 1-year both in FL and NFL groups. Conclusions: Long-term and periodical screening, evaluation and treatment are needed for PSD after the onset of ischemic stroke, particularly for patients with frontal lobe infarction.	[Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China; [Shi, Yu-Zhi; Wu, Shuo-Lin; Zhang, Ning; Wang, Shuo; Wang, Yi-Long; Zhao, Xing-Quan; Wang, Yong-Jun; Wang, Chun-Xue] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Xiang, Yu-Tao] Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China; [Xiang, Yu-Tao; Chiu, Helen F. K.] Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Xiang, Yu-Tao] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Zhou, Juan] Capital Med Univ, Beijing Daxing Dist Hosp, Dept Neurol, Beijing, Peoples R China; [Bai, Ying] Xinjiang Prod & Construct Corps 13 Div Red Star H, Xinjiang, Peoples R China; [Ungvari, Gabor S.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Ungvari, Gabor S.] Univ Notre Dame Australia, Marian Ctr, Perth, WA, Australia	Capital Medical University; University of Macau; Chinese University of Hong Kong; Capital Medical University; Capital Medical University; University of Western Australia; University of Notre Dame Australia	Wang, CX (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.	snowsen@126.com		Shi, YuZhi/0000-0002-4018-6984	Beijing Science and Technology Committee [7102050]; National Science Foundation [81071115]	Beijing Science and Technology Committee; National Science Foundation(National Science Foundation (NSF))	This study was funded jointly by the Beijing Science and Technology Committee (grant no. 7102050, www.bjkw.gov.cn), and the National Science Foundation (grant no. 81071115, www.nsfc.gov.cn). This does not alter the authors' adherence to all the policies about sharing data and materials. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Ayerbe L, 2013, J NEUROL NEUROSURG P; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26; Bilge C, 2008, EUR J PHYS REHAB MED, V44, P13; Bour A, 2010, J NUTR HEALTH AGING, V14, P488; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; de Bilbao F, 2000, EUR J NEUROSCI, V12, P921, DOI 10.1046/j.1460-9568.2000.00984.x; Dihne M, 2002, STROKE, V33, P3006, DOI 10.1161/01.STR.0000039406.64644.CB; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Eker C, 2010, WORLD J BIOL PSYCHIA, V11, P19, DOI [10.1080/15622970902737998, 10.3109/15622970902737998]; Eriksson M, 2004, STROKE, V35, P936, DOI 10.1161/01.STR.0000121643.86762.9a; Glodzik-Sobanska L, 2006, PSYCHIAT RES-NEUROIM, V148, P111, DOI 10.1016/j.pscychresns.2006.08.004; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hadidi N, 2009, HEART LUNG, V38, P151, DOI 10.1016/j.hrtlng.2008.05.002; Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; MacHale SM, 1998, J NEUROL NEUROSUR PS, V64, P371, DOI 10.1136/jnnp.64.3.371; Meyer JH, 2012, CLIN PHARMACOL THER, V91, P201, DOI 10.1038/clpt.2011.285; Mikami K, 2011, AM J GERIAT PSYCHIAT, V19, P1007, DOI 10.1097/JGP.0b013e31821181b0; Nys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Santos M, 2009, J NEUROL SCI, V283, P158, DOI 10.1016/j.jns.2009.02.334; Saxena SK, 2007, ACTA NEUROL SCAND, V115, P339, DOI 10.1111/j.1600-0404.2006.00751.x; Schmid AA, 2011, NEUROLOGY, V76, P1000, DOI 10.1212/WNL.0b013e318210435e; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Singh A, 2000, STROKE, V31, P637, DOI 10.1161/01.STR.31.3.637; Starkstein SE, 2008, EXPERT OPIN PHARMACO, V9, P1291, DOI 10.1517/14656566.9.8.1291 ; Tang WK, 2011, J GERIATR PSYCH NEUR, V24, P44, DOI 10.1177/0891988710392375; Terroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242; Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925; Vataja R, 2004, J NEUROPSYCH CLIN N, V16, P156, DOI 10.1176/appi.neuropsych.16.2.156; White CL, 2011, CEREBROVASC DIS, V32, P354, DOI 10.1159/000330350; Whyte EM, 2004, J AM GERIATR SOC, V52, P774, DOI 10.1111/j.1532-5415.2004.52217.x; Yan TT, 2010, NEUROCHEM INT, V56, P529, DOI 10.1016/j.neuint.2010.01.013; Zhang LS, 2013, EUR NEUROL, V69, P336, DOI 10.1159/000345374; Zhang N, 2012, CNS NEUROSCI THER, V18, P475, DOI 10.1111/j.1755-5949.2012.00312.x	40	13	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100456	10.1371/journal.pone.0100456	http://dx.doi.org/10.1371/journal.pone.0100456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003990	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700009
J	Yao, LB; Heuser-Baker, J; Herlea-Pana, O; Zhang, N; Szweda, LI; Griffin, TM; Barlic-Dicen, J				Yao, Longbiao; Heuser-Baker, Janet; Herlea-Pana, Oana; Zhang, Nan; Szweda, Luke I.; Griffin, Timothy M.; Barlic-Dicen, Jana			Deficiency in adipocyte chemokine receptor CXCR4 exacerbates obesity and compromises thermoregulatory responses of brown adipose tissue in a mouse model of diet-induced obesity	FASEB JOURNAL			English	Article						chemotactic cytokine system; adaptive thermogenesis	INSULIN-RESISTANCE; MACROPHAGE RECRUITMENT; COLD-EXPOSURE; ADULT HUMANS; T-CELLS; FAT; MICE; INFLAMMATION; CALIBRATION; METABOLISM	The chemokine receptor CXCR4 is expressed on adipocytes and macrophages in adipose tissue, but its role in this tissue remains unknown. We evaluated whether deficiency in either adipocyte or myeloid leukocyte CXCR4 affects body weight (BW) and adiposity in a mouse model of high-fat-diet (HFD)-induced obesity. We found that ablation of adipocyte, but not myeloid leukocyte, CXCR4 exacerbated obesity. The HFD-fed adipocyte-specific CXCR4-knockout (AdCXCR4ko) mice, compared to wild-type C57BL/6 control mice, had increased BW (average: 52.0 g vs. 35.5 g), adiposity (average: 49.3 vs. 21.0% of total BW), and inflammatory leukocyte content in white adipose tissue (WAT), despite comparable food intake. As previously reported, HFD feeding increased uncoupling protein 1 (UCP1) expression (fold increase: 3.5) in brown adipose tissue (BAT) of the C57BL/6 control mice. However, no HFD-induced increase in UCP1 expression was observed in the AdCXCR4ko mice, which were cold sensitive. Thus, our study suggests that adipocyte CXCR4 limits development of obesity by preventing excessive inflammatory cell recruitment into WAT and by supporting thermogenic activity of BAT. Since CXCR4 is conserved between mouse and human, the newfound role of CXCR4 in mouse adipose tissue may parallel the role of this chemokine receptor in human adipose tissue.	[Yao, Longbiao; Heuser-Baker, Janet; Herlea-Pana, Oana; Zhang, Nan; Barlic-Dicen, Jana] Oklahoma Med Res Fdn, Cardiovasc Biol Program, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Griffin, Timothy M.] Oklahoma Med Res Fdn, Free Radical Biol & Aging Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation	Barlic-Dicen, J (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	jana-barlic-dicen@omrf.org	Griffin, Timothy M./V-8838-2019	Griffin, Timothy M./0000-0001-8840-9940; Zhang, Nan/0000-0002-6736-2781	U.S. National Institutes of Health; National Center for Research Resources [5 P20 RR018758-08]; National Institute of General Medical Sciences [8 P20 GM103441-08]; Oklahoma Center for the Advancement of Science and Technology [HR10-099]; Oklahoma Center for Adult Stem Cell Research [4340-03-06]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103441] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology; Oklahoma Center for Adult Stem Cell Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Hudson for assistance with DEXA and M. Pederson-Rambo for editing the manuscript. This work was supported by grants from the U.S. National Institutes of Health, National Center for Research Resources (5 P20 RR018758-08) and National Institute of General Medical Sciences (8 P20 GM103441-08), the Oklahoma Center for the Advancement of Science and Technology (HR10-099), and the Oklahoma Center for Adult Stem Cell Research (4340-03-06). The authors declare no conflicts of intrest.	Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Carey AL, 2013, PHARMACOL THERAPEUT, V140, P26, DOI 10.1016/j.pharmthera.2013.05.009; Chavey C, 2009, CELL METAB, V9, P339, DOI 10.1016/j.cmet.2009.03.002; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Enerback S, 2010, INT J OBESITY, V34, pS43, DOI 10.1038/ijo.2010.183; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Garteiser P, 2013, METABOLISM, V62, P1686, DOI 10.1016/j.metabol.2013.06.009; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Hazan U, 2002, FASEB J, V16, P1254, DOI 10.1096/fj.01-0947fje; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HEATON JM, 1972, J ANAT, V112, P35; Johnston SL, 2005, OBES RES, V13, P1558, DOI 10.1038/oby.2005.191; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Levitsky DA, 2012, PUBLIC HEALTH NUTR, V15, P126, DOI 10.1017/S1368980011002187; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nishimura S, 2013, CELL METAB, V18, P759, DOI 10.1016/j.cmet.2013.09.017; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ota T, 2013, DIABETES METAB J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Surmi BK, 2010, VASC PHARMACOL, V52, P27, DOI 10.1016/j.vph.2009.12.004; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Virtue S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00128; Vosselman MJ, 2013, MOL CELL ENDOCRINOL, V379, P43, DOI 10.1016/j.mce.2013.04.017; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	41	19	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4534	4550		10.1096/fj.14-249797	http://dx.doi.org/10.1096/fj.14-249797			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25016030	Green Published			2022-12-25	WOS:000342222700029
J	Barras, D; Chevalier, N; Zoete, V; Dempsey, R; Lapouge, K; Olayioye, MA; Michielin, O; Widmann, C				Barras, David; Chevalier, Nadja; Zoete, Vincent; Dempsey, Rosemary; Lapouge, Karine; Olayioye, Monilola A.; Michielin, Olivier; Widmann, Christian			A WXW Motif Is Required for the Anticancer Activity of the TAT-RasGAP(317-326) Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell-penetrating peptide (CPP); Deleted in Liver Cancer 1 (DLC1); Docking; GTPase-activating Protein (GAP); Peptides; RasGAP; TAT-RasGAP(317-326); Anticancer Peptide; Sensitizer	GTPASE-ACTIVATING PROTEIN; SUPPRESSOR PROTEIN; TUMOR-SUPPRESSOR; CELL-MIGRATION; DATA-BANK; RASGAP; CLEAVAGE; FRAGMENT; GROWTH; SITE	Background: TAT-RasGAP(317-326) is a Ras GTPase-activating protein (RasGAP)-derived peptide that requires deleted in liver cancer-1 (DLC1) for its antimetastatic activities. Results: A WXW motif within TAT-RasGAP(317-326) mediates RasGAP-DLC1 interaction. Conclusion: The tryptophan residues of TAT-RasGAP(317-326) are crucial for its activity Significance: The WXW motif could be used to design anticancer small molecules bearing TAT-RasGAP(317-326) activities. TAT-RasGAP(317-326), a cell-permeable 10-amino acid-long peptide derived from the N2 fragment of p120 Ras GTPase-activating protein (RasGAP), sensitizes tumor cells to apoptosis induced by various anticancer therapies. This RasGAP-derived peptide, by targeting the deleted in liver cancer-1 (DLC1) tumor suppressor, also hampers cell migration and invasion by promoting cell adherence and by inhibiting cell movement. Here, we systematically investigated the role of each amino acid within the RasGAP(317-326) sequence for the anticancer activities of TAT-RasGAP(317-326). We report here that the first three amino acids of this sequence, tryptophan, methionine, and tryptophan (WMW), are necessary and sufficient to sensitize cancer cells to cisplatin-induced apoptosis and to reduce cell migration. The WMW motif was found to be critical for the binding of fragment N2 to DLC1. These results define the interaction mode between the active anticancer sequence of RasGAP and DLC1. This knowledge will facilitate the design of small molecules bearing the tumor-sensitizing and antimetastatic activities of TAT-RasGAP(317-326).	[Barras, David; Chevalier, Nadja; Dempsey, Rosemary; Widmann, Christian] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland; [Zoete, Vincent; Michielin, Olivier] SIB, Mol Modeling Grp, CH-1015 Lausanne, Switzerland; [Lapouge, Karine] Univ Lausanne, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland; [Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Stuttgart	Widmann, C (corresponding author), Dept Physiol, Bugnon 7, CH-1005 Lausanne, Switzerland.	Christian.Widmann@unil.ch	Michielin, Olivier/ABE-7924-2020; Widmann, Christian/N-9851-2013	Lapouge, Karine/0000-0003-0620-9553; Widmann, Christian/0000-0002-6881-0363	Oncosuisse [KFS-02543-02-2010]	Oncosuisse	This work was supported by a grant from Oncosuisse (KFS-02543-02-2010). C. W. is a co-inventor of the TAT-RasGAP<INF>317-326</INF> compound as an antitumor agent (patent owned by the University of Lausanne) and may receive royalties from patent licensing if the compound is commercialized.	ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; Barras D, 2014, ONCOGENE, V33, P5163, DOI 10.1038/onc.2013.465; Barras D, 2014, CANCER METAST REV, V33, P87, DOI 10.1007/s10555-013-9458-0; Barras D, 2014, INT J CANCER, V135, P242, DOI 10.1002/ijc.28674; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Holeiter G, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.13; Holeiter G, 2008, CANCER RES, V68, P8743, DOI 10.1158/0008-5472.CAN-08-0984; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Lapouge K, 2013, RNA BIOL, V10, P1031, DOI 10.4161/rna.24771; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Ng DCH, 2006, FEBS LETT, V580, P191, DOI 10.1016/j.febslet.2005.11.073; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; O'Neill MAA, 2011, INT J PHARMACEUT, V417, P83, DOI 10.1016/j.ijpharm.2011.01.038; Pomerance M, 1996, MOL CELL BIOL, V16, P3179; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Saladin PM, 2009, IDRUGS, V12, P779; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498	33	15	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23701	23711		10.1074/jbc.M114.576272	http://dx.doi.org/10.1074/jbc.M114.576272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008324	hybrid, Green Published			2022-12-25	WOS:000341505000038
J	Chen, F; Kumar, S; Yu, YF; Aggarwal, S; Gross, C; Wang, YS; Chakraborty, T; Verin, AD; Catravas, JD; Lucas, R; Black, SM; Fulton, DJR				Chen, Feng; Kumar, Sanjiv; Yu, Yanfang; Aggarwal, Saurabh; Gross, Christine; Wang, Yusi; Chakraborty, Trinad; Verin, Alexander D.; Catravas, John D.; Lucas, Rudolf; Black, Stephen M.; Fulton, David J. R.			PKC-Dependent Phosphorylation of eNOS at T495 Regulates eNOS Coupling and Endothelial Barrier Function in Response to G(+) -Toxins	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; ACUTE LUNG INJURY; MICROVASCULAR PERMEABILITY; SUPEROXIDE ANION; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL PNEUMONIA; VASCULAR-PERMEABILITY; PORE FORMATION; PNEUMOLYSIN	Gram positive (G(+)) infections make up similar to 50% of all acute lung injury cases which are characterized by extensive permeability edema secondary to disruption of endothelial cell (EC) barrier integrity. A primary cause of increased permeability are cholesterol-dependent cytolysins (CDCs) of G(+)-bacteria, such as pneumolysin (PLY) and listeriolysin-O (LLO) which create plasma membrane pores, promoting Ca2+-influx and activation of PKC alpha. In human lung microvascular endothelial cells (HLMVEC), pretreatment with the nitric oxide synthase (NOS) inhibitor, ETU reduced the ability of LLO to increase microvascular cell permeability suggesting an endothelial nitric oxide synthase (eNOS)-dependent mechanism. LLO stimulated superoxide production from HLMVEC and this was prevented by silencing PKC alpha or NOS inhibition suggesting a link between these pathways. Both LLO and PLY stimulated eNOS T495 phosphorylation in a PKC-dependent manner. Expression of a phosphomimetic T495D eNOS (human isoform) resulted in increased superoxide and diminished nitric oxide (NO) production. Transduction of HLMVEC with an active form of PKC alpha resulted in the robust phosphorylation of T495 and increased peroxynitrite production, indicative of eNOS uncoupling. To determine the mechanisms underlying eNOS uncoupling, HLMVEC were stimulated with LLO and the amount of hsp90 and caveolin-1 bound to eNOS determined. LLO stimulated the dissociation of hsp90, and in particular, caveolin-1 from eNOS. Both hsp90 and caveolin-1 have been shown to influence eNOS uncoupling and a peptide mimicking the scaffolding domain of caveolin-1 blocked the ability of PKC alpha to stimulate eNOS-derived superoxide. Collectively, these results suggest that the G(+) pore-forming toxins promote increased EC permeability via activation of PKC alpha, phosphorylation of eNOS-T495, loss of hsp90 and caveolin-1 binding which collectively promote eNOS uncoupling and the production of barrier disruptive superoxide.	[Chen, Feng] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Chen, Feng; Kumar, Sanjiv; Yu, Yanfang; Aggarwal, Saurabh; Gross, Christine; Wang, Yusi; Verin, Alexander D.; Lucas, Rudolf; Black, Stephen M.; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30901 USA; [Lucas, Rudolf; Fulton, David J. R.] Georgia Regents Univ, Med Coll Georgia, Dept Pharmacol, Augusta, GA USA; [Chakraborty, Trinad] Univ Giessen, Inst Med Microbiol, D-35390 Giessen, Germany; [Catravas, John D.] Old Dominion Univ, Norfolk, VA USA	Nanjing Medical University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Justus Liebig University Giessen; Old Dominion University	Fulton, DJR (corresponding author), Georgia Regents Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30901 USA.	dfulton@gru.edu	Lucas, Rudolf/ABA-3011-2020; Chen, Feng/E-1133-2011	Lucas, Rudolf/0000-0003-3805-8868	National Institutes of Health [RO1 HL085827, P01 HL101902-01A1, R01HL092446, R01HL094609]; AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085827, P01HL101902, R01HL092446, R01HL094609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1 HL085827, P01 HL101902-01A1 (DJRF), R01HL092446 (DF), R01HL094609 (RL) and by a Postdoctoral Fellowship from the AHA (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANTHRAMAN A, 1983, RESPIRATION, V44, P153, DOI 10.1159/000194542; Bonev BB, 2001, J BIOL CHEM, V276, P5714, DOI 10.1074/jbc.M005126200; Cai L, 2014, AM J PHYSL LUNG CELL; Catravas JD, 2010, VASCUL PHARM; Chatterjee A, 2008, AM J PHYSIOL-LUNG C, V294, pL755, DOI 10.1152/ajplung.00350.2007; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chiasson VL, 2011, J PHARMACOL EXP THER, V337, P718, DOI 10.1124/jpet.110.178095; Church JE, 2006, J BIOL CHEM, V281, P1477, DOI 10.1074/jbc.M505968200; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Ferro TJ, 1997, AM J PHYSIOL-LUNG C, V272, pL979, DOI 10.1152/ajplung.1997.272.5.L979; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 2005, J BIOL CHEM, V280, P35943, DOI 10.1074/jbc.M504606200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; GUICE KS, 1989, ANN SURG, V210, P740, DOI 10.1097/00000658-198912000-00008; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Karuppiah K, 2011, AM J PHYSIOL-HEART C, V301, pH903, DOI 10.1152/ajpheart.00936.2010; Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064; KUROSE I, 1995, CIRC RES, V76, P30, DOI 10.1161/01.RES.76.1.30; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Lucas R, 2012, AM J RESP CELL MOL, V47, P445, DOI 10.1165/rcmb.2011-0332OC; McElroy MC, 1997, AM J PHYSIOL-LUNG C, V272, pL631, DOI 10.1152/ajplung.1997.272.4.L631; McQuaid KE, 1997, EXP PHYSIOL, V82, P369, DOI 10.1113/expphysiol.1997.sp004032; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Qian J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00347; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; RUBINS JB, 1994, INFECT IMMUN, V62, P3829, DOI 10.1128/IAI.62.9.3829-3836.1994; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; SOUTHAN GJ, 1995, BRIT J PHARMACOL, V114, P510, DOI 10.1111/j.1476-5381.1995.tb13256.x; Sprague RS, 1998, J PHARMACOL EXP THER, V284, P443; Stringaris AK, 2002, NEUROBIOL DIS, V11, P355, DOI 10.1006/nbdi.2002.0561; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Sugimoto M, 2007, BIOCHEM BIOPH RES CO, V361, P462, DOI 10.1016/j.bbrc.2007.07.030; Sun X, 2014, AM J RESP CELL MOL B; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tanita T, 1999, SURG TODAY, V29, P755, DOI 10.1007/BF02482321; TERADA LS, 1992, P NATL ACAD SCI USA, V89, P3362, DOI 10.1073/pnas.89.8.3362; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9; Witzenrath M, 2007, CRIT CARE MED, V35, P1756, DOI 10.1097/01.CCM.0000269212.84709.23; Wright JK, 1999, ARCH SURG-CHICAGO, V134, P293, DOI 10.1001/archsurg.134.3.293; Xiong C, 2010, VASCUL PHARM; Xiong CL, 2010, VASC PHARMACOL, V52, P207, DOI 10.1016/j.vph.2009.12.010; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	66	43	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e99823	10.1371/journal.pone.0099823	http://dx.doi.org/10.1371/journal.pone.0099823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020117	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600004
J	Li, CP; Lai, QL; Li, GZ; Liu, Y; Sun, FQ; Shao, ZZ				Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze			Multilocus Sequence Analysis for the Assessment of Phylogenetic Diversity and Biogeography in Hyphomonas Bacteria from Diverse Marine Environments	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; MICROBIAL DIVERSITY; SPECIES DEFINITION; ANALYSIS REVEALS; SP NOV.; SEDIMENT; STRAINS; WATER; HYPHOMICROBIUM; PROSTHECATE	Hyphomonas, a genus of budding, prosthecate bacteria, are primarily found in the marine environment. Seven type strains, and 35 strains from our collections of Hyphomonas, isolated from the Pacific Ocean, Atlantic Ocean, Arctic Ocean, South China Sea and the Baltic Sea, were investigated in this study using multilocus sequence analysis (MLSA). The phylogenetic structure of these bacteria was evaluated using the 16S rRNA gene, and five housekeeping genes (leuA, clpA, pyrH, gatA and rpoD) as well as their concatenated sequences. Our results showed that each housekeeping gene and the concatenated gene sequence all yield a higher taxonomic resolution than the 16S rRNA gene. The 42 strains assorted into 12 groups. Each group represents an independent species, which was confirmed by virtual DNA-DNA hybridization (DDH) estimated from draft genome sequences. Hyphomonas MLSA interspecies and intraspecies boundaries ranged from 93.3% to 96.3%, similarity calculated using a combined DDH and MLSA approach. Furthermore, six novel species (groups I, II, III, IV, V and XII) of the genus Hyphomonas exist, based on sequence similarities of the MLSA and DDH values. Additionally, we propose that the leuA gene (93.0% sequence similarity across our dataset) alone could be used as a fast and practical means for identifying species within Hyphomonas. Finally, Hyphomonas' geographic distribution shows that strains from the same area tend to cluster together as discrete species. This study provides a framework for the discrimination and phylogenetic analysis of the genus Hyphomonas for the first time, and will contribute to a more thorough understanding of the biological and ecological roles of this genus.	[Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] State Key Lab Breeding Base Marine Genet Resource, Xiamen, Peoples R China; [Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] Third Inst State Ocean Adm, Key Lab Marine Genet Resources, Xiamen, Peoples R China; [Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] Collaborat Innovat Ctr Marine Biol Resources, Xiamen, Peoples R China; [Li, Chongping; Lai, Qiliang; Li, Guizhen; Liu, Yang; Sun, Fengqin; Shao, Zongze] Key Lab Marine Genet Resources Fujian Prov, Xiamen, Peoples R China		Shao, ZZ (corresponding author), State Key Lab Breeding Base Marine Genet Resource, Xiamen, Peoples R China.	shaozz@163.com		Liu, Yang/0000-0002-2362-9501	COMRA program [DY125-15-R-01]; Public Welfare Project of SOA [201005032]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2013-9]	COMRA program; Public Welfare Project of SOA; National Infrastructure of Natural Resources for Science and Technology Program of China	This work was financially supported by COMRA program (No. DY125-15-R-01), Public Welfare Project of SOA (201005032) and National Infrastructure of Natural Resources for Science and Technology Program of China (No. NIMR-2013-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; Balboa S, 2013, SYST APPL MICROBIOL, V36, P183, DOI 10.1016/j.syapm.2012.12.004; Bolt F, 2010, J CLIN MICROBIOL, V48, P4177, DOI 10.1128/JCM.00274-10; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Coulon F, 2007, ENVIRON MICROBIOL, V9, P177, DOI 10.1111/j.1462-2920.2006.01126.x; Curtis SM, 2012, SYST APPL MICROBIOL, V35, P441, DOI 10.1016/j.syapm.2012.08.001; de la Haba RR, 2012, INT J SYST EVOL MICR, V62, P520, DOI 10.1099/ijs.0.032938-0; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gray ND, 2007, ISME J, V1, P596, DOI 10.1038/ismej.2007.74; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; Hara A, 2003, ENVIRON MICROBIOL, V5, P746, DOI 10.1046/j.1468-2920.2003.00468.x; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lai OL, 2009, INT J SYST EVOL MICR, V59, P1278, DOI 10.1099/ijs.0.003889-0; Laranjo M, 2012, SYST APPL MICROBIOL, V35, P359, DOI 10.1016/j.syapm.2012.06.002; LEIFSON E, 1964, ANTON VAN LEE J M S, V30, P249, DOI 10.1007/BF02046730; Liu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080097, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0079417, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0082678]; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maeda R, 2009, FEMS MICROBIOL LETT, V292, P203, DOI 10.1111/j.1574-6968.2009.01497.x; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Meier-Kolthoff JP, 2013, ARCH MICROBIOL, V195, P413, DOI 10.1007/s00203-013-0888-4; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mo S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-24; MOORE RL, 1984, INT J SYST BACTERIOL, V34, P71, DOI 10.1099/00207713-34-1-71; MOORE RL, 1981, ANNU REV MICROBIOL, V35, P567, DOI 10.1146/annurev.mi.35.100181.003031; Nzoue A, 2009, SYST APPL MICROBIOL, V32, P400, DOI 10.1016/j.syapm.2009.06.002; Oakley BB, 2010, ISME J, V4, P488, DOI 10.1038/ismej.2009.146; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Poindexter JS, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P72, DOI 10.1007/0-387-30745-1_4; PONGRATZ E., 1957, SCHWEIZ ZEITSCHR ALLG PATH U BAKT, V20, P593; Rebollar EA, 2012, ENVIRON MICROBIOL, V14, P2323, DOI 10.1111/j.1462-2920.2012.02784.x; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; Rong XY, 2009, SYST APPL MICROBIOL, V32, P314, DOI 10.1016/j.syapm.2009.05.003; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tamura T, 2012, ANTON LEEUW INT J G, V102, P481, DOI 10.1007/s10482-012-9780-5; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Vinuesa P, 2008, APPL ENVIRON MICROB, V74, P6987, DOI 10.1128/AEM.00875-08; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Wang BJ, 2008, ENVIRON MICROBIOL, V10, P1948, DOI 10.1111/j.1462-2920.2008.01611.x; Wang BJ, 2010, INT J SYST EVOL MICR, V60, P1289, DOI 10.1099/ijs.0.012930-0; Wang Jianning, 2012, Weishengwu Xuebao, V52, P1011; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Weiner RM, 2000, INT J SYST EVOL MICR, V50, P459, DOI 10.1099/00207713-50-2-459; WEINER RM, 1985, INT J SYST BACTERIOL, V35, P237, DOI 10.1099/00207713-35-3-237; WEINER RM, 1980, CAN J MICROBIOL, V26, P1366, DOI 10.1139/m80-226; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Zhang F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00760	60	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101394	10.1371/journal.pone.0101394	http://dx.doi.org/10.1371/journal.pone.0101394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019154	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600015
J	Nelson, AE; Forbes, AA				Nelson, Amanda E.; Forbes, Andrew A.			Urban Land Use Decouples Plant-Herbivore-Parasitoid Interactions at Multiple Spatial Scales	PLOS ONE			English	Article							HABITAT; RESPONSES; HOST; DISPERSAL; CONSEQUENCES; BIODIVERSITY; POPULATIONS; DIVERSITY; LOCATION; SERVICES	Intense urban and agricultural development alters habitats, increases fragmentation, and may decouple trophic interactions if plants or animals cannot disperse to needed resources. Specialist insects represent a substantial proportion of global biodiversity and their fidelity to discrete microhabitats provides a powerful framework for investigating organismal responses to human land use. We sampled site occupancy and densities for two plant-herbivore-parasitoid systems from 250 sites across a 360 km(2) urban/agricultural landscape to ask whether and how human development decouples interactions between trophic levels. We compared patterns of site occupancy, host plant density, herbivory and parasitism rates of insects at two trophic levels with respect to landcover at multiple spatial scales. Geospatial analyses were used to identify landcover characters predictive of insect distributions. We found that herbivorous insect densities were decoupled from host tree densities in urban landcover types at several spatial scales. This effect was amplified for the third trophic level in one of the two insect systems: despite being abundant regionally, a parasitoid species was absent from all urban/suburban landcover even where its herbivore host was common. Our results indicate that human land use patterns limit distributions of specialist insects. Dispersal constraints associated with urban built development are specifically implicated as a limiting factor.	[Nelson, Amanda E.; Forbes, Andrew A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Nelson, AE (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	amanda-nelson@uiowa.edu		Forbes, Andrew/0000-0001-8332-6652; Nelson, Amanda/0000-0003-3868-5271	University of Iowa Department of Biology	University of Iowa Department of Biology	We wish to thank Stephen Hendrix and Christopher Patrick for helpful comments on early versions of this manuscript. George Malanson and Dale Zimmerman were instrumental in formulation of experimental designs. We thank four anonymous reviewers for comments and suggestions that greatly improved our manuscript. We extend thanks to numerous undergraduate research assistants, especially Katherine Weldon, Benjamin Worrell, and Francis Waisath, for help with field collections, insect husbandry, and data entry. We are also grateful for generous support from the University of Iowa Department of Biology and many private and public landowners in Johnson County, IA.	Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2005, EXPLORING SPATIAL DA; Bergerot B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011294; BOLLER EF, 1976, ANNU REV ENTOMOL, V21, P223, DOI 10.1146/annurev.en.21.010176.001255; BUSH GL, 1969, AM NAT, V103, P669, DOI 10.1086/282634; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Coladonato M., 1991, FIRE EFFECTS INFORM; Daoust SP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00300.1; Di Giulio M, 2009, J ENVIRON MANAGE, V90, P2959, DOI 10.1016/j.jenvman.2009.05.002; Doncaster CP, 1997, AM NAT, V150, P425, DOI 10.1086/286074; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Granchietti A, 2012, BIOL CONTROL, V61, P7, DOI 10.1016/j.biocontrol.2011.10.015; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Holt Robert D., 1996, P313; HUNTER AF, 1991, OIKOS, V60, P275, DOI 10.2307/3545068; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Jenkinson GL, 1969, HIST LAKE MACBRIDE S; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Kruess A, 2003, ECOGRAPHY, V26, P283, DOI 10.1034/j.1600-0587.2003.03402.x; LANDSBERG J, 1995, AUST J ECOL, V20, P299, DOI 10.1111/j.1442-9993.1995.tb00542.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Luck M, 2002, LANDSCAPE ECOL, V17, P327, DOI 10.1023/A:1020512723753; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Meehan TD, 2013, J INSECT CONSERV, V17, P411, DOI 10.1007/s10841-012-9523-y; Muesebeck C., 1980, USDA TECHNICAL B, V1617; Myers SW, 2006, ENVIRON ENTOMOL, V35, P219, DOI 10.1603/0046-225X-35.2.219; O'Rourke ME, 2011, ECOL APPL, V21, P1782, DOI 10.1890/10-0241.1; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Piechnik DA, 2013, ACTA OECOL, V47, P85, DOI 10.1016/j.actao.2012.11.002; PROKOPY RJ, 1984, AM SCI, V72, P41; Quilici Serge, 2012, Insects, V3, P1220, DOI 10.3390/insects3041220; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Ries L, 2004, ECOLOGY, V85, P2917, DOI 10.1890/03-8021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Rousset F, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P266; Rull J, 2011, ANN ENTOMOL SOC AM, V104, P202, DOI 10.1603/AN10095; Schnitzler FR, 2011, ECOL ENTOMOL, V36, P241, DOI 10.1111/j.1365-2311.2011.01266.x; Senger SE, 2007, ENTOMOL EXP APPL, V123, P91, DOI 10.1111/j.1570-7458.2007.00529.x; Smith RF, 2009, J N AM BENTHOL SOC, V28, P1022, DOI 10.1899/08-176.1; Stelinski LL, 2004, FLA ENTOMOL, V87, P124, DOI 10.1653/0015-4040(2004)087[0124:FOQAOT]2.0.CO;2; Strevens CMJ, 2011, J ANIM ECOL, V80, P282, DOI 10.1111/j.1365-2656.2010.01768.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Uchytil R.J., 1991, FIRE EFFECTS INFORM; USDA-NASS, 2011, CROPSCAPE; USDA-NRCS, 2005, SOIL SURV GEOG DAT; Vinatier F, 2013, LANDSCAPE ECOL, V28, P217, DOI 10.1007/s10980-012-9822-4; Wharton R.A., 1978, Journal of the Washington Academy of Sciences, V68, P147; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	57	19	21	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102127	10.1371/journal.pone.0102127	http://dx.doi.org/10.1371/journal.pone.0102127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019962	Green Published, gold			2022-12-25	WOS:000339618600048
J	Barbosa, AJB; Sampaio, I; Schneider, H; Santos, S				Barreto Barbosa, Andressa Jisely; Sampaio, Iracilda; Schneider, Horacio; Santos, Simoni			Molecular Phylogeny of Weakfish Species of the Stellifer Group (Sciaenidae, Perciformes) of the Western South Atlantic Based on Mitochondrial and Nuclear Data	PLOS ONE			English	Article							MACRODON-ANCYLODON SCIAENIDAE; CAETE RIVER ESTUARY; GENETIC-DIVERGENCE; COASTAL WATERS; FISH; TELEOSTEI; AMERICA; REEF; PHYLOGEOGRAPHY; POPULATIONS	The phylogenetic relationships within the Stellifer group of weakfishes (Stellifer, Odontoscion, Ophioscion, and Bairdiella) were evaluated using 2723 base pairs comprising sequences of nuclear (rhodopsin, TMO-4C4, RAG-1) and mitochondrial (16S rRNA and COI) markers obtained from specimens of nine species. Our results indicate a close relationship between Bairdiella and Odontoscion, and also that the genus Stellifer is not monophyletic, but rather that it consists of two distinct lineages, one clade containing S. microps/S. naso/S. brasiliensis and the other, S. rastrifer/S. stellifer/Stellifer sp. B, which is closer to Ophioscion than the former clade. The O. punctatissimus populations from the northern and southern Brazilian coast were also highly divergent in both nuclear (0.8% for rhodopsin and 0.9% for RAG-1) and mitochondrial sequences (2.2% for 16S rRNA and 7.3% for COI), which we conclude is consistent with the presence of two distinct species. The morphological similarities of the members of the Stellifer group is reinforced by the molecular data from both the present study and previous analyses, which have questioned the taxonomic status of the Stellifer group. If, on the one hand, the group is in fact composed of four genera (Stellifer, Ophioscion, Odontoscion, and Bairdiella), one of the two Stellifer clades should be reclassified as a new genus. However, if the close relationship and the reduced genetic divergence found within the group is confirmed in a more extensive study, including representatives of additional taxa, this, together with the morphological evidence, would support downgrading the whole group to a single genus. Obviously, these contradictory findings reinforce the need for a more systematic taxonomic revision of the Stellifer group as a whole.	[Barreto Barbosa, Andressa Jisely; Sampaio, Iracilda; Schneider, Horacio; Santos, Simoni] Fed Univ Para, Lab Genet & Mol Biol, Inst Coastal Studies IECOS, Braganca, Para, Brazil	Universidade Federal do Para	Santos, S (corresponding author), Fed Univ Para, Lab Genet & Mol Biol, Inst Coastal Studies IECOS, Braganca, Para, Brazil.	simoni@ufpa.br	Schneider, Horacio/J-7131-2012; SAMPAIO, IRACILDA/J-6514-2012	Schneider, Horacio/0000-0002-5987-6395; SAMPAIO, IRACILDA/0000-0002-2137-4656	Brazilian National Council for Scientific and Technological Development (CNPq); CNPq [306233/2009-6, 478027/2007-9]; FAPESPA; PROPESP/UFPA; FADESP;  [APP064/2011]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); PROPESP/UFPA; FADESP; 	This study was part of the MS dissertation of AJBB, which was financed by the Brazilian National Council for Scientific and Technological Development (CNPq). This research was also funded by CNPq (Grants 306233/2009-6 to IS; 478027/2007-9 to SS; and 306233/2009-6 to HS), APP064/2011 to IS, FAPESPA (PRONEX 2007 to HS), PROPESP/UFPA (http://www.propesp.ufpa.br), and FADESP (https://www.fadesp.org.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar SSC, 2012, THESIS U FEDERAL PAR; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Barleta-Bergan A, 2002, ESTUAR COAST SHELF S, V54, P193, DOI 10.1006/ecss.2001.0842; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Barletta M, 2003, MAR ECOL PROG SER, V256, P217, DOI 10.3354/meps256217; Barletta-Bergan A, 2002, J FISH BIOL, V61, P33, DOI [10.1006/jfbi.2002.2065, 10.1111/j.1095-8649.2002.tb01759.x]; Barletta-Bergan Audrey, 2009, Open Fish Science Journal, V2, P15; Beheregaray LB, 2002, P ROY SOC B-BIOL SCI, V269, P65, DOI 10.1098/rspb.2001.1838; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Brunner PC, 2001, EVOLUTION, V55, P573, DOI 10.1554/0014-3820(2001)055[0573:HPOACS]2.0.CO;2; Carvalho-Filho A., 1999, PEIXES COSTA BRASILE; Carvalho-Filho Alfredo, 2010, Zootaxa, V2519, P48; Casey KS, 1999, J CLIMATE, V12, P1848, DOI 10.1175/1520-0442(1999)012<1848:ACOSAI>2.0.CO;2; CASTRO B. M. F., 1998, SEA, P209; Cervigon F., 1993, FAO SPECIES IDENTIFI; CHAO L N, 1978, NOAA (National Oceanic and Atmospheric Administration) Technical Report NMFS (National Marine Fisheries Service) Circular, P1; Chen DL, 2010, MOL PHYLOGENET EVOL, V55, P1167, DOI 10.1016/j.ympev.2010.01.039; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cooke GM, 2012, J BIOGEOGR, V39, P724, DOI 10.1111/j.1365-2699.2011.02635.x; da Costa AJG, 2011, J COASTAL RES, P1960; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farias IP, 2000, J EXP ZOOL, V288, P76, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;76::AID-JEZ8&gt;3.0.CO;2-P; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueiredo J.L., 2003, CAT LOGO ESP CIES PE, P9; Grunwald C, 2002, MOL ECOL, V11, P1885, DOI 10.1046/j.1365-294X.2002.01575.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; Leray M, 2010, EVOLUTION, V64, P1218, DOI 10.1111/j.1558-5646.2009.00917.x; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Menezes NA, 1980, MAN PEIXES MARINHOS; Musilova Zuzana, 2009, Vertebrate Zoology, V59, P131; Nelson JS, 1984, FISHES WORLD; Palumbi Stephen R., 1996, P205; Planes S, 2001, EVOLUTION, V55, P2263; Pombo M, 2012, BRAZ J OCEANOGR, V60, P271, DOI 10.1590/S1679-87592012000300001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2008, FIGTREE V 1 4 0; Rambaut A, 2007, TRACER V 1 4; RAMSEY PR, 1987, COPEIA, P682; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2008, MOL PHYLOGENET EVOL, V48, P918, DOI 10.1016/j.ympev.2008.05.024; Rodrigues JL, 2011, BRAZ J BIOL, V71, P991, DOI 10.1590/S1519-69842011000500019; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos S, 2003, GENET MOL BIOL, V26, P151, DOI 10.1590/S1415-47572003000200008; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Santos S, 2013, MOL PHYLOGENET EVOL, V66, P423, DOI 10.1016/j.ympev.2012.09.020; SASAKI K, 1989, Memoirs of the Faculty of Fisheries Hokkaido University, V36, P1; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Stepien CA, 2001, EVOLUTION, V55, P1852, DOI 10.1111/j.0014-3820.2001.tb00834.x; Streelman JT, 1997, P ROY SOC B-BIOL SCI, V264, P1011, DOI 10.1098/rspb.1997.0140; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinas J, 2010, J BIOGEOGR, V37, P557, DOI 10.1111/j.1365-2699.2009.02225.x; Vinson C, 2004, GENET MOL BIOL, V27, P174, DOI 10.1590/S1415-47572004000200008; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	61	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102250	10.1371/journal.pone.0102250	http://dx.doi.org/10.1371/journal.pone.0102250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25020128	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400082
J	Canuel, M; Abdous, B; Belanger, D; Gosselin, P				Canuel, Magalie; Abdous, Belkacem; Belanger, Diane; Gosselin, Pierre			Development of Composite Indices to Measure the Adoption of Pro-Environmental Behaviours across Canadian Provinces	PLOS ONE			English	Article							ENGLISH; ATTITUDES; VALUES; FAMILY; IMPACT	Objective: The adoption of pro-environmental behaviours reduces anthropogenic environmental impacts and subsequent human health effects. This study developed composite indices measuring adoption of pro-environmental behaviours at the household level in Canada. Methods: The 2007 Households and the Environment Survey conducted by Statistics Canada collected data on Canadian environmental behaviours at households' level. A subset of 55 retained questions from this survey was analyzed by Multiple Correspondence Analysis (MCA) to develop the index. Weights attributed by MCA were used to compute scores for each Canadian province as well as for socio-demographic strata. Scores were classified into four categories reflecting different levels of adoption of pro-environmental behaviours. Results: Two indices were finally created: one based on 23 questions related to behaviours done inside the dwelling and a second based on 16 questions measuring behaviours done outside of the dwelling. British Columbia, Quebec, Prince-Edward-Island and Nova-Scotia appeared in one of the two top categories of adoption of pro-environmental behaviours for both indices. Alberta, Saskatchewan, Manitoba and Newfoundland-and- Labrador were classified in one of the two last categories of pro-environmental behaviours adoption for both indices. Households with a higher income, educational attainment, or greater number of persons adopted more indoor pro-environmental behaviours, while on the outdoor index, they adopted fewer such behaviours. Households with low-income fared better on the adoption of outdoors pro-environmental behaviours. Conclusion: MCA was successfully applied in creating Indoor and Outdoor composite Indices of pro-environmental behaviours. The Indices cover a good range of environmental themes and the analysis could be applied to similar surveys worldwide (as baseline weights) enabling temporal trend comparison for recurring themes. Much more than voluntary measures, the study shows that existing regulations, dwelling type, households composition and income as well as climate are the major factors determining pro-environmental behaviours.	[Canuel, Magalie; Gosselin, Pierre] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Abdous, Belkacem; Belanger, Diane; Gosselin, Pierre] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Abdous, Belkacem] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Belanger, Diane; Gosselin, Pierre] Inst Natl Rech Sci, Ctr Eau Terre Environm, Quebec City, PQ, Canada	Institut national de sante publique du Quebec (INSPQ); Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS)	Canuel, M (corresponding author), Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada.	magalie.canuel@inspq.qc.ca			Quebec government	Quebec government	This study was funded by the Green Fund for Action 21 of the 2006-2012 Climate Change Action Plan of the Quebec government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GREEN HOUS BEH OV 20; [Anonymous], EN EFF TRENDS CAN 19; Asselin LM., 2002, COMPOSITE INDICATOR; Atiles J. H., 2003, Southern Rural Sociology, V19, P97; Babooram A, 2008, ENVIROSTATS, V2, P7; BAER DE, 1984, CAN J SOCIOL, V9, P405, DOI 10.2307/3340527; Baillargeon J.P, 1994, RECH SOCIOGRAPH, V35, P255; BChydro, 2013, BUY BUILD RENT EFF H; Birrell C, 2008, ENVIROSTATS, V2, P19; Blumenberg E, 2010, TRANSPORTATION, V37, P429, DOI 10.1007/s11116-010-9262-4; Bohon SA, 2008, POPUL RES POLICY REV, V27, P273, DOI 10.1007/s11113-008-9075-8; Bonsal B, 2013, DROUGHTS; Canada mortgage and Housing Corporation, 2013, RED EN COST; Charreire H, 2010, INT J OBESITY, V34, P1293, DOI 10.1038/ijo.2010.39; Corbeil J. P, 2012, LINGUISTIC CHARACTER; CORTINOVIS I, 1993, SOC SCI MED, V36, P1087, DOI 10.1016/0277-9536(93)90127-P; Dossa LH, 2011, HUM ECOL, V39, P569, DOI 10.1007/s10745-011-9421-z; Environment Canada, 2011, OTT MUN WAT US REP; Environment Canada, 2013, WIS WAT US; Environment Canada, 2010, WAT CLIM CHANG; Environment Canada, 2013, AMM EM; Esty D. C., 2005, 2005 ENV SUSTAINABIL; Gibbons WD, 2008, ENVIROSTATS, V2, P8; Gibson KL, 2008, J SOC PSYCHOL, V148, P133, DOI 10.3200/SOCP.148.2.133-166; Greenacre M, 2010, PACKAGE CA SIMPLE MU; Greenacre M., 2007, CORRES ANAL PRACTICE; Hardie D, 2009, RURAL SMALL TOWN CAN, V7, P1; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Human Resources and Skills Development Canada, 2007, WHAT DIFF DOES LEARN; Kinkead J, 2006, ANAL CANADIAN OTHER; Kollmuss A., 2012, ENVIRON EDUC RES, V8, P239, DOI DOI 10.1080/13504620220145401; Lopez A, 2007, J WILDLIFE MANAGE, V71, P1275, DOI 10.2193/2006-480; Lynch MF, 2007, ENVIROSTATS, V1, P9; Mainieri T, 1997, J SOC PSYCHOL, V137, P189, DOI 10.1080/00224549709595430; Mekis E, 2011, ATMOS OCEAN, V49, P163, DOI 10.1080/07055900.2011.583910; Melgar N, 2013, ENV BEHAV DO PERSONA; Milito AC, 2008, ENVIROSTATS, V2, P3; Ministere du Developpement durable de l'Environnement de la Faune et des Parcs, 2011, PEST MAN COD HIGHL; Munro A, 2010, RECYCLING CANADIAN H; Mustapha I., 2013, ENVIROSTATS, V7, P1; Mustapha I, 2012, 16201X STAT CANADAOT; Nardo M., 2005, HDB CONSTRUCTING COM, P17, DOI [10.1787/533411815016, DOI 10.1787/533411815016]; Nelligan T, 2008, ENVIROSTATS, V2, P17; Oaks, 2012, PROV TERR WAT EFF CO; Price CE, 2012, POPUL RES POLICY REV, V31, P119, DOI 10.1007/s11113-011-9216-3; Reynaud A, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR004195; *STAT CAN, 2008, HUM ACT ENV ANN STAT; Statistics Canada, 2010, MICR US GUID HOUS EN; Statistics Canada, 2009, 11526X STAT CAN; Statistics Canada, 2011, CANSIM TABL 027 0017; Statistics Canada, 2011, IMM CAN PORTR FOR BO; Stewart D., 2007, FOCUS GROUPS; Todd A, 2014, CHALLENGES, V5, P138; U.S. Environmental Protection Agency, 1998, WASH DC WAT CONS PLA; Wu Z, 1996, J COMP FAM STUD, V27, P437, DOI 10.3138/jcfs.27.3.437; Xiao CY, 2010, POPUL ENVIRON, V32, P88, DOI 10.1007/s11111-010-0115-z; Young N, 2012, CAN J SOCIOL, V37, P25, DOI 10.29173/cjs9733	57	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101569	10.1371/journal.pone.0101569	http://dx.doi.org/10.1371/journal.pone.0101569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25013929	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000339378400028
J	Corchado, S; Lopez-Cortes, LF; Rivero-Juarez, A; Torres-Cornejo, A; Rivero, A; Marquez-Coello, M; Giron-Gonzalez, JA				Corchado, Sara; Lopez-Cortes, Luis F.; Rivero-Juarez, Antonio; Torres-Cornejo, Almudena; Rivero, Antonio; Marquez-Coello, Mercedes; Giron-Gonzalez, Jose-Antonio			Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients	PLOS ONE			English	Article							INTERFERON PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON; GENOTYPE 1; VIRAL KINETICS; HIV; TELAPREVIR; INFECTION; MANAGEMENT; SERUM	Objective: To establish the role of liver fibrosis as a predictive tool of response to pegylated interferon alpha (Peg-IFN) and ribavirin (RBV) treatment in human immunodeficiency (HIV)/hepatitis C virus (HCV) coinfected patients, in addition to recognized predictive factors (HCV load, HCV genotype, IL-28B polymorphism). Patients and Methods: A sample of 267 HIV/HCV coinfected patients was treated with Peg-IFN and RBV. Predictive factors of rapid (RVR) and sustained (SVR) virological response were analyzed. Independent variables were age, sex, IL28B, -238 TNF-alpha and -592 IL-10 polymorphisms, HCV genotype, HCV-RNA levels, significant fibrosis or cirrhosis and CD4+ T cell count. Results: Patients infected by HCV genotype 1 (n = 187) showed RVR and SVR in 12% and 39% of cases, respectively. The parameters associated with RVR were IL28B genotype CC and plasma HCV-RNA levels <600000 IU/ml. Advanced liver fibrosis was negatively associated with SVR in patients without RVR. A SVR was obtained in 42% of subjects with HCV genotype 4, and the independent factors associated with SVR were IL28B genotype CC and an HCV-RNA <600000 IU/ml. A SVR was obtained in 66% of patients with HCV genotypes 2/3; in this case, the independent parameter associated with SVR was the absence of significant liver fibrosis. TNF-alpha and IL-10 polymorphisms were not associated with SVR, although a significantly higher percentage of -238 TNF-alpha genotype GG was detected in patients with significant liver fibrosis. Conclusions: In HIV/HCV coinfected patients with HCV genotypes 1 or 4, RVR, mainly influenced by genotype IL28B and HCV-RNA levels, reliably predicted SVR after 4 weeks of therapy with Peg-IFN plus RBV. In patients infected by HCV genotype 3, an elevated relapse rate compromised the influence of RVR on SVR. Relapses were related to the presence of advanced liver fibrosis. Liver cirrhosis was associated with a -238 TNF-alpha polymorphism in these patients.	[Corchado, Sara; Marquez-Coello, Mercedes; Giron-Gonzalez, Jose-Antonio] Hosp Univ Puerta del Mar, Unidad Enfermedades Infecciosas, Cadiz, Spain; [Lopez-Cortes, Luis F.; Torres-Cornejo, Almudena] Univ Seville, CSIC, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Seville, Spain; [Rivero-Juarez, Antonio; Rivero, Antonio] Reina Sofia Univ Hosp, Maimonides Inst Res Biomed Cordoba, Cordoba, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Giron-Gonzalez, JA (corresponding author), Hosp Univ Puerta del Mar, Unidad Enfermedades Infecciosas, Cadiz, Spain.	joseantonio.giron@uca.es	Girón-González, José-Antonio/H-3990-2014; Girón-González, José-Antonio/AAG-4199-2020; Rivero, Antonio/ABE-5294-2020; IBIS, VIH/O-8856-2015; Lopez.Cortes, Luis Fernando/W-8323-2019; Rivero-Juarez, Antonio/E-4528-2019	Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Rivero, Antonio/0000-0001-5005-8268; Marquez-Coello, Mercedes/0000-0003-3948-6258; Rivero-Juarez, Antonio/0000-0002-5813-6889; Rivero Roman, Antonio/0000-0002-8643-4250	Consejeria de Salud, Junta de Andalucia [PI-0076/2008, PI-0157/2011, PI-0430/2012]; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III [PI 08/0869, PI 11/00605]; Intensificacion de la Actividad Investigadora en el S.N.S, Instituto de Salud Carlos III; Intensificacion de la Actividad Investigadora en el Servicio Andaluz de Salud, Junta de Andalucia	Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Intensificacion de la Actividad Investigadora en el S.N.S, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Intensificacion de la Actividad Investigadora en el Servicio Andaluz de Salud, Junta de Andalucia(Junta de Andalucia)	This work has been performed with grants of the "Consejeria de Salud, Junta de Andalucia (PI-0076/2008, PI-0157/2011 and PI-0430/2012), and "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (PI 08/0869 and PI 11/00605)''. JA Giron-Gonzalez has a grant for "Intensificacion de la Actividad Investigadora en el S.N.S, Instituto de Salud Carlos III'', 2011, and a grant for "Intensificacion de la Actividad Investigadora en el Servicio Andaluz de Salud, Junta de Andalucia'', 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia Espanola del Medicamento y Productos Sanitarios, 2014, CRT REC GEN TRAT CON; Bataller R, 2003, HEPATOLOGY, V37, P493, DOI 10.1053/jhep.2003.50127; Brau N, 2005, SEMIN LIVER DIS, V25, P33, DOI 10.1055/s-2005-864780; Chang MH, 2012, CLIN THER, V34, P2021, DOI 10.1016/j.clinthera.2012.08.009; Corchado S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066619; Crespo M, 2007, AIDS, V21, P477, DOI 10.1097/QAD.0b013e328012b5ba; Dieterich D, 2013, 20 C RETR OPP INF AT; Fabris C, 1998, J INTERF CYTOK RES, V18, P705, DOI 10.1089/jir.1998.18.705; Foster GR, 2013, J HEPATOL, V58, P488, DOI 10.1016/j.jhep.2012.11.013; Friedman SL, 1997, J GASTROENTEROL, V32, P424, DOI 10.1007/BF02934504; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giron-Gonzalez JA, 2005, SCAND J GASTROENTERO, V40, P217, DOI 10.1080/00365520510011470; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Jonsson JR, 2008, HEPATOLOGY, V48, P80, DOI 10.1002/hep.22311; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Kwo PY, 2012, LIVER INT, V32, P39, DOI 10.1111/j.1478-3231.2011.02709.x; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Mandorfer M, 2013, AIDS, V27, P2707, DOI 10.1097/01.aids.0000432460.44593.ef; Mangia A, 2004, CYTOKINE, V25, P103, DOI 10.1016/j.cyto.2003.10.005; Marin-Serrano E, 2006, J VIRAL HEPATITIS, V13, P230, DOI 10.1111/j.1365-2893.2005.00679.x; Martel-Laferriere V, 2014, J CLIN GASTROENTEROL, V48, P106, DOI 10.1097/MCG.0000000000000010; Martin-Carbonero L, 2008, AIDS, V22, P15, DOI 10.1097/QAD.0b013e3282f1da99; Medrano J, 2010, CLIN INFECT DIS, V51, P1209, DOI 10.1086/656811; Mira JA, 2007, ANTIVIR THER, V12, P1225; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mira JA, 2012, AIDS, V26, P1721, DOI 10.1097/QAD.0b013e3283568884; Moreno A, 2006, J VIRAL HEPATITIS, V13, P466, DOI 10.1111/j.1365-2893.2005.00710.x; Moreno A, 2004, ANTIVIR THER, V9, P133; Naggie S, 2014, 21 C RETR OPP INF BO; Neukam K, 2013, J INFECTION, V67, P59, DOI 10.1016/j.jinf.2013.03.010; Neukam K, 2012, J HEPATOL, V56, P788, DOI 10.1016/j.jhep.2011.11.008; Nunez M, 2007, JAIDS-J ACQ IMM DEF, V45, P439, DOI 10.1097/QAI.0b013e318061b5d9; Payan C, 2007, GUT, V56, P1111, DOI 10.1136/gut.2006.106690; Perry CM, 2012, DRUGS, V72, P619, DOI 10.2165/11208370-000000000-00000; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rivero-Juarez A, 2012, J ANTIMICROB CHEMOTH, V67, P202, DOI 10.1093/jac/dkr439; Rodriguez-Inigo E, 2005, J MOL DIAGN, V7, P535, DOI 10.1016/S1525-1578(10)60585-5; Seden K, 2011, CURR OPIN HIV AIDS, V6, P514, DOI 10.1097/COH.0b013e32834b54dc; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Soriano V, 2004, AIDS RES HUM RETROV, V20, P351, DOI 10.1089/088922204323048096; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Zhu Y, 2013, WORLD J GASTROENTERO, V19, P8963, DOI 10.3748/wjg.v19.i47.8963	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101760	10.1371/journal.pone.0101760	http://dx.doi.org/10.1371/journal.pone.0101760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013899	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400034
J	Lee, M; Kim, W; Choi, Y; Kim, S; Kim, D; Yu, SJ; Lee, JH; Kim, HY; Jung, YJ; Kim, BG; Kim, YJ; Yoon, JH; Lee, KL; Lee, HS				Lee, Minjong; Kim, Won; Choi, Yunhee; Kim, Sunhee; Kim, Donghee; Yu, Su Jong; Lee, Jeong-Hoon; Kim, Hwi Young; Jung, Yong Jin; Kim, Byeong Gwan; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Kook Lae; Lee, Hyo-Suk			Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis	PLOS ONE			English	Article							DISEASE; MODELS; POLYMORPHISMS; PATHOGENESIS; MANAGEMENT; ADH2	The accurate prognostic stratification of alcoholic hepatitis (AH) is essential for individualized therapeutic decisions. The aim of this study was to develop a new prognostic model to predict liver-related mortality in Asian AH patients. We conducted a hospital-based, retrospective cohort study using 308 patients with AH between 1999 and 2011 (a derivation cohort) and 106 patients with AH between 2005 and 2012 (a validation cohort). The Cox proportional hazards model was constructed to select significant predictors of liver-related death from the derivation cohort. A new prognostic model was internally validated using a bootstrap sampling method. The discriminative performance of this new model was compared with those of other prognostic models using a concordance index in the validation cohort. Bilirubin, prothrombin time, creatinine, potassium at admission, and a spontaneous change in bilirubin levels from day 0 to day 7 (SCBL) were incorporated into a model for AH to grade the severity in an Asian patient cohort (MAGIC). For risk stratification, four risk groups were identified with cutoff scores of 29, 37, and 46 based on the different survival probabilities (P < 0.001). In addition, MAGIC showed better discriminative performance for liver-related mortality than any other scoring system in the validation cohort. MAGIC can accurately predict liver-related mortality in Asian patients hospitalized for AH. Therefore, SCBL may help us decide whether patients with AH urgently require corticosteroid treatment.	[Lee, Minjong; Yu, Su Jong; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Kook Lae; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Minjong; Yu, Su Jong; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan; Lee, Kook Lae; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Won; Kim, Hwi Young; Jung, Yong Jin; Kim, Byeong Gwan; Lee, Kook Lae] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Choi, Yunhee; Kim, Sunhee] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Kim, Donghee] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Dept Internal Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, W (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	drwon1@snu.ac.kr	Kim, Won/H-6940-2019; Lee, Jeong-Hoon/Q-1055-2018; Kim, Donghee/C-4288-2013	Kim, Won/0000-0002-2926-1007; Lee, Jeong-Hoon/0000-0002-0315-2080; Kim, Yoon Jun/0000-0001-9141-7773; Kim, Donghee/0000-0003-1919-6800; Yoon, Jung-Hwan/0000-0002-9128-3610; , minjong/0000-0002-3159-5444; Yu, Su Jong/0000-0001-8888-7977	Korean Association	Korean Association	This study was supported by the 2012 Korean Association for the Study of the Liver Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dominguez M, 2008, AM J GASTROENTEROL, V103, P2747, DOI 10.1111/j.1572-0241.2008.02104.x; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Elphick DA, 2007, AM J GASTROENTEROL, V102, P780, DOI 10.1111/j.1572-0241.2006.01034.x; Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781; Forrest EH, 2012, J HEPATOL, V56, P1427, DOI 10.1016/j.jhep.2011.12.028; GOEDDE HW, 1992, HUM GENET, V88, P344; Haber PS, 2003, J GASTROEN HEPATOL, V18, P1332, DOI 10.1046/j.1440-1746.2003.03217.x; HARDISON WG, 1966, NEW ENGL J MED, V275, P61, DOI 10.1056/NEJM196607142750201; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Konishi T, 2003, ALCOHOL ALCOHOLISM, V38, P93, DOI 10.1093/alcalc/agg021; Laine C, 2000, J SUBST ABUSE, V12, P271, DOI 10.1016/S0899-3289(00)00054-7; Leise MD, 2011, GASTROENTEROLOGY, V140, P1952, DOI 10.1053/j.gastro.2011.02.017; Li You-Min, 2005, Hepatobiliary Pancreat Dis Int, V4, P170; Louvet A, 2013, J HEPATOL, V58, pS52, DOI 10.1016/S0168-8278(13)60119-1; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 1996, GASTROENTEROLOGY, V110, P1847, DOI 10.1053/gast.1996.v110.pm8964410; Mathurin P, 2003, HEPATOLOGY, V38, P1363, DOI 10.1016/j.hep.2003.09.038; McCullough AJ, 1998, AM J GASTROENTEROL, V93, P2022; McCullough AJ, 2011, J DIGEST DIS, V12, P257, DOI 10.1111/j.1751-2980.2010.00470.x; Rongey C, 2006, WORLD J GASTROENTERO, V12, P6909, DOI 10.3748/wjg.v12.i43.6909; Saito H, 2004, HEPATOL RES, V30, P193, DOI 10.1016/j.hepres.2004.08.016; SAVOLAINEN VT, 1993, ALCOHOL CLIN EXP RES, V17, P1112, DOI 10.1111/j.1530-0277.1993.tb05673.x; Singal AK, 2011, GASTROENTEROL CLIN N, V40, P611, DOI 10.1016/j.gtc.2011.06.008; Stewart SH, 2002, ARCH INTERN MED, V162, P2236, DOI 10.1001/archinte.162.19.2236; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vidal F, 2004, J HEPATOL, V41, P744, DOI 10.1016/j.jhep.2003.06.003	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100870	10.1371/journal.pone.0100870	http://dx.doi.org/10.1371/journal.pone.0100870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013906	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400013
J	Celiku, O; Johnson, S; Zhao, SP; Camphausen, K; Shankavaram, U				Celiku, Orieta; Johnson, Seth; Zhao, Shuping; Camphausen, Kevin; Shankavaram, Uma			Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP	PLOS ONE			English	Article							CANCER GENOMICS DATA; TEMOZOLOMIDE; EXPRESSION; BROWSER; GENES	Validation of clinical biomarkers and response to therapy is a challenging topic in cancer research. An important source of information for virtual validation is the datasets generated from multi-center cancer research projects such as The Cancer Genome Atlas project (TCGA). These data enable investigation of genetic and epigenetic changes responsible for cancer onset and progression, response to cancer therapies, and discovery of the molecular profiles of various cancers. However, these analyses often require bulk download of data and substantial bioinformatics expertise, which can be intimidating for investigators. Here, we report on the development of a new resource available to scientists: a data base called Glioblastoma Bio Discovery Portal (GBM-BioDP). GBM-BioDP is a free web-accessible resource that hosts a subset of the glioblastoma TCGA data and enables an intuitive query and interactive display of the resultant data. This resource provides visualization tools for the exploration of gene, miRNA, and protein expression, differential expression within the subtypes of GBM, and potential associations with clinical outcome, which are useful for virtual biological validation. The tool may also enable generation of hypotheses on how therapies impact GBM molecular profiles, which can help in personalization of treatment for optimal outcome. The resource can be accessed freely at http://gbm-biodp.nci.nih.gov (a tutorial is included).	[Celiku, Orieta; Johnson, Seth; Zhao, Shuping; Camphausen, Kevin; Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shankavaram, U (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	uma@mail.nih.gov		Celiku, Orieta/0000-0002-0500-1032; Johnson, Seth/0000-0001-5957-2052	National Institutes of Health, National Cancer Institute, Center for Cancer Research	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addeo R, 2011, J NEURO-ONCOL, V102, P417, DOI 10.1007/s11060-010-0329-z; Addeo R, 2009, CANCER CHEMOTH PHARM, V64, P863, DOI 10.1007/s00280-009-1086-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Fiume M, 2012, NUCLEIC ACIDS RES, V40, pW615, DOI 10.1093/nar/gks427; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lex A, 2012, COMPUT GRAPH FORUM, V31, P1175, DOI 10.1111/j.1467-8659.2012.03110.x; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; R Core Team R, 2022, R LANG ENV STAT COMP; Raza SM, 2004, CLIN CANCER RES, V10, P212, DOI 10.1158/1078-0432.CCR-0155-3; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Sasaki A, 2012, ANTICANCER RES, V32, P4709; Schroeder MP, 2013, GENOME MED, V5, DOI 10.1186/gm413; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805	29	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101239	10.1371/journal.pone.0101239	http://dx.doi.org/10.1371/journal.pone.0101239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010047	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800015
J	Liu, B; Ouyang, ZG; Zhang, YF; Li, XH; Hong, YB; Huang, L; Liu, SX; Zhang, HJ; Li, DY; Song, FM				Liu, Bo; Ouyang, Zhigang; Zhang, Yafen; Li, Xiaohui; Hong, Yongbo; Huang, Lei; Liu, Shixia; Zhang, Huijuan; Li, Dayong; Song, Fengming			Tomato NAC Transcription Factor SlSRN1 Positively Regulates Defense Response against Biotic Stress but Negatively Regulates Abiotic Stress Response	PLOS ONE			English	Article							FACTOR GENE FAMILY; COMPREHENSIVE ANALYSIS; DROUGHT RESISTANCE; GRAIN-YIELD; HYPERSENSITIVE RESPONSE; PHYTOPHTHORA-INFESTANS; PATHOGEN RESISTANCE; FUNCTIONAL-ANALYSIS; LEAF SENESCENCE; DOMAIN PROTEIN	Biotic and abiotic stresses are major unfavorable factors that affect crop productivity worldwide. NAC proteins comprise a large family of transcription factors that play important roles in plant growth and development as well as in responses to biotic and abiotic stresses. In a virus-induced gene silencing-based screening to identify genes that are involved in defense response against Botrytis cinerea, we identified a tomato NAC gene SlSRN1 (Solanum lycopersicum Stress-related NAC1). SlSRN1 is a plasma membrane-localized protein with transactivation activity in yeast. Expression of SlSRN1 was significantly induced by infection with B. cinerea or Pseudomonas syringae pv. tomato (Pst) DC3000, leading to 6-8 folds higher than that in the mock-inoculated plants. Expression of SlSRN1 was also induced by salicylic acid, jasmonic acid and 1-amino cyclopropane-1-carboxylic acid and by drought stress. Silencing of SlSRN1 resulted in increased severity of diseases caused by B. cinerea and Pst DC3000. However, silencing of SlSRN1 resulted in increased tolerance against oxidative and drought stresses. Furthermore, silencing of SlSRN1 accelerated accumulation of reactive oxygen species but attenuated expression of defense genes after infection by B. cinerea. Our results demonstrate that SlSRN1 is a positive regulator of defense response against B. cinerea and Pst DC3000 but is a negative regulator for oxidative and drought stress response in tomato.	[Liu, Bo; Ouyang, Zhigang; Zhang, Yafen; Li, Xiaohui; Hong, Yongbo; Huang, Lei; Liu, Shixia; Zhang, Huijuan; Li, Dayong; Song, Fengming] Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Song, FM (corresponding author), Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	fmsong@zju.edu.cn			National Basic Research Program of China [2009CB119005]; National Key Technology R & D Program of China [2011BAD12B04]; National High-Tech R D Program [2012AA101504]; Research Fund for the Doctoral Program of Higher Education of China [20120101110070]	National Basic Research Program of China(National Basic Research Program of China); National Key Technology R & D Program of China(National Key Technology R&D Program); National High-Tech R D Program(National High Technology Research and Development Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (2009CB119005), the National Key Technology R & D Program of China (2011BAD12B04), the National High-Tech R & D Program (No. 2012AA101504) and the Research Fund for the Doctoral Program of Higher Education of China (20120101110070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2008, PLANT CELL, V20, P1964, DOI 10.1105/tpc.108.059477; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; Bollhoner B, 2012, J EXP BOT, V63, P1081, DOI 10.1093/jxb/err438; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Chen X, 2014, PLANT CELL PHYSIOL, V55, P604, DOI 10.1093/pcp/pct204; Chen YJ, 2013, PLANT MOL BIOL, V83, P577, DOI 10.1007/s11103-013-0109-1; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hendelman A, 2013, J EXP BOT, V64, P5497, DOI 10.1093/jxb/ert324; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang WZ, 2013, NEW PHYTOL, V197, P1214, DOI 10.1111/nph.12096; Hussey SG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00325; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kim HS, 2012, NUCLEIC ACIDS RES, V40, P9182, DOI 10.1093/nar/gks683; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim YS, 2013, PLANT CELL PHYSIOL, V54, P1660, DOI 10.1093/pcp/pct113; Kuzniak E, 2005, PLANTA, V222, P192, DOI 10.1007/s00425-005-1514-8; Kuzniak E, 2004, J EXP BOT, V55, P605, DOI 10.1093/jxb/erh076; Le Henanff G, 2013, J EXP BOT, V64, P4877, DOI 10.1093/jxb/ert277; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Ma NN, 2013, PHYSIOL PLANTARUM, V149, P474, DOI 10.1111/ppl.12049; McLellan H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003670; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Oh SK, 2005, PLANTA, V222, P876, DOI 10.1007/s00425-005-0030-1; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Orellana S, 2010, PLANT CELL ENVIRON, V33, P2191, DOI 10.1111/j.1365-3040.2010.02220.x; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Ricachenevsky FK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00226; Saga H, 2012, MOL PLANT MICROBE IN, V25, P684, DOI 10.1094/MPMI-09-11-0244; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Sun Li-Jun, 2012, Yichuan, V34, P993, DOI 10.3724/SP.J.1005.2012.00993; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Virk N, 2013, ACTA PHYSIOL PLANT, V35, P1211, DOI 10.1007/s11738-012-1160-2; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yang RC, 2011, MOL BIOL REP, V38, P857, DOI 10.1007/s11033-010-0177-0; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhu MK, 2014, PLANT CELL PHYSIOL, V55, P119, DOI 10.1093/pcp/pct162	86	53	60	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102067	10.1371/journal.pone.0102067	http://dx.doi.org/10.1371/journal.pone.0102067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010573	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800064
J	Muller, S; Kruger, B; Lange, F; Bock, CN; Nizze, H; Glass, A; Ibrahim, SM; Jaster, R				Mueller, Sarah; Krueger, Burkhard; Lange, Falko; Bock, Cristin N.; Nizze, Horst; Glass, Aenne; Ibrahim, Saleh M.; Jaster, Robert			The mtDNA nt7778 G/T Polymorphism Augments Formation of Lymphocytic Foci but Does Not Aggravate Cerulein-Induced Acute Pancreatitis in Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE PANCREATITIS; FREE-RADICALS; ORGANELLAR DYSFUNCTION; MULTIPLE-SCLEROSIS; MRL/MP-MOUSE; ACINAR-CELLS; MITOCHONDRIAL; PATHOGENESIS; INFLAMMATION	A polymorphism in the ATP synthase 8 (ATP8) gene of the murine mitochondrial genome, G-to-T transversion at position 7778, has been suggested to increase susceptibility to multiple autoimmune diseases, including autoimmune pancreatitis (AIP). The polymorphism also induces mitochondrial reactive oxygen species generation, secretory dysfunction and beta-cell mass adaptation. Here, we have used two conplastic mouse strains, C57BL/6N-mtAKR/J (B6-mtAKR; nt7778 G; control) and C57BL/6N-mtFVB/N (B6-mtFVB; nt7778 T), to address the question if the polymorphism also affects the course of cerulein-induced acute pancreatitis in mice. Therefore, two age groups of mice (3 and 12-month-old, respectively) were subjected to up to 7 injections of the secretagogue cerulein (50 mu g/kg body weight) at hourly intervals. Disease severity was assessed at time points from 3 hours to 7 days based on pancreatic histopathology, serum levels of alpha-amylase and activities of myeloperoxidase (MPO) in lung tissue. A comparison of cerulein-induced pancreatic tissue damage and increases of alpha-amylase and MPO activities showed no differences between the age-matched groups of both strains. Interestingly, histological evaluation of pancreatic tissue of both untreated and cerulein-treated B6-mtAKR and B6-mtFVB mice also revealed the presence of infiltrates of immune cells surrounding ducts and vessels; a finding that is compatible with an early stage of AIP. After recovery from cerulein-induced pancreatitis (day 7 after the injections), 12-month-old B6-mtFVB mice but not B6-mtAKR mice displayed aggravated lymphocytic lesions. A comparison of 12-month-old mice with other age groups of both strains revealed that lymphocytic foci were largely absent in 3-month-old mice, while 24-month-old mice were more affected. Together, our data suggest that the mtDNA nt7778 G/T polymorphism does not aggravate cerulein-induced acute pancreatitis. Autoimmune-like lesions, however, may progress faster if additional tissue damage occurs.	[Mueller, Sarah; Lange, Falko; Bock, Cristin N.; Jaster, Robert] Univ Med Rostock, Div Gastroenterol, Dept Med 2, Rostock, Germany; [Krueger, Burkhard] Univ Med Rostock, Div Med Biol, Rostock, Germany; [Lange, Falko] Univ Med Rostock, Oscar Langendorff Inst Physiol, Rostock, Germany; [Nizze, Horst] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Glass, Aenne] Univ Med Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Lubeck	Jaster, R (corresponding author), Univ Med Rostock, Div Gastroenterol, Dept Med 2, Rostock, Germany.	jaster@med.uni-rostock.de	Ibrahim, Saleh/AAO-9541-2020	Lange, Falko/0000-0001-8782-5205; Ibrahim, Saleh/0000-0001-7827-2290	Bundesministerium fur Bildung und Forschung [0315892A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (0315892A, GERONTOSYS program, http://www.bmbf.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahari SE, 2007, CELL MOL NEUROBIOL, V27, P695, DOI 10.1007/s10571-007-9160-2; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Eipel C, 2011, LIFE SCI, V88, P343, DOI 10.1016/j.lfs.2010.12.011; Fitzner B, 2009, PANCREATOLOGY, V9, P233, DOI 10.1159/000199434; Gimsa U, 2009, ANN NY ACAD SCI, V1153, P131, DOI 10.1111/j.1749-6632.2008.03960.x; Gukovskaya AS, 2004, PANCREATOLOGY, V4, P567, DOI 10.1159/000082182; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Jonsen A, 2009, LUPUS, V18, P309, DOI 10.1177/0961203308097477; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; KANNO H, 1992, CLIN EXP IMMUNOL, V89, P68; Kruger B, 1998, LAB INVEST, V78, P763; Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lorentz K, 1998, CLIN CHEM LAB MED, V36, P185, DOI 10.1515/CCLM.1998.034; Maleth J, 2013, ACTA PHYSIOL, V207, P226, DOI 10.1111/apha.12037; Maleth J, 2011, GUT, V60, P136, DOI 10.1136/gut.2009.192153; Mathews CE, 2005, DIABETOLOGIA, V48, P261, DOI 10.1007/s00125-004-1644-8; Muller S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094494; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Okamura D, 2012, AGING CELL, V11, P760, DOI 10.1111/j.1474-9726.2012.00841.x; Park BK, 2003, WORLD J GASTROENTERO, V9, P2266; RUTLEDGE PL, 1987, GASTROENTEROLOGY, V93, P41, DOI 10.1016/0016-5085(87)90311-8; SANFEY H, 1984, ANN SURG, V200, P405, DOI 10.1097/00000658-198410000-00003; Sorg H, 2008, AM J PHYSIOL-GASTR L, V295, pG1274, DOI 10.1152/ajpgi.90341.2008; Takahashi H, 2012, AGING CELL, V11, P305, DOI 10.1111/j.1474-9726.2011.00787.x; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tzagoloff A, 2004, J BIOL CHEM, V279, P19775, DOI 10.1074/jbc.M401506200; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Vyshkina T, 2008, CLIN IMMUNOL, V129, P31, DOI 10.1016/j.clim.2008.07.011; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Weiss H, 2012, ENDOCRINOLOGY, V153, P4666, DOI 10.1210/en.2012-1296; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Yu XH, 2009, HUM MOL GENET, V18, P4689, DOI 10.1093/hmg/ddp432; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102266	10.1371/journal.pone.0102266	http://dx.doi.org/10.1371/journal.pone.0102266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010670	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800087
J	Shatwell, T; Kohler, J; Nicklisch, A				Shatwell, Tom; Koehler, Jan; Nicklisch, Andreas			Temperature and Photoperiod Interactions with Phosphorus-Limited Growth and Competition of Two Diatoms	PLOS ONE			English	Article							STEADY-STATE GROWTH; BLUE-GREEN-ALGA; PHYTOPLANKTON GROWTH; ENVIRONMENTAL-FACTORS; PHOSPHATE-UPTAKE; EUKARYOTIC MICROALGAE; OSCILLATORIA-REDEKEI; LIGHT-INTENSITY; KINETICS; LIMITATION	In lakes, trophic change and climate change shift the relationship between nutrients and physical factors, like temperature and photoperiod, and interactions between these factors should affect the growth of phytoplankton species differently. We therefore determined the relationship between P-limited specific growth rates and P-quota (biovolume basis) of Stephanodiscus minutulus and Nitzschia acicularis (diatoms) at or near light saturation in axenic, semi-continuous culture at 10, 15 and 20 degrees C and at 6, 9 and 12 h d(-1) photoperiod. Photoperiod treatments were performed at constant daily light exposure to allow comparison. Under these conditions, we also performed competition experiments and estimated relative P-uptake rates of the species. Temperature strongly affected P-limited growth rates and relative P uptake rates, whereas photoperiod only affected maximum growth rates. S. minutulus used internal P more efficiently than N. acicularis. N. acicularis was the superior competitor for P due to a higher relative uptake rate and its superiority increased with increasing temperature and photoperiod. S. minutulus conformed to the Droop relationship but N. acicularis did not. A model with a temperature-dependent normalised half-saturation coefficient adequately described the factor interactions of both species. The temperature dependence of the quota model reflected each species' specific adaptation to its ecological niche. The results demonstrate that increases in temperature or photoperiod can partially compensate for a decrease in P-quota under moderately limiting conditions, like during spring in temperate lakes. Thus warming may counteract de-eutrophication to some degree and a relative shift in growth factors can influence the phytoplankton species composition.	[Shatwell, Tom] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecohydrol, Berlin, Germany; [Koehler, Jan; Nicklisch, Andreas] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecosyst Res, Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Shatwell, T (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecohydrol, Berlin, Germany.	shatwell@igb-berlin.de	Shatwell, Tom/K-2937-2013; Shatwell, Tom/ABF-1308-2020; Köhler, Jan/C-2633-2014	Shatwell, Tom/0000-0002-4520-7916; Shatwell, Tom/0000-0002-4520-7916; Köhler, Jan/0000-0003-1894-2912	Nafog grant from the federal state of Berlin	Nafog grant from the federal state of Berlin	This work was funded by a Nafog grant to TS from the federal state of Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN G, 1988, HYDROBIOLOGIA, V170, P191, DOI 10.1007/BF00024905; AHLGREN G, 1987, OIKOS, V49, P177, DOI 10.2307/3566025; Andersen T., 1997, PELAGIC NUTR CYCLES; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; AZAD HS, 1970, ENVIRON SCI TECHNOL, V4, P737, DOI 10.1021/es60044a008; BROWN EJ, 1979, J PHYCOL, V15, P305, DOI 10.1111/j.1529-8817.1979.tb02643.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; BUTTON DK, 1978, DEEP-SEA RES, V25, P1163, DOI 10.1016/0146-6291(78)90011-5; CAPERON J, 1972, DEEP-SEA RES, V19, P601, DOI 10.1016/0011-7471(72)90089-7; CASTENHOLZ RW, 1964, PHYSIOL PLANTARUM, V17, P951, DOI 10.1111/j.1399-3054.1964.tb08222.x; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V10, P317; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V11, P13, DOI 10.3109/10408418409105902; Darley W.M., 1977, BOTANICAL MONOGRAPHS, P198; DEV, 2007, 38405 DEV DIN 21; Dickman EM, 2006, OECOLOGIA, V149, P676, DOI 10.1007/s00442-006-0473-5; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; Ducobu H, 1998, J PHYCOL, V34, P467, DOI 10.1046/j.1529-8817.1998.340467.x; FALKNER G, 1995, J PHYCOL, V31, P745, DOI 10.1111/j.0022-3646.1995.00745.x; Flynn KJ, 2008, J PLANKTON RES, V30, P423, DOI 10.1093/plankt/fbn007; Flynn KJ, 2008, OCEANOGR MAR BIOL, V46, P1, DOI 10.1201/9781420065756.ch1; Flynn KJ, 2002, J PHYCOL, V38, P961, DOI 10.1046/j.1529-8817.2002.t01-1-01235.x; FOY R H, 1976, British Phycological Journal, V11, P151; FOY RH, 1993, EUR J PHYCOL, V28, P203, DOI 10.1080/09670269300650311; FUHS GW, 1969, J PHYCOL, V5, P312, DOI 10.1111/j.1529-8817.1969.tb02620.x; GIBSON CE, 1983, BRIT PHYCOL J, V18, P39, DOI 10.1080/00071618300650051; GIBSON CE, 1987, BRIT PHYCOL J, V22, P187, DOI 10.1080/00071618700650231; Giersdorf K, 1988, EINFLUSS LICHT TEMPE, P117; GOLDMAN JC, 1977, LIMNOL OCEANOGR, V22, P932, DOI 10.4319/lo.1977.22.5.0932; GOLDMAN JC, 1979, MICROB ECOL, V5, P153, DOI 10.1007/BF02013523; GOTHAM IJ, 1981, J PHYCOL, V17, P257, DOI 10.1111/j.1529-8817.1981.tb00848.x; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P341, DOI 10.4319/lo.1989.34.2.0341; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; HEALEY FP, 1973, J PHYCOL, V9, P383, DOI 10.1111/j.0022-3646.1973.00383.x; HEALEY FP, 1980, MICROBIAL ECOL, V5, P281, DOI 10.1007/BF02020335; HEALEY FP, 1985, J PHYCOL, V21, P134, DOI 10.1111/j.0022-3646.1985.00134.x; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E., 2010, CLIMATE CHANGE IMPAC, P119, DOI DOI 10.1002/9781444327397.CH6; KILHAM P, 1986, LIMNOL OCEANOGR, V31, P1169, DOI 10.4319/lo.1986.31.6.1169; Kirillin G, 2010, BOREAL ENVIRON RES, V15, P279; Klausmeier CA, 2008, ECOL RES, V23, P479, DOI 10.1007/s11284-008-0470-8; Klausmeier CA, 2004, LIMNOL OCEANOGR, V49, P1463, DOI 10.4319/lo.2004.49.4_part_2.1463; KOHL JG, 1991, PROC INT ASSOC THE 4, V24, P2652; Kohler J, 2005, FRESHWATER BIOL, V50, P1639, DOI 10.1111/j.1365-2427.2005.01430.x; LEHMAN JT, 1975, LIMNOL OCEANOGR, V20, P343, DOI 10.4319/lo.1975.20.3.0343; Litchman E, 2004, LIMNOL OCEANOGR, V49, P1457, DOI 10.4319/lo.2004.49.4_part_2.1457; Litchman E, 2003, FRESHWATER BIOL, V48, P2141, DOI 10.1046/j.1365-2427.2003.01157.x; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Nicklisch A, 1998, J PLANKTON RES, V20, P105, DOI 10.1093/plankt/20.1.105; Nicklisch A, 1999, INT REV HYDROBIOL, V84, P233; Nicklisch A, 2008, J PLANKTON RES, V30, P75, DOI 10.1093/plankt/fbm099; Nicklisch A, 2009, EUR J PHYCOL, V44, P297, DOI 10.1080/09670260802578518; OLSEN Y, 1989, J PHYCOL, V25, P486, DOI 10.1111/j.1529-8817.1989.tb00254.x; PAASCHE E, 1968, PHYSIOL PLANTARUM, V21, P66, DOI 10.1111/j.1399-3054.1968.tb07231.x; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; R Core Team, 2021, R LANG ENV STAT COMP; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P649, DOI 10.4319/lo.1981.26.4.0649; Riegman R, 2000, J PHYCOL, V36, P87, DOI 10.1046/j.1529-8817.2000.99023.x; RIEGMAN R, 1985, ARCH MICROBIOL, V142, P72, DOI 10.1007/BF00409240; Rinke K, 2010, FRESHWATER BIOL, V55, P1674, DOI 10.1111/j.1365-2427.2010.02401.x; ROLOFF B, 1993, ARCH HYDROBIOL, V126, P405; Schreiber U., 1993, Progress in Botany, V54, P151; Shatwell T, 2008, GLOBAL CHANGE BIOL, V14, P2194, DOI 10.1111/j.1365-2486.2008.01630.x; Shatwell T, 2013, J PLANKTON RES, V35, P957, DOI 10.1093/plankt/fbt058; Shatwell T, 2012, LIMNOL OCEANOGR, V57, P541, DOI 10.4319/lo.2012.57.2.0541; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; SOMMER U, 1994, LIMNOL OCEANOGR, V39, P1680, DOI 10.4319/lo.1994.39.7.1680; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1995, LINKING SPECIES & ECOSYSTEMS, P240; TEMPEST DW, 1965, J GEN MICROBIOL, V41, P267, DOI 10.1099/00221287-41-2-267; Thompson P, 1999, J PHYCOL, V35, P1215, DOI 10.1046/j.1529-8817.1999.3561215.x; Tilman D., 1982, Monographs in Population Biology, pi; VANDONK E, 1990, J PHYCOL, V26, P40; WERNICKE P, 1986, INT REV GES HYDROBIO, V71, P297, DOI 10.1002/iroh.19860710302	74	13	13	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102367	10.1371/journal.pone.0102367	http://dx.doi.org/10.1371/journal.pone.0102367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010420	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800095
J	Wang, ZR; Hou, XM; Qu, B; Wang, J; Gao, XJ; Li, QZ				Wang, Zhuoran; Hou, Xiaoming; Qu, Bo; Wang, Jie; Gao, Xuejun; Li, Qingzhang			Pten Regulates Development and Lactation in the Mammary Glands of Dairy Cows	PLOS ONE			English	Article							TISSUE-SPECIFIC REGULATION; GENE-EXPRESSION; EPITHELIAL-CELLS; AKT; PROLACTIN; PATHWAY; ACTIVATION; CANCER; MILK; OVEREXPRESSION	Pten is a tumor suppressor gene regulating many cellular processes, including growth, adhesion, and apoptosis. In the aim of investigating the role of Pten during mammary gland development and lactation of dairy cows, we analyzed Pten expression levels in the mammary glands of dairy cows by using western blotting, immunohistochemistry, and quantitative polymerase chain reaction (qPCR) assays. Dairy cow mammary epithelial cells (DCMECs) were used to study the function of Pten in vitro. We determined concentrations of beta-casein, triglyceride, and lactose in the culture medium following Pten overexpression and siRNA inhibition. To determine whether Pten affected DCMEC viability and proliferation, cells were analyzed by CASY-TT and flow cytometry. Genes involved in lactation-related signaling pathways were detected. Pten expression was also assessed by adding prolactin and glucose to cell cultures. When Pten was overexpressed, proliferation of DCMECs and concentrations for beta-casein, triglyceride, and lactose were significantly decreased. Overexpression of Pten down-regulated expression of MAPK, CYCLIN D1, AKT, MTOR, S6K1, STAT5, SREBP1, PPAR gamma, PRLR, and GLUT1, but up-regulated 4EBP1 in DCMECs. The Pten siRNA inhibition experiments revealed results that opposed those from the gene overexpression experiments. Introduction of prolactin (PRL) increased secretion of beta-casein, triglyceride, and lactose, but decreased Pten expression levels. Introduction of glucose also increased beta-casein and triglyceride concentrations, but did not significantly alter Pten expression levels. The Pten mRNA and protein expression levels were decreased 0.3- and 0.4-fold in mammary glands of lactating cows producing high quality milk (milk protein >3.0%, milk fat >3.5%), compared with those cows producing low quality milk (milk protein <3.0%, milk fat <3.5%). In conclusion, Pten functions as an inhibitor during mammary gland development and lactation in dairy cows. It can down-regulate DCMECs secretion of beta-casein, triglyceride, and lactose, and plays a critical role in lactation related signaling pathways.	[Wang, Zhuoran; Hou, Xiaoming; Qu, Bo; Wang, Jie; Gao, Xuejun; Li, Qingzhang] Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Li, QZ (corresponding author), Northeast Agr Univ, Educ Minist, Key Lab Dairy Sci, Harbin, Heilongjiang, Peoples R China.	qzli@neau.edu.cn			Major State Basic Research Development Program of China (973 Program) [2011CB 100804]; National High Technology Research and Development Program of China (863 Program) [2006AA10Z1A4]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was financially supported by the Major State Basic Research Development Program of China (973 Program, No. 2011CB 100804), and the National High Technology Research and Development Program of China (863 Program, 2006AA10Z1A4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn J, 2002, J PHARMACOL EXP THER, V303, P487, DOI 10.1124/jpet.102.038315; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Bian CX, 2010, BIOCHEM BIOPH RES CO, V398, P395, DOI 10.1016/j.bbrc.2010.06.080; Blagosklonny MV, 2013, AGING-US, V5, P490, DOI 10.18632/aging.100580; Blanco AC, 2010, PLOS ONE, V5, P1; Boutinaud M, 2004, REPROD NUTR DEV, V44, P499, DOI 10.1051/rnd:2004054; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carver KC, 2009, MOL CELL ENDOCRINOL, V307, P1, DOI 10.1016/j.mce.2009.03.014; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan GK, 2013, PLOS ONE, V8, P1; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Chen CC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2640; Cui W, 2011, MOL CELL BIOCHEM, V355, P17, DOI 10.1007/s11010-011-0834-1; Dai XJ, 2007, J INVEST DERMATOL, V127, P1728, DOI 10.1038/sj.jid.5700758; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goo CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045806; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hou T, 2014, INT J CLIN EXP PATHO, V7, P280; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Jeurink PV, 2013, BENEF MICROBES, V4, P17, DOI 10.3920/BM2012.0040; Kark T, 2008, MOL PHARMACOL, V73, P1405, DOI 10.1124/mol.107.043323; Lee HJ, 2012, TRENDS ENDOCRIN MET, V23, P292, DOI 10.1016/j.tem.2012.02.006; Li HM, 2012, MOLECULES, V17, P12037, DOI 10.3390/molecules171012037; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066092; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Liu XF, 2012, IN VITRO CELL DEV-AN, V48, P554, DOI 10.1007/s11626-012-9545-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macheda ML, 2003, CELL TISSUE RES, V311, P91, DOI 10.1007/s00441-002-0661-5; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao J, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290073; Moon SH, 2013, INT J ONCOL, V42, P921, DOI 10.3892/ijo.2013.1765; Nilsson J, 2006, MOL CELL BIOL, V26, P5663, DOI 10.1128/MCB.02095-05; Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Qi XF, 2013, MOL IMMUNOL, V54, P327, DOI 10.1016/j.molimm.2013.01.001; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Santos SJ, 2009, J STEROID BIOCHEM, V115, P161, DOI 10.1016/j.jsbmb.2009.04.001; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stephane P, 2008, J CLIN INVEST, V118, P1765; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Trott JF, 2009, J ENDOCRINOL, V202, P153, DOI 10.1677/JOE-08-0486; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zhou BR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-156; Zhu GY, 2013, BIOCHEM BIOPH RES CO, V433, P526, DOI 10.1016/j.bbrc.2013.03.018	54	21	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102118	10.1371/journal.pone.0102118	http://dx.doi.org/10.1371/journal.pone.0102118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009983	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800069
J	Yan, H; Fan, SX; Guo, CX; Hu, J; Dong, L				Yan, Hai; Fan, Shuxin; Guo, Chenxiao; Hu, Jie; Dong, Li			Quantifying the Impact of Land Cover Composition on Intra-Urban Air Temperature Variations at a Mid-Latitude City	PLOS ONE			English	Article							URBAN HEAT-ISLAND; TROPICAL CITY; GREEN AREAS; VEGETATION; CLIMATE; PARKS; COMFORT; STREET; CITIES; CANYON	The effects of land cover on urban-rural and intra-urban temperature differences have been extensively documented. However, few studies have quantitatively related air temperature to land cover composition at a local scale which may be useful to guide landscape planning and design. In this study, the quantitative relationships between air temperature and land cover composition at a neighborhood scale in Beijing were investigated through a field measurement campaign and statistical analysis. The results showed that the air temperature had a significant positive correlation with the coverage of man-made surfaces, but the degree of correlation varied among different times and seasons. The different land cover types had different effects on air temperature, and also had very different spatial extent dependence: with increasing buffer zone size (from 20 to 300 m in radius), the correlation coefficient of different land cover types varied differently, and their relative impacts also varied among different times and seasons. At noon in summer, similar to 37% of the variations in temperature were explained by the percentage tree cover, while similar to 87% of the variations in temperature were explained by the percentage of building area and the percentage tree cover on summer night. The results emphasize the key role of tree cover in attenuating urban air temperature during daytime and nighttime in summer, further highlighting that increasing vegetation cover could be one effective way to ameliorate the urban thermal environment.	[Yan, Hai; Fan, Shuxin; Guo, Chenxiao; Dong, Li] Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China; [Yan, Hai] Zhejiang Agr & Forestry Univ, Sch Landscape Architecture, Linan, Zhejiang, Peoples R China; [Hu, Jie] Tsinghua Univ, Sch Architecture, Beijing 100084, Peoples R China; [Hu, Jie] Beijing Tsinghua Urban Planning & Design Inst, Res Ctr Landscape Architecture, Beijing, Peoples R China	Beijing Forestry University; Zhejiang A&F University; Tsinghua University	Dong, L (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing, Peoples R China.	dongli@bjfu.edu.cn						Ali-Toudert F, 2006, BUILD ENVIRON, V41, P94, DOI 10.1016/j.buildenv.2005.01.013; BARRADAS VL, 1991, INT J BIOMETEOROL, V35, P24, DOI 10.1007/BF01040959; Buyantuyev A, 2010, LANDSCAPE ECOL, V25, P17, DOI 10.1007/s10980-009-9402-4; Cao X, 2010, LANDSCAPE URBAN PLAN, V96, P224, DOI 10.1016/j.landurbplan.2010.03.008; Chang CR, 2007, LANDSCAPE URBAN PLAN, V80, P386, DOI 10.1016/j.landurbplan.2006.09.005; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Giridharan R, 2008, BUILD ENVIRON, V43, P1583, DOI 10.1016/j.buildenv.2007.10.003; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hamada S, 2010, URBAN FOR URBAN GREE, V9, P15, DOI 10.1016/j.ufug.2009.10.002; HENRY JA, 1987, LANDSCAPE URBAN PLAN, V14, P21, DOI 10.1016/0169-2046(87)90003-X; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Jansson C, 2007, THEOR APPL CLIMATOL, V89, P185, DOI 10.1007/s00704-006-0259-z; JAUREGUI E, 1991, ENERG BUILDINGS, V15, P457; Jonsson P, 2004, INT J CLIMATOL, V24, P1307, DOI 10.1002/joc.1064; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Kruger E, 2007, BUILD ENVIRON, V42, P1685, DOI 10.1016/j.buildenv.2006.02.019; Li XM, 2012, LANDSCAPE ECOL, V27, P887, DOI 10.1007/s10980-012-9731-6; Mackey CW, 2012, BUILD ENVIRON, V49, P348, DOI 10.1016/j.buildenv.2011.08.004; Ng E, 2012, BUILD ENVIRON, V47, P256, DOI 10.1016/j.buildenv.2011.07.014; NUNEZ M, 1977, J APPL METEOROL, V16, P11, DOI 10.1175/1520-0450(1977)016<0011:TEBOAU>2.0.CO;2; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; OKE TR, 1989, PHILOS T ROY SOC B, V324, P335, DOI 10.1098/rstb.1989.0051; Oliveira S, 2011, BUILD ENVIRON, V46, P2186, DOI 10.1016/j.buildenv.2011.04.034; Peng SS, 2012, ENVIRON SCI TECHNOL, V46, P696, DOI 10.1021/es2030438; Rizwan AM, 2008, J ENVIRON SCI, V20, P120, DOI 10.1016/S1001-0742(08)60019-4; Saaroni H, 2000, LANDSCAPE URBAN PLAN, V48, P1, DOI 10.1016/S0169-2046(99)00075-4; Shashua-Bar L, 2000, ENERG BUILDINGS, V31, P221, DOI 10.1016/S0378-7788(99)00018-3; Spronken-Smith RA, 1998, INT J REMOTE SENS, V19, P2085, DOI 10.1080/014311698214884; Stewart ID, 2011, INT J CLIMATOL, V31, P200, DOI 10.1002/joc.2141; Sun CY, 2011, THEOR APPL CLIMATOL, V106, P433, DOI 10.1007/s00704-011-0444-6; Sun CY, 2009, THEOR APPL CLIMATOL, V98, P323, DOI 10.1007/s00704-009-0120-2; Sun RH, 2012, LANDSCAPE URBAN PLAN, V105, P27, DOI 10.1016/j.landurbplan.2011.11.018; UN, 2011, WORLD POPULATION PRO; Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Wong NH, 2007, BUILD ENVIRON, V42, P2949, DOI 10.1016/j.buildenv.2006.06.004; Wong NH, 2005, HABITAT INT, V29, P547, DOI 10.1016/j.habitatint.2004.04.008; Wong NH, 2009, J URBAN PLAN D-ASCE, V136, P261; Yokobori T, 2009, CLIM RES, V39, P61, DOI 10.3354/cr00800; Yokohari M, 2001, LANDSCAPE URBAN PLAN, V53, P17, DOI 10.1016/S0169-2046(00)00123-7; Yu C, 2006, ENERG BUILDINGS, V38, P105, DOI 10.1016/j.enbuild.2005.04.003; Yu M, 2013, CLIMATIC CHANGE, V120, P123, DOI 10.1007/s10584-013-0788-2; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	43	31	31	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102124	10.1371/journal.pone.0102124	http://dx.doi.org/10.1371/journal.pone.0102124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010134	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800071
J	Batres, C; Perrett, DI				Batres, Carlota; Perrett, David I.			The Influence of the Digital Divide on Face Preferences in El Salvador: People without Internet Access Prefer More Feminine Men, More Masculine Women, and Women with Higher Adiposity	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; MATE PREFERENCES; PREDICTS; CUES	Previous studies on face preferences have found that online and laboratory experiments yield similar results with samples from developed countries, where the majority of the population has internet access. No study has yet explored whether the same holds true in developing countries, where the majority of the population does not have internet access. This gap in the literature has become increasingly important given that several online studies are now using cross-country comparisons. We therefore sought to determine if an online sample is representative of the population in the developing country of El Salvador. In studies of Hispanic men and women aged 18-25, we tested facial masculinity and adiposity preferences by collecting data in person as well as online. Our results showed that there were no differences in preferences between people who reported having internet access, whether they were tested online or in person. This provides evidence that testing style does not bias preferences among the same population. On the other hand, our results showed multiple differences in preferences between people who reported having internet access and people who reported not having internet access. More specifically, we found that people without internet access preferred more feminine men, more masculine women, and women with higher adiposity than people with internet access. We also found that people without internet access had fewer resources (e.g. running water) than people with internet access, suggesting that harshness in the environment may be influencing face preferences. These findings suggest that online studies may provide a distorted perspective of the populations in developing countries.	[Batres, Carlota; Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of St Andrews	Batres, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	jcb23@st-andrews.ac.uk	Perrett, David/AAA-6264-2020; Batres, Carlota/J-2294-2015	Perrett, David/0000-0002-6025-0939; Batres, Carlota/0000-0002-3833-7667	Russell Trust	Russell Trust	CB received funding from the Russell Trust to support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DEF REC EL SALV SEG; [Anonymous], 2013, PERC IND US INT; Becker A, 2004, CULT MED PSYCHIAT, V28, P533, DOI 10.1007/s11013-004-1067-5; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Censo de Poblacion y Vivienda, 2008, CENS POBL VIV; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; de Barra M, 2013, EVOL HUM BEHAV, V34, P384, DOI 10.1016/j.evolhumbehav.2013.07.001; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; DiMaggio P, 2001, ANNU REV SOCIOL, V27, P307, DOI 10.1146/annurev.soc.27.1.307; Furnham A, 2002, PERS INDIV DIFFER, V32, P729, DOI 10.1016/S0191-8869(01)00073-3; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Hargittai Eszter, 2002, 1 MONDAY; Harris J., 2002, International Review for the Sociology of Sport, V37, P397, DOI 10.1177/1012690202037004024; Hoerger M, 2011, PSYCHOL ASSESSMENT, V23, P725, DOI 10.1037/a0023286; Jones BC, 2007, EVOL HUM BEHAV, V28, P439, DOI 10.1016/j.evolhumbehav.2007.07.006; Lee AJ, 2011, BIOL LETTERS, V7, P892, DOI 10.1098/rsbl.2011.0454; Little AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P967, DOI 10.1007/s00265-006-0325-7; Moore FR, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0050; Mueller U, 1996, SOC FORCES, V74, P823, DOI 10.2307/2580383; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2495; Re DE, 2013, EVOL PSYCHOL-US, V11, P89, DOI 10.1177/147470491301100109; Re DE, 2013, Q J EXPT PSYCHOL; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Schramm, 1964, MASS MEDIA NATL DEV; Swami V., 2007, J EVOLUTIONARY PSYCH, V5, P149, DOI [10.1556/JEP.2007.1005, DOI 10.1556/JEP.2007.1005]; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Voracek M, 2006, ARCH SEX BEHAV, V35, P297, DOI 10.1007/s10508-006-9021-y	36	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100966	10.1371/journal.pone.0100966	http://dx.doi.org/10.1371/journal.pone.0100966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006801	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600026
J	Bishop, FL; Aizlewood, L; Adams, AEM				Bishop, Felicity L.; Aizlewood, Lizzi; Adams, Alison E. M.			When and Why Placebo-Prescribing Is Acceptable and Unacceptable: A Focus Group Study of Patients' Views	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE; QUALITATIVE RESEARCH; INTERVENTIONS; ETHICS; OSTEOARTHRITIS; PARTICIPANTS; PHYSICIANS; ATTITUDES; COMMUNICATION	Background: Surveys of doctors suggest that they use placebos and placebo effects clinically to help patients. However, patients' views are not well-understood. We aimed to identify when and why placebo-prescribing in primary care might be acceptable and unacceptable to patients. Methods: A purposive diverse sample of 58 English-speaking adults (18 men; aged 19-80 years) participated in 11 focus groups. Vignettes describing doctors prescribing placebos in primary care were used to initiate discussions. Data were analyzed inductively. Results: Participants discussed diverse harms and benefits of placebo-prescribing for individual patients, carers, healthcare providers, and society. Two perspectives on placebo-prescribing were identified. First, the "consequentialist'' perspective focused on the potential for beneficial outcomes of placebo-prescribing. Here, some participants thought placebos are beneficial and should be used clinically; they often invoked the power of the mind or mind-body interactions. Others saw placebos as ineffective and therefore a waste of time and money. Second, the "respecting autonomy'' perspective emphasized the harms caused by the deceptive processes thought necessary for placebo-prescribing. Here, participants judged placebo-prescribing unacceptable because placebo-prescribers deceive patients, thus a doctor who prescribes placebos cannot be trusted and patients' autonomy is compromised. They also saw placebo-responders as gullible, which deterred them from trying placebos themselves. Overall, the word "placebo'' was often thought to imply "ineffective''; some participants suggested alternative carefully chosen language that could enable doctors to prescribe placebos without directly lying to patients. Conclusions: Negative views of placebos derive from beliefs that placebos do not work and/or that they require deception by the doctor. Positive views are pragmatic in that if placebos work then any associated processes (e.g. mechanisms, deception) are deemed unimportant. Public education about placebos and their effects is warranted and research to identify optimal ways of harnessing placebo effects in clinical practice is needed.	[Bishop, Felicity L.; Aizlewood, Lizzi] Univ Southampton, Ctr Applicat Hlth Psychol, Southampton, Hants, England; [Adams, Alison E. M.] No Arizona Univ, Dept Biol, Flagstaff, AZ 86011 USA	University of Southampton; Northern Arizona University	Bishop, FL (corresponding author), Univ Southampton, Ctr Applicat Hlth Psychol, Southampton, Hants, England.	F.L.Bishop@southampton.ac.uk		Bishop, Felicity/0000-0002-8737-6662	Primary Care and Population Sciences, University of Southampton	Primary Care and Population Sciences, University of Southampton	This study was supported by an internal grant from Primary Care and Population Sciences, University of Southampton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2013, BIOETHICS, V27, P186, DOI 10.1111/j.1467-8519.2011.01943.x; Barrett B, 2011, ANN FAM MED, V9, P312, DOI 10.1370/afm.1250; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Berthelot JM, 2001, JOINT BONE SPINE, V68, P65, DOI 10.1016/S1297-319X(00)00225-6; Bishop FL, 2012, QUAL HEALTH RES, V22, P1138, DOI 10.1177/1049732312448544; Bishop FL, 2012, SOC SCI MED, V74, P767, DOI 10.1016/j.socscimed.2011.11.020; BOK S, 1974, SCI AM, V231, P17, DOI 10.1038/scientificamerican1174-17; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Brody H, 2000, J FAM PRACTICE, V49, P649; BRODY H, 1982, ANN INTERN MED, V97, P112, DOI 10.7326/0003-4819-97-1-112; Chassany O, 2006, J RHEUMATOL, V33, P1827; Chen GF, 2009, NEW ZEAL MED J, V122, P35; COMAROFF J, 1976, SOCIOL REV, V24, P79, DOI 10.1111/j.1467-954X.1976.tb00574.x; Fassler M, 2011, BRIT J GEN PRACT, V61, P101, DOI 10.3399/bjgp11X556209; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hull SC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3757; Jonas WB, 2011, PHILOS T R SOC B, V366, P1896, DOI 10.1098/rstb.2010.0405; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Kisaalita NR, 2012, J PAIN, V13, P891, DOI 10.1016/j.jpain.2012.06.003; Kisaalita NR, 2011, J PAIN, V12, P920, DOI 10.1016/j.jpain.2011.02.353; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lichtenberg P, 2004, J MED ETHICS, V30, P551, DOI 10.1136/jme.2002.002832; Linde K, 2013, COMPLEMENT THER MED, V21, P109, DOI 10.1016/j.ctim.2012.11.010; Linde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092938; Linde K, 2011, PHILOS T R SOC B, V366, P1905, DOI 10.1098/rstb.2010.0383; LYNOE N, 1993, SOC SCI MED, V36, P767, DOI 10.1016/0277-9536(93)90037-5; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Patton M. Q., 2001, QUALITATIVE RES EVAL; Suarez-Almazor ME, 2010, ARTHRIT CARE RES, V62, P1229, DOI 10.1002/acr.20225; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Tilburt JC, 2008, BMJ-BRIT MED J, V337, P1097, DOI DOI 10.1136/BMJ.A1938; Vase L, 2011, PHILOS T R SOC B, V366, P1913, DOI 10.1098/rstb.2010.0402; Verheul W, 2010, PATIENT EDUC COUNS, V80, P300, DOI 10.1016/j.pec.2010.06.017; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; Yardley L., 1999, PSYCHOL HEALTH, V15, P1; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015	48	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101822	10.1371/journal.pone.0101822	http://dx.doi.org/10.1371/journal.pone.0101822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006673	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000339040600069
J	Dolny, A; Harabis, F; Mizicova, H				Dolny, Ales; Harabis, Filip; Mizicova, Hana			Home Range, Movement, and Distribution Patterns of the Threatened Dragonfly Sympetrum depressiusculum (Odonata: Libellulidae): A Thousand Times Greater Territory to Protect?	PLOS ONE			English	Article							FRESH-WATER; LANDSCAPE STRUCTURE; SPECIES-DIVERSITY; MALE HARASSMENT; MARKED ANIMALS; RAIN-FOREST; HABITAT USE; DISPERSAL; MANAGEMENT; SURVIVAL	Dragonflies are good indicators of environmental health and biodiversity. Most studies addressing dragonfly ecology have focused on the importance of aquatic habitats, while the value of surrounding terrestrial habitats has often been overlooked. However, species associated with temporary aquatic habitats must persist in terrestrial environments for long periods. Little is known about the importance of terrestrial habitat patches for dragonflies, or about other factors that initiate or influence dispersal behaviour. The aim of this study was to reveal the relationship between population dynamics of the threatened dragonfly species Sympetrum depressiusculum at its natal site and its dispersal behaviour or routine movements within its terrestrial home range. We used a mark-release-recapture method (marking 2,881 adults) and exuviae collection with the Jolly-Seber model and generalized linear models to analyse seasonal and spatial patterns of routine movement in a heterogeneous Central European landscape. Our results show that utilisation of terrestrial habitat patches by adult dragonflies is not random and may be relatively long term (approximately 3 mo). Adult dragonflies were present only in areas with dense vegetation that provided sufficient resources; the insects were absent from active agricultural patches (p = 0.019). These findings demonstrate that even a species tightly linked to its natal site utilises an area that is several orders of magnitude larger than the natal site. Therefore, negative trends in the occurrence of various dragonfly species may be associated not only with disturbances to their aquatic habitats, but also with changes in the surrounding terrestrial landscape.	[Dolny, Ales; Mizicova, Hana] Univ Ostrava, Fac Sci, Inst Environm Technol, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic; [Harabis, Filip] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	University of Ostrava; Czech University of Life Sciences Prague	Dolny, A (corresponding author), Univ Ostrava, Fac Sci, Inst Environm Technol, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic.	ales.dolny@osu.cz	Dolny, Ales/ABA-5480-2020; Harabiš, Filip/AAD-1887-2019; Sigutova, Hana/AGX-5626-2022	Dolny, Ales/0000-0002-6245-8442; Harabis, Filip/0000-0002-2936-8218; Sigutova, Hana/0000-0003-1134-248X	Research and Development for Innovations Operational Programme - Structural Funds of the European Union; state budget of the Czech Republic; National Feasibility Programme I [LO1208]; Internal Grant Agency of Czech University of Life Sciences Prague [42110/1312/3118]	Research and Development for Innovations Operational Programme - Structural Funds of the European Union; state budget of the Czech Republic; National Feasibility Programme I; Internal Grant Agency of Czech University of Life Sciences Prague	The work was funded by the Research and Development for Innovations Operational Programme financed by the Structural Funds of the European Union, the state budget of the Czech Republic, and by project LO1208 of the National Feasibility Programme I. This study was supported by Grant GA FZP No. 42110/1312/3118 from the Internal Grant Agency of Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2009, ANIMAL BEHAV; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Anholt BR, 2001, CAN J ZOOL, V79, P895, DOI 10.1139/cjz-79-5-895; Benard MF, 2008, AM NAT, V171, P553, DOI 10.1086/587072; Benton TG, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P41; Bernath B, 2002, FRESHWATER BIOL, V47, P1707, DOI 10.1046/j.1365-2427.2002.00931.x; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Bretz F., 2010, MULTIPLE COMP USING; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chaput-Bardy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010694; Clark TE, 1996, J APPL ECOL, V33, P1001, DOI 10.2307/2404681; Cooch E., 2012, PROGRAM MARK ANAL DA; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Crawley MJ., 2007, R BOOK; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Dijkstra K.-D.-B., 2006, FIELD GUIDE DRAGONFL; Dolny A, 2013, J INSECT CONSERV, V17, P821, DOI 10.1007/s10841-013-9564-x; Dolny A, 2012, TROP ZOOL, V25, P141, DOI 10.1080/03946975.2012.717480; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Flick T, 2012, AGR ECOSYST ENVIRON, V156, P123, DOI 10.1016/j.agee.2012.05.006; Foote AL, 2005, ECOL ENTOMOL, V30, P273, DOI 10.1111/j.0307-6946.2005.00701.x; Fric Z, 2007, BASIC APPL ECOL, V8, P377, DOI 10.1016/j.baae.2006.06.005; GERKEN B., 1999, EXUVIEN EUROPAISCHER; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Hamasaki K, 2009, ECOL RES, V24, P597, DOI 10.1007/s11284-008-0531-z; Harabis F, 2011, ODONATOLOGICA, V40, P17; Harabis F, 2013, ECOL ENG, V55, P51, DOI 10.1016/j.ecoleng.2013.02.007; Hassall C, 2011, BIODIVERS CONSERV, V20, P3189, DOI 10.1007/s10531-011-0142-9; Jonsen ID, 2000, OIKOS, V88, P553, DOI 10.1034/j.1600-0706.2000.880312.x; Kalkman VJ, 2008, HYDROBIOLOGIA, V595, P351, DOI 10.1007/s10750-007-9029-x; Kalkman VJ, 2010, IUCN PUBLICATIONS OF, V38; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Koch Kamilla, 2006, International Journal of Odonatology, V9, P71; KOENIG WD, 1990, J ANIM ECOL, V59, P317, DOI 10.2307/5175; Konvicka M, 2008, J INSECT CONSERV, V12, P549, DOI 10.1007/s10841-007-9087-4; Kutcher TE, 2014, ECOL INDIC, V38, P31, DOI 10.1016/j.ecolind.2013.10.028; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; McCauley SJ, 2010, ECOL ENTOMOL, V35, P377, DOI 10.1111/j.1365-2311.2010.01191.x; MICHIELS NK, 1991, ECOL ENTOMOL, V16, P449, DOI 10.1111/j.1365-2311.1991.tb00238.x; New TR, 2005, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9780511542114; Oertli Beat, 2008, P79; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Oppel Steffen, 2006, International Journal of Odonatology, V9, P89; Purse BV, 2003, J APPL ECOL, V40, P716, DOI 10.1046/j.1365-2664.2003.00829.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raebel EM, 2010, J INSECT CONSERV, V14, P523, DOI 10.1007/s10841-010-9281-7; Remsburg AJ, 2009, J N AM BENTHOL SOC, V28, P44, DOI 10.1899/08-004.1; Sahlen Goran, 2004, International Journal of Odonatology, V7, P385; Samways MJ, 1996, BIOL CONSERV, V78, P279, DOI 10.1016/S0006-3207(96)00032-8; Sang A, 2011, INSECT CONSERV DIVER, V4, P257, DOI 10.1111/j.1752-4598.2011.00134.x; Seifert LI, 2012, FRESHWATER BIOL, V57, P1449, DOI 10.1111/j.1365-2427.2012.02807.x; Sirot LK, 2001, ANIM BEHAV, V61, P415, DOI 10.1006/anbe.2000.1605; STERNBERG K., 2000, LIBELLEN BADEN WURTT, V2; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Suhonen J, 2010, CONSERV BIOL, V24, P1148, DOI 10.1111/j.1523-1739.2010.01504.x; TAYLOR PD, 1995, OIKOS, V73, P43, DOI 10.2307/3545723; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wildermuth H., 1994, Advances in Odonatology, V6, P223	61	43	47	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100408	10.1371/journal.pone.0100408	http://dx.doi.org/10.1371/journal.pone.0100408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006671	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600012
J	Songstad, NT; Serrano, MC; Sitras, V; Johansen, D; Ytrehus, K; Acharya, G				Songstad, Nils Thomas; Serrano, Maria C.; Sitras, Vasilis; Johansen, Davis; Ytrehus, Kirsti; Acharya, Ganesh			Coronary Flow Reserve in Pregnant Rats with Increased Left Ventricular Afterload	PLOS ONE			English	Article							COLOR DOPPLER-ECHOCARDIOGRAPHY; BLOOD-FLOW; VELOCITY RESERVE; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; NONINVASIVE ASSESSMENT; MEDIATED DILATATION; VASOMOTOR FUNCTION; ARTERY; ULTRASOUND	Background: Coronary flow reserve (CFR) is used as a measure of coronary endothelial function. We investigated the effect of increased afterload on CFR of pregnant and non-pregnant rats. Methods: Afterload increase in Wister rats (both pregnant and non-pregnant) was achieved by the infusion of angiotensin II (Ang II) for similar to 10 days or by subjecting them to transverse aortic constriction (TAC) for similar to 14 days. Control groups were infused with 0.9% NaCl or had sham surgery, respectively. In pregnant rats, the experiments were performed close to term gestation. Doppler velocity waveforms of the left main coronary artery were recorded using a high resolution ultrasound imaging system (Vevo 770, VisualSonics, Canada) at baseline while the animals were anesthetized with 1.5% inhaled isoflurane, and during maximal coronary dilatation obtained by the inhalation of 3.5% of isoflurane. CFR was calculated as the ratio between the peak coronary flow velocities (CFRpeak) and the velocity-time integrals (CFRVTI) recorded at hyperemia and at baseline. Results: CFR could be calculated in 60 of 75 (80%) animals. There were no differences in CFR between intervention and control groups irrespective of whether afterload was increased by Ang II or TAC. In the TAC-study CFRpeak (1.54 +/- 0.07 vs 1.85 +/- 0.17; p = 0.03) was decreased in pregnant compared to non-pregnant shams. When sham animals from both studies were pooled together both CFRpeak (1.42 +/- 0.07 vs 1.86 +/- 0.16; p = 0.005) as well as CFRVTI (1.45 +/- 0.07 vs 1.78 +/- 0.12; p = 0.03) were significantly lower in pregnant rats compared to non-pregnant. Conclusions: CFR can be measured non-invasively in rats using Doppler echocardiography and high concentrations of inhaled isoflurane as a coronary vasodilator. In pregnant rats, CFR is reduced close to term. CFR is not affected by increased left ventricular afterload caused by chronic Ang II infusion or TAC.	[Songstad, Nils Thomas; Sitras, Vasilis; Acharya, Ganesh] UiT Arctic Univ Norway, Fac Hlth Sci, Inst Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway; [Songstad, Nils Thomas] Univ Hosp Northern Norway, Dept Pediat, Tromso, Norway; [Serrano, Maria C.] Univ Miami, Jackson Mem Hosp, Dept Pediat, Div Pediat Cardiol, Miami, FL 33136 USA; [Sitras, Vasilis; Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynecol, Tromso, Norway; [Johansen, Davis; Ytrehus, Kirsti] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Miami; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Songstad, NT (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Inst Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway.	Nils.songstad@unn.no	Sitras, Vasilis/R-1287-2018	Sitras, Vasilis/0000-0003-3264-3302	Northern Norway Regional Health Authority [1411, 1668, 2038]	Northern Norway Regional Health Authority	This work was supported by research grants from the Northern Norway Regional Health Authority, grant numbers 1411, 1668 and 2038 (http://www.helse-nord.no/about-helse-nord/category5770.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2009, NORSK EPIDEMIOLOGI, V19; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Aljabri MB, 2011, ACTA PHYSIOL, V201, P445, DOI 10.1111/j.1748-1716.2010.02234.x; Baumgart D, 1998, AM HEART J, V136, P136, DOI 10.1016/S0002-8703(98)70194-2; Blanco PG, 2011, VET J, V190, P154, DOI 10.1016/j.tvjl.2010.08.013; Bottcher M, 2001, CIRCULATION, V103, P1109; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Dorup I, 1999, AM J PHYSIOL-HEART C, V276, pH821; Gan LM, 2013, J CARDIOVASC TRANSL, V6, P715, DOI 10.1007/s12265-013-9497-5; Hagg U, 2005, CLIN SCI, V109, P325, DOI 10.1042/CS20050052; Hartley CJ, 2008, ULTRASOUND MED BIOL, V34, P892, DOI 10.1016/j.ultrasmedbio.2007.11.019; Hartley CJ, 2007, ULTRASOUND MED BIOL, V33, P512, DOI 10.1016/j.ultrasmedbio.2006.11.002; Hirata K, 2004, CLIN SCI, V107, P449, DOI 10.1042/CS20040226; Hirata K, 2001, J AM COLL CARDIOL, V38, P1879, DOI 10.1016/S0735-1097(01)01658-8; Hirata K, 2007, ARTHRITIS RHEUM-US, V56, P1904, DOI 10.1002/art.22702; HITTINGER L, 1989, CIRC RES, V65, P971, DOI 10.1161/01.RES.65.4.971; HOFFMAN JIE, 1984, CIRCULATION, V70, P153, DOI 10.1161/01.CIR.70.2.153; HOFFMAN JIE, 1990, PHYSIOL REV, V70, P331, DOI 10.1152/physrev.1990.70.2.331; Hozumi T, 1998, CIRCULATION, V97, P1557, DOI 10.1161/01.CIR.97.16.1557; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Khan F, 2008, CLIN SCI, V115, P295, DOI 10.1042/CS20070431; Kinzler WL, 2004, OBSTET GYNECOL, V104, P362, DOI 10.1097/01.AOG.0000134787.24959.9b; LANG RM, 1991, AM HEART J, V121, P1768, DOI 10.1016/0002-8703(91)90024-C; Lethen H, 2003, AM J CARDIOL, V91, P412, DOI 10.1016/S0002-9149(02)03235-6; MARCUS ML, 1982, NEW ENGL J MED, V307, P1362, DOI 10.1056/NEJM198211253072202; Pieper PG, 2013, CIRCULATION, V128, P2478, DOI 10.1161/CIRCULATIONAHA.113.002810; Quinton AE, 2007, HYPERTENS PREGNANCY, V26, P273, DOI 10.1080/10641950701366841; Roos-Hesselink JW, 2013, EUR HEART J, V34, P657, DOI 10.1093/eurheartj/ehs270; Saarelainen H, 2006, CIRC J, V70, P768, DOI 10.1253/circj.70.768; Savvidou MD, 2000, ULTRASOUND OBST GYN, V15, P502, DOI 10.1046/j.1469-0705.2000.00131.x; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Seeliger C, 2012, Ultraschall Med, V33, pE126, DOI 10.1055/s-0031-1273488; Sierra-Laguado J, 2006, INT J GYNECOL OBSTET, V93, P60, DOI 10.1016/j.ijgo.2006.01.015; Songstad NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089559; Valensise H, 2000, ULTRASOUND OBST GYN, V15, P487, DOI 10.1046/j.1469-0705.2000.00135.x; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102147	10.1371/journal.pone.0102147	http://dx.doi.org/10.1371/journal.pone.0102147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007056	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600101
J	Schaedler, TA; Thornton, JD; Kruse, I; Schwarzlander, M; Meyer, AJ; van Veen, HW; Balk, J				Schaedler, Theresia A.; Thornton, Jeremy D.; Kruse, Inga; Schwarzlaender, Markus; Meyer, Andreas J.; van Veen, Hendrik W.; Balk, Janneke			A Conserved Mitochondrial ATP-binding Cassette Transporter Exports Glutathione Polysulfide for Cytosolic Metal Cofactor Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Arabidopsis; Iron-Sulfur Protein; Mitochondria; Yeast; Glutathione; Transportomics	IRON-SULFUR PROTEINS; HIGH-THROUGHPUT CLONING; ABC TRANSPORTER; LACTOCOCCUS-LACTIS; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; ETHYLMALONIC ENCEPHALOPATHY; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; P-GLYCOPROTEIN	Background: ABC transporters of mitochondria (ATM) are required for formation of cytosolic iron-sulfur clusters and molybdenum cofactor. Results:Arabidopsis ATM3 and yeast Atm1 transport radiolabeled glutathione disulfide (GSSG). Transport of glutathione trisulfide (GS-S-SG) was demonstrated by mass spectrometry. Conclusion: A mitochondrial transporter exports glutathione polysulfide. Significance: Identification of substrate(s) of ATMs defines their role in metal cofactor assembly and iron homeostasis. An ATP-binding cassette transporter located in the inner mitochondrial membrane is involved in iron-sulfur cluster and molybdenum cofactor assembly in the cytosol, but the transported substrate is unknown. ATM3 (ABCB25) from Arabidopsis thaliana and its functional orthologue Atm1 from Saccharomyces cerevisiae were expressed in Lactococcus lactis and studied in inside-out membrane vesicles and in purified form. Both proteins selectively transported glutathione disulfide (GSSG) but not reduced glutathione in agreement with a 3-fold stimulation of ATPase activity by GSSG. By contrast, Fe2+ alone or in combination with glutathione did not stimulate ATPase activity. Arabidopsis atm3 mutants were hypersensitive to an inhibitor of glutathione biosynthesis and accumulated GSSG in the mitochondria. The growth phenotype of atm3-1 was strongly enhanced by depletion of the mitochondrion-localized, GSH-dependent persulfide oxygenase ETHE1, suggesting that the physiological substrate of ATM3 contains persulfide in addition to glutathione. Consistent with this idea, a transportomics approach using mass spectrometry showed that glutathione trisulfide (GS-S-SG) was transported by Atm1. We propose that mitochondria export glutathione polysulfide, containing glutathione and persulfide, for iron-sulfur cluster assembly in the cytosol.	[Schaedler, Theresia A.; Thornton, Jeremy D.; Kruse, Inga; Balk, Janneke] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Schaedler, Theresia A.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Schwarzlaender, Markus; Meyer, Andreas J.] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53113 Bonn, Germany; [van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Kruse, Inga; Balk, Janneke] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Cambridge; University of Bonn; University of Cambridge; University of East Anglia	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Res Pk,44-1603-450621, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk; janneke.balk@jic.ac.uk	Meyer, Andreas J/C-4734-2013; Schwarzländer, Markus/HGE-3726-2022; van Veen, Hendrik W./A-4162-2008	Meyer, Andreas J/0000-0001-8144-4364; van Veen, Hendrik W./0000-0002-9658-8077; Schwarzlander, Markus/0000-0003-0796-8308; Kruse, Inga/0000-0003-1935-1647; Schaedler, Theresia/0000-0002-7247-4091	Biotechnology and Biological Sciences Research Council [BB/H00288X/1]; Biotechnology and Biological Sciences Research Council; University of East Anglia; Deutsche Forschungsgemeinschaft [SCHW 1719/1-1, ME 1567/5-1, Inst 217/651-1 FUGG]; Royal Society University Research Fellowship; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0657, BB/K008838/1] Funding Source: researchfish; BBSRC [BB/H00288X/1, BB/K008838/1, BBS/E/J/000C0657] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of East Anglia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Royal Society University Research Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council Grant BB/H00288X/1.; Supported by a Biotechnology and Biological Sciences Research Council Institute Strategic Programme grant ( to the John Innes Centre).; Supported by a Dean's studentship from the University of East Anglia.; Supported by Deutsche Forschungsgemeinschaft through the Emmy Noether Programme Grant SCHW 1719/1-1.; Supported by Deutsche Forschungsgemeinschaft Grants ME 1567/5-1 and Inst 217/651-1 FUGG.; Supported by a Royal Society University Research Fellowship and by a start-up grant from the University of East Anglia. To whom correspondence may be addressed: John Innes Centre, Norwich Research Park, Norwich NR4 7UH, United Kingdom. Tel.: 44-1603-450621; E-mail: janneke.balk@jic.ac.uk.	Albrecht SC, 2014, J BIOMOL SCREEN, V19, P379, DOI 10.1177/1087057113499634; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bernard DG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0259; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Birke H, 2012, BIOCHEM J, V445, P275, DOI 10.1042/BJ20120038; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Csere P, 1998, FEBS LETT, V441, P266, DOI 10.1016/S0014-5793(98)01560-9; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krussel L, 2014, PLANT PHYSIOL, V165, P92, DOI 10.1104/pp.114.239764; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mao QC, 1999, BBA-BIOMEMBRANES, V1461, P69, DOI 10.1016/S0005-2736(99)00150-9; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; WOOD JL, 1987, METHOD ENZYMOL, V143, P25	57	106	107	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23264	23274		10.1074/jbc.M114.553438	http://dx.doi.org/10.1074/jbc.M114.553438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006243	Green Published, hybrid			2022-12-25	WOS:000341505000001
J	Al-Daghri, NM; Guerini, FR; Al-Attas, OS; Alokail, MS; Alkharfy, KM; Draz, HM; Agliardi, C; Costa, AS; Saulle, I; Mohammed, AK; Biasin, M; Clerici, M				Al-Daghri, Nasser M.; Guerini, Franca R.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Draz, Hossam M.; Agliardi, Cristina; Costa, Andrea S.; Saulle, Irma; Mohammed, Abdul Khader; Biasin, Mara; Clerici, Mario			Vitamin D Receptor Gene Polymorphisms Are Associated with Obesity and Inflammosome Activity	PLOS ONE			English	Article							TYPE-2 DIABETIC SUBJECTS; CARDIOVASCULAR-DISEASE; CIRCULATING ENDOTOXIN; INSULIN-RESISTANCE; IMMUNE ACTIVATION; LIVER-DISEASE; GLUCOSE; INFLAMMATION; LIPOPOLYSACCHARIDE; ADIPOCYTES	To explore the mechanisms underlying the suggested role of the vitamin D/vitamin D receptor (VDR) complex in the pathogenesis of obesity we performed genetic and immunologic analyses in obese and non-obese Saudi individuals without other concomitant chronic diseases. Genomic DNA was genotyped for gene single nucleotide polymorphisms (SNPs) of VDR by allelic discrimination in 402 obese (body mass index -BMI >= 30 kg/m2) and 489 non-obese (BMI<30 kg/m2) Saudis. Q-PCR analyses were performed using an ABI Prism 7000 Sequence Detection System. The inflammosome pathway was analysed by PCR, cytokines and plasma lipopolysaccaride (LPS) concentrations with ELISA assays. Results showed that the VDR SNPs rs731236 (G) (TaqI) and rs1544410 (T) (Bsm-I) minor allele polymorphisms are significantly more frequent in obese individuals (p = 0.009, beta = 0.086 and p = 0.028, beta = 0.072, respectively). VDR haplotypes identified are positively (GTA) (p = 0.008, beta = 1.560); or negatively (ACC) (p = 0.044, beta = 0.766) associated with obesity and higher BMI scores. The GTA "risk" haplotype was characterized by an up-regulation of inflammosome components, a higher production of proinflammatory cytokines (p<0.05) and a lower VDR expression. Plasma LPS concentration was also increased in GTA obese individuals (p<0.05), suggesting an alteration of gut permeability leading to microbial translocation. Data herein indicate that polymorphisms affecting the vitamin D/VDR axis play a role in obesity that is associated with an ongoing degree of inflammation, possibly resulting from alterations of gut permeability and microbial translocation. These results could help the definition of VDR fingerprints that predict an increased risk of developing obesity and might contribute to the identification of novel therapeutic strategies for this metabolic condition.	[Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Draz, Hossam M.; Mohammed, Abdul Khader; Clerici, Mario] King Saud Univ, Coll Sci, Biomarkers Res Program, Dept Biochem, Riyadh 11451, Saudi Arabia; [Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.] King Saud Univ, Coll Sci, Prince Mutaib Chair Biomarkers Osteoporosis, Riyadh 11451, Saudi Arabia; [Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia; [Guerini, Franca R.; Agliardi, Cristina; Costa, Andrea S.; Clerici, Mario] ONLUS, Don Gnocchi Fdn, Milan, Italy; [Guerini, Franca R.; Agliardi, Cristina; Costa, Andrea S.; Clerici, Mario] Univ Milan, Milan, Italy; [Alkharfy, Khalid M.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia; [Draz, Hossam M.] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Saulle, Irma; Biasin, Mara; Clerici, Mario] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy	King Saud University; King Saud University; King Saud University; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan; King Saud University; University of Quebec; Institut national de la recherche scientifique (INRS); University of Milan	Al-Daghri, NM (corresponding author), King Saud Univ, Coll Sci, Biomarkers Res Program, Dept Biochem, Riyadh 11451, Saudi Arabia.	aldaghri2011@gmail.com	Al-Daghri, Nasser/G-7736-2011; Al-Daghri, Nasser/A-8360-2011; biasin, mara/G-7426-2012; Al-okail, Majed S/E-5565-2016; Agliardi, Cristina/K-1401-2016; Costa, Andrea Saul/R-2586-2017; Costa, Andrea Saul/Z-5611-2019	Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; biasin, mara/0000-0003-3671-4235; Al-okail, Majed S/0000-0001-8147-3499; Agliardi, Cristina/0000-0003-2022-3386; Costa, Andrea Saul/0000-0002-7353-157X; Costa, Andrea Saul/0000-0002-7353-157X; Saulle, Irma/0000-0002-8600-2503; Clerici, Mario/0000-0001-5920-6191; Draz, Hossam/0000-0002-7351-3339; Mohammed, Abdul Khader/0000-0002-8774-0014	College of Science Research Center, King Saud University, Riyadh, Saudi Arabia	College of Science Research Center, King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project has been funded by the College of Science Research Center, King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2012, J IMMUNOL, V188, P1325, DOI 10.4049/jimmunol.1101954; Alkharfy KM, 2013, METAB SYNDR RELAT D, V11, P283, DOI 10.1089/met.2012.0068; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Dee Anne, 2014, BMC Res Notes, V7, P242, DOI 10.1186/1756-0500-7-242; Dixon AN, 2008, INT J CLIN PRACT, V62, P1124, DOI 10.1111/j.1742-1241.2008.01800.x; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Eleftheriadis T, 2010, INT UROL NEPHROL, V42, P181, DOI 10.1007/s11255-009-9541-1; Habib SS, 2013, BIOMED ENVIRON SCI, V26, P94, DOI 10.3967/0895-3988.2013.02.003; Harte AL, 2012, DIABETES CARE, V35, P375, DOI 10.2337/dc11-1593; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hofer U, 2009, SEMIN IMMUNOPATHOL, V31, P257, DOI 10.1007/s00281-009-0158-3; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Miller MA, 2009, ATHEROSCLEROSIS, V203, P494, DOI 10.1016/j.atherosclerosis.2008.06.018; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Piya MK, 2013, J ENDOCRINOL, V216, pT1, DOI 10.1530/JOE-12-0498; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Schuch NJ, 2009, ARQ BRAS ENDOCRINOL, V53, P625, DOI 10.1590/S0004-27302009000500015; Suganami Takayoshi, 2013, Nihon Rinsho, V71, P225; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Yang LN, 2011, CELL IMMUNOL, V271, P173, DOI 10.1016/j.cellimm.2011.06.017; Ye WZ, 2001, EUR J ENDOCRINOL, V145, P181, DOI 10.1530/eje.0.1450181	32	61	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102141	10.1371/journal.pone.0102141	http://dx.doi.org/10.1371/journal.pone.0102141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020064	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600049
J	Many, AM; Brown, AMC				Many, Alexander M.; Brown, Anthony M. C.			Both Canonical and Non-Canonical Wnt Signaling Independently Promote Stem Cell Growth in Mammospheres	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; TYROSINE KINASE ROR2; N-TERMINAL KINASE; TRANSGENIC MICE; SELF-RENEWAL; TGF-BETA; STEM/PROGENITOR CELLS; RECEPTOR; PROTEINS; INDUCE	The characterization of mammary stem cells, and signals that regulate their behavior, is of central importance in understanding developmental changes in the mammary gland and possibly for targeting stem-like cells in breast cancer. The canonical Wnt/beta-catenin pathway is a signaling mechanism associated with maintenance of self-renewing stem cells in many tissues, including mammary epithelium, and can be oncogenic when deregulated. Wnt1 and Wnt3a are examples of ligands that activate the canonical pathway. Other Wnt ligands, such as Wnt5a, typically signal via non-canonical, beta-cateninin-dependent, pathways that in some cases can antagonize canonical signaling. Since the role of non-canonical Wnt signaling in stem cell regulation is not well characterized, we set out to investigate this using mammosphere formation assays that reflect and quantify stem cell properties. Ex vivo mammosphere cultures were established from both wild-type and Wnt1 transgenic mice and were analyzed in response to manipulation of both canonical and non-canonical Wnt signaling. An increased level of mammosphere formation was observed in cultures derived from MMTV-Wnt1 versus wild-type animals, and this was blocked by treatment with Dkk1, a selective inhibitor of canonical Wnt signaling. Consistent with this, we found that a single dose of recombinant Wnt3a was sufficient to increase mammosphere formation in wild-type cultures. Surprisingly, we found that Wnt5a also increased mammosphere formation in these assays. We confirmed that this was not caused by an increase in canonical Wnt/beta-catenin signaling but was instead mediated by non-canonical Wnt signals requiring the receptor tyrosine kinase Ror2 and activity of the Jun N-terminal kinase, JNK. We conclude that both canonical and non-canonical Wnt signals have positive effects promoting stem cell activity in mammosphere assays and that they do so via independent signaling mechanisms.	[Many, Alexander M.; Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	Cornell University	Brown, AMC (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA.	amcbrown@med.cornell.edu			New York Stem Cell Science [C024286]; National Institutes of Health [R25 CA105012, R01 CA123238]; Strang Cancer Prevention Institute; NATIONAL CANCER INSTITUTE [R01CA123238, R25CA105012] Funding Source: NIH RePORTER	New York Stem Cell Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Strang Cancer Prevention Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by New York Stem Cell Science (http://stemcell.ny.gov/) grant C024286 (AB and AM), National Institutes of Health (http://www.nih.gov/) grant R25 CA105012 (AM), Strang Cancer Prevention Institute, and National Institutes of Health grant R01 CA123238 (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Alexander CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008037; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dong QX, 2013, STEM CELL RES, V10, P396, DOI 10.1016/j.scr.2013.01.007; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Incassati A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2723; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jonsson M, 2002, CANCER RES, V62, P409; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067811; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Many AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2631; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pavlovich AL, 2011, EXP CELL RES, V317, P1872, DOI 10.1016/j.yexcr.2011.03.017; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	87	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101800	10.1371/journal.pone.0101800	http://dx.doi.org/10.1371/journal.pone.0101800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019931	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600029
J	Nishiyama, K; Hirai, K				Nishiyama, Keiji; Hirai, Keisuke			The Melatonin Agonist Ramelteon Induces Duration-Dependent Clock Gene Expression through cAMP Signaling in Pancreatic INS-1 beta-Cells	PLOS ONE			English	Article							INSULIN-SECRETION; PARS TUBERALIS; SUPRACHIASMATIC NUCLEI; RAT-1 FIBROBLASTS; MESSENGER-RNA; RECEPTOR MT1; SENSITIZATION; METABOLISM; ISLETS; PHOSPHORYLATION	Prolonged exposure to melatonin improves glycemic control in animals. Although glucose metabolism is controlled by circadian clock genes, little is known about the role of melatonin signaling and its duration in the regulation of clock gene expression in pancreatic beta-cells. Activation of MT1 and MT2 melatonin receptors inhibits cAMP signaling, which mediates clock gene expression. Therefore, this study investigated exposure duration-dependent alterations in cAMP element-binding protein (CREB) phosphorylation and clock gene expression that occur during and after exposure to ramelteon, a selective melatonin agonist used to treat insomnia. In rat INS-1 cells, a pancreatic beta-cell line endogenously expressing melatonin receptors, ramelteon persistently decreased CREB phosphorylation during the treatment period (2-14 h), whereas the subsequent washout induced an enhancement of forskolin-stimulated CREB phosphorylation in a duration and concentration-dependent manner. This augmentation was blocked by forskolin or the melatonin receptor antagonist luzindole. Similarly, gene expression analyses of 7 clock genes revealed the duration dependency of the effects of ramelteon on Rev-erb alpha and Bmal1 expression through melatonin receptor-mediated cAMP signaling; longer exposure times (14 h) resulted in greater increases in the expression and signaling of Rev-erb alpha, which is related to b-cell functions. Interestingly, this led to amplified oscillatory Rev-erb alpha and Bmal1 expression after agonist washout and forskolin stimulation. These results provide new insights into the duration-dependent effects of ramelteon on clock gene expression in INS-1 cells and may improve the understanding of its effect in vivo. The applicability of these results to pancreatic islets awaits further investigation.	[Nishiyama, Keiji; Hirai, Keisuke] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CNS Drug Discovery Unit, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Hirai, K (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CNS Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	keisuke.hirai@takeda.com			Takeda Pharmaceutical Company Ltd.	Takeda Pharmaceutical Company Ltd.(Takeda Pharmaceutical Company Ltd)	This study was supported by Takeda Pharmaceutical Company Ltd. The publication steering committee of Takeda Pharmaceutical Company Ltd. played a role in the decision to publish. One of the authors (K. H.), a senior director of Takeda, is a member of the committee and is responsible for the decision on the present publication. The funder provided support in the form of salaries for authors KN and KH, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript.	Agez L, 2007, NEUROSCIENCE, V144, P522, DOI 10.1016/j.neuroscience.2006.09.030; Agez L, 2009, J PINEAL RES, V46, P95, DOI 10.1111/j.1600-079X.2008.00636.x; Agil A, 2012, J PINEAL RES, V52, P203, DOI 10.1111/j.1600-079X.2011.00928.x; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Barrett P, 2012, J PINEAL RES, V52, P376, DOI 10.1111/j.1600-079X.2011.00963.x; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bazwinsky-Wutschke I, 2012, J PINEAL RES, V53, P344, DOI 10.1111/j.1600-079X.2012.01004.x; Alonso-Vale MIC, 2008, J PINEAL RES, V45, P422, DOI 10.1111/j.1600-079X.2008.00610.x; Dardente H, 2003, MOL BRAIN RES, V114, P101, DOI 10.1016/S0169-328X(03)00134-7; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Garfinkel D, 2011, DIABETES METAB SYNDR, V4, P307, DOI 10.2147/DMSO.S23904; Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Imbesi M, 2009, J PINEAL RES, V46, P87, DOI 10.1111/j.1600-079X.2008.00634.x; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Muhlbauer E, 2012, J PINEAL RES, V52, P446, DOI 10.1111/j.1600-079X.2012.00959.x; Muhlbauer E, 2007, J PINEAL RES, V42, P105, DOI 10.1111/j.1600-079X.2006.00399.x; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Picinato MC, 2002, J PINEAL RES, V33, P156, DOI 10.1034/j.1600-079X.2002.02903.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Schwartz WJ, 2005, NEUROSCI LETT, V385, P87, DOI 10.1016/j.neulet.2005.05.018; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Uchikawa O, 2002, J MED CHEM, V45, P4222, DOI 10.1021/jm0201159; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Von Gall C, 2005, ANN NY ACAD SCI, V1040, P508, DOI 10.1196/annals.1327.105; Wagner GC, 2007, EUR J NEUROSCI, V25, P485, DOI 10.1111/j.1460-9568.2006.05291.x; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Weaver DR, 1996, NEUROREPORT, V8, P109, DOI 10.1097/00001756-199612200-00022; Witt-Enderby PA, 2000, CELL MOTIL CYTOSKEL, V46, P28, DOI 10.1002/(SICI)1097-0169(200005)46:1<28::AID-CM4>3.0.CO;2-5; Witt-Enderby PA, 1998, ENDOCRINOLOGY, V139, P3064, DOI 10.1210/en.139.7.3064; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Xiang S, 2012, BREAST CANCER-BASIC, V6, P137, DOI 10.4137/BCBCR.S9673; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X	46	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102073	10.1371/journal.pone.0102073	http://dx.doi.org/10.1371/journal.pone.0102073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013953	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400063
J	Loudon, JE; Grobler, JP; Sponheimer, M; Moyer, K; Lorenz, JG; Turner, TR				Loudon, James E.; Grobler, J. Paul; Sponheimer, Matt; Moyer, Kimberly; Lorenz, Joseph G.; Turner, Trudy R.			Using the Stable Carbon and Nitrogen Isotope Compositions of Vervet Monkeys (Chlorocebus pygerythrus) to Examine Questions in Ethnoprimatology	PLOS ONE			English	Article							CERCOPITHECUS-AETHIOPS; BONE-COLLAGEN; 4 SITES; HAIR; DIET; DELTA-N-15; RATIOS; VARIABILITY; DELTA-C-13; PATTERNS	This study seeks to understand how humans impact the dietary patterns of eight free-ranging vervet monkey (Chlorocebus pygerythrus) groups in South Africa using stable isotope analysis. Vervets are omnivores that exploit a wide range of habitats including those that have been anthropogenically-disturbed. As humans encroach upon nonhuman primate landscapes, human-nonhuman primate interconnections become increasingly common, which has led to the rise of the field of ethnoprimatology. To date, many ethnoprimatological studies have examined human-nonhuman primate associations largely in qualitative terms. By using stable carbon (delta C-13) and nitrogen (delta N-15) isotope analysis, we use quantitative data to understand the degree to which humans impact vervet monkey dietary patterns. Based on initial behavioral observations we placed the eight groups into three categories of anthropogenic disturbance (low, mid, and high). Using delta C-13 and delta N-15 values we estimated the degree to which each group and each anthropogenically-disturbed category was consuming C-4 plants (primarily sugar cane, corn, or processed foods incorporating these crops). delta C-13 values were significantly different between groups and categories of anthropogenic-disturbance. delta N-15 values were significantly different at the group level. The two vervet groups with the highest consumption of C-4 plants inhabited small nature reserves, appeared to interact with humans only sporadically, and were initially placed in the mid level of anthropogenic-disturbance. However, further behavioral observations revealed that the high delta C-13 values exhibited by these groups were linked to previously unseen raiding of C-4 crops. By revealing these cryptic feeding patterns, this study illustrates the utility of stable isotopes analysis for some ethnoprimatological questions.	[Loudon, James E.] E Carolina Univ, Dept Anthropol, Greenville, NC 27858 USA; [Loudon, James E.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Grobler, J. Paul; Turner, Trudy R.] Univ Orange Free State, Dept Genet, Bloemfontein, South Africa; [Moyer, Kimberly] Univ Colorado, Denver, CO 80202 USA; [Lorenz, Joseph G.] Cent Washington Univ, Dept Anthropol, Ellensburg, WI USA; [Turner, Trudy R.] Univ Wisconsin, Dept Anthropol, Milwaukee, WI 53201 USA	University of North Carolina; East Carolina University; University of Colorado System; University of Colorado Boulder; University of the Free State; University of Colorado System; University of Colorado Denver; University of Wisconsin System; University of Wisconsin Milwaukee	Loudon, JE (corresponding author), E Carolina Univ, Dept Anthropol, Greenville, NC 27858 USA.	loudonj@ecu.edu	; Sponheimer, Matt/A-6075-2013	Grobler, Paul/0000-0002-5913-7031; Sponheimer, Matt/0000-0002-8743-1123	National Science Foundation [BCS 0938969]; National Institutes of Health [R01RR016300]; Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR016300] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Science Foundation (BCS 0938969); National Institutes of Health (R01RR016300); The Fulbright Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Cardini A, 2013, J BIOGEOGR, V40, P370, DOI 10.1111/j.1365-2699.2012.02783.x; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Codron D, 2005, S AFR J SCI, V101, P245; Codron D, 2008, BIOL J LINN SOC, V94, P755, DOI 10.1111/j.1095-8312.2008.01028.x; Codron J, 2013, J QUATERNARY SCI, V28, P301, DOI 10.1002/jqs.2614; Cramer JD, 2013, AM J PRIMATOL, V75, P752, DOI 10.1002/ajp.22156; Crowley BE, 2012, INT J PRIMATOL, V33, P673, DOI 10.1007/s10764-012-9582-7; DRACOPOLI NC, 1983, AM J PHYS ANTHROPOL, V61, P39, DOI 10.1002/ajpa.1330610105; Fourie NH, 2008, AM J PHYS ANTHROPOL, V135, P121, DOI 10.1002/ajpa.20713; Fuentes A., 2002, PRIMATES FACE FACE; Fuentes A, 2012, ANNU REV ANTHROPOL, V41, P101, DOI 10.1146/annurev-anthro-092611-145808; Fuentes A, 2010, AM J PRIMATOL, V72, P841, DOI 10.1002/ajp.20844; Gonedele Bi Sery, 2009, Primate Conservation, V24, P91; Grobler JP, 2010, S AFR J WILDL RES, V40, P163, DOI 10.3957/056.040.0208; GROBLER P., 2006, ECOLOGICAL ENV ANTHR, V2, P12; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Jones-Engel Lisa, 2011, P295; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Loudon JE, 2007, AM J PHYS ANTHROPOL, V133, P978, DOI 10.1002/ajpa.20605; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Murphy BP, 2006, FUNCT ECOL, V20, P1062, DOI 10.1111/j.1365-2435.2006.01186.x; O'Regan HJ, 2008, J HUM EVOL, V55, P617, DOI 10.1016/j.jhevol.2008.05.001; Pampush JD., 2010, THESIS U WISCONSIN M; RICHARD AF, 1989, INT J PRIMATOL, V10, P569, DOI 10.1007/BF02739365; Riley E. P., 2006, ECOLOGICAL ENV ANTHR, V2, P75; Riley EP, 2011, PRIMATES PERSPECTIVE, P676; Riley EP, 2013, TECH ECOL CONSERVAT, P128; Sandberg PA, 2012, AM J PRIMATOL, V74, P969, DOI 10.1002/ajp.22053; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; Schoeninger MJ, 1998, OECOLOGIA, V113, P222, DOI 10.1007/s004420050372; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schurr MR, 2012, PRIMATES, V53, P31, DOI 10.1007/s10329-011-0268-0; SCHWARCZ HP, 1985, J ARCHAEOL SCI, V12, P187, DOI 10.1016/0305-4403(85)90020-2; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Sponheimer M, 2001, OECOLOGIA, V126, P153, DOI 10.1007/s004420000498; Sponheimer M, 2009, AM J PHYS ANTHROPOL, V140, P661, DOI 10.1002/ajpa.21111; Struhsaker TT, 1967, KENYA ECOLOGY, V48, P892; TAPPEN NC, 1960, CURR ANTHROPOL, V1, P91, DOI 10.1086/200088; TURNER TR, 1994, FOLIA PRIMATOL, V63, P177, DOI 10.1159/000156815; Turner TR, 1997, AM J PHYS ANTHROPOL, V103, P19, DOI 10.1002/(SICI)1096-8644(199705)103:1<19::AID-AJPA3>3.0.CO;2-8; TURNER TR, 1981, AM J PHYS ANTHROPOL, V55, P225, DOI 10.1002/ajpa.1330550211; VOGEL JC, 1978, S AFR J SCI, V74, P298	47	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100758	10.1371/journal.pone.0100758	http://dx.doi.org/10.1371/journal.pone.0100758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010211	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800006
J	Quesada-Romero, L; Mena-Ulecia, K; Tiznado, W; Caballero, J				Quesada-Romero, Luisa; Mena-Ulecia, Karel; Tiznado, William; Caballero, Julio			Insights into the Interactions between Maleimide Derivates and GSK3 beta Combining Molecular Docking and QSAR	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SUBSTITUTED PYRAZOLE DERIVATIVES; B-RAF KINASE; PANCREATIC-CANCER; CELL-SURVIVAL; ACTIVE-SITE; INHIBITORS; GSK-3-BETA; DYNAMICS; 3-BETA	Many protein kinase (PK) inhibitors have been reported in recent years, but only a few have been approved for clinical use. The understanding of the available molecular information using computational tools is an alternative to contribute to this process. With this in mind, we studied the binding modes of 77 maleimide derivates inside the PK glycogen synthase kinase 3 beta (GSK3 beta) using docking experiments. We found that the orientations that these compounds adopt inside GSK3 beta binding site prioritize the formation of hydrogen bond (HB) interactions between the maleimide group and the residues at the hinge region (residues Val135 and Asp133), and adopt propeller-like conformations (where the maleimide is the propeller axis and the heterocyclic substituents are two slanted blades). In addition, quantitative structure-activity relationship (QSAR) models using CoMSIA methodology were constructed to explain the trend of the GSK3 beta inhibitory activities for the studied compounds. We found a model to explain the structure-activity relationship of non-cyclic maleimide (NCM) derivatives (54 compounds). The best CoMSIA model (training set included 44 compounds) included steric, hydrophobic, and HB donor fields and had a good Q(2) value of 0.539. It also predicted adequately the most active compounds contained in the test set. Furthermore, the analysis of the plots of the steric CoMSIA field describes the elements involved in the differential potency of the inhibitors that can be considered for the selection of suitable inhibitors.	[Quesada-Romero, Luisa; Caballero, Julio] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Mena-Ulecia, Karel; Tiznado, William] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Santiago, Chile	Universidad de Talca; Universidad Andres Bello	Caballero, J (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile.	jcaballero@utalca.cl	Tiznado, william/G-7479-2014; Caballero, Julio/G-3654-2014	Tiznado, william/0000-0002-6061-8879; Caballero, Julio/0000-0003-0182-1444; KAREL, MENA-ULECIA/0000-0001-6651-511X; Quesada Romero, Luisa/0000-0002-7607-4853	Fondecyt, Chile [1130141]	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the grant no. 1130141 (J.C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate-Morales J, 2010, J CHEM INF MODEL, V50, P110, DOI 10.1021/ci900302z; Alzate-Morales JH, 2010, J CHEM INF MODEL, V50, P1101, DOI 10.1021/ci100049h; [Anonymous], 1699, SYBYL VERS 7 3; [Anonymous], 2011, SUIT 2011 LIGPREP VE; Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; Bruce L., 1993, J COMPUT AID MOL DES, V7, P587; Caballero J, 2012, EUR J MED CHEM, V58, P272, DOI 10.1016/j.ejmech.2012.10.020; Caballero J, 2012, MED CHEM RES, V21, P1912, DOI 10.1007/s00044-011-9714-1; Caballero J, 2012, CURR PHARM DESIGN, V18, P2946, DOI 10.2174/138161212800672705; Caballero J, 2011, J CHEM INF MODEL, V51, P2920, DOI 10.1021/ci200306w; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Caballero J, 2011, J COMPUT AID MOL DES, V25, P349, DOI 10.1007/s10822-011-9425-1; Darrington RS, 2012, INT J CANCER, V131, pE872, DOI 10.1002/ijc.27620; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fang JS, 2011, J CHEM INF MODEL, V51, P1431, DOI 10.1021/ci2001154; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gaisina IN, 2009, J MED CHEM, V52, P1853, DOI 10.1021/jm801317h; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kozikowski AP, 2007, J AM CHEM SOC, V129, P8328, DOI 10.1021/ja068969w; Kuo GH, 2003, J MED CHEM, V46, P4021, DOI 10.1021/jm030115o; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; Ojha PK, 2011, CHEMOMETR INTELL LAB, V107, P194, DOI 10.1016/j.chemolab.2011.03.011; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Zhang HC, 2007, BIOORG MED CHEM LETT, V17, P2863, DOI 10.1016/j.bmcl.2007.02.059; Zhang HC, 2003, BIOORG MED CHEM LETT, V13, P3049, DOI 10.1016/S0960-894X(03)00644-9	36	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102212	10.1371/journal.pone.0102212	http://dx.doi.org/10.1371/journal.pone.0102212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010341	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800083
J	Zeynalov, E; Rezvani, N; Miyazaki, C; Liu, XG; Littleton-Kearney, MT				Zeynalov, Emil; Rezvani, Niloofar; Miyazaki, Chikao; Liu, Xiaoguang; Littleton-Kearney, Marguerite T.			Reproductive Senescence Blunts Response of Estrogen Receptor-alpha Expression to Estrogen Treatment in Rat Post-Ischemic Cerebral Microvessels	PLOS ONE			English	Article							FEMALE RATS; VASCULAR ACTIONS; BLOOD-VESSELS; PIAL ARTERY; STROKE; AGE; BRAIN; SEX; DEPRIVATION; THERAPY	Background: Several studies demonstrate that estrogen treatment improves cerebral blood flow in ischemic brain regions of young ovariectomized (OVX) rats. Estrogen receptor-alpha (ER-alpha) may mediate estrogen's beneficial actions via its effects on the cerebral microvasculature. However, estrogen-derived benefit may be attenuated in aged, reproductively senescent (RS) rats. Our goal was to determine the effects of aging, estrogen deprivation and estrogen repletion with oral conjugated estrogens (CE) on postischemic cerebral microvascular protein expression of ER-alpha and ER-beta. Methods: Fisher-344 (n = 37) female rats were randomly divided into the following groups: OVX, OVX CE-treated, RS untreated, and RS CE-treated. After 30 days pretreatment with CE (0.01 mg/kg) rats were subjected to 15 min. transient global cerebral ischemia. Non-ischemic naive, OVX and RS rats were used as controls. Expression of ER-alpha and ER-beta in isolated cortical cerebral microvessels (20 to 100 mu m in diameter) was assessed using Western blot and immunohistochemistry techniques. Results: Age and reproductive status blunted nonischemic ER-alpha expression in microvessels of OVX rats (0.31 +/- 0.05) and RS rats (0.33 +/- 0.06) compared to naive rats (0.45 +/- 0.02). Postischemic microvascular expression of ER-alpha in OVX rats (0.01 +/- 0.0) was increased by CE treatment (0.04 +/- 0.01). Expression of ER-alpha in microvessels of RS rats (0.03 +/- 0.02) was unaffected by CE treatment (0.01 +/- 0.02). Western blot data are presented as a ratio of ER-alpha or ER-beta proteins to beta-actin and. Oral CE treatment had no effect on ER-beta expression in postischemic microvessels of OVX and RS rats. Statistical analysis was performed by One-Way ANOVA and a Newman-Keuls or Student's post-hoc test. Conclusion: Chronic treatment with CE increases ER-alpha but not ER-beta expression in cerebral microvessels of OVX rats. Aging appears to reduce the normal ability of estrogen to increase ER-alpha expression in postischemic cerebral microvessels.	[Zeynalov, Emil; Rezvani, Niloofar; Littleton-Kearney, Marguerite T.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Miyazaki, Chikao; Liu, Xiaoguang] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Uniformed Services University of the Health Sciences - USA; Johns Hopkins University	Zeynalov, E (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	emil.zeynalov@healthonecares.com			National Institutes of Health (NIH) [R01NR005339]; Ruth L. Kirshstein National Research Service Award; NIH [GM075774-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005339] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirshstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by National Institutes of Health (NIH) grant R01NR005339, the Ruth L. Kirshstein National Research Service Award, and NIH Clinician-Scientist Award T-32, ID No: GM075774-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell Cheryl, 2009, Curr Treat Options Cardiovasc Med, V11, P241; Geary GG, 1998, BRIT J PHARMACOL, V123, P1533, DOI 10.1038/sj.bjp.0701761; Jesmin S, 2003, J CEREBR BLOOD F MET, V23, P181, DOI 10.1097/01.WCB.0000043341.09; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Li M, 2009, MICROCIRCULATION, V16, P403, DOI 10.1080/10739680902827738; Littleton-Kearney MT, 2005, J CEREBR BLOOD F MET, V25, P421, DOI 10.1038/sj.jcbfm.9600052; Lobo RA, 2007, CLIMACTERIC, V10, P27, DOI 10.1080/13697130701550903; LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193; Macrae IM, 2006, BIOCHEM SOC T, V34, P1362, DOI 10.1042/BST0341362; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Mendelsohn ME, 2002, AM J CARDIOL, V90, p3F, DOI 10.1016/S0002-9149(02)02418-9; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; Murata T, 2013, STROKE, V44, P779, DOI 10.1161/STROKEAHA.112.678177; Ospina JA, 2003, AM J PHYSIOL-HEART C, V285, pH241, DOI 10.1152/ajpheart.00018.2003; Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807; Qin XY, 2005, J CEREBR BLOOD F MET, V25, P1041, DOI 10.1038/sj.jcbfm.9600105; Razmara A, 2008, J PHARMACOL EXP THER, V325, P782, DOI 10.1124/jpet.107.134072; RODEGHIERO F, 1990, RES CLIN LAB, V20, P143; Sandoval KE, 2011, MICROVASC RES, V81, P198, DOI 10.1016/j.mvr.2010.12.007; SASS B, 1975, J NATL CANCER I, V54, P1449, DOI 10.1093/jnci/54.6.1449; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Sharma N, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn298; Smiley DA, 2009, CURR MED CHEM, V16, P1863, DOI 10.2174/092986709788186093; Sohrabji F, 2005, ANN NY ACAD SCI, V1052, P75, DOI 10.1196/annals.1347.006; Sone K, 2007, EXP ANIM TOKYO, V56, P139, DOI 10.1538/expanim.56.139; Stirone C, 2003, AM J PHYSIOL-ENDOC M, V284, pE184, DOI 10.1152/ajpendo.00165.2002; Thakur M, 2008, BIOGERONTOLOGY, V9, P467, DOI 10.1007/s10522-008-9166-2; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; Vehkavaara S, 2000, CIRCULATION, V102, P2687, DOI 10.1161/01.CIR.102.22.2687; Wilson ME, 2002, MECH AGEING DEV, V123, P593, DOI 10.1016/S0047-6374(01)00406-7; Wynne FL, 2004, HYPERTENSION, V43, P405, DOI 10.1161/01.HYP.0000111833.82664.0c; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102194	10.1371/journal.pone.0102194	http://dx.doi.org/10.1371/journal.pone.0102194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010766	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800079
J	Ang, M; Chong, W; Huang, HQ; Wong, TY; He, MG; Aung, T; Mehta, JS				Ang, Marcus; Chong, Wesley; Huang, Huiqi; Wong, Tien Yin; He, Ming-Guang; Aung, Tin; Mehta, Jodhbir S.			Determinants of Posterior Corneal Biometric Measurements in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; IN-SITU KERATOMILEUSIS; AUTOMATED ENDOTHELIAL KERATOPLASTY; LENS POWER CALCULATION; ANTERIOR SEGMENT OCT; ANGLE-CLOSURE; ULTRASOUND BIOMICROSCOPY; REFRACTIVE SURGERY; ASSESSMENT PROGRAM; CHINESE EYES	Purpose: To describe the corneal and anterior segment determinants of posterior corneal arc length (PCAL) and posterior corneal curvature (PCC). Methods: Cross-sectional, population-based study of 1069 subjects (1069 eyes) aged 40-80 years, from three major Asian ethnic groups. All underwent anterior segment optical coherence tomography imaging and analysis with Zhongshan Angle Assessment Program. Our main outcome measures were determinants of PCAL and PCC using adjusted, multivariate linear regression analysis, adjusted for confounders to obtain the estimated marginal means (EMM) with standard error (SE). Results: The overall mean (+/- SD) of PCC was: 6.51 +/- 0.39 mm; and PCAL was: 12.52 +/- 0.59 mm. Malays had a relatively longer PCAL (EMM = 12.74 mm, SE = 0.04 mm) than Chinese (EMM = 12.48 mm, SE = 0.03 mm, P<0.001), and Indians (EMM = 12.42 mm, SE = 0.03 mm, P<0.001). Anterior segment parameters had weak-moderate correlations with PCAL, which included: anterior chamber depth (ACD) (r = 0.55, P<0.001), PCC (r = 0.27, P<0.001), anterior corneal curvature (ACC) (r = 0.14, P<0.001) and central corneal thickness (CCT) (r = -0.07, P = 0.023). In multivariate analysis, anterior segment parameters explained only 37.6% of the variance of PCAL, with ACD being the most important determinant (partial R-2 = 0.300; P<0.001). The determinants of PCC included ACC, PCAL and CCT (explaining 72.1% variation of PCC), with ACC being the most important determinant (partial R-2 = 0.683; P<0.001). Conclusion: There was moderate correlation of PCAL with ACD, but anterior segment parameters accounted for only a small proportion of the variation in PCAL. The significant differences in PCAL and PCC amongst different Asian ethnic groups suggests that there is a need to consider this factor when planning for anterior segment surgeries such as endothelial keratoplasty.	[Ang, Marcus; Chong, Wesley; Wong, Tien Yin; Aung, Tin; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Ang, Marcus; Huang, Huiqi; Wong, Tien Yin; Aung, Tin; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien Yin; Aung, Tin] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Wong, Tien Yin; Mehta, Jodhbir S.] Duke Natl Univ Singapore, Grad Sch Med, Off Clin Sci, Singapore, Singapore; [He, Ming-Guang] Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.	jodmehta@gmail.com	He, Mingguang/AAY-5239-2020; Wong, Tien Yin/AAC-9724-2020	He, Mingguang/0000-0002-6912-2810; Wong, Tien Yin/0000-0002-8448-1264	National Research Foundation Translational and Clinical Research Programme [TCR: R621/42/2008]	National Research Foundation Translational and Clinical Research Programme	National Research Foundation Translational and Clinical Research Programme Grant (TCR: R621/42/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P95; ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P105; Ang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065559; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P120, DOI 10.1167/iovs.11-8386; [Anonymous], 2002, OPHTHALMOLOGY, V109, P651; [Anonymous], 2000, J REFRACT SURG, V16, P349; Avila M, 2006, J CATARACT REFR SURG, V32, P1836, DOI 10.1016/j.jcrs.2006.07.015; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Chan JB, 2011, INVEST OPHTH VIS SCI, V52, P8884, DOI 10.1167/iovs.10-6411; Cheng LS, 2011, ACTA OPHTHALMOL, V89, P417, DOI 10.1111/j.1755-3768.2009.01732.x; Congdon NG, 1997, OPHTHALMOLOGY, V104, P1489, DOI 10.1016/S0161-6420(97)30112-2; Console JW, 2008, BRIT J OPHTHALMOL, V92, P1612, DOI 10.1136/bjo.2007.129932; Dada T, 2007, J CATARACT REFR SURG, V33, P837, DOI 10.1016/j.jcrs.2007.01.021; Dorairaj S, 2007, T AM OPHTHAL SOC, V105, P108; Dorairaj Syril, 2007, Trans Am Ophthalmol Soc, V105, P99; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Hall RC, 2011, J CATARACT REFR SURG, V37, P544, DOI 10.1016/j.jcrs.2010.10.037; Hosny M, 2000, J REFRACT SURG, V16, P336; Jin HY, 2012, J CATARACT REFR SURG, V38, P1749, DOI 10.1016/j.jcrs.2012.06.048; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; Kim SW, 2009, J REFRACT SURG, V25, P285, DOI 10.3928/1081597X-20090301-08; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Leung CK, 2010, BRIT J OPHTHALMOL, V94, P1184, DOI 10.1136/bjo.2009.167296; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Nolan WP, 2006, AM J OPHTHALMOL, V141, P896, DOI 10.1016/j.ajo.2005.12.008; Prasher P, 2010, J CATARACT REFR SURG, V36, P1358, DOI 10.1016/j.jcrs.2010.01.032; Qin B, 2012, OPHTHAL SURG LAS IM, P1; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Sakata LM, 2008, ARCH OPHTHALMOL-CHIC, V126, P181, DOI 10.1001/archophthalmol.2007.46; Su DHW, 2008, BRIT J OPHTHALMOL, V92, P103, DOI 10.1136/bjo.2007.122572; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tan GS, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-19; Vijaya L, 2010, OPHTHALMOLOGY, V117, P700, DOI 10.1016/j.ophtha.2009.09.025; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yuen LH, 2010, INVEST OPHTH VIS SCI, V51, P3433, DOI 10.1167/iovs.09-4307; Zheng YF, 2011, OPHTHALMOLOGY	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101483	10.1371/journal.pone.0101483	http://dx.doi.org/10.1371/journal.pone.0101483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006679	Green Published, gold			2022-12-25	WOS:000339040600039
J	Kleimann, A; Toto, S; Eberlein, CK; Kielstein, JT; Bleich, S; Frieling, H; Sieberer, M				Kleimann, Alexandra; Toto, Sermin; Eberlein, Christian K.; Kielstein, Jan T.; Bleich, Stefan; Frieling, Helge; Sieberer, Marcel			Psychiatric Symptoms in Patients with Shiga Toxin-Producing E-coli O104:H4 Induced Haemolytic-Uraemic Syndrome	PLOS ONE			English	Article							THERAPEUTIC PLASMA-EXCHANGE; MANIFESTATIONS; INVENTORY; INFECTION	Background: In May 2011 an outbreak of Shiga toxin-producing enterohaemorrhagic E. coli (STEC) O104:H4 in Northern Germany led to a high number of in-patients, suffering from post-enteritis haemolytic-uraemic syndrome (HUS) and often severe affection of the central nervous system. To our knowledge so far only neurological manifestations have been described systematically in literature. Aim: To examine psychiatric symptoms over time and search for specific symptom clusters in affected patients. Methods: 31 in-patients suffering from E. coli O104:H4 associated HUS, were examined and followed up a week during the acute hospital stay. Psychopathology was assessed by clinical interview based on the AMDP Scale, the Brief Symptom Inventory and the Clinical Global Impressions Scale. Results: At baseline mental disorder due to known physiological condition (ICD-10 F06.8) was present in 58% of the examined patients. Patients suffered from various manifestations of cognitive impairment (n = 27) and hallucinations (n = 4). Disturbances of affect (n = 28) included severe panic attacks (n = 9). Psychiatric disorder was significantly associated with higher age (p<0.0001), higher levels of C-reactive protein (p<0.05), and positive family history of heart disease (p<0.05). Even within the acute hospital stay with a median follow up of 7 days, symptoms improved markedly over time (p <0.0001). Conclusions: Aside from severe neurological symptoms the pathology in E. coli O104:H4 associated HUS frequently includes particular psychiatric disturbances. Long term follow up has to clarify whether or not these symptoms subside.	[Kleimann, Alexandra; Toto, Sermin; Eberlein, Christian K.; Bleich, Stefan; Frieling, Helge; Sieberer, Marcel] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany; [Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Kleimann, A (corresponding author), Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany.	kleimann.alexandra@mh-hannover.de	Bleich, Stefan/ABC-1796-2020; Frieling, Helge/C-5299-2015; Kielstein, Jan T./I-2956-2019	Frieling, Helge/0000-0001-5146-9720; Kielstein, Jan T./0000-0001-8110-9064; Neyazi, Alexandra/0000-0003-0882-631X	Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany	Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany	This work was funded by the research budget of the Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany. The funding department as an institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SP, 2002, PEDIATR NEPHROL, V17, P293, DOI 10.1007/s00467-001-0783-0; Dankbaar JW, 2009, J NEURORADIOLOGY, V36, P219, DOI 10.1016/j.neurad.2009.01.001; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Donnerstag F, 2012, EUR RADIOL, V22, P506, DOI 10.1007/s00330-011-2286-0; Duivis HE, 2010, J AM COLL CARDIOL, V29, P31; Dundas S, 1999, LANCET, V354, P1327, DOI 10.1016/S0140-6736(99)01251-9; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Franke H., 2000, BSI BRIEF SYMPTOM IN; Greinacher A, 2011, LANCET, V378, P1166, DOI 10.1016/S0140-6736(11)61253-1; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Guy W, 1976, ECDEU ASSESSMENT MAN; HAMANO S, 1993, ACTA PAEDIATR, V82, P454, DOI 10.1111/j.1651-2227.1993.tb12721.x; Kielstein JT, 2012, NEPHROL DIAL TRANSPL, V27, P3807, DOI 10.1093/ndt/gfs394; Kielstein JT, 2011, NEPHROL DIAL TRANSPL, V26, P2723, DOI 10.1093/ndt/gfr462; Lorenzen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047215; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meuth SG, 2012, ANN NEUROL; Moller HJ, 2009, WORLD J BIOL PSYCHIA, V10, P6, DOI 10.1080/15622970802264606; Nathanson S, 2010, CLIN J AM SOC NEPHRO, V5, P1218, DOI 10.2215/CJN.08921209; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; PIERSMA HL, 1994, J CLIN PSYCHOL, V50, P555, DOI 10.1002/1097-4679(199407)50:4<555::AID-JCLP2270500410>3.0.CO;2-G; Pietzcker A, 1983, Mod Probl Pharmacopsychiatry, V20, P88; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Recklitis CJ, 2007, PSYCHO-ONCOLOGY, V16, P429, DOI 10.1002/pon.1069; Renfordt E, 1983, Mod Probl Pharmacopsychiatry, V20, P125; Robert-Koch-Institut, 2011, AUSBR FALLD EHEC HUS; SIEGLER RL, 1994, PEDIATRICS, V94, P35; Skripuletz T, 2013, BRAIN, V136, DOI 10.1093/brain/aws361; Lucero MS, 2012, MICROB PATHOGENESIS, V53, P87, DOI 10.1016/j.micpath.2012.05.005; Teramoto T, 2009, PEDIATR INT, V51, P107, DOI 10.1111/j.1442-200X.2008.02672.x; Tironi-Farinati C, 2010, J NEUROIMMUNOL, V222, P48, DOI 10.1016/j.jneuroim.2010.03.001; Weissenborn K, 2012, NEUROLOGY, V79, P1466, DOI 10.1212/WNL.0b013e31826d5f26; WHO, 1992, WHO ICD 10 CLASS MEN; ZOJA C, 1992, J LAB CLIN MED, V120, P229	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101839	10.1371/journal.pone.0101839	http://dx.doi.org/10.1371/journal.pone.0101839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007072	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600072
J	Wan, L; Zhang, FJ; He, QL; Tsang, WP; Lu, L; Li, QN; Wu, ZH; Qiu, GX; Zhou, GQ; Wan, C				Wan, Lin; Zhang, Fengjie; He, Qiling; Tsang, Wing Pui; Lu, Li; Li, Qingnan; Wu, Zhihong; Qiu, Guixing; Zhou, Guangqian; Wan, Chao			EPO Promotes Bone Repair through Enhanced Cartilaginous Callus Formation and Angiogenesis	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR; SKELETAL DEVELOPMENT; FRACTURE; EXPRESSION; MICE; OSTEOGENESIS; REGENERATION; PATHWAY; NONUNION; ISCHEMIA	Erythropoietin (EPO)/erythropoietin receptor (EPOR) signaling is involved in the development and regeneration of several non-hematopoietic tissues including the skeleton. EPO is identified as a downstream target of the hypoxia inducible factor-alpha (HIF-alpha) pathway. It is shown that EPO exerts a positive role in bone repair, however, the underlying cellular and molecular mechanisms remain unclear. In the present study we show that EPO and EPOR are expressed in the proliferating, pre-hypertrophic and hypertrophic zone of the developing mouse growth plates as well as in the cartilaginous callus of the healing bone. The proliferation rate of chondrocytes is increased under EPO treatment, while this effect is decreased following siRNA mediated knockdown of EPOR in chondrocytes. EPO treatment increases biosynthesis of proteoglycan, accompanied by up-regulation of chondrogenic marker genes including SOX9, SOX5, SOX6, collagen type 2, and aggrecan. The effects are inhibited by knockdown of EPOR. Blockage of the endogenous EPO in chondrocytes also impaired the chondrogenic differentiation. In addition, EPO promotes metatarsal endothelial sprouting in vitro. This coincides with the in vivo data that local delivery of EPO increases vascularity at the mid-stage of bone healing (day 14). In a mouse femoral fracture model, EPO promotes cartilaginous callus formation at days 7 and 14, and enhances bone healing at day 28 indexed by improved X-ray score and micro-CT analysis of microstructure of new bone regenerates, which results in improved biomechanical properties. Our results indicate that EPO enhances chondrogenic and angiogenic responses during bone repair. EPO's function on chondrocyte proliferation and differentiation is at least partially mediated by its receptor EPOR. EPO may serve as a therapeutic agent to facilitate skeletal regeneration.	[Wan, Lin; Zhang, Fengjie; Tsang, Wing Pui; Lu, Li; Wan, Chao] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Fengjie; Tsang, Wing Pui; Wan, Chao] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci, Core Lab, Shenzhen, Peoples R China; [He, Qiling] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [He, Qiling] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Lu, Li; Li, Qingnan] Guangdong Pharmaceut Univ, Guangdong Key Lab Pharmaceut Bioact Subst, New Drug Funct Res Ctr, Sch Life Sci & Biopharm, Guangzhou, Guangdong, Peoples R China; [Wu, Zhihong; Qiu, Guixing] Peking Union Med Coll, Dept Orthopaed, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Wu, Zhihong; Qiu, Guixing] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhou, Guangqian] Shenzhen Univ, Ctr Antiageing & Regenerat Med, Sch Med, Shenzhen, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Guangdong Pharmaceutical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Shenzhen University	Wan, C (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Minist Educ,Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China.	cwan@cuhk.edu.hk	wu, zhi/GXH-3041-2022; Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006; Qiu, Guixing/0000-0002-4597-9350	Hong Kong Research Grant Council General Research Fund [RGC GRF 475910]; National Natural Science Foundation of China [NSFC 81130034]; NSFC-RGC Joint Research Scheme [CUHK445/10]	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC))	This work was supported by Hong Kong Research Grant Council General Research Fund (RGC GRF 475910), National Natural Science Foundation of China (NSFC 81130034), and NSFC-RGC Joint Research Scheme (CUHK445/10) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brandi ML, 2013, EXPERT OPIN PHARMACO, V14, P1441, DOI 10.1517/14656566.2013.801959; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Casazza K, 2013, WORLD J DIABETES, V4, P145, DOI 10.4239/wjd.v4.i4.145; Cianferotti L, 2014, ENDOCRINE, V45, P165, DOI 10.1007/s12020-013-0026-8; De Spiegelaere W, 2010, MOL CELL BIOCHEM, V337, P287, DOI 10.1007/s11010-009-0310-3; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Derks M, 2013, CELLS TISSUES ORGANS, V198, P179, DOI 10.1159/000354897; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; Fassbender M, 2011, EUR CELLS MATER, V22, P1; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Fisher JW, 1997, P SOC EXP BIOL MED, V216, P358; Garcia P, 2011, J ORTHOP RES, V29, P165, DOI 10.1002/jor.21219; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Haigh JJ, 2000, DEVELOPMENT, V127, P1445; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Hak DJ, 2006, J ORTHOP RES, V24, P11, DOI 10.1002/jor.20022; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kigami R, 2013, IMPLANT DENT, V22, P422, DOI 10.1097/ID.0b013e31829d19f0; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; LANE JM, 1987, ORTHOP CLIN N AM, V18, P213; LEE MY, 1991, BLOOD, V77, P2135; Lee YJ, 2008, J KOREAN NEUROSURG S, V43, P149, DOI 10.3340/jkns.2008.43.3.149; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; Mihmanli A, 2009, J ORAL MAXIL SURG, V67, P2337, DOI 10.1016/j.joms.2008.06.082; Ovchinnikov D., 2009, COLD SPRING HARB PRO, V2009, pt5170, DOI 10.1101/pdb.prot5170; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sheng Matilda H C, 2014, J Bone Metab, V21, P41, DOI 10.11005/jbm.2014.21.1.41; Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853; Siddiqui NA, 2013, CURR STEM CELL RES T, V8, P192; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; Solomon DH, 2014, J BONE MINER RES; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Sun HL, 2012, TISSUE ENG PT A, V18, P2095, DOI [10.1089/ten.tea.2011.0742, 10.1089/ten.TEA.2011.0742]; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; Takenaka Tsuneo, 2003, International Urology and Nephrology, V35, P407, DOI 10.1023/B:UROL.0000022950.00626.e4; TAN CC, 1991, KIDNEY INT, V40, P69, DOI 10.1038/ki.1991.181; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Warren SM, 2001, J SURG RES, V99, P147, DOI 10.1006/jsre.2001.6128; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yi CL, 2012, INJURY, V43, P402, DOI 10.1016/j.injury.2010.12.011; Zelzer E, 2002, DEVELOPMENT, V129, P1893	59	50	60	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102010	10.1371/journal.pone.0102010	http://dx.doi.org/10.1371/journal.pone.0102010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003898	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700099
J	Turapov, O; Waddell, SJ; Burke, B; Glenn, S; Sarybaeva, AA; Tudo, G; Labesse, G; Young, DI; Young, M; Andrew, PW; Butcher, PD; Cohen-Gonsaud, M; Mukamolova, GV				Turapov, Obolbek; Waddell, Simon J.; Burke, Bernard; Glenn, Sarah; Sarybaeva, Asel A.; Tudo, Griselda; Labesse, Gilles; Young, Danielle I.; Young, Michael; Andrew, Peter W.; Butcher, Philip D.; Cohen-Gonsaud, Martin; Mukamolova, Galina V.			Oleoyl Coenzyme A Regulates Interaction of Transcriptional Regulator RaaS (Rv1219c) with DNA in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACID; TUBERCULOSIS; ACCUMULATION; FAMILY	We have recently shown that RaaS (regulator of antimicrobial-assisted survival), encoded by Rv1219c in Mycobacterium tuberculosis and by bcg_1279c in Mycobacterium bovis bacillus Calmette-Guerin, plays an important role in mycobacterial survival in prolonged stationary phase and during murine infection. Here, we demonstrate that long chain acyl-CoA derivatives (oleoyl-CoA and, to lesser extent, palmitoyl-CoA) modulate RaaS binding to DNA and expression of the downstream genes that encode ATP-dependent efflux pumps. Moreover, exogenously added oleic acid influences RaaS-mediated mycobacterial improvement of survival and expression of the RaaS regulon. Our data suggest that long chain acyl-CoA derivatives serve as biological indicators of the bacterial metabolic state. Dysregulation of efflux pumps can be used to eliminate non-growing mycobacteria.	[Turapov, Obolbek; Burke, Bernard; Glenn, Sarah; Sarybaeva, Asel A.; Andrew, Peter W.; Mukamolova, Galina V.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Waddell, Simon J.] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Tudo, Griselda; Butcher, Philip D.] St Georges Univ London, Div Clin Sci, Ctr Infect & Immun, London SW17 0RE, England; [Labesse, Gilles; Cohen-Gonsaud, Martin] CNRS, Ctr Biochim Struct, UMR 5048, F-34090 Montpellier, France; [Labesse, Gilles; Cohen-Gonsaud, Martin] Univ Montpellier I, INSERM, U1054, F-34090 Montpellier, France; [Labesse, Gilles; Cohen-Gonsaud, Martin] Univ Montpellier 2, INSERM, U1054, F-34090 Montpellier, France; [Young, Danielle I.; Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales	University of Leicester; University of Brighton; University of Sussex; St Georges University London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Mukamolova, GV (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England.	gvm4@le.ac.uk	Burke, Bernard/C-5075-2019; Waddell, Simon J/A-9170-2013; Andrew, Peter W/G-7526-2012	Burke, Bernard/0000-0001-5483-800X; Waddell, Simon J/0000-0002-3684-9116; Tudo, Griselda/0000-0002-9241-7051; Cohen-Gonsaud, Martin/0000-0002-0150-9912; Labesse, Gilles/0000-0002-6861-3300; Mukamolova, Galina/0000-0001-5697-2018; Butcher, Philip/0000-0003-1223-9097	Colorado State University [HHSN266200400091C]; Colorado State University (National Institutes of Health from NIAID) [N01-AI-40091]; BBSRC [BB/H008586/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008586/1] Funding Source: researchfish	Colorado State University; Colorado State University (National Institutes of Health from NIAID); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Natalie Garton and the Atelier de Bio & Chimie Informatique Structurale team for helpful discussions. M. tuberculosis DNA was provided by Colorado State University (Contract HHSN266200400091C, National Institutes of Health Grant N01-AI-40091 from NIAID).	Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cheah E. S., 2011, PLOS PATHOG, V7; Cheah ESG, 2010, J MOL DIAGN, V12, P250, DOI 10.2353/jmoldx.2010.090030; Deng WY, 2013, CELL SIGNAL, V25, P1608, DOI 10.1016/j.cellsig.2013.04.003; Dutta NK, 2014, MBIO, V5, DOI 10.1128/mBio.01066-13; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; KILBURN JO, 1981, ANTIMICROB AGENTS CH, V20, P401, DOI 10.1128/AAC.20.3.401; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar N, 2014, PROTEIN SCI, V23, P423, DOI 10.1002/pro.2424; Nazarova EV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P636, DOI 10.1134/S0006297911060034; Parrish NM, 1999, J ANTIMICROB CHEMOTH, V43, P219, DOI 10.1093/jac/43.2.219; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Radhakrishnan A, 2014, J BIOL CHEM, V289, P16526, DOI 10.1074/jbc.M113.538959; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Turapov O, 2014, ANTIMICROB AGENTS CH, V58, P2798, DOI 10.1128/AAC.02774-13; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Waddell SJ, 2010, METHODS MOL BIOL, V642, P75, DOI 10.1007/978-1-60327-279-7_6; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; World Health Organization, 2013, GLOB TUB CONTR REP 2	26	3	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25241	25249		10.1074/jbc.M114.577338	http://dx.doi.org/10.1074/jbc.M114.577338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012658	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000341985300043
J	Chi, ZX; Liu, RT; You, H; Ma, SS; Cui, H; Zhang, Q				Chi, Zhenxing; Liu, Rutao; You, Hong; Ma, Shanshan; Cui, Hao; Zhang, Qiang			Probing the In Vitro Cytotoxicity of the Veterinary Drug Oxytetracycline	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; OXOLINIC ACID; BLOOD; TETRACYCLINES; TOXICITY; ERYTHROCYTE; GLUTATHIONE; MECHANISM; MEMBRANES	The study investigated the effect of oxytetracycline (OTC) on the anti-oxidative defense system, the structure (hemolysis rate and morphology) and function (ATP enzyme activity) of human red blood cells (hRBCs) to investigate the possible toxic mechanism of OTC to hRBCs. The experimental results indicate that OTC can cause a decline in the function of the antioxidant defense system of hRBCs, resulting in oxidative stress. OTC can bring about morphological changes to hRBCs, and further leads to hemolysis, when the concentration of OTC is over 8x10(-5) M (about 164 mu g/ml). At a low OTC concentration, below 4x10(-5) M (82 mu g/ml), OTC can enhance the activity of ATP enzyme of hRBCs, known as hormesis. However, at a high concentration, above 4x10(-5) M (about 82 mu g/ml), the ATP enzymatic activity was inhibited, affecting the function of hRBCs. The estalished mechanism of toxicity of OTC to hRBCs can facilitate a deeper understanding of the toxicity of OTC in vivo.	[Chi, Zhenxing; You, Hong] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China; [Chi, Zhenxing; You, Hong; Ma, Shanshan; Cui, Hao; Zhang, Qiang] Harbin Inst Technol Weihai, Sch Marine Sci & Technol, Weihai, Peoples R China; [Liu, Rutao] Shandong Univ, Sch Environm Sci & Engn, Jinan 250100, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Shandong University	Chi, ZX (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China.	Zhenxingchi@gmail.com	YOU, Hong/G-6189-2012; Chi, Zhenxing/AAX-2123-2021	YOU, Hong/0000-0001-9454-1681; chi, zhen xing/0000-0001-7513-1580	State Key Laboratory of Urban Water Resource and Environment, HIT [2013DX09]; China Postdoctoral Science Foundation [2013M540297]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2014126]; NSFC [21277081]; Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China [708058]; Independent innovation program of Jinan [201202083]; Independent innovation foundation of Shandong University natural science projects [2012DX002]	State Key Laboratory of Urban Water Resource and Environment, HIT; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology); NSFC(National Natural Science Foundation of China (NSFC)); Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China(Ministry of Education, China); Independent innovation program of Jinan; Independent innovation foundation of Shandong University natural science projects	State Key Laboratory of Urban Water Resource and Environment, HIT (2013DX09); China Postdoctoral Science Foundation funded project (2013M540297); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology (HIT.NSRIF.2014126); NSFC (21277081); The Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (708058); Independent innovation program of Jinan (201202083); Independent innovation foundation of Shandong University natural science projects (2012DX002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATURE, V272, P552; Aruoma OI, 1998, J AM OIL CHEM SOC, V75, P199, DOI 10.1007/s11746-998-0032-9; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; BLOBEL H., 1960, JOUR AMER VET MED ASSOC, V137, P701; Boleas S, 2005, J HAZARD MATER, V122, P233, DOI 10.1016/j.jhazmat.2005.03.003; Brentnall C, 2013, RES VET SCI, V94, P687, DOI 10.1016/j.rvsc.2013.01.012; CANTLEY LC, 1978, NATURE, V272, P552, DOI 10.1038/272552a0; Chi ZX, 2010, J HAZARD MATER, V180, P741, DOI 10.1016/j.jhazmat.2010.04.110; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Das S, 2000, CURR SCI INDIA, V78, P486; de Campos HH, 2006, CLIMACTERIC, V9, P312, DOI 10.1080/13697130600871947; DEJONGE HR, 1973, BIOCHEM PHARMACOL, V22, P2659, DOI 10.1016/0006-2952(73)90127-5; Dinsmore RP, 1996, J AM VET MED ASSOC, V209, P1753; Doi AM, 1998, J VET PHARMACOL THER, V21, P364, DOI 10.1046/j.1365-2885.1998.00162.x; GABLER WL, 1991, RES COMMUN CHEM PATH, V72, P39; Gao N, 2007, ELECTROPHORESIS, V28, P3966, DOI 10.1002/elps.200700124; GIRARDI C, 1990, PHARMACOL RES, V22, P79, DOI 10.1016/1043-6618(90)90703-G; Gokalp O, 2006, MOL CELL BIOCHEM, V290, P55, DOI 10.1007/s11010-006-9157-z; Ferreira CSG, 2007, ECOTOX ENVIRON SAFE, V67, P452, DOI 10.1016/j.ecoenv.2006.10.006; Hammer M, 1998, APPL OPTICS, V37, P7410, DOI 10.1364/AO.37.007410; Herken H, 2001, MOL PSYCHIATR, V6, P66, DOI 10.1038/sj.mp.4000789; Hill A, 2007, BRIT J HAEMATOL, V137, P181, DOI 10.1111/j.1365-2141.2007.06554.x; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; HOBUSCH D, 1971, EXP PATHOL-JENA, V5, P298; Jiao SJ, 2008, J ENVIRON SCI, V20, P806, DOI 10.1016/S1001-0742(08)62130-0; Kong WD, 2007, ENVIRON POLLUT, V147, P187, DOI 10.1016/j.envpol.2006.08.016; Li KX, 2008, CHEMOSPHERE, V72, P473, DOI 10.1016/j.chemosphere.2008.02.008; Li Zhao-li, 2006, Journal of Ecology and Rural Environment, V22, P84; Lin YS, 2010, J AM CHEM SOC, V132, P4834, DOI 10.1021/ja910846q; Loke ML, 2003, J CHROMATOGR B, V783, P11, DOI 10.1016/S1570-0232(02)00468-3; Lorenzo C, 1999, INT J PANCREATOL, V26, P181, DOI 10.1385/IJGC:26:3:181; Lunden T, 1998, FISH SHELLFISH IMMUN, V8, P217, DOI 10.1006/fsim.1998.0142; Manrique-Moreno M, 2010, BIOPHYS CHEM, V147, P53, DOI 10.1016/j.bpc.2009.12.010; Mates JM, 1999, BLOOD CELL MOL DIS, V25, P103, DOI 10.1006/bcmd.1999.0234; Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X; NOUWS JFM, 1983, VET QUART, V5, P165, DOI 10.1080/01652176.1983.9693891; Omoregie E, 2002, J WORLD AQUACULT SOC, V33, P377, DOI 10.1111/j.1749-7345.2002.tb00514.x; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Parmentier C, 1999, ELECTROPHORESIS, V20, P2938; [曲甍甍 Qu Mengmeng], 2004, [农业环境科学学报, Journal of Agro-environment science], V23, P240; Reja A, 1996, VET HUM TOXICOL, V38, P344; Rigos G, 2004, AQUAT TOXICOL, V69, P281, DOI 10.1016/j.aquatox.2004.05.009; Roncada P, 2000, J VET PHARMACOL THER, V23, P281, DOI 10.1046/j.1365-2885.2000.00260.x; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Roversi FM, 2006, CLIN CHIM ACTA, V364, P316, DOI 10.1016/j.cca.2005.07.022; SELWYN MJ, 1970, EUR J BIOCHEM, V14, P120, DOI 10.1111/j.1432-1033.1970.tb00268.x; Shcharbin D, 2010, J CONTROL RELEASE, V141, P110, DOI 10.1016/j.jconrel.2009.09.030; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Skaper SD, 1997, FREE RADICAL BIO MED, V22, P669, DOI 10.1016/S0891-5849(96)00383-8; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Sun YC, 2002, J CONTROL RELEASE, V85, P125, DOI 10.1016/S0168-3659(02)00286-9; Suwalsky M, 2009, J INORG BIOCHEM, V103, P797, DOI 10.1016/j.jinorgbio.2009.02.009; Uno K, 1996, AQUACULTURE, V143, P33, DOI 10.1016/0044-8486(95)01225-7; Mamani MCV, 2009, FOOD CHEM, V117, P545, DOI 10.1016/j.foodchem.2009.04.032; Virolainen NE, 2008, J AGR FOOD CHEM, V56, P11065, DOI 10.1021/jf801797z; Wadsworth RM, 2008, EXP PHYSIOL, V93, P155, DOI 10.1113/expphysiol.2007.038687; WENNMALM A, 1992, BRIT J PHARMACOL, V106, P507, DOI 10.1111/j.1476-5381.1992.tb14365.x; Xiong J, 2013, J PHYS C SER, V418, P1; Ye ZQ, 2007, ANAL CHEM, V79, P1135, DOI 10.1021/ac060972a; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	60	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102334	10.1371/journal.pone.0102334	http://dx.doi.org/10.1371/journal.pone.0102334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019386	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600070
J	Dai, CL; Yan, ZH; You, Q; Du, MY; Zhao, MW				Dai, Caili; Yan, Zhihu; You, Qing; Du, Mingyong; Zhao, Mingwei			Formation of Worm-Like Micelles in Mixed N-Hexadecyl-N-Methylpyrrolidinium Bromide-Based Cationic Surfactant and Anionic Surfactant Systems	PLOS ONE			English	Article							CETYLTRIMETHYLAMMONIUM BROMIDE; VISCOELASTIC PROPERTIES; RHEOLOGICAL BEHAVIOR; NMR-SPECTROSCOPY; IONIC LIQUIDS; BICELLES; DYNAMICS	Through the descriptive and rheological characterization of worm-like micelles formed by N-hexadecyl-N-methylpyrrolidinium bromide and sodium laurate, the formation and properties of the worm-like micelles were affected by the concentrations of sodium laurate and temperature. Additionally, cryogenic transmission electron microscopy images further validated the formation of worm-like micelles.	[Dai, Caili; Yan, Zhihu; Du, Mingyong; Zhao, Mingwei] China Univ Petr Huadong, Sch Petr Engn, Qingdao, Shandong, Peoples R China; [You, Qing] China Univ Geosci, Sch Energy Resources, Beijing, Peoples R China	China University of Petroleum; China University of Geosciences	Zhao, MW (corresponding author), China Univ Petr Huadong, Sch Petr Engn, Qingdao, Shandong, Peoples R China.	zhaomingwei@upc.edu.cn	Du, Mingyong/O-6384-2017	Du, Mingyong/0000-0001-7006-2125; Dai, Cai li/0000-0002-7477-8865	National Natural Science Foundation of China [51174221, 21303268]; Program for New Century Excellent Talents in University [20110226]; China Postdoctoral Science Foundation [2013T60689]; National Ministry of Education [20120133110010]; Fundamental Research Funds for the Central Universities [14CX02041A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was sponsored by the National Natural Science Foundation of China (number 51174221, 21303268), the Program for New Century Excellent Talents in University (number 20110226), China Postdoctoral Science Foundation funded project (number 2013T60689), Doctoral Fund from National Ministry of Education (number 20120133110010) and the Fundamental Research Funds for the Central Universities (number 14CX02041A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya DP, 2004, PHYS CHEM CHEM PHYS, V6, P1627, DOI 10.1039/b312940c; Ali AA, 1999, COLLOID POLYM SCI, V277, P270; Anderson VJ, 2006, RHEOLOGY REV, V2006, P217; CANDAU SJ, 1988, J COLLOID INTERF SCI, V122, P430, DOI 10.1016/0021-9797(88)90377-3; CANDAU SJ, 1985, J COLLOID INTERF SCI, V105, P521, DOI 10.1016/0021-9797(85)90327-3; Cates ME, 2006, ADV PHYS, V55, P799, DOI 10.1080/00018730601082029; CATES ME, 1990, J PHYS-CONDENS MAT, V2, P6869, DOI 10.1088/0953-8984/2/33/001; Chu ZL, 2013, CHEM SOC REV, V42, P7174, DOI 10.1039/c3cs35490c; Davies TS, 2006, J AM CHEM SOC, V128, P6669, DOI 10.1021/ja060021e; Dong B, 2008, COLLOID SURFACE A, V317, P666, DOI 10.1016/j.colsurfa.2007.12.001; Dong B, 2007, LANGMUIR, V23, P4178, DOI 10.1021/la0633029; Dvinskikh S, 2006, J AM CHEM SOC, V128, P6326, DOI 10.1021/ja061153a; Dvinskikh SV, 2007, J AM CHEM SOC, V129, P794, DOI 10.1021/ja065536k; Dvinskikh SV, 2007, J MAGN RESON, V184, P228, DOI 10.1016/j.jmr.2006.10.004; Geng F, 2010, PROCESS BIOCHEM, V45, P306, DOI 10.1016/j.procbio.2009.10.001; GRANEK R, 1992, J CHEM PHYS, V96, P4758, DOI 10.1063/1.462787; HOFFMANN H, 1992, LANGMUIR, V8, P2140, DOI 10.1021/la00045a013; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kumar R, 2007, LANGMUIR, V23, P12849, DOI 10.1021/la7028559; Li J, 2012, COLLOID SURFACE A, V396, P16, DOI 10.1016/j.colsurfa.2011.12.019; Lin Z, 1996, LANGMUIR, V12, P1729, DOI 10.1021/la950570q; Lu T, 2008, J PHYS CHEM B, V112, P2909, DOI 10.1021/jp0766205; Magid LJ, 1998, J PHYS CHEM B, V102, P4064, DOI 10.1021/jp9730961; Moitzi C, 2005, J PHYS CHEM B, V109, P16161, DOI 10.1021/jp0441691; Pei XM, 2011, J COLLOID INTERF SCI, V356, P176, DOI 10.1016/j.jcis.2010.12.065; REHAGE H, 1988, J PHYS CHEM-US, V92, P4712, DOI 10.1021/j100327a031; REHAGE H, 1991, MOL PHYS, V74, P933, DOI 10.1080/00268979100102721; Shi LJ, 2012, RSC ADV, V2, P11922, DOI 10.1039/c2ra21467a; SHIKATA T, 1987, LANGMUIR, V3, P1081, DOI 10.1021/la00078a035; Shrestha RG, 2007, J COLLOID INTERF SCI, V311, P276, DOI 10.1016/j.jcis.2007.02.050; Shrestha RG, 2009, COLLOID SURFACE A, V332, P103, DOI 10.1016/j.colsurfa.2008.09.002; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Xu J, 2008, ANGEW CHEM, V120, P7982; Yamamoto K, 2009, LANGMUIR, V25, P7010, DOI 10.1021/la900200s; Zhao MW, 2011, PHYS CHEM CHEM PHYS, V13, P1332, DOI 10.1039/c0cp00342e	35	10	10	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102539	10.1371/journal.pone.0102539	http://dx.doi.org/10.1371/journal.pone.0102539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019152	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600093
J	Tonnessen, E; Sylta, O; Haugen, TA; Hem, E; Svendsen, IS; Seiler, S				Tonnessen, Espen; Sylta, Oystein; Haugen, Thomas A.; Hem, Erlend; Svendsen, Ida S.; Seiler, Stephen			The Road to Gold: Training and Peaking Characteristics in the Year Prior to a Gold Medal Endurance Performance	PLOS ONE			English	Article							INTENSITY DISTRIBUTION; AEROBIC POWER; ELITE MALE; DURATION; TAPER; COMPETITION; ADAPTATION; CYCLISTS; RUNNERS; TOUR	Purpose: To describe training variations across the annual cycle in Olympic and World Champion endurance athletes, and determine whether these athletes used tapering strategies in line with recommendations in the literature. Methods: Eleven elite XC skiers and biathletes (4 male; 28 +/- 1 yr, 85 +/- 5 mL. min(-1). kg(-1) (V) over dotO(2max), 7 female, 25 +/- 4 yr, 73 +/- 3 mL.min(-1).kg(-1) (V) over dotO(2max) reported one year of day-to-day training leading up to the most successful competition of their career. Training data were divided into periodization and peaking phases and distributed into training forms, intensity zones and endurance activity forms. Results: Athletes trained similar to 800 h/500 sessions.year(-1), including similar to 500 h. year(-1) of sport-specific training. Ninety-four percent of all training was executed as aerobic endurance training. Of this, similar to 90% was low intensity training (LIT, below the first lactate threshold) and 10% high intensity training (HIT, above the first lactate threshold) by time. Categorically, 23% of training sessions were characterized as HIT with primary portions executed at or above the first lactate turn point. Training volume and specificity distribution conformed to a traditional periodization model, but absolute volume of HIT remained stable across phases. However, HIT training patterns tended to become more polarized in the competition phase. Training volume, frequency and intensity remained unchanged from pre-peaking to peaking period, but there was a 32 +/- 15% (P<.01) volume reduction from the preparation period to peaking phase. Conclusions: The annual training data for these Olympic and World champion XC skiers and biathletes conforms to previously reported training patterns of elite endurance athletes. During the competition phase, training became more sport-specific, with 92% performed as XC skiing. However, they did not follow suggested tapering practice derived from short-term experimental studies. Only three out of 11 athletes took a rest day during the final 5 days prior to their most successful competition.	[Tonnessen, Espen; Haugen, Thomas A.; Hem, Erlend] Norwegian Olymp Federat, Oslo, Norway; [Sylta, Oystein; Seiler, Stephen] Univ Agder, Fac Hlth & Sport Sci, Kristiansand, Norway; [Svendsen, Ida S.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England	University of Agder; Loughborough University	Tonnessen, E (corresponding author), Norwegian Olymp Federat, Oslo, Norway.	espen.tonnessen@olympiatoppen.no	Haugen, Thomas/AAQ-5280-2021; Haugen, Thomas/I-9580-2015	Haugen, Thomas/0000-0001-5929-0389				Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Bompa T.O., 2009, PERIODIZATION THEORY, VFifth; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Esteve-Lanao J, 2007, J STRENGTH COND RES, V21, P943, DOI 10.1519/00124278-200708000-00048; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; FOSTER C, 1995, EUR J APPL PHYSIOL O, V70, P367, DOI 10.1007/BF00865035; Gao J., 2008, J BEIJING SPORT U, V31, P832; Garcia-Pallares J, 2010, EUR J APPL PHYSIOL, V110, P99, DOI 10.1007/s00421-010-1484-9; Guellich A, 2009, INT J SPORT PHYSIOL, V4, P448, DOI 10.1123/ijspp.4.4.448; HICKSON RC, 1985, J APPL PHYSIOL, V58, P492, DOI 10.1152/jappl.1985.58.2.492; HICKSON RC, 1982, J APPL PHYSIOL, V53, P225, DOI 10.1152/jappl.1982.53.1.225; HOUMARD JA, 1994, MED SCI SPORT EXER, V26, P624; Ingham SA, 2012, INT J SPORT PHYSIOL, V7, P193, DOI 10.1123/ijspp.7.2.193; Karp J R, 2008, NEW STUDIES ATHLETIC, V23, P31; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Le Meur Y, 2012, SCI SPORT, V27, P77, DOI 10.1016/j.scispo.2011.06.013; Losnegard T, 2013, J STRENGTH COND RES, V27, P1780, DOI 10.1519/JSC.0b013e31827368f6; Lucia A, 1999, INT J SPORTS MED, V20, P167, DOI 10.1055/s-2007-971112; Lucia A, 2003, MED SCI SPORT EXER, V35, P872, DOI 10.1249/01.MSS.0000064999.82036.B4; Matwejew, 1975, PERIODISIERUNG SPORT; McNeely E, 2007, STRENGTH COND J, V29, P18; Mujika I, 1995, Can J Appl Physiol, V20, P395; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Mujika I, 2003, MED SCI SPORT EXER, V35, P1182, DOI 10.1249/01.MSS.0000074448.73931.11; Mujika I, 2002, INT J SPORTS MED, V23, P582, DOI 10.1055/s-2002-35526; Mujika I, 2010, SCAND J MED SCI SPOR, V20, P24, DOI 10.1111/j.1600-0838.2010.01189.x; Mujika I, 2002, INT J SPORTS MED, V23, P367, DOI 10.1055/s-2002-33146; Mujika I, 2013, INT J SPORT IN PRESS; Neal CM, 2011, J SPORT SCI, V29, P1515, DOI 10.1080/02640414.2011.596217; NSF, 1985, TREN LANGR; NSF, 1992, TREN LANGR; NSSF, 1991, TREN SKISK; Orie J, 2014, INT J SPORT PHYSIOL, V9, P93, DOI 10.1123/IJSPP.2013-0427; Pyne DB, 2009, J SPORT SCI, V27, P195, DOI 10.1080/02640410802509136; Ronnestad BR, 2010, EUR J APPL PHYSIOL, V110, P1269, DOI 10.1007/s00421-010-1622-4; Sandbakk O, 2011, SCAND J MED SCI SPOR, V21, pE9, DOI 10.1111/j.1600-0838.2010.01117.x; Sandbakk O, 2014, INT J SPORT PHYSIOL, V9, P117, DOI [10.1123/ijspp.2013-0373, 10.1123/IJSPP.2013-0373]; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P1029; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Seiler S, 2009, SPORTSCIENCE, V13, P1; Seiler S, 2010, INT J SPORT PHYSIOL, V5, P276, DOI 10.1123/ijspp.5.3.276; SHEPLEY B, 1992, J APPL PHYSIOL, V72, P706, DOI 10.1152/jappl.1992.72.2.706; Siewierski M., 2010, POL J SPORT TOUR, V17, P227; Steinacker JM, 1998, MED SCI SPORT EXER, V30, P1158, DOI 10.1097/00005768-199807000-00022; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P100, DOI 10.1123/IJSPP.2013-0298; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P85, DOI [10.1123/ijspp.2013-0203, 10.1123/IJSPP.2013-0203]; TANAKA H, 1994, SPORTS MED, V18, P330, DOI 10.2165/00007256-199418050-00005; Thomas L, 2005, MED SCI SPORT EXER, V37, P1615, DOI 10.1249/01.mss.0000177461.94156.4b; Tjelta Leif Inge, 2013, IJASS(International Journal of Applied Sports Sciences), V25, P11; Tjelta LI, 2014, INT J SPORTS SCI COA, V9, P139, DOI 10.1260/1747-9541.9.1.139; Tonnessen E., 2009, HVORFOR BLE BESTE BE; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Yu HJ, 2012, INT J SPORT PHYSIOL, V7, P103, DOI 10.1123/ijspp.7.2.103; Zapico AG, 2007, J SPORT MED PHYS FIT, V47, P191	57	126	129	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101796	10.1371/journal.pone.0101796	http://dx.doi.org/10.1371/journal.pone.0101796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019608	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600028
J	Belzer, C; Gerber, GK; Roeselers, G; Delaney, M; DuBois, A; Liu, Q; Belavusava, V; Yeliseyev, V; Houseman, A; Onderdonk, A; Cavanaugh, C; Bry, L				Belzer, Clara; Gerber, Georg K.; Roeselers, Guus; Delaney, Mary; DuBois, Andrea; Liu, Qing; Belavusava, Vera; Yeliseyev, Vladimir; Houseman, Andres; Onderdonk, Andrew; Cavanaugh, Colleen; Bry, Lynn			Dynamics of the Microbiota in Response to Host Infection	PLOS ONE			English	Article							CITROBACTER-RODENTIUM INFECTION; GENE-EXPRESSION DATA; MUCOSAL INFECTION; GUT MICROBIOME; MICE; INFLAMMATION; DIVERSITY; SEQUENCES; PATHOGEN; COLITIS	Longitudinal studies of the microbiota are important for discovering changes in microbial communities that affect the host. The complexity of these ecosystems requires rigorous integrated experimental and computational methods to identify temporal signatures that promote physiologic or pathophysiologic responses in vivo. Employing a murine model of infectious colitis with the pathogen Citrobacter rodentium, we generated a 2-month time-series of 16S rDNA gene profiles, and quantitatively cultured commensals, from multiple intestinal sites in infected and uninfected mice. We developed a computational framework to discover time-varying signatures for individual taxa, and to automatically group signatures to identify microbial sub-communities within the larger gut ecosystem that demonstrate common behaviors. Application of this model to the 16S rDNA dataset revealed dynamic alterations in the microbiota at multiple levels of resolution, from effects on systems-level metrics to changes across anatomic sites for individual taxa and species. These analyses revealed unique, time-dependent microbial signatures associated with host responses at different stages of colitis. Signatures included a Mucispirillum OTU associated with early disruption of the colonic surface mucus layer, prior to the onset of symptomatic colitis, and members of the Clostridiales and Lactobacillales that increased with successful resolution of inflammation, after clearance of the pathogen. Quantitative culture data validated findings for predominant species, further refining and strengthening model predictions. These findings provide new insights into the complex behaviors found within host ecosystems, and define several time-dependent microbial signatures that may be leveraged in studies of other infectious or inflammatory conditions.	[Belzer, Clara; Gerber, Georg K.; Delaney, Mary; DuBois, Andrea; Liu, Qing; Belavusava, Vera; Yeliseyev, Vladimir; Onderdonk, Andrew; Bry, Lynn] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Belzer, Clara; Gerber, Georg K.; Onderdonk, Andrew; Bry, Lynn] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gerber, Georg K.; Delaney, Mary; DuBois, Andrea; Liu, Qing; Belavusava, Vera; Yeliseyev, Vladimir; Onderdonk, Andrew; Bry, Lynn] Harvard Univ, Brigham & Womens Hosp, Ctr Clin & Translat Metagenom, Harvard Digest Dis Ctr,Med Sch, Boston, MA 02115 USA; [Roeselers, Guus; Cavanaugh, Colleen] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Houseman, Andres] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Bry, L (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	lbry@partners.org	Roeselers, Guus/J-2971-2012; Belzer, Clara/P-6500-2018; Young, Richard A/F-6495-2012	Roeselers, Guus/0000-0002-4725-6105; Belzer, Clara/0000-0001-6922-836X; Young, Richard A/0000-0001-8855-8647; Onderdonk, Andrew/0000-0001-8998-8972; Houseman, Eugene Andres/0000-0003-0703-1830; Bry, Lynn/0000-0002-8792-8527	Harvard Digestive Diseases Center (NIH) [P30-DK034854, R01-HD061916]; Netherlands Organization for Scientific Research, NWO; Stanley L. Robbins Memorial Research award; Harvard Catalyst; Harvard Clinical and Translational Science Center [UL1 RR 025758]; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Harvard Digestive Diseases Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO)); Stanley L. Robbins Memorial Research award; Harvard Catalyst; Harvard Clinical and Translational Science Center; Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work supported by a pilot feasibility grant from the Harvard Digestive Diseases Center (NIH Award #P30-DK034854; CMC, LB), R01-HD061916 (LB, CB), Rubicon grant from the Netherlands Organization for Scientific Research, NWO (GR), Stanley L. Robbins Memorial Research award (GKG), and Harvard Catalyst, The Harvard Clinical and Translational Science Center (AH; NIH Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Bar-Joseph Z, 2003, P NATL ACAD SCI USA, V100, P10146, DOI 10.1073/pnas.1732547100; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bishop AL, 2007, MICROBES INFECT, V9, P1316, DOI 10.1016/j.micinf.2007.06.006; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chen CC, 2005, PEDIATR RES, V58, P1185, DOI 10.1203/01.pdr.0000183660.39116.83; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Gerber GK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002624; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HINTZ HF, 1978, J ANIM SCI, V46, P1803, DOI 10.2527/jas1978.4661803x; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Johnson-Henry KC, 2005, J INFECT DIS, V191, P2106, DOI 10.1086/430318; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Murray PR, 2010, TOPLEY WILSONS MICRO; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Robertson BR, 2005, INT J SYST EVOL MICR, V55, P1199, DOI 10.1099/ijs.0.63472-0; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	44	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e95534	10.1371/journal.pone.0095534	http://dx.doi.org/10.1371/journal.pone.0095534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014551	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400001
J	Murugesan, GR; Romero, LF; Persia, ME				Murugesan, Ganapathi R.; Romero, Luis F.; Persia, Michael E.			Effects of Protease, Phytase and a Bacillus sp. Direct-Fed Microbial on Nutrient and Energy Digestibility, Ileal Brush Border Digestive Enzyme Activity and Cecal Short-Chain Fatty Acid Concentration in Broiler Chickens	PLOS ONE			English	Article							APPARENT METABOLIZABLE ENERGY; SUBTILIS VAR. NATTO; GROWTH-PERFORMANCE; SOYBEAN-MEAL; FEED RESTRICTION; LIVE PERFORMANCE; YOUNG BROILERS; AMINO-ACIDS; DIETS; SUPPLEMENTATION	Two experiments were conducted to determine the effects of protease and phytase (PP) and a Bacillus sp. direct-fed microbial (DFM) on dietary energy and nutrient utilization in broiler chickens. In the first experiment, Ross 308 broiler chicks were fed diets supplemented with PP and DFM in a 262 factorial arrangement. The 4 diets (control (CON), CON + PP, CON + DFM, and CON + PP + DFM) were fed from 15-21 days of age. In Experiment 1, significant interaction (P <= 0.01) between PP and DFM on the apparent ileal digestibility coefficient for starch, crude protein, and amino acid indicated that both additives increased the digestibility. Both additives increased the nitrogen retention coefficient with a significant interaction (P <= 0.01). Although no interaction was observed, significant main effects (P <= 0.01) for nitrogen-corrected apparent ME (AMEn) for PP or DFM indicated an additive response. In a follow-up experiment, Ross 308 broiler chicks were fed the same experimental diets from 1-21 days of age. Activities of ileal brush border maltase, sucrase, and L-alanine aminopeptidase were increased (P <= 0.01) by PP addition, while a trend (P = 0.07) for increased sucrase activity was observed in chickens fed DFM, in Experiment 2. The proportion of cecal butyrate was increased (P <= 0.01) by DFM addition. Increased nutrient utilization and nitrogen retention appear to involve separate but complementary mechanisms for PP and DFM, however AMEn responses appear to have separate and additive mechanisms.	[Murugesan, Ganapathi R.; Persia, Michael E.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Romero, Luis F.] DuPont Ind Biosci, Danisco Anim Nutr, Marlborough, England	Iowa State University	Persia, ME (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	mpersia@vt.edu		Murugesan, Raj/0000-0002-1285-2126	Danisco Animal Nutrition - DuPont Industrial Biosciences	Danisco Animal Nutrition - DuPont Industrial Biosciences	The experiments were funded by Danisco Animal Nutrition - DuPont Industrial Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aacc, 2011, J AACC INT; Aoac, 2006, J AOAC INT; Apata DF, 2008, J SCI FOOD AGR, V88, P1253, DOI 10.1002/jsfa.3214; Aviagen, 2011, ROSS 308 PER STAND M; Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213; COLLINGTON GK, 1990, BRIT J NUTR, V64, P59, DOI 10.1079/BJN19900009; Colombatto D, 2009, J ANIM SCI, V87, P1097, DOI 10.2527/jas.2008-1262; Cowieson AJ, 2008, BRIT POULTRY SCI, V49, P37, DOI 10.1080/00071660701812989; Cowieson AJ, 2009, WORLD POULTRY SCI J, V65, P609, DOI 10.1017/S0043933909000427; DAHLQVIST A, 1964, ANAL BIOCHEM, V7, P18, DOI 10.1016/0003-2697(64)90115-0; Douglas MW, 2000, J APPL POULTRY RES, V9, P74, DOI 10.1093/japr/9.1.74; Fritts CA, 2000, J APPL POULTRY RES, V9, P149, DOI 10.1093/japr/9.2.149; Fujiwara K, 2009, J POULT SCI, V46, P116, DOI 10.2141/jpsa.46.116; Ghazi S, 2002, BRIT POULTRY SCI, V43, P70, DOI 10.1080/00071660120109935; Hooge DM, 2004, J APPL POULTRY RES, V13, P222, DOI 10.1093/japr/13.2.222; Jin LZ, 2000, POULTRY SCI, V79, P886, DOI 10.1093/ps/79.6.886; Kocher A, 2003, J APPL POULTRY RES, V12, P275, DOI 10.1093/japr/12.3.275; Kumprecht I, 1998, CZECH J ANIM SCI, V43, P327; Lemme A, 2004, WORLD POULTRY SCI J, V60, P423, DOI 10.1079/WPS200426; LEONE JL, 1973, J ASSOC OFF ANA CHEM, V56, P535; Li LL, 2008, J SCI FOOD AGR, V88, P35, DOI 10.1002/jsfa.2910; Liu N, 2009, ARCH ANIM NUTR, V63, P292, DOI 10.1080/17450390903020422; Lopez G, 2005, POULTRY SCI, V84, P1069, DOI 10.1093/ps/84.7.1069; MAROUX S, 1973, BIOCHIM BIOPHYS ACTA, V321, P282, DOI 10.1016/0005-2744(73)90083-1; Marsman GJP, 1997, POULTRY SCI, V76, P864, DOI 10.1093/ps/76.6.864; Mathlouthi N, 2011, INT J POULT SCI, V10; Meng X, 2005, POULTRY SCI, V84, P1242, DOI 10.1093/ps/84.8.1242; Murugesan GR, 2013, POULTRY SCI, V92, P1238, DOI 10.3382/ps.2012-02719; Olukosi OA, 2008, BRIT J NUTR, V99, P682, DOI 10.1017/S0007114507815807; Pinheiro DF, 2004, POULTRY SCI, V83, P1544, DOI 10.1093/ps/83.9.1544; Ravindran V, 2000, BRIT POULTRY SCI, V41, P193, DOI 10.1080/00071660050022263; Saartchit J, 1990, POULTRY SCI, V69, P1966; Samanya M, 2002, COMP BIOCHEM PHYS A, V133, P95, DOI 10.1016/S1095-6433(02)00121-6; SANTOSO U, 1995, BRIT J NUTR, V74, P523, DOI 10.1079/BJN19950155; Santoso U, 2001, ASIAN AUSTRAL J ANIM, V14, P333; SAS Institute Inc, 2012, SAS; Scott M. L., 1982, NUTR CHICKEN, V3rd; Shirley RB, 2003, POULTRY SCI, V82, P671, DOI 10.1093/ps/82.4.671; Wang ZR, 2005, POULTRY SCI, V84, P875, DOI 10.1093/ps/84.6.875; Yu B, 2007, ANIM FEED SCI TECH, V134, P283, DOI 10.1016/j.anifeedsci.2006.09.017; Zanella I, 1999, POULTRY SCI, V78, P561, DOI 10.1093/ps/78.4.561; Zhou Y, 2009, POULTRY SCI, V88, P316, DOI 10.3382/ps.2008-00231	42	33	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101888	10.1371/journal.pone.0101888	http://dx.doi.org/10.1371/journal.pone.0101888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013936	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400045
J	Pena-Soler, E; Fernandez, FJ; Lopez-Estepa, M; Garces, F; Richardson, AJ; Quintana, JF; Rudd, KE; Coll, M; Vega, MC				Pena-Soler, Esther; Fernandez, Francisco J.; Lopez-Estepa, Miguel; Garces, Fernando; Richardson, Andrew J.; Quintana, Juan F.; Rudd, Kenneth E.; Coll, Miquel; Cristina Vega, M.			Structural Analysis and Mutant Growth Properties Reveal Distinctive Enzymatic and Cellular Roles for the Three Major L-Alanine Transaminases of Escherichia coli	PLOS ONE			English	Article							HISTIDINOL-PHOSPHATE AMINOTRANSFERASE; DOUBLE SUBSTRATE RECOGNITION; ASPARTATE-AMINOTRANSFERASE; PYRIDOXAL 5'-PHOSPHATE; CRYSTAL-STRUCTURES; ENZYMES; MECHANISM; GLUTAMATE; MITOCHONDRIAL; REFINEMENT	In order to maintain proper cellular function, the metabolism of the bacterial microbiota presents several mechanisms oriented to keep a correctly balanced amino acid pool. Central components of these mechanisms are enzymes with alanine transaminase activity, pyridoxal 5'-phosphate-dependent enzymes that interconvert alanine and pyruvate, thereby allowing the precise control of alanine and glutamate concentrations, two of the most abundant amino acids in the cellular amino acid pool. Here we report the 2.11-A crystal structure of full-length AlaA from the model organism Escherichia coli, a major bacterial alanine aminotransferase, and compare its overall structure and active site composition with detailed atomic models of two other bacterial enzymes capable of catalyzing this reaction in vivo, AlaC and valine-pyruvate aminotransferase (AvtA). Apart from a narrow entry channel to the active site, a feature of this new crystal structure is the role of an active site loop that closes in upon binding of substrate-mimicking molecules, and which has only been previously reported in a plant enzyme. Comparison of the available structures indicates that beyond superficial differences, alanine aminotransferases of diverse phylogenetic origins share a universal reaction mechanism that depends on an array of highly conserved amino acid residues and is similarly regulated by various unrelated motifs. Despite this unifying mechanism and regulation, growth competition experiments demonstrate that AlaA, AlaC and AvtA are not freely exchangeable in vivo, suggesting that their functional repertoire is not completely redundant thus providing an explanation for their independent evolutionary conservation.	[Pena-Soler, Esther; Fernandez, Francisco J.; Lopez-Estepa, Miguel; Quintana, Juan F.; Cristina Vega, M.] CSIC, Ctr Invest Biol, Spanish Natl Res Council, Madrid, Spain; [Pena-Soler, Esther; Coll, Miquel] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Coll, Miquel] Inst Biol Mol Barcelona IBMB CSIC, Barcelona, Spain; [Garces, Fernando] Scripps Res Inst, La Jolla, CA 92037 USA; [Richardson, Andrew J.; Rudd, Kenneth E.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Scripps Research Institute; University of Miami	Vega, MC (corresponding author), CSIC, Ctr Invest Biol, Spanish Natl Res Council, Madrid, Spain.	cvega@cib.csic.es	Peña, Esther/AAB-8217-2019; Coll, Miquel/L-5999-2014; Fernandez, Francisco J./C-3647-2011; Vega, M. Cristina/C-3640-2011	Coll, Miquel/0000-0003-4471-8674; Pena, Esther/0000-0003-2750-0614; Fernandez, Francisco J./0000-0002-5015-1849; Vega, M. Cristina/0000-0003-0628-8378	Spanish Ministry of Economy and Competitiveness [PET2008_0101, BIO2009-11184, BFU2010-22260-C02-02, BFU2008-02372/BMC, CSD 2006-23, BFU2011-22588]; Generalitat de Catalunya [SGR2009-1309]; European Commission [279039]; US National Institutes of Health [1-R01-GM58560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058560] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Spanish Ministry of Economy and Competitiveness (grants PET2008_0101, BIO2009-11184 and BFU2010-22260-C02-02 to MCV and BFU2008-02372/ BMC, CSD 2006-23 and BFU2011-22588 to MC), the Generalitat de Catalunya (grant SGR2009-1309 to MC), the European Commission (Framework Programme 7 (FP7) projects ComplexINC No. 279039 to MCV), and the US National Institutes of Health (grant 1-R01-GM58560 to KER and AJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cho BK, 2012, NAT CHEM BIOL, V8, P65, DOI 10.1038/nchembio.710; Cook PD, 2007, BIOCHEMISTRY-US, V46, P14215, DOI 10.1021/bi701686s; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duff SMG, 2012, ARCH BIOCHEM BIOPHYS, V528, P90, DOI 10.1016/j.abb.2012.06.006; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez FJ, 2004, J BIOL CHEM, V279, P21478, DOI 10.1074/jbc.M400291200; Fernandez FJ, 2012, BBA-PROTEINS PROTEOM, V1824, P339, DOI 10.1016/j.bbapap.2011.10.016; GEHRING H, 1984, BIOCHEMISTRY-US, V23, P6335, DOI 10.1021/bi00321a007; Glinghammar B, 2009, INT J MOL MED, V23, P621, DOI 10.3892/ijmm_00000173; Goto M, 2003, BIOCHEMISTRY-US, V42, P3725, DOI 10.1021/bi026722f; Graber R, 1999, J BIOL CHEM, V274, P31203, DOI 10.1074/jbc.274.44.31203; Griswold WR, 2011, J AM CHEM SOC, V133, P14823, DOI 10.1021/ja2061006; Haruyama K, 2001, BIOCHEMISTRY-US, V40, P4633, DOI 10.1021/bi002769u; Hayashi H, 1998, BIOCHEMISTRY-US, V37, P15076, DOI 10.1021/bi981517e; Hayashi H, 2003, BBA-PROTEINS PROTEOM, V1647, P103, DOI 10.1016/S1570-9639(03)00068-2; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Islam MM, 2005, BIOCHEMISTRY-US, V44, P8218, DOI 10.1021/bi050071g; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim SH, 2010, J BACTERIOL, V192, P5304, DOI 10.1128/JB.00738-10; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Kleywegt Gerard J, 2007, Methods Mol Biol, V364, P255; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Liangpunsakul S, 2005, AM J MED SCI, V329, P111, DOI 10.1097/00000441-200503000-00001; MALASHKEVICH VN, 1993, BIOCHEMISTRY-US, V32, P13451, DOI 10.1021/bi00212a010; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Mizuguchi H, 2003, BBA-PROTEINS PROTEOM, V1647, P321, DOI 10.1016/S1570-9639(03)00082-7; Mizuguchi H, 2001, BIOCHEMISTRY-US, V40, P353, DOI 10.1021/bi001403e; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Ouchi T, 2009, BIOCHEM BIOPH RES CO, V388, P21, DOI 10.1016/j.bbrc.2009.07.096; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; WANG MD, 1987, J BACTERIOL, V169, P5610, DOI 10.1128/jb.169.12.5610-5614.1987; WANG MD, 1987, J BACTERIOL, V169, P4228, DOI 10.1128/jb.169.9.4228-4234.1987; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Ward DE, 2000, J BACTERIOL, V182, P2559, DOI 10.1128/JB.182.9.2559-2566.2000; Watanabe N, 2008, J MOL BIOL, V384, P1314, DOI 10.1016/j.jmb.2008.10.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235; Zhou JD, 2011, METHODS MOL BIOL, V765, P3, DOI 10.1007/978-1-61779-197-0_1; Zhou W, SE COLLABOR IN PRESS	59	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102139	10.1371/journal.pone.0102139	http://dx.doi.org/10.1371/journal.pone.0102139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014014	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000339378400069
J	Shen, YC; Weng, SF; Wang, JJ; Tien, KJ				Shen, Yuan-Chi; Weng, Shih-Feng; Wang, Jhi-Joung; Tien, Kai-Jen			Erectile Dysfunction and Risk of End Stage Renal Disease Requiring Dialysis: A Nationwide Population-Based Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; SEXUAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; PREVALENCE; MEN; HYPERTENSION; PREDICTOR; SEVERITY	Background: Previous studies have suggested that erectile dysfunction (ED) is an independent risk factor for macrovascular disease. Very few studies have evaluated the relationship between ED and risk of end stage renal disease (ESRD) requiring dialysis. Methods: A random sample of 1,000,000 individuals from Taiwan's National Health Insurance database was collected. We selected the control group by matching the subjects and controls by age, diabetes, hypertension, coronary heart disease, hyperlipidemia, area of residence, monthly income and index date. We identified 3985 patients with newly-diagnosed ED between 2000 and 2008 and compared them with a matched cohort of 23910 patients without ED. All patients were tracked from the index date to identify which patients subsequently developed a need for dialysis. Results: The incidence rates of dialysis in the ED cohort and comparison groups were 10.85 and 9.06 per 10000 person-years, respectively. Stratified by age, the incidence rate ratio for dialysis was greater in ED patients aged <50 years (3.16, 95% CI: 1.62-6.19, p = 0.0008) but not in aged 50-64 (0.94, 95% CI: 0.52-1.69, p = 0.8397) and those aged >= 65 (0.69, 95% CI: 0.32-1.52, p = 0.3594). After adjustment for patient characteristics and medial comorbidities, the adjusted HR for dialysis remained greater in ED patients aged <50 years (adjusted HR: 2.08, 95% CI: 1.05-4.11, p<0.05). The log-rank test revealed that ED patients <50-years-old had significantly higher cumulative incidence rates of dialysis than those without (p = 0.0004). Conclusion: Patients with ED, especially younger patients, are at an increased risk for ESRD requiring dialysis later in life.	[Shen, Yuan-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Shen, Yuan-Chi] Cheng Shiu Univ, Kaohsiung, Taiwan; [Weng, Shih-Feng; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Tien, Kai-Jen] Chi Mei Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Tainan, Taiwan; [Tien, Kai-Jen] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan	Chang Gung Memorial Hospital; Cheng Shiu University; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Tien, KJ (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Tainan, Taiwan.	cmmctkj@gmail.com		Weng, Shih-Feng/0000-0001-8684-3487				Aversa A, 2010, INT J UROL, V17, P38, DOI 10.1111/j.1442-2042.2009.02426.x; Bellinghieri G, 2008, J NEPHROL, V21, pS113; Blumentals W A, 2003, Aging Male, V6, P217, DOI 10.1080/13685530312331309752; Chew KK, 2010, J SEX MED, V7, P192, DOI 10.1111/j.1743-6109.2009.01576.x; Chuang YC, 2012, J SEX MED, V9, P1055, DOI 10.1111/j.1743-6109.2011.02586.x; Hermans MP, 2009, DIABETES METAB, V35, P484, DOI 10.1016/j.diabet.2009.06.003; Hwang TIS, 2010, J SEX MED, V7, P2817, DOI 10.1111/j.1743-6109.2010.01837.x; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Ma RCW, 2008, J AM COLL CARDIOL, V51, P2045, DOI 10.1016/j.jacc.2008.02.051; Marumo K, 2001, INT J UROL, V8, P53, DOI 10.1046/j.1442-2042.2001.00258.x; McKinlay JB, 2000, INT J IMPOT RES, V12, pS6, DOI 10.1038/sj.ijir.3900567; Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016; O'Leary MP, 2006, J UROLOGY, V175, P1058, DOI 10.1016/S0022-5347(05)00418-0; Ponholzer A, 2005, EUR UROL, V48, P512, DOI 10.1016/j.eururo.2005.05.014; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; RECKELHOFF JF, 1993, AM J PHYSIOL, V265, pR1126, DOI 10.1152/ajpregu.1993.265.5.R1126; Salem S, 2009, J SEX MED, V6, P3425, DOI 10.1111/j.1743-6109.2009.01515.x; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Siu SC, 2001, DIABETIC MED, V18, P732, DOI 10.1046/j.0742-3071.2001.00557.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Uhlig K, 2002, TRADITIONAL CARDIAC, P118; Viigimaa M, 2011, J HYPERTENS, V29, P403, DOI 10.1097/HJH.0b013e328342c659; Weinberg AE, 2013, J SEX MED, V10, P3102, DOI 10.1111/jsm.12318; Yamasaki H, 2004, DIABETES RES CLIN PR, V66, pS173, DOI 10.1016/j.diabres.2003.09.019; Zoccali C, 2011, KIDNEY INT SUPPL, V1, P2, DOI 10.1038/kisup.2011.4	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102055	10.1371/journal.pone.0102055	http://dx.doi.org/10.1371/journal.pone.0102055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013905	Green Submitted, gold, Green Published			2022-12-25	WOS:000339378400059
J	Chen, MN; Li, X; Yang, QL; Chi, XY; Pan, LJ; Chen, N; Yang, Z; Wang, T; Wang, MA; Yu, SL				Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin			Dynamic Succession of Soil Bacterial Community during Continuous Cropping of Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; MICROBIAL COMMUNITIES; YIELD DECLINE; LAND-USE; PLANT; DIVERSITY; MICROORGANISMS; POPULATIONS; MANAGEMENT; AGGREGATION	Plant health and soil fertility are affected by plant-microbial interactions in soils. Peanut is an important oil crop worldwide and shows considerable adaptability, but growth and yield are negatively affected by continuous cropping. In this study, 16S rRNA gene clone library analyses were used to study the succession of soil bacterial communities under continuous peanut cultivation. Six libraries were constructed for peanut over three continuous cropping cycles and during its seedling and pod-maturing growth stages. Cluster analyses indicated that soil bacterial assemblages obtained from the same peanut cropping cycle were similar, regardless of growth period. The diversity of bacterial sequences identified in each growth stage library of the three peanut cropping cycles was high and these sequences were affiliated with 21 bacterial groups. Eight phyla: Acidobacteria, Actinobacteria, Bacteroidetes, Chloroflexi, Gemmatimonadetes, Planctomycetes, Proteobacteria and Verrucomicrobia were dominant. The related bacterial phylotypes dynamic changed during continuous cropping progress of peanut. This study demonstrated that the bacterial populations especially the beneficial populations were positively selected. The simplification of the beneficial microbial communities such as the phylotypes of Alteromonadales, Burkholderiales, Flavobacteriales, Pseudomonadales, Rhizobiales and Rhodospirillales could be important factors contributing to the decline in peanut yield under continuous cropping. The microbial phylotypes that did not successively changed with continuous cropping, such as populations related to Rhizobiales and Rhodospirillales, could potentially resist stress due to continuous cropping and deserve attention. In addition, some phylotypes, such as Acidobacteriales, Chromatiales and Gemmatimonadales, showed a contrary tendency, their abundance or diversity increased with continuous peanut cropping progress. Some bacterial phylotypes including Acidobacteriales, Burkholderiales, Bdellovibrionales, and so on, also were affected by plant age.	[Chen, Mingna; Li, Xiao; Yang, Qingli; Chi, Xiaoyuan; Pan, Lijuan; Chen, Na; Yang, Zhen; Wang, Tong; Wang, Mian; Yu, Shanlin] Shandong Peanut Res Inst, Qingdao, Peoples R China		Yu, SL (corresponding author), Shandong Peanut Res Inst, Qingdao, Peoples R China.	yshanlin1956@163.com		Li, Xiao/0000-0002-0505-1654	China Agriculture Research System [C ARS-14]; National Natural Science Foundation of China [31000728, 31100205, 31200211]; Natural Science Fund of Shandong Province [ZR2011CQ 036, ZR2012586 CQ031]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2010NY023]; Qingdao Municipal Science and Technology Plan Project [11-2-4-9-(3)-jic, 11-2-3-26-nsh, 12-1-4-11-(2)-jch]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shandong Province; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province; Qingdao Municipal Science and Technology Plan Project	This study was supported by grants from China Agriculture Research System (C ARS-14), the National Natural Science Foundation of China (31000728; 31100205; 31200211), the Natural Science Fund of Shandong Province (ZR2011CQ 036; ZR2012586 CQ031), the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2010NY023), Qingdao Municipal Science and Technology Plan Project (11-2-4-9-(3)-jic; 11-2-3-26-nsh; 12-1-4-11-(2)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2013, SOIL BIOL BIOCHEM, V57, P144, DOI 10.1016/j.soilbio.2012.09.003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avidano L, 2005, APPL SOIL ECOL, V30, P21, DOI 10.1016/j.apsoil.2005.01.003; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Caesar-TonThat T, 2010, EUR J SOIL BIOL, V46, P119, DOI 10.1016/j.ejsobi.2009.12.004; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Ehteshami S M R, 2007, Pak J Biol Sci, V10, P3585, DOI 10.3923/pjbs.2007.3585.3591; Elmer WH, 2011, PLANT DIS, V95, P960, DOI 10.1094/PDIS-10-10-0741; Fabra A, 2010, CRIT REV MICROBIOL, V36, P179, DOI 10.3109/10408410903584863; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Guan XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-820; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; JOHNSON NC, 1992, AGRON J, V84, P387, DOI 10.2134/agronj1992.00021962008400030007x; Kandeler E, 2006, SOIL BIOL BIOCHEM, V38, P2448, DOI 10.1016/j.soilbio.2006.02.021; Kihara J, 2012, APPL SOIL ECOL, V58, P12, DOI 10.1016/j.apsoil.2012.03.004; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Li XG, 2014, SOIL BIOL BIOCHEM, V72, P11, DOI 10.1016/j.soilbio.2014.01.019; Li YG, 2012, APPL MECH MATER, V108, P127, DOI 10.4028/www.scientific.net/AMM.108.127; Liddycoat SM, 2009, CAN J MICROBIOL, V55, P388, DOI [10.1139/w08-144, 10.1139/W08-144]; Lithourgidis AS, 2006, EUR J AGRON, V25, P208, DOI 10.1016/j.eja.2006.05.003; Liu JS, 2013, OMEGA-INT J MANAGE S, V41, P3, DOI 10.1016/j.omega.2010.12.006; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nayyar A, 2009, APPL SOIL ECOL, V43, P115, DOI 10.1016/j.apsoil.2009.06.008; Picard C, 2000, APPL ENVIRON MICROB, V66, P948, DOI 10.1128/AEM.66.3.948-955.2000; Pliego C, 2011, PLANT SOIL, V340, P505, DOI 10.1007/s11104-010-0615-8; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Reichardt W, 1997, APPL ENVIRON MICROB, V63, P233, DOI 10.1128/AEM.63.1.233-238.1997; Saharan BC, 2011, LIFE SCI MED RES, V21, P1, DOI DOI 10.4172/2157-7471.1000266; Sharma KK, 2006, METH MOL B, V343, P347; Spaepen S, 2009, ADV BOT RES, V51, P283, DOI 10.1016/S0065-2296(09)51007-5; Sudini H, 2011, PHYTOPATHOLOGY, V101, P819, DOI 10.1094/PHYTO-11-10-0310; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Welbaum GE, 2004, CRIT REV PLANT SCI, V23, P175, DOI 10.1080/07352680490433295; Wieland G, 2001, APPL ENVIRON MICROB, V67, P5849, DOI 10.1128/AEM.67.12.5849-5854.2001; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2	47	41	54	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101355	10.1371/journal.pone.0101355	http://dx.doi.org/10.1371/journal.pone.0101355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010658	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800021
J	Kalamida, D; Karagounis, IV; Giatromanolaki, A; Koukourakis, MI				Kalamida, Dimitra; Karagounis, Ilias V.; Giatromanolaki, Alexandra; Koukourakis, Michael I.			Important Role of Autophagy in Endothelial Cell Response to Ionizing Radiation	PLOS ONE			English	Article							CANCER-CELLS; PATHWAY	Objectives: Vasculature damage is an important contributor to the side-effects of radiotherapy. The aim of this study is to provide insights into the radiobiology of the autophagic response of endothelial cells. Methods and Materials: Human umbilical vascular endothelial cells (HUVEC) were exposed to 2 Gy of ionizing radiation (IR) and studied using confocal microscopy and western blot analysis, at 4 and 8 days post-irradiation. The role of autophagy flux in HUVEC radio-sensitivity was also examined. Results: IR-induced accumulation of LC3A+, LC3B+ and p62 cytoplasmic vacuoles, while in double immunostaining with lysosomal markers (LAMP2a and CathepsinD) repression of the autophagolysosomal flux was evident. Autophagy-related proteins (ATF4, HIF1 alpha, HIF2 alpha, Beclin1) were, however, induced excluding an eventual repressive effect of radiation on autophagy initiating protein expression. Exposure of HUVEC to SMER28, an mTOR-independent inducer of autophagy, enhanced proLC3 and LC3A, B-I protein expression and accelerated the autophagic flux. Pre-treatment of HUVEC with SMER28 protected against the blockage of autophagic flux induced by IR and conferred radio-resistance. Suppression of LC3A/LC3B proteins with siRNAs resulted in radio-sensitization. Conclusions: The current data provide a rationale for the development of novel radioprotection policies targeting the autophagic pathway.	[Kalamida, Dimitra; Karagounis, Ilias V.; Koukourakis, Michael I.] Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis, Greece; [Kalamida, Dimitra; Karagounis, Ilias V.; Giatromanolaki, Alexandra; Koukourakis, Michael I.] Univ Gen Hosp Alexandroupolis, Alexandroupolis, Greece; [Giatromanolaki, Alexandra] Democritus Univ Thrace, Dept Pathol, Alexandroupolis, Greece	Democritus University of Thrace; Democritus University of Thrace	Koukourakis, MI (corresponding author), Democritus Univ Thrace, Dept Radiotherapy Oncol, Alexandroupolis, Greece.	targ@her.forthnet.gr	Karagounis, Ilias V/A-6497-2013	Karagounis, Ilias V/0000-0003-1642-1996	TRAINING AND LIFELONG LEARNING - ARISTEIA project [520]; ESPA; GGET [12605/26.09.2012]	TRAINING AND LIFELONG LEARNING - ARISTEIA project; ESPA; GGET	The study has been funded by the TRAINING AND LIFELONG LEARNING - ARISTEIA project, code no 520, ESPA 2007-2013, GGET decision number 12605/26.09.2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou I, 2013, BIOCHEM BIOPH RES CO, V431, P456, DOI 10.1016/j.bbrc.2012.12.146; BAKER DG, 1989, CANCER INVEST, V7, P287, DOI 10.3109/07357908909039849; Belka C, 2001, BRIT J CANCER, V85, P1233, DOI 10.1054/bjoc.2001.2100; Bohensky J, 2009, ARTHRITIS RHEUM-US, V60, P1406, DOI 10.1002/art.24444; Dumont FJ, 2012, CURR CANCER DRUG TAR, V12, P899; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Gorbunov NV, 2009, J PATHOL, V219, P242, DOI 10.1002/path.2591; Ito H, 2005, INT J ONCOL, V26, P1401; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang N, 2013, CELL SIGNAL, V25, P2530, DOI 10.1016/j.cellsig.2013.08.010; Paglin S, 2001, CANCER RES, V61, P439; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; Quarmby S, 1999, INT J CANCER, V82, P385, DOI 10.1002/(SICI)1097-0215(19990730)82:3<385::AID-IJC12>3.0.CO;2-5; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zachari MA, 2014, DOSE RESPON IN PRESS; Zhao Y, 2012, J CELL PHYSIOL, V227, P639, DOI 10.1002/jcp.22768; Zois CE, 2011, BIOCHEM BIOPH RES CO, V404, P552, DOI 10.1016/j.bbrc.2010.12.024; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	22	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102408	10.1371/journal.pone.0102408	http://dx.doi.org/10.1371/journal.pone.0102408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010689	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800099
J	Tryon, RC; Johnson, SL				Tryon, Robert C.; Johnson, Stephen L.			Clonal Analysis of kit ligand a Functional Expression Reveals Lineage-Specific Competence to Promote Melanocyte Rescue in the Mutant Regenerating Caudal Fin	PLOS ONE			English	Article							ZEBRAFISH; PROLIFERATION; DEDIFFERENTIATION; DIFFERENTIATION; MORPHOGENESIS; REQUIREMENTS; TISSUE; ROLES; CELLS	The study of regeneration in an in vivo vertebrate system has the potential to reveal targetable genes and pathways that could improve our ability to heal and repair damaged tissue. We have developed a system for clonal labeling of discrete cell lineages and independently inducing gene expression under control of the heat shock promoter in the zebrafish caudal fin. Consequently we are able to test the affects of overexpressing a single gene in the context of regeneration within each of the nine different cell lineage classes that comprise the caudal fin. This can test which lineage is necessary or sufficient to provide gene function. As a first example to demonstrate this approach, we explored which lineages were competent to functionally express the kit ligand a protein as assessed by the local complementation of the mutation in the sparse-like (kitlga(tc244b)) background. We show that dermal fibroblast expression of kit ligand a robustly supports the rescue of melanocytes in the regenerating caudal fin. kit ligand a expression from skin and osteoblasts results in more modest and variable rescue of melanocytes, while lateral line expression was unable to complement the mutation.	[Tryon, Robert C.; Johnson, Stephen L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Tryon, RC (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	rtryon@genetics.wustl.edu			NIH [GM056988]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056988, R56GM056988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant GM056988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Azevedo AS, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-24; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Duszynski RJ, 2011, ZEBRAFISH, V8, P211, DOI 10.1089/zeb.2011.0693; Frohnhofer HG, 2013, DEVELOPMENT, V140, P2997, DOI 10.1242/dev.096719; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Grotek B, 2013, DEVELOPMENT, V140, P1412, DOI 10.1242/dev.087452; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Hultman KA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000544; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Johnson SL, 1999, METHOD CELL BIOL, V59, P301; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lee Y, 2009, DEV BIOL, V331, P270, DOI 10.1016/j.ydbio.2009.05.545; Mari-Beffa M, 2010, DEV DYNAM, V239, P2779, DOI 10.1002/dvdy.22444; Mathew LK, 2009, BIOCHEM PHARMACOL, V77, P498, DOI 10.1016/j.bcp.2008.09.025; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Nechiporuk A, 2003, DEV BIOL, V258, P291, DOI 10.1016/S0012-1606(03)00129-5; O'Reilly-Pol T, 2013, DEVELOPMENT, V140, P996, DOI 10.1242/dev.088112; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Patterson LB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003561; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Rawls JF, 2000, DEVELOPMENT, V127, P3715; Rawls JF, 2001, DEVELOPMENT, V128, P1943; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Tryon RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021010; Tu SM, 2010, CANCER TREAT RES, V154, P137, DOI 10.1007/978-1-4419-5968-3_13; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Yamanaka H, 2014, P NATL ACAD SCI USA, V111, P1867, DOI 10.1073/pnas.1315416111	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102317	10.1371/journal.pone.0102317	http://dx.doi.org/10.1371/journal.pone.0102317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009992	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800091
J	Esposito, U; Giugliano, M; van Rossum, M; Vasilaki, E				Esposito, Umberto; Giugliano, Michele; van Rossum, Mark; Vasilaki, Eleni			Measuring Symmetry, Asymmetry and Randomness in Neural Network Connectivity	PLOS ONE			English	Article							CIRCUIT RECONSTRUCTION; MODEL	Cognitive functions are stored in the connectome, the wiring diagram of the brain, which exhibits non-random features, so-called motifs. In this work, we focus on bidirectional, symmetric motifs, i.e. two neurons that project to each other via connections of equal strength, and unidirectional, non-symmetric motifs, i.e. within a pair of neurons only one neuron projects to the other. We hypothesise that such motifs have been shaped via activity dependent synaptic plasticity processes. As a consequence, learning moves the distribution of the synaptic connections away from randomness. Our aim is to provide a global, macroscopic, single parameter characterisation of the statistical occurrence of bidirectional and unidirectional motifs. To this end we define a symmetry measure that does not require any a priori thresholding of the weights or knowledge of their maximal value. We calculate its mean and variance for random uniform or Gaussian distributions, which allows us to introduce a confidence measure of how significantly symmetric or asymmetric a specific configuration is, i.e. how likely it is that the configuration is the result of chance. We demonstrate the discriminatory power of our symmetry measure by inspecting the eigenvalues of different types of connectivity matrices. We show that a Gaussian weight distribution biases the connectivity motifs to more symmetric configurations than a uniform distribution and that introducing a random synaptic pruning, mimicking developmental regulation in synaptogenesis, biases the connectivity motifs to more asymmetric configurations, regardless of the distribution. We expect that our work will benefit the computational modelling community, by providing a systematic way to characterise symmetry and asymmetry in network structures. Further, our symmetry measure will be of use to electrophysiologists that investigate symmetry of network connectivity.	[Esposito, Umberto; Giugliano, Michele; Vasilaki, Eleni] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Giugliano, Michele; Vasilaki, Eleni] Univ Antwerp, Dept Biomed Sci, Theoret Neurobiol & Neuroengn Lab, Antwerp, Belgium; [Giugliano, Michele] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Neural Microcircuitry, Lausanne, Switzerland; [van Rossum, Mark] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	University of Sheffield; University of Antwerp; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Edinburgh	Vasilaki, E (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	e.vasilaki@sheffield.ac.uk	van Rossum, Mark/AAF-6620-2019; Giugliano, Michele/A-5666-2012	van Rossum, Mark/0000-0001-6525-6814; Giugliano, Michele/0000-0003-2626-594X; Vasilaki, Eleni/0000-0003-3705-7070	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN") [264872]; Royal Society [JP091330-2009/R4]; Interuniversity Attraction Poles Program (IUAP); Future Emerging Technology programme project "BRAINLEAP" [306502]; Engineering and Physical Sciences Research Council (EPSRC) [EP/J019534/1]; EPSRC e-futures award [EFXD12003/EFXD12004]; EPSRC [EP/J019534/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J019534/1] Funding Source: researchfish	European Commission (FP7 Marie Curie Initial Training Network "NAMASEN")(European Commission); Royal Society(Royal Society of London); Interuniversity Attraction Poles Program (IUAP)(Belgian Federal Science Policy Office); Future Emerging Technology programme project "BRAINLEAP"; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC e-futures award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partly supported by the European Commission (FP7 Marie Curie Initial Training Network "NAMASEN", grant n. 264872 (EV, MG), the Royal Society travel grant JP091330-2009/R4 (EV, MG), the Interuniversity Attraction Poles Program (IUAP), initiated by the Belgian Science Policy Office (MG), the Future Emerging Technology programme project "BRAINLEAP" grant n. 306502 (MG), the Engineering and Physical Sciences Research Council (EPSRC), grant n. EP/J019534/1 (EV) and the EPSRC e-futures award EFXD12003/EFXD12004 (EV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babadi B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002906; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bourjaily MA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00037; Bourjaily MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001091; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Clopath C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000248; Dayan P., 2001, THEORETICAL NEUROSCI; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Insel TR, 2003, PLOS BIOL, V1, P9, DOI 10.1371/journal.pbio.0000017; Kistler Gerstner, 2002, SPIKING NEURON MODEL; Koslow S, 2005, DATABASING BRAIN DAT; Kotter R, 2001, PHILOS T ROY SOC B, V356, P1111, DOI 10.1098/rstb.2001.0902; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Pignatelli, 2009, THESIS ECOLE POLYTEC; Richmond P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018539; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vasilaki E, 2012, ICANN 2012 22 INT C; Vasilaki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084626; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586; Vasilaki E, 2009, BIOL CYBERN, V100, P147, DOI 10.1007/s00422-008-0288-z; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	34	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100805	10.1371/journal.pone.0100805	http://dx.doi.org/10.1371/journal.pone.0100805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006663	Green Published, Green Accepted, gold			2022-12-25	WOS:000339040600019
J	Lyu, YH; Zheng, W; Zheng, TL; Tian, Y				Lyu, Yihua; Zheng, Wei; Zheng, Tianling; Tian, Yun			Biodegradation of Polycyclic Aromatic Hydrocarbons by Novosphingobium pentaromativorans US6-1	PLOS ONE			English	Article							SP NOV.; PHENANTHRENE DEGRADATION; GENOME SEQUENCE; MANGROVE; BIOAVAILABILITY; CONTAMINATION; SEDIMENTS; PAHS; PCR	Novosphingobium pentaromativorans US6-1, a marine bacterium isolated from muddy sediments of Ulsan Bay, Republic of Korea, was previously shown to be capable of degrading multiple polycyclic aromatic hydrocarbons (PAHs). In order to gain insight into the characteristics of PAHs degradation, a proteome analysis of N. pentaromativorans US6-1 exposed to phenanthrene, pyrene, and benzo[a]pyrene was conducted. Several enzymes associated with PAHs degradation were identified, including 4-hydroxybenzoate 3-monooxygenase, salicylaldehyde dehydrogenase, and PAH ring-hydroxylating dioxygenase alpha subunit. Reverse transcription and real-time quantitative PCR was used to compare RHD alpha and 4-hydroxybenzoate 3-monooxygenase gene expression, and showed that the genes involved in the production of these two enzymes were upregulated to varying degrees after exposing the bacterium to PAHs. These results suggested that N. pentaromativorans US6-1 degraded PAHs via the metabolic route initiated by ring-hydroxylating dioxygenase, and further degradation occurred via the o-phthalate pathway or salicylate pathway. Both pathways subsequently entered the tricarboxylic acid (TCA) cycle, and were mineralized to CO2.	[Lyu, Yihua; Zheng, Wei; Zheng, Tianling; Tian, Yun] Xiamen Univ, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Lyu, Yihua; Zheng, Wei; Zheng, Tianling; Tian, Yun] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Xiamen University; Xiamen University	Tian, Y (corresponding author), Xiamen Univ, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China.	tianyun@xmu.edu.cn			National Natural Science Foundation of China [40976069, 41176093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (40976069, 41176093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baboshin MA, 2012, MICROBIOLOGY+, V81, P639, DOI 10.1134/S0026261712060021; Baboshin M, 2008, BIODEGRADATION, V19, P567, DOI 10.1007/s10532-007-9162-2; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Colquhoun DR, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/408690; Daugulis AJ, 2003, BIOTECHNOL LETT, V25, P1441, DOI 10.1023/A:1025007729355; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Herbst FA, 2013, PROTEOMICS, V13, P2910, DOI 10.1002/pmic.201200569; Iwagami SG, 2000, APPL ENVIRON MICROB, V66, P1499, DOI 10.1128/AEM.66.4.1499-1508.2000; Johnsen AR, 2007, APPL MICROBIOL BIOT, V76, P533, DOI 10.1007/s00253-007-1045-2; Johnson DR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-250; Kanaly RA, 2010, MICROB BIOTECHNOL, V3, P136, DOI 10.1111/j.1751-7915.2009.00130.x; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kurokawa J, 2010, J BIOSCI BIOENG, V109, P218, DOI 10.1016/j.jbiosc.2009.09.040; Kweon O, 2011, J BACTERIOL, V193, P4326, DOI 10.1128/JB.00215-11; Liu HJ, 2010, MAR POLLUT BULL, V60, P2056, DOI 10.1016/j.marpolbul.2010.07.013; Liu HJ, 2008, J EXP MAR BIOL ECOL, V367, P111, DOI 10.1016/j.jembe.2008.09.008; Luo YR, 2009, MAR POLLUT BULL, V58, P1159, DOI 10.1016/j.marpolbul.2009.03.024; Luo YR, 2012, J BACTERIOL, V194, P907, DOI 10.1128/JB.06476-11; Madhumita R, 2012, MICROBIOL, V156, P685; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Marin M, 2012, J BACTERIOL, V194, P3851, DOI 10.1128/JB.00430-12; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Nayak AS, 2009, BIODEGRADATION, V20, P837, DOI 10.1007/s10532-009-9271-1; Niharika N, 2013, INT J SYST EVOL MICR, V63, P667, DOI 10.1099/ijs.0.039826-0; Pinyakong O, 2003, BIOCHEM BIOPH RES CO, V301, P350, DOI 10.1016/S0006-291X(02)03036-X; Ramdine G, 2012, ECOTOX ENVIRON SAFE, V79, P80, DOI 10.1016/j.ecoenv.2011.12.005; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schuler L, 2009, APPL MICROBIOL BIOT, V83, P465, DOI 10.1007/s00253-009-1858-2; Sim HW, 2013, J KOREAN SOC APPL BI, V56, P401, DOI 10.1007/s13765-013-3080-2; Sohn JH, 2004, INT J SYST EVOL MICR, V54, P1483, DOI 10.1099/ijs.0.02945-0; Somnath M, 2011, CRIT REV MICROBIOL, V37, P64; Suparna K, 2012, ENVIRON ENG SCI, V7, P189; Tatyana YI, 2013, RES MICROBIOL, V164, P244; Tian L, 2002, PROCESS BIOCHEM, V37, P1431, DOI 10.1016/S0032-9592(02)00032-8; Tian Y, 2008, MAR POLLUT BULL, V56, P1184, DOI 10.1016/j.marpolbul.2008.02.014; Vaysse PJ, 2009, RES MICROBIOL, V160, P829, DOI 10.1016/j.resmic.2009.09.010; Verma N, 2012, PROTEOMICS, V12, P1731, DOI 10.1002/pmic.201100466; Woo JH, 2009, APPL MICROBIOL BIOT, V82, P873, DOI 10.1007/s00253-008-1791-9; Yuan J, 2009, INT J SYST EVOL MICR, V59, P2084, DOI 10.1099/ijs.0.002873-0; Yun SH, 2014, PLOS ONE, V3, P1, DOI DOI 10.1038/0NC.2013.472; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624	42	69	72	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101438	10.1371/journal.pone.0101438	http://dx.doi.org/10.1371/journal.pone.0101438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007154	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600036
J	Passamani, LM; Abdala, AP; Moraes, DJD; Sampaio, KN; Mill, JG; Paton, JFR				Passamani, Luciana Mesquita; Abdala, Ana Paula; de Almeida Moraes, Davi Jose; Sampaio, Karla Nivea; Mill, Jose Geraldo; Richmond Paton, Julian Francis			Temporal Profile and Mechanisms of the Prompt Sympathoexcitation following Coronary Ligation in Wistar Rats	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYMPATHETIC-NERVE ACTIVITY; NUCLEUS-TRACTUS-SOLITARII; HEART-RATE-VARIABILITY; ANGIOTENSIN-II; BAROREFLEX CONTROL; CAROTID-BODY; TIME-COURSE; CARDIAC DYSFUNCTION; THERAPEUTIC TARGET	Our aim was to assess the timing and mechanisms of the sympathoexcitation that occurs immediately after coronary ligation. We recorded thoracic sympathetic (tSNA) and phrenic activities, heart rate (HR) and perfusion pressure in Wistar rats subjected to either ligation of the left anterior descending coronary artery (LAD) or Sham operated in the working heart-brainstem preparation. Thirty minutes after LAD ligation, tSNA had increased (basal: 2.5 +/- 0.2 mu V, 30 min: 3.5 +/- 0.3 mu V), being even higher at 60 min (5.2 +/- 0.5 mu V, P<0.01); while no change was observed in Sham animals. HR increased significantly 45 min after LAD (P<0.01). Sixty minutes after LAD ligation, there was: (i) an augmented peripheral chemoreflex - greater sympathoexcitatory response (50, 45 and 27% of increase to 25, 50 and 75 mu L injections of NaCN 0.03%, respectively, when compared to Sham, P<0.01); (ii) an elevated pressor response (32 +/- 1 versus 23 +/- 1 mmHg in Sham, P<0.01) and a reduced baroreflex sympathetic gain (1.3 +/- 0.1 versus Sham 2.0 +/- 0.1%. mmHg(-1), P<0.01) to phenylephrine injection; (iii) an elevated cardiac sympathetic tone (Delta HR after atenolol: -108 +/- 8 versus -82 +/- 7 bpm in Sham, P<0.05). In contrast, no changes were observed in cardiac vagal tone and bradycardic response to both baroreflex and chemoreflex between LAD and Sham groups. The immediate sympathoexcitatory response in LAD rats was dependent on an excitatory spinal sympathetic cardiocardiac reflex, whereas at 3 h an angiotensin II type 1 receptor mechanism was essential since Losartan curbed the response by 34% relative to LAD rats administered saline (P<0.05). A spinal reflex appears key to the immediate sympathoexcitatory response after coronary ligation. Therefore, the sympathoexcitatory response seems to be maintained by an angiotensinergic mechanism and concomitant augmentation of sympathoexcitatory reflexes.	[Passamani, Luciana Mesquita; Abdala, Ana Paula; Richmond Paton, Julian Francis] Univ Bristol, Bristol Heart Inst, Sch Physiol & Pharmacol, Bristol, Avon, England; [Passamani, Luciana Mesquita; Mill, Jose Geraldo] Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Physiol Sci, Vitoria, Espirito Santo, Brazil; [de Almeida Moraes, Davi Jose] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Sampaio, Karla Nivea] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil	University of Bristol; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade de Sao Paulo	Paton, JFR (corresponding author), Univ Bristol, Bristol Heart Inst, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol, Avon, England.	Julian.F.R.Paton@Bristol.ac.uk	Moraes, Davi/AAG-6248-2019; Paton, Julian/AAM-2121-2020; Sampaio, Karla/AAI-1195-2021; Sheikh, Ana Paula Abdala/G-9104-2014	Sampaio, Karla/0000-0003-0293-0482; Sheikh, Ana Paula Abdala/0000-0001-6566-9205; Paton, Julian/0000-0001-7410-2913; Mesquita Passamani, Luciana/0000-0002-5700-0111	British Heart Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; British Heart Foundation [PG/10/23/28277, RG/12/6/29670] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); British Heart Foundation(British Heart Foundation)	This work was supported by The British Heart Foundation and "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIGGER JT, 1991, J AM COLL CARDIOL, V18, P1643, DOI 10.1016/0735-1097(91)90497-W; Boscan P, 2001, NEUROSCIENCE, V103, P153, DOI 10.1016/S0306-4522(00)00559-5; Bristow M, 2003, CIRCULATION, V107, P1100, DOI 10.1161/01.CIR.0000054530.87613.36; BROWN AM, 1967, J PHYSIOL-LONDON, V190, P35, DOI 10.1113/jphysiol.1967.sp008191; BROWN AM, 1971, J PHYSIOL-LONDON, V212, P685, DOI 10.1113/jphysiol.1971.sp009350; BUNNEMANN B, 1992, J CHEM NEUROANAT, V5, P245, DOI 10.1016/0891-0618(92)90049-V; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; CERATI D, 1991, CIRC RES, V69, P1389, DOI 10.1161/01.RES.69.5.1389; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DIBONA GF, 1995, AM J PHYSIOL-REG I, V269, pR1189, DOI 10.1152/ajpregu.1995.269.5.R1189; FELDER RB, 1979, CIRC RES, V45, P728, DOI 10.1161/01.RES.45.6.728; FELDER RB, 1981, CIRC RES, V48, P685, DOI 10.1161/01.RES.48.5.685; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Fu Liang-Wu, 2009, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-540-79090-7_6; Gao L, 2008, HYPERTENSION, V52, P708, DOI 10.1161/HYPERTENSIONAHA.108.116228; GOLDSTEIN RE, 1975, CIRC RES, V36, P571, DOI 10.1161/01.RES.36.5.571; Graham LN, 2002, CIRCULATION, V106, P793, DOI 10.1161/01.CIR.0000025610.14665.21; GRIFFITHS J, 1971, AM HEART J, V82, P171, DOI 10.1016/0002-8703(71)90262-6; Huang Bing S, 2009, Curr Heart Fail Rep, V6, P81; Huang BS, 2009, AM J PHYSIOL-HEART C, V297, pH968, DOI 10.1152/ajpheart.00317.2009; Huang CH, 1999, AM J PHYSIOL-HEART C, V276, pH368, DOI 10.1152/ajpheart.1999.276.2.H368; Huang CH, 2011, ANN THORAC SURG, V92, P1727, DOI 10.1016/j.athoracsur.2011.06.094; Jardine DL, 2007, AM J PHYSIOL-HEART C, V293, pH433, DOI 10.1152/ajpheart.01262.2006; Jardine DL, 2005, J PHYSIOL-LONDON, V565, P325, DOI 10.1113/jphysiol.2004.082198; KARLSBERG RP, 1981, AM HEART J, V102, P24, DOI 10.1016/0002-8703(81)90408-7; Kasparov S, 1999, J PHYSIOL-LONDON, V521, P227, DOI 10.1111/j.1469-7793.1999.00227.x; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; La Rocca HPB, 2001, EUR HEART J, V22, P1136, DOI 10.1053/euhj.2000.2407; La Rovere MT, 1998, LANCET, V351, P478; Liu DM, 2008, CIRC RES, V103, P186, DOI 10.1161/CIRCRESAHA.108.179408; Liu DM, 2006, CIRC RES, V99, P1004, DOI 10.1161/01.RES.0000247066.19878.93; Liu JL, 1999, CIRC RES, V84, P417, DOI 10.1161/01.RES.84.4.417; LOMBARDI F, 1987, AM J CARDIOL, V60, P1239, DOI 10.1016/0002-9149(87)90601-1; LOMBARDI F, 1984, CARDIOVASC RES, V18, P14, DOI 10.1093/cvr/18.1.14; Lombardi F, 1996, AM J CARDIOL, V77, P1037; MacDougall J D, 1995, Can J Appl Physiol, V20, P480; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; MALLIANI A, 1969, AM J PHYSIOL, V217, P703, DOI 10.1152/ajplegacy.1969.217.3.703; McAlpine H M, 1988, Am J Med, V84, P61, DOI 10.1016/0002-9343(88)90206-9; McBryde FD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3395; MCCANCE AJ, 1989, BRIT HEART J, V61, P238; MELLER ST, 1992, NEUROSCIENCE, V48, P501, DOI 10.1016/0306-4522(92)90398-L; Murakami H, 1997, HYPERTENSION, V29, P564, DOI 10.1161/01.HYP.29.2.564; NINOMIYA I, 1986, AM J PHYSIOL, V251, pH528, DOI 10.1152/ajpheart.1986.251.3.H528; PANTRIDGE JF, 1981, PROG CARDIOVASC DIS, V23, P265, DOI 10.1016/0033-0620(81)90016-5; Paton JFR, 1999, J PHYSIOL-LONDON, V521, P213, DOI 10.1111/j.1469-7793.1999.00213.x; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Petersson M, 2005, EUR HEART J, V26, P906, DOI 10.1093/eurheartj/ehi184; Polson JW, 2007, AM J PHYSIOL-REG I, V293, pR1954, DOI 10.1152/ajpregu.00041.2007; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; ROSENSHTRAUKH L, 1994, CIRC RES, V75, P722, DOI 10.1161/01.RES.75.4.722; Schultz HD, 2007, RESP PHYSIOL NEUROBI, V157, P171, DOI 10.1016/j.resp.2007.02.011; SIGGERS DC, 1971, BRIT HEART J, V33, P878; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; Sun SY, 1999, J APPL PHYSIOL, V86, P1264, DOI 10.1152/jappl.1999.86.4.1264; THAMES MD, 1993, J AM COLL CARDIOL, V22, pA56, DOI 10.1016/0735-1097(93)90464-C; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; VIDEBAEK J, 1972, CIRCULATION, V46, P846, DOI 10.1161/01.CIR.46.5.846; Wang W, 2000, Heart Fail Rev, V5, P57; WEBB SW, 1972, BMJ-BRIT MED J, V3, P89, DOI 10.1136/bmj.3.5818.89; Yoshimura R, 2000, J CARD FAIL, V6, P66, DOI 10.1016/S1071-9164(00)00013-0; Zoccal DB, 2008, J PHYSIOL-LONDON, V586, P3253, DOI 10.1113/jphysiol.2008.154187; Zucker IH, 2009, AM J PHYSIOL-HEART C, V297, pH1557, DOI 10.1152/ajpheart.00073.2009	65	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101886	10.1371/journal.pone.0101886	http://dx.doi.org/10.1371/journal.pone.0101886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006809	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600077
J	Suzuki, Y; Iida, M; Miura, I; Inubushi, T; Morikawa, S				Suzuki, Yoshikazu; Iida, Mitsuru; Miura, Iwao; Inubushi, Toshiro; Morikawa, Shigehiro			A Polymer-Based Magnetic Resonance Tracer for Visualization of Solid Tumors by C-13 Spectroscopic Imaging	PLOS ONE			English	Article							DIFFERENT MOLECULAR-WEIGHTS; TO-NOISE RATIO; POLY(ETHYLENE GLYCOL); ACCUMULATION	Morphological imaging precedes lesion-specific visualization in magnetic resonance imaging (MRI) because of the superior ability of this technique to depict tissue morphology with excellent spatial and temporal resolutions. To achieve lesion-specific visualization of tumors by MRI, we investigated the availability of a novel polymer-based tracer. Although the C-13 nucleus is a candidate for a detection nucleus because of its low background signal in the body, the low magnetic resonance sensitivity of the nucleus needs to be resolved before developing a C-13-based tracer. In order to overcome this problem, we enriched polyethylene glycol (PEG), a biocompatible polymer, with C-13 atoms. C-13-PEG40,000 (C-13-PEG with an average molecular weight of 40 kDa) emitted a single C-13 signal with a high signal-to-noise ratio due to its ability to maintain signal sharpness, as was confirmed by in vivo investigation, and displayed a chemical shift sufficiently distinct from that of endogenous fat. C-13-PEG40,000 intravenously injected into mice showed long retention in circulation, leading to its effective accumulation in tumors reflecting the well-known phenomenon that macromolecules accumulate in tumors because of leaky tumor capillaries. These properties of C-13-PEG40,000 allowed visualization of tumors in mice by C-13 spectroscopic imaging. These findings suggest that a technique based on C-13-PEG is a promising strategy for tumor detection.	[Suzuki, Yoshikazu; Iida, Mitsuru] Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima 77101, Japan; [Miura, Iwao] Otsuka Pharmaceut Co Ltd, Div Pharmaceut, Tokushima 77101, Japan; [Inubushi, Toshiro; Morikawa, Shigehiro] Shiga Univ Med Sci, Biomed MR Sci Res Ctr, Otsu, Shiga 52021, Japan	Otsuka Pharmaceutical; Otsuka Pharmaceutical; Shiga University of Medical Science	Suzuki, Y (corresponding author), Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima 77101, Japan.	suzukiyo@otsuka.jp			Grants-in-Aid for Scientific Research [24650278, 26670554, 26282145] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bhattacharya P, 2007, J MAGN RESON, V186, P150, DOI 10.1016/j.jmr.2007.01.017; Chaumeil MM, 2014, CANCER RES, V74, P4247, DOI 10.1158/0008-5472.CAN-14-0680; Dafni H, 2010, CANCER RES, V70, P7400, DOI 10.1158/0008-5472.CAN-10-0883; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Golman K, 2001, MAGNET RESON MED, V46, P1, DOI 10.1002/mrm.1152; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mignion L, 2014, CANCER RES, V74, P686, DOI 10.1158/0008-5472.CAN-13-1914; Murakami Y, 1997, DRUG DELIV, V4, P23, DOI 10.3109/10717549709033184; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Posey JA, 2005, CLIN CANCER RES, V11, P7866, DOI 10.1158/1078-0432.CCR-05-0783; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Sack M, 2014, NMR BIOMED, V27, P709, DOI 10.1002/nbm.3110; Schmidt R, 2014, J MAGN RESON, V240, P8, DOI 10.1016/j.jmr.2013.12.013; Vandegriff KD, 1997, BIOPHYS CHEM, V69, P23, DOI 10.1016/S0301-4622(97)00079-3; Vasos PR, 2009, P NATL ACAD SCI USA, V106, P18469, DOI 10.1073/pnas.0908123106; Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005; YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102132	10.1371/journal.pone.0102132	http://dx.doi.org/10.1371/journal.pone.0102132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007334	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600097
J	Wang, T; Liu, HJ; Ning, YY; Xu, Q				Wang, Tong; Liu, Huijuan; Ning, Yanyang; Xu, Qiong			The Histone Acetyltransferase p300 Regulates the Expression of Pluripotency Factors and Odontogenic Differentiation of Human Dental Pulp Cells	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; ACETYLATION; NANOG; PROTEINS; SOX2	p300 is a well-known histone acetyltransferase (HAT) and coactivator that plays vital roles in many physiological processes. Despite extensive research on the involvement of p300 in the regulation of transcription in numerous cell lines, the roles of this protein in regulating pluripotency genes and odontogenic differentiation in human dental pulp cells (HDPCs) are poorly understood. To address this issue, we investigated the expression of OCT4, NANOG and SOX2 and the proliferation and odontogenic differentiation capacity of HDPCs following p300 overexpression. We found that p300 overexpression did not overtly affect the ability of HDPCs to proliferate. The overexpression of p300 upregulated the promoter activity and the mRNA and protein expression of NANOG and SOX2. The HAT activity of p300 appeared to partially mediate the regulation of these factors; indeed, when a mutant form of p300 lacking the HAT domain was overexpressed, the promoter activity and expression of NANOG and SOX2 decreased relative to p300 overexpression but was greater than in the control. Furthermore, we demonstrated that the mRNA levels of the odontogenic marker genes dentine matrix protein-1 (DMP-1), dentin sialophosphoprotein (DSPP), dentin sialoprotein (DSP), osteopontin (OPN) and osteocalcin (OCN) were significantly decreased in HDPCs overexpressing p300 cultured under normal culture conditions and increased in HDPCs inducted to undergo odontogenic differentiation. This finding was further confirmed by measuring levels of alkaline phosphatase (ALP) activity and assessing the formation of mineralized nodules. The HAT activity of p300 had no significant effect on odontogenic differentiation. p300 was recruited to the promoter regions of OCN and DSPP and might be acting as a coactivator to increase the acetylation of lysine 9 of histone H3 of OCN and DSPP. Collectively, our results show that p300 plays an important role in regulating the expression of key pluripotency genes in HDPCs and modifying odontogenic differentiation.	[Wang, Tong; Liu, Huijuan; Ning, Yanyang; Xu, Qiong] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Tong; Liu, Huijuan; Ning, Yanyang; Xu, Qiong] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Tong] Hefei Stomatol Hosp, Hefei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xu, Q (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	xqiong@mail.sysu.edu.cn			National Natural Science Foundation of China [81170953]; Natural Science Foundation of Guangdong Province [S2011010004931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants of National Natural Science Foundation of China (No. 81170953) and Natural Science Foundation of Guangdong Province (No. S2011010004931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Chan HM, 2001, J CELL SCI, V114, P2363; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Z, 2012, IN VITRO CELL DEV-AN, V48, P61, DOI 10.1007/s11626-011-9472-x; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dissanayaka WL, 2011, J ENDODONT, V37, P1074, DOI 10.1016/j.joen.2011.04.004; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hening AK, 2013, PLOS ONE, V8; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jin H, 2013, TISSUE ENG PT A, V19, P613, DOI [10.1089/ten.tea.2012.0163, 10.1089/ten.TEA.2012.0163]; Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Le May Melanie, 2013, Methods Mol Biol, V977, P315, DOI 10.1007/978-1-62703-284-1_25; Li T, 2009, J GENET GENOMICS, V36, P335, DOI 10.1016/S1673-8527(08)60122-8; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu L, 2011, J ENDODONT, V37, P466, DOI 10.1016/j.joen.2010.12.012; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Nozaki T, 2011, J PHARMACOL SCI, V115, P354, DOI 10.1254/jphs.10163FP; Paino F, 2014, STEM CELLS, V32, P279, DOI 10.1002/stem.1544; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Suh JS, 2012, J DENT RES, V91, P90, DOI 10.1177/0022034511424746; Sun HC, 2010, LIFE SCI, V87, P707, DOI 10.1016/j.lfs.2010.10.009; Suzuki K, 2005, BIOORGAN MED CHEM, V13, P4014, DOI 10.1016/j.bmc.2005.03.053; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200	35	21	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102117	10.1371/journal.pone.0102117	http://dx.doi.org/10.1371/journal.pone.0102117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007265	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600096
J	Yap, DYH; Yung, SS; Zhang, Q; Tang, CL; Chan, TM				Yap, Desmond Y. H.; Yung, Susan; Zhang, Qing; Tang, Colin; Chan, Tak Mao			Mesangial Cell-Binding Activity of Serum Immunoglobulin G in Patients with Lupus Nephritis	PLOS ONE			English	Article							ANTI-DNA ANTIBODIES; LABORATORY TESTS; ERYTHEMATOSUS; GLOMERULONEPHRITIS; CLASSIFICATION; INFLAMMATION; COMPLEMENT; GLOMERULI	In vitro data showed that immunoglobulin G (IgG) from patients with lupus nephritis (LN) could bind to cultured human mesangial cells (HMC). The clinical relevance of such binding was unknown. Binding of IgG and subclasses was measured in 189 serial serum samples from 23 patients with Class III/IV +/- V LN (48 during renal flares, 141 during low level disease activity (LLDA)). 64 patients with non-lupus glomerular diseases (NLGD) and 23 healthy individuals were used as controls. HMC-binding was measured with cellular ELISA and expressed as OD index. HMC-binding index of total IgG was 0.12 +/- 0.09, 0.36 +/- 0.25, 0.59 +/- 0.37 and 0.74 +/- 0.42 in healthy subjects, NLGD, LN patients during LLDA, and LN flares respectively (P = 0.046, LN flare vs. LLDA; P, 0.001, for healthy controls or NLGD vs. LN during flare or LLDA). Binding of serum IgG1 to HMC was 0.05 +/- 0.05, 0.15 +/- 0.11, 0.41 +/- 0.38 and 0.55 +/- 0.40 for the corresponding groups respectively (P = 0.007, LN flare vs. remission; P, 0.001, for healthy controls or NLGD vs. LN during flare or remission). IgG(2), IgG(3) and IgG(4) from patients and controls did not show significant binding to HMC. Total IgG and IgG1 HMC-binding index correlated with anti-dsDNA level (r = 0.26 and 0.39 respectively, P, 0.001 for both), and inversely with C3 (r = 20.17 and 20.45, P, 0.05 for both). Sensitivity/specificity of total IgG or IgG1 binding to HMC in predicting renal flares were 81.3%/39.7% (ROC AUC 0.61, P = 0.03) and 83.8%/41.8% (AUC 0.63, P = 0.009) respectively. HMC-binding by IgG1, but not total IgG, correlated with mesangial immune deposition in LN renal biopsies under electron microscopy. Our results showed that binding of serum total IgG and IgG1 in LN patients correlates with disease activity. The correlation between IgG1 HMC-binding and mesangial immune deposition suggests a potential pathogenic significance.	[Yap, Desmond Y. H.; Yung, Susan; Zhang, Qing; Tang, Colin; Chan, Tak Mao] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, TM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Nephrol, Hong Kong, Hong Kong, Peoples R China.	dtmchan@hku.hk	/E-7196-2012; /C-4468-2009	/0000-0001-8179-8293; /0000-0003-3124-1328; Chan, Tak Mao/0000-0002-3495-4051	Hong Kong Society of Nephrology Research Grant; endowment fund of the Yu Chiu Kwong Professorship in Medicine at University of Hong Kong; Wai Hung Charitable Foundation	Hong Kong Society of Nephrology Research Grant; endowment fund of the Yu Chiu Kwong Professorship in Medicine at University of Hong Kong; Wai Hung Charitable Foundation	This project was supported by the Hong Kong Society of Nephrology Research Grant 2009 awarded to Desmond Y. H. YAP and the endowment fund of the Yu Chiu Kwong Professorship in Medicine at University of Hong Kong awarded to T. M. Chan. S. Yung is supported by the Wai Hung Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Budhai L, 1996, J CLIN INVEST, V98, P1585, DOI 10.1172/JCI118952; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; Chan TM, 1997, J AUTOIMMUN, V10, P433, DOI 10.1006/jaut.1997.9998; COREMANS IEM, 1995, AM J KIDNEY DIS, V26, P595, DOI 10.1016/0272-6386(95)90595-2; Esdaile JM, 1996, J RHEUMATOL, V23, P1891; Esdaile JM, 1996, ARTHRITIS RHEUM, V39, P370, DOI 10.1002/art.1780390304; GOLBUS J, 1994, RHEUM DIS CLIN N AM, V20, P213; Ho A, 2001, ARTHRITIS RHEUM-US, V44, P2350, DOI 10.1002/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A; Ho A, 2001, ARTHRITIS RHEUM, V44, P2342, DOI 10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8; Imai H, 1997, KIDNEY INT, V51, P270, DOI 10.1038/ki.1997.32; KALUNIAN KC, 1989, ARTHRITIS RHEUM, V32, P513, DOI 10.1002/anr.1780320502; Mery J P, 1975, Proc Eur Dial Transplant Assoc, V11, P506; Moroni G, 2009, ANN RHEUM DIS, V68, P234, DOI 10.1136/ard.2008.094508; ROTHFIELD NF, 1967, J CLIN INVEST, V46, P1785, DOI 10.1172/JCI105669; Rovin BH, 2007, BULL HOSP JT DIS, V65, P187; Rovin BH, 2009, CLIN J AM SOC NEPHRO, V4, P1858, DOI 10.2215/CJN.03530509; Saxena R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3378; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TERMAAT RM, 1993, LAB INVEST, V68, P164; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; WINFIELD JB, 1977, J CLIN INVEST, V59, P90, DOI 10.1172/JCI108626; Yung S, 2005, J AM SOC NEPHROL, V16, P3281, DOI 10.1681/ASN.2004110917; Yung S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/317682; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Yung S, 2010, J AM SOC NEPHROL, V21, P1912, DOI 10.1681/ASN.2009080805	29	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101987	10.1371/journal.pone.0101987	http://dx.doi.org/10.1371/journal.pone.0101987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007094	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600086
J	Foottit, RG; Maw, E; Hebert, PDN				Foottit, Robert G.; Maw, Eric; Hebert, P. D. N.			DNA Barcodes for Nearctic Auchenorrhyncha (Insecta: Hemiptera)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; GENETIC-STRUCTURE; MITOCHONDRIAL; POPULATIONS; PHYLOGEOGRAPHY; LEAFHOPPER; CALIFORNIA; DIVERSITY; HOMOPTERA; REVEAL	Background: Many studies have shown the suitability of sequence variation in the 59 region of the mitochondrial cytochrome c oxidase I (COI) gene as a DNA barcode for the identification of species in a wide range of animal groups. We examined 471 species in 147 genera of Hemiptera: Auchenorrhyncha drawn from specimens in the Canadian National Collection of Insects to assess the effectiveness of DNA barcoding in this group. Methodology/Principal Findings: Analysis of the COI gene revealed less than 2% intra-specific divergence in 93% of the taxa examined, while minimum interspecific distances exceeded 2% in 70% of congeneric species pairs. Although most species are characterized by a distinct sequence cluster, sequences for members of many groups of closely related species either shared sequences or showed close similarity, with 25% of species separated from their nearest neighbor by less than 1%. Conclusions/Significance: This study, although preliminary, provides DNA barcodes for about 8% of the species of this hemipteran suborder found in North America north of Mexico. Barcodes can enable the identification of many species of Auchenorrhyncha, but members of some species groups cannot be discriminated. Future use of DNA barcodes in regulatory, pest management, and environmental applications will be possible as the barcode library for Auchenorrhyncha expands to include more species and broader geographic coverage.	[Foottit, Robert G.; Maw, Eric] Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON, Canada; [Foottit, Robert G.; Maw, Eric] Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Hebert, P. D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; University of Guelph	Foottit, RG (corresponding author), Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON, Canada.	Robert.Foottit@agr.gc.ca	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	NSERC, Genome Canada (through the Ontario Genomics Institute); Agriculture and Agri-Food Canada	NSERC, Genome Canada (through the Ontario Genomics Institute)(Natural Sciences and Engineering Research Council of Canada (NSERC)Genome Canada); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was supported by funding to the Canadian Barcode of Life Network from NSERC, Genome Canada (through the Ontario Genomics Institute), and by Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballman ES, 2011, J ECON ENTOMOL, V104, P279, DOI 10.1603/EC10112; Bennett GM, 2012, MOL PHYLOGENET EVOL, V65, P705, DOI 10.1016/j.ympev.2012.07.024; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Consortium for the Barcode of Life, 2005, DAT STAND BARCODE RE; Cryan JR, 2010, SYST ENTOMOL, V35, P393, DOI 10.1111/j.1365-3113.2009.00520.x; de Leon JH, 2006, ENTOMOL EXP APPL, V119, P109, DOI 10.1111/j.1570-7458.2006.00399.x; Deitz LL, 2012, ZOOTAXA, P1; Doering K. C., 1930, Journal of the Kansas Entomological Society, V3, P53; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hamilton KGA, 2012, ZOOTAXA, P41; Hamilton K. G. Andrew, 2011, American Entomologist, V57, P102; Hamilton K.G. Andrew, 2010, P169, DOI 10.3752/9780968932148.ch8; Hamilton KGA, 2005, BIOSCIENCE, V55, P49, DOI 10.1641/0006-3568(2005)055[0049:BRAELN]2.0.CO;2; HAMILTON KGA, 1982, J KANSAS ENTOMOL SOC, V55, P547; Hamilton KGA, 1985, AGR CANADA PUBLICATI; Hamilton KGA, 1982, AGR CANADA PUBLICATI; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson A, 2010, SOUTHWEST ENTOMOL, V35, P241, DOI 10.3958/059.035.0303; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; Kamitani Satoshi, 2011, Esakia, P81; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Roux JJ, 2009, ANN APPL BIOL, V154, P429, DOI 10.1111/j.1744-7348.2008.00315.x; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Lee YJ, 2010, SYST ENTOMOL, V35, P277, DOI 10.1111/j.1365-3113.2009.00509.x; Lin CP, 2007, MOL PHYLOGENET EVOL, V45, P750, DOI 10.1016/j.ympev.2007.06.005; Lin CP, 2004, SYST BIOL, V53, P400, DOI 10.1080/10635150490445869; Lin CP, 2002, ANN ENTOMOL SOC AM, V95, P162, DOI 10.1603/0013-8746(2002)095[0162:MPOTNA]2.0.CO;2; Marshall DC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-177; Marshall DC, 2011, SYST BIOL, V60, P482, DOI 10.1093/sysbio/syr017; Maryanska-Nadachowska A, 2010, SYST ENTOMOL, V35, P318, DOI 10.1111/j.1365-3113.2009.00510.x; Metcalf ZP, 1946, GEN CATALOGUE HOMOPT, V8; Metcalf ZP, 1960, GEN CATALOGUE HOMOPT; Metcalf ZP, 1947, GEN CATALOGUE HOMOPT; Nickel H, 2003, AGR ECOSYST ENVIRON, V98, P183, DOI 10.1016/S0167-8809(03)00080-X; Nielson MW, 1968, USDA ARS TECH B, V1382; OMAN PAUL WILSON, 1949, MEM ENT SOC WASHINGTON, V3, P1; Palomera V, 2012, FLA ENTOMOL, V95, P150, DOI 10.1653/024.095.0123; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sanborn AF, 2012, THOMAS SAY PUBLICATI, V32; Seabra SG, 2010, MOL PHYLOGENET EVOL, V56, P462, DOI 10.1016/j.ympev.2010.03.023; Shabani M, 2013, J PEST SCI, V86, P173, DOI 10.1007/s10340-012-0463-9; Smith PT, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.41; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virant-Doberlet M, 2011, MOL ECOL, V20, P2204, DOI 10.1111/j.1365-294X.2011.05038.x; Wallace Mathew S., 2011, Zootaxa, V3047, P1; Zahiri R, 2014, PLOS ONE IN PRESS	56	23	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101385	10.1371/journal.pone.0101385	http://dx.doi.org/10.1371/journal.pone.0101385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004106	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700028
J	An, D; Kim, K; Lu, WG				An, Daniel; Kim, Kyunghwan; Lu, Wange			Defective Entry into Mitosis 1 (Dim1) Negatively Regulates Osteoclastogenesis by Inhibiting the Expression of Nuclear Factor of Activated T-cells, Cytoplasmic, Calcineurin-dependent 1 (NFATc1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS); Gene Expression; NFAT Transcription Factor; Osteoclast; Dim1; NFATc1; Osteoclastogenesis; RANKL; c-Fos	BONE-RESORPTION; CRYSTAL-STRUCTURE; C-FOS; DIFFERENTIATION; RANKL; PROTEIN; LIGAND; GENE; HOMEOSTASIS; INDUCTION	Background: The potential role of Dim1 in RANKL-mediated induction of osteoclast differentiation is unknown. Results: Dim1 directly interacts with c-Fos to diminish the expression of NFATc1 target genes that are essential for RANKL-induced osteoclatogenesis. Conclusion: Dim1 functions as a negative regulator of RANKL-induced osteoclast differentiation. Significance: Understanding of the inhibitory role of Dim1 in RANKL-induced osteoclastogenesis might provide therapeutic benefits for treating various types of bone diseases. Bone remodeling is a continuous process of osteoblastic bone formation and osteoclastic bone resorption to maintain normal bone mass. NFATc1 is the master regulator of osteoclastogensis and transcriptionally activated by c-Fos and NF-B in response to receptor activator of NF-B ligand (RANKL) treatment. Defective entry into mitosis 1 (Dim1) is a nuclear protein that is implicated in pre-mRNA splicing and cell cycle progression, but the possible role of Dim1 in regulating other cellular processes remains unknown. Here, we demonstrate that Dim1 attenuates RANKL-induced osteoclastogenesis by targeting NFATc1 signaling pathway. Expression levels of Dim1 and NFATc1 are significantly increased during the formation of multinucleated osteoclasts. RNAi-mediated knockdown of Dim1 markedly enhances the expression of NFATc1 and its target genes, leading to the increase of RANKL-induced osteoclastogenesis in bone marrow-derived macrophages. Conversely, ectopic expression of Dim1 decreases RANKL-induced osteoclast differentiation by silencing NFATc1 and its target genes, further linking Dim1 to the dynamic regulation of osteoclastogenesis. Consistent with this notion, ChIP and interaction studies show that Dim1 directly associates with c-Fos and prevents c-Fos from binding to the NFATc1 promoter, resulting in targeted inactivation of the NFATc1 gene. Therefore, our studies reveal an unrecognized role for Dim1 as a master modulator of osteoclast differentiation, as well as the molecular mechanism underlying its repressive action toward osteoclastogensis.	[An, Daniel; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90089 USA; [Kim, Kyunghwan] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [An, Daniel] Univ So Calif, Neurosci Program, Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Kim, K (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	kyunghki@usc.edu; wangelu@usc.edu						Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Berry LD, 1999, MOL CELL BIOL, V19, P2535; Chen S., 2013, HEMATOL THROMB DIS, DOI [10.4172/2329-8790.1000102, DOI 10.4172/2329-8790.1000102]; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mehrabadi M, 2013, J INVERTEBR PATHOL, V113, P152, DOI 10.1016/j.jip.2013.02.005; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Simeoni F, 2005, BIOCHEMISTRY-US, V44, P11997, DOI 10.1021/bi050427o; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang YZ, 1999, PHYSIOL GENOMICS, V1, P109, DOI 10.1152/physiolgenomics.1999.1.3.109; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	32	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24366	24373		10.1074/jbc.M114.563817	http://dx.doi.org/10.1074/jbc.M114.563817			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023277	hybrid, Green Published			2022-12-25	WOS:000341505600031
J	Edri, S; Tuller, T				Edri, Shlomit; Tuller, Tamir			Quantifying the Effect of Ribosomal Density on mRNA Stability	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSLATION INITIATION; GENE-EXPRESSION; HALF-LIFE; YEAST; DECAY; DEGRADATION	Gene expression is a fundamental cellular process by which proteins are eventually synthesized based on the information coded in the genes. This process includes four major steps: transcription of the DNA segment corresponding to a gene to mRNA molecules, the degradation of the mRNA molecules, the translation of mRNA molecules to proteins by the ribosome and the degradation of the proteins. We present an innovative quantitative study of the interaction between the gene translation stage and the mRNA degradation stage using large scale genomic data of S. cerevisiae, which include measurements of mRNA levels, mRNA half-lives, ribosomal densities and protein abundances, for thousands of genes. The reported results support the conjecture that transcripts with higher ribosomal density, which is related to the translation stage, tend to have elevated half-lives, and we suggest a novel quantitative estimation of the strength of this relation. Specifically, we show that on average, an increase of 78% in ribosomal density yields an increase of 25% in mRNA half-life, and that this relation between ribosomal density and mRNA half-life is not function specific. In addition, our analyses demonstrate that ribosomal density along the entire ORF, and not in specific locations, has a significant effect on the transcript half-life. Finally, we show that the reported relation cannot be explained by different expression levels among genes. A plausible explanation for the reported results is that ribosomes tend to protect the mRNA molecules from the exosome complexes degrading them; however, additional non-mutually exclusive possible explanations for the reported relation and experiments for their verifications are discussed in the paper.	[Edri, Shlomit; Tuller, Tamir] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University	Tuller, T (corresponding author), Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	tamirtul@post.tau.ac.il		Tuller, Tamir/0000-0003-4194-7068; Edri, Shlomit/0000-0001-5377-1595	Israel Cancer Research Fund (ICRF); German-Israeli Foundation (GIF)	Israel Cancer Research Fund (ICRF); German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	The study was partially supported by the Israel Cancer Research Fund (ICRF) and German-Israeli Foundation (GIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberts B, 2002, MOL BIOL CELL; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Dana A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002755; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Newbury SF, 2006, BIOCHEM SOC T, V34, P30, DOI 10.1042/BST0340030; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pedersen M, 2011, J MOL BIOL, V407, P35, DOI 10.1016/j.jmb.2011.01.025; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Roy B, 2013, TRENDS GENETICS; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Shalgi R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r86; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shirley RL, 1998, J CELL SCI, V111, P3129; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Tourriere H, 2002, BIOCHIMIE, V84, P821, DOI 10.1016/S0300-9084(02)01445-1; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	47	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102308	10.1371/journal.pone.0102308	http://dx.doi.org/10.1371/journal.pone.0102308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020060	gold, Green Published			2022-12-25	WOS:000339618600065
J	M'Dahoma, S; Bourgoin, S; Kayser, V; Barthelemy, S; Chevarin, C; Chali, F; Orsal, D; Hamon, M				M'Dahoma, Said; Bourgoin, Sylvie; Kayser, Valerie; Barthelemy, Sandrine; Chevarin, Caroline; Chali, Farah; Orsal, Didier; Hamon, Michel			Spinal Cord Transection-Induced Allodynia in Rats - Behavioral, Physiopathological and Pharmacological Characterization	PLOS ONE			English	Article							CENTRAL NEUROPATHIC PAIN; DORSAL-HORN NEURONS; TACTILE ALLODYNIA; MICROGLIAL ACTIVATION; NEUROTROPHIC FACTOR; LOCOMOTOR FUNCTION; INJURY; RECEPTOR; MODEL; STIMULATION	In humans, spinal cord lesions induce not only major motor and neurovegetative deficits but also severe neuropathic pain which is mostly resistant to classical analgesics. Better treatments can be expected from precise characterization of underlying physiopathological mechanisms. This led us to thoroughly investigate (i) mechanical and thermal sensory alterations, (ii) responses to acute treatments with drugs having patent or potential anti-allodynic properties and (iii) the spinal/ganglion expression of transcripts encoding markers of neuronal injury, microglia and astrocyte activation in rats that underwent complete spinal cord transection (SCT). SCT was performed at thoracic T8-T9 level under deep isoflurane anaesthesia, and SCT rats were examined for up to two months post surgery. SCT induced a marked hyper-reflexia at hindpaws and strong mechanical and cold allodynia in a limited (6 cm(2)) cutaneous territory just rostral to the lesion site. At this level, pressure threshold value to trigger nocifensive reactions to locally applied von Frey filaments was 100-fold lower in SCT-versus sham-operated rats. A marked up-regulation of mRNAs encoding ATF3 (neuronal injury) and glial activation markers (OX-42, GFAP, P2x4, P2x7, TLR4) was observed in spinal cord and/or dorsal root ganglia at T6-T11 levels from day 2 up to day 60 post surgery. Transcripts encoding the proinflammatory cytokines IL-1 beta, IL-6 and TNF-alpha were also markedly but differentially up-regulated at T6-T11 levels in SCT rats. Acute treatment with ketamine (50 mg/kg i.p.), morphine (3-10 mg/kg s.c.) and tapentadol (10-20 mg/kg i.p.) significantly increased pressure threshold to trigger nocifensive reaction in the von Frey filaments test, whereas amitriptyline, pregabalin, gabapentin and clonazepam were ineffective. Because all SCT rats developed long lasting, reproducible and stable allodynia, which could be alleviated by drugs effective in humans, thoracic cord transection might be a reliable model for testing innovative therapies aimed at reducing spinal cord lesion-induced central neuropathic pain.	[M'Dahoma, Said; Bourgoin, Sylvie; Kayser, Valerie; Barthelemy, Sandrine; Chevarin, Caroline; Hamon, Michel] Univ Paris 05, INSERM, U894, Ctr Psychiat & Neurosci, Paris, France; [M'Dahoma, Said; Bourgoin, Sylvie; Kayser, Valerie; Barthelemy, Sandrine; Chevarin, Caroline; Hamon, Michel] Fac Med Pierre & Marie Curie, Paris, France; [Chali, Farah; Orsal, Didier] Univ Paris 06, CNRS, UMR 7101, Lab Neurobiol Signaux Intercellulaires, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	M'Dahoma, S (corresponding author), Univ Paris 05, INSERM, U894, Ctr Psychiat & Neurosci, Paris, France.	said.mdahoma@yahoo.fr	Chevarin, Caroline/M-1438-2015		Institut National de la Sante et de la Recherche Medicale (INSERM); University Pierre and Marie Curie (UPMC); Agence Nationale de la Recherche [ANR 11BSV4 017 04]; Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Ministere de la Recherche et de l'Enseignement Superieur (France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Pierre and Marie Curie (UPMC); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Ministere de la Recherche et de l'Enseignement Superieur (France)	This research has been supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), University Pierre and Marie Curie (UPMC), Agence Nationale de la Recherche (Contract ANR 11BSV4 017 04, TrkBDNFarmod), and Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME, Contract "M.Hamon, 2010-2011''). Said M'Dahoma was supported by fellowships from the Ministere de la Recherche et de l'Enseignement Superieur (France) during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguggia M, 2013, NEUROL SCI, V34, pS37, DOI 10.1007/s10072-013-1382-0; Amaya-Castellanos E, 2011, PHARMACOL BIOCHEM BE, V99, P591, DOI 10.1016/j.pbb.2011.06.005; Antri M, 2005, NEUROSCI LETT, V384, P162, DOI 10.1016/j.neulet.2005.04.062; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; ATTAL N, 1990, PAIN, V41, P235, DOI 10.1016/0304-3959(90)90022-6; Baastrup C, 2011, BRAIN RES, V1370, P129, DOI 10.1016/j.brainres.2010.11.008; Baastrup C, 2010, PAIN, V151, P670, DOI 10.1016/j.pain.2010.08.024; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bennett AD, 2000, BRAIN RES, V859, P72, DOI 10.1016/S0006-8993(99)02483-X; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Bryce TN, 2012, SPINAL CORD, V50, P413, DOI 10.1038/sc.2011.156; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Chen YH, 2009, J NEUROSCI RES, V87, P418, DOI 10.1002/jnr.21860; Colpaert FC, 2004, EUR J PHARMACOL, V497, P29, DOI 10.1016/j.ejphar.2004.06.026; Constandil L, 2012, J PAIN, V13, P579, DOI 10.1016/j.jpain.2012.03.008; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; Densmore VS, 2010, PAIN, V151, P184, DOI 10.1016/j.pain.2010.07.007; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; FENOLLOSA P, 1993, PARAPLEGIA, V31, P722, DOI 10.1038/sc.1993.114; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Finnerup NB, 2001, SPINAL CORD, V39, P256, DOI 10.1038/sj.sc.3101161; Gao TL, 2013, J NEUROSCI METH, V212, P317, DOI 10.1016/j.jneumeth.2012.11.008; Garrison MK, 2011, EXP NEUROL, V227, P104, DOI 10.1016/j.expneurol.2010.09.019; Genovese T, 2009, J NEUROCHEM, V108, P1360, DOI 10.1111/j.1471-4159.2009.05899.x; Graziano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054350; Guptarak J, 2013, PAIN, V154, P1115, DOI 10.1016/j.pain.2013.03.026; Gwak YS, 2012, EXP NEUROL, V234, P362, DOI 10.1016/j.expneurol.2011.10.010; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Gwak YS, 2006, J NEUROTRAUM, V23, P1111, DOI 10.1089/neu.2006.23.1111; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hajebrahimi Z, 2008, NEUROSCI LETT, V441, P261, DOI 10.1016/j.neulet.2008.06.046; HOLE K, 1993, PAIN, V53, P247, DOI 10.1016/0304-3959(93)90220-J; Hoschouer EL, 2010, PAIN, V148, P328, DOI 10.1016/j.pain.2009.11.023; Hubscher CH, 2008, J NEUROTRAUM, V25, P1241, DOI 10.1089/neu.2008.0515; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Humanes-Valera D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069655; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Jung JI, 2008, KOREAN J PHYSIOL PHA, V12, P299, DOI 10.4196/kjpp.2008.12.6.299; Kayser V, 2002, BRIT J PHARMACOL, V137, P1287, DOI 10.1038/sj.bjp.0704979; Kayser V, 2010, PHARM PAIN, P185, DOI [10.1007/s11724-017-0486-3, DOI 10.1007/S11724-017-0486-3]; Kayser V, 2007, PAIN, V130, P235, DOI 10.1016/j.pain.2006.11.015; Kayser V, 2011, EUR J PAIN, V15, P451, DOI 10.1016/j.ejpain.2010.09.012; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kim JY, 2013, J KOREAN MED SCI, V28, P295, DOI 10.3346/jkms.2013.28.2.295; Kim K, 2013, J CLIN NEUROSCI, V20, P804, DOI 10.1016/j.jocn.2012.07.009; Latremoliere A, 2008, J NEUROSCI, V28, P8489, DOI 10.1523/JNEUROSCI.2552-08.2008; LOTTA S, 1991, PARAPLEGIA, V29, P247, DOI 10.1038/sc.1991.35; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; Marcillo A, 2012, EXP NEUROL, V233, P687, DOI 10.1016/j.expneurol.2011.06.008; McCleane GJ, 2003, ANESTH ANALG, V97, P1474, DOI 10.1213/01.ANE.0000085640.69855.51; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nakae A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939023; Niesters M, 2012, EXPERT OPIN DRUG MET, V8, P1409, DOI 10.1517/17425255.2012.712686; Norrbrink C, 2009, CLIN J PAIN, V25, P177, DOI 10.1097/AJP.0b013e31818a744d; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Ramsey JBG, 2010, J NEUROTRAUM, V27, P1709, DOI 10.1089/neu.2010.1382; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62, DOI 10.1111/j.1600-0404.2010.01378.x; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Santos-Nogueira E, 2012, J NEUROTRAUM, V29, P898, DOI 10.1089/neu.2010.1700; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh R, 2011, INDIAN J ORTHOP, V45, P141, DOI 10.4103/0019-5413.77134; Suzuki R, 2004, BRAIN RES, V1019, P68, DOI 10.1016/j.brainres.2004.05.108; Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Tzellos TG, 2008, EUR J CLIN PHARMACOL, V64, P851, DOI 10.1007/s00228-008-0523-5; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; Vanelderen P, 2013, REGION ANESTH PAIN M, V38, P124, DOI 10.1097/AAP.0b013e31827d611b; Wallin J, 2002, EUR J PAIN-LONDON, V6, P261, DOI 10.1053/eujp.2002.0329; Wang JG, 2005, ANESTHESIOLOGY, V102, P152, DOI 10.1097/00000542-200501000-00024; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Yasuda T, 1999, JPN J PHARMACOL, V79, P65, DOI 10.1254/jjp.79.65; Yezierski R P, 2000, Prog Brain Res, V129, P429; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	85	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102027	10.1371/journal.pone.0102027	http://dx.doi.org/10.1371/journal.pone.0102027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019623	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600038
J	Sang, SW; Yin, WW; Bi, P; Zhang, HL; Wang, CG; Liu, XB; Chen, B; Yang, WZ; Liu, QY				Sang, Shaowei; Yin, Wenwu; Bi, Peng; Zhang, Honglong; Wang, Chenggang; Liu, Xiaobo; Chen, Bin; Yang, Weizhong; Liu, Qiyong			Predicting Local Dengue Transmission in Guangzhou, China, through the Influence of Imported Cases, Mosquito Density and Climate Variability	PLOS ONE			English	Article							AEDES-AEGYPTI; HEMORRHAGIC-FEVER; GUANGDONG PROVINCE; PUERTO-RICO; TEMPERATURE; INFECTIONS; OUTBREAK; INDEXES; EPIDEMIOLOGY; THAILAND	Introduction: Each year there are approximately 390 million dengue infections worldwide. Weather variables have a significant impact on the transmission of Dengue Fever (DF), a mosquito borne viral disease. DF in mainland China is characterized as an imported disease. Hence it is necessary to explore the roles of imported cases, mosquito density and climate variability in dengue transmission in China. The study was to identify the relationship between dengue occurrence and possible risk factors and to develop a predicting model for dengue's control and prevention purpose. Methodology and Principal Findings: Three traditional suburbs and one district with an international airport in Guangzhou city were selected as the study areas. Autocorrelation and cross-correlation analysis were used to perform univariate analysis to identify possible risk factors, with relevant lagged effects, associated with local dengue cases. Principal component analysis (PCA) was applied to extract principal components and PCA score was used to represent the original variables to reduce multi-collinearity. Combining the univariate analysis and prior knowledge, time-series Poisson regression analysis was conducted to quantify the relationship between weather variables, Breteau Index, imported DF cases and the local dengue transmission in Guangzhou, China. The goodness-of-fit of the constructed model was determined by pseudo-R-2, Akaike information criterion (AIC) and residual test. There were a total of 707 notified local DF cases from March 2006 to December 2012, with a seasonal distribution from August to November. There were a total of 65 notified imported DF cases from 20 countries, with forty-six cases (70.8%) imported from Southeast Asia. The model showed that local DF cases were positively associated with mosquito density, imported cases, temperature, precipitation, vapour pressure and minimum relative humidity, whilst being negatively associated with air pressure, with different time lags. Conclusions: Imported DF cases and mosquito density play a critical role in local DF transmission, together with weather variables. The establishment of an early warning system, using existing surveillance datasets will help to control and prevent dengue in Guangzhou, China.	[Sang, Shaowei; Wang, Chenggang; Liu, Xiaobo; Chen, Bin; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Sang, Shaowei; Yin, Wenwu; Zhang, Honglong; Liu, Xiaobo; Yang, Weizhong; Liu, Qiyong] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Bi, Peng] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia; [Wang, Chenggang] Shandong Univ Tradit Chinese Med, Dept Prevent Med, Coll Basic Med Sci, Jinan, Shandong, Peoples R China; [Chen, Bin] Xiamen Entry Exit Inspect & Quarantine Bur, Xiamen, Peoples R China; [Sang, Shaowei; Liu, Xiaobo; Liu, Qiyong] WHO Collaborating Ctr Vector Surveillance & Manag, Beijing, Peoples R China; [Liu, Qiyong] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld 4111, Australia; [Sang, Shaowei; Wang, Chenggang; Liu, Qiyong] Shandong Univ, Climate Change & Hlth Ctr, Jinan 250100, Peoples R China; [Sang, Shaowei; Liu, Xiaobo; Liu, Qiyong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Adelaide; Shandong University of Traditional Chinese Medicine; Griffith University; Shandong University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yangwz@chinacdc.cn; liuqiyong@icdc.cn	Smith, Gary B/A-8235-2013	Bi, Peng/0000-0002-3238-3427	National Basic Research Program of China (973 Program) [2012CB955504]; National Natural Science Foundation of China (NSFC) [81273139]; Special Research Program for Health [201202006]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Research Program for Health	The study was supported by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955504); The National Natural Science Foundation of China (NSFC) (Grant No. 81273139); The Special Research Program for Health (Grant No. 201202006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x; Bi P, 2008, J INFECTION, V57, P317, DOI 10.1016/j.jinf.2008.08.004; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Fan J, 2013, EPIDEMIOL INFECT, V142, P1; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; Pham HV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-172; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Rohani A, 2009, SE ASIAN J TROP MED, V40, P942; Roriz-Cruz M, 2010, B WORLD HEALTH ORGAN, V88, P244, DOI 10.2471/BLT.10.076935; Rosa-Freitas Maria Goreti, 2006, Rev Panam Salud Publica, V20, P256, DOI 10.1590/S1020-49892006000900006; Sanchez L, 2006, EMERG INFECT DIS, V12, P800; Schreiber KV, 2001, INT J BIOMETEOROL, V45, P81, DOI 10.1007/s004840100090; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Scott TW, 2003, WAG UR FRON, V2, P187; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; TunLin W, 1996, AM J TROP MED HYG, V54, P543, DOI 10.4269/ajtmh.1996.54.543; Wang C, 2013, ASIA-PAC POWER ENERG; Wang C, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-9; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504	47	71	73	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102755	10.1371/journal.pone.0102755	http://dx.doi.org/10.1371/journal.pone.0102755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019967	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600099
J	Voorn, EL; Brehm, MA; Beelen, A; de Haan, A; Nollet, F; Gerrits, KHL				Voorn, Eric L.; Brehm, Merel A.; Beelen, Anita; de Haan, Arnold; Nollet, Frans; Gerrits, Karin H. L.			Reliability of Contractile Properties of the Knee Extensor Muscles in Individuals with Post-Polio Syndrome	PLOS ONE			English	Article							QUADRICEPS FEMORIS MUSCLE; MAXIMAL VOLUNTARY; FATIGUE; STRENGTH; ENDURANCE; POLIOMYELITIS; PERFORMANCE; DISABILITY; VARIABLES; EXERCISE	Objective: To assess the reliability of contractile properties of the knee extensor muscles in 23 individuals with post-polio syndrome (PPS) and 18 age-matched healthy individuals. Methods: Contractile properties of the knee extensors were assessed from repeated electrically evoked contractions on 2 separate days, with the use of a fixed dynamometer. Reliability was determined for fatigue resistance, rate of torque development (MRTD), and early and late relaxation time (RT50 and RT25), using the intraclass correlation coefficient (ICC) and standard error of measurement (SEM, expressed as % of the mean). Results: In both groups, reliability for fatigue resistance was good, with high ICCs (>0.90) and small SEM values (PPS: 7.1%, healthy individuals: 7.0%). Reliability for contractile speed indices varied, with the best values found for RT50 (ICCs>0.82, SEM values <2.8%). We found no systematic differences between test and retest occasions, except for RT50 in healthy subjects (p = 0.016). Conclusions: In PPS and healthy individuals, the reliability of fatigue resistance, as obtained from electrically evoked contractions is high. The reliability of contractile speed is only moderate, except for RT50 in PPS, demonstrating high reliability. Significance: This was the first study to examine the reliability of electrically evoked contractile properties in individuals with PPS. Our results demonstrate its potential to study mechanisms underlying muscle fatigue in PPS and to evaluate changes in contractile properties over time in response to interventions or from natural course.	[Voorn, Eric L.; Brehm, Merel A.; Beelen, Anita; Nollet, Frans] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [Voorn, Eric L.; de Haan, Arnold; Gerrits, Karin H. L.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Voorn, EL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.l.voorn@amc.uva.nl	Brehm, Merel-Anne/K-8638-2017; Brehm, Merel-Anne/AAK-7419-2020	Brehm, Merel-Anne/0000-0002-3425-4661; Brehm, Merel-Anne/0000-0002-3425-4661; Voorn, Eric/0000-0003-0807-2124	Prinses Beatrix Spierfonds (PBF); Dutch Public Fund for Neuromuscular Disorders; Netherlands Organization for Health Research and Development [ZonMW 89000003]; Department of Rehabilitation AMC	Prinses Beatrix Spierfonds (PBF); Dutch Public Fund for Neuromuscular Disorders; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Department of Rehabilitation AMC	This study was supported by the Prinses Beatrix Spierfonds (PBF); The Dutch Public Fund for Neuromuscular Disorders, The Netherlands Organization for Health Research and Development (ID: ZonMW 89000003) and the Department of Rehabilitation AMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre JC, 1997, ARCH PHYS MED REHAB, V78, P681, DOI 10.1016/S0003-9993(97)90073-3; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen GM, 2004, MUSCLE NERVE, V30, P172, DOI 10.1002/mus.20094; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; Burnley M, 2009, J APPL PHYSIOL, V106, P975, DOI 10.1152/japplphysiol.91474.2008; de Ruiter CJ, 2004, J APPL PHYSIOL, V97, P1693, DOI 10.1152/japplphysiol.00230.2004; de Vet H. C. W., 2011, MEASUREMENT IN MEDIC; Ernstoff B, 1996, ARCH PHYS MED REHAB, V77, P843, DOI 10.1016/S0003-9993(96)90268-3; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Gerrits HL, 2001, CLIN PHYSIOL, V21, P105, DOI 10.1046/j.1365-2281.2001.00293.x; GRIMBY G, 1994, PHYS THER, V74, P415, DOI 10.1093/ptj/74.5.415; Grimby G, 1998, MUSCLE NERVE, V21, P1428, DOI 10.1002/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.3.CO;2-D; HALSTEAD LS, 1991, ORTHOPEDICS, V14, P1209; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Hildegunn L, 2007, PHYSIOTHER RES INT, V12, P39, DOI DOI 10.1002/PRI.352; Hunter S, 1998, J GERONTOL A-BIOL, V53, pB204, DOI 10.1093/gerona/53A.3.B204; Ivanyi B, 1996, MUSCLE NERVE, V19, P738, DOI 10.1002/(SICI)1097-4598(199606)19:6<738::AID-MUS8>3.0.CO;2-B; Koopman FS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-8; LEE J, 1989, COMPUT BIOL MED, V19, P61, DOI 10.1016/0010-4825(89)90036-X; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Luciano CA, 1996, MUSCLE NERVE, V19, P1413, DOI 10.1002/(SICI)1097-4598(199611)19:11<1413::AID-MUS5>3.3.CO;2-3; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; March of Dimes, 2000, INTERNATIONAL CONFER; MCDONNELL MK, 1987, PHYS THER, V67, P941, DOI 10.1093/ptj/67.6.941; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morris MG, 2008, J SPORT SCI MED, V7, P431; Nollet F, 1999, ARCH PHYS MED REHAB, V80, P136, DOI 10.1016/S0003-9993(99)90110-7; SNYDERMACKLER L, 1993, MED SCI SPORT EXER, V25, P783, DOI 10.1249/00005768-199307000-00005; Voorn EL, 2013, NEUROMUSCULAR DISORD, V23, P892, DOI 10.1016/j.nmd.2013.06.372; [No title captured]	33	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101660	10.1371/journal.pone.0101660	http://dx.doi.org/10.1371/journal.pone.0101660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019943	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600021
J	Chavez-Dozal, AA; Gorman, C; Lostroh, CP; Nishiguchi, MK				Chavez-Dozal, Alba A.; Gorman, Clayton; Lostroh, C. Phoebe; Nishiguchi, Michele K.			Gene-Swapping Mediates Host Specificity among Symbiotic Bacteria in a Beneficial Symbiosis	PLOS ONE			English	Article							VIBRIO-FISCHERI; SEPIOLID SQUID; NEISSERIA-GONORRHOEAE; ADHERENCE; CELL; PILC	Environmentally acquired beneficial associations are comprised of a wide variety of symbiotic species that vary both genetically and phenotypically, and therefore have differential colonization abilities, even when symbionts are of the same species. Strain variation is common among conspecific hosts, where subtle differences can lead to competitive exclusion between closely related strains. One example where symbiont specificity is observed is in the sepiolid squid-Vibrio mutualism, where competitive dominance exists among V. fischeri isolates due to subtle genetic differences between strains. Although key symbiotic loci are responsible for the establishment of this association, the genetic mechanisms that dictate strain specificity are not fully understood. We examined several symbiotic loci (lux-bioluminescence, pil = pili, and msh-mannose sensitive hemagglutinin) from mutualistic V. fischeri strains isolated from two geographically distinct squid host species (Euprymna tasmanica-Australia and E. scolopes-Hawaii) to determine whether slight genetic differences regulated host specificity. Through colonization studies performed in naive squid hatchlings from both hosts, we found that all loci examined are important for specificity and host recognition. Complementation of null mutations in non-native V. fischeri with loci from the native V. fischeri caused a gain in fitness, resulting in competitive dominance in the non-native host. The competitive ability of these symbiotic loci depended upon the locus tested and the specific squid species in which colonization was measured. Our results demonstrate that multiple bacterial genetic elements can determine V. fischeri strain specificity between two closely related squid hosts, indicating how important genetic variation is for regulating conspecific beneficial interactions that are acquired from the environment.	[Chavez-Dozal, Alba A.; Gorman, Clayton; Nishiguchi, Michele K.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Lostroh, C. Phoebe] Colorado Coll, Dept Biol, Colorado Springs, CO 80903 USA	New Mexico State University; Colorado College	Nishiguchi, MK (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	nish@nmsu.edu		Lostroh, Phoebe/0000-0002-7956-9536	NMSU National Institutes of Health (NIH) RISE [NIH NIGMS R25GM061222]; NASA (NMSGC) fellowships; NMSU NIH MARC program [NIH-GM0007667-34]; National Science Foundation (NSF); NIH [NSF IOS-0744498, NIH NIAID1SC1AI081659-01, NIH ARRA-3SC1AI081659-02S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI081659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007667, R25GM061222] Funding Source: NIH RePORTER	NMSU National Institutes of Health (NIH) RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA (NMSGC) fellowships; NMSU NIH MARC program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.A.C-D. was supported by NMSU National Institutes of Health (NIH) RISE to the doctorate (NIH NIGMS R25GM061222) and NASA (NMSGC) fellowships. C.G. was supported by the NMSU NIH MARC program (NIH-GM0007667-34). Support for the research was through National Science Foundation (NSF) and NIH awards (NSF IOS-0744498, NIH NIAID1SC1AI081659-01 and NIH ARRA-3SC1AI081659-02S1) to M.K.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyakumar DS, 2009, FEMS MICROBIOL LETT, V299, P65, DOI 10.1111/j.1574-6968.2009.01732.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Browne-Silva J, 2008, INT J SYST EVOL MICR, V58, P1292, DOI 10.1099/ijs.0.65370-0; Castle W, 2013, THESIS NEW MEXICO ST; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Gaida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017782; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Naughton LM, 2009, APPL ENVIRON MICROB, V75, P2802, DOI 10.1128/AEM.01698-08; Nishiguchi MK, 2002, MICROB ECOL, V44, P10, DOI 10.1007/BF03036870; Nyholm SV, 2008, VIE MILIEU, V58, P175; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Pollack-Berti A, 2010, ENVIRON MICROBIOL, V12, P2302, DOI 10.1111/j.1462-2920.2010.02250.x; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Soto W, 2012, EVOLUTION, V66, P1308, DOI 10.1111/j.1558-5646.2011.01547.x; Soto W, 2014, MICROB ECOL, V67, P700, DOI 10.1007/s00248-013-0356-3; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Urbanczyk H, 2008, J BACTERIOL, V190, P3494, DOI 10.1128/JB.00101-08; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	27	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101691	10.1371/journal.pone.0101691	http://dx.doi.org/10.1371/journal.pone.0101691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014649	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400032
J	Calvino-Cancela, M; Mendez-Rial, R; Reguera-Salgado, J; Martin-Herrero, J				Calvino-Cancela, Maria; Mendez-Rial, Roi; Reguera-Salgado, Javier; Martin-Herrero, Julio			Alien Plant Monitoring with Ultralight Airborne Imaging Spectroscopy	PLOS ONE			English	Article							CLASSIFICATION; COMMUNITIES; INVASIONS	Effective management of invasive plants requires a precise determination of their distribution. Remote sensing techniques constitute a promising alternative to field surveys and hyperspectral sensors (also known as imaging spectrometers, with a large number of spectral bands and high spectral resolution) are especially suitable when very similar categories are to be distinguished (e.g. plant species). A main priority in the development of this technology is to lower its cost and simplify its use, so that its demonstrated aptitude for many environmental applications can be truly realized. With this aim, we have developed a system for hyperspectral imaging (200 spectral bands in the 380-1000 nm range and circa 3 nm spectral resolution) operated on board ultralight aircraft (namely a gyrocopter), which allows a drastic reduction of the running costs and operational complexity of image acquisition, and also increases the spatial resolution of the images (circa 5-8 pixels/m(2) at circa 65 km/h and 300 m height). The detection system proved useful for the species tested (Acacia melanoxylon, Oxalis pes-caprae, and Carpobrotus aff. edulis and acinaciformis), with user's and producer's accuracy always exceeding 90%. The detection accuracy reported corresponds to patches down to 0.125 m(2) (50% of pixels 0.5x0.5 m in size), a very small size for many plant species, making it very effective for initial stages of invasive plant spread. In addition, its low operating costs, similar to those of a 4WD ground vehicle, facilitate frequent image acquisition. Acquired images constitute a permanent record of the status of the study area, with great amount of information that can be analyzed in the future for other purposes, thus greatly facilitating the monitoring of natural areas at detailed spatial and temporal scales for improved management.	[Calvino-Cancela, Maria] Univ Vigo, Dept Ecol & Anim Biol, Vigo 36310, Galicia, Spain; [Mendez-Rial, Roi; Reguera-Salgado, Javier; Martin-Herrero, Julio] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Galicia, Spain	Universidade de Vigo; Universidade de Vigo	Calvino-Cancela, M (corresponding author), Univ Vigo, Dept Ecol & Anim Biol, Vigo 36310, Galicia, Spain.	maria@uvigo.es	Martin-Herrero, Julio/D-3827-2009	Martin-Herrero, Julio/0000-0003-1109-6338; Mendez-Rial, Roi/0000-0002-9991-0316; Calvino-Cancela, Maria/0000-0002-7833-4671	Organismo Autonomo de Parques Nacionales; Ministerio de Medio Ambiente y Medio Rural y Marino [023/2008]; ERDF; Xunta de Galicia Consolidation of Research Units [2009/062]; AtlanTIC	Organismo Autonomo de Parques Nacionales; Ministerio de Medio Ambiente y Medio Rural y Marino(Spanish Government); ERDF(European Commission); Xunta de Galicia Consolidation of Research Units; AtlanTIC	This work was partially supported by the Organismo Autonomo de Parques Nacionales, Ministerio de Medio Ambiente y Medio Rural y Marino (023/2008), ERDF, Xunta de Galicia Consolidation of Research Units (2009/062), and AtlanTIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C, 2011, WEED SCI, V59, P145, DOI 10.1614/WS-D-10-00094.1; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Burkart A, 2014, IEEE SENS J, V14, P62, DOI 10.1109/JSEN.2013.2279720; Calvino-Cancela M, 2007, ECOSCIENCE, V14, P529, DOI 10.2980/1195-6860(2007)14[529:EPTEOA]2.0.CO;2; Camps-Valls G, 2004, IEEE T GEOSCI REMOTE, V42, P1530, DOI 10.1109/TGRS.2004.827262; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x; Giardino C, 2007, REMOTE SENS ENVIRON, V109, P183, DOI 10.1016/j.rse.2006.12.017; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jorgensen RH, 2009, FLORA, V204, P289, DOI 10.1016/j.flora.2008.03.002; KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lass LW, 2005, WEED SCI, V53, P242, DOI 10.1614/WS-04-044R2; Leishman J., 2002, PRINCIPLES HELICOPTE, V2nd; Lucas R, 2008, REMOTE SENS ENVIRON, V112, P2088, DOI 10.1016/j.rse.2007.10.011; Mack Richard N., 2005, SCOPE, V63, P179; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin-Herrero J, 2007, IEEE T GEOSCI REMOTE, V45, P1386, DOI 10.1109/TGRS.2007.894569; Mendez-Rial R, 2012, IEEE GEOSCI REMOTE S, V9, P214, DOI 10.1109/LGRS.2011.2164050; Panetta FD, 2005, DIVERS DISTRIB, V11, P435, DOI 10.1111/j.1366-9516.2005.00179.x; Peerbhay KY, 2013, ISPRS J PHOTOGRAMM, V79, P19, DOI 10.1016/j.isprsjprs.2013.01.013; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Reguera-Salgado J, 2012, INT GEOSCI REMOTE SE, P4086, DOI 10.1109/IGARSS.2012.6350729; Reguera-Salgado J, 2012, IEEE T GEOSCI REMOTE, V50, P4409, DOI 10.1109/TGRS.2012.2192938; Sanz-Elorza M., 2001, Lazaroa, V22, P121; Scholkopf B., 1997, SUPPORT VECTOR LEARN; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Underwood EC, 2007, ENVIRON MANAGE, V39, P63, DOI 10.1007/s00267-005-0228-9; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x	37	19	20	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102381	10.1371/journal.pone.0102381	http://dx.doi.org/10.1371/journal.pone.0102381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010601	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800097
J	Cheng, D; He, QF				Cheng, Dan; He, Qingfang			PfsR Is a Key Regulator of Iron Homeostasis in Synechocystis PCC 6803	PLOS ONE			English	Article							CHLOROPHYLL-BINDING-PROTEIN; SYNECHOCOCCUS SP PCC7942; SP STRAIN PCC-7120; OXIDATIVE STRESS; SP PCC-6803; PHOTOSYSTEM-I; ISIA GENE; TETRAPYRROLE BIOSYNTHESIS; ELECTRON-TRANSPORT; ESCHERICHIA-COLI	Iron is an essential cofactor in numerous cellular processes. The iron deficiency in the oceans affects the primary productivity of phytoplankton including cyanobacteria. In this study, we examined the function of PfsR, a TetR family transcriptional regulator, in iron homeostasis of the cyanobacterium Synechocystis PCC 6803. Compared with the wild type, the pfsR deletion mutant displayed stronger tolerance to iron limitation and accumulated significantly more chlorophyll a, carotenoid, and phycocyanin under iron-limiting conditions. The mutant also maintained more photosystem I and photosystem II complexes than the wild type after iron deprivation. In addition, the activities of photosystem I and photosystem II were much higher in pfsR deletion mutant than in wild-type cells under iron-limiting conditions. The transcripts of pfsR were enhanced by iron limitation and inactivation of the gene affected pronouncedly expression of fut genes (encoding a ferric iron transporter), feoB (encoding a ferrous iron transporter), bfr genes (encoding bacterioferritins), ho genes (encoding heme oxygenases), isiA (encoding a chlorophyll-binding protein), and furA (encoding a ferric uptake regulator). The iron quota in pfsR deletion mutant cells was higher than in wild-type cells both before and after exposure to iron limitation. Electrophoretic mobility shift assays showed that PfsR bound to its own promoter and thereby autoregulated its own expression. These data suggest that PfsR is a critical regulator of iron homeostasis.	[Cheng, Dan; He, Qingfang] Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	He, QF (corresponding author), Univ Arkansas, Dept Appl Sci, Little Rock, AR 72204 USA.	qfhe@ualr.edu		Cheng, Dan/0000-0001-5302-950X	U.S. National Science Foundation [MCB 1120153]; National Natural Science Foundation of China [31270102]; Shandong Province "Taishan Scholar" Foundation [tshw20091014]	U.S. National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province "Taishan Scholar" Foundation	This work was supported by U.S. National Science Foundation (http://www.nsf.gov/) [grant number MCB 1120153]; National Natural Science Foundation of China (http://www.nsfc.gov.cn/) [grant number 31270102]; and Shandong Province "Taishan Scholar" Foundation (http://www.shandong.gov.cn/) [grant number tshw20091014]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrizhiyevskaya EG, 2002, BBA-BIOENERGETICS, V1556, P265, DOI 10.1016/S0005-2728(02)00371-7; Aspinwall CL, 2004, FEBS LETT, V574, P126, DOI 10.1016/j.febslet.2004.08.016; Babykin M. M., 2003, Genetika, V39, P25; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Bibby TS, 2001, J BIOL CHEM, V276, P43246, DOI 10.1074/jbc.M106541200; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Cheng Y, 2006, J BACTERIOL, V188, P4822, DOI 10.1128/JB.00258-06; Choudhary M, 2007, ECOTOX ENVIRON SAFE, V66, P204, DOI 10.1016/j.ecoenv.2006.02.002; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; ENTSCH B, 1983, MAR BIOL, V73, P17, DOI 10.1007/BF00396281; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; FERREIRA F, 1994, J APPL PHYCOL, V6, P199, DOI 10.1007/BF02186073; Fraser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059861; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Ghassemian M, 1996, MICROBIOL-SGM, V142, P1469, DOI 10.1099/13500872-142-6-1469; Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hernandez JA, 2004, FEMS MICROBIOL LETT, V236, P275, DOI 10.1016/j.femsle.2004.05.050; Hernandez-Prieto MA, 2012, G3-GENES GENOM GENET, V2, P1475, DOI 10.1534/g3.112.003863; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Jantaro S, 2006, J BIOL CHEM, V281, P30865, DOI 10.1074/jbc.M606252200; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Karapetyan NV, 2008, PHOTOSYNTH RES, V97, P195, DOI 10.1007/s11120-008-9336-8; Kashiyama Y, 2012, P NATL ACAD SCI USA, V109, P17328, DOI 10.1073/pnas.1207347109; Katoh H, 2000, J BACTERIOL, V182, P6523, DOI 10.1128/JB.182.22.6523-6524.2000; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kirik I. A., 2003, Molekulyarnaya Biologiya (Moscow), V37, P1035; Kunert A, 2003, FEMS MICROBIOL LETT, V227, P255, DOI 10.1016/S0378-1097(03)00689-X; Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Martin-Luna B, 2011, J PLANT PHYSIOL, V168, P2244, DOI 10.1016/j.jplph.2011.08.006; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Michel KP, 2003, PHOTOSYNTH RES, V75, P71, DOI 10.1023/A:1022459919040; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Nefedova L. N., 2003, Genetika, V39, P336; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; OQUIST G, 1974, PHYSIOL PLANTARUM, V31, P55, DOI 10.1111/j.1399-3054.1974.tb03677.x; Pareja E, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-29; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; SANDMANN G, 1990, PHOTOSYNTH RES, V26, P119, DOI 10.1007/BF00047083; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; Sandstrom S, 2002, PHYSIOL PLANTARUM, V116, P255, DOI 10.1034/j.1399-3054.2002.1160216.x; Sandstrom S, 2001, PHOTOCHEM PHOTOBIOL, V74, P431, DOI 10.1562/0031-8655(2001)074<0431:CTIGPF>2.0.CO;2; Sevilla E, 2011, MICROBIOL-SGM, V157, P3398, DOI 10.1099/mic.0.048231-0; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Shinar G, 2006, P NATL ACAD SCI USA, V103, P3999, DOI 10.1073/pnas.0506610103; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Stekel DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-6; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sukrong S, 2012, MOL PLANT, V5, P1310, DOI 10.1093/mp/sss065; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Wall ME, 2003, J MOL BIOL, V332, P861, DOI 10.1016/S0022-2836(03)00948-3; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yilmaz M, 2010, PHOTOSYNTH RES, V103, P47, DOI 10.1007/s11120-009-9506-3; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	78	8	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101743	10.1371/journal.pone.0101743	http://dx.doi.org/10.1371/journal.pone.0101743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010795	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800035
J	Couldrey, C; Brauning, R; Bracegirdle, J; Maclean, P; Henderson, HV; McEwan, JC				Couldrey, Christine; Brauning, Rudiger; Bracegirdle, Jeremy; Maclean, Paul; Henderson, Harold V.; McEwan, John C.			Genome-Wide DNA Methylation Patterns and Transcription Analysis in Sheep Muscle	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; CPG; ISLANDS; TISSUES	DNA methylation plays a central role in regulating many aspects of growth and development in mammals through regulating gene expression. The development of next generation sequencing technologies have paved the way for genome-wide, high resolution analysis of DNA methylation landscapes using methodology known as reduced representation bisulfite sequencing (RRBS). While RRBS has proven to be effective in understanding DNA methylation landscapes in humans, mice, and rats, to date, few studies have utilised this powerful method for investigating DNA methylation in agricultural animals. Here we describe the utilisation of RRBS to investigate DNA methylation in sheep Longissimus dorsi muscles. RRBS analysis of similar to 1% of the genome from Longissimus dorsi muscles provided data of suitably high precision and accuracy for DNA methylation analysis, at all levels of resolution from genome-wide to individual nucleotides. Combining RRBS data with mRNAseq data allowed the sheep Longissimus dorsi muscle methylome to be compared with methylomes from other species. While some species differences were identified, many similarities were observed between DNA methylation patterns in sheep and other more commonly studied species. The RRBS data presented here highlights the complexity of epigenetic regulation of genes. However, the similarities observed across species are promising, in that knowledge gained from epigenetic studies in human and mice may be applied, with caution, to agricultural species. The ability to accurately measure DNA methylation in agricultural animals will contribute an additional layer of information to the genetic analyses currently being used to maximise production gains in these species.	[Couldrey, Christine; Maclean, Paul; Henderson, Harold V.] AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand; [Brauning, Rudiger; McEwan, John C.] AgResearch Ltd, Invermay Agr Ctr, Puddle Alley, Mosgiel, New Zealand; [Bracegirdle, Jeremy] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand	Couldrey, C (corresponding author), AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand.	Christine.Couldrey@agresearch.co.nz	McEwan, John/A-1143-2008	McEwan, John/0000-0003-4801-6207; Bracegirdle, Jeremy/0000-0002-9471-4527; Henderson, Harold/0000-0001-9660-5298; Maclean, Paul/0000-0001-8898-8276; Brauning, Rudiger/0000-0001-5068-9166	AgResearch	AgResearch	This work was supported by AgResearch internal funding (AgResearch research and capability fund - emerging leaders grant). This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Couldrey C, 2011, CELL REPROGRAM, V13, P171, DOI 10.1089/cell.2010.0065; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doherty R, 2014, FRONTIERS GENETICS, DOI [10.3389/fgene.2014, DOI 10.3389/FGENE.2014]; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Fass J, 2010, TRIMBWASTYLE PL; Goddard ME, 2010, GENET RES, V92, P413, DOI 10.1017/S0016672310000613; Hartung T, 2012, EPIGENETICS-US, V7, P421, DOI 10.4161/epi.19565; Kosaki K, 1997, AM J MED GENET, V73, P308; LEWIS J, 1991, FEBS LETT, V285, P155, DOI 10.1016/0014-5793(91)80795-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J., 2002, MOL CLONING LAB MANU; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	22	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101853	10.1371/journal.pone.0101853	http://dx.doi.org/10.1371/journal.pone.0101853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010796	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800046
J	Hua, XF; Wang, YW; Tang, YX; Yu, SQ; Jin, SH; Meng, XM; Li, HF; Liu, FJ; Sun, Q; Wang, HY; Li, JY				Hua, Xiu-feng; Wang, Yan-wei; Tang, Yu-xiao; Yu, Sheng-qiang; Jin, Shao-hua; Meng, Xiao-mei; Li, Hua-feng; Liu, Fu-jun; Sun, Qiang; Wang, Hai-yan; Li, Jian-yuan			Pancreatic Insulin-Producing Cells Differentiated from Human Embryonic Stem Cells Correct Hyperglycemia in SCID/NOD Mice, an Animal Model of Diabetes	PLOS ONE			English	Article							TRANSPLANTATION; THERAPY; GROWTH	Background: Human pancreatic islet transplantation is a prospective curative treatment for diabetes. However, the lack of donor pancreases greatly limits this approach. One approach to overcome the limited supply of donor pancreases is to generate functional islets from human embryonic stem cells (hESCs), a cell line with unlimited proliferative capacity, through rapid directed differentiation. This study investigated whether pancreatic insulin-producing cells (IPCs) differentiated from hESCs could correct hyperglycemia in severe combined immunodeficient (SCID)/non-obese diabetic (NOD) mice, an animal model of diabetes. Methods: We generated pancreatic IPCs from two hESC lines, YT1 and YT2, using an optimized four-stage differentiation protocol in a chemically defined culture system. Then, about 5-7x10(6) differentiated cells were transplanted into the epididymal fat pad of SCID/NOD mice (n = 20). The control group were transplanted with undifferentiated hESCs (n = 6). Graft survival and function were assessed using immunohistochemistry, and measuring serum human C-peptide and blood glucose levels. Results: The pancreatic IPCs were generated by the four-stage differentiation protocol using hESCs. About 17.1% of differentiated cells expressed insulin, as determined by flow cytometry. These cells secreted insulin/C-peptide following glucose stimulation, similarly to adult human islets. Most of these IPCs co-expressed mature beta cell-specific markers, including human C-peptide, GLUT2, PDX1, insulin, and glucagon. After implantation into the epididymal fat pad of SCID/NOD mice, the hESC-derived pancreatic IPCs corrected hyperglycemia for >= 8 weeks. None of the animals transplanted with pancreatic IPCs developed tumors during the time. The mean survival of recipients was increased by implanted IPCs as compared to implanted undifferentiated hESCs (P<0.0001). Conclusions: The results of this study confirmed that human terminally differentiated pancreatic IPCs derived from hESCs can correct hyperglycemia in SCID/NOD mice for >8 weeks.	[Hua, Xiu-feng; Tang, Yu-xiao; Meng, Xiao-mei; Li, Hua-feng] Yuhuangding Hosp, Dept Endocrinol, Yantai, Shandong, Peoples R China; [Wang, Yan-wei; Liu, Fu-jun; Wang, Hai-yan; Li, Jian-yuan] Yuhuangding Hosp, Cent Lab, Res Ctr Stem Cell Engn Shandong, Yantai, Shandong, Peoples R China; [Yu, Sheng-qiang] Yuhuangding Hosp, Dept Urol, Yantai, Shandong, Peoples R China; [Jin, Shao-hua] Yuhuangding Hosp, Dept Clin Lab, Yantai, Shandong, Peoples R China; [Sun, Qiang] Chinese Peoples Liberat Army Navy 407 Hosp, Dept Orthoped, Yantai, Shandong, Peoples R China		Li, JY (corresponding author), Yuhuangding Hosp, Cent Lab, Res Ctr Stem Cell Engn Shandong, Yantai, Shandong, Peoples R China.	sdscli@yeah.net	yu, shengqiang/AAT-4994-2020		Science and Technology Plan Project of Yantai City, China [2008142-9, 2011204]	Science and Technology Plan Project of Yantai City, China	This work was supported by the Science and Technology Plan Project of Yantai City, China (2008142-9 and 2011204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand SJ, 2002, PHARMACOL TOXICOL, V91, P414, DOI 10.1034/j.1600-0773.2002.910621.x; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Guo TX, 2009, ENDOCR REV, V30, P214, DOI 10.1210/er.2009-0004; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hua XF, 2006, ZHONGGUO YISHI ZA ZH, V8, P1297; Hua XF, 2012, NEURAL REGEN RES, V7, P506, DOI 10.3969/j.issn.1673-5374.2012.07.005; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jurewicz M, 2010, DIABETES, V59, P3139, DOI 10.2337/db10-0542; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Liew CG, 2005, ANN MED, V37, P521, DOI 10.1080/07853890500379463; Liu FJ, 2012, ONCOL REP, V27, P1932, DOI 10.3892/or.2012.1714; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Wang YW, 2012, HUM CELL, V25, P16, DOI 10.1007/s13577-011-0039-7; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	21	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102198	10.1371/journal.pone.0102198	http://dx.doi.org/10.1371/journal.pone.0102198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009980	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800080
J	Sun, YY; Xu, RD; Chen, LN; Kong, RQ; Hu, XP				Sun, Yuanyuan; Xu, Rudan; Chen, Lina; Kong, Ruiqing; Hu, Xiaopeng			A Novel Fractal Coding Method Based on M-J Sets	PLOS ONE			English	Article							IMAGE COMPRESSION; CLASSIFICATION; SEARCH; SCHEME	In this paper, we present a novel fractal coding method with the block classification scheme based on a shared domain block pool. In our method, the domain block pool is called dictionary and is constructed from fractal Julia sets. The image is encoded by searching the best matching domain block with the same BTC (Block Truncation Coding) value in the dictionary. The experimental results show that the scheme is competent both in encoding speed and in reconstruction quality. Particularly for large images, the proposed method can avoid excessive growth of the computational complexity compared with the traditional fractal coding algorithm.	[Sun, Yuanyuan; Xu, Rudan; Kong, Ruiqing; Hu, Xiaopeng] Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China; [Chen, Lina] Chinese Acad Sci, Natl Astron Observ, Beijing, Peoples R China	Dalian University of Technology; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Sun, YY (corresponding author), Dalian Univ Technol, Coll Comp Sci & Technol, Dalian, Peoples R China.	syuan@dlut.edu.cn			National Natural Science Foundation of China [61103147, 61075018, 61070098, 61272523]; National Key Project of Science and Technology of China [2011ZX05039-003-4]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Science and Technology of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (No. 61103147, 61075018, 61070098, 61272523, http://www.nsfc.gov.cn), the National Key Project of Science and Technology of China (No. 2011ZX05039-003-4, http://www.most.gov.cn) and the Fundamental Research Funds for the Central Universities (No. DUT12JB06, http://www.dlut.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnsley M., 1992, FRACTAL IMAGE COMPRE; Barnsley M. F., 1988, VIS COMM IM PROC 88, P122; Baviskar AG, 2012, ADV COMPUTER SCI ENG, V166, P353; Chen HN, 2010, IMAGE VISION COMPUT, V28, P518, DOI 10.1016/j.imavis.2009.08.007; DELP EJ, 1979, IEEE T COMMUN, V27, P1335, DOI 10.1109/TCOM.1979.1094560; Douda S., 2011, ELECT LETT COMPUTER, V10, P11; Duh DJ, 2005, IMAGE VISION COMPUT, V23, P1115, DOI 10.1016/j.imavis.2005.05.013; Jacquin AE, 1990, AC SPEECH SIGN PROC, P2225; Jacquin AE, 1992, IEEE T IMAGE PROCESS, V1, P18, DOI 10.1109/83.128028; Jaferzadeh K, 2012, IET IMAGE PROCESS, V6, P1024, DOI 10.1049/iet-ipr.2011.0181; Li ZH, 2010, APPL MECH MAT, V34, P1360; Lin YL, 2011, COMPUT MATH APPL, V62, P310, DOI 10.1016/j.camwa.2011.05.011; Linde Y Buzo A, 1980, IEEE T COMMUN, V28, P702; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Ozawa K, 2008, IMAGE VISION COMPUT, V26, P622, DOI 10.1016/j.imavis.2007.07.012; Pi MH, 2005, IEEE T MULTIMEDIA, V7, P597, DOI 10.1109/TMM.2005.846796; Schwartz WR, 2011, INT J IMAGE GRAPH, V11, P571, DOI 10.1142/S0219467811004251; Sze CJ, 1996, IMAGE VISION COMPUT, V14, P401, DOI 10.1016/0262-8856(95)01074-2; Tong CS, 2001, IEEE T IMAGE PROCESS, V10, P1269, DOI 10.1109/83.941851; Truong TK, 2004, CHAOS SOLITON FRACT, V22, P1071, DOI 10.1016/j.chaos.2004.03.015; Wang JJ, 2013, IEEE T IMAGE PROCESS, V22, P3690, DOI 10.1109/TIP.2013.2268977; Wohlberg B, 1999, IEEE T IMAGE PROCESS, V8, P1716, DOI 10.1109/83.806618	22	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101697	10.1371/journal.pone.0101697	http://dx.doi.org/10.1371/journal.pone.0101697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010686	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800033
J	Ulyshen, MD				Ulyshen, Michael D.			Interacting Effects of Insects and Flooding on Wood Decomposition	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; SUBTERRANEAN TERMITES; DEAD WOOD; FOREST; DEBRIS; RHINOTERMITIDAE; RETICULITERMES; DIVERSITY; LITTER; MODEL	Saproxylic arthropods are thought to play an important role in wood decomposition but very few efforts have been made to quantify their contributions to the process and the factors controlling their activities are not well understood. In the current study, mesh exclusion bags were used to quantify how arthropods affect loblolly pine (Pinus taeda L.) decomposition rates in both seasonally flooded and unflooded forests over a 31-month period in the southeastern United States. Wood specific gravity (based on initial wood volume) was significantly lower in bolts placed in unflooded forests and for those unprotected from insects. Approximately 20.5% and 13.7% of specific gravity loss after 31 months was attributable to insect activity in flooded and unflooded forests, respectively. Importantly, minimal between-treatment differences in water content and the results from a novel test carried out separately suggest the mesh bags had no significant impact on wood mass loss beyond the exclusion of insects. Subterranean termites (Isoptera: Rhinotermitidae: Reticulitermes spp.) were 5-6 times more active below-ground in unflooded forests compared to flooded forests based on wooden monitoring stakes. They were also slightly more active above-ground in unflooded forests but these differences were not statistically significant. Similarly, seasonal flooding had no detectable effect on above-ground beetle (Coleoptera) richness or abundance. Although seasonal flooding strongly reduced Reticulitermes activity below-ground, it can be concluded from an insignificant interaction between forest type and exclusion treatment that reduced above-ground decomposition rates in seasonally flooded forests were due largely to suppressed microbial activity at those locations. The findings from this study indicate that southeastern U. S. arthropod communities accelerate above-ground wood decomposition significantly and to a similar extent in both flooded and unflooded forests. Seasonal flooding has the potential to substantially reduce the contributions of these organisms to wood decomposition below-ground, however.	US Forest Serv, Southern Res Stn, USDA, Asheville, NC 28804 USA	United States Department of Agriculture (USDA); United States Forest Service	Ulyshen, MD (corresponding author), US Forest Serv, Southern Res Stn, USDA, Asheville, NC 28804 USA.	mulyshen@fs.fed.us			United States Department of Agriculture forest service southern research station	United States Department of Agriculture forest service southern research station(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by United States Department of Agriculture forest service southern research station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1980, REV ECOL BIOL SOL, V17, P23; Abe T., 1978, Malayan Nature Journal, V30, P391; Ballinger A, 2010, RIVER RES APPL, V26, P207, DOI 10.1002/rra.1254; Braccia A, 2008, CAN J FOREST RES, V38, P2697, DOI 10.1139/X08-113; Braccia A, 2001, WETLANDS, V21, P18, DOI 10.1672/0277-5212(2001)021[0018:IAWWDI]2.0.CO;2; Chang TT, 2003, PLANT DIS, V87, P1201, DOI 10.1094/PDIS.2003.87.10.1201; COE R, 2000, EFFECT SIZE CALCULAT; Collins N. M., 1983, Tropical rain forest: ecology and management. Special Publication Number 2 of the British Ecological Society, P311; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Delaney M, 1998, BIOTROPICA, V30, P2, DOI 10.1111/j.1744-7429.1998.tb00364.x; EDMONDS RL, 1989, CAN J FOREST RES, V19, P853, DOI 10.1139/x89-130; Forschler BT, 1995, ENVIRON ENTOMOL, V24, P1592, DOI 10.1093/ee/24.6.1592; GENTRY JB, 1982, OECOLOGIA, V54, P63, DOI 10.1007/BF00541109; Gonzalez G, 2008, AMBIO, V37, P588, DOI 10.1579/0044-7447-37.7.588; Guyette RP, 2002, CAN J FISH AQUAT SCI, V59, P578, DOI 10.1139/F02-026; Hedges L.V., 1985, STAT METHODS META AN; HOPKINS B, 1966, J ECOL, V54, P687, DOI 10.2307/2257811; HOWARD RW, 1982, ENVIRON ENTOMOL, V11, P1290, DOI 10.1093/ee/11.6.1290; Kampichler C, 2009, BIOL REV, V84, P375, DOI 10.1111/j.1469-185X.2009.00078.x; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Leach JG, 1937, J AGRIC RES, V55, P0129; Lim Su Yee, 2012, Insects, V3, P62, DOI 10.3390/insects3010062; Lloyd AH, 1997, ECOLOGY, V78, P1199, DOI 10.1890/0012-9658(1997)078[1199:HDOTFI]2.0.CO;2; MARTIUS C, 1994, PEDOBIOLOGIA, V38, P407; MARTIUS C, 1989, UNTERSUCHUNGEN OKOLO; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; Mouzinho JRC, 2010, J NAT HIST, V44, P589, DOI 10.1080/00222930903384758; Muller MM, 2002, FOREST ECOL MANAG, V166, P165, DOI 10.1016/S0378-1127(01)00671-5; MULLER RN, 1991, CAN J FOREST RES, V21, P1567, DOI 10.1139/x91-218; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Progar RA, 2000, OECOLOGIA, V124, P426, DOI 10.1007/PL00008868; RASTETTER EB, 1991, TREE PHYSIOL, V9, P101, DOI 10.1093/treephys/9.1-2.101; Rayner ADM, 1988, FUNGAL DECOMPOSITION; *SAS I, 1999, SAS SYST WIND VERS 8; Schuurman G, 2005, ECOLOGY, V86, P1236, DOI 10.1890/03-0570; Stokland J.N., 2012, BIODIVERSITY DEAD WO; SU NY, 1993, ENVIRON ENTOMOL, V22, P1113, DOI 10.1093/ee/22.5.1113; SWIFT MJ, 1977, SCI PROG, V64, P175; Thorne B.L., 1998, NATL PEST CONTROL AS, P1; Torres JA, 2005, BIOTROPICA, V37, P452, DOI 10.1111/j.1744-7429.2005.00059.x; TURNER DP, 1995, ECOL APPL, V5, P421, DOI 10.2307/1942033; Ulyshen MD, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00365.1; Ulyshen MD, 2013, INSECT CONSERV DIVER, V6, P393, DOI 10.1111/j.1752-4598.2012.00220.x; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Ulyshen MD, 2009, FOREST ECOL MANAG, V257, P653, DOI 10.1016/j.foreco.2008.09.047; Unger IM, 2009, APPL SOIL ECOL, V42, P1, DOI 10.1016/j.apsoil.2009.01.007; Warren RJ, 2012, INSECT SOC, V59, P215, DOI 10.1007/s00040-011-0208-4; WHITFORD WG, 1981, ECOLOGY, V62, P275, DOI 10.2307/1936687; WHITFORD WG, 1982, OECOLOGIA, V55, P298, DOI 10.1007/BF00376915	49	26	26	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101867	10.1371/journal.pone.0101867	http://dx.doi.org/10.1371/journal.pone.0101867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009985	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800047
J	Warnke, P; Warning, L; Podbielski, A				Warnke, Philipp; Warning, Liesa; Podbielski, Andreas			Some Are More Equal - A Comparative Study on Swab Uptake and Release of Bacterial Suspensions	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PORT-A-CUL; TRANSPORT-SYSTEMS; ANAEROBIC-BACTERIA; NEISSERIA-GONORRHOEAE; NASAL CARRIAGE; HOSPITAL ADMISSION; MICROBIAL ECOLOGY; FLOCKED SWABS; UNITED-STATES	Objectives: Swabs are widely used to collect samples for microbiological analyses from various clinical settings. They vary by material, size, and structure of the tip. This study investigates the uptake and release capacities for liquid and bacteria. Methods: Five swabs were analyzed for their uptake and release capacities of Staphylococcus aureus and Staphylococcus epidermidis suspensions. Two approaches were investigated providing volume-restricted and unrestricted amounts of bacterial suspensions to mimic various clinical situations. Volume and bacterial uptake and release were measured in milligrams and by counting colony forming units (CFU), respectively. Results: Volume uptake and release in the unrestricted setting varied highly significant between 239.6 mg and 88.7 mg (p<0.001) and between 65.2 mg and 2.2 mg (p<0.001), respectively. In the volume-restricted setting the complete volume was absorbed by all swabs, volume release could only be detected for flocked swabs (2.7 mg; p<0.001). Highest amount of CFU release was detected for the MWE Dryswab in the unrestricted setting for both S. aureus and S. epidermidis with 1544 CFU and 553 CFU, respectively, lowest release for the Sarstedt neutral swab with 32 CFU and 17 CFU, respectively (p<0.001). In the volume-restricted setting MWE Sigma-Swab released the highest bacterial amount with 135 CFU S. aureus and 55 CFU S. epidermidis, respectively, the lowest amount was released by Mast Mastaswab with 2 CFU S. aureus and 1 CFU S. epidermidis, respectively (p<0.001). Within the range of the utilized bacterial concentrations, uptake/release ratios were identical for the particular swab types and independent of the bacterial species. Conclusions: The influence of the swab type on subsequent diagnostic results is often underestimated. Uptake and release of the investigated bacteria vary significantly between different swab types and sampling conditions. For best diagnostic outcome swabs should be chosen according to the examined situation and the swab performance profile.	[Warnke, Philipp; Warning, Liesa; Podbielski, Andreas] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany	University of Rostock	Warnke, P (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Barber S, 1998, PATHOLOGY, V30, P179, DOI 10.1080/00313029800169196; BROOK I, 1987, J CLIN MICROBIOL, V25, P2020, DOI 10.1128/JCM.25.10.2020-2022.1987; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Citron DM, 2000, J CLIN MICROBIOL, V38, P892, DOI 10.1128/JCM.38.2.892-894.2000; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; Dalmaso Giblerto, 2008, PDA J Pharm Sci Technol, V62, P191; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Drake C, 2005, J CLIN MICROBIOL, V43, P1301, DOI 10.1128/JCM.43.3.1301-1303.2005; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farhat SE, 2001, J CLIN MICROBIOL, V39, P2958, DOI 10.1128/JCM.39.8.2958-2960.2001; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hernes SS, 2011, EUR J CLIN MICROBIOL, V30, P159, DOI 10.1007/s10096-010-1064-2; Hindiyeh M, 2001, J CLIN MICROBIOL, V39, P377, DOI 10.1128/JCM.39.1.377-380.2001; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Krech T, 2009, J VIROL METHODS, V162, P291, DOI 10.1016/j.jviromet.2009.08.011; Morosini MI, 2006, DIAGN MICR INFEC DIS, V56, P19, DOI 10.1016/j.diagmicrobio.2006.02.011; NCCLS (The National Committee for Clinical Laboratory Standards), 2003, M40A NCCLS; Olsen CC, 1999, J CLIN MICROBIOL, V37, P3583, DOI 10.1128/JCM.37.11.3583-3585.1999; Osterblad M, 2003, J CLIN MICROBIOL, V41, P1894, DOI 10.1128/JCM.41.5.1894-1900.2003; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Perry JL, 1997, J CLIN MICROBIOL, V35, P1269, DOI 10.1128/JCM.35.5.1269-1271.1997; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Roelofsen E, 1999, J CLIN MICROBIOL, V37, P3041, DOI 10.1128/JCM.37.9.3041-3043.1999; ROTH RR, 1989, J AM ACAD DERMATOL, V20, P367, DOI 10.1016/S0190-9622(89)70048-7; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Smismans A, 2009, DIAGN MICR INFEC DIS, V65, P108, DOI 10.1016/j.diagmicrobio.2009.06.015; Stahl DL, 2012, ANAESTHESIA, V67, P479, DOI 10.1111/j.1365-2044.2011.06916.x; Tan TY, 2014, PATHOLOGY, V46, P230, DOI 10.1097/PAT.0000000000000074; Tjeenk RM, 2005, INJURY, V36, P100, DOI 10.1016/j.injury.2004.04.011; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Van Horn KG, 2008, DIAGN MICR INFEC DIS, V62, P471, DOI 10.1016/j.diagmicrobio.2008.08.004; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; Wiley DJ, 2013, J LOW GENIT TRACT DI, V17, P414, DOI 10.1097/LGT.0b013e318281d36e; York MK, 2010, CLIN MICROBIOLOGY PR, V1, P3319	47	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102215	10.1371/journal.pone.0102215	http://dx.doi.org/10.1371/journal.pone.0102215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010422	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800084
J	Lane, M; McPherson, NO; Fullston, T; Spillane, M; Sandeman, L; Kang, WX; Zander-Fox, DL				Lane, Michelle; McPherson, Nicole O.; Fullston, Tod; Spillane, Marni; Sandeman, Lauren; Kang, Wan Xian; Zander-Fox, Deirdre L.			Oxidative Stress in Mouse Sperm Impairs Embryo Development, Fetal Growth and Alters Adiposity and Glucose Regulation in Female Offspring	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; DIET-INDUCED OBESITY; BODY-MASS INDEX; TRANSCRIPTIONAL PROFILE; BLASTOCYST DEVELOPMENT; PHYSIOLOGICAL CONTROL; HUMAN SPERMATOZOA; PATERNAL OBESITY; FERTILIZATION; RESTRICTION	Paternal health cues are able to program the health of the next generation however the mechanism for this transmission is unknown. Reactive oxygen species (ROS) are increased in many paternal pathologies, some of which program offspring health, and are known to induce DNA damage and alter the methylation pattern of chromatin. We therefore investigated whether a chemically induced increase of ROS in sperm impairs embryo, pregnancy and offspring health. Mouse sperm was exposed to 1500 mu M of hydrogen peroxide (H2O2), which induced oxidative damage, however did not affect sperm motility or the ability to bind and fertilize an oocyte. Sperm treated with H2O2 delayed on-time development of subsequent embryos, decreased the ratio of inner cell mass cells (ICM) in the resulting blastocyst and reduced implantation rates. Crown-rump length at day 18 of gestation was also reduced in offspring produced by H2O2 treated sperm. Female offspring from H2O2 treated sperm were smaller, became glucose intolerant and accumulated increased levels of adipose tissue compared to control female offspring. Interestingly male offspring phenotype was less severe with increases in fat depots only seen at 4 weeks of age, which was restored to that of control offspring later in life, demonstrating sex-specific impacts on offspring. This study implicates elevated sperm ROS concentrations, which are common to many paternal health pathologies, as a mediator of programming offspring for metabolic syndrome and obesity.	[Lane, Michelle; McPherson, Nicole O.; Fullston, Tod; Spillane, Marni; Sandeman, Lauren; Kang, Wan Xian; Zander-Fox, Deirdre L.] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia; [Lane, Michelle; McPherson, Nicole O.; Fullston, Tod; Spillane, Marni; Sandeman, Lauren; Kang, Wan Xian; Zander-Fox, Deirdre L.] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Lane, Michelle; Zander-Fox, Deirdre L.] Repromed, Dulwich, SA, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide	Lane, M (corresponding author), Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA 5005, Australia.	michelle.lane@adelaide.edu.au		McPherson, Nicole/0000-0002-3492-9403	NHMRC; Australian Post Graduate Award; Prospective Lodge Freemasons Scholarship; Freemasons Lodge St Albans Research Scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Post Graduate Award(Australian Government); Prospective Lodge Freemasons Scholarship; Freemasons Lodge St Albans Research Scholarship	This research was funded by NHMRC project grant awarded to ML. ML was supported by NHMRC Senior Research Fellowship, NOM by an Australian Post Graduate Award and a Prospective Lodge Freemasons Scholarship, TF by NHMRC Peter Doherty Fellowship, and MS by 2012 Freemasons Lodge St Albans Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Aitken RJ, 2002, INT J ANDROL, V25, P191, DOI 10.1046/j.1365-2605.2002.03521.x; Aitken RJ, 2011, ANTIOXID REDOX SIGN, V14, P367, DOI 10.1089/ars.2010.3186; ALVAREZ JG, 1995, MOL REPROD DEV, V42, P334, DOI 10.1002/mrd.1080420311; Aziz N, 2004, FERTIL STERIL, V81, P349, DOI 10.1016/j.fertnstert.2003.06.026; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; BALHORN R, 1977, BIOCHEMISTRY-US, V16, P4074, DOI 10.1021/bi00637a021; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Binder NK, 2012, REPROD FERT DEVELOP, V24, P804, DOI 10.1071/RD11256; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Chang Jeffrey S., 2009, V472, P103, DOI 10.1007/978-1-60327-492-0_5; Chen SJ, 2013, ARCH GYNECOL OBSTET, V288, P191, DOI 10.1007/s00404-013-2801-4; Danielzik S, 2002, EUR J NUTR, V41, P132, DOI 10.1007/s00394-002-0367-1; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; El-Helaly M, 2011, INT J OCCUP MED ENV, V24, P218, DOI 10.2478/s13382-011-0019-x; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Fullston T, 2011, REPROD FERT DEVELOP, V23, P691, DOI 10.1071/RD10292; Gardner DK, 2000, MOL REPROD DEV, V57, P256, DOI 10.1002/1098-2795(200011)57:3&lt;256::AID-MRD7&gt;3.0.CO;2-P; Gatford KL, 2010, PLACENTA, V31, pS60, DOI 10.1016/j.placenta.2009.12.015; Gawecka JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056385; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Han MD, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.007; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koppers AJ, 2010, FREE RADICAL BIO MED, V48, P112, DOI 10.1016/j.freeradbiomed.2009.10.033; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; Lea RG, 1996, DIABETES, V45, P1463, DOI 10.2337/diabetes.45.11.1463; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; Lin CC, 2008, INT J OCCUP ENV HEAL, V14, P112, DOI 10.1179/oeh.2008.14.2.112; McPherson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071459; McPherson NO, 2014, FERTIL STERIL; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Naule L, 2014, J ENDOCRINOL, V220, P375, DOI 10.1530/JOE-13-0607; Ng SF, 2014, FASEB J; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Rathod R, 2014, BRAIN DEV; Robbins WA, 2008, J ANDROL, V29, P115, DOI 10.2164/jandrol.107.003541; Sathishkumar K, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-110; Sellayah D, 2014, EUR J NUTR; Shaman JA, 2007, J CELL BIOCHEM, V102, P680, DOI 10.1002/jcb.21321; Silva PFN, 2007, THERIOGENOLOGY, V67, P609, DOI 10.1016/j.theriogenology.2006.09.032; Sung TI, 2009, BIRTH DEFECTS RES A, V85, P119, DOI 10.1002/bdra.20496; Tesarik J, 2004, HUM REPROD, V19, P611, DOI 10.1093/humrep/deh127; THOMPSON JG, 1995, BIOL REPROD, V53, P1385, DOI 10.1095/biolreprod53.6.1385; Tunc O, 2011, ANDROLOGIA, V43, P121, DOI 10.1111/j.1439-0272.2009.01032.x; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Xiao JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038742; Zorn B, 2003, INT J ANDROL, V26, P279, DOI 10.1046/j.1365-2605.2003.00424.x	64	85	88	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100832	10.1371/journal.pone.0100832	http://dx.doi.org/10.1371/journal.pone.0100832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006800	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600020
J	Xiao, WF; Ge, XG; Zeng, LX; Huang, ZL; Lei, JP; Zhou, BZ; Li, MH				Xiao, Wenfa; Ge, Xiaogai; Zeng, Lixiong; Huang, Zhilin; Lei, Jingpin; Zhou, Benzhi; Li, Maihe			Rates of Litter Decomposition and Soil Respiration in Relation to Soil Temperature and Water in Different-Aged Pinus massoniana Forests in the Three Gorges Reservoir Area, China	PLOS ONE			English	Article							CO2 EFFLUX; HETEROTROPHIC RESPIRATION; OAK FOREST; CARBON; MOISTURE; PLANTATION; DIVERSITY; CHEMISTRY; RESPONSES; DYNAMICS	To better understand the soil carbon dynamics and cycling in terrestrial ecosystems in response to environmental changes, we studied soil respiration, litter decomposition, and their relations to soil temperature and soil water content for 18-months (Aug. 2010-Jan. 2012) in three different-aged Pinus massoniana forests in the Three Gorges Reservoir Area, China. Across the experimental period, the mean total soil respiration and litter respiration were 1.94 and 0.81, 2.00 and 0.60, 2.19 and 0.71 mu mol CO2 m(-2) s(-1), and the litter dry mass remaining was 57.6%, 56.2% and 61.3% in the 20-, 30-, and 46-year-old forests, respectively. We found that the temporal variations of soil respiration and litter decomposition rates can be well explained by soil temperature at 5 cm depth. Both the total soil respiration and litter respiration were significantly positively correlated with the litter decomposition rates. The mean contribution of the litter respiration to the total soil respiration was 31.0%-45.9% for the three different-aged forests. The present study found that the total soil respiration was not significantly affected by forest age when P. masonniana stands exceed a certain age (e.g. >20 years old), but it increased significantly with increased soil temperature. Hence, forest management strategies need to protect the understory vegetation to limit soil warming, in order to reduce the CO2 emission under the currently rapid global warming. The contribution of litter decomposition to the total soil respiration varies across spatial and temporal scales. This indicates the need for separate consideration of soil and litter respiration when assessing the climate impacts on forest carbon cycling.	[Xiao, Wenfa; Ge, Xiaogai; Zeng, Lixiong; Huang, Zhilin] Chinese Acad Forestry, State Forestry Adm, Key Lab Forest Ecol & Environm, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Ge, Xiaogai; Zhou, Benzhi] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China; [Lei, Jingpin] Chinese Acad Forestry, Res Inst Forestry, Key Lab Forest Silviculture, State Forestry Adm, Beijing, Peoples R China; [Li, Maihe] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Li, Maihe] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Xiao, WF (corresponding author), Chinese Acad Forestry, State Forestry Adm, Key Lab Forest Ecol & Environm, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	xiaowenf@caf.ac.cn; gexiaogai2006@163.com	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	Special Research Programme In Forestry Industry, State Forestry Administration of China [201104008]; National 'Twelfth Five-Year'' Plan for Science & Technology Project of China [2011BAD38B04]; Zigui National Forest Ecological Research Station; CFERN&GENE Award Funds on Ecological Paper	Special Research Programme In Forestry Industry, State Forestry Administration of China; National 'Twelfth Five-Year'' Plan for Science & Technology Project of China; Zigui National Forest Ecological Research Station; CFERN&GENE Award Funds on Ecological Paper	This work was supported by the Special Research Programme In Forestry Industry, State Forestry Administration of China (Project No. 201104008), National 'Twelfth Five-Year'' Plan for Science & Technology Project of China (2011BAD38B04), Zigui National Forest Ecological Research Station and CFERN&GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 1997, OIKOS, V80, P353, DOI 10.2307/3546603; Badot PM, 1998, ANN FOREST SCI, V56, P221; Barlow J, 2007, FOREST ECOL MANAG, V247, P91, DOI 10.1016/j.foreco.2007.04.017; Berbeco MR, 2012, PLANT SOIL, V344, P10; Berger TW, 2010, SOIL BIOL BIOCHEM, V42, P986, DOI 10.1016/j.soilbio.2010.02.020; Berryman EM, 2014, CAN J FOREST RES, V44, P432, DOI 10.1139/cjfr-2013-0334; Bini D, 2013, EUR J SOIL BIOL, V55, P117, DOI 10.1016/j.ejsobi.2012.12.010; Bolstad PV, 2004, TREE PHYSIOL, V24, P493, DOI 10.1093/treephys/24.5.493; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Butenschoen O, 2011, SOIL BIOL BIOCHEM, V43, P1902, DOI 10.1016/j.soilbio.2011.05.011; Cisneros-Dozal LM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000197; Cortez J, 1998, SOIL BIOL BIOCHEM, V30, P783, DOI 10.1016/S0038-0717(97)00163-6; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; DESANTO AV, 1993, SOIL BIOL BIOCHEM, V25, P1423, DOI 10.1016/0038-0717(93)90057-I; EWEL KC, 1987, CAN J FOREST RES, V17, P325, DOI 10.1139/x87-054; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fanin N, 2011, SOIL BIOL BIOCHEM, V43, P1014, DOI 10.1016/j.soilbio.2011.01.018; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Fioretto A, 1998, SOIL BIOL BIOCHEM, V30, P721, DOI 10.1016/S0038-0717(97)00182-X; Gong Z.T., 2003, CHINESE SOIL TAXONOM; HANSON PJ, 1993, TREE PHYSIOL, V13, P1, DOI 10.1093/treephys/13.1.1; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Kammer A, 2012, BIOGEOCHEMISTRY, V108, P395, DOI 10.1007/s10533-011-9607-x; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lee H, 2014, SOIL BIOL BIOCHEM, V72, P123, DOI 10.1016/j.soilbio.2014.01.027; Lellei-Kovacs E, 2011, EUR J SOIL BIOL, V47, P247, DOI 10.1016/j.ejsobi.2011.05.004; Li FL, 2013, APPL SOIL ECOL, V64, P1, DOI 10.1016/j.apsoil.2012.10.006; Liu LL, 2009, GLOBAL CHANGE BIOL, V15, P441, DOI 10.1111/j.1365-2486.2008.01747.x; Luan JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064167; Luan JW, 2011, SOIL BIOL BIOCHEM, V43, P503, DOI 10.1016/j.soilbio.2010.11.010; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Moyano FE, 2012, BIOGEOSCIENCES, V9, P1173, DOI 10.5194/bg-9-1173-2012; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Nguyen Tu TT, 2011, SOIL BIOL BIOCHEM, V43, P2222, DOI 10.1016/j.soilbio.2011.07.009; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Pandey RR, 2007, FOREST ECOL MANAG, V240, P96, DOI 10.1016/j.foreco.2006.12.013; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Prevost-Boure NC, 2010, APPL SOIL ECOL, V46, P26, DOI 10.1016/j.apsoil.2010.06.004; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Raich JW, 1998, FOREST ECOL MANAG, V107, P309, DOI 10.1016/S0378-1127(97)00347-2; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Reynolds BC, 2001, SOIL BIOL BIOCHEM, V33, P1641, DOI 10.1016/S0038-0717(01)00085-2; Rubino M, 2010, SOIL BIOL BIOCHEM, V42, P1009, DOI 10.1016/j.soilbio.2010.02.018; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Schaefer DA, 2009, SOIL BIOL BIOCHEM, V41, P1000, DOI 10.1016/j.soilbio.2008.11.015; Shi WY, 2012, SOIL BIOL BIOCHEM, V52, P99, DOI 10.1016/j.soilbio.2012.04.020; Smolander A, 2008, FOREST ECOL MANAG, V256, P1080, DOI 10.1016/j.foreco.2008.06.008; Subke JA, 2004, OECOLOGIA, V139, P551, DOI 10.1007/s00442-004-1540-4; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Vasconcelos HL, 2005, OECOLOGIA, V144, P456, DOI 10.1007/s00442-005-0117-1; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wiseman PE, 2004, FOREST ECOL MANAG, V192, P297, DOI 10.1016/j.foreco.2004.01.017; Xiao W.F., 2000, TERRESTRIAL ANIMAL P, P320; Xuluc-Tolosa FJ, 2003, FOREST ECOL MANAG, V174, P401, DOI 10.1016/S0378-1127(02)00059-2; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1	66	53	56	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101890	10.1371/journal.pone.0101890	http://dx.doi.org/10.1371/journal.pone.0101890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004164	Green Published, gold			2022-12-25	WOS:000339242700083
J	Liang, XH; Deng, WB; Li, M; Zhao, ZA; Wang, TS; Feng, XH; Cao, YJ; Duan, EK; Yang, ZM				Liang, Xiao-Huan; Deng, Wen-Bo; Li, Ming; Zhao, Zhen-Ao; Wang, Tong-Song; Feng, Xu-Hui; Cao, Yu-Jing; Duan, En-Kui; Yang, Zeng-Ming			Egr1 Protein Acts Downstream of Estrogen-Leukemia Inhibitory Factor (LIF)-STAT3 Pathway and Plays a Role during Implantation through Targeting Wnt4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Early Growth Response Protein 1 (Egr1); Estrogen; Mouse; STAT3; Transcription Factor; Embryo Implantation; Uterus; Decidualization	MOUSE UTERUS; TRANSCRIPTION-3 STAT3; EMBRYO IMPLANTATION; SIGNAL TRANSDUCER; EARLY-PREGNANCY; BLASTOCYST IMPLANTATION; DIFFERENTIAL EXPRESSION; FACTOR LIF; DECIDUALIZATION; MICE	Background: The downstream molecules of estrogen-LIF-STAT3 pathway during implantation are still unclear. Results: Egr1 is regulated by estrogen through LIF-STAT3 pathway in mouse uterus and regulates decidualization by targeting Wnt4. Conclusion: We showed Egr1 as a downstream target of LIF-STAT3 pathway and its involvement in decidualization. Significance: Our data could be a valuable source for future study on embryo implantation. Embryo implantation is a highly synchronized process between an activated blastocyst and a receptive uterus. Successful implantation relies on the dynamic interplay of estrogen and progesterone, but the key mediators underlying embryo implantation are not fully understood. Here we show that transcription factor early growth response 1 (Egr1) is regulated by estrogen as a downstream target through leukemia inhibitory factor (LIF) signal transducer and activator of transcription 3 (STAT3) pathway in mouse uterus. Egr1 is localized in the subluminal stromal cells surrounding the implanting embryo on day 5 of pregnancy. Estrogen rapidly, markedly, and transiently enhances Egr1 expression in uterine stromal cells, which fails in estrogen receptor knock-out mouse uteri. STAT3 is phosphorylated by LIF and subsequently recruited on Egr1 promoter to induce its expression. Our results of Egr1 expression under induced decidualization in vivo and in vitro show that Egr1 is rapidly induced after deciduogenic stimulus. Egr1 knockdown can inhibit in vitro decidualization of cultured uterine stromal cells. Chromatin immunoprecipitation data show that Egr1 is recruited to the promoter of wingless-related murine mammary tumor virus integration site 4 (Wnt4). Collectively, our study presents for the first time that estrogen regulates Egr1 expression through LIF-STAT3 signaling pathway in mouse uterus, and Egr1 functions as a critical mediator of stromal cell decidualization by regulating Wnt4.	[Liang, Xiao-Huan; Deng, Wen-Bo; Yang, Zeng-Ming] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Li, Ming; Feng, Xu-Hui] Xiamen Univ, Coll Life Sci, Xiamen 361005, Peoples R China; [Zhao, Zhen-Ao; Cao, Yu-Jing; Duan, En-Kui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Wang, Tong-Song] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China	South China Agricultural University; Xiamen University; Chinese Academy of Sciences; Institute of Zoology, CAS; Shantou University	Yang, ZM (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	zmyang@scau.edu.cn	feng, xuhui/AAD-9832-2019; feng, xuhui/D-9450-2017	feng, xuhui/0000-0003-4649-183X; Yang, Zeng-Ming/0000-0001-6775-0082	National Basic Research Program of China [2011CB944402, 2013CB910803]; National Natural Science Foundation of China [31071276, 31272263]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2011CB944402 and 2013CB910803 and National Natural Science Foundation of China Grants 31071276 and 31272263.	BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Dimitriadis E, 2006, ENDOCRINOLOGY, V147, P3809, DOI 10.1210/en.2006-0264; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hewitt SC, 2002, BIOL REPROD, V67, P1268, DOI [10.1095/biolreprod67.4.1268, 10.1095/biolreprod.102.002436]; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Laszlo GS, 2003, J BIOL CHEM, V278, P27750, DOI 10.1074/jbc.M303670200; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Luan LM, 2011, BIOL REPROD, V85, P996, DOI 10.1095/biolreprod.110.090126; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Nakamura H, 2006, FEBS LETT, V580, P2717, DOI 10.1016/j.febslet.2006.04.029; Nashta AAF, 2004, J ENDOCRINOL, V181, P477, DOI 10.1677/joe.0.1810477; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Saegusa M, 2008, J PATHOL, V216, P521, DOI 10.1002/path.2404; Scherle PA, 2000, J BIOL CHEM, V275, P37086, DOI 10.1074/jbc.M006168200; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Su RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015513; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	45	52	58	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23534	23545		10.1074/jbc.M114.588897	http://dx.doi.org/10.1074/jbc.M114.588897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012664	Green Published, hybrid			2022-12-25	WOS:000341505000024
J	Wang, O; Zachmann, LJ; Sesnie, SE; Olsson, AD; Dickson, BG				Wang, Ophelia; Zachmann, Luke J.; Sesnie, Steven E.; Olsson, Aaryn D.; Dickson, Brett G.			An Iterative and Targeted Sampling Design Informed by Habitat Suitability Models for Detecting Focal Plant Species over Extensive Areas	PLOS ONE			English	Article							INVASIVE PLANT; BRASSICA-TOURNEFORTII; CLIMATE-CHANGE; MOJAVE DESERT; FIRE; GRASS; DISTRIBUTIONS; DISPERSAL; ECOLOGY; ABSENCE	Prioritizing areas for management of non-native invasive plants is critical, as invasive plants can negatively impact plant community structure. Extensive and multi-jurisdictional inventories are essential to prioritize actions aimed at mitigating the impact of invasions and changes in disturbance regimes. However, previous work devoted little effort to devising sampling methods sufficient to assess the scope of multi-jurisdictional invasion over extensive areas. Here we describe a large-scale sampling design that used species occurrence data, habitat suitability models, and iterative and targeted sampling efforts to sample five species and satisfy two key management objectives: 1) detecting non-native invasive plants across previously unsampled gradients, and 2) characterizing the distribution of non-native invasive plants at landscape to regional scales. Habitat suitability models of five species were based on occurrence records and predictor variables derived from topography, precipitation, and remotely sensed data. We stratified and established field sampling locations according to predicted habitat suitability and phenological, substrate, and logistical constraints. Across previously unvisited areas, we detected at least one of our focal species on 77% of plots. In turn, we used detections from 2011 to improve habitat suitability models and sampling efforts in 2012, as well as additional spatial constraints to increase detections. These modifications resulted in a 96% detection rate at plots. The range of habitat suitability values that identified highly and less suitable habitats and their environmental conditions corresponded to field detections with mixed levels of agreement. Our study demonstrated that an iterative and targeted sampling framework can address sampling bias, reduce time costs, and increase detections. Other studies can extend the sampling framework to develop methods in other ecosystems to provide detection data. The sampling methods implemented here provide a meaningful tool when understanding the potential distribution and habitat of species over multi-jurisdictional and extensive areas is needed for achieving management objectives.	[Wang, Ophelia; Zachmann, Luke J.; Sesnie, Steven E.; Olsson, Aaryn D.; Dickson, Brett G.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Lab Landscape Ecol & Conservat Biol, Flagstaff, AZ 86011 USA; [Zachmann, Luke J.; Dickson, Brett G.] Conservat Sci Partners Inc, Truckee, CA USA; [Sesnie, Steven E.] US Fish & Wildlife Serv, Albuquerque, NM USA	Northern Arizona University; United States Department of the Interior; US Fish & Wildlife Service	Wang, O (corresponding author), No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Lab Landscape Ecol & Conservat Biol, Flagstaff, AZ 86011 USA.	Ophelia.Wang@nau.edu			U.S. Department of Defense, through the Strategic Environmental Research and Development Program (SERDP) [RC-1722]; Joint Fire Science Program (JFSP) [10-1-04-7]	U.S. Department of Defense, through the Strategic Environmental Research and Development Program (SERDP)(United States Department of Defense); Joint Fire Science Program (JFSP)	This research was supported by the U.S. Department of Defense, through the Strategic Environmental Research and Development Program (SERDP; project RC-1722), and by the Joint Fire Science Program (JFSP; project ID 10-1-04-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2012, INVAS PLANT SCI MANA, V5, P47, DOI 10.1614/IPSM-D-11-00030.1; Abella SR, 2009, ENVIRON MONIT ASSESS, V151, P221, DOI 10.1007/s10661-008-0263-0; Andrew ME, 2009, DIVERS DISTRIB, V15, P627, DOI 10.1111/j.1472-4642.2009.00568.x; Anonymous, 2005, Transactions of the Kansas Academy of Science, V108, P83, DOI 10.1660/0022-8443(2005)108[0083:DIAHOS]2.0.CO;2; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Barnett DT, 2007, ENVIRON MONIT ASSESS, V132, P235, DOI 10.1007/s10661-006-9530-0; Barrows CW, 2009, BIOL INVASIONS, V11, P673, DOI 10.1007/s10530-008-9282-6; Bass DA, 2006, EUPHYTICA, V148, P97, DOI 10.1007/s10681-006-5944-6; Bowers Janice E., 2006, Madrono, V53, P252, DOI 10.3120/0024-9637(2006)53[252:TDOCID]2.0.CO;2; Bradley BA, 2010, ECOGRAPHY, V33, P198, DOI 10.1111/j.1600-0587.2009.05684.x; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Brown DE, 1994, BIOTIC COMMUNITIES S; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Chen DM, 2002, PHOTOGRAMM ENG REM S, V68, P1155; Crall AW, 2013, ECOL APPL, V23, P60, DOI 10.1890/12-0465.1; Crossman ND, 2011, ECOL INDIC, V11, P183, DOI 10.1016/j.ecolind.2008.10.011; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dorazio RM, 2012, BIOMETRICS, V68, P1303, DOI 10.1111/j.1541-0420.2012.01779.x; Edwards TC, 2005, ECOLOGY, V86, P1081, DOI 10.1890/04-0608; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Esque TC, 2002, AZ S DES M, P165; Forseth IN, 2004, CRIT REV PLANT SCI, V23, P401, DOI 10.1080/07352680490505150; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Gavier-Pizarro GI, 2010, LANDSCAPE ECOL, V25, P1505, DOI 10.1007/s10980-010-9516-8; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hefley T, 2013, METHODS ECOL EVOL, DOI [10.1111/2041-1210X.12144, DOI 10.1111/2041-1210X.12144]; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Ibanez I, 2014, ECOL APPL, V24, P25, DOI 10.1890/13-0776.1; Jackson J, 2005, AUSTRAL ECOL, V30, P505, DOI 10.1111/j.1442-9993.2005.01465.x; Joly M, 2011, ENVIRON MANAGE, V48, P514, DOI 10.1007/s00267-011-9711-7; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kalkhan MA, 2007, DIVERS DISTRIB, V13, P379, DOI 10.1111/j.1472-4642.2007.00333.x; Kerns BK, 2009, INVAS PLANT SCI MANA, V2, P200, DOI 10.1614/IPSM-08-120.1; Le Lay G, 2010, ECOGRAPHY, V33, P1015, DOI 10.1111/j.1600-0587.2010.06338.x; Manier DJ, 2014, RANGELAND ECOL MANAG, V67, P160, DOI 10.2111/REM-D-12-00056.1; Maxwell BD, 2012, INVAS PLANT SCI MANA, V5, P178, DOI 10.1614/IPSM-D-11-00022.1; McDonald CJ, 2011, RANGELAND ECOL MANAG, V64, P384, DOI 10.2111/REM-D-10-00036.1; MCLAUGHLIN SP, 1982, ECOLOGY, V63, P246, DOI 10.2307/1937048; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morisette JT, 2006, FRONT ECOL ENVIRON, V4, P11, DOI 10.1890/1540-9295(2006)004[0012:ATHSMF]2.0.CO;2; Olsson AD, 2012, DIVERS DISTRIB, V18, P10, DOI 10.1111/j.1472-4642.2011.00825.x; Philippi T, 2005, ECOLOGY, V86, P1091, DOI 10.1890/04-0621; Phillips S, 2009, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rew LJ, 2007, CAN J PLANT SCI, V87, P1029, DOI 10.4141/CJPS07121; Rew LJ, 2006, BIOL INVASIONS, V8, P523, DOI 10.1007/s10530-005-6420-2; Rorabaugh JC, 2010, SW DESERT RESOURCES, P181; Sanchez-Flores E, 2007, ECOL MODEL, V204, P457, DOI 10.1016/j.ecolmodel.2007.02.002; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Steers RJ, 2010, RESTOR ECOL, V18, P334, DOI 10.1111/j.1526-100X.2009.00622.x; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevens J., 2009, Ecological Restoration, V27, P417, DOI 10.3368/er.27.4.417; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; Suazo AA, 2012, BIOL INVASIONS, V14, P215, DOI 10.1007/s10530-011-9998-6; Sullivan WP, 2008, J GREAT LAKES RES, V34, P86, DOI 10.3394/0380-1330(2008)34[86:ACSEDO]2.0.CO;2; SWETNAM TW, 1990, USDA ROCKY, V191, P6; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tellman B, 2002, INVASIVE EXOTIC SPEC; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; Trader Melissa R., 2006, Madrono, V53, P313, DOI 10.3120/0024-9637(2006)53[313:SPBTNB]2.0.CO;2; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Van Devender T.R., 1997, P CAL EX PEST PLANT, P1; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Wang L, 2013, PROF GEOGR, V65, P1, DOI 10.1080/00330124.2012.679440; Williams NSG, 2008, ECOL APPL, V18, P347, DOI 10.1890/07-0868.1; Xu YG, 2009, PHOTOGRAMM ENG REM S, V75, P313, DOI 10.14358/PERS.75.3.313; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	79	8	8	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101196	10.1371/journal.pone.0101196	http://dx.doi.org/10.1371/journal.pone.0101196			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019621	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600011
J	Eggert, D; Rosch, K; Reimer, R; Herker, E				Eggert, Dennis; Roesch, Kathrin; Reimer, Rudolph; Herker, Eva			Visualization and Analysis of Hepatitis C Virus Structural Proteins at Lipid Droplets by Super-Resolution Microscopy	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; CORE PROTEIN; FLUORESCENCE MICROSCOPY; DIACYLGLYCEROL ACYLTRANSFERASE-1; RESOLUTION LIMIT; CELL-CULTURE; LOCALIZATION; REPLICATION; ASSOCIATION; DETERMINANT	Cytosolic lipid droplets are central organelles in the Hepatitis C Virus (HCV) life cycle. The viral capsid protein core localizes to lipid droplets and initiates the production of viral particles at lipid droplet-associated ER membranes. Core is thought to encapsidate newly synthesized viral RNA and, through interaction with the two envelope proteins E1 and E2, bud into the ER lumen. Here, we visualized the spatial distribution of HCV structural proteins core and E2 in vicinity of small lipid droplets by three-color 3D super-resolution microscopy. We observed and analyzed small areas of colocalization between the two structural proteins in HCV-infected cells with a diameter of approximately 100 nm that might represent putative viral assembly sites.	[Eggert, Dennis; Roesch, Kathrin; Reimer, Rudolph; Herker, Eva] Univ Hamburg, Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Eggert, Dennis] Univ Hamburg, Inst Phys Chem, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University of Hamburg	Herker, E (corresponding author), Univ Hamburg, Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	eva.herker@hpi.uni-hamburg.de	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484	Free and Hanseatic City of Hamburg; Federal Ministry of Health	Free and Hanseatic City of Hamburg; Federal Ministry of Health	The Heinrich Pette Institute, Leibniz Institute for Experimental Virology is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI 10.1007/ BF02956173; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Eggert D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04159; Flottmann B, 2013, BIOTECHNIQUES, V55, P245, DOI 10.2144/000114099; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Han JJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016011; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5; Pereira CF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-84; Popescu CI, 2011, VIRUSES-BASEL, V3, P2238, DOI 10.3390/v3112238; Rouille Y, 2006, J CLIN VIROL, V36, pS53, DOI 10.1016/S1386-6532(06)80164-2; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wakita T, 2009, PRODUCTION USE EPITO; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697	42	19	19	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102511	10.1371/journal.pone.0102511	http://dx.doi.org/10.1371/journal.pone.0102511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25019511	Green Submitted, gold, Green Published			2022-12-25	WOS:000339378400100
J	Gray, TJ; Kong, FR; Jelfs, P; Sintchenko, V; Chen, SCA				Gray, Timothy J.; Kong, Fanrong; Jelfs, Peter; Sintchenko, Vitali; Chen, Sharon C. -A.			Improved Identification of Rapidly Growing Mycobacteria by a 16S-23S Internal Transcribed Spacer Region PCR and Capillary Gel Electrophoresis	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RIBOSOMAL-RNA; CLARITHROMYCIN RESISTANCE; ABSCESSUS GROUP; MASSILIENSE; AMPLIFICATION; INFECTION; SEQUENCES; DIFFERENTIATION	The identification of rapidly growing mycobacteria (RGM) remains problematic because of evolving taxonomy, limitations of current phenotypic methods and absence of a universal gene target for reliable speciation. This study evaluated a novel method of identification of RGM by amplification of the mycobacterial 16S-23S rRNA internal transcribed spacer (ITS) followed by resolution of amplified fragments by capillary gel electrophoresis (CGE). Nineteen American Type Culture Collection (ATCC) Mycobacterium strains and 178 clinical isolates of RGM (12 species) were studied. All RGM ATCC strains generated unique electropherograms with no overlap with slowly growing mycobacteria species, including M. tuberculosis. A total of 47 electropherograms for the 178 clinical isolates were observed allowing the speciation of 175/178 (98.3%) isolates, including the differentiation of the closely related species, M. massiliense (M. abscessus subspecies bolletii) and M. abscessus (M. abscessus sensu stricto). ITS fragment size ranged from 332 to 534 bp and 33.7% of clinical isolates generated electropherograms with two distinct peaks, while the remainder where characterized with a single peak. Unique peaks (fragment lengths) were identified for 11/12 (92%) RGM species with only M. moriokaense having an indistinguishable electropherogram from a rarely encountered CGE subtype of M. fortuitum. We conclude that amplification of the 16S-23S ITS gene region followed by resolution of fragments by CGE is a simple, rapid, accurate and reproducible method for species identification and characterization of the RGM.	[Gray, Timothy J.; Kong, Fanrong; Jelfs, Peter; Sintchenko, Vitali; Chen, Sharon C. -A.] Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Sintchenko, Vitali; Chen, Sharon C. -A.] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Westmead, NSW 2145, Australia; [Sintchenko, Vitali; Chen, Sharon C. -A.] Univ Sydney, Sydney Med Sch, Marie Bashir Inst Emerging Infect & Biosecur, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Gray, TJ (corresponding author), Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia.	tim.gray@tpg.com.au		Sintchenko, Vitali/0000-0002-9261-3650	Westmead Research Network	Westmead Research Network	This work was supported by a grant provided by the Westmead Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751; Brown-Elliot BA, 2011, MANUAL CLIN MICROBIO, P525; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; Choi GE, 2012, AM J RESP CRIT CARE, V186, P917, DOI 10.1164/rccm.201111-2005OC; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2940 CLSI; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Han XY, 2007, AM J CLIN PATHOL, V128, P612, DOI 10.1309/1KB2GKYT1BUEYLB5; Harada T, 2012, J CLIN MICROBIOL, V50, P3556, DOI 10.1128/JCM.01175-12; Heydari H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062443; Hoffmann M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-90; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Iwamoto T, 2002, J CLIN MICROBIOL, V40, P4705, DOI 10.1128/JCM.40.12.4705-4712.2002; Katoch VM, 2007, INDIAN J MED RES, V125, P155; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Macheras E, 2009, J CLIN MICROBIOL, V47, P2596, DOI 10.1128/JCM.00037-09; Pignone M, 2006, J CLIN MICROBIOL, V44, P1963, DOI 10.1128/JCM.01959-05; Redelman-Sidi G, 2010, CLIN INFECT DIS, V51, P422, DOI 10.1086/655140; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Sassi M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-3; Shallom SJ, 2013, J CLIN MICROBIOL, V51, P2943, DOI 10.1128/JCM.01132-13; Shin SJ, 2013, CLIN INFECT DIS, V57, P32, DOI 10.1093/cid/cit172; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Stout JE, 2011, CLIN INFECT DIS, V53, P787, DOI 10.1093/cid/cir539; Teng SH, 2013, J CLIN MICROBIOL, V51, P3113, DOI 10.1128/JCM.01239-13; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Wallace RJ, 1996, ANTIMICROB AGENTS CH, V40, P1676, DOI 10.1128/AAC.40.7.1676; Wehrhahn MC, 2012, J CLIN MICROBIOL, V50, P3478, DOI 10.1128/JCM.01311-12; Xiao M, 2012, J CLIN MICROBIOL, V50, P2755, DOI 10.1128/JCM.00777-12; Xiong LK, 2006, J CLIN MICROBIOL, V44, P3544, DOI 10.1128/JCM.00633-06	35	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102290	10.1371/journal.pone.0102290	http://dx.doi.org/10.1371/journal.pone.0102290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013955	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400084
J	Ha, BG; Park, JE; Shin, EJ; Shon, YH				Ha, Byung Geun; Park, Jung-Eun; Shin, Eun Ji; Shon, Yun Hee			Modulation of Glucose Metabolism by Balanced Deep-Sea Water Ameliorates Hyperglycemia and Pancreatic Function in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; MAGNESIUM; MELLITUS; CELLS; AMPK; SUPPLEMENTATION; DYSFUNCTION; OBESITY; TISSUE	The aim of this study was to determine the effects of balanced deep-sea water (BDSW) on hyperglycemia and glucose intolerance in streptozotocin (STZ)-induced diabetic mice. BDSW was prepared by mixing DSW mineral extracts and desalinated water to yield a final hardness of 1000-4000 ppm. Male ICR mice were assigned to 6 groups; mice in each group were given tap water (normal and STZ diabetic groups) or STZ with BDSW of varying hardness (0, 1000, 2000, and 4000 ppm) for 4 weeks. The STZ with BDSW group exhibited lowered fasting plasma glucose levels than the STZ-induced diabetic group. Oral glucose tolerance tests showed that BDSW improves impaired glucose tolerance in STZ-induced diabetic mice. Histopathological evaluation of the pancreas showed that BDSW restores the morphology of the pancreatic islets of Langerhans and increases the secretion of insulin in STZ-induced diabetic mice. Quantitative real-time PCR assay revealed that the expression of hepatic genes involved in gluconeogenesis, glucose oxidation, and glycogenolysis was suppressed, while the expression of the genes involved in glucose uptake, beta-oxidation, and glucose oxidation in muscle were increased in the STZ with BDSW group. BDSW stimulated PI3-K, AMPK, and mTOR pathway-mediated glucose uptake in C2C12 myotubes. BDSW increased AMPK phosphorylation in C2C12 myotubes and improved impaired AMPK phosphorylation in the muscles of STZ-induced diabetic mice. Taken together, these results suggest that BDSW is a potential anti-diabetic agent, owing to its ability to suppress hyperglycemia and improve glucose intolerance by modulating glucose metabolism, recovering pancreatic islets of Langerhans and increasing glucose uptake.	[Ha, Byung Geun; Park, Jung-Eun; Shin, Eun Ji; Shon, Yun Hee] Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea	Kyungpook National University; Kyungpook National University Hospital	Shon, YH (corresponding author), Kyungpook Natl Univ Hosp, Biomed Res Inst, Taegu, South Korea.	yhshon@hmail.knu.ac.kr			Ministry of Oceans and Fisheries of the Republic of Korea	Ministry of Oceans and Fisheries of the Republic of Korea	This research was supported by a grant (technical development for supporting the DSW industry) from the Ministry of Oceans and Fisheries of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak JP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-108; Chen IS, 2013, J CHIN MED ASSOC, V76, P95, DOI 10.1016/j.jcma.2012.10.008; Clark TA, 2014, HEART FAIL REV, V19, P123, DOI 10.1007/s10741-013-9380-0; Friedrichsen M, 2013, MOL CELL ENDOCRINOL, V366, P204, DOI 10.1016/j.mce.2012.06.013; Fu ZY, 2012, J MED FOOD, V15, P535, DOI 10.1089/jmf.2011.2007; Gu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081724; Gu P, 2013, REV ENDOCR METAB DIS, V14, P49, DOI 10.1007/s11154-012-9230-8; Ha BG, 2014, OBESITY, V22, P1669, DOI 10.1002/oby.20740; Ha BG, 2013, MAR DRUGS, V11, P4193, DOI 10.3390/md11114193; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hata A, 2013, DIABETIC MED, V30, P1487, DOI 10.1111/dme.12250; Hocking S, 2013, ENDOCR REV, V34, P463, DOI 10.1210/er.2012-1041; Hruby A, 2013, NUTRIENTS, V5, P4990, DOI 10.3390/nu5124990; Hwang HS, 2009, MAR BIOTECHNOL, V11, P531, DOI 10.1007/s10126-008-9171-0; Jung DW, 2011, MOL BIOSYST, V7, P346, DOI 10.1039/c0mb00089b; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Kundu Dipankar, 2013, J Nat Sci Biol Med, V4, P113, DOI 10.4103/0976-9668.107270; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055106; Mostafavi E, 2013, CLIN HEMORHEOL MICRO, V53, P239, DOI 10.3233/CH-2012-1546; Nagai N, 2013, J OLEO SCI, V62, P403, DOI 10.5650/jos.62.403; Ozturk N, 2013, WORLD J DIABETES, V4, P92, DOI 10.4239/wjd.v4.i4.92; Potter KJ, 2014, DIABETES, V63, P12, DOI 10.2337/db12-0364; Ramalingam L, 2013, CELL MOL LIFE SCI, V70, P2815, DOI 10.1007/s00018-012-1176-1; Sales CH, 2014, CLIN NUTR, V33, P879, DOI 10.1016/j.clnu.2013.10.004; Sarmento RA, 2013, ARQ BRAS CARDIOL, V101, P240, DOI 10.5935/abc.20130146; Scherer T, 2013, ENDOCRIN METAB CLIN, V42, P109, DOI 10.1016/j.ecl.2012.11.002; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Tahrani AA, 2010, PHARMACOL THERAPEUT, V125, P328, DOI 10.1016/j.pharmthera.2009.11.001; Via Michael, 2012, ISRN Endocrinol, V2012, P103472, DOI 10.5402/2012/103472; Volpe SL, 2013, ADV NUTR, V4, p378S, DOI 10.3945/an.112.003483; Wieser V, 2013, ARCH IMMUNOL THER EX, V61, P119, DOI 10.1007/s00005-012-0210-1; Xita N, 2012, CURR MED CHEM, V19, P5451, DOI 10.2174/092986712803833182; Xu JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056750; Yerlikaya FH, 2013, INDIAN J MED RES, V137, P339	36	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102095	10.1371/journal.pone.0102095	http://dx.doi.org/10.1371/journal.pone.0102095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013896	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400065
J	Malhotra, A; Kobes, S; Bogardus, C; Knowler, WC; Baier, LJ; Hanson, RL				Malhotra, Alka; Kobes, Sayuko; Bogardus, Clifton; Knowler, William C.; Baier, Leslie J.; Hanson, Robert L.			Assessing Accuracy of Genotype Imputation in American Indians	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMER-DISEASE; POWER	Background: Genotype imputation is commonly used in genetic association studies to test untyped variants using information on linkage disequilibrium (LD) with typed markers. Imputing genotypes requires a suitable reference population in which the LD pattern is known, most often one selected from HapMap. However, some populations, such as American Indians, are not represented in HapMap. In the present study, we assessed accuracy of imputation using HapMap reference populations in a genome-wide association study in Pima Indians. Results: Data from six randomly selected chromosomes were used. Genotypes in the study population were masked (either 1% or 20% of SNPs available for a given chromosome). The masked genotypes were then imputed using the software Markov Chain Haplotyping Algorithm. Using four HapMap reference populations, average genotype error rates ranged from 7.86% for Mexican Americans to 22.30% for Yoruba. In contrast, use of the original Pima Indian data as a reference resulted in an average error rate of 1.73%. Conclusions: Our results suggest that the use of HapMap reference populations results in substantial inaccuracy in the imputation of genotypes in American Indians. A possible solution would be to densely genotype or sequence a reference American Indian population.	[Malhotra, Alka; Kobes, Sayuko; Bogardus, Clifton; Knowler, William C.; Baier, Leslie J.; Hanson, Robert L.] NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ 85014 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Malhotra, A (corresponding author), NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ 85014 USA.	alka@niddk.nih.gov	Hanson, Robert L/O-3238-2015	Hanson, Robert L/0000-0002-4252-7068	National Institute of Diabetes and Digestive and Kidney Diseases; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069071, ZIADK075012, ZIADK069028, ZIADK069000] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and a mentor grant from the American Diabetes Association (Clifton Bogardus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Beecham GW, 2010, ANN HUM GENET, V74, P189, DOI 10.1111/j.1469-1809.2010.00573.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011018; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Malhotra A, 2011, OBESITY, V19, P2102, DOI 10.1038/oby.2011.178; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Pei YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010827; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102544	10.1371/journal.pone.0102544	http://dx.doi.org/10.1371/journal.pone.0102544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014012	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400103
J	Wen, QY; Li, J; Wang, WY; Xie, GY; Xu, LN; Luo, JD; Chu, SZ; She, L; Li, D; Huang, DH; Fan, SQ				Wen, Qiuyuan; Li, Jiao; Wang, Weiyuan; Xie, Guiyuan; Xu, Lina; Luo, Jiadi; Chu, Shuzhou; She, Lei; Li, Duo; Huang, Donghai; Fan, Songqing			Increased Expression of Flotillin-2 Protein as a Novel Biomarker for Lymph Node Metastasis in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							E-CADHERIN; PROGRESSION; CANCER; IDENTIFICATION; MELANOMA; SURVIVAL; ADHESION; CELLS; NGX6	Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor rare throughout most of the world but common in Southeast Asia, especially in Southern China. Flotillin-2 (Flot-2) is not only an important component of cellular membrane, but also involves in various cellular processes such as membrane trafficking, T cell and B cell activation, regulation of several signaling pathways associated with cell growth and malignant transformation, keeping structure and junction of epidermal cells and formation of filopodia. Although such molecular effects of Flot-2 have been reported, whether the expression of Flot-2 protein is associated with clinicopathologic implication for NPC has not been reported. The purpose of this research is to investigate the expression of Flot-2 protein in NPC and control nasopharyngeal epithelial tissues by immunohistochemistry and elucidate the association between the expression of Flot-2 protein and clinicopathological characteristics of NPC. The results showed that the positive percentage of Flot-2 expression in the NPC, nasopharyngeal epithelia with atypical hyperplasia and in the control nasopharyngeal mucosa epithelia was 88.8% (119/134), 76.9% (10/13) and 5.7% (5/88), respectively. There was significantly higher expression of Flot-2 protein in NPC and nasopharyngeal epithelia with atypical hyperplasia compared to the control nasopharyngeal mucosa epithelia (P<0.001, respectively). The positive percentage of Flot-2 protein expression in NPC patients with lymph node metastasis was significantly higher than those without lymph node metastasis. Increasing of Flot-2 expression was obviously correlated with clinical stages of NPC patients. The expression of Flot-2 was proved to be the independent predicted factor for lymph node metastasis by multivariate analysis. The sensitivity of Flot-2 for predicting lymph node metastasis of NPC patients was 93%. Taken together, our results suggest that the increased expression of Flot-2 protein is a novel higher sensitivity biomarker that can predict lymph node metastases in NPC.	[Wen, Qiuyuan; Li, Jiao; Wang, Weiyuan; Xu, Lina; Luo, Jiadi; Chu, Shuzhou; She, Lei; Li, Duo; Fan, Songqing] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China; [Huang, Donghai] Cent S Univ, Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Fan, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	fansongqing2003@hotmail.com	xu, li/GNH-3667-2022		National Natural Sciences Foundations of China [81071820, 81201523, 81272566, 81372906]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Sciences Foundations of China (NO: 81071820, 81201523, 81272566 and 81372906), http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Berger T, 2013, ONCOGENE, V32, P4989, DOI 10.1038/onc.2012.499; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Hazarika P, 1999, J CELL BIOCHEM, V75, P147, DOI 10.1002/(SICI)1097-4644(19991001)75:1<147::AID-JCB15>3.0.CO;2-D; Hwang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084218; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lee CC, 2008, CLIN OTOLARYNGOL, V33, P442, DOI 10.1111/j.1749-4486.2008.01770.x; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pei XJ, 2014, INT J MED SCI, V11, P106, DOI 10.7150/ijms.7264; Peng SP, 2006, ONCOLOGY-BASEL, V71, P273, DOI 10.1159/000106073; Peng SP, 2007, CANCER SCI, V98, P341, DOI 10.1111/j.1349-7006.2007.00410.x; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Shen Zhi-Hua, 2008, Ai Zheng, V27, P165; Solis GP, 2013, INT J MOL SCI, V14, P5130, DOI 10.3390/ijms14035130; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Wang X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-190; Xu L, 2013, HUM PATHOL, V44, P1357, DOI 10.1016/j.humpath.2012.10.025; Xuan SH, 2013, CANCER BIOMARK, V13, P323, DOI 10.3233/CBM-130361; Yang XY, 2005, CELL ONCOL, V27, P215; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220; Zhu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062365	28	18	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101676	10.1371/journal.pone.0101676	http://dx.doi.org/10.1371/journal.pone.0101676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014228	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400030
J	Molfese, C; Beare, D; Hall-Spencer, JM				Molfese, Carlotta; Beare, Doug; Hall-Spencer, Jason M.			Overfishing and the Replacement of Demersal Finfish by Shellfish: An Example from the English Channel	PLOS ONE			English	Article							MARINE FOOD WEBS; TROPHIC LEVEL; TOP-DOWN; FISHERIES; ECOSYSTEM; SEA	The worldwide depletion of major fish stocks through intensive industrial fishing is thought to have profoundly altered the trophic structure of marine ecosystems. Here we assess changes in the trophic structure of the English Channel marine ecosystem using a 90-year time-series (1920-2010) of commercial fishery landings. Our analysis was based on estimates of the mean trophic level (mTL) of annual landings and the Fishing-in-Balance index (FiB). Food webs of the Channel ecosystem have been altered, as shown by a significant decline in the mTL of fishery landings whilst increases in the FiB index suggest increased fishing effort and fishery expansion. Large, high trophic level species (e. g. spurdog, cod, ling) have been increasingly replaced by smaller, low trophic level fish (e. g. small spotted catsharks) and invertebrates (e. g. scallops, crabs and lobster). Declining trophic levels in fisheries catches have occurred worldwide, with fish catches progressively being replaced by invertebrates. We argue that a network of fisheries closures would help rebalance the trophic status of the Channel and allow regeneration of marine ecosystems.	[Molfese, Carlotta; Hall-Spencer, Jason M.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Beare, Doug] Worldfish, Batu Maung, Penang, Malaysia	University of Plymouth; CGIAR; Worldfish	Molfese, C (corresponding author), Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	carlotta0911@gmail.com	Hall-Spencer, Jason/AFN-7866-2022	Hall-Spencer, Jason/0000-0002-6915-2518				Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; [Anonymous], 1984, 5 STANF U LAB COMP S; [Anonymous], EC FISH COOP B; Arancibia H, 2005, SCI MAR, V69, P295, DOI 10.3989/scimar.2005.69n2295; Baeta F, 2009, FISH RES, V97, P216, DOI 10.1016/j.fishres.2009.02.006; Baisre JA, 2000, 394 FAO FISH; Beare D, 2010, NATURWISSENSCHAFTEN, V97, P797, DOI 10.1007/s00114-010-0696-5; Bhathal B, 2008, FISH RES, V91, P26, DOI 10.1016/j.fishres.2007.10.022; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Dauvin JC, 2012, MAR POLLUT BULL, V64, P463, DOI 10.1016/j.marpolbul.2011.12.010; Engelhard GH, CHARM 3 PROJECT; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Freire KMF, 2010, FISH RES, V105, P57, DOI 10.1016/j.fishres.2010.02.008; Garstang W., 1900, J MAR BIOL ASSOC UK, V6, P1, DOI [10.1017/S0025315400072374, DOI 10.1017/S0025315400072374]; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Genner MJ, 2001, ARCHIVING ANAL MBA B, P1; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hawkins SJ, 2003, SCI TOTAL ENVIRON, V310, P245, DOI 10.1016/S0048-9697(02)00645-9; Heath MR, 2012, AQUAT CONSERV, V22, P337, DOI 10.1002/aqc.2244; Howarth LM, 2014, FISH FISH, V15, P690, DOI 10.1111/faf.12041; ICES, 2010, ICES CATCH STAT 1903; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaureguizar AJ, 2008, SCI MAR, V72, P25; Jones PJS, 2012, ENVIRON CONSERV, V39, P248, DOI 10.1017/S0376892912000136; Kleisner K, 2011, FISHERIES CTR RES RE, V19, P41; Marine Management Organization, 2010, FISH STAT; McHugh M, 2011, J SEA RES, V65, P187, DOI 10.1016/j.seares.2010.09.006; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; O'Leary BC, 2011, MAR POLLUT BULL, V62, P2642, DOI 10.1016/j.marpolbul.2011.09.032; Pauly D, 2003, LAR MAR ECOSYST, V12, P337; Pauly D, 2001, CAN J FISH AQUAT SCI, V58, P51, DOI 10.1139/cjfas-58-1-51; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D., 2000, CIESM WORKSHOP SERIE, V12, P61; Pauly D., 2003, PERFECT OCEAN STATE; Pew Charitable Trust, 1999, SEA AROUND US PROJ; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; R Core Team, 2021, R LANG ENV STAT COMP; Roberts C., 2007, UNNATURAL HIST SEA F; Robinson LA, 2008, AMBIO, V37, P362, DOI 10.1579/07-A-300.1; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; Sheehan EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083883; SOUTHWARD AJ, 1988, J MAR BIOL ASSOC UK, V68, P423, DOI 10.1017/S0025315400043320; Stanford Robert, 2004, University of British Columbia Fisheries Centre Research Reports, V12, P1; Stergiou K, 2005, STATE HELLENIC MARIN, P326; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Thurstan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011767; Valtysson Hthorn, 2003, COMPETITIVENESS GLOB, P12; Walker PA, 1998, ICES J MAR SCI, V55, P392, DOI 10.1006/jmsc.1997.0325; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	50	35	36	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101506	10.1371/journal.pone.0101506	http://dx.doi.org/10.1371/journal.pone.0101506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010196	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800027
J	Cruickshank-Quinn, CI; Mahaffey, S; Justice, MJ; Hughes, G; Armstrong, M; Bowler, RP; Reisdorph, R; Petrache, I; Reisdorph, N				Cruickshank-Quinn, Charmion I.; Mahaffey, Spencer; Justice, Matthew J.; Hughes, Grant; Armstrong, Michael; Bowler, Russell P.; Reisdorph, Richard; Petrache, Irina; Reisdorph, Nichole			Transient and Persistent Metabolomic Changes in Plasma following Chronic Cigarette Smoke Exposure in a Mouse Model	PLOS ONE			English	Article							MASS-SPECTROMETRY; ADENOSINE-TRIPHOSPHATE; FATTY-ACIDS; HUMAN URINE; BIOMARKERS; NICOTINE; DISEASE; TOBACCO; PATHWAY; PENTAPHOSPHATE	Cigarette smoke exposure is linked to the development of a variety of chronic lung and systemic diseases in susceptible individuals. Metabolomics approaches may aid in defining disease phenotypes, may help predict responses to treatment, and could identify biomarkers of risk for developing disease. Using a mouse model of chronic cigarette smoke exposure sufficient to cause mild emphysema, we investigated whether cigarette smoke induces distinct metabolic profiles and determined their persistence following smoking cessation. Metabolites were extracted from plasma and fractionated based on chemical class using liquid-liquid and solid-phase extraction prior to performing liquid chromatography mass spectrometry-based metabolomics. Metabolites were evaluated for statistically significant differences among group means (p-value <= 0.05) and fold change >= 1.5). Cigarette smoke exposure was associated with significant differences in amino acid, purine, lipid, fatty acid, and steroid metabolite levels compared to air exposed animals. Whereas 60% of the metabolite changes were reversible, 40% of metabolites remained persistently altered even following 2 months of smoking cessation, including nicotine metabolites. Validation of metabolite species and translation of these findings to human plasma metabolite signatures induced by cigarette smoking may lead to the discovery of biomarkers or pathogenic pathways of smoking-induced disease.	[Cruickshank-Quinn, Charmion I.; Mahaffey, Spencer; Armstrong, Michael; Reisdorph, Richard; Reisdorph, Nichole] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Cruickshank-Quinn, Charmion I.; Mahaffey, Spencer; Armstrong, Michael; Reisdorph, Richard; Reisdorph, Nichole] Univ Colorado, Sch Med, Denver, CO USA; [Mahaffey, Spencer] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA; [Justice, Matthew J.; Petrache, Irina] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Justice, Matthew J.; Petrache, Irina] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Hughes, Grant] Univ Colorado Denver, Dept Biostat & Informat, Aurora, CO USA; [Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Reisdorph, Richard] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Petrache, Irina] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Petrache, I (corresponding author), Indiana Univ, Dept Med, Indianapolis, IN 46202 USA.	ipetrach@iu.edu; ReisdorphN@NJHealth.org	Mahaffey, Spencer/AAC-8712-2021; Petrache, Irina/AAZ-9648-2020; Reisdorph, Nichole/AAX-8774-2020	Reisdorph, Nichole/0000-0002-0425-8012; Cruickshank-Quinn, Charmion/0000-0002-5553-8663	National Heart, Lung and Blood Institute (NHLBI) [RO1HL 09543, P20 HL-113445-01, U01 HL089856, U01 HL089897]; NCRR/HIH [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328, R01HL095432, R01HL089856, P20HL113445, U01HL089897, R01HL105772, U01HL089856] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR/HIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung and Blood Institute (NHLBI RO1HL 095432, P20 HL-113445-01, U01 HL089856, U01 HL089897); and UL1 RR025780 from NCRR/HIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon M, 2013, TALANTA, V115, P896, DOI 10.1016/j.talanta.2013.07.010; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Bolte G, 2006, CLIN EXP ALLERGY, V36, P293, DOI 10.1111/j.1365-2222.2006.02441.x; Diab KJ, 2010, AM J RESP CRIT CARE, V181, P344, DOI 10.1164/rccm.200906-0826OC; Dong J, 2010, METABOLOMICS, V6, P478, DOI 10.1007/s11306-010-0215-x; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Duskova M, 2013, J STEROID BIOCH MOL; Esther CR, 2011, CHEST, V140, P954, DOI 10.1378/chest.10-2471; FIELD AE, 1994, J CLIN ENDOCR METAB, V79, P1310, DOI 10.1210/jc.79.5.1310; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Golfman LS, 1999, J LIPID RES, V40, P1818; Hecht SS, 1999, CHEM RES TOXICOL, V12, P172, DOI 10.1021/tx980214i; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu CW, 2014, ARCH TOXICOL, V88, P291, DOI 10.1007/s00204-013-1137-y; HUANG TW, 1977, AM J PATHOL, V87, P647; Hughes G, 2014, BIOINFORMATICS, V30, P133, DOI 10.1093/bioinformatics/btt589; Jacob P, 1999, AM J PUBLIC HEALTH, V89, P731, DOI 10.2105/AJPH.89.5.731; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; Kapoor D, 2005, EUR J ENDOCRINOL, V152, P491, DOI 10.1530/eje.1.01867; Lazar Z, 2008, INFLAMM RES, V57, P367, DOI 10.1007/s00011-008-8009-6; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Luo JK, 2004, HYPERTENSION, V43, P1055, DOI 10.1161/01.hyp.0000126110.46402.dd; M'Koma AE, 2007, BIOCHEM BIOPH RES CO, V353, P829, DOI 10.1016/j.bbrc.2006.12.111; Matsuyama W, 2005, CHEST, V128, P3817, DOI 10.1378/chest.128.6.3817; Murphy SE, 2013, J EXPO SCI ENV EPID, V23, P513, DOI 10.1038/jes.2013.7; OOSTERHOFF Y, 1993, AM REV RESPIR DIS, V147, P553, DOI 10.1164/ajrccm/147.3.553; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrusca DN, 2010, J BIOL CHEM, V285, P40322, DOI 10.1074/jbc.M110.137604; Saha S, 2013, ANAL BIOANAL CHEM, V405, P9265, DOI 10.1007/s00216-013-7351-x; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sumner L. W., 2007, PROPOSED MINIMUM REP; Tolle M, 2006, J HYPERTENS, V24, P1991; Togna AR, 2008, PLATELETS, V19, P537, DOI 10.1080/09537100802272626; Ubhi BK, 2012, MOL BIOSYST, V8, P3125, DOI 10.1039/c2mb25194a; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Versluis M, 2009, VIRCHOWS ARCH, V454, P273, DOI 10.1007/s00428-009-0727-9; Virmani Ashraf, 2004, Molecular Aspects of Medicine, V25, P533, DOI 10.1016/j.mam.2004.06.003; WAGNER R, 1986, PHYSIOL PLANTARUM, V68, P667, DOI 10.1111/j.1399-3054.1986.tb03415.x; Weems JM, 2009, TOXICOL SCI, V112, P59, DOI 10.1093/toxsci/kfp201; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xie FW, 2013, TALANTA, V115, P435, DOI 10.1016/j.talanta.2013.05.048; Xu T, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-60; Yang YH, 2013, J CHROMATOGR A, V1300, P217, DOI 10.1016/j.chroma.2013.04.030	50	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101855	10.1371/journal.pone.0101855	http://dx.doi.org/10.1371/journal.pone.0101855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007263	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600074
J	Dovega, R; Tsutakawa, S; Quistgaard, EM; Anandapadamanaban, M; Low, C; Nordlund, P				Dovega, Rebecca; Tsutakawa, Susan; Quistgaard, Esben M.; Anandapadamanaban, Madhanagopal; Low, Christian; Nordlund, Par			Structural and Biochemical Characterization of Human PR70 in Isolation and in Complex with the Scaffolding Subunit of Protein Phosphatase 2A	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; SERINE/THREONINE PHOSPHATASES; REGULATORY SUBUNIT; B''/PR72 SUBUNIT; PP2A; IDENTIFICATION; CONFORMATIONS; COMPUTATION; HOLOENZYME; INTERACTS	Protein Phosphatase 2A (PP2A) is a major Ser/Thr phosphatase involved in the regulation of various cellular processes. PP2A assembles into diverse trimeric holoenzymes, which consist of a scaffolding (A) subunit, a catalytic (C) subunit and various regulatory (B) subunits. Here we report a 2.0 angstrom crystal structure of the free B ''/PR70 subunit and a SAXS model of an A/PR70 complex. The crystal structure of B ''/PR70 reveals a two domain elongated structure with two Ca2+ binding EF-hands. Furthermore, we have characterized the interaction of both binding partner and their calcium dependency using biophysical techniques. Ca2+ biophysical studies with Circular Dichroism showed that the two EF-hands display different affinities to Ca2+. In the absence of the catalytic C-subunit, the scaffolding A-subunit remains highly mobile and flexible even in the presence of the B ''/PR70 subunit as judged by SAXS. Isothermal Titration Calorimetry studies and SAXS data support that PR70 and the A-subunit have high affinity to each other. This study provides additional knowledge about the structural basis for the function of B '' containing holoenzymes.	[Dovega, Rebecca; Quistgaard, Esben M.; Anandapadamanaban, Madhanagopal; Low, Christian; Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Tsutakawa, Susan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Anandapadamanaban, Madhanagopal] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Nordlund, Par] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Linkoping University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Nordlund, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	par.nordlund@ki.se	Anandapadamanaban, Madhanagopal/F-3702-2014	Quistgaard, Esben/0000-0002-1381-3364; Loew, Christian/0000-0003-0764-7483; Tsutakawa, Susan/0000-0002-4918-4571; Anandapadamanaban, Madhanagopal/0000-0002-4237-0048	Danish Council for Independent Research (Medical Sciences) [271-09-0187]; European Molecular Biology Organization (EMBO); Swedish Research council; European Community under BioStruct-X [783]; Swedish Cancer Society	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Swedish Research council(Swedish Research CouncilEuropean Commission); European Community under BioStruct-X; Swedish Cancer Society(Swedish Cancer Society)	The authors thank their group members for suggestions and comments on the manuscript. E.M.Q. was supported by The Danish Council for Independent Research (Medical Sciences; grant 271-09-0187). C.L. was supported by a European Molecular Biology Organization (EMBO) postdoctoral fellowship. This research was further supported by grants from the Swedish Research council and Swedish Cancer Society. The authors thank Diamond Light Source for access to beamline 104 (MX5873 and MX6603) that contributed to the results presented here. The authors acknowledge the Protein Science Facility at the Karolinska Institutet for providing crystallization infrastructure. The research leading to these results has furthermore received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under BioStruct-X (grant agreement No783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Classen S, 2010, J SYNCHROTRON RADIAT, V17, P774, DOI 10.1107/S0909049510028566; COOK WJ, 1993, J MOL BIOL, V229, P461, DOI 10.1006/jmbi.1993.1046; Creyghton MP, 2006, P NATL ACAD SCI USA, V103, P5397, DOI 10.1073/pnas.0507237103; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; DeLano W, 2003, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lambrecht C, 2013, METHODS MOL BIOL, V1053, P283, DOI 10.1007/978-1-62703-562-0_17; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Low C, 2013, BBA-GEN SUBJECTS, V1830, P3497, DOI 10.1016/j.bbagen.2013.02.001; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Magenta A, 2008, MOL CELL BIOL, V28, P873, DOI 10.1128/MCB.00480-07; Magnusdottir A, 2009, PROTEINS, V74, P212, DOI 10.1002/prot.22150; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tsutakawa SE, 2011, P NATL ACAD SCI USA, V108, P17672, DOI 10.1073/pnas.1110480108; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	59	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101846	10.1371/journal.pone.0101846	http://dx.doi.org/10.1371/journal.pone.0101846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007185	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600073
J	Kared, H; Saeed, S; Klein, MB; Shoukry, NH				Kared, Hassen; Saeed, Sahar; Klein, Marina B.; Shoukry, Naglaa H.			CD127 Expression, Exhaustion Status and Antigen Specific Proliferation Predict Sustained Virologic Response to IFN in HCV/HIV Co-Infected Individuals	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HUMAN-IMMUNODEFICIENCY-VIRUS; CD8 T-CELLS; INTERLEUKIN-7 RECEPTOR-ALPHA; LIVER-DISEASE; PLUS RIBAVIRIN; HIV-INFECTION; LYMPHOCYTE ACTIVATION; IMMUNE ACTIVATION; GENE-EXPRESSION	Hepatitis C virus (HCV) infection is a major cause of morbidity and mortality in the HIV co-infected population. Interferon-alpha (IFN-alpha) remains a major component of anti-HCV therapy despite its deleterious effects on the immune system. Furthermore, IFN-alpha was recently shown to diminish the size of the latent HIV reservoir. The objectives of this study were to monitor the impact of IFN-alpha on T cell phenotype and proliferation of HIV and HCV-specific T cells during IFN therapy, and to identify immune markers that can predict the response to IFN in HICV/HIV co-infected patients. We performed longitudinal analyses of T cell numbers, phenotype and function in co-infected patients undergoing IFN-alpha therapy with different outcomes including IFN-alpha non-responders (NR) (n = 9) and patients who achieved sustained virologic response (SVR) (n = 19). We examined the expression of activation (CD38, HLA-DR), functional (CD127) and exhaustion markers (PD1, Tim-3, CD160 and CD244) on total CD4 and CD8 T cells before, during and after therapy. In addition, we examined the HIV- and HCV-specific proliferative responses against HIV-p24 and HCV-NS3 proteins. Frequencies of CD127(+) CD4 T cells were higher in SVR than in NR patients at baseline. An increase in CD127 expression on CD8 T cells was observed after IFN-alpha therapy in all patients. In addition, CD8 T cells from NR patients expressed a higher exhaustion status at baseline. Finally, SVR patients exhibited higher proliferative response against both HIV and HCV antigens at baseline. Altogether, SVR correlated with higher expression of CD127, lower T cell exhaustion status and better HIV and HCV proliferative responses at baseline. Such factors might be used as non-invasive methods to predict the success of IFN-based therapies in co-infected individuals.	[Kared, Hassen; Shoukry, Naglaa H.] CRCHUM, Montreal, PQ, Canada; [Saeed, Sahar; Klein, Marina B.] McGill Univ, Hlth Ctr, Royal Victoria Hosp, Dept Med,Div Infect Dis,Chron Viral Illness Serv, Montreal, PQ, Canada; [Shoukry, Naglaa H.] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; McGill University; Royal Victoria Hospital; Universite de Montreal	Shoukry, NH (corresponding author), CRCHUM, Montreal, PQ, Canada.	naglaa.shoukry@umontreal.ca	Kared, Hassen/AAD-7247-2020	Klein, Marina/0000-0002-3063-8430; Saeed, Sahar/0000-0002-0224-379X	Canadian Foundation of AIDS Research (CANFAR); Canadian Institutes for Health Research (CIHR); Fonds de recherche du Quebec - Sante (FRQS); FRQS; FRQS AIDS and Infectious Disease Network (Reseau FRQS SIDA-MI); Canadian Institutes of Health Research [CIHR MOP-79529]; CIHR Canadian HIV Trials Network [CTN222]	Canadian Foundation of AIDS Research (CANFAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); FRQS; FRQS AIDS and Infectious Disease Network (Reseau FRQS SIDA-MI); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Foundation of AIDS Research (CANFAR). HK received a postdoctoral fellowship from the Canadian Institutes for Health Research (CIHR). NHS is supported by a Chercheur boursier - Senior career award from the Fonds de recherche du Quebec - Sante (FRQS). MBK is supported by a Chercheur nationaux career award from the FRQS. This Canadian Co-infection cohort is funded by the FRQS AIDS and Infectious Disease Network (Reseau FRQS SIDA-MI), the Canadian Institutes of Health Research (CIHR MOP-79529) and the CIHR Canadian HIV Trials Network (CTN222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mohsen M, 2014, J VIROL, V88, P763, DOI 10.1128/JVI.02687-13; Al-Mohri H, 2005, HIV MED, V6, P375, DOI 10.1111/j.1468-1293.2005.00330.x; Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Beq S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034326; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Byrnes AA, 2001, EUR J IMMUNOL, V31, P2026, DOI 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.3.CO;2-L; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chandele A, 2008, J IMMUNOL, V180, P5309, DOI 10.4049/jimmunol.180.8.5309; Chattopadhyay PK, 2010, CYTOM PART A, V77A, P614, DOI 10.1002/cyto.a.20905; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; EYSTER ME, 1994, BLOOD, V84, P1020; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goedert JJ, 2002, BLOOD, V100, P1584; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Grenningloh R, 2011, J IMMUNOL, V186, P969, DOI 10.4049/jimmunol.1002099; Haas A, 2011, J VIROL, V85, P12102, DOI 10.1128/JVI.05607-11; He XS, 1999, P NATL ACAD SCI USA, V96, P5692, DOI 10.1073/pnas.96.10.5692; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim AY, 2006, PLOS MED, V3, P2324, DOI 10.1371/journal.pmed.0030492; Kim AY, 2005, BLOOD, V105, P1170, DOI 10.1182/blood-2004-06-2336; Klein MB, 2010, INT J EPIDEMIOL, V39, P1162, DOI 10.1093/ije/dyp297; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Labarga P, 2010, JAIDS-J ACQ IMM DEF, V53, P364, DOI 10.1097/QAI.0b013e3181bd5ce1; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Luetkemeyer A, 2006, JAIDS-J ACQ IMM DEF, V41, P31, DOI 10.1097/01.qai.0000191281.77954.27; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; McNamara LA, 2013, J INFECT DIS, V207, P201, DOI 10.1093/infdis/jis667; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Naggie S, 2012, GASTROENTEROLOGY, V142, P1324, DOI 10.1053/j.gastro.2012.02.012; Netski DM, 2007, J INFECT DIS, V195, P857, DOI 10.1086/511826; Oo YH, 2010, DIGEST DIS, V28, P31, DOI 10.1159/000282062; Parker R, 2010, BLOOD, V116, P5589, DOI 10.1182/blood-2010-03-276261; PLEIMAN CM, 1991, MOL CELL BIOL, V11, P3052, DOI 10.1128/MCB.11.6.3052; RAMZAOUI S, 1995, CLIN IMMUNOL IMMUNOP, V77, P33, DOI 10.1016/0090-1229(95)90134-5; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Shields PL, 1999, J IMMUNOL, V163, P6236; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Sulkowski MS, 2007, J VIRAL HEPATITIS, V14, P371, DOI 10.1111/j.1365-2893.2006.00816.x; Sulkowski MS, 2013, LIVER INT, V33, P63, DOI 10.1111/liv.12082; Taylor LE, 2012, CLIN INFECT DIS, V55, pS33, DOI 10.1093/cid/cis367; Thomas DL, 1996, J INFECT DIS, V174, P690, DOI 10.1093/infdis/174.4.690; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598	70	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101441	10.1371/journal.pone.0101441	http://dx.doi.org/10.1371/journal.pone.0101441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007250	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600037
J	Zheng, HZ; Gaff, H; Smith, G; DeLisle, S				Zheng, Hongzhang; Gaff, Holly; Smith, Gary; DeLisle, Sylvain			Epidemic Surveillance Using an Electronic Medical Record: An Empiric Approach to Performance Improvement	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; ECHINOCOCCUS-GRANULOSUS; CYSTIC ECHINOCOCCOSIS; RAPID DETECTION; CANINE ECHINOCOCCOSIS; HYDATID-DISEASE; MULTILOCULARIS; LAMP; INFECTION; DIAGNOSIS	Backgrounds: Electronic medical records (EMR) form a rich repository of information that could benefit public health. We asked how structured and free-text narrative EMR data should be combined to improve epidemic surveillance for acute respiratory infections (ARI). Methods: Eight previously characterized ARI case detection algorithms (CDA) were applied to historical EMR entries to create authentic time series of daily ARI case counts (background). An epidemic model simulated influenza cases (injection). From the time of the injection, duster-detection statistics were applied daily on paired background+injection (combined) and background-only time series. This cycle was then repeated with the injection shifted to each week of the evaluation year. We computed: a) the time from injection to the first statistical alarm uniquely found in the combined dataset (Detection Delay); b) how often alarms originated in the background-only dataset (false-alarm rate, or FAR); and c) the number of cases found within these false alarms (Caseload). For each CDA, we plotted the Detection Delay as a function of FAR or Caseload, over a broad range of alarm thresholds. Results: CDAs that combined text analyses seeking ARI symptoms in clinical notes with provider-assigned diagnostic codes in order to maximize the precision rather than the sensitivity of case-detection lowered Detection Delay at any given FAR or Caseload. Conclusion: An empiric approach can guide the integration of EMR data into case-detection methods that improve both the timeliness and efficiency of epidemic detection.	[Zheng, Hongzhang; DeLisle, Sylvain] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; [Zheng, Hongzhang; DeLisle, Sylvain] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Gaff, Holly] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Smith, Gary] Univ Penn, Sch Vet Med, Kennett Sq, PA USA	University System of Maryland; University of Maryland Baltimore; Old Dominion University; University of Pennsylvania	DeLisle, S (corresponding author), Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA.	sdelisle@umaryland.edu		Gaff, Holly/0000-0002-4034-2684	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [IIR 06-119-1]; Centers for Disease Control and Prevention [R01 CI000098, 5U38HK000013-02]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000098] Funding Source: NIH RePORTER	Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This material is the result of work supported with resources and the use of facilities at the VA Maryland Health Care System. This work was also supported in part by grant IIR 06-119-1 from the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs. Development and validation of the ARI case-detection algorithm was supported by grants R01 CI000098 and 5U38HK000013-02 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrasi I, 2003, AM J TROP MED HYG, V69, P324, DOI 10.4269/ajtmh.2003.69.324; Aminzhanov M, 1975, Veterinariia, P70; Atkinson JAM, 2013, GLOBAL CHANGE BIOL, V19, P677, DOI 10.1111/gcb.12088; Bart JM, 2006, PARASITOLOGY, V133, P571, DOI 10.1017/S0031182006000734; Benner C, 2010, B WORLD HEALTH ORGAN, V88, P49, DOI 10.2471/BLT.09.066795; Boda K, 2002, STUD HEALTH TECHNOL, V90, P437; Boufana B, 2013, ACTA TROP, V127, P21, DOI 10.1016/j.actatropica.2013.02.019; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Chai Jun-Jie, 1995, Biomedical and Environmental Sciences, V8, P122; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; CRAIG PS, 1995, VET PARASITOL, V56, P293, DOI 10.1016/0304-4017(94)00680-B; Deplazes P., 1996, Applied Parasitology, V37, P245; Dinkel A, 1998, J CLIN MICROBIOL, V36, P1871, DOI 10.1128/JCM.36.7.1871-1876.1998; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; GEMMELL MA, 1986, PARASITOLOGY, V92, P599, DOI 10.1017/S0031182000065483; Heath D, 2006, PARASITOL INT, V55, pS247, DOI 10.1016/j.parint.2005.11.052; Hegglin D, 2013, INT J PARASITOL, V43, P327, DOI 10.1016/j.ijpara.2012.11.013; Huang Y, 2014, J HELMINTHOL, V88, P189, DOI 10.1017/S0022149X12000922; Ibrahim MM, 2010, ACTA TROP, V113, P26, DOI 10.1016/j.actatropica.2009.08.029; Jia WZ, 2011, CHINESE MED J-PEKING, V124, P2849, DOI 10.3760/cma.j.issn.0366-6999.2011.18.010; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Le TH, 2002, PARASITOLOGY, V124, P97, DOI 10.1017/S0031182001008976; Lin ZB, 2012, VET PARASITOL, V185, P296, DOI 10.1016/j.vetpar.2011.10.016; Ma JY, 2012, PARASITOL RES, V111, P179, DOI 10.1007/s00436-012-2815-z; Ma ML, 2011, J CLIN MICROBIOL, V49, P2143, DOI 10.1128/JCM.02536-10; Mathis A, 1996, J HELMINTHOL, V70, P219, DOI 10.1017/S0022149X00015443; McManus DP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3866; McManus DP, 2003, PARASITOLOGY, V127, pS37, DOI 10.1017/S0031182003003524; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Morel N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001967; Nakao R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-296; Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08; Otero-Abad B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002249; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Salant H, 2012, AM J TROP MED HYG, V87, P883, DOI 10.4269/ajtmh.2012.12-0184; Sanchez E, 2010, MEM I OSWALDO CRUZ, V105, P806, DOI 10.1590/S0074-02762010000600013; Stefanic S, 2004, PARASITOL RES, V92, P347, DOI 10.1007/s00436-003-1043-y; Torgerson PR, 2009, TRENDS PARASITOL, V25, P164, DOI 10.1016/j.pt.2008.12.008; Varcasia A, 2011, VET PARASITOL, V181, P335, DOI 10.1016/j.vetpar.2011.05.006; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Wang L, 2012, T ROY SOC TROP MED H, V106, P743, DOI 10.1016/j.trstmh.2012.09.003; Wang ZH, 2008, ECOHEALTH, V5, P115, DOI 10.1007/s10393-008-0174-0; Wassermann M, 2014, VET PARASITOL, V200, P97, DOI 10.1016/j.vetpar.2013.12.012; Xiao N, 2006, AM J TROP MED HYG, V75, P292, DOI 10.4269/ajtmh.2006.75.292; Yang YR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000426; Zhang WB, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000534; Zhang YL, 2006, VET PARASITOL, V139, P244, DOI 10.1016/j.vetpar.2006.03.003; Zhang YL, 2005, CHINESE J PARASITOLO, V18, P333	48	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100845	10.1371/journal.pone.0100845	http://dx.doi.org/10.1371/journal.pone.0100845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006878	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600021
J	Jojart, B; Posa, M; Fiser, B; Szori, M; Farkas, Z; Viskolcz, B				Jojart, Balazs; Posa, Mihalj; Fiser, Bela; Szori, Milan; Farkas, Zita; Viskolcz, Bela			Mixed Micelles of Sodium Cholate and Sodium Dodecylsulphate 1:1 Binary Mixture at Different Temperatures - Experimental and Theoretical Investigations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; COUNTERION CONDENSATION THEORY; BILE-ACID SALTS; INITIAL CONFIGURATIONS; AQUEOUS-SOLUTIONS; SOLUBILIZATION; MICELLIZATION; ASSOCIATION; COMPLEXES; MORPHINE	Micellisation process for sodium dodecyl sulphate and sodium cholate in 1:1 molar ratio was investigated in a combined approach, including several experimental methods and coarse grained molecular dynamics simulation. The critical micelle concentration (cmc) of mixed micelle was determined by spectrofluorimetric and surface tension measurements in the temperature range of 0-50 degrees C and the values obtained agreed with each other within the statistical error of the measurements. In range of 0-25 degrees C the cmc values obtained are temperature independent while cmc values were increased at higher temperature, which can be explained by the intensive motion of the monomers due to increased temperature. The evidence of existing synergistic effect among different constituent units of the micelle is indicated clearly by the interaction parameter (beta(1,2)) calculated from cmc values according to Rubingh. As the results of the conductivity measurements showed the negative surface charges of the SDS-NaCA micelle are not neutralized by counterions. Applying a 10 mu s long coarse-grained molecular dynamics simulation for system including 30-30 SDS and CA (with appropriate number of Na+ cations and water molecules) we obtained semi-quantitative agreement with the experimental results. Spontaneous aggregation of the surfactant molecules was obtained and the key steps of the micelle formation are identified: First a stable SDS core was formed and thereafter due to the entering CA molecules the size of the micelle increased and the SDS content decreased. In addition the size distribution and composition as well as the shape and structure of micelles are also discussed.	[Jojart, Balazs; Fiser, Bela; Szori, Milan; Viskolcz, Bela] Univ Szeged, Fac Educ, Dept Chem Informat, Szeged, Hungary; [Posa, Mihalj; Farkas, Zita] Univ Novi Sad, Fac Med, Dept Pharm, Novi Sad 21000, Serbia	Szeged University; University of Novi Sad	Jojart, B (corresponding author), Univ Szeged, Fac Educ, Dept Chem Informat, Szeged, Hungary.	jojartb@jgypk.u-szeged.hu	Viskolcz, Béla/Q-6225-2019; Szőri, Milán/B-7152-2011; Viskolcz, Bela/R-3927-2017	Viskolcz, Béla/0000-0002-0777-9569; Szőri, Milán/0000-0003-4895-0999; Viskolcz, Bela/0000-0002-0777-9569; Fiser, Bela/0000-0003-0603-4626; Posa, Mihalj/0000-0002-8044-2655	Hungary-Serbia IPA Cross-border Co-operation programme Bile Acid Nanosystems as Molecule Carriers in Pharmaceutical Applications (BANAMOCA) [HUSRB/1002/214/193]; New Functional Materials and Their Biological and Environmental Answers' [TAMOP-4.2.2.A-11/1/KONV-2012-0047]; European Union and Hungary - European Social Fund in the framework of TAMOP [4.2.4.A/2-11-1-2012-0001]; National Excellence Program [A2-MZPD-12-0139]; European Union; European Social Fund through project Supercomputer, the national virtual lab [TAMOP-4.2.2.C-11/1/KONV-2012-0010]	Hungary-Serbia IPA Cross-border Co-operation programme Bile Acid Nanosystems as Molecule Carriers in Pharmaceutical Applications (BANAMOCA); New Functional Materials and Their Biological and Environmental Answers'; European Union and Hungary - European Social Fund in the framework of TAMOP; National Excellence Program; European Union(European Commission); European Social Fund through project Supercomputer, the national virtual lab	This work was supported by the Hungary-Serbia IPA Cross-border Co-operation programme Bile Acid Nanosystems as Molecule Carriers in Pharmaceutical Applications (BANAMOCA) (project ID: HUSRB/1002/214/193). Infrastructural support was provided by "New Functional Materials and Their Biological and Environmental Answers'' (project ID: the TAMOP-4.2.2.A-11/1/KONV-2012-0047,). M.Sz. is a Magyary Zoltan fellow supported by the European Union and Hungary, co-financed by the European Social Fund in the framework of TAMOP (project ID: 4.2.4.A/2-11-1-2012-0001 'National Excellence Program' (A2-MZPD-12-0139)). This work was partially supported by the European Union and the European Social Fund through project Supercomputer, the national virtual lab (grant no.: TAMOP-4.2.2.C-11/1/KONV-2012-0010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazs J, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869832; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Calabresi M, 2007, MOLECULES, V12, P1731, DOI 10.3390/12081731; Camile W., 2003, PRACTICE MED CHEM; CLINT JH, 1975, J CHEM SOC FARAD T 1, V71, P1327, DOI 10.1039/f19757101327; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Jalili S, 2009, COLLOID SURFACE A, V352, P99, DOI 10.1016/j.colsurfa.2009.10.007; KAWAMURA H, 1989, J PHYS CHEM-US, V93, P3321, DOI 10.1021/j100345a087; Kim JH, 1999, J PHYS CHEM B, V103, P10582, DOI 10.1021/jp991720z; Kuhajda I, 2009, EUR J DRUG METAB PH, V34, P73; MACKERELL AD, 1995, J PHYS CHEM-US, V99, P1846, DOI 10.1021/j100007a011; Manning GS, 2007, J PHYS CHEM B, V111, P8554, DOI 10.1021/jp0670844; Manning GS, 2010, J PHYS CHEM B, V114, P5435, DOI 10.1021/jp912234x; Manning GS, 2002, BIOPHYS CHEM, V101, P461, DOI 10.1016/S0301-4622(02)00162-X; Manning GS, 1996, PHYSICA A, V231, P236, DOI 10.1016/0378-4371(95)00452-1; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, FALK SYMP, V139, P98; Martinez JM, 2003, J COMPUT CHEM, V24, P819, DOI 10.1002/jcc.10216; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mikov M., 2007, BILE ACIDS; Mittal K.L., 1979, SOLUTION CHEM SURFAC; Partay LB, 2007, J PHYS CHEM B, V111, P9886, DOI 10.1021/jp072974k; PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019; Posa M, 2008, EUR J PHARM SCI, V34, P281, DOI 10.1016/j.ejps.2008.04.011; Posa M, 2012, COLLOID SURFACE B, V94, P317, DOI 10.1016/j.colsurfb.2012.02.014; Posa M, 2011, STEROIDS, V76, P85, DOI 10.1016/j.steroids.2010.09.003; Posa M, 2010, COLLECT CZECH CHEM C, V75, P767, DOI 10.1135/cccc2009559; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RODA A, 1983, J BIOL CHEM, V258, P6362; Small D.M., 1971, BILE ACIDS CHEM PHYS, V1; Subuddhi U, 2007, COLLOID SURFACE B, V57, P102, DOI 10.1016/j.colsurfb.2007.01.009; Yu HR, 2000, J COLLOID INTERF SCI, V229, P375, DOI 10.1006/jcis.2000.7032	32	23	23	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102114	10.1371/journal.pone.0102114	http://dx.doi.org/10.1371/journal.pone.0102114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004142	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700110
J	Stoneburner, R; Korenromp, E; Lazenby, M; Tassie, JM; Letebele, J; Motlapele, D; Granich, R; Boerma, T; Low-Beer, D				Stoneburner, Rand; Korenromp, Eline; Lazenby, Mark; Tassie, Jean-Michel; Letebele, Judith; Motlapele, Diemo; Granich, Reuben; Boerma, Ties; Low-Beer, Daniel			Using Health Surveillance Systems Data to Assess the Impact of AIDS and Antiretroviral Treatment on Adult Morbidity and Mortality in Botswana	PLOS ONE			English	Article							HIV; THERAPY; PREVALENCE; COMMUNITY; SPECTRUM; DEATHS; TRENDS; BRAZIL; RISK	Introduction: Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% coverage of persons with CD4<350 cells/mu l by 2009-10. We explored impact on mortality and HIV prevalence, analyzing surveillance and civil registration data. Methods: Hospital natural cause admissions and deaths from the Health Statistics Unit (HSU) over 1990-2009, all-cause deaths from Midnight Bed Census (MNC) over 1990-2011, institutional and non-institutional deaths recorded in the Registry of Birth and Deaths (RBD) over 2003-2010, and antenatal sentinel surveillance (ANC) over 1992-2011 were compared to numbers of persons receiving ART. Mortality was adjusted for differential coverage and completeness of institutional and non-institutional deaths, and compared to WHO and UNAIDS Spectrum projections. Results: HSU deaths per 1000 admissions declined 49% in adults 15-64 years over 2003-2009. RBD mortality declined 44% (807 to 452/100,000 population in adults 15-64 years) over 2003-2010, similarly in males and females. Generally, death rates were higher in males; declines were greater and earlier in younger adults, and in females. In contrast, death rates in adults 65+, particularly females increased over 2003-2006. MNC all-age post-neonatal mortality declined 46% and 63% in primary and secondary level hospitals, over 2003-2011. We estimated RBD captured 80% of adult deaths over 2006-2011. Comparing empirical, completeness-adjusted deaths to Spectrum estimates, declines over 2003-2009 were similar overall (47% vs. 54%); however, Spectrum projected larger and earlier declines particularly in women. Following stabilization and modest decreases over 1998-2002, HIV prevalence in pregnant women 15-24 and 25-29-years declined by >50% and >30% through 2011, while continuing to increase in older women. Conclusions: Adult mortality in Botswana fell markedly as ART coverage increased. HIV prevalence declines may reflect ART-associated reductions in sexual transmission. Triangulation of surveillance system data offers a reasonable approach to evaluate impact of HIV/AIDS interventions, complementing cohort approaches that monitor individual-level health outcomes.	[Stoneburner, Rand; Granich, Reuben] UNAIDS, Geneva, Switzerland; [Korenromp, Eline] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lazenby, Mark] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Tassie, Jean-Michel] World Hlth Org, Geneva, Switzerland; [Letebele, Judith; Motlapele, Diemo] Republ Botswana Minist Hlth, Gaborone, Botswana; [Low-Beer, Daniel] Grad Inst Int & Dev Studies, Global Hlth Program, Geneva, Switzerland	UNAIDS; Erasmus University Rotterdam; Erasmus MC; Yale University; World Health Organization	Stoneburner, R (corresponding author), UNAIDS, Geneva, Switzerland.	rlstoneburner@gmail.com			Health Metrics Network, WHO	Health Metrics Network, WHO	The study was carried out as a collaborative investigation between UNAIDS (R. S. and R.G.), WHO (J.T. and T.B.), the Global Fund (E.K. and D.L.), the Yale University School of Nursing (M.L.) and the Botswana Ministry of Health (J.L. and D.M). The lead author (R. S.) was supported as an employee of UNAIDS from September 2009-2011 and afterwards, along with M.L under a contract from the Health Metrics Network, WHO. The conclusions and views are those of the authors, and do not necessarily represent the decisions, policy or views of UNAIDS, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Health Organization, the Yale University School of Nursing, or the Botswana Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; *BOTSW CENTR STAT, 2005, BOTSW AIDS IMP SURV; Botswana Central Statistics Office, 2011, BOTSW POP HOUS CENS; Botswana Central Statistics Office Botswana National AIDS Coordinating Agency, 2009, 2008 BOTSW AIDS IMP; Botswana National AIDS Control Programme (NACA), 2012, 4 BOTSW HIV AIDS IMP; Bradshaw D, 2012, RAPID MORTALITY SURV; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Chiasson MA, 1999, J ACQ IMMUN DEF SYND, V21, P59, DOI 10.1097/00126334-199905010-00008; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dako-Gyeke P, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-62; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Fazito E, 2012, SEX TRANSM INFECT, V88, pI86, DOI 10.1136/sextrans-2012-050632; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Joubert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064592; Krishnan S, 2012, JAIDS-J ACQ IMM DEF, V61, P381, DOI 10.1097/QAI.0b013e3182690e3c; Lazenby M, 2010, PALLIAT SUPPORT CARE, V8, P177, DOI 10.1017/S1478951509990939; Letamo G, 2011, J BIOSOC SCI, V43, P75, DOI 10.1017/S0021932010000519; Majelantle A, 2006, COMMUNICATION; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Ministry of Health of the Republic of Botswana, 2011, 2011 BOTSW 2 GEN HIV; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; STONEBURNER RL, 1988, SCIENCE, V242, P916, DOI 10.1126/science.3187532; Stoneburner RL, 1996, AM J EPIDEMIOL, V144, P682, DOI 10.1093/oxfordjournals.aje.a008981; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Taffa N, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-24; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; THOMAS PA, 1993, AM J EPIDEMIOL, V137, P121, DOI 10.1093/oxfordjournals.aje.a116652; Todd J, 2012, TROP MED INT HEALTH, V17, pe1, DOI 10.1111/j.1365-3156.2011.02947.x; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; UNAIDS, 2010, UNAIDS REP GLOB AIDS; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2011, SPECTR EPP HIV POL M; United Nations Dept. of Economic and Social Affairs - population division peaps, 2012, WORLD POP PROSP 2012; United Nations Development Indicators Unit Statistics Division, 2008, MILL DEV GOALS IND; van Schalkwyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069437; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, GLOB HLTH OBS DAT RE; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100431	10.1371/journal.pone.0100431	http://dx.doi.org/10.1371/journal.pone.0100431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003870	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700008
J	Howes, JM; Bihan, D; Slatter, DA; Hamaia, SW; Packman, LC; Knauper, V; Visse, R; Farndale, RW				Howes, Joanna-Marie; Bihan, Dominique; Slatter, David A.; Hamaia, Samir W.; Packman, Len C.; Knauper, Vera; Visse, Robert; Farndale, Richard W.			The Recognition of Collagen and Triple-helical Toolkit Peptides by MMP-13 SEQUENCE SPECIFICITY FOR BINDING AND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Matrix Metalloproteinase (MMP); Protease; Protein Conformation; Substrate Specificity; MMP-13; Toolkit Peptides; Collagenolysis; Hemopexin Domain	C-TERMINAL DOMAIN; MATRIX METALLOPROTEINASE-13; MAMMALIAN COLLAGENASES; SUBSTRATE-SPECIFICITY; STRUCTURAL INSIGHTS; ACTIVATION; SITES; ORGANIZATION; PROTEOLYSIS; HYDROLYSIS	Background: MMP-13 recognizes poorly-defined sequences in collagens. Results: MMP-13 binds key residues in the canonical cleavage site and another site near the collagen N terminus. Conclusion: MMP-1 and MMP-13 differ in their recognition and cleavage of collagen, which is regulated primarily through the Hpx domain of MMP-13. Significance: Our data explain the preference of MMP-13 for collagen II. Remodeling of collagen by matrix metalloproteinases (MMPs) is crucial to tissue homeostasis and repair. MMP-13 is a collagenase with a substrate preference for collagen II over collagens I and III. It recognizes a specific, well-known site in the tropocollagen molecule where its binding locally perturbs the triple helix, allowing the catalytic domain of the active enzyme to cleave the collagen chains sequentially, at Gly(775)-Leu(776) in collagen II. However, the specific residues upon which collagen recognition depends within and surrounding this locus have not been systematically mapped. Using our triple-helical peptide Collagen Toolkit libraries in solid-phase binding assays, we found that MMP-13 shows little affinity for Collagen Toolkit III, but binds selectively to two triple-helical peptides of Toolkit II. We have identified the residues required for the adhesion of both proMMP-13 and MMP-13 to one of these, Toolkit peptide II-44, which contains the canonical collagenase cleavage site. MMP-13 was unable to bind to a linear peptide of the same sequence as II-44. We also discovered a second binding site near the N terminus of collagen II (starting at helix residue 127) in Toolkit peptide II-8. The pattern of binding of the free hemopexin domain of MMP-13 was similar to that of the full-length enzyme, but the free catalytic subunit bound none of our peptides. The susceptibility of Toolkit peptides to proteolysis in solution was independent of the very specific recognition of immobilized peptides by MMP-13; the enzyme proved able to cleave a range of dissolved collagen peptides.	[Howes, Joanna-Marie; Bihan, Dominique; Slatter, David A.; Hamaia, Samir W.; Packman, Len C.; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Knauper, Vera] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Visse, Robert] Kennedy Inst, London W6 8LH, England	University of Cambridge; Cardiff University; University of Oxford	Farndale, RW (corresponding author), Univ Cambridge, Dept Biochem, Downing Site, Cambridge CB2 1QW, England.	rwf10@cam.ac.uk	Slatter, David/AAV-5771-2020; Slatter, David/AAW-6938-2021	Knauper, Vera/0000-0002-3965-9924	British Heart Foundation Grants [RG/009/003/27122, NH/11/1/28922]; Medical Research Council; Wellcome Trust; British Heart Foundation [RG/09/003/27122, NH/11/1/28922] Funding Source: researchfish	British Heart Foundation Grants; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants RG/009/003/27122 and NH/11/1/28922, and peptide synthesis, by grants from the Medical Research Council and Wellcome Trust.	Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Hijova E, 2005, Bratisl Lek Listy, V106, P127; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kennedy AM, 2005, J CLIN INVEST, V115, P2832, DOI 10.1172/JCI22900; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Rawlings ND, 2009, LARGE ACCURATE COLLE; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rosenblum G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011043; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Slatter DA, 2012, PEPTIDES, V36, P86, DOI 10.1016/j.peptides.2012.04.013; Steplewski A, 2007, J STRUCT BIOL, V157, P297, DOI 10.1016/j.jsb.2006.10.009; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	41	38	39	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24091	24101		10.1074/jbc.M114.583443	http://dx.doi.org/10.1074/jbc.M114.583443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25008319	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000341505600009
J	Strickland, M; Juarez, O; Neehaul, Y; Cook, DA; Barquera, B; Hellwig, P				Strickland, Madeleine; Juarez, Oscar; Neehaul, Yashvin; Cook, Darcie A.; Barquera, Blanca; Hellwig, Petra			The Conformational Changes Induced by Ubiquinone Binding in the Na+-pumping NADH:Ubiquinone Oxidoreductase (Na+-NQR) Are Kinetically Controlled by Conserved Glycines 140 and 141 of the NqrB Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Infrared Spectroscopy (IR spectroscopy); Oxidation-Reduction (redox); Respiratory Chain; Ubiquinone; HQNO; Membrane Proteins; NQR; Sodium Pumping	NADH-QUINONE OXIDOREDUCTASE; TRANSLOCATING NADHQUINONE OXIDOREDUCTASE; MARINE VIBRIO-ALGINOLYTICUS; IRON-SULFUR PROTEINS; ESCHERICHIA-COLI; COMPLEX-I; NADH/QUINONE OXIDOREDUCTASE; DIFFERENCE SPECTROSCOPY; PROSTHETIC GROUPS; ELECTRON-TRANSFER	Background: Na+-pumping NADH:ubiquinone oxidoreductase (Na+-NQR) is a respiratory enzyme which reduces ubiquinone. Results: Two ubiquinone binding sites were found of which only one is catalytically relevant. Conclusion: Gly-140/Gly-141 residues in the NqrB subunit control entry to the catalytic binding site. Significance: Learning how conformational changes are linked to ubiquinone reduction is directly relevant to a large number of respiratory enzymes. Na+-pumping NADH:ubiquinone oxidoreductase (Na+-NQR) is responsible for maintaining a sodium gradient across the inner bacterial membrane. This respiratory enzyme, which couples sodium pumping to the electron transfer between NADH and ubiquinone, is not present in eukaryotes and as such could be a target for antibiotics. In this paper it is shown that the site of ubiquinone reduction is conformationally coupled to the NqrB subunit, which also hosts the final cofactor in the electron transport chain, riboflavin. Previous work showed that mutations in conserved NqrB glycine residues 140 and 141 affect ubiquinone reduction and the proper functioning of the sodium pump. Surprisingly, these mutants did not affect the dissociation constant of ubiquinone or its analog HQNO (2-n-heptyl-4-hydroxyquinoline N-oxide) from Na+-NQR, which indicates that these residues do not participate directly in the ubiquinone binding site but probably control its accessibility. Indeed, redox-induced difference spectroscopy showed that these mutations prevented the conformational change involved in ubiquinone binding but did not modify the signals corresponding to bound ubiquinone. Moreover, data are presented that demonstrate the NqrA subunit is able to bind ubiquinone but with a low non-catalytically relevant affinity. It is also suggested that Na+-NQR contains a single catalytic ubiquinone binding site and a second site that can bind ubiquinone but is not active.	[Strickland, Madeleine; Neehaul, Yashvin; Hellwig, Petra] CNRS Univ Strasbourg, Lab Bioelectrochim & Spect, UMR 7140, F-67000 Strasbourg, France; [Juarez, Oscar; Cook, Darcie A.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	barqub@rpi.edu; hellwig@unistra.fr	Strickland, Madeleine/L-8425-2019	Strickland, Madeleine/0000-0001-8160-070X; hellwig, petra/0000-0001-6294-5163; Juarez, Oscar/0000-0002-2915-8413	Institut Universitaire de France; CNRS; FRC-LABEX CSC; Agence Nationale de la Recherche; National Science Foundation [MCB-1052234]	Institut Universitaire de France; CNRS(Centre National de la Recherche Scientifique (CNRS)); FRC-LABEX CSC; Agence Nationale de la Recherche(French National Research Agency (ANR)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Institut Universitaire de France, the CNRS, the FRC-LABEX CSC and the Agence Nationale de la Recherche (to P. H. and M. S.) and National Science Foundation Grant MCB-1052234 (to B. B., O. J., and D. A. C.).	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; BRETON J, 1994, BIOCHEMISTRY-US, V33, P4953, DOI 10.1021/bi00182a026; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P449, DOI 10.1016/0005-2728(86)90113-1; El Khoury Y, 2011, CHEMPHYSCHEM, V12, P2669, DOI 10.1002/cphc.201100165; FRIEDRICH T, 1994, BIOCHEM SOC T, V22, P226, DOI 10.1042/bst0220226; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P14683, DOI 10.1021/bi991267h; Hellwig P, 2000, BIOCHEMISTRY-US, V39, P10884, DOI 10.1021/bi000842a; Hellwig P., 2010, HDB PORPHYRIN SCI AP, P462; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Lunin VY, 2012, ACTA CRYSTALLOGR D, V68, P724, DOI 10.1107/S0907444912012012; MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Rahmelow K, 1998, ANAL BIOCHEM, V257, P1, DOI 10.1006/abio.1997.2502; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; TOKUDA H, 1982, J BIOL CHEM, V257, P7; UNEMOTO T, 1993, J GEN MICROBIOL, V139, P2779, DOI 10.1099/00221287-139-11-2779; Wille G, 2003, BIOCHEMISTRY-US, V42, P14814, DOI 10.1021/bi035219f; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	44	18	18	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23723	23733		10.1074/jbc.M114.574640	http://dx.doi.org/10.1074/jbc.M114.574640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006248	Green Published, hybrid			2022-12-25	WOS:000341505000040
J	Ferrandiz, MJ; Arnanz, C; Martin-Galiano, AJ; Rodriguez-Martin, C; de la Campa, AG				Ferrandiz, Maria-Jose; Arnanz, Cristina; Martin-Galiano, Antonio J.; Rodriguez-Martin, Carlos; de la Campa, Adela G.			Role of Global and Local Topology in the Regulation of Gene Expression in Streptococcus pneumoniae	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; ESCHERICHIA-COLI GYRA; DNA GYRASE; H-NS; TOPOISOMERASE-I; TRANSCRIPTION; NOVOBIOCIN; FIS; PROMOTERS; RESISTANT	The most basic level of transcription regulation in Streptococcus pneumoniae is the organization of its chromosome in topological domains. In response to drugs that caused DNA-relaxation, a global transcriptional response was observed. Several chromosomal domains were identified based on the transcriptional response of their genes: up-regulated (U), down-regulated (D), non-regulated (N), and flanking (F). We show that these distinct domains have different expression and conservation characteristics. Microarray fluorescence units under non-relaxation conditions were used as a measure of gene transcriptional level. Fluorescence units were significantly lower in F genes than in the other domains with a similar AT content. The transcriptional level of the domains categorized them was D>U>F. In addition, a comparison of 12 S. pneumoniae genome sequences showed a conservation of gene composition within U and D domains, and an extensive gene interchange in F domains. We tested the organization of chromosomal domains by measuring the relaxation-mediated transcription of eight insertions of a heterologous P(tc)cat cassette, two in each type of domain, showing that transcription depended on their chromosomal location. Moreover, transcription from the four promoters directing the five genes involved in supercoiling homeostasis, located either in U (gyrB), D (topA), or N (gyrA and parEC) domains was analyzed both in their chromosomal locations and in a replicating plasmid. Although expression from the chromosomal P-gyrB and P-topA showed the expected domain regulation, their expression was down-regulated in the plasmid, which behaved as a D domain. However, both P-parE and P-gyrA carried their own regulatory signals, their topology-dependent expression being equivalent in the plasmid or in the chromosome. In P-gyrA a DNA bend acted as a DNA supercoiling sensor. These results revealed that DNA topology functions as a general transcriptional regulator, superimposed upon other more specific regulatory mechanisms.	[Ferrandiz, Maria-Jose; Arnanz, Cristina; Martin-Galiano, Antonio J.; Rodriguez-Martin, Carlos; de la Campa, Adela G.] Inst Salud Carlos III, Unidad Genet Bacteriana, Ctr Nacl Microbiol, Madrid, Spain; [Ferrandiz, Maria-Jose; Arnanz, Cristina; Martin-Galiano, Antonio J.; Rodriguez-Martin, Carlos; de la Campa, Adela G.] CIBER Enfermedades Resp, Madrid, Spain; [de la Campa, Adela G.] CSIC, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC)	de la Campa, AG (corresponding author), Inst Salud Carlos III, Unidad Genet Bacteriana, Ctr Nacl Microbiol, Madrid, Spain.	agcampa@isciii.es	de la Campa, Adela G/K-1654-2014; Ferrandiz, Maria-Jose/K-2820-2014	de la Campa, Adela G/0000-0002-3598-2548; Ferrandiz, Maria-Jose/0000-0003-1428-9506; Rodriguez-Martin, Carlos/0000-0003-3279-1292; Martin-Galiano, Antonio Javier/0000-0002-6662-329X	Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion [BIO2011-25343]	Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grant BIO2011-25343 from Plan Nacional de I+D+I of Ministerio de Ciencia e Innovacion. CIBER Enfermedades Respiratorias is an initiative from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balas D, 1998, J BACTERIOL, V180, P2854, DOI 10.1128/JB.180.11.2854-2861.1998; BALLESTER S, 1990, GENE, V86, P71, DOI 10.1016/0378-1119(90)90115-8; BALLESTER S, 1986, GENE, V41, P153, DOI 10.1016/0378-1119(86)90094-6; Balsalobre L, 2008, ANTIMICROB AGENTS CH, V52, P822, DOI 10.1128/AAC.00731-07; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Choulet F, 2006, MOL BIOL EVOL, V23, P2361, DOI 10.1093/molbev/msl108; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dorman CJ, 2009, NUCLEIC ACIDS RES, V37, P672, DOI 10.1093/nar/gkn996; DORMAN CJ, 1991, INFECT IMMUN, V59, P745, DOI 10.1128/IAI.59.3.745-749.1991; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; FENOLL A, 1994, MOL MICROBIOL, V12, P587, DOI 10.1111/j.1365-2958.1994.tb01045.x; Ferrandiz MJ, 2010, NUCLEIC ACIDS RES, V38, P3570, DOI 10.1093/nar/gkq106; Garcia-Vallve S, 2003, NUCLEIC ACIDS RES, V31, P187, DOI 10.1093/nar/gkg004; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Gmuender H, 2001, GENOME RES, V11, P28, DOI 10.1101/gr.157701; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Jeong KS, 2006, PLOS GENET, V2, P1464, DOI 10.1371/journal.pgen.0020152; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Marr C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-18; Martin-Galiano AJ, 2004, MICROBIOL-SGM, V150, P2313, DOI 10.1099/mic.0.27097-0; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; MENZEL R, 1987, J BACTERIOL, V169, P1272, DOI 10.1128/jb.169.3.1272-1278.1987; MENZEL R, 1987, P NATL ACAD SCI USA, V84, P4185, DOI 10.1073/pnas.84.12.4185; MUNOZ R, 1995, J BACTERIOL, V177, P4166, DOI 10.1128/jb.177.14.4166-4170.1995; Ouafa ZA, 2012, NUCLEIC ACIDS RES, V40, P4306, DOI 10.1093/nar/gks014; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; PEREZMARTIN J, 1991, EMBO J, V10, P1375, DOI 10.1002/j.1460-2075.1991.tb07657.x; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; POLJAK LG, 1987, NUCLEIC ACIDS RES, V15, P5433, DOI 10.1093/nar/15.13.5433; Ruiz-Cruz S, 2010, J MICROBIOL METH, V83, P156, DOI 10.1016/j.mimet.2010.08.004; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Slage J, 2014, CELL, V157, P95; Stellwagen E, 2005, NUCLEIC ACIDS RES, V33, P4425, DOI 10.1093/nar/gki748; THIARA AS, 1989, GENE, V81, P65, DOI 10.1016/0378-1119(89)90337-5; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TSEDINH YC, 1985, NUCLEIC ACIDS RES, V13, P4751, DOI 10.1093/nar/13.13.4751; Unniraman S, 2002, J BACTERIOL, V184, P5449, DOI 10.1128/JB.184.19.5449-5456.2002; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Weinstein-Fischer D, 2007, MOL MICROBIOL, V63, P1131, DOI 10.1111/j.1365-2958.2006.05569.x	46	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101574	10.1371/journal.pone.0101574	http://dx.doi.org/10.1371/journal.pone.0101574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019515	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600019
J	Hyde, GD; Taylor, RF; Ashton, N; Borland, SJ; Wu, HSG; Gilmore, AP; Canfield, AE				Hyde, Gareth D.; Taylor, Rebecca F.; Ashton, Nick; Borland, Samantha J.; Wu, Hon Sing Geoffrey; Gilmore, Andrew P.; Canfield, Ann E.			Axl Tyrosine Kinase Protects against Tubulo-Interstitial Apoptosis and Progression of Renal Failure in a Murine Model of Chronic Kidney Disease and Hyperphosphataemia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARREST-SPECIFIC GENE-6; PHOSPHATE-INDUCED CALCIFICATION; ARTERIAL MEDIAL CALCIFICATION; OSTEOGENIC DIFFERENTIATION; CARDIOVASCULAR MORTALITY; DIABETIC-NEPHROPATHY; AORTIC CALCIFICATION; GENDER-DIFFERENCES; ALL-CAUSE	Chronic kidney disease (CKD) is defined as the progressive loss of renal function often involving glomerular, tubulointerstitial and vascular pathology. CKD is associated with vascular calcification; the extent of which predicts morbidity and mortality. However, the molecular regulation of these events and the progression of chronic kidney disease are not fully elucidated. To investigate the function of Axl receptor tyrosine kinase in CKD we performed a sub-total nephrectomy and fed high phosphate (1%) diet to Axl+/+ and Axl-/- mice. Plasma Gas6 (Axl' ligand), renal Axl expression and downstream Akt signalling were all significantly up-regulated in Axl+/+ mice following renal mass reduction and high phosphate diet, compared to age-matched controls. Axl-/- mice had significantly enhanced uraemia, reduced bodyweight and significantly reduced survival following sub-total nephrectomy and high phosphate diet compared to Axl+/+ mice; only 45% of Axl-/- mice survived to 14 weeks post-surgery compared to 87% of Axl+/+ mice. Histological analysis of kidney remnants revealed no effect of loss of Axl on glomerular hypertrophy, calcification or renal sclerosis but identified significantly increased tubulo-interstitial apoptosis in Axl-/- mice. Vascular calcification was not induced in Axl+/+ or Axl-/- mice in the time frame we were able to examine. In conclusion, we identify the up-regulation of Gas6/Axl signalling as a protective mechanism which reduces tubulo-interstitial apoptosis and slows progression to end-stage renal failure in the murine nephrectomy and high phosphate diet model of CKD.	[Hyde, Gareth D.; Taylor, Rebecca F.; Borland, Samantha J.; Canfield, Ann E.] Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Lancs, England; [Hyde, Gareth D.; Taylor, Rebecca F.; Gilmore, Andrew P.; Canfield, Ann E.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Ashton, Nick; Wu, Hon Sing Geoffrey; Gilmore, Andrew P.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Canfield, AE (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Lancs, England.	ann.canfield@manchester.ac.uk		Taylor, Rebecca/0000-0003-4033-3793; Borland, Samantha/0000-0001-7358-5829; Ashton, Nick/0000-0003-3366-1617; Canfield, Ann/0000-0002-8983-5674	British Heart Foundation [PG/08/075/25545]; Wellcome Trust [097820/Z/11/Z, 088785/Z/09/Z]; BBSRC; University of Manchester Strategic Fund	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund	This work was supported by the British Heart Foundation [PG/08/075/25545] and the Wellcome Trust [097820/Z/11/Z]. The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust [088785/Z/09/Z]. The Bioimaging Facility microscopes used were purchased with grants from BBSRC, Wellcome Trust and the University of Manchester Strategic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchu N, 2013, HYPERTENSION, V62, P302, DOI 10.1161/HYPERTENSIONAHA.113.01382; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Carrero JJ, 2010, KIDNEY BLOOD PRESS R, V33, P383, DOI 10.1159/000320389; Collett G, 2003, CIRC RES, V92, P1123, DOI 10.1161/01.RES.0000074881.56564.46; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fiebeler A, 2004, AM J KIDNEY DIS, V43, P286, DOI 10.1053/j.ajkd.2003.10.016; Guo JK, 2012, J AM SOC NEPHROL, V23, P429, DOI 10.1681/ASN.2011040396; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Lee IJ, 2012, NEPHROL DIAL TRANSPL, V27, P4166, DOI 10.1093/ndt/gfs337; Lemos CCS, 2005, J NEPHROL, V18, P368; Li KL, 2012, CARDIOVASC J AFR, V23, pE1, DOI 10.5830/CVJA-2011-069; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066759; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shao WH, 2010, CLIN IMMUNOL, V136, P236, DOI 10.1016/j.clim.2010.04.002; Silbiger S, 2008, GENDER MED, V5, pS3, DOI 10.1016/j.genm.2008.03.002; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Yin JL, 2003, TRANSPL INT, V16, P681, DOI 10.1007/s00147-003-0593-3; Yin JL, 2002, TRANSPLANTATION, V73, P657, DOI 10.1097/00007890-200202270-00032	40	15	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102096	10.1371/journal.pone.0102096	http://dx.doi.org/10.1371/journal.pone.0102096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019319	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600044
J	Zhu, ZL; Wang, YY; Liang, Z; Wang, WW; Zhang, HM; Li, BH; Ying, GG				Zhu, Zhongling; Wang, Yuanyuan; Liang, Zheng; Wang, Wenwen; Zhang, Huamei; Li, Binghui; Ying, Guoguang			Regulation of Cell Transformation by Rb-controlled Redox Homeostasis	PLOS ONE			English	Article							KINASE INHIBITORS; N-ACETYLCYSTEINE; LUNG-CANCER; PROTEIN; MECHANISMS; RESISTANCE; MUTATIONS; APOPTOSIS; OXIDANTS; BCL-2	Rb is a tumor suppressor, and regulates various biological progresses, such as cell proliferation, development, metabolism and cell death. In the current study, we show that Rb knockout in 3T3 cells leads to oxidative redox state and low mitochondrial membrane potential by regulating mitochondrial activity. Our results indicate that Rb plays an important role in controlling redox homeostasis. More importantly, the functions of Rb in modulating cell proliferation, death and transformation are, at least in part, mediated by its controlling cellular redox state. In addition, our results also suggest that the cellular redox state possibly determines various biological activities, including cell survival, death and transformation, where Rb is functioning as a regulator of redox homeostasis.	[Zhu, Zhongling; Wang, Yuanyuan; Liang, Zheng; Wang, Wenwen; Zhang, Huamei; Li, Binghui; Ying, Guoguang] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Canc Cell Biol Lab, Tianjin, Peoples R China	Tianjin Medical University	Li, BH (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Canc Cell Biol Lab, Tianjin, Peoples R China.	binghuili@tmu.edu.cn; yingguoguang@tmu.edu.cn	Lv, Yuanjie/AER-0767-2022	Liang, Zheng/0000-0003-4532-4888	National Natural Science Foundation of China [81171898, 81372185]; 973 program from National Basic Research Program of China [2011CB933100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program from National Basic Research Program of China(National Basic Research Program of China)	This work is supported by Grants 81171898 and 81372185 from National Natural Science Foundation of China, and 973 program 2011CB933100 from National Basic Research Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clem BF, 2012, CLIN CANCER RES, V18, P6096, DOI 10.1158/1078-0432.CCR-11-3164; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; Coughlan MT, 2009, J AM SOC NEPHROL, V20, P742, DOI 10.1681/ASN.2008050514; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Huang RFS, 2002, J NUTR, V132, P2151, DOI 10.1093/jn/132.8.2151; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kontzias A, 2012, CURR OPIN PHARMACOL, V12, P464, DOI 10.1016/j.coph.2012.06.008; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Nicolay BN, 2013, GENE DEV, V27, P182, DOI 10.1101/gad.206227.112; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Premzl A, 2001, BIOL CHEM, V382, P853, DOI 10.1515/BC.2001.104; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; ROBINSON JP, 1994, METHOD CELL BIOL, V41, P437; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Verbon EH, 2012, GENE, V511, P1, DOI 10.1016/j.gene.2012.08.038; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102582	10.1371/journal.pone.0102582	http://dx.doi.org/10.1371/journal.pone.0102582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019272	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600094
J	Kruger, R; Rasmussen, LM; Argraves, WS; Eugen-Olsen, J; Nielsen, OW; Blyme, A; Willenheimer, R; Wachtell, K; Olsen, MH				Kruger, Ruan; Rasmussen, Lars M.; Argraves, William S.; Eugen-Olsen, Jesper; Nielsen, Olav W.; Blyme, Adam; Willenheimer, Ronnie; Wachtell, Kristian; Olsen, Michael H.			Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study)	PLOS ONE			English	Article							ECHOCARDIOGRAPHIC ASSESSMENT; CARDIOVASCULAR-DISEASE; SIMVASTATIN; EZETIMIBE; RISK	Background: Fibulin-1, a circulating extracellular matrix glycoprotein, has been associated with arterial disease and elevated N-terminal prohormone B-type natriuretic peptide (NT-proBNP) in diabetes. Soluble urokinase plasminogen activator receptor (suPAR), a marker of inflammation, has been associated with subclinical atherosclerosis. Therefore, we aimed to explore the interplay between these biomarkers and mild to moderate aortic valve stenosis (AS). Methods: In 374 patients with mild to moderate AS, we investigated the relationship of fibulin-1 with NT-proBNP, levels of suPAR and the degree of AS at baseline and after one and four years of treatment with Simvastatin 40 mg and Ezetimibe 10 mg or placebo. Results: During treatment, fibulin-1 became more closely associated with NT-proBNP (beta(year0) = 0.10, p = 0.08, beta(year1) = 0.16, p = 0.005, beta(year4) = 0.22, p < 0.001) and suPAR (beta(year0) = 0.05, p = 0.34, beta(year1) = 0.16, p = 0.006, beta(year4) = 0.13, p = 0.03) at the expense of the association to aortic valve area index (AVAI) (beta(year0) = -0.14, p = 0.005, beta(year1) = -0.08, p = 0.11, beta(year4) = -0.06, p = 0.22) independently of age, gender, creatinine, and serum aspartate aminotransferase (Adj.R-year0(2) = 0.19, Adj.R-year1(2) = 0.22, Adj.R-year4(2) = 0.27). Fibulin-1 was unrelated to aortic regurgitation, left ventricular mass, and ejection fraction. In patients with baseline AVAI < 0.58 cm(2)/m(2) (median value), fibulin-1 was more closely associated to NT-proBNP (beta(year0) = 0.25, beta(year1) = 0.21, beta(year4) = 0.22, all p < 0.01), and suPAR (beta(year0) = 0.09, p = 0.26, beta(year1) = 0.23, beta(year4) = 0.21, both p < 0.01) independently of age, gender, AST and treatment allocation. Conclusions: Increased levels of fibulin-1 were independently associated with higher levels of suPAR and NT-proBNP especially in patients with lower AVAI, suggesting that fibulin-1 may be an early marker of AS as well as cardiac fibrosis secondarily to elevated left ventricular hemodynamic load.	[Kruger, Ruan; Olsen, Michael H.] North West Univ, Hypertens Africa Res Team, Potchefstroom, South Africa; [Kruger, Ruan; Olsen, Michael H.] Odense Univ Hosp, Cardiovasc & Metab Prevent Clin, Dept Endocrinol, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense, Denmark; [Rasmussen, Lars M.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense, Denmark; [Argraves, William S.] Med Univ S Carolina, Dept Cell Biol, Charleston, SC 29425 USA; [Eugen-Olsen, Jesper] Hvidovre Univ Hosp, Clin Res Ctr 136, Copenhagen, Denmark; [Nielsen, Olav W.] Bispebjerg Hosp, Dept Cardiol, DK-2400 Copenhagen, Denmark; [Blyme, Adam] Glostrup Cty Hosp, Dept Cardiol, Copenhagen, Denmark; [Willenheimer, Ronnie] Lund Univ, Malmo, Sweden; [Willenheimer, Ronnie] Heart Hlth Grp, Malmo, Sweden; [Wachtell, Kristian] Glostrup Cty Hosp, Dept Med, Copenhagen, Denmark	North West University - South Africa; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Medical University of South Carolina; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Lund University; University of Copenhagen	Kruger, R (corresponding author), North West Univ, Hypertens Africa Res Team, Potchefstroom, South Africa.	ruan.kruger@nwu.ac.za	Olsen, Michael H/H-8176-2014; Nielsen, Olav Wendelboe/S-4390-2016; Kruger, Ruan/N-7618-2015	Nielsen, Olav Wendelboe/0000-0003-3532-9431; Kruger, Ruan/0000-0001-7680-2032; Olsen, Michael Hecht/0000-0003-2230-5780; Rasmussen, Lars Melholt/0000-0001-5795-4794; Eugen-Olsen, Jesper/0000-0002-4630-4275	Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Agno FS, 2005, J HYPERTENS, V23, P867, DOI 10.1097/01.hjh.0000163157.14493.c7; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; Cangemi C, 2011, CLIN CHEM, V57, P1556, DOI 10.1373/clinchem.2011.162966; Cosmi JE, 2002, ARCH INTERN MED, V162, P2345, DOI 10.1001/archinte.162.20.2345; CURRIE PJ, 1985, CIRCULATION, V71, P1162, DOI 10.1161/01.CIR.71.6.1162; Dahl JS, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003889; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drolet MC, 2006, J AM COLL CARDIOL, V47, P850, DOI 10.1016/j.jacc.2005.09.049; Drolet MC, 2003, J AM COLL CARDIOL, V41, P1211, DOI 10.1016/S0735-1097(03)00090-1; Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fay WP, 2007, ARTERIOSCL THROM VAS, V27, P1231, DOI 10.1161/ATVBAHA.107.140046; Fuhrman B, 2012, ATHEROSCLEROSIS, V222, P8, DOI 10.1016/j.atherosclerosis.2011.10.044; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Hutchinson KR, 2010, J MOL CELL CARDIOL, V48, P564, DOI 10.1016/j.yjmcc.2009.06.001; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Kruger R, 2012, ATHEROSCLEROSIS, V222, P216, DOI 10.1016/j.atherosclerosis.2012.01.045; Kruger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058506; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Nicholl Suzanne M., 2006, Current Vascular Pharmacology, V4, P101, DOI 10.2174/157016106776359880; NODAHEINY H, 1995, ARTERIOSCL THROM VAS, V15, P37, DOI 10.1161/01.ATV.15.1.37; PERAKIS AC, 1990, EUR HEART J, V11, P492, DOI 10.1093/oxfordjournals.eurheartj.a059741; Rajamannan NM, 2001, J HEART VALVE DIS, V10, P371; Ramaraj R, 2008, BMJ-BRIT MED J, V336, P550, DOI 10.1136/bmj.39478.498819.AD; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Rossebo AB, 2007, AM J CARDIOL, V99, P970, DOI 10.1016/j.amjcard.2006.10.064; Sackner-Bernstein J D, 2000, Curr Cardiol Rep, V2, P112, DOI 10.1007/s11886-000-0007-4; Scholze A, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-6; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; VILLARI B, 1995, CIRCULATION, V91, P2353, DOI 10.1161/01.CIR.91.9.2353; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101522	10.1371/journal.pone.0101522	http://dx.doi.org/10.1371/journal.pone.0101522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014213	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400025
J	Woolpert, T; Phillips, CJ; Sevick, C; Crum-Cianflone, NF; Blair, PJ; Faix, D				Woolpert, Tabitha; Phillips, Christopher J.; Sevick, Carter; Crum-Cianflone, Nancy F.; Blair, Patrick J.; Faix, Dennis			Health-Related Behaviors and Effectiveness of Trivalent Inactivated versus Live Attenuated Influenza Vaccine in Preventing Influenza-Like Illness among Young Adults	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; IMMUNE-RESPONSE; DISEASES; VIRUS; SURVEILLANCE; INDUCTION; HUMANS; ABUSE	Background: Vaccination is the preferred preventive strategy against influenza. Though health behaviors are known to affect immunity and vaccine delivery modes utilize different immune processes, data regarding the preferred influenza vaccine type among adults endorsing specific health-related behaviors (alcohol use, tobacco use, and exercise level) are limited. Methods: The relative effectiveness of two currently available influenza vaccines were compared for prevention of influenza-like illness during 2 well-matched influenza seasons (2006/2007, 2008/2009) among US military personnel aged 18-49 years. Relative vaccine effectiveness was compared between those self-reporting and not reporting recent smoking history and potential alcohol problem, and by exercise level using Cox proportional hazard modeling adjusted for sociodemographic and military factors, geographic area, and other health behaviors. Results: 28,929 vaccination events and 3936 influenza-like illness events over both influenza seasons were studied. Of subjects, 27.5% were smokers, 7.7% had a potential alcohol-related problem, 10.5% reported minimal exercise, and 4.4% reported high exercise levels. Overall, the risk of influenza-like illness did not significantly differ between live attenuated and trivalent inactivated influenza vaccine recipients (hazard ratio, 0.98; 95% confidence interval, 0.90-1.06). In the final adjusted model, the relative effectiveness of the 2 vaccine types did not differ by smoking status (p = 0.10), alcohol status (p = 0.21), or activity level (p = 0.11). Conclusions: Live attenuated and trivalent inactivated influenza vaccines were similarly effective in preventing influenza-like illness among young adults and did not differ by health-related behavior status. Influenza vaccine efforts should continue to focus simply on delivering vaccine.	[Woolpert, Tabitha; Phillips, Christopher J.; Sevick, Carter; Crum-Cianflone, Nancy F.; Blair, Patrick J.; Faix, Dennis] Naval Hlth Res Ctr, San Diego, CA 92106 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Phillips, CJ (corresponding author), Naval Hlth Res Ctr, San Diego, CA 92106 USA.	chris.phillips@med.navy.mil			US Military Vaccine Agency (MILVAX)	US Military Vaccine Agency (MILVAX)	This work was supported by the US Military Vaccine Agency (MILVAX). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Brown LAS, 2006, ALCOHOL CLIN EXP RES, V30, P1624, DOI 10.1111/j.1530-0277.2006.00195.x; Bruunsgaard H, 1997, MED SCI SPORT EXER, V29, P1176, DOI 10.1097/00005768-199709000-00009; Centers for Disease Control and P, 2008, 2007 2008 INFL FLU S; Centers for Disease Control and P, 2008, INFL ACT US WORLDW 2, P692; Centers for Disease Control and P, 2007, UPD INFL ACT US WORL, P789; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Centers for Disease Control Prevention, 2011, MUCH PHYS ACT DO AD; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Cruijff M, 1999, VACCINE, V17, P426, DOI 10.1016/S0264-410X(98)00213-8; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DUDDING BA, 1973, AM J EPIDEMIOL, V97, P187, DOI 10.1093/oxfordjournals.aje.a121499; Edwards D, 2009, COPD, V6, P48, DOI 10.1080/15412550902724206; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; ESKOLA J, 1978, CLIN EXP IMMUNOL, V32, P339; FINKLEA JF, 1969, AM J EPIDEMIOL, V90, P390, DOI 10.1093/oxfordjournals.aje.a121084; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; GAYDOS CA, 1995, MIL MED, V160, P300, DOI 10.1093/milmed/160.6.300; Gleeson M, 1996, CLIN EXP IMMUNOL, V105, P238, DOI 10.1046/j.1365-2249.1996.d01-752.x; Gleeson M, 1999, MED SCI SPORT EXER, V31, P67, DOI 10.1097/00005768-199901000-00012; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Lau AH, 2009, TRENDS IMMUNOL, V30, P13, DOI 10.1016/j.it.2008.09.005; Mackinnon L., 1993, AUST J SCI MED SPORT, V25, P94; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Meyerholz DK, 2008, J IMMUNOL, V181, P641, DOI 10.4049/jimmunol.181.1.641; Nieman DC, 1999, SPORTS MED, V27, P73, DOI 10.2165/00007256-199927020-00001; Pavia CS, 2004, BIOMED PHARMACOTHER, V58, P84, DOI 10.1016/j.biopha.2003.12.005; Roseman C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3923; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; STANLEY WM, 1945, J EXP MED, V81, P193, DOI 10.1084/jem.81.2.193; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Szabo G, 1999, J CLIN IMMUNOL, V19, P67, DOI 10.1023/A:1020518703050; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; United States Department of Health and Human Services, 2004, HLTH CONS SMOK REP S; Venkatraman JT, 1997, AGING CLIN EXP RES, V9, P42, DOI 10.1007/BF03340127; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265	46	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102154	10.1371/journal.pone.0102154	http://dx.doi.org/10.1371/journal.pone.0102154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013931	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400073
J	Zhang, SC; Gremer, L; Heise, H; Janning, P; Shymanets, A; Cirstea, IC; Krause, E; Nurnberg, B; Ahmadian, MR				Zhang, Si-Cai; Gremer, Lothar; Heise, Henrike; Janning, Petra; Shymanets, Aliaksei; Cirstea, Ion C.; Krause, Eberhard; Nuernberg, Bernd; Ahmadian, Mohammad Reza			Liposome Reconstitution and Modulation of Recombinant Prenylated Human Rac1 by GEFs, GDI1 and Pak1	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; GTPASE-ACTIVATING PROTEINS; NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; NADPH OXIDASE; MEMBRANE TRANSLOCATION; STRUCTURAL BASIS; IN-VIVO; COMPLEX; BINDING	Small Rho GTPases are well known to regulate a variety of cellular processes by acting as molecular switches. The regulatory function of Rho GTPases is critically dependent on their posttranslational modification at the carboxyl terminus by isoprenylation and association with proper cellular membranes. Despite numerous studies, the mechanisms of recycling and functional integration of Rho GTPases at the biological membranes are largely unclear. In this study, prenylated human Rac1, a prominent member of the Rho family, was purified in large amount from baculovirus-infected Spodoptera frugiperda insect cells using a systematic detergent screening. In contrast to non-prenylated human Rac1 purified from Escherichia coli, prenylated Rac1 from insect cells was able to associate with synthetic liposomes and to bind Rho-specific guanine nucleotide dissociation inhibitor 1 (GDI1). Subsequent liposome reconstitution experiments revealed that GDI1 efficiently extracts Rac1 from liposomes preferentially in the inactive GDP-bound state. The extraction was prevented when Rac1 was activated to its GTP-bound state by Rac-specific guanine nucleotide exchange factors (GEFs), such as Vav2, Dbl, Tiam1, P-Rex1 and TrioN, and bound by the downstream effector Pak1. We found that dissociation of Rac1-GDP from its complex with GDI1 strongly correlated with two distinct activities of especially Dbl and Tiam1, including liposome association and the GDP/GTP exchange. Taken together, our results provided first detailed insights into the advantages of the in vitro liposome-based reconstitution system to study both the integration of the signal transducing protein complexes and the mechanisms of regulation and signaling of small GTPases at biological membranes.	[Zhang, Si-Cai; Gremer, Lothar; Cirstea, Ion C.; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Gremer, Lothar; Heise, Henrike] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Gremer, Lothar; Heise, Henrike] Res Ctr Julich GmbH, ICS 6, Inst Complex Syst, Julich, Germany; [Janning, Petra] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Shymanets, Aliaksei; Nuernberg, Bernd] Tubingen Med Sch, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany; [Cirstea, Ion C.] Leibniz Inst Age Res, Jena, Germany; [Krause, Eberhard] Leibniz Inst Mol Pharmacol, Lab Mass Spectrometry, Berlin, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Heise, Henrike/A-7703-2010; Cirstea, Ion Cristian/AAQ-7670-2020; Gremer, Lothar/H-9128-2013	Heise, Henrike/0000-0002-9081-3894; Cirstea, Ion Cristian/0000-0003-3204-1598; Gremer, Lothar/0000-0001-7065-5027; Nurnberg, Bernd/0000-0002-5995-6555	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 [SFB 974]; International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich-Heine-University of Dusseldorf; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf	German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974; International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich-Heine-University of Dusseldorf; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf	This research was gratefully supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration'', and the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich-Heine-University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2009, CHEMBIOCHEM, V10, P98, DOI 10.1002/cbic.200800275; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Boissier P, 2013, TRAFFIC, V14, P1255, DOI 10.1111/tra.12123; Boura E, 2012, P NATL ACAD SCI USA, V109, P1901, DOI 10.1073/pnas.1117597109; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Contreras-Gomez A, 2013, BIOTECHNOL PROG; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fansa EK, 2013, BIOCHEM BIOPH RES CO, V434, P785, DOI 10.1016/j.bbrc.2013.04.012; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; FUCHS A, 1994, EUR J BIOCHEM, V226, P587, DOI 10.1111/j.1432-1033.1994.tb20084.x; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Herbrand U, 2006, BIOL CHEM, V387, P311, DOI 10.1515/BC.2006.041; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2013, BIOL CHEM, V394, P89, DOI 10.1515/hsz-2012-0207; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mena JA, 2003, BIOTECHNIQUES, V34, P260, DOI 10.2144/03342bm05; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Ognibene M, 2014, GENE, V537, P220, DOI 10.1016/j.gene.2013.12.064; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Philips MR, 2007, J CLIN INVEST, V117, P1223, DOI 10.1172/JCI32108; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shymanets A, 2012, BIOCHEM J, V441, P851, DOI 10.1042/BJ20111664; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Tnimov Z, 2012, J BIOL CHEM, V287, P26549, DOI 10.1074/jbc.M112.371294; Triola G, 2012, ACS CHEM BIOL, V7, P87, DOI 10.1021/cb200460u; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Weise K, 2012, J AM CHEM SOC, V134, P11503, DOI 10.1021/ja305518h; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	72	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102425	10.1371/journal.pone.0102425	http://dx.doi.org/10.1371/journal.pone.0102425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014207	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400096
J	Coquery, CM; Wade, NS; Loo, WM; Kinchen, JM; Cox, KM; Jiang, C; Tung, KS; Erickson, LD				Coquery, Christine M.; Wade, Nekeithia S.; Loo, William M.; Kinchen, Jason M.; Cox, Kelly M.; Jiang, Chao; Tung, Kenneth S.; Erickson, Loren D.			Neutrophils Contribute to Excess Serum BAFF Levels and Promote CD4(+) T Cell and B Cell Responses in Lupus-Prone Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS; INTERFERON-GAMMA; IFN-GAMMA; LYMPHOCYTE STIMULATOR; MURINE LUPUS; DEFICIENT MICE; PLASMA-CELLS; ERYTHEMATOSUS; AUTOIMMUNITY; ACTIVATION	Despite increased frequencies of neutrophils found in autoimmune diseases such as systemic lupus erythematosus (SLE), how they contribute to disease pathogenesis and the mechanisms that affect the accumulation of neutrophils are poorly understood. The aim of this study was to identify factors in autoantibody-mediated autoimmunity that controls the accumulation of spleen resident neutrophils and to determine whether neutrophils contribute to abnormal B cell responses. Increased levels of the cytokine BAFF have been linked to loss of B cell tolerance in autoimmunity, but the cellular source responsible for excess BAFF is unknown. B cell maturation antigen (BCMA) is a receptor for BAFF and is critical for the survival of bone marrow plasma cells. Paradoxically, BCMA deficiency exacerbates the formation of autoantibody-secreting plasma cells in spleens of lupus-prone mice and the reasons for this effect are not understood. Here we analyzed the phenotype, localization and function of neutrophils in spleens of healthy mice and congenic lupus-prone mice, and compared mice sufficient or deficient in BCMA expression. Neutrophils were found to be significantly increased in frequency and activation status in spleens of lupus-prone mice when BCMA was absent. Furthermore, neutrophils localized within T cell zones and enhanced CD4(+) T cell proliferation and IFN gamma production through the production of BAFF. Reduced BAFF and IFN gamma serum levels, decreased frequencies of IFN gamma-producing T cells, germinal center B cells, and autoantibody production after neutrophil depletion indicated the involvement of neutrophils in these autoimmune traits. Thus, we have identified a novel role for BCMA to control excess BAFF production in murine lupus through restraining the accumulation of BAFF-producing neutrophils. Our data suggests that devising therapeutic strategies to reduce neutrophils in autoimmunity may decrease BAFF levels and ameliorate disease.	[Coquery, Christine M.; Kinchen, Jason M.; Cox, Kelly M.; Erickson, Loren D.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Coquery, Christine M.; Wade, Nekeithia S.; Loo, William M.; Kinchen, Jason M.; Cox, Kelly M.; Tung, Kenneth S.; Erickson, Loren D.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA USA; [Kinchen, Jason M.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA USA; [Tung, Kenneth S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Jiang, Chao] NIH, Div Extramural Res, Bethesda, MD 20892 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; National Institutes of Health (NIH) - USA	Erickson, LD (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	lde9w@virginia.edu	Kinchen, Jason/ABC-5663-2021	Kinchen, Jason/0000-0001-8430-2265	National Institutes of Health [R01 AI 093722, F31 AR 064145, 5T32A1007496-19]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041236, R01AI093722, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR064145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant R01 AI 093722, F31 AR 064145, and 5T32A1007496-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Assi LK, 2007, ARTHRITIS RHEUM-US, V56, P1776, DOI 10.1002/art.22697; Atzeni F, 2002, CELL IMMUNOL, V220, P20, DOI 10.1016/S0008-8749(03)00002-9; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Bonville CA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-14; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BUCKLE AM, 1989, J IMMUNOL, V143, P2295; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coquery CM, 2012, CYTOM PART A, V81A, P806, DOI 10.1002/cyto.a.22096; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gloyn AL, 2006, DIABETES, V55, P2272, DOI 10.2337/db06-0216; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Huard B, 2001, J IMMUNOL, V167, P6225, DOI 10.4049/jimmunol.167.11.6225; Huard B, 2004, INT IMMUNOL, V16, P467, DOI 10.1093/intimm/dxh043; Jiang C, 2011, J IMMUNOL, V186, P6136, DOI 10.4049/jimmunol.1001931; Jorgensen TN, 2010, J IMMUNOL, V184, P775, DOI 10.4049/jimmunol.0901322; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Kim J, 2011, AUTOIMMUNITY, V44, P69, DOI 10.3109/08916934.2010.509122; KIM T, 1987, CLIN EXP IMMUNOL, V70, P562; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peng SL, 1997, J CLIN INVEST, V99, P1936, DOI 10.1172/JCI119361; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Pollard KM, 2013, DISCOV MED, V16, P123; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ratner PA, 2006, J EPIDEMIOL COMMUN H, V60, P606, DOI 10.1136/jech.2005.037952; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009; Scapini P, 2010, J EXP MED, V207, P1757, DOI 10.1084/jem.20100086; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; Ye OR, 2004, EUR J IMMUNOL, V34, P2750, DOI 10.1002/eji.200425198; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	53	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102284	10.1371/journal.pone.0102284	http://dx.doi.org/10.1371/journal.pone.0102284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010693	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800088
J	Costes, LMM; van der Vliet, J; Farro, G; Matteoli, G; van Bree, SHW; Olivier, BJ; Nolte, MA; Boeckxstaens, GE; Cailotto, C				Costes, Lea M. M.; van der Vliet, Jan; Farro, Giovanna; Matteoli, Gianluca; van Bree, Sjoerd H. W.; Olivier, Brenda J.; Nolte, Martijn A.; Boeckxstaens, Guy E.; Cailotto, Cathy			The Spleen Responds to Intestinal Manipulation but Does Not Participate in the Inflammatory Response in a Mouse Model of Postoperative Ileus	PLOS ONE			English	Article							LYMPHOID-TISSUE; T-CELLS; CHEMOKINE; STROKE; MICE; STIMULATION; TRAFFICKING; INNERVATION; CONTRIBUTES; ACTIVATION	Background: Postoperative ileus is characterized by a transient impairment of the gastrointestinal motility after abdominal surgery. The intestinal inflammation, triggered by handling of the intestine, is the main factor responsible for the prolonged dysmotility of the gastrointestinal tract. Secondary lymphoid organs of the intestine were identified as essential components in the dissemination of inflammation to the entire gastrointestinal tract also called field effect. The involvement of the spleen, however, remains unclear. Aim: In this study, we investigated whether the spleen responds to manipulation of the intestine and participates in the intestinal inflammation underlying postoperative ileus. Methods: Mice underwent Laparotomy (L) or Laparotomy followed by Intestinal Manipulation (IM). Twenty-four hours later, intestinal and colonic inflammation was assessed by QPCR and measurement of the intestinal transit was performed. Analysis of homeostatic chemokines in the spleen was performed by QPCR and splenic cell populations analysed by Flow Cytometry. Blockade of the egress of cells from the spleen was performed by administration of the Sphingosine-1-phosphate receptor 1 (S1P(1)) agonist CYM-5442 10 h after L/IM. Results: A significant decrease in splenic weight and cellularity was observed in IM mice 24 h post-surgery, a phenomenon associated with a decreased splenic expression level of the homeostatic chemokine CCL19. Splenic denervation restored the expression of CCL19 and partially prevented the reduction of splenocytes in IM mice. Treatment with CYM-5442 prevented the egress of splenocytes but did not ameliorate the intestinal inflammation underlying postoperative ileus. Conclusions: Intestinal manipulation results in two distinct phenomena: local intestinal inflammation and a decrease in splenic cellularity. The splenic response relies on an alteration of cell trafficking in the spleen and is partially regulated by the splenic nerve. The spleen however does not participate in the intestinal inflammation during POI.	[Costes, Lea M. M.; van der Vliet, Jan; van Bree, Sjoerd H. W.; Olivier, Brenda J.; Cailotto, Cathy] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Olivier, Brenda J.; Nolte, Martijn A.] Sanquin Res & Landsteiner Lab AMC UvA, Dept Hematopoiesis, Adapt Immun Lab, Amsterdam, Netherlands; [Farro, Giovanna; Matteoli, Gianluca; Boeckxstaens, Guy E.] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; KU Leuven	Costes, LMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.m.costes@amc.nl	Nolte, Martijn A./AAC-8092-2022; Boeckxstaens, Guy/AAP-2502-2020	Nolte, Martijn A./0000-0002-5447-0839; Matteoli, Gianluca/0000-0002-2902-4976	Netherlands Organization for Scientific Research (NWO Vici grant) [918-76 623]; Maag Lever Darm Stichting [W09-30]	Netherlands Organization for Scientific Research (NWO Vici grant)(Netherlands Organization for Scientific Research (NWO)); Maag Lever Darm Stichting	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO Vici grant 918-76 623) (http://www.nwo.nl/) and by the Maag Lever Darm Stichting (W09-30) (http://www.mdl.nl/p_home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Asgeirsson T, 2010, J AM COLL SURGEONS, V210, P228, DOI 10.1016/j.jamcollsurg.2009.09.028; Cailotto C, 2012, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HARRIS TJ, 1995, J AM COLL CARDIOL, V26, P102, DOI 10.1016/0735-1097(95)00123-H; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; Iyer S, 2009, J MANAGE CARE PHARM, V15, P485, DOI 10.18553/jmcp.2009.15.6.485; Kalff JC, 1999, GASTROENTEROLOGY, V117, P378, DOI 10.1053/gast.1999.0029900378; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Koscielny A, 2013, AM J PHYSIOL-GASTR L, V304, pG401, DOI 10.1152/ajpgi.00161.2012; Koscielny A, 2011, AM J PHYSIOL-GASTR L, V300, pG665, DOI 10.1152/ajpgi.00224.2010; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Perez SD, 2009, BRAIN RES, V1302, P106, DOI 10.1016/j.brainres.2009.09.012; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; Seeley EJ, 2013, J IMMUNOL, V190, P4717, DOI 10.4049/jimmunol.1300027; Seifert HA, 2012, J NEUROIMMUNE PHARM, V7, P1017, DOI 10.1007/s11481-012-9406-8; Stewart IB, 2002, SPORTS MED, V32, P361, DOI 10.2165/00007256-200232060-00002; Stoffels B, 2009, GUT, V58, P648, DOI 10.1136/gut.2008.153288; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van Bree SHW, 2013, NEUROGASTROENT MOTIL, V25, pE540, DOI 10.1111/nmo.12157; van Bree SHW, 2012, NAT REV GASTRO HEPAT, V9, P675, DOI 10.1038/nrgastro.2012.134; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang J, 2007, EUR J PHARMACOL, V565, P76, DOI 10.1016/j.ejphar.2007.02.030; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102211	10.1371/journal.pone.0102211	http://dx.doi.org/10.1371/journal.pone.0102211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010202	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800082
J	Maloney, SR; Almarines, D; Goolkasian, P				Maloney, Sean R.; Almarines, David; Goolkasian, Paula			Vitamin D Levels and Monospot Tests in Military Personnel with Acute Pharyngitis: A Retrospective Chart Review	PLOS ONE			English	Review							SEASONAL-VARIATION; 25-HYDROXYVITAMIN-D	Some recent studies have proposed an important role for vitamin D in reducing the risk of infection by assisting in the suppression of viruses and by controlling the inflammatory response. A low vitamin D state may have a detrimental effect on the immune system's ability to produce activated CD8+ T cells, and it may increase the inflammatory reaction to Epstein Barr virus. The aim of this chart review was to see if serum 25 OH vitamin D-3 levels in service members with acute pharyngitis were lower in those who had positive rather than negative monospot tests. A retrospective chart review was conducted on the medical records of service members who presented to sick call at Camp Lejeune, NC with acute pharyngitis from October 8, 2010 until June 30, 2011. Serum 25 OH vitamin D-3 levels were compared between those with positive and negative monospot test results. Of the 25 records that were reviewed, there were 9 (36%) service members with positive results, and they were found to have lower vitamin D levels (Median = 20.80 ng/ml, Interquartile range = 10.15) than those with negative test results (Median = 30.35 ng/ml, Interquartile range = 17.05), Mann-Whitney U = 41, p = .039. Only 1 of the 9 with positive test results had a normal serum 25 OH vitamin D-3 level (30 ng/ml or greater) compared with 9 of the 16 with negative test results. Optimal vitamin D stores may play a significant role in reducing the risk of developing acute mononucleosis but larger, prospective studies will be needed to verify these findings.	[Maloney, Sean R.; Almarines, David] Navy Mobilizat Proc Site, Deployment Proc Command East, Camp Lejeune, NC USA; [Maloney, Sean R.] WG Bill Hefner VA Med Ctr, Salisbury, NC USA; [Goolkasian, Paula] Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Goolkasian, P (corresponding author), Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA.	pagoolka@uncc.edu	Goolkasian, Paula/AAP-7727-2020	Goolkasian, Paula/0000-0002-0463-6992; Maloney, Sean/0000-0002-4574-9344	U.S. Navy; Office of Research and Training at Naval Hospital Camp Lejeune	U.S. Navy(United States Department of Defense); Office of Research and Training at Naval Hospital Camp Lejeune	This paper is based on research supported by the U.S. Navy and the Office of Research and Training at Naval Hospital Camp Lejeune during the mobilization of CAPT Sean R. Maloney MC USN as a medical officer to the Navy Mobilization Processing Site, Deployment Processing Command - East, Camp Lejeune, N.C. including part time assignment to the Sports Medicine Clinic, Naval Hospital Camp Lejeune between August 2010 and May 2012.	Adams J, 2008, J MARIT ARCHAEOL, V3, P1, DOI 10.1007/s11457-008-9028-8; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Candy B, 2002, BRIT J GEN PRACT, V52, P844; Cunha BA, 2013, INFECT MONONUCLEOSIS; D'Alessandro DM, WHAT CAUSES FALSE PO; Ebell MH, 2004, AM FAM PHYSICIAN, V70, P1279; Gordon Y, 2004, INVEST OPHTHALMOL VI, V45; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Maloney CDRSR, 2013, MED HYPOTHESES, V80, P220, DOI 10.1016/j.mehy.2012.11.024; Moran-Auth Y, 2013, J STEROID BIOCHEM, V136, P83, DOI 10.1016/j.jsbmb.2013.02.005; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Pender MP, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/189096; Salzer J, 2013, MULT SCLER J, V19, P1587, DOI 10.1177/1352458513483888; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; VANCAUWENBERGE PB, 1991, PEDIATR INFECT DIS J, V10, pS39, DOI 10.1097/00006454-199110001-00009; Zwart SR, 2011, J NUTR, V141, P692, DOI 10.3945/jn.110.134742	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101180	10.1371/journal.pone.0101180	http://dx.doi.org/10.1371/journal.pone.0101180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009977	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800014
J	Rocchi, L; Barbosa, AJM; Onofrillo, C; Del Rio, A; Montanaro, L				Rocchi, Laura; Barbosa, Armenio J. M.; Onofrillo, Carmine; Del Rio, Alberto; Montanaro, Lorenzo			Inhibition of Human Dyskerin as a New Approach to Target Ribosome Biogenesis	PLOS ONE			English	Article							PHASE-II EVALUATION; GUIDED PSEUDOURIDINE SYNTHASE; MESSENGER-RNA TRANSLATION; HUMAN BREAST-CANCER; TELOMERASE ACTIVITY; PYRAZOFURIN; EXPRESSION; THERAPEUTICS; MECHANISM; CARCINOMA	The product of the DKC1 gene, dyskerin, is required for both ribosome biogenesis and telomerase complex stabilization. Targeting these cellular processes has been explored for the development of drugs to selectively or preferentially kill cancer cells. Presently, intense research is conducted involving the identification of new biological targets whose modulation may simultaneously interfere with multiple cellular functions that are known to be hyper-activated by neoplastic transformations. Here, we report, for the first time, the computational identification of small molecules able to inhibit dyskerin catalytic activity. Different in silico techniques were applied to select compounds and analyze the binding modes and the interaction patterns of ligands in the human dyskerin catalytic site. We also describe a newly developed and optimized fast real-time PCR assay that was used to detect dyskerin pseudouridylation activity in vitro. The identification of new dyskerin inhibitors constitutes the first proof of principle that the pseudouridylation activity can be modulated by means of small molecule agents. Therefore, the presented results, obtained through the usage of computational tools and experimental validation, indicate an alternative therapeutic strategy to target ribosome biogenesis pathway.	[Rocchi, Laura; Barbosa, Armenio J. M.; Onofrillo, Carmine; Del Rio, Alberto; Montanaro, Lorenzo] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Rocchi, Laura] Univ Hosp Parma, Surg Pathol Unit, Parma, Italy; [Onofrillo, Carmine] Univ Bologna, Giorgio Prodi Interdept Canc Res Ctr, Bologna, Italy; [Del Rio, Alberto] CNR, Inst Organ Chem & Photoreact, Bologna, Italy	University of Bologna; University of Parma; University Hospital of Parma; University of Bologna; Consiglio Nazionale delle Ricerche (CNR)	Del Rio, A (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	alberto.delrio@gmail.com; lorenzo.montanaro@unibo.it	Barbosa, Arménio J Moura/O-2456-2015; Montanaro, Lorenzo/I-4236-2019; Barbosa, Arménio Moura/AAO-1899-2020; Del Rio, Alberto/F-5230-2010; Onofrillo, Carmine/X-7557-2019	Barbosa, Arménio J Moura/0000-0002-9756-4958; Montanaro, Lorenzo/0000-0001-9776-9518; Barbosa, Arménio Moura/0000-0002-9756-4958; Del Rio, Alberto/0000-0002-1890-6797; Onofrillo, Carmine/0000-0002-1076-6419; Onofrillo, Carmine/0000-0003-2537-6672	Associazione Italiana per la Ricerca sul Cancro (AIRC) - Emilia Romagna Start-Up grant [6266, IG-11416]; PRIN grant from the Italian Ministry of Education, University and Research [20104AE23N_002]; "Cassa di risparmio di Bologna (Carisbo)'' foundation	Associazione Italiana per la Ricerca sul Cancro (AIRC) - Emilia Romagna Start-Up grant(Fondazione AIRC per la ricerca sul cancro); PRIN grant from the Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); "Cassa di risparmio di Bologna (Carisbo)'' foundation	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) - Emilia Romagna Start-Up grant 6266 to ADR and IG-11416 to LM and by PRIN grant from the Italian Ministry of Education, University and Research n. 20104AE23N_002 to LM. The authors thank "Cassa di risparmio di Bologna (Carisbo)'' foundation for supporting LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alawi F, 2011, HEAD NECK-J SCI SPEC, V33, P1041, DOI 10.1002/hed.21579; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barbosa AJM, 2012, CURR TOP MED CHEM, V12, P866; Bellodi C, 2010, CANCER RES, V70, P6026, DOI 10.1158/0008-5472.CAN-09-4730; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUDMAN D, 1977, CANCER TREAT REP, V61, P1733; CADMAN EC, 1978, CANCER RES, V38, P682; CARROLL DS, 1979, CANCER TREAT REP, V63, P139; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cormier WJ, CANC TREAT REP, V64, P655; CUMMINGS FJ, 1979, CANCER TREAT REP, V63, P1363; Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014; Del Rio A, 2010, MOL BIOSYST, V6, P2122, DOI 10.1039/c0mb00039f; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Duan JQ, 2009, MOL CELL, V34, P427, DOI 10.1016/j.molcel.2009.05.005; Edmonson JH, CANC TREAT REP, V65, P1127; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRALLA RJ, 1978, CANCER TREAT REP, V62, P1573; GRALLA RJ, 1978, CANCER TREAT REP, V62, P451; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Hoang C, 2005, PROTEIN SCI, V14, P2201, DOI 10.1110/ps.051493605; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li S, 2011, GENE DEV, V25, P2409, DOI 10.1101/gad.175299.111; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043147; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; Montanaro L, 2010, J PATHOL, V222, P345, DOI 10.1002/path.2777; Montanaro L, 2010, CANCER RES, V70, P4767, DOI 10.1158/0008-5472.CAN-09-4024; NICHOLS WC, 1978, CANCER TREAT REP, V62, P837; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Rocchi L, 2013, NUCLEIC ACIDS RES, P1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shay JW, 2002, CANCER CELL, V2, P257, DOI 10.1016/S1535-6108(02)00159-9; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sieron P, 2009, BRIT J CANCER, V101, P1410, DOI 10.1038/sj.bjc.6605299; Turano M, 2008, ACTA ONCOL, V47, P1598, DOI 10.1080/02841860801898616; VOGLER WR, 1978, CANCER TREAT REP, V62, P1569; Wang C, 2002, MOL CELL BIOL, V22, P8457, DOI 10.1128/MCB.22.24.8457-8466.2002; Wright WE, 1996, DEV GENET, V18, P173; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	49	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101971	10.1371/journal.pone.0101971	http://dx.doi.org/10.1371/journal.pone.0101971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010840	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800056
J	Knikou, M				Knikou, Maria			Transpinal and Transcortical Stimulation Alter Corticospinal Excitability and Increase Spinal Output	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; ELECTRICAL-STIMULATION; TIBIALIS ANTERIOR; REFLEX RESPONSES; CORD STIMULATION; BASIC PRINCIPLES; H-REFLEX; POTENTIALS; ACTIVATION	The objective of this study was to assess changes in corticospinal excitability and spinal output following noninvasive transpinal and transcortical stimulation in humans. The size of the motor evoked potentials (MEPs), induced by transcranial magnetic stimulation (TMS) and recorded from the right plantar flexor and extensor muscles, was assessed following transcutaneous electric stimulation of the spine (tsESS) over the thoracolumbar region at conditioning-test (C-T) intervals that ranged from negative 50 to positive 50 ms. The size of the transpinal evoked potentials (TEPs), induced by tsESS and recorded from the right and left plantar flexor and extensor muscles, was assessed following TMS over the left primary motor cortex at 0.7 and at 1.1 x MEP resting threshold at C-T intervals that ranged from negative 50 to positive 50 ms. The recruitment curves of MEPs and TEPs had a similar shape, and statistically significant differences between the sigmoid function parameters of MEPs and TEPs were not found. Anodal tsESS resulted in early MEP depression followed by long-latency MEP facilitation of both ankle plantar flexors and extensors. TEPs of ankle plantar flexors and extensors were increased regardless TMS intensity level. Subthreshold and suprathreshold TMS induced short-latency TEP facilitation that was larger in the TEPs ipsilateral to TMS. Noninvasive transpinal stimulation affected ipsilateral and contralateral actions of corticospinal neurons, while corticocortical and corticospinal descending volleys increased TEPs in both limbs. Transpinal and transcortical stimulation is a noninvasive neuromodulation method that alters corticospinal excitability and increases motor output of multiple spinal segments in humans.	[Knikou, Maria] CUNY, Grad Ctr, New York, NY 10021 USA; [Knikou, Maria] CUNY, Coll Staten Isl, Dept Phys Therapy, Staten Isl, NY USA; [Knikou, Maria] CUNY, Coll Staten Isl, Dept Neurosci, Staten Isl, NY USA; [Knikou, Maria] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Knikou, Maria] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Knikou, M (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.	Maria.Knikou@csi.cuny.edu	Knikou, Maria/E-5568-2015	Knikou, Maria/0000-0002-6277-236X				Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005; BERARDELLI A, 1990, NEUROSCI LETT, V112, P54, DOI 10.1016/0304-3940(90)90321-Y; Brinkworth RSA, 2003, J NEUROSCI METH, V122, P179, DOI 10.1016/S0165-0270(02)00321-7; BURKE D, 1993, J PHYSIOL-LONDON, V470, P383, DOI 10.1113/jphysiol.1993.sp019864; Capaday C, 1997, J NEUROSCI METH, V74, P201, DOI 10.1016/S0165-0270(97)02250-4; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CRAYTON JW, 1981, J NEUROL NEUROSUR PS, V44, P239, DOI 10.1136/jnnp.44.3.239; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; Deng ZD, 2014, CLIN NEUROPHYSIOL, V125, P1202, DOI 10.1016/j.clinph.2013.11.038; DENOORDHOUT AM, 1988, J NEUROL NEUROSUR PS, V51, P174, DOI 10.1136/jnnp.51.2.174; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Devanne H, 2009, EUR J NEUROSCI, V30, P439, DOI 10.1111/j.1460-9568.2009.06815.x; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00018; Duclay J, 2011, J PHYSIOL-LONDON, V589, P2901, DOI 10.1113/jphysiol.2011.207472; Einhorn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076940; ELLAWAY PH, 1978, ELECTROEN CLIN NEURO, V45, P302, DOI 10.1016/0013-4694(78)90017-2; Geertsen SS, 2010, J PHYSIOL-LONDON, V588, P2391, DOI 10.1113/jphysiol.2010.190678; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hofstoetter US, 2008, ARTIF ORGANS, V32, P644, DOI 10.1111/j.1525-1594.2008.00616.x; HUNTER JP, 1994, J PHYSIOL-LONDON, V474, P407, DOI 10.1113/jphysiol.1994.sp020032; INGHILLERI M, 1989, J NEUROL NEUROSUR PS, V52, P970, DOI 10.1136/jnnp.52.8.970; Jackson A, 2006, J PHYSIOL-LONDON, V573, P107, DOI 10.1113/jphysiol.2005.100537; Kaneko K, 1996, MUSCLE NERVE, V19, P659, DOI 10.1002/(SICI)1097-4598(199605)19:5<659::AID-MUS17>3.3.CO;2-B; Kaneko K, 1997, J NEUROL SCI, V151, P217, DOI 10.1016/S0022-510X(97)00135-4; KATZ R, 1977, J NEUROL NEUROSUR PS, V40, P575, DOI 10.1136/jnnp.40.6.575; Khaslavskaia S, 2002, EXP BRAIN RES, V145, P309, DOI 10.1007/s00221-002-1094-9; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; Klimstra M, 2008, EXP BRAIN RES, V186, P93, DOI 10.1007/s00221-007-1207-6; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Knikou M, 2013, CLIN NEUROPHYSIOL, V124, P2431, DOI 10.1016/j.clinph.2013.06.004; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P630, DOI 10.1002/bem.21808; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P200, DOI 10.1002/bem.21768; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; KONRAD PE, 1994, SPINE, V19, P2812, DOI 10.1097/00007632-199412150-00014; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; Lamy JC, 2005, EXP BRAIN RES, V166, P248, DOI 10.1007/s00221-005-2360-4; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lontis ER, 2006, J CLIN NEUROPHYSIOL, V23, P462; MILLS KR, 1986, ELECTROEN CLIN NEURO, V63, P582, DOI 10.1016/0013-4694(86)90145-8; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Miranda PC, 2003, IEEE T BIO-MED ENG, V50, P1074, DOI 10.1109/TBME.2003.816079; Mrachacz-Kersting N, 2007, J NEUROPHYSIOL, V97, P1951, DOI 10.1152/jn.01176.2006; Nielsen J, 1999, EEG CL N SU, P93; NIELSEN J, 1994, J PHYSIOL-LONDON, V477, P47, DOI 10.1113/jphysiol.1994.sp020170; PATTON HD, 1954, J NEUROPHYSIOL, V17, P345, DOI 10.1152/jn.1954.17.4.345; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Pierrot-Deseilligny E., 2012, SPINAL CORTICOSPINAL; Poon DE, 2008, EXP BRAIN RES, V188, P13, DOI 10.1007/s00221-008-1334-8; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Roy FD, 2008, J PHYSIOL-LONDON, V586, P4091, DOI 10.1113/jphysiol.2008.153726; Roy FD, 2014, EXP BRAIN RES, V232, P1717, DOI 10.1007/s00221-014-3864-6; Roy FD, 2012, EXP BRAIN RES, V223, P281, DOI 10.1007/s00221-012-3258-6; Schneider C, 2004, J APPL PHYSIOL, V97, P2220, DOI 10.1152/japplphysiol.00542.2004; Sharpe AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016005; Toschi N, 2008, J PSYCHIATR RES, V43, P255, DOI 10.1016/j.jpsychires.2008.04.008; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002	66	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102313	10.1371/journal.pone.0102313	http://dx.doi.org/10.1371/journal.pone.0102313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007330	gold, Green Published			2022-12-25	WOS:000339040600111
J	van Ackeren, MJ; Rueschemeyer, SA				van Ackeren, Markus J.; Rueschemeyer, Shirley-Ann			Cross-Modal Integration of Lexical-Semantic Features during Word Processing: Evidence from Oscillatory Dynamics during EEG	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; THETA-POWER INCREASES; WORKING-MEMORY; BRAIN; MOTOR; BINDING; REPRESENTATION; FLEXIBILITY; PERCEPTION; ACTIVATION	In recent years, numerous studies have provided converging evidence that word meaning is partially stored in modality-specific cortical networks. However, little is known about the mechanisms supporting the integration of this distributed semantic content into coherent conceptual representations. In the current study we aimed to address this issue by using EEG to look at the spatial and temporal dynamics of feature integration during word comprehension. Specifically, participants were presented with two modality-specific features (i.e., visual or auditory features such as silver and loud) and asked to verify whether these two features were compatible with a subsequently presented target word (e.g., WHISTLE). Each pair of features described properties from either the same modality (e.g., silver, tiny = visual features) or different modalities (e.g., silver, loud = visual, auditory). Behavioral and EEG data were collected. The results show that verifying features that are putatively represented in the same modality-specific network is faster than verifying features across modalities. At the neural level, integrating features across modalities induces sustained oscillatory activity around the theta range (4-6 Hz) in left anterior temporal lobe (ATL), a putative hub for integrating distributed semantic content. In addition, enhanced long-range network interactions in the theta range were seen between left ATL and a widespread cortical network. These results suggest that oscillatory dynamics in the theta range could be involved in integrating multimodal semantic content by creating transient functional networks linking distributed modality-specific networks and multimodal semantic hubs such as left ATL.	[van Ackeren, Markus J.; Rueschemeyer, Shirley-Ann] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	van Ackeren, MJ (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	mjva500@york.ac.uk			Department of Psychology at the University of York	Department of Psychology at the University of York	This work was funded by the Department of Psychology at the University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou L. W., 2003, CATEGORIZATION INSID, DOI [10.1037/11156-014, DOI 10.1037/11156-014]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bastiaansen MCM, 2008, BRAIN LANG, V106, P15, DOI 10.1016/j.bandl.2007.10.006; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Bastiaansen MCM, 2002, NEUROSCI LETT, V323, P13, DOI 10.1016/S0304-3940(01)02535-6; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Boulenger V, 2009, CEREB CORTEX, V19, P1905, DOI 10.1093/cercor/bhn217; Chatterjee A, 2010, LANG COGN, V2, P79, DOI 10.1515/LANGCOG.2010.004; Damasio AR, 1989, NEURAL COMPUT, V1, P123, DOI 10.1162/neco.1989.1.1.123; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Gonzalez J, 2006, NEUROIMAGE, V32, P906, DOI 10.1016/j.neuroimage.2006.03.037; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hald LA, 2006, BRAIN LANG, V96, P90, DOI 10.1016/j.bandl.2005.06.007; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00050; Hoenig K, 2008, J COGNITIVE NEUROSCI, V20, P1799, DOI 10.1162/jocn.2008.20123; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kiefer M, 2008, J NEUROSCI, V28, P12224, DOI 10.1523/JNEUROSCI.3579-08.2008; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lynott D, 2009, BEHAV RES METHODS, V41, P558, DOI 10.3758/BRM.41.2.558; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; McNorgan C, 2011, COGNITION, V118, P211, DOI 10.1016/j.cognition.2010.10.017; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R, 2003, CLIN NEUROPHYSIOL, V114, P1194, DOI 10.1016/S1388-2457(03)00059-2; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pecher D, 2003, PSYCHOL SCI, V14, P119, DOI 10.1111/1467-9280.t01-1-01429; Plaut DC, 2002, COGN NEUROPSYCHOL, V19, P603, DOI 10.1080/02643290244000112; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Rosenblum LD, 2008, CURR DIR PSYCHOL SCI, V17, P405, DOI 10.1111/j.1467-8721.2008.00615.x; Schneider TR, 2008, NEUROIMAGE, V42, P1244, DOI 10.1016/j.neuroimage.2008.05.033; Schneider TR, 2008, EXP PSYCHOL, V55, P121, DOI 10.1027/1618-3169.55.2.121; Schneider TR, 2011, J NEUROSCI, V31, P2502, DOI 10.1523/JNEUROSCI.6447-09.2011; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Simmons WK, 2007, NEUROPSYCHOLOGIA, V45, P2802, DOI 10.1016/j.neuropsychologia.2007.05.002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Van Ackeren M J, 2012, J COGN NEUROSCI, V24; van Dam WO, 2012, HUM BRAIN MAPP, V33, P2322, DOI 10.1002/hbm.21365; van Dantzig S, 2011, BEHAV RES METHODS, V43, P145, DOI 10.3758/s13428-010-0038-8; Van der Werf J, 2008, J NEUROSCI, V28, P8397, DOI 10.1523/JNEUROSCI.0630-08.2008; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Wang L, 2012, HUM BRAIN MAPP, V33, P2898, DOI 10.1002/hbm.21410; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Wu X, 2007, NEUROIMAGE, V35, P1654, DOI 10.1016/j.neuroimage.2007.02.011	57	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101042	10.1371/journal.pone.0101042	http://dx.doi.org/10.1371/journal.pone.0101042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007074	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600028
J	Zhang, LC; Liang, J; Luo, WZ; Liu, X; Yan, H; Zhao, KB; Shi, HB; Zhang, YB; Wang, LG; Wang, LX				Zhang, Longchao; Liang, Jing; Luo, Weizhen; Liu, Xin; Yan, Hua; Zhao, Kebin; Shi, Huibi; Zhang, Yuebo; Wang, Ligang; Wang, Lixian			Genome-Wide Scan Reveals LEMD3 and WIF1 on SSC5 as the Candidates for Porcine Ear Size	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; MUSCLE MASS; TGF-BETA; WNT; TRAITS; GENE; QTL; GROWTH; LOCUS; CELLS	The quantitative trait loci (QTL) for porcine ear size was previously reported to mainly focus on SSC5 and SSC7. Recently, a missense mutation, G32E, in PPARD in the QTL interval on SSC7 was identified as the causative mutation for ear size. However, on account of the large interval of QTL, the responsible gene on SSC5 has not been identified. In this study, an intercross population was constructed from the large-eared Minzhu, an indigenous Chinese pig breed, and the Western commercial Large White pig to examine the genetic basis of ear size diversity. A GWAS was performed to detect SNPs significantly associated with ear size. Thirty-five significant SNPs defined a 10.78-Mb (30.14-40.92 Mb) region on SSC5. Further, combining linkage disequilibrium and haplotype sharing analysis, a reduced region of 3.07-Mb was obtained. Finally, by using a selective sweep analysis, a critical region of about 450-kb interval containing two annotated genes LEMD3 and WIF1 was refined in this work. Functional analysis indicated that both represent biological candidates for porcine ear size, with potential application in breeding programs. The two genes could also be used as novel references for further study of the mechanism underlying human microtia.	[Zhang, Longchao; Liang, Jing; Liu, Xin; Yan, Hua; Zhao, Kebin; Shi, Huibi; Zhang, Yuebo; Wang, Ligang; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Luo, Weizhen] Beijing Sanyuan Breeding Technol Co Ltd, Anim Husb Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Wang, LG (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	ligwang@126.com; iaswlx@263.net	Liang, Jing/GOK-1970-2022		Agricultural Science and Technology Innovation Program [ASTIP-IAS02]; earmarked fund for Modern Agro-industry Technology Research System; National Key Technology R&D Program of China [2011BAD28B01]; National Natural Science Foundation of China [31201781]; National Technology Program of China [2011ZX08006-003]; Chinese Academy of Agricultural Sciences Foundation [2011cj-5, 2012ZL069]	Agricultural Science and Technology Innovation Program; earmarked fund for Modern Agro-industry Technology Research System; National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology Program of China; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences)	This research was supported by Agricultural Science and Technology Innovation Program (ASTIP-IAS02), earmarked fund for Modern Agro-industry Technology Research System, the National Key Technology R&D Program of China (No. 2011BAD28B01), National Natural Science Foundation of China (31201781), National Technology Program of China (No. 2011ZX08006-003), and Chinese Academy of Agricultural Sciences Foundation (No. 2011cj-5 and No. 2012ZL069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Li PH, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-6; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Ma J, 2009, ANIM GENET, V40, P463, DOI 10.1111/j.1365-2052.2009.01867.x; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Madsen P., 2006, WORLD C GENETICS APP; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nezer C, 2003, GENETICS, V165, P277; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rooryck C, 2009, EUR J MED GENET, V52, P446, DOI 10.1016/j.ejmg.2009.08.005; ROTHSCHILD MF, 1998, GENETICS PIG; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei WH, 2007, ANIM GENET, V38, P222, DOI 10.1111/j.1365-2052.2007.01591.x; XIANG X, 1990, SCIENCE, V247, P967, DOI 10.1126/science.2305264; Yang Q, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S134; ZHANG Z, 1986, PIG BREEDS CHINA; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	40	16	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102085	10.1371/journal.pone.0102085	http://dx.doi.org/10.1371/journal.pone.0102085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006967	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600093
J	Gonzalez-Perez, A; Saez, ME; Johansson, S; Nagy, P; Rodriguez, LAG				Gonzalez-Perez, Antonio; Saez, Maria E.; Johansson, Saga; Nagy, Peter; Garcia Rodriguez, Luis A.			Risk Factors Associated with Uncomplicated Peptic Ulcer and Changes in Medication Use after Diagnosis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON-PUMP INHIBITORS; HELICOBACTER-PYLORI; GASTROINTESTINAL COMPLICATIONS; ASPIRIN; POPULATION; DISEASE; BLEEDING/PERFORATION; THERAPY; REDUCE	Background: Few epidemiologic studies have investigated predictors of uncomplicated peptic ulcer disease (PUD) separately from predictors of complicated PUD. Objective: To analyze risk factors associated with uncomplicated PUD and medication use after diagnosis. Methods: Patients diagnosed with uncomplicated PUD (n = 3,914) were identified from The Health Improvement Network database among individuals aged 40-84 years during 1997-2005, with no previous history of PUD. Prescription records for the year after the date of diagnosis were reviewed and a nested case-control analysis was performed to calculate the odds ratios for the association of potential risk factors with PUD. Results: Medications associated with developing uncomplicated PUD included current use of acetylsalicylic acid (ASA), nonsteroidal anti-inflammatory drugs (NSAIDs), paracetamol, selective serotonin reuptake inhibitors, antidepressants, antihypertensives or acid suppressants. Uncomplicated PUD was significantly associated with being a current or former smoker and having had a score of at least 3 on the Townsend deprivation index. Approximately 50% of patients who were users of ASA (19% of patients) or chronic users of NSAIDs (7% of patients) at diagnosis did not receive another prescription of the medication in the 60 days after diagnosis, and 30% were not represcribed therapy within a year. Among patients who were current users of ASA or chronic NSAIDs at the time of the PUD diagnosis and received a subsequent prescription for their ASA or NSAID during the following year, the vast majority (80-90%) also received a proton pump inhibitor coprescription. Conclusions: Our results indicate that several risk factors for upper gastrointestinal bleeding are also predictors of uncomplicated PUD, and that some patients do not restart therapy with ASA or NSAIDs after a diagnosis of uncomplicated PUD. Further investigation is needed regarding the consequences for these patients in terms of increased cardiovascular burden due to discontinuation of antiplatelet therapy.	[Gonzalez-Perez, Antonio; Saez, Maria E.; Garcia Rodriguez, Luis A.] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid, Spain; [Gonzalez-Perez, Antonio; Saez, Maria E.] Andalusian Bioinformat Res Ctr CAEBi, Seville, Spain; [Johansson, Saga; Nagy, Peter] AstraZeneca R&D, Molndal, Sweden	AstraZeneca	Rodriguez, LAG (corresponding author), Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid, Spain.	lagarcia@ceife.es	Gonzalez-Perez, Antonio/A-5247-2010; rodriguez, luis a garcia/B-1980-2010; González-Pérez, Antonio/AAY-4179-2021; Saez, Maria E/C-8093-2012	Gonzalez-Perez, Antonio/0000-0001-9771-5982; González-Pérez, Antonio/0000-0001-9771-5982; Nagy, Peter/0000-0001-8836-2310; Saez, Maria/0000-0001-9299-2534	AstraZeneca R&D, Molndal, Sweden	AstraZeneca R&D, Molndal, Sweden(AstraZeneca)	The study was funded by AstraZeneca R&D, Molndal, Sweden. Two of the manuscript authors, Saga Johansson and Peter Nagy, are employees of AstraZeneca. Saga Johansson and Peter Nagy provided input on the design of the study, were involved in analysis and interpretation of the data and contributed fully to the development and finalization of the manuscript, and approved it for submission. Other employees of AstraZeneca were given the opportunity to comment on manuscript drafts and the authors gave consideration to any relevant comments received.	Barkun A, 2010, AM J MED, V123, P358, DOI 10.1016/j.amjmed.2009.09.031; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Bourke Alison, 2004, Inform Prim Care, V12, P171; Cai S, 2009, ALIMENT PHARM THER, V30, P1039, DOI 10.1111/j.1365-2036.2009.04131.x; Dall M, 2012, ALIMENT PHARM THER, V35, P948, DOI 10.1111/j.1365-2036.2012.05006.x; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Rodriguez LAG, 2011, CIRCULATION, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hernandez-Diaz S, 2002, J CLIN EPIDEMIOL, V55, P157, DOI 10.1016/S0895-4356(01)00461-9; Hernandez-Diaz S, 2013, DIGEST DIS SCI, V58, P1653, DOI 10.1007/s10620-013-2561-9; Lanas A, 2012, AM J GASTROENTEROL, V107, P707, DOI 10.1038/ajg.2012.13; Lassen A, 2006, AM J GASTROENTEROL, V101, P945, DOI 10.1111/j.1572-0241.2006.00518.x; Lau JY, 2011, DIGESTION, V84, P102, DOI 10.1159/000323958; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lin KJ, 2011, GASTROENTEROLOGY, V141, P71, DOI 10.1053/j.gastro.2011.03.049; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Margulis AV, 2009, PHARMACOEPIDEM DR S, V18, P900, DOI 10.1002/pds.1787; Martin-Merino E, 2012, PRAGMAT OBS RES, V3, P1, DOI 10.2147/POR.S29557; Miyake K, 2013, DIGEST ENDOSC, V25, P25, DOI 10.1111/j.1443-1661.2012.01334.x; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; ONEIL M, 1995, METHOD INFORM MED, V34, P187; PETERSON WL, 1991, NEW ENGL J MED, V324, P1043, DOI 10.1056/NEJM199104113241507; Pilotto A, 2004, ALIMENT PHARM THER, V20, P1091, DOI 10.1111/j.1365-2036.2004.02246.x; Rodriguez LAG, 2004, AM J EPIDEMIOL, V159, P23, DOI 10.1093/aje/kwh005; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Stack WA, 2002, ALIMENT PHARM THER, V16, P497, DOI 10.1046/j.1365-2036.2002.01197.x; Townsend PP., 1988, HLTH DEPRIVATION INE; Udd M, 2007, SCAND J GASTROENTERO, V42, P1395, DOI 10.1080/00365520701478758; Yeomans ND, 2011, J GASTROEN HEPATOL, V26, P426, DOI 10.1111/j.1440-1746.2010.06569.x	32	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101768	10.1371/journal.pone.0101768	http://dx.doi.org/10.1371/journal.pone.0101768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003908	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700063
J	Wilkins, JM; McConnell, C; Tipton, PA; Hannink, M				Wilkins, Jordan M.; McConnell, Cyrus; Tipton, Peter A.; Hannink, Mark			A Conserved Motif Mediates both Multimer Formation and Allosteric Activation of Phosphoglycerate Mutase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MITOCHONDRIAL DYNAMICS; CELL-DEATH; PGAM5; PHOSPHORYLATION; PHOSPHATASE; FISSION; P62/SQSTM1; MITOPHAGY; APOPTOSIS	Phosphoglycerate mutase 5 (PGAM5) is an atypical mitochondrial Ser/Thr phosphatase that modulates mitochondrial dynamics and participates in both apoptotic and necrotic cell death. The mechanisms that regulate the phosphatase activity of PGAM5 are poorly understood. The C-terminal phosphoglycerate mutase domain of PGAM5 shares homology with the catalytic domains found in other members of the phosphoglycerate mutase family, including a conserved histidine that is absolutely required for catalytic activity. However, this conserved domain is not sufficient for maximal phosphatase activity. We have identified a highly conserved amino acid motif, WDXNWD, located within the unique N-terminal region, which is required for assembly of PGAM5 into large multimeric complexes. Alanine substitutions within the WDXNWD motif abolish the formation of multimeric complexes and markedly reduce phosphatase activity of PGAM5. A peptide containing the WDXNWD motif dissociates the multimeric complex and reduces but does not fully abolish phosphatase activity. Addition of the WDXNWD-containing peptide in trans to a mutant PGAM5 protein lacking the WDXNWD motif markedly increases phosphatase activity of the mutant protein. Our results are consistent with an intermolecular allosteric regulation mechanism for the phosphatase activity of PGAM5, in which the assembly of PGAM5 into multimeric complexes, mediated by the WDX-NWD motif, results in maximal activation of phosphatase activity. Our results suggest the possibility of identifying small molecules that function as allosteric regulators of the phosphatase activity of PGAM5.	[Wilkins, Jordan M.; McConnell, Cyrus; Hannink, Mark] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Tipton, Peter A.; Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Hannink, M (corresponding author), Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr, Bond Life Sci Ctr 440E, Columbia, MO 65211 USA.	hanninkm@missouri.edu			National Institutes of Health [P50AT006273]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant P50AT006273.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Niture SK, 2011, J BIOL CHEM, V286, P44542, DOI 10.1074/jbc.M111.275073; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sadatomi D, 2013, INT J MOL SCI, V14, P4596, DOI 10.3390/ijms14034596; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022	24	20	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25137	25148		10.1074/jbc.M114.565549	http://dx.doi.org/10.1074/jbc.M114.565549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012655	Green Published, hybrid			2022-12-25	WOS:000341985300035
J	Chen, M; Yi, B; Sun, JX				Chen, Ming; Yi, Bing; Sun, Jianxin			Inhibition of Cardiomyocyte Hypertrophy by Protein Arginine Methyltransferase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiomyocyte; Post-translational Modification (PTM); Protein Arginine N-Methyltransferase 5 (PRMT5); Transcription Factor; Transcription Regulation	TRANSCRIPTION FACTORS GATA4; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; SM PROTEINS; IN-VIVO; SIGNALING PATHWAYS; HEART-FAILURE; METHYLATION; PRMT5; IDENTIFICATION	Background: Protein arginine methyltransferase 5 (PRMT5) is a type II protein arginine methyltransferase that catalyzes the symmetrical dimethylation of arginine residues within target proteins. Results: PRMT5 interacts with and methylates GATA4 in cardiomyocytes. Conclusion: PRMT5 suppresses hypertrophic responses in cardiomyocytes by attenuating GATA4 transcriptional activity. Significance: Targeting PRMT5 may represent a novel therapeutic strategy for preventing cardiac hypertrophy and heart failure. Protein arginine methyltransferase 5 (PRMT5), a protein arginine methyltransferase that catalyzes the symmetrical dimethylation of arginine residues within target proteins, has been implicated in many essential cellular processes ranging from the regulation of gene expression to cell proliferation and differentiation. PRMT5 is highly expressed in the heart; the functional role of PRMT5 in the heart, however, remains largely elusive. In the present study, we show that PRMT5 specifically interacts with GATA4 in both co-transfected HEK293T cells and neonatal rat cardiomyocytes by co-immunoprecipitation. Importantly, this interaction leads to the arginine methylation of GATA4 at positions of 229, 265, and 317, which leads to an inhibition of the GATA4 transcriptional activity, predominantly through blocking the p300-mediated acetylation of GATA4 in cardiomyocytes. Moreover, overexpression of PRMT5 substantially inhibited the acetylation of GATA4 and cardiac hypertrophic responses in phenylephrine-stimulated cardiomyocytes, whereas knockdown of PRMT5 induced GATA4 activation and cardiomyocyte hypertrophy. Furthermore, in response to phenylephrine stimulation, PRMT5 translocates into the cytoplasm, thus relieving its repression on GATA4 activity in the nucleus and leading to hypertrophic gene expression in cardiomyocytes. These findings indicate that PRMT5 is an essential regulator of myocardial hypertrophic signaling and suggest that strategies aimed at activating PRMT5 in the heart may represent a potential therapeutic approach for the prevention of cardiac hypertrophy and heart failure.	[Chen, Ming; Yi, Bing; Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA 19107 USA	Jefferson University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Rm 368G, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu			National Institutes of Health [HL103869]; Chinese Natural Science Foundation [381170114, 81370418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL103869. This work was also supported from Chinese Natural Science Foundation Grants 381170114 and 81370418 (to J. S.).	Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bevilacqua A, 2014, CARDIOVASC PATHOL, V23, P85, DOI 10.1016/j.carpath.2013.09.003; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dai YS, 2001, J BIOL CHEM, V276, P37178, DOI 10.1074/jbc.M103731200; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Hannan RD, 1996, J BIOL CHEM, V271, P3213, DOI 10.1074/jbc.271.6.3213; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hong E, 2012, BIOGERONTOLOGY, V13, P329, DOI 10.1007/s10522-012-9379-2; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Loffredo FS, 2014, CIRC RES, V115, P97, DOI 10.1161/CIRCRESAHA.115.302929; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	47	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24325	24335		10.1074/jbc.M114.577494	http://dx.doi.org/10.1074/jbc.M114.577494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012667	Green Published, hybrid			2022-12-25	WOS:000341505600028
J	Lin, B; Gupta, D; Heinen, CD				Lin, Bo; Gupta, Dipika; Heinen, Christopher D.			Human Pluripotent Stem Cells Have a Novel Mismatch Repair-dependent Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Damage Response; DNA Mismatch Repair; DNA Repair; Embryonic Stem Cell; Induced Pluripotent Stem Cells; Pluripotent Stem Cells	DNA-REPAIR; IONIZING-RADIATION; MUTS-ALPHA; APOPTOSIS; ATR; O-6-METHYLGUANINE; PHOSPHORYLATION; METHYLATION; ARREST; AUTOPHOSPHORYLATION	Background: Mismatch repair is involved in the cellular response to DNA-alkylating agents. Results: Alkylation damage causes mismatch repair-dependent apoptosis in human pluripotent stem cells (PSCs) in the first S phase after damage. Conclusion: Human PSCs utilize a unique MMR-dependent damage response to alkylation damage. Significance: Understanding how PSCs respond to DNA damage is crucial for their potential use in regenerative medicine. Human pluripotent stem cells (PSCs) are presumed to have robust DNA repair pathways to ensure genome stability. PSCs likely need to protect against mutations that would otherwise be propagated throughout all tissues of the developing embryo. How these cells respond to genotoxic stress has only recently begun to be investigated. Although PSCs appear to respond to certain forms of damage more efficiently than somatic cells, some DNA damage response pathways such as the replication stress response may be lacking. Not all DNA repair pathways, including the DNA mismatch repair (MMR) pathway, have been well characterized in PSCs to date. MMR maintains genomic stability by repairing DNA polymerase errors. MMR is also involved in the induction of cell cycle arrest and apoptosis in response to certain exogenous DNA-damaging agents. Here, we examined MMR function in PSCs. We have demonstrated that PSCs contain a robust MMR pathway and are highly sensitive to DNA alkylation damage in an MMR-dependent manner. Interestingly, the nature of this alkylation response differs from that previously reported in somatic cell types. In somatic cells, a permanent G(2)/M cell cycle arrest is induced in the second cell cycle after DNA damage. The PSCs, however, directly undergo apoptosis in the first cell cycle. This response reveals that PSCs rely on apoptotic cell death as an important defense to avoid mutation accumulation. Our results also suggest an alternative molecular mechanism by which the MMR pathway can induce a response to DNA damage that may have implications for tumorigenesis.	Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Heinen, CD (corresponding author), UConn Hlth Ctr, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	cheinen@uchc.edu		Gupta, Dipika/0000-0002-6512-5256	National Institutes of Health [CA115783]; State of Connecticut Stem Cell Grant [13SCB-UCHC-06]; NATIONAL CANCER INSTITUTE [R01CA115783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut Stem Cell Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115783. This work was also supported by State of Connecticut Stem Cell Grant 13SCB-UCHC-06.	Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cejka P, 2003, CANCER RES, V63, P8113; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dietmaier W, 1997, CANCER RES, V57, P4749; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fan JS, 2011, MUTAT RES-FUND MOL M, V713, P8, DOI 10.1016/j.mrfmmm.2011.05.018; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Fung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020514; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; Kane MF, 1997, CANCER RES, V57, P808; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Luo LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030541; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Mastrocola AS, 2010, HUM MUTAT, V31, pE1699, DOI 10.1002/humu.21333; Mastrocola AS, 2010, DNA REPAIR, V9, P120, DOI 10.1016/j.dnarep.2009.11.003; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Noonan EM, 2012, INTEGR BIOL-UK, V4, P1237, DOI 10.1039/c2ib20091k; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rajesh P, 2010, DNA REPAIR, V9, P458, DOI 10.1016/j.dnarep.2010.01.009; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wilson KD, 2010, CANCER RES, V70, P5539, DOI 10.1158/0008-5472.CAN-09-4238; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853; Zhang H, 1999, CANCER RES, V59, P3021; Zhou BS, 2009, ANAL BIOCHEM, V388, P167, DOI 10.1016/j.ab.2009.02.020	48	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24314	24324		10.1074/jbc.M114.570937	http://dx.doi.org/10.1074/jbc.M114.570937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012654	Green Published, hybrid			2022-12-25	WOS:000341505600027
J	Beenstock, J; Ben-Yehuda, S; Melamed, D; Admon, A; Livnah, O; Ahn, NG; Engelberg, D				Beenstock, Jonah; Ben-Yehuda, Sheer; Melamed, Dganit; Admon, Arie; Livnah, Oded; Ahn, Natalie G.; Engelberg, David			The p38 beta Mitogen-activated Protein Kinase Possesses an Intrinsic Autophosphorylation Activity, Generated by a Short Region Composed of the alpha-G Helix and MAPK Insert	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitogen-activated Protein Kinase (MAPK); p38; p38 MAPK; Phosphorylation; Signal Transduction; Autophosphorylation	P38-ALPHA ACTIVATION; P38; PHOSPHORYLATION; IDENTIFICATION; MECHANISM; VARIANTS; MUTANTS; INDUCE; SPECIFICITY; FEATURES	Background: Kinases, involved in all processes of life, are enzymes capable of self-activation. MAP kinases, a kinase subfamily, do not self-activate. Results: We found that p38 is a unique MAP kinase that can self-activate. Significance: Through this we disclosed the element responsible for self-activation. Conclusion: Minor differences between kinases impose dramatic differences on their self-activation property. Protein kinases are regulated by a large number of mechanisms that vary from one kinase to another. However, a fundamental activation mechanism shared by all protein kinases is phosphorylation of a conserved activation loop threonine residue. This is achieved in many cases via autophosphorylation. The mechanism and structural basis for autophosphorylation are not clear and are in fact enigmatic because this phosphorylation occurs when the kinase is in its inactive conformation. Unlike most protein kinases, MAP kinases are not commonly activated by autophosphorylation but rather by MEK-dependent phosphorylation. Here we show that p38, a p38 isoform that is almost identical to p38, is exceptional and spontaneously autoactivates by autophosphorylation. We identified a 13-residue-long region composed of part of the G-helix and the MAPK insert that triggers the intrinsic autophosphorylation activity of p38. When inserted into p38, this fragment renders it spontaneously active in vitro and in mammalian cells. We further found that an interaction between the N terminus and a particular region of the C-terminal extension suppresses the intrinsic autophosphorylation of p38 in mammalian cells. Thus, this study identified the structural motif responsible for the unique autophosphorylation capability of p38 and the motif inhibiting this activity in living cells. It shows that the MAPK insert and C-terminal extension, structural motifs that are unique to MAPKs, play a critical role in controlling autophosphorylation.	[Beenstock, Jonah; Ben-Yehuda, Sheer; Livnah, Oded; Engelberg, David] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Melamed, Dganit; Admon, Arie] Technion Israel Inst Technol, Fac Biol, Smoler Prote Ctr, IL-32000 Haifa, Israel; [Ahn, Natalie G.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Engelberg, David] Natl Univ Singapore, Cellular & Mol Mech Inflammat Program, CREATE NUS HUJ, Singapore 138602, Singapore	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; National University of Singapore	Engelberg, D (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	engelber@cc.huji.ac.il		Admon, Arie/0000-0003-0504-3950	Israel Science Foundation [180/09, 1772/13]; Bi-national US-Israel Science Foundation [2009116]; Israel Cancer Research Fund; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	Israel Science Foundation(Israel Science Foundation); Bi-national US-Israel Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	This study was supported by the Israel Science Foundation (Center of Excellence Grants 180/09 and 1772/13), the Bi-national US-Israel Science Foundation (Grant 2009116), the Israel Cancer Research Fund, and Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE).	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Maayan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044749; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Patel SB, 2009, ACTA CRYSTALLOGR D, V65, P777, DOI 10.1107/S090744490901600X; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	44	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23546	23556		10.1074/jbc.M114.578237	http://dx.doi.org/10.1074/jbc.M114.578237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006254	Green Published, hybrid			2022-12-25	WOS:000341505000025
J	Swenson, AM; Trivedi, DV; Rauscher, AA; Wang, Y; Takagi, Y; Palmer, BM; Malnasi-Csizmadia, A; Debold, EP; Yengo, CM				Swenson, Anja M.; Trivedi, Darshan V.; Rauscher, Anna A.; Wang, Yuan; Takagi, Yasuharu; Palmer, Bradley M.; Malnasi-Csizmadia, Andras; Debold, Edward P.; Yengo, Christopher M.			Magnesium Modulates Actin Binding and ADP Release in Myosin Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Contractile Protein; Enzyme Kinetics; Magnesium; Muscle; Myosin	DEPENDENT ADENOSINE-TRIPHOSPHATASE; CYTOSOLIC-FREE MAGNESIUM; CROSS-BRIDGE CYCLE; SKELETAL-MUSCLE; ATPASE ACTIVITY; POWER STROKE; RAT-HEART; V MOTOR; MG2+; DISSOCIATION	Background: Magnesium may be an important physiological regulator of myosin motor activity. Results: Mg2+ inhibits the ADP release rate constant in the subset of myosins examined and reduces actin affinity in the post-hydrolysis state in myosin V. Conclusion: Mg2+ alters contractile velocity without altering overall tension-generating capacity. Significance: Mg2+-dependent regulation of motor activity is conserved in myosin motors. We examined the magnesium dependence of five class II myosins, including fast skeletal muscle myosin, smooth muscle myosin, -cardiac myosin (CMIIB), Dictyostelium myosin II (DdMII), and nonmuscle myosin IIA, as well as myosin V. We found that the myosins examined are inhibited in a Mg2+-dependent manner (0.3-9.0 mm free Mg2+) in both ATPase and motility assays, under conditions in which the ionic strength was held constant. We found that the ADP release rate constant is reduced by Mg2+ in myosin V, smooth muscle myosin, nonmuscle myosin IIA, CMIIB, and DdMII, although the ADP affinity is fairly insensitive to Mg2+ in fast skeletal muscle myosin, CMIIB, and DdMII. Single tryptophan probes in the switch I (Trp-239) and switch II (Trp-501) region of DdMII demonstrate these conserved regions of the active site are sensitive to Mg2+ coordination. Cardiac muscle fiber mechanic studies demonstrate cross-bridge attachment time is increased at higher Mg2+ concentrations, demonstrating that the ADP release rate constant is slowed by Mg2+ in the context of an activated muscle fiber. Direct measurements of phosphate release in myosin V demonstrate that Mg2+ reduces actin affinity in the MADPP(i) state, although it does not change the rate of phosphate release. Therefore, the Mg2+ inhibition of the actin-activated ATPase activity observed in class II myosins is likely the result of Mg2+-dependent alterations in actin binding. Overall, our results suggest that Mg2+ reduces the ADP release rate constant and rate of attachment to actin in both high and low duty ratio myosins.	[Swenson, Anja M.; Trivedi, Darshan V.; Yengo, Christopher M.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; [Rauscher, Anna A.; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Wang, Yuan; Palmer, Bradley M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Takagi, Yasuharu] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Debold, Edward P.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 02210 USA; [Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Hungarian Acad Sci, Mol Biophys Res Grp, H-1117 Budapest, Hungary	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Eotvos Lorand University; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Massachusetts System; University of Massachusetts Amherst; Eotvos Lorand University; Hungarian Academy of Sciences	Yengo, CM (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	cyengo@hmc.psu.edu	Rauscher, Anna Á/I-3941-2017; Csizmadia, András Málnási/K-7632-2018	Rauscher, Anna Á/0000-0002-4062-960X; Csizmadia, András Málnási/0000-0002-2430-8398; Touma, Anja/0000-0001-9953-9695	National Institutes of Health [R01 EY016419, R01 HL086902]; Pennsylvania Department of Health; National Science Foundation [EPS-1101317]; European Research Council [Ideas 208319]; NATIONAL EYE INSTITUTE [R01EY018141, R03EY016419] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY016419 and Grant R01 HL086902 (to B. M. P.). This work was also supported by a grant from the Pennsylvania Department of Health (to C. M. Y.), National Science Foundation Grant EPS-1101317, and European Research Council Ideas 208319 (to A. M. C.).	BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; BLATTER LA, 1990, PFLUG ARCH EUR J PHY, V416, P238, DOI 10.1007/BF00392059; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; BURI A, 1993, EXP PHYSIOL, V78, P221, DOI 10.1113/expphysiol.1993.sp003682; Cahours X, 1998, CHROMATOGRAPHIA, V48, P739, DOI 10.1007/BF02467641; Chizhov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064797; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Geeves M A, 1995, Biophys J, V68, p194S; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; GUNZEL D, 1991, PFLUG ARCH EUR J PHY, V417, P446, DOI 10.1007/BF00370938; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; HEADRICK JP, 1991, J MOL CELL CARDIOL, V23, P991, DOI 10.1016/0022-2828(91)91635-5; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; HUXLEY HE, 1990, J BIOL CHEM, V265, P8347; Iotti S, 2000, MAGN RESON IMAGING, V18, P607, DOI 10.1016/S0730-725X(00)00132-6; Iotti S, 2008, MAGNESIUM RES, V21, P157, DOI 10.1684/mrh.2008.0142; IRVING M, 1989, J GEN PHYSIOL, V93, P585, DOI 10.1085/jgp.93.4.585; Jackson DR, 2014, ARCH BIOCHEM BIOPHYS, V552, P74, DOI 10.1016/j.abb.2013.12.012; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Malmqvist UP, 2004, BIOCHEMISTRY-US, V43, P15058, DOI 10.1021/bi0495329; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; MURPHY E, 1989, J BIOL CHEM, V264, P5622; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Olivares AO, 2005, P NATL ACAD SCI USA, V102, P13719, DOI 10.1073/pnas.0507068102; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Puchert E, 2003, PFLUG ARCH EUR J PHY, V447, P135, DOI 10.1007/s00424-003-1154-4; PUTKEY JA, 1987, METHOD ENZYMOL, V139, P303; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sanders GT, 1999, CLIN CHEM LAB MED, V37, P1011, DOI 10.1515/CCLM.1999.151; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Stewart TJ, 2013, CELL MOL BIOENG, V6, P26, DOI 10.1007/s12195-013-0274-y; Sun MX, 2008, P NATL ACAD SCI USA, V105, P8631, DOI 10.1073/pnas.0710793105; Sun MX, 2006, J BIOL CHEM, V281, P5711, DOI 10.1074/jbc.M508103200; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Wang Y, 2013, J MOL CELL CARDIOL, V54, P1, DOI 10.1016/j.yjmcc.2012.10.010; Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Zeng W, 2004, PHILOS T R SOC B, V359, P1843, DOI 10.1098/rstb.2004.1527	71	22	22	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23977	23991		10.1074/jbc.M114.562231	http://dx.doi.org/10.1074/jbc.M114.562231			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006251	hybrid, Green Published			2022-12-25	WOS:000341505000062
J	Jin, ZY; Wu, M; Han, RQ; Zhang, XF; Wang, XS; Liu, AM; Zhou, JY; Lu, QY; Kim, CH; Mu, LN; Zhang, ZF; Zhao, JK				Jin, Zi-Yi; Wu, Ming; Han, Ren-Qiang; Zhang, Xiao-Feng; Wang, Xu-Shan; Liu, Ai-Ming; Zhou, Jin-Yi; Lu, Qing-Yi; Kim, Claire H.; Mu, Lina; Zhang, Zuo-Feng; Zhao, Jin-Kou			Household Ventilation May Reduce Effects of Indoor Air Pollutants for Prevention of Lung Cancer: A Case-Control Study in a Chinese Population	PLOS ONE			English	Article							COOKING OIL FUMES; TOBACCO-SMOKE; RISK; POLLUTION; COAL; WOMEN; EMISSIONS; FUELS	Background: Although the International Agency for Research on Cancer (IARC) has classified various indoor air pollutants as carcinogenic to humans, few studies evaluated the role of household ventilation in reducing the impact of indoor air pollutants on lung cancer risk. Objectives: To explore the association between household ventilation and lung cancer. Methods: A population-based case-control study was conducted in a Chinese population from 2003 to 2010. Epidemiologic and household ventilation data were collected using a standardized questionnaire. Unconditional logistic regression was employed to estimate adjusted odds ratios (ORadj) and their 95% confidence intervals (CI). Results: Among 1,424 lung cancer cases and 4,543 healthy controls, inverse associations were observed for good ventilation in the kitchen (ORadj = 0.86, 95% CI: 0.75, 0.98), bedroom (ORadj = 0.90, 95% CI: 0.79, 1.03), and both kitchen and bedroom (ORadj = 0.87, 95% CI: 0.75, 1.00). Stratified analyses showed lung cancer inversely associated with good ventilation among active smokers (ORadj = 0.85, 95% CI: 0.72, 1.00), secondhand smokers at home (ORadj = 0.77, 95% CI: 0.63, 0.94), and those exposed to high-temperature cooking oil fumes (ORadj = 0.82, 95% CI: 0.68, 0.99). Additive interactions were found between household ventilation and secondhand smoke at home as well as number of household pollutant sources. Conclusions: A protective association was observed between good ventilation of households and lung cancer, most likely through the reduction of exposure to indoor air pollutants, indicating ventilation may serve as one of the preventive measures for lung cancer, in addition to tobacco cessation.	[Jin, Zi-Yi; Wu, Ming; Han, Ren-Qiang; Zhou, Jin-Yi; Zhao, Jin-Kou] Jiangsu Prov Ctr Dis Control & Prevent, Dept Noncommunicable Chron Dis Control, Nanjing, Jiangsu, Peoples R China; [Jin, Zi-Yi] Jiangyin Ctr Dis Control & Prevent, Jiangyin, Jiangsu, Peoples R China; [Zhang, Xiao-Feng; Wang, Xu-Shan] Ganyu Ctr Dis Control & Prevent, Ganyu, Jiangsu, Peoples R China; [Liu, Ai-Ming] Dafeng Ctr Dis Control & Prevent, Dafeng, Jiangsu, Peoples R China; [Lu, Qing-Yi] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Human Nutr, Los Angeles, CA 90095 USA; [Kim, Claire H.; Zhang, Zuo-Feng] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Mu, Lina] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	Jiangsu Provincial Center for Disease Control & Prevention; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhao, JK (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Noncommunicable Chron Dis Control, Nanjing, Jiangsu, Peoples R China.	jinkouzhao@hotmail.com		Lu, Qing-Yi/0000-0002-1704-382X; Zhang, Zuo-Feng/0000-0002-4669-3995; Zhao, Jinkou/0000-0001-9184-3385; Jin, Zi-Yi/0000-0002-8091-2266	Jiangsu Provincial Health Department [RC 2003090]; National Institutes of Health, National Institute of Environmental Health Sciences, National Cancer Institute, Department of Health and Human Services [ES06718, ES01167, CA90833, CA077954, CA09142, CA96134, DA11386]; Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA090833, R03CA077954, T32CA009142, U01CA096134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011386] Funding Source: NIH RePORTER	Jiangsu Provincial Health Department; National Institutes of Health, National Institute of Environmental Health Sciences, National Cancer Institute, Department of Health and Human Services; Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by Jiangsu Provincial Health Department (RC 2003090); was partially supported by the National Institutes of Health, National Institute of Environmental Health Sciences, National Cancer Institute, Department of Health and Human Services, Grants ES06718, ES01167, CA90833, CA077954, CA09142, CA96134, DA11386; and the Alper Research Center for Environmental Genomics of the University of California, Los Angeles Jonsson Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Boffetta P, 2002, SCAND J WORK ENV HEA, V28, P30; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galeone C, 2008, EUR J CANCER PREV, V17, P473, DOI 10.1097/CEJ.0b013e328305a0b9; Gao YT, 1996, LUNG CANCER-J IASLC, V14, pS39, DOI 10.1016/S0169-5002(96)90209-3; Hao J, 2011, CHINESE CANC REGISTR; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hoh E, 2012, ENVIRON SCI TECHNOL, V46, P4174, DOI 10.1021/es300267g; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; IARC, GLOBOCAN 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V95, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin ZY, 2013, CANCER PREV RES, V6, P711, DOI 10.1158/1940-6207.CAPR-13-0015; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Ko YC, 2000, AM J EPIDEMIOL, V151, P140, DOI 10.1093/oxfordjournals.aje.a010181; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Lan Q, 2000, CANCER EPIDEM BIOMAR, V9, P605; Lee CH, 2010, INT J CANCER, V127, P932, DOI 10.1002/ijc.25108; Lee T, 2013, J IMMIGR MINOR HEALT, V15, P646, DOI 10.1007/s10903-012-9651-1; Li MC, 2008, LUNG CANCER, V62, P145, DOI 10.1016/j.lungcan.2008.03.002; Lissowska J, 2005, AM J EPIDEMIOL, V162, P326, DOI 10.1093/aje/kwi204; MOHTASHAMIPUR E, 1990, J CANCER RES CLIN, V116, P604, DOI 10.1007/BF01637081; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; Mu LN, 2005, INT J CANCER, V116, P972, DOI 10.1002/ijc.21137; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; QING L, 1993, AM J EPIDEMIOL, V137, P145, DOI 10.1093/oxfordjournals.aje.a116654; Taylor R, 2007, INT J EPIDEMIOL, V36, P1048, DOI 10.1093/ije/dym158; Travis WD, 2004, PATHOLOGY GENETICS T; Wang XR, 2009, ANN ONCOL, V20, P746, DOI 10.1093/annonc/mdn699; Yu ITS, 2006, CANCER RES, V66, P4961, DOI 10.1158/0008-5472.CAN-05-2932; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; Zhao JK, 2004, ZHONGGUO ZHONGLIU, V13, P757; Zhao Y, 2006, SCI TOTAL ENVIRON, V366, P500, DOI 10.1016/j.scitotenv.2005.10.010	38	13	13	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102685	10.1371/journal.pone.0102685	http://dx.doi.org/10.1371/journal.pone.0102685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019554	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600097
J	Kidera, Y; Kawakami, H; Sakiyama, T; Okamoto, K; Tanaka, K; Takeda, M; Kaneda, H; Nishina, S; Tsurutani, J; Fujiwara, K; Nomura, M; Yamazoe, Y; Chiba, Y; Nishida, S; Tamura, T; Nakagawa, K				Kidera, Yasuhiro; Kawakami, Hisato; Sakiyama, Tsutomu; Okamoto, Kunio; Tanaka, Kaoru; Takeda, Masayuki; Kaneda, Hiroyasu; Nishina, Shin-ichi; Tsurutani, Junji; Fujiwara, Kimiko; Nomura, Morihiro; Yamazoe, Yuzuru; Chiba, Yasutaka; Nishida, Shozo; Tamura, Takao; Nakagawa, Kazuhiko			Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection	PLOS ONE			English	Article							PATIENTS RECEIVING CISPLATIN; HIGH-DOSE CISPLATIN; INDUCED HYPOMAGNESEMIA; PERFORMANCE STATUS; ONCOLOGY-GROUP; LUNG-CANCER; CHEMOTHERAPY; TRIAL	Background: Nephrotoxicity remains a problem for patients who receive cisplatin chemotherapy. We retrospectively evaluated potential risk factors for cisplatin-induced nephrotoxicity as well as the potential impact of intravenous magnesium supplementation on such toxicity. Patients and Methods: We reviewed clinical data for 401 patients who underwent chemotherapy including a high dose (>= 60 mg/m(2)) of cisplatin in the first-line setting. Nephrotoxicity was defined as an increase in the serum creatinine concentration of at least grade 2 during the first course of cisplatin chemotherapy, as assessed on the basis of National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0. The severity of nephrotoxicity was evaluated on the basis of the mean change in the serum creatinine level. Magnesium was administered intravenously to 67 patients (17%). Results: Cisplatin-induced nephrotoxicity was observed in 127 patients (32%). Multivariable analysis revealed that an Eastern Cooperative Oncology Group performance status of 2 (risk ratio, 1.876; P = 0.004) and the regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) (risk ratio, 1.357; P = 0.047) were significantly associated with an increased risk for cisplatin nephrotoxicity, whereas intravenous magnesium supplementation was associated with a significantly reduced risk for such toxicity (risk ratio, 0.175; P = 0.0004). The development of hypomagnesemia during cisplatin treatment was significantly associated with a greater increase in serum creatinine level (P = 0.0025). Magnesium supplementation therapy was also associated with a significantly reduced severity of renal toxicity (P = 0.012). Conclusions: A relatively poor performance status and the regular use of NSAIDs were significantly associated with cisplatin-induced nephrotoxicity, although the latter association was marginal. Our findings also suggest that the ability of magnesium supplementation to protect against the renal toxicity of cisplatin warrants further investigation in a prospective trial.	[Kidera, Yasuhiro; Nishida, Shozo] Kinki Univ, Fac Pharm, Div Pharmacotherapy, Higashiosaka, Osaka 577, Japan; [Kidera, Yasuhiro; Fujiwara, Kimiko; Nomura, Morihiro; Yamazoe, Yuzuru] Kinki Univ, Fac Med, Dept Pharm, Osaka, Japan; [Kawakami, Hisato; Sakiyama, Tsutomu; Okamoto, Kunio; Tanaka, Kaoru; Takeda, Masayuki; Kaneda, Hiroyasu; Nishina, Shin-ichi; Tsurutani, Junji; Tamura, Takao; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Chiba, Yasutaka] Kinki Univ, Fac Med, Div Biostat, Clin Res Ctr, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University)	Kawakami, H (corresponding author), Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan.	kawakami_h@dotd.med.kindai.ac.jp	Kawakami, Hisato/L-6845-2019	Kawakami, Hisato/0000-0002-3280-4850	Grants-in-Aid for Scientific Research [24701037] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Al Bahrani B J, 2009, Gulf J Oncolog, P30; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Ariceta G, 1997, MED PEDIATR ONCOL, V28, P35, DOI 10.1002/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U; Bodnar L, 2008, EUR J CANCER, V44, P2608, DOI 10.1016/j.ejca.2008.08.005; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; DAUGAARD G, 1988, CLIN PHARMACOL THER, V44, P164, DOI 10.1038/clpt.1988.132; de Jongh FE, 2003, BRIT J CANCER, V88, P1199, DOI 10.1038/sj.bjc.6600884; EVANS TRJ, 1995, EUR J CANCER, V31A, P174, DOI 10.1016/0959-8049(94)00420-A; Gridelli C, 2006, ANN ONCOL, V17, pV72, DOI 10.1093/annonc/mdj955; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Hesketh PJ, 2006, J THORAC ONCOL, V1, P537, DOI 10.1097/01243894-200607000-00007; KOVACH JS, 1973, CANCER CHEMOTH REP 1, V57, P357; Lajer H, 2005, CANCER CHEMOTH PHARM, V56, P535, DOI 10.1007/s00280-005-1010-7; Lajer H, 1999, CANCER TREAT REV, V25, P47, DOI 10.1053/ctrv.1999.0097; MARTIN M, 1992, AM J CLIN ONCOL-CANC, V15, P348, DOI 10.1097/00000421-199208000-00016; MAVICHAK V, 1985, KIDNEY INT, V28, P914, DOI 10.1038/ki.1985.217; National Comprehensive Cancer Network, 2013, NCCN CHEM ORD TEMPL; NETTEN PM, 1990, ANN ONCOL, V1, P369, DOI 10.1093/oxfordjournals.annonc.a057776; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; POPE JE, 1993, ARCH INTERN MED, V153, P477, DOI 10.1001/archinte.153.4.477; RIES F, 1986, AM J KIDNEY DIS, V8, P368, DOI 10.1016/S0272-6386(86)80112-3; Ripamonti CI, 2011, ANN ONCOL S, V22, pvi69; ROZENCWEIG M, 1977, ANN INTERN MED, V86, P803, DOI 10.7326/0003-4819-86-6-803; STEWART AF, 1985, AM J OBSTET GYNECOL, V153, P660, DOI 10.1016/S0002-9378(85)80255-6; Stewart DJ, 1997, CANCER CHEMOTH PHARM, V40, P293, DOI 10.1007/s002800050661; Sweeney CJ, 2001, CANCER, V92, P2639, DOI 10.1002/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8; Tiseo M, 2007, TUMORI, V93, P138; VOKES EE, 1990, BRIT J CANCER, V62, P1015, DOI 10.1038/bjc.1990.429; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Whelton A, 2000, Am J Ther, V7, P159, DOI 10.1097/00045391-200007030-00004; WILLOX JC, 1986, BRIT J CANCER, V54, P19, DOI 10.1038/bjc.1986.147; Yokoo K, 2009, CLIN EXP NEPHROL, V13, P578, DOI 10.1007/s10157-009-0215-1	32	83	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101902	10.1371/journal.pone.0101902	http://dx.doi.org/10.1371/journal.pone.0101902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020203	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600032
J	Laine, M; Morin, S; Tison-Rosebery, J				Laine, Manon; Morin, Soizic; Tison-Rosebery, Juliette			A Multicompartment Approach - Diatoms, Macrophytes, Benthic Macroinvertebrates and Fish - To Assess the Impact of Toxic Industrial Releases on a Small French River	PLOS ONE			English	Article							INVERTEBRATE COMMUNITIES; RIOU-MORT; STREAM; INDEX; BIOFILM; CONTAMINATION; COLONIZATION; INDICATORS; RESPONSES; HEALTH	The River Luzou flows through a sandy substrate in the South West of France. According to the results of two assessment surveys, the Water Agency appraised that this river may not achieve the good ecological status by 2015 as required by the Water Framework Directive (2000/60/EC). This ecosystem is impacted by industrial effluents (organic matter, metals and aromatic compounds). In order to assess and characterize the impact, this study aimed to combine a set of taxonomic and non-taxonomic metrics for diatoms, macrophytes, macroinvertebrates and fish along the up-to downstream gradient of the river. Diversity metrics, biological indices, biological and ecological traits were determined for the four biological quality elements (BQE). Various quantitative metrics (biomass estimates) were also calculated for diatom communities. The results were compared to physicochemical analysis. Biological measurements were more informative than physicochemical analysis, in the context of the study. Biological responses indicated both the contamination of water and its intensity. Diversity metrics and biological indices strongly decreased with pollution for all BQE but diatoms. Convergent trait selection with pollution was observed among BQE: reproduction, colonization strategies, or trophic regime were clearly modified at impaired sites. Taxon size and relation to the substrate diverged among biological compartments. Multiple anthropogenic pollution calls for alternate assessment methods of rivers' health. Our study exemplifies the fact that, in the case of complex contaminations, biological indicators can be more informative for environmental risk, than a wide screening of contaminants by chemical analysis alone. The combination of diverse biological compartments provided a refined diagnostic about the nature (general mode of action) and intensity of the contamination.	[Laine, Manon; Morin, Soizic; Tison-Rosebery, Juliette] Irstea, UR EABX, Cestas, France	INRAE	Morin, S (corresponding author), Irstea, UR EABX, Cestas, France.	soizic.morin@irstea.fr	Morin, Soizic/J-1204-2019	Morin, Soizic/0000-0003-0360-9383; Tison-Rosebery, Juliette/0000-0003-1090-7020	Adour-Garonne Water Agency	Adour-Garonne Water Agency	This study was funded by the Adour-Garonne Water Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFNOR, 2009, XP T90 333 QUAL EAU; AFNOR, 2005, 872 ISO EN, P10; AFNOR, 2004, T90350 AFNOR NF; AFNOR, 2011, T90344 AFNOR NF; AFNOR, 2003, QUAL EAU CHANT POISS; AFNOR, 2010, T90388 AFNOR XP; AFNOR, 2003, T90395 AFNOR NF; AFNOR (Association Francaise de Normalisation), 2007, T90354 AFNOR NF; [Anonymous], 1982, ETUDE METHODES BIOL; Archaimbault V., 2010, SCI EAUX TERRITOIRES, P46; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Beketov MA, 2008, ENVIRON POLLUT, V156, P980, DOI 10.1016/j.envpol.2008.05.005; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; BOURNAUD M, 1984, B ECOL, V15, P199; BURKHOLDER JM, 1990, APPL ENVIRON MICROB, V56, P2882, DOI 10.1128/AEM.56.9.2882-2890.1990; Camargo JA, 2011, ECOL INDIC, V11, P911, DOI 10.1016/j.ecolind.2010.10.001; Cellamare M, 2012, ENVIRON MONIT ASSESS, V184, P4685, DOI 10.1007/s10661-011-2295-0; Cortelezzi A, 2013, ENVIRON MONIT ASSESS, V185, P5801, DOI 10.1007/s10661-012-2985-2; Coste M, 2009, ECOL INDIC, V9, P621, DOI 10.1016/j.ecolind.2008.06.003; De Mendiburu F., 2007, AGRICOLAE STAT PROCE; Falasco E, 2009, HYDROBIOLOGIA, V623, P1, DOI 10.1007/s10750-008-9687-3; Gillett ND, 2011, HYDROBIOLOGIA, V665, P79, DOI 10.1007/s10750-011-0606-7; HELSEL DR, 1990, ENVIRON SCI TECHNOL, V24, P1766, DOI 10.1021/es00082a001; Hering D, 2006, FRESHWATER BIOL, V51, P1757, DOI 10.1111/j.1365-2427.2006.01610.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Johnson RK, 2006, HYDROBIOLOGIA, V566, P139, DOI 10.1007/s10750-006-0100-9; Keith P, 2001, ATLAS POISSONS EAU D; Kelly M. G, 2005, COMMON FRESHWATER DI; Khoshmanesh A, 1997, CHEM ENG J, V65, P13; Krammer K., 1991, BACILLARIOPHYCEAE 1; Lange-Bertalot H, 1995, ANNOTATED DIATOM MON, V1-23; Lavoie I, 2012, SCI TOTAL ENVIRON, V425, P231, DOI 10.1016/j.scitotenv.2012.02.057; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Luis AT, 2014, ECOTOXICOLO IN PRESS; Marzin A, 2014, ECOL INDIC, V43, P195, DOI 10.1016/j.ecolind.2014.02.011; Marzin A, 2012, ECOL INDIC, V23, P56, DOI 10.1016/j.ecolind.2012.03.010; Mondy CP, 2012, ECOL INDIC, V18, P452, DOI 10.1016/j.ecolind.2011.12.013; Morin S, 2008, ENVIRON POLLUT, V151, P532, DOI 10.1016/j.envpol.2007.04.023; Morin S, 2010, VIE MILIEU, V60, P109; Morin S, 2012, EMERGING PRIORITY PO, P117, DOI [10.1007/978-3-642-25722-3_5, DOI 10.1007/978-3-642-25722-3_5]; Morin S, 2008, HYDROBIOLOGIA, V614, P285, DOI 10.1007/s10750-008-9513-y; Morin S, 2007, FUND APPL LIMNOL, V168, P179, DOI 10.1127/1863-9135/2007/0168-0179; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Potapova M, 2003, FRESHWATER BIOL, V48, P1311, DOI 10.1046/j.1365-2427.2003.01080.x; R Core Team, 2022, R LANG ENV STAT COMP; Rogers C., 2005, CREATION BASE DONNEE; Rosebery J, 2010, BILAN HYDROBIOLOGIQU; Schultheis AS, 1997, HYDROBIOLOGIA, V346, P85, DOI 10.1023/A:1002909914774; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Stevenson RJ, 1999, PERIPHYTON PROTOCOLS, V6, P1; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; Tison J, 2005, WATER RES, V39, P3177, DOI 10.1016/j.watres.2005.05.029; TOWNSEND CR, 1976, J ANIM ECOL, V45, P759, DOI 10.2307/3579; Usseglio-Polatera, 2010, INVERTEBRES EAU DOUC, V15; Usseglio-Polatera P, 2000, FRESHWATER BIOL, V43, P175, DOI 10.1046/j.1365-2427.2000.00535.x; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; Wang YK, 2005, J N AM BENTHOL SOC, V24, P990, DOI 10.1899/03-028.1; Willby NJ, 2000, FRESHWATER BIOL, V43, P43, DOI 10.1046/j.1365-2427.2000.00523.x	63	21	21	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102358	10.1371/journal.pone.0102358	http://dx.doi.org/10.1371/journal.pone.0102358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019954	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600073
J	Plongthongkum, N; van Eijk, KR; de Jong, S; Wang, T; Sul, JH; Boks, MPM; Kahn, RS; Fung, HL; Ophoff, RA; Zhang, K				Plongthongkum, Nongluk; van Eijk, Kristel R.; de Jong, Simone; Wang, Tina; Sul, Jae Hoon; Boks, Marco P. M.; Kahn, Rene S.; Fung, Ho-Lim; Ophoff, Roel A.; Zhang, Kun			Characterization of Genome-Methylome Interactions in 22 Nuclear Pedigrees	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; GENE-EXPRESSION VARIATION; DNA METHYLATION; GENOTYPE IMPUTATION; HUMAN AUTOSOMES; GNAS LOCUS; DISEASE; WIDESPREAD; RESOLUTION; SIGNATURES	Genetic polymorphisms can shape the global landscape of DNA methylation, by either changing substrates for DNA methyltransferases or altering the DNA binding affinity of cis-regulatory proteins. The interactions between CpG methylation and genetic polymorphisms have been previously investigated by methylation quantitative trait loci (mQTL) and allele-specific methylation (ASM) analysis. However, it remains unclear whether these approaches can effectively and comprehensively identify all genetic variants that contribute to the inter-individual variation of DNA methylation levels. Here we used three independent approaches to systematically investigate the influence of genetic polymorphisms on variability in DNA methylation by characterizing the methylation state of 96 whole blood samples in 52 parent-child trios from 22 nuclear pedigrees. We performed targeted bisulfite sequencing with padlock probes to quantify the absolute DNA methylation levels at a set of 411,800 CpG sites in the human genome. With mid-parent offspring analysis (MPO), we identified 10,593 CpG sites that exhibited heritable methylation patterns, among which 70.1% were SNPs directly present in methylated CpG dinucleotides. We determined the mQTL analysis identified 49.9% of heritable CpG sites for which regulation occurred in a distal cis-regulatory manner, and that ASM analysis was only able to identify 5%. Finally, we identified hundreds of clusters in the human genome for which the degree of variation of CpG methylation, as opposed to whether or not CpG sites were methylated, was associated with genetic polymorphisms, supporting a recent hypothesis on the genetic influence of phenotypic plasticity. These results show that cis-regulatory SNPs identified by mQTL do not comprise the full extent of heritable CpG methylation, and that ASM appears overall unreliable. Overall, the extent of genome-methylome interactions is well beyond what is detectible with the commonly used mQTL and ASM approaches, and is likely to include effects on plasticity.	[Plongthongkum, Nongluk; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [de Jong, Simone; Wang, Tina; Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA; [van Eijk, Kristel R.; Boks, Marco P. M.; Kahn, Rene S.; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Sul, Jae Hoon] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	Ophoff, RA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA.	ROphoff@mednet.ucla.edu; kzhang@bioeng.ucsd.edu	Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; de Jong, Simone/0000-0002-8002-7195; Boks, Marco/0000-0001-6163-7484; Plongthongkum, Nongluk/0000-0002-1305-285X	National Institutes of Health Grants [GM097253, HG003233, DA028526, MH090553]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028526] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by National Institutes of Health Grants GM097253 and HG003233 to K.Z., and DA028526 and MH090553 to R.A.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bastepe M, 2007, CURR GENOMICS, V8, P398, DOI 10.2174/138920207783406488; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fraser HB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r8; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Greaves IK, 2012, EPIGENETICS-US, V7, P800, DOI 10.4161/epi.20820; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hellman A, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-11; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Luykx J. J., 2013, MOL PSYCHIAT; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Plagge A, 2006, CYTOGENET GENOME RES, V113, P178, DOI 10.1159/000090830; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Teperino R, 2013, CELLULAR MOL LIFE SC; Tycko B, 2010, HUM MOL GENET, V19, pR210, DOI 10.1093/hmg/ddq376; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e99313	10.1371/journal.pone.0099313	http://dx.doi.org/10.1371/journal.pone.0099313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019935	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600002
J	Yuan, W; Sui, CG; Liu, Q; Tang, WY; An, HY; Ma, J				Yuan, Wei; Sui, Chenguang; Liu, Qian; Tang, Wanyan; An, Huaying; Ma, Jie			Up-Regulation of MicroRNA-145 Associates with Lymph Node Metastasis in Colorectal Cancer	PLOS ONE			English	Article							SHOCK-PROTEIN 27; COLON-CANCER; PROSTATE-CANCER; EXPRESSION; CELLS; CARCINOMA; INVASION; TISSUES; IDENTIFICATION; MIR-145	Metastasis is the main cause of mortality in patients with solid tumours. Identifying the exact molecules associated with CRC metastasis may be crucial to understand the process, which might also be translated to the diagnosis and treatment of CRC. In this study, we investigate the association of microRNA expression patterns with the lymph node metastasis of colorectal cancer. Among these candidate miRNAs, the expression of miRNA-145 was significantly related to lymph node metastasis of CRC. Both in vitro and in vivo study demonstrated that up-regulation of miR-145 could improve the ability of migration and invasion of colorectal cancer cell, while no effect on proliferation was observed. The mechanism of this promotion is associated with the stabilization of Hsp-27, a protein which plays an important role in the promotion of metastasis. These results may be crucial to understanding CRC metastasis and may be translated to the diagnosis and treatment of CRC.	[Yuan, Wei; Sui, Chenguang; Tang, Wanyan; An, Huaying; Ma, Jie] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Qian] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg Oncol, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Ma, J (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Peking Union Med Coll, Beijing 100730, Peoples R China.	majie1965@163.com			National Basic Research Program of China [2011CB911004]; The Beijing Training Project for The Leading Talents [Z131107000513001]; Beijing Nova Program [Z131107000413066]; Beijing Natural Science Foundation of China [7122150]	National Basic Research Program of China(National Basic Research Program of China); The Beijing Training Project for The Leading Talents; Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This study was supported by the National Basic Research Program of China (Grant no. 2011CB911004), The Beijing Training Project for The Leading Talents (Z131107000513001), Beijing Nova Program (Z131107000413066) and Beijing Natural Science Foundation of China (Grant no. 7122150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Choong LY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011030; Cornford PA, 2000, CANCER RES, V60, P7099; Dai SJ, 2008, J PROTEOME RES, V7, P4384, DOI 10.1021/pr800376w; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Pei HP, 2007, J PROTEOME RES, V6, P2495, DOI 10.1021/pr060644r; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Reinert JT, 2008, CANC RES, V68, P6416; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Song HY, 2006, J CANCER RES CLIN, V132, P92, DOI 10.1007/s00432-005-0044-x; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhu ZK, 2010, MOL PHARMACEUT, V7, P1283, DOI 10.1021/mp100073s	33	28	32	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102017	10.1371/journal.pone.0102017	http://dx.doi.org/10.1371/journal.pone.0102017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019299	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600035
J	Busch, S; Kannt, A; Kolibabka, M; Schlotterer, A; Wang, Q; Lin, JH; Feng, YX; Hoffmann, S; Gretz, N; Hammes, HP				Busch, Stephanie; Kannt, Aimo; Kolibabka, Matthias; Schlotterer, Andreas; Wang, Qian; Lin, Jihong; Feng, Yuxi; Hoffmann, Sigrid; Gretz, Norbert; Hammes, Hans-Peter			Systemic Treatment with Erythropoietin Protects the Neurovascular Unit in a Rat Model of Retinal Neurodegeneration	PLOS ONE			English	Article							EXPERIMENTAL DIABETIC-RETINOPATHY; INTRAVITREAL INJECTION; TISSUE INHIBITOR; DEGENERATION; NEUROPROTECTION; ISCHEMIA; DISEASE; ANGIOGENESIS; POLYCYSTIN-2; MICROGLIA	Rats expressing a transgenic polycystic kidney disease (PKD) gene develop photoreceptor degeneration and subsequent vasoregression, as well as activation of retinal microglia and macroglia. To target the whole neuroglialvascular unit, neuro- and vasoprotective Erythropoietin (EPO) was intraperitoneally injected into four -week old male heterozygous PKD rats three times a week at a dose of 256 IU/kg body weight. For comparison EPO-like peptide, lacking unwanted side effects of EPO treatment, was given five times a week at a dose of 10 mg/kg body weight. Matched EPO treated Sprague Dawley and water-injected PKD rats were held as controls. After four weeks of treatment the animals were sacrificed and analysis of the neurovascular morphology, glial cell activity and pAkt localization was performed. The number of endothelial cells and pericytes did not change after treatment with EPO or EPO-like peptide. There was a nonsignificant reduction of migrating pericytes by 23% and 49%, respectively. Formation of acellular capillaries was significantly reduced by 49% (p<0.001) or 40% (p<0.05). EPO-treatment protected against thinning of the central retina by 10% (p<0.05), a composite of an increase of the outer nuclear layer by 12% (p<0.01) and in the outer segments of photoreceptors by 26% (p<0.001). Quantification of cell nuclei revealed no difference. Microglial activity, shown by gene expression of CD74, decreased by 67% (p<0.01) after EPO and 36% (n.s.) after EPO-like peptide treatment. In conclusion, EPO safeguards the neuroglialvascular unit in a model of retinal neurodegeneration and secondary vasoregression. This finding strengthens EPO in its protective capability for the whole neuroglialvascular unit.	[Busch, Stephanie; Kolibabka, Matthias; Schlotterer, Andreas; Wang, Qian; Lin, Jihong; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany; [Kannt, Aimo] Sanofi Diabet Res & Translat Med, Frankfurt, Germany; [Feng, Yuxi] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Mannheim, Germany; [Hoffmann, Sigrid; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; Sanofi-Aventis; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Busch, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany.	StephanieBusch@web.de	Hammes, Hans-Peter/S-3719-2019; Kannt, Aimo/AAZ-6898-2020; Kolibabka, Matthias/T-5812-2017	Kolibabka, Matthias/0000-0001-6741-5436; Kannt, Aimo/0000-0002-5197-2286	DDG (Deutsche Diabetes Gesellschaft); DFG (Deutsche Forschungsgemeinschaft)	DDG (Deutsche Diabetes Gesellschaft); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This research was supported by the DDG (Deutsche Diabetes Gesellschaft) and the DFG (Deutsche Forschungsgemeinschaft). Both institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabpoor Zohreh, 2012, Adv Biomed Res, V1, P50, DOI 10.4103/2277-9175.100157; Barbera L, 2010, RADIOTHER ONCOL, V95, P269, DOI 10.1016/j.radonc.2010.02.008; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Busch S, 2012, CELL PHYSIOL BIOCHEM, V30, P1436, DOI 10.1159/000343331; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Garcia-Ramirez M, 2008, DIABETES CARE, V31, P1189, DOI 10.2337/dc07-2075; Garcia-Ramirez M, 2011, CELL SIGNAL, V23, P1596, DOI 10.1016/j.cellsig.2011.05.011; Guo LJ, 2006, CALCIFIED TISSUE INT, V78, P285, DOI 10.1007/s00223-005-0092-x; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hernandez C, 2012, ENDOCRINE, V41, P220, DOI 10.1007/s12020-011-9579-6; Hu Liu-Mei, 2011, Front Biosci (Elite Ed), V3, P1541; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kanaan NM, 2006, BRAIN RES, V1068, P221, DOI 10.1016/j.brainres.2005.10.078; Kawachi K, 2012, HEART VESSELS, V27, P79, DOI 10.1007/s00380-011-0197-2; Keogh CL, 2007, J PHARMACOL EXP THER, V322, P521, DOI 10.1124/jpet.107.121392; Lippi G, 2010, SEMIN THROMB HEMOST, V36, P537, DOI 10.1055/s-0030-1255448; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Mitsuhashi J, 2013, EXP EYE RES, V106, P64, DOI 10.1016/j.exer.2012.11.001; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Pfister F, 2008, DIABETES, V57, P2495, DOI 10.2337/db08-0325; Rezaeian F, 2010, LAB INVEST, V90, P40, DOI 10.1038/labinvest.2009.117; Shang YC, 2012, AGING-US, V4, P187, DOI 10.18632/aging.100440; Sorg H, 2012, MED RES REV; Souvenir R, 2011, NEUROBIOL DIS, V44, P28, DOI 10.1016/j.nbd.2011.05.020; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang Q, 2011, CELL PHYSIOL BIOCHEM, V27, P769, DOI 10.1159/000330085; Wang ZY, 2011, MED HYPOTHESES, V76, P266, DOI 10.1016/j.mehy.2010.10.017; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721	35	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102013	10.1371/journal.pone.0102013	http://dx.doi.org/10.1371/journal.pone.0102013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013951	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400054
J	Liu, C; Zhang, W; Yang, H; Sun, WD; Gong, XD; Zhao, JX; Sun, Y; Diao, GW				Liu, Chang; Zhang, Wang; Yang, Hao; Sun, Weidong; Gong, Xiangdong; Zhao, Junxian; Sun, Yun; Diao, Guowang			A Water-Soluble Inclusion Complex of Pedunculoside with the Polymer beta-Cyclodextrin: A Novel Anti-Inflammation Agent with Low Toxicity	PLOS ONE			English	Article							SAFETY EVALUATION; EAR EDEMA; IN-VITRO; TERPENOIDS; MICE; INHIBITORS; EFFICACY; CANCER; CELLS; OIL	More than 50% of new drug candidates in drug discovery are lipophilic and exhibit poor aqueous solubility, which results in poor bioavailability and a lack of dose proportionality. Here, we improved the solubility of pedunculoside (PE) by generating a water-soluble inclusion complex composed of PE and the polymer beta-cyclodextrin (CDP). We characterized this novel complex by H-1 NMR, FT-IR, UV-vis spectroscopy, powder X-ray diffractometry and thermogravimetric analysis. The ratio of beta-cyclodextrin (beta-CD) units in CDP to PE was determined to be 2:1. The K-D value of the inclusion complex was determined to be 4.29x10(-3) mol.L-1. In contrast to the low solubility of PE, the water-solubility of the PE-CDP complex was greatly enhanced. A preclinical toxicological study indicated that PE-CDP was well tolerated for a single administration. Importantly, the anti-inflammation potency of the PE-CDP complex was higher than that of PE. As a result, the formation of inclusion complexes by water-soluble CDP opens up possible aqueous applications of insoluble drug candidates in drug delivery.	[Liu, Chang; Yang, Hao; Zhao, Junxian; Sun, Yun] Yangzhou Univ, Coll Med, Yangzhou, Jiangsu, Peoples R China; [Zhang, Wang; Gong, Xiangdong; Diao, Guowang] Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou, Jiangsu, Peoples R China; [Sun, Weidong] Chinese Med Hosp Yangzhou City, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Sun, Y (corresponding author), Yangzhou Univ, Coll Med, Yangzhou, Jiangsu, Peoples R China.	ysun@yzu.edu.cn; gwdiao@yzu.edu.cn	Liu, Chang/J-6985-2019; Zhang, Wang/H-7304-2013; Zhang, Wang/AAH-2938-2019	Zhang, Wang/0000-0002-4558-3487; 	National Natural Science Foundation of China [21273195]; Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions	This work was largely supported by grants from the National Natural Science Foundation of China (Grant Nos. 21273195), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Arima H, 2002, RRD CHE PHA, V2, P155; Boztas AO, 2013, MOL PHARMACEUT, V10, P2676, DOI 10.1021/mp400101k; Cao F, 2012, MOL PHARMACEUT, V9, P2127, DOI 10.1021/mp200447r; Chen M, 2006, CHEMOSPHERE, V63, P522, DOI 10.1016/j.chemosphere.2005.08.033; Fan DS, 2011, FITOTERAPIA, V82, P805, DOI 10.1016/j.fitote.2011.04.007; Glojnaric I, 2013, TOXICOL LETT, V221, pS93, DOI 10.1016/j.toxlet.2013.05.123; Huang XX, 2011, AAPS PHARMSCITECH, V12, P665, DOI 10.1208/s12249-011-9631-0; IRIE T, 1982, J PHARMACOBIO-DYNAM, V5, P741; Irie T, 1997, J PHARM SCI-US, V86, P147, DOI 10.1021/js960213f; Jahromi MAF, 1999, PHARM BIOL, V37, P37, DOI 10.1076/phbi.37.1.37.6314; Jean-Baptiste E, 2012, EUR J VASC ENDOVASC, V43, P188, DOI 10.1016/j.ejvs.2011.10.017; Jiang Y, 2011, INT J PHARMACEUT, V415, P252, DOI 10.1016/j.ijpharm.2011.05.056; Kulkarni AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063798; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Li G., 2013, PLOS ONE, V8; Li HQ, 2014, BIOMACROMOLECULES, V15, P43, DOI 10.1021/bm4012562; Liu C, 2013, ORG BIOMOL CHEM, V11, P4993, DOI 10.1039/c3ob40715b; Liu J, 2007, AM J CHINESE MED, V35, P317, DOI 10.1142/S0192415X07004849; May M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060628; Mondjinou YA, 2013, BIOMACROMOLECULES, V14, P4189, DOI 10.1021/bm400922a; *OECD, 2002, 11 ADD OECD GUID TES; RANDHAWA PS, 1993, AM J SURG PATHOL, V17, P60, DOI 10.1097/00000478-199301000-00007; Renard E, 1997, EUR POLYM J, V33, P49, DOI 10.1016/S0014-3057(96)00123-1; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Saraiva RA, 2011, J ETHNOPHARMACOL, V136, P504, DOI 10.1016/j.jep.2010.07.002; Sawadogo WR, 2013, MOLECULES, V18, P3641, DOI 10.3390/molecules18043641; Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t; Silva F, 2014, FOOD CHEM, V145, P115, DOI 10.1016/j.foodchem.2013.08.034; Sugiura Y, 2013, J FUNCT FOODS, V5, P2019, DOI 10.1016/j.jff.2013.08.010; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Totterman AM, 1997, J PHARM PHARMACOL, V49, P43; Wang C, 2012, CHINESE J STRUC CHEM, V31, P1729; Watson R, 2012, BIOACTIVE FOOD DIETA; Wen XA, 2008, J MED CHEM, V51, P3540, DOI 10.1021/jm8000949; Wilmer JL, 1997, IN VITRO TOXICOL, V10, P429; Xian YF, 2011, J ETHNOPHARMACOL, V137, P1425, DOI 10.1016/j.jep.2011.08.014; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428; Yanez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041072; Ye M, 2014, CHEMOSPHERE, V105, P119, DOI 10.1016/j.chemosphere.2013.12.058; Zhang W, 2014, J MATER CHEM B, V2, P5107, DOI 10.1039/c4tb00560k; Zhang W, 2013, CARBON, V61, P154, DOI 10.1016/j.carbon.2013.04.079; Zhang W, 2013, CARBOHYD POLYM, V95, P366, DOI 10.1016/j.carbpol.2013.03.020; Zhang W, 2012, PHYS CHEM CHEM PHYS, V14, P9729, DOI 10.1039/c2cp41092c; Zhang W, 2011, ELECTROCHIM ACTA, V56, P5129, DOI 10.1016/j.electacta.2011.03.062	45	29	31	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101761	10.1371/journal.pone.0101761	http://dx.doi.org/10.1371/journal.pone.0101761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013908	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400035
J	Schultz, RD; Bennett, EE; Ellis, EA; Gumienny, TL				Schultz, Robbie D.; Bennett, Emily E.; Ellis, E. Ann; Gumienny, Tina L.			Regulation of Extracellular Matrix Organization by BMP Signaling in Caenorhabditis elegans	PLOS ONE			English	Article							TGF-BETA; BODY-SIZE; SMAD PROTEINS; C-ELEGANS; GENES; EXPRESSION; CUTICLE; GROWTH; TRANSPORT; RECEPTOR	In mammals, Bone Morphogenetic Protein (BMP) pathway signaling is important for the growth and homeostasis of extracellular matrix, including basement membrane remodeling, scarring, and bone growth. A conserved BMP member in Caenorhabditis elegans, DBL-1, regulates body length in a dose-sensitive manner. Loss of DBL-1 pathway signaling also results in increased anesthetic sensitivity. However, the physiological basis of these pleiotropic phenotypes is largely unknown. We created a DBL-1 over-expressing strain and show that sensitivity to anesthetics is inversely related to the dose of DBL-1. Using pharmacological, genetic analyses, and a novel dye permeability assay for live, microwave-treated animals, we confirm that DBL-1 is required for the barrier function of the cuticle, a specialized extracellular matrix. We show that DBL-1 signaling is required to prevent animals from forming tail-entangled aggregates in liquid. Stripping lipids off the surface of wild-type animals recapitulates this phenotype. Finally, we find that DBL-1 signaling affects ultrastructure of the nematode cuticle in a dose-dependent manner, as surface lipid content and cuticular organization are disrupted in animals with genetically altered DBL-1 levels. We propose that the lipid layer coating the nematode cuticle normally prevents tail entanglement, and that reduction of this layer by loss of DBL-1 signaling promotes aggregation. This work provides a physiological mechanism that unites the DBL-1 signaling pathway roles of not only body size regulation and drug responsiveness, but also the novel Hoechst 33342 staining and aggregation phenotypes, through barrier function, content, and organization of the cuticle.	[Schultz, Robbie D.; Bennett, Emily E.; Gumienny, Tina L.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Schultz, Robbie D.; Gumienny, Tina L.] Texas A&M Univ, Interdisciplinary Program Genet, College Stn, TX USA; [Ellis, E. Ann] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Gumienny, TL (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	gumienny@medicine.tamhsc.edu	Gumienny, Tina/AAJ-5273-2020	Gumienny, Tina/0000-0002-3932-7815	NIH [1R01GM097591]; MCMD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097591] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MCMD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant 1R01GM097591 from the NIH (http://www.nih.gov/) and by MCMD departmental start-up funds to TLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health.	Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Baird SE, 1999, DEV BIOL, V212, P93, DOI 10.1006/dbio.1999.9322; Bandyopadhyay Amitabha, 2006, PLoS Genet, V2, pe216; BARBERCHECK ME, 1991, ENVIRON ENTOMOL, V20, P582, DOI 10.1093/ee/20.2.582; Beifuss KK, 2012, JOVE-J VIS EXP, DOI 10.3791/3442; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; BRENNER S, 1974, GENETICS, V77, P71; Carmichael FJ, 1985, PRINCIPLES MED PHARM, P265; Croll N.A., 1970, BEHAV NEMATODES THEI; de Gives PM, 1999, PARASITOLOGY, V119, P95, DOI 10.1017/S0031182099004424; DUNCAN HM, 1966, J BIOL CHEM, V241, P1694; Ellis EA, 2006, MICROSC MICROANAL, V12, P288, DOI DOI 10.1017/S1431927606062660; Fang-Yen C, 2012, METHOD CELL BIOL, V107, P177, DOI 10.1016/B978-0-12-394620-1.00006-0; Fernando T, 2011, DEV BIOL, V352, P92, DOI 10.1016/j.ydbio.2011.01.016; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Gullapalli RR, 2008, PHYS CHEM CHEM PHYS, V10, P3548, DOI 10.1039/b716979e; Gumienny Tina L, 2013, WormBook, P1, DOI 10.1895/wormbook.1.22.2; Hall DH, 2012, METHOD CELL BIOL, V107, P93, DOI 10.1016/B978-0-12-394620-1.00004-7; Haut H. van, 1956, Nematologica, V1, P165; HERWEIJER MA, 1985, BIOCHIM BIOPHYS ACTA, V809, P81, DOI 10.1016/0005-2728(85)90170-7; HIMMELHOCH S, 1983, EXP PARASITOL, V55, P299, DOI 10.1016/0014-4894(83)90026-7; HO NFH, 1992, MOL BIOCHEM PARASIT, V52, P1, DOI 10.1016/0166-6851(92)90031-E; HO NFH, 1994, J PHARM SCI, V83, P1052, DOI 10.1002/jps.2600830725; HO NFH, 1990, MOL BIOCHEM PARASIT, V41, P153, DOI 10.1016/0166-6851(90)90178-O; Hodgkin J, 2013, CURR BIOL, V23, P2157, DOI 10.1016/j.cub.2013.08.060; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JANSSON HB, 1986, J NEMATOL, V18, P570; Jiang LI, 1999, DEV BIOL, V211, P88, DOI 10.1006/dbio.1999.9293; JONES JT, 1991, J MICROSC-OXFORD, V164, P43, DOI 10.1111/j.1365-2818.1991.tb03190.x; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Krishna S, 1999, DEVELOPMENT, V126, P251; Lee Byung H., 2002, Current Topics in Medicinal Chemistry, V2, P779, DOI 10.2174/1568026023393705; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; LINK CD, 1992, GENETICS, V131, P867; LINK CD, 1988, DEVELOPMENT, V103, P485; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Lozano E, 2006, CURR BIOL, V16, P493, DOI 10.1016/j.cub.2006.01.048; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Morita K, 1999, DEVELOPMENT, V126, P1337; Nagamatsu Y, 2004, GENES CELLS, V9, P39, DOI 10.1111/j.1356-9597.2004.00700.x; Natsuka S, 2005, J BIOCHEM, V138, P209, DOI 10.1093/jb/mvi117; Nystrom J, 2002, GENETICS, V161, P83; Page AP, 2007, C ELEGANS RES COMMUN, DOI DOI 10.1895/WORMBOOK.1.138.1; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Portal-Celhay C, 2013, FASEB J, V27, P760, DOI 10.1096/fj.12-218420; PYE AE, 1981, NEMATOLOGICA, V27, P117, DOI 10.1163/187529281X00133; Rand JB, 1995, METHOD CELL BIOL, V48, P187; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roberts AF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-61; Ruiz-Lancheros E, 2011, INT J PARASITOL, V41, P455, DOI 10.1016/j.ijpara.2010.11.009; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Savage-Dunn C, 2000, DEV BIOL, V223, P70, DOI 10.1006/dbio.2000.9713; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schultz RD, 2012, JOVE-J VIS EXP, DOI 10.3791/3362; Shaham Sm, 2006, METHOD CELL BIOL, DOI [10.1895/wormbook.1.49.1, DOI 10.1895/WORMBOOK.1.49.1]; SHEPHERD AM, 1976, NEMATOLOGICA, V22, P332, DOI 10.1163/187529276X00625; So SH, 2011, MECH AGEING DEV, V132, P210, DOI 10.1016/j.mad.2011.02.005; Stock SP, 2005, NEMATOLOGY, V7, P363, DOI 10.1163/156854105774355590; SUDHAUS W, 1994, NEMATOLOGICA, V40, P508, DOI 10.1163/003525994X00391; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Taneja-Bageshwar S, 2012, DEV BIOL, V371, P66, DOI 10.1016/j.ydbio.2012.08.006; TEICHMAN RJ, 1972, BIOL REPROD, V7, P73, DOI 10.1093/biolreprod/7.1.73; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Tuck S, 2014, EXP CELL RES, V321, P71, DOI 10.1016/j.yexcr.2013.11.007; VANDERBEND RL, 1985, ARCH BIOCHEM BIOPHYS, V241, P461, DOI 10.1016/0003-9861(85)90571-5; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; Woodring JL., 1988, SO COOPERATIVE SERIE, V331; Wyeth RC, 2009, J NEUROSCI METH, V176, P121, DOI 10.1016/j.jneumeth.2008.08.028; YOELI M., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P132, DOI 10.1016/0035-9203(57)90057-3; Yoshida S, 2001, DEV BIOL, V240, P32, DOI 10.1006/dbio.2001.0443; ZUCKERMAN BM, 1979, EXP PARASITOL, V47, P419, DOI 10.1016/0014-4894(79)90095-X; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	87	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101929	10.1371/journal.pone.0101929	http://dx.doi.org/10.1371/journal.pone.0101929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013968	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400047
J	Ando, K; Takahashi, F; Kato, M; Kaneko, N; Doi, T; Ohe, Y; Koizumi, F; Nishio, K; Takahashi, K				Ando, Katsutoshi; Takahashi, Fumiyuki; Kato, Motoyasu; Kaneko, Norihiro; Doi, Tokuhide; Ohe, Yuichiro; Koizumi, Fumiaki; Nishio, Kazuto; Takahashi, Kazuhisa			Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer	PLOS ONE			English	Article							ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; WEIGHT-LOSS; PANCREATIC-CANCER; CASTLEMAN-DISEASE; BEARING MICE; TUMOR-GROWTH; T-CELLS; INTERLEUKIN-6; MECHANISMS; PROGNOSIS	Background: We previously reported the role of IL-6 in a murine model of cancer cachexia and currently documented a patient in whom tocilizumab, anti-IL-6 receptor antibody, dramatically improved cachexia induced by IL-6 over-expressing lung cancer. Despite this potential to alleviate cancer cachexia, tocilizumab has not been approved for this clinical use. Therefore, preceding our planned clinical trial of tocilizumab, we designed the two studies described here to evaluate the levels of IL-6 in patients with lung cancer and the effect of tocilizumab in a murine model of human cancer cachexia. Methods: First, we measured serum IL-6 levels in patients with lung cancer and analyzed its association with cachexia and survival. Next, we examined the effect of a rodent analog of tocilizumab (MR16-1) in the experimental cachexia model. Results: Serum IL-6 levels were higher in patients with cachexia than those without cachexia. In patients with chemotherapy-resistant lung cancer, a high IL-6 serum level correlated strongly with survival, and the cut-off level for affecting their prognosis was 21 pg/mL. Meanwhile, transplantation of IL-6-expressing Lewis Lung Carcinoma cells caused cachexia in mice, which then received either MR16-1 or 0.9% saline. Tumor growth was similar in both groups; however, the MR16-1 group lost less weight, maintained better food and water intake and had milder cachectic features in blood. MR16-1 also prolonged the survival of LLC-IL6 transplanted mice (36.6 vs. 28.5 days, p = 0.016). Conclusion: Our clinical and experimental studies revealed that serum IL-6 is a surrogate marker for evaluating cachexia and the prognosis of patients with chemotherapy resistant metastatic lung cancer and that tocilizumab has the potential of improving prognosis and ameliorating the cachexia that so devastates their quality of life. This outcome greatly encourages our clinical trials to evaluate the safety and efficacy of tocilizumab treatment for patients with increased serum IL-6.	[Ando, Katsutoshi; Takahashi, Fumiyuki; Kato, Motoyasu; Takahashi, Kazuhisa] Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan; [Ando, Katsutoshi; Takahashi, Fumiyuki; Kato, Motoyasu; Takahashi, Kazuhisa] Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Kaneko, Norihiro] Kameda Med Ctr, Dept Resp Internal Med, Kamogawa City, Chiba, Japan; [Doi, Tokuhide] Fukuoka Clin, Adachi Ku, Tokyo, Japan; [Ohe, Yuichiro] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; [Koizumi, Fumiaki] Natl Canc Ctr, Shien Lab, Chuo Ku, Tokyo, Japan; [Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan	Juntendo University; National Cancer Center - Japan; National Cancer Center - Japan; Kindai University (Kinki University)	Ando, K (corresponding author), Juntendo Univ, Fac Med, Div Resp Med, Tokyo, Japan.	kando@juntendo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21591003, 23591906]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research no. 21591003 (Kazuhisa Takahashi) and no. 23591906 (Fumiyuki Takahashi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ando K, 2013, J CLIN ONCOL, V31, P2971, DOI 10.1200/JCO.2013.50.4324; Ando K, 2013, J CLIN ONCOL, V31, pE69, DOI 10.1200/JCO.2012.44.2020; Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; BRUERA E, 1985, CANCER TREAT REP, V69, P751; Davis MP, 2004, J CLIN ONCOL, V22, P1510, DOI 10.1200/JCO.2004.03.103; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Gioulbasanis I, 2011, LUNG CANCER, V74, P516, DOI 10.1016/j.lungcan.2011.05.009; Gordon JN, 2005, QJM-INT J MED, V98, P779, DOI 10.1093/qjmed/hci127; Hirama M, 2003, CANCER LETT, V198, P107, DOI 10.1016/S0304-3835(03)00286-6; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Lambert JW, 2013, UROLOGY, V81, P587, DOI 10.1016/j.urology.2012.10.055; Lu HJ, 2013, JPN J CLIN ONCOL, V43, P532, DOI 10.1093/jjco/hyt043; MERRIMAN RL, 1989, CANCER RES, V49, P4509; Mori K, 2009, BIOMED RES-TOKYO, V30, P47, DOI 10.2220/biomedres.30.47; MOSHAGE HJ, 1987, J CLIN INVEST, V79, P1635, DOI 10.1172/JCI113000; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Narita Y, 2013, J IMMUNOL, V190, P812, DOI 10.4049/jimmunol.1103797; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Ogata A, 2012, CLIN MED INSIGHTS-AR, V5, P27, DOI 10.4137/CMAMD.S7371; OHE Y, 1993, BRIT J CANCER, V67, P939, DOI 10.1038/bjc.1993.174; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; POPIELA T, 1989, EUR J CANCER CLIN ON, V25, P1823; RAMADORI G, 1988, EUR J IMMUNOL, V18, P1259, DOI 10.1002/eji.1830180817; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; SUGIURA K, 1955, CANCER RES, V15, P38; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Tisdale Michael J, 2003, J Support Oncol, V1, P159; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Yae S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/976926; Zhang YF, 2008, INT IMMUNOPHARMACOL, V8, P1767, DOI 10.1016/j.intimp.2008.08.008	44	70	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102436	10.1371/journal.pone.0102436	http://dx.doi.org/10.1371/journal.pone.0102436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010770	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800101
J	Hennigs, JK; Muller, J; Adam, M; Spin, JM; Riedel, E; Graefen, M; Bokemeyer, C; Sauter, G; Huland, H; Schlomm, T; Minner, S				Hennigs, Jan K.; Mueller, Julia; Adam, Matti; Spin, Joshua M.; Riedel, Emilia; Graefen, Markus; Bokemeyer, Carsten; Sauter, Guido; Huland, Hartwig; Schlomm, Thorsten; Minner, Sarah			Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse	PLOS ONE			English	Article							TARGETED CYTOTOXIC ANALOGS; ISUP CONSENSUS CONFERENCE; GENE-EXPRESSION; IMMUNOHISTOCHEMICAL EXPRESSION; INTERNATIONAL-SOCIETY; PANCREATIC-CARCINOMA; LUNG-CARCINOMA; GROWTH; INHIBITION; THERAPY	Somatostatin receptor subtype 2 (SSTR2) is the most frequently expressed SSTR subtype in normal human tissues. SSTR2 expression is differentially regulated in various tumor types and therapeutic somatostatin analogs binding to SSTR2 are in clinical use. In prostate cancers highly contradictory results in terms of SSTR2 expression and its consequences have been published over the past years. The aim of this study was to clarify prevalence and clinical significance of SSTR2 expression in prostate cancer. Therefore, quantitative immunohistochemistry (IHC) using a tissue microarray containing samples from 3,261 prostate cancer patients with extensive clinical and molecular cancer characteristics and oncological follow-up data was performed. IHC data was compared to publicly available Gene Expression Omnibus datasets of human prostate cancer gene expression arrays. While membranous SSTR2 staining was always seen in normal prostate epithelium, SSTR2 staining was absent in more than half (56.1%) of 2,195 interpretable prostate cancer samples. About 13% of all analyzed prostate cancers showed moderate to strong cytoplasmic and membranous SSTR2 staining. Staining intensities were inversely correlated with high Gleason grade, advanced pT category, high tumor cell proliferation (p<0.0001 each), high preoperative PSA levels, (p = 0.0011) and positive surgical margins (p = 0.006). In silico analysis confirmed lower SSTR2 gene expression in prostate cancers vs. normal adjacent tissue (p = 0.0424), prostate cancer metastases vs. primary cancers (p = 0.0011) and recurrent vs. non-recurrent prostate cancers (p = 0.0438). PSA-free survival gradually declined with SSTR2 staining intensity (p<0.0001). SSTR2-negative cancers were more likely to develop metastases over time (p<0.05). In conclusion, most prostate cancers are indeed SSTR2-negative and loss of SSTR2 strongly predicts an unfavorable tumor phenotype and poor prognosis. Therefore, SSTR2 expression seems an important factor in the pathogenesis of prostate cancer and re-introduction of the receptor in SSTR2-negative prostate cancers may feature a promising target for novel gene therapy approaches.	[Hennigs, Jan K.; Mueller, Julia; Sauter, Guido; Minner, Sarah] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [Hennigs, Jan K.; Bokemeyer, Carsten] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med Oncol 2, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,UCCH, Hamburg, Germany; [Adam, Matti; Spin, Joshua M.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Adam, Matti; Spin, Joshua M.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA; [Graefen, Markus; Huland, Hartwig; Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Stanford University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hennigs, JK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany.	j.hennigs@uke.de		Adam, Matti/0000-0002-6990-8135; Spin, Joshua/0000-0002-4256-9161; Schlomm, Thorsten/0000-0001-9557-4653; Hennigs, Jan K./0000-0002-7784-8267	University Medical Center Hamburg-Eppendorf; Hubertus Wald Tumorzentrum / University Cancer Center Hamburg	University Medical Center Hamburg-Eppendorf; Hubertus Wald Tumorzentrum / University Cancer Center Hamburg	This work was funded by the University Medical Center Hamburg-Eppendorf. JKH received a research fellowship from the "Hubertus Wald Tumorzentrum / University Cancer Center Hamburg" during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appetecchia M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-19; Barbieri F, 2008, ENDOCRINOLOGY, V149, P4736, DOI 10.1210/en.2007-1762; Barbieri F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1078, DOI 10.1152/ajpendo.00292.2009; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Buchholz S, 2006, P NATL ACAD SCI USA, V103, P10403, DOI 10.1073/pnas.0602971103; Buscail L, 1996, CANCER RES, V56, P1823; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Engel JB, 2005, CANCER-AM CANCER SOC, V104, P1312, DOI 10.1002/cncr.21327; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Cariaga-Martinez AE, 2009, ADV UROL, V2009, DOI 10.1155/2009/723831; Evangelou I, 2012, EUR J CLIN INVEST, V42, P777, DOI 10.1111/j.1365-2362.2012.02648.x; Feng Yanping, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P68; Grozinsky-Glasberg S, 2008, ENDOCR-RELAT CANCER, V15, P701, DOI 10.1677/ERC-07-0288; Halmos G, 2000, J CLIN ENDOCR METAB, V85, P2564, DOI 10.1210/jc.85.7.2564; Hansson J, 2002, PROSTATE, V53, P50, DOI 10.1002/pros.10121; He Y, 2009, ACTA PHARMACOL SIN, V30, P1053, DOI 10.1038/aps.2009.59; Keller G, 2005, INT J CANCER, V114, P831, DOI 10.1002/ijc.20806; Keller G, 2006, INT J ONCOL, V28, P1507; Kiaris H, 2001, EUR J CANCER, V37, P620, DOI 10.1016/S0959-8049(00)00437-8; Kwekkeboom D, 2000, J NUCL MED, V41, P1704; Kwekkeboom DJ, 2010, ENDOCR-RELAT CANCER, V17, pR53, DOI 10.1677/ERC-09-0078; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; Lopez F, 1997, J BIOL CHEM, V272, P24448, DOI 10.1074/jbc.272.39.24448; Mazzucchelli R, 2011, CELL ONCOL, V34, P235, DOI 10.1007/s13402-011-0031-y; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Morichetti D, 2010, BJU INT, V106, P1072, DOI 10.1111/j.1464-410X.2010.09238.x; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATEL YC, 1994, ENDOCRINOLOGY, V135, P2814, DOI 10.1210/en.135.6.2814; Plonowski A, 1999, CANCER RES, V59, P1947; Port M, 2011, UROL ONCOL-SEMIN ORI, V29, P764, DOI 10.1016/j.urolonc.2009.08.008; Qiu CZ, 2006, WORLD J GASTROENTERO, V12, P2011, DOI 10.3748/wjg.v12.i13.2011; REUBI JC, 1995, J CLIN ENDOCR METAB, V80, P2806, DOI 10.1210/jc.80.9.2806; Rochaix P, 1999, HUM GENE THER, V10, P995, DOI 10.1089/10430349950018391; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Szepeshazi K, 2003, CANCER, V98, P1401, DOI 10.1002/cncr.11649; Szepeshazi K, 2002, CANCER RES, V62, P781; Szereday Z, 2003, INT J ONCOL, V22, P1141; Tan PH, 2011, MODERN PATHOL, V24, P48, DOI 10.1038/modpathol.2010.155; Tang XY, 2010, INT J ONCOL, V37, P1077, DOI 10.3892/ijo_00000759; TAYLOR JE, 1994, PEPTIDES, V15, P1229, DOI 10.1016/0196-9781(94)90146-5; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Torrisani J, 2008, ENDOCRINOLOGY, V149, P3137, DOI 10.1210/en.2007-1525; Trock BJ, 2014, CURR OPIN UROL, V24, P293, DOI 10.1097/MOU.0000000000000050; Vernejoul F, 2002, CANCER RES, V62, P6124; Vockel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019740; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhou TH, 2009, ACTA ONCOL, V48, P401, DOI 10.1080/02841860802314746; Ziegler CG, 2009, P NATL ACAD SCI USA, V106, P15879, DOI 10.1073/pnas.0907843106; Zou Y, 2009, ONCOL REP, V21, P379, DOI 10.3892/or_00000233	53	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e100469	10.1371/journal.pone.0100469	http://dx.doi.org/10.1371/journal.pone.0100469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010045	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800004
J	Lundberg, IV; Burstrom, AL; Edin, S; Eklof, V; Oberg, A; Stenling, R; Palmqvist, R; Wikberg, ML				Lundberg, Ida V.; Burstrom, Anna Lofgren; Edin, Sofia; Eklof, Vincy; Oberg, Ake; Stenling, Roger; Palmqvist, Richard; Wikberg, Maria L.			SOX2 Expression Is Regulated by BRAF and Contributes to Poor Patient Prognosis in Colorectal Cancer	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; TRANSCRIPTION FACTOR SOX2; DNA COPY NUMBER; GENE-EXPRESSION; MICROSATELLITE INSTABILITY; V600E MUTATION; LUNG-CANCER; STEM-CELLS; CARCINOMA; GROWTH	Sporadic colorectal cancer (CRC) is a common malignancy and also one of the main causes of cancer deaths worldwide. Aberrant expression of the transcription factor SOX2 has recently been observed in several cancer types, but its role in CRC has not been fully elucidated. Here we studied the expression of SOX2 in 441 CRC patients by immunohistochemistry and related the expression to clinicopathological and molecular variables and patient prognosis. SOX2 was expressed in 11% of the tumors and was significantly associated to BRAF(V600E) mutation, but not to KRAS mutations (codon 12 and 13). SOX2 positivity was correlated to poor patient survival, especially in BRAF(V600E) mutated cases. In vitro studies showed that cells expressing the constitutively active BRAF(V600E) had increased SOX2 expression, a finding not found in cells expressing KRAS(G12V). Furthermore, blocking downstream BRAF signalling using a MEK-inhibitor resulted in a decreased expression of SOX2. Since SOX2 overexpression has been correlated to increased migration and invasion, we investigated the SOX2 expression in human CRC liver metastasis and found that a SOX2 positive primary CRC also had SOX2 expression in corresponding liver metastases. Finally we found that cells overexpressing SOX2 in vitro showed enhanced expression of FGFR1, which has been reported to correlate with liver metastasis in CRC. Our novel findings suggest that SOX2 expression is partly regulated by BRAF signalling, and an increased SOX2 expression may promote CRC metastasis and mediate a poor patient prognosis.	[Lundberg, Ida V.; Burstrom, Anna Lofgren; Edin, Sofia; Eklof, Vincy; Stenling, Roger; Palmqvist, Richard; Wikberg, Maria L.] Umea Univ, Dept Med Biosci, Umea, Sweden; [Oberg, Ake] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University	Wikberg, ML (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	maria.wikberg@medbio.umu.se			Cancer Research Foundation in Northern Sweden; OE and Edla Johanssons foundation; Petrus and Augusta Hedlunds Foundation; Magn Bergvall Foundation; Swedish Cancer Society; Swedish Research Council; Umea University	Cancer Research Foundation in Northern Sweden; OE and Edla Johanssons foundation; Petrus and Augusta Hedlunds Foundation; Magn Bergvall Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University	This study was supported by grants from The Cancer Research Foundation in Northern Sweden, OE and Edla Johanssons foundation, Petrus and Augusta Hedlunds Foundation, Magn Bergvall Foundation, The Swedish Cancer Society, The Swedish Research Council and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Cimpean AM, 2011, CLIN EXP MED, V11, P251, DOI 10.1007/s10238-010-0127-0; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Fang XF, 2010, OMICS, V14, P369, DOI 10.1089/omi.2010.0053; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gallo M, 2013, CANCER RES, V73, P417, DOI 10.1158/0008-5472.CAN-12-1881; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jang JH, 2005, ONCOGENE, V24, P945, DOI 10.1038/sj.onc.1208254; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Li XL, 2004, INT J ONCOL, V24, P257; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Lou XY, 2013, OMICS, V17, P510, DOI 10.1089/omi.2013.0058; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Park ET, 2008, INT J CANCER, V122, P1253, DOI 10.1002/ijc.23225; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Pham DL, 2013, INT J GYNECOL PATHOL, V32, P358, DOI 10.1097/PGP.0b013e31826a642b; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Ruan J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0445-z; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang XB, 2013, AURIS NASUS LARYNX, V40, P481, DOI 10.1016/j.anl.2013.01.003; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yang F, 2013, INT J CLIN EXP PATHO, V6, P2846	40	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101957	10.1371/journal.pone.0101957	http://dx.doi.org/10.1371/journal.pone.0101957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010701	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800054
J	Askarian-Amiri, ME; Seyfoddin, V; Smart, CE; Wang, JL; Kim, JE; Hansji, H; Baguley, BC; Finlay, GJ; Leung, EY				Askarian-Amiri, Marjan E.; Seyfoddin, Vahid; Smart, Chanel E.; Wang, Jingli; Kim, Ji Eun; Hansji, Herah; Baguley, Bruce C.; Finlay, Graeme J.; Leung, Euphemia Y.			Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; TAMOXIFEN RESISTANCE; HUMAN FIBROBLASTS; EXPRESSION; CARCINOMA; IDENTIFICATION; TRANSCRIPTION; TUMOR; GENERATION	The transcription factor SOX2 is essential for maintaining pluripotency in a variety of stem cells. It has important functions during embryonic development, is involved in cancer stem cell maintenance, and is often deregulated in cancer. The mechanism of SOX2 regulation has yet to be clarified, but the SOX2 gene lies in an intron of a long multi-exon non-coding RNA called SOX2 overlapping transcript (SOX2OT). Here, we show that the expression of SOX2 and SOX2OT is concordant in breast cancer, differentially expressed in estrogen receptor positive and negative breast cancer samples and that both are up-regulated in suspension culture conditions that favor growth of stem cell phenotypes. Importantly, ectopic expression of SOX2OT led to an almost 20-fold increase in SOX2 expression, together with a reduced proliferation and increased breast cancer cell anchorage-independent growth. We propose that SOX2OT plays a key role in the induction and/or maintenance of SOX2 expression in breast cancer.	[Askarian-Amiri, Marjan E.; Seyfoddin, Vahid; Wang, Jingli; Kim, Ji Eun; Hansji, Herah; Baguley, Bruce C.; Finlay, Graeme J.; Leung, Euphemia Y.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Smart, Chanel E.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	University of Auckland; University of Queensland	Finlay, GJ (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	g.finlay@auckland.ac.nz; e.leung@auckland.ac.nz	Leung, Euphemia/D-2642-2009; Askarian-Amiri, Marjan E./F-7910-2010; Smart, Chanel E/C-9583-2011	Leung, Euphemia/0000-0002-6932-3188; Askarian-Amiri, Marjan E./0000-0003-3524-9626; 	New Zealand Breast Cancer Foundation; Maurice and Phyllis Paykel trust; Auckland Medical Research Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	New Zealand Breast Cancer Foundation; Maurice and Phyllis Paykel trust; Auckland Medical Research Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	Funding for this work was obtained from the New Zealand Breast Cancer Foundation, the Maurice and Phyllis Paykel trust, Auckland Medical Research Foundation, and the Robert McClelland Trust. This work is also supported by Auckland Cancer Society Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Baguley B.C., 2011, BREAST CANC CARCINOG, P245; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Carninci P, 2007, J EXP BIOL, V210, P1497, DOI 10.1242/jeb.000406; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Corominas-Faja B, 2013, CELL CYCLE, V12, P3109, DOI 10.4161/cc.26173; Cox JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044087; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Leis O, 2011, ONCOGENE; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Leung E, 2014, BREAST CERV IN PRESS; Leung E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836769; Leung E, 2012, INVEST NEW DRUG, V30, P2103, DOI 10.1007/s10637-011-9768-4; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Li XL, 2004, INT J ONCOL, V24, P257; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nielsen MM, 2014, RNA, V20, P236, DOI 10.1261/rna.038927.113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Simoes BM, 2011, BREAST CANCER RES TR, V129, P23, DOI 10.1007/s10549-010-1169-4; Smart CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064388; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wu F, 2012, CELL SIGNAL, V24, P1989, DOI 10.1016/j.cellsig.2012.07.008; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	57	96	102	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102140	10.1371/journal.pone.0102140	http://dx.doi.org/10.1371/journal.pone.0102140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006803	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600099
J	Leze, E; Maciel-Osorio, CFE; Mandarim-de-Lacerda, CA				Leze, Eduardo; Maciel-Osorio, Clarice F. E.; Mandarim-de-Lacerda, Carlos A.			Advantages of Evaluating Mean Nuclear Volume as an Adjunct Parameter in Prostate Cancer	PLOS ONE			English	Article							INTEROBSERVER REPRODUCIBILITY; GLEASON SCORE; RADICAL PROSTATECTOMY; TUMOR BIOLOGY; BIOPSY; CARCINOMA; GRADE; PATHOLOGISTS; ANTIGEN; DETERMINANTS	Background: Efforts to improve the diagnosis, prognosis and surveillance of prostate cancer (PCa) are relevant. Gleason score (GSc) overestimation may subject individuals to unnecessary aggressive treatment. We aimed to use stereology in PCa evaluations and investigate whether mean nuclear volume (MNV) correlates with the Gleason primary pattern (Gpp) and to improve the subjective GSc to obtain an objective and reliable method without inter-observer dissension. Methods: We identified 74 radical prostatectomy specimens that were divided into six groups based on Gpp, from 3 to 5. Controls (C) were designed in paired non-tumor regions of the same specimens. MNV was estimated using the "point-sampled intercepts'' method. Differences in MNV among the C groups and the Gpp groups were tested with the Kruskall-Wallis test and Dunn post-hoc test. Differences between each Gpp group and its control counterpart were tested with the Wilcoxon test. Correlations were evaluated with the Spearman rank correlation (R-[Spearman]). Results: The correlations between prostate-specific antigen (PSA) and GSc (R-[Spearman] of 0.76) and between PSA and MNV (R-[Spearman] of 0.78) were moderately strong and highly significant, and the correlation between MNV and Gpp (R-[Spearman] of 0.53) was moderate and highly significant. MNV was significantly greater in cancerous regions than in paired-control regions. Limitations included sample size. Conclusions: Proper planning of a study, as well as the availability of equipment and software for morphological quantification, can provide incentive to quickly and accurately estimate MNV as an adjunct parameter in the assessment of PCa. Current data are in favor of the use of MNV associated with GSc and PSA in the assessment of PCa.	[Leze, Eduardo; Maciel-Osorio, Clarice F. E.; Mandarim-de-Lacerda, Carlos A.] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mandarim@uerj.br	Mandarim-de-Lacerda, Carlos A/F-7125-2012; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978				Allsbrook WC, 2001, HUM PATHOL, V32, P74, DOI 10.1053/hupa.2001.21134; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Arai Y, 2001, BJU INT, V88, P909, DOI 10.1046/j.1464-4096.2001.01558.x; Arai Y, 2001, PROSTATE, V46, P134, DOI 10.1002/1097-0045(20010201)46:2<134::AID-PROS1017>3.0.CO;2-9; Arima K, 1997, BRIT J CANCER, V76, P234, DOI 10.1038/bjc.1997.367; Billis A, 2008, J UROLOGY, V180, P548, DOI 10.1016/j.juro.2008.04.018; Buhmeida AB, 2000, ANAL QUANT CYTOL, V22, P291; Burchardt M, 2008, J CANCER RES CLIN, V134, P1071, DOI 10.1007/s00432-008-0388-0; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045178; Cirak Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0526-7; Corcoran NM, 2012, BJU INT, V110, P36, DOI 10.1111/j.1464-410X.2011.10681.x; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Egevad L, 2013, HISTOPATHOLOGY, V62, P247, DOI 10.1111/his.12008; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Fanning DM, 2010, BJU INT, V105, P631, DOI 10.1111/j.1464-410X.2009.08810.x; Fujikawa K, 2000, J UROLOGY, V164, P1587, DOI 10.1016/S0022-5347(05)67034-6; Fujikawa K, 2000, ANAL QUANT CYTOL, V22, P55; Goodman M, 2012, PROSTATE, V72, P1389, DOI 10.1002/pros.22484; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Haas GP, 2008, CAN J UROL, V15, P3866; Helpap B, 2008, ANAL QUANT CYTOL, V30, P133; Katz B, 2012, UROL ONCOL-SEMIN ORI, V30, P794, DOI 10.1016/j.urolonc.2010.10.010; Matsui Y, 2004, J UROLOGY, V171, P687, DOI 10.1097/01.ju.0000106864.91375.80; Oh JJ, 2012, BJU INT, V110, pE494, DOI 10.1111/j.1464-410X.2012.11182.x; Oyama T, 2005, ARCH PATHOL LAB MED, V129, P1004; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Rapiti E, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-19; Shapiro RH, 2012, UROLOGY, V80, P661, DOI 10.1016/j.urology.2012.06.022; Veltri RW, 2008, CANCER EPIDEM BIOMAR, V17, P102, DOI 10.1158/1055-9965.EPI-07-0175	29	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102156	10.1371/journal.pone.0102156	http://dx.doi.org/10.1371/journal.pone.0102156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007252	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600103
J	Reeves, ME; Firek, M; Chen, ST; Amaar, YG				Reeves, Mark E.; Firek, Matthew; Chen, Shin-Tai; Amaar, Yousef G.			Evidence that RASSF1C Stimulation of Lung Cancer Cell Proliferation Depends on IGFBP-5 and PIWIL1 Expression Levels	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EPIGENETIC INACTIVATION; GROWTH; PROTEIN; BREAST; IDENTIFICATION; PROMOTES; 3P21.3; AMPK	RASSF1C is a major isoform of the RASSF1 gene, and is emerging as an oncogene. This is in contradistinction to the RASSF1A isoform, which is an established tumor suppressor. We have previously shown that RASSF1C promotes lung cancer cell proliferation and have identified RASSF1C target genes with growth promoting functions. Here, we further report that RASSF1C promotes lung cancer cell migration and enhances lung cancer cell tumor sphere formation. We also show that RASSF1C over-expression reduces the inhibitory effects of the anti-cancer agent, betulinic acid ( BA), on lung cancer cell proliferation. In previous work, we demonstrated that RASSF1C up-regulates piwil1 gene expression, which is a stem cell self-renewal gene that is over-expressed in several human cancers, including lung cancer. Here, we report on the effects of BA on piwil1 gene expression. Cells treated with BA show decreased piwil1 expression. Also, interaction of IGFBP-5 with RASSF1C appears to prevent RASSF1C from up-regulating PIWIL1 protein levels. These findings suggest that IGFBP-5 may be a negative modulator of RASSF1C/PIWIL1 growth-promoting activities. In addition, we found that inhibition of the ATM-AMPK pathway up-regulates RASSF1C gene expression.	[Reeves, Mark E.; Firek, Matthew; Amaar, Yousef G.] Loma Linda VA Med Ctr, Surg Oncol Lab, Loma Linda, CA 92354 USA; [Chen, Shin-Tai] Loma Linda VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA; [Reeves, Mark E.; Amaar, Yousef G.] Loma Linda Univ, Sch Med, Dept Surg, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University	Amaar, YG (corresponding author), Loma Linda VA Med Ctr, Surg Oncol Lab, Loma Linda, CA 92354 USA.	yousef.amaar@va.gov			Loma Linda University Cancer Center	Loma Linda University Cancer Center	We thank Dr. Donna Strong for the critical reading of the manuscript. This work was carried out at the Loma Linda VA Medical Center, Loma Linda, CA; and the work was supported by a grant from Loma Linda University Cancer Center.	Agathanggelou A, 2003, CANCER RES, V63, P5344; Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Amaar YG, 2005, J BONE MINER RES, V20, P1430, DOI 10.1359/JBMR.050311; Amaar YG, 2006, AM J PHYSIOL-LUNG C, V291, pL1185, DOI 10.1152/ajplung.00072.2006; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2001, ONCOGENE, V20, P3563, DOI 10.1038/sj.onc.1204469; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Gheorgheosu D, 2014, ANTICANCER AGENTS ME; Gullu G, 2012, CHIN J CANCER, V31, P266, DOI 10.5732/cjc.011.10405; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Hsu YF, 2012, BBA-GEN SUBJECTS, V1820, P104, DOI 10.1016/j.bbagen.2011.11.011; Li JF, 2004, ONCOGENE, V23, P5941, DOI 10.1038/sj.onc.1207789; Liang D, 2013, ASIAN PAC J CANCER P, V14, P1067, DOI 10.7314/APJCP.2013.14.2.1067; Liu LM, 2002, ONCOGENE, V21, P6835, DOI 10.1038/sj.onc.1205814; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Pelosi G, 2010, ANTICANCER RES, V30, P4269; Reeves M. E., 2013, MOL BIOL INT, V2013, P145096; Reeves Mark E, 2012, BMC Res Notes, V5, P239, DOI 10.1186/1756-0500-5-239; Reeves ME, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-562; Rzeski W, 2009, BASIC CLIN PHARMACOL, V105, P425, DOI 10.1111/j.1742-7843.2009.00471.x; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Siddiqi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033711; Siddiqi S, 2012, J CELL BIOCHEM, V113, P373, DOI 10.1002/jcb.23363; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tommasi S, 2005, CANCER RES, V65, P92; Vos MD, 2000, J BIOL CHEM, V275, P35669, DOI 10.1074/jbc.C000463200; Yang LJ, 2010, ACTA PHARMACOL SIN, V31, P66, DOI 10.1038/aps.2009.177	32	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101679	10.1371/journal.pone.0101679	http://dx.doi.org/10.1371/journal.pone.0101679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007054	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600057
J	Yin, J; Wang, LM; Zheng, L; Wang, X; Shi, YJ; Shao, AZ; Ding, GW; Liu, C; Chen, SC; Tang, WF; Gu, HY				Yin, Jun; Wang, Liming; Zheng, Liang; Wang, Xu; Shi, Yijun; Shao, Aizhong; Ding, Guowen; Liu, Chao; Chen, Suocheng; Tang, Weifeng; Gu, Haiyong			TERT-CLPTM1L Rs401681 C > T Polymorphism Was Associated with a Decreased Risk of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CARCINOMA; GENE; TERT	Background: Esophageal cancer was the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related death in China in 2009. Esophageal squamous cell carcinoma (ESCC) accounts for more than 90 percent of esophageal cancers. Genetic factors probably play an important role in the ESCC carcinogenesis. Methods: We conducted a hospital based case-control study to evaluate functional hTERT rs2736098 G>A and TERT-CLPTM1L rs401681 C>T single nucleotide polymorphisms (SNPs) on the risk of ESCC. Six hundred and twenty-nine ESCC cases and 686 controls were recruited. Their genotypes were determined using the ligation detection reaction (LDR) method. Results: When the TERT-CLPTM1L rs401681 CC homozygote genotype was used as the reference group, the CT genotype was associated with a significantly decreased risk of ESCC (adjusted OR = 0.74, 95% CI = 0.58-0.94, p = 0.012); the CT/TT variants were associated with a 26% decreased risk of ESCC (adjusted OR = 0.74, 95% CI = 0.59-0.93, P = 0.009). The significantly decreased risk of ESCC associated with the TERT-CLPTM1L rs401681 C>T polymorphism was associated with male sex, young age (<63 years in our study) and alcohol consumption. No association between the hTERT rs2736098 G>A polymorphism and ESCC risk was observed. Conclusion: TERT-CLPTM1L rs401681 CT and CT/TT genotypes were associated with decreased risk of ESCC, particularly among men, young patients and those reported to be drinkers. However, our results are preliminary conclusions. Larger studies with more rigorous study designs are required to confirm the current findings.	[Yin, Jun; Wang, Xu; Shi, Yijun; Shao, Aizhong; Ding, Guowen; Liu, Chao; Chen, Suocheng; Tang, Weifeng; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China; [Wang, Liming] Jiangsu Univ, Peoples Hosp, Inst Canc, Dept Chemotherapy, Zhenjiang, Jiangsu, Peoples R China; [Zheng, Liang] Suzhou Univ, Peoples Hosp Changzhou 1, Dept Cardiothorac Surg, Changzhou, Jiangsu, Peoples R China; [Zheng, Liang] Suzhou Univ, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Tang, WF (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China.	twf001001@126.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and Science-Technology Foundation of Health Bureau [QN201102]; "333" Elitist Training Program of Jiangsu [BRA2013135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and Science-Technology Foundation of Health Bureau; "333" Elitist Training Program of Jiangsu	This study was supported in part by National Natural Science Foundation of China (81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017), Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102), and The "333" Elitist Training Program of Jiangsu (BRA2013135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Colombo J, 2009, ONCOL REP, V21, P649, DOI 10.3892/or_00000268; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; James MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036116; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084277; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; Liu ZS, 2010, CARCINOGENESIS, V31, P1977, DOI 10.1093/carcin/bgq179; MACFARLANE GJ, 1994, J ROY SOC MED, V87, P334; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; MORITA M, 1994, INT J CANCER, V58, P207, DOI 10.1002/ijc.2910580211; Myneni AA, 2013, LUNG CANCER, V80, P131, DOI 10.1016/j.lungcan.2013.01.021; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250; Young NS, 2010, HEMATOL-AM SOC HEMAT, P30, DOI 10.1182/asheducation-2010.1.30; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	26	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100667	10.1371/journal.pone.0100667	http://dx.doi.org/10.1371/journal.pone.0100667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007268	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600017
J	Samanta, K; Douglas, S; Parekh, AB				Samanta, Krishna; Douglas, Sophie; Parekh, Anant B.			Mitochondrial Calcium Uniporter MCU Supports Cytoplasmic Ca2+ Oscillations, Store-Operated Ca2+ Entry and Ca2+-Dependent Gene Expression in Response to Receptor Stimulation	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE; ESSENTIAL COMPONENT; ENDOPLASMIC-RETICULUM; ACTIVATION; RELEASE; INACTIVATION; PROTEINS; DETERMINANTS; MICRODOMAINS; CHANNELS	Ca2+ flux into mitochondria is an important regulator of cytoplasmic Ca2+ signals, energy production and cell death pathways. Ca2+ uptake can occur through the recently discovered mitochondrial uniporter channel (MCU) but whether the MCU is involved in shaping Ca2+ signals and downstream responses to physiological levels of receptor stimulation is unknown. Here, we show that modest stimulation of leukotriene receptors with the pro-inflammatory signal LTC4 evokes a series of cytoplasmic Ca2+ oscillations that are rapidly and faithfully propagated into mitochondrial matrix. Knockdown of MCU or mitochondrial depolarisation, to reduce the driving force for Ca2+ entry into the matrix, prevents the mitochondrial Ca2+ rise and accelerates run down of the oscillations. The loss of cytoplasmic Ca2+ oscillations appeared to be a consequence of enhanced Ca2+ -dependent inactivation of InsP(3) receptors, which arose from the loss of mitochondrial Ca2+ buffering. Ca2+ dependent gene expression in response to leukotriene receptor activation was suppressed following knockdown of the MCU. In addition to buffering Ca2+ release, mitochondria also sequestrated Ca2+ entry through storeoperated Ca2+ channels and this too was prevented following loss of MCU. MCU is therefore an important regulator of physiological pulses of cytoplasmic Ca2+.	[Samanta, Krishna; Douglas, Sophie; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; American Asthma Foundation	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); American Asthma Foundation	This work received funding from the Medical Research Council and the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Gilabert JA, 2001, EMBO J, V20, P2672, DOI 10.1093/emboj/20.11.2672; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Huang G, 2014, NATURW COMMUNICATION, V4, P2865; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kar P, 2012, CURR BIOL, V22, P242, DOI 10.1016/j.cub.2011.12.025; Kar P, 2011, J BIOL CHEM, V286, P14795, DOI 10.1074/jbc.M111.220582; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Prudent J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3330; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641	49	61	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101188	10.1371/journal.pone.0101188	http://dx.doi.org/10.1371/journal.pone.0101188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004162	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700020
J	Roach, CR; Hall, DE; Zerbe, P; Bohlmann, J				Roach, Christopher R.; Hall, Dawn E.; Zerbe, Philipp; Bohlmann, Joerg			Plasticity and Evolution of (-)-3-Carene Synthase and (-)-Sabinene Synthase Functions of a Sitka Spruce Monoterpene Synthase Gene Family Associated with Weevil Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanism; Enzyme Mutation; Plant; Plant Biochemistry; Plant Defense; Terpenoid; Terpenoid Synthase	WHITE-PINE WEEVIL; TERPENE SYNTHASE; ARISTOLOCHENE SYNTHASE; DIRECTED MUTAGENESIS; ABIES-GRANDIS; BIOSYNTHESIS; (+)-3-CARENE; CATALYSIS; CONIFERS; DEFENSE	Background: (+)-3-Carene/(-)-sabinene synthases are associated with insect resistance in Sitka spruce. Results: Amino acid position 596 is critical for the monoterpene synthase product profile. Conclusion: This work revealed mechanistic underpinnings for patterns of functional evolution of this monoterpene synthase family. Significance: Catalytic plasticity of conifer monoterpene synthases is a major factor in the diversification of the TPS-d family and evolution of insect resistance. The monoterpene (+)-3-carene is associated with resistance of Sitka spruce against white pine weevil, a major North American forest insect pest of pine and spruce. High and low levels of (+)-3-carene in, respectively, resistant and susceptible Sitka spruce genotypes are due to variation of (+)-3-carene synthase gene copy number, transcript and protein expression levels, enzyme product profiles, and enzyme catalytic efficiency. A family of multiproduct (+)-3-carene synthase-like genes of Sitka spruce include the three (+)-3-carene synthases, PsTPS-3car1, PsTPS-3car2, PsTPS-3car3, and the (-)-sabinene synthase PsTPS-sab. Of these, PsTPS-3car2 is responsible for the relatively higher levels of (+)-3-carene in weevil-resistant trees. Here, we identified features of the PsTPS-3car1, PsTPS-3car2, PsTPS-3car3, and PsTPS-sab proteins that determine different product profiles. A series of domain swap and site-directed mutations, supported by structural comparisons, identified the amino acid in position 596 as critical for product profiles dominated by (+)-3-carene in PsTPS-3car1, PsTPS-3car2, and PsTPS-3car3, or (-)-sabinene in PsTPS-sab. A leucine in this position promotes formation of (+)-3-carene, whereas phenylalanine promotes (-)-sabinene. Homology modeling predicts that position 596 directs product profiles through differential stabilization of the reaction intermediate. Kinetic analysis revealed position 596 also plays a role in catalytic efficiency. Mutations of position 596 with different side chain properties resulted in a series of enzymes with different product profiles, further highlighting the inherent plasticity and potential for evolution of alternative product profiles of these monoterpene synthases of conifer defense against insects.	[Roach, Christopher R.; Hall, Dawn E.; Zerbe, Philipp; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Roach, Christopher R.; Bohlmann, Joerg] Univ British Columbia, Genome Sci & Technol Program, Vancouver, BC V5Z 4S6, Canada	University of British Columbia; University of British Columbia	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca	Zerbe, Philipp/H-8348-2015	Zerbe, Philipp/0000-0001-5163-9523	Natural Sciences and Engineering Research Council of Canada; Genome Canada; Genome BC; Genome Quebec; Genome Science and Technology program; British Columbia Epilepsy Society	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada(Genome Canada); Genome BC; Genome Quebec; Genome Science and Technology program; British Columbia Epilepsy Society	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada (to J. B.), Genome Canada, Genome BC, and Genome Quebec in support of the SMarTForests Project LSARP Program (to Project Leader J. B.).; Recipient of graduate student scholarship awards from Genome Science and Technology program and the British Columbia Epilepsy Society.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; Davis EM, 2000, TOP CURR CHEM, V209, P53; Faldt J, 2003, PLANT MOL BIOL, V51, P119, DOI 10.1023/A:1020714403780; Faraldos JA, 2011, J AM CHEM SOC, V133, P13906, DOI 10.1021/ja205927u; Hall DE, 2011, PLANT J, V65, P936, DOI 10.1111/j.1365-313X.2010.04478.x; Hong YJ, 2014, NAT CHEM, V6, P104, DOI [10.1038/NCHEM.1843, 10.1038/nchem.1843]; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Katoh S, 2004, ARCH BIOCHEM BIOPHYS, V425, P65, DOI 10.1016/j.abb.2004.02.015; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; King JN, 2004, FORESTRY, V77, P269, DOI 10.1093/forestry/77.4.269; Krause ST, 2013, ARCH BIOCHEM BIOPHYS, V529, P112, DOI 10.1016/j.abb.2012.12.003; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; O'Maille PE, 2004, ANAL BIOCHEM, V335, P210, DOI 10.1016/j.ab.2004.09.011; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Robert JA, 2010, BOTANY, V88, P810, DOI 10.1139/B10-049; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Tantillo DJ, 2010, CHEM SOC REV, V39, P2847, DOI 10.1039/b917107j; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Weitman M, 2010, J AM CHEM SOC, V132, P6349, DOI 10.1021/ja910134x; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Zulak KG, 2009, PLANT J, V60, P1015, DOI 10.1111/j.1365-313X.2009.04020.x	30	37	37	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23859	23869		10.1074/jbc.M114.571703	http://dx.doi.org/10.1074/jbc.M114.571703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016016	Green Published, hybrid			2022-12-25	WOS:000341505000052
J	Espinola, SM; Ferreira, HB; Zaha, A				Espinola, Sergio Martin; Ferreira, Henrique Bunselmeyer; Zaha, Arnaldo			Validation of Suitable Reference Genes for Expression Normalization in Echinococcus spp. Larval Stages	PLOS ONE			English	Article							MULTILOCULARIS METACESTODES; RELATIVE EXPRESSION; GENUS ECHINOCOCCUS; PCR DATA; RT-PCR; GRANULOSUS; ANTIGEN; CYSTS; HOST; QUANTIFICATION	In recent years, a significant amount of sequence data (both genomic and transcriptomic) for Echinococcus spp. has been published, thereby facilitating the analysis of genes expressed during a specific stage or involved in parasite development. To perform a suitable gene expression quantification analysis, the use of validated reference genes is strongly recommended. Thus, the aim of this work was to identify suitable reference genes to allow reliable expression normalization for genes of interest in Echinococcus granulosus sensu stricto (s.s.) (G1) and Echinococcus ortleppi upon induction of the early pre-adult development. Untreated protoscoleces (PS) and pepsin-treated protoscoleces (PSP) from E. granulosus s.s. (G1) and E. ortleppi metacestode were used. The gene expression stability of eleven candidate reference genes (beta TUB, NDUFV2, RPL13, TBP, CYP-1, RPII, EF-1 alpha, beta ACT-1, GAPDH, ETIF4A-III and MAPK3) was assessed using geNorm, Normfinder, and RefFinder. Our qPCR data showed a good correlation with the recently published RNA-seq data. Regarding expression stability, EF-1 alpha and TBP were the most stable genes for both species. Interestingly, beta ACT-1 (the most commonly used reference gene), and GAPDH and ETIF4A-III (previously identified as housekeeping genes) did not behave stably in our assay conditions. We propose the use of EF-1 alpha as a reference gene for studies involving gene expression analysis in both PS and PSP experimental conditions for E. granulosus s.s. and E. ortleppi. To demonstrate its applicability, EF-1 alpha was used as a normalizer gene in the relative quantification of transcripts from genes coding for antigen B subunits. The same EF-1 alpha reference gene may be used in studies with other Echinococcus sensu lato species. This report validates suitable reference genes for species of class Cestoda, phylum Platyhelminthes, thus providing a foundation for further validation in other epidemiologically important cestode species, such as those from the Taenia genus.	[Espinola, Sergio Martin; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Ferreira, Henrique Bunselmeyer; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, BR-90049 Porto Alegre, RS, Brazil; [Ferreira, Henrique Bunselmeyer; Zaha, Arnaldo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Zaha, A (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.	zaha@cbiot.ufrgs.br	Espinola, Sergio/L-1504-2015; Zaha, Arnaldo/D-3165-2013; Ferreira, Henrique B/H-4189-2012	Espinola, Sergio/0000-0001-9000-2883; Ferreira, Henrique B/0000-0003-3611-6040; Zaha, Arnaldo/0000-0001-6336-474X	CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (www.cnpq.br) and CAPES (www.capes.gov.br) grants. SME is a recipient of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balbinotti H, 2012, VET PARASITOL, V188, P255, DOI 10.1016/j.vetpar.2012.04.007; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cabrera G, 2008, J CELL PHYSIOL, V216, P498, DOI 10.1002/jcp.21418; CAMERON TWM, 1969, CAN J ZOOLOG, V47, P1405, DOI 10.1139/z69-216; Colebrook AL, 2004, PARASITOLOGY, V129, P497, DOI 10.1017/S0031182004005773; Cui SJ, 2013, J PROTEOMICS, V84, P158, DOI 10.1016/j.jprot.2013.04.013; Graichen DAS, 2007, GENE, V392, P98, DOI 10.1016/j.gene.2006.11.015; Koziol U, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-10; Li J, 2011, CHINESE MED J-PEKING, V124, P2838, DOI 10.3760/cma.j.issn.0366-6999.2011.18.008; Liu S, 2012, MOL BIOCHEM PARASIT, V182, P75, DOI 10.1016/j.molbiopara.2011.12.007; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mamuti W, 2006, EXP PARASITOL, V113, P75, DOI 10.1016/j.exppara.2005.12.007; Matsumoto J, 2006, PARASITOLOGY, V132, P83, DOI 10.1017/S0031182005008632; McManus DP, 2013, PARASITOLOGY, V140, P1617, DOI 10.1017/S0031182013000802; Monteiro KM, 2010, PROTEOMICS, V10, P1985, DOI 10.1002/pmic.200900506; Muzulin PM, 2008, EXP PARASITOL, V118, P156, DOI 10.1016/j.exppara.2007.07.004; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Pan D, 2010, J HELMINTHOL, V84, P394, DOI 10.1017/S0022149X10000064; Pan D, 2010, J HELMINTHOL, V84, P241, DOI 10.1017/S0022149X09990605; Parkinson J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001897; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Santos GB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-327; Siles-Lucas M, 2001, PARASITOLOGY, V122, P281, DOI 10.1017/S0031182001007405; Swijsen Ann, 2012, BMC Res Notes, V5, P685, DOI 10.1186/1756-0500-5-685; Thompson RCA, 2008, EXP PARASITOL, V119, P439, DOI 10.1016/j.exppara.2008.04.016; Thompson R. C. A., 1995, P1; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANKEULEN H, 1985, MOL BIOCHEM PARASIT, V15, P215, DOI 10.1016/0166-6851(85)90121-5; Zhang WB, 2003, AM J TROP MED HYG, V68, P40, DOI 10.4269/ajtmh.2003.68.40; Zhang WB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000784; Zheng HJ, 2013, NAT GENET, V45, P1168, DOI 10.1038/ng.2757	36	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102228	10.1371/journal.pone.0102228	http://dx.doi.org/10.1371/journal.pone.0102228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014071	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400078
J	Lo Sasso, G; Ryu, D; Mouchiroud, L; Fernando, SC; Anderson, CL; Katsyuba, E; Piersigilli, A; Hottiger, MO; Schoonjans, K; Auwerx, J				Lo Sasso, Giuseppe; Ryu, Dongryeol; Mouchiroud, Laurent; Fernando, Samodha C.; Anderson, Christopher L.; Katsyuba, Elena; Piersigilli, Alessandra; Hottiger, Michael O.; Schoonjans, Kristina; Auwerx, Johan			Loss of Sirt1 Function Improves Intestinal Anti-Bacterial Defense and Protects from Colitis-Induced Colorectal Cancer	PLOS ONE			English	Article							PANETH CELL-DIFFERENTIATION; ETS TRANSCRIPTION FACTOR; STEM-CELLS; ULCERATIVE-COLITIS; GENE-EXPRESSION; COLON-CANCER; MICE; DEACETYLASE; METABOLISM; EPITHELIUM	Dysfunction of Paneth and goblet cells in the intestine contributes to inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC). Here, we report a role for the NAD(+)-dependent histone deacetylase SIRT1 in the control of anti-bacterial defense. Mice with an intestinal specific Sirt1 deficiency (Sirt1(int-/-)) have more Paneth and goblet cells with a consequent rearrangement of the gut microbiota. From a mechanistic point of view, the effects on mouse intestinal cell maturation are mediated by SIRT1-dependent changes in the acetylation status of SPDEF, a master regulator of Paneth and goblet cells. Our results suggest that targeting SIRT1 may be of interest in the management of IBD and CAC.	[Lo Sasso, Giuseppe; Ryu, Dongryeol; Mouchiroud, Laurent; Katsyuba, Elena; Piersigilli, Alessandra; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Fernando, Samodha C.; Anderson, Christopher L.] Univ Nebraska, Dept Anim Sci, Lincoln, NE USA; [Anderson, Christopher L.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Piersigilli, Alessandra] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, Zurich, Switzerland; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Bern; University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Hottiger, Michael O./J-7747-2013; Ryu, Dongryeol/AAQ-3642-2020	Hottiger, Michael O./0000-0002-7323-2270; Ryu, Dongryeol/0000-0001-5905-6760; Anderson, Christopher/0000-0002-2385-1049; Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393	Outgoing Italian Association for Cancer Research (AIRC)/Marie Curie Fellowship; Ecole Polytechnique Federale de Lausanne; EU Ideas program [AdG-231138]; Swiss National Science Foundation [31003A-140780, 310030-143748]; Krebsforschung Schweiz [KFS-3082-02-2013, KFS-2809-08-2011]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	Outgoing Italian Association for Cancer Research (AIRC)/Marie Curie Fellowship(Fondazione AIRC per la ricerca sul cancro); Ecole Polytechnique Federale de Lausanne; EU Ideas program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Krebsforschung Schweiz; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GLS is supported by an Outgoing Italian Association for Cancer Research (AIRC)/Marie Curie Fellowship. JA KS laboratory is supported by grants from the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (AdG-231138), the Swiss National Science Foundation (31003A-140780 and 310030-143748), the Krebsforschung Schweiz (KFS-3082-02-2013 and KFS-2809-08-2011), and NIH (R01AG043930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Angelakis E, 2014, ANTIMICROB AGENTS CH; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; Gregorieff A, 2010, CURR PROTOC STEM CEL; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gubelmann C, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.38; GUSTAFSSON BE, 1970, SCAND J GASTROENTERO, V5, P309; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kazgan N, 2013, GASTROENTEROLOGY; Leko V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066283; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Morotomi M, 2008, INT J SYST EVOL MICR, V58, P2716, DOI 10.1099/ijs.0.2008/000810-0; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Noah TK, 2013, GASTROENTEROLOGY, V144, P1012, DOI 10.1053/j.gastro.2013.01.043; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pal M, 2013, J BIOL CHEM, V288, P12222, DOI 10.1074/jbc.M112.434225; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035294; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	48	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102495	10.1371/journal.pone.0102495	http://dx.doi.org/10.1371/journal.pone.0102495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013930	Green Published, Green Accepted, gold			2022-12-25	WOS:000339378400099
J	Puig-Vilanova, E; Ausin, P; Martinez-Llorens, J; Gea, J; Barreiro, E				Puig-Vilanova, Ester; Ausin, Pilar; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther			Do Epigenetic Events Take Place in the Vastus Lateralis of Patients with Mild Chronic Obstructive Pulmonary Disease?	PLOS ONE			English	Article							OXIDATIVE STRESS; MUSCLE DYSFUNCTION; PREDICTION EQUATIONS; QUADRICEPS MUSCLE; GENE-EXPRESSION; COPD; ACETYLATION; ENDURANCE; ATROPHY; IDENTIFICATION	Muscle dysfunction is a major comorbidity in Chronic Obstructive Pulmonary Disease (COPD). Several biological mechanisms including epigenetic events regulate muscle mass and function in models of muscle atrophy. Investigations conducted so far have focused on the elucidation of biological mechanisms involved in muscle dysfunction in advanced COPD. We assessed whether the epigenetic profile may be altered in the vastus lateralis of patients with mild COPD, normal body composition, and mildly impaired muscle function and exercise capacity. In vastus lateralis (VL) of mild COPD patients with well-preserved body composition and in healthy age-matched controls, expression of DNA methylation, muscle-enriched microRNAs, histone acetyltransferases (HTAs) and deacetylases (HDACs), protein acetylation, small ubiquitin-related modifier (SUMO) ligases, and muscle structure were explored. All subjects were clinically evaluated. Compared to healthy controls, in the VL of mild COPD patients, muscle function and exercise capacity were moderately reduced, DNA methylation levels did not differ, miR-1 expression levels were increased and positively correlated with both forced expiratory volume in one second (FEV1) and quadriceps force, HDAC4 protein levels were increased, and muscle fiber types and sizes were not different. Moderate skeletal muscle dysfunction is a relevant feature in patients with mild COPD and preserved body composition. Several epigenetic events are differentially expressed in the limb muscles of these patients, probably as an attempt to counterbalance the underlying mechanisms that alter muscle function and mass. The study of patients at early stages of their disease is of interest as they are a target for timely therapeutic interventions that may slow down the course of the disease and prevent the deleterious effects of major comorbidities.	[Puig-Vilanova, Ester; Ausin, Pilar; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] Univ Pompeu Fabra, Dept Pulmonol, Muscle & Resp Syst Res Unit URMAR, IMIM Hosp del Mar,Hlth & Expt Sci Dept CEXS, Barcelona, Spain; [Puig-Vilanova, Ester; Ausin, Pilar; Martinez-Llorens, Juana; Gea, Joaquim; Barreiro, Esther] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Barreiro, E (corresponding author), Univ Pompeu Fabra, Dept Pulmonol, Muscle & Resp Syst Res Unit URMAR, IMIM Hosp del Mar,Hlth & Expt Sci Dept CEXS, Parc Salut Mar,Barcelona Biomed Res Pk PRBB, Barcelona, Spain.	ebarreiro@imim.es	Gea, Joaquim/E-4841-2014	Gea, Joaquim/0000-0001-8718-7346; Ausin, Pilar/0000-0003-4559-567X	Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES); Fondo de Investigaciones Sanitarias (FIS) [11/02029]; FIS [12/02534]; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); FUCAP; Marato TV3 (Spain) [MTV3-07-1010]; European Respiratory Society (ERS) COPD Research Award;  [SAF-2011-26908];  [2009-SGR-393]	Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Fundacio Catalana de Pneumologia (FUCAP); FUCAP; Marato TV3 (Spain); European Respiratory Society (ERS) COPD Research Award; ; 	This study has been supported by Centro de Investigacion en Red de Enfermedades Respiratorias (CIBERES); Fondo de Investigaciones Sanitarias (FIS) 11/02029; FIS 12/02534; SAF-2011-26908; 2009-SGR-393; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) 2009; Fundacio Catalana de Pneumologia (FUCAP) 2011; FUCAP 2012; and Marato TV3 (MTV3-07-1010) (Spain). Dr. Esther Barreiro was a recipient of the European Respiratory Society (ERS) COPD Research Award 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Natanek SA, 2011, ARCH BRONCONEUMOL, V47, P296, DOI 10.1016/j.arbres.2011.02.015; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Barreiro E, 2005, AM J RESP CRIT CARE, V171, P1116, DOI 10.1164/rccm.200407-887OC; Barreiro E, 2009, THORAX, V64, P13, DOI 10.1136/thx.2008.105163; Barreiro E, 2013, J APPL PHYSIOL, V114, P1263, DOI 10.1152/japplphysiol.01027.2012; Barreiro E, 2011, J APPL PHYSIOL, V111, P808, DOI 10.1152/japplphysiol.01017.2010; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Donaldson A, 2013, THORAX, V68, P1140, DOI 10.1136/thoraxjnl-2012-203129; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Gagnon P, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-4; Gayan-Ramirez G, 2013, J APPL PHYSIOL, V114, P1291, DOI 10.1152/japplphysiol.00847.2012; Gea J, 2013, J APPL PHYSIOL, V114, P1222, DOI 10.1152/japplphysiol.00981.2012; Hadoux J, 2014, INT J CANCER, V135, P2711, DOI 10.1002/ijc.28913; Hussain SNA, 2013, J APPL PHYSIOL, V114, P1273, DOI 10.1152/japplphysiol.00893.2012; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maltais Francois, 2014, Am J Respir Crit Care Med, V189, pe15, DOI 10.1164/rccm.201402-0373ST; Marin-Corral J, 2009, EUR RESPIR J, V33, P1309, DOI 10.1183/09031936.00072008; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P1, DOI 10.1016/S0300-2896(14)70070-5; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P247, DOI 10.1016/j.arbres.2012.04.001; Miravitlles M, 2012, ARCH BRONCONEUMOL, V48, P86, DOI 10.1016/j.arbres.2011.10.007; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Ortega F, 2002, AM J RESP CRIT CARE, V166, P669, DOI 10.1164/rccm.2107081; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puente-Maestu L, 2013, J APPL PHYSIOL, V114, P1282, DOI 10.1152/japplphysiol.00815.2012; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Rieger-Reyes C, 2014, ARCH BRONCONEUMOL, V50, P129, DOI 10.1016/j.arbres.2013.09.014; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Roca J, 1998, RESP MED, V92, P454, DOI 10.1016/S0954-6111(98)90291-8; ROCA J, 1990, AM REV RESPIR DIS, V141, P1026, DOI 10.1164/ajrccm/141.4_Pt_1.1026; Rodriguez DA, 2012, FREE RADICAL BIO MED, V52, P88, DOI 10.1016/j.freeradbiomed.2011.09.022; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sancho-Munoz A, 2014, ARCH BRONCONEUMOL, V50, P221, DOI 10.1016/j.arbres.2013.10.011; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Shrikrishna D, 2012, EUR RESPIR J, V40, P1115, DOI 10.1183/09031936.00170111; Slot IGM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090150; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; van den Borst B, 2013, J APPL PHYSIOL, V114, P1319, DOI 10.1152/japplphysiol.00508.2012; Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35	56	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102296	10.1371/journal.pone.0102296	http://dx.doi.org/10.1371/journal.pone.0102296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013984	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400085
J	Schmitt, DR; Kuper, J; Elias, A; Kisker, C				Schmitt, Dominik R.; Kuper, Jochen; Elias, Agnes; Kisker, Caroline			The Structure of the TFIIH p34 Subunit Reveals a Von Willebrand Factor A Like Fold	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; SNAKE-VENOM; P44 SUBUNIT; DNA; DOMAIN; REPAIR; DISSOCIATION; ARCHITECTURE	RNA polymerase II dependent transcription and nucleotide excision repair are mediated by a multifaceted interplay of subunits within the general transcription factor II H (TFIIH). A better understanding of the molecular structure of TFIIH is the key to unravel the mechanism of action of this versatile protein complex within these vital cellular processes. The importance of this complex becomes further evident in the context of severe diseases like xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy, that arise from single point mutations in TFIIH subunits. Here we describe the structure of the p34 subunit of the TFIIH complex from the eukaryotic thermophilic fungus Chaetomium thermophilum. The structure revealed that p34 contains a von Willebrand Factor A (vWA) like domain, a fold which is generally known to be involved in protein-protein interactions. Within TFIIH p34 strongly interacts with p44, a positive regulator of the helicase XPD. Putative protein-protein interfaces are analyzed and possible binding sites for the p34-p44 interaction suggested.	[Schmitt, Dominik R.; Kuper, Jochen; Elias, Agnes; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany	University of Wurzburg	Kisker, C (corresponding author), Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019	Kisker, Caroline/0000-0002-0216-6026	Deutsche Forschungsgemeinschaft [KI-562/2, Forschungszentrum FZ-82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft (KI-562/2 and Forschungszentrum FZ-82). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguilar-Fuentes J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000253; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andressoo JO, 2005, MUTAT RES-FUND MOL M, V577, P179, DOI 10.1016/j.mrfmmm.2005.04.004; [Anonymous], PYMOL MOL GRAPH SYST; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bedez F, 2013, GENOMICS, V101, P178, DOI 10.1016/j.ygeno.2012.11.003; Busso D, 2000, J BIOL CHEM, V275, P22815, DOI 10.1074/jbc.M002578200; Castro J, 2002, DNA REPAIR, V1, P359, DOI 10.1016/S1568-7864(02)00012-5; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chen J, 2003, CELL CYCLE, V2, P503, DOI 10.4161/cc.2.6.558; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Fribourg S, 2001, J MOL BIOL, V306, P363, DOI 10.1006/jmbi.2000.4376; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Hashimoto S, 2009, HUM MOL GENET, V18, pR224, DOI 10.1093/hmg/ddp390; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kainov DE, 2010, DNA REPAIR, V9, P33, DOI 10.1016/j.dnarep.2009.10.002; Kellenberger E, 2005, J BIOL CHEM, V280, P20785, DOI 10.1074/jbc.M412999200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraemer Kenneth H, 2007, Mech Ageing Dev, V128, P229, DOI 10.1016/j.mad.2006.11.028; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mourgues S, 2013, P NATL ACAD SCI USA, V110, P17927, DOI 10.1073/pnas.1305009110; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Riedinger C, 2010, J BIOL CHEM, V285, P33992, DOI 10.1074/jbc.M110.134510; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sahin Erinc, 2012, Methods Mol Biol, V899, P403, DOI 10.1007/978-1-61779-921-1_25; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Tremeau-Bravard A, 2001, J BIOL CHEM, V276, P27693, DOI 10.1074/jbc.M102457200; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	57	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102389	10.1371/journal.pone.0102389	http://dx.doi.org/10.1371/journal.pone.0102389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013903	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400092
J	Zhang, W; Hetzel, A; Shah, B; Atchley, D; Blume, SR; Padival, MA; Rosenkranz, JA				Zhang, Wei; Hetzel, Andrea; Shah, Bijal; Atchley, Derek; Blume, Shannon R.; Padival, Mallika A.; Rosenkranz, J. Amiel			Greater Physiological and Behavioral Effects of Interrupted Stress Pattern Compared to Daily Restraint Stress in Rats	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; CORTICOTROPIN-RELEASING-FACTOR; BODY-WEIGHT; PLASMA-CATECHOLAMINE; SOCIAL STRESS; ADRENAL AXIS; CORTICOSTERONE RESPONSE; COLONIC TRANSIT; VARIABLE STRESS; LIFE STRESS	Repeated stress can trigger a range of psychiatric disorders, including anxiety. The propensity to develop abnormal behaviors after repeated stress is related to the severity, frequency and number of stressors. However, the pattern of stress exposure may contribute to the impact of stress. In addition, the anxiogenic nature of repeated stress exposure can be moderated by the degree of coping that occurs, and can be reflected in homotypic habituation to the repeated stress. However, expectations are not clear when a pattern of stress presentation is utilized that diminishes habituation. The purpose of these experiments is to test whether interrupted stress exposure decreases homotypic habituation and leads to greater effects on anxiety-like behavior in adult male rats. We found that repeated interrupted restraint stress resulted in less overall homotypic habituation compared to repeated daily restraint stress. This was demonstrated by greater production of fecal boli and greater corticosterone response to restraint. Furthermore, interrupted restraint stress resulted in a lower body weight and greater adrenal gland weight than daily restraint stress, and greater anxiety-like behavior in the elevated plus maze. Control experiments demonstrated that these effects of the interrupted pattern could not be explained by differences in the total number of stress exposures, differences in the total number of days that the stress periods encompased, nor could it be explained as a result of only the stress exposures after an interruption from stress. These experiments demonstrate that the pattern of stress exposure is a significant determinant of the effects of repeated stress, and that interrupted stress exposure that decreases habituation can have larger effects than a greater number of daily stress exposures. Differences in the pattern of stress exposure are therefore an important factor to consider when predicting the severity of the effects of repeated stress on psychiatric disorders.	[Zhang, Wei; Hetzel, Andrea; Shah, Bijal; Atchley, Derek; Blume, Shannon R.; Padival, Mallika A.; Rosenkranz, J. Amiel] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Rosenkranz, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA.	amiel.rosenkranz@rosalindfranklin.edu			National Institutes of Health [MH84970]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research was funded by National Institutes of Health (www.nih.gov; MH84970) to JAR. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 1996, ENDOCR RES, V22, P433, DOI 10.1080/07435809609043729; ARMARIO A, 1988, NEUROENDOCRINOLOGY, V47, P263, DOI 10.1159/000124921; ARMARIO A, 1986, NEUROSCI BIOBEHAV R, V10, P245, DOI 10.1016/0149-7634(86)90011-4; BARONE FC, 1990, AM J PHYSIOL, V258, pG329, DOI 10.1152/ajpgi.1990.258.3.G329; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bevans K, 2008, DEV PSYCHOPATHOL, V20, P257, DOI 10.1017/S0954579408000126; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; BILLINGS AG, 1984, J PERS SOC PSYCHOL, V46, P877, DOI 10.1037/0022-3514.46.4.877; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Blanchard RJ, 1998, PHYSIOL BEHAV, V63, P561, DOI 10.1016/S0031-9384(97)00508-8; BROWN SA, 1990, J ABNORM PSYCHOL, V99, P344, DOI 10.1037/0021-843X.99.4.344; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; DEBOER SF, 1989, PHYSIOL BEHAV, V45, P789, DOI 10.1016/0031-9384(89)90296-5; DESOUZA EB, 1982, ENDOCRINOLOGY, V110, P23, DOI 10.1210/endo-110-1-23; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; GAMALLO A, 1986, PHYSIOL BEHAV, V36, P217, DOI 10.1016/0031-9384(86)90006-5; Gray M, 2010, J NEUROENDOCRINOL, V22, P92, DOI 10.1111/j.1365-2826.2009.01941.x; Grissom N, 2008, BEHAV BRAIN RES, V191, P219, DOI 10.1016/j.bbr.2008.03.030; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Harris RBS, 2002, PHYSIOL BEHAV, V76, P543, DOI 10.1016/S0031-9384(02)00754-0; Harris RBS, 2006, HORM BEHAV, V49, P615, DOI 10.1016/j.yhbeh.2005.12.001; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; KANT GJ, 1985, PHARMACOL BIOCHEM BE, V22, P631; Kearns RR, 2013, PHYSIOL BEHAV, V122, P193, DOI 10.1016/j.physbeh.2013.03.029; Kendler KS, 2001, PSYCHOL MED, V31, P411, DOI 10.1017/S0033291701003622; KONARSKA M, 1990, PHYSIOL BEHAV, V47, P647, DOI 10.1016/0031-9384(90)90072-C; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Li HY, 1998, J COMP NEUROL, V393, P244; Ma XM, 1998, J PHYSIOL-LONDON, V510, P605, DOI 10.1111/j.1469-7793.1998.605bk.x; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Marin TJ, 2007, HEALTH PSYCHOL, V26, P447, DOI 10.1037/0278-6133.26.4.447; Marti, 1997, Stress, V1, P179; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; MARTI O, 1993, PSYCHONEUROENDOCRINO, V18, P67, DOI 10.1016/0306-4530(93)90056-Q; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; MEERLO P, 1996, STRESS, V1, P21, DOI DOI 10.3109/10253899609001093; MONNIKES H, 1993, GASTROENTEROLOGY, V104, P716; MOTOWIDLO SJ, 1986, J APPL PSYCHOL, V71, P618, DOI 10.1037/0021-9010.71.4.618; NATELSON BH, 1988, PHYSIOL BEHAV, V43, P41, DOI 10.1016/0031-9384(88)90096-0; ORR TE, 1990, PSYCHONEUROENDOCRINO, V15, P317, DOI 10.1016/0306-4530(90)90057-G; Ostrander MM, 2006, ENDOCRINOLOGY, V147, P2008, DOI 10.1210/en.2005-1041; PITMAN DL, 1995, BEHAV NEUROSCI, V109, P767, DOI 10.1037/0735-7044.109.4.767; PITMAN DL, 1990, BEHAV NEUROSCI, V104, P28, DOI 10.1037/0735-7044.104.1.28; PITMAN DL, 1988, PHYSIOL BEHAV, V43, P47, DOI 10.1016/0031-9384(88)90097-2; Rabasa C, 2013, STRESS, V16, P698, DOI 10.3109/10253890.2013.824964; Rabasa C, 2011, PHYSIOL BEHAV, V103, P125, DOI 10.1016/j.physbeh.2011.02.022; RATNER A, 1989, PSYCHONEUROENDOCRINO, V14, P393, DOI 10.1016/0306-4530(89)90008-5; Ruis MAW, 1999, PSYCHONEUROENDOCRINO, V24, P285, DOI 10.1016/S0306-4530(98)00050-X; SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7; Smith AS, 2013, STRESS, V16, P531, DOI 10.3109/10253890.2013.794449; Stamp JA, 1999, NEUROSCIENCE, V94, P1313, DOI 10.1016/S0306-4522(99)00368-1; Tamashiro KLK, 2007, AM J PHYSIOL-REG I, V293, pR1864, DOI 10.1152/ajpregu.00371.2007; TERRAZZINO S, 1995, J NEUROCHEM, V65, P263; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; WILLIAMS CL, 1987, AM J PHYSIOL, V253, pG582, DOI 10.1152/ajpgi.1987.253.4.G582; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026	60	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102247	10.1371/journal.pone.0102247	http://dx.doi.org/10.1371/journal.pone.0102247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014526	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400081
J	Fitzgerald, AJ; Pickwell-MacPherson, E; Wallace, VP				Fitzgerald, Anthony J.; Pickwell-MacPherson, Emma; Wallace, Vincent P.			Use of Finite Difference Time Domain Simulations and Debye Theory for Modelling the Terahertz Reflection Response of Normal and Tumour Breast Tissue	PLOS ONE			English	Article							HUMAN SKIN; DIELECTRIC-RELAXATION; EX-VIVO; IN-VIVO; SPECTROSCOPY; CANCER; GEOMETRY; WATER	The aim of this work was to evaluate the capabilities of Debye theory combined with Finite Difference Time Domain (FDTD) methods to simulate the terahertz (THz) response of breast tissues. Being able to accurately model breast tissues in the THz regime would facilitate the understanding of image contrast parameters used in THz imaging of breast cancer. As a test case, the model was first validated using liquid water and simulated reflection pulses were compared to experimental measured pulses with very good agreement (p = 1.00). The responses of normal and cancerous breast tissues were simulated with Debye properties and the correlation with measured data was still high for tumour (p = 0.98) and less so for normal breast (p = 0.82). Sections of the time domain pulses showed clear differences that were also evident in the comparison of pulse parameter values. These deviations may arise from the presence of adipose and other inhomogeneities in the breast tissue that are not accounted for when using the Debye model. In conclusion, the study demonstrates the power of the model for simulating THz reflection imaging; however, for biological tissues extra Debye terms or a more detailed theory may be required to link THz image contrast to physiological composition and structural changes of breast tissue associated with differences between normal and tumour tissues.	[Fitzgerald, Anthony J.; Wallace, Vincent P.] Univ Western Australia, Sch Phys, Nedlands, WA 6009, Australia; [Pickwell-MacPherson, Emma] Chinese Univ Hong Kong, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China	University of Western Australia; Chinese University of Hong Kong	Wallace, VP (corresponding author), Univ Western Australia, Sch Phys, Nedlands, WA 6009, Australia.	vincent.wallace@uwa.edu.au	Wallace, Vincent P/A-9320-2012; MacPherson, Emma/AAO-5260-2020	Wallace, Vincent P/0000-0003-3814-5400; MacPherson, Emma/0000-0001-6062-5959	Australia Research Council [DP1096514]	Australia Research Council(Australian Research Council)	We acknowledge funding from the Australia Research Council (DP1096514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth P, 2008, INTRAOPERATIVE THZ P; Ashworth PC, 2009, OPT EXPRESS, V17, P12444, DOI 10.1364/OE.17.012444; Bennett DB, 2011, IEEE SENS J, V11, P1253, DOI 10.1109/JSEN.2010.2088387; Brun MA, 2010, PHYS MED BIOL, V55, P4615, DOI 10.1088/0031-9155/55/16/001; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Chen H, 2011, OPT EXPRESS, V19, P21552, DOI 10.1364/OE.19.021552; Chen H, 2011, OPT EXPRESS, V19, P19523, DOI 10.1364/OE.19.019523; Cole BE, 2001, PROC SPIE, V4276, P1, DOI 10.1117/12.448865; Debye P., 1913, INTERSCIENCE NEW YOR, V15, P777; Eadie LH, 2013, EXPERT SYST APPL, V40, P2043, DOI 10.1016/j.eswa.2012.10.019; Feldman Y, 2002, CHEM PHYS, V284, P139, DOI 10.1016/S0301-0104(02)00545-1; Fitzgerald AJ, 2006, RADIOLOGY, V239, P533, DOI 10.1148/radiol.2392041315; Fitzgerald AJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016005; Huang S, 2009, OPT EXPRESS, V17, P3848, DOI 10.1364/OE.17.003848; Ji YB, 2009, OPT EXPRESS, V17, P17082, DOI 10.1364/OE.17.017082; Joseph CS, 2011, LASER SURG MED, V43, P457, DOI 10.1002/lsm.21078; Jung E, 2011, J OPT SOC KOREA, V15, P155, DOI 10.3807/JOSK.2011.15.2.155; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; LIEBE HJ, 1991, INT J INFRARED MILLI, V12, P659, DOI 10.1007/BF01008897; Oh SJ, 2009, OPT EXPRESS, V17, P3469, DOI 10.1364/OE.17.003469; Pickwell E, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2137667; Pickwell E, 2004, PHYS MED BIOL, V49, P1595, DOI 10.1088/0031-9155/49/9/001; Pickwell E, 2004, APPL PHYS LETT, V84, P2190, DOI 10.1063/1.1688448; Pickwell-MacPherson E, 2012, P SOC PHOTO-OPT INS, V8221, p82210M; Pickwell-MacPherson E, 2007, IEEE MTT S INT MICR, P1375; Png GM, 2009, ELECTRON LETT, V45, P343, DOI 10.1049/el.2009.3413; Reid CB, 2011, PHYS MED BIOL, V56, P4333, DOI 10.1088/0031-9155/56/14/008; Reid CB, 2010, PHYS MED BIOL, V55, P4825, DOI 10.1088/0031-9155/55/16/013; Ronne C, 1997, J CHEM PHYS, V107, P5319, DOI 10.1063/1.474242; Ronne C, 2002, J MOL LIQUIDS, V101; Sy S, 2010, PHYS MED BIOL, V55, P7587, DOI 10.1088/0031-9155/55/24/013; Taday P. F., 2004, Spectroscopy Europe, V16, P20; Truong BCQ, 2012, IEEE ENG MED BIO, P5474, DOI 10.1109/EMBC.2012.6347233; Truong BCQ, 2012, 2012 FOURTH INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND ELECTRONICS (ICCE), P364, DOI 10.1109/CCE.2012.6315929; Wahaia F, 2011, J MOL STRUCT, V1006, P77, DOI 10.1016/j.molstruc.2011.05.049; Wallace VP, 2004, BRIT J DERMATOL, V151, P424, DOI 10.1111/j.1365-2133.2004.06129.x; Wallace VP, 2004, FARADAY DISCUSS, V126, P255, DOI 10.1039/b309357n; Woodward RM, 2002, P SOC PHOTO-OPT INS, V4625, P160, DOI 10.1117/12.469785; Woodward RM, 2002, PHYS MED BIOL, V47, P3853, DOI 10.1088/0031-9155/47/21/325; Yaroslavsky A, 2012, LASER SURG MED, V44, P36	40	32	34	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e99291	10.1371/journal.pone.0099291	http://dx.doi.org/10.1371/journal.pone.0099291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010734	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800001
J	Karatayev, VA; Karatayev, AY; Burlakova, LE; Rudstam, LG				Karatayev, Vadim A.; Karatayev, Alexander Y.; Burlakova, Lyubov E.; Rudstam, Lars G.			Eutrophication and Dreissena Invasion as Drivers of Biodiversity: A Century of Change in the Mollusc Community of Oneida Lake	PLOS ONE			English	Article							POLYMORPHA PALLAS INVASION; FRESH-WATER BIODIVERSITY; ZEBRA MUSSELS; BENTHIC INVERTEBRATES; INTERMEDIATE HOST; GENETIC-STRUCTURE; SHALLOW LAKES; ECOSYSTEM; IMPACTS; STATE	Changes in nutrient loading and invasive species are among the strongest human-driven disturbances in freshwater ecosystems, but our knowledge on how they affect the biodiversity of lakes is still limited. We conducted a detailed historical analysis of the mollusc community of Oneida Lake based on our comprehensive lakewide study in 2012 and previous surveys dating back to 1915. In the early 20th century, the lake had a high water clarity, with abundant macrophytes and benthic algae, and hosted the most diverse molluscan community in New York State, including 32 gastropod and 9 unionid species. By the 1960s, lake turbidity increased during a period of anthropogenic eutrophication, resulting in a 38% decline in species richness and a 95% reduction in abundance of native gastropods grazing on benthic algae. Following the invasion of Dreissena spp. in 1991 and subsequent increases in water clarity, native gastropod species richness expanded by 37% and abundance increased 20-fold by 2012. In contrast, filter-feeding unionids were unaffected by increased turbidity during the period of eutrophication but were extirpated by dreissenids. Through contrasting effects on turbidity, eutrophication and Dreissena spp. have likely driven the observed changes in native grazing gastropods by affecting the abundance of light-limited benthic algae. Given the high species richness and ecological importance of benthic grazers, monitoring and managing turbidity is important in preserving molluscan diversity.	[Karatayev, Vadim A.] Cornell Univ, Off Undergrad Biol, Ithaca, NY 14850 USA; [Karatayev, Alexander Y.; Burlakova, Lyubov E.] SUNY Buffalo, Great Lakes Ctr, Buffalo, NY 14260 USA; [Burlakova, Lyubov E.] SUNY Buffalo, Res Fdn, Buffalo, NY 14260 USA; [Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Cornell Biol Field Stn, Bridgeport, NY USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cornell University	Karatayev, VA (corresponding author), Cornell Univ, Off Undergrad Biol, Ithaca, NY 14850 USA.	vkaratayev@ucdavis.edu		Karatayev, Vadim/0000-0001-7112-8069; Burlakova, Lyubov/0000-0002-2995-919X; Rudstam, Lars/0000-0002-3732-6368	Cornell University Agricultural Experiment Station federal formula funds; National Institute of Food and Agriculture (NIFA) [NYC-14453]; United States Department of Agriculture (USDA); Research Foundation for SUNY/Buffalo State	Cornell University Agricultural Experiment Station federal formula funds; National Institute of Food and Agriculture (NIFA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Research Foundation for SUNY/Buffalo State	This research was supported in part by the Cornell University Agricultural Experiment Station federal formula funds, Project No. NYC-14453 received from the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (USDA), and the Research Foundation for SUNY/Buffalo State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the view of NIFA, USDA, or SUNY RF.	Akcakaya H.R., 2006, KEY TOPICS CONSERVAT, P64; Baker F. C., 1916, NEW YORK STATE COLL, V16, P1; BAKER F. C., 1918, NEW YORK STATE COLL, V9, P1; Barbiero RP, 2011, J GREAT LAKES RES, V37, P78, DOI 10.1016/j.jglr.2010.11.013; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Botts PS, 1996, J N AM BENTHOL SOC, V15, P179, DOI 10.2307/1467947; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown KM, 2010, AQUAT ECOL SER, P277, DOI 10.1016/B978-0-12-374855-3.00010-8; Bunnell DB, 2014, BIOSCIENCE, V64, P26, DOI 10.1093/biosci/bit001; Burlakova LE, 2000, INT REV HYDROBIOL, V85, P529, DOI 10.1002/1522-2632(200011)85:5/6<529::AID-IROH529>3.3.CO;2-F; Burlakova LE, 2012, HYDROBIOLOGIA, V685, P121, DOI 10.1007/s10750-011-0791-4; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; CATTANEO A, 1987, CAN J FISH AQUAT SCI, V44, P296, DOI 10.1139/f87-038; Cecala RK, 2008, J INTEGR PLANT BIOL, V50, P1452, DOI 10.1111/j.1744-7909.2008.00755.x; Charbonnel N, 2002, J EVOLUTION BIOL, V15, P248, DOI 10.1046/j.1420-9101.2002.00381.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; DeVanna KM, 2011, J GREAT LAKES RES, V37, P632, DOI 10.1016/j.jglr.2011.07.005; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Fetzer WW, 2013, DISENTANGLING EFFECT; Fitzgerald DG, ONEIDA LAKE LONG TER; Gow JL, 2004, MOL ECOL, V13, P3561, DOI 10.1111/j.1365-294X.2004.02339.x; Greeson P. E, 1971, LIMNOLOGY ONEIDA LAK; HANSSON LA, 1990, FRESHWATER BIOL, V24, P265, DOI 10.1111/j.1365-2427.1990.tb00707.x; HARMAN WN, 1970, LIMNOL OCEANOGR, V15, P454, DOI 10.4319/lo.1970.15.3.0454; Harman WN, 2000, NAUTILUS, V114, P120; Harman WN, 1998, J FRESHWATER ECOL, V13, P207, DOI 10.1080/02705060.1998.9663608; Harman WN, 1993, SUNY ONEONTA BIOL FI, P202; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Ibelings BW, 2007, ECOSYSTEMS, V10, P4, DOI 10.1007/s10021-006-9009-4; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2003, LIMNOL OCEANOGR, V48, P1913, DOI 10.4319/lo.2003.48.5.1913; Johnson PD, 2013, FISHERIES, V38, P247, DOI 10.1080/03632415.2013.785396; Jokinen EH, 1992, NY STATE MUS B, V482, P1; Karatayev AY, 2008, HYDROBIOLOGIA, V605, P99, DOI 10.1007/s10750-008-9323-2; Karatayev AY, 2007, J SHELLFISH RES, V26, P205, DOI 10.2983/0730-8000(2007)26[205:TIBDPA]2.0.CO;2; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Karatayev AY, 1997, J SHELLFISH RES, V16, P187; KENKEL NC, 1986, ECOLOGY, V67, P919, DOI 10.2307/1939814; Kummu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020578; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lucy F.E., 2014, QUAGGA ZEBRA MUSSELS, V2nd ed., P623; Manly BFJ, 1992, DESIGN ANAL RES STUD; Mayer CM, 2002, J N AM BENTHOL SOC, V21, P616, DOI 10.2307/1468434; Mayer CM, 2001, CAN J FISH AQUAT SCI, V58, P2459, DOI 10.1139/cjfas-58-12-2459; Mayer CM., 2014, QUAGGA ZEBRA MUSSELS, V2, P575; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Mills EL, ONEIDA LAKE LONG TER; Muenscher WC, 1928, 17 NY CONS DEP ANN S, P140; Noble LR, 1968, EFFECT LIMNOLOGICAL; Pieczynska E, 1998, HYDROBIOLOGIA, V391, P9, DOI 10.1023/A:1003503731720; Ricciardi A, 1998, J ANIM ECOL, V67, P613, DOI 10.1046/j.1365-2656.1998.00220.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Romme WH, 1998, ECOSYSTEMS, V1, P524, DOI 10.1007/s100219900048; Rudstam LG, 2013, LIMNOLOGICAL DATA DE; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Stewart TW, 1998, J N AM BENTHOL SOC, V17, P81, DOI 10.2307/1468053; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Strayer DL, 2009, FRONT ECOL ENVIRON, V7, P135, DOI 10.1890/080020; Thorp JH, 2010, AQUAT ECOL SER, P1, DOI 10.1016/B978-0-12-374855-3.00001-7; Uddin MB, 2011, THESIS U BAYREUTH; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; vandenBerg MS, 1997, HYDROBIOLOGIA, V342, P143, DOI 10.1023/A:1017094013491; Vander Zanden MJ, 2011, ECOSYSTEMS, V14, P894, DOI 10.1007/s10021-011-9454-6; Viard F, 1997, EVOLUTION, V51, P1518, DOI [10.2307/2411204, 10.1111/j.1558-5646.1997.tb01475.x]; Zhu B, 2006, ECOSYSTEMS, V9, P1017, DOI 10.1007/s10021-005-0049-y	74	16	17	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101388	10.1371/journal.pone.0101388	http://dx.doi.org/10.1371/journal.pone.0101388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010705	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800023
J	Rossi, E; Radi, O; De Lorenzi, L; Vetro, A; Groppetti, D; Bigliardi, E; Luvoni, GC; Rota, A; Camerino, G; Zuffardi, O; Parma, P				Rossi, Elena; Radi, Orietta; De Lorenzi, Lisa; Vetro, Annalisa; Groppetti, Debora; Bigliardi, Enrico; Luvoni, Gaia Cecilia; Rota, Ada; Camerino, Giovanna; Zuffardi, Orsetta; Parma, Pietro			Sox9 Duplications Are a Relevant Cause of Sry-Negative XX Sex Reversal Dogs	PLOS ONE			English	Article							TESTIS DEVELOPMENT; REGION UPSTREAM; GENE; DIFFERENTIATION; GENOME; EXPRESSION; MUTATIONS; ENHANCER; MAMMALS; PROTEIN	Sexual development in mammals is based on a complicated and delicate network of genes and hormones that have to collaborate in a precise manner. The dark side of this pathway is represented by pathological conditions, wherein sexual development does not occur properly either in the XX and the XY background. Among them a conundrum is represented by the XX individuals with at least a partial testis differentiation even in absence of SRY. This particular condition is present in various mammals including the dog. Seven dogs characterized by XX karyotype, absence of SRY gene, and testicular tissue development were analysed by Array-CGH. In two cases the array-CGH analysis detected an interstitial heterozygous duplication of chromosome 9. The duplication contained the SOX9 coding region. In this work we provide for the first time a causative mutation for the XXSR condition in the dog. Moreover this report supports the idea that the dog represents a good animal model for the study of XXSR condition caused by abnormalities in the SOX9 locus.	[Rossi, Elena; Radi, Orietta; Camerino, Giovanna; Zuffardi, Orsetta] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [De Lorenzi, Lisa; Parma, Pietro] Univ Milan, Dept Agr & Environm Sci, Milan, Italy; [Vetro, Annalisa] Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Pavia, Italy; [Groppetti, Debora] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Bigliardi, Enrico] Univ Parma, Dept Vet Sci, I-43100 Parma, Italy; [Luvoni, Gaia Cecilia] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Rota, Ada] Univ Turin, Dept Vet Sci, Turin, Italy	University of Pavia; University of Milan; IRCCS Fondazione San Matteo; University of Milan; University of Parma; University of Milan; University of Turin	Parma, P (corresponding author), Univ Milan, Dept Agr & Environm Sci, Milan, Italy.	pietro.parma@unimi.it	Groppetti, Debora/U-3648-2019; Vetro, Annalisa/J-8203-2018; Groppetti, Debora/K-5939-2017; Luvoni, Gaia Cecilia/M-4339-2019; Rossi, Elena/O-1664-2016	Vetro, Annalisa/0000-0003-2437-7526; Groppetti, Debora/0000-0003-0566-1580; Luvoni, Gaia Cecilia/0000-0002-9598-9098; Rossi, Elena/0000-0001-9152-435X; bigliardi, enrico/0000-0001-7969-1518; zuffardi, orsetta/0000-0002-1466-4559; Rota, Ada/0000-0002-4765-9764; Parma, Pietro/0000-0003-1544-6673				Bannasch D, 2007, VET J, V173, P437, DOI 10.1016/j.tvjl.2005.11.008; Benko S, 2011, J MED GENET, V48, P825, DOI 10.1136/jmedgenet-2011-100255; Berglund J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r73; Bigliardi E, REPROD BIOL ENDOCRIN, V9, P12; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Chen YS, 2013, P NATL ACAD SCI USA, V110, pE3567, DOI 10.1073/pnas.1300828110; Cox JJ, 2011, NEW ENGL J MED, V364, P91, DOI 10.1056/NEJMc1010311; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Lorenzi L, 2008, SEX DEV, V2, P84, DOI 10.1159/000129693; De Lorenzi L, 2010, CYTOGENET GENOME RES, V129, P298, DOI 10.1159/000315891; DEGROUCHY J, 1964, ANN GENET-PARIS, V7, pG45; Fonseca ACS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-50; Georg I, 2010, SEX DEV, V4, P321, DOI 10.1159/000320142; Groppetti D, 2012, SEX DEV, V6, P135, DOI 10.1159/000331274; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Meyers-Wallen VN, 2009, REPROD DOMEST ANIM, V44, P40, DOI 10.1111/j.1439-0531.2009.01433.x; Montazer-Torbati F, 2010, DEV DYNAM, V239, P3324, DOI 10.1002/dvdy.22452; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; PAILHOUX E, 1994, ANIM GENET, V25, P299, DOI 10.1111/j.1365-2052.1994.tb00362.x; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; PAILHOUX E, 1994, J REPROD FERTIL, V100, P491, DOI 10.1530/jrf.0.1000491; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Pujar S, 2007, J HERED, V98, P438, DOI 10.1093/jhered/esm028; Quilez J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-339; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Rota A, 2010, REPROD DOMEST ANIM, V45, P743, DOI 10.1111/j.1439-0531.2008.01335.x; Sekido R, 2013, SEX DEV, V7, P21, DOI 10.1159/000342221; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SELDEN JR, 1984, HUM GENET, V67, P62, DOI 10.1007/BF00270560; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Vetro A, 2011, J MED GENET, V48, P710, DOI 10.1136/jmedgenet-2011-100036; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wachtel SS, 1994, MOL GENETICS SEX DET, P267; WILKER CE, 1994, J AM VET MED ASSOC, V204, P112; Xiao B, 2013, EUR J MED GENET, V56, P695, DOI 10.1016/j.ejmg.2013.10.001	43	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101244	10.1371/journal.pone.0101244	http://dx.doi.org/10.1371/journal.pone.0101244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010117	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800016
J	Gonzalez, OJA; van Aerde, KI; Mansvelder, HD; van Pelt, J; van Ooyen, A				Gonzalez, Oscar J. Avella; van Aerde, Karlijn I.; Mansvelder, Huibert D.; van Pelt, Jaap; van Ooyen, Arjen			Inter-Network Interactions: Impact of Connections between Oscillatory Neuronal Networks on Oscillation Frequency and Pattern	PLOS ONE			English	Article							LONG-RANGE SYNCHRONIZATION; GAMMA OSCILLATIONS; BETA RHYTHMS; TEMPORAL CORRELATIONS; BRAIN OSCILLATIONS; THETA-OSCILLATIONS; REALISTIC NETWORK; WORKING-MEMORY; HIPPOCAMPUS; INHIBITION	Oscillations in electrical activity are a characteristic feature of many brain networks and display a wide variety of temporal patterns. A network may express a single oscillation frequency, alternate between two or more distinct frequencies, or continually express multiple frequencies. In addition, oscillation amplitude may fluctuate over time. The origin of this complex repertoire of activity remains unclear. Different cortical layers often produce distinct oscillation frequencies. To investigate whether interactions between different networks could contribute to the variety of oscillation patterns, we created two model networks, one generating on its own a relatively slow frequency (20 Hz; slow network) and one generating a fast frequency (32 Hz; fast network). Taking either the slow or the fast network as source network projecting connections to the other, or target, network, we systematically investigated how type and strength of inter-network connections affected target network activity. For high inter-network connection strengths, we found that the slow network was more effective at completely imposing its rhythm on the fast network than the other way around. The strongest entrainment occurred when excitatory cells of the slow network projected to excitatory or inhibitory cells of the fast network The fast network most strongly imposed its rhythm on the slow network when its excitatory cells projected to excitatory cells of the slow network. Interestingly, for lower inter-network connection strengths, multiple frequencies coexisted in the target network. Just as observed in rat prefrontal cortex, the target network could express multiple frequencies at the same time, alternate between two distinct oscillation frequencies, or express a single frequency with alternating episodes of high and low amplitude. Together, our results suggest that input from other oscillating networks may markedly alter a network's frequency spectrum and may partly be responsible for the rich repertoire of temporal oscillation patterns observed in the brain.	[Gonzalez, Oscar J. Avella; van Aerde, Karlijn I.; Mansvelder, Huibert D.; van Pelt, Jaap; van Ooyen, Arjen] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Ooyen, A (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands.	arjen.van.ooyen@falw.vu.nl	Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	EC Marie Curie Research and Training Network (RTN), NEURoVERS-it [019247]	EC Marie Curie Research and Training Network (RTN), NEURoVERS-it	OJAG was supported by a grant from the EC Marie Curie Research and Training Network (RTN), NEURoVERS-it 019247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 2011, J NEUROSCI, V31, P17040, DOI 10.1523/JNEUROSCI.2209-11.2011; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Bazhenov M, 2008, J NEUROPHYSIOL, V100, P1562, DOI 10.1152/jn.90613.2008; BIANCHI R, 1994, J NEUROPHYSIOL, V72, P131, DOI 10.1152/jn.1994.72.1.131; Bibbig A, 2002, J NEUROPHYSIOL, V88, P1634, DOI 10.1152/jn.2002.88.4.1634; Bibbig A, 2007, J NEUROPHYSIOL, V97, P2812, DOI 10.1152/jn.01105.2006; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; BORISYUK GN, 1995, B MATH BIOL, V57, P809, DOI 10.1016/S0092-8240(95)80002-6; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Buia C, 2006, J COMPUT NEUROSCI, V20, P247, DOI 10.1007/s10827-006-6358-0; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Draguhn A, 2009, J PHYSIOL-LONDON, V587, P5297, DOI 10.1113/jphysiol.2009.182105; Engel AK, 1999, CONSCIOUS COGN, V8, P128, DOI 10.1006/ccog.1999.0389; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Gonzalez OJA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002666; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; Heistek TS, 2013, J PHYSIOL-LONDON, V591, P845, DOI 10.1113/jphysiol.2012.243725; Heistek TS, 2010, FRONTIERS CELLULAR N, V4, P1; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; JOHANSSON S, 1992, J PHYSIOL-LONDON, V445, P129, DOI 10.1113/jphysiol.1992.sp018915; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kopell N., 2002, HDB DYN SYST, V2, P3, DOI [10.1016/S1874-575X(02)80022-4, DOI 10.1016/S1874-575X(02)80022-4]; Lim DH, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00011; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Pauluis Q, 1999, J COMPUT NEUROSCI, V6, P27, DOI 10.1023/A:1008804916112; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pfurtscheller G, 2000, NEUROSCI LETT, V286, P66, DOI 10.1016/S0304-3940(00)01055-7; Poil SS, 2011, EUR J NEUROSCI, V34, P394, DOI 10.1111/j.1460-9568.2011.07748.x; Raffone A, 2001, J COGNITIVE NEUROSCI, V13, P766, DOI 10.1162/08989290152541430; Roopun AK, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.001.2008; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; van Aerde KI, 2009, J PHYSIOL-LONDON, V587, P5177, DOI 10.1113/jphysiol.2009.178384; van Aerde KI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002725; VANOOYEN A, 1992, BIOL CYBERN, V67, P269, DOI 10.1007/BF00204400; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Widmer H, 2006, HIPPOCAMPUS, V16, P617, DOI 10.1002/hipo.20191; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002	60	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100899	10.1371/journal.pone.0100899	http://dx.doi.org/10.1371/journal.pone.0100899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007325	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600024
J	Stapleton, S; LaRue, M; Lecomte, N; Atkinson, S; Garshelis, D; Porter, C; Atwood, T				Stapleton, Seth; LaRue, Michelle; Lecomte, Nicolas; Atkinson, Stephen; Garshelis, David; Porter, Claire; Atwood, Todd			Polar Bears from Space: Assessing Satellite Imagery as a Tool to Track Arctic Wildlife	PLOS ONE			English	Article							SURVIVAL	Development of efficient techniques for monitoring wildlife is a priority in the Arctic, where the impacts of climate change are acute and remoteness and logistical constraints hinder access. We evaluated high resolution satellite imagery as a tool to track the distribution and abundance of polar bears. We examined satellite images of a small island in Foxe Basin, Canada, occupied by a high density of bears during the summer ice-free season. Bears were distinguished from other light-colored spots by comparing images collected on different dates. A sample of ground-truthed points demonstrated that we accurately classified bears. Independent observers reviewed images and a population estimate was obtained using mark-recapture models. This estimate (N : 94; 95% Confidence Interval: 92-105) was remarkably similar to an abundance estimate derived from a line transect aerial survey conducted a few days earlier (N: 102; 95% CI: 69-152). Our findings suggest that satellite imagery is a promising tool for monitoring polar bears on land, with implications for use with other Arctic wildlife. Large scale applications may require development of automated detection processes to expedite review and analysis. Future research should assess the utility of multi-spectral imagery and examine sites with different environmental characteristics.	[Stapleton, Seth; Atwood, Todd] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Garshelis, David] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [LaRue, Michelle; Porter, Claire] Univ Minnesota, Dept Earth Sci, St Paul, MN 55108 USA; [Lecomte, Nicolas; Atkinson, Stephen] Govt Nunavut, Dept Environm, Igloolik, NU, Canada; [Garshelis, David] Minnesota Dept Nat Resources, Grand Rapids, MN USA	United States Department of the Interior; United States Geological Survey; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stapleton, S (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	stapl078@umn.edu		Lecomte, Nicolas/0000-0002-8473-5375				Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Boltunov A, 2012, SPACE TECHNOLOGY MAR; Buckland S.T., 2001, pi; Burkanov V, 2008, IUCN 2012 IUCN RED L; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Eberhardt L. L., 1979, WILDLIFE MONOGR, V63, P3; Fretwell PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033751; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lowry L, 2008, IUCN 2012 IUCN RED L; Marques TA, 2006, WILDLIFE SOC B, V34, P759, DOI 10.2193/0091-7648(2006)34[759:TUOGPS]2.0.CO;2; Maslowski W, 2012, ANNU REV EARTH PL SC, V40, P625, DOI 10.1146/annurev-earth-042711-105345; McDonald LL, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P37; Obbard M.E., 2010, P 15 WORK M IUCN SSC; OTIS DL, 1978, WILDLIFE MONOGR, P1; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Platonov NG, 2013, BIOL BULL+, V40, P197, DOI 10.1134/S1062359013020106; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; Schliebe S, 2008, IUCN 2013 IUCN RED L; Stapleton S, 2012, FOXE BASIN POLAR BEA; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Updike T., 2010, RADIOMETRIC USE WORL; Vongraven Dag, 2012, Ursus Monograph Series, V5, P1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	32	32	34	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101513	10.1371/journal.pone.0101513	http://dx.doi.org/10.1371/journal.pone.0101513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006979	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600041
J	Kodahl, AR; Zeuthen, P; Binder, H; Knoop, AS; Ditzel, HJ				Kodahl, Annette R.; Zeuthen, Pernille; Binder, Harald; Knoop, Ann S.; Ditzel, Henrik J.			Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women	PLOS ONE			English	Article							BLOOD-BASED MARKERS; MICRORNAS; SERUM; EXPRESSION; BIOMARKERS; PLASMA; RNAS	Introduction: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set. Methods: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR). Results: Numbers of specific miRNAs detected in the samples ranged from 142 to 161, with 107 miRNAs detectable in all samples. After correction for multiple comparisons, 3 circulating miRNAs (miR-338-3p, miR-223 and miR-148a) exhibited significantly lower, and 1 miRNA (miR-107) higher levels in post-operative vs. pre-operative samples (p<0.05). No miRNAs were consistently undetectable in the post-operative samples compared to the pre-operative samples. Subsequently, our findings were compared to a dataset from a comparable patient population analyzed using similar study design and the same qPCR profiling platform, resulting in limited agreement. Conclusions: A panel of 4 circulating miRNAs exhibited significantly altered levels following radical resection of primary ER+ breast cancers in post-menopausal women. These specific miRNAs may be involved in tumorigenesis and could potentially be used to monitor whether all cancer cells have been removed at surgery and/or, subsequently, whether the patients develop recurrence.	[Kodahl, Annette R.; Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Kodahl, Annette R.; Ditzel, Henrik J.] Univ Southern Denmark, Odense, Denmark; [Zeuthen, Pernille] Odense Univ Hosp, Dept Surg Z, DK-5000 Odense, Denmark; [Binder, Harald] Johannes Gutenberg Univ Mainz, IMBEI, D-55122 Mainz, Germany; [Knoop, Ann S.] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark; [Ditzel, Henrik J.] Univ Southern Denmark, Dept Canc & Inflammat, Inst Mol Med, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Johannes Gutenberg University of Mainz; Rigshospitalet; University of Copenhagen; University of Southern Denmark	Kodahl, AR (corresponding author), Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark.	annette.kodahl@rsyd.dk	Knoop, Ann Soeegaard/GLR-2775-2022; Binder, Harald/C-7413-2009	Knoop, Ann Soeegaard/0000-0003-2898-1093; Binder, Harald/0000-0002-5666-8662; Kodahl, Annette/0000-0003-0515-9144; Ditzel, Henrik J./0000-0003-3927-5135	Odense University Hospital; Region of Southern Denmark and University of Southern Denmark; A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation; Beckett Foundation; Danish Cancer Society; Danish Research Council; Danish Center for Translational Breast Cancer Research (DCTB); A Race Against Breast Cancer; The Danish Cancer Society [R99-A6362] Funding Source: researchfish	Odense University Hospital; Region of Southern Denmark and University of Southern Denmark; A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation; Beckett Foundation; Danish Cancer Society(Danish Cancer Society); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Center for Translational Breast Cancer Research (DCTB); A Race Against Breast Cancer; The Danish Cancer Society(Danish Cancer Society)	This study was supported by Odense University Hospital. The support for this research was provided by The Region of Southern Denmark (http://www.regionsyddanmark.dk/wm157175) and University of Southern Denmark (http://www.sdu.dk/en/). Further support was obtained from A. P. Moller and wife Chastine Mc-Kinney Mollers Foundation (http://www.apmollerfonde.dk/), Beckett Foundation (http://www.beckett-fonden.dk/), Danish Cancer Society (http://www.cancer.dk/), Danish Research Council (http://ufm.dk/en), Danish Center for Translational Breast Cancer Research (DCTB) and A Race Against Breast Cancer (http://www.araceagainstbreastcancer.dk/dctb/Service/En). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Chan M., 2013, CLIN CANC RES; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gong B, 2013, BIOMED PHARMACOTHER, V67, P629, DOI 10.1016/j.biopha.2013.06.006; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kodahl AR, 2014, MOL ONCOL, V8, P874, DOI 10.1016/j.molonc.2014.03.002; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; McDermott AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087032; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mirza NQ, 2002, ANN SURG ONCOL, V9, P256, DOI 10.1245/aso.2002.9.3.256; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Pinatel EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084859; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Siegel R., 2014, CA CANC J CLIN; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Wijnhoven BPL, 2007, BRIT J SURG, V94, P23, DOI 10.1002/bjs.5673; Wu Q, 2012, CLIN CHIM ACTA, V413, P1058, DOI 10.1016/j.cca.2012.02.016; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Yu J, 2011, J BIOMED RES, V25, P170, DOI 10.1016/S1674-8301(11)60022-5; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	38	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101950	10.1371/journal.pone.0101950	http://dx.doi.org/10.1371/journal.pone.0101950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004125	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700092
J	Amini, ZN; Olson, KE; Muller, UF				Amini, Zhaleh N.; Olson, Karen E.; Mueller, Ulrich F.			Spliceozymes: Ribozymes that Remove Introns from Pre-mRNAs in Trans	PLOS ONE			English	Article							GROUP-I INTRON; SELF-SPLICING RNA; GUANOSINE-BINDING-SITE; HUMAN CANCER-CELLS; TRANSSPLICING RIBOZYMES; TETRAHYMENA RIBOZYME; SELECTIVE INDUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MAMMALIAN-CELLS	Group I introns are pre-mRNA introns that do not require the spliceosome for their removal. Instead, they fold into complex three-dimensional structures and catalyze two transesterification reactions, thereby excising themselves and joining the flanking exons. These catalytic RNAs (ribozymes) have been modified previously to work in trans, whereby the ribozymes can recognize a splice site on a substrate RNA and replace the 5'- or 3'-portion of the substrate. Here we describe a new variant of the group I intron ribozyme from Tetrahymena that recognizes two splice sites on a substrate RNA, removes the intron sequences between the splice sites, and joins the flanking exons, analogous to the action of the spliceosome. This 'group I spliceozyme' functions in vitro and in vivo, and it is able to mediate a growth phenotype in E. coli cells. The intron sequences of the target pre-mRNAs are constrained near the splice sites but can carry a wide range of sequences in their interior. Because the splice site recognition sequences can be adjusted to different splice sites, the spliceozyme may have the potential for wide applications as tool in research and therapy.	[Amini, Zhaleh N.; Olson, Karen E.; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			National Institutes of Health [T32GM008326]; Hellman Family foundation [2011/2012, 2012/2013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hellman Family foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Molecular Biophysics Training Grant (grant number T32GM008326) to ZNA and by the Hellman Family foundation (http://www.hellmanfellows.org/hellman-fellows-fund/) with two fellowships (2011/2012 and 2012/2013) to UFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Alexander RC, 2005, BIOCHEMISTRY-US, V44, P7796, DOI 10.1021/bi047284a; Ayre BG, 1999, P NATL ACAD SCI USA, V96, P3507, DOI 10.1073/pnas.96.7.3507; Baum DA, 2005, RNA, V11, P897, DOI 10.1261/rna.2050505; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; Bell MA, 2004, BIOCHEMISTRY-US, V43, P4323, DOI 10.1021/bi035874n; Bell MA, 2002, BIOCHEMISTRY-US, V41, P15327, DOI 10.1021/bi0267386; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BURKE JM, 1989, FEBS LETT, V250, P129, DOI 10.1016/0014-5793(89)80704-5; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Dayie KT, 2008, RNA, V14, P1697, DOI 10.1261/rna.1154408; Dotson PP, 2008, NUCLEIC ACIDS RES, V36, P5281, DOI 10.1093/nar/gkn507; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; Hagen M, 1999, EMBO J, V18, P6491, DOI 10.1093/emboj/18.22.6491; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Hatton AR, 1998, MOL CELL, V2, P787, DOI 10.1016/S1097-2765(00)80293-2; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; Hsu SN, 2009, RNA BIOL, V6, P526, DOI 10.4161/rna.6.5.9860; INOUE T, 1985, CELL, V43, P431, DOI 10.1016/0092-8674(85)90173-4; Jones JT, 1997, NAT BIOTECHNOL, V15, P902, DOI 10.1038/nbt0997-902; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; LEGAULT P, 1992, NUCLEIC ACIDS RES, V20, P6613, DOI 10.1093/nar/20.24.6613; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; Nikolcheva T, 1999, J MOL BIOL, V292, P557, DOI 10.1006/jmbi.1999.3083; Olson KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086473; Olson KE, 2012, RNA, V18, P581, DOI 10.1261/rna.028472.111; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; Russell R, 1999, RNA, V5, P158, DOI 10.1017/S1355838299981839; Ryu KJ, 2003, MOL THER, V7, P386, DOI 10.1016/S1525-0016(02)00063-1; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; Shaw W V, 1975, Methods Enzymol, V43, P737; SHAW WV, 1967, J BIOL CHEM, V242, P687; Shin KS, 2004, MOL THER, V10, P365, DOI 10.1016/j.ymthe.2004.05.007; Song MS, 2006, FEBS LETT, V580, P5033, DOI 10.1016/j.febslet.2006.08.021; Stahley MR, 2006, CURR OPIN STRUC BIOL, V16, P319, DOI 10.1016/j.sbi.2006.04.005; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; TRITTON TR, 1979, ARCH BIOCHEM BIOPHYS, V197, P10, DOI 10.1016/0003-9861(79)90212-1; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; Watanabe T, 2000, P NATL ACAD SCI USA, V97, P8490, DOI 10.1073/pnas.150104097; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Will CL, 2011, COLD SPRING HARB PER, V3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	11	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101932	10.1371/journal.pone.0101932	http://dx.doi.org/10.1371/journal.pone.0101932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014025	Green Published, gold			2022-12-25	WOS:000339378400048
J	Giallongo, C; Parrinello, N; Tibullo, D; La Cava, P; Romano, A; Chiarenza, A; Barbagallo, I; Palumbo, GA; Stagno, F; Vigneri, P; Di Raimondo, F				Giallongo, Cesarina; Parrinello, Nunziatina; Tibullo, Daniele; La Cava, Piera; Romano, Alessandra; Chiarenza, Annalisa; Barbagallo, Ignazio; Palumbo, Giuseppe A.; Stagno, Fabio; Vigneri, Paolo; Di Raimondo, Francesco			Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients	PLOS ONE			English	Article							COMPLETE MOLECULAR REMISSION; CML PATIENTS; DENDRITIC CELLS; IMMUNE-RESPONSES; T-CELLS; IMATINIB; CANCER; DISCONTINUATION; RECRUITMENT; NEUTROPHILS	Tumor immune tolerance can derive from the recruitment of suppressor cell population, including myeloid derived suppressor cells (MDSCs), able to inhibit T cells activity. We identified a significantly expanded MDSCs population in chronic myeloid leukemia (CML) patients at diagnosis that decreased to normal levels after imatinib therapy. In addition, expression of arginase 1 (Arg1) that depletes microenvironment of arginine, an essential aminoacid for T cell function, resulted in an increase in patients at diagnosis. Purified CML CD11b+CD33+CD14-HLADR- cells markedly suppressed normal donor T cell proliferation in vitro. Comparing CML Gr-MDSCs to autologous polymorphonuclear leukocytes (PMNs) we observed a higher Arg1 expression and activity in PMNs, together with an inhibitory effect on T cells in vitro. Our data indicate that CML cells create an immuno-tolerant environment associated to MDSCs expansion with immunosuppressive capacity mediated by Arg1. In addition, we demonstrated for the first time also an immunosuppressive activity of CML PMNs, suggesting a strong potential immune escape mechanism created by CML cells, which control the anti-tumor reactive T cells. MDSCs should be monitored in imatinib discontinuation trials to understand their importance in relapsing patients.	[Giallongo, Cesarina; Parrinello, Nunziatina; Tibullo, Daniele; La Cava, Piera; Romano, Alessandra; Chiarenza, Annalisa; Palumbo, Giuseppe A.; Stagno, Fabio; Di Raimondo, Francesco] Univ Catania, Dept Clin & Mol Biomed, Ferrarotto Hosp, Sect Hematol, Catania, Italy; [Barbagallo, Ignazio] Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy; [Vigneri, Paolo] Univ Catania, Dept Pediat & Med Sci, Catania, Italy	University of Catania; University of Catania; University of Catania	Tibullo, D (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Ferrarotto Hosp, Sect Hematol, Catania, Italy.		TIBULLO, Daniele/AAC-1276-2019; Vigneri, Paolo G/K-8504-2016; Tibullo, Daniele/J-3946-2016; Romano, Alessandra/I-9201-2012; Stagno, Fabio/AAH-2033-2020; parrinello, nunziatina laura/J-4099-2016; Palumbo, Giuseppe/W-7072-2019; Giallongo, Cesarina/J-7225-2016; Di Raimondo, Francesco/K-7965-2016; Chiarenza, Annalisa/AAC-2013-2019	TIBULLO, Daniele/0000-0002-4416-8556; Vigneri, Paolo G/0000-0002-5943-6066; Tibullo, Daniele/0000-0002-4416-8556; Romano, Alessandra/0000-0002-6333-4433; Stagno, Fabio/0000-0002-7947-158X; parrinello, nunziatina laura/0000-0002-9978-2908; Palumbo, Giuseppe/0000-0003-1859-6319; Giallongo, Cesarina/0000-0002-7667-6088; Di Raimondo, Francesco/0000-0002-7749-0293; Chiarenza, Annalisa/0000-0002-8759-4854; Barbagallo, Ignazio/0000-0002-7761-0662	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	This study has been supported in part by A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania and by FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachy E, 2011, BRIT J HAEMATOL, V153, P139, DOI 10.1111/j.1365-2141.2010.08453.x; Bertazzoli C, 2000, CLIN CANCER RES, V6, P1931; Boelte KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018534; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Chen X, 2000, BRIT J HAEMATOL, V111, P817, DOI 10.1046/j.1365-2141.2000.02415.x; Chen XL, 2008, CANCER BIOL THER, V7, P622, DOI 10.4161/cbt.7.5.5689; Chikamatsu K, 2012, CANCER SCI, V103, P976, DOI 10.1111/j.1349-7006.2012.02248.x; Christiansson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055818; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Davies J, 2011, LANCET ONCOL, V12, P826, DOI 10.1016/S1470-2045(11)70228-5; Dong R, 2003, BLOOD, V101, P3560, DOI 10.1182/blood-2002-06-1841; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hus I, 2011, FOLIA HISTOCHEM CYTO, V49, P153, DOI 10.5603/FHC.2011.0022; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mellqvist UH, 2000, BLOOD, V96, P1961, DOI 10.1182/blood.V96.5.1961.h8001961_1961_1968; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Muller L, 2002, LEUKEMIA LYMPHOMA, V43, P943, DOI 10.1080/10428190290021687; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Ohyashiki K, 2012, BRIT J HAEMATOL, V157, P254, DOI 10.1111/j.1365-2141.2011.08939.x; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Pawelec G, 1996, CANCER IMMUNOL IMMUN, V42, P193, DOI 10.1007/s002620050270; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Rojas JM, 2010, EXP HEMATOL, V38, P1209, DOI 10.1016/j.exphem.2010.09.004; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Rotondo R, 2011, J LEUKOCYTE BIOL, V89, P721, DOI 10.1189/jlb.1109737; Rotondo R, 2009, INT J CANCER, V125, P887, DOI 10.1002/ijc.24448; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Simonsson B, 2011, CURR DRUG TARGETS, V12, P420, DOI 10.2174/138945011794815301; Thakur A, 2012, CANCER IMMUNOL IMMUN, V61, P497, DOI 10.1007/s00262-011-1116-1; Tibullo D, 2012, CURR PHARM DES; Van Rompaey N, 2011, METHODS MOL BIOL, V677, P169, DOI 10.1007/978-1-60761-869-0_12; Zitta K, 2012, MOL MED, V18, P29, DOI 10.2119/molmed.2011.00278	50	56	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101848	10.1371/journal.pone.0101848	http://dx.doi.org/10.1371/journal.pone.0101848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014230	Green Submitted, gold, Green Published			2022-12-25	WOS:000339378400041
J	Marcombe, S; Farajollahi, A; Healy, SP; Clark, GG; Fonseca, DM				Marcombe, Sebastien; Farajollahi, Ary; Healy, Sean P.; Clark, Gary G.; Fonseca, Dina M.			Insecticide Resistance Status of United States Populations of Aedes albopictus and Mechanisms Involved	PLOS ONE			English	Article							PYRETHROID RESISTANCE; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; GROWTH-REGULATORS; CULEX-PIPIENS; MOSQUITO; SUSCEPTIBILITY; AEGYPTI; DENGUE; VECTOR	Aedes albopictus (Skuse) is an invasive mosquito that has become an important vector of chikungunya and dengue viruses. Immature Ae. albopictus thrive in backyard household containers that require treatment with larvicides and when adult populations reach pest levels or disease transmission is ongoing, adulticiding is often required. To assess the feasibility of control of USA populations, we tested the susceptibility of Ae. albopictus to chemicals representing the main insecticide classes with different modes of action: organochlorines, organophosphates, carbamates, pyrethroids, insect growth regulators (IGR), naturalytes, and biolarvicides. We characterized a susceptible reference strain of Ae. albopictus, ATM95, and tested the susceptibility of eight USA populations to five adulticides and six larvicides. We found that USA populations are broadly susceptible to currently available larvicides and adulticides. Unexpectedly, however, we found significant resistance to dichlorodiphenyltrichloroethane (DDT) in two Florida populations and in a New Jersey population. We also found resistance to malathion, an organophosphate, in Florida and New Jersey and reduced susceptibility to the IGRs pyriproxyfen and methoprene. All populations tested were fully susceptible to pyrethroids. Biochemical assays revealed a significant up-regulation of GSTs in DDT-resistant populations in both larval and adult stages. Also, beta-esterases were up-regulated in the populations with suspected resistance to malathion. Of note, we identified a previously unknown amino acid polymorphism (Phe -> Leu) in domain III of the VGSC, in a location known to be associated with pyrethroid resistance in another container-inhabiting mosquito, Aedes aegypti L. The observed DDT resistance in populations from Florida may indicate multiple introductions of this species into the USA, possibly from tropical populations. In addition, the mechanisms underlying DDT resistance often result in pyrethroid resistance, which would undermine a remaining tool for the control of Ae. albopictus. Continued monitoring of the insecticide resistance status of this species is imperative.	[Marcombe, Sebastien; Farajollahi, Ary; Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA; [Farajollahi, Ary] Mercer Cty Mosquito Control, West Trenton, NJ USA; [Healy, Sean P.] Monmouth Cty Mosquito Exterminat Commiss, Eatontown, NJ USA; [Clark, Gary G.] Agr Res Serv, Mosquito & Fly Res Unit, USDA, Gainesville, FL USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Fonseca, DM (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08903 USA.	dinafons@rci.rutgers.edu	Fonseca, Dina/HHS-1320-2022; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100	United States Department of Agriculture (USDA); Rutgers University [USDA-ARS58-6615-8-105]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Rutgers University	This work was funded by a cooperative Agreement between the United States Department of Agriculture (USDA) and Rutgers University (USDA-ARS-58-6615-8-105) entitled "Area-wide Pest Management Program for the Asian Tiger Mosquito in New Jersey." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1995, J AM MOSQUITO CONTR, V11, P72; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; ANDRIGHETTI MTM, 2008, DENGUE B, V32, P186; [Anonymous], 2006, PESTICIDES THEIR APP; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chen C D, 2005, Trop Biomed, V22, P195; Chen L, 2013, REGUL TOXICOL PHARM, V65, P287, DOI 10.1016/j.yrtph.2012.12.010; Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x; Coleman M, 2007, J PESTIC SCI, V32, P69, DOI 10.1584/jpestics.R07-01; Crans WJ, 1996, J AM MOSQUITO CONTR, V12, P307; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; Davis RS, 2007, INTEGR ENVIRON ASSES, V3, P373, DOI 10.1002/ieam.5630030308; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; Finney D.J., 1971, PROBIT ANAL; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Hamdan Hidayati, 2005, Trop Biomed, V22, P45; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kasai S, 2011, JPN J INFECT DIS, V64, P217; Kawada H, 2010, JPN J INFECT DIS, V63, P19; KHOO BK, 1988, J AM MOSQUITO CONTR, V4, P310; Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152; Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946; Lo Presti A, 2012, INFECT GENETICS EVOL; Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; McAllister JC, 2012, J VECTOR ECOL, V37, P325, DOI 10.1111/j.1948-7134.2012.00234.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Mogi M, 2012, J MED ENTOMOL, V49, P1233, DOI 10.1603/ME12104; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; MOUCHET J, 1972, B WORLD HEALTH ORGAN, V46, P675; Nayar JK, 2002, J AM MOSQUITO CONTR, V18, P196; NENG W, 1992, J AM MOSQUITO CONTR, V8, P394; Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Ranson H., 2010, INSECTICIDE RESISTAN; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; ROBERT LL, 1989, J AM MOSQUITO CONTR, V5, P251; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Romi R, 2003, J AM MOSQUITO CONTR, V19, P419; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Selvi S, 2010, TROP BIOMED, V27, P534; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; WESSON DM, 1990, J AM MOSQUITO CONTR, V6, P258; World Health Organization, 2005, GUIDELINES LAB FIELD	65	128	134	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101992	10.1371/journal.pone.0101992	http://dx.doi.org/10.1371/journal.pone.0101992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013910	Green Published, gold			2022-12-25	WOS:000339378400052
J	Cadavez, L; Montane, J; Alcarraz-Vizan, G; Visa, M; Vidal-Fabrega, L; Servitja, JM; Novials, A				Cadavez, Lisa; Montane, Joel; Alcarraz-Vizan, Gema; Visa, Montse; Vidal-Fabrega, Laia; Servitja, Joan-Marc; Novials, Anna			Chaperones Ameliorate Beta Cell Dysfunction Associated with Human Islet Amyloid Polypeptide Overexpression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN DISULFIDE-ISOMERASE; FATTY-ACIDS; ER STRESS; MOLECULAR CHAPERONES; INSULIN-SECRETION; LEPTIN RESISTANCE; INDUCED APOPTOSIS; OXIDATIVE STRESS; TRANSGENIC MICE	In type 2 diabetes, beta-cell dysfunction is thought to be due to several causes, one being the formation of toxic protein aggregates called islet amyloid, formed by accumulations of misfolded human islet amyloid polypeptide (hIAPP). The process of hIAPP misfolding and aggregation is one of the factors that may activate the unfolded protein response (UPR), perturbing endoplasmic reticulum (ER) homeostasis. Molecular chaperones have been described to be important in regulating ER response to ER stress. In the present work, we evaluate the role of chaperones in a stressed cellular model of hIAPP overexpression. A rat pancreatic beta-cell line expressing hIAPP exposed to thapsigargin or treated with high glucose and palmitic acid, both of which are known ER stress inducers, showed an increase in ER stress genes when compared to INS1E cells expressing rat IAPP or INS1E control cells. Treatment with molecular chaperone glucose-regulated protein 78 kDa (GRP78, also known as BiP) or protein disulfite isomerase (PDI), and chemical chaperones taurine-conjugated ursodeoxycholic acid (TUDCA) or 4-phenylbutyrate (PBA), alleviated ER stress and increased insulin secretion in hIAPP-expressing cells. Our results suggest that the overexpression of hIAPP induces a stronger response of ER stress markers. Moreover, endogenous and chemical chaperones are able to ameliorate induced ER stress and increase insulin secretion, suggesting that improving chaperone capacity can play an important role in improving beta-cell function in type 2 diabetes.	[Cadavez, Lisa; Montane, Joel; Alcarraz-Vizan, Gema; Visa, Montse; Vidal-Fabrega, Laia; Servitja, Joan-Marc; Novials, Anna] Hosp Clin Barcelona, IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Cadavez, Lisa; Montane, Joel; Alcarraz-Vizan, Gema; Visa, Montse; Servitja, Joan-Marc; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Novials, A (corresponding author), Hosp Clin Barcelona, IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain.	anovials@clinic.ub.es	Montane, Joel/ABE-6021-2021; Visa, Montse/AAQ-8529-2021	SERVITJA, JOAN-MARC/0000-0002-1241-8004; Montane, Joel/0000-0001-9531-9580; Novials, Anna/0000-0003-0465-2949; Alcarraz-Vizan, Gema/0000-0002-2429-0597	Fundacao da Ciencia e Tecnologia (FCT-PhD) - POPH-QREN [SFRH/BD/65645/2009]; IDIBAPS - European Community [229673]; Spanish Ministry of Economy and Competitiveness (MINECO) [COFUND2013-40261]; FIS [PI08/0088, PI1100679]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Fundacao da Ciencia e Tecnologia (FCT-PhD) - POPH-QREN; IDIBAPS - European Community; Spanish Ministry of Economy and Competitiveness (MINECO); FIS(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	LC was a recipient of Fundacao da Ciencia e Tecnologia (FCT-PhD) fellowship SFRH/BD/65645/2009 financed by POPH-QREN. JM is a recipient of an IDIBAPS Postdoctoral Fellowship BIOTRACK, supported by the European Community's Seventh Framework Programme (ECFP7/2007-2013) under grant agreement number 229673 and the Spanish Ministry of Economy and Competitiveness (MINECO) through the grant COFUND2013-40261. This work was supported by grants from FIS (PI08/0088 and PI1100679) and Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Chien V, 2010, BIOCHEM J, V432, P113, DOI 10.1042/BJ20100434; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hong J, 2009, DIABETES OBES METAB, V11, P397, DOI 10.1111/j.1463-1326.2008.00971.x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marzban L, 2005, MOL ENDOCRINOL, V19, P2154, DOI 10.1210/me.2004-0407; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Montane J, 2014, METABOLIC SYNDROME O, V2014, P24; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Papp E, 2006, FASEB J, V20, P1018, DOI 10.1096/fj.05-5065fje; Penas C, 2011, CELL DEATH DIFFER, V18, P1617, DOI 10.1038/cdd.2011.24; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Potter KJ, 2014, DIABETES, V63, P12, DOI 10.2337/db12-0364; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Sitia Roberto, 2004, Sci STKE, V2004, ppe27, DOI 10.1126/stke.2392004pe27; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Soty M, 2011, J BIOL CHEM, V286, P40857, DOI 10.1074/jbc.M111.232801; Srivastava S, 2007, FREE RADICAL RES, V41, P38, DOI 10.1080/10715760600943900; Sun AH, 2010, J PROTEOME RES, V9, P50, DOI 10.1021/pr900191p; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; Teodoro-Morrison T, 2013, DIABETOLOGIA, V56, P1057, DOI 10.1007/s00125-013-2855-7; Tokuyama T, 1997, METABOLISM, V46, P1044, DOI 10.1016/S0026-0495(97)90276-6; Wu X, 2011, 71 SCI SESS AM DIAB; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	53	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101797	10.1371/journal.pone.0101797	http://dx.doi.org/10.1371/journal.pone.0101797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010593	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800042
J	Chen, WT; Tseng, CH; Tsai, CW				Chen, Wei-Te; Tseng, Chien-Hao; Tsai, Chi-Wei			Effect of Watermelon Silver Mottle Virus on the Life History and Feeding Preference of Thrips palmi	PLOS ONE			English	Article							SPOTTED WILT VIRUS; FRANKLINIELLA-OCCIDENTALIS; FLOWER THRIPS; INSECT VECTOR; DEVELOPMENT TIME; SALICYLIC-ACID; PLANT-VIRUSES; HOST PLANTS; TOSPOVIRUS; INFECTION	Thrips-borne tospoviruses cause numerous plant diseases that produce severe economic losses worldwide. In the disease system, thrips not only damage plants through feeding but also transmit causative agents of epidemics. In addition, thrips are infected with tospoviruses in the course of virus transmission. Most studies on the effect of tospoviruses on vector thrips have focused on the Tomato spotted wilt virus-Frankliniella occidentalis system. Thus, we focused on another thrips-borne tospovirus, Watermelon silver mottle virus (WSMoV), to examine the effect of virus infection on its vector, Thrips palmi. In this study, the direct and indirect effects of WSMoV on the life history traits and feeding preference of T. palmi were examined. The survival rate and developmental time of the WSMoV-infected larval thrips did not differ significantly from those of the virus-free thrips. Comparing the developmental time of larval thrips fed on the healthy plants, thrips-damaged plants, and thrips-inoculated plants (the WSMoV-infected plants caused by thrips feeding), feeding on the thrips-damaged plants reduced the developmental time, and the WSMoV infection in host plants partially canceled the effect of thrips damage on the developmental time. In addition, no significant variations between the virus-free and WSMoV-infected adult thrips regarding longevity and fecundity were observed. These results implied that WSMoV did not directly affect the life history traits of T. palmi, but the WSMoV infection indirectly affected the development of T. palmi through the virus-infected plants. Furthermore, feeding preference tests indicated that T. palmi preferred feeding on either the thrips-damaged plants or the thrips-inoculated plants to the healthy plants. The effect of tospoviruses on the life history and feeding preference of vector thrips might vary among host plants, virus species, vector species, and environmental factors.	[Chen, Wei-Te; Tseng, Chien-Hao; Tsai, Chi-Wei] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan	National Taiwan University	Tsai, CW (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan.	chiwei@ntu.edu.tw		TSAI, CHI-WEI/0000-0002-3880-7251	National Science Council of Taiwan [NSC 100-2321-B-002-035-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council of Taiwan (NSC 100-2321-B-002-035-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; BAUTISTA RC, 1995, PHYTOPATHOLOGY, V85, P953, DOI 10.1094/Phyto-85-953; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Chen G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02253; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; DEANGELIS JD, 1993, ENVIRON ENTOMOL, V22, P1308, DOI 10.1093/ee/22.6.1308; Hamilton JGC, 2005, J CHEM ECOL, V31, P1369, DOI 10.1007/s10886-005-1351-z; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hosmer DWJ., 2008, APPL SURVIVAL ANAL; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2005, EUR J PLANT PATHOL, V113, P119, DOI 10.1007/s10658-005-2334-1; Kritzman A, 2002, ARCH VIROL, V147, P2143, DOI 10.1007/s00705-002-0871-x; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Medina-Ortega KJ, 2009, ENVIRON ENTOMOL, V38, P836, DOI 10.1603/022.038.0337; Milne M, 2002, J INSECT BEHAV, V15, P351, DOI 10.1023/A:1016265109231; Nagata T, 1999, J GEN VIROL, V80, P507, DOI 10.1099/0022-1317-80-2-507; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; NUESSLY GS, 1995, FLA ENTOMOL, V78, P258, DOI 10.2307/3495898; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Persley DM, 2006, AUSTRALAS PLANT PATH, V35, P161, DOI 10.1071/AP06015; Radwan DEM, 2007, PLANT PHYSIOL BIOCH, V45, P480, DOI 10.1016/j.plaphy.2007.03.002; Reiskind MH, 2010, J VECTOR ECOL, V35, P61, DOI 10.1111/j.1948-7134.2010.00029.x; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Roca E, 1997, PLANT PATHOL, V46, P407, DOI 10.1046/j.1365-3059.1997.d01-29.x; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Shrestha A, 2012, ENTOMOL EXP APPL, V145, P260, DOI 10.1111/eea.12011; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Stumpf CF, 2005, ENTOMOL EXP APPL, V114, P215, DOI 10.1111/j.1570-7458.2005.00251.x; Stumpf CF, 2007, ENTOMOL EXP APPL, V123, P139, DOI 10.1111/j.1570-7458.2007.00541.x; Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2; Uga H, 2005, PHYTOPATHOLOGY, V95, P166, DOI 10.1094/PHYTO-95-0166; Ullman DE, 2002, ADV BOT RES, V36, P113, DOI 10.1016/S0065-2296(02)36061-0; ULLMAN DE, 1993, PHYTOPATHOLOGY, V83, P456, DOI 10.1094/Phyto-83-456; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; WIJKAMP I, 1993, J GEN VIROL, V74, P341, DOI 10.1099/0022-1317-74-3-341; Wijkamp I, 1996, ENTOMOL EXP APPL, V81, P285, DOI 10.1007/BF00187037; YEH SD, 1992, PLANT DIS, V76, P835, DOI 10.1094/PD-76-0835; Zhang PJ, 2011, PHYSIOL ENTOMOL, V36, P317, DOI 10.1111/j.1365-3032.2011.00796.x	43	14	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102021	10.1371/journal.pone.0102021	http://dx.doi.org/10.1371/journal.pone.0102021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010157	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800060
J	Hung, SF; Huang, CY; Lin, CL; Chung, SD; Chung, CJ; Kao, CH; Chang, CH				Hung, Shun-Fa; Huang, Chao-Yuan; Lin, Cheng-Li; Chung, Shiu-Dong; Chung, Chi-Jung; Kao, Chia-Hung; Chang, Chao-Hsiang			Increased Risk of Acute Coronary Syndrome among Patients with Urinary Stone Disease: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							METABOLIC SYNDROME; KIDNEY-STONES; FOLLOW-UP; NEPHROLITHIASIS; ASSOCIATION; HYPERTENSION; MORTALITY; DEFINITION; PREVALENCE; SEVERITY	Background/Objectives: Urinary stones (US) are associated with systemic metabolic and endocrine disorders that share risk factors typically associated with acute coronary syndrome (ACS). Methods: For this investigation, 30 142 patients with US were set as the research group, and 121 768 randomly selected patients were set as the comparison group through frequency matching by age, sex, and index year. Each patient was individually tracked to identify those who developed ACS during the follow-up period. Cox proportional hazards regression and the Kaplan-Meier method were adopted to calculate the hazard ratios of ACS risk and plot the survival curve. Results: Overall, 275 (13.4 per 10 000 person-y) and 736 events (9.1 per 10 000 person-y) were observed among patients in the research and comparison cohorts, respectively. The patients with US had a substantially lower ACS-free survival rate compared with that of the patients in the comparison cohort (P<.001). After adjusting for potential risk factors, the patients with US were observed to have a 1.22-fold higher risk of ACS compared with patients in the comparison cohort (95% confidence interval = 1.05-1.40, P<.001), particularly among younger patients. Conclusions: The results indicate that US is associated with increased risk of developing ACS, particularly among young (<= 49 years) and male adults. Future studies should examine the possible mechanisms of US-related ACS morbidity by conducting multicenter recruitment and measurements of laboratory data.	[Hung, Shun-Fa] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Hung, Shun-Fa] Fu Jen Catholic Univ, Grad Inst Clin Med, Coll Med, New Taipei, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Chang, Chao-Hsiang] China Med Univ, Coll Med, Taichung, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei, Taiwan; [Chung, Shiu-Dong] Fu Jen Catholic Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chung, Shiu-Dong] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Chung, Shiu-Dong] Tzu Chi Univ, Hualien, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Chang, Chao-Hsiang] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Far Eastern Memorial Hospital; Fu Jen Catholic University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.	d10040@mail.cmuh.org.tw; urology8395@yahoo.com.tw	Chung, Chi-Jung/G-4755-2013	HUANG, CHAO-YUAN/0000-0002-9322-6062	China Medical University Hospital [DMR-103-012, DMR-103-018]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW103-TD-B-111-03]; International Research-Intensive Centers of Excellence, Taiwan [NSC101-2911-I-002-303]	China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan); International Research-Intensive Centers of Excellence, Taiwan	This study was supported by grants from China Medical University Hospital (DMR-103-012 and DMR-103-018); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002); Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03, Taiwan); and the International Research-Intensive Centers of Excellence, Taiwan (NSC101-2911-I-002-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Aydin H, 2011, UROL RES, V39, P451, DOI 10.1007/s00240-011-0383-9; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; Cameron MA, 2006, J AM SOC NEPHROL, V17, P1422, DOI 10.1681/ASN.2005121246; CAPPUCCIO FP, 1990, BRIT MED J, V300, P1234, DOI 10.1136/bmj.300.6734.1234; Chung SD, 2011, J UROLOGY, V186, P1888, DOI 10.1016/j.juro.2011.07.011; Daudon M, 2006, J AM SOC NEPHROL, V17, P2026, DOI 10.1681/ASN.2006030262; Domingos F, 2011, NEPHROL DIAL TRANSPL, V26, P864, DOI 10.1093/ndt/gfq501; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Ferraro PM, 2013, JAMA-J AM MED ASSOC, V310, P408, DOI 10.1001/jama.2013.8780; Findlay IN, 2005, HEART, V91, P857, DOI 10.1136/hrt.2004.052795; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Gillen DL, 2005, AM J KIDNEY DIS, V46, P263, DOI 10.1053/j.ajkd.2005.04.030; Gorbachinsky Ilya, 2010, Rev Urol, V12, pe157; Gumina RJ, 2007, MED CLIN N AM, V91, P729, DOI 10.1016/j.mcna.2007.04.003; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Jeong IG, 2011, AM J KIDNEY DIS, V58, P383, DOI 10.1053/j.ajkd.2011.03.021; Kohjimoto Y, 2013, AM J KIDNEY DIS, V61, P923, DOI 10.1053/j.ajkd.2012.12.028; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Maalouf NM, 2007, CLIN J AM SOC NEPHRO, V2, P883, DOI 10.2215/CJN.00670207; Meigs JB, 2003, ACTA DIABETOL, V40, pS358, DOI 10.1007/s00592-003-0120-0; Pak CYC, 2003, UROLOGY, V61, P523, DOI 10.1016/S0090-4295(02)02421-4; Reiner AP, 2011, J UROLOGY, V185, P920, DOI 10.1016/j.juro.2010.10.086; Rendina D, 2009, NEPHROL DIAL TRANSPL, V24, P900, DOI 10.1093/ndt/gfn548; Rule AD, 2010, J AM SOC NEPHROL, V21, P1641, DOI 10.1681/ASN.2010030253; Sakhaee K, 2002, KIDNEY INT, V62, P971, DOI 10.1046/j.1523-1755.2002.00508.x; Sakhaee K, 2008, CURR OPIN NEPHROL HY, V17, P304, DOI 10.1097/MNH.0b013e3282f8b34d; Sakhaee K, 2012, NEPHROL DIAL TRANSPL, V27, P3201, DOI 10.1093/ndt/gfr703; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stoller ML, 2004, J UROLOGY, V171, P1920, DOI 10.1097/01.ju.0000120291.90839.49; Tang J, 2013, AM J NEPHROL, V37, P501, DOI 10.1159/000350691; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Weinberg AE, 2014, EUR UROL, V65, P242, DOI 10.1016/j.eururo.2013.03.026; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; Worcester EM, 2007, AM J PHYSIOL-RENAL, V292, pF66, DOI 10.1152/ajprenal.00115.2006	39	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102349	10.1371/journal.pone.0102349	http://dx.doi.org/10.1371/journal.pone.0102349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010058	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800092
J	Kawakami, S; Kumazaki, Y; Manda, Y; Oki, K; Minagi, S				Kawakami, Shigehisa; Kumazaki, Yohei; Manda, Yosuke; Oki, Kazuhiro; Minagi, Shogo			Specific Diurnal EMG Activity Pattern Observed in Occlusal Collapse Patients: Relationship between Diurnal Bruxism and Tooth Loss Progression	PLOS ONE			English	Article							SLEEP	Aim: The role of parafunctional masticatory muscle activity in tooth loss has not been fully clarified. This study aimed to reveal the characteristic activity of masseter muscles in bite collapse patients while awake and asleep. Materials and Methods: Six progressive bite collapse patients (PBC group), six age-and gender-matched control subjects (MC group), and six young control subjects (YC group) were enrolled. Electromyograms (EMG) of the masseter muscles were continuously recorded with an ambulatory EMG recorder while patients were awake and asleep. Diurnal and nocturnal parafunctional EMG activity was classified as phasic, tonic, or mixed using an EMG threshold of 20% maximal voluntary clenching. Results: Highly extended diurnal phasic activity was observed only in the PBC group. The three groups had significantly different mean diurnal phasic episodes per hour, with 13.29 +/- 7.18 per hour in the PBC group, 0.95 +/- 0.97 per hour in the MC group, and 0.87 +/- 0.98 per hour in the YC group (p<0.01). ROC curve analysis suggested that the number of diurnal phasic episodes might be used to predict bite collapsing tooth loss. Conclusion: Extensive bite loss might be related to diurnal masticatory muscle parafunction but not to parafunction during sleep. Clinical Relevance: Scientific rationale for study: Although mandibular parafunction has been implicated in stomatognathic system breakdown, a causal relationship has not been established because scientific modalities to evaluate parafunctional activity have been lacking. Principal findings: This study used a newly developed EMG recording system that evaluates masseter muscle activity throughout the day. Our results challenge the stereotypical idea of nocturnal bruxism as a strong destructive force. We found that diurnal phasic masticatory muscle activity was most characteristic in patients with progressive bite collapse. Practical implications: The incidence of diurnal phasic contractions could be used for the prognostic evaluation of stomatognathic system stability.	[Kawakami, Shigehisa; Kumazaki, Yohei; Manda, Yosuke; Oki, Kazuhiro; Minagi, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008530, Japan	Okayama University	Kawakami, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Occlusal & Oral Funct Rehabil, Okayama 7008530, Japan.	s-kawa-10@t.okadai.jp	Minagi, Shogo/B-2473-2011; Kawakami, Shigehisa/F-5057-2011; Manda, Yousuke/AAD-7055-2022	Minagi, Shogo/0000-0002-7559-3627; Manda, Yousuke/0000-0001-6666-908X	MEXT KAKENHI [24390433]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by MEXT KAKENHI (grant number 24390433 to SM; http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bernhardt O, 2006, J PERIODONTOL, V77, P506, DOI 10.1902/jop.2006.050167; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fujisawa M, 2013, J ORAL REHABIL, V40, P731, DOI 10.1111/joor.12087; Hiltunen K, 2002, INT J PROSTHODONT, V15, P539; HOUSTON F, 1987, ACTA ODONTOL SCAND, V45, P239, DOI 10.3109/00016358709097536; Ikebe K, 2010, INT J PROSTHODONT, V23, P521; Kalaykova SI, 2011, J OROFAC PAIN, V25, P153; Kato T, 2013, J PROSTHODONT RES, V57, P69, DOI 10.1016/j.jpor.2013.03.001; Kumazaki Y, 2014, J ORAL REHABIL, V41, P266, DOI 10.1111/joor.12138; Lavigne GJ, 1996, J DENT RES, V75, P546, DOI 10.1177/00220345960750010601; Manfredini D, 2013, J OROFAC PAIN, V27, P99, DOI 10.11607/jop.921; VELLYMIGUEL AM, 1992, J CRANIOMANDIB DISOR, V6, P71; Watanabe A, 2011, J PROSTHODONT RES, V55, P75, DOI 10.1016/j.jpor.2010.09.003	14	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101882	10.1371/journal.pone.0101882	http://dx.doi.org/10.1371/journal.pone.0101882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010348	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800050
J	Qin, YY; Gong, W; Zhang, MD; Wang, JD; Tang, ZH; Quan, ZW				Qin, Yiyu; Gong, Wei; Zhang, Mingdi; Wang, Jiandong; Tang, Zhaohui; Quan, Zhiwei			Forkhead Box L1 Is Frequently Downregulated in Gallbladder Cancer and Inhibits Cell Growth through Apoptosis Induction by Mitochondrial Dysfunction	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; INCREASES SENSITIVITY; PANCREATIC-CANCER; CYTOCHROME-C; LUNG-CANCER; EXPRESSION; LYMPHOMA; PROTEINS; CANDIDATE; SURVIVAL	Background: Forkhead box L1 (FOXL1), considered as a novel candidate tumor suppressor, suppresses proliferation and invasion in certain cancers. However, the regulation and function of FOXL1 in gallbladder cancer (GBC) remains unclear. Methods: FOXL1 expression at mRNA and protein levels in GBC tissues and cell lines were examined by RT-PCR, immunohistochemistry and western blot assay. FOXL1 expression in GBC cell lines was up-regulated by transfection with pcDNA-FOXL1. The effects of FOXL1 overexpression on cell proliferation, apoptosis, migration and invasion were evaluated in vitro or in vivo. In addition, the status of mediators involved in migration, invasion and apoptosis was examined using western blot after transfection with pcDNA-FOXL1. Results: FOXL1 was frequently downregulated in GBC tissues and cell lines. Its higher expression is associated with better prognosis, while its lower expression is correlated with advanced TNM stage and poor differentiation. FOXL1 overexpression in NOZ cells significantly suppresses cell proliferation, migration and invasion in vitro and tumorigenicity in nude mice. FOXL1 overexpression disrupted mitochondrial transmembrane potential and triggered mitochondria-mediated apoptosis in NOZ cells. In addition, FOXL1 overexpression suppressed ZEB1 expression and induced E-cadherin expression in NOZ cells. Conclusion: Our findings suggested that dysregulated FOXL1 is involved in tumorigenesis and progression of GBC and may serve as a predictor of clinical outcome or even a therapeutic target for patients with GBC.	[Qin, Yiyu; Gong, Wei; Zhang, Mingdi; Wang, Jiandong; Tang, Zhaohui; Quan, Zhiwei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, JD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.	wangjiandongdr@163.com; zhiwquan@163.com			National Natural Science Foundation of China [81272747, 81372642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81272747 and No. 81372642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kiran RP, 2007, ANN SURG ONCOL, V14, P827, DOI 10.1245/s10434-006-9224-4; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; NAGORNEY DM, 1988, SEMIN ONCOL, V15, P106; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Priya TP, 2010, VIRCHOWS ARCH, V456, P507, DOI 10.1007/s00428-010-0908-6; Rosen A, 1997, J CELL BIOCHEM, V64, P50, DOI 10.1002/(SICI)1097-4644(199701)64:1<50::AID-JCB8>3.0.CO;2-Z; Sasaki CY, 2000, INT J CANCER, V86, P660, DOI 10.1002/(SICI)1097-0215(20000601)86:5<660::AID-IJC9>3.0.CO;2-X; Segara D, 2005, CLIN CANCER RES, V11, P3587, DOI 10.1158/1078-0432.CCR-04-1813; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Streubel B, 2005, LEUKEMIA, V19, P652, DOI 10.1038/sj.leu.2403644; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yao-qin Y, 2003, J TONGJI U MED SCI, V24, P457; Zhang G, 2013, CANCER RES, V73, P5416, DOI 10.1158/0008-5472.CAN-13-0362	28	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102084	10.1371/journal.pone.0102084	http://dx.doi.org/10.1371/journal.pone.0102084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010679	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800066
J	Szabo, A; Salameh, MA; Ludwig, M; Radisky, ES; Sahin-Toth, M				Szabo, Andras; Salameh, Moh'd A.; Ludwig, Maren; Radisky, Evette S.; Sahin-Toth, Miklos			Tyrosine Sulfation of Human Trypsin Steers S2 ' Subsite Selectivity towards Basic Amino Acids	PLOS ONE			English	Article							HUMAN CATIONIC TRYPSINOGEN; HUMAN ANIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; PROTEASE INHIBITORS; CONVERTING TRYPSIN; S1 SPECIFICITY; ACTIVE-SITE; CHYMOTRYPSIN; BPTI; ACTIVATION	Human cationic and anionic trypsins are sulfated on Tyr154, a residue which helps to shape the prime side substrate-binding subsites. Here, we used phage display technology to assess the significance of tyrosine sulfation for the specificity of human trypsins. The prime side residues P1'-P4' in the binding loop of bovine pancreatic trypsin inhibitor (BPTI) were fully randomized and tight binding inhibitor phages were selected against non-sulfated and sulfated human cationic trypsin. The selection pattern for the two targets differed mostly at the P2' position, where variants selected against non-sulfated trypsin contained primarily aliphatic residues (Leu, Ile, Met), while variants selected against sulfated trypsin were enriched also for Arg. BPTI variants carrying Arg, Lys, Ile, Leu or Ala at the P2' position of the binding loop were purified and equilibrium dissociation constants were determined against non-sulfated and sulfated cationic and anionic human trypsins. BPTI variants harboring apolar residues at P2' exhibited 3-12-fold lower affinity to sulfated trypsin relative to the non-sulfated enzyme, whereas BPTI variants containing basic residues at P2' had comparable affinity to both trypsin forms. Taken together, the observations demonstrate that the tyrosyl sulfate in human trypsins interacts with the P2' position of the substrate-like inhibitor and this modification increases P2' selectivity towards basic side chains.	[Szabo, Andras; Ludwig, Maren; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA; [Salameh, Moh'd A.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL USA; [Ludwig, Maren] Tech Univ Munich, D-80290 Munich, Germany; [Ludwig, Maren] Tech Univ Munich, EKFZ, D-80290 Munich, Germany	Boston University; Mayo Clinic; Technical University of Munich; Technical University of Munich	Szabo, A (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.	szaboa@bu.edu	Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X; Ewers, Maren/0000-0002-9029-2240; Szabo, Andras/0000-0001-8687-470X; Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01DK058088, R01DK082412, R01DK095753, R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK058088, R01DK082412, and R01DK095753 (to MS-T) and R01CA154387 (to ESR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; CHRISTENSEN U, 1979, BIOCHIM BIOPHYS ACTA, V569, P177, DOI 10.1016/0005-2744(79)90052-4; CREIGHTON TE, 1987, J MOL BIOL, V194, P11, DOI 10.1016/0022-2836(87)90711-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Grahn S, 1999, BBA-PROTEIN STRUCT M, V1431, P329, DOI 10.1016/S0167-4838(99)00059-X; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; Itkonen O, 2008, FEBS J, V275, P289, DOI 10.1111/j.1742-4658.2007.06200.x; Kiczak L, 2001, BBA-PROTEIN STRUCT M, V1550, P153, DOI 10.1016/S0167-4838(01)00282-5; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kurth T, 1998, BIOCHEMISTRY-US, V37, P11434, DOI 10.1021/bi980842z; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Marcello MR, 2011, J BIOL CHEM, V286, P13060, DOI 10.1074/jbc.M110.175463; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Navaneetham D, 2010, J BIOCHEM, V148, P467, DOI 10.1093/jb/mvq080; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Petrassi HM, 2005, BIOORG MED CHEM LETT, V15, P3162, DOI 10.1016/j.bmcl.2005.04.019; Rezaie AR, 1997, BIOCHEMISTRY-US, V36, P1026, DOI 10.1021/bi9620823; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Rosendahl J, 2010, PANCREATOLOGY, V10, P165, DOI 10.1159/000231979; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1994, BIOCHEMISTRY-US, V33, P4251, DOI 10.1021/bi00180a020; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Westmuckett AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071822; Westmuckett AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020406	40	7	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102063	10.1371/journal.pone.0102063	http://dx.doi.org/10.1371/journal.pone.0102063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010489	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800063
J	Wang, SQ; Li, XJ; Qiu, HB; Jiang, ZM; Simon, M; Ma, XR; Liu, L; Liu, JX; Wang, FF; Liang, YF; Wu, JM; Di, WH; Zhou, SB				Wang, Shu-Qiu; Li, Xiao-Jie; Qiu, Hong-Bin; Jiang, Zhi-Mei; Simon, Maria; Ma, Xiao-Ru; Liu, Lei; Liu, Jun-Xing; Wang, Fang-Fang; Liang, Yan-Feng; Wu, Jia-Mei; Di, Wei-Hua; Zhou, Shaobo			Anti-Epileptic Effect of Ganoderma Lucidum Polysaccharides by Inhibition of Intracellular Calcium Accumulation and Stimulation of Expression of CaMKII alpha in Epileptic Hippocampal Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-II; SEIZURE ACTIVITY; CULTURE MODEL; PILOCARPINE MODEL; RURAL CHINA; MECHANISMS; CA2+; INACTIVATION; DISCHARGES; ACTIVATION	Purpose: To investigate the mechanism of the anti-epileptic effect of Ganoderma lucidum polysaccharides (GLP), the changes of intracellular calcium and CaMK II alpha expression in a model of epileptic neurons were investigated. Method: Primary hippocampal neurons were divided into: 1) Control group, neurons were cultured with Neurobasal medium, for 3 hours; 2) Model group I: neurons were incubated with Mg2+ free medium for 3 hours; 3) Model group II: neurons were incubated with Mg2+ free medium for 3 hours then cultured with the normal medium for a further 3 hours; 4) GLP group I: neurons were incubated with Mg2+ free medium containing GLP (0.375 mg/ml) for 3 hours; 5) GLP group II: neurons were incubated with Mg2+ free medium for 3 hours then cultured with a normal culture medium containing GLP for a further 3 hours. The CaMK II alpha protein expression was assessed by Western-blot. Ca2+ turnover in neurons was assessed using Fluo-3/AM which was added into the replacement medium and Ca2+ turnover was observed under a laser scanning confocal microscope. Results: The CaMK II alpha expression in the model groups was less than in the control groups, however, in the GLP groups, it was higher than that observed in the model group. Ca2+ fluorescence intensity in GLP group I was significantly lower than that in model group I after 30 seconds, while in GLP group II, it was reduced significantly compared to model group II after 5 minutes. Conclusion: GLP may inhibit calcium overload and promote CaMK II alpha expression to protect epileptic neurons.	[Wang, Shu-Qiu; Ma, Xiao-Ru; Liu, Lei; Liu, Jun-Xing; Wang, Fang-Fang; Liang, Yan-Feng; Wu, Jia-Mei; Di, Wei-Hua; Zhou, Shaobo] Jiamusi Univ, Sch Basic Med Sci, Dept Pathophysiol, Jiamusi, Peoples R China; [Li, Xiao-Jie; Jiang, Zhi-Mei] Jiamusi Univ, Sch Rehabil Med Sci, Children Neural Rehabil Lab, Jiamusi, Heilongjiang Pr, Peoples R China; [Qiu, Hong-Bin] Jiamusi Univ, Sch Publ Hlth, Jiamusi, Heilongjiang Pr, Peoples R China; [Simon, Maria; Zhou, Shaobo] Univ Bedfordshire, Inst Biomed & Environm Sci & Technol, Dept Life Sci, Luton, Beds, England	Jiamusi University; Jiamusi University; Jiamusi University; University of Bedfordshire	Wang, SQ (corresponding author), Jiamusi Univ, Sch Basic Med Sci, Dept Pathophysiol, Jiamusi, Peoples R China.	wangshuq_jms@163.com	Zhou, Shaobo/I-1536-2019	Zhou, Shaobo/0000-0001-5214-2973	National Natural Science Foundation, Beijing, P. R. China [81241112]; Heilongjiang Province, P. R. China [2012TD013]; Jiamusi University, P. R. China [04099904]	National Natural Science Foundation, Beijing, P. R. China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province, P. R. China; Jiamusi University, P. R. China	This work was supported by the National Natural Science Foundation, Beijing, P. R. China (No. 81241112); Scientific and technological innovation team on mechanism of neurological cell injury and its protection in Universities (2012TD013, Heilongjiang Province, P. R. China); Team focus on fostering technological innovation project funding (project number: 04099904, Jiamusi University, P. R. China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET, V380, P1121, DOI 10.1016/S0140-6736(12)61646-8; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Blair RE, 1999, BRAIN RES, V851, P54, DOI 10.1016/S0006-8993(99)02100-9; Blair RE, 2008, EUR J PHARMACOL, V588, P64, DOI 10.1016/j.ejphar.2008.04.021; BRONSTEIN J, 1988, NEUROCHEM RES, V13, P83, DOI 10.1007/BF00971859; BRONSTEIN JM, 1992, BRAIN RES, V584, P257, DOI 10.1016/0006-8993(92)90903-M; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Churn SB, 2000, BRAIN RES, V875, P66, DOI 10.1016/S0006-8993(00)02623-8; CHURN SB, 1995, J NEUROSCI, V15, P3200; CROUCHER MJ, 1992, NEUROCHEM RES, V17, P409, DOI 10.1007/BF00969885; Croucher MJ, 1997, EUR J PHARMACOL, V319, P207, DOI 10.1016/S0014-2999(96)00868-0; Daniel S, 2012, PLOS ONE, V7; DeCoster MA, 1995, ADV NEUROIMMUNOL, V5, P233, DOI 10.1016/0960-5428(95)00015-T; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; DeLorenzo Robert J, 2006, Adv Neurol, V97, P187; Dong Y, 2004, NEUROSCI LETT, V357, P95, DOI 10.1016/j.neulet.2003.11.069; Goodkin HP, 2005, J NEUROSCI, V25, P5511, DOI 10.1523/JNEUROSCI.0900-05.2005; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Ilangaratne NB, 2012, B WORLD HEALTH ORGAN, V90, P871, DOI 10.2471/BLT.12.113183; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kwan P, 2013, EPILEPSIA, V54, P537, DOI 10.1111/epi.12022; Loughrey CM, 2003, CELL CALCIUM, V34, P1, DOI 10.1016/S0143-4160(03)00012-5; Mangan PS, 2004, J NEUROPHYSIOL, V91, P946, DOI 10.1152/jn.00547.2003; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Pal S, 2001, CELL CALCIUM, V30, P285, DOI 10.1054/ceca.2001.0236; Pal S, 2000, CELL CALCIUM, V28, P181, DOI 10.1054/ceca.2000.0146; PERLIN JB, 1992, EPILEPSY RES, V11, P111, DOI 10.1016/0920-1211(92)90045-U; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Wang H, 2005, ZHONGGUO LINCHUANG K, V48, P71; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061687; Wang WZ, 2012, EPILEPSY RES, V102, P201, DOI 10.1016/j.eplepsyres.2012.06.004; Wang WQ, 2005, HEILONGJIANG MED PHA, P48; Xu DF, 2006, J ANHUI MED U, V41, P522; Yamagata Y, 2006, NEUROSCIENCE, V140, P981, DOI 10.1016/j.neuroscience.2006.02.054; Yi YL, 2004, J CAPITAL MED U, V25, P540; Zhang SL, 2008, NEURAL REGEN RES, V3, P1304; Zhao S, 2005, HEILONGJIANG YIYAO K, V28, P1; [赵爽 ZHAO Shuang], 2007, [中国病理生理杂志, Chinese Journal of Pathophysiology], V23, P1153	46	22	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102161	10.1371/journal.pone.0102161	http://dx.doi.org/10.1371/journal.pone.0102161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010576	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800075
J	Dhimal, M; Aryal, KK; Dhimal, ML; Gautam, I; Singh, SP; Bhusal, CL; Kuch, U				Dhimal, Meghnath; Aryal, Krishna Kumar; Dhimal, Mandira Lamichhane; Gautam, Ishan; Singh, Shanker Pratap; Bhusal, Chop Lal; Kuch, Ulrich			Knowledge, Attitude and Practice Regarding Dengue Fever among the Healthy Population of Highland and Lowland Communities in Central Nepal	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; VIRUS; TRANSMISSION; ALBOPICTUS; CULICIDAE; RESPONSES; DISEASE; BURDEN; FRANCE; URBAN	Background: Dengue fever (DF) is the most rapidly spreading mosquito-borne viral disease in the world. In this decade it has expanded to new countries and from urban to rural areas. Nepal was regarded DF free until 2004. Since then dengue virus (DENV) has rapidly expanded its range even in mountain regions of Nepal, and major outbreaks occurred in 2006 and 2010. However, no data on the local knowledge, attitude and practice (KAP) of DF in Nepal exist although such information is required for prevention and control measures. Methods: We conducted a community based cross-sectional survey in five districts of central Nepal between September 2011 and February 2012. We collected information on the socio-demographic characteristics of the participants and their knowledge, attitude and practice regarding DF using a structured questionnaire. We then statistically compared highland and lowland communities to identify possible causes of observed differences. Principal Findings: Out of 589 individuals interviewed, 77% had heard of DF. Only 12% of the sample had good knowledge of DF. Those living in the lowlands were five times more likely to possess good knowledge than highlanders (P<0.001). Despite low knowledge levels, 83% of the people had good attitude and 37% reported good practice. We found a significantly positive correlation among knowledge, attitude and practice (P<0.001). Among the socio-demographic variables, the education level of the participants was an independent predictor of practice level (P<0.05), and education level and interaction between the sex and age group of the participants were independent predictors of attitude level (P<0.05). Conclusion: Despite the rapid expansion of DENV in Nepal, the knowledge of people about DF was very low. Therefore, massive awareness programmes are urgently required to protect the health of people from DF and to limit its further spread in this country.	[Dhimal, Meghnath; Aryal, Krishna Kumar; Singh, Shanker Pratap; Bhusal, Chop Lal] NHRC, Kathmandu, Nepal; [Dhimal, Meghnath; Dhimal, Mandira Lamichhane; Kuch, Ulrich] Senckenberg Gesell Naturforsch BiK F, Frankfurt, Germany; [Dhimal, Meghnath] Goethe Univ Frankfurt, Inst Atmosphere & Environm, D-60054 Frankfurt, Germany; [Dhimal, Mandira Lamichhane] Goethe Univ Frankfurt, Fac Social Sci, D-60054 Frankfurt, Germany; [Gautam, Ishan] Tribhuvan Univ, Nat Hist Museum, Kathmandu, Nepal	Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Goethe University Frankfurt; Tribhuvan University	Dhimal, M (corresponding author), NHRC, Kathmandu, Nepal.	meghdhimal@gmail.com	Dhimal, Meghnath/AAD-7261-2021	Dhimal, Meghnath/0000-0001-7176-7821; Lamichhane Dhimal, Mandira/0000-0003-0258-5148	Government of Nepal; DAAD PhD scholarship; research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of the Ministry of Higher Education, Research; Arts of the State of Hesse, Germany	Government of Nepal; DAAD PhD scholarship; research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of the Ministry of Higher Education, Research; Arts of the State of Hesse, Germany	This research was performed as a part of the collaborative research project "A longitudinal study on Aedes mosquitoes and climate change along an altitudinal transect in central Nepal'' by the Nepal Health Research Council (NHRC) and the Biodiversity and Climate Research Centre (BiK-F). It was financially supported by a research grant from the Government of Nepal, a DAAD PhD scholarship to MD and the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz'' of the Ministry of Higher Education, Research and the Arts of the State of Hesse, Germany. The funding bodies had no role in the study design, data collection, data analysis, interpretation of results, decision to publish or preparation of manuscript.	Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Ali M, 2003, AM J TROP MED HYG, V69, P634, DOI 10.4269/ajtmh.2003.69.634; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Arya SC, 2009, TRANSFUS APHER SCI, V41, P231, DOI 10.1016/j.transci.2009.09.009; BARKERHUDSON P, 1988, J MED ENTOMOL, V25, P178, DOI 10.1093/jmedent/25.3.178; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; Crawley MJ., 2007, R BOOK; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DARSIE R F JR, 1990, Mosquito Systematics, V22, P69; Dhimal M, 2009, J NEPAL HLTH RES COU, V7, P140; DOHS, 2012, 206768 DOHS GOV NEP; Dumre SP, 2013, AM J TROP MED HYG, V88, P677, DOI 10.4269/ajtmh.12-0436; Gautam I., 2009, J NATURAL HIST MUSEU, V24, P156, DOI [10.3126/jnhm.v24i1.2298, DOI 10.3126/JNHM.V24I1.2298, DOI 10.3126/jnhm.v24i1.2298]; Gautam I, 2012, J NAT HIST MUS, V26, P181, DOI DOI 10.3126/jnhm.v26i0.14142; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Griffiths K, 2013, J TROP MED, V2013, P8; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gupta Pushpa, 1998, Journal of Communicable Diseases, V30, P107; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Iacobucci D, 2003, J CONSUM PSYCHOL, V13, P478, DOI 10.1207/S15327663JCP1304_14; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; LUMSDEN W. H. R., 1957, BULL ENT RES, V48, P769, DOI 10.1017/S0007485300002881; Luskin RC, 2011, J POLIT, V73, P547, DOI 10.1017/S0022381611000132; Malla S, 2008, EMERG INFECT DIS, V14, P1669, DOI 10.3201/eid1410.080432; Mayxay M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-434; NELSON MJ, 1978, J MED ENTOMOL, V14, P504, DOI 10.1093/jmedent/14.5.504; Nepal Health Research Council (NHRC), 2011, NAT ETH GUID HLTH RE; Pandey Basu D, 2013, Trop Med Health, V41, P103, DOI 10.2149/tmh.2012-17; Pandey BD, 2008, EMERG INFECT DIS, V14, P514, DOI 10.3201/eid1403.070473; Pandey Basu Dev, 2004, Nepal Med Coll J, V6, P157; Peters W., 1956, Indian Journal of Malariology, V10, P37; Petersen LR, 2012, TRANSFUSION, V52, P1647, DOI 10.1111/j.1537-2995.2011.03529.x; Pun SB, 2011, J NEPAL MED ASSOC, V51, P203; R Development Core Team, 2012, R LANG ENV STAT COMP; Radhakrishna RB., 2007, J EXT, V45, P1; Sedhain A, 2011, INT J INFECT DIS, V15, pS113, DOI 10.1016/S1201-9712(11)60396-2; Sharma B, 2012, INT J PHARM BIOL ARC, V3, P1383; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Shuaib F, 2010, W INDIAN MED J, V59, P139; Takasaki T, 2008, J TRAVEL MED, V15, P46, DOI 10.1111/j.1708-8305.2007.00165.x; Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673; Uma Deavi Ayyamani, 1986, Med J Malaysia, V41, P108; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Wang H, 1997, J ENVIRON ECON MANAG, V32, P219, DOI 10.1006/jeem.1996.0965; WHO/SEARO, 2011, COMPR GUID PREV CONT; WHO/TDR, 2009, DENG GUID DIAGN TREA; Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319; Yboa BC, 2013, AM J PUBLIC HLTH RES, V1, P47, DOI [10.12691/ajphr-1-2-2, DOI 10.12691/AJPHR-1-2-2]	58	93	97	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102028	10.1371/journal.pone.0102028	http://dx.doi.org/10.1371/journal.pone.0102028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007284	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600088
J	Oshima, N; Yamada, Y; Nagayama, S; Kawada, K; Hasegawa, S; Okabe, H; Sakai, Y; Aoi, T				Oshima, Nobu; Yamada, Yasuhiro; Nagayama, Satoshi; Kawada, Kenji; Hasegawa, Suguru; Okabe, Hiroshi; Sakai, Yoshiharu; Aoi, Takashi			Induction of Cancer Stem Cell Properties in Colon Cancer Cells by Defined Factors	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; SIDE-POPULATION; HUMAN FIBROBLASTS; MARKER; EXPRESSION; PHENOTYPE; CARCINOMA; NANOG; CDX2; ADENOCARCINOMAS	Cancer stem cells (CSCs) are considered to be responsible for the dismal prognosis of cancer patients. However, little is known about the molecular mechanisms underlying the acquisition and maintenance of CSC properties in cancer cells because of their rarity in clinical samples. We herein induced CSC properties in cancer cells using defined factors. We retrovirally introduced a set of defined factors (OCT3/4, SOX2 and KLF4) into human colon cancer cells, followed by culture with conventional serum-containing medium, not human embryonic stem cell medium. We then evaluated the CSC properties in the cells. The colon cancer cells transduced with the three factors showed significantly enhanced CSC properties in terms of the marker gene expression, sphere formation, chemoresistance and tumorigenicity. We designated the cells with CSC properties induced by the factors, a subset of the transduced cells, as induced CSCs (iCSCs). Moreover, we established a novel technology to isolate and collect the iCSCs based on the differences in the degree of the dye-effluxing activity enhancement. The xenografts derived from our iCSCs were not teratomas. Notably, in contrast to the tumors from the parental cancer cells, the iCSC-based tumors mimicked actual human colon cancer tissues in terms of their immunohistological findings, which showed colonic lineage differentiation. In addition, we confirmed that the phenotypes of our iCSCs were reproducible in serial transplantation experiments. By introducing defined factors, we generated iCSCs with lineage specificity directly from cancer cells, not via an induced pluripotent stem cell state. The novel method enables us to obtain abundant materials of CSCs that not only have enhanced tumorigenicity, but also the ability to differentiate to recapitulate a specific type of cancer tissues. Our method can be of great value to fully understand CSCs and develop new therapies targeting CSCs.	[Oshima, Nobu; Yamada, Yasuhiro] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Kyoto, Japan; [Oshima, Nobu; Aoi, Takashi] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Fundamental Cell Technol, Kyoto, Japan; [Oshima, Nobu; Nagayama, Satoshi; Kawada, Kenji; Hasegawa, Suguru; Okabe, Hiroshi; Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan; [Nagayama, Satoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Ctr, Tokyo, Japan; [Aoi, Takashi] Kobe Univ, Grad Sch Med, Dept iPS Cell Applicat, Kobe, Hyogo 657, Japan	Kyoto University; Kyoto University; Kyoto University; Japanese Foundation for Cancer Research; Kobe University	Aoi, T (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Fundamental Cell Technol, Kyoto, Japan.	takaaoi@med.kobe-u.ac.jp			Shinryokukai General Incorporated Association; Japan Society for the Promotion of Science (JSPS) [10J06242]	Shinryokukai General Incorporated Association; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study had been made possible thanks to the Balzan Prize to Shinya Yamanaka (http://www.balzan.org/en/about-us/balzan-prize-milan), and supported by Research Assistance Funds from Shinryokukai General Incorporated Association (https://www.shinryokukai.com/) (to TA) which is a not for profit alumni association of Kobe university school of medicine, and Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/index.html): 10J06242 (to NO), and NO was JSPS research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bayrak R, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-9; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033544; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; EE HC, 1995, AM J PATHOL, V147, P586; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; MOLL R, 1992, AM J PATHOL, V140, P427; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Neumann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-518; Nishi M., 2013, ONCOGENE; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tot T, 2002, EUR J CANCER, V38, P758, DOI 10.1016/S0959-8049(02)00008-4; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	43	68	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101735	10.1371/journal.pone.0101735	http://dx.doi.org/10.1371/journal.pone.0101735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006808	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600063
J	Fukushima, T; Iizuka, H; Yokota, A; Suzuki, T; Ohno, C; Kono, Y; Nishikiori, M; Seki, A; Ichiba, H; Watanabe, Y; Hongo, S; Utsunomiya, M; Nakatani, M; Sadamoto, K; Yoshio, T				Fukushima, Takeshi; Iizuka, Hideaki; Yokota, Ayaka; Suzuki, Takehiro; Ohno, Chihiro; Kono, Yumiko; Nishikiori, Minami; Seki, Ayaka; Ichiba, Hideaki; Watanabe, Yoshinori; Hongo, Seiji; Utsunomiya, Mamoru; Nakatani, Masaki; Sadamoto, Kiyomi; Yoshio, Takashi			Quantitative Analyses of Schizophrenia-Associated Metabolites in Serum: Serum D-Lactate Levels Are Negatively Correlated with Gamma-Glutamylcysteine in Medicated Schizophrenia Patients	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; COLUMN-SWITCHING HPLC; ANTIOXIDANT ENZYME-ACTIVITIES; ACID-BINDING PROTEIN; D-SERINE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; KYNURENIC ACID; FATTY-ACIDS; PLASMA	The serum levels of several metabolites are significantly altered in schizophrenia patients. In this study, we performed a targeted analysis of 34 candidate metabolites in schizophrenia patients (n = 25) and compared them with those in age- and gender-matched healthy subjects (n = 27). Orthogonal partial least square-discriminant analysis revealed that complete separation between controls and patients was achieved based on these metabolites. We found that the levels of gamma-glutamylcysteine (gamma-GluCys), linoleic acid, arachidonic acid, D-serine, 3-hydroxybutyrate, glutathione (GSH), 5-hydroxytryptamine, threonine, and tyrosine were significantly lower, while D-lactate, tryptophan, kynurenine, and glutamate levels were significantly higher in schizophrenia patients compared to controls. Using receiver operating characteristics (ROC) curve analysis, the sensitivity, specificity, and the area under curve of gamma-GluCys, a precursor of GSH, and D-lactate, a terminal metabolite of methylglyoxal, were 88.00%, 81.48%, and 0.8874, and 88.00%, 77.78%, and 0.8415, respectively. In addition, serum levels of D-lactate were negatively correlated with gamma-GluCys levels in patients, but not in controls. The present results suggest that oxidative stress-induced damage may be involved in the pathogenesis of schizophrenia.	[Fukushima, Takeshi; Iizuka, Hideaki; Yokota, Ayaka; Suzuki, Takehiro; Ohno, Chihiro; Kono, Yumiko; Nishikiori, Minami; Seki, Ayaka; Ichiba, Hideaki] Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Funabashi, Chiba 274, Japan; [Watanabe, Yoshinori; Hongo, Seiji] Med Corp JISENKAI, Nanko Clin Psychiat, Himorogi Grp, Shirakawa, Fukushima, Japan; [Utsunomiya, Mamoru; Nakatani, Masaki] Sumiyoshi kaiseikai Sumiyoshi Hosp, Publ Interest Inc Fdn, Koufu, Yamanashi, Japan; [Sadamoto, Kiyomi] Yokohama Coll Pharm, Dept Clin Pharm, Yokohama, Kanagawa, Japan; [Yoshio, Takashi] Toho Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Funabashi, Chiba 274, Japan	Toho University; Toho University	Fukushima, T (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan.	t-fukushima@phar.toho-u.ac.jp			Japan Society for the Promotion of Science; Faculty of Pharmaceutical sciences, Toho University;  [23617027];  [25460224]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Faculty of Pharmaceutical sciences, Toho University; ; 	This research was financially supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C) Grant Numbers 23617027 and 25460224, and the Faculty of Pharmaceutical sciences, Toho University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama C, 2004, BIOMED CHROMATOGR, V18, P630, DOI 10.1002/bmc.365; Arai M, 2010, ARCH GEN PSYCHIAT, V67, P589, DOI 10.1001/archgenpsychiatry.2010.62; Batabyal D, 2007, J AM CHEM SOC, V129, P15690, DOI 10.1021/ja076186k; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Cai HL, 2012, J PROTEOME RES, V11, P4338, DOI 10.1021/pr300459d; Calcia MA, 2012, SCHIZOPHR RES, V142, P83, DOI 10.1016/j.schres.2012.09.014; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Fukushima T, 2004, BIOMED CHROMATOGR, V18, P813, DOI 10.1002/bmc.394; Fukushima T, 2007, CLIN CHIM ACTA, V377, P174, DOI 10.1016/j.cca.2006.09.019; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hasegawa H, 2003, ANAL BIOANAL CHEM, V377, P886, DOI 10.1007/s00216-003-2108-6; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hsu WY, 2011, J CHROMATOGR B, V879, P3331, DOI 10.1016/j.jchromb.2011.07.038; Hubbard KE, 2010, BIOMED CHROMATOGR, V24, P626, DOI 10.1002/bmc.1338; Isokawa M, 2013, ANALYST, V138, P3802, DOI 10.1039/c3an00527e; Iwayama Y, 2010, AM J MED GENET B, V153B, P484, DOI 10.1002/ajmg.b.31004; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Maekawa M, 2011, CURR PHARM DESIGN, V17, P168, DOI 10.2174/138161211795049615; Miljevic C, 2013, HUM PSYCHOPHARM CLIN, V28, P1, DOI 10.1002/hup.2272; Mitsuhashi S, 2006, ANAL CHIM ACTA, V562, P36, DOI 10.1016/j.aca.2006.01.031; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; Nichenarnetla SN, 2008, FREE RADICAL BIO MED, V45, P645, DOI 10.1016/j.freeradbiomed.2008.05.012; Ohashi H, 2013, INT J TRYPTOPHAN RES, P9, DOI 10.4137/IJTR.S11459; Prados P, 1997, ANAL CHIM ACTA, V344, P227, DOI 10.1016/S0003-2670(97)00020-2; Raffa M, 2009, PROG NEURO-PSYCHOPH, V33, P1178, DOI 10.1016/j.pnpbp.2009.06.018; Ramos-Loyo J, 2013, PROG NEURO-PSYCHOPH, V44, P154, DOI 10.1016/j.pnpbp.2013.02.007; Reiter RJ, 2008, NEUROENDOCRINOL LETT, V29, P391; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; THORNALLEY PJ, 1994, AMINO ACIDS, V6, P15, DOI 10.1007/BF00808119; Tomiya M, 2007, CLIN CHIM ACTA, V380, P186, DOI 10.1016/j.cca.2007.02.011; Tomiya M, 2006, BIOMED CHROMATOGR, V20, P628, DOI 10.1002/bmc.677; Tortorella A, 2001, NEUROPSYCHOBIOLOGY, V44, P167, DOI 10.1159/000054937; Tsai YC, 2003, ANAL BIOCHEM, V319, P34, DOI 10.1016/S0003-2697(03)00283-5; Xuan JK, 2011, J PROTEOME RES, V10, P5433, DOI 10.1021/pr2006796; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603	46	65	69	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101652	10.1371/journal.pone.0101652	http://dx.doi.org/10.1371/journal.pone.0101652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004141	Green Submitted, Green Published, gold			2022-12-25	WOS:000339242700047
J	La Clair, JJ; Loveridge, ST; Tenney, K; O'Neil-Johnson, M; Chapman, E; Crews, P				La Clair, James J.; Loveridge, Steven T.; Tenney, Karen; O'Neil-Johnson, Mark; Chapman, Eli; Crews, Phillip			In Situ Natural Product Discovery via an Artificial Marine Sponge	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; ACTIN; AGENTS; DEPSIPEPTIDES; BIOSYNTHESIS; MYXOBACTERIA; DIVERSITY; APPARATUS; DRUGS	There is continuing international interest in exploring and developing the therapeutic potential of marine-derived small molecules. Balancing the strategies for ocean based sampling of source organisms versus the potential to endanger fragile ecosystems poses a substantial challenge. In order to mitigate such environmental impacts, we have developed a deployable artificial sponge. This report provides details on its design followed by evidence that it faithfully recapitulates traditional natural product collection protocols. Retrieving this artificial sponge from a tropical ecosystem after deployment for 320 hours afforded three actin-targeting jasplakinolide depsipeptides that had been discovered two decades earlier using traditional sponge specimen collection and isolation procedures. The successful outcome achieved here could reinvigorate marine natural products research, by producing new environmentally innocuous sources of natural products and providing a means to probe the true biosynthetic origins of complex marine-derived scaffolds.	[La Clair, James J.] Xenobe Res Inst, San Diego, CA 92116 USA; [Loveridge, Steven T.; Tenney, Karen; Crews, Phillip] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [O'Neil-Johnson, Mark] Sequoia Sci Inc, Lead Discovery & Rapid Struct Elucidat Grp, St Louis, MO USA; [Chapman, Eli] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of California System; University of California Santa Cruz; University of Arizona	La Clair, JJ (corresponding author), Xenobe Res Inst, San Diego, CA 92116 USA.	i@xenobe.org; chapman@pharmacy.arizona.edu; pcrews@ucsc.edu			NIH [R01CA047135]; Xenobe Research Institute; University of Arizona; NATIONAL CANCER INSTITUTE [R01CA047135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xenobe Research Institute; University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the NIH, R01CA047135 (P. C.), program funds from the Xenobe Research Institute (J. J. L.), as well as startup funds from the University of Arizona (E. C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Ayers J, 2007, PHILOS T R SOC A, V365, P273, DOI 10.1098/rsta.2006.1910; Blunt J., 2012, HDB MARINE NATURAL P, P3, DOI [10.1007/978-90-481-3834-0_1, DOI 10.1007/978-90-481-3834-0_1]; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; COLL JC, 1982, J EXP MAR BIOL ECOL, V60, P293, DOI 10.1016/0022-0981(82)90166-6; CREWS P, 1986, TETRAHEDRON LETT, V27, P2797, DOI 10.1016/S0040-4039(00)84645-6; DeLong EF, 1997, TRENDS BIOTECHNOL, V15, P203, DOI 10.1016/S0167-7799(97)01044-5; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hill R., 2005, U.S. Patent, Patent No. [20050244938A1, 20050244938, 20,050,244,938 A1]; Iizuka T, 2006, J ANTIBIOT, V59, P385, DOI 10.1038/ja.2006.55; Johnson TA, 2012, BIOORGAN MED CHEM, V20, P4348, DOI 10.1016/j.bmc.2012.05.043; KUNZE B, 1995, J ANTIBIOT, V48, P1262, DOI 10.7164/antibiotics.48.1262; La Clair JJ, 2010, NAT PROD REP, V27, P969, DOI 10.1039/b909989c; Lee J, 2012, NAT PROD REP, V29, P404, DOI 10.1039/c2np00065b; Leys SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027787; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Nagle A, 2006, CURR DRUG TARGETS, V7, P305, DOI 10.2174/138945006776054933; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Newman DJ, 2009, FUTURE MED CHEM, V1, P1415, DOI 10.4155/FMC.09.113; Noro JC, 2012, CHEM BIODIVERS, V9, P2077, DOI 10.1002/cbdv.201100292; Park EY, 2004, ADV BIOCHEM ENG BIOT, V90, P1; Peraud O, 2006, THESIS U MARYLAND; Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017; Robinson SJ, 2010, J MED CHEM, V53, P1651, DOI 10.1021/jm9013554; Rodriguez AD, 2008, J AM CHEM SOC, V130, P7256, DOI 10.1021/ja7114019; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; SCHULTE BA, 1991, J CHEM ECOL, V17, P1327, DOI 10.1007/BF00983765; Sharma R, 2005, CURR SCI INDIA, V89, P72; Tannert R, 2010, J AM CHEM SOC, V132, P3063, DOI 10.1021/ja9095126; Terracciano S, 2008, BIOORGAN MED CHEM, V16, P6580, DOI 10.1016/j.bmc.2008.05.019; THOMPSON JE, 1983, ACTA ZOOL-STOCKHOLM, V64, P199, DOI 10.1111/j.1463-6395.1983.tb00801.x; Tsukimoto M, 2011, J NAT PROD, V74, P2329, DOI 10.1021/np200543z; Watts KR, 2011, J NAT PROD, V74, P341, DOI 10.1021/np100721g; Xu Y, 2012, J AM CHEM SOC, V134, P8625, DOI 10.1021/ja301735a; Zabriskie MT, 1987, J AM CHEM SOC, V108, P3123; Zampella A, 1999, J NAT PROD, V62, P332, DOI 10.1021/np9803225	38	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e100474	10.1371/journal.pone.0100474	http://dx.doi.org/10.1371/journal.pone.0100474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004127	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700010
J	Burgie, ES; Wang, T; Bussell, AN; Walker, JM; Li, HL; Vierstra, RD				Burgie, E. Sethe; Wang, Tong; Bussell, Adam N.; Walker, Joseph M.; Li, Huilin; Vierstra, Richard D.			Crystallographic and Electron Microscopic Analyses of a Bacterial Phytochrome Reveal Local and Global Rearrangements during Photoconversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Photomorphogenesis; Photoreceptor; Phototransduction; Plant Biochemistry; Protein Structure; X-ray Crystallography; Bilin; Photoconversion; Phytochrome	PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; CRYSTAL-STRUCTURE; GROUND-STATE; BILIVERDIN CHROMOPHORE; PLANT PHYTOCHROME; LIGHT; CYANOBACTERIOCHROMES; PHOTORECEPTORS; TRANSDUCTION	Background: Phytochromes are dimeric bili-proteins central to photoperception by plants and microorganisms. Results: An informative perspective on photoconversion from the dark-adapted to the photoactivated state was provided by crystallographic and electron microscopic analyses of a bacterial version. Conclusion: Light-induced conformational changes in the bilin induce a large scale reorientation of the sister output modules. Significance: The structures offer a model for signal transmission by phytochromes. Phytochromes are multidomain photoswitches that drive light perception in plants and microorganisms by coupling photoreversible isomerization of their bilin chromophore to various signaling cascades. How changes in bilin conformation affect output by these photoreceptors remains poorly resolved and might include several species-specific routes. Here, we present detailed three-dimensional models of the photosensing module and a picture of an entire dimeric photoreceptor through structural analysis of the Deinococcus radiodurans phytochrome BphP assembled with biliverdin (BV). A 1.16- resolution crystal structure of the bilin-binding pocket in the dark-adapted red light-absorbing state illuminated the intricate network of bilin/protein/water interactions and confirmed the protonation and ZZZssa conformation of BV. Structural and spectroscopic comparisons with the photochemically compromised D207A mutant revealed that substitutions of Asp-207 allow inclusion of cyclic porphyrins in addition to BV. A crystal structure of the entire photosensing module showed a head-to-head, twisted dimeric arrangement with bowed helical spines and a hairpin protrusion connecting the cGMP phosphodiesterase/adenylyl cyclase/FhlA (GAF) and phytochrome-specific (PHY) domains. A key conserved hairpin feature is its anti-parallel, two -strand stem, which we show by mutagenesis to be critical for BphP photochemistry. Comparisons of single particle electron microscopic images of the full-length BphP dimer in the red light-absorbing state and the photoactivated far-red light-absorbing state revealed a large scale reorientation of the PHY domain relative to the GAF domain, which alters the position of the downstream histidine kinase output module. Together, our data support a toggle model whereby bilin photoisomerization alters GAF/PHY domain interactions through conformational modification of the hairpin, which regulates signaling by impacting the relationship between sister output modules.	[Burgie, E. Sethe; Bussell, Adam N.; Walker, Joseph M.; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wang, Tong; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu		Li, Huilin/0000-0001-8085-8928	National Institutes of Health [R01 AI070285]; National Science Foundation [MCB-1329956]; Brookhaven National Laboratory Laboratory [10-16]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Brookhaven National Laboratory Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI070285 (to H. L.). This work was also supported by National Science Foundation Grant MCB-1329956 (to R. D. V.) and Brookhaven National Laboratory Laboratory-directed Research Project 10-16.	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bellini D, 2012, STRUCTURE, V20, P1436, DOI 10.1016/j.str.2012.06.002; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Bussell A.N., 2014, CELL BIOL CYANOBACTE, P149; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornilescu CC, 2014, J BIOL CHEM, V289, P3055, DOI 10.1074/jbc.M113.531053; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2014, P NATL ACAD SCI USA, V111, P3871, DOI 10.1073/pnas.1401871111; Rockwell NC, 2013, P NATL ACAD SCI USA, V110, P806, DOI 10.1073/pnas.1220690110; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892	50	77	78	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24573	24587		10.1074/jbc.M114.571661	http://dx.doi.org/10.1074/jbc.M114.571661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006244	Green Published, hybrid			2022-12-25	WOS:000341505600048
J	Knyazev, DG; Winter, L; Bauer, BW; Siligan, C; Pohl, P				Knyazev, Denis G.; Winter, Lukas; Bauer, Benedikt W.; Siligan, Christine; Pohl, Peter			Ion Conductivity of the Bacterial Translocation Channel SecYEG Engaged in Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Lipid Bilayer; Membrane Transport; Membrane Transporter Reconstitution; Protein Translocation; Proton Motive Force	PROTEIN TRANSLOCATION; ESCHERICHIA-COLI; PLUG DOMAIN; SMALL MOLECULES; WATER CHANNEL; VOLTAGE-CLAMP; SECA ATPASE; MEMBRANE; PERMEABILITY; CONDUCTANCE	Background: How SecYEG excludes ions during protein translocation is not known. Results: SecYEG gating is voltage-sensitive. Conclusion: Voltage minimizes the ion leak that is induced by stalling a translocation intermediate. Significance: Preservation of the proton motif force requires voltage-driven conformational changes. While engaged in protein transport, the bacterial translocon SecYEG must maintain the membrane barrier to small ions. The preservation of the proton motif force was attributed to (i) cation exclusion, (ii) engulfment of the nascent chain by the hydrophobic pore ring, and (iii) a half-helix partly plugging the channel. In contrast, we show here that preservation of the proton motif force is due to a voltage-driven conformational change. Preprotein or signal peptide binding to the purified and reconstituted SecYEG results in large cation and anion conductivities only when the membrane potential is small. Physiological values of membrane potential close the activated channel. This voltage-dependent closure is not dependent on the presence of the plug domain and is not affected by mutation of 3 of the 6 constriction residues to glycines. Cellular ion homeostasis is not challenged by the small remaining leak conductance.	[Knyazev, Denis G.; Winter, Lukas; Bauer, Benedikt W.; Siligan, Christine; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria	Johannes Kepler University Linz	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.pohl@jku.at	Pohl, Peter/A-5361-2008; Knyazev, Denis G/E-5045-2019	Pohl, Peter/0000-0002-1792-2314; Knyazev, Denis G/0000-0003-3197-1849	Austrian Science Fund (FWF) [P20872]; Austrian Science Fund (FWF) [P 20872] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant P20872 from the Austrian Science Fund (FWF) (to P. P.).	ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Bauer BW, 2009, P NATL ACAD SCI USA, V106, P20800, DOI 10.1073/pnas.0910550106; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kannan P, 2009, INDIAN J BIOCHEM BIO, V46, P261; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Saparov SM, 2000, BIOPHYS J, V79, P2526, DOI 10.1016/S0006-3495(00)76493-9; Saparov SM, 2005, BIOL CELL, V97, P545; SCHIEBEL E, 1992, J BIOL CHEM, V267, P7505; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WOODBURY DJ, 1988, BIOPHYS J, V54, P1053, DOI 10.1016/S0006-3495(88)83042-X; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182	28	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24611	24616		10.1074/jbc.M114.588491	http://dx.doi.org/10.1074/jbc.M114.588491			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016015	Green Published, hybrid			2022-12-25	WOS:000341505600051
J	Roret, T; Tsan, P; Couturier, J; Zhang, B; Johnson, MK; Rouhier, N; Didierjean, C				Roret, Thomas; Tsan, Pascale; Couturier, Jeremy; Zhang, Bo; Johnson, Michael K.; Rouhier, Nicolas; Didierjean, Claude			Structural and Spectroscopic Insights into BolA-Glutaredoxin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutathione; Iron Metabolism; Iron-Sulfur Protein; Redox Regulation; Thiol; BolA; Complexes; Glutaredoxin	MONOTHIOL GLUTAREDOXINS; RESONANCE RAMAN; IRON; CLUSTER; PROTEIN; RIESKE; SYSTEM; STRESS; LIGAND; GRX4	Background: BolA and glutaredoxin interact together in the iron metabolism. Results: They form two types of heterodimers with different binding surfaces depending on the presence or absence of an iron-sulfur cluster. Conclusion: The function of both proteins is likely modulated by the nature of the interaction. Significance: Understanding the molecular mechanisms responsible for iron sensing is crucial for all iron-mediated cellular processes. BolA proteins are defined as stress-responsive transcriptional regulators, but they also participate in iron metabolism. Although they can form [2Fe-2S]-containing complexes with monothiol glutaredoxins (Grx), structural details are lacking. Three Arabidopsis thaliana BolA structures were solved. They differ primarily by the size of a loop referred to as the variable [H/C] loop, which contains an important cysteine (BolA_C group) or histidine (BolA_H group) residue. From three-dimensional modeling and spectroscopic analyses of A. thaliana GrxS14-BolA1 holo-heterodimer (BolA_H), we provide evidence for the coordination of a Rieske-type [2Fe-2S] cluster. For BolA_C members, the cysteine could replace the histidine as a ligand. NMR interaction experiments using apoproteins indicate that a completely different heterodimer was formed involving the nucleic acid binding site of BolA and the C-terminal tail of Grx. The possible biological importance of these complexes is discussed considering the physiological functions previously assigned to BolA and to Grx-BolA or Grx-Grx complexes.	[Roret, Thomas; Tsan, Pascale; Didierjean, Claude] Univ Lorraine, F-54506 Vandoeuvre Les Nancy, France; [Roret, Thomas; Tsan, Pascale; Didierjean, Claude] CNRS, BioMod Grp, UMR 7036 CRM2, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Rouhier, Nicolas] Univ Lorraine, UMR Interact Arbres Microorganismes 1136, F-54500 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Rouhier, Nicolas] INRA, UMR Interact Arbres Microorganismes 1136, F-54280 Champenoux, France; [Zhang, Bo; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Zhang, Bo; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine; INRAE; Universite de Lorraine; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Didierjean, C (corresponding author), Univ Lorraine, BioMod Grp, UMR7036 CRM2, F-54506 Vandoeuvre Les Nancy, France.	claude.didierjean@univ-lorraine.fr	Couturier, Jérémy/AAF-6588-2020; DIDIERJEAN, Claude/L-1493-2013	Couturier, Jérémy/0000-0003-3127-2669; DIDIERJEAN, Claude/0000-0002-3176-8974; tsan, pascale/0000-0002-0218-0258; Rouhier, Nicolas/0000-0002-2036-7884	ANR as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [2010BLAN1616, ANR-11-LABX-0002-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524] Funding Source: NIH RePORTER	ANR as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a grant overseen by ANR (Grant 2010BLAN1616) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; BERTRAND P, 1985, BIOCHIM BIOPHYS ACTA, V831, P261, DOI 10.1016/0167-4838(85)90044-5; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZH, 2011, MOL MICROBIOL, V82, P1217, DOI 10.1111/j.1365-2958.2011.07885.x; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Couturier J, 2014, MOL PLANT, V7, P187, DOI 10.1093/mp/sst156; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Iwasaki T, 2004, J AM CHEM SOC, V126, P4788, DOI 10.1021/ja031976p; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kounosu A, 2004, J BIOL CHEM, V279, P12519, DOI 10.1074/jbc.M305923200; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li LN, 2010, ACTA CRYSTALLOGR D, V66, P725, DOI 10.1107/S0907444910013119; Li ST, 2011, PLANT PHYSIOL, V157, P2056, DOI 10.1104/pp.111.185199; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rotsaert FAJ, 2003, J BIOL INORG CHEM, V8, P318, DOI 10.1007/s00775-002-0417-4; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Shukla M., 2012, PLOS ONE, V7, P1; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeung N, 2011, BIOCHEMISTRY-US, V50, P8957, DOI 10.1021/bi2008883	58	37	41	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24588	24598		10.1074/jbc.M114.572701	http://dx.doi.org/10.1074/jbc.M114.572701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012657	Green Published, hybrid			2022-12-25	WOS:000341505600049
J	Roose, JL; Frankel, LK; Bricker, TM				Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.			The PsbP Domain Protein 1 Functions in the Assembly of Lumenal Domains in Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Membrane Protein; Photosynthesis; Plant Biochemistry; Protein Assembly; Photosystem I	SYNECHOCOCCUS SP PCC-7002; ARABIDOPSIS-THALIANA; CHLAMYDOMONAS-REINHARDTII; PHOTOSYNTHETIC ACCLIMATION; PHOTOAUTOTROPHIC GROWTH; HIGHER-PLANTS; SUBUNIT; GENE; PSI; INACTIVATION	Background: The assembly of Photosystem I requires additional protein factors. Results:Arabidopsis RNAi mutants of PPD1 were characterized for Photosystem I function and assembly. Conclusion: The PPD1 protein serves as a factor to facilitate functional assembly of Photosystem I. Significance: RNAi suppression of PPD1 provides new details on its function in Photosystem I assembly. Photosystem I (PS I) is a multisubunit membrane protein complex that functions as a light-driven plastocyanin-ferredoxin oxidoreductase. The PsbP domain protein 1 (PPD1; At4g15510) is located in the thylakoid lumen of plant chloroplasts and is essential for photoautotrophy, functioning as a PS I assembly factor. In this work, RNAi was used to suppress PPD1 expression, yielding mutants displaying a range of phenotypes with respect to PS I accumulation and function. These PPD1 RNAi mutants showed a loss of assembled PS I that was correlated with loss of the PPD1 protein. In the most severely affected PPD1 RNAi lines, the accumulated PS I complexes exhibited defects in electron transfer from plastocyanin to the oxidized reaction center P-700(+). The defects in PS I assembly in the PPD1 RNAi mutants also had secondary effects with respect to the association of light-harvesting antenna complexes to PS I. Because of the imbalance in photosystem function in the PPD1 RNAi mutants, light-harvesting complex II associated with and acted as an antenna for the PS I complexes. These results provide new evidence for the role of PPD1 in PS I biogenesis, particularly as a factor essential for proper assembly of the lumenal portion of the complex.	[Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-98ER20310]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG02-98ER20310 (to T. M. B. and L. K. F.).	Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Bricker TM, 2013, PHOTOSYNTH RES, V116, P235, DOI 10.1007/s11120-013-9820-7; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; Dietzel L, 2008, FEBS J, V275, P1080, DOI 10.1111/j.1742-4658.2008.06264.x; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hohmann-Marriott MF, 2010, FEBS LETT, V584, P1021, DOI 10.1016/j.febslet.2010.01.052; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Ihnatowicz A, 2004, PLANT J, V37, P839, DOI 10.1111/j.1365-313X.2004.02011.x; Ihnatowicz A, 2007, PLANTA, V226, P889, DOI 10.1007/s00425-007-0534-y; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Liu J, 2012, PLANT CELL, V24, P4992, DOI 10.1105/tpc.112.106542; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Ozawa S, 2010, J BIOL CHEM, V285, P20072, DOI 10.1074/jbc.M109.098954; Pesaresi P, 2010, PLANT SIGNAL BEHAV, V5, P21, DOI 10.4161/psb.5.1.10198; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WILDE A, 1995, PLANT CELL, V7, P649, DOI 10.1105/tpc.7.5.649; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Yi XP, 2008, PHOTOSYNTH RES, V98, P439, DOI 10.1007/s11120-008-9352-8	43	14	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23776	23785		10.1074/jbc.M114.589085	http://dx.doi.org/10.1074/jbc.M114.589085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008325	hybrid, Green Published			2022-12-25	WOS:000341505000045
J	Ng, OW; Keng, CT; Leung, CSW; Peiris, JSM; Poon, LLM; Tan, YJ				Ng, Oi-Wing; Keng, Choong-Tat; Leung, Cynthia Sau-Wai; Peiris, J. S. Malik; Poon, Leo Lit Man; Tan, Yee-Joo			Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; ANGIOTENSIN-CONVERTING ENZYME-2; RECEPTOR-BINDING DOMAIN; FUNCTIONAL-CHARACTERIZATION; FUSION CORE; PROTEIN; COV; VIRUS; VACCINE; ENTRY	The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is the etiological agent for the infectious disease, SARS, which first emerged 10 years ago. SARS-CoV is a zoonotic virus that has crossed the species barriers to infect humans. Bats, which harbour a diverse pool of SARS-like CoVs (SL-CoVs), are believed to be the natural reservoir. The SARS-CoV surface Spike (S) protein is a major antigenic determinant in eliciting neutralizing antibody production during SARS-CoV infection. In our previous work, we showed that a panel of murine monoclonal antibodies (mAbs) that target the S2 subunit of the S protein are capable of neutralizing SARS-CoV infection in vitro (Lip KM et al, J Virol. 2006 Jan; 80(2): 941-50). In this study, we report our findings on the characterization of one of these mAbs, known as 1A9, which binds to the S protein at a novel epitope within the S2 subunit at amino acids 1111-1130. MAb 1A9 is a broadly neutralizing mAb that prevents viral entry mediated by the S proteins of human and civet SARS-CoVs as well as bat SL-CoVs. By generating mutant SARS-CoV that escapes the neutralization by mAb 1A9, the residue D1128 in S was found to be crucial for its interaction with mAb 1A9. S protein containing the substitution of D1128 with alanine (D1128A) exhibited a significant decrease in binding capability to mAb 1A9 compared to wild-type S protein. By using a pseudotyped viral entry assay, it was shown that the D1128A substitution in the escape virus allows it to overcome the viral entry blockage by mAb 1A9. In addition, the D1128A mutation was found to exert no effects on the S protein cell surface expression and incorporation into virion particles, suggesting that the escape virus retains the same viral entry property as the wild-type virus.	[Ng, Oi-Wing; Tan, Yee-Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, NUHS, Singapore 117595, Singapore; [Keng, Choong-Tat; Tan, Yee-Joo] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Leung, Cynthia Sau-Wai; Peiris, J. S. Malik; Poon, Leo Lit Man] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Hong Kong	Tan, YJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, NUHS, Singapore 117595, Singapore.	Yee_Joo_TAN@NUHS.edu.sg	Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Tan, Yee-Joo/0000-0002-2278-4497; KENG, CHOONG TAT/0000-0003-2898-5924	A*STAR BMRC Grant [10/1/21/19/652]	A*STAR BMRC Grant(Agency for Science Technology & Research (A*STAR))	This work was supported by an A*STAR BMRC Grant (10/1/21/19/652) awarded to Y.-J. Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Chakraborti S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-73; Coughlin MM, 2012, REV MED VIROL, V22, P2, DOI 10.1002/rmv.706; Coughlin MM, 2009, VIROLOGY, V394, P39, DOI 10.1016/j.virol.2009.07.028; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Duan JZ, 2005, BIOCHEM BIOPH RES CO, V333, P186, DOI 10.1016/j.bbrc.2005.05.089; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Garcia JM, 2011, EXPERT REV ANTI-INFE, V9, P443, DOI [10.1586/eri.11.25, 10.1586/ERI.11.25]; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He YX, 2006, J IMMUNOL, V176, P6085, DOI 10.4049/jimmunol.176.10.6085; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Hofmann H, 2004, J VIROL, V78, P6134, DOI 10.1128/JVI.78.12.6134-6142.2004; Keng CT, 2005, J VIROL, V79, P3289, DOI 10.1128/JVI.79.6.3289-3296.2005; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Lip KM, 2006, J VIROL, V80, P941, DOI 10.1128/JVI.80.2.941-950.2006; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; McReynolds S, 2008, BIOCHEMISTRY-US, V47, P6802, DOI 10.1021/bi800622t; Mitsuki YY, 2008, MICROBES INFECT, V10, P908, DOI 10.1016/j.micinf.2008.05.009; Miyoshi-Akiyama T, 2011, J INFECT DIS, V203, P1574, DOI 10.1093/infdis/jir084; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; Sainz B, 2006, VIRUS RES, V120, P146, DOI 10.1016/j.virusres.2006.03.001; Shi ZL, 2008, VIRUS RES, V133, P74, DOI 10.1016/j.virusres.2007.03.012; Spiga O, 2003, BIOCHEM BIOPH RES CO, V310, P78, DOI 10.1016/j.bbrc.2003.08.122; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005; Temperton NJ, 2005, EMERG INFECT DIS, V11, P411, DOI 10.3201/eid1103.040906; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; Tripp RA, 2005, J VIROL METHODS, V128, P21, DOI 10.1016/j.jviromet.2005.03.021; Tsunetsugu-Yokota Y, 2006, REV MED VIROL, V16, P117, DOI 10.1002/rmv.492; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Xu YH, 2004, BIOCHEMISTRY-US, V43, P14064, DOI 10.1021/bi049101q; Yeung KS, 2006, MED RES REV, V26, P414, DOI 10.1002/med.20055; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104	55	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102415	10.1371/journal.pone.0102415	http://dx.doi.org/10.1371/journal.pone.0102415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019613	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600081
J	Zeug, SC; Cavallo, BJ				Zeug, Steven C.; Cavallo, Bradley J.			Controls on the Entrainment of Juvenile Chinook Salmon (Oncorhynchus tshawytscha) into Large Water Diversions and Estimates of Population-Level Loss	PLOS ONE			English	Article							JOAQUIN RIVER DELTA; IRRIGATION CANALS; FISH ENTRAINMENT; POWER-STATION; SURVIVAL; ESTUARY; BIODIVERSITY; CONSERVATION; MIGRATION; SYSTEM	Diversion of freshwater can cause significant changes in hydrologic dynamics and this can have negative consequences for fish populations. Additionally, fishes can be directly entrained into diversion infrastructure (e.g. canals, reservoirs, pumps) where they may become lost to the population. However, the effect of diversion losses on fish population dynamics remains unclear. We used 15 years of release and recovery data from coded-wire-tagged juvenile Chinook Salmon (Oncorhynchus tshawytscha) to model the physical, hydrological and biological predictors of salvage at two large water diversions in the San Francisco Estuary. Additionally, entrainment rates were combined with estimates of mortality during migration to quantify the proportion of total mortality that could be attributed to diversions. Statistical modeling revealed a strong positive relationship between diversion rate and fish entrainment at both diversions and all release locations. Other significant relationships were specific to the rivers where the fish were released, and the specific diversion facility. Although significant relationships were identified in statistical models, entrainment loss and the mean contribution of entrainment to total migration mortality were low. The greatest entrainment mortality occurred for fish released along routes that passed closest to the diversions and certain runs of Chinook Salmon released in the Sacramento River suffered greater mortality but only at the highest diversion rates observed during the study. These results suggest losses at diversions should be put into a population context in order to best inform effective management of Chinook Salmon populations.	[Zeug, Steven C.; Cavallo, Bradley J.] Cramer Fish Sci, Auburn, CA 95602 USA		Zeug, SC (corresponding author), Cramer Fish Sci, Auburn, CA 95602 USA.	stevez@fishsciences.net		Zeug, Steven/0000-0003-4330-1236	California Department of Water Resources	California Department of Water Resources	This study was funded by the California Department of Water Resources. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Staff from the funding agency participated in data collection in coordination with other state and federal resource agencies.	Baumgartner LJ, 2009, FISHERIES MANAG ECOL, V16, P429, DOI 10.1111/j.1365-2400.2009.00693.x; Buchanan RA, 2013, N AM J FISH MANAGE, V33, P216, DOI 10.1080/02755947.2012.728178; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carlson AJ, 2007, T AM FISH SOC, V136, P1335, DOI 10.1577/T06-111.1; Carter KL, 2000, FISHERIES MANAG ECOL, V7, P447, DOI 10.1046/j.1365-2400.2000.00224.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gingras M, 1997, TECHNICAL REPORT; Grimaldo LF, 2009, N AM J FISH MANAGE, V29, P1253, DOI 10.1577/M08-062.1; Hadderingh RH, 2002, J FISH BIOL, V61, P105, DOI 10.1006/jfbi.2002.2071; KELSO J R M, 1979, Journal of Great Lakes Research, V5, P182; Kimmerer W.J., 2008, SAN FRANCISCO ESTUAR, V6, particl; Michel CJ, 2010, THESIS U CALIFORNIA; Moyle PB, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:UA]2.0.CO;2; National Marine Fisheries Service, 2009, NMFS FIN 2009 BIOL O; Newman K.B., 2008, EVALUATION 4 SACRAME; Newman KB, 2003, STAT MODEL, V3, P157, DOI 10.1191/1471082X03st055oa; Newman KB, 2002, J AM STAT ASSOC, V97, P983, DOI 10.1198/016214502388618771; Newman KB, 2010, N AM J FISH MANAGE, V30, P157, DOI 10.1577/M07-188.1; Nobriga ML, 2004, AM FISH S S, V39, P281; Perry R. W., 2010, THESIS U WASHINGTON; Perry RW, 2010, N AM J FISH MANAGE, V30, P142, DOI 10.1577/M08-200.1; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Post JR, 2006, N AM J FISH MANAGE, V26, P875, DOI 10.1577/M05-047.1; R Core Team, 2012, R LANG ENV STAT COMP; Roberts JJ, 2008, T AM FISH SOC, V137, P951, DOI 10.1577/T07-058.1; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Walters AW, 2012, T AM FISH SOC, V141, P1180, DOI 10.1080/00028487.2012.679019; Yoshiyama R.M., 2001, FISH B-NOAA, V179, P71; Zabel RW, 2008, HYDROBIOLOGIA, V609, P289, DOI 10.1007/s10750-008-9407-z; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719; Zeug SC, 2013, ECOL FRESHW FISH, V22, P157, DOI 10.1111/eff.12013	31	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101479	10.1371/journal.pone.0101479	http://dx.doi.org/10.1371/journal.pone.0101479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019205	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600016
J	Han, XQ; Yue, GL; Yue, RQ; Dong, CX; Chan, CL; Ko, CH; Cheung, WS; Luo, KW; Dai, H; Wong, CK; Leung, PC; Han, QB				Han, Xiao-Qiang; Yue, Gar-Lee; Yue, Rui-Qi; Dong, Cai-Xia; Chan, Chung-Lap; Ko, Chun-Hay; Cheung, Wing-Shing; Luo, Ke-Wang; Dai, Hui; Wong, Chun-Kwok; Leung, Ping-Chung; Han, Quan-Bin			Structure Elucidation and Immunomodulatory Activity of A Beta Glucan from the Fruiting Bodies of Ganoderma Sinense	PLOS ONE			English	Article							EDIBLE MUSHROOM; PLEUROTUS-FLORIDA; B-CELLS; POLYSACCHARIDE; MACROPHAGES; ANTITUMOR; IMMUNITY; LUCIDUM; CULTURE; EDODES	A polysaccharide named GSP-2 with a molecular size of 32 kDa was isolated from the fruiting bodies of Ganoderma sinense. Its structure was well elucidated, by a combined utilization of chemical and spectroscopic techniques, to be a beta-glucan with a backbone of (1 -> 4)- and (1 -> 6)-Glcp, bearing terminal- and (1 -> 3)-Glcp side-chains at O-3 position of (1 -> 6)-Glcp. Immunological assay exhibited that GSP-2 significantly induced the proliferation of BALB/c mice splenocytes with target on only B cells, and enhanced the production of several cytokines in human peripheral blood mononuclear cells and derived dendritic cells. Besides, the fluorescent labeled GSP-2 was phagocytosed by the RAW 264.7 cells and induced the nitric oxide secretion from the cells.	[Han, Xiao-Qiang; Yue, Gar-Lee; Chan, Chung-Lap; Ko, Chun-Hay; Cheung, Wing-Shing; Luo, Ke-Wang; Wong, Chun-Kwok; Leung, Ping-Chung; Han, Quan-Bin] Chinese Univ Hong Kong, Inst Chinese Med, State Key Lab Phytochem & Plant Resources West Ch, Shatin, Hong Kong, Peoples R China; [Han, Xiao-Qiang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China; [Yue, Rui-Qi; Dong, Cai-Xia; Han, Quan-Bin] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Dai, Hui] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Hong Kong Baptist University; Peking University	Dai, H (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, Beijing 100871, Peoples R China.	daihui@bjmu.edu.cn; simonhan@hkbu.edu.hk	Wong, CK/H-3256-2016; Yue, Grace Gar-Lee/AAY-3945-2020; Ko, Chun Hay/H-9652-2013	Wong, CK/0000-0002-5637-8331; Yue, Grace Gar-Lee/0000-0002-1726-3566; Han, Quanbin/0000-0001-9051-1485; Ko, Chun Hay/0000-0001-9180-2196	Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region [ITS/311/09, InP/108/10]; National Natural Science Foundation of China [81303210, 81102253]; Hong Kong Baptist University [FRG2/11-12/048, FRG1/12-13/018, FRG2/12-13/006]	Innovation and Technology Fund of the Government of the Hong Kong Special Administrative Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Baptist University	The chemical research work of this study is funded by the Innovation and Technology Fund (ITS/311/09 and InP/108/10) of the Government of the Hong Kong Special Administrative Region, Hong Kong Baptist University (FRG2/11-12/048, FRG1/12-13/018, FRG2/12-13/006, and RC-start up grant). The immune study is funded by the National Natural Science Foundation of China (81303210, 81102253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando I, 2002, INT IMMUNOPHARMACOL, V2, P1155, DOI 10.1016/S1567-5769(02)00076-0; Bhanja SK, 2012, CARBOHYD RES, V357, P83, DOI 10.1016/j.carres.2012.04.007; Bhunia SK, 2011, CARBOHYD RES, V346, P2039, DOI 10.1016/j.carres.2011.05.029; Chan C. F. G., 2009, J HEMATOL ONCOL, V25, P1; Chen XP, 2009, CARBOHYD POLYM, V77, P389, DOI 10.1016/j.carbpol.2009.01.009; Cheng CH, 2010, NUTR CANCER, V62, P648, DOI 10.1080/01635581003605516; Da J, 2012, J CHROMATOGR A, V1222, P59, DOI 10.1016/j.chroma.2011.12.017; Delamarre L, 2011, SEMIN IMMUNOL, V23, P2, DOI 10.1016/j.smim.2011.02.001; Dey B, 2010, CARBOHYD RES, V345, P2736, DOI 10.1016/j.carres.2010.09.032; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P1301, DOI 10.1016/S1567-5769(03)00118-8; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P683, DOI 10.1016/S1567-5769(03)00056-0; Han SB, 2001, INT IMMUNOPHARMACOL, V1, P1969, DOI 10.1016/S1567-5769(01)00124-2; Han XQ, 2012, INT J BIOL MACROMOL, V51, P597, DOI 10.1016/j.ijbiomac.2012.06.029; Han XQ, 2012, J AGR FOOD CHEM, V60, P4276, DOI 10.1021/jf205056u; Ito H, 1977, SUBJECT STRAIN BIBLI; Jimenez E, 2005, CANCER IMMUNOL IMMUN, V54, P395, DOI 10.1007/s00262-004-0601-1; Kim HM, 1996, INT J IMMUNOPHARMACO, V18, P295, DOI 10.1016/0192-0561(96)00028-8; LAWRENCE JF, 1985, J CHROMATOGR, V350, P237, DOI 10.1016/S0021-9673(01)93522-8; Lin YL, 2009, J LEUKOCYTE BIOL, V86, P877, DOI 10.1189/jlb.0708441; Liu JQ, 2012, PLANTA MED, V78, P368, DOI 10.1055/s-0031-1280441; Liu JJ, 2009, EXP MOL PATHOL, V86, P208, DOI 10.1016/j.yexmp.2009.01.006; Liu MQ, 1998, IMMUNOPHARMACOLOGY, V40, P187, DOI 10.1016/S0162-3109(98)00043-5; Liu YW, 2009, J AGR FOOD CHEM, V57, P3087, DOI 10.1021/jf900011f; Lv GP, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-10; Maji PK, 2013, CARBOHYD RES, V368, P22, DOI 10.1016/j.carres.2012.12.008; Mandal EK, 2012, CARBOHYD RES, V347, P172, DOI 10.1016/j.carres.2011.10.040; Mandal S, 2010, CARBOHYD RES, V345, P2657, DOI 10.1016/j.carres.2010.10.005; NEEDS PW, 1993, CARBOHYD RES, V245, P1, DOI 10.1016/0008-6215(93)80055-J; Nie S., 2013, BIOACT CARBOHYDRATES, V1, P10, DOI [10.1016/j.bcdf.2013.01.001, DOI 10.1016/J.BCDF.2013.01.001]; Ojha AK, 2010, CARBOHYD RES, V345, P2157, DOI 10.1016/j.carres.2010.06.015; Ooi V. E. C., 1999, International Journal of Medicinal Mushrooms, V1, P195; Rice PJ, 2005, J PHARMACOL EXP THER, V314, P1079, DOI 10.1124/jpet.105.085415; Rout D, 2008, CARBOHYD RES, V343, P982, DOI 10.1016/j.carres.2007.12.022; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sato N, 2009, CHEM PHARM BULL, V57, P1076, DOI 10.1248/cpb.57.1076; Sliva D, 2006, LEUKEMIA RES, V30, P767, DOI 10.1016/j.leukres.2005.12.015; STAUB A. M., 1965, METHOD CARBOHYD CHEM, V5, P5; SWEET DP, 1975, CARBOHYD RES, V40, P217, DOI 10.1016/S0008-6215(00)82604-X; Yue GGL, 2006, J ALTERN COMPLEM MED, V12, P777, DOI 10.1089/acm.2006.12.777; Yue GGL, 2013, NUTR CANCER, V65, P765, DOI 10.1080/01635581.2013.788725	40	73	77	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100380	10.1371/journal.pone.0100380	http://dx.doi.org/10.1371/journal.pone.0100380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014571	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400008
J	Yamamoto, K; Mizumoto, A; Nishimura, K; Uda, A; Mukai, A; Yamashita, K; Kume, M; Makimoto, H; Bito, T; Nishigori, C; Nakagawa, T; Hirano, T; Hirai, M				Yamamoto, Kazuhiro; Mizumoto, Atsushi; Nishimura, Kohji; Uda, Atsushi; Mukai, Akira; Yamashita, Kazuhiko; Kume, Manabu; Makimoto, Hiroo; Bito, Toshinori; Nishigori, Chikako; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori			Association of Toxicity of Sorafenib and Sunitinib for Human Keratinocytes with Inhibition of Signal Transduction and Activator of Transcription 3 (STAT3)	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; FOOT SKIN REACTION; KINASE; APOPTOSIS; MANAGEMENT; THERAPY; PROLIFERATION; EXPRESSION; TARGETS; CANCER	Hand-foot skin reaction is a most common multi-kinase inhibitor-related adverse event. This study aimed to examine whether the toxicity of sorafenib and sunitinib for human keratinocytes was associated with inhibiting signal transduction and activator of transcription 3 (STAT3). We studied whether STAT3 activity affects sorafenib-and sunitinib-induced cell growth inhibition in HaCaT cells by WST-8 assay. Stattic enhanced the cell-growth inhibitory and apoptotic effects of sorafenib and sunitinib. HaCaT cells transfected with constitutively-active STAT3 (STAT3C) were resistant to the sorafenib-and sunitinib-induced cell growth inhibition. STAT3 activity decreased after short-term treatment with sorafenib and sunitinib in a dose-dependent manner and recovered after long-term treatment with sorafenib and sunitinib at low doses. Moreover, the expression of survivin and bcl-2 decreased after treatment with sorafenib and sunitinib was concomitant with variations in STAT3 activity. Sorafenib-induced STAT3 inhibition was mediated by regulation via MAPK pathways in HaCaT cells, while sunitinib-induced STAT3 inhibition was not. Thus, STAT3 activation mediating apoptosis suppressors may be a key factor in sorafenib and sunitinib-induced keratinocyte cytotoxicity.	[Yamamoto, Kazuhiro; Uda, Atsushi; Mukai, Akira; Yamashita, Kazuhiko; Kume, Manabu; Makimoto, Hiroo; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori] Kobe Univ Hosp, Dept Pharm, Kobe, Hyogo, Japan; [Mizumoto, Atsushi; Nishimura, Kohji; Nakagawa, Tsutomu; Hirano, Takeshi; Hirai, Midori] Kobe Univ, Grad Sch Med, Div Pharmacokinet, Kobe, Hyogo 657, Japan; [Bito, Toshinori; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Div Dermatol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University	Yamamoto, K (corresponding author), Kobe Univ Hosp, Dept Pharm, Kobe, Hyogo, Japan.	yamakz@med.kobe-u.ac.jp	HIRAI, Midori/GYR-2866-2022		Nakatomi Foundation; JSPS KAKENHI [24790156]; Grants-in-Aid for Scientific Research [26860104] Funding Source: KAKEN	Nakatomi Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research grant from The Nakatomi Foundation and JSPS KAKENHI (Grant Number 24790156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Bai LF, 2012, INT J CANCER, V130, P2693, DOI 10.1002/ijc.26303; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Calvo E, 2013, CANCER TREAT REV, V39, P366, DOI 10.1016/j.ctrv.2012.06.010; Carlo-Stella C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061603; Carlomagno F, 2006, JNCI-J NATL CANCER I, V98, P326, DOI 10.1093/jnci/djj069; Coriat R, 2012, MOL CANCER THER, V11, P2284, DOI 10.1158/1535-7163.MCT-12-0093; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Degen A, 2010, J DTSCH DERMATOL GES, V8, P652, DOI 10.1111/j.1610-0387.2010.07449.x; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fortugno P, 2002, J CELL SCI, V115, P575; Fournier Christa, 2010, Dermatol Online J, V16, P17; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Iijima M, 2011, J DERMATOL, V38, P261, DOI 10.1111/j.1346-8138.2010.01059.x; Lacouture ME, 2008, ONCOLOGIST, V13, P1001, DOI 10.1634/theoncologist.2008-0131; Larkin J, 2013, EXPERT OPIN PHARMACO, V14, P27, DOI 10.1517/14656566.2013.758713; Lee WJ, 2009, BRIT J DERMATOL, V161, P1045, DOI 10.1111/j.1365-2133.2009.09290.x; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Marconi A, 2007, STEM CELLS, V25, P149, DOI 10.1634/stemcells.2006-0165; McLellan B, 2011, DERMATOL THER, V24, P396, DOI 10.1111/j.1529-8019.2011.01435.x; Park GB, 2014, INT J ONCOL, V44, P977, DOI 10.3892/ijo.2014.2252; Poprach A, 2012, ANN ONCOL, V23, P3137, DOI 10.1093/annonc/mds145; Quadros MRD, 2004, CANCER RES, V64, P3934, DOI 10.1158/0008-5472.CAN-04-0214; Rainer PP, 2012, BJU INT, V110, P1455, DOI 10.1111/j.1464-410X.2012.11134.x; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Sonpavde G, 2012, EUR UROL, V61, P307, DOI 10.1016/j.eururo.2011.10.032; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Tarutani M, 2013, J DERMATOL SCI, V72, P110, DOI 10.1016/j.jdermsci.2013.06.007; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yamamoto K, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-83; Yang CH, 2010, EXPERT OPIN DRUG SAF, V9, P459, DOI 10.1517/14740331003596349; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	39	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102110	10.1371/journal.pone.0102110	http://dx.doi.org/10.1371/journal.pone.0102110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013907	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400066
J	Agam, Y; Vangel, M; Roffman, JL; Gallagher, PJ; Chaponis, J; Haddad, S; Goff, DC; Greenberg, JL; Wilhelm, S; Smoller, JW; Manoach, DS				Agam, Yigal; Vangel, Mark; Roffman, Joshua L.; Gallagher, Patience J.; Chaponis, Jonathan; Haddad, Stephen; Goff, Donald C.; Greenberg, Jennifer L.; Wilhelm, Sabine; Smoller, Jordan W.; Manoach, Dara S.			Dissociable Genetic Contributions to Error Processing: A Multimodal Neuroimaging Study	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE SCALE; DOPAMINE-D4 RECEPTOR GENE; SURFACE-BASED ANALYSIS; ANTERIOR CINGULATE; COMMON MUTATION; CEREBRAL-CORTEX; POLYMORPHISM; BRAIN; ASSOCIATION; NEURONS	Background: Neuroimaging studies reliably identify two markers of error commission: the error-related negativity (ERN), an event-related potential, and functional MRI activation of the dorsal anterior cingulate cortex (dACC). While theorized to reflect the same neural process, recent evidence suggests that the ERN arises from the posterior cingulate cortex not the dACC. Here, we tested the hypothesis that these two error markers also have different genetic mediation. Methods: We measured both error markers in a sample of 92 comprised of healthy individuals and those with diagnoses of schizophrenia, obsessive-compulsive disorder or autism spectrum disorder. Participants performed the same task during functional MRI and simultaneously acquired magnetoencephalography and electroencephalography. We examined the mediation of the error markers by two single nucleotide polymorphisms: dopamine D4 receptor (DRD4) C-521T (rs1800955), which has been associated with the ERN and methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133), which has been associated with error-related dACC activation. We then compared the effects of each polymorphism on the two error markers modeled as a bivariate response. Results: We replicated our previous report of a posterior cingulate source of the ERN in healthy participants in the schizophrenia and obsessive-compulsive disorder groups. The effect of genotype on error markers did not differ significantly by diagnostic group. DRD4 C-521T allele load had a significant linear effect on ERN amplitude, but not on dACC activation, and this difference was significant. MTHFR C677T allele load had a significant linear effect on dACC activation but not ERN amplitude, but the difference in effects on the two error markers was not significant. Conclusions: DRD4 C-521T, but not MTHFR C677T, had a significant differential effect on two canonical error markers. Together with the anatomical dissociation between the ERN and error-related dACC activation, these findings suggest that these error markers have different neural and genetic mediation.	[Agam, Yigal; Roffman, Joshua L.; Goff, Donald C.; Greenberg, Jennifer L.; Wilhelm, Sabine; Smoller, Jordan W.; Manoach, Dara S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Agam, Yigal; Vangel, Mark; Manoach, Dara S.] Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Gallagher, Patience J.; Chaponis, Jonathan; Haddad, Stephen; Smoller, Jordan W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Manoach, DS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	dara@nmr.mgh.harvard.edu	Roffman, Joshua/G-8228-2012	Roffman, Joshua/0000-0003-4073-532X	NIH [F32 MH088081, K24MH094614, R01 MH67720]; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094614, F32MH088081, R01MH067720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIH grants F32 MH088081 (YA); K24MH094614 (JWS); and R01 MH67720 (DSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; Althaus M, 2009, CLIN NEUROPHYSIOL, V120, P93, DOI 10.1016/j.clinph.2008.10.012; Anokhin AP, 2008, PSYCHOPHYSIOLOGY, V45, P524, DOI 10.1111/j.1469-8986.2008.00664.x; Belopolsky AV, 2006, BRAIN RES, V1081, P171, DOI 10.1016/j.brainres.2006.01.082; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Biehl SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028396; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Bruijn ERA, 2006, BRAIN RES, V1105, P122, DOI 10.1016/j.brainres.2006.01.006; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Endrass T, 2005, J PSYCHOPHYSIOL, V19, P275, DOI 10.1027/0269-8803.19.4.275; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Frank MJ, 2007, COGN AFFECT BEHAV NE, V7, P297, DOI 10.3758/CABN.7.4.297; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GOLDMANRAKIC PS, 1989, P NATL ACAD SCI USA, V86, P9015, DOI 10.1073/pnas.86.22.9015; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen MS, 1984, TKKFA559 U TECHN DEP; Heilbronner SR, 2013, NEURON, V80, P1384, DOI 10.1016/j.neuron.2013.09.028; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito J, 2006, J GERIATR PSYCH NEUR, V19, P46, DOI 10.1177/0891988705284716; Kereszturi E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-18; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lord C., 1999, AUTISM DIAGNOSTIC OB; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Manoach DS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00350; Meyer A, 2012, GENES BRAIN BEHAV, V11, P695, DOI 10.1111/j.1601-183X.2012.00812.x; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller MW, 2009, CINGULATE NEUROBIOLO, P163; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Okuyama Y, 1999, BIOCHEM BIOPH RES CO, V258, P292, DOI 10.1006/bbrc.1999.0630; Osinsky R, 2012, BRAIN RES, V1452, P108, DOI 10.1016/j.brainres.2012.02.054; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Purcell S, 2007, AM J HUM GENET, P81; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROFFMAN JL, 2008, AM J MED GENET B; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Roffman JL, 2008, BIOL PSYCHIAT, V63, P42, DOI 10.1016/j.biopsych.2006.12.017; Roffman JL, 2007, SCHIZOPHR RES, V92, P181, DOI 10.1016/j.schres.2007.01.003; Roffman JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025253; Roffman JL, 2011, BRAIN IMAGING BEHAV, V5, P65, DOI 10.1007/s11682-010-9111-2; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Rutter M, 2003, SOCIAL COMMUNICATION; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Taulu S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1935742; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Wittfoth M, 2008, BRAIN RES, V1194, P118, DOI 10.1016/j.brainres.2007.11.067; Xing QH, 2003, SCHIZOPHR RES, V65, P9, DOI 10.1016/S0920-9964(03)00064-1; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	74	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101784	10.1371/journal.pone.0101784	http://dx.doi.org/10.1371/journal.pone.0101784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010186	Green Published, gold			2022-12-25	WOS:000338763800038
J	Ishikawa, T; Takahashi, S; Morita, K; Okinaga, H; Teramoto, T				Ishikawa, Toshio; Takahashi, Satoshi; Morita, Koji; Okinaga, Hiroko; Teramoto, Tamio			Induction of AhR-Mediated Gene Transcription by Coffee	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; CULTURE-MEDIUM; CELLS; EXPRESSION; ACTIVATION; SERUM; IDENTIFICATION; ASSOCIATION; CONSUMPTION	Background: Aryl hydrocarbon receptor (AhR) is classically known to be activated by xenobiotics such as dioxins and polycyclic aromatic hydrocarbons (PAHs). Although it has been reported that PAHs are contained in roasted coffee beans, in general coffee beverages are not considered to be AhR activators. We tested whether exposure to coffee would activate AhR in cultured cells. Methods: HepG2 cells stably expressing an AhR-responsive reporter gene were treated with coffee samples. Also, expression of CYP1A1, an endogenous AhR-responsive gene, was quantitated by RT-PCR and Western blotting in HepG2, Caco-2, and MCF-7 cells, after treatment with coffee. In order to obtain sensitive and reproducible results, all the experiments were performed with the cells placed in either phosphate-buffered saline (PBS) or pure serum, instead of routinely-used culture medium, whose intrinsic AhR-stimulating activity turned out to be so strong as to interfere with the analyses. Results: All the coffee samples tested robustly stimulated AhR-mediated transcription in the reporter gene assays. Of note, to what extent coffee and other AhR agonists activated AhR was different, depending on whether the experiments were done in PBS or serum. CYP1A1 mRNA was induced by coffee, in HepG2, Caco-2, and MCF-7 cells placed in either PBS or serum. CYP1A1 protein expression, which was not detected in these cells incubated in PBS, was also increased by coffee in cells placed in serum. Conclusions: By using culture medium-free experimental settings, we have shown that coffee is a strong AhR activator. Our observation may help elucidate as-yet-unrecognized effects of coffee on human health.	[Ishikawa, Toshio; Takahashi, Satoshi; Morita, Koji; Okinaga, Hiroko] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Teramoto, Tamio] Teikyo Univ, Teikyo Acad Res Ctr, Tokyo 173, Japan	Teikyo University; Teikyo University	Ishikawa, T (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	tishi-tky@umin.ac.jp						Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Chen C, 1998, SOMAT CELL MOLEC GEN, V24, P249, DOI 10.1023/B:SCAM.0000007127.80657.10; Chobtang J, 2011, SENSORS-BASEL, V11, P11692, DOI 10.3390/s111211692; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Grover IS, 2013, ENVIRON MONIT ASSESS, V185, P6459, DOI 10.1007/s10661-012-3037-7; Hestermann EV, 2002, BIOCHEM PHARMACOL, V63, P1405, DOI 10.1016/S0006-2952(02)00892-4; Hestermann EV, 2000, TOXICOL SCI, V53, P316, DOI 10.1093/toxsci/53.2.316; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Ilchmann A, 2012, MOL IMMUNOL, V51, P42, DOI 10.1016/j.molimm.2012.02.005; Ishikawa T, 2004, MOL CELL BIOL, V24, P8323, DOI 10.1128/MCB.24.19.8323-8331.2004; Ishikawa T, 2012, THYROID, V22, P769, DOI 10.1089/thy.2012.0057; Kalthoff S, 2010, GASTROENTEROLOGY, V139, P1699, DOI 10.1053/j.gastro.2010.06.048; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Korashy HM, 2005, TOXICOL SCI, V88, P39, DOI 10.1093/toxsci/kfi282; Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020; Miller CA, 1997, J BIOL CHEM, V272, P32824, DOI 10.1074/jbc.272.52.32824; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Okamura S, 2005, BIOL PHARM BULL, V28, P271, DOI 10.1248/bpb.28.271; Okey Allan B, 2005, Toxicol Appl Pharmacol, V207, P43, DOI 10.1016/j.taap.2004.12.028; Pieterse B, 2013, ENVIRON SCI TECHNOL, V47, P11651, DOI 10.1021/es403810w; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; Tilg H, 2012, NEW ENGL J MED, V366, P181, DOI 10.1056/NEJMcibr1113158; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217; Zhou YP, 2012, PREV MED, V55, P14, DOI 10.1016/j.ypmed.2012.04.020	24	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102152	10.1371/journal.pone.0102152	http://dx.doi.org/10.1371/journal.pone.0102152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007155	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600102
J	Sumigray, K; Zhou, K; Lechler, T				Sumigray, Kaelyn; Zhou, Kang; Lechler, Terry			Cell-Cell Adhesions and Cell Contractility Are Upregulated upon Desmosome Disruption	PLOS ONE			English	Article							TIGHT JUNCTIONS; ADHERENS JUNCTIONS; PEMPHIGUS-VULGARIS; E-CADHERIN; EPIDERMAL BARRIER; ALPHA-CATENIN; COMPLEX; AUTOANTIBODIES; KERATINOCYTES; PATHOGENICITY	Desmosomes are perturbed in a number of disease states - including genetic disorders, autoimmune and bacterial diseases. Here, we report unexpected changes in other cell-cell adhesion structures upon loss of desmosome function. We found that perturbation of desmosomes by either loss of the core desmosomal protein desmoplakin or treatment with pathogenic anti-desmoglein 3 (Dsg3) antibodies resulted in changes in adherens junctions consistent with increased tension. The total amount of myosin IIA was increased in desmoplakin-null epidermis, and myosin IIA became highly localized to cell contacts in both desmoplakin-null and anti-Dsg3-treated mouse keratinocytes. Inhibition of myosin II activity reversed the changes to adherens junctions seen upon desmosome disruption. The increased cortical myosin IIA promoted epithelial sheet fragility, as myosin IIA-null cells were less susceptible to disruption by anti-Dsg3 antibodies. In addition to the changes in adherens junctions, we found a significant increase in the expression of a number of claudin genes, which encode for transmembrane components of the tight junction that provide barrier function. These data demonstrate that desmosome disruption results in extensive transcriptional and posttranslational changes that alter the activity of other cell adhesion structures.	[Lechler, Terry] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27705 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Lechler, T (corresponding author), Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27705 USA.	terry.lechler@duke.edu		Sumigray, Kaelyn/0000-0002-1267-7559	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR055926]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055926] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R01AR055926) to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Amagai M, 2010, P JPN ACAD B-PHYS, V86, P524, DOI 10.2183/pjab.86.524; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Bektas M, 2013, J BIOL CHEM, V288, P9447, DOI 10.1074/jbc.M112.438010; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Ishiyama N, 2013, J BIOL CHEM, V288, P15913, DOI 10.1074/jbc.M113.453928; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Lai-Cheong JE, 2007, J INVEST DERMATOL, V127, P2713, DOI 10.1038/sj.jid.5700727; Lanza A, 2008, J BIOL CHEM, V283, P8736, DOI 10.1074/jbc.M702186200; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; LEWIS JE, 1994, J INVEST DERMATOL, V102, P870, DOI 10.1111/1523-1747.ep12382690; Mao X, 2013, J INVEST DERMATOL; Michels C, 2009, J INVEST DERMATOL, V129, P2072, DOI 10.1038/jid.2009.17; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Raiko L, 2012, EXP DERMATOL, V21, P586, DOI 10.1111/j.1600-0625.2012.01520.x; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Saito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050696; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Sumigray KD, 2012, J CELL BIOL, V199, P513, DOI 10.1083/jcb.201206143; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turksen K, 2002, DEVELOPMENT, V129, P1775; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200; YONEMURA S, 1995, J CELL SCI, V108, P127; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	35	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101824	10.1371/journal.pone.0101824	http://dx.doi.org/10.1371/journal.pone.0101824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006807	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600070
J	Wu, LL; Cai, HJ; Gu, RL; Luo, YLL; Zhang, JX; Yang, J; Shi, YY; Ding, L				Wu, Lili; Cai, Huajian; Gu, Ruolei; Luo, Yu L. L.; Zhang, Jianxin; Yang, Jing; Shi, Yuanyuan; Ding, Lei			Neural Manifestations of Implicit Self-Esteem: An ERP Study	PLOS ONE			English	Article							SOCIAL COMPARISONS; AMYGDALA ACTIVITY; ASSOCIATION TEST; BRAIN; RACE; ATTITUDES; EXPLICIT; COMPONENTS; METAANALYSIS; CATEGORY	Behavioral research has established that humans implicitly tend to hold a positive themselves. In this study, we employed the event-related potential (ERP) technique to explore neural manifestations of positive implicit self-esteem using the Go/Nogo association task (GNAT). Participants generated a response (Go) or withheld a response (Nogo) to self or others words and good or bad attributes. Behavioral data showed that participants responded faster to the self paired with good he self paired with bad, whereas the opposite proved true for others, reflecting the positive nature of implicit self-esteem. ERP results showed an augmented N200 over the frontal areas in Nogo responses relative to Go responses. Moreover, the positive implicit self-positivity bias delayed the onset time of the N200 wave difference between Nogo and Gotrails, suggesting that positive implicit self-esteem is manifested on neural activity about 270 ms after the presentation of self-relevant stimuli. These findings provide neural evidence for the positivity and automaticity of implicit self-esteem.	[Wu, Lili; Zhang, Jianxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Cai, Huajian; Gu, Ruolei; Luo, Yu L. L.; Yang, Jing; Shi, Yuanyuan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Ding, Lei] Univ Oklahoma, Sch Elect & Comp Engn, Norman, OK 73019 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Oklahoma System; University of Oklahoma - Norman	Cai, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	caihj@psych.ac.cn	Gu, Ruolei/H-6946-2019	Gu, Ruolei/0000-0001-8722-2172; Shi, Yuanyuan/0000-0003-0005-7106	National Natural Science Foundation of China [31200789, 31070919]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y0CX363501]; Hundred Talents Program [Y0C2024002]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-8]; Directorate For Engineering [0955260] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program(Chinese Academy of Sciences); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Natural Science Foundation of China [Grant Nos. 31200789, 31070919], the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Grant No. Y0CX363501], the Hundred Talents Program [Grant No. Y0C2024002] and the Knowledge Innovation Program of the Chinese Academy of Sciences [Grant No. KSCX2-EW-J-8]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Banfield JF, 2006, NEUROIMAGE, V31, P1841, DOI 10.1016/j.neuroimage.2006.02.017; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Beer JS, 2010, J COGNITIVE NEUROSCI, V22, P2108, DOI 10.1162/jocn.2009.21359; Borsboom D, 2004, PSYCHOL REV, V111, P1061, DOI 10.1037/0033-295x.111.4.1061; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Boucher HC, 2009, J CROSS CULT PSYCHOL, V40, P24, DOI 10.1177/0022022108326195; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Cai HJ, 2009, ASIAN J SOC PSYCHOL, V12, P104, DOI 10.1111/j.1467-839X.2009.01278.x; Chavez RS, 2015, SOC COGN AFFECT NEUR, V10, P364, DOI 10.1093/scan/nsu063; De Houwer J., 2007, IMPLICIT MEASURES AT, P179; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Dickter CL, 2010, PSYCHOPHYSIOLOGY, V47, P596, DOI 10.1111/j.1469-8986.2010.00963.x; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GEMBA DH, 1989, NEUROSCI LETT, V101, P263, DOI 10.1016/0304-3940(89)90543-0; Gozzi M, 2010, HUM BRAIN MAPP, V31, P1763, DOI 10.1002/hbm.20976; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Gregg AP, 2010, SELF IDENTITY, V9, P142, DOI 10.1080/15298860902815451; He Y, 2009, SOC NEUROSCI-UK, V4, P426, DOI 10.1080/17470910902949184; Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2010, SOC COGNITION, V28, P686, DOI 10.1521/soco.2010.28.6.686; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Knutson KM, 2006, SOC NEUROSCI-UK, V1, P25, DOI 10.1080/17470910600670603; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Li HJ, 2013, NEUROSCI LETT, V548, P286, DOI 10.1016/j.neulet.2013.05.071; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lieberman MD, 2005, NAT NEUROSCI, V8, P720, DOI 10.1038/nn1465; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Moran JM, 2009, SOC NEUROSCI-UK, V4, P197, DOI 10.1080/17470910802250519; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Pinter B, 2005, EXP PSYCHOL, V52, P74, DOI 10.1027/1618-3169.52.1.74; Rameson LT, 2010, NEUROIMAGE, V50, P701, DOI 10.1016/j.neuroimage.2009.12.098; Ronquillo J, 2007, SOC COGN AFFECT NEUR, V2, P39, DOI 10.1093/scan/nsl043; SASAKI K, 1993, NEUROSCI RES, V18, P249, DOI 10.1016/0168-0102(93)90062-U; Schiller NO, 2006, BRAIN RES, V1082, P153, DOI 10.1016/j.brainres.2006.01.087; Schmitt BM, 2001, J COGNITIVE NEUROSCI, V13, P510, DOI 10.1162/08989290152001925; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sharot T, 2012, CURR BIOL, V22, P1477, DOI 10.1016/j.cub.2012.05.053; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1017/S0048577201000610; van der Lugt AH, 2012, BRAIN RES, V1429, P98, DOI 10.1016/j.brainres.2011.10.032; Watson LA, 2007, BRAIN RES, V1152, P106, DOI 10.1016/j.brainres.2007.03.049; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; WOOD JV, 1989, PSYCHOL BULL, V106, P231, DOI 10.1037/0033-2909.106.2.231; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x; Yang J, 2014, BIOL PSYCHOL, V97, P22, DOI 10.1016/j.biopsycho.2014.01.004; Yang J, 2013, NEUROCASE, V19, P470, DOI 10.1080/13554794.2012.701636; Yang J, 2012, BRAIN RES, V1471, P75, DOI 10.1016/j.brainres.2012.06.033; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]	67	97	101	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101837	10.1371/journal.pone.0101837	http://dx.doi.org/10.1371/journal.pone.0101837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006966	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600071
J	Zhao, KL; Li, Y; Yue, BS; Wu, M				Zhao, Kelei; Li, Yi; Yue, Bisong; Wu, Min			Genes as Early Responders Regulate Quorum-Sensing and Control Bacterial Cooperation in Pseudomonas aeruginosa	PLOS ONE			English	Article							SMALL RNAS; SECONDARY METABOLISM; HOMOSERINE LACTONE; BIOFILM FORMATION; SYSTEM; GACA; INHIBITORS; VIRULENCE; QUANTIFICATION; IDENTIFICATION	Quorum-sensing (QS) allows bacterial communication to coordinate the production of extracellular products essential for population fitness at higher cell densities. It has been generally accepted that a significant time duration is required to reach appropriate cell density to activate the relevant quiescent genes encoding these costly but beneficial public goods. Which regulatory genes are involved and how these genes control bacterial communication at the early phases are largely unexplored. By determining time-dependent expression of QS-related genes of the opportunistic pathogen Pseudomonas aerugionsa, we show that the induction of social cooperation could be critically influenced by environmental factors to optimize the density of population. In particular, small regulatory RNAs (RsmY and RsmZ) serving as early responders, can promote the expression of dependent genes (e. g. lasR) to boost the synthesis of intracellular enzymes and coordinate instant cooperative behavior in bacterial cells. These early responders, acting as a rheostat to finely modulate bacterial cooperation, which may be quickly activated under environment threats, but peter off when critical QS dependent genes are fully functional for cooperation. Our findings suggest that RsmY and RsmZ critically control the timing and levels of public goods production, which may have implications in sociomicrobiology and infection control.	[Zhao, Kelei; Li, Yi; Wu, Min] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA; [Zhao, Kelei; Yue, Bisong] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China	University of North Dakota Grand Forks; Sichuan University	Yue, BS (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.	bsyue@scu.edu.cn; min.wu@med.und.edu		Wu, Min/0000-0003-1205-982X	National Basic Research Program of China [2012CB722207]; Flight Attendant Medical Research Institute (FAMRI) [103007]; National Institutes of Health [AI101973-01, AI097532-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097532, R15AI101973] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Flight Attendant Medical Research Institute (FAMRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: National Basic Research Program of China (973 Project: 2012CB722207)(www.973.gov.cn); Flight Attendant Medical Research Institute (FAMRI, Grant #103007)(www.famri.org); National Institutes of Health (AI101973-01, and AI097532-01A1)(www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENCIC A, 2009, MOL MICROBIOL, V73, P434, DOI DOI 10.1111/j.1365-2958.2009.06782.x; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Deng X, 2013, CELL HOST MICROBE, V13, P358, DOI 10.1016/j.chom.2013.02.004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Frangipani E, 2014, ENVIRON MICROBIOL, V16, P676, DOI 10.1111/1462-2920.12164; Garg N, 2014, ANTON LEEUW INT J G, V105, P289, DOI 10.1007/s10482-013-0082-3; Geske GD, 2005, J AM CHEM SOC, V127, P12762, DOI 10.1021/ja0530321; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Intile PJ, 2014, J BACTERIOL, V196, P357, DOI 10.1128/JB.01199-13; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kim C, 2008, APPL MICROBIOL BIOT, V80, P37, DOI 10.1007/s00253-008-1474-6; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Maeda T, 2012, ISME J, V6, P493, DOI 10.1038/ismej.2011.122; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popat R, 2012, P ROY SOC B-BIOL SCI, V279, P4765, DOI 10.1098/rspb.2012.1976; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Ryan WJ, 2013, APPL ENVIRON MICROB, V79, P1795, DOI 10.1128/AEM.02962-12; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2013, ANNU REV MICROBIOL, V67, P43, DOI 10.1146/annurev-micro-092412-155635; Smith DR, 2010, MBIO, V1, DOI 10.1128/mBio.00131-10; Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Wilder CN, 2011, ISME J, V5, P1332, DOI 10.1038/ismej.2011.13; WITZANY G, 2008, OPEN EVOL J, V2, P44; Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223; Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08; Yuan KF, 2011, J BIOL CHEM, V286, P21814, DOI 10.1074/jbc.M111.237628; Zhao KL, 2013, INFECT IMMUN, V81, P4509, DOI 10.1128/IAI.01008-13; Zhou XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4619	42	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101887	10.1371/journal.pone.0101887	http://dx.doi.org/10.1371/journal.pone.0101887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006971	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600078
J	Dorfman, D; Aranda, ML; Fleitas, MFG; Chianelli, MS; Fernandez, DC; Sande, PH; Rosenstein, RE				Dorfman, Damian; Aranda, Marcos L.; Gonzalez Fleitas, Maria Florencia; Chianelli, Monica S.; Fernandez, Diego C.; Sande, Pablo H.; Rosenstein, Ruth E.			Environmental Enrichment Protects the Retina from Early Diabetic Damage in Adult Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED RETINOPATHY; CEREBRAL-ISCHEMIA; OXIDATIVE DAMAGE; NEURAL APOPTOSIS; BDNF; EXPRESSION; EXERCISE; MICE; SYNAPTOPHYSIN	Diabetic retinopathy is a leading cause of reduced visual acuity and acquired blindness. Available treatments are not completely effective. We analyzed the effect of environmental enrichment on retinal damage induced by experimental diabetes in adult Wistar rats. Diabetes was induced by an intraperitoneal injection of streptozotocin. Three days after vehicle or streptozotocin injection, animals were housed in enriched environment or remained in a standard environment. Retinal function (electroretinogram, and oscillatory potentials), retinal morphology, blood-retinal barrier integrity, synaptophysin, astrocyte and Muller cell glial fibrillary acidic protein, vascular endothelial growth factor, tumor necrosis factor-alpha, and brain-derived neurotrophic factor levels, as well as lipid peroxidation were assessed in retina from diabetic animals housed in standard or enriched environment. Environmental enrichment preserved scotopic electroretinogram a-wave, b-wave and oscillatory potential amplitude, avoided albumin-Evan's blue leakage, prevented the decrease in retinal synaptophysin and astrocyte glial fibrillary acidic protein levels, the increase in Muller cell glial fibrillary acidic protein, vascular endothelial growth factor and tumor necrosis factor-alpha levels, as well as oxidative stress induced by diabetes. In addition, enriched environment prevented the decrease in retinal brain-derived neurotrophic factor levels induced by experimental diabetes. When environmental enrichment started 7 weeks after diabetes onset, retinal function was significantly preserved. These results indicate that enriched environment could attenuate the early diabetic damage in the retina from adult rats.	[Dorfman, Damian; Aranda, Marcos L.; Gonzalez Fleitas, Maria Florencia; Chianelli, Monica S.; Fernandez, Diego C.; Sande, Pablo H.; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina; [Fernandez, Diego C.] Univ Moron, Histol Lab, Sch Med, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rosenstein, RE (corresponding author), Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Aranda, Marcos/0000-0003-1891-3476; Fernandez, Diego Carlos/0000-0002-4363-1318; Gonzalez Fleitas, Maria Florencia/0000-0001-5795-8365	Agencia Nacional de Promocion Cientifica y Tecnica [PICT 0610]; Consejo Nacional de Investigacion Cientifica y Tecnica [PIP 0446]; Universidad de Buenos Aires [UBACyT 20020100100678]; Fundacion Florencio Fiorini	Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Consejo Nacional de Investigacion Cientifica y Tecnica; Universidad de Buenos Aires(University of Buenos Aires); Fundacion Florencio Fiorini	Agencia Nacional de Promocion Cientifica y Tecnica (PICT 0610), Consejo Nacional de Investigacion Cientifica y Tecnica (PIP 0446) and Universidad de Buenos Aires (UBACyT 20020100100678) and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2004, NEUROSCIENCE, V124, P985, DOI 10.1016/j.neuroscience.2003.12.039; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barone I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050726; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dorfman D, 2013, EXP NEUROL, V240, P146, DOI 10.1016/j.expneurol.2012.11.017; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Jurgens HA, 2012, BRAIN BEHAV IMMUN, V26, P1006, DOI 10.1016/j.bbi.2012.05.015; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2008, CONTEMP DIABETES, P137, DOI 10.1007/978-1-59745-563-3_5; Kiss P, 2013, INT J MOL SCI, V14, P16111, DOI 10.3390/ijms140816111; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Landi S, 2007, FASEB J, V21, P130, DOI 10.1096/fj.06-6083com; Landi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000346; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Liu Y, 2013, MOL MED REP, V7, P1773, DOI 10.3892/mmr.2013.1433; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma NL, 1996, AM J PATHOL, V149, P1745; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Okoye G, 2003, J NEUROSCI, V23, P4164; Ola MS, 2013, CELL MOL NEUROBIOL, V33, P359, DOI 10.1007/s10571-012-9901-8; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Piazza FV, 2011, BEHAV BRAIN RES, V217, P16, DOI 10.1016/j.bbr.2010.09.017; Pinaud R, 2002, MOL BRAIN RES, V98, P93, DOI 10.1016/S0169-328X(01)00328-X; Prusky GT, 2000, BEHAV BRAIN RES, V114, P11, DOI 10.1016/S0166-4328(00)00186-8; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Salido EM, 2012, EXP NEUROL, V236, P151, DOI 10.1016/j.expneurol.2012.04.010; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Shinoda K, 2007, CLIN EXP OPHTHALMOL, V35, P847, DOI 10.1111/j.1442-9071.2007.01607.x; Tarr JM, 2013, ADV EXP MED BIOL, V771, P88; Tolentino MJ, 2002, AM J OPHTHALMOL, V133, P373, DOI 10.1016/S0002-9394(01)01381-2; Tremolada G, 2012, EXP DIABETES RES, DOI 10.1155/2012/728325; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; WALAAS SI, 1988, SYNAPSE, V2, P516, DOI 10.1002/syn.890020507; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wei Michael, 2003, Heart Lung Circ, V12, P44, DOI 10.1046/j.1444-2892.2003.00160.x; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Xu XH, 2009, EXP BIOL MED, V234, P296, DOI 10.3181/0804-RM-128; Yoshida Y, 2009, DIABETES-METAB RES, V25, P678, DOI 10.1002/dmrr.1007; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yu KW, 2013, BRAIN RES, V1538, P93, DOI 10.1016/j.brainres.2013.09.036; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	53	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101829	10.1371/journal.pone.0101829	http://dx.doi.org/10.1371/journal.pone.0101829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004165	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700074
J	Wang, KX; Sturt-Gillespie, B; Hittle, JC; Macdonald, D; Chan, GK; Yen, TJ; Liu, ST				Wang, Kexi; Sturt-Gillespie, Brianne; Hittle, James C.; Macdonald, Dawn; Chan, Gordon K.; Yen, Tim J.; Liu, Song-Tao			Thyroid Hormone Receptor Interacting Protein 13 (TRIP13) AAA-ATPase Is a Novel Mitotic Checkpoint-silencing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases Associated with Diverse Cellular Activities (AAA); Checkpoint Control; E3 Ubiquitin Ligase; Mitosis; Protein Complex; MAD2; Mitotic Checkpoint Complex (MCC); TRIP13; Anaphase-promoting Complex; Cyclosome (APC; C); p31comet	SPINDLE-ASSEMBLY CHECKPOINT; CLOSED MAD2 C-MAD2; CHROMOSOMAL INSTABILITY; KINETOCHORE ATTACHMENT; QUANTITATIVE PHOSPHOPROTEOMICS; INTERACTION NETWORK; ANAPHASE INHIBITOR; MAMMALIAN-CELLS; IN-VIVO; COMPLEX	Background: How the mitotic checkpoint is silenced is not fully understood. Results: Interference with TRIP13 AAA-ATPase causes delayed activation of the anaphase-promoting complex/cyclosome and stalled metaphase-to-anaphase transition. Conclusion: TRIP13 is a novel mitotic checkpoint-silencing protein. Significance: TRIP13 overexpression may lead to premature chromosome segregation and chromosomal instability. The mitotic checkpoint (or spindle assembly checkpoint) is a fail-safe mechanism to prevent chromosome missegregation by delaying anaphase onset in the presence of defective kinetochore-microtubule attachment. The target of the checkpoint is the E3 ubiquitin ligase anaphase-promoting complex/cyclosome. Once all chromosomes are properly attached and bioriented at the metaphase plate, the checkpoint needs to be silenced. Previously, we and others have reported that TRIP13 AAA-ATPase binds to the mitotic checkpoint-silencing protein p31(comet). Here we show that endogenous TRIP13 localizes to kinetochores. TRIP13 knockdown delays metaphase-to-anaphase transition. The delay is caused by prolonged presence of the effector for the checkpoint, the mitotic checkpoint complex, and its association and inhibition of the anaphase-promoting complex/cyclosome. These results suggest that TRIP13 is a novel mitotic checkpoint-silencing protein. The ATPase activity of TRIP13 is essential for its checkpoint function, and interference with TRIP13 abolished p31(comet)-mediated mitotic checkpoint silencing. TRIP13 overexpression is a hallmark of cancer cells showing chromosomal instability, particularly in certain breast cancers with poor prognosis. We suggest that premature mitotic checkpoint silencing triggered by TRIP13 overexpression may promote cancer development.	[Wang, Kexi; Sturt-Gillespie, Brianne; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Hittle, James C.; Yen, Tim J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Macdonald, Dawn; Chan, Gordon K.] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University System of Ohio; University of Toledo; Fox Chase Cancer Center; University of Alberta	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Chan, Gordon/AAN-7784-2020; Liu, Song-Tao/Y-4732-2019	Chan, Gordon/0000-0003-0497-9407; Yen, Tim/0000-0003-2159-0997; Liu, Song-Tao/0000-0002-9623-8579	National Institutes of Health [CA169706, CA06927, R01CA169500]; Canadian Breast Cancer Foundation; Prairies/NWT region; Fox Chase Cancer Center Board of Associates; National Science Foundation [MCB-1052413]; NATIONAL CANCER INSTITUTE [R21CA169706, R21CA182651, P30CA006927, R01CA169500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Prairies/NWT region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Fox Chase Cancer Center Board of Associates; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA169706 and CA06927 (to T. J. Y.) and R01CA169500 (to S. T. L.). This work was also supported by an operating grant from the Canadian Breast Cancer Foundation, Prairies/NWT region (to G. K. C.); the Fox Chase Cancer Center Board of Associates and an appropriation from the Commonwealth of Pennsylvania (to T. J. Y.); and National Science Foundation Grant MCB-1052413 (to S. T. L.).	Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hardwick Kevin G, 2010, F1000 Biol Rep, V2, P55, DOI 10.3410/B2-55; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Joyce EF, 2009, GENETICS, V181, P39, DOI 10.1534/genetics.108.093112; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Maldonado M, 2011, DEV CELL, V20, P733, DOI 10.1016/j.devcel.2011.05.017; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Miao CB, 2013, PLANT CELL, V25, P2998, DOI 10.1105/tpc.113.113175; Miniowitz-Shemtov S, 2012, P NATL ACAD SCI USA, V109, P8056, DOI 10.1073/pnas.1204081109; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neuwald AF, 1999, GENOME RES, V9, P27; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Skinner JJ, 2008, J CELL BIOL, V183, P761, DOI 10.1083/jcb.200808122; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Tipton AR, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-15; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vanoosthuyse V, 2009, GENE DEV, V23, P2799, DOI 10.1101/gad.1882109; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yasugi T, 1997, J VIROL, V71, P5942, DOI 10.1128/JVI.71.8.5942-5951.1997	70	98	99	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23928	23937		10.1074/jbc.M114.585315	http://dx.doi.org/10.1074/jbc.M114.585315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012665	hybrid, Green Published			2022-12-25	WOS:000341505000058
J	Catalan, A; Simons, CJP; Bustamante, S; Drukker, M; Madrazo, A; de Artaza, MG; Gorostiza, I; van Os, J; Gonzalez-Torres, MA				Catalan, Ana; Simons, Claudia J. P.; Bustamante, Sonia; Drukker, Marjan; Madrazo, Aranzazu; Gonzalez de Artaza, Maider; Gorostiza, Inigo; van Os, Jim; Gonzalez-Torres, Miguel A.			Novel Evidence hat Attributing Affectively Salient Signal to Random Noise Is Associated with Psychosis	PLOS ONE			English	Article							AUDITORY HALLUCINATIONS; SCHIZOPHRENIA; RELIABILITY; INSTRUMENT; FAILURE; RISK; CAPE	We wished to replicate evidence that an experimental paradigm of speech illusions is associated with psychotic experiences. Fifty-four patients with a first episode of psychosis (FEP) and 150 healthy subjects were examined in an experimental paradigm assessing the presence of speech illusion in neutral white noise. Socio-demographic, cognitive function and family history data were collected. The Positive and Negative Syndrome Scale (PANSS) was administered in the patient group and the Structured Interview for Schizotypy-Revised (SIS-R), and the Community Assessment of Psychic Experiences (CAPE) in the control group. Patients had a much higher rate of speech illusions (33.3% versus 8.7%, ORadjusted: 5.1, 95% CI: 2.3-11.5), which was only partly explained by differences in IQ (ORadjusted: 3.4, 95% CI: 1.4-8.3). Differences were particularly marked for signals in random noise that were perceived as affectively salient (ORadjusted: 9.7, 95% CI: 1.8-53.9). Speech illusion tended to be associated with positive symptoms in patients (ORadjusted: 3.3, 95% CI: 0.9-11.6), particularly affectively salient illusions (ORadjusted: 8.3, 95% CI: 0.7-100.3). In controls, speech illusions were not associated with positive schizotypy (ORadjusted: 1.1, 95% CI: 0.3-3.4) or self-reported psychotic experiences (ORadjusted: 1.4, 95% CI: 0.4-4.6). Experimental paradigms indexing the tendency to detect affectively salient signals in noise may be used to identify liability to psychosis.	[Catalan, Ana; Bustamante, Sonia; Gonzalez de Artaza, Maider; Gonzalez-Torres, Miguel A.] Univ Basque Country, Dept Neurosci, Basque Country, Spain; [Catalan, Ana; Bustamante, Sonia; Madrazo, Aranzazu; Gonzalez-Torres, Miguel A.] Basurto Univ Hosp, Dept Psychiat, Bilbao, Spain; [Simons, Claudia J. P.; Drukker, Marjan; van Os, Jim] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, Maastricht, Netherlands; [Simons, Claudia J. P.] GGzE, Eindhoven, Netherlands; [Gorostiza, Inigo] Basurto Univ Hosp, REDISSEC, Res Unit, Bilbao, Spain; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London WC2R 2LS, England	University of Basque Country; Basurto Hospital; Maastricht University; Basurto Hospital; University of London; King's College London	Catalan, A (corresponding author), Univ Basque Country, Dept Neurosci, Basque Country, Spain.	ana.catalanalcantara@gmail.com	van Os, Jim/V-8884-2019; Catalan, Ana/AAL-2224-2020; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Catalan, Ana/0000-0002-0418-7904; Gonzalez-Torres, Miguel Angel/0000-0002-4017-2785; Madrazo, Arantza/0000-0002-5142-7245; Bustamante, Sonia/0000-0002-7226-2910; Gorostiza, Inigo/0000-0001-5896-6148				Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Brebion G, 2000, PSYCHIAT RES, V95, P119, DOI 10.1016/S0165-1781(00)00174-8; Choong C, 2007, Curr Psychiatry Rep, V9, P206, DOI 10.1007/s11920-007-0020-z; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; de Leede-Smith S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00367; Franck N, 2000, SCHIZOPHR RES, V41, P357, DOI 10.1016/S0920-9964(99)00067-5; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; Hoffman RE, 2007, BRIT J PSYCHIAT, V191, P355, DOI 10.1192/bjp.bp.106.031195; Honig A, 1998, J NERV MENT DIS, V186, P646, DOI 10.1097/00005053-199810000-00009; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Mossaheb N, 2012, SCHIZOPHR RES, V141, P210, DOI 10.1016/j.schres.2012.08.008; Peralta Martin V, 1994, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V22, P171; Sommer IEC, 2010, SCHIZOPHRENIA BULL, V36, P633, DOI 10.1093/schbul/sbn130; StataCorp, 2019, STATA STAT SOFTWARE; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Vercammen A, 2010, SCHIZOPHRENIA BULL, V36, P151, DOI 10.1093/schbul/sbn063; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482	20	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102520	10.1371/journal.pone.0102520	http://dx.doi.org/10.1371/journal.pone.0102520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25020079	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600091
J	Ferrer, MCC; Shuvaev, VV; Zern, BJ; Composto, RJ; Muzykantov, VR; Eckmann, DM				Ferrer, M. Carme Coll; Shuvaev, Vladimir V.; Zern, Blaine J.; Composto, Russell J.; Muzykantov, Vladimir R.; Eckmann, David M.			ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; ACUTE LUNG INJURY; DRUG-DELIVERY; INTRACELLULAR DELIVERY; POSTOPERATIVE NAUSEA; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; IN-VIVO; NANOPARTICLES; ANTIOXIDANT	Lysozyme dextran nanogels (NG) have great potential in vitro as a drug delivery platform, combining simple chemistry with rapid uptake and cargo release in target cells with "stealth'' properties and low toxicity. In this work, we study for the first time the potential of targeted NG as a drug delivery platform in vivo to alleviate acute pulmonary inflammation in animal model of LPS-induced lung injury. NG are targeted to the endothelium via conjugation with an antibody (Ab) directed to Intercellular Adhesion Molecule-1(ICAM-NG), whereas IgG conjugated NG (IgG-NG) are used for control formulations. The amount of Ab conjugated to the NG and distribution in the body after intravenous (IV) injection have been quantitatively analyzed using a tracer isotope-labeled [I-125]IgG. As a proof of concept, Ab-NG are loaded with dexamethasone, an anti-inflammatory therapeutic, and the drug uptake and release kinetics are measured by HPLC. In vivo studies in mice showed that: i) ICAM-NG accumulates in mouse lungs (similar to 120% ID/g vs similar to 15% ID/g of IgG-NG); and, ii) DEX encapsulated in ICAM-NG, but not in IgG-NG practically blocks LPS-induced overexpression of pro-inflammatory cell adhesion molecules including ICAM-1 in the pulmonary inflammation.	[Ferrer, M. Carme Coll; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Zern, Blaine J.; Muzykantov, Vladimir R.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Zern, Blaine J.; Muzykantov, Vladimir R.] Univ Penn, Ctr Targeted Therapeut & Translat Nanomed, Philadelphia, PA 19104 USA; [Ferrer, M. Carme Coll; Composto, Russell J.] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Eckmann, DM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	eckmanndm@uphs.upenn.edu	Eckmann, David/O-5472-2016; Shuvaev, Vladimir/O-1719-2014	Eckmann, David/0000-0002-8954-8827; 	National Institutes of Health [NIH R01 EB006818]; NSF Nano-Bio Interface Center [DMR08-32802]; NSF [DMR09-07493]; NSF/CEMRI [DMR11-20901]; Center for Translational Targeted Therapeutics and Nanomedicine (CT3) of the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Nano-Bio Interface Center; NSF(National Science Foundation (NSF)); NSF/CEMRI; Center for Translational Targeted Therapeutics and Nanomedicine (CT3) of the National Center for Advancing Translational Sciences of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The National Institutes of Health provided support via grant NIH R01 EB006818 (DME). A pilot grant from NSF Nano-Bio Interface Center DMR08-32802 (RJC) facilitated this work, as well as partial support from NSF DMR09-07493 (RJC). Facilities at the Nanoscale Characterization Center supported by NSF/CEMRI (DMR11-20901) are acknowledged. Research reported in this publication was supported in part by the Center for Translational Targeted Therapeutics and Nanomedicine (CT3) of the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Arruebo M, 2009, J NANOMATER, V2009, DOI 10.1155/2009/439389; Asgeirdottir SA, 2007, MOL PHARMACOL, V72, P121, DOI 10.1124/mol.107.034140; Buxton DB, 2009, NANOMEDICINE-UK, V4, P331, DOI [10.2217/nnm.09.8, 10.2217/NNM.09.8]; Carnemolla R, 2010, SEMIN THROMB HEMOST, V36, P332, DOI 10.1055/s-0030-1253455; Charoenphol P, 2011, ATHEROSCLEROSIS, V217, P364, DOI 10.1016/j.atherosclerosis.2011.04.016; Chen CC, 2012, WORLD J SURG, V36, P61, DOI 10.1007/s00268-011-1343-9; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Chittasupho C, 2009, EUR J PHARM SCI, V37, P141, DOI 10.1016/j.ejps.2009.02.008; Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003; Cliffel DE, 2009, WIRES NANOMED NANOBI, V1, P47, DOI 10.1002/wnan.20; Coll Ferrer M. C., 2013, J NANOTECHNOLOGY ENG, V4; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; DANILOV SM, 1991, LAB INVEST, V64, P118; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Eberhart LHJ, 2000, ANAESTHESIST, V49, P713, DOI 10.1007/PL00002508; El Azab SR, 2002, BRIT J ANAESTH, V88, P496, DOI 10.1093/bja/88.4.496; Everts M, 2002, J IMMUNOL, V168, P883, DOI 10.4049/jimmunol.168.2.883; Ferrer M.C.C., 2013, J NANOTECHNOLOGY ENG, V4, P1; Ferrer MCC, 2012, SOFT MATTER, V8, P2423, DOI 10.1039/c2sm06969e; Ferrer MCC, 2014, ACTA BIOMAT IN PRESS; Ferrer MCC, 2013, J NANOPART RES, V15, P1; Greineder CF, 2013, BLOOD, V122, P1565, DOI 10.1182/blood-2013-03-453498; Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038; Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00127; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Li J, 2008, LANGMUIR, V24, P3486, DOI 10.1021/la702785b; Liu J, 2010, P NATL ACAD SCI USA, V107, P16530, DOI 10.1073/pnas.1006611107; MARUYAMA K, 1990, J PHARM SCI, V79, P978, DOI 10.1002/jps.2600791107; MITTAL V., 2012, ANAL IMAGING TECHNIQ; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muro S, 2008, MOL THER, V16, P1450, DOI 10.1038/mt.2008.127; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Muzykantov VR, 1996, P NATL ACAD SCI USA, V93, P5213, DOI 10.1073/pnas.93.11.5213; Pan H, 2013, FASEB J, V27, P255, DOI 10.1096/fj.12-218081; Rocksen D, 2000, CLIN EXP IMMUNOL, V122, P249, DOI 10.1046/j.1365-2249.2000.01373.x; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Simionescu M, 2002, MICROSC RES TECHNIQ, V57, P269, DOI 10.1002/jemt.10086; TAKEI F, 1985, J IMMUNOL, V134, P1403; Vinogradov SV, 2002, ADV DRUG DELIVER REV, V54, P135, DOI 10.1016/S0169-409X(01)00245-9; Zern BJ, 2013, ACS NANO, V7, P2461, DOI 10.1021/nn305773f; Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z	47	54	55	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102329	10.1371/journal.pone.0102329	http://dx.doi.org/10.1371/journal.pone.0102329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019304	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600069
J	Rodriguez, A; Villegas, E; Montoya-Rosales, A; Rivas-Santiago, B				Rodriguez, Alexis; Villegas, Elba; Montoya-Rosales, Alejandra; Rivas-Santiago, Bruno			Characterization of Antibacterial and Hemolytic Activity of Synthetic Pandinin 2 Variants and Their Inhibition against Mycobacterium tuberculosis	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; HELICAL ANTIMICROBIAL PEPTIDES; CIRCULAR-DICHROISM SPECTRA; TRANSMEMBRANE HELICES; SECONDARY STRUCTURE; SKIN SECRETIONS; AMPHIBIAN SKIN; VENOM; CELLS; PROTEINS	The contention and treatment of Mycobacterium tuberculosis and other bacteria that cause infectious diseases require the use of new type of antibiotics. Pandinin 2 (Pin2) is a scorpion venom antimicrobial peptide highly hemolytic that has a central proline residue. This residue forms a structural "kink'' linked to its pore-forming activity towards human erythrocytes. In this work, the residue Pro14 of Pin2 was both substituted and flanked using glycine residues (P14G and P14GPG) based on the low hemolytic activities of antimicrobial peptides with structural motifs Gly and GlyProGly such as magainin 2 and ponericin G1, respectively. The two Pin2 variants showed antimicrobial activity against E. coli, S. aureus, and M. tuberculosis. However, Pin2 [GPG] was less hemolytic (30%) than that of Pin2 [G] variant. In addition, based on the primary structure of Pin2 [G] and Pin2 [GPG], two short peptide variants were designed and chemically synthesized keeping attention to their physicochemical properties such as hydrophobicity and propensity to adopt alpha-helical conformations. The aim to design these two short antimicrobial peptides was to avoid the drawback cost associated to the synthesis of peptides with large sequences. The short Pin2 variants named Pin2 [14] and Pin2 [17] showed antibiotic activity against E. coli and M. tuberculosis. Besides, Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 mu M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration. Furthermore, these short antimicrobial peptides had better activity at molar concentrations against multidrug resistance M. tuberculosis than that of the conventional antibiotics ethambutol, isoniazid and rifampicin. Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.	[Rodriguez, Alexis; Rivas-Santiago, Bruno] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Rodriguez, Alexis; Villegas, Elba] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico; [Montoya-Rosales, Alejandra; Rivas-Santiago, Bruno] UIMZ IMSS, Mexican Inst Social Secur, Med Res Unit Zacatecas, Zacatecas, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Instituto Mexicano del Seguro Social	Rivas-Santiago, B (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico.	corzo@ibt.unam.mx	Rivas-Santiago, Bruno/AAJ-1885-2020; Rodríguez, Alexis/C-5086-2015; Corzo, Gerardo/B-3778-2014	Rivas-Santiago, Bruno/0000-0002-1521-1519; Rodríguez, Alexis/0000-0002-1503-5156; Corzo, Gerardo/0000-0002-9513-1622; Villegas Villarreal, Elba Cristina/0000-0003-1795-0427; Montoya-Rosales, Alejandra del Rocio/0000-0003-0565-4380	CONACyT [153606, 83962/2007, 106949/2008]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was also supported by CONACyT project Grants 153606 to GC, and 83962/2007 and 106949/2008 to Elba Villegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bywater RP, 2001, J COMPUT AID MOL DES, V15, P533, DOI 10.1023/A:1011197908960; Conlon JM, 2012, PEPTIDES, V37, P113, DOI 10.1016/j.peptides.2012.07.005; Conlon JM, 2005, DEV COMP IMMUNOL, V29, P83, DOI 10.1016/j.dci.2004.05.003; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Dathe M, 1998, BBA-BIOMEMBRANES, V1370, P175, DOI 10.1016/S0005-2736(97)00260-5; DEMPSEY CE, 1991, FEBS LETT, V281, P240, DOI 10.1016/0014-5793(91)80402-O; erovsky V, 2008, PEPTIDES, V29, P992; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Gopal R, 2012, INT J MOL SCI, V13, P3229, DOI 10.3390/ijms13033229; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Jin LL, 2009, INT J ANTIMICROB AG, V33, P538, DOI 10.1016/j.ijantimicag.2008.11.010; Kamysz Wojciech, 2005, Nucl Med Rev Cent East Eur, V8, P78; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KREIL G, 1973, FEBS LETT, V33, P241, DOI 10.1016/0014-5793(73)80202-9; KUBICA G P, 1972, International Journal of Systematic Bacteriology, V22, P99; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladokhin AS, 1999, BIOCHEMISTRY-US, V38, P12313, DOI 10.1021/bi9907936; Liu L, 2008, IFMBE PROC, V19, P167, DOI 10.1007/978-3-540-79039-6_43; Liu R, 2011, J PROTEOME RES, V10, P1806, DOI 10.1021/pr101285n; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Oh H, 2000, ANTIMICROB AGENTS CH, V44, P68, DOI 10.1128/AAC.44.1.68-72.2000; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Orivel J, 2001, J BIOL CHEM, V276, P17823, DOI 10.1074/jbc.M100216200; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; Patrzykat A, 2003, ANTIMICROB AGENTS CH, V47, P2464, DOI 10.1128/AAC.47.8.2464-2470.2003; Rastogi N, 1996, CURR MICROBIOL, V33, P167, DOI 10.1007/s002849900095; Riemen AJ, 2010, ORG BIOMOL CHEM, V8, P5411, DOI 10.1039/c0ob00202j; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Rivas-Santiago B, 2008, SCAND J IMMUNOL, V67, P448, DOI 10.1111/j.1365-3083.2008.02088.x; Rivas-Santiago B, 2013, INT J ANTIMICROB AG, V41, P143, DOI 10.1016/j.ijantimicag.2012.09.015; Rodriguez A, 2011, AMINO ACIDS, V40, P61, DOI 10.1007/s00726-009-0449-y; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Shin SY, 1999, B KOR CHEM SOC, V20, P1078; Slaninova J, 2012, PEPTIDES, V33, P18, DOI 10.1016/j.peptides.2011.11.002; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang H, 2012, PEPTIDES, V33, P27, DOI 10.1016/j.peptides.2011.10.030; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yanmei L, 2012, PEPTIDES, V37, P2207; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zidovetzki R, 2003, BIOPHYS CHEM, V100, P555, DOI 10.1016/S0301-4622(02)00306-X	56	44	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101742	10.1371/journal.pone.0101742	http://dx.doi.org/10.1371/journal.pone.0101742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019413	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600027
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			The Enigmatic Marine Reptile Nanchangosaurus from the Lower Triassic of Hubei, China and the Phylogenetic Affinities of Hupehsuchia	PLOS ONE			English	Article							DIAPSIDA SAUROPTERYGIA; SOUTHWESTERN CHINA; EVOLUTION; PROVINCE; POLAND	The study of the holotype and of a new specimen of Nanchangosaurus suni (Reptilia; Diapsida; Hupehsuchia) revealed a suite of hitherto unrecognized characters. For example, Nanchangosaurus has bipartite neural spines and its vertebral count is nearly identical to that of Hupehsuchus. It differs from the latter in having poorly developed forelimbs despite the advanced ossification in the rest of the skeleton. Other differences all pertain to hupehsuchian plesiomorphies retained in Nanchangosaurus, such as low neural spines. The relationship of Hupehsuchia within Diapsida was analyzed based on a data matrix containing 41 taxa coded for 213 characters, of which 18 were identified as aquatic adaptations from functional inferences. These aquatic adaptations may be vulnerable to the argumentation of character homology because expectation for homoplasy is high. There is an apparent incongruence between phylogenetic signals from aquatic adaptations and the rest of the data, with aquatic adaptations favoring all marine reptiles but Helveticosaurus to form a super-clade. However, this super-clade does not obtain when aquatic adaptations were deleted, whereas individual marine reptile clades are all derived without them. We examined all possible combinations of the 18 aquatic adaptations (n = 262143) and found that four lineages of marine reptiles are recognized almost regardless of which of these features were included in the analysis: Hupehsuchia-Ichthyopterygia clade, Sauropterygia-Saurosphargidae clade, Thalattosauria, and Helveticosaurus. The interrelationships among these four depended on the combination of aquatic adaptations to be included, i.e., assumed to be homologous a priori by bypassing character argumentation. Hupehsuchia always appeared as the sister taxon of Ichthyopterygia.	[Chen, Xiao-hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Dept Geol, MOE, Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	China Geological Survey [1212010611603, 1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]	China Geological Survey(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Geological Survey Project 1212010611603 to Xiao-hong Chen, the China Geological Survey Projects 1212011120148 to Long Cheng, and the National Natural Science Foundation of China Projects 40920124002 and 41372016 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094396; Cheng L, 2012, J EARTH SCI-CHINA, V23, P33, DOI 10.1007/s12583-012-0231-z; de Ricgles A., 1975, Annales Paleont (Vert), V61, P49; Dong Z.-m., 1979, Rivista Italiana di Paleontologia e Stratigrafia, V85, P1231; Evans Susan E., 2009, Palaeontologia Polonica, P145; Evans Susan E., 2009, Palaeontologia Polonica, P179; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Jiang DY, 2008, J VERTEBR PALEONTOL, V28, P1055, DOI 10.1671/0272-4634-28.4.1055; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Li C, 2014, GEOL MAG, V151, P100, DOI 10.1017/S001675681300023X; Li C, 2011, J VERTEBR PALEONTOL, V31, P303, DOI 10.1080/02724634.2011.550368; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; MCGOWAN C, 1992, CAN J EARTH SCI, V29, P380, DOI 10.1139/e92-034; McGowan C., 2003, ICHTHYOPTERYGIA; Merriam JC, 1906, U CALIFORNIA PLUBLIC, V5, P71; Motani R, 1998, NATURE, V393, P255, DOI 10.1038/30473; Motani R, 1999, J PALEONTOL, V73, P924, DOI 10.1017/S0022336000040750; Motani R, J VERTEBRAT IN PRESS; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Reisz RR, 2011, P ROY SOC B-BIOL SCI, V278, P3731, DOI 10.1098/rspb.2011.0439; Rieppel O, 1999, PALAEOGEOGR PALAEOCL, V153, P1, DOI 10.1016/S0031-0182(99)00067-X; Rieppel O, 1989, PALAEONTOGR ABT A, P123; Rieppel O, 2000, HDB PALAOHERPETOLO A; Rieppel O, 2008, J VERTEBR PALEONTOL, V28, P95, DOI 10.1671/0272-4634(2008)28[95:TSAOTT]2.0.CO;2; Rieppel O, 2013, CLADISTICS, V29, P328, DOI 10.1111/j.1096-0031.2012.00428.x; Rieppel O, 2009, BIOL PHILOS, V24, P607, DOI 10.1007/s10539-008-9122-1; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Wu XC, 2011, J VERTEBR PALEONTOL, V31, P70, DOI 10.1080/02724634.2011.546724; Young CC, 1972, AQUATIC REPTILES TRI, P28	33	28	34	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102361	10.1371/journal.pone.0102361	http://dx.doi.org/10.1371/journal.pone.0102361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014493	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400089
J	Deres, L; Bartha, E; Palfi, A; Eros, K; Riba, A; Lantos, J; Kalai, T; Hideg, K; Sumegi, B; Gallyas, F; Toth, K; Halmosi, R				Deres, Laszlo; Bartha, Eva; Palfi, Anita; Eros, Krisztian; Riba, Adam; Lantos, Janos; Kalai, Tamas; Hideg, Kalman; Sumegi, Balazs; Gallyas, Ferenc; Toth, Kalman; Halmosi, Robert			PARP-Inhibitor Treatment Prevents Hypertension Induced Cardiac Remodeling by Favorable Modulation of Heat Shock Proteins, Akt-1/GSK-3 beta and Several PKC Isoforms	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ENDOTHELIAL DYSFUNCTION; ISCHEMIA-REPERFUSION; SIGNALING PATHWAYS; OXIDATIVE STRESS; ANGIOTENSIN-II; FAILURE; RATS; ACTIVATION; APOPTOSIS	Spontaneously hypertensive rat (SHR) is a suitable model for studies of the complications of hypertension. It is known that activation of poly(ADP-ribose) polymerase enzyme (PARP) plays an important role in the development of postinfarction as well as long-term hypertension induced heart failure. In this study, we examined whether PARP-inhibitor (L-2286) treatment could prevent the development of hypertensive cardiopathy in SHRs. 6-week-old SHR animals were treated with L-2286 (SHR-L group) or placebo (SHR-C group) for 24 weeks. Wistar-Kyoto rats were used as aged-matched, normotensive controls (WKY group). Echocardiography was performed, brain-derived natriuretic peptide (BNP) activity and blood pressure were determined at the end of the study. We detected the extent of fibrotic areas. The amount of heat-shock proteins (Hsps) and the phosphorylation state of Akt-1(Ser473), glycogen synthase kinase (GSK)-3 beta(Ser9), forkhead transcription factor (FKHR)(Ser256), mitogen activated protein kinases (MAPKs), and protein kinase C (PKC) isoenzymes were monitored. The elevated blood pressure in SHRs was not influenced by PARP-inhibitor treatment. Systolic left ventricular function and BNP activity did not differ among the three groups. L-2286 treatment decreased the marked left ventricular (LV) hypertrophy which was developed in SHRs. Interstitial collagen deposition was also decreased by L-2286 treatment. The phosphorylation of extracellular signal-regulated kinase (ERK) 1/2(Thr183-Tyr185), Akt-1(Ser473), GSK-3 beta(Ser9), FKHRSer256, and PKC epsilon(Ser729) and the level of Hsp90 were increased, while the activity of PKC alpha/beta IIThr638/641, zeta/lambda(410/403) were mitigated by L-2286 administration. We could detect signs of LV hypertrophy without congestive heart failure in SHR groups. This alteration was prevented by PARP inhibition. Our results suggest that PARP-inhibitor treatment has protective effect already in the early stage of hypertensive myocardial remodeling.	[Deres, Laszlo; Bartha, Eva; Palfi, Anita; Eros, Krisztian; Riba, Adam; Toth, Kalman; Halmosi, Robert] Univ Pecs, Dept Med 1, Div Cardiol, Pecs, Hungary; [Deres, Laszlo; Eros, Krisztian; Riba, Adam; Sumegi, Balazs; Halmosi, Robert] Univ Pecs, Sch Med, Szentagothai Janos Res Ctr, Pecs, Hungary; [Lantos, Janos] Univ Pecs, Dept Surg Res & Tech, Pecs, Hungary; [Kalai, Tamas] Univ Pecs, Dept Organ & Med Chem, Pecs, Hungary; [Hideg, Kalman; Sumegi, Balazs; Gallyas, Ferenc] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary; [Sumegi, Balazs; Gallyas, Ferenc] MTA PTE Nuclear Mitochondrial Interact Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Halmosi, R (corresponding author), Univ Pecs, Dept Med 1, Div Cardiol, Pecs, Hungary.	dr.halmosi.robert@gmail.com	Gallyas, Ferenc/C-2272-2012; Halmosi, Róbert/AAK-1880-2020; Gallyas, Ferenc/AAY-5343-2020	Halmosi, Robert/0000-0002-6965-7743; Gallyas, Ferenc/0000-0002-1906-4333; Bartha, Eva/0000-0003-4318-9459	Hungarian National Research Foundations [OTKA F-46594, OTKA K-73738, OTKA K-81123, OTKA NN-109841]	Hungarian National Research Foundations(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The work was supported by Hungarian National Research Foundations (OTKA F-46594, OTKA K-73738, OTKA K-81123, OTKA NN-109841). This research was realized in the frames of SROP 4.2.1.B-10/2/KONV-2010-0002, 4.2.4. A/2-11-1-2012-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Bogoyevitch MA, 2000, CARDIOVASC RES, V45, P826, DOI 10.1016/S0008-6363(99)00386-7; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; COOPER RS, 1990, AM J CARDIOL, V65, P441, DOI 10.1016/0002-9149(90)90807-D; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Garcia-Hoz C, 2012, J BIOL CHEM, V287, P7792, DOI 10.1074/jbc.M111.282210; Inagaki K, 2002, J MOL CELL CARDIOL, V34, P1377, DOI 10.1006/jmcc.2002.2089; Ito N, 2007, AM J HYPERTENS, V20, P792, DOI 10.1016/j.amjhyper.2007.02.004; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Koide Y, 2003, HYPERTENS RES, V26, P421, DOI 10.1291/hypres.26.421; Kokubo M, 2005, HYPERTENS RES, V28, P601, DOI 10.1291/hypres.28.601; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Kovacs K, 2006, BIOCHEM PHARMACOL, V71, P441, DOI 10.1016/j.bcp.2005.05.036; KULCSAR GY, 2006, ARKIVOC, V4, P121; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Lip GYH, 2000, EUR HEART J, V21, P1653, DOI 10.1053/euhj.2000.2339; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; McCrossan ZA, 2004, CARDIOVASC RES, V63, P283, DOI 10.1016/j.cardiores.2004.04.013; Meurrens K, 2007, CARDIOVASC RES, V76, P311, DOI 10.1016/j.cardiores.2007.06.033; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Pacher P, 2002, INT J MOL MED, V9, P659; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Palfi A, 2005, J PHARMACOL EXP THER, V315, P273, DOI 10.1124/jpet.105.088336; Palfi A, 2006, J MOL CELL CARDIOL, V41, P149, DOI 10.1016/j.yjmcc.2006.03.427; PFEFFER JM, 1982, P NATL ACAD SCI-BIOL, V79, P3310, DOI 10.1073/pnas.79.10.3310; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Shinohara T, 2007, AM J PHYSIOL-HEART C, V293, pH1892, DOI 10.1152/ajpheart.00493.2007; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Szabo C, 2004, MOL MED, V10, P28, DOI 10.2119/2004-00001.Szabo; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589	40	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102148	10.1371/journal.pone.0102148	http://dx.doi.org/10.1371/journal.pone.0102148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014216	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400071
J	Dorca-Arevalo, J; Pauillac, S; Diaz-Hidalgo, L; Martin-Satue, M; Popoff, MR; Blasi, J				Dorca-Arevalo, Jonatan; Pauillac, Serge; Diaz-Hidalgo, Laura; Martin-Satue, Mireia; Popoff, Michel R.; Blasi, Juan			Correlation between In Vitro Cytotoxicity and In Vivo Lethal Activity in Mice of Epsilon Toxin Mutants from Clostridium perfringens	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; MDCK CELLS; BINDING; BRAINS; SYSTEM; SHEEP; PORE; ENTEROTOXEMIA; HIPPOCAMPUS; PROTOTOXIN	Epsilon toxin (Etx) from Clostridium perfringens is a pore-forming protein with a lethal effect on livestock, producing severe enterotoxemia characterized by general edema and neurological alterations. Site-specific mutations of the toxin are valuable tools to study the cellular and molecular mechanism of the toxin activity. In particular, mutants with paired cysteine substitutions that affect the membrane insertion domain behaved as dominant-negative inhibitors of toxin activity in MDCK cells. We produced similar mutants, together with a well-known non-toxic mutant (Etx-H106P), as green fluorescent protein (GFP) fusion proteins to perform in vivo studies in an acutely intoxicated mouse model. The mutant (GFP-Etx-I51C/A114C) had a lethal effect with generalized edema, and accumulated in the brain parenchyma due to its ability to cross the blood-brain barrier (BBB). In the renal system, this mutant had a cytotoxic effect on distal tubule epithelial cells. The other mutants studied (GFP-Etx-V56C/F118C and GFP-Etx-H106P) did not have a lethal effect or cross the BBB, and failed to induce a cytotoxic effect on renal epithelial cells. These data suggest a direct correlation between the lethal effect of the toxin, with its cytotoxic effect on the kidney distal tubule cells, and the ability to cross the BBB.	[Dorca-Arevalo, Jonatan; Diaz-Hidalgo, Laura; Martin-Satue, Mireia; Blasi, Juan] Univ Barcelona, Lab Cellular & Mol Neurosci, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Dorca-Arevalo, Jonatan; Martin-Satue, Mireia; Blasi, Juan] IDIBELL Bellvitge Biomed Res Inst, Barcelona, Spain; [Pauillac, Serge; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Blasi, J (corresponding author), Univ Barcelona, Lab Cellular & Mol Neurosci, Dept Pathol & Expt Therapeut, Barcelona, Spain.	blasi@ub.edu	Popoff, Michel/O-7719-2016; Dorca, Jonatan/C-9220-2018; Dorca-Arévalo, Jonatan/F-8984-2016; Blasi, Juan/K-7943-2014	Popoff, Michel/0000-0001-9305-8989; Dorca, Jonatan/0000-0001-7606-0462; Blasi, Juan/0000-0002-0482-9444	MINECO, Spanish Government) [SAF2011-27566]; AGAUR (Generalitat de Catalunya) [2009 SGR 152]	MINECO, Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This work was supported by grant SAF2011-27566 (MINECO, Spanish Government) and grant 2009 SGR 152 from AGAUR (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUXTON D, 1976, J COMP PATHOL, V86, P67, DOI 10.1016/0021-9975(76)90029-3; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; Femandez-Miyakawa ME, 2008, VET MICROBIOL, V127, P379, DOI 10.1016/j.vetmic.2007.09.013; Miyakawa MEF, 2011, HUM EXP TOXICOL, V30, P275, DOI 10.1177/0960327110371700; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P4282, DOI 10.1128/IAI.00562-07; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P1443, DOI 10.1128/IAI.01672-06; Finnie JW, 1999, J COMP PATHOL, V120, P415, DOI 10.1053/jcpa.1998.0289; Finnie JW, 2004, ANAEROBE, V10, P145, DOI 10.1016/j.anaerobe.2003.08.003; FINNIE JW, 1984, J COMP PATHOL, V94, P445, DOI 10.1016/0021-9975(84)90031-8; FINNIE JW, 1992, AUST VET J, V69, P261, DOI 10.1111/j.1751-0813.1992.tb09878.x; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; GRINER LA, 1961, AM J VET RES, V22, P443; HUNTER SEC, 1992, INFECT IMMUN, V60, P102, DOI 10.1128/IAI.60.1.102-110.1992; Ivie SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017787; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Lonchamp E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013046; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; MORGAN KT, 1975, J COMP PATHOL, V85, P461, DOI 10.1016/0021-9975(75)90034-1; MORINAGA G, 1965, J BACTERIOL, V90, P826, DOI 10.1128/JB.90.3.826-826.1965; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Oyston PCF, 1998, MICROBIOL-SGM, V144, P333, DOI 10.1099/00221287-144-2-333; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Pelish TM, 2009, J BIOL CHEM, V284, P29446, DOI 10.1074/jbc.M109.021782; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Robertson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022053; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Shimamoto S, 2005, MICROBIOL IMMUNOL, V49, P245, DOI 10.1111/j.1348-0421.2005.tb03726.x; Shortt SJ, 2000, HUM EXP TOXICOL, V19, P108, DOI 10.1191/096032700678815710; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Stiles BG, 2013, TOXINS, V5, P2138, DOI 10.3390/toxins5112138; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; WORTHINGTON R W, 1975, Onderstepoort Journal of Veterinary Research, V42, P25; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	48	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102417	10.1371/journal.pone.0102417	http://dx.doi.org/10.1371/journal.pone.0102417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013927	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400093
J	Garrison-Schilling, KL; Kaluskar, ZM; Lambert, B; Pettis, GS				Garrison-Schilling, Katherine L.; Kaluskar, Zelam M.; Lambert, Bliss; Pettis, Gregg S.			Genetic Analysis and Prevalence Studies of the brp Exopolysaccharide Locus of Vibrio vulnificus	PLOS ONE			English	Article							PHASE VARIATION; CAPSULAR POLYSACCHARIDES; COLONY MORPHOLOGY; ESCHERICHIA-COLI; IDENTIFICATION; VIRULENCE; PATHOGENESIS; BIOFILMS; BIOSYNTHESIS; MUTAGENESIS	Phase variation in the Gram-negative human pathogen Vibrio vulnificus involves three colonial morphotypes-smooth opaque colonies due to production of capsular polysaccharide (CPS), smooth translucent colonies as the result of little or no CPS expression, and rugose colonies due to production of a separate extracellular polysaccharide (EPS), which greatly enhances biofilm formation. Previously, it was shown that the brp locus, which consists of nine genes arranged as an operon, is up-regulated in rugose strains in a c-di-GMP-dependent manner, and that plasmid insertions into the locus resulted in loss of rugosity and efficient biofilm production. Here, we have used non-polar mutagenesis to assess the involvement of individual brp genes in production of EPS and related phenotypes. Inactivation of genes predicted to be involved in various stages of EPS biosynthesis eliminated both the rugose colonial appearance and production of EPS, while knockout of a predicted flippase function involved in EPS transport resulted in a dry, lightly striated phenotype, which was associated with a reduction of brp-encoded EPS on the cell surface. All brp mutants retained the reduced motility characteristic of rugose strains. Lastly, we provide evidence that the brp locus is highly prevalent among strains of V.vulnificus.	[Garrison-Schilling, Katherine L.; Kaluskar, Zelam M.; Lambert, Bliss; Pettis, Gregg S.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Pettis, GS (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	gpettis@lsu.edu	Kaluskar, Zelam/AAE-3759-2020	Kaluskar, Zelam/0000-0002-2826-1769	Louisiana Sea Grant College Program; National Oceanic and Atmospheric Administration Office of Sea Grant, Department of Commerce [NA06OAR4170022, R/PMO-21]; Louisiana State University	Louisiana Sea Grant College Program; National Oceanic and Atmospheric Administration Office of Sea Grant, Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA); Louisiana State University	This work was supported by the Louisiana Sea Grant College Program (http://www.laseagrant.org/) with funds from the National Oceanic and Atmospheric Administration Office of Sea Grant, Department of Commerce, under grant no. NA06OAR4170022, project no. R/PMO-21 and Louisiana State University. Statements, findings, conclusions, and recommendations are those of the author(s) and do not necessarily reflect the views of either the Louisiana Sea Grant College Program or the U.S. Department of Commerce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; BRASCH MA, 1993, J BACTERIOL, V175, P3067, DOI 10.1128/JB.175.10.3067-3074.1993; Brown RN, 2009, INFECT IMMUN, V77, P3768, DOI 10.1128/IAI.00205-09; Chatzidaki-Livanis M, 2006, J BACTERIOL, V188, P1987, DOI 10.1128/JB.188.5.1987-1998.2006; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Garrison-Schilling KL, 2011, ENVIRON MICROBIOL, V13, P643, DOI 10.1111/j.1462-2920.2010.02369.x; Grau BL, 2005, J BACTERIOL, V187, P2519, DOI 10.1128/JB.187.7.2519-2525.2005; Grau BL, 2008, INFECT IMMUN, V76, P1485, DOI 10.1128/IAI.01289-07; Gulig PA, 2005, J MICROBIOL, V43, P118; Guo YZ, 2011, ENVIRON MICROBIOL, V13, P2888, DOI 10.1111/j.1462-2920.2011.02564.x; Guo YZ, 2010, INFECT IMMUN, V78, P1390, DOI 10.1128/IAI.01188-09; Hilton T, 2006, APPL ENVIRON MICROB, V72, P6986, DOI 10.1128/AEM.00544-06; Hong YQ, 2014, J BACTERIOL, V196, P1713, DOI 10.1128/JB.01323-13; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kajimura J, 2005, J BACTERIOL, V187, P6917, DOI 10.1128/JB.187.20.6917-6927.2005; KELLEY JT, 1981, J BACTERIOL, V145, P1018, DOI 10.1128/JB.145.2.1018-1024.1981; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; MARTIN SJ, 1991, J CLIN MICROBIOL, V29, P1684, DOI 10.1128/JCM.29.8.1684-1688.1991; MENARD R, 1993, J BACTERIOL, V175, P5899; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanjuan E, 2004, APPL ENVIRON MICROB, V70, P7024, DOI 10.1128/AEM.70.12.7024-7032.2004; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SIMPSON LM, 1987, INFECT IMMUN, V55, P269, DOI 10.1128/IAI.55.1.269-272.1987; Smith AB, 2003, INFECT IMMUN, V71, P1091, DOI 10.1128/IAI.71.3.1091-1097.2003; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wright AC, 2001, INFECT IMMUN, V69, P6893, DOI 10.1128/IAI.69.11.6893-6901.2001; YOSHIDA SI, 1985, INFECT IMMUN, V47, P446, DOI 10.1128/IAI.47.2.446-451.1985; ZAKARIAMEEHAN Z, 1988, INFECT IMMUN, V56, P275, DOI 10.1128/IAI.56.1.275-277.1988; Zuppardo AB, 1998, INFECT IMMUN, V66, P2601, DOI 10.1128/IAI.66.6.2601-2606.1998	43	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100890	10.1371/journal.pone.0100890	http://dx.doi.org/10.1371/journal.pone.0100890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013926	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400015
J	Edwards, JK; Cole, SR; Westreich, D; Moore, R; Mathews, C; Geng, E; Eron, JJ; Mugavero, MJ				Edwards, Jessie K.; Cole, Stephen R.; Westreich, Daniel; Moore, Richard; Mathews, Christopher; Geng, Elvin; Eron, Joseph J.; Mugavero, Michael J.		CNICS Res Network	Loss to Clinic and Five-Year Mortality among HIV-Infected Antiretroviral Therapy Initiators	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; FOLLOW-UP; PRIMARY-CARE; RETENTION; PROGRAMS; AFRICA; NONADHERENCE; PREVENTION; SURVIVAL; OUTCOMES	Missing outcome data due to loss to follow-up occurs frequently in clinical cohort studies of HIV-infected patients. Censoring patients when they become lost can produce inaccurate results if the risk of the outcome among the censored patients differs from the risk of the outcome among patients remaining under observation. We examine whether patients who are considered lost to follow up are at increased risk of mortality compared to those who remain under observation. Patients from the US Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) who newly initiated combination antiretroviral therapy between January 1, 1998 and December 31, 2009 and survived for at least one year were included in the study. Mortality information was available for all participants regardless of continued observation in the CNICS. We compare mortality between patients retained in the cohort and those lost-to-clinic, as commonly defined by a 12-month gap in care. Patients who were considered lost-to-clinic had modestly elevated mortality compared to patients who remained under observation after 5 years (risk ratio (RR): 1.2; 95% CI: 0.9, 1.5). Results were similar after redefining loss-to-clinic as 6 months (RR: 1.0; 95% CI: 0.8, 1.3) or 18 months (RR: 1.2; 95% CI: 0.8, 1.6) without a documented clinic visit. The small increase in mortality associated with becoming lost to clinic suggests that these patients were not lost to care, rather they likely transitioned to care at a facility outside the study. The modestly higher mortality among patients who were lost-to-clinic implies that when we necessarily censor these patients in studies of time-varying exposures, we are likely to incur at most a modest selection bias.	[Edwards, Jessie K.; Cole, Stephen R.; Westreich, Daniel] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Moore, Richard] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Mathews, Christopher] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Geng, Elvin] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Eron, Joseph J.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham	Edwards, JK (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	jessedwards@unc.edu		Edwards, Jessie/0000-0002-1741-335X; Westreich, Daniel/0000-0003-3069-1650	National Institutes of Health [NIH R01AI100654, NIH R24AI067039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI050410, R01AI100654, U01AI069918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health [NIH R01AI100654 and NIH R24AI067039]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Efron B., 1994, INTRO BOOTSTRAP; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2012, AM J EPIDEMIOL, V175, P1080, DOI 10.1093/aje/kwr444; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hill T, 2010, J CLIN EPIDEMIOL, V63, P1101, DOI 10.1016/j.jclinepi.2009.12.007; Horberg MA, 2013, AIDS PATIENT CARE ST, V27, P442, DOI 10.1089/apc.2013.0073; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kitahata MM, 2008, INT J EPIDEMIOL, V37, P948, DOI 10.1093/ije/dym231; Klein JP, 2005, SURVIVAL ANAL TECHNI; Lanoy E, 2009, HIV MED, V10, P236, DOI 10.1111/j.1468-1293.2008.00678.x; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sitapati AM, 2012, J HEALTH CARE POOR U, V23, P81, DOI 10.1353/hpu.2012.0139; Toh S, 2010, EPIDEMIOLOGY, V21, P528, DOI 10.1097/EDE.0b013e3181df1b69; Westreich D, 2010, AM J EPIDEMIOL, V171, P691, DOI 10.1093/aje/kwp418; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102305	10.1371/journal.pone.0102305	http://dx.doi.org/10.1371/journal.pone.0102305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010739	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800089
J	Silhavy, J; Zidek, V; Mlejnek, P; Landa, V; Simakova, M; Strnad, H; Oliyarnyk, O; Skop, V; Kazdova, L; Kurtz, T; Pravenec, M				Silhavy, Jan; Zidek, Vaclav; Mlejnek, Petr; Landa, Vladimir; Simakova, Miroslava; Strnad, Hynek; Oliyarnyk, Olena; Skop, Vojtech; Kazdova, Ludmila; Kurtz, Theodore; Pravenec, Michal			Fumaric Acid Esters Can Block Pro-Inflammatory Actions of Human CRP and Ameliorate Metabolic Disturbances in Transgenic Spontaneously Hypertensive Rats	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FALSE DISCOVERY RATE; DIMETHYL FUMARATE; OXIDATIVE STRESS; NICOTINIC-ACID; GPR109A; INNATE	Inflammation and oxidative stress have been implicated in the pathogenesis of metabolic disturbances. Esters of fumaric acid, mainly dimethyl fumarate, exhibit immunomodulatory, anti-inflammatory, and anti-oxidative effects. In the current study, we tested the hypothesis that fumaric acid ester (FAE) treatment of an animal model of inflammation and metabolic syndrome, the spontaneously hypertensive rat transgenically expressing human C-reactive protein (SHR-CRP), will ameliorate inflammation, oxidative stress, and metabolic disturbances. We studied the effects of FAE treatment by administering Fumaderm, 10 mg/kg body weight for 4 weeks, to male SHR-CRP. Untreated male SHR-CRP rats were used as controls. All rats were fed a high sucrose diet. Compared to untreated controls, rats treated with FAE showed significantly lower levels of endogenous CRP but not transgenic human CRP, and amelioration of inflammation (reduced levels of serum IL6 and TNF alpha) and oxidative stress (reduced levels of lipoperoxidation products in liver, heart, kidney, and plasma). FAE treatment was also associated with lower visceral fat weight and less ectopic fat accumulation in liver and muscle, greater levels of lipolysis, and greater incorporation of glucose into adipose tissue lipids. Analysis of gene expression profiles in the liver with Affymetrix arrays revealed that FAE treatment was associated with differential expression of genes in pathways that involve the regulation of inflammation and oxidative stress. These findings suggest potentially important antiinflammatory, anti-oxidative, and metabolic effects of FAE in a model of inflammation and metabolic disturbances induced by human CRP.	[Silhavy, Jan; Zidek, Vaclav; Mlejnek, Petr; Landa, Vladimir; Simakova, Miroslava; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Strnad, Hynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Oliyarnyk, Olena; Skop, Vojtech; Kazdova, Ludmila] Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic; [Kurtz, Theodore] Univ Calif San Francisco, San Francisco, CA 94143 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM); University of California System; University of California San Francisco	Pravenec, M (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	pravenec@biomed.cas.cz	Strnad, Hynek/B-7361-2008; Pravenec, Michal/B-1666-2012; Simakova, Miroslava/B-7493-2012; Landa, Vladimir/B-8908-2012; Zidek, Vaclav/C-6685-2012; Oliyarnyk, Olena/Q-6380-2019; Simakova, Miroslava/R-5367-2019; Mlejnek, Petr/C-2305-2012; Silhavy, Jan/B-5292-2014	Strnad, Hynek/0000-0002-0141-8340; Pravenec, Michal/0000-0001-9197-5871; Simakova, Miroslava/0000-0003-1468-5832; Mlejnek, Petr/0000-0002-4218-8983; Silhavy, Jan/0000-0001-8042-5890; Skop, Vojtech/0000-0002-4685-4429; Oliyarnyk, Olena/0000-0002-4912-6187	Ministry of Health of the Czech Republic [NT/14325]; MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM") [IN 0002301]; Ministry Education, Youth and Sports of the Czech Republic [LH12061, LL1204]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM"); Ministry Education, Youth and Sports of the Czech Republic	This study was supported by grant NT/14325 from the Ministry of Health of the Czech Republic, grant MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM, IN 0002301") and grants LH12061 to VL and LL1204 (within the ERC CZ program) from the Ministry Education, Youth and Sports of the Czech Republic to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Benes J, 2011, CLIN SCI, V121, P29, DOI 10.1042/CS20100527; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; Chai JT, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0325-9; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanson J, 2010, J CLIN INVEST, V120, P2910, DOI 10.1172/JCI42273; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Litjens Nicolle H. R., 2004, BMC Pharmacology, V4, P22, DOI 10.1186/1471-2210-4-22; Malinska H, 2010, MOL CELL BIOCHEM, V335, P119, DOI 10.1007/s11010-009-0248-5; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meissner M, 2012, J DTSCH DERMATOL GES, V10, P793, DOI 10.1111/j.1610-0387.2012.07996.x; Paraskevas KI, 2008, CURR MED RES OPIN, V24, P75, DOI 10.1185/030079908X253654; Pravenec M, 2011, HYPERTENSION, V57, P731, DOI 10.1161/HYPERTENSIONAHA.110.164350; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Silhavy J, 2014, CARDIOVASC THER, V32, P59, DOI 10.1111/1755-5922.12061; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Zhang KM, 2011, J CELL BIOCHEM, V112, P488, DOI 10.1002/jcb.22936	32	18	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101906	10.1371/journal.pone.0101906	http://dx.doi.org/10.1371/journal.pone.0101906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010431	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800051
J	Weber, AR; Schuermann, D; Schar, P				Weber, Alain R.; Schuermann, David; Schaer, Primo			Versatile Recombinant SUMOylation System for the Production of SUMO-Modified Protein	PLOS ONE			English	Article							THYMINE-DNA GLYCOSYLASE; ESCHERICHIA-COLI; STRUCTURAL BASIS; IN-VITRO; UBIQUITIN; UBC9; COMPLEX; REPAIR; PURIFICATION; CONJUGATION	Posttranslational modification by small ubiquitin-like modifiers (SUMO) is being associated with a growing number of regulatory functions in diverse cellular processes. The biochemical investigation into the underlying molecular mechanisms, however, has been lagging behind due to the difficulty to generate sufficient amounts of recombinant SUMOylated proteins. Here, we present two newly designed two-component vector systems for the expression and purification of SUMO-modified target proteins in Escherichia coli. One system consists of a vector for SUMO conjugation, expressing human SUMO-activating (SAE1/SAE2) and conjugating (Ubc9) enzymes together with His(6)-tagged SUMO1, 2 or 3, that can be combined with commonly used expression constructs for any gene of interest. To facilitate SUMOylation of targets normally requiring a SUMO-E3 ligase for efficient modification, a second system is designed to express the target protein as a fusion with the human SUMO-conjugating enzyme Ubc9, thus compensating the absence of a potential SUMO ligase. We demonstrate the proficiency of these systems by SUMOylation of two DNA repair proteins, the thymine DNA glycosylase (TDG) and XRCC1, and describe purification schemes for SUMOylated proteins in native and active form. This SUMO toolbox facilitates "in-cell'' and "in-extract'' production and purification of recombinant SUMO-modified target proteins for functional and structural analysis.	[Weber, Alain R.; Schuermann, David; Schaer, Primo] Univ Basel, Dept Biomed, Basel, Switzerland	University of Basel	Schuermann, D (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	david.schuermann@unibas.ch; primo.schaer@unibas.ch	Schuermann, David/AAC-4075-2019; Schär, Primo/G-5967-2012	Schuermann, David/0000-0003-2904-1378; Schär, Primo/0000-0003-1843-6147	Swiss National Science Foundation [SNF 3100A0-122574/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation to PS (SNF 3100A0-122574/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bologna Serena, 2013, Frontiers in Genetics, V4, P106, DOI 10.3389/fgene.2013.00106; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Flotho A, 2012, METHODS MOL BIOL, V832, P93, DOI 10.1007/978-1-61779-474-2_5; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gocke CB, 2005, J BIOL CHEM, V280, P5004, DOI 10.1074/jbc.M411718200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kim ET, 2009, BIOCHEM BIOPH RES CO, V388, P41, DOI 10.1016/j.bbrc.2009.07.103; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lens Z, 2011, PROTEIN EXPRES PURIF, V80, P211, DOI 10.1016/j.pep.2011.06.009; Mencia M, 2004, PROTEIN EXPRES PURIF, V37, P409, DOI 10.1016/j.pep.2004.07.001; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Niedenthal Rainer, 2009, V497, P63, DOI 10.1007/978-1-59745-566-4_5; O'Brien SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038671; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	39	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102157	10.1371/journal.pone.0102157	http://dx.doi.org/10.1371/journal.pone.0102157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007328	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600104
J	Christner, M; Trusch, M; Rohde, H; Kwiatkowski, M; Schluter, H; Wolters, M; Aepfelbacher, M; Hentschke, M				Christner, Martin; Trusch, Maria; Rohde, Holger; Kwiatkowski, Marcel; Schlueter, Hartmut; Wolters, Manuel; Aepfelbacher, Martin; Hentschke, Moritz			Rapid MALDI-TOF Mass Spectrometry Strain Typing during a Large Outbreak of Shiga-Toxigenic Escherichia coli	PLOS ONE			English	Article							ASSISTED LASER-DESORPTION; HEMOLYTIC-UREMIC SYNDROME; IONIZATION-TIME; IDENTIFICATION; DESORPTION/IONIZATION; BACTERIA; PACKAGE; GERMANY	Background: In 2011 northern Germany experienced a large outbreak of Shiga-Toxigenic Escherichia coli O104:H4. The large amount of samples sent to microbiology laboratories for epidemiological assessment highlighted the importance of fast and inexpensive typing procedures. We have therefore evaluated the applicability of a MALDI-TOF mass spectrometry based strategy for outbreak strain identification. Methods: Specific peaks in the outbreak strain's spectrum were identified by comparative analysis of archived pre-outbreak spectra that had been acquired for routine species-level identification. Proteins underlying these discriminatory peaks were identified by liquid chromatography tandem mass spectrometry and validated against publicly available databases. The resulting typing scheme was evaluated against PCR genotyping with 294 E. coli isolates from clinical samples collected during the outbreak. Results: Comparative spectrum analysis revealed two characteristic peaks at m/z 6711 and m/z 10883. The underlying proteins were found to be of low prevalence among genome sequenced E. coli strains. Marker peak detection correctly classified 292 of 293 study isolates, including all 104 outbreak isolates. Conclusions: MALDI-TOF mass spectrometry allowed for reliable outbreak strain identification during a large outbreak of Shiga-Toxigenic E. coli. The applied typing strategy could probably be adapted to other typing tasks and might facilitate epidemiological surveys as part of the routine pathogen identification workflow.	[Christner, Martin; Rohde, Holger; Wolters, Manuel; Aepfelbacher, Martin; Hentschke, Moritz] Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany; [Trusch, Maria] Univ Hamburg, Inst Organ Chem, Mass Spectrometry Facil, Hamburg, Germany; [Kwiatkowski, Marcel; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Christner, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, Hamburg, Germany.	m.christner@uke.de	Schluter, Hartmut/D-1371-2015; Kwiatkowski, Marcel/M-3384-2016; Riedner, Maria/W-5546-2019	Schluter, Hartmut/0000-0002-9358-7036; Kwiatkowski, Marcel/0000-0002-5804-6031; Rohde, Holger/0000-0001-8587-4433	Bundesministerium fur Bildung und Forschung [0315341B]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/), grant number 0315341B to Hartmut Schluter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boggs SR, 2012, J MED MICROBIOL, V61, P640, DOI 10.1099/jmm.0.037978-0; Dieckmann R, 2011, APPL ENVIRON MICROB, V77, P4136, DOI 10.1128/AEM.02418-10; Fagerquist CK, 2010, ANAL CHEM, V82, P2717, DOI 10.1021/ac902455d; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Griffin PM, 2012, J CLIN MICROBIOL, V50, P2918, DOI 10.1128/JCM.01000-12; Grosse-Herrenthey A, 2008, ANAEROBE, V14, P242, DOI 10.1016/j.anaerobe.2008.06.002; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Karger A, 2011, APPL ENVIRON MICROB, V77, P896, DOI 10.1128/AEM.01686-10; Kuhns M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040004; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mulet M, 2012, SYST APPL MICROBIOL, V35, P145, DOI 10.1016/j.syapm.2011.12.003; Munoz R, 2011, SYST APPL MICROBIOL, V34, P69, DOI 10.1016/j.syapm.2010.11.012; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pritchard L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034498; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; R Core Team, 2022, R LANG ENV STAT COMP; Reil M, 2011, EUR J CLIN MICROBIOL, V30, P1431, DOI 10.1007/s10096-011-1238-6; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Sato H, 2011, SYST APPL MICROBIOL, V34, P76, DOI 10.1016/j.syapm.2010.07.003; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	37	66	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101924	10.1371/journal.pone.0101924	http://dx.doi.org/10.1371/journal.pone.0101924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003758	Green Published, gold, Green Submitted			2022-12-25	WOS:000339242700089
J	Estay, SA; Labra, FA; Sepulveda, RD; Bacigalupe, LD				Estay, Sergio A.; Labra, Fabio A.; Sepulveda, Roger D.; Bacigalupe, Leonardo D.			Evaluating Habitat Suitability for the Establishment of Monochamus spp. through Climate-Based Niche Modeling	PLOS ONE			English	Article							PINE WILT DISEASE; POTENTIAL DISTRIBUTION; PEST RISK; SPECIES DISTRIBUTIONS; GLOBAL INVASION; COLEOPTERA; PREDICTION; HYMENOPTERA; TEMPERATURE; ASSESSMENTS	Pine sawyer beetle species of the genus Monochamus are vectors of the nematode pest Bursaphelenchus xylophilus. The introduction of these species into new habitats is a constant threat for those regions where the forestry industry depends on conifers, and especially on species of Pinus. To obtain information about the potential risk of establishment of these insects in Chile, we performed climate-based niche modeling using data for five North American and four Eurasian Monochamus species using a Maxent approach. The most important variables that account for current distribution of these species are total annual precipitation and annual and seasonal average temperatures, with some differences between North American and Eurasian species. Projections of potential geographic distribution in Chile show that all species could occupy at least 37% of the area between 30 degrees and 53 degrees S, where industrial plantations of P. radiata are concentrated. Our results indicated that Chile seems more suitable for Eurasian than for North American species.	[Estay, Sergio A.; Sepulveda, Roger D.; Bacigalupe, Leonardo D.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Labra, Fabio A.] Univ Santo Tomas, Fac Ciencias, Ctr Invest & Innovac Cambio Climat, Santiago, Chile	Universidad Austral de Chile; Universidad Santo Tomas	Estay, SA (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	sergio.estay@uach.cl	Labra, Fabio A/B-6992-2013	Labra, Fabio A/0000-0003-2881-3313; Sepulveda, Roger D./0000-0003-0226-5662; Estay, Sergio/0000-0002-3797-8964	CONICYT [79100021]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funded by CONICYT grant No 79100021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2012, FOREST PATHOL, V42, P89, DOI 10.1111/j.1439-0329.2011.00733.x; [Anonymous], 2010, GLOBAL FOREST RESOUR; BAIN J, 1988, New Zealand Forestry, V32, P19; Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Bidinger K, 2012, J APPL ENTOMOL, V136, P109, DOI 10.1111/j.1439-0418.2010.01598.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CABI, 2013, INV SPEC COMP; Campbell FT, 2001, BIOSCIENCE, V51, P148, DOI 10.1641/0006-3568(2001)051[0148:TSORAF]2.0.CO;2; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chen SL, 2010, ACTA ENTOMOL SINICA, V53, P183; Cherepanov AI, 1983, CERAMBYCIDAE NORTHEM, V3; Dillon L. S., 1941, READING PUBLIC MUSEU, V1; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Dwinell LD, 1989, SE55 USDA FOREST SER; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; EPPO, 2013, PQR EPPO DAT QUAR PE; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Ferrada R, 2007, INTERCEPCIONES INSEC; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Geospatial-Intelligence Agency, 2013, GEONET NAMES SERVER; Getty Information Institute, 2013, TGN THESAURUS GEOGRA; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gray GM, 1998, RISK ANAL, V18, P773, DOI 10.1023/B:RIAN.0000005922.65955.69; Herborg L. M., 2009, BIOECONOMICS INVASIV, P63; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; HOSMER DW, 1989, APPL LOGISTIC REGRES; INFOR, 2010, EST FOR CHIL 2008; IPPC (2012) International Standards for Phytosanitary Measures (ISPM) 27, 2012, INT STAND PHYT MEAS; Jikumaru S, 1996, APPL ENTOMOL ZOOL, V31, P145, DOI 10.1303/aez.31.145; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Koch FH, 2008, ENVIRON ENTOMOL, V37, P442, DOI 10.1603/0046-225X(2008)37[442:SAOXGC]2.0.CO;2; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Leung B, 2012, ECOL LETT, V15, P1475, DOI 10.1111/ele.12003; Liebhold A.M., 1995, FOREST SCI MONOGRAPH; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Ma RY, 2006, ENVIRON ENTOMOL, V35, P881, DOI 10.1603/0046-225X-35.4.881; Mack R. N., 2003, Invasive species: vectors and management strategies, P3; MacLeod A, 2002, CROP PROT, V21, P635, DOI 10.1016/S0261-2194(02)00016-9; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; McKenney D, 2003, ENVIRON MONIT ASSESS, V88, P445, DOI 10.1023/A:1025502030803; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Nam Chang Park, 1992, Research Report of the Forestry Research Institute (Seoul), V44, P151; Naves P, 2009, J PEST SCI, V82, P1, DOI 10.1007/s10340-008-0210-4; ODEPA, 2007, 7 CENS NAC AGR FOR; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; PERSHING JC, 1986, ENVIRON ENTOMOL, V15, P251, DOI 10.1093/ee/15.2.251; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimentel D., 2002, BIOL INVASIONS EC EN; Quantum GIS Development Team, 2012, QUANT GIS GEOGR INF; R Core Team, 2021, R LANG ENV STAT COMP; RUTHERFORD TA, 1987, CAN J FOREST RES, V17, P1050, DOI 10.1139/x87-161; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Stohlgren Thomas J., 2009, P19; Strange JP, 2011, BIOL INVASIONS, V13, P2115, DOI 10.1007/s10530-011-0030-y; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Zhao B.G., 2008, PINE WILT DISEASE, P18; Zhao BG., 2008, PINE WILT DIS; [No title captured]	68	9	12	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102592	10.1371/journal.pone.0102592	http://dx.doi.org/10.1371/journal.pone.0102592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019408	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600096
J	Schlederer, M; Mueller, KM; Haybaeck, J; Heider, S; Huttary, N; Rosner, M; Hengstschlager, M; Moriggl, R; Dolznig, H; Kenner, L				Schlederer, Michaela; Mueller, Kristina M.; Haybaeck, Johannes; Heider, Susanne; Huttary, Nicole; Rosner, Margit; Hengstschlaeger, Markus; Moriggl, Richard; Dolznig, Helmut; Kenner, Lukas			Reliable Quantification of Protein Expression and Cellular Localization in Histological Sections	PLOS ONE			English	Article							MULTICOLOR TISSUE CYTOMETRY; HEPATIC GROWTH-HORMONE; BREAST-CANCER; SEMIQUANTITATIVE ASSESSMENT; IMAGE-ANALYSIS; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MICE	In targeted therapy, patient tumors are analyzed for aberrant activations of core cancer pathways, monitored based on biomarker expression, to ensure efficient treatment. Thus, diagnosis and therapeutic decisions are often based on the status of biomarkers determined by immunohistochemistry in combination with other clinical parameters. Standard evaluation of cancer specimen by immunohistochemistry is frequently impeded by its dependence on subjective interpretation, showing considerable intra-and inter-observer variability. To make treatment decisions more reliable, automated image analysis is an attractive possibility to reproducibly quantify biomarker expression in patient tissue samples. We tested whether image analysis could detect subtle differences in protein expression levels. Gene dosage effects generate well-graded expression patterns for most gene-products, which vary by a factor of two between wildtype and haploinsufficient cells lacking one allele. We used conditional mouse models with deletion of the transcription factors Stat5ab in the liver as well Junb deletion in a T-cell lymphoma model. We quantified the expression of total or activated STAT5AB or JUNB protein in normal (Stat5ab(+/+) or JunB(+/+)), hemizygous (Stat5ab(+/Delta) or JunB(+/Delta)) or knockout (Stat5ab (Delta/Delta) or JunB (Delta/Delta)) settings. Image analysis was able to accurately detect hemizygosity at the protein level. Moreover, nuclear signals were distinguished from cytoplasmic expression and translocation of the transcription factors from the cytoplasm to the nucleus was reliably detected and quantified using image analysis. We demonstrate that image analysis supported pathologists to score nuclear STAT5AB expression levels in immunohistologically stained human hepatocellular patient samples and decreased inter-observer variability.	[Schlederer, Michaela; Mueller, Kristina M.; Moriggl, Richard; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res LBI CR, Vienna, Austria; [Haybaeck, Johannes] Med Univ Graz, Inst Pathol, Graz, Austria; [Moriggl, Richard] Univ Vet Med Vienna Vetmeduni Vienna, Unit Translat Methods Canc Res, Vienna, Austria; [Heider, Susanne; Huttary, Nicole; Kenner, Lukas] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Rosner, Margit; Hengstschlaeger, Markus; Dolznig, Helmut] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Kenner, Lukas] Univ Vet Med Vienna Vetmeduni Vienna, Unit Pathol Lab Anim, Vienna, Austria	Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Vienna; Medical University of Vienna	Dolznig, H (corresponding author), Med Univ Vienna, Inst Med Genet, Vienna, Austria.	helmut.dolznig@meduniwien.ac.at; lukas.kenner@meduniwien.ac.at	Moriggl, Richard/H-8118-2019; Dolznig, Helmut/L-7005-2015	Moriggl, Richard/0000-0003-0918-9463; Dolznig, Helmut/0000-0002-6063-3585; Kenner, Lukas/0000-0003-2184-1338	Herzfelder Family Foundation; Niederosterr. Forschungs-und Bildungsges.m.b.H (nfb); Austrian Science Fund (FWF) [SFB-F2807, SFB-F4707]; FWF; Genome Research-Austria project "Inflammobiota'';  [P26011]; Austrian Science Fund (FWF) [F 2807] Funding Source: researchfish	Herzfelder Family Foundation; Niederosterr. Forschungs-und Bildungsges.m.b.H (nfb); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Genome Research-Austria project "Inflammobiota''; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Helmut Dolznig is supported by the Herzfelder Family Foundation and the Niederosterr. Forschungs-und Bildungsges. m.b.H (nfb). Kristina Mueller and Richard Moriggl were supported by grant SFB-F2807 and SFB-F4707 from the Austrian Science Fund (FWF). Lukas Kenner was supported by FWF, P26011 and the Genome Research-Austria project "Inflammobiota''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham N, 2005, ONCOGENE, V24, P5252, DOI 10.1038/sj.onc.1208726; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cross SS, 2001, J CLIN PATHOL, V54, P385, DOI 10.1136/jcp.54.5.385; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Diaz LK, 2005, ADV ANAT PATHOL, V12, P10, DOI 10.1097/00125480-200501000-00003; Ecker RC, 2006, CYTOM PART A, V69A, P119, DOI 10.1002/cyto.a.20219; Eckert RC, 2004, CYTOM PART A, V59A, P182, DOI 10.1002/cyto.a.20052; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Friedbichler K, 2012, HEPATOLOGY, V55, P941, DOI 10.1002/hep.24765; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Lehr HA, 2001, AM J CLIN PATHOL, V115, P814; Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Paizs M, 2009, J MICROSC-OXFORD, V234, P103, DOI 10.1111/j.1365-2818.2009.03146.x; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Rhodes A, 2000, J CLIN PATHOL, V53, P292, DOI 10.1136/jcp.53.4.292; Rudiger T, 2002, AM J SURG PATHOL, V26, P873, DOI 10.1097/00000478-200207000-00005; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Sirota RL, 2005, ARCH PATHOL LAB MED, V129, P1228; Steiner GE, 2003, LAB INVEST, V83, P1131, DOI 10.1097/01.LAB.0000081388.40145.65; Steiner GE, 2000, J IMMUNOL METHODS, V237, P39, DOI 10.1016/S0022-1759(99)00240-9; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; TAYLOR CR, 1994, HUM PATHOL, V25, P2, DOI 10.1016/0046-8177(94)90164-3; Umemura S, 2004, APPL IMMUNOHISTO M M, V12, P8; Walker RA, 2006, HISTOPATHOLOGY, V49, P406, DOI 10.1111/j.1365-2559.2006.02514.x; Yu LR, 2007, PROTEOM CLIN APPL, V1, P1042, DOI 10.1002/prca.200700102; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	37	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e100822	10.1371/journal.pone.0100822	http://dx.doi.org/10.1371/journal.pone.0100822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013898	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400012
J	Fens, MH; Larkin, SK; Oronsky, B; Scicinski, J; Morris, CR; Kuypers, FA				Fens, Marcel H.; Larkin, Sandra K.; Oronsky, Bryan; Scicinski, Jan; Morris, Claudia R.; Kuypers, Frans A.			The Capacity of Red Blood Cells to Reduce Nitrite Determines Nitric Oxide Generation under Hypoxic Conditions	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; S-NITROSOHEMOGLOBIN; FLOW REGULATION; RELAXING FACTOR; HEMOGLOBIN; DISEASE; SYNTHASE; NO; MECHANISMS; RELEASE	Nitric oxide (NO) is a key regulator of vascular tone. Endothelial nitric oxide synthase (eNOS) is responsible for NO generation under normoxic conditions. Under hypoxia however, eNOS is inactive and red blood cells (RBC) provide an alternative NO generation pathway from nitrite to regulate hypoxic vasodilation. While nitrite reductase activity of hemoglobin is well acknowledged, little is known about generation of NO by intact RBC with physiological hemoglobin concentrations. We aimed to develop and apply a new approach to provide insights in the ability of RBC to convert nitrite into NO under hypoxic conditions. We established a novel experimental setup to evaluate nitrite uptake and the release of NO from RBC into the gas-phase under different conditions. NO measurements were similar to well-established clinical measurements of exhaled NO. Nitrite uptake was rapid, and after an initial lag phase NO release from RBC was constant in time under hypoxic conditions. The presence of oxygen greatly reduced NO release, whereas inhibition of eNOS and xanthine oxidoreductase (XOR) did not affect NO release. A decreased pH increased NO release under hypoxic conditions. Hypothermia lowered NO release, while hyperthermia increased NO release. Whereas fetal hemoglobin did not alter NO release compared to adult hemoglobin, sickle RBC showed an increased ability to release NO. Under all conditions nitrite uptake by RBC was similar. This study shows that nitrite uptake into RBC is rapid and release of NO into the gas-phase continues for prolonged periods of time under hypoxic conditions. Changes in the RBC environment such as pH, temperature or hemoglobin type, affect NO release.	[Fens, Marcel H.; Larkin, Sandra K.; Kuypers, Frans A.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Oronsky, Bryan; Scicinski, Jan] RadioRx Inc, Mountain View, CA USA; [Morris, Claudia R.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Emory University	Kuypers, FA (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	fkuypers@chori.org		Scicinski, Jan/0000-0002-1063-7705	Netherlands Organisation for Scientific Research, The Hague, The Netherlands	Netherlands Organisation for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	MHF is supported by the Netherlands Organisation for Scientific Research, The Hague, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; ARMSTRONG DH, 1963, BLOOD, V22, P554, DOI 10.1182/blood.V22.5.554.554; Cabrales P, 2011, AM J PHYSIOL-HEART C, V300, pH49, DOI 10.1152/ajpheart.00665.2010; Cantu-Medellin N, 2011, NITRIC OXIDE-BIOL CH, V25, P59, DOI 10.1016/j.niox.2011.01.006; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Deem S, 2007, AM J PHYSIOL-HEART C, V292, pH963, DOI 10.1152/ajpheart.00812.2006; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DeNicola LR, 2000, PEDIATR EMERG CARE, V16, P290, DOI 10.1097/00006565-200008000-00021; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Girgis RE, 2003, AM J HEMATOL, V72, P177, DOI 10.1002/ajh.10284; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Jensen FB, 2005, ACTA PHYSIOL SCAND, V184, P243, DOI 10.1111/j.1365-201X.2005.01448.x; Jensen FB, 2010, AM J PHYSIOL-REG I, V298, pR972, DOI 10.1152/ajpregu.00813.2009; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; LEVINE RL, 1993, FASEB J, V7, P1242, DOI 10.1096/fasebj.7.13.8405809; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Lundberg JO, 2004, FREE RADICAL BIO MED, V37, P395, DOI 10.1016/j.freeradbiomed.2004.04.027; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Mack AK, 2008, BRIT J HAEMATOL, V142, P971, DOI 10.1111/j.1365-2141.2008.07259.x; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morris CR, 2004, AM J RESP CRIT CARE, V170, P148, DOI 10.1164/rccm.200309-1304OC; Morris CR, 2003, J PEDIAT HEMATOL ONC, V25, P629, DOI 10.1097/00043426-200308000-00008; Noritomi DT, 2009, CRIT CARE MED, V37, P2733, DOI 10.1097/CCM.0b013e3181a59165; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Radhakrishnan DK, 2012, J PEDIATR-US, V160, P93, DOI 10.1016/j.jpeds.2011.06.048; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Ritkind JM, 2007, NITRIC OXIDE-BIOL CH, V16, P448, DOI 10.1016/j.niox.2007.04.002; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Silkoff PE, 1999, CHEST, V116, P754, DOI 10.1378/chest.116.3.754; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Sullivan KJ, 2010, J PEDIAT HEMATOL ONC, V32, pE249, DOI 10.1097/MPH.0b013e3181ec0ae5; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Vitturi DA, 2009, AM J PHYSIOL-HEART C, V296, pH1398, DOI 10.1152/ajpheart.01303.2008; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Zhurova M., 2012, J BLOOD TRANSFUSION, V2012, P1, DOI [10.1155/2012/102809, DOI 10.1155/2012/102809]	53	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101626	10.1371/journal.pone.0101626	http://dx.doi.org/10.1371/journal.pone.0101626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007272	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600051
J	Ekram, MB; Kim, J				Ekram, Muhammad B.; Kim, Joomyeong			High-Throughput Targeted Repeat Element Bisulfite Sequencing (HT-TREBS): Genome-Wide DNA Methylation Analysis of IAP LTR Retrotransposon	PLOS ONE			English	Article							L1 RETROTRANSPOSITION; CYTOSINE METHYLATION; CELLS; MOUSE; MAPS; METHYLTRANSFERASE; TRANSCRIPTION; PLURIPOTENT; MAINTENANCE; DIVERSITY	In vertebrates, DNA methylation-mediated repression of retrotransposons is essential for the maintenance of genomic integrity. In the current study, we developed a technique termed HT-TREBS (High-Throughput Targeted Repeat Element Bisulfite Sequencing). This technique is designed to measure the DNA methylation levels of individual loci of any repeat families with next-generation sequencing approaches. To test the feasibility of HT-TREBS, we analyzed the DNA methylation levels of the IAP LTR family using a set of 12 different genomic DNA isolated from the brain, liver and kidney of 4 one-week-old littermates of the mouse strain C57BL/6N. This technique has successfully generated the CpG methylation data of 5,233 loci common in all the samples, representing more than 80% of the individual loci of the five targeted subtypes of the IAP LTR family. According to the results, approximately 5% of the IAP LTR loci have less than 80% CpG methylation levels with no genomic position preference. Further analyses of the IAP LTR loci also revealed the presence of extensive DNA methylation variations between different tissues and individuals. Overall, these data demonstrate the efficiency and robustness of the new technique, HT-TREBS, and also provide new insights regarding the genome-wide DNA methylation patterns of the IAP LTR repeat elements.	[Ekram, Muhammad B.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institute of Health [R01-GM066225, R15-ES019118]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health [R01-GM066225, R15-ES019118]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; Ekram MB, 2012, EPIGENETICS-US, V7, P370, DOI 10.4161/epi.19462; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lees-Murdock DJ, 2008, EPIGENETICS-US, V3, P5, DOI 10.4161/epi.3.1.5553; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lutsik P, 2011, NUCLEIC ACIDS RES, V39, pW551, DOI 10.1093/nar/gkr312; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	37	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101683	10.1371/journal.pone.0101683	http://dx.doi.org/10.1371/journal.pone.0101683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003790	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700053
J	Akl, TJ; Wilson, MA; Ericson, MN; Farquhar, E; Cote, GL				Akl, Tony J.; Wilson, Mark A.; Ericson, M. Nance; Farquhar, Ethan; Cote, Gerard L.			Wireless Monitoring of Liver Hemodynamics In Vivo	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; IMPLANTABLE SENSOR; ALLOGRAFT FAILURE; OXYGENATION; PERFUSION; NIRS; SIGNALS	Liver transplants have their highest technical failure rate in the first two weeks following surgery. Currently, there are limited devices for continuous, real-time monitoring of the graft. In this work, a three wavelengths system is presented that combines near-infrared spectroscopy and photoplethysmography with a processing method that can uniquely measure and separate the venous and arterial oxygen contributions. This strategy allows for the quantification of tissue oxygen consumption used to study hepatic metabolic activity and to relate it to tissue stress. The sensor is battery operated and communicates wirelessly with a data acquisition computer which provides the possibility of implantation provided sufficient miniaturization. In two in vivo porcine studies, the sensor tracked perfusion changes in hepatic tissue during vascular occlusions with a root mean square error (RMSE) of 0.135 mL/min/g of tissue. We show the possibility of using the pulsatile wave to measure the arterial oxygen saturation similar to pulse oximetry. The signal is also used to extract the venous oxygen saturation from the direct current (DC) levels. Arterial and venous oxygen saturation changes were measured with an RMSE of 2.19% and 1.39% respectively when no vascular occlusions were induced. This error increased to 2.82% and 3.83% when vascular occlusions were induced during hypoxia. These errors are similar to the resolution of a commercial oximetry catheter used as a reference. This work is the first realization of a wireless optical sensor for continuous monitoring of hepatic hemodynamics.	[Akl, Tony J.; Cote, Gerard L.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Wilson, Mark A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Wilson, Mark A.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Ericson, M. Nance; Farquhar, Ethan] Oak Ridge Natl Lab, Oak Ridge, TN USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; United States Department of Energy (DOE); Oak Ridge National Laboratory	Akl, TJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	tja161@gmail.com	Ericson, Milton/H-9880-2016	Ericson, Milton/0000-0002-6628-4865	National Institutes of Health (NIH) through a Bioengineering Research Partnership (BRP) grant [5R01-GM077150]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077150] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through a Bioengineering Research Partnership (BRP) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH) through a Bioengineering Research Partnership (BRP) grant (#5R01-GM077150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl TJ, 2013, J BIOMEDICAL OPTICS; Akl TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077008; Akl TJ, 2011, BIOMED OPT EXPRESS, V2, P2096, DOI 10.1364/BOE.2.2096; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Eghtesad B, 2009, CLEVELAND CLIN CURRE, P564; El-Desoky AEH, 1999, LIVER TRANSPLANT SUR, V5, P219, DOI 10.1002/lt.500050316; Ericson M. N., 2011, Proceedings of the 2011 Future of Instrumentation International Workshop (FIIW), P63, DOI 10.1109/FIIW.2011.6476801; Ericson MN, 2004, MINIM INVASIV THER, V13, P87, DOI 10.1080/13645700410027866; Friebel M, 2009, J BIOMED OPT, V14; Gagnon RE, 2006, SPECTROSC-INT J, V20, P253, DOI 10.1155/2006/285157; Grassi B, 1999, J APPL PHYSIOL, V87, P348, DOI 10.1152/jappl.1999.87.1.348; Guyton AC, 1991, TXB MED PHYSL; Humeau A, 2007, MED BIOL ENG COMPUT, V45, P421, DOI 10.1007/s11517-007-0170-5; Khot MB, 2005, PLAST RECONSTR SURG, V115, P1103, DOI 10.1097/01.PRS.0000156546.45229.84; Klar E, 1996, Transpl Int, V9 Suppl 1, pS140, DOI 10.1111/j.1432-2277.1996.tb01591.x; Klar E, 1997, TRANSPL P, V29, P362, DOI 10.1016/S0041-1345(96)00120-0; Lane NJ, 1996, TRANSPLANTATION, V61, P689, DOI 10.1097/00007890-199603150-00003; Laustsen J, 1996, EUR J VASC ENDOVASC, V12, P91, DOI 10.1016/S1078-5884(96)80282-6; Lipcsey M, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-11; Mannheimer PD, 1997, IEEE T BIO-MED ENG, V44, P148, DOI 10.1109/10.554761; Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR), 2012, OPTN SRTR 2011 ANN D; QUIROGA J, 1991, HEPATOLOGY, V14, P1054, DOI 10.1016/0270-9139(91)90128-I; Rusch TL, 1996, COMPUT BIOL MED, V26, P143, DOI 10.1016/0010-4825(95)00049-6; Sahni R, 2012, CLIN PERINATOL, V39, P573, DOI 10.1016/j.clp.2012.06.012; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Subramanian H, 2005, IEEE T BIO-MED ENG, V52, P2016, DOI 10.1109/TBME.2005.857667; Subramanian H, 2005, IEEE T BIO-MED ENG, V52, P1355, DOI 10.1109/TBME.2005.847552; TAKAYA S, 1993, TRANSPLANT INT, V6, P73, DOI 10.1007/BF00336648; Tong YJ, 2010, NEUROIMAGE, V53, P553, DOI 10.1016/j.neuroimage.2010.06.049; Tortoriello TA, 2005, PEDIATR ANESTH, V15, P495, DOI 10.1111/j.1460-9592.2005.01488.x; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012	32	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102396	10.1371/journal.pone.0102396	http://dx.doi.org/10.1371/journal.pone.0102396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019160	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600076
J	Bashar, MK; Yamagata, K; Kobayashi, TJ				Bashar, Md Khayrul; Yamagata, Kazuo; Kobayashi, Tetsuya J.			Improved and Robust Detection of Cell Nuclei from Four Dimensional Fluorescence Images	PLOS ONE			English	Article							STEM-CELLS; LINEAGE; SEGMENTATION; TRACKING	Segmentation-free direct methods are quite efficient for automated nuclei extraction from high dimensional images. A few such methods do exist but most of them do not ensure algorithmic robustness to parameter and noise variations. In this research, we propose a method based on multiscale adaptive filtering for efficient and robust detection of nuclei centroids from four dimensional (4D) fluorescence images. A temporal feedback mechanism is employed between the enhancement and the initial detection steps of a typical direct method. We estimate the minimum and maximum nuclei diameters from the previous frame and feed back them as filter lengths for multiscale enhancement of the current frame. A radial intensity-gradient function is optimized at positions of initial centroids to estimate all nuclei diameters. This procedure continues for processing subsequent images in the sequence. Above mechanism thus ensures proper enhancement by automated estimation of major parameters. This brings robustness and safeguards the system against additive noises and effects from wrong parameters. Later, the method and its single-scale variant are simplified for further reduction of parameters. The proposed method is then extended for nuclei volume segmentation. The same optimization technique is applied to final centroid positions of the enhanced image and the estimated diameters are projected onto the binary candidate regions to segment nuclei volumes. Our method is finally integrated with a simple sequential tracking approach to establish nuclear trajectories in the 4D space. Experimental evaluations with five image-sequences (each having 271 3D sequential images) corresponding to five different mouse embryos show promising performances of our methods in terms of nuclear detection, segmentation, and tracking. A detail analysis with a sub-sequence of 101 3D images from an embryo reveals that the proposed method can improve the nuclei detection accuracy by 9 % over the previous methods, which used inappropriate large valued parameters. Results also confirm that the proposed method and its variants achieve high detection accuracies (> 98% mean F-measure) irrespective of the large variations of filter parameters and noise levels.	[Bashar, Md Khayrul] Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan; [Yamagata, Kazuo] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan; [Kobayashi, Tetsuya J.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	Ochanomizu University; Osaka University; University of Tokyo	Bashar, MK (corresponding author), Ochanomizu Univ, Leading Grad Sch Promot Ctr, Tokyo 112, Japan.	bashar.md.khayrul@ocha.ac.jp	Bashar, Md Khayrul/AHB-9800-2022	Bashar, Md Khayrul/0000-0002-5580-0422	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology;  [21116006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (KAKENHI), Grant No. 21116006; Japan Society for the Promotion of Science; and the Ministry of Education, Culture, Sports, Science and Technology. http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bashar M. K., 2012, 2012 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2012), P621, DOI 10.1109/IECBES.2012.6498044; Bashar M. K., 2012, 2012 7th International Conference on Electrical & Computer Engineering (ICECE), P256, DOI 10.1109/ICECE.2012.6471534; Bashar MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035550; Bashar MK, 2012, P 34 ANN INT C IEEE, P134; Byun JY, 2006, MOL VIS, V12, P949; Dzyubachyk O, 2010, IEEE T MED IMAGING, V29, P852, DOI 10.1109/TMI.2009.2038693; Godinez WJ, 2012, IEEE T MED IMAGING, V31, P1786, DOI 10.1109/TMI.2012.2203142; Han J, 2011, J MICROSC-OXFORD, V241, P315, DOI 10.1111/j.1365-2818.2010.03442.x; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Khan AM, 2012, LECT NOTES COMPUT SC, V7666, P575, DOI 10.1007/978-3-642-34478-7_70; Kurihara D, 2013, DEV GROWTH DIFFER, V55, P462, DOI 10.1111/dgd.12040; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lee GG, 2013, IEEE T BIOMED CIRC S, V7, P158, DOI 10.1109/TBCAS.2013.2253463; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Press W. H., 1992, ART SCI COMPUTING; Santella A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-580; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Yamagata K, 2013, DEV GROWTH DIFFER, V55, P378, DOI 10.1111/dgd.12048; Yamagata K, 2010, METHODS, V52, P259, DOI 10.1016/j.ymeth.2010.04.008	27	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101891	10.1371/journal.pone.0101891	http://dx.doi.org/10.1371/journal.pone.0101891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020042	Green Submitted, gold, Green Published			2022-12-25	WOS:000339618600030
J	Kulshreshtha, V; Ayalew, LE; Islam, A; Tikoo, SK				Kulshreshtha, Vikas; Ayalew, Lisanework E.; Islam, Azharul; Tikoo, Suresh K.			Conserved Arginines of Bovine Adenovirus-3 33K Protein Are Important for Transportin-3 Mediated Transport and Virus Replication	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; MAMMALIAN-CELLS; SR PROTEINS; SUBNUCLEAR LOCALIZATION; VIRAL REPLICATION; GENE-EXPRESSION; SPLICING FACTOR; L4-22K PROTEIN; ALPHA; TRANSCRIPTION	The L6 region of bovine adenovirus (BAdV)-3 encodes a spliced protein designated 33K. The 33K specific sera detected five major proteins and three minor proteins in transfected or virus infected cells, which could arise by internal initiation of translation and alternative splicing. The 33K protein is predominantly localized to the nucleus of BAdV-3 infected cells. The 33K nuclear transport utilizes both classical importin-alpha/-beta and importin-beta dependent nuclear import pathways and preferentially binds to importin-alpha 5 and transportin-3 receptors, respectively. Analysis of mutant 33K proteins demonstrated that amino acids 201-240 of the conserved C-terminus of 33K containing RS repeat are required for nuclear localization and, binding to both importin-alpha 5 and transportin-3 receptors. Interestingly, the arginine residues of conserved RS repeat are required for binding to transportin-3 receptor but not to importin-alpha 5 receptor. Moreover, mutation of arginines residues of RS repeat proved lethal for production of progeny virus. Our results suggest that arginines of RS repeat are required for efficient nuclear transport of 33K mediated by transportin-3, which appears to be essential for replication and production of infectious virion.	[Kulshreshtha, Vikas; Ayalew, Lisanework E.; Islam, Azharul; Tikoo, Suresh K.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Kulshreshtha, Vikas; Ayalew, Lisanework E.; Tikoo, Suresh K.] Univ Saskatchewan, Saskatoon, SK, Canada; [Tikoo, Suresh K.] Univ Saskatchewan, Sch Publ Hlth, Vaccinol & Immunotherapeut Program, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Tikoo, SK (corresponding author), Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada.	Suresh.tik@usask.ca		Ayalew, Lisanework E./0000-0002-4157-9552	NSERC Canada [155081-2007]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by NSERC Canada (WWW.NSERC.CA) Grant #155081-2007. The funders have no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Ali H, 2007, J VIROL, V81, P1327, DOI 10.1128/JVI.01584-06; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Du EQ, 2010, J GENE MED, V12, P840, DOI 10.1002/jgm.1505; Ewing SG, 2007, J VIROL, V81, P12450, DOI 10.1128/JVI.01470-07; Farley DC, 2004, J VIROL, V78, P1782, DOI 10.1128/JVI.78.4.1782-1791.2004; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Finnen RL, 2001, VIROLOGY, V289, P388, DOI 10.1006/viro.2001.1130; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Guimet D, 2013, J VIROL, V87, P7688, DOI 10.1128/JVI.00859-13; Hamelberg D, 2007, P NATL ACAD SCI USA, V104, P14947, DOI 10.1073/pnas.0703151104; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hindley CE, 2007, TRAFFIC, V8, P1313, DOI 10.1111/j.1600-0854.2007.00618.x; IMAMOTO N, 1995, J BIOL CHEM, V270, P8559, DOI 10.1074/jbc.270.15.8559; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kulshreshtha V, 2004, VIROLOGY, V323, P59, DOI 10.1016/j.virol.2004.02.024; Kulshreshtha V, 2009, THESIS U SASKATCHEWA; Kulshreshtha V, 2008, VIROLOGY, V381, P29, DOI 10.1016/j.virol.2008.08.015; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Ostapchuk P, 2006, J VIROL, V80, P6973, DOI 10.1128/JVI.00123-06; Ostberg S, 2012, VIROLOGY, V433, P273, DOI 10.1016/j.virol.2012.08.021; Pante N, 1996, CURR OPIN CELL BIOL, V8, P397, DOI 10.1016/S0955-0674(96)80016-0; Paterson CP, 2012, VIROLOGY, V432, P63, DOI 10.1016/j.virol.2012.05.021; Reddy PS, 1999, J VIROL, V73, P9137, DOI 10.1128/JVI.73.11.9137-9144.1999; Reddy PS, 1998, J VIROL, V72, P1394, DOI 10.1128/JVI.72.2.1394-1402.1998; Tachibana T, 2000, CELL STRUCT FUNCT, V25, P115, DOI 10.1247/csf.25.115; Tormanen H, 2006, J BIOL CHEM, V281, P36510, DOI 10.1074/jbc.M607601200; Welch K, 1999, MOL CELL BIOL, V19, P8400; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Wu K, 2013, J VIROL, V87, P6739, DOI 10.1128/JVI.00652-13; Wu K, 2012, J VIROL, V86, P10474, DOI 10.1128/JVI.01463-12; Wu Q, 2004, ARCH VIROL, V149, P1783, DOI 10.1007/s00705-004-0323-x; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zakhartchouk AN, 1998, VIROLOGY, V250, P220, DOI 10.1006/viro.1998.9351	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101216	10.1371/journal.pone.0101216	http://dx.doi.org/10.1371/journal.pone.0101216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019945	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600012
J	Vargo, EL; Crissman, JR; Booth, W; Santangelo, RG; Mukha, DV; Schal, C				Vargo, Edward L.; Crissman, Jonathan R.; Booth, Warren; Santangelo, Richard G.; Mukha, Dmitry V.; Schal, Coby			Hierarchical Genetic Analysis of German Cockroach (Blattella germanica) Populations from within Buildings to across Continents	PLOS ONE			English	Article							COPTOTERMES-FORMOSANUS ISOPTERA; BIOLOGICAL INVASIONS; APARTMENT BUILDINGS; PERIPLANETA-AMERICANA; MOLECULAR MARKERS; DNA-SEQUENCES; UNITED-STATES; F-STATISTICS; DISPERSAL; DISTANCE	Understanding the population structure of species that disperse primarily by human transport is essential to predicting and controlling human-mediated spread of invasive species. The German cockroach (Blattella germanica) is a widespread urban invader that can actively disperse within buildings but is spread solely by human-mediated dispersal over longer distances; however, its population structure is poorly understood. Using microsatellite markers we investigated population structure at several spatial scales, from populations within single apartment buildings to populations from several cities across the U. S. and Eurasia. Both traditional measures of genetic differentiation and Bayesian clustering methods revealed increasing levels of genetic differentiation at greater geographic scales. Our results are consistent with active dispersal of cockroaches largely limited to movement within a building. Their low levels of genetic differentiation, yet limited active spread between buildings, suggests a greater likelihood of human-mediated dispersal at more local scales (within a city) than at larger spatial scales (within and between continents). About half the populations from across the U. S. clustered together with other U. S. populations, and isolation by distance was evident across the U. S. Levels of genetic differentiation among Eurasian cities were greater than those in the U. S. and greater than those between the U. S. and Eurasia, but no clear pattern of structure at the continent level was detected. MtDNA sequence variation was low and failed to reveal any geographical structure. The weak genetic structure detected here is likely due to a combination of historical admixture among populations and periodic population bottlenecks and founder events, but more extensive studies are needed to determine whether signatures of global movement may be present in this species.	[Vargo, Edward L.; Crissman, Jonathan R.; Booth, Warren; Santangelo, Richard G.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Vargo, Edward L.; Crissman, Jonathan R.; Booth, Warren; Santangelo, Richard G.; Schal, Coby] N Carolina State Univ, WM Ctr Behav Biol, Raleigh, NC 27695 USA; [Mukha, Dmitry V.] Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Russian Academy of Sciences; Vavilov Institute of General Genetics	Vargo, EL (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	ed_vargo@ncsu.edu	Mukha, Dmitry V/AAO-5635-2020; Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Mukha, Dmitry/0000-0002-7380-0776	National Research Initiative of the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service [2004-35302-14880]; USDA Risk Avoidance and Mitigation Program [2005-51101-02388]; U.S. Department of Housing and Urban Development [NCHHU0001-11]; Blanton J. Whitmire endowment at North Carolina State University; North Carolina Pest Management Association	National Research Initiative of the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA Risk Avoidance and Mitigation Program; U.S. Department of Housing and Urban Development; Blanton J. Whitmire endowment at North Carolina State University; North Carolina Pest Management Association	This work was supported by the National Research Initiative of the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service, grant number 2004-35302-14880; the USDA Risk Avoidance and Mitigation Program, grant number 2005-51101-02388; the U.S. Department of Housing and Urban Development, grant NCHHU0001-11; the Blanton J. Whitmire endowment at North Carolina State University; and the North Carolina Pest Management Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Appel Arthur G., 1995, P1; Austin JW, 2006, FLA ENTOMOL, V89, P183, DOI 10.1653/0015-4040(2006)89[183:GEFTIO]2.0.CO;2; Avise J.C., 2004, MOL MARKERS NATURAL; Booth W, 2007, MOL ECOL NOTES, V7, P648, DOI 10.1111/j.1471-8286.2006.01663.x; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Booth W, 2011, J HERED, V102, P175, DOI 10.1093/jhered/esq108; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cloarec A, 1999, ENTOMOL EXP APPL, V92, P311, DOI 10.1023/A:1003877800605; CLOAREC A, 1992, EPIDEMIOL INFECT, V109, P483, DOI 10.1017/S0950268800050470; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crissman JR, 2010, J MED ENTOMOL, V47, P553, DOI 10.1603/ME09036; Elgderi RM, 2006, ANN TROP MED PARASIT, V100, P55, DOI 10.1179/136485906X78463; FOTEDAR R, 1992, ACTA TROP, V50, P339, DOI 10.1016/0001-706X(92)90069-A; FOTEDAR R, 1991, EPIDEMIOL INFECT, V107, P181, DOI 10.1017/S0950268800048809; Garb JE, 2004, MOL PHYLOGENET EVOL, V31, P1127, DOI 10.1016/j.ympev.2003.10.012; Gore JC, 2007, ANNU REV ENTOMOL, V52, P439, DOI 10.1146/annurev.ento.52.110405.091313; Gore JC, 2004, J ECON ENTOMOL, V97, P715, DOI 10.1603/0022-0493-97.2.715; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graczyk TK, 2005, CLIN MICROBIOL REV, V18, P128, DOI 10.1128/CMR.18.1.128-132.2005; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Jobet E, 2000, MOL ECOL, V9, P481, DOI 10.1046/j.1365-294x.2000.00880.x; Jones CJ, 1997, MOL BREEDING, V3, P381, DOI 10.1023/A:1009612517139; Lack JB, 2013, BIOL INVASIONS, V15, P1067, DOI 10.1007/s10530-012-0351-5; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P684, DOI 10.1603/008.102.0413; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Mukha DV, 2007, MED VET ENTOMOL, V21, P132, DOI 10.1111/j.1365-2915.2007.00670.x; Nagaraja, 2004, GENES GENET SYST, V79, P293, DOI 10.1266/ggs.79.293; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pai HH, 2003, ACTA TROP, V87, P355, DOI 10.1016/S0001-706X(03)00140-2; Pai HH, 2005, ACTA TROP, V93, P259, DOI 10.1016/j.actatropica.2004.11.006; Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; ROTH LM, 1985, ENTOMOL SCAND, P1; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; RUNSTROM ES, 1984, J ECON ENTOMOL, V77, P407, DOI 10.1093/jee/77.2.407; RUNSTROM ES, 1990, J MED ENTOMOL, V27, P515, DOI 10.1093/jmedent/27.4.515; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schal C., 2011, MALLIS HDB PEST CONT, P150; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; TAJIMA F, 1983, GENETICS, V105, P437; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilson GA, 2003, GENETICS, V163, P1177; WRIGHT S, 1951, ANN EUGENIC, V15, P323; XIONG B, 1991, GENOME, V34, P306, DOI 10.1139/g91-050	58	22	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102321	10.1371/journal.pone.0102321	http://dx.doi.org/10.1371/journal.pone.0102321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020136	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600066
J	Cremona, F; Koiv, T; Kisand, V; Laas, A; Zingel, P; Agasild, H; Feldmann, T; Jarvalt, A; Noges, P; Noges, T				Cremona, Fabien; Koiv, Toomas; Kisand, Veljo; Laas, Alo; Zingel, Priit; Agasild, Helen; Feldmann, Tonu; Jarvalt, Ain; Noges, Peeter; Noges, Tiina			From Bacteria to Piscivorous Fish: Estimates of Whole-Lake and Component-Specific Metabolism with an Ecosystem Approach	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; LARGE SHALLOW LAKE; PHYTOPLANKTON PRODUCTION; RESPIRATION RATES; TEMPORAL DYNAMICS; GROWTH EFFICIENCY; BENTHIC PATHWAYS; EUTROPHIC LAKE; CARBON BUDGET; MASS-BALANCE	The influence of functional group specific production and respiration patterns on a lake's metabolic balance remains poorly investigated to date compared to whole-system estimates of metabolism. We employed a summed component ecosystem approach for assessing lake-wide and functional group-specific metabolism (gross primary production (GPP) and respiration (R)) in shallow and eutrophic Lake Vortsjarv in central Estonia during three years. Eleven functional groups were considered: piscivorous and benthivorous fish; phyto-, bacterio-, proto-and metazooplankton; benthic macroinvertebrates, bacteria and ciliates; macrophytes and their associated epiphytes. Metabolism of these groups was assessed by allometric equations coupled with daily records of temperature and hydrology of the lake and measurements of food web functional groups biomass. Results revealed that heterotrophy dominated most of the year, with a short autotrophic period observed in late spring. Most of the metabolism of the lake could be attributed to planktonic functional groups, with phytoplankton contributing the highest share (90% of GPP and 43% of R). A surge of protozooplankton and bacterioplankton populations forming the microbial loop caused the shift from auto-to heterotrophy in midsummer. Conversely, the benthic functional groups had overall a very small contribution to lake metabolism. We validated our ecosystem approach by comparing the GPP and R with those calculated from O-2 measurements in the lake. Our findings are also in line with earlier productivity studies made with C-14 or chlorophyll a (chl-a) based equations. Ideally, the ecosystem approach should be combined with diel O-2 approach for investigating critical periods of metabolism shifts caused by dynamics in food-web processes.	[Cremona, Fabien; Koiv, Toomas; Kisand, Veljo; Laas, Alo; Zingel, Priit; Agasild, Helen; Feldmann, Tonu; Jarvalt, Ain; Noges, Peeter; Noges, Tiina] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia; [Kisand, Veljo] Univ Tartu, Inst Technol, Fac Sci & Technol, EE-50090 Tartu, Estonia	Estonian University of Life Sciences; University of Tartu	Cremona, F (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia.	fabien.cremona@emu.ee	Nõges, Peeter/AAL-5343-2020; Noges, Tiina/AAL-5373-2020; Cremona, Fabien/D-1385-2013; Laas, Alo/G-7992-2016; Kõiv, Toomas/H-3466-2016; Kisand, Veljo/H-2466-2012; Cremona, Fabien/AAP-1362-2020; Zingel, Priit/H-8822-2016	Nõges, Peeter/0000-0003-2919-6038; Noges, Tiina/0000-0002-4558-7373; Cremona, Fabien/0000-0002-0559-6259; Laas, Alo/0000-0002-4801-0377; Kõiv, Toomas/0000-0002-0051-3952; Kisand, Veljo/0000-0002-5535-1639; Cremona, Fabien/0000-0002-0559-6259; Zingel, Priit/0000-0003-1629-2063	Estonian Ministry of Education and Research [SF0170011s08, IUT 21-2]; Estonian Science Foundation [ETF9102, ETF8486, ETF8729]; MARS project (Managing Aquatic ecosystems and water Resources under multiple Stress) under the 7th EU Framework Programme [603378]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; MARS project (Managing Aquatic ecosystems and water Resources under multiple Stress) under the 7th EU Framework Programme	The study was supported by institutional research funding (SF0170011s08 and IUT 21-2) of the Estonian Ministry of Education and Research, by the Estonian Science Foundation through grants ETF9102, ETF8486 and ETF8729, and by the MARS project (Managing Aquatic ecosystems and water Resources under multiple Stress) funded under the 7th EU Framework Programme, Theme 6 (Environment including Climate Change), Contract No. 603378 (http://www.mars-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasild H, 2007, HYDROBIOLOGIA, V584, P167, DOI 10.1007/s10750-007-0575-z; Andersson E, 2006, AQUAT SCI, V68, P52, DOI 10.1007/s00027-005-0807-0; Andersson E, 2006, AMBIO, V35, P476, DOI 10.1579/0044-7447(2006)35[476:COAMBA]2.0.CO;2; Apple JK, 2006, AQUAT MICROB ECOL, V43, P243, DOI 10.3354/ame043243; Arst H, 2008, AQUAT BIOL, V3, P19, DOI 10.3354/ab00059; Balushkina EV, 1979, HEADLINES WATER ECOS, P169; Berggren M, 2012, ISME J, V6, P984, DOI 10.1038/ismej.2011.157; Biddanda B, 2001, LIMNOL OCEANOGR, V46, P730, DOI 10.4319/lo.2001.46.3.0730; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Coloso JJ, 2011, ECOSYSTEMS, V14, P935, DOI 10.1007/s10021-011-9455-5; Cremona F, 2014, HYDROBIOLOGIA, V731, P109, DOI 10.1007/s10750-013-1686-3; Cremona F, 2014, FRESHWATER IN PRESS, V33; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; DELGIORGIO PA, 1993, CAN J FISH AQUAT SCI, V50, P282, DOI 10.1139/f93-032; DELGIORGIO PA, 1994, LIMNOL OCEANOGR, V39, P772, DOI 10.4319/lo.1994.39.4.0772; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duhamel S, 2006, J MICROBIOL METH, V64, P316, DOI 10.1016/j.mimet.2005.05.008; FENCHEL T, 1983, MICROBIAL ECOL, V9, P99, DOI 10.1007/BF02015125; FINLAY BJ, 1982, ARCH PROTISTENKD, V125, P215, DOI 10.1016/S0003-9365(82)80018-3; Finlay K, 2010, LIMNOL OCEANOGR, V55, P1551, DOI 10.4319/lo.2010.55.4.1551; FOY RH, 1982, BRIT PHYCOL J, V17, P183, DOI 10.1080/00071618200650181; Freiberg R, 2011, EST J EARTH SCI, V60, P91, DOI 10.3176/earth.2011.2.03; Galkowskaya GA, 1980, IZV AKAD NAUK BSSR, V6, P114; Giere, 2009, MEIOBENTHOLOGY THE M; Hallfors G, 2004, BALTIC SEA ENV P; Hanson PC, 2003, LIMNOL OCEANOGR, V48, P1112, DOI 10.4319/lo.2003.48.3.1112; Heinsalu A, 2008, HYDROBIOLOGIA, V599, P23, DOI 10.1007/s10750-007-9206-y; Ikeda T., 2000, P455, DOI 10.1016/B978-012327645-2/50011-6; Jaani A., 1973, VORTSJARV, P37; Jarvalt A., 2011, VORTSJARVE KALAVARUD; Jonasson Petur M., 2004, P341; Joung SH, 2006, J MICROBIOL, V44, P562; Kangur K., 2004, LAKE VORTSJARV, P265; KAUTSKY U, 1995, THESIS STOCKHOLM U S; Kemp WM, 1997, MAR ECOL PROG SER, V150, P229, DOI 10.3354/meps150229; Laas A, 2012, HYDROBIOLOGIA, V694, P57, DOI 10.1007/s10750-012-1131-z; Liboriussen L, 2003, FRESHWATER BIOL, V48, P418, DOI 10.1046/j.1365-2427.2003.01018.x; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Lopez-Rodas V, 2006, PHYCOLOGIA, V45, P243, DOI 10.2216/04-31.1; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lovett G, 2006, ECOSYSTEMS, V9, P152, DOI 10.1007/s10021-005-0036-3; Middelburg Jack J., 2005, P206; Noges P, 1995, REPORT SERIES GEOPHY, V32, P81; NOGES P, 2004, LAKE VORTSJARV, P217; Noges Peeter, 1998, Proceedings of the Estonian Academy of Sciences Biology Ecology, V47, P268; Noges Peeter, 2012, Estonian Journal of Ecology, V61, P227, DOI 10.3176/eco.2012.4.01; Noges P, 2010, HYDROBIOLOGIA, V646, P33, DOI 10.1007/s10750-010-0178-y; Noges T, 1999, HYDROBIOLOGIA, V408, P277; Noges T., 2004, LAKE VORTSJARV, P335; Noges T, 2011, HYDROBIOLOGIA, V667, P205, DOI 10.1007/s10750-011-0647-y; Noges T, 2010, AQUAT ECOL, V44, P83, DOI 10.1007/s10452-009-9249-4; Piirsoo K, 2012, J HYDROL, V475, P306, DOI 10.1016/j.jhydrol.2012.10.015; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Plus M, 2003, CONT SHELF RES, V23, P1877, DOI 10.1016/j.csr.2003.03.001; Reinart Anu, 1999, Proceedings of the Estonian Academy of Sciences Biology Ecology, V48, P267; Ruttner-Kolisko A., 1977, ARCH HYDROBIOL, V8, P71; Staehr PA, 2007, LIMNOL OCEANOGR, V52, P108, DOI 10.4319/lo.2007.52.1.0108; Staehr PA, 2012, AQUAT SCI, V74, P15, DOI 10.1007/s00027-011-0199-2; Studenikina E. I., 1969, Gidrobiologicheskii Zhurnal, V5, P89; Suschenya LM, 1972, RESP CRUSTACEANS; TANG EPY, 1995, J PLANKTON RES, V17, P303, DOI 10.1093/plankt/17.2.303; Toming K, 2013, LIMNOL OCEANOGR, V58, P1259, DOI 10.4319/lo.2013.58.4.1259; Tsertova N, 2013, AQUAT MICROB ECOL, V70, P77, DOI 10.3354/ame01647; Tsertova N, 2011, ENV MICROBIOL REP, V3, P270, DOI 10.1111/j.1758-2229.2010.00221.x; Utermohl H., 1931, MITTEILUNGEN INT VER, V5, P567, DOI DOI 10.1080/05384680.1958; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vis C, 2006, CAN J FISH AQUAT SCI, V63, P1014, DOI 10.1139/F06-021; Welker M, 1999, HYDROBIOLOGIA, V408, P233, DOI 10.1023/A:1017027723782; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Winberg GG, 1983, J GEN BIOL, V44, P31; WOODWELL GM, 1968, AM ZOOL, V8, P19; Zingel P, 2007, MICROB ECOL, V53, P134, DOI 10.1007/s00248-006-9155-4	74	20	20	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101845	10.1371/journal.pone.0101845	http://dx.doi.org/10.1371/journal.pone.0101845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014117	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400040
J	Wang, YY; Freemantle, N; Nazareth, I; Hunt, K				Wang, Yingying; Freemantle, Nick; Nazareth, Irwin; Hunt, Kate			Gender Differences in Survival and the Use of Primary Care Prior to Diagnosis of Three Cancers: An Analysis of Routinely Collected UK General Practice Data	PLOS ONE			English	Article							CELL LUNG-CANCER; COLORECTAL-CANCER; ILLNESS BEHAVIOR; SEX DISPARITIES; COMORBIDITY; SEEKING; MORTALITY; SYMPTOMS; PATIENT; DELAY	Objective: To explore whether there are gender differences in the number of GP recorded cases, the probability of survival and consulting pattern prior to diagnosis amongst patients with three non-sex-specific cancers. Design: Cross sectional study. Setting: UK primary care. Subjects: 12,189 patients aged 16 years or over diagnosed with colorectal cancer (CRC), 11,081 patients with lung cancer and 4,352 patients with malignant melanoma, with first record of cancer diagnosis during 1997-2006. Main outcome measures: Cancer cases recorded in primary care; probability of survival following diagnosis; and number of GP contacts within the 24 months preceding diagnosis. Results: From 1997-2006, overall rates of GP recorded CRC and lung cancer cases recorded were higher in men than in women, but rates of malignant melanoma were higher in women than in men. Gender differences in survival were small; 49% of men and 53% of women survived at least 5 years following CRC diagnosis; 9% of men and 12% of women with lung cancer, and 77% of men and 86% of women with malignant melanoma. The adjusted male to female relative hazard ratio of death in all patients was 1.20 (95% CI 1.13-1.30), 1.24 (95% CI 1.16-1.33) and 1.73 (95% CI 1.51-2.00) for CRC, lung cancer and malignant melanoma respectively. However, gender differences in the relative risk were much smaller amongst those who died during follow-up. For each cancer, there was little evidence of gender difference in the percentage who consulted and the number of GP contacts made within 24 months prior to diagnosis. Conclusions: This study found that patterns of consulting prior to cancer diagnosis differed little between two genders, providing no support for the hypothesis that gender differences in survival are explained by gender differences in consultation for more serious illness, and suggests the need for a more critical view of gender and consultation.	[Wang, Yingying; Hunt, Kate] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Freemantle, Nick; Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; University College London	Wang, YY (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	Ying-Ying.Wang@glasgow.ac.uk	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022		Medical Research Council; MRC [MC_UU_12017/3, MC_U130059811] Funding Source: UKRI; Medical Research Council [MC_U130059811, MC_UU_12017/3] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; Bird CE, 1999, SOC SCI MED, V48, P745, DOI 10.1016/S0277-9536(98)00402-X; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bowen EF, 2002, LUNG CANCER-J IASLC, V37, P227, DOI 10.1016/S0169-5002(02)00143-5; Cancer Research UK, 2012, CANC STATS CANC CAS; Cancer Research UK, 2011, CANC MORT STAT CANC; Cancer Research UK, 2013, EXC CANC BURD MEN; Cancer Research UK, 2012, CANC STATS ALL CANC; Cancer Research UK, 2012, CANC INC STAT CANC I; Cegedim, 2012, CEG STRAT DAT DAT; Christensen KG, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-224; Clarke N, 2013, EXCESS BURDEN CANC M; Cockburn J, 2003, AM J HEALTH BEHAV, V27, P401, DOI 10.5993/AJHB.27.4.12; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Galdas P. M., 2009, MENS HLTH BODY IDENT; Gatta G, 2000, GUT, V47, P533, DOI 10.1136/gut.47.4.533; Grann AF, 2013, BRIT J CANCER, V109, P265, DOI 10.1038/bjc.2013.246; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Haynes K, 2009, PHARMACOEPIDEM DR S, V18, P730, DOI 10.1002/pds.1774; Hippisley-Cox J, 2009, TREND CONSULTATION R; Hunt K, 2010, PALGRAVE HDB GENDER, P207, DOI DOI 10.1057/9780230290334_13; Iyen-Omofoman B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-857; Janssen-Heijnen MLG, 2005, CRIT REV ONCOL HEMAT, V55, P231, DOI 10.1016/j.critrevonc.2005.04.008; Keeble S, 2014, INT J CANC; Koo JH, 2008, AM J GASTROENTEROL, V103, P1488, DOI 10.1111/j.1572-0241.2007.01779.x; Luchtenborg M, 2012, EUR J CANCER, V48, P3386, DOI 10.1016/j.ejca.2012.06.012; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Majek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068077; MARSHALL JR, 1986, WOMEN HEALTH, V11, P67; MARSHALL JR, 1982, J HEALTH SOC BEHAV, V23, P197, DOI 10.2307/2136629; McArdle CS, 2004, BRIT J SURG, V91, P605, DOI 10.1002/bjs.4456; McArdle CS, 2003, BRIT J SURG, V90, P711, DOI 10.1002/bjs.4098; McCartney G, 2011, TOB CONTROL, V20, P166, DOI 10.1136/tc.2010.037929; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Micheli A, 1998, EUR J CANCER, V34, P2271, DOI 10.1016/S0959-8049(98)00324-4; Najari BB, 2013, J UROLOGY, V189, P1470, DOI 10.1016/j.juro.2012.11.153; Ogle KS, 2000, CANCER, V88, P653, DOI 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1; Ries LAG, 2003, ONCOLOGIST, V8, P541; Shack LG, 2010, POSTGRAD MED J, V86, P73, DOI 10.1136/pgmj.2009.084566; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Tudiver F, 1999, J FAM PRACTICE, V48, P47; Waldron I, 1999, GENDER INEQUALITIES IN HEALTH, P150; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Wichmann MW, 2001, BRIT J SURG, V88, P1092, DOI 10.1046/j.0007-1323.2001.01819.x; Wilkins D, 2006, P EXP S HELD LEEDS M; Wizemann TM, 2001, EXPLOREING BIOL CONT; Yancik R, 1998, CANCER, V82, P2123, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.0.CO;2-W; Young CJ, 2000, AUST NZ J SURG, V70, P635, DOI 10.1046/j.1440-1622.2000.01916.x	53	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101562	10.1371/journal.pone.0101562	http://dx.doi.org/10.1371/journal.pone.0101562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014510	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000339378400027
J	Zhu, Y; Wu, N; Huang, HD; Dong, YC; Sun, QY; Zhang, W; Wang, Q; Li, Q				Zhu, Ying; Wu, Ning; Huang, Hai-Dong; Dong, Yu-Chao; Sun, Qin-Ying; Zhang, Wei; Wang, Qin; Li, Qiang			A Clinical Study of Tracheobronchopathia Osteochondroplastica: Findings from a Large Chinese Cohort	PLOS ONE			English	Article							TRACHEOPATHIA OSTEOPLASTICA; BRONCHOSCOPY; DIAGNOSIS; BRONCHUS	Background and Study Aims: Tracheobronchopathia osteochondroplastica (TO) is an uncommon disease of the tracheobronchial system that leads to narrowing of the airway lumen from cartilaginous and/or osseous submucosal nodules. The aim of this study is to perform a detailed review of this rare disease in a large cohort of patients with TO proven by fiberoptic bronchoscopy from China. Patients and Methods: Retrospective chart review was performed on 41,600 patients who underwent bronchoscopy in the Department of Respiratory Medicine of Changhai Hospital between January 2005 and December 2012. Cases of TO were identified based on characteristic features during bronchoscopic examination. Results: 22 cases of bronchoscopic TO were identified. Among whom one-half were male and the mean age was 47.45 +/- 10.91 years old. The most frequent symptoms at presentation were chronic cough (n = 14) and increased sputum production (n = 10). Radiographic abnormalities were observed in 3/18 patients and findings on computed tomography consistent with TO such as beaded intraluminal calcifications and/or increased luminal thickenings were observed in 18/22 patients. Patients were classified into the following categories based on the severity of bronchoscopic findings: Stage I (n = 2), Stage II (n = 6) and Stage III (n = 14). The result that bronchoscopic improvement was observed in 2 patients administered with inhaled corticosteroids suggested that resolution of this disease is possible. Conclusions: TO is a benign disease with slow progression, which could be roughly divided into 3 stages on the basis of the characteristic endoscopic features and histopathologic findings. Chronic inflammation was thought to be more important than the other existing plausible hypotheses in the course of TO. Inhaled corticosteroids might have some impact on patients at Stage I/II.	[Zhu, Ying; Wu, Ning; Huang, Hai-Dong; Dong, Yu-Chao; Sun, Qin-Ying; Zhang, Wei; Wang, Qin; Li, Qiang] Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China	Naval Medical University	Li, Q (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China.	liqres@hotmail.com	Zhang, Wei/AAE-9322-2021	Zhang, Wei/0000-0001-5292-7308; Zhu, Ying/0000-0002-0256-3216				Abu-Hijleh M, 2008, LUNG, V186, P353, DOI 10.1007/s00408-008-9113-7; Barthwal M S, 2004, Indian J Chest Dis Allied Sci, V46, P43; Bioque C., 2001, J BRONCHOL, V8, P78; Chen AY, 1997, OTOLARYNG HEAD NECK, V117, pS102, DOI 10.1016/S0194-5998(97)70071-8; Coetmeur D, 1997, RESP MED, V91, P496, DOI 10.1016/S0954-6111(97)90116-5; Dalgaard Jorgen B., 1947, ACTA PATH ET MICROBIOL SCAND, V24, P118; Doshi H, 2005, J THORAC CARDIOV SUR, V130, P901, DOI 10.1016/j.jtcvs.2005.01.020; Dutau H, 2004, J BRONCHOL INTERV PU, V11, P182; Fabrega RM, 2006, EUROPEAN J RADIOLOGY, V59, P111; Hantous-Zannad S, 2003, EUR J RADIOL, V45, P113, DOI 10.1016/S0720-048X(02)00028-1; Harma R, 1997, ACTA OTO-LARYNGOL, V84, P118; Hiebaum K, 1934, FRANKFURT Z PATHOL, V47, P249; HODGES MK, 1988, CHEST, V94, P842, DOI 10.1378/chest.94.4.842; Huang CC, 2010, CAN MED ASSOC J, V182, pE859, DOI 10.1503/cmaj.091762; Jabbardarjani HR, 2008, LUNG, V186, P293, DOI 10.1007/s00408-008-9088-4; JEPSEN O, 1960, Acta Otolaryngol, V51, P79, DOI 10.3109/00016486009124466; JONES AW, 1977, BRIT J DIS CHEST, V71, P268, DOI 10.1016/0007-0971(77)90124-3; Karlikaya C, 2000, Respirology, V5, P377, DOI 10.1046/j.1440-1843.2000.00278.x; Khan AM, 2006, J THORAC CARDIOV SUR, V132, P714, DOI 10.1016/j.jtcvs.2006.05.024; Kirbas G, 2009, YONSEI MED J, V50, P721, DOI 10.3349/ymj.2009.50.5.721; Kutlu CA, 2002, EUR J CARDIO-THORAC, V21, P140, DOI 10.1016/S1010-7940(01)01080-6; Leske V, 2001, MEDICINE, V80, P378, DOI 10.1097/00005792-200111000-00004; Li Shiyue, 2001, Zhonghua Jiehe He Huxi Zazhi, V24, P414; Li Yuan-yuan, 2009, Zhonghua Jiehe He Huxi Zazhi, V32, P489, DOI 10.3760/cma.j.issn.1001-0939.2009.07.003; LUNDGREN R, 1981, CHEST, V80, P706, DOI 10.1378/chest.80.6.706; Magro P, 2007, REV MAL RESPIR, V24, P883, DOI 10.1016/S0761-8425(07)91391-1; MARTIN CJ, 1974, ARCH OTOLARYNGOL, V100, P290; Matsuba T, 2001, Diagn Ther Endosc, V7, P63, DOI 10.1155/DTE.7.63; Meyer CN, 1997, RESP MED, V91, P499, DOI 10.1016/S0954-6111(97)90117-7; Muckleston HS, 1909, LARYNGOSCOPE, V19, P881; Nanushi M, 2011, EUROPEAN J INTERNA S, V22s, ps1; NIENHUIS DM, 1990, ANN OTO RHINOL LARYN, V99, P689, DOI 10.1177/000348949009900903; PEREZRODRIGUEZ E, 1990, CHEST, V97, P763, DOI 10.1378/chest.97.3.763a; PRAKASH UBS, 1989, MAYO CLIN PROC, V64, P1091, DOI 10.1016/S0025-6196(12)64978-7; Prakash UBS, 2002, SEMIN RESP CRIT CARE, V23, P167, DOI 10.1055/s-2002-25305; SECREST PG, 1964, AM J MED, V36, P815, DOI 10.1016/0002-9343(64)90189-5; Shigematsu Y, 2005, ANN THORAC SURG, V80, P1936, DOI 10.1016/j.athoracsur.2004.06.101; Tadjeddein A, 2006, ANN THORAC SURG, V81, P1480, DOI 10.1016/j.athoracsur.2005.04.013; Tatar D, 2012, CHINESE MED J-PEKING, V125, P2942, DOI 10.3760/cma.j.issn.0366-6999.2012.16.026; VILKMAN S, 1995, RESPIRATION, V62, P151; White B D, 2005, Australas Radiol, V49, P319, DOI 10.1111/j.1440-1673.2005.01444.x; Willms H, 2008, COUGH, V4, P4, DOI DOI 10.1186/1745-9974-4-4; Wilson R, 1996, EUR RESPIR J, V9, P1523, DOI 10.1183/09031936.96.09071523; Wong JSW, 2005, CHEST, V128, P3671, DOI 10.1378/chest.128.5.3671; Zhu Y, 2012, CHIN J RESP CRIT CAR, V11, P596; 谢宝松, 2008, [中华结核和呼吸杂志, Chinese Journal of Tuberculosis and Respiratiory Diseases], V31, P786	46	27	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102068	10.1371/journal.pone.0102068	http://dx.doi.org/10.1371/journal.pone.0102068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013916	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400061
J	Di Battista, A; Godfrey, C; Soo, C; Catroppa, C; Anderson, V				Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki			Depression and Health Related Quality of Life in Adolescent Survivors of a Traumatic Brain Injury: A Pilot Study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; ANXIETY DISORDERS; SYMPTOMS; RELIABILITY; PREVALENCE; PREDICTORS; CHILDHOOD; SEVERITY; VALIDITY; IMPACT	Traumatic brain injury is (TBI) a leading cause of morbidity and mortality in youth. Adult survivors of a severe pediatric TBI are vulnerable to global impairments, including greater employment difficulties, poor quality of life (HRQoL) and increased risk of mental health problems. When estimating the health related quality of life in adolescents, the presence of anxiety and depression and the quality of social relationships are important considerations, because adolescents are entrenched in social development during this phase of maturation. The influence of anxiety, depression and loneliness on health related quality of life in adolescent survivors of TBI has not been documented. This pilot study aimed to identify and measure the relationship between anxiety, depression and loneliness and perceived health related quality of life in adolescent survivors of a TBI. Method: mixed method/cohort pilot study (11 adolescents, mild to severe TBI; 9 parents), using self-report and proxy-report measures of anxiety, depression, health related quality of life, loneliness and clinical psychiatric interviews (adolescent only). Results: Self-reported depression was significantly correlated with self-reported HRQoL (rs [11] = 20.88, p<0.001). Age at injury was significantly correlated with self-reported HRQoL (rs [11] = -0.68, p = 0.02). Self-reported depression predicted self-reported HRQoL (R-2 = 0.79, F [1,10] = 33.48, p<0.001), but age at injury did not (R-2 = 0.19, F [1,10] = 2.09, p = 0.18). Conclusions: Our results suggest that depression is a predictor of health related quality of life in youth post-TBI. The possibility of using targeted assessment and therapy for depression post-TBI to improve health related quality of life should be explored.	[Di Battista, Ashley; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Di Battista, Ashley] Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Di Battista, Ashley; Godfrey, Celia; Soo, Cheryl; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	University of Melbourne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne	Di Battista, A (corresponding author), Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia.	ashley.dibattista@sickkids.ca	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Government; Victorian Neurotrauma Initiative; Australian National Health & Medical Research Council; Canadian Institutes of Health Research; Canadian Institutes of Health Research (CIHR), Canada; Victorian Government, Australia	Victorian Government; Victorian Neurotrauma Initiative; Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR), Canada(Canadian Institutes of Health Research (CIHR)); Victorian Government, Australia	Funding provided by Victorian Government Operational Infrastructure Scheme, Victorian Neurotrauma Initiative - fellowship to CS, Australian National Health & Medical Research Council - fellowships to VA and CC and Canadian Institutes of Health Research - Doctoral Research Award to AD. This research was supported in part by grants from the Canadian Institutes of Health Research (CIHR) Doctoral Research Award (DRA), Canada - awarded to ADB, and the Victorian Government Operations Infrastructure Funding, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson VA, 2010, J NEUROTRAUM, V27, P1; Avenevoli S, 2001, BIOL PSYCHIAT, V49, P1071, DOI 10.1016/S0006-3223(01)01142-8; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom D, 1997, J INT NEUROPSYCH SOC, V5, P127; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Eapen V, 2012, CURR OPIN PSYCHIATR, V25, P7, DOI 10.1097/YCO.0b013e32834de3bd; First MB., 1997, USERS GUIDE STRUCTUR; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Graham S., 2001, PEER HARASSMENT SCH; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1111/1469-7610.00629; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Hoza B, 2000, J CLIN CHILD PSYCHOL, V29, P119, DOI 10.1207/S15374424jccp2901_12; Irons C, 2005, J ADOLESCENCE, V28, P325, DOI 10.1016/j.adolescence.2004.07.004; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kazadin AE, 1983, J AM ACAD CHILD ADOL, V22, P157; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kovacs M., 1992, CHILDRENS DEPRESSION; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCarthy ML, 2006, ARCH PHYS MED REHAB, V160, P253; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Riley AW, 2004, AMBUL PEDIATR, V4, P371, DOI 10.1367/A03-178R.1; Saro J, 2013, BEST PRACTICES USING; SCHMIDT N, 1983, J PERS SOC PSYCHOL, V44, P1038, DOI 10.1037/0022-3514.44.5.1038; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Statistics ABo, 2008, STAT ABO ED UPD 17 J; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Ware JE, 1994, SF 36 PHYSL MENTAL H; Wechsler D, 1999, CORPORATION TP	42	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101842	10.1371/journal.pone.0101842	http://dx.doi.org/10.1371/journal.pone.0101842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010719	Green Published, gold			2022-12-25	WOS:000338763800045
J	Lentes, CJ; Mir, SH; Boehm, M; Ganea, C; Fendler, K; Hunte, C				Lentes, Christopher J.; Mir, Syed H.; Boehm, Marc; Ganea, Constanta; Fendler, Klaus; Hunte, Carola			Molecular Characterization of the Na+/H+-Antiporter NhaA from Salmonella Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEMBRANE-PROTEINS; TRANSPORT PROTEINS; OLIGOMERIC STATE; ALKALINE PH; EXPRESSION; DETERGENT; GENE; MECHANISM; MIGRATION	Na+/H+ antiporters are integral membrane proteins that are present in almost every cell and in every kingdom of life. They are essential for the regulation of intracellular pH-value, Na+-concentration and cell volume. These secondary active transporters exchange sodium ions against protons via an alternating access mechanism, which is not understood in full detail. Na+/H+ antiporters show distinct species-specific transport characteristics and regulatory properties that correlate with respective physiological functions. Here we present the characterization of the Na+/H+ antiporter NhaA from Salmonella enterica serovar Thyphimurium LT2, the causing agent of food-born human gastroenteritis and typhoid like infections. The recombinant antiporter was functional in vivo and in vitro. Expression of its gene complemented the Na+ sensitive phenotype of an E. coli strain that lacks the main Na+/H+ antiporters. Purified to homogeneity, the antiporter was a dimer in solution as accurately determined by size-exclusion chromatography combined with multi-angle laser-light scattering and refractive index monitoring. The purified antiporter was fully capable of electrogenic Na+(Li+)/H+-antiport when reconstituted in proteoliposomes and assayed by solid-supported membrane-based electrophysiological measurements. Transport activity was inhibited by 2-aminoperimidine. The recorded negative currents were in agreement with a 1Na(+)(Li+)/2H(+) stoichiometry. Transport activity was low at pH 7 and up-regulation above this pH value was accompanied by a nearly 10-fold decrease of K-m(Na) (16 mM at pH 8.5) supporting a competitive substrate binding mechanism. K+ does not affect Na+ affinity or transport of substrate cations, indicating that selectivity of the antiport arises from the substrate binding step. In contrast to homologous E. coli NhaA, transport activity remains high at pH values above 8.5. The antiporter from S. Typhimurium is a promising candidate for combined structural and functional studies to contribute to the elucidation of the mechanism of pH-dependent Na+/H+ antiporters and to provide insights in the molecular basis of species-specific growth and survival strategies.	[Lentes, Christopher J.; Mir, Syed H.; Hunte, Carola] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, ZBMZ, Inst Biochem & Mol Biol, D-79106 Freiburg, Germany; [Lentes, Christopher J.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Mir, Syed H.] Univ Kashmir, Dept Clin Biochem, Srinagar 190006, Jammu & Kashmir, India; [Boehm, Marc] Max Planck Inst Biophys, Dept Mol Membrane Biol, Frankfurt, Germany; [Ganea, Constanta] Carol Davila Univ Med & Pharm, Fac Med, Dept Biophys, Bucharest, Romania; [Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany	University of Freiburg; University of Freiburg; University of Kashmir; Max Planck Society; Carol Davila University of Medicine & Pharmacy; Max Planck Society	Hunte, C (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, ZBMZ, Inst Biochem & Mol Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	carola.hunte@biochemie.uni-freiburg.de	Hunte, Carola/E-4071-2015; Ganea, Constanta/A-8561-2011	Hunte, Carola/0000-0002-0826-3986; Ganea, Constanta/0000-0003-3489-6901; Fendler, Klaus/0000-0002-5699-7060	Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; German Research Foundation [SFB 746]; European Community [HEALTH-F4-2007-201924]	Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; German Research Foundation(German Research Foundation (DFG)); European Community(European Commission)	This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294 to C.H.), SFB 746 (German Research Foundation to C.H.) and received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no HEALTH-F4-2007-201924, EDICT Consortium (to C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadeff R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025182; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Calinescu O, 2014, FEBS LETT IN PRESS; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Dibrov P, 2005, FEBS LETT, V579, P373, DOI 10.1016/j.febslet.2004.11.098; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Furrer EM, 2007, FEBS LETT, V581, P572, DOI 10.1016/j.febslet.2006.12.059; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Grewer C, 2013, ANNU REV BIOPHYS, V42, P95, DOI 10.1146/annurev-biophys-083012-130312; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Inoue H, 1999, FEBS LETT, V443, P11, DOI 10.1016/S0014-5793(98)01652-4; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Mager T, 2013, J BIOL CHEM, V288, P24666, DOI 10.1074/jbc.M113.484071; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Minato Y, 2013, INFECT IMMUN, V81, P3163, DOI 10.1128/IAI.00071-13; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2013, BIOCHIM BIOPHYS ACTA, V1837, P1047, DOI DOI 10.1016/J.BBABI0.2013.12.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; PINNER E, 1992, ARCH MICROBIOL, V157, P323, DOI 10.1007/BF00248676; PINNER E, 1993, J BIOL CHEM, V268, P1729; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.2006.07.019; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	48	18	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101575	10.1371/journal.pone.0101575	http://dx.doi.org/10.1371/journal.pone.0101575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010413	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800029
J	Tzeng, TJ; Cao, L; Fu, YX; Zeng, HW; Cheng, WH				Tzeng, Tiffany J.; Cao, Lei; Fu, YangXin; Zeng, Huawei; Cheng, Wen-Hsing			Methylseleninic Acid Sensitizes Notch3-Activated OVCA429 Ovarian Cancer Cells to Carboplatin	PLOS ONE			English	Article							NOTCH SIGNALING PATHWAY; DNA-DAMAGE RESPONSE; COPPER TRANSPORTER CTR1; PROSTATE-CANCER; OXIDATIVE STRESS; INDUCED OTOTOXICITY; N-ACETYLCYSTEINE; TARGETING NOTCH; SELENIUM; CISPLATIN	Ovarian cancer, the deadliest of gynecologic cancers, is usually not diagnosed until advanced stages. Although carboplatin has been popular for treating ovarian cancer for decades, patients eventually develop resistance to this platinum-containing drug. Expression of neurogenic locus notch homolog 3 (Notch3) is associated with chemoresistance and poor overall survival in ovarian cancer patients. Overexpression of NICD3 (the constitutively active form of Notch3) in OVCA429 ovarian cancer cells (OVCA429/NICD3) renders them resistance to carboplatin treatment compared to OVCA429/pCEG cells expressing an empty vector. We have previously shown that methylseleninic acid (MSeA) induces oxidative stress and activates ataxia-telangiectasia mutated and DNA-dependent protein kinase in cancer cells. Here we tested the hypothesis that MSeA and carboplatin exerted a synthetic lethal effect on OVCA429/NICD3 cells. Co-treatment with MSeA synergistically sensitized OVCA429/NICD3 but not OVCA429/pCEG cells to the killing by carboplatin. This synergism was associated with a cell cycle exit at the G2/M phase and the induction of NICD3 target gene HES1. Treatment of N-acetyl cysteine or inhibitors of the above two kinases did not directly impact on the synergism in OVCA429/NICD3 cells. Taken together, these results suggest that the efficacy of carboplatin in the treatment of high grade ovarian carcinoma can be enhanced by a combinational therapy with MSeA.	[Tzeng, Tiffany J.; Cheng, Wen-Hsing] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Cao, Lei; Cheng, Wen-Hsing] Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA; [Fu, YangXin] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Zeng, Huawei] ARS, USDA, Grand Forks Human Res Ctr, Grand Forks, ND USA	University System of Maryland; University of Maryland College Park; Mississippi State University; University of Alberta; United States Department of Agriculture (USDA)	Cheng, WH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	wcheng@fsnhp.msstate.edu			Maryland Agricultural Experimental Station; Mississippi Agricultural and Forestry Experimental Station; Women and Children's Health Research Institute; Royal Alexandra Hospital Foundation, Canada	Maryland Agricultural Experimental Station; Mississippi Agricultural and Forestry Experimental Station; Women and Children's Health Research Institute; Royal Alexandra Hospital Foundation, Canada	This study was partially supported by Maryland Agricultural Experimental Station and Mississippi Agricultural and Forestry Experimental Station (to W.-H. Cheng), and by Women and Children's Health Research Institute with funding donated by the Royal Alexandra Hospital Foundation, Canada (to Y. Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alana L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-74; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Camphausen K, 2004, MOL CANCER THER, V3, P409; Chen HH, 2010, MOL PHARMACOL, V78, P36, DOI 10.1124/mol.109.061101; Chen HP, 2013, J ONCOL, V2013, DOI 10.1155/2013/872957; Cheng CF, 2008, APOPTOSIS, V13, P883, DOI 10.1007/s10495-008-0214-9; Cheng WH, 2012, BIOCHEM BIOPH RES CO, V420, P24, DOI 10.1016/j.bbrc.2012.02.104; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Combs GF, 2004, BRIT J CANCER, V91, P195, DOI 10.1038/sj.bjc.6601974; Cruet-Hennequart S, 2009, CELL CYCLE, V8, P3039; Dailey DD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-130; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; El-Sehemy A, 2013, CELL SIGNAL, V25, P2780, DOI 10.1016/j.cellsig.2013.09.008; Fakih MG, 2008, CANCER CHEMOTH PHARM, V62, P499, DOI 10.1007/s00280-007-0631-4; Finley JW, 2000, J NUTR, V130, P2384, DOI 10.1093/jn/130.9.2384; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Guo X, 2013, MOL CARCINOGEN, V52, P879, DOI 10.1002/mc.21933; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Itamochi H, 2002, OBSTET GYNECOL, V100, P281, DOI 10.1016/S0029-7844(02)02040-9; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kwintkiewicz J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096032; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Maillard I, 2003, CANCER CELL, V3, P203, DOI 10.1016/S1535-6108(03)00052-7; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Moon IJ, 2011, CLIN EXP OTORHINOLAR, V4, P11, DOI 10.3342/ceo.2011.4.1.11; OGURI S, 1988, J CLIN PHARMACOL, V28, P208, DOI 10.1002/j.1552-4604.1988.tb03134.x; Okur E, 2007, LARYNGOSCOPE, V117, P2183, DOI 10.1097/MLG.0b013e31813e6041; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Park JT, 2010, AM J PATHOL, V177, P1087, DOI 10.2353/ajpath.2010.100316; Qi YF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031539, 10.1371/journal.pone.0033859]; Qi YM, 2010, J BIOL CHEM, V285, P33010, DOI 10.1074/jbc.M110.137406; Qian XZ, 2006, MOL CANCER THER, V5, P2086, DOI 10.1158/1535-7163.MCT-06-0111; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Rocourt CRB, 2013, J NUTR BIOCHEM, V24, P781, DOI 10.1016/j.jnutbio.2012.04.011; Rose SL, 2009, INT J GYNECOL CANCER, V19, P564, DOI 10.1111/IGC.0b013e3181a12ed2; SHAMBERGER RJ, 1969, CAN MED ASSOC J, V100, P682; Song IS, 2004, MOL CANCER THER, V3, P1543; Steinbrenner H, 2013, ANTIOXID REDOX SIGN, V19, P181, DOI 10.1089/ars.2013.5246; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Uchida T, 2014, EXP HEMATOL, V42, P369, DOI 10.1016/j.exphem.2014.01.009; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang L, 2014, NUTR CANCER, V66, P295, DOI 10.1080/01635581.2014.868911; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wu L, 2004, J BIOL CHEM, V279, P12126, DOI 10.1074/jbc.M307097200; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781; Wu XJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-192; Yin ST, 2012, APOPTOSIS, V17, P388, DOI 10.1007/s10495-011-0687-9; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zeng HW, 2011, BIOL TRACE ELEM RES, V143, P1209, DOI 10.1007/s12011-010-8935-3; Zhang S, 2011, J NUTR BIOCHEM, V22, P1137, DOI 10.1016/j.jnutbio.2010.09.014	62	6	7	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101664	10.1371/journal.pone.0101664	http://dx.doi.org/10.1371/journal.pone.0101664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010594	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800031
J	Xu, FY; Zhou, GQ; Han, SL; Yuan, WG; Chen, S; Fu, ZK; Li, DL; Zhang, H; Li, DJ; Pang, D				Xu, Fengyan; Zhou, Guiqin; Han, Shaoli; Yuan, Weiguang; Chen, Shuang; Fu, Zhenkun; Li, Dalin; Zhang, Hua; Li, Dianjun; Pang, Da			Association of TNF-alpha, TNFRSF1A and TNFRSF1B Gene Polymorphisms with the Risk of Sporadic Breast Cancer in Northeast Chinese Han Women	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MULTIPLE-SCLEROSIS; FACTOR RECEPTOR; INFLAMMATION; EXPRESSION; PROMOTER; SUSCEPTIBILITY; BENIGN; SNPS; LTA	Background: The interaction of tumor necrosis factor-alpha (TNF-alpha) with its receptors: TNFRSF1A and TNFRSF1B is critical for the promotion of tumor growth, invasion and metastasis. To better understand the roles of single nucleotide polymorphisms (SNPs) in the TNF-alpha, TNFRSF1A and TNFRSF1B genes in the development of breast cancer, we explored the associations between SNPs in these three genes and breast cancer susceptibility in northeast Chinese Han women. Methodology/Principal Findings: This case-control study was conducted among 1016 breast cancer patients and 806 age-matched healthy controls. Seven SNPs in the TNF-alpha (rs1800629, rs361525), TNFRSF1A (rs767455, rs4149577 and rs1800693) and TNFRSF1B (rs1061622 and rs1061624) genes were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. In TNFRSF1B, the rs1061622 GT genotype and the G allele conferred a reduced susceptibility to breast cancer (P = 0.000662, OR = 0.706, 95% CI: 0.578-0.863; P = 0.002, OR = 0.769, 95% CI; 0.654-0.905, respectively). Moreover, the AG genotype, the AA genotype and the A allele in rs1061624 conferred an increased risk of breast cancer (P = 0.007, OR = 1.470, 95% CI: 1.112-1.943; P = 0.00109, OR = 1.405 95% CI: 1.145-1.724; P = 0.001, OR = 1.248 95% CI: 1.092-1.426, respectively). These two SNPs also had associations with breast cancer risk under the dominant model. In haplotype analysis, the CTA (rs767455 C-rs4149577 T-rs1800693 A) haplotype in TNFRSF1A and the TA (rs1061622 T-rs1061624 A) haplotype in TNFRSF1B had higher frequencies in breast cancer patients (P = 0.00324; P = 0.000370, respectively), but the frequency of GG (rs1061622 G-rs1061624 G) haplotype in TNFRSF1B was lower in breast cancer patients (P = 0.000251). The associations of the three haplotypes remained significant after correcting for multiple testing. In addition, significant associations were also observed between TNFRSF1A polymorphisms and lymph node metastasis, P53, estrogen receptor (ER) and progesterone receptor (PR) statuses. Conclusions: Our results suggest that rs1061622 and rs1061624 in TNFRSF1B may affect breast cancer risk, and SNPs in TNFRSF1A are associated with the clinical features of breast cancer.	[Xu, Fengyan] Harbin Med Univ, Dept Anat, Harbin, Peoples R China; [Zhou, Guiqin; Han, Shaoli; Chen, Shuang; Fu, Zhenkun; Zhang, Hua; Li, Dianjun] Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Yuan, Weiguang; Li, Dianjun] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China; [Li, Dalin; Pang, Da] Harbin Med Univ, Dept Surg, Affiliated Hosp 3, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, DJ (corresponding author), Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China.	dianjunli@163.com; pangdasir@163.com			National Natural Science Foundation of China [31070780]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (31070780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Davidson SI, 2011, ANN RHEUM DIS, V70, P289, DOI 10.1136/ard.2010.133322; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Fang F, 2010, BREAST CANCER RES TR, V122, P267, DOI 10.1007/s10549-009-0698-1; Ferguson LR, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/591704; Ferrajoli A, 2002, BLOOD, V100, P1215, DOI 10.1182/blood.V100.4.1215.h81602001215_1215_1219; Garcia-Tunon I, 2006, CANCER SCI, V97, P1044, DOI 10.1111/j.1349-7006.2006.00277.x; Gaudet MM, 2007, HUM GENET, V121, P483, DOI 10.1007/s00439-006-0315-x; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Guan XX, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-447; Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Int Multiple Sclerosis Genetics, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018813; Kamali-Sarvestani E, 2005, CANCER LETT, V223, P113, DOI 10.1016/j.canlet.2004.09.025; Karaderi T, 2012, CLIN EXP RHEUMATOL, V30, P110; Kohaar I, 2009, BREAST CANCER RES TR, V114, P347, DOI 10.1007/s10549-008-0006-5; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Leek RD, 1998, BRIT J CANCER, V77, P2246, DOI 10.1038/bjc.1998.373; Lejeune FJ, 1998, CURR OPIN IMMUNOL, V10, P573, DOI 10.1016/S0952-7915(98)80226-4; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; Mokrousov I, 2011, INFECT GENET EVOL, V11, P1312, DOI 10.1016/j.meegid.2011.04.025; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Ni B, 2014, PLOS ONE, V28; Park KS, 2002, EUR J IMMUNOGENET, V29, P7, DOI 10.1046/j.0960-7420.2001.00260.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pooja S, 2011, BREAST CANCER RES TR, V126, P739, DOI 10.1007/s10549-010-1175-6; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Steenholdt C, 2012, ALIMENT PHARM THER, V36, P650, DOI 10.1111/apt.12010; Stendahl M, 2006, CLIN CANCER RES, V12, P4614, DOI 10.1158/1078-0432.CCR-06-0248; Till A, 2005, J BIOL CHEM, V280, P5994, DOI 10.1074/jbc.M411541200; Tran TA, 1998, CANCER, V83, P276, DOI 10.1002/(SICI)1097-0142(19980715)83:2<276::AID-CNCR11>3.3.CO;2-5; Weiss RB, 2003, J CLIN ONCOL, V21, P1825, DOI 10.1200/JCO.2003.09.006; Xu FY, 2012, BREAST CANCER RES TR, V133, P1105, DOI 10.1007/s10549-012-1987-7; Yang Y, 2011, BREAST CANCER RES TR, V129, P513, DOI 10.1007/s10549-011-1494-2	40	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101138	10.1371/journal.pone.0101138	http://dx.doi.org/10.1371/journal.pone.0101138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010932	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800013
J	Kefayati, S; Milner, JS; Holdsworth, DW; Poepping, TL				Kefayati, Sarah; Milner, Jaques S.; Holdsworth, David W.; Poepping, Tamie L.			In Vitro Shear Stress Measurements Using Particle Image Velocimetry in a Family of Carotid Artery Models: Effect of Stenosis Severity, Plaque Eccentricity, and Ulceration	PLOS ONE			English	Article							INDUCED PLATELET ACTIVATION; BLOOD-MIMICKING FLUID; WALL SHEAR; TRANSITIONAL FLOW; BIFURCATION; RUPTURE; AGGREGATION; SIMULATION; THROMBOSIS; MORPHOLOGY	Atherosclerotic disease, and the subsequent complications of thrombosis and plaque rupture, has been associated with local shear stress. In the diseased carotid artery, local variations in shear stress are induced by various geometrical features of the stenotic plaque. Greater stenosis severity, plaque eccentricity (symmetry) and plaque ulceration have been associated with increased risk of cerebrovascular events based on clinical trial studies. Using particle image velocimetry, the levels and patterns of shear stress (derived from both laminar and turbulent phases) were studied for a family of eight matched-geometry models incorporating independently varied plaque features - i.e. stenosis severity up to 70%, one of two forms of plaque eccentricity, and the presence of plaque ulceration). The level of laminar (ensemble-averaged) shear stress increased with increasing stenosis severity resulting in 2-16 Pa for free shear stress (FSS) and approximately double (4-36 Pa) for wall shear stress (WSS). Independent of stenosis severity, marked differences were found in the distribution and extent of shear stress between the concentric and eccentric plaque formations. The maximum WSS, found at the apex of the stenosis, decayed significantly steeper along the outer wall of an eccentric model compared to the concentric counterpart, with a 70% eccentric stenosis having 249% steeper decay coinciding with the large outer-wall recirculation zone. The presence of ulceration (in a 50% eccentric plaque) resulted in both elevated FSS and WSS levels that were sustained longer (similar to 20 ms) through the systolic phase compared to the non-ulcerated counterpart model, among other notable differences. Reynolds (turbulent) shear stress, elevated around the point of distal jet detachment, became prominent during the systolic deceleration phase and was widely distributed over the large recirculation zone in the eccentric stenoses.	[Kefayati, Sarah; Poepping, Tamie L.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Milner, Jaques S.; Holdsworth, David W.; Poepping, Tamie L.] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada; [Holdsworth, David W.] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Poepping, TL (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON, Canada.	poepping@uwo.ca	Poepping, Tamie L/E-3015-2015; Holdsworth, David W/F-6315-2012	Poepping, Tamie L/0000-0002-4953-5204; Holdsworth, David W/0000-0002-0603-5322	Canada Foundation for Innovation (PIV system); Ontario Ministry of Research and Innovation (PIV system, Early Researcher Award), Heart and Stroke Foundation of Ontario [T-6427]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Training Fellowship in Vascular Research	Canada Foundation for Innovation (PIV system); Ontario Ministry of Research and Innovation (PIV system, Early Researcher Award), Heart and Stroke Foundation of Ontario; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Training Fellowship in Vascular Research(Canadian Institutes of Health Research (CIHR))	Financial support is acknowledged from the Canada Foundation for Innovation (PIV system) and Ontario Ministry of Research and Innovation (PIV system, Early Researcher Award), Heart and Stroke Foundation of Ontario (operating grant #T-6427), Natural Sciences and Engineering Research Council of Canada (Discovery Grant), S. K. was partially supported by a Canadian Institutes of Health Research Training Fellowship in Vascular Research. D. W. H. is the Dr. Sandy Kirkley Chair of Musculoskeletal Research in the Schulich School of Medicine and Dentistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu Y, 2007, ARTIF ORGANS, V31, P677, DOI 10.1111/j.1525-1594.2007.00446.x; [Anonymous], 1991, STROKE, V22, P816; Antiga L, 2009, BIORHEOLOGY, V46, P77, DOI 10.3233/BIR-2009-0538; Bark DL, 2010, J BIOMECH, V43, P2970, DOI 10.1016/j.jbiomech.2010.07.011; Bascom PAJ, 1997, ULTRASOUND MED BIOL, V23, P25, DOI 10.1016/S0301-5629(96)00171-8; Birchall D, 2006, EUR RADIOL, V16, P1074, DOI 10.1007/s00330-005-0048-6; Bluestein D, 2000, J BIOMECH ENG-T ASME, V122, P125, DOI 10.1115/1.429634; Bluestein D, 1999, ANN BIOMED ENG, V27, P763, DOI 10.1114/1.230; Buchmann NA, 2011, EXP FLUIDS, V50, P1131, DOI 10.1007/s00348-011-1042-1; Clemens MS, 2007, NEUROSURGERY, V61, P842, DOI [10.1227/01.NEU.0000280081.68618.22, 10.1227/01.NEU.0000280054.23770.3E]; COLANTUONI G, 1977, T AM SOC ART INT ORG, V23, P626; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Fisher M, 2005, STROKE, V36, P253, DOI 10.1161/01.STR.0000152336.71224.21; Ford MD, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2900724; Gijsen FJH, 2008, AM J PHYSIOL-HEART C, V295, pH1608, DOI 10.1152/ajpheart.01081.2007; Goldstein LB, 2003, STROKE, V34, P2767, DOI 10.1161/01.STR.0000097803.90702.31; Grinberg L, 2009, ANN BIOMED ENG, V37, P2200, DOI 10.1007/s10439-009-9769-z; Groen HC, 2007, STROKE, V38, P2379, DOI 10.1161/STROKEAHA.107.484766; Harloff A, 2013, EUR RADIOL; Heffernan KS, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.22; HELLUMS JD, 1994, ANN BIOMED ENG, V22, P445, DOI 10.1007/BF02367081; Holdsworth DW, 1999, PHYSIOL MEAS, V20, P219, DOI 10.1088/0967-3334/20/3/301; HOLDSWORTH DW, 1991, MED BIOL ENG COMPUT, V29, P565, DOI 10.1007/BF02446086; HOLDSWORTH RJ, 1995, EUR J VASC ENDOVASC, V9, P80, DOI 10.1016/S1078-5884(05)80229-1; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; HUNG TC, 1976, T AM SOC ART INT ORG, V22, P285; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Kaazempur-Mofrad MR, 2005, INT J HEAT MASS TRAN, V48, P4510, DOI 10.1016/j.ijheatmasstransfer.2005.05.004; Kahler CJ, 2012, EXP FLUIDS, V52, P1641, DOI 10.1007/s00348-012-1307-3; Kefayati S, 2014, J BIOMECH, V47, P253, DOI 10.1016/j.jbiomech.2013.09.007; Kefayati S, 2013, MED ENG PHYS, V35, P898, DOI 10.1016/j.medengphy.2012.08.020; KLANCHAR M, 1990, CIRC RES, V66, P1624, DOI 10.1161/01.RES.66.6.1624; Leach JR, 2010, ANN BIOMED ENG, V38, P2748, DOI 10.1007/s10439-010-0004-8; Lee SE, 2008, J BIOMECH, V41, P2551, DOI 10.1016/j.jbiomech.2008.03.038; Li FY, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-37; Lu PC, 2001, J BIOMECH, V34, P1361, DOI 10.1016/S0021-9290(01)00084-7; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Massai D, 2012, EUR J MECH B-FLUID, V35, P92, DOI 10.1016/j.euromechflu.2012.03.011; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Niu LL, 2012, CLIN PHYSIOL FUNCT I, V32, P323, DOI 10.1111/j.1475-097X.2012.01130.x; Ohara T, 2008, AM J NEURORADIOL, V29, P1200, DOI 10.3174/ajnr.A0997; Pedley TJ., 1980, FLUID MECH LARGE BLO; PERKTOLD K, 1995, J BIOMECH, V28, P845, DOI 10.1016/0021-9290(95)95273-8; Poelma C, 2012, EUR J MECH B-FLUID, V35, P70, DOI 10.1016/j.euromechflu.2012.03.003; Poepping TL, 2010, ULTRASOUND MED BIOL, V36, P1125, DOI 10.1016/j.ultrasmedbio.2010.02.005; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Ramnarine KV, 1998, ULTRASOUND MED BIOL, V24, P451, DOI 10.1016/S0301-5629(97)00277-9; RAMSTACK JM, 1979, J BIOMECH, V12, P113, DOI 10.1016/0021-9290(79)90150-7; Raschi M, 2012, INT J NUMER METH BIO, V28, P214, DOI 10.1002/cnm.1459; Raz S, 2007, ANN BIOMED ENG, V35, P493, DOI 10.1007/s10439-007-9257-2; REYNOLDS WC, 1972, J FLUID MECH, V54, P263, DOI 10.1017/S0022112072000679; Rothwell PM, 2000, STROKE, V31, P615, DOI 10.1161/01.STR.31.3.615; Rouleau L, 2010, J BIOMECH ENG, V132; Sadat U, 2010, EUR J VASC ENDOVASC, V40, P485, DOI 10.1016/j.ejvs.2010.07.015; SALLAM AM, 1984, BIORHEOLOGY, V21, P783; Schirmer CM, 2008, NEUROSURGERY, V63, P326, DOI 10.1227/01.NEU.0000313119.73941.9E; Schirmer CM, 2012, BRAIN BEHAV, V2, P42, DOI 10.1002/brb3.25; Shadden S, 2012, BIOMECH MODEL MECHAN, DOI [10.1007/s10237-012-0417-4:1-8, DOI 10.1007/S10237-012-0417-4:1-8]; Sheriff J, 2010, ANN BIOMED ENG, V38, P1442, DOI 10.1007/s10439-010-9936-2; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P456, DOI 10.1038/ncpcardio0298; Smith RF, 1999, JMRI-J MAGN RESON IM, V10, P533, DOI 10.1002/(SICI)1522-2586(199910)10:4<533::AID-JMRI6>3.0.CO;2-Z; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; Spencer A.J.M., 2004, CONTINUUM MECH, Vfirst; Steinman DA, 2000, ANN BIOMED ENG, V28, P415, DOI 10.1114/1.279; Stroud JS, 2002, J BIOMECH ENG-T ASME, V124, P9, DOI 10.1115/1.1427042; Tambasco M, 2003, ANN BIOMED ENG, V31, P1054, DOI 10.1114/1.1603257; Teng ZZ, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001028; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103; Vetel J, 2009, EXP FLUIDS, V46, P1067, DOI 10.1007/s00348-009-0615-8; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; WURZINGER LJ, 1985, THROMB HAEMOSTASIS, V54, P381; Xue YJ, 2008, ACTA RADIOL, V49, P558, DOI 10.1080/02841850801918548; Yousif MY, 2011, EXP FLUIDS, V50, P769, DOI 10.1007/s00348-010-0958-1; Zheng HR, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216875	74	25	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e98209	10.1371/journal.pone.0098209	http://dx.doi.org/10.1371/journal.pone.0098209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007248	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600002
J	Kim, Y; Escalante, AA; Schneider, KA				Kim, Yuseob; Escalante, Ananias A.; Schneider, Kristan A.			A Population Genetic Model for the Initial Spread of Partially Resistant Malaria Parasites under Anti-Malarial Combination Therapy and Weak Intrahost Competition	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DRUG-RESISTANCE; ARTEMISININ RESISTANCE; EVOLUTION; CHEMOTHERAPY; EMERGENCE; TRANSMISSION; ELIMINATION; MUTATIONS; SELECTION	To develop public-health policies that extend the lifespan of affordable anti-malarial drugs as effective treatment options, it is necessary to understand the evolutionary processes leading to the origin and spread of mutations conferring drug resistance in malarial parasites. We built a population-genetic model for the emergence of resistance under combination drug therapy. Reproductive cycles of parasites are specified by their absolute fitness determined by clinical parameters, thus coupling the evolutionary-genetic with population-dynamic processes. Initial mutations confer only partial drug-resistance. Therefore, mutant parasites rarely survive combination therapy and within-host competition is very weak among parasites. The model focuses on the early phase of such unsuccessful recurrent mutations. This ends in the rare event of mutants enriching in an infected individual from which the successful spread of resistance over the entire population is initiated. By computer simulations, the waiting time until the establishment of resistant parasites is analysed. Resistance spreads quickly following the first appearance of a host infected predominantly by mutant parasites. This occurs either through a rare transmission of a resistant parasite to an uninfected host or through a rare failure of drugs in removing "transient'' mutant alleles. The emergence of resistance is delayed with lower mutation rate, earlier treatment, higher metabolic cost of resistance, longer duration of high drug dose, and higher drug efficacy causing a stronger reduction in the sensitive and resistant parasites' fitnesses. Overall, contrary to other studies' proposition, the current model based on absolute fitness suggests that aggressive drug treatment delays the emergence of drug resistance.	[Kim, Yuseob] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Kim, Yuseob] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Escalante, Ananias A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Escalante, Ananias A.] Arizona State Univ, Ctr Evolutionary Med & Informat, Biodesign Inst, Tempe, AZ USA; [Schneider, Kristan A.] Univ Appl Sci, Dept Math, Mittweida, Germany	Ewha Womans University; Ewha Womans University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Kim, Y (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul, South Korea.	yuseob@ewha.ac.kr		Escalante, Ananias/0000-0002-1532-3430; Schneider, Kristan/0000-0003-4138-1180	National Research Foundation of Korea grants - Korean government (MEST) [20110001575]; Ewha Global Top5 of Ewha Womans University; WTZ [KR 05/2011]; U.S. National Institutes of Health [R01GM084320, 1U19AI089702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084320] Funding Source: NIH RePORTER	National Research Foundation of Korea grants - Korean government (MEST); Ewha Global Top5 of Ewha Womans University; WTZ; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Research Foundation of Korea grants funded by the Korean government (MEST) (Grant number: 20110001575) and by the Ewha Global Top5 Grant 2013 of Ewha Womans University to YK, the WTZ project KR 05/2011 to KS, and by the grants R01GM084320 and 1U19AI089702 from the U.S. National Institutes of Health to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2011, P ROY SOC B-BIOL SCI, V278, P1705, DOI 10.1098/rspb.2010.1907; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Consortium REX, 2013, TRENDS ECOL EVOL, V28, P111; CURTIS CF, 1986, T ROY SOC TROP MED H, V80, P889, DOI 10.1016/0035-9203(86)90248-8; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; DYE C, 1991, PARASITOL TODAY, V7, P236, DOI 10.1016/0169-4758(91)90236-H; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Ellegren H, 2009, EVOLUTION, V63, P301, DOI 10.1111/j.1558-5646.2008.00560.x; Escalante AA, 2009, TRENDS PARASITOL, V25, P557, DOI 10.1016/j.pt.2009.09.008; Gatton ML, 2002, AM J TROP MED HYG, V66, P467, DOI 10.4269/ajtmh.2002.66.467; Hastings I, 2011, TRENDS PARASITOL, V27, P67, DOI 10.1016/j.pt.2010.09.005; Hastings IM, 1997, PARASITOLOGY, V115, P133, DOI 10.1017/S0031182097001261; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Hastings IM, 2004, TRENDS PARASITOL, V20, P512, DOI 10.1016/j.pt.2004.08.006; Hastings IM, 2002, PHILOS T ROY SOC B, V357, P505, DOI 10.1098/rstb.2001.1036; Hastings IM, 1998, PARASITOLOGY, V117, P411, DOI 10.1017/S0031182098003291; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Hedrick P., 2011, GENETICS POPULATIONS; Huijben S, 2010, EVOLUTION, V64, P2952, DOI 10.1111/j.1558-5646.2010.01068.x; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; Klein EY, 2014, J THEOR BIOL, V340, P177, DOI 10.1016/j.jtbi.2013.09.022; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Mackinnon MJ, 1998, T ROY SOC TROP MED H, V92, P188, DOI 10.1016/S0035-9203(98)90745-3; Mackinnon MJ, 2005, ACTA TROP, V94, P207, DOI 10.1016/j.actatropica.2005.04.006; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Miotto O, 2013, NATURE GENETICS; Na-Bangchang K, 2013, EXPERT REV CLIN PHAR, V6, P307, DOI [10.1586/ecp.13.17, 10.1586/ECP.13.17]; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; PETERS W, 1990, PHARMACOL THERAPEUT, V47, P499, DOI 10.1016/0163-7258(90)90067-C; Pongtavornpinyo W, 2009, EVOL APPL, V2, P52, DOI 10.1111/j.1752-4571.2008.00067.x; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; White NJ, 1998, DRUG RESIST UPDATE, V1, P3, DOI 10.1016/S1368-7646(98)80208-2; WHO, 2010, GUID TREATM MAL, V2nd	44	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101601	10.1371/journal.pone.0101601	http://dx.doi.org/10.1371/journal.pone.0101601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007207	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600050
J	Rodriguez-Carballo, E; Gamez, B; Sedo-Cabezon, L; Sanchez-Feutrie, M; Zorzano, A; Manzanares-Cespedes, C; Rosa, JL; Ventura, F				Rodriguez-Carballo, Edgardo; Gamez, Beatriz; Sedo-Cabezon, Lara; Sanchez-Feutrie, Manuela; Zorzano, Antonio; Manzanares-Cespedes, Cristina; Rosa, Jose Luis; Ventura, Francesc			The p38 alpha MAPK Function in Osteoprecursors Is Required for Bone Formation and Bone Homeostasis in Adult Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; ACTIVATED PROTEIN-KINASE; MALE C57BL/6J MICE; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; TRABECULAR BONE; MOUSE SKELETON; BODY-WEIGHT; P38; PHOSPHORYLATION	Background: p38 MAPK activity plays an important role in several steps of the osteoblast lineage progression through activation of osteoblast-specific transcription factors and it is also essential for the acquisition of the osteoblast phenotype in early development. Although reports indicate p38 signalling plays a role in early skeletal development, its specific contributions to adult bone remodelling are still to be clarified. Methodology/Principal Findings: We evaluated osteoblast-specific deletion of p38 alpha to determine its significance in early skeletogenesis, as well as for bone homeostasis in adult skeleton. Early p38 alpha deletion resulted in defective intramembranous and endochondral ossification in both calvaria and long bones. Mutant mice showed reduction of trabecular bone volume in distal femurs, associated with low trabecular thickness. In addition, knockout mice also displayed decreased femoral cortical bone volume and thickness. Deletion of p38 alpha did not affect osteoclast function. Yet it impaired osteoblastogenesis and osteoblast maturation and activity through decreased expression of osteoblast-specific transcription factors and their targets. Furthermore, the inducible Cre system allowed us to control the onset of p38 alpha disruption after birth by removal of doxycycline. Deletion of p38 alpha at three or eight weeks postnatally led to significantly lower trabecular and cortical bone volume after 6 or 12 months. Conclusions: Our data demonstrates that, in addition to early skeletogenesis, p38 alpha is essential for osteoblasts to maintain their function in mineralized adult bone, as bone anabolism should be sustained throughout life. Moreover, our data also emphasizes that clinical development of p38 inhibitors should take into account their potential bone effects.	[Rodriguez-Carballo, Edgardo; Gamez, Beatriz; Sedo-Cabezon, Lara; Rosa, Jose Luis; Ventura, Francesc] Univ Barcelona, IDIBELL, Hosp Llobregat, Dept Ciencies Fisiol 2, E-08007 Barcelona, Spain; [Manzanares-Cespedes, Cristina] Univ Barcelona, IDIBELL, Hosp Llobregat, Dept Patol & Terapeut Expt, E-08007 Barcelona, Spain; [Sanchez-Feutrie, Manuela; Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Sanchez-Feutrie, Manuela; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Sanchez-Feutrie, Manuela; Manzanares-Cespedes, Cristina] CIBER Diabet Enfermedades Metab Asociadas CIBERDE, Inst Salud Carlos III, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Hosp Llobregat, Dept Ciencies Fisiol 2, E-08007 Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014; Céspedes, Maria Cristina Manzanares/H-5489-2015; Ventura, Francesc/ABG-2285-2020; Zorzano, Antonio/R-5479-2018; Sedo-Cabezon, Lara/H-5359-2015	Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Céspedes, Maria Cristina Manzanares/0000-0002-4585-4953; Ventura, Francesc/0000-0001-9673-9405; Sedo-Cabezon, Lara/0000-0003-0563-8903; Rodriguez-Carballo, Eddie/0000-0003-4321-508X	MEC (Ministry of Education of Spain) [BFU2011-24254]; La Marato de TV3	MEC (Ministry of Education of Spain); La Marato de TV3	This research was supported by grants from the MEC (Ministry of Education of Spain) (BFU2011-24254) and La Marato de TV3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2011, EUR J PAIN, V15, P1040, DOI 10.1016/j.ejpain.2011.04.005; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bidder M, 1998, J BONE MINER RES, V13, P609, DOI 10.1359/jbmr.1998.13.4.609; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Caverzasio J, 2008, J BONE MINER RES, V23, P1389, DOI 10.1359/JBMR.080410; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Fritton JC, 2008, J BONE MINER RES, V23, P663, DOI [10.1359/jbmr.080104, 10.1359/JBMR.080104]; Frost HM, 1999, J BONE MINER RES, V14, P1816, DOI 10.1359/jbmr.1999.14.11.1816; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Greenblatt M. B., 2013, ANN REV CELL DEV BIO; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; HANSON DA, 1992, J BONE MINER RES, V7, P1251; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; Joos H, 2010, BRIT J PHARMACOL, V160, P1252, DOI 10.1111/j.1476-5381.2010.00760.x; Ortuno MJ, 2013, BONE, V52, P548, DOI 10.1016/j.bone.2012.11.007; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kawano T, 2013, BONE, V52, P70, DOI 10.1016/j.bone.2012.09.024; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Maatta JA, 2013, FASEB J, V27, P478, DOI 10.1096/fj.12-213587; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI 10.1089/ten.TEA.2009.0738; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salazar VS, 2013, J CELL SCI, V126, P4974, DOI 10.1242/jcs.131953; Seeman E, 2001, Rev Endocr Metab Disord, V2, P45; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Thouverey C, 2012, CELL MOL LIFE SCI, V69, P3115, DOI 10.1007/s00018-012-0983-8; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	54	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102032	10.1371/journal.pone.0102032	http://dx.doi.org/10.1371/journal.pone.0102032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007355	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600089
J	Lynfield, R; Davey, R; Dwyer, DE; Losso, MH; Wentworth, D; Cozzi-Lepri, A; Herman-Lamin, K; Cholewinska, G; David, D; Kuetter, S; Ternesgen, Z; Uyeki, TM; Lane, HC; Lundgren, J; Neaton, JD				Lynfield, Ruth; Davey, Richard; Dwyer, Dominic E.; Losso, Marcelo H.; Wentworth, Deborah; Cozzi-Lepri, Alessandro; Herman-Lamin, Kathy; Cholewinska, Grazyna; David, Daniel; Kuetter, Stefan; Ternesgen, Zelalem; Uyeki, Timothy M.; Lane, H. Clifford; Lundgren, Jens; Neaton, James D.		INSIGHT Influenza Study Grp	Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies	PLOS ONE			English	Article							2009 H1N1 INFLUENZA; A H1N1; UNITED-STATES; HOSPITALIZED-PATIENTS; BACTERIAL; ILLNESS; ADULTS; RISK; SURVEILLANCE; COINFECTION	Background: Data from prospectively planned cohort studies on risk of major clinical outcomes and prognostic factors for patients with influenza A(H1N1)pdm09 virus are limited. In 2009, in order to assess outcomes and evaluate risk factors for progression of illness, two cohort studies were initiated: FLU 002 in outpatients and FLU 003 in hospitalized patients. Methods and Findings: Between October 2009 and December 2012, adults with influenza-like illness (ILI) were enrolled; outpatients were followed for 14 days and inpatients for 60 days. Disease progression was defined as hospitalization and/or death for outpatients, and hospitalization for >28 days, transfer to intensive care unit (ICU) if enrolled from general ward, and/or death for inpatients. Infection was confirmed by RT-PCR. 590 FLU 002 and 392 FLU 003 patients with influenza A(H1N1)pdm09 were enrolled from 81 sites in 17 countries at 2 days (IQR 1-3) and 6 days (IQR 4-10) following ILI onset, respectively. Disease progression was experienced by 29 (1 death) outpatients (5.1%; 95% CI: 3.4-7.2%) and 80 inpatients [death (32), hospitalization >28 days (43) or ICU transfer (20)] (21.6%; 95% CI: 17.5-26.2%). Disease progression (death) for hospitalized patients was 53.1% (26.6%) and 12.8% (3.8%), respectively, for those enrolled in the ICU and general ward. In pooled analyses for both studies, predictors of disease progression were age, longer duration of symptoms at enrollment and immunosuppression. Patients hospitalized during the pandemic period had a poorer prognosis than in subsequent seasons. Conclusions: Patients with influenza A(H1N1)pdm09, particularly when requiring hospital admission, are at high risk for disease progression, especially if they are older, immunodeficient, or admitted late in infection. These data reinforce the need for international trials of novel treatment strategies for influenza infection and serve as a reminder of the need to monitor the severity of seasonal and pandemic influenza epidemics globally.	[Lynfield, Ruth] Minnesota Dept Hlth, Div Infect Dis, St Paul, MN 55124 USA; [Davey, Richard; Lane, H. Clifford] NIAID, NIH, Bethesda, MD 20892 USA; [Dwyer, Dominic E.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Dept Virol, Westmead, NSW 2145, Australia; [Dwyer, Dominic E.] Univ Sydney, Westmead, NSW 2145, Australia; [Losso, Marcelo H.] Hosp Jose Maria Ramos Mejia, Dept Med, HIV Unit, Buenos Aires, DF, Argentina; [Wentworth, Deborah; Herman-Lamin, Kathy; Lundgren, Jens] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Cozzi-Lepri, Alessandro] UCL, Res Dept Infect & Populat Hlth, London, England; [Cholewinska, Grazyna] Hosp Infect Dis, Warsaw, Poland; [David, Daniel] Hosp Rawson, Cordoba, Argentina; [Kuetter, Stefan] Marlow Med Grp, Marlow, Bucks, England; [Ternesgen, Zelalem] Mayo Clin, Rochester, MN USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Lundgren, Jens] Univ Copenhagen Hosp, Dept Infect Dis, Rigshosp, DK-2100 Copenhagen, Denmark; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark	Minnesota Department of Health (MHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Sydney; University of Sydney; Hospital Ramos Mejia; University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; Mayo Clinic; Centers for Disease Control & Prevention - USA; Rigshospitalet; University of Copenhagen; University of Copenhagen	Lynfield, R (corresponding author), Minnesota Dept Hlth, Div Infect Dis, St Paul, MN 55124 USA.	Ruth.Lynfield@state.mn.us	Montejano, Rocio/H-5344-2017; Emery, Sean/J-3825-2017; Lundgren, Jens/AAE-6876-2019; Ostergaard, Lars/AAA-3020-2020; Montejano, Rocio/P-6141-2019; Emery, Sean/O-9122-2019; Soriano, Vicente/O-5730-2018	Montejano, Rocio/0000-0002-3446-0545; Emery, Sean/0000-0001-6072-8309; Ostergaard, Lars/0000-0003-2459-0511; Montejano, Rocio/0000-0002-3446-0545; Emery, Sean/0000-0001-6072-8309; Soriano, Vicente/0000-0002-4624-5199; Estrada, Vicente/0000-0002-7795-5986; Polenakovik, Hari/0000-0001-5793-5729; Carbone, Javier/0000-0003-2056-0534; Lundgren, Jens/0000-0001-8901-7850	Leidos Prime [HHSN261200800001E]; NCI/NIAID; Medical Research Council [MC_UU_12023/16, MC_U122886352] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000936, ZIAAI000984] Funding Source: NIH RePORTER; MRC [MC_UU_12023/16, MC_U122886352] Funding Source: UKRI	Leidos Prime; NCI/NIAID; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Leidos Prime Contract HHSN261200800001E, NCI/NIAID. The funders had no role in study design, data collection and analysis, decision to Funding: publish, or preparation of the manuscript.	Almond MH, 2013, THORAX, V68, P684, DOI 10.1136/thoraxjnl-2012-203009; [Anonymous], INFL SURV MON; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Centers for Disease Control and Prevention, SEAS INFL FLU; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517; Davey RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057121; Dwyer DE, 2011, VACCINE, V29, pB56, DOI 10.1016/j.vaccine.2011.04.105; Fleming DM, 2003, VACCINE, V21, P1749, DOI 10.1016/S0264-410X(03)00066-5; Food and Drug Administration, 2011, CLIN ANT INFL DEV DR; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Ison MG, 2010, J INFECT DIS, V201, P1654, DOI 10.1086/652498; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Joseph C, 2013, INFLUENZA OTHER RESP, V7, P105, DOI 10.1111/irv.12089; Karlsson EA, 2012, INFLUENZA OTHER RESP, V6, P449, DOI 10.1111/j.1750-2659.2012.00342.x; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Martin-Loeches I, 2011, CRIT CARE, V15, DOI 10.1186/cc10573; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ortiz JR, 2013, CRIT CARE MED, V41, P1345, DOI 10.1097/CCM.0b013e3182771386; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23; Sedyaningsih ER, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3039; Sheth Anandi N, 2011, Curr HIV/AIDS Rep, V8, P181, DOI 10.1007/s11904-011-0086-4; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Szewczuk E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-113; van Hoek AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017030; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Venkata C, 2010, MAYO CLIN PROC, V85, P798, DOI 10.4065/mcp.2010.0166; Viasus D, 2011, CLIN MICROBIOL INFEC, V17, P738, DOI 10.1111/j.1469-0691.2010.03362.x; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010	45	26	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101785	10.1371/journal.pone.0101785	http://dx.doi.org/10.1371/journal.pone.0101785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004134	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700065
J	Naganuma, T; Kihara, A				Naganuma, Tatsuro; Kihara, Akio			Two Modes of Regulation of the Fatty Acid Elongase ELOVL6 by the 3-Ketoacyl-CoA Reductase KAR in the Fatty Acid Elongation Cycle	PLOS ONE			English	Article							STARGARDT-3 MACULAR DYSTROPHY; SACCHAROMYCES-CEREVISIAE; PERMEABILITY BARRIER; MENTAL-RETARDATION; GENE; MUTATION; PROTEIN; CELLS; MICE; IDENTIFICATION	Fatty acids (FAs) are diverse molecules, and such diversity is important for lipids to exert their functions under several environmental conditions. FA elongation occurs at the endoplasmic reticulum and produces a variety of FA species; the FA elongation cycle consists of four distinct enzyme reactions. For this cycle to be driven efficiently, there must exist coordinated regulation of protein components of the FA elongation machinery. However, such regulation is poorly understood. In the present study, we performed biochemical analyses using the FA elongase ELOVL6 and the 3-ketoacyl-CoA reductase KAR, which catalyze the first and second steps of the FA elongation cycle, respectively. In vitro FA elongation assays using membrane fractions demonstrated that ELOVL6 activity was enhanced similar to 10-fold in the presence of NADPH, although ELOVL6 itself did not require NADPH for its catalysis. On the other hand, KAR does use NADPH as a reductant in its enzyme reaction. Activity of purified ELOVL6 was enhanced by similar to 3-fold in the presence of KAR. This effect was KAR enzyme activity-independent, since it was observed in the absence of NADPH and in the KAR mutant. However, ELOVL6 enzyme activity was further enhanced in a KAR enzyme activity-dependent manner. Therefore, KAR regulates ELOVL6 via two modes. In the first mode, KAR may induce conformational changes in ELOVL6 to become structure that can undergo catalysis. In the second mode, conversion of 3-ketoacyl-CoA to 3-hydroxyacyl-CoA by KAR may facilitate release of the product from the presumed ELOVL6-KAR complex.	[Naganuma, Tatsuro; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido 060, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita 12, Sapporo, Hokkaido 060, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788; Naganuma, Tatsuro/0000-0002-8653-5553	Japan Society for the Promotion of Science (JSPS) [26251010]; JSPS Fellows [25-744]; Grants-in-Aid for Scientific Research [26251010] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (A) (26251010) to AK from the Japan Society for the Promotion of Science (JSPS) and by a Grant-in-Aid for JSPS Fellows (25-744) to TN from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Kihara A, 2003, J BIOL CHEM, V278, P14578, DOI 10.1074/jbc.M211416200; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Konishi H, 2010, J BIOCHEM, V148, P617, DOI 10.1093/jb/mvq092; Li WM, 2007, INT J BIOL SCI, V3, P120; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; McMahon A, 2007, FEBS LETT, V581, P5459, DOI 10.1016/j.febslet.2007.10.050; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Naganuma T, 2011, FEBS LETT, V585, P3337, DOI 10.1016/j.febslet.2011.09.024; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okuda A, 2010, MOL VIS, V16, P2438; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Park H, 2010, J LIPID RES, V51, P480, DOI 10.1194/jlr.M000984; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Sunaga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3563; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Zadravec D, 2011, J LIPID RES, V52, P245, DOI 10.1194/jlr.M011346; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	42	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101823	10.1371/journal.pone.0101823	http://dx.doi.org/10.1371/journal.pone.0101823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003994	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700072
J	Tang, K; Luo, C; Li, Y; Lu, CS; Zhou, WQ; Huang, HH; Chen, XG				Tang, Ke; Luo, Can; Li, Yan; Lu, Chenshu; Zhou, Wanqi; Huang, Haihong; Chen, Xiaoguang			The Study of a Novel Sorafenib Derivative HLC-080 as an Antitumor Agent	PLOS ONE			English	Article							REFRACTORY SOLID TUMORS; FACTOR RECEPTOR INHIBITOR; RAF KINASE; MULTIKINASE INHIBITOR; COLORECTAL-CANCER; COLON-CANCER; HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; SIGNALING PATHWAY; IN-VIVO	In this study, our objective is to evaluate the potential of a novel Sorafenib derivative, named HLC-080, as a new anticancer agent for colon cancer. We firstly carried out MTT assay, colony formation assay, flow cytometry analysis and transwell invasion assay to determine effect of our compound HLC-080 on cell viability, anti-proliferation activity, cell cycle arrest and the intervention on cell invasion, respectively. On the other hand, in vivo antitumor activity of HLC-080 was also tested using H22 xenograft model and the angiogenesis effect of HLC-080 was measured by EA.hy926 tube formation assay. The expression levels of various proteins in HLC-080 treated with HT-29 cell lines were examined using Western blot and ELISA experiments. The results showed that HLC-080 could dramatically inhibit the growth and colony formation of various tumor cells, therefore exhibited remarkable antitumor activity. HLC-080 can induce cell cycle arrest at G1 phase in HT-29 cells and subsequently inhibit the invasive potential of colon cancer cells. HLC-080 also exhibits anti-angiogenesis effect in EA.hy926 model. Additionally, the in vivo study showed that HLC-080 was able to reduced the tumor weight with the rate of 35.81%. And at the concentration of 0.352 +/- 0.034 mu M, HLC-080 is able to reduce half of the regular protein level of p-c-Raf (Ser259), consequently block Raf/MEK/ERK signaling in HT-29 cell lines. In conclusion, our study suggests that Sorafenib derivative HLC-080 has the potential to inhibit cell proliferation and angiogenesis, Since, HLC-080 is particularly active against human colon cancer cells, our study highlights that HLC-080 and its related analogues may serve as a new anti-cancer drug, particularly against colon cancer.	[Tang, Ke; Luo, Can; Li, Yan; Lu, Chenshu; Zhou, Wanqi; Huang, Haihong; Chen, Xiaoguang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Tang, Ke; Luo, Can; Li, Yan; Lu, Chenshu; Zhou, Wanqi; Huang, Haihong; Chen, Xiaoguang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, HH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	joyce@imm.ac.cn; chxg@imm.ac.cn			National Science AMP; Technology Major Project [2009ZX09301-003-9-1]	National Science AMP; Technology Major Project	This subject was financially supported by the National Science & Technology Major Project (2009ZX09301-003-9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2013, CURR PHARM IN PRESS; Al-Marrawi MY, 2013, CANCER BIOL THER, V14, P703, DOI 10.4161/cbt.25191; Chaparro M, 2008, ALIMENT PHARM THER, V28, P1269, DOI 10.1111/j.1365-2036.2008.03857.x; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Dahut WL, 2008, CLIN CANCER RES, V14, P209, DOI 10.1158/1078-0432.CCR-07-1355; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dent P, 2013, CANCER BIOL THER, V14, P877, DOI 10.4161/cbt.26176; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Guruvayoorappan C, 2008, IMMUNOPHARM IMMUNOT, V30, P711, DOI 10.1080/08923970802278276 ; Huang D, 2006, CANCER LETT, V233, P289, DOI 10.1016/j.canlet.2005.03.019; Joudeh J, 2013, ADV EXP MED BIOL, V779, P1, DOI 10.1007/978-1-4614-6176-0_1; Komorowski J, 2006, LIFE SCI, V78, P2558, DOI 10.1016/j.lfs.2005.10.016; Li M, 2005, WORLD J GASTROENTERO, V11, P4685, DOI 10.3748/wjg.v11.i30.4685; Li QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033379; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Luo C, 2013, SCI CHINA CHEM, V56, P1564, DOI 10.1007/s11426-013-4903-z; Luo WJ, 2013, J CELL MOL MED, V17, P1316, DOI 10.1111/jcmm.12108; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011; Mo SY, 2004, J NAT PROD, V67, P823, DOI 10.1021/np030505d; Moore M, 2005, ANN ONCOL, V16, P1688, DOI 10.1093/annonc/mdi310; Nelson VM, 2013, J GASTROINTEST ONCOL, V4, P245, DOI 10.3978/j.issn.2078-6891.2013.035; Olsen Sonja K, 2010, Therap Adv Gastroenterol, V3, P55, DOI 10.1177/1756283X09346669; Pignochino Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-118; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Reimann Manja, 2013, Exp Transl Stroke Med, V5, P7, DOI 10.1186/2040-7378-5-7; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; [唐克 Tang Ke], 2011, [中国新药杂志, Chinese Journal New Drugs], V20, P2434; Wang XQ, 2011, INT J PHARMACEUT, V419, P339, DOI 10.1016/j.ijpharm.2011.08.003; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wu DD, 2010, PEPTIDES, V31, P850, DOI 10.1016/j.peptides.2010.01.007; Xu RH, 2010, CHINA PHARM, V14, P1254; Xu YF, 2007, EUR J PHARMACOL, V564, P1, DOI 10.1016/j.ejphar.2007.01.086; Yao Z, 2006, PEPTIDES, V27, P1167, DOI 10.1016/j.peptides.2005.02.026; Yoon JH, 2002, CANCER RES, V62, P6500; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Yu M, 2012, THER ADV GASTROENTER, V5, P319, DOI 10.1177/1756283X12448456; Yuan F, 2008, EUR J PHARM BIOPHARM, V70, P770, DOI 10.1016/j.ejpb.2008.06.028; Zhou AP, 2006, ONCOLOGY PROGR, V6, P529	43	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101889	10.1371/journal.pone.0101889	http://dx.doi.org/10.1371/journal.pone.0101889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004130	Green Published, Green Submitted, gold			2022-12-25	WOS:000339242700082
J	Bhavsar, RB; Tsonis, PA				Bhavsar, Rital B.; Tsonis, Panagiotis A.			Exogenous Oct-4 Inhibits Lens Transdifferentiation in the Newt Notophthalmus viridescens	PLOS ONE			English	Article							REGENERATION; CELL; EXPRESSION	From the cocktail of four factors that were able to induce pluripotent stem cells from differentiated cells, Oct-4, c-Myc, Sox-2 and Klf4, only Oct-4 was not expressed during regeneration in newts. To explore the possible action of this stemness factor we developed an assay where we introduced exogenous Oct-4 protein to an in vitro system for lens regeneration in newts. We found that exogenous Oct-4 inhibits differentiation of iris pigmented epithelial cells into lens cells and also regulates Sox-2 and Pax-6, both important players during lens development. Thus, presence of Oct-4 hinders transdifferentiation of iris cells.	[Tsonis, Panagiotis A.] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; Univ Dayton, Ctr Tissue Regenerat & Engn, Dayton, OH 45469 USA	University of Dayton; University of Dayton	Tsonis, PA (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	ptsonis1@udayton.edu			National Eye Institute grant [10540]	National Eye Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute grant 10540 to PAT. URL: https://www.nei.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Bhavsar RB, 2011, JOVE-J VIS EXP, DOI 10.3791/2713; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Dang CV, 1999, MOL CELL BIOL, V19, P1; Hoffmann A, 2013, TISSUE ENG C; Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk; Madhavan M, 2006, P NATL ACAD SCI USA, V103, P14848, DOI 10.1073/pnas.0601949103; Makarev E, 2007, FEBS LETT, V581, P1865, DOI 10.1016/j.febslet.2007.03.082; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Neff AW, 2011, DEV DYNAM, V240, P979, DOI 10.1002/dvdy.22554; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Sterneckert J, 2012, STEM CELLS, V30, P15, DOI 10.1002/stem.765; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	14	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102510	10.1371/journal.pone.0102510	http://dx.doi.org/10.1371/journal.pone.0102510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019378	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600088
J	Cushnie, EK; Ulery, BD; Nelson, SJ; Deng, M; Sethuraman, S; Doty, SB; Lo, KWH; Khan, YM; Laurencin, CT				Cushnie, Emily K.; Ulery, Bret D.; Nelson, Stephen J.; Deng, Meng; Sethuraman, Swaminathan; Doty, Stephen B.; Lo, Kevin W. H.; Khan, Yusuf M.; Laurencin, Cato T.			Simple Signaling Molecules for Inductive Bone Regenerative Engineering	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; TISSUE; CELLS; FRACTURES; COMPOSITE; SCAFFOLDS; REPAIR; HYDROXYAPATITE; DEGRADATION; MATRICES	With greater than 500,000 orthopaedic procedures performed in the United States each year requiring a bone graft, the development of novel graft materials is necessary. We report that some porous polymer/ceramic composite scaffolds possess intrinsic osteoinductivity as shown through their capacity to induce in vivo host osteoid mineralization and in vitro stem cell osteogenesis making them attractive synthetic bone graft substitutes. It was discovered that certain low crystallinity ceramics partially dissociate into simple signaling molecules (i.e., calcium and phosphate ions) that induce stem cells to endogenously produce their own osteoinductive proteins. Review of the literature has uncovered a variety of simple signaling molecules (i.e., gases, ions, and redox reagents) capable of inducing other desirable stem cell differentiation through endogenous growth factor production. Inductive simple signaling molecules, which we have termed inducerons, represent a paradigm shift in the field of regenerative engineering where they can be utilized in place of recombinant protein growth factors.	[Ulery, Bret D.; Deng, Meng; Lo, Kevin W. H.; Khan, Yusuf M.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA; [Ulery, Bret D.; Deng, Meng; Khan, Yusuf M.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Ctr Biol Phys & Engn Sc, Farmington, CT USA; [Cushnie, Emily K.] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA; [Ulery, Bret D.; Deng, Meng; Khan, Yusuf M.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT USA; [Nelson, Stephen J.] Univ Connecticut, Ctr Hlth, Sch Med, Farmington, CT USA; [Sethuraman, Swaminathan] SASTRA Univ, Sch Chem & Biotechnol, Ctr Nanotechnol & Adv Biomat, Thanjavur, Tamil Nadu, India; [Doty, Stephen B.] Hosp Special Surg, New York, NY 10021 USA; [Lo, Kevin W. H.] Univ Connecticut, Ctr Hlth, Dept Med, Div Endocrinol, Farmington, CT USA; [Khan, Yusuf M.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT USA; [Laurencin, Cato T.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Virginia; University of Connecticut; University of Connecticut; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); University of Connecticut; University of Connecticut; University of Connecticut	Laurencin, CT (corresponding author), Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA.	Laurencin@uchc.edu		Khan, Yusuf/0000-0003-3792-3477	National Institutes of Health [R21AR062771, R21AR060480, R01AR052536]; National Science Foundation [EFRI0736002]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052536, R21AR060480, R21AR062771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the National Institutes of Health (Grant No. R21AR062771, Grant No. R21AR060480, and Grant No. R01AR052536) (www.nih.gov) and the National Science Foundation (Grant No. EFRI0736002) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrosio AM, 2001, J BIOMEDICAL MAT RES, V58, P295; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267; Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5; Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5; Brinker MR, 2004, J BONE JOINT SURG AM, V86A, P290, DOI 10.2106/00004623-200402000-00011; Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.tea.2010.0160, 10.1089/ten.TEA.2010.0160]; Chen NF, 2010, J NEUROSURG-SPINE, V12, P40, DOI 10.3171/2009.4.SPINE0876; Cushnie EK, 2008, J BIOMED MATER RES A, V84A, P54, DOI 10.1002/jbm.a.31380; Cushnie EK, 2010, J BIOMED MATER RES A, V94A, P568, DOI 10.1002/jbm.a.32722; Deng M, 2011, MRS P, V1417; Ensor CR, 2011, PHARMACOTHERAPY, V31, P1111, DOI 10.1592/phco.31.11.1111; Fasolis M, 2012, OR SURG OR MED OR PA, V114, P586, DOI 10.1016/j.oooo.2012.01.038; Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311; GlobalData, 2011, MARK RES REP; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Graham SM, 2010, EXPERT OPIN BIOL TH, V10, P885, DOI 10.1517/14712598.2010.481669; HOLDEN JL, 1995, J BONE MINER RES, V10, P1400; Hwang CJ, 2009, J NEUROSURG-SPINE, V10, P443, DOI 10.3171/2009.1.SPINE08473; Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023; Kanakaris NK, 2008, INJURY, V39, pS83, DOI 10.1016/S0020-1383(08)70019-6; Kappe T, 2010, CELL TISSUE BANK, V11, P253, DOI 10.1007/s10561-009-9140-5; Khan YM, 2004, J BIOMED MATER RES A, V69A, P728, DOI 10.1002/jbm.a.30051; Khan YM, 2007, J MATER SCI, V42, P4183, DOI 10.1007/s10853-006-0636-0; Lin FH, 1999, ARTIF ORGANS, V23, P186, DOI 10.1046/j.1525-1594.1999.06164.x; Mayer H, 1996, CALCIFIED TISSUE INT, V58, P249; Nauth A, 2009, INJURY, V40, P27; Pollock R, 2008, EUR SPINE J, V17, P845, DOI 10.1007/s00586-008-0648-3; Pramanik S., 2005, TRENDS BIOMATERIALS, V19, P46; Rupani A, 2012, J BIOMED MATER RES A, V100A, P1089, DOI 10.1002/jbm.a.34037; Singhatanadgit W, 2008, INT J BIOCHEM CELL B, V40, P2854, DOI 10.1016/j.biocel.2008.06.005; US Department of Health and Human Services, ORG PROC TRANSPL NET; Ylinen P, 2002, INT J ORAL MAX SURG, V31, P405, DOI 10.1054/ijom.2002.0252; Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	35	29	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101627	10.1371/journal.pone.0101627	http://dx.doi.org/10.1371/journal.pone.0101627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019622	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600020
J	Yu, ER; Fan, CC; Yang, QY; Li, XD; Wan, BX; Dong, YN; Wang, XM; Zhou, YM				Yu, Erru; Fan, Chuchuan; Yang, Qingyong; Li, Xiaodong; Wan, Bingxi; Dong, Yanni; Wang, Xuemin; Zhou, Yongming			Identification of Heat Responsive Genes in Brassica napus Siliques at the Seed-Filling Stage through Transcriptional Profiling	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; ARABIDOPSIS-THALIANA; ACQUIRED THERMOTOLERANCE; REACTIVE OXYGEN; SHOCK PROTEINS; KEY REGULATOR; ABSCISIC-ACID; EXPRESSION; TOLERANCE; ETHYLENE	High temperature stress results in yield loss and alterations to seed composition during seed filling in oilseed rape (Brassica napus). However, the mechanism underlying this heat response is poorly understood. In this study, global transcription profiles of 20 d-old siliques of B. napus were analyzed after heat stress using a Brassica 95k EST microarray. The up-regulated genes included many HSF/HSP transcripts and other heat-related marker genes, such as ROF2, DREB2a, MBF1c and Hsa32, reflecting the conservation of key heat resistance factors among plants. Other up-regulated genes were preferentially expressed in heat-stressed silique walls or seeds, including some transcription factors and potential developmental regulators. In contrast, down-regulated genes differed between the silique wall and seeds and were largely tied to the biological functions of each tissue, such as glucosinolate metabolism in the silique wall and flavonoid synthesis in seeds. Additionally, a large proportion (one-third) of these differentially expressed genes had unknown functions. Based on these gene expression profiles, Arabidopsis mutants for eight heat-induced Brassica homologous genes were treated with different heat stress methods, and thermotolerance varied with each mutation, heat stress regimen and plant development stage. At least two of the eight mutants exhibited sensitivity to the heat treatments, suggesting the importance of the respective genes in responding to heat stress. In summary, this study elucidated the molecular bases of the heat responses in siliques during later reproductive stages and provides valuable information and gene resources for the genetic improvement of heat tolerance in oilseed rape breeding.	[Yu, Erru; Fan, Chuchuan; Yang, Qingyong; Li, Xiaodong; Wan, Bingxi; Dong, Yanni; Zhou, Yongming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Li, Xiaodong] Guizhou Acad Agr Sci, Guizhou Inst Prataculture, Guiyang, Guizhou, Peoples R China; [Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Huazhong Agricultural University; Guizhou Academy of Agricultural Sciences; University of Missouri System; University of Missouri Saint Louis	Zhou, YM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	ymzhou@mail.hzau.edu.cn	Wang, Xuemin/M-2853-2013	Fan, Chuchuan/0000-0001-8443-7194; wang, xuemin/0000-0002-6251-6745; Yang, Qing-Yong/0000-0002-3510-8906	National Natural Science Foundation of China [30900787, 31171188]; Ministry of Agriculture of China [nycytx-00503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by National Natural Science Foundation of China (No. 30900787 and 31171188), and Ministry of Agriculture of China (nycytx-00503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksouh-Harradj NM, 2006, CAN J PLANT SCI, V86, P967, DOI 10.4141/P05-130; Angadi SV, 2000, CAN J PLANT SCI, V80, P693, DOI 10.4141/P99-152; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Cao MJ, 2013, PLANT J, V73, P607, DOI 10.1111/tpj.12059; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Charng YY, 2006, PLANT PHYSIOL, V140, P1297, DOI 10.1104/pp.105.074898; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; DEBOUILLE P, 1989, PLANT PHYSIOL, V90, P876, DOI 10.1104/pp.90.3.876; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; FOWLER DB, 1970, CAN J PLANT SCI, V50, P233, DOI 10.4141/cjps70-047; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Gan Y, 2004, CAN J PLANT SCI, V84, P697, DOI 10.4141/P03-109; Giorno Filomena, 2013, Plants-Basel, V2, P489, DOI 10.3390/plants2030489; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Guan M, 2012, PLANT CELL REP, V31, P929, DOI 10.1007/s00299-011-1213-9; Hall A.E., 1992, PLANT BREEDING REV, P129, DOI DOI 10.1002/9780470650011.CH5; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; Huang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-256; Jenkins ME, 1997, PLANT PHYSIOL, V115, P1351, DOI 10.1104/pp.115.4.1351; JOHNSONFLANAGAN AM, 1994, PLANT PHYSIOL, V106, P601, DOI 10.1104/pp.106.2.601; JONSSON R, 1977, HEREDITAS, V87, P205; KITTOCK DL, 1988, J AGRON CROP SCI, V161, P305, DOI 10.1111/j.1439-037X.1988.tb00673.x; Ko CB, 2007, PLANT PHYSIOL BIOCH, V45, P722, DOI 10.1016/j.plaphy.2007.07.010; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kuno N, 2003, PLANT CELL, V15, P2476, DOI 10.1105/tpc.014217; Kutcher HR, 2010, AGR FOREST METEOROL, V150, P161, DOI 10.1016/j.agrformet.2009.09.011; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Liu JJ, 2013, PLANT PHYSIOL, V162, P512, DOI 10.1104/pp.112.205864; Lomascolo A, 2012, APPL MICROBIOL BIOT, V95, P1105, DOI 10.1007/s00253-012-4250-6; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Meiri D, 2010, PLANT MOL BIOL, V72, P191, DOI 10.1007/s11103-009-9561-3; Morrison MJ, 2002, CROP SCI, V42, P797, DOI 10.2135/cropsci2002.0797; MORRISON MJ, 1993, CAN J BOT, V71, P303, DOI 10.1139/b93-031; MURPHY DJ, 1989, J PLANT PHYSIOL, V135, P63, DOI 10.1016/S0176-1617(89)80225-1; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Nesi N, 2009, PLANT CELL REP, V28, P601, DOI 10.1007/s00299-008-0667-x; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nishizawa-Yokoi A, 2009, BIOSCI BIOTECH BIOCH, V73, P890, DOI 10.1271/bbb.80809; Noh YS, 1999, PLANT MOL BIOL, V41, P195, DOI 10.1023/A:1006389803990; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Oshino T, 2007, MOL GENET GENOMICS, V278, P31, DOI 10.1007/s00438-007-0229-x; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Park CH, 2010, PHYTOCHEMISTRY, V71, P380, DOI 10.1016/j.phytochem.2009.11.003; Park HY, 2011, BIOCHEM BIOPH RES CO, V414, P135, DOI 10.1016/j.bbrc.2011.09.039; PAULSEN GM, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P365; Peltonen-Sainio P, 2010, AGR ECOSYST ENVIRON, V139, P483, DOI 10.1016/j.agee.2010.09.006; Poschet G, 2011, PLANT PHYSIOL, V157, P1664, DOI 10.1104/pp.111.186825; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Redovnikovic IR, 2012, PLANT PHYSIOL BIOCH, V53, P77, DOI 10.1016/j.plaphy.2012.01.015; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Rose J, 2008, U.S. Patent Application, Patent No. [12/665,893, 12665893]; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Rozwadowski K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-88; SAINI HS, 1983, AUST J PLANT PHYSIOL, V10, P137, DOI 10.1071/PP9830137; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; SCHOPER JB, 1987, CROP SCI, V27, P27, DOI 10.2135/cropsci1987.0011183X002700010007x; Schramm F, 2008, PLANT J, V53, P264, DOI 10.1111/j.1365-313X.2007.03334.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tanabe N, 2007, PLANT CELL PHYSIOL, V48, P1036, DOI 10.1093/pcp/pcm069; TAYO TO, 1975, J AGR SCI-CAMBRIDGE, V85, P103, DOI 10.1017/S0021859600053466; Thomas J, 2012, PLANT J, V72, P935, DOI 10.1111/tpj.12004; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Tsutsui T, 2009, J PLANT RES, V122, P633, DOI 10.1007/s10265-009-0252-6; VANDEYNZE AE, 1993, CAN J PLANT SCI, V73, P383; Vivian-Smith A, 1999, PLANT PHYSIOL, V121, P437, DOI 10.1104/pp.121.2.437; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; WANG XM, 1988, PHYSIOL PLANTARUM, V72, P127, DOI 10.1111/j.1399-3054.1988.tb06633.x; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; WHITECROSS MI, 1972, AUST J BOT, V20, P87, DOI 10.1071/BT9720087; Wingenter K, 2010, PLANT PHYSIOL, V154, P665, DOI 10.1104/pp.110.162040; WORKMAN C, 2002, GENOME BIOL, V0003; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yang KA, 2006, PLANT SCI, V171, P175, DOI 10.1016/j.plantsci.2006.03.013; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yoshimura K, 2011, PLANT CELL PHYSIOL, V52, P1786, DOI 10.1093/pcp/pcr115; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038; Yu BY, 2010, PLANT SCI, V178, P381, DOI 10.1016/j.plantsci.2010.02.007; Yu HD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002669; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; ZANEWICH KP, 1993, J PLANT GROWTH REGUL, V12, P41, DOI 10.1007/BF00193677; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652	98	33	38	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101914	10.1371/journal.pone.0101914	http://dx.doi.org/10.1371/journal.pone.0101914			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013950	gold, Green Published			2022-12-25	WOS:000339378400046
J	Harvig, L; Frei, KM; Price, TD; Lynnerup, N				Harvig, Lise; Frei, Karin Margarita; Price, T. Douglas; Lynnerup, Niels			Strontium Isotope Signals in Cremated Petrous Portions as Indicator for Childhood Origin	PLOS ONE			English	Article							BONE; PATTERNS; TEETH	Dental enamel is currently of high informative value in studies concerning childhood origin and human mobility because the strontium isotope ratio in human dental enamel is indicative of geographical origin. However, many prehistoric burials involve cremation and although strontium retains its original biological isotopic composition, even when exposed to very high temperatures, intact dental enamel is rarely preserved in cremated or burned human remains. When preserved, fragments of dental enamel may be difficult to recognize and identify. Finding a substitute material for strontium isotope analysis of burned human remains, reflecting childhood values, is hence of high priority. This is the first study comparing strontium isotope ratios from cremated and non-cremated petrous portions with enamel as indicator for childhood origin. We show how strontium isotope ratios in the otic capsule of the petrous portion of the inner ear are highly correlated with strontium isotope ratios in dental enamel from the same individual, whether inhumed or cremated. This implies that strontium isotope ratios in the petrous bone, which practically always survives cremation, are indicative of childhood origin for human skeletal remains. Hence, the petrous bone is ideal as a substitute material for strontium isotope analysis of burned human remains.	[Harvig, Lise; Lynnerup, Niels] Univ Copenhagen, Fac Hlth Sci, Dept Forens Med, Lab Biol Anthropol, Copenhagen, Denmark; [Frei, Karin Margarita] Natl Museum Denmark, Conservat & Nat Sci Dept, Copenhagen, Denmark; [Frei, Karin Margarita] Danish Natl Res Fdn, Ctr Text Res CTR Prinsens Palae, Copenhagen, Denmark; [Price, T. Douglas] Univ Wisconsin, Lab Archaeol Chem, Madison, WI USA	University of Copenhagen; Danmarks Grundforskningsfond; University of Wisconsin System; University of Wisconsin Madison	Lynnerup, N (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Forens Med, Lab Biol Anthropol, Copenhagen, Denmark.	nly@sund.ku.dk			Elisabeth Munksgaard Foundation; Danish National Research Foundation (DNRF) [64]; European Union / ERC [269442]	Elisabeth Munksgaard Foundation; Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); European Union / ERC(European Research Council (ERC))	We thank the Elisabeth Munksgaard Foundation for funding the actual Sr Isotope analyses. K.M.F. thanks The Danish National Research Foundation (DNRF Grant Number-64) and European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 269442 (THE RISE) for financial support and Robert Frei for access to the laboratory facilities at the Danish Center for Isotope Geology, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley RA, 2005, ARCHAEOMETRY, V47, P629, DOI 10.1111/j.1475-4754.2005.00223.x; Bohnert M, 1997, FORENSIC SCI INT, V87, P55, DOI 10.1016/S0379-0738(97)02136-1; Dolphin AE, 2005, AM J PHYS ANTHROPOL, V128, P878, DOI 10.1002/ajpa.20213; Frei KM, 2011, APPL GEOCHEM, V26, P325, DOI 10.1016/j.apgeochem.2010.12.006; Frei KM, 2012, ARCHAEOL ANTHROP SCI, V4, P103, DOI 10.1007/s12520-011-0087-7; Frisch T, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/000348940010900106; Harbeck M, 2011, FORENSIC SCI INT, V204, P191, DOI 10.1016/j.forsciint.2010.06.004; HILLSON S, 1996, DENT ANTHR; HORWITZ EP, 1992, SOLVENT EXTR ION EXC, V10, P313, DOI 10.1080/07366299208918107; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jorkov MLS, 2009, AM J PHYS ANTHROPOL, V138, P199, DOI 10.1002/ajpa.20919; Montgomery J, 2010, ANN HUM BIOL, V37, P325, DOI 10.3109/03014461003649297; Price T, 2013, APPL GEOCHEM, V9, P413; Price TD, 2012, J ARCHAEOL SCI, V39, P3714, DOI 10.1016/j.jas.2012.06.015; Price TD, 2011, ANTIQUITY, V85, P476, DOI 10.1017/S0003598X00067880; Price TD, 2013, DANISH J ARCHAEOLOGY, V1, P93; Schmidt CW, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P55, DOI 10.1016/B978-012372510-3.50005-8; Schweissing MM, 2003, J ARCHAEOL SCI, V30, P1373, DOI 10.1016/S0305-4403(03)00025-6; Sorensen MS., 1994, ACTA OTOLARYNGOL, V114, P5, DOI [10.3109/00016489409127318, DOI 10.3109/00016489409127318]; Sorensen MS, 1997, KUGLER PUBLICATIONS, P23; Symes SA, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P15, DOI 10.1016/B978-012372510-3.50004-6; Ubelaker DH, 1999, ANN ARCHAEOLOGY, V2; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125	23	47	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101603	10.1371/journal.pone.0101603	http://dx.doi.org/10.1371/journal.pone.0101603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010496	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800030
J	Minois, N; Rockenfeller, P; Smith, TK; Carmona-Gutierrez, D				Minois, Nadege; Rockenfeller, Patrick; Smith, Terry K.; Carmona-Gutierrez, Didac			Spermidine Feeding Decreases Age-Related Locomotor Activity Loss and Induces Changes in Lipid Composition	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; DROSOPHILA-MELANOGASTER; STRESS RESISTANCE; AUTOPHAGY; POLYAMINES; LONGEVITY; RAPAMYCIN; RESVERATROL; SURVIVAL; HEALTH	Spermidine is a natural polyamine involved in many important cellular functions, whose supplementation in food or water increases life span and stress resistance in several model organisms. In this work, we expand spermidine's range of age-related beneficial effects by demonstrating that it is also able to improve locomotor performance in aged flies. Spermidine's mechanism of action on aging has been primarily related to general protein hypoacetylation that subsequently induces autophagy. Here, we suggest that the molecular targets of spermidine also include lipid metabolism: Spermidine-fed flies contain more triglycerides and show altered fatty acid and phospholipid profiles. We further determine that most of these metabolic changes are regulated through autophagy. Collectively, our data suggests an additional and novel lipid-mediated mechanism of action for spermidine-induced autophagy.	[Minois, Nadege; Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Rockenfeller, Patrick; Carmona-Gutierrez, Didac] Graz Univ, Inst Mol Biosci, Graz, Austria	University of St Andrews; University of Graz	Minois, N (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews, Fife, Scotland.	nm61@st-andrews.ac.uk; carmonag@uni-graz.at		Carmona-Gutierrez, Didac/0000-0001-7548-7771	TKS Wellcome Trust [093228]; FWF [P23490, P24381, I1000]	TKS Wellcome Trust(Wellcome Trust); FWF(Austrian Science Fund (FWF))	This work was supported in part by TKS Wellcome Trust grant 093228. DCG and PR are grateful to the FWF for grants LIPOTOX, P23490, P24381, and I1000 (DACH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Banerjee KK, 2012, AGING-US, V4, P206, DOI 10.18632/aging.100435; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bennetzen MV, 2012, CELL CYCLE, V11, P1827, DOI 10.4161/cc.20233; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Carmona-Gutierrez D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.43; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cheng L, 2012, J ZHEJIANG UNIV-SC B, V13, P283, DOI 10.1631/jzus.B1100060; Choi YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-31; Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004; Eckmann J, 2013, INT J BIOCHEM CELL B, V45, P76, DOI 10.1016/j.biocel.2012.06.009; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gonzalez-Covarrubias V, 2013, BIOGERONTOLOGY, V14, P663, DOI 10.1007/s10522-013-9450-7; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Harrison B, 2010, GERIATR GERONTOL INT, V10, P110, DOI 10.1111/j.1447-0594.2009.00569.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huang X, 2013, BIOCH BIOPHYS ACTA; Hyvonen MT, 2013, BIOCHEM J, DOI [10.1043/BJ20130263, DOI 10.1043/BJ20130263]; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Lee NKL, 2011, J CELL PHYSIOL, V226, P1453, DOI 10.1002/jcp.22569; Lee SH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/854502; Liao CY, 2011, AGING CELL, V10, P629, DOI 10.1111/j.1474-9726.2011.00702.x; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lin Yuh-Ru, 2011, Small GTPases, V2, P158; Lin YR, 2011, AGING CELL, V10, P438, DOI 10.1111/j.1474-9726.2011.00678.x; Luchessi AD, 2009, J CELL PHYSIOL, V218, P480, DOI 10.1002/jcp.21619; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Markaki M, 2011, BIOGERONTOLOGY, V12, P377, DOI 10.1007/s10522-011-9324-9; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Minois N, 2014, GERONTOLOGY, V60, P319, DOI 10.1159/000356748; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; O'Rourke EJ, 2013, GENE DEV, V27, P429, DOI 10.1101/gad.205294.112; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; Poon PC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000356; Pucciarelli S, 2012, REJUV RES, V15, P590, DOI 10.1089/rej.2012.1349; Rajeeve V, 2013, BIOCHEM J, V450, P619, DOI 10.1042/BJ20121525; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slack C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000881; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Stark F, 2011, CELL SIGNAL, V23, P876, DOI 10.1016/j.cellsig.2011.01.013; Suppola S, 2001, BIOCHEM J, V358, P343, DOI 10.1042/0264-6021:3580343; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P266, DOI 10.1016/0003-2697(65)90014-X; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	68	32	37	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102435	10.1371/journal.pone.0102435	http://dx.doi.org/10.1371/journal.pone.0102435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010732	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800100
J	Shi, XQ; Qi, YH; Shi, D; Yan, C; Shi, JX; Cao, BL; Liu, D; Luo, LR; Wang, HY				Shi, Xiu-Quan; Qi, Yong-Hong; Shi, Dan; Yan, Cheng; Shi, Junxin; Cao, Bo-Ling; Liu, Dan; Luo, Li-Rong; Wang, Hai-Yan			Features and Risk Factors of Nonfatal Injury among the Rural Children: A Survey of Seven Schools in a Mountain Area in Southwest China	PLOS ONE			English	Article							UNINTENTIONAL INJURIES; EPIDEMIOLOGIC SURVEY; EMERGENCY-DEPARTMENT; LOGISTIC-REGRESSION; CHILDHOOD INJURIES; SAMPLE-SIZE; PREVENTION; URBAN	Objective: We aimed to investigate the patterns and risk factors of nonfatal injuries among rural mountain-area children in southwest China. Methods: A stratified sampling method was used to recruit rural children aged 8 to 17 years (mainly 9-14 years) from 7 schools. Self-reported injuries during the past 12 months and relevant concerns were collected from June to December 2012 by using a structured questionnaire in a class interview. Results: The mean age of the 2,854 children was 12.2 +/- 1.5 years. The probability of annual injury was 16.7% (95% confidence interval [95% CI] 15.3-18.1%), with slightly higher injury risk for boys than girls (17.7% vs. 16.0%; P>0.05). The top 3 causes of injuries were falls (37.3%), animal-related incidents (20.6%), and burns (14.9%). The main injury risk factors included being involved in a violent episode (odds ratio [OR] 1.34, 95% CI 1.08-1.66, P = 0.007), maltreatment by parents or guardians (1.42, 1.17-1.72, P<0.001), and being from a single-child family (1.30, 1.10-1.66, P = 0.039). Older age was a protective factor (0.81, 0.76-0.87, P<0.001). Conclusions: The incidence of nonfatal injury among rural children was high, and falls were the leading cause. Younger children and boys from poor-care and poor-living environments were at increased risk of injury, which requires urgent attention. Injury prevention programs targeting these issues are needed in this mountain area and similar rural regions of China.	[Shi, Xiu-Quan; Qi, Yong-Hong; Cao, Bo-Ling; Liu, Dan; Wang, Hai-Yan] Zunyi Med Coll, Sch Publ Hlth, Zunyi, Peoples R China; [Shi, Dan; Yan, Cheng] Ctr Dis Control & Prevent Zunyi City, Zunyi, Peoples R China; [Shi, Junxin] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Injury Res & Policy,Res Inst, Columbus, OH 43210 USA; [Luo, Li-Rong] Zunyi Med Coll, Affiliated Hosp, Zunyi, Peoples R China	Zunyi Medical University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Zunyi Medical University	Shi, XQ (corresponding author), Zunyi Med Coll, Sch Publ Hlth, Zunyi, Peoples R China.	xqshi@zmc.edu.cn			National Natural Science Foundation of China [81160350]; Specific Foundation for the Scientific Educational Talent of President of Guizhou Province, China [Qian [2011]55]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Foundation for the Scientific Educational Talent of President of Guizhou Province, China	This project was funded by the National Natural Science Foundation of China (grant No. 81160350) and the Specific Foundation for the Scientific Educational Talent of President of Guizhou Province, China (grant No. Qian [2011]55). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Demidenko E, 2008, STAT MED, V27, P36, DOI 10.1002/sim.2980; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Donroe J, 2009, INJURY PREV, V15, P390, DOI 10.1136/ip.2008.019893; Fang XM, 2014, SOC SCI MED, V102, P33, DOI 10.1016/j.socscimed.2013.11.022; Fatmi Z, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-152; Hu M, 2012, BIOMED ENVIRON SCI, V25, P407, DOI 10.3967/0895-3988.2012.04.005; Jiang X, 2010, ACCIDENT ANAL PREV, V42, P320, DOI 10.1016/j.aap.2009.08.012; Li Shaohua, 2013, J Inj Violence Res, V5, P89, DOI 10.5249/jivr.v5i2.304; Ma JX, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-122; MacInnes K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-120; Mo Health, 2007, INJ PREV REP CHIN; Monuteaux MC, 2012, ACAD EMERG MED, V19, P535, DOI 10.1111/j.1553-2712.2012.01341.x; Morrongiello BA, 2006, J PEDIATR PSYCHOL, V31, P540, DOI 10.1093/jpepsy/jsj073; Moshiro C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-11; Otters H, 2005, BRIT J GEN PRACT, V55, P630; Schnitzer PG, 2006, AM FAM PHYSICIAN, V74, P1864; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; Shen M, 2009, INJURY PREV, V15, P244, DOI 10.1136/ip.2008.019869; Shi HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-531; UNICEF, 2009, STAT WORLDS CHILDR S; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; WHO UNICEF, 2008, WORLD REPORT CHILD I; Xiang Wei, 2003, Zhonghua Er Ke Za Zhi, V41, P876; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409; Zhu HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037766; Zhu Xiao-xia, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P911	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102099	10.1371/journal.pone.0102099	http://dx.doi.org/10.1371/journal.pone.0102099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK9RG	25010712	gold, Green Published, Green Submitted			2022-12-25	WOS:000338763800067
J	Tang, YY; George, A; Nouvet, F; Sweet, S; Emeagwali, N; Taylor, HE; Simmons, G; Hildreth, JEK				Tang, Yuyang; George, Alvin; Nouvet, Franklin; Sweet, Stephanie; Emeagwali, Nkiruka; Taylor, Harry E.; Simmons, Glenn; Hildreth, James E. K.			Infection of Female Primary Lower Genital Tract Epithelial Cells after Natural Pseudotyping of HIV-1: Possible Implications for Sexual Transmission of HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LIPID RAFTS; INTRACELLULAR TRAFFICKING; HUMAN CYTOMEGALOVIRUS; VIRAL ENTRY; HIGH-RISK; TYPE-1; TROPISM; IDENTIFICATION; EPIDEMIOLOGY	The global AIDS pandemic continues to expand and in some regions of the world, such as southern Africa, the prevalence of HIV-1 infection exceeds 20%. The devastating spread of the virus in young women in these countries appears disproportional to overall risk of infection. Regions with high prevalence of HIV-1 are often also highly endemic for other pathogenic viruses including HSV, CMV and HTLV. We propose that acquisition by HIV-1 of the envelope glycoproteins of other viruses, in a process we call "natural pseudotyping,'' expands the cellular tropism of HIV-1, enabling it to infect female genital epithelial cells directly and thereby dramatically increasing risk of infection during sexual intercourse. In this proof-of-concept study, we demonstrate that when HIV-1 co-infects T cells along with the gammaretrovirus xenotropic murine leukemia virus-related virus (XMRV), progeny HIV-1 particles are produced capable of infecting primary vaginal, ectocervical and endocervical epithelial cells. These cell types are normally resistant to HIV-1 infection. Infection of primary genital cells was neutralized by antisera against the XMRV glycoprotein, confirming that infection was mediated by the XMRV glycoprotein acquired through pseudotyping of HIV. Inhibition by AZT showed that active replication of HIV-1 occurred in these cells and ruled out non-specific endocytic uptake of the virus. These results demonstrate that natural pseudotyping can expand the tropism of HIV-1 to include genital epithelial cells and have potential implications for sexual transmission of the virus.	[Tang, Yuyang; George, Alvin; Nouvet, Franklin; Hildreth, James E. K.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Sweet, Stephanie] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [Emeagwali, Nkiruka; Taylor, Harry E.; Simmons, Glenn] Meharry Med Coll, Dept Microbiol & Immunol, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA	University of California System; University of California Davis; University of California System; University of California Davis; Meharry Medical College	Hildreth, JEK (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA.	jekhildreth@ucdavis.edu	Tang, Yuyang/AAX-5681-2020; Simmons, Glenn/AAT-6135-2020; Simmons, Glenn/A-1777-2015	Simmons, Glenn/0000-0003-2081-5672; Simmons, Glenn/0000-0003-2081-5672	NIH [8DP1HD075625]; NATIONAL CANCER INSTITUTE [U54CA163069, U54CA163066, U54CA163072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funder (NIH; grant 8DP1HD075625 to JEKH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; An DS, 2001, J VIROL, V75, P3488, DOI 10.1128/JVI.75.7.3488-3489.2001; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Arien KK, 2011, REV MED VIROLOGY; Beilke MA, 2012, AIDS RES HUM RETROV, V28, P139, DOI [10.1089/aid.2011.0342, 10.1089/AID.2011.0342]; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brites C, 2009, AIDS REV, V11, P8; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Calistri A, 1999, J ACQ IMMUN DEF SYND, V21, P90; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; CANIVET M, 1990, VIROLOGY, V178, P543, DOI 10.1016/0042-6822(90)90352-R; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; Chentoufi Aziz Alami, 2012, Curr Trends Immunol, V13, P51; Cingoz O, 2011, J VIROLOGY; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cooke FJ, 2005, J MED VIROL, V76, P143, DOI 10.1002/jmv.20336; Costa H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003609; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferreira OC, 1997, BLOOD REV, V11, P91, DOI 10.1016/S0268-960X(97)90015-1; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Holmes D, 2012, LANCET INFECT DIS, V12, P834, DOI 10.1016/S1473-3099(12)70254-2; HOUSSET C, 1993, J HEPATOL, V19, P252, DOI 10.1016/S0168-8278(05)80579-3; Huang A S, 1975, Bibl Haematol, P313; HUANG AS, 1974, NATURE, V252, P743, DOI 10.1038/252743a0; Jenness SM, 2011, AM J PUBLIC HEALTH, V101, P745, DOI 10.2105/AJPH.2009.181883; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Kaushic C, 2011, METHODS, V55, P114, DOI 10.1016/j.ymeth.2011.09.022; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; LeGoff J, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-2; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Li L, 2013, J VIROLOGY; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Linde ME, 2013, J PROTEOME RES, V12, P2045, DOI 10.1021/pr300918r; Liu R, 2013, J INFECT DIS; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Makarova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018272; Manel N, 2005, ONCOGENE, V24, P6016, DOI 10.1038/sj.onc.1208972; MCCUNE JM, 1990, SCIENCE, V250, P1152, DOI 10.1126/science.2174574; Micsenyi AM, 2013, J INFECT DIS; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; NELSON JA, 1988, VIROLOGY, V165, P286, DOI 10.1016/0042-6822(88)90685-X; Nguyen DH, 1999, MOL BIOL CELL, V10, p304A; Northfield JW, 2005, ARCH IMMUNOL THER EX, V53, P3; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Provitera P, 2001, BIOPHYS J, V80, p292A; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; RAFFANTI A, 1991, AIDS, V5, P769, DOI 10.1097/00002030-199106000-00021; Ramaswamy M, 2007, EXPERT REV ANTI-INFE, V5, P231, DOI 10.1586/14787210.5.2.231; Ranjbar R, 2011, IRAN RED CRESCENT ME, V13, P855; Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x; Sandrin V, 2006, J BIOL CHEM, V281, P528, DOI 10.1074/jbc.M506070200; Sandrin V, 2004, J VIROL, V78, P7153, DOI 10.1128/JVI.78.13.7153-7164.2004; Schwarzer R, 2012, BIOPHYS J, V102, p640A, DOI 10.1016/j.bpj.2011.11.3482; Shankar Esaki Muthu, 2011, Curr Infect Dis Rep, V13, P47, DOI 10.1007/s11908-010-0142-z; Shen RZ, 2010, J LEUKOCYTE BIOL, V87, P663, DOI 10.1189/jlb.0909605; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Sinzger C, 1996, INTERVIROLOGY, V39, P302, DOI 10.1159/000150502; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-70; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Sutton RE, 1996, J VIROL, V70, P7322, DOI 10.1128/JVI.70.10.7322-7326.1996; Tang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048013; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; TOTH FD, 1995, J VIROL, V69, P2223; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; VANKUYK R, 1995, VIROLOGY, V209, P643, DOI 10.1006/viro.1995.1297; Varani S, 2012, J CLIN VIROL, V53, P360, DOI 10.1016/j.jcv.2011.12.028; Vidricaire G, 2004, J VIROL, V78, P11904, DOI 10.1128/JVI.78.21.11904-11915.2004; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wilflingseder D, 2007, FRONT BIOSCI-LANDMRK, V12, P2124, DOI 10.2741/2216; Witteck A, 2009, SWISS MED WKLY, V139, P207, DOI smw-12575; Wood C, 2005, CELL RES, V15, P947, DOI 10.1038/sj.cr.7290372; WOODHOUSE DE, 1994, AIDS, V8, P1331, DOI 10.1097/00002030-199409000-00018; Zehender G, 2004, J MED VIROL, V74, P207, DOI 10.1002/jmv.20165; ZHU ZH, 1990, J ACQ IMMUN DEF SYND, V3, P215	100	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101367	10.1371/journal.pone.0101367	http://dx.doi.org/10.1371/journal.pone.0101367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010677	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800022
J	Grsboll, K; Nielsen, SS; Toft, N; Christiansen, LE				Grsboll, Kaare; Nielsen, Soren Saxmose; Toft, Nils; Christiansen, Lasse Engbo			How Fitness Reduced, Antimicrobial Resistant Bacteria Survive and Spread: A Multiple Pig - Multiple Bacterial Strain Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; MATHEMATICAL-MODEL; IN-VITRO; POPULATIONS; IMPACT; EMERGENCE; REGIMENS	More than 30% of E. coli strains sampled from pig farms in Denmark over the last five years were resistant to the commonly used antimicrobial tetracycline. This raises a number of questions: How is this high level sustained if resistant bacteria have reduced growth rates? Given that there are multiple susceptible and resistant bacterial strains in the pig intestines, how can we describe their coexistence? To what extent does the composition of these multiple strains in individual pigs influence the total bacterial population of the pig pen? What happens to a complex population when antimicrobials are used? To investigate these questions, we created a model where multiple strains of bacteria coexist in the intestines of pigs sharing a pen, and explored the parameter limits of a stable system; both with and without an antimicrobial treatment. The approach taken is a deterministic bacterial population model with stochastic elements of bacterial distributions and transmission. The rates that govern the model are process-oriented to represent growth, excretion, and uptake from environment, independent of herd and meta-population structures. Furthermore, an entry barrier and elimination process for the individual strains in each pig were implemented. We demonstrate how competitive growth between multiple bacterial strains in individual pigs, and the transmission between pigs in a pen allow for strains of antimicrobial resistant bacteria to persist in a pig population to different extents, and how quickly they can become dominant if antimicrobial treatment is initiated. The level of spread depends in a non-linear way of the parameters that govern excretion and uptake. Furthermore, the sampling of initial distributions of strains and stochastic transmission events give rise to large variation in how homogenous and how resistant the bacterial population becomes. Most important: resistant bacteria are demonstrated to survive with a disadvantage in growth rate of well over 10%.	[Grsboll, Kaare; Christiansen, Lasse Engbo] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Nielsen, Soren Saxmose; Toft, Nils] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark; [Toft, Nils] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark	Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Grsboll, K (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark.	kagr@dtu.dk		Graesboll, Kaare/0000-0002-6258-8212; Toft, Nils/0000-0002-0265-3764; Christiansen, Lasse Engbo/0000-0001-5019-1931; Nielsen, Soren/0000-0003-2417-0787	Danish Strategic Research Council [10-0934909]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Danish Strategic Research Council (http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research/the-danish-council-for-strategic-research), grant number 10-0934909, through the MINIRESIST project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatih EN, 2009, J THEOR BIOL, V256, P561, DOI 10.1016/j.jtbi.2008.10.017; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; DANMAP, 2012, TECHNICAL REPORT; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; GARBER AM, 1987, THEOR POPUL BIOL, V32, P326, DOI 10.1016/0040-5809(87)90053-0; Hellweger FL, 2013, FEMS MICROBIOL ECOL, V83, P622, DOI 10.1111/1574-6941.12019; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LI RC, 1994, J PHARM SCI-US, V83, P970, DOI 10.1002/jps.2600830711; Li YJ, 2008, INT J ANTIMICROB AG, V31, P369, DOI 10.1016/j.ijantimicag.2007.11.015; Mouton JW, 2005, J ANTIMICROB CHEMOTH, V55, P601, DOI 10.1093/jac/dki079; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Philipsen KR, 2010, J THEOR BIOL, V263, P134, DOI 10.1016/j.jtbi.2009.11.011; R Core Team, 2022, R LANG ENV STAT COMP; Reeve R, 2013, J BIOPHARM STAT, V23, P648, DOI 10.1080/10543406.2012.756496; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Spicknall IH, 2013, AM J EPIDEMIOLOGY; Teale CJ, 2012, REV SCI TECH OIE, V31, P343; Temime L, 2008, EPIDEMIOL INFECT, V136, P289, DOI 10.1017/S0950268807009442; Treyaprasert W, 2007, INT J ANTIMICROB AG, V29, P263, DOI 10.1016/j.ijantimicag.2006.08.049; Volkova VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036738; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003	27	22	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100458	10.1371/journal.pone.0100458	http://dx.doi.org/10.1371/journal.pone.0100458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006965	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600014
J	Raman, H; Raman, R; Kilian, A; Detering, F; Carling, J; Coombes, N; Diffey, S; Kadkol, G; Edwards, D; McCully, M; Ruperao, P; Parkin, IAP; Batley, J; Luckett, DJ; Wratten, N				Raman, Harsh; Raman, Rosy; Kilian, Andrzej; Detering, Frank; Carling, Jason; Coombes, Neil; Diffey, Simon; Kadkol, Gururaj; Edwards, David; McCully, Margaret; Ruperao, Pradeep; Parkin, Isobel A. P.; Batley, Jacqueline; Luckett, David J.; Wratten, Neil			Genome-Wide Delineation of Natural Variation for Pod Shatter Resistance in Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SILIQUA STRENGTH; CELL-SEPARATION; SEED DISPERSAL; SNP DISCOVERY; OILSEED RAPE; LINKAGE MAP; ARABIDOPSIS; GENE; QTL	Resistance to pod shattering (shatter resistance) is a target trait for global rapeseed (canola, Brassica napus L.), improvement programs to minimise grain loss in the mature standing crop, and during windrowing and mechanical harvest. We describe the genetic basis of natural variation for shatter resistance in B. napus and show that several quantitative trait loci (QTL) control this trait. To identify loci underlying shatter resistance, we used a novel genotyping-by-sequencing approach DArT-Seq. QTL analysis detected a total of 12 significant QTL on chromosomes A03, A07, A09, C03, C04, C06, and C08; which jointly account for approximately 57% of the genotypic variation in shatter resistance. Through Genome-Wide Association Studies, we show that a large number of loci, including those that are involved in shattering in Arabidopsis, account for variation in shatter resistance in diverse B. napus germplasm. Our results indicate that genetic diversity for shatter resistance genes in B. napus is limited; many of the genes that might control this trait were not included during the natural creation of this species, or were not retained during the domestication and selection process. We speculate that valuable diversity for this trait was lost during the natural creation of B. napus. To improve shatter resistance, breeders will need to target the introduction of useful alleles especially from genotypes of other related species of Brassica, such as those that we have identified.	[Raman, Harsh; Raman, Rosy; Coombes, Neil; Luckett, David J.; Wratten, Neil] Wagga Wagga Agr Inst, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Kilian, Andrzej; Detering, Frank; Carling, Jason] Univ Canberra, Div Arrays Technol Pty Ltd, Bruce, ACT, Australia; [Diffey, Simon] Univ Wollongong, Wollongong, NSW, Australia; [Kadkol, Gururaj] Tamworth Agr Inst, 4NSW Dept Primary Ind, Tamworth, NSW, Australia; [Edwards, David; Ruperao, Pradeep] Univ Queensland, Sch Agr & Food Sci, Australian Ctr Plant Funct Gen, St Lucia, Qld, Australia; [Edwards, David; Batley, Jacqueline] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [McCully, Margaret] CSIRO Div Plant Ind, Canberra, ACT, Australia; [Ruperao, Pradeep] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Parkin, Isobel A. P.] Agr & Agri Food Canada, Saskatoon, SK, Canada; [Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia	University of Canberra; University of Wollongong; NSW Department of Primary Industries; University of Queensland; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Agriculture & Agri Food Canada; University of Queensland	Raman, H (corresponding author), Wagga Wagga Agr Inst, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	harsh.raman@dpi.nsw.gov.au	Parkin, Isobel/AAD-6625-2020; Batley, Jacqueline/A-5723-2008; RAMAN, HARSH/N-8891-2016; Edwards, David/H-3710-2015	Batley, Jacqueline/0000-0002-5391-5824; RAMAN, HARSH/0000-0001-9761-1518; Edwards, David/0000-0001-7599-6760; Parkin, Isobel/0000-0002-5807-9466; Diffey, Simon/0000-0001-5583-0480; Kilian, Andrzej/0000-0002-2730-7462; Luckett, David John/0000-0002-1687-5413	Australian Grains Research and Development Corporation [DAN00117]	Australian Grains Research and Development Corporation(Grains R&D Corp)	This work was funded by the Australian Grains Research and Development Corporation (research project DAN00117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Bedo J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-35; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Butler D.G., 2009, TECHNICAL REPORT; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Coombes N.E, 2002, THESIS LIVERPOOL J M; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Girin T, 2010, PLANT J, V63, P329, DOI 10.1111/j.1365-313X.2010.04244.x; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Hossain S, 2011, PLANT BREEDING, P313; Hou JN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-238; Hu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034253; Inaba R, 2002, THEOR APPL GENET, V105, P1159, DOI 10.1007/s00122-002-0968-3; Jenkins ES, 1999, PLANT CELL ENVIRON, V22, P159, DOI 10.1046/j.1365-3040.1999.00372.x; KADKOL GP, 1986, CAN J GENET CYTOL, V28, P365, DOI 10.1139/g86-054; KADKOL GP, 1985, EUPHYTICA, V34, P915, DOI 10.1007/BF00035431; KADKOL GP, 1986, AUST J BOT, V34, P595, DOI 10.1071/BT9860595; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; LIU XY, 1994, J TEXTURE STUD, V25, P179, DOI 10.1111/j.1745-4603.1994.tb01325.x; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; MacLeod J., 1981, HARVESTING OILSEED R, P107; Matsuzawa Y, 1986, CRUCIFERAE NEWSLETTE, V11, P17; MCNAUGHT.IH, 1973, EUPHYTICA, V22, P301, DOI 10.1007/BF00022638; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mongkolporn O, 2003, PLANT BREEDING, V122, P479, DOI 10.1046/j.0179-9541.2003.00910.x; Morgan CL, 2000, J AGR SCI, V135, P347, DOI 10.1017/S0021859699008424; Muhlhausen A, 2013, PLANT J, V73, P824, DOI 10.1111/tpj.12079; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Osborn TC, 2003, GENETICS, V165, P1569; Ostergaard L, 2006, PLANT BIOTECHNOL J, V4, P45, DOI 10.1111/j.1467-7652.2005.00156.x; Peng P, 2011, P 13 INT RAP C 05 09, P185; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Rajani S, 2001, CURR BIOL, V11, P1914, DOI 10.1016/S0960-9822(01)00593-0; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Raman H, 2013, THEOR APPL GENET, V126, P119, DOI 10.1007/s00122-012-1966-8; Raman H, 2012, DNA RES, V19, P51, DOI 10.1093/dnares/dsr041; Raman H, 2010, GENOME, V53, P957, DOI 10.1139/G10-058; Raman R, 2012, THEOR APPL GENET, V125, P405, DOI 10.1007/s00122-012-1842-6; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; SONG K, 1990, THEOR APPL GENET, V79, P497, DOI 10.1007/BF00226159; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; U. N., 1935, Japanese Journal of Botany, V7, P389; Verbyla AP, 2007, THEOR APPL GENET, V116, P95, DOI 10.1007/s00122-007-0650-x; Wang R, 2007, PLANT BREEDING, V126, P588, DOI 10.1111/j.1439-0523.2007.01382.x; Wen YC, 2012, CROP PASTURE SCI, V63, P1082, DOI 10.1071/CP12318; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383; Zou XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045751	69	132	142	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101673	10.1371/journal.pone.0101673	http://dx.doi.org/10.1371/journal.pone.0101673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006804	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600055
J	Ferecatu, I; Goncalves, S; Golinelli-Cohen, MP; Clemancey, M; Martelli, A; Riquier, S; Guittet, E; Latour, JM; Puccio, H; Drapier, JC; Lescop, E; Bouton, C				Ferecatu, Ioana; Goncalves, Sergio; Golinelli-Cohen, Marie-Pierre; Clemancey, Martin; Martelli, Alain; Riquier, Sylvie; Guittet, Eric; Latour, Jean-Marc; Puccio, Helene; Drapier, Jean-Claude; Lescop, Ewen; Bouton, Cecile			The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; MITOCHONDRIAL-MEMBRANE PROTEIN; AZOTOBACTER-VINELANDII (NIF)ISCA; NITRIC-OXIDE; ESCHERICHIA-COLI; OXIDATIVE STRESS; 2FE-2S CLUSTER; FUNCTIONAL-CHARACTERIZATION; INSULIN SENSITIVITY; SCAFFOLD PROTEIN	In eukaryotes, mitochondrial iron-sulfur cluster (ISC), export and cytosolic iron-sulfur cluster assembly (CIA) machineries carry out biogenesis of iron-sulfur (Fe-S) clusters, which are critical for multiple essential cellular pathways. However, little is known about their export out of mitochondria. Here we show that Fe-S assembly of mitoNEET, the first identified Fe-S protein anchored in the mitochondrial outer membrane, strictly depends on ISC machineries and not on the CIA or CIAPIN1. We identify a dedicated ISC/export pathway in which augmenter of liver regeneration, a mitochondrial Mia40-dependent protein, is specific to mitoNEET maturation. Wheninserted, the Fe-S cluster confers mitoNEET folding and stability in vitro and in vivo. The holo-form of mitoNEET is resistant to NO and H2O2 and is capable of repairing oxidatively damaged Fe-S of iron regulatory protein 1 (IRP1), a master regulator of cellular iron that has recently been involved in the mitochondrial iron supply. Therefore, our findings point to IRP1 as the missing link to explain the function of mitoNEET in the control of mitochondrial iron homeostasis.	[Ferecatu, Ioana; Goncalves, Sergio; Golinelli-Cohen, Marie-Pierre; Riquier, Sylvie; Guittet, Eric; Drapier, Jean-Claude; Lescop, Ewen; Bouton, Cecile] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91190 Gif Sur Yvette, France; [Clemancey, Martin; Latour, Jean-Marc] Univ Grenoble 1, Direct Sci Vivant, Inst Life Sci Res & Technol,CEA Grenoble, Chem & Biol Met Lab,UMR 5249,CEA,CNRS,Equipe Phys, F-38054 Grenoble 09, France; [Martelli, Alain; Puccio, Helene] IGBMC, F-67400 Illkirch Graffenstaden, France; [Martelli, Alain; Puccio, Helene] INSERM, U596, Illkirch Graffenstaden, France; [Martelli, Alain; Puccio, Helene] CNRS, UMR7104, Illkirch Graffenstaden, France; [Martelli, Alain; Puccio, Helene] Univ Strasbourg, F-67000 Strasbourg, France; [Martelli, Alain; Puccio, Helene] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France; [Golinelli-Cohen, Marie-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, F-75205 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Bouton, C (corresponding author), CNRS, Inst Chim Subst Nat, UPR 2301, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	cecile.bouton@cnrs.fr	Lescop, Ewen/AAA-8700-2019; Ferecatu, Ioana/AAW-5055-2021; Puccio, Hélène/G-1717-2013; Golinelli, Marie-Pierre/K-4287-2013	Ferecatu, Ioana/0000-0001-6842-9506; Puccio, Hélène/0000-0003-4711-2248; Golinelli, Marie-Pierre/0000-0002-6738-8631; Guittet, Eric/0000-0002-8368-6719; Lescop, Ewen/0000-0002-2623-9365; Martelli, Alain/0000-0001-5246-565X	ICSN-CNRS; Fondation de la Recherche Medicale [ING20101220983]; Agence Nationale de la Recherche [ANR-13-BSV8-0017-01]	ICSN-CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an ICSN-CNRS fellowship (to I. F.), by the Fondation de la Recherche Medicale (ING20101220983 to S. G.), and by the Agence Nationale de la Recherche (ANR-13-BSV8-0017-01).	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Aniya Y, 2011, DRUG METAB REV, V43, P292, DOI 10.3109/03602532.2011.552913; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; Bouton C., 2003, SCI STKE, pe17; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Carboni M, 2012, INORG CHEM, V51, P10447, DOI 10.1021/ic301725z; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; Fillebeen C, 2002, REDOX REP, V7, P15, DOI 10.1179/135100002125000136; Fischer Manuel, 2013, Int J Cell Biol, V2013, P742923, DOI 10.1155/2013/742923; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Markley JL, 2013, FEBS LETT, V587, P1172, DOI 10.1016/j.febslet.2013.01.003; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nicolet Y, 2013, P NATL ACAD SCI USA, V110, P7188, DOI 10.1073/pnas.1302388110; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Peleh V, 2014, MICROB CELL, V1, P81, DOI 10.15698/mic2014.01.130; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Qi WB, 2014, CHEM COMMUN, V50, P3795, DOI 10.1039/c3cc48239a; Qi WB, 2012, J AM CHEM SOC, V134, P10745, DOI 10.1021/ja302186j; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; TA DT, 1992, J BIOL CHEM, V267, P11120; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	75	73	75	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28070	28086		10.1074/jbc.M114.548438	http://dx.doi.org/10.1074/jbc.M114.548438			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25012650	Green Published, hybrid			2022-12-25	WOS:000343765400002
J	Baertschi, S; Baur, N; Lueders-Lefevre, V; Voshol, J; Keller, H				Baertschi, Stefan; Baur, Nina; Lueders-Lefevre, Valerie; Voshol, Johannes; Keller, Hansjoerg			Class I and IIa Histone Deacetylases Have Opposite Effects on Sclerostin Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTORS; MYOCYTE ENHANCER FACTOR-2; NUCLEAR EXPORT; PARATHYROID-HORMONE; TRICHOSTATIN-A; BONE-FORMATION; INHIBITORS; DIFFERENTIATION; SOST	Adult bone mass is controlled by the bone formation repressor sclerostin (SOST). Previously, we have shown that intermittent parathyroid hormone (PTH) bone anabolic therapy involves SOST expression reduction by inhibiting myocyte enhancer factor 2 (MEF2), which activates a distant bone enhancer. Here, we extended our SOST gene regulation studies by analyzing a role of class I and IIa histone deacetylases (HDACs), which are known regulators of MEF2s. Expression analysis using quantitative PCR (qPCR) showed high expression of HDACs 1 and 2, lower amounts of HDACs 3, 5, and 7, low amounts of HDAC4, and no expression of HDACs 8 and 9 in constitutively SOST-expressing UMR106 osteocytic cells. PTH-induced Sost suppression was associated with specific rapid nuclear accumulation of HDAC5 and co-localization with MEF2s in nuclear speckles requiring serine residues 259 and 498, whose phosphorylations control nucleocytoplasmic shuttling. Increasing nuclear levels of HDAC5 in UMR106 by blocking nuclear export with leptomycin B (LepB) or overexpression in transient transfection assays inhibited endogenous Sost transcription and reporter gene expression, respectively. This repressor effect of HDAC5 did not require catalytic activity using specific HDAC inhibitors. In contrast, inhibition of class I HDAC activities and expression using RNA interference suppressed constitutive Sost expression in UMR106 cells. An unbiased comprehensive search for involved HDAC targets using an acetylome analysis revealed several non-histone proteins as candidates. These findings suggest that PTH-mediated Sost repression involves nuclear accumulation of HDAC inhibiting the MEF2-dependent Sost bone enhancer, and class I HDACs are required for constitutive Sost expression in osteocytes.	[Baertschi, Stefan; Lueders-Lefevre, Valerie; Keller, Hansjoerg] Novartis Inst BioMed Res, Musculoskeletal Dis Area, CH-4056 Basel, Switzerland; [Baur, Nina; Voshol, Johannes] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland	Novartis; Novartis	Keller, H (corresponding author), WSJ 360-6-05, CH-4056 Basel, Switzerland.	hansjoerg.keller@novartis.com						Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Buglio D, 2010, BRIT J HAEMATOL, V151, P387, DOI 10.1111/j.1365-2141.2010.08342.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Jung HM, 2010, BIOMATERIALS, V31, P29, DOI 10.1016/j.biomaterials.2009.09.019; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim HN, 2009, EUR J PHARMACOL, V623, P22, DOI 10.1016/j.ejphar.2009.09.025; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kwon YJ, 2007, J BIOMOL SCREEN, V12, P621, DOI 10.1177/1087057107301319; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Nakamura T, 2005, J IMMUNOL, V175, P5809, DOI 10.4049/jimmunol.175.9.5809; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Ontoria JM, 2009, J MED CHEM, V52, P6782, DOI 10.1021/jm900555u; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Soragni E, 2012, J CHILD NEUROL, V27, P1164, DOI 10.1177/0883073812448533; Thomas EA, 2014, PHARMACEUTICALS, V7, P634, DOI 10.3390/ph7060634; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058	58	30	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24995	25009		10.1074/jbc.M114.564997	http://dx.doi.org/10.1074/jbc.M114.564997			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012661	Green Published, hybrid			2022-12-25	WOS:000341985300024
J	Maeda, S; Wada, H; Naito, Y; Nagano, H; Simmons, S; Kagawa, Y; Naito, A; Kikuta, J; Ishii, T; Tomimaru, Y; Hama, N; Kawamoto, K; Kobayashi, S; Eguchi, H; Umeshita, K; Ishii, H; Doki, Y; Mori, M; Ishii, M				Maeda, Sakae; Wada, Hiroshi; Naito, Yoko; Nagano, Hiroaki; Simmons, Szandor; Kagawa, Yoshinori; Naito, Atsushi; Kikuta, Junichi; Ishii, Taeko; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Eguchi, Hidetoshi; Umeshita, Koji; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki; Ishii, Masaru			Interferon-alpha Acts on the S/G(2)/M Phases to Induce Apoptosis in the G(1) Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Cycle; Cell Death; Hepatocellular Carcinoma; Interferon; Fucci	PORTAL-VEIN THROMBOSIS; MUTATIONAL ANALYSIS; CYCLE ARREST; P53; 5-FLUOROURACIL; RECEPTOR; THERAPY; GROWTH; PHOSPHORYLATION; COMBINATION	Background: The mode of action of interferon- has been unknown. Results: Its point of action in the cell cycle was analyzed by single cell tracking using time lapse confocal imaging. Conclusion: Interferon- activates p63 in S/G(2)/M and induces apoptosis and cell cycle arrest in the subsequent G(1). Significance: Tracking cell cycle progression is crucial for understanding the mechanisms of interferon-. Interferon- (IFN-) is used clinically to treat hepatocellular carcinoma (HCC), although the detailed therapeutic mechanisms remain elusive. In particular, IFN- has long been implicated in control of the cell cycle, but its actual point of action has not been clarified. Here, using time lapse imaging analyses of the human HCC cell line HuH7 carrying a fluorescence ubiquitination-based cell cycle indicator (Fucci), we found that IFN- induced cell cycle arrest in the G(0)/G(1) phases, leading to apoptosis through an IFN- type-2 receptor (IFNAR2)-dependent signaling pathway. Detailed analyses by time lapse imaging and biochemical assays demonstrated that the IFN-/IFNAR2 axis sensitizes cells to apoptosis in the S/G(2)/M phases in preparation for cell death in the G(0)/G(1) phases. In summary, this study is the first to demonstrate the detailed mechanism of IFN- as an anticancer drug, using Fucci-based time lapse imaging, which will be informative for treating HCC with IFN- in clinical practice.	[Maeda, Sakae; Naito, Yoko; Simmons, Szandor; Kagawa, Yoshinori; Naito, Atsushi; Kikuta, Junichi; Ishii, Taeko; Ishii, Masaru] Osaka Univ, Dept Immunol, Grad Sch Med & Frontier Biosci, Suita, Osaka 5650871, Japan; [Maeda, Sakae; Wada, Hiroshi; Nagano, Hiroaki; Kagawa, Yoshinori; Naito, Atsushi; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Eguchi, Hidetoshi; Umeshita, Koji; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med & Frontier Biosci, Suita, Osaka 5650871, Japan; [Simmons, Szandor; Kikuta, Junichi; Ishii, Masaru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Mori, M (corresponding author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med & Frontier Biosci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	mmori@gesrug.med.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Ishii, Hideshi/AAV-5317-2020; Kikuta, Junichi/HHS-8875-2022	Simmons, Szandor/0000-0002-5309-9863	FIRST Program from the Ministry of Education, Science, Sports, and Culture of Japan; International Human Frontier Science Program [RGY0077/2011]; Cell Science Research Foundation; Japan Society for the Promotion of Science KAKENHI [24791414];  [22113007];  [25253070]; Grants-in-Aid for Scientific Research [22113007] Funding Source: KAKEN	FIRST Program from the Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Human Frontier Science Program(Human Frontier Science Program); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas 22113007; by Grant-in-Aid for Scientific Research (A) 25253070; by the FIRST Program from the Ministry of Education, Science, Sports, and Culture of Japan; by grants from the International Human Frontier Science Program (RGY0077/2011); and by grants from the Cell Science Research Foundation. This work was also supported by Japan Society for the Promotion of Science KAKENHI Grant 24791414.	Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; COPELAND NG, 1995, GENOMICS, V29, P225, DOI 10.1006/geno.1995.1235; Damdinsuren B, 2007, HEPATOL RES, V37, P77, DOI 10.1111/j.1872-034X.2007.00007.x; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Fogal V, 2005, EMBO J, V24, P2768, DOI 10.1038/sj.emboj.7600735; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hagiwara K, 1999, CANCER RES, V59, P4165; HUBERMAN JA, 1981, CELL, V23, P647, DOI 10.1016/0092-8674(81)90426-8; Kondo M, 2005, CLIN CANCER RES, V11, P1277; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy D, 2001, HEPATOLOGY, V33, P346, DOI 10.1053/jhep.2001.21749; Nagano H, 2007, CANCER-AM CANCER SOC, V110, P2493, DOI 10.1002/cncr.23033; Nagano H, 2011, ONCOLOGY-BASEL, V80, P63, DOI 10.1159/000328281; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Sangfelt O, 1997, CELL GROWTH DIFFER, V8, P343; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Waltermann A, 2003, ONCOGENE, V22, P5686, DOI 10.1038/sj.onc.1206859; Yano H, 2006, J GASTROEN HEPATOL, V21, P1720, DOI 10.1111/j.1440-1746.2006.04357.x; Yoshikawa H, 1999, ONCOGENE, V18, P3415, DOI 10.1038/sj.onc.1202677	32	28	32	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23786	23795		10.1074/jbc.M114.551879	http://dx.doi.org/10.1074/jbc.M114.551879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012666	Green Published, hybrid			2022-12-25	WOS:000341505000046
J	Jo, G; Lim, W; Bae, SM; Bazer, FW; Song, G				Jo, Gahee; Lim, Whasun; Bae, Seung-Min; Bazer, Fuller W.; Song, Gwonhwa			Avian SERPINB12 Expression in the Avian Oviduct Is Regulated by Estrogen and Up-Regulated in Epithelial Cell-Derived Ovarian Carcinomas of Laying Hens	PLOS ONE			English	Article							TISSUE-SPECIFIC EXPRESSION; CHICK OVIDUCT; DIFFERENTIAL EXPRESSION; PARADOXICAL EXPRESSION; PROTEIN-SYNTHESIS; OVALBUMIN; CANCER; GENE; EVOLUTION; TUMORS	Serine protease inhibitors (SERPINs) are involved in a variety of biological processes such as blood clotting, angiogenesis, immune system, and embryogenesis. Although, of these, SERPINB12 is identified as the latest member of clade B in humans, little is known of it in chickens. Thus, in this study, we investigated SERPINB12 expression profiles in various tissues of chickens and focused on effects of steroid hormone regulation of its expression. In the chicken oviduct, SERPINB12 mRNA and protein are abundant in the luminal (LE) and glandular (GE) epithelia of the magnum in response to endogenous or exogenous estrogen. Furthermore, SERPINB12 mRNA and protein increase significantly in GE of cancerous ovaries of laying hens with epithelia-derived ovarian cancer. Collectively, these results indicate that SERPINB12 is a novel estrogen-stimulated gene that is up-regulated by estrogen in epithelial cells of the chicken oviduct and that it is a potential biomarker for early detection of ovarian carcinomas in laying hens and women.	[Jo, Gahee; Lim, Whasun; Bae, Seung-Min; Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Korea University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	gwonhwa, song/H-3208-2015; Lim, Whasun/AAP-3156-2020; Song, Gwonhwa/H-3647-2015; Bazer, Fuller/AAF-4317-2021	Lim, Whasun/0000-0002-1328-0465; Bazer, Fuller/0000-0002-5823-5086	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2013R1A1A2A10005948]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008142]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(National Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was funded by the Basic Science Research Program (2013R1A1A2A10005948) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SE, 2012, GEN COMP ENDOCR, V175, P194, DOI 10.1016/j.ygcen.2011.11.013; Ahn SE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-100; Askew YS, 2001, J BIOL CHEM, V276, P49320, DOI 10.1074/jbc.M108879200; Bae SM, 2014, MOL CELL ENDOCRINOL, V382, P46, DOI 10.1016/j.mce.2013.09.010; Baekelandt MM, 2008, ANN ONCOL, V19, P19, DOI 10.1093/annonc/mdn113; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; BERRY WD, 1985, POULTRY SCI, V64, P2027, DOI 10.3382/ps.0642027; Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971; Chechlinska M, 2010, TUMOR BIOL, V31, P559, DOI 10.1007/s13277-010-0069-x; CREGER CR, 1977, POULTRY SCI, V56, P1706; Crum CP, 2012, CLIN OBSTET GYNECOL, V55, P24, DOI 10.1097/GRF.0b013e31824b1725; Dougherty DC, 2005, TRENDS ENDOCRIN MET, V16, P414, DOI 10.1016/j.tem.2005.09.001; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; GRONROOS M, 1987, ANN CHIR GYNAECOL FE, V76, P76; Hsu KF, 2007, INT J GYNECOL CANCER, V17, P174, DOI 10.1111/j.1525-1438.2006.00663.x; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076784; Jeong W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049204; Jeong W, 2012, EXP BIOL MED, V237, P758, DOI 10.1258/ebm.2012.011433; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051592; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; Li HWR, 2007, ONCOL REP, V17, P393; Lim W, 2013, MOL CELL ENDOCRINOL, V366, P1, DOI 10.1016/j.mce.2012.10.031; Lim W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049869; Lim W, 2012, BIOCHEM BIOPH RES CO, V422, P494, DOI 10.1016/j.bbrc.2012.05.026; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Lim W, 2011, BIOL REPROD, V85, P1260, DOI 10.1095/biolreprod.111.093526; Lim W, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; MCKNIGHT GS, 1978, CELL, V14, P403; Nakashima T, 2006, HEAD NECK-J SCI SPEC, V28, P24, DOI 10.1002/hed.20293; PALMITER RD, 1972, J BIOL CHEM, V247, P6770; PALMITER RD, 1972, J BIOL CHEM, V247, P6450; SANDERS MM, 1988, BIOCHEMISTRY-US, V27, P6550, DOI 10.1021/bi00417a053; Shiiba M, 2010, ONCOL REP, V24, P241, DOI 10.3892/or_00000852; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Stewart MD, 2000, BIOL REPROD, V62, P1779, DOI 10.1095/biolreprod62.6.1779; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; Trevino Lindsey S., 2010, Hormones & Cancer, V1, P177, DOI 10.1007/s12672-010-0024-8	51	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e99792	10.1371/journal.pone.0099792	http://dx.doi.org/10.1371/journal.pone.0099792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25020046	Green Submitted, Green Published, gold			2022-12-25	WOS:000339618600003
J	Pavese, JM; Ogden, IM; Voll, EA; Huang, XK; Xu, L; Jovanovic, B; Bergan, RC				Pavese, Janet M.; Ogden, Irene M.; Voll, Eric A.; Huang, Xiaoke; Xu, Li; Jovanovic, Borko; Bergan, Raymond C.			Mitogen-Activated Protein Kinase Kinase 4 (MAP2K4) Promotes Human Prostate Cancer Metastasis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE TYPE-2; N-TERMINAL KINASE; CELL INVASION; SIGNALING PATHWAYS; ANDROGEN ABLATION; MMP-2A EXPRESSION; SUPPRESSOR GENE; MKK4; MIGRATION; PROGRESSION	Prostate cancer (PCa) is the second leading cause of cancer death in the US. Death from PCa primarily results from metastasis. Mitogen-activated protein kinase kinase 4 (MAP2K4) is overexpressed in invasive PCa lesions in humans, and can be inhibited by small molecule therapeutics that demonstrate favorable activity in phase II studies. However, MAP2K4's role in regulating metastatic behavior is controversial and unknown. To investigate, we engineered human PCa cell lines which overexpress either wild type or constitutive active MAP2K4. Orthotopic implantation into mice demonstrated MAP2K4 increases formation of distant metastasis. Constitutive active MAP2K4, though not wild type, increases tumor size and circulating tumor cells in the blood and bone marrow. Complementary in vitro studies establish stable MAP2K4 overexpression promotes cell invasion, but does not affect cell growth or migration. MAP2K4 overexpression increases the expression of heat shock protein 27 (HSP27) protein and protease production, with the largest effect upon matrix metalloproteinase 2 (MMP-2), both in vitro and in mouse tumor samples. Further, MAP2K4-mediated increases in cell invasion are dependent upon heat shock protein 27 (HSP27) and MMP-2, but not upon MAP2K4's immediate downstream targets, p38 MAPK or JNK. We demonstrate that MAP2K4 increases human PCa metastasis, and prolonged over expression induces long term changes in cell signaling pathways leading to independence from p38 MAPK and JNK. These findings provide a mechanistic explanation for human studies linking increases in HSP27 and MMP-2 to progression to metastatic disease. MAP2K4 is validated as an important therapeutic target for inhibiting human PCa metastasis.	[Pavese, Janet M.; Ogden, Irene M.; Voll, Eric A.; Huang, Xiaoke; Xu, Li; Bergan, Raymond C.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Jovanovic, Borko; Bergan, Raymond C.] Northwestern Univ, Dept Preventat Med, Chicago, IL 60611 USA; [Jovanovic, Borko; Bergan, Raymond C.] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Bergan, Raymond C.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Bergan, RC (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	r-bergan@northwestern.edu			National Institutes of Health (NIH) [CA122985]; Prostate SPORE [CA90386]; NIH [T32 AG000260]; Walter S. And Lucienne Driskill Graduate Program in Life Sciences at Northwestern University; NATIONAL CANCER INSTITUTE [R01CA122985, P50CA090386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter S. And Lucienne Driskill Graduate Program in Life Sciences at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (NIH) to R. C. B., CA122985 and Prostate SPORE CA90386, and to J.M.P, NIH T32 AG000260 "Drug Discovery Training in Age-Related Disorders'', and by the Walter S. And Lucienne Driskill Graduate Program in Life Sciences at Northwestern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATCC, 2007, ATCC TECHN B, V8, P1; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Ben-Ami I, 2011, J BIOL CHEM, V286, P31022, DOI 10.1074/jbc.M111.247726; Bjorkblom B, 2012, MOL CELL BIOL, V32, P3513, DOI 10.1128/MCB.00713-12; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cornford PA, 2000, CANCER RES, V60, P7099; Craft CS, 2008, MOL PHARMACOL, V73, P235, DOI 10.1124/mol.107.038935; Cunningham SC, 2006, CANCER RES, V66, P5560, DOI 10.1158/0008-5472.CAN-06-0555; Ding Yongzeng, 2007, J Biomol Tech, V18, P321; El-Haibi CP, 2011, CELL PROLIFERAT, V44, P311, DOI 10.1111/j.1365-2184.2011.00757.x; Griend DJV, 2005, CANCER RES, V65, P10984, DOI 10.1158/0008-5472.CAN-05-2382; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Hickson JA, 2006, CANCER RES, V66, P2264, DOI 10.1158/0008-5472.CAN-05-3676; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Ishikawa M, 2010, ONCOLOGY-BASEL, V79, P238, DOI 10.1159/000322644; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kim HL, 2001, CANCER RES, V61, P2833; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; Lakshman M, 2011, CLIN EXP METASTAS, V28, P39, DOI 10.1007/s10585-010-9356-6; Liang H, 2012, J ANESTH, V26, P381, DOI 10.1007/s00540-011-1317-y; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Liu YQ, 2002, ONCOGENE, V21, P8272, DOI 10.1038/sj.onc.1206117; Liu YQ, 2001, PROSTATE CANCER P D, V4, P81, DOI 10.1038/sj.pcan.4500506; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan TL, 2007, J PATHOL, V212, P386, DOI 10.1002/path.2194; Miyake H, 2010, UROL ONCOL-SEMIN ORI, V28, P145, DOI 10.1016/j.urolonc.2008.08.001; Nakayama K, 2006, CANCER BIOL THER, V5, P630, DOI 10.4161/cbt.5.6.2675; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Schilling D, 2012, NAT REV UROL; Shen KH, 2010, MOL CELL BIOCHEM, V333, P279, DOI 10.1007/s11010-009-0229-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stearns M, 1996, ONCOL RES, V8, P69; Stearns ME, 1996, ONCOL RES, V8, P63; STEARNS ME, 1993, CANCER RES, V53, P878; Szmulewitz RZ, 2012, INT J CANCER, V130, P509, DOI 10.1002/ijc.26005; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Wang L, 2004, ONCOGENE, V23, P5978, DOI 10.1038/sj.onc.1207802; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wood M, 1997, CLIN EXP METASTAS, V15, P246, DOI 10.1023/A:1018421431388; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Yeasmin S, 2011, TUMOR BIOL, V32, P661, DOI 10.1007/s13277-011-0166-5; Zelefsky M, 2008, CANC PRINCIPLES PRAC	47	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102289	10.1371/journal.pone.0102289	http://dx.doi.org/10.1371/journal.pone.0102289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019290	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600060
J	Xu, WR; Jiao, YT; Li, RM; Zhang, NB; Xiao, DM; Ding, XL; Wang, ZP				Xu, Weirong; Jiao, Yuntong; Li, Ruimin; Zhang, Ningbo; Xiao, Dongming; Ding, Xiaoling; Wang, Zhenping			Chinese Wild-Growing Vitis amurensis ICE1 and ICE2 Encode MYC-Type bHLH Transcription Activators that Regulate Cold Tolerance in Arabidopsis	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; FREEZING TOLERANCE; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; DNA-BINDING; DROUGHT; ACCLIMATION; PROTEINS; OVEREXPRESSION; GRAPEVINE	Winter hardiness is an important trait for grapevine breeders and producers, so identification of the regulatory mechanisms involved in cold acclimation is of great potential value. The work presented here involves the identification of two grapevine ICE gene homologs, VaICE1 and VaICE2, from an extremely cold-tolerant accession of Chinese wild-growing Vitis amurnensis, which are phylogenetically related to other plant ICE1 genes. These two structurally different ICE proteins contain previously reported ICE-specific amino acid motifs, the bHLH-ZIP domain and the S-rich motif. Expression analysis revealed that VaICE1 is constitutively expressed but affected by cold stress, unlike VaICE2 that shows not such changed expression as a consequence of cold treatment. Both genes serve as transcription factors, potentiating the transactivation activities in yeasts and the corresponding proteins localized to the nucleus following transient expression in onion epidermal cells. Overexpression of either VaICE1 or VaICE2 in Arabidopsis increase freezing tolerance in nonacclimated plants. Moreover, we show that they result in multiple biochemical changes that were associated with cold acclimation: VaICE1/2-overexpressing plants had evaluated levels of proline, reduced contents of malondialdehyde (MDA) and decreased levels of electrolyte leakage. The expression of downstream cold responsive genes of CBF1, COR15A, and COR47 were significantly induced in Arabidopsis transgenically overexpressing VaICE1 or VaICE2 upon cold stress. VaICE2, but not VaICE1 overexpression induced KIN1 expression under cold-acclimation conditions. Our results suggest that VaICE1 and VaICE2 act as key regulators at an early step in the transcriptional cascade controlling freezing tolerance, and modulate the expression levels of various low-temperature associated genes involved in the C-repeat binding factor (CBF) pathway.	[Xu, Weirong; Zhang, Ningbo; Xiao, Dongming; Ding, Xiaoling; Wang, Zhenping] Ningxia Univ, Sch Agron, Ningxia, Peoples R China; [Xu, Weirong; Zhang, Ningbo; Xiao, Dongming; Ding, Xiaoling; Wang, Zhenping] Ningxia Univ, Minist Educ, Engn Res Ctr Grape & Wine, Ningxia, Peoples R China; [Xu, Weirong; Zhang, Ningbo; Xiao, Dongming; Wang, Zhenping] Ningxia Univ, Ningxia Engn & Technol Res Ctr Grape & Wine, Ningxia, Peoples R China; [Jiao, Yuntong; Li, Ruimin] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Ningxia University; Ningxia University; Ningxia University; Northwest A&F University - China	Xu, WR (corresponding author), Ningxia Univ, Sch Agron, Ningxia, Peoples R China.	xuwr@nxu.edu.cn; wzhenping@yahoo.com	Xu, Weirong/I-2671-2016	Xu, Weirong/0000-0003-2821-0360	National Natural Science Foundation of China [31101512]; Ningxia Innovation Program for the Returned Overseas Scholars	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningxia Innovation Program for the Returned Overseas Scholars	This work was supported by the National Natural Science Foundation of China (Grant no. 31101512) and Ningxia Innovation Program for the Returned Overseas Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi M, 2008, PLANT CELL PHYSIOL, V49, P1237, DOI 10.1093/pcp/pcn100; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; C FAaL, 2013, ENV EXPT BOT; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Christen D, 2007, ENVIRON EXP BOT, V60, P504, DOI 10.1016/j.envexpbot.2007.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Daldoul S, 2010, PLANT SCI, V179, P489, DOI 10.1016/j.plantsci.2010.07.017; Deng YM, 2011, PLANT CELL REP, V30, P2177, DOI 10.1007/s00299-011-1123-x; Dexter ST, 1932, PLANT PHYSIOL, V7, P63, DOI 10.1104/pp.7.1.63; Dong C, 2013, PLANT PHYSIOL BIOCH, V71, P212, DOI 10.1016/j.plaphy.2013.07.012; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; GUY CL, 1992, PLANT PHYSIOL, V100, P502, DOI 10.1104/pp.100.1.502; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; ITURRIAGA G, 1992, PLANT MOL BIOL, V20, P555, DOI 10.1007/BF00040614; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kadioglu A, 2012, PLANT SCI, V182, P42, DOI 10.1016/j.plantsci.2011.01.013; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kaye C, 1998, PLANT PHYSIOL, V116, P1367, DOI 10.1104/pp.116.4.1367; Kobayashi M, 2010, J PLANT PHYSIOL, V167, P812, DOI 10.1016/j.jplph.2009.12.005; KOSZO F, 1974, BIOCHIM BIOPHYS ACTA, V363, P182, DOI 10.1016/0005-2736(74)90057-1; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li JT, 2014, SCI HORTIC-AMSTERDAM, V165, P266, DOI 10.1016/j.scienta.2013.11.002; Lin Y, 2013, J PLANT BIOCHEM BIOT, P1; Liu LY, 2010, SCI HORTIC-AMSTERDAM, V124, P29, DOI 10.1016/j.scienta.2009.11.018; Liu LY, 2013, CAN J PLANT SCI, V93, P565, DOI 10.4141/CJPS2012-202; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Miura K, 2012, PLANT BIOTECHNOL-NAR, V29, P253, DOI 10.5511/plantbiotechnology.12.0303a; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nakamura J, 2011, PLANT BIOTECHNOL-NAR, V28, P303, DOI 10.5511/plantbiotechnology.11.0421a; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Nanjo T, 1999, FEBS LETT, V461, P205, DOI 10.1016/S0014-5793(99)01451-9; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Rahman MA, 2014, ENV EXPT BOT; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; Sato Y, 2011, PLANT CELL REP, V30, P399, DOI 10.1007/s00299-010-0985-7; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Wan YZ, 2008, VITIS, V47, P77; Wang Xinglong, 2005, Mol Biol (Mosk), V39, P21; Wang Y, 2012, PLANT CELL REP, V31, P27, DOI 10.1007/s00299-011-1136-5; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Weigel RR, 2001, PLANT MOL BIOL, V46, P143, DOI 10.1023/A:1010652620115; Xiang DJ, 2013, MOL BREEDING, V32, P617, DOI 10.1007/s11032-013-9894-0; Xu WR, 2014, MOL BIOL REP, V41, P5329, DOI 10.1007/s11033-014-3404-2; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang Y, 2012, AM J ENOL VITICULT, V63, P377, DOI 10.5344/ajev.2012.12006	70	40	46	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102303	10.1371/journal.pone.0102303	http://dx.doi.org/10.1371/journal.pone.0102303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019620	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600063
J	Yang, XH; Shen, XR; Li, WJ; Yang, YF				Yang, Xiaohong; Shen, Xiangrong; Li, Weijun; Yang, Yufang			How Listeners Weight Acoustic Cues to Intonational Phrase Boundaries	PLOS ONE			English	Article							SYNTACTIC BOUNDARIES; PROSODIC BOUNDARIES; GERMAN INFANTS; PERCEPTION; DISCOURSE; DURATION; MANDARIN; CHINESE; SPEECH; ALOUD	The presence of an intonational phrase boundary is often marked by three major acoustic cues: pause, final lengthening, and pitch reset. The present study investigates how these three acoustic cues are weighted in the perception of intonational phrase boundaries in two experiments. Sentences that contained two intonational phrases with a critical boundary between them were used as the experimental stimuli. The roles of the three acoustic cues at the critical boundary were manipulated in five conditions. The first condition featured none of the acoustic cues. The following three conditions featured only one cue each: pause, final lengthening, and pitch reset, respectively. The fifth condition featured both pause duration and pre-final lengthening. A baseline condition was also included in which all three acoustic cues were preserved intact. Listeners were asked to detect the presence of the critical boundaries in Experiment 1 and judge the strength of the critical boundaries in Experiment 2. The results of both experiments showed that listeners used all three acoustic cues in the perception of prosodic boundaries. More importantly, these acoustic cues were weighted differently across the two experiments: Pause was a more powerful perceptual cue than both final lengthening and pitch reset, with the latter two cues perceptually equivalent; the effect of pause and the effects of the other two acoustic cues were not additive. These results suggest that the weighting of acoustic cues contributes significantly to the perceptual differences of intonational phrase boundary.	[Yang, Xiaohong; Shen, Xiangrong; Li, Weijun; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Shen, Xiangrong] Shanghai Normal Univ, Coll Humanities & Commun, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Shanghai Normal University	Li, WJ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liwj88@gmail.com; yangyf@psych.ac.cn			National Natural Science Foundation of China [31000505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31000505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman M, 1986, PHONOLOGY YB, V3, P5; Bei W, 2005, ACTA ACUSTICA, V2, P177; BERKOVITS R, 1994, LANG SPEECH, V37, P237, DOI 10.1177/002383099403700302; Byrd D, 2006, J ACOUST SOC AM, V120, P1589, DOI 10.1121/1.2217135; Carlson R, 2005, SPEECH COMMUN, V46, P326, DOI 10.1016/j.specom.2005.02.013; Chen YY, 2006, J PHONETICS, V34, P176, DOI 10.1016/j.wocn.2005.05.002; Cole J, 2010, LANG COGNITIVE PROC, V25, P1141, DOI 10.1080/01690960903525507; COOPER WE, 1977, J ACOUST SOC AM, V62, P683, DOI 10.1121/1.381556; den Ouden H, 2009, SPEECH COMMUN, V51, P116, DOI 10.1016/j.specom.2008.06.003; DEPIJPER JR, 1994, J ACOUST SOC AM, V96, P2037, DOI 10.1121/1.410145; Ellis RJ, 2009, J EXP PSYCHOL HUMAN, V35, P264, DOI 10.1037/a0013482; Fon J, 2004, LANG SPEECH, V47, P57, DOI 10.1177/00238309040470010301; Fon J, 2011, LANG SPEECH, V54, P5, DOI 10.1177/0023830910372492; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; Hirst D. J., 1998, INTONATION SYSTEMS S, P1; Krivokapic J, 2012, J PHONETICS; Krivokapic J, 2007, J PHONETICS, V35, P162, DOI 10.1016/j.wocn.2006.04.001; Li W, 2009, NEUROSCIENCE, V158, P1416, DOI 10.1016/j.neuroscience.2008.10.065; Liang J, 2007, TONES TUNES, V2, P12; Lin HY, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P808; Mannel C, 2009, J COGNITIVE NEUROSCI, V21, P1988, DOI 10.1162/jocn.2009.21221; Mo Y., 2010, J ACOUST SOC AM, V127, P1956; Nakai S, 2009, J PHONETICS, V37, P29, DOI 10.1016/j.wocn.2008.08.002; Nesport M, 2007, PROSODIC PHONOLOGY N; PRICE PJ, 1991, J ACOUST SOC AM, V90, P2956, DOI 10.1121/1.401770; SCOTT DR, 1982, J ACOUST SOC AM, V71, P996, DOI 10.1121/1.387581; Seidl A, 2007, J MEM LANG, V57, P24, DOI 10.1016/j.jml.2006.10.004; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Shen X.S., 1992, J INT PHON ASSOC, V22, P35; SLUIJTER AMC, 1993, PHONETICA, V50, P180, DOI 10.1159/000261938; Smith CL, 2004, SPEECH COMMUN, V42, P247, DOI 10.1016/j.specom.2003.09.004; Steinhauer K, 2003, BRAIN LANG, V86, P142, DOI 10.1016/S0093-934X(02)00542-4; STREETER LA, 1978, J ACOUST SOC AM, V64, P1582, DOI 10.1121/1.382142; SWERTS M, 1994, J ACOUST SOC AM, V96, P2064, DOI 10.1121/1.410148; THORSEN NG, 1986, J ACOUST SOC AM, V80, P1041, DOI 10.1121/1.393845; Vaissiere J., 1983, PROSODY MODELS MEASU, P53; Vaissiere J, 2006, USAGE-B LINGUIST INF, V3, P47; Venditti JJ, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P287; Wagner M, 2010, LANG COGNITIVE PROC, V99999, P1; Wellmann C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00580; WIGHTMAN CW, 1992, J ACOUST SOC AM, V91, P1707, DOI 10.1121/1.402450; Yang XH, 2012, IEEE T AUDIO SPEECH, V20, P1196, DOI 10.1109/TASL.2011.2173676; Zhang X., 2012, THESIS U MICHIGAN	43	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102166	10.1371/journal.pone.0102166	http://dx.doi.org/10.1371/journal.pone.0102166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1PC	25019156	Green Published, Green Submitted, gold			2022-12-25	WOS:000339618600051
J	AlKhatib, Z; Lagedroste, M; Fey, I; Kleinschrodt, D; Abts, A; Smits, SHJ				AlKhatib, Zainab; Lagedroste, Marcel; Fey, Iris; Kleinschrodt, Diana; Abts, Andre; Smits, Sander H. J.			Lantibiotic Immunity: Inhibition of Nisin Mediated Pore Formation by NisI	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; PRECURSOR LIPID II; LACTOCOCCUS-LACTIS; PEPTIDE; BACTERIOCINS; PROTEIN; BIOSYNTHESIS; ORIENTATION; MECHANISM; PROVIDES	Nisin, a 3.4 kDa antimicrobial peptide produced by some Lactococcus lactis strains is the most prominent member of the lantibiotic family. Nisin can inhibit cell growth and penetrates the target Gram-positive bacterial membrane by binding to Lipid II, an essential cell wall synthesis precursor. The assembled nisin-Lipid II complex forms pores in the target membrane. To gain immunity against its own-produced nisin, Lactococcus lactis is expressing two immunity protein systems, NisI and NisFEG. Here, we show that the NisI expressing strain displays an IC50 of 736 +/- 10 nM, an 8-10-fold increase when compared to the non-expressing sensitive strain. When the nisin concentration is raised above 70 nM, the cells expressing full-length NisI stop growing rather than being killed. NisI is inhibiting nisin mediated pore formation, even at nisin concentrations up to 1 mu M. This effect is induced by the C-terminus of NisI that protects Lipid II. Its deletion showed pore formation again. The expression of NisI in combination with externally added nisin mediates an elongation of the chain length of the Lactococcus lactis cocci. While the sensitive strain cell-chains consist mainly of two cells, the NisI expressing cells display a length of up to 20 cells. Both results shed light on the immunity of lantibiotic producer strains, and their survival in high levels of their own lantibiotic in the habitat.	[AlKhatib, Zainab; Lagedroste, Marcel; Fey, Iris; Kleinschrodt, Diana; Abts, Andre; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	sander.smits@hhu.de			CLIB Graduate Cluster Industrial Biotechnology	CLIB Graduate Cluster Industrial Biotechnology	This work was supported by CLIB Graduate Cluster Industrial Biotechnology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Abts A., 2011, INT J PEPT, V2011, DOI DOI 10.1155/2011/175145; Abts A, 2013, BIOCHEMISTRY-US, V52, P5387, DOI 10.1021/bi4008116; Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Barbour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077751; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1998, BIOCHEMISTRY-US, V37, P8153, DOI 10.1021/bi972797l; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chatterjee C, 2005, J AM CHEM SOC, V127, P15332, DOI 10.1021/ja0543043; Christ NA, 2012, J BIOL CHEM, V287, P35286, DOI 10.1074/jbc.M112.401620; Claessen D, 2014, NAT REV MICROBIOL, V12, P115, DOI 10.1038/nrmicro3178; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Demel RA, 1996, EUR J BIOCHEM, V235, P267, DOI 10.1111/j.1432-1033.1996.00267.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Draper LA, 2008, CURR PROTEIN PEPT SC, V9, P39; DRIESSEN AJM, 1995, BIOCHEMISTRY-US, V34, P1606, DOI 10.1021/bi00005a017; Galvin M, 1999, LETT APPL MICROBIOL, V28, P355, DOI 10.1046/j.1365-2672.1999.00550.x; GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x; Giffard CJ, 1997, BIOCHEMISTRY-US, V36, P3802, DOI 10.1021/bi962506t; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hoffmann A, 2004, APPL ENVIRON MICROB, V70, P3263, DOI 10.1128/AEM.70.6.3263-3271.2004; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; JUNG G, 1991, ANGEW CHEM INT EDIT, V30, P1051, DOI 10.1002/anie.199110513; Koponen O, 2004, FEMS MICROBIOL LETT, V231, P85, DOI 10.1016/S0378-1097(03)00934-0; Koponen O, 2002, MICROBIOL-SGM, V148, P3561, DOI 10.1099/00221287-148-11-3561; KORDEL M, 1989, FEBS LETT, V244, P99, DOI 10.1016/0014-5793(89)81171-8; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Li HP, 2006, J BACTERIOL, V188, P8496, DOI 10.1128/JB.00946-06; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Piper C, 2011, MICROB BIOTECHNOL, V4, P375, DOI 10.1111/j.1751-7915.2010.00207.x; QIAO MQ, 1995, FEMS MICROBIOL LETT, V131, P75, DOI 10.1111/j.1574-6968.1995.tb07757.x; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Ra SR, 1996, MICROBIOL-SGM, V142, P1281, DOI 10.1099/13500872-142-5-1281; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; SAHL HG, 1987, ARCH MICROBIOL, V149, P120, DOI 10.1007/BF00425076; Sambrook J, 2001, MOL CLONING LAB MANU; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; Takala TM, 2006, MICROBIOL-SGM, V152, P3543, DOI 10.1099/mic.0.29083-0; van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x; VANDEVEN FJM, 1991, EUR J BIOCHEM, V202, P1181, DOI 10.1111/j.1432-1033.1991.tb16488.x; Visweswaran GRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072167; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	59	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102246	10.1371/journal.pone.0102246	http://dx.doi.org/10.1371/journal.pone.0102246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014359	gold, Green Submitted, Green Published			2022-12-25	WOS:000339378400080
J	Chauhan, A; Sun, YY; Pani, B; Quenumzangbe, F; Sharma, J; Singh, BB; Mishra, BB				Chauhan, Arun; Sun, Yuyang; Pani, Biswaranjan; Quenumzangbe, Fredice; Sharma, Jyotika; Singh, Brij B.; Mishra, Bibhuti B.			Helminth Induced Suppression of Macrophage Activation Is Correlated with Inhibition of Calcium Channel Activity	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TAENIA-SOLIUM CYSTICERCOSIS; JUNCTIONAL COMPLEX PROTEINS; CENTRAL-NERVOUS-SYSTEM; GLAND FLUID SECRETION; OPERATED CA2+ ENTRY; INNATE IMMUNITY; MURINE NEUROCYSTICERCOSIS; DIFFERENTIAL CHANGES; STIM1	Helminth parasites cause persistent infections in humans and yet many infected individuals are asymptomatic. Neurocysticercosis (NCC), a disease of the central nervous system (CNS) caused by the cestode Taenia solium, has a long asymptomatic phase correlated with an absence of brain inflammation. However, the mechanisms of immune suppression remain poorly understood. Here we report that murine NCC displays a lack of cell surface maturation markers in infiltrating myeloid cells. Furthermore, soluble parasite ligands (PL) failed to induce maturation of macrophages, and inhibited TLR-induced inflammatory cytokine production. Importantly, PL treatment abolished both LPS and thapsigargin-induced store operated Ca2+ entry (SOCE). Moreover, electrophysiological recordings demonstrated PL-mediated inhibition of LPS or Tg-induced currents that were TRPC1-dependent. Concomitantly STIM1-TRPC1 complex was also impaired that was essential for SOCE and sustained Ca2+ entry. Likewise loss of SOCE due to PL further inhibited NFkB activation. Overall, our results indicate that the negative regulation of agonist induced Ca2+ signaling pathway by parasite ligands may be a novel immune suppressive mechanism to block the initiation of the inflammatory response associated with helminth infections.	[Chauhan, Arun; Sun, Yuyang; Pani, Biswaranjan; Quenumzangbe, Fredice; Sharma, Jyotika; Singh, Brij B.; Mishra, Bibhuti B.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Mishra, BB (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58201 USA.	bibhuti.mishra@und.med.edu	Pani, Biswaranjan/GLT-9217-2022	Singh, Brij/0000-0003-0535-5997	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER; NIAID NIH HHS [1R03AI09753] Funding Source: Medline; NIDCR NIH HHS [R01 DE017102, R01DE017102,] Funding Source: Medline; NIGMS NIH HHS [P30GM103329, P30 GM103329] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Alvarez JI, 2002, J NEUROIMMUNOL, V127, P139, DOI 10.1016/S0165-5728(02)00101-7; Alvarez JI, 2002, J COMP PATHOL, V127, P186, DOI 10.1053/jcpa.2002.0579; Alvarez JI, 2007, BRAIN RES, V1169, P98, DOI 10.1016/j.brainres.2007.07.010; Alvarez JI, 2007, J NEUROIMMUNOL, V187, P102, DOI 10.1016/j.jneuroim.2007.05.005; Alvarez JI, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000218; Ambudkar IS, 2006, CELL CALCIUM, V40, P495, DOI 10.1016/j.ceca.2006.08.011; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Brannstrom K, 2009, INFECT IMMUN, V77, P1144, DOI 10.1128/IAI.01126-08; Cardona AE, 1999, J IMMUNOL, V162, P995; Cardona AE, 2002, J IMMUNOL, V169, P3163, DOI 10.4049/jimmunol.169.6.3163; Cardona AE, 2003, INFECT IMMUN, V71, P2634, DOI 10.1128/IAI.71.5.2634-2642.2003; Cooke A, 2012, CURR OPIN RHEUMATOL, V24, P394, DOI 10.1097/BOR.0b013e3283535937; Cooke A, 2009, IMMUNOLOGY, V126, P12, DOI 10.1111/j.1365-2567.2008.03009.x; DAVIS LE, 1991, EUR NEUROL, V31, P229, DOI 10.1159/000116683; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Garcia HH, 2005, LANCET NEUROL, V4, P653, DOI 10.1016/S1474-4422(05)70194-0; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gomez-Garcia L, 2005, PARASITE IMMUNOL, V27, P395, DOI 10.1111/j.1365-3024.2005.00790.x; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Medzhitov R, 2007, SEMIN IMMUNOL, V19, P1, DOI 10.1016/j.smim.2007.02.001; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Mishra BB, 2009, INFECT IMMUN; Mishra BB, 2006, J NEUROIMMUNOL, V181, P46, DOI 10.1016/j.jneuroim.2006.07.019; Mishra BB, 2009, CURR TOP MICROBIOL, V336, P83, DOI 10.1007/978-3-642-00549-7_5; Mishra BB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-53; MOLINARI JL, 1990, ANN TROP MED PARASIT, V84, P205, DOI 10.1080/00034983.1990.11812458; Nash TE, 2006, NEUROLOGY, V67, P1120, DOI 10.1212/01.wnl.0000238514.51747.3a; Ong HL, 2007, J BIOL CHEM, V282, P12176, DOI 10.1074/jbc.M609435200; Pani B, 2008, J BIOL CHEM, V283, P17333, DOI 10.1074/jbc.M800107200; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Pani B, 2012, FRONT BIOSCI-LANDMRK, V17, P805, DOI 10.2741/3958; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Putney JW, 2001, J CELL SCI, V114, P2223; Restrepo BI, 2001, INFECT IMMUN, V69, P4554, DOI 10.1128/IAI.69.7.4554-4560.2001; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Robinson P, 1997, INFECT IMMUN, V65, P2925, DOI 10.1128/IAI.65.7.2925-2931.1997; Sciutto E, 2007, PARASITE IMMUNOL, V29, P621, DOI 10.1111/j.1365-3024.2007.00967.x; SCIUTTO E, 1995, INFECT IMMUN, V63, P2277, DOI 10.1128/IAI.63.6.2277-2281.1995; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Singh BB, 2001, FASEB J, V15, P1652, DOI 10.1096/fj.00-0749fje; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Terrazas LI, 2008, CURR TOP MED CHEM, V8, P383, DOI 10.2174/156802608783790848; Weinstock JV, 2006, ANN NY ACAD SCI, V1072, P356, DOI 10.1196/annals.1326.033; White AC, 1997, CHEM IMMUNOL, V66, P209; White AC, 2000, ANNU REV MED, V51, P187, DOI 10.1146/annurev.med.51.1.187; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003	69	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101023	10.1371/journal.pone.0101023	http://dx.doi.org/10.1371/journal.pone.0101023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013939	Green Submitted, Green Published, gold			2022-12-25	WOS:000339378400016
J	De Preester, H; Tsakiris, M				De Preester, Helena; Tsakiris, Manos			Sensitivity to Differences in the Motor Origin of Drawings: From Human to Robot	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; IMPLIED MOTION; PERCEPTION; BRAIN; INVOLVEMENT; MECHANISMS; IMITATION; CORTEX; ART	This study explores the idea that an observer is sensitive to differences in the static traces of drawings that are due to differences in motor origin. In particular, our aim was to test if an observer is able to discriminate between drawings made by a robot and by a human in the case where the drawings contain salient kinematic cues for discrimination and in the case where the drawings only contain more subtle kinematic cues. We hypothesized that participants would be able to correctly attribute the drawing to a human or a robot origin when salient kinematic cues are present. In addition, our study shows that observers are also able to detect the producer behind the drawings in the absence of these salient kinematic cues. The design was such that in the absence of salient kinematic cues, the drawings are visually very similar, i.e. only differing in subtle kinematic differences. Observers thus had to rely on these subtle kinematic differences in the line trajectories between drawings. However, not only motor origin (human versus robot) but also motor style (natural versus mechanic) plays a role in attributing a drawing to the correct producer, because participants scored less high when the human hand draws in a relatively mechanical way. Overall, this study suggests that observers are sensitive to subtle kinematic differences between visually similar marks in drawings that have a different motor origin. We offer some possible interpretations inspired by the idea of "motor resonance''.	[De Preester, Helena] Univ Ghent, Univ Coll Ghent, Sch Arts, B-9000 Ghent, Belgium; [De Preester, Helena] Univ Ghent, Dept Philosophy & Moral Sci, B-9000 Ghent, Belgium; [Tsakiris, Manos] Univ London, Dept Psychol, London, England	Ghent University; HOGENT University College of Applied Sciences & Arts; Ghent University; University of London	De Preester, H (corresponding author), Univ Ghent, Univ Coll Ghent, Sch Arts, B-9000 Ghent, Belgium.	helena.depreester@ugent.be	De Preester, Helena/AAQ-2629-2020; TSAKIRIS, MANOS/C-1529-2008	TSAKIRIS, MANOS/0000-0001-7753-7576	University College Ghent (Belgium); Volkswagen Foundation	University College Ghent (Belgium); Volkswagen Foundation(Volkswagen)	This study was funded by the Research Fund of University College Ghent (Belgium) to HDP and European Platform for Life Sciences, Mind Sciences and Humanities of the Volkswagen Foundation to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00079; Beilock SL, 2001, J EXP PSYCHOL GEN, V130, P701, DOI 10.1037/0096-3445.130.4.701; Bull George, 1987, LIVES ARTISTS, VI; Calvo-Merino B, 2008, CONSCIOUS COGN, V17, P911, DOI 10.1016/j.concog.2007.11.003; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cross ES, 2012, HUM BRAIN MAPP, V33, P2238, DOI 10.1002/hbm.21361; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Freud Sigmund., 1919, STANDARD EDITION, P217; Gallagher S., 2005, BODY SHAPES MIND; Galle J, 2011, POETISCHE MACHINE AR; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; GALLESE V., 2011, ARTS SENSES, P455; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jentsch Ernst, 1997, ANGELAKI, P7, DOI DOI 10.1080/09697259708571910; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kim CY, 2007, SPATIAL VISION, V20, P545, DOI 10.1163/156856807782758395; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Longcamp M, 2006, NEUROIMAGE, V33, P681, DOI 10.1016/j.neuroimage.2006.06.042; Longcamp M, 2005, NEUROPSYCHOLOGIA, V43, P1801, DOI 10.1016/j.neuropsychologia.2005.01.020; Longcamp M, 2008, J COGNITIVE NEUROSCI, V20, P802, DOI 10.1162/jocn.2008.20504; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Osaka N, 2010, NEUROREPORT, V21, P264, DOI 10.1097/WNR.0b013e328335b371; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosand D, 2002, DRAWING ACTS STUDIES, pxii; Rosand David, 2013, MOVING IMAGINATION M, P205; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Sheets-Johnstone Maxine, 2013, MOVING IMAGINATION E, P19; Sofia Gabriele, 2013, MOVING IMAGINATION E, P69; Umilta A, 2012, PROSPETTIVE TEATRO N, P51; Umilta A, 2012, FRONTIERS NEUROSCIEN, DOI [10.3389/fnhum.2012.00311, DOI 10.3389/FNHUM.2012.00311]; Varela F.J., 1992, EMBODIED MIND COGNIT; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102318	10.1371/journal.pone.0102318	http://dx.doi.org/10.1371/journal.pone.0102318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8HH	25014198	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400087
J	Song, Y; Zhan, L; Yu, MZ; Huang, C; Meng, XM; Ma, TT; Zhang, L; Li, J				Song, Yang; Zhan, Lei; Yu, Mingzhe; Huang, Cheng; Meng, Xiaoming; Ma, Taotao; Zhang, Lei; Li, Jun			TRPV4 Channel Inhibits TGF-beta 1-Induced Proliferation of Hepatic Stellate Cells	PLOS ONE			English	Article							CARDIAC FIBROBLAST DIFFERENTIATION; LIVER FIBROSIS; MICRORNAS; DISEASE; MECHANISMS; FIBROGENESIS; MIGRATION; MICE	TRPV4, one of the TRP channels, is implicated in diverse physiological and pathological processes including cell proliferation. However, the role of TRPV4 in liver fibrosis is largely unknown. Here, we characterized the role of TRPV4 in regulating HSC-T6 cell proliferation. TRPV4 mRNA and protein were measured by RT-PCR and Western blot in patients and rat model of liver fibrosis in vivo and TGF-beta 1-activated HSC-T6 cells in vitro. Both mRNA and protein of TRPV4 were dramatically increased in liver fibrotic tissues of both patients and CCl4-treated rats. Stimulation of HSC-T6 cells with TGF-beta 1 resulted in increase of TRPV4 mRNA and protein. However, TGF-beta 1-induced HSC-T6 cell proliferation was inhibited by Ruthenium Red (Ru) or synthetic siRNA targeting TRPV4, and this was accompanied by downregulation of myofibroblast markers including alpha-SMA and Col1 alpha 1. Moreover, our study revealed that miR-203 was downregulated in liver fibrotic tissues and TGF-beta 1-treated HSC-T6 cell. Bioinformatics analyses predict that TRPV4 is the potential target of miR-203. In addition, overexpression of miR-203 in TGF-beta 1-induced HSC significantly reduced TRPV4 expression, indicating TRPV4, which was regulated by miR-203, may function as a novel regulator to modulate TGF-beta 1-induced HSC-T6 proliferation.	[Song, Yang; Zhan, Lei; Yu, Mingzhe; Huang, Cheng; Meng, Xiaoming; Ma, Taotao; Zhang, Lei; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China; [Song, Yang; Zhan, Lei; Yu, Mingzhe; Huang, Cheng; Meng, Xiaoming; Ma, Taotao; Zhang, Lei; Li, Jun] Anhui Med Univ, Inst Liver Dis, Hefei, Peoples R China; [Song, Yang] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Peoples R China.	lj@ahmu.edu.cn			National Science Foundation of China [81072686, 81273526, 81202978]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Science Foundation of China (NO 81072686, 81273526, 81202978) and publication fees were covered by NSFC (NO 81273526). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Chun JN, 2013, PFLUGERS ARCH; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fang L, 2013, TOXICOL APPL PHARM, V272, P713, DOI 10.1016/j.taap.2013.08.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hatano N, 2013, LIFE SCI, V92, P317, DOI 10.1016/j.lfs.2013.01.002; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; He Y, 2012, CELL SIGNAL, V24, P1923, DOI 10.1016/j.cellsig.2012.06.003; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hu F, 2012, ARCH ORAL BIOL; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Jordt S. E., 2007, V45, P253; Lafyatis Robert, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P395; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Liu H, 2012, LIFE SCI, V90, P612, DOI 10.1016/j.lfs.2012.02.012; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Thodeti CK, 2013, CHANNELS, V7, P211, DOI 10.4161/chan.24328; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Troidl C, 2009, J CELL MOL MED, V13, P2613, DOI 10.1111/j.1582-4934.2008.00579.x; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Zaninetti R, 2011, J NEUROCHEM, V116, P606, DOI 10.1111/j.1471-4159.2010.07144.x	31	28	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101179	10.1371/journal.pone.0101179	http://dx.doi.org/10.1371/journal.pone.0101179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013893	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400020
J	Fox, GJ; Sy, DN; Nhung, NV; Yu, B; Ellis, MK; Hung, NV; Cuong, NK; Lien, LT; Marks, GB; Saunders, BM; Britton, WJ				Fox, Gregory J.; Dinh Ngoc Sy; Nguyen Viet Nhung; Yu, Bing; Ellis, Magda K.; Nguyen Van Hung; Nguyen Kim Cuong; Luu Thi Lien; Marks, Guy B.; Saunders, Bernadette M.; Britton, Warwick J.			Polymorphisms of SP110 Are Associated with both Pulmonary and Extra-Pulmonary Tuberculosis among the Vietnamese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; VENOOCCLUSIVE DISEASE; INNATE IMMUNITY; SUSCEPTIBILITY; EPIDEMIOLOGY; POPULATION; EFFICIENCY; VARIANTS; LOCUS	Background: Tuberculosis (TB) is an infectious disease that remains a major cause of morbidity and mortality worldwide, yet reasons why only 10% of people infected with Mycobacterium tuberculosis go on to develop clinical disease are poorly understood. Genetically determined variation in the host immune response is one factor influencing the response to M. tuberculosis. SP110 is an interferon-responsive nuclear body protein with critical roles in cell cycling, apoptosis and immunity to infection. However association studies of the gene with clinical TB in different populations have produced conflicting results. Methods: To examine the importance of the SP110 gene in immunity to TB in the Vietnamese we conducted a case-control genetic association study of 24 SP110 variants, in 663 patients with microbiologically proven TB and 566 unaffected control subjects from three tertiary hospitals in northern Vietnam. Results: Five SNPs within SP110 were associated with all forms of TB, including four SNPs at the C terminus (rs10208770, rs10498244, rs16826860, rs11678451) under a dominant model and one SNP under a recessive model, rs7601176. Two of these SNPs were associated with pulmonary TB (rs10208770 and rs16826860) and one with extra-pulmonary TB (rs10498244). Conclusion: SP110 variants were associated with increased susceptibility to both pulmonary and extra-pulmonary TB in the Vietnamese. Genetic variants in SP110 may influence macrophage signaling responses and apoptosis during M. tuberculosis infection, however further research is required to establish the mechanism by which SP110 influences immunity to tuberculosis infection.	[Fox, Gregory J.; Marks, Guy B.] Woolcock Inst Med Res, Resp & Environm Epidemiol Res Grp, Sydney, NSW, Australia; [Fox, Gregory J.; Yu, Bing; Marks, Guy B.; Saunders, Bernadette M.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Fox, Gregory J.; Ellis, Magda K.; Saunders, Bernadette M.; Britton, Warwick J.] Centenary Inst, TB Res Grp, Sydney, NSW, Australia; [Dinh Ngoc Sy; Nguyen Viet Nhung; Nguyen Van Hung] Natl Lung Hosp, Hanoi, Vietnam; [Nguyen Kim Cuong] Hanoi Med Univ, Hanoi, Vietnam; [Yu, Bing] Royal Prince Alfred Hosp, Dept Med Genom, Sydney, NSW, Australia; [Luu Thi Lien] Hanoi Lung Hosp, Hanoi, Vietnam; [Marks, Guy B.] Liverpool Hosp, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Centenary Institute; Hanoi Medical University; University of Sydney; Liverpool Hospital	Fox, GJ (corresponding author), Woolcock Inst Med Res, Resp & Environm Epidemiol Res Grp, Sydney, NSW, Australia.	greg.fox@sydney.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Britton, Warwick/0000-0001-6721-9646; Yu, Bing/0000-0001-6013-5220; Saunders, Bernadette/0000-0003-0540-4445	Australian National Health and Medical Research Council Postgraduate Scholarship [571220]; Rebecca L. Cooper Foundation	Australian National Health and Medical Research Council Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Foundation	This work was supported by Australian National Health and Medical Research Council Postgraduate Scholarship [571220 to GJF] and a grant from the Rebecca L. Cooper Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhimanyu, 2011, HUM IMMUNOL, V72, P576, DOI 10.1016/j.humimm.2011.03.014; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Babb C, 2007, HUM GENET, V121, P521, DOI 10.1007/s00439-007-0335-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cliffe ST, 2012, J ALLERGY CLIN IMMUN, V130, P735, DOI 10.1016/j.jaci.2012.02.054; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fox GJ, 2013, ADV EXP MED BIOL, V783, P1, DOI 10.1007/978-1-4614-6111-1_1; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hijikata M, 2012, HUM GENET, V131, P675, DOI 10.1007/s00439-011-1112-8; Lei X, 2012, INFECT GENET EVOL, V12, P1473, DOI 10.1016/j.meegid.2012.05.011; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Liang L, 2011, INFECT GENET EVOL, V11, P934, DOI 10.1016/j.meegid.2011.02.017; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; MELLIS C, 1976, J PEDIATR-US, V88, P236, DOI 10.1016/S0022-3476(76)80988-2; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Nyholt DR, 2001, HUM GENET, V109, P564, DOI 10.1007/s00439-001-0611-4; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Png E, 2012, INFECT GENET EVOL, V12, P1319, DOI 10.1016/j.meegid.2012.04.006; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Szeszko JS, 2007, HUM GENET, V121, P155, DOI 10.1007/s00439-006-0293-z; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; van der Eijk EA, 2007, AM J RESP CRIT CARE, V176, P1281, DOI 10.1164/rccm.200703-435OC; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Yan BS, 2007, J IMMUNOL, V179, P6919, DOI 10.4049/jimmunol.179.10.6919; Zembrzuski VM, 2010, TUBERCULOSIS, V90, P44, DOI 10.1016/j.tube.2009.11.002	42	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99496	10.1371/journal.pone.0099496	http://dx.doi.org/10.1371/journal.pone.0099496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006821	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600006
J	Koch, FH; Yemshanov, D; Haack, RA; Magarey, RD				Koch, Frank H.; Yemshanov, Denys; Haack, Robert A.; Magarey, Roger D.			Using a Network Model to Assess Risk of Forest Pest Spread via Recreational Travel	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; DISPERSAL; FIREWOOD; TRANSPORT; PATHWAYS; SURVEILLANCE; INSECTS; TRADE	Long-distance dispersal pathways, which frequently relate to human activities, facilitate the spread of alien species. One pathway of concern in North America is the possible spread of forest pests in firewood carried by visitors to campgrounds or recreational facilities. We present a network model depicting the movement of campers and, by extension, potentially infested firewood. We constructed the model from US National Recreation Reservation Service data documenting more than seven million visitor reservations (including visitors from Canada) at campgrounds nationwide. This bi-directional model can be used to identify likely origin and destination locations for a camper-transported pest. To support broad-scale decision making, we used the model to generate summary maps for 48 US states and seven Canadian provinces that depict the most likely origins of campers traveling from outside the target state or province. The maps generally showed one of two basic spatial patterns of out-of-state (or out-of-province) origin risk. In the eastern United States, the riskiest out-of-state origin locations were usually found in a localized region restricted to portions of adjacent states. In the western United States, the riskiest out-of-state origin locations were typically associated with major urban areas located far from the state of interest. A few states and the Canadian provinces showed characteristics of both patterns. These model outputs can guide deployment of resources for surveillance, firewood inspections, or other activities. Significantly, the contrasting map patterns indicate that no single response strategy is appropriate for all states and provinces. If most out-of-state campers are traveling from distant areas, it may be effective to deploy resources at key points along major roads (e.g., interstate highways), since these locations could effectively represent bottlenecks of camper movement. If most campers are from nearby areas, they may have many feasible travel routes, so a more widely distributed deployment may be necessary.	[Koch, Frank H.] USDA, Forest Serv, Southern Res Stn, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC 27709 USA; [Yemshanov, Denys] Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada; [Haack, Robert A.] USDA, Forest Serv, No Res Stn, E Lansing, MI USA; [Magarey, Roger D.] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); United States Forest Service; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; North Carolina State University	Koch, FH (corresponding author), USDA, Forest Serv, Southern Res Stn, Eastern Forest Environm Threat Assessment Ctr, Res Triangle Pk, NC 27709 USA.	fhkoch@fs.fed.us		Koch, Frank/0000-0002-3750-4507; Magarey, Roger/0000-0002-5651-5965	US Department of Agriculture; interdepartmental Natural Resources Canada - Canadian Food Inspection Agency Forest Invasive Alien Species initiative	US Department of Agriculture(United States Department of Agriculture (USDA)); interdepartmental Natural Resources Canada - Canadian Food Inspection Agency Forest Invasive Alien Species initiative(Natural Resources CanadaCanadian Forest Service)	This work was supported by the US Department of Agriculture and an interdepartmental Natural Resources Canada - Canadian Food Inspection Agency Forest Invasive Alien Species initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal H, 2004, TOURISM MANAGE, V25, P387, DOI 10.1016/S0261-5177(03)00135-3; Barlow LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090511; Bodin O, 2010, ECOL MODEL, V221, P2393, DOI 10.1016/j.ecolmodel.2010.06.017; Cappaert David, 2005, American Entomologist, V51, P152; Cook DC, 2010, RISK ANAL, V30, P1303, DOI 10.1111/j.1539-6924.2010.01439.x; Cordell H. K., 2008, Forest History Today, P4; Cordell H.K., 2012, SRS150 USDA FOR SERV, P1, DOI [10.2737/SRS-GTR-150, DOI 10.2737/SRS-GTR-150]; Cordell HK., 2008, INT J WILDERNESS, V14, P7; Eagles P. F. J., 2002, Journal of Sustainable Tourism, V10, P132, DOI 10.1080/09669580208667158; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; Filbey M, 2002, HALTING INVASION STA; Guichard S, 2012, J APPL ECOL, V49, P287, DOI 10.1111/j.1365-2664.2011.02072.x; Haack R.A., 1987, P449; Haack R. A., 2011, Bulletin OEPP, V41, P39, DOI 10.1111/j.1365-2338.2010.02432.x; Haack RA, 1997, J FOREST, V95, P11; Haack RA, 2010, J ECON ENTOMOL, V103, P1682, DOI 10.1603/EC10041; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Hengeveld R., 1989, DYNAMICS BIOL INVASI; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jacobi WR, 2012, J ECON ENTOMOL, V105, P1645, DOI 10.1603/EC12069; Jacobi W. R., 2011, Arboriculture & Urban Forestry, V37, P126; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Koch FH, 2012, J ECON ENTOMOL, V105, P438, DOI 10.1603/EC11270; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2007, INVASION ECOLOGY; Lue C.C., 1996, J TRAVEL RES, V35, P41, DOI DOI 10.1177/004728759603500107; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Moslonka-Lefebvre M, 2011, PHYTOPATHOLOGY, V101, P392, DOI 10.1094/PHYTO-07-10-0192; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Ontario Ministry of Natural Resources, 2011, AR YOU MOV FIR IMP I; Paini DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044589; Peterson K, 2009, RES MANAGEMENT FINDI; Peterson K, 2012, J ENVIRON MANAGE, V112, P104, DOI 10.1016/j.jenvman.2012.06.023; Petrice TR, 2006, J ECON ENTOMOL, V99, P790, DOI 10.1603/0022-0493-99.3.790; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; Reaser JK, 2008, BIOL INVASIONS, V10, P1085, DOI 10.1007/s10530-007-9186-x; Ricciardi A, 2011, BIOSCIENCE, V61, P312, DOI 10.1525/bio.2011.61.4.11; Savage D, 2011, ECOL MODEL, V222, P1673, DOI 10.1016/j.ecolmodel.2011.03.003; Siikamaki J, 2011, P NATL ACAD SCI USA, V108, P14031, DOI 10.1073/pnas.1108688108; SOLOMON JD, 1995, AGR HDB, V706; Tobin PC, 2010, J ECON ENTOMOL, V103, P1569, DOI 10.1603/EC10140; United States Government Accountability Office, 2006, INV FOR PESTS LESS L; USDA Animal and Plant Health Inspection Service, 2011, RISK ASS MOV FIR US; VANDENBOSCH F, 1990, J MATH BIOL, V28, P529, DOI 10.1007/BF00164162; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Yemshanov D, 2013, J ENVIRON MANAGE, V129, P173, DOI 10.1016/j.jenvman.2013.07.013; Yemshanov D, 2012, DIVERS DISTRIB, V18, P33, DOI 10.1111/j.1472-4642.2011.00848.x	58	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102105	10.1371/journal.pone.0102105	http://dx.doi.org/10.1371/journal.pone.0102105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25007186	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600095
J	Torres-Leguizamon, M; Mathieu, J; Decaens, T; Dupont, L				Torres-Leguizamon, Magally; Mathieu, Jerome; Decaens, Thibaud; Dupont, Lise			Genetic Structure of Earthworm Populations at a Regional Scale: Inferences from Mitochondrial and Microsatellite Molecular Markers in Aporrectodea icterica (Savigny 1826)	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION ROUTES; LUMBRICUS-TERRESTRIS; DIVERSITY; DNA; SOFTWARE; BEHAVIOR; TESTS; PHYLOGEOGRAPHY; BOTTLENECKS; NEUTRALITY	Despite the fundamental role that soil invertebrates (e. g. earthworms) play in soil ecosystems, the magnitude of their spatial genetic variation is still largely unknown and only a few studies have investigated the population genetic structure of these organisms. Here, we investigated the genetic structure of seven populations of a common endogeic earthworm (Aporrectodea icterica) sampled in northern France to explore how historical species range changes, microevolutionary processes and human activities interact in shaping genetic variation at a regional scale. Because combining markers with distinct modes of inheritance can provide extra, complementary information on gene flow, we compared the patterns of genetic structure revealed using nuclear (7 microsatellite loci) and mitochondrial markers (COI). Both types of markers indicated low genetic polymorphism compared to other earthworm species, a result that can be attributed to ancient bottlenecks, for instance due to species isolation in southern refugia during the ice ages with subsequent expansion toward northern Europe. Historical events can also be responsible for the existence of two divergent, but randomly interbreeding mitochondrial lineages within all study populations. In addition, the comparison of observed heterozygosity among microsatellite loci and heterozygosity expected under mutation-drift equilibrium suggested a recent decrease in effective size in some populations that could be due to contemporary events such as habitat fragmentation. The absence of relationship between geographic and genetic distances estimated from microsatellite allele frequency data also suggested that dispersal is haphazard and that human activities favour passive dispersal among geographically distant populations.	[Torres-Leguizamon, Magally; Dupont, Lise] Univ Paris Est Creteil, Inst Ecol & Environm Sci Paris, Creteil, France; [Torres-Leguizamon, Magally] INRA, Unite Zool Forestiere UR0633, Orleans, France; [Mathieu, Jerome] Univ Paris 06, Inst Ecol & Environm Sci Paris, Paris, France; [Decaens, Thibaud] Univ Rouen, EA ECODIV 1293, Mont St Aignan, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Rouen Normandie	Dupont, L (corresponding author), Univ Paris Est Creteil, Inst Ecol & Environm Sci Paris, Creteil, France.	lise.dupont@u-pec.fr	mathieu, jerome/B-8478-2008; Decaens, Thibaud/AAA-5287-2020; Dupont, Lise/M-1712-2013	mathieu, jerome/0000-0002-9106-6106; Dupont, Lise/0000-0003-4824-2685	French National Research Agency (ANR) [ANR-08-JCJC-0023]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the French National Research Agency (ANR) as a part of the project EDISP No ANR-08-JCJC-0023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; ASMUSSEN MA, 1994, GENETICS, V138, P1351; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Basten CJ, 1997, GENETICS, V146, P1165; Bernier N, 1998, BIOL FERT SOILS, V26, P215, DOI 10.1007/s003740050370; Bouche M.B., 1972, LOMBRICIENS FRANCE E; Bouma J., 1991, ADV AGRONOMY, V46, P1; Brown George G., 2004, P13; Capowiez Y, 2006, SOIL BIOL BIOCHEM, V38, P285, DOI 10.1016/j.soilbio.2005.05.014; Capowiez Y, 2005, BIOL FERT SOILS, V41, P135, DOI 10.1007/s00374-004-0829-0; Capowiez Y, 2006, ECOTOX ENVIRON SAFE, V64, P198, DOI 10.1016/j.ecoenv.2005.02.013; Capowiez Y, 2010, ENVIRON POLLUT, V158, P388, DOI 10.1016/j.envpol.2009.09.003; Caro G, 2013, SOIL BIOL BIOCHEM, V58, P181, DOI 10.1016/j.soilbio.2012.11.019; Casellato S., 1987, Collana U.Z.I. Selected Symposia and Monographs, P75; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Costa D, 2013, APPL SOIL ECOL, V68, P61, DOI 10.1016/j.apsoil.2013.03.003; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Dupont L, 2007, DIVERS DISTRIB, V13, P808, DOI 10.1111/j.1472-4642.2007.00405.x; Dupont L, 2011, PEDOBIOLOGIA, V54, P217, DOI 10.1016/j.pedobi.2011.03.004; Edwards Clive A., 2004, P3; Eijsackers H, 2011, APPL SOIL ECOL, V50, P1, DOI 10.1016/j.apsoil.2011.07.008; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez R, 2011, SOIL BIOL BIOCHEM, V43, P2085, DOI 10.1016/j.soilbio.2011.06.007; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Gorres JH, 2001, SOIL BIOL BIOCHEM, V33, P1881, DOI 10.1016/S0038-0717(01)00068-2; Goudet J., 2000, FSTAT PROGRAM ESTIMA; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harper GL, 2006, MOL ECOL NOTES, V6, P325, DOI 10.1111/j.1471-8286.2005.01219.x; HARRISON RG, 1991, ANNU REV ECOL SYST, V22, P281, DOI 10.1146/annurev.ecolsys.22.1.281; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; King RA, 2008, MOL ECOL, V17, P4694; Knott KE, 2010, HEREDITY, V105, P341, DOI 10.1038/hdy.2010.31; Kvie KS, 2013, ECOL EVOL, V3, P126, DOI 10.1002/ece3.434; Laossi KR, 2008, PEDOBIOLOGIA, V51, P397, DOI 10.1016/j.pedobi.2007.11.001; Lavelle P, 2002, ECOL RES, V17, P441, DOI 10.1046/j.1440-1703.2002.00509.x; Lavelle P, 2001, EARTHWORM ECOLOGY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Mathieu J, 2014, J BIOGEOGR IN PRESS; Mathieu J, 2010, SOIL BIOL BIOCHEM, V42, P203, DOI 10.1016/j.soilbio.2009.10.018; MINAMIYA Y, 2009, EUR J SOIL BIOL, V45, P423, DOI DOI 10.1016/j.ejsobi.2009.06.004; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Novo M, 2008, MOL ECOL RESOUR, V8, P901, DOI 10.1111/j.1755-0998.2008.02105.x; Novo M, 2010, PEDOBIOLOGIA, V53, P375, DOI 10.1016/j.pedobi.2010.07.002; Novo Marta, 2009, Zoologica Scripta, V38, P537, DOI 10.1111/j.1463-6409.2009.00389.x; Nuria R, 2011, SOIL BIOL BIOCHEM, V43, P2032, DOI 10.1016/j.soilbio.2011.05.019; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pelosi C, 2013, AGR ECOSYST ENVIRON, V181, P223, DOI 10.1016/j.agee.2013.10.003; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Ponge JF, 2013, SOIL BIOL BIOCHEM, V67, P271, DOI 10.1016/j.soilbio.2013.08.026; Postma-Blaauw MB, 2006, PEDOBIOLOGIA, V50, P243, DOI 10.1016/j.pedobi.2006.02.001; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 1997, GENETICS, V145, P1219; Scheu S, 2002, OECOLOGIA, V133, P254, DOI 10.1007/s00442-002-1023-4; SCHWERT DP, 1977, CAN J ZOOL, V55, P245, DOI 10.1139/z77-029; Siqueira FD, 2013, PEDOBIOLOGIA, V56, P15, DOI 10.1016/j.pedobi.2012.08.006; Somers CM, 2011, PEDOBIOLOGIA, V54, P111, DOI 10.1016/j.pedobi.2010.11.002; Strunk H, 2012, EUR J SOIL BIOL, V48, P56, DOI 10.1016/j.ejsobi.2011.11.004; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas E, 2012, PLOS ONE, V7; Tomimatsu H, 2009, MOL ECOL, V18, P3918, DOI 10.1111/j.1365-294X.2009.04341.x; Torres-Leguizamon M, 2012, SOIL BIOL BIOCHEM, V51, P16, DOI 10.1016/j.soilbio.2012.03.020; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Velavan TP, 2007, MOL ECOL NOTES, V7, P1060, DOI 10.1111/j.1471-8286.2007.01776.x; Velavan TP, 2009, SOIL BIOL BIOCHEM, V41, P1591, DOI 10.1016/j.soilbio.2009.03.026; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; YOUNG AG, 1993, HEREDITY, V71, P277, DOI 10.1038/hdy.1993.136	80	27	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101597	10.1371/journal.pone.0101597	http://dx.doi.org/10.1371/journal.pone.0101597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003795	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700044
J	Anders, K; Gutt, A; Gartner, W; Essen, LO				Anders, Katrin; Gutt, Alexander; Gaertner, Wolfgang; Essen, Lars-Oliver			Phototransformation of the Red Light Sensor Cyanobacterial Phytochrome 2 from Synechocystis Species Depends on Its Tongue Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT PHYTOCHROME; P-R; THERMODYNAMIC ANALYSIS; CHROMOPHORE; FEMTOSECOND; TEMPERATURE; KINETICS; PHOTOCONVERSION; ISOMERIZATION; SPECTROSCOPY	Phytochromes are photoreceptors using a bilin tetrapyrrole as chromophore, which switch in canonical phytochromes between red (P-r) and far red (P-fr) light-absorbing states. Cph2 from Synechocystis sp., a noncanonical phytochrome, harbors besides a cyanobacteriochrome domain a second photosensory module, a P-r/P-fr-interconverting GAF-GAF bidomain (SynCph2(1-2)). As in the canonical phytochromes, a unique motif of the second GAF domain, the tongue region, seals the bilin-binding site in the GAF1 domain from solvent access. Time-resolved spectroscopy of the SynCph2(1-2) module shows four intermediates during P-r -> P-fr phototransformation and three intermediates during P-fr -> P-r back-conversion. A mutation in the tongue's conserved PRXSF motif, S385A, affects the formation of late intermediate R3 and of a P-fr-like state but not the back-conversion to P-r via a lumi-F-like state. In contrast, a mutation in the likewise conserved WXE motif, W389A, changes the photocycle at intermediate R2 and causes an alternative red light-adapted state. Here, back-conversion to P-r proceeds via intermediates differing from SynCph2(1-2). Replacement of this tryptophan that is similar to 15 angstrom distant from the chromophore by another aromatic amino acid, W389F, restores native P-r -> P-fr phototransformation. These results indicate large scale conformational changes within the tongue region of GAF2 during the final processes of phototransformation. We propose that in early intermediates only the chromophore and its nearest surroundings are altered, whereas late changes during R2 formation depend on the distant WXE motifs of the tongue region. Ser-385 within the PRXSF motif affects only late intermediate R3, when refolding of the tongue and docking to the GAF1 domain are almost completed.	[Anders, Katrin; Essen, Lars-Oliver] Univ Marburg, Dept Chem, D-35032 Marburg, Germany; [Anders, Katrin; Essen, Lars-Oliver] Univ Marburg, Dept Biol, D-35032 Marburg, Germany; [Gutt, Alexander; Gaertner, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany	Philipps University Marburg; Philipps University Marburg; Max Planck Society	Gartner, W (corresponding author), Max Planck Inst Chem Energy Convers, Stiftstr 34-36, D-45470 Mulheim, Germany.	wolfgang.gaertner@cec.mpg.de; essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026; Gartner, Wolfgang/0000-0002-6898-7011	Deutsche Forschungsgemeinschaft [ES152/9, ES152/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants ES152/9 and ES152/10.	Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Andel F, 1997, BIOSPECTROSCOPY, V3, P421, DOI 10.1002/(SICI)1520-6343(1997)3:6<421::AID-BSPY1>3.0.CO;2-3; Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Anders K, 2011, PHOTOCHEM PHOTOBIOL, V87, P160, DOI 10.1111/j.1751-1097.2010.00845.x; Bischoff M, 2001, BIOCHEMISTRY-US, V40, P181, DOI 10.1021/bi0011734; Borucki B, 2006, PHOTOCH PHOTOBIO SCI, V5, P553, DOI 10.1039/b603846h; BRANDLMEIER T, 1981, Z NATURFORSCH C, V36, P431; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Chizhov I, 2001, BIOPHYS J, V81, P1600, DOI 10.1016/S0006-3495(01)75814-6; Chizhov I, 2013, BIOPHYS J, V105, P2210, DOI 10.1016/j.bpj.2013.09.033; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Gartner W, 1996, EUR J BIOCHEM, V236, P978, DOI 10.1111/j.1432-1033.1996.00978.x; Heyes DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052418; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Jorissen HJMM, 2002, EUR J BIOCHEM, V269, P2662, DOI 10.1046/j.1432-1033.2002.02928.x; Kim PW, 2013, J PHYS CHEM LETT, V4, P2605, DOI 10.1021/jz401443q; MARGULIES L, 1979, J AM CHEM SOC, V101, P743, DOI 10.1021/ja00497a046; Michler I, 2001, PHOTOCHEM PHOTOBIOL, V74, P624, DOI 10.1562/0031-8655(2001)074&lt;0624:TRTAOT&gt;2.0.CO;2; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Remberg A, 1999, EUR J BIOCHEM, V266, P201, DOI 10.1046/j.1432-1327.1999.00844.x; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; Remberg A, 1998, BIOCHEMISTRY-US, V37, P9983, DOI 10.1021/bi980575x; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Schwinte P, 2009, PHOTOCHEM PHOTOBIOL, V85, P239, DOI 10.1111/j.1751-1097.2008.00426.x; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Song C, 2013, PHOTOCHEM PHOTOBIOL, V89, P259, DOI 10.1111/php.12029; Stanek M, 1998, CHEM-EUR J, V4, P1653, DOI 10.1002/(SICI)1521-3765(19980904)4:9<1653::AID-CHEM1653>3.0.CO;2-K; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang Y, 2012, J AM CHEM SOC, V134, P1408, DOI 10.1021/ja209413d; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548	39	17	17	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25590	25600		10.1074/jbc.M114.562082	http://dx.doi.org/10.1074/jbc.M114.562082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25012656	Green Published, hybrid			2022-12-25	WOS:000342130800020
J	Caceres, PS; Mendez, M; Ortiz, PA				Caceres, Paulo S.; Mendez, Mariela; Ortiz, Pablo A.			Vesicle-associated Membrane Protein 2 (VAMP2) but Not VAMP3 Mediates cAMP-stimulated Trafficking of the Renal Na+-K+-2Cl(-) Co-transporter NKCC2 in Thick Ascending Limbs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic AMP (cAMP); Epithelial Cell; Exocytosis; Kidney; Membrane Trafficking; SNARE Proteins; Na-K-Cl Co-transporter 2 (NKCC2); Epithelial Sodium Transport	K-CL COTRANSPORTER; SNARE-COMPLEX; CALCIUM-CHANNELS; COLLECTING DUCT; RAT-KIDNEY; N-TYPE; NA-K-2CL COTRANSPORTER; FUNCTIONAL IMPACT; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE	Background: Exocytic delivery of the renal co-transporter NKCC2 to the cell surface is a major mechanism for NaCl reabsorption. Results: We describe a mechanism that mediates cAMP-stimulated NKCC2 delivery in renal cells. Conclusion: Vesicle fusion protein VAMP2 interacts with NKCC2 and mediates cAMP-stimulated NKCC2 exocytic delivery. Significance: The molecular mechanism mediating NKCC2 exocytic delivery could provide new targets for treatment of hypertension. In the kidney, epithelial cells of the thick ascending limb (TAL) reabsorb NaCl via the apical Na+/K+/2Cl(-) co-transporter NKCC2. Steady-state surface NKCC2 levels in the apical membrane are maintained by a balance between exocytic delivery, endocytosis, and recycling. cAMP is the second messenger of hormones that enhance NaCl absorption. cAMP stimulates NKCC2 exocytic delivery via protein kinase A (PKA), increasing steady-state surface NKCC2. However, the molecular mechanism involved has not been studied. We found that several members of the SNARE family of membrane fusion proteins are expressed in TALs. Here we report that NKCC2 co-immunoprecipitates with VAMP2 in rat TALs, and they co-localize in discrete domains at the apical surface. cAMP stimulation enhanced VAMP2 exocytic delivery to the plasma membrane of renal cells, and stimulation of PKA enhanced VAMP2-NKCC2 co-immunoprecipitation in TALs. In vivo silencing of VAMP2 but not VAMP3 in TALs blunted cAMP-stimulated steady-state surface NKCC2 expression and completely blocked cAMP-stimulated NKCC2 exocytic delivery. VAMP2 was not involved in constitutive NKCC2 delivery. We concluded that VAMP2 but not VAMP3 selectively mediates cAMP-stimulated NKCC2 exocytic delivery and surface expression in TALs. We also demonstrated that cAMP stimulation enhances VAMP2 exocytosis and promotes VAMP2 interaction with NKCC2.	[Caceres, Paulo S.; Mendez, Mariela; Ortiz, Pablo A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Caceres, Paulo S.; Ortiz, Pablo A.] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ortiz, PA (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, 2799 W Grand Blvd,E&R 7044, Detroit, MI 48202 USA.	portiz1@hfhs.org	Mendez, Mariela/D-7033-2019	Mendez, Mariela/0000-0002-2537-7272; Ortiz, Pablo/0000-0002-7512-7255; Caceres, Paulo/0000-0003-0197-8177	National Institutes of Health [RO1 HL080409]; National Research Service Award [F32 HL096346-01]; American Heart Association [13IRG14770033, 10PRE3710001, 12PRE12070224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409, F32HL096346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL080409 (to P. A. O.) and National Research Service Award F32 HL096346-01 (to M. M.). This work was also supported by American Heart Association Grant 13IRG14770033 (to P. A. O.) and American Heart Association Predoctoral Fellowships 10PRE3710001 and 12PRE12070224 (to P. S. C.).	Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Breton S, 2002, AM J PHYSIOL-RENAL, V282, pF523, DOI 10.1152/ajprenal.00128.2001; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Fujita-Yoshigaki J, 1999, J BIOL CHEM, V274, P23642, DOI 10.1074/jbc.274.33.23642; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Haque MZ, 2011, AM J PHYSIOL-RENAL, V300, pF1096, DOI 10.1152/ajprenal.00600.2010; Inoue T, 1998, AM J PHYSIOL-RENAL, V275, pF752, DOI 10.1152/ajprenal.1998.275.5.F752; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; Mandon B, 1997, AM J PHYSIOL-RENAL, V273, pF718, DOI 10.1152/ajprenal.1997.273.5.F718; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MartinMoutot N, 1996, J BIOL CHEM, V271, P6567, DOI 10.1074/jbc.271.12.6567; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Mistry AC, 2007, J BIOL CHEM, V282, P30097, DOI 10.1074/jbc.M705866200; Mistry AC, 2010, AM J PHYSIOL-CELL PH, V298, pC1431, DOI 10.1152/ajpcell.00497.2009; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; NIELSEN S, 1995, J CLIN INVEST, V96, P1834, DOI 10.1172/JCI118229; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Sevilla L, 1997, ENDOCRINOLOGY, V138, P3006, DOI 10.1210/en.138.7.3006; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonalker PA, 2004, J PHARMACOL EXP THER, V311, P1052, DOI 10.1124/jpet.104.071209; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsuk S, 2008, BIOCHEMISTRY-US, V47, P8342, DOI 10.1021/bi800512p; Wang CC, 2010, MOL CELL BIOL, V30, P333, DOI 10.1128/MCB.00814-09; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Yokoyama CT, 1997, J NEUROSCI, V17, P6929; Yoshihara M, 1999, J NEUROSCI, V19, P2432; Zhu LQ, 2010, J NEUROSCI, V30, P3624, DOI 10.1523/JNEUROSCI.5223-09.2010	59	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23951	23962		10.1074/jbc.M114.589333	http://dx.doi.org/10.1074/jbc.M114.589333			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008321	Green Published, hybrid			2022-12-25	WOS:000341505000060
J	Keov, P; Lopez, L; Devine, SM; Valant, C; Lane, JR; Scammells, PJ; Sexton, PM; Christopoulos, A				Keov, Peter; Lopez, Laura; Devine, Shane M.; Valant, Celine; Lane, J. Robert; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur			Molecular Mechanisms of Bitopic Ligand Engagement with the M-1 Muscarinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Drug Discovery; Mutagenesis; Pharmacology; Receptor Structure-Function; Bitopic Ligand; Muscarinic Acetylcholine Receptors	2ND EXTRACELLULAR LOOP; SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTORS; ALLOSTERIC AGONIST; AMINO-ACIDS; PHARMACOLOGICAL AGONISM; FUNCTIONAL SELECTIVITY; SCANNING MUTAGENESIS; N-DESMETHYLCLOZAPINE; FORCE-FIELD	Background: Bitopic ligands bind concomitantly to orthosteric and allosteric receptor sites. Results: Residues affecting binding and biased signaling of the selective agonists TBPB and 77-LH-28-1 were identified at the M-1 muscarinic receptor. Conclusion: Novel bitopic ligand binding poses and mechanisms of receptor activation were identified. Significance: Understanding the basis of bitopic ligand mechanisms can enable the design of selective ligands. TBPB and 77-LH-28-1 are selective agonists of the M-1 muscarinic acetylcholine receptor (mAChR) that may gain their selectivity through a bitopic mechanism, interacting concomitantly with the orthosteric site and part of an allosteric site. The current study combined site-directed mutagenesis, analytical pharmacology,and molecular modeling to gain further insights into the structural basis underlying binding and signaling by these agonists. Mutations within the orthosteric binding site caused similar reductions in affinity and signaling efficacy for both selective and prototypical orthosteric ligands. In contrast, the mutation of residues within transmembrane helix (TM) 2 and the second extracellular loop (ECL2) discriminated between the different classes of ligand. In particular, ECL2 appears to be involved in the selective binding of bitopic ligands and in coordinating biased agonism between intracellular calcium mobilization and ERK1/2 phosphorylation. Molecular modeling of the interaction between TBPB and the M-1 mAChR revealed a binding pose predicted to extend from the orthosteric site up toward a putative allosteric site bordered by TM2, TM3, and TM7, thus consistent with a bitopic mode of binding. Overall, these findings provide valuable structural and mechanistic insights into bitopic ligand actions and receptor activation and support a role for ECL2 in dictating the active states that can be adopted by a G protein-coupled receptor. This may enable greater selective ligand design and development for mAChRs and facilitate improved identification of bitopic ligands.	[Keov, Peter; Lopez, Laura; Valant, Celine; Lane, J. Robert; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia; [Keov, Peter; Lopez, Laura; Valant, Celine; Lane, J. Robert; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia; [Devine, Shane M.; Scammells, Peter J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem Theme, Parkville, Vic 3052, Australia	Monash University; Monash University; Monash University	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Parade, Parkville, Vic 3052, Australia.	arthur.christopoulos@monash.edu	Sexton, Patrick M/B-1319-2008; Devine, Shane/AAO-5994-2020; Keov, Peter/AGE-7936-2022; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Devine, Shane/0000-0001-8727-7392; Christopoulos, Arthur/0000-0003-4442-3294; Lane, J. Robert/0000-0002-7361-7875; Scammells, Peter/0000-0003-2930-895X; Keov, Peter/0000-0002-3829-6455; Valant, Celine/0000-0002-2509-7465	Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne [VR0024]	Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne	We are grateful for the assistance of Dr. Nathan E. Hall for help with the selection of some of the mutations for this study and to Drs. Michael Crouch and Ron Osmond (TGR Biosciences) for the generous supply of the SureFire ERK1/2 kit. The computational studies were supported by Resource Allocation Scheme Grant VR0024 from the Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne.	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Babaoglu K, 2006, NAT CHEM BIOL, V2, P720, DOI 10.1038/nchembio831; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bee MS, 2007, J BIOL CHEM, V282, P32471, DOI 10.1074/jbc.M703909200; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLACK JW, 1985, BRIT J PHARMACOL, V84, P561, DOI 10.1111/j.1476-5381.1985.tb12941.x; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Bridges TM, 2008, BIOORG MED CHEM LETT, V18, P5439, DOI 10.1016/j.bmcl.2008.09.023; Budzik B, 2010, ACS MED CHEM LETT, V1, P244, DOI 10.1021/ml100105x; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Gregory KJ, 2012, J BIOL CHEM, V287, P37066, DOI 10.1074/jbc.M112.408534; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Jacobson MA, 2010, MOL PHARMACOL, V78, P648, DOI 10.1124/mol.110.065771; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Keov P, 2013, MOL PHARMACOL, V84, P425, DOI 10.1124/mol.113.087320; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Koole C, 2012, J BIOL CHEM, V287, P3659, DOI 10.1074/jbc.M111.309369; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Krejci A, 2001, MOL PHARMACOL, V60, P761; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Lebois EP, 2010, ACS CHEM NEUROSCI, V1, P104, DOI 10.1021/cn900003h; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANSOUR A, 1992, EUR J PHARM-MOLEC PH, V227, P205, DOI 10.1016/0922-4106(92)90129-J; Marlo JE, 2009, MOL PHARMACOL, V75, P577, DOI 10.1124/mol.108.052886; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Narlawar R, 2010, J MED CHEM, V53, P3028, DOI 10.1021/jm901252a; Nathan PJ, 2013, INT J NEUROPSYCHOPH, V16, P721, DOI 10.1017/S1461145712000752; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Steinfeld T, 2007, MOL PHARMACOL, V72, P291, DOI 10.1124/mol.106.033746; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRUMPPKALLMEYER S, 1992, J MED CHEM, V35, P3448, DOI 10.1021/jm00097a002; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; WANG CD, 1993, MOL PHARMACOL, V43, P931; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Ward SDC, 1999, MOL PHARMACOL, V56, P1031, DOI 10.1124/mol.56.5.1031	62	45	46	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23817	23837		10.1074/jbc.M114.582874	http://dx.doi.org/10.1074/jbc.M114.582874			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006252	hybrid, Green Published			2022-12-25	WOS:000341505000049
J	Liu, SZ; Jiang, LG; Meng, XQ; Han, XY; Cheng, D; Zhang, TL; Miao, YL				Liu, ShuZhen; Jiang, LiGang; Meng, XiaoQian; Han, XiaoYing; Cheng, Dong; Zhang, TianLiang; Miao, YiLiang			Effects of Aroclor 1254 on In Vivo Oocyte Maturation in the Mouse	PLOS ONE			English	Article							POLYCHLORINATED BIPHENYL MIXTURES; PERSISTENT ORGANIC POLLUTANTS; GENE-EXPRESSION; ENVIRONMENTAL CONTAMINANTS; ORGANOCHLORINE COMPOUNDS; REPRODUCTIVE TOXICITY; CUMULUS CELLS; BREAST-MILK; EXPOSURE; PCBS	Polychlorinated biphenyls (PCBs) are stable, lipophilic compounds that accumulate in the environment and in the food chain. Though some studies provided evidence that PCBs had adverse effects on reproductive function, most of these results were from in vitro models. Therefore we investigated the effect of Aroclor 1254 (a commercial PCBs mixture) treatments on in vivo maturation and developmental potential of mouse oocytes. In the present study, female ICR mice were treated with different doses (12.5, 25 and 50 mg/kg) of Aroclor 1254 (a commercial PCB mixture) once every 72 hours by intraperitoneal injection for 9 days. After three treatments of Aroclor 1254, the mice were superovulated to collect oocytes one day after the last exposure. The effects of Aroclor 1254 on oocyte maturation, fertilization, and preimplantation embryonic development were investigated. Immunofluorescence-stained oocytes were observed under a confocal microscope to assess the effects of Aroclor 1254 on spindle morphology. Parthenogenic activation and the incidence of cumulus apoptosis in cumulus-oocyte complexes were observed as well. Oocytes exposed to different doses of Aroclor 1254 in vivo were associated with a significant decrease in outgrowth potential, abnormal spindle configurations, and the inhibition of parthenogenetic activation of ovulated oocytes. Furthermore, the incidence of apoptosis in cumulus cells was increased after exposed to Aroclor 1254. These results may provide reference for the treatment of reproductive diseases such as infertility or miscarriage caused by environmental contaminants.	[Liu, ShuZhen; Meng, XiaoQian; Han, XiaoYing] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China; [Jiang, LiGang] Shandong Univ, Ctr Reprod Med, Qilu Hosp, Jinan 250100, Peoples R China; [Cheng, Dong; Zhang, TianLiang] Shandong Ctr Dis Control & Prevent, Dept Toxicol, Jinan, Peoples R China; [Miao, YiLiang] Huazhong Agr Univ, Coll Anim Sci & Technol, Minist Educ, Key Lab Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Shandong Normal University; Shandong University; Huazhong Agricultural University	Liu, SZ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China.	shuzhen26@163.com			National Nature Science Foundation of China [31101068]; Shandong Province Postdoctoral Innovation Project [201103102]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Postdoctoral Innovation Project	This study was supported by the National Nature Science Foundation of China (number 31101068) and Shandong Province Postdoctoral Innovation Project (number 201103102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini David F, 2003, Reprod Biomed Online, V6, P410; Arena SM, 2003, ARCH ENVIRON CON TOX, V44, P272, DOI 10.1007/s00244-002-2022-5; Bake MA, 2007, INT J HYG ENVIR HEAL, V210, P483, DOI 10.1016/j.ijheh.2007.01.016; BERGMAN A, 1994, ENVIRON HEALTH PERSP, V102, P464, DOI 10.2307/3432042; Brevini T, 2009, EUR J HISTOCHEM, V48, P347; Cai JL, 2011, TOXICOLOGY, V287, P21, DOI 10.1016/j.tox.2011.05.010; Campagna C, 2006, MOL REPROD DEV, V73, P83, DOI 10.1002/mrd.20365; Czaja K, 1999, ARCH ENVIRON CON TOX, V36, P498, DOI 10.1007/PL00006623; De Felip E, 2004, CHEMOSPHERE, V54, P1445, DOI 10.1016/j.chemosphere.2003.10.040; DUARTEDAVIDSON R, 1994, ENVIRON POLLUT, V84, P69, DOI 10.1016/0269-7491(94)90072-8; Foster W, 2000, J CLIN ENDOCR METAB, V85, P2954, DOI 10.1210/jc.85.8.2954; Frame GM, 1996, CHEMOSPHERE, V33, P603, DOI 10.1016/0045-6535(96)00214-7; Fromberg A, 1999, CHEMOSPHERE, V38, P3075, DOI 10.1016/S0045-6535(98)00514-1; Guillette LJ, 1999, ARCH ENVIRON CON TOX, V36, P447, DOI 10.1007/PL00006617; Kato Y, 2009, DRUG METAB DISPOS, V38, P697; Katz-Jaffe MG, 2009, THERIOGENOLOGY, V71, P939, DOI 10.1016/j.theriogenology.2008.10.024; KHOLKUTE SD, 1994, REPROD TOXICOL, V8, P487, DOI 10.1016/0890-6238(94)90031-0; Kietz S, 2003, MOL REPROD DEV, V64, P251, DOI 10.1002/mrd.10226; KIMBROUGH RD, 1995, CRIT REV TOXICOL, V25, P133, DOI 10.3109/10408449509021611; Kostyniak PJ, 1999, ENVIRON RES, V80, pS166, DOI 10.1006/enrs.1998.3939; Kruger N, 2008, CURR BIOL, V18, pR646, DOI 10.1016/j.cub.2008.06.069; Ma SF, 2005, THERIOGENOLOGY, V64, P1142, DOI 10.1016/j.theriogenology.2005.03.002; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Meo SC, 2005, THERIOGENOLOGY, V63, P2089, DOI 10.1016/j.theriogenology.2004.08.012; Miao YL, 2007, THERIOGENOLOGY, V68, P640, DOI 10.1016/j.theriogenology.2007.04.061; Miao YL, 2009, ENVIRON MOL MUTAGEN, V50, P666, DOI 10.1002/em.20506; Mori T, 2000, BIOL REPROD, V62, P913, DOI 10.1095/biolreprod62.4.913; Norstrom K, 2010, ENVIRON INT, V36, P855, DOI 10.1016/j.envint.2009.03.005; Olivero J, 2001, BIOCHEM PHARMACOL, V62, P1125, DOI 10.1016/S0006-2952(01)00768-7; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Pauwels A, 2000, ENVIRON HEALTH PERSP, V108, P553, DOI 10.1289/ehp.00108553; Pocar P, 2005, REPRODUCTION, V130, P857, DOI 10.1530/rep.1.00761; Pocar P, 2001, MOL REPROD DEV, V58, P411, DOI 10.1002/1098-2795(20010401)58:4&lt;411::AID-MRD8&gt;3.0.CO;2-R; Pocar P, 2006, REPROD TOXICOL, V22, P242, DOI 10.1016/j.reprotox.2006.04.023; Ptak G, 2012, HUM REPROD, V27, P1034, DOI 10.1093/humrep/der454; Ramos L, 1999, CHEMOSPHERE, V38, P3141, DOI 10.1016/S0045-6535(98)00521-9; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Segre M, 2002, TOXICOLOGY, V174, P163, DOI 10.1016/S0300-483X(02)00039-2; SIMMONS GJ, 1992, FUND APPL TOXICOL, V19, P446, DOI 10.1016/0272-0590(92)90184-J; Stack AS, 1999, TOXICOLOGY, V139, P137; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; TRAPP M, 1984, FERTIL STERIL, V42, P146; Van Emon JM, 2013, SCI TOTAL ENVIRON, V463, P326, DOI 10.1016/j.scitotenv.2013.05.020; van Woudenberg AB, 2012, REPROD TOXICOL, V34, P251, DOI 10.1016/j.reprotox.2012.05.098; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; Xia L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023996; Younglai EV, 2002, ARCH ENVIRON CON TOX, V43, P121, DOI 10.1007/s00244-001-0048-8; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102064	10.1371/journal.pone.0102064	http://dx.doi.org/10.1371/journal.pone.0102064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013911	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400060
J	Zhao, HS; Wang, LL; Dong, LL; Sun, HY; Gao, ZM				Zhao, Hansheng; Wang, Lili; Dong, Lili; Sun, Huayu; Gao, Zhimin			Discovery and Comparative Profiling of microRNAs in Representative Monopodial Bamboo (Phyllostachys edulis) and Sympodial Bamboo (Dendrocalamus latiflorus)	PLOS ONE			English	Article							SBP-BOX GENE; TARGET GENES; CDNA LIBRARY; MOSO BAMBOO; SMALL RNAS; ARABIDOPSIS; EVOLUTION; IDENTIFICATION; PLANT; SEQUENCES	Background: According to the growth pattern of bamboo, sympodial bamboo and monopodial bamboo are considered as two mainly kinds of bamboo. They have different phenotypes and different characteristics in developmental stage. Much attention had been paid on the study of bamboo cultivation, processing, physiology, biochemistry and molecular biology, which had made great progresses in the last decade, especially for the highlighted achievement of the bamboo genomics. However, there is no information available on concerning comparative profiling of miRNAs between sympodial bamboo and monopodial bamboo, which might play important roles in the regulation of bamboo development. Methodology/Principal Findings: We identified the profiles of small RNAs using leaf tissues from one sympodial bamboo i.e. moso bamboo (Phyllostachys edulis) and another monopodial bamboo i. e. mabamboo (Dendrocalamus latiflorus). The result showed that there were 19,295,759 and 11,513,888 raw sequence reads, in which 92 and 69 conserved miRNAs, as well as 95 and 62 novel miRNAs were identified in moso bamboo and ma bamboo, respectively. The ratio of high conserved miRNA families in ma bamboo is more than that in moso bamboo. In addition, a total of 49 and 106 potential targets were predicted in moso bamboo and ma bamboo, respectively, in which several targets for novel miRNAs are transcription factors that play important roles in plant development. More importantly, annotation of differentially expressed target genes was performed based on the analysis of pathway and gene ontology terms enrichment. Conclusions/Significance: This study provides the first large-scale sight of discovery and comparative characterization of miRNAomes between two representative bamboos belonged to sympodial bamboo and monopodial bamboo, respectively. Although it will be necessary to validate the function of miRNAs through more experimental research in further, these results lay a foundation for unraveling the miRNA-mediated molecular processes in different kinds of bamboo.	[Zhao, Hansheng; Wang, Lili; Dong, Lili; Sun, Huayu; Gao, Zhimin] Int Ctr Bamboo & Rattan, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China	International Centre for Bamboo & Rattan	Gao, ZM (corresponding author), Int Ctr Bamboo & Rattan, Key Open Lab Sci & Technol Bamboo & Rattan, State Forestry Adm, Beijing, Peoples R China.	gaozhimin@icbr.ac.cn	zhao, hansheng/GRS-2764-2022; wang, lili/HDL-7210-2022		State Forestry Administration of China [2011-4-55]; International Center for Bamboo and Rattan [1632013009]	State Forestry Administration of China; International Center for Bamboo and Rattan	This work was financially supported under the introduction project of "948'' by the State Forestry Administration of China (No. 2011-4-55) and the fundamental research fund of International Center for Bamboo and Rattan (No. 1632013009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Arteaga-Vazquez M, 2006, PLANT CELL, V18, P3355, DOI 10.1105/tpc.106.044420; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Han JG, 2009, MICROB ECOL, V58, P363, DOI 10.1007/s00248-009-9491-2; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Li YF, 2013, PLANT SCI, V203, P17, DOI 10.1016/j.plantsci.2012.12.014; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobovikov M., 2007, FOOD AGR ORG; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Ruiyang Chen, 2003, CHROMSOME ATLAS VARI, VIV; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Tang GL, 2010, SEMIN CELL DEV BIOL, V21, P782, DOI 10.1016/j.semcdb.2010.07.009; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wei Qiang, 2013, Yichuan, V35, P315, DOI 10.3724/SP.J.1005.2013.00315; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6; Zhao HS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau006; Zhao HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078755; Zhou Ben-zhi, 2005, Journal of Forestry Research (Harbin), V16, P143, DOI 10.1007/BF02857909	44	9	15	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102375	10.1371/journal.pone.0102375	http://dx.doi.org/10.1371/journal.pone.0102375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013900	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400091
J	Afonso, AS; Andrade, HA; Hazin, FHV				Afonso, Andre S.; Andrade, Humber A.; Hazin, Fabio H. V.			Structure and Dynamics of the Shark Assemblage off Recife, Northeastern Brazil	PLOS ONE			English	Article							JUVENILE SANDBAR SHARKS; GALEOCERDO-CUVIER; TIGER SHARKS; RELATIVE ABUNDANCE; ENVIRONMENTAL VARIABLES; NEGAPRION-BREVIROSTRIS; GINGLYMOSTOMA CIRRATUM; CARCHARHINUS-ACRONOTUS; TRIAKIS-SEMIFASCIATA; POPULATION-STRUCTURE	Understanding the ecological factors that regulate elasmobranch abundance in nearshore waters is essential to effectively manage coastal ecosystems and promote conservation. However, little is known about elasmobranch populations in the western South Atlantic Ocean. An 8-year, standardized longline and drumline survey conducted in nearshore waters off Recife, northeastern Brazil, allowed us to describe the shark assemblage and to monitor abundance dynamics using zero-inflated generalized additive models. This region is mostly used by several carcharhinids and one ginglymostomid, but sphyrnids are also present. Blacknose sharks, Carcharhinus acronotus, were mostly mature individuals and declined in abundance throughout the survey, contrasting with nurse sharks, Ginglymostoma cirratum, which proliferated possibly due to this species being prohibited from all harvest since 2004 in this region. Tiger sharks, Galeocerdo cuvier, were mostly juveniles smaller than 200 cm and seem to use nearshore waters off Recife between January and September. No long-term trend in tiger shark abundance was discernible. Spatial distribution was similar in true coastal species (i.e. blacknose and nurse sharks) whereas tiger sharks were most abundant at the middle continental shelf. The sea surface temperature, tidal amplitude, wind direction, water turbidity, and pluviosity were all selected to predict shark abundance off Recife. Interspecific variability in abundance dynamics across spatiotemporal and environmental gradients suggest that the ecological processes regulating shark abundance are generally independent between species, which could add complexity to multi-species fisheries management frameworks. Yet, further research is warranted to ascertain trends at population levels in the South Atlantic Ocean.	[Afonso, Andre S.; Andrade, Humber A.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Afonso, Andre S.] Univ Algarve, Fac Ciencias & Tecnol, Faro, Portugal	Universidade Federal Rural de Pernambuco (UFRPE); Universidade do Algarve	Afonso, AS (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil.	afonso.andre@gmail.com		Afonso, Andre/0000-0001-9129-278X; Hazin, Fabio/0000-0003-3755-5379	State Government of Pernambuco, Brazil; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/37065/2007]	State Government of Pernambuco, Brazil; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Financial support was obtained from the State Government of Pernambuco (www.sds.pe.gov.br), Brazil, and Fundacao para a Ciencia e Tecnologia (www.fct.pt), Portugal (contract no. SFRH/BD/37065/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Afonso AS, 2011, FISH RES, V108, P336, DOI 10.1016/j.fishres.2011.01.007; Afonso AS, 2013, THESIS U ALGRAVE FAR; [Anonymous], 2009, SHARKS RAYS AUSTR; Barreto RR, 2011, FISH RES, V110, P170, DOI 10.1016/j.fishres.2011.04.003; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Belcher CN, 2010, ENVIRON BIOL FISH, V88, P349, DOI 10.1007/s10641-010-9648-3; Bethea DM, 2004, MAR ECOL PROG SER, V268, P245, DOI 10.3354/meps268245; Bigelow H. B., 1953, MEM SEARS FDN MAR RE, V2, P514; Bigelow HB, 1948, FISHES W N ATLANTI 1, P59; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Carlson JK, 2001, ENVIRON BIOL FISH, V61, P427, DOI 10.1023/A:1011641302048; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Castro JI, 1996, B MAR SCI, V59, P508; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Cohen J., 1988, STAT POWER ANAL BEHA, P567; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; COMPAGNO LJV, 2005, FIELD GUIDE SHARKS W; Conrath CL, 2008, ENVIRON BIOL FISH, V82, P123, DOI 10.1007/s10641-007-9263-0; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Cunningham RB, 2005, ECOLOGY, V86, P1135, DOI 10.1890/04-0589; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DUDLEY SFJ, 1993, S AFR J MARINE SCI, V13, P237, DOI 10.2989/025776193784287356; Ferreira LC, 2013, ENVIRON BIOL FISH, V96, P735, DOI 10.1007/s10641-012-0067-5; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fisher RA, 1914, BIOMETRIKA, V10, P507; Giraudoux P., 2011, PGIRMESS DATA ANAL E; Green M, 2009, REPORT NSW SHARK MES; Grubbs R. Dean, 2007, V50, P87; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hazin FHV, 2014, ANIM CONSERV, V17, P287, DOI 10.1111/acv.12096; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Hazin Fabio Hissa Vieira, 2000, Arquivos de Ciencias do Mar, V33, P33; Hazin FHV, 2002, FISH B-NOAA, V100, P143; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hopkins TE, 2003, ENVIRON BIOL FISH, V66, P279, DOI 10.1023/A:1023907121605; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Liu H, 2011, SCAND J STAT, V38, P650, DOI 10.1111/j.1467-9469.2011.00748.x; Liu H, 2011, J AGR BIOL ENVIR ST, V16, P185, DOI 10.1007/s13253-010-0044-4; Liu H, 2010, J STAT SOFTW, V35, P1; Mann K.H, 2000, ECOLOGY COASTAL WATE, P406; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Minami M, 2007, FISH RES, V84, P210, DOI 10.1016/j.fishres.2006.10.019; Morgan M, 2009, IUCN 2013 IUCN RED L, P2; Ortiz M, 2004, FISH RES, V70, P275, DOI 10.1016/j.fishres.2004.08.028; Parsons GR, 2005, COPEIA, P914, DOI 10.1643/0045-8511(2005)005[0914:SCITDA]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahman NA, 1968, COURSE THEORETICAL S, P542; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Robins C. R., 1986, FIELD GUIDE ATLANTIC; Santander-Neto J, 2011, J MAR BIOL ASSOC UK, V91, P1193, DOI 10.1017/S0025315410001293; SCHWARTZ F J, 1984, Northeast Gulf Science, V7, P29; Shepherd TD, 2005, ECOL LETT, V8, P1095, DOI 10.1111/j.1461-0248.2005.00807.x; Siegfried KI, 2007, 13AW03 NOAA NMFS FIS; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Skomal Gregory B., 2007, V50, P17; SMITH SE, 1990, FISH B-NOAA, V88, P371; SNELSON F F JR, 1978, Florida Scientist, V41, P1; SNELSON FF, 1984, B MAR SCI, V34, P71; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; SUCHANEK TH, 1994, AM ZOOL, V34, P100; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Ulrich Glenn F., 2007, V50, P125; Vaudo JJ, 2009, MAR BIOL, V156, P2579, DOI 10.1007/s00227-009-1282-2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; Wiley TR, 2007, B MAR SCI, V80, P171; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	91	21	22	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102369	10.1371/journal.pone.0102369	http://dx.doi.org/10.1371/journal.pone.0102369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010514	gold, Green Submitted, Green Published			2022-12-25	WOS:000338763800096
J	Maejima, H; Nagashio, R; Yanagita, K; Hamada, Y; Amoh, Y; Sato, Y; Katsuoka, K				Maejima, Hideki; Nagashio, Ryo; Yanagita, Kengo; Hamada, Yuko; Amoh, Yasuyuki; Sato, Yuichi; Katsuoka, Kensei			Moesin and Stress-Induced Phosphoprotein-1 Are Possible Sero-Diagnostic Markers of Psoriasis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LIPOCORTIN-I; HUMAN SKIN; ANNEXIN-I; DISEASE; EXPRESSION; ARTHRITIS; KERATINOCYTES; ETANERCEPT; ACTIVATION	To identify diagnostic markers for psoriasis vulgaris and psoriatic arthritis, autoantibodies in sera from psoriasis vulgaris and psoriatic arthritis patients were screened by two-dimensional immunoblotting (2D-IB). Based on 2D-IB and MADLI TOF/TOF-MS analyses, eleven proteins each in psoriasis vulgaris and psoriatic arthritis were identified as autoantigens. Furthermore, serum levels of moesin, keratin 17 (K17), annexin A1 (ANXA1), and stress-induced phophoprotein-1 (STIP1), which were detected as autoantigens, were studied by dot blot analysis with psoriasis patients and healthy controls. The levels of moesin and STIP1 were significantly higher in sera from patients with psoriasis vulgaris than in the controls (moesin: P<0.05, STIP1: P<0.005). The area under the curve (AUC) for moesin and STIP1 between patients with psoraisis vulgaris and controls was 0.747 and 0.792, respectively. STIP1 and K17 levels were significantly higher in sera from patients with psoriatic arthritis than in those with psoriasis vulgaris (P<0.05 each). The AUC for STIP1 and K17 between patients with psoriatic arthritis and psoriasis vulgaris was 0.69 and 0.72, respectively. The STIP1 or moesin, CK17 serum level was not correlated with disease activity of psoriasis patients. These data suggest that STIP1 and moesin may be novel and differential sero-diagnostic markers for psoriasis vulgaris and psoriatic arthritis.	[Maejima, Hideki; Hamada, Yuko; Amoh, Yasuyuki; Katsuoka, Kensei] Kitasato Univ, Sch Med, Dept Dermatol, Sagamihara, Kanagawa 228, Japan; [Nagashio, Ryo; Yanagita, Kengo; Sato, Yuichi] Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Sagamihara, Kanagawa 228, Japan; [Nagashio, Ryo; Yanagita, Kengo; Sato, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University	Sato, Y (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Appl Tumor Pathol, Sagamihara, Kanagawa 228, Japan.	yuichi@med.kitasato-u.ac.jp						Boyman O, 2005, BRIT J DERMATOL, V152, P1211, DOI 10.1111/j.1365-2133.2005.06701.x; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; D'Acquisto F, 2008, RHEUMATOLOGY, V47, P636, DOI 10.1093/rheumatology/ken062; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; DEJONG EMGJ, 1991, ARCH DERMATOL RES, V283, P480, DOI 10.1007/BF00371788; FIERLBECK G, 1990, ARCH DERMATOL, V126, P351, DOI 10.1001/archderm.126.3.351; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Fu M, 2012, J DERMATOL SCI, V67, P161, DOI 10.1016/j.jdermsci.2012.06.008; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Hayem G, 1999, ANN RHEUM DIS, V58, P291, DOI 10.1136/ard.58.5.291; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; JIANG CK, 1994, MOL CELL BIOL, V14, P4759, DOI 10.1128/MCB.14.7.4759; KITAJIMA Y, 1991, J INVEST DERMATOL, V97, P1032, DOI 10.1111/1523-1747.ep12492494; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Lories RJU, 2008, CLIN EXP RHEUMATOL, V26, P96; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Nagashio R, 2010, PATHOL INT, V60, P71, DOI 10.1111/j.1440-1827.2009.02487.x; Nagashio R, 2008, LUNG CANCER, V62, P364, DOI 10.1016/j.lungcan.2008.03.026; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Paulus HE, 1999, J RHEUMATOL, V26, P2324; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; RIVERS JK, 1990, BRIT J DERMATOL, V123, P569, DOI 10.1111/j.1365-2133.1990.tb01472.x; SatoMatsumura KC, 1996, ARCH DERMATOL RES, V288, P565, DOI 10.1007/BF02505257; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Strober B, 2008, BRIT J DERMATOL, V159, P322, DOI 10.1111/j.1365-2133.2008.08628.x; Tagoe CE, 2008, J IMMUNOL, V181, P2813, DOI 10.4049/jimmunol.181.4.2813; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tsai CL, 2012, CELL REP, V2, P283, DOI 10.1016/j.celrep.2012.07.002; Wang CH, 2013, NAT IMMUNOL, V14, P72, DOI 10.1038/ni.2479	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101773	10.1371/journal.pone.0101773	http://dx.doi.org/10.1371/journal.pone.0101773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010044	Green Published, Green Submitted, gold			2022-12-25	WOS:000338763800037
J	Bourgeois, FT; Kim, JM; Mandl, KD				Bourgeois, Florence T.; Kim, Jeong Min; Mandl, Kenneth D.			Premarket Safety and Efficacy Studies for ADHD Medications in Children	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; ONCE-A-DAY; FOLLOW-UP; OROS METHYLPHENIDATE; EXTENDED-RELEASE; DOUBLE-BLIND; OPEN-LABEL; MTA; PHARMACOTHERAPY	Background: Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacotherapy is the mainstay of treatment, with a variety of ADHD medications available to patients. However, it is unclear to what extent the long-term safety and efficacy of ADHD drugs have been evaluated prior to their market authorization. We aimed to quantify the number of participants studied and their length of exposure in ADHD drug trials prior to marketing. Methods: We identified all ADHD medications approved by the Food and Drug Administration (FDA) and extracted data on clinical trials performed by the sponsor and used by the FDA to evaluate the drug's clinical efficacy and safety. For each ADHD medication, we measured the total number of participants studied and the length of participant exposure and identified any FDA requests for post-marketing trials. Results: A total of 32 clinical trials were conducted for the approval of 20 ADHD drugs. The median number of participants studied per drug was 75 (IQR 0, 419). Eleven drugs (55%) were approved after <100 participants were studied and 14 (70%) after <300 participants. The median trial length prior to approval was 4 weeks (IQR 2, 9), with 5 (38%) drugs approved after participants were studied <4 weeks and 10 (77%) after <6 months. Six drugs were approved with requests for specific additional post-marketing trials, of which 2 were performed. Conclusions: Clinical trials conducted for the approval of many ADHD drugs have not been designed to assess rare adverse events or long-term safety and efficacy. While post-marketing studies can fill in some of the gaps, better assurance is needed that the proper trials are conducted either before or after a new medication is approved.	[Bourgeois, Florence T.; Mandl, Kenneth D.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Bourgeois, Florence T.; Mandl, Kenneth D.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Bourgeois, Florence T.; Mandl, Kenneth D.] Boston Childrens Hosp, Harvard MIT Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Kim, Jeong Min] Wellesley Coll, Fac Arts & Sci, Wellesley, MA 02181 USA; [Mandl, Kenneth D.] Ctr Biomed Informat, Harvard Med Sch, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Wellesley College; Harvard University; Harvard Medical School	Bourgeois, FT (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Bourgeois, Florence/H-6710-2016	Bourgeois, Florence/0000-0001-7798-4560	National Institute of Child Health and Human Development [1R21HD072382]; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD072382] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Drs. Bourgeois and Mandl were supported by a grant from the National Institute of Child Health and Human Development (1R21HD072382), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PHARM PLANN E2E; [Anonymous], 1994, ICH HARM TRIP GUID E; [Anonymous], 1999, ARCH GEN PSYCHIAT, V56, P1073; [Anonymous], 2001, ICH TOP E10 CHOIC CO; Avorn J, 2006, CIRCULATION, V113, P2173, DOI 10.1161/CIRCULATIONAHA.106.625749; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Biederman J, 2008, PEDIATRICS, V121, pE73, DOI 10.1542/peds.2006-3695; Biederman J, 2007, BIOL PSYCHIAT, V62, P970, DOI 10.1016/j.biopsych.2007.04.015; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Duijnhoven RG, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001407; European Medicines Agency, 2008, GUID CLIN INV MED PR; European Medicines Agency, 2012, GUID GOOD PHARM PRAC; Findling RL, 2010, J CHILD ADOL PSYCHOP, V20, P365, DOI 10.1089/cap.2009.0122; Findling RL, 2010, CNS SPECTRUMS, V15, P419, DOI 10.1017/S1092852900000353; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Huang YS, 2011, CNS DRUGS, V25, P539, DOI 10.2165/11589380-000000000-00000; Jain Rakesh, 2011, Child Adolesc Psychiatry Ment Health, V5, P35, DOI 10.1186/1753-2000-5-35; Jain R, 2011, J AM ACAD CHILD PSY, V50, P171, DOI 10.1016/j.jaac.2010.11.005; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Manos MJ, 2007, J MANAGE CARE PHARM, V13, pS2; May DE, 2010, DRUGS, V70, P15, DOI 10.2165/11530540-000000000-00000; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; NIH Consensus Development Program, 1998, DIAGN TREATM ATT DEF; Pelham WE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e105; Raine J, 2011, CLIN PHARMACOL THER, V89, P650, DOI 10.1038/clpt.2011.28; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1015, DOI 10.1097/chi.0b013e3180686d7e; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502; U.S. Department of Health and Human Services, FDA REG INF; U.S. Food and Drug Administration, 2004, MED REV FOC XR; U.S. Food and Drug Administration, 1996, APPR LETT ADD; U.S. Food and Drug Administration, 2002, DRUG APPR PACK METH; U.S. Food and Drug Administration, 2012, FED REGISTER, V77, P13339; U.S. Food and Drug Administration, FDA ASKS ATT DEF HYP; U.S. Food and Drug Administration: Center for drug evaluation and research, 2010, SUPPL APPR KAPV; U.S. Food and Drug Administration: Center for drug evaluation and research, 2007, MED REV VYV; Visser SN, 2007, PEDIATRICS, V119, pS99, DOI 10.1542/peds.2006-2089O; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Voort JLV, 2014, J AM ACAD C IN PRESS; Warikoo N, 2013, EXPERT OPIN PHARMACO; Wigal SB, 2009, CNS DRUGS, V23, P21, DOI 10.2165/00023210-200923000-00004; Wilens T, 2005, J AM ACAD CHILD PSY, V44, P1015, DOI 10.1097/01.chi.0000173291.28688.e7; Wolraich ML, 2001, PEDIATRICS, V108, P883, DOI 10.1542/peds.108.4.883; 2007, FDA NEWS	44	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102249	10.1371/journal.pone.0102249	http://dx.doi.org/10.1371/journal.pone.0102249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007171	Green Submitted, Green Published, gold			2022-12-25	WOS:000339040600109
J	Brodie, A; Tovia-Brodie, O; Ofran, Y				Brodie, Aharon; Tovia-Brodie, Oholi; Ofran, Yanay			Large Scale Analysis of Phenotype-Pathway Relationships Based on GWAS Results	PLOS ONE			English	Article							GENE SET ENRICHMENT; HUMAN-IMMUNODEFICIENCY-VIRUS; GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULES; NASOPHARYNGEAL CARCINOMA; CANCER-RISK; DISEASE; EXPRESSION; NETWORKS; LOCI	The widely used pathway-based approach for interpreting Genome Wide Association Studies (GWAS), assumes that since function is executed through the interactions of multiple genes, different perturbations of the same pathway would result in a similar phenotype. This assumption, however, was not systemically assessed on a large scale. To determine whether SNPs associated with a given complex phenotype affect the same pathways more than expected by chance, we analyzed 368 phenotypes that were studied in >5000 GWAS. We found 216 significant phenotype-pathway associations between 70 of the phenotypes we analyzed and known pathways. We also report 391 strong phenotype-phenotype associations between phenotypes that are affected by the same pathways. While some of these associations confirm previously reported connections, others are new and could shed light on the molecular basis of these diseases. Our findings confirm that phenotype-associated SNPs cluster into pathways much more than expected by chance. However, this is true for <20% (70/368) of the phenotypes. Different types of phenotypes show markedly different tendencies: Virtually all autoimmune phenotypes show strong clustering of SNPs into pathways, while most cancers and metabolic conditions, and all electrophysiological phenotypes, could not be significantly associated with any pathway despite being significantly associated with a large number of SNPs. While this may be due to missing data, it may also suggest that these phenotypes could result only from perturbations of specific genes and not from other perturbations of the same pathway. Further analysis of pathway-associated versus gene-associated phenotypes is, therefore, needed in order to understand disease etiology and in order to promote better drug target selection.	[Brodie, Aharon; Ofran, Yanay] Bar Ilan Univ, Goodman Fac Life Sci, Ramat Gan, Israel; [Tovia-Brodie, Oholi] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, IL-69978 Tel Aviv, Israel	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Ofran, Y (corresponding author), Bar Ilan Univ, Goodman Fac Life Sci, Nanotechnol Bldg, Ramat Gan, Israel.	Yanay@ofranlab.org	Brodie, Oholi Tovia/AAH-6425-2019		Microsoft Research	Microsoft Research(Microsoft)	This work is supported by Microsoft Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1993, LAB INVEST, V68, P4; Alter G, 2006, CURR MOL MED, V6, P621, DOI 10.2174/156652406778195035; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Altman T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-112; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; BROWN B, 2012, DES ISSUES, V28, P1; Brumme ZL, 2006, AIDS REV, V8, P78; BUELL P, 1974, CANCER RES, V34, P1189; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Chang ET, 2006, ENIGMATIC EPIDEMIOLO; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Chen F, 2005, MEDICINE, V84, P98, DOI 10.1097/01.md.0000159082.45703.90; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Christy AL, 2007, J IMMUNOL, V179, P2673, DOI 10.4049/jimmunol.179.5.2673; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engsig Frederik N, 2011, Clin Epidemiol, V3, P217, DOI 10.2147/CLEP.S19875; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Franks AL, 2012, ANTICANCER RES, V32, P1119; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Friis AMC, 2012, VACCINE, V30, P6093, DOI 10.1016/j.vaccine.2012.07.041; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Goh KI, 2012, BRIEF FUNCT GENOMICS, V11, P533, DOI 10.1093/bfgp/els032; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hassen E, 2010, MOL BIOL REP, V37, P119, DOI 10.1007/s11033-009-9548-9; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Jia WH, 2004, CANCER-AM CANCER SOC, V101, P363, DOI 10.1002/cncr.20372; Juliano RL, 1993, CURR OPIN CELL BIOL, V5, P812, DOI 10.1016/0955-0674(93)90030-T; Kahaly GJ, 2009, POLYGLANDULAR AUTOIM; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik Donna, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s40; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Kofler R, 2012, BIOINFORMATICS, V28, P2084, DOI 10.1093/bioinformatics/bts315; Margulies DH, 2009, NAT IMMUNOL, V10, P566, DOI 10.1038/ni0609-566; Mavilio D, 2003, NATURAL KILLER CELLS; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Naeem H, 2012, BIOINFORMATICS, V28, P1480, DOI 10.1093/bioinformatics/bts164; Newby PR, 2010, EUR J HUM GENET, V18, P1021, DOI 10.1038/ejhg.2010.55; NIEDOBITEK G, 1992, AM J PATHOL, V140, P879; Niller HH, 2008, AUTOIMMUNITY, V41, P298, DOI 10.1080/08916930802024772; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Robbie-Ryan M, 2002, CURR OPIN IMMUNOL, V14, P728, DOI 10.1016/S0952-7915(02)00394-1; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Rose NR, 2006, E SCHERING RES FDN W, V55, P141; Rottem M, 2003, INT ARCH ALLERGY IMM, V132, P210, DOI 10.1159/000074301; Rottem Menachem, 2002, Dev Immunol, V9, P161, DOI 10.1080/1044667031000137638; Schoof N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029451; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shioda T, 2006, INT J HEMATOL, V84, P12, DOI 10.1532/IJH97.06100; Shnayder Y, 2001, LARYNGOSCOPE, V111, P1842, DOI 10.1097/00005537-200110000-00032; Song GG, 2013, J MOL NEUROSCI, V51, P428, DOI 10.1007/s12031-013-0047-z; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumpter TL, 2004, ROLE AUTOIMMUNITY OR; Takarabe D, 2010, AUTOIMMUNE DIABETES; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; van Baarle D, 2001, BLOOD, V98, P146, DOI 10.1182/blood.V98.1.146; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; WHO, 2012, ICD 10 CLASS MENT BE; Yun HD, 2012, MAYO CLIN PROC, V87, P953, DOI 10.1016/j.mayocp.2012.05.020; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1; Zendehdel K, 2003, CANC INCIDENCE PATIE; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zheng Z, 1999, HUM PATHOL, V30, P458, DOI 10.1016/S0046-8177(99)90123-5; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	83	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100887	10.1371/journal.pone.0100887	http://dx.doi.org/10.1371/journal.pone.0100887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007247	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600023
J	Feijen, EAM; van der Pal, HJ; van Dalen, EC; Mulder, RL; Bardi, E; Kuehni, C; Tissing, WJE; Kremer, LCM				Feijen, Elizabeth (Lieke) A. M.; van der Pal, Helena J.; van Dalen, Elvira C.; Mulder, Renee L.; Bardi, Edit; Kuehni, Claudia; Tissing, Wim J. E.; Kremer, Leontine C. M.			A New Method to Facilitate Valid and Consistent Grading Cardiac Events in Childhood Cancer Survivors Using Medical Records	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; WEIGHTED KAPPA; GUIDELINES; DIAGNOSIS; OUTCOMES; COHORT; ESC	Background: Cardiac events (CEs) are among the most serious late effects following childhood cancer treatment. To establish accurate risk estimates for the occurrence of CEs it is essential that they are graded in a valid and consistent manner, especially for international studies. We therefore developed a data-extraction form and a set of flowcharts to grade CEs and tested the validity and consistency of this approach in a series of patients. Methods: The Common Terminology Criteria for Adverse Events version 3.0 and 4.0 were used to define the CEs. Forty patients were randomly selected from a cohort of 72 subjects with known CEs that had been graded by a physician for an earlier study. To establish whether the new method was valid for appropriate grading, a non-physician graded the CEs by using the new method. To evaluate consistency of the grading, the same charts were graded again by two other non-physicians, one with receiving brief introduction and one with receiving extensive training on the new method. We calculated weighted Kappa statistics to quantify inter-observer agreement. Results: The inter-observer agreement was 0.92 (95% CI 0.80-1.00) for validity, and 0.88 (0.79-0.98) and 0.99 (0.96-1.00) for consistency with the outcome assessors who had the brief introduction and the extensive training, respectively. Conclusions: The newly developed standardized method to grade CEs using data from medical records has shown excellent validity and consistency. The study showed that the method can be correctly applied by researchers without a medical background, provided that they receive adequate training.	[Feijen, Elizabeth (Lieke) A. M.; van Dalen, Elvira C.; Mulder, Renee L.; Kremer, Leontine C. M.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [van der Pal, Helena J.] Acad Med Ctr, Dept Oncol, Amsterdam, Netherlands; [Bardi, Edit] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Kuehni, Claudia] Univ Bern, Inst Social & Prevent Med, Dept Pediat Oncol, Bern, Switzerland; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Oncol, Groningen, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Semmelweis University; University of Bern; University of Groningen	Feijen, EAM (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands.	e.a.feijen@amc.uva.nl		kremer, leontien/0000-0002-7619-7845; Kremer, Leontien/0000-0001-7422-3248; Kuehni, Claudia E./0000-0001-8957-2002	PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant) [257505]; Swiss Cancer League [KLS-02783-02-2011]	PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant); Swiss Cancer League	Financial support for this study was provided in part by a: grant from PanCare Childhood and Adolescent Cancer Survivor care and Follow-up studies Consortium (EU-Grant agreement number 257505) and Swiss Cancer League (KLS-02783-02-2011). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report.	Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Atkinson TM, 2012, QUAL LIFE RES, V21, P1159, DOI 10.1007/s11136-011-0031-4; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Orwin RG, 1994, HDB RES SYNTHESIS, P177; R Core Team, 2022, R LANG ENV STAT COMP; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730	15	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100432	10.1371/journal.pone.0100432	http://dx.doi.org/10.1371/journal.pone.0100432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL3PK	25006805	Green Published, gold, Green Submitted			2022-12-25	WOS:000339040600013
J	Oliver, KL; Lukic, V; Thorne, NP; Berkovic, SF; Scheffer, IE; Bahlo, M				Oliver, Karen L.; Lukic, Vesna; Thorne, Natalie P.; Berkovic, Samuel F.; Scheffer, Ingrid E.; Bahlo, Melanie			Harnessing Gene Expression Networks to Prioritize Candidate Epileptic Encephalopathy Genes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; GRIN2A MUTATIONS; WEB TOOLS; CLASSIFICATION; ASSOCIATIONS; EPILEPSIES; DISCOVERY; PROTEINS; SEIZURES; APHASIA	We apply a novel gene expression network analysis to a cohort of 182 recently reported candidate Epileptic Encephalopathy genes to identify those most likely to be true Epileptic Encephalopathy genes. These candidate genes were identified as having single variants of likely pathogenic significance discovered in a large-scale massively parallel sequencing study. Candidate Epileptic Encephalopathy genes were prioritized according to their co-expression with 29 known Epileptic Encephalopathy genes. We utilized developing brain and adult brain gene expression data from the Allen Human Brain Atlas (AHBA) and compared this to data from Celsius: a large, heterogeneous gene expression data warehouse. We show replicable prioritization results using these three independent gene expression resources, two of which are brain-specific, with small sample size, and the third derived from a heterogeneous collection of tissues with large sample size. Of the nineteen genes that we predicted with the highest likelihood to be true Epileptic Encephalopathy genes, two (GNAO1 and GRIN2B) have recently been independently reported and confirmed. We compare our results to those produced by an established in silico prioritization approach called Endeavour, and finally present gene expression networks for the known and candidate Epileptic Encephalopathy genes. This highlights sub-networks of gene expression, particularly in the network derived from the adult AHBA gene expression dataset. These networks give clues to the likely biological interactions between Epileptic Encephalopathy genes, potentially highlighting underlying mechanisms and avenues for therapeutic targets.	[Oliver, Karen L.; Lukic, Vesna; Thorne, Natalie P.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Oliver, Karen L.; Berkovic, Samuel F.; Scheffer, Ingrid E.] Univ Melbourne, Austin Hlth, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic, Australia; [Scheffer, Ingrid E.] Florey Inst, Melbourne, Vic, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne	Bahlo, M (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia.	bahlo@wehi.edu.au	Oliver, Karen Louise/O-6159-2018; jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013	Oliver, Karen Louise/0000-0001-5188-6153; Scheffer, Ingrid E/0000-0002-2311-2174; Bahlo, Melanie/0000-0001-5132-0774; Berkovic, Samuel/0000-0003-4580-841X	Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS; Australian Research Council Future Fellowship [FT100100764]; National Health and Medical Research Council of Australia Program Grant [628952]; Practitioner Fellowship [1006110]	Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	MB, NT and VL were supported by Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS funding to their institute. MB was also supported by an Australian Research Council Future Fellowship (FT100100764). SFB and IES were supported by a National Health and Medical Research Council of Australia Program Grant 628952 and IES was supported by Practitioner Fellowship 1006110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Campbell IM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003797; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Chen YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021137; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Jia PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017162; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Oti M, 2011, METHODS MOL BIOL, V760, P189, DOI 10.1007/978-1-61779-176-5_12; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Piro RM, 2012, FEBS J, V279, P678, DOI 10.1111/j.1742-4658.2012.08471.x; Piro RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023149; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tebbenkamp ATN, 2014, CURR OPIN NEUROL, V27, P149, DOI 10.1097/WCO.0000000000000069; Tranchevent LC, 2011, BRIEF BIOINFORM, V12, P22, DOI 10.1093/bib/bbq007; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Warnes GR, 2014, GTOOLS VARIOUS R PRO; Wickham H, 2007, J STAT SOFTW, V21, P1; Zheng T, 2006, J AM STAT ASSOC, V101, P409, DOI 10.1198/016214505000001168	40	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e102079	10.1371/journal.pone.0102079	http://dx.doi.org/10.1371/journal.pone.0102079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25014031	Green Published, gold			2022-12-25	WOS:000339040600091
J	Roy, A; Modi, KK; Khasnavis, S; Ghosh, S; Watson, R; Pahan, K				Roy, Avik; Modi, Khushbu K.; Khasnavis, Saurabh; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			Enhancement of Morphological Plasticity in Hippocampal Neurons by a Physically Modified Saline via Phosphatidylinositol-3 Kinase	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; RESPONSE ELEMENT-BINDING; KAPPA-B ACTIVATION; ALZHEIMERS-DISEASE; UP-REGULATION; NITRIC-OXIDE; PROTEIN-LEVELS; EXPRESSION; MEMORY; RECEPTORS	Increase of the density of dendritic spines and enhancement of synaptic transmission through ionotropic glutamate receptors are important events, leading to synaptic plasticity and eventually hippocampus-dependent spatial learning and memory formation. Here we have undertaken an innovative approach to upregulate hippocampal plasticity. RNS60 is a 0.9% saline solution containing charge-stabilized nanobubbles that are generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. RNS60, but not NS (normal saline), PNS60 (saline containing a comparable level of oxygen without the TCP modification), or RNS10.3 (TCP-modified normal saline without excess oxygen), stimulated morphological plasticity and synaptic transmission via NMDA- and AMPA-sensitive calcium influx in cultured mouse hippocampal neurons. Using mRNA-based targeted gene array, real-time PCR, immunoblot, and immunofluorescence analyses, we further demonstrate that RNS60 stimulated the expression of many plasticity-associated genes in cultured hippocampal neurons. Activation of type IA, but not type IB, phosphatidylinositol-3 (PI-3) kinase by RNS60 together with abrogation of RNS60-mediated upregulation of plasticity-related proteins (NR2A and GluR1) and increase in spine density, neuronal size, and calcium influx by LY294002, a specific inhibitor of PI-3 kinase, suggest that RNS60 upregulates hippocampal plasticity via activation of PI-3 kinase. Finally, in the 5XFAD transgenic model of Alzheimer's disease (AD), RNS60 treatment upregulated expression of plasticity-related proteins PSD95 and NR2A and increased AMPA-and NMDA-dependent hippocampal calcium influx. These results describe a novel property of RNS60 in stimulating hippocampal plasticity, which may help AD and other dementias.	[Roy, Avik; Modi, Khushbu K.; Khasnavis, Saurabh; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Khasnavis, Saurabh/K-2249-2019		Revalesio Corporation	Revalesio Corporation	This work was supported by Revalesio Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Clayton DA, 2002, J NEUROSCI, V22, P3628; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Desjardins S, 1997, NEUROBIOL AGING, V18, P37, DOI 10.1016/S0197-4580(96)00206-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Geerts H, 2006, J CLIN PHARMACOL, V46, p8S, DOI 10.1177/0091270006288734; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Good PF, 1996, AM J PATHOL, V149, P21; Grinevich V, 2012, Endocr Regul, V46, P153; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 2001, Sci STKE, V2001, ppe1; Isaac J, 2001, NEURON, V32, P963, DOI 10.1016/S0896-6273(01)00545-1; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Jana M, 2007, NEUROCHEM RES, V32, P2015, DOI 10.1007/s11064-007-9340-y; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P218, DOI 10.1007/s11481-013-9503-3; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Medina AE, 2001, NEURON, V32, P553, DOI 10.1016/S0896-6273(01)00514-1; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Myers SJ, 1999, ANNU REV PHARMACOL, V39, P221, DOI 10.1146/annurev.pharmtox.39.1.221; Olney JW, 1998, RESTOR NEUROL NEUROS, V13, P75; Proctor DT, 2010, J ALZHEIMERS DIS, V21, P795, DOI 10.3233/JAD-2010-100090; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Rossom Rebecca, 2004, Am J Geriatr Pharmacother, V2, P303, DOI 10.1016/j.amjopharm.2004.12.006; Roy A, 2013, PLOS ONE, V7; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selvakumar B, 2013, P NATL ACAD SCI USA, V110, P1077, DOI 10.1073/pnas.1221295110; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Xia ZG, 2012, LEARN MEMORY, V19, P369, DOI 10.1101/lm.027128.112; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101883	10.1371/journal.pone.0101883	http://dx.doi.org/10.1371/journal.pone.0101883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007337	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600075
J	Sun, NX; Ye, C; Zhao, Q; Zhang, Q; Xu, C; Wang, SB; Jin, ZJ; Sun, SH; Wang, F; Li, W				Sun, Ning-xia; Ye, Chen; Zhao, Qian; Zhang, Qing; Xu, Chen; Wang, Shao-bing; Jin, Zhi-jun; Sun, Shu-han; Wang, Fang; Li, Wen			Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer	PLOS ONE			English	Article							ZESTE HOMOLOG 2; EXPRESSION; GENE; METASTASIS; ENHANCER; PROLIFERATION; ACTIVATION; INSIGHTS; LINKS	In recent years, long noncoding RNAs (lncRNAs) have been demonstrated to play key roles in tumorgenesis. However, the contributions of lncRNAs to cervical cancer (CC) remain largely unknown. In this study, differentially expressed lncRNAs and mRNAs in cervical cancer and paired peritumoral tissues were detected by transcriptome microarray analysis. We found 708 probe sets of lncRNAs increased and 836 probe sets decreased in CC tissues, while 1288 mRNA differential probe sets increased and 901 mRNA probe sets decreased. The results were validated by quantitative real-time polymerase chain reaction (qPCR). Then, we found a specific differentially expressed lncRNA can physically bind to enhancer of zeste homolog2 (EZH2) by using RNA immunoprecipitation. We termed it as EZH2-binding lncRNA in cervical cancer [lncRNA-EBIC]. Wound healing assays and Matrigel invasion assays were used to determine the function of this lncRNA by silencing it. We observed that the migration and invasion of cervical cancer cells in vitro were inhibited upon suppression of lncRNA-EBIC by siRNA. We also found that the association between lncRNA-EBIC and EZH2 was required for the repression of E-cadherin, which was a key molecular in the metastasis of cervical cancer. Conclusion: These results demonstrated that lncRNA-EBIC was an oncogenic lncRNA, which could promote tumor cell invasion in CC by binding to EZH2 and inhibiting E-cadherin expression.	[Sun, Ning-xia; Ye, Chen; Zhao, Qian; Zhang, Qing; Xu, Chen; Jin, Zhi-jun; Li, Wen] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Obstet & Gynaecol, Shanghai, Peoples R China; [Wang, Shao-bing; Sun, Shu-han; Wang, Fang] Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Wang, F (corresponding author), Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China.	wfsjz@163.com; liwenchzh@126.com			Nature Science Foundation of China [81272213]; Natural Science Foundation of Shanghai [13ZR1414300]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This study was supported by the Nature Science Foundation of China (No. 81272213), http://www.nsfc.gov.cn/Portal0/default152.htm, and the Natural Science Foundation of Shanghai(13ZR1414300), http://www.stcsm.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chang SCH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00048; D'Costa ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048954; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang J, 2011, AM J MED SCI, V342, P198, DOI 10.1097/MAJ.0b013e31821335a9; Gibb EA, 2012, INT J GYNECOL CANCER, V22, P1557, DOI 10.1097/IGC.0b013e318272f2c9; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Holland D, 2008, CANCER RES, V68, P9964, DOI 10.1158/0008-5472.CAN-08-1134; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Krieger Nancy, 2012, Lancet, V379, P1391, DOI 10.1016/S0140-6736(12)60596-0; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li H, 2010, MOL CANCER RES, V8, P1610, DOI 10.1158/1541-7786.MCR-10-0398; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Qin W, 2012, ONCOGENE, V31, P4067, DOI 10.1038/onc.2011.561; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Wang C, 2013, MOL CARCINOGEN, V52, P229, DOI 10.1002/mc.21848; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	31	106	115	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e100340	10.1371/journal.pone.0100340	http://dx.doi.org/10.1371/journal.pone.0100340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007342	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600011
J	Wu, S; Li, XJ; Gunawardana, M; Maguire, K; Guerrero-Given, D; Schaudinn, C; Wang, C; Baum, MM; Webster, P				Wu, Siva; Li, Xiaojin; Gunawardana, Manjula; Maguire, Kathleen; Guerrero-Given, Debbie; Schaudinn, Christoph; Wang, Charles; Baum, Marc M.; Webster, Paul			Beta-Lactam Antibiotics Stimulate Biofilm Formation in Non-Typeable Haemophilus influenzae by Up-Regulating Carbohydrate Metabolism	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; COAGULASE-NEGATIVE STAPHYLOCOCCI; OBSTRUCTIVE PULMONARY-DISEASE; SUBINHIBITORY CONCENTRATIONS; BACTERIAL BIOFILMS; EXTRACELLULAR DNA; ANTIMICROBIAL TREATMENT; GENE-EXPRESSION; THIN-SECTIONS; CHILDREN	Non-typeable Haemophilus influenzae (NTHi) is a common acute otitis media pathogen, with an incidence that is increased by previous antibiotic treatment. NTHi is also an emerging causative agent of other chronic infections in humans, some linked to morbidity, and all of which impose substantial treatment costs. In this study we explore the possibility that antibiotic exposure may stimulate biofilm formation by NTHi bacteria. We discovered that sub-inhibitory concentrations of beta-lactam antibiotic (i.e., amounts that partially inhibit bacterial growth) stimulated the biofilm-forming ability of NTHi strains, an effect that was strain and antibiotic dependent. When exposed to sub-inhibitory concentrations of beta-lactam antibiotics NTHi strains produced tightly packed biofilms with decreased numbers of culturable bacteria but increased biomass. The ratio of protein per unit weight of biofilm decreased as a result of antibiotic exposure. Antibiotic-stimulated biofilms had altered ultrastructure, and genes involved in glycogen production and transporter function were up regulated in response to antibiotic exposure. Down-regulated genes were linked to multiple metabolic processes but not those involved in stress response. Antibiotic-stimulated biofilm bacteria were more resistant to a lethal dose (10 mg/mL) of cefuroxime. Our results suggest that beta-lactam antibiotic exposure may act as a signaling molecule that promotes transformation into the biofilm phenotype. Loss of viable bacteria, increase in biofilm biomass and decreased protein production coupled with a concomitant up-regulation of genes involved with glycogen production might result in a biofilm of sessile, metabolically inactive bacteria sustained by stored glycogen. These biofilms may protect surviving bacteria from subsequent antibiotic challenges, and act as a reservoir of viable bacteria once antibiotic exposure has ended.	[Wu, Siva] Univ Calif Berkeley, Div Life Sci, Berkeley, CA 94720 USA; [Li, Xiaojin] ApolloGen Inc, Mol Diagnost Lab, Irvine, CA USA; [Gunawardana, Manjula; Baum, Marc M.; Webster, Paul] Oak Crest Inst Sci, Pasadena, CA 91107 USA; [Maguire, Kathleen] Univ Calif San Diego, San Diego, CA 92103 USA; [Guerrero-Given, Debbie] Max Planck Florida Inst, Jupiter, FL USA; [Schaudinn, Christoph] Robert Koch Inst, Berlin, Germany; [Wang, Charles] Loma Linda Univ, Sch Med, Ctr Genom, Loma Linda, CA USA; [Wang, Charles] Loma Linda Univ, Sch Med, Div Microbiol & Mol Genet, Loma Linda, CA USA; [Webster, Paul] Univ So Calif, Ctr Elect Microscopy & Microanal, Los Angeles, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Diego; Max Planck Society; Robert Koch Institute; Loma Linda University; Loma Linda University; University of Southern California	Webster, P (corresponding author), Oak Crest Inst Sci, Pasadena, CA 91107 USA.	pwebster@usc.edu		Webster, Paul/0000-0002-1980-6931; Baum, Marc/0000-0003-1558-5649	National Science Foundation (NSF) [0722354]; NIH/NIDCD [5 P-30 DC006276-03]; Ahmanson Foundation; Los Angeles Hope for Hearing Foundation; Deafness Research Foundation; Fritz Burns Foundation; Hearst Foundation; Capita Foundation; House Research Institute; Oak Crest Institute of Science; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC006276] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ahmanson Foundation; Los Angeles Hope for Hearing Foundation; Deafness Research Foundation; Fritz Burns Foundation; Hearst Foundation; Capita Foundation; House Research Institute; Oak Crest Institute of Science; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Parts of this work was carried out was carried out using equipment funded by the National Science Foundation (NSF #0722354) as well as support from the NIH/NIDCD (5 P-30 DC006276-03), and the following foundations; Ahmanson Foundation; Los Angeles Hope for Hearing Foundation; Deafness Research Foundation; Fritz Burns Foundation, Hearst Foundation and the Capita Foundation. Additional support was provided by the House Research Institute and the Oak Crest Institute of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Anon JB, 2004, OTOLARYNG HEAD NECK, V130, P1, DOI 10.1016/j.otohns.2003.12.003; [Anonymous], 2000, Otolaryngol Head Neck Surg, V123, P5; [Anonymous], 2004, PEDIATRICS, V5, P1451; Barkai G, 2009, PEDIATR INFECT DIS J, V28, P466, DOI 10.1097/INF.0b013e3181950c74; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Baum MM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-103; Bezakova N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2525; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Canafax DM, 1998, PEDIATR INFECT DIS J, V17, P149, DOI 10.1097/00006454-199802000-00014; Cargill JS, 2009, J CLIN PATHOL, V62, P1112, DOI 10.1136/jcp.2009.069021; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; De Schutter I, 2011, CLIN INFECT DIS, V52, P1437, DOI 10.1093/cid/cir235; DIPERSIO JR, 1974, J GEN MICROBIOL, V83, P349, DOI 10.1099/00221287-83-2-349; Droste JHJ, 2000, CLIN EXP ALLERGY, V30, P1547; DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390; Fagerlind MG, 2012, J THEOR BIOL, V295, P23, DOI 10.1016/j.jtbi.2011.10.007; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flemming HC, 2001, WATER SCI TECHNOL, V43, P1; Gallaher TK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-65; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Goodman SD, 2011, MUCOSAL IMMUNOL; GU XX, 1995, INFECT IMMUN, V63, P4115, DOI 10.1128/IAI.63.10.4115-4120.1995; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Hildebrand H, 2008, SCAND J GASTROENTERO, V43, P961, DOI 10.1080/00365520801971736; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoffman M., 1999, MICROBIAL EXTRACELLU; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jahn A, 1999, BIOFOULING, V14, P49, DOI 10.1080/08927019909378396; Jordens JZ, 1995, EUR J CLIN MICROBIOL, V14, P935, DOI 10.1007/BF01691374; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kaplan JB, 2011, RES MICROBIOL; Klein JO, 1997, PEDIATR INFECT DIS J, V16, pS5, DOI 10.1097/00006454-199702001-00002; Law DK, 2007, FEMS IMMUNOL MED MIC, V51, P270; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; MUI S, 2005, ENT-EAR NOSE THROAT, V84, P420; Mui S, 2005, ENT-EAR NOSE THROAT, V84, P418; Mui Stanley, 2005, Ear Nose Throat J, V84, P420; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; Novotny LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067629; Pelzer ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049965; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Poje Grant, 2003, Methods Mol Med, V71, P51; Qu Y, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-16; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Sailer FC, 2003, FEMS MICROBIOL LETT, V226, P245, DOI 10.1016/S0378-1097(03)00616-5; SCHADOW KH, 1988, J INFECT DIS, V157, P71, DOI 10.1093/infdis/157.1.71; Schaudin C, 2007, MICROBE, V5, P231, DOI [10.1128/microbe.2.231.1, DOI 10.1128/MICROBE.2.231.1]; Schmelzle J, 2008, CAN FAM PHYSICIAN, V54, P1123; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Sill ML, 2008, ANTIMICROB AGENTS CH, V52, P1551, DOI 10.1128/AAC.01580-07; Smith A, 2011, OTOLARYNG HEAD NECK, V144, P338, DOI 10.1177/0194599810391620; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Starner TD, 2008, ANTIMICROB AGENTS CH, V52, P137, DOI 10.1128/AAC.00607-07; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Swords WE, 2004, INFECT IMMUN, V72, P106, DOI 10.1128/IAI.72.1.106-113.2004; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; Thanavala Y, 2011, ADV OTO-RHINO-LARYNG, V72, P170, DOI 10.1159/000324785; Vlastarakos PV, 2007, EUR J PEDIATR, V166, P385, DOI 10.1007/s00431-006-0367-x; VYE MV, 1971, J CELL SCI, V9, P727; Wang Q, 2010, ANTIMICROB AGENTS CH, V54, P2707, DOI 10.1128/AAC.01565-09; Wang SW, 2013, ENVIRON MICROBIOL, V15, P2238, DOI 10.1111/1462-2920.12095; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Webster P, 2004, BIOFILMS, V1, P165, DOI DOI 10.1017/S1479050504001425; Webster P, 2006, J HISTOCHEM CYTOCHEM; Xu QF, 2011, INT J PEDIATR OTORHI, V75, P239, DOI 10.1016/j.ijporl.2010.11.008; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	82	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e99204	10.1371/journal.pone.0099204	http://dx.doi.org/10.1371/journal.pone.0099204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007395	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600004
J	Babcock, HE; Dutta, S; Alur, RP; Brocker, C; Vasiliou, V; Vitale, S; Abu-Asab, M; Brooks, BP				Babcock, Holly E.; Dutta, Sunit; Alur, Ramakrishna P.; Brocker, Chad; Vasiliou, Vasilis; Vitale, Susan; Abu-Asab, Mones; Brooks, Brian P.			aldh7a1 Regulates Eye and Limb Development in Zebrafish	PLOS ONE			English	Article							RETINOIC ACID; OCULAR DEVELOPMENT; COLOBOMA MAC; MUTATIONS; MICROPHTHALMIA; ANOPHTHALMIA; EXPRESSION; GENES; ANTIQUITIN; SPECTRUM	Uveal coloboma is a potentially blinding congenital ocular malformation caused by failure of the optic fissure to close during development. Although mutations in numerous genes have been described, these account for a minority of cases, complicating molecular diagnosis and genetic counseling. Here we describe a key role of aldh7a1 as a gene necessary for normal eye development. We show that morpholino knockdown of aldh7a1 in zebrafish causes uveal coloboma and misregulation of nlz1, another known contributor to the coloboma phenotype, as well as skeletal abnormalities. Knockdown of aldh7a1 leads to reduced cell proliferation in the optic cup of zebrafish, delaying the approximation of the edges of the optic fissure. The aldh7a1 morphant phenotype is partially rescued by co-injection of nlz1 mRNA suggesting that nlz1 is functionally downstream of aldh7a1 in regulating cell proliferation in the optic cup. These results support a role of aldh7a1 in ocular development and skeletal abnormalities in zebrafish.	[Babcock, Holly E.; Dutta, Sunit; Alur, Ramakrishna P.; Brooks, Brian P.] NEI, Unit Pediat Dev & Genet Ophthalmol, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Brocker, Chad; Vasiliou, Vasilis] Univ Colorado Denver, Mol Toxicol & Environm Hlth Sci Program, Dept Pharmaceut Sci, Aurora, CO USA; [Vitale, Susan] NEI, Div Biostat & Epidemiol, Clin Trials Branch, NIH, Bethesda, MD 20892 USA; [Abu-Asab, Mones] NEI, Immunopathol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Brooks, BP (corresponding author), NEI, Unit Pediat Dev & Genet Ophthalmol, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA.	brooksb@mail.nih.gov		vitale, susan/0000-0002-5972-6848; vasiliou, vasilis/0000-0003-2552-3118; Brocker, Chad/0000-0003-4262-3567	Intramural Program of the National Eye Institute; National Institutes of Health; US Dpt. Of Health and Human Services; NATIONAL EYE INSTITUTE [ZIAEY000469] Funding Source: NIH RePORTER	Intramural Program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Dpt. Of Health and Human Services; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the Intramural Program of the National Eye Institute, National Institutes of Health, US Dpt. Of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balow SA, 2013, DEV BIOL, V382, P57, DOI 10.1016/j.ydbio.2013.07.026; Bennett CL, 2009, EPILEPSIA, V50, P1167, DOI 10.1111/j.1528-1167.2008.01816.x; Bermejo E, 1998, AM J MED GENET, V75, P497, DOI 10.1002/(SICI)1096-8628(19980217)75:5<497::AID-AJMG8>3.0.CO;2-K; Brocker C, 2011, CHEM-BIOL INTERACT, V191, P269, DOI 10.1016/j.cbi.2011.02.016; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; Brooks BP, 2013, EMERY RIMOINS PRINCI, P3952; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Chan CL, 2011, CHEM-BIOL INTERACT, V191, P165, DOI 10.1016/j.cbi.2010.12.019; Chang L, 2006, CURR OPIN OPHTHALMOL, V17, P447, DOI 10.1097/01.icu.0000243020.82380.f6; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; French CR, 2013, INVEST OPHTH VIS SCI, V54, P4636, DOI 10.1167/iovs.13-11674; Gallagher RC, 2009, ANN NEUROL, V65, P550, DOI 10.1002/ana.21568; Gonzalez-Rodriguez J, 2010, BRIT J OPHTHALMOL, V94, P1100, DOI 10.1136/bjo.2009.173500; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Hornby S J, 2000, Ophthalmic Epidemiol, V7, P127; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; Lehman DM, 2001, AM J MED GENET, V101, P114, DOI 10.1002/ajmg.1330; Liu MN, 2008, DEV DYNAM, V237, P3387, DOI 10.1002/dvdy.21763; Lupo G, 2011, P NATL ACAD SCI USA, V108, P8698, DOI 10.1073/pnas.1103802108; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; Maumenee I H, 1990, Trans Am Ophthalmol Soc, V88, P123; MAUMENEE IH, 1990, T AM OPHTHAL SOC, V88, P133; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Nakamura KM, 2011, ARCH OPHTHALMOL-CHIC, V129, P69, DOI 10.1001/archophthalmol.2010.320; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; PAGON RA, 1981, AM J MED GENET, V9, P189, DOI 10.1002/ajmg.1320090304; Scharer G, 2010, J INHERIT METAB DIS, V33, P571, DOI 10.1007/s10545-010-9187-2; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; Tang WK, 2005, FEBS LETT, V579, P3759, DOI 10.1016/j.febslet.2005.05.070; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van den Hoogen C, 2011, CLIN EXP METASTAS, V28, P615, DOI 10.1007/s10585-011-9395-7; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yahyavi M, 2013, HUM MOL GENET, V22, P3250, DOI 10.1093/hmg/ddt179; Zhang XH, 2009, MOL VIS, V15, P2911; ZLOTOGORA J, 1994, AM J MED GENET, V49, P261, DOI 10.1002/ajmg.1320490302	45	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101782	10.1371/journal.pone.0101782	http://dx.doi.org/10.1371/journal.pone.0101782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25004007	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700064
J	Vernochet, C; Damilano, F; Mourier, A; Bezy, O; Mori, MA; Smyth, G; Rosenzweig, A; Larsson, NG; Kahn, CR				Vernochet, Cecile; Damilano, Federico; Mourier, Arnaud; Bezy, Olivier; Mori, Marcelo A.; Smyth, Graham; Rosenzweig, Anthony; Larsson, Nils-Goeran; Kahn, C. Ronald			Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications	FASEB JOURNAL			English	Article						TFAM; WAT; BAT; diabetes; hypertension; cardiomegaly	TRANSCRIPTION-FACTOR; HIV-INFECTION; GENERALIZED LIPODYSTROPHY; COPY NUMBER; MICE; OBESITY; DNA; ADIPONECTIN; MAINTENANCE; INSIGHTS	Mitochondrial dysfunction in adipose tissue occurs in obesity, type 2 diabetes, and some forms of lipodystrophy, but whether this dysfunction contributes to or is the result of these disorders is unknown. To investigate the physiological consequences of severe mitochondrial impairment in adipose tissue, we generated mice deficient in mitochondrial transcription factor A (TFAM) in adipocytes by using mice carrying adiponectin-Cre and TFAM floxed alleles. These adiponectin TFAM-knockout (adipo-TFAM-KO) mice had a 75-81% reduction in TFAM in the subcutaneous and intra-abdominal white adipose tissue (WAT) and interscapular brown adipose tissue (BAT), causing decreased expression and enzymatic activity of proteins in complexes I, III, and IV of the electron transport chain (ETC). This mitochondrial dysfunction led to adipocyte death and inflammation in WAT and a whitening of BAT. As a result, adipo-TFAM-KO mice were resistant to weight gain, but exhibited insulin resistance on both normal chow and high-fat diets. These lipodystrophic mice also developed hypertension, cardiac hypertrophy, and cardiac dysfunction. Thus, isolated mitochondrial dysfunction in adipose tissue can lead a syndrome of lipodystrophy with metabolic syndrome and cardiovascular complications.-Vernochet, C., Damilano, F., Mourier, A., Bezy, O., Mori, M. A., Smyth, G., Rosenzweig, A., Larsson, N.-G., Kahn, C. R. Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications.	[Vernochet, Cecile; Bezy, Olivier; Mori, Marcelo A.; Smyth, Graham; Kahn, C. Ronald] Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Vernochet, Cecile; Damilano, Federico; Bezy, Olivier; Mori, Marcelo A.; Smyth, Graham; Rosenzweig, Anthony; Kahn, C. Ronald] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Damilano, Federico; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; [Mourier, Arnaud; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, Cologne, Germany	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Max Planck Society	Kahn, CR (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	MOURIER, Arnaud/F-9657-2019; Kahn, Ronald/AAY-2435-2021; Mori, Marcelo A/R-2881-2018; MOURIER, Arnaud/I-8117-2012; Rosenzweig, Anthony/AAD-7893-2019	MOURIER, Arnaud/0000-0002-5413-611X; Kahn, Ronald/0000-0002-7583-9228; Mori, Marcelo A/0000-0001-7112-5263; MOURIER, Arnaud/0000-0002-5413-611X; Larsson, Nils-Goran/0000-0001-5100-996X; Bezy, Olivier/0000-0003-4367-5043	U.S. National Institutes of Health (NIH) [R01-DK082659]; Eli Lilly Foundation; Joslin Diabetes Research Center (NIH) [P30-DK036836]; Mary K. Iacocca Professorship; NIH [R01-HL094677]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK082659, R01DK033201] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Foundation(Eli Lilly); Joslin Diabetes Research Center (NIH); Mary K. Iacocca Professorship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) grant R01-DK082659 (C.R.K.), a grant from the Eli Lilly Foundation, Joslin Diabetes Research Center (NIH grant P30-DK036836), the Mary K. Iacocca Professorship, and NIH grant R01-HL094677 (A.R.).	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Caron M, 2004, AIDS, V18, P2127, DOI 10.1097/00002030-200411050-00004; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; Dela F, 2013, INT J BIOCHEM CELL B, V45, P11, DOI 10.1016/j.biocel.2012.09.019; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garg A, 2004, ENDOCRIN METAB CLIN, V33, P305, DOI 10.1016/j.ecl.2004.03.003; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Gusev K, 2009, CIRC RES, V105, P42, DOI 10.1161/CIRCRESAHA.108.189779; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herichova I, 2013, Endocr Regul, V47, P39; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Lamounier-Zepter V, 2008, MOL CELL ENDOCRINOL, V280, P39, DOI 10.1016/j.mce.2007.09.012; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Lupsa BC, 2010, MEDICINE, V89, P245, DOI 10.1097/MD.0b013e3181e9442f; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Nelson MD, 2013, AM J CARDIOL, V112, P1019, DOI 10.1016/j.amjcard.2013.05.036; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Rivard K, 2011, AM J PHYSIOL-HEART C, V301, pH2018, DOI 10.1152/ajpheart.01092.2010; Romano AD, 2014, CURR PHARM DESIGN, V20, P2978, DOI 10.2174/13816128113196660700; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; Scherrer-Crosbie M, 2010, J MOL CELL CARDIOL, V48, P512, DOI 10.1016/j.yjmcc.2009.07.004; Shibata R, 2012, CURR MED CHEM, V19, P5459, DOI 10.2174/092986712803833164; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691; Villarroya J, 2009, OBESITY, V17, P1814, DOI 10.1038/oby.2009.152; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391	41	104	106	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4408	4419		10.1096/fj.14-253971	http://dx.doi.org/10.1096/fj.14-253971			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	25005176	Green Published			2022-12-25	WOS:000342222700019
J	Geetha-Loganathan, P; Nimmagadda, S; Fu, K; Richman, JM				Geetha-Loganathan, Poongodi; Nimmagadda, Suresh; Fu, Katherine; Richman, Joy M.			Avian Facial Morphogenesis Is Regulated by c-Jun N-terminal Kinase/Planar Cell Polarity (JNK/PCP) Wingless-related (WNT) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Craniofacial Development; Embryo; Morphogenesis; Retrovirus; Cleft Lip; Disheveled; Luciferase Reporter Assay; Micromass Culture; Optical Projection Tomography	RECESSIVE ROBINOW-SYNDROME; SYNDROMIC CLEFT-LIP; CHICK-EMBRYO; PRIMARY PALATE; FRONTONASAL MORPHOGENESIS; CRANIOFACIAL DEVELOPMENT; MOLECULAR-MECHANISMS; NONCANONICAL WNT; GENE-EXPRESSION; TOOTH AGENESIS	Background: Numerous genes contribute to the increased risk of facial clefting, but the cellular mechanisms involved are not well understood. Results: JNK/PCP wingless-related signaling is demonstrated as a major regulator of face shape. Conclusion: WNT11 induces clefting via inhibiting proliferation, compressing facial prominences, and changing cell behavior. Significance: JNK/PCP WNT signaling is implicated in the pathophysiology underlying craniofacial abnormalities. Wingless-related proteins (WNTs) regulate extension of the central axis of the vertebrate embryo (convergent extension) as well as morphogenesis of organs such as limbs and kidneys. Here, we asked whether WNT signaling directs facial morphogenesis using a targeted approach in chicken embryos. WNT11 is thought to mainly act via -catenin-independent pathways, and little is known about its role in craniofacial development. RCAS::WNT11 retrovirus was injected into the maxillary prominence, and the majority of embryos developed notches in the upper beak or the equivalent of cleft lip. Three-dimensional morphometric analysis revealed that WNT11 prevented lengthening of the maxillary prominence, which was due in part to decreased proliferation. We next determined, using a series of luciferase reporters, that WNT11 strongly induced JNK/planar cell polarity signaling while repressing the -catenin-mediated pathway. The activation of the JNK-ATF2 reporter was mediated by the DEP domain of Dishevelled. The impacts of altered signaling on the mesenchyme were assessed by implanted Wnt11- or Wnt3a-expressing cells (activates -catenin pathway) into the maxillary prominence or by knocking down endogenous WNT11 with RNAi. Host cells were attracted to Wnt11 donor cells. In contrast, cells exposed to Wnt3a or the control cells did not migrate. Cells in which endogenous WNT11 was knocked down were more oriented and shorter than those exposed to exogenous WNT11. The data suggest that JNK/planar cell polarity WNT signaling operates in the face to regulate several morphogenetic events leading to lip fusion.	[Geetha-Loganathan, Poongodi; Nimmagadda, Suresh; Fu, Katherine; Richman, Joy M.] Univ British Columbia, Fac Dent, Inst Life Sci, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Richman, JM (corresponding author), Univ British Columbia, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	richman@dentistry.ubc.ca	Richman, Joy/AAD-9445-2020; Richman, Joy M./C-3111-2018	Richman, Joy/0000-0002-1409-8163; Richman, Joy M./0000-0002-1409-8163	Michael Smith Foundation for Health Research; MSFHR; Canadian Institutes of Health Research; Canadian Institutes of Health Research [MOP-123536, MOP-102671]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by postdoctoral awards from Michael Smith Foundation for Health Research (to P. G.-L.), MSFHR and Canadian Institutes of Health Research (to S. N.), and Operating Grants MOP-123536 and MOP-102671 from Canadian Institutes of Health Research (to J. M. R.).	Abramyan J, 2014, J EXP ZOOL PART B, V322, P73, DOI 10.1002/jez.b.22547; Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Ashique AM, 2002, DEVELOPMENT, V129, P4647; BAILEY LJ, 1988, J CRAN GENET DEV BIO, V8, P167; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chiquet BT, 2008, HUM MOL GENET, V17, P2212, DOI 10.1093/hmg/ddn121; COULY GF, 1993, DEVELOPMENT, V117, P409; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; DIEWERT VM, 1993, J CRAN GENET DEV BIO, V13, P162; DIEWERT VM, 1992, CRIT REV ORAL BIOL M, V4, P111, DOI 10.1177/10454411920040010201; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Economou AD, 2013, DEVELOPMENT, V140, P4740, DOI 10.1242/dev.096545; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Geetha-Loganathan P, 2011, DEV DYNAM, V240, P2108, DOI 10.1002/dvdy.22708; Geetha-Loganathan P, 2009, DEV DYNAM, V238, P1150, DOI 10.1002/dvdy.21934; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Higashihori N, 2010, DEV DYNAM, V239, P458, DOI 10.1002/dvdy.22182; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hosseini-Farahabadi S, 2013, MATRIX BIOL, V32, P252, DOI 10.1016/j.matbio.2013.02.005; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jagomagi T, 2010, EUR J ORAL SCI, V118, P213, DOI 10.1111/j.1600-0722.2010.00729.x; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Lee SH, 2004, DEV BIOL, V276, P207, DOI 10.1016/j.ydbio.2004.08.045; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Li X, 2013, HUM MOL GENET, V22, P5160, DOI 10.1093/hmg/ddt369; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Logan Cairine, 2008, V461, P363, DOI 10.1007/978-1-60327-483-8_26; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; McGonnell IM, 1998, DEV DYNAM, V212, P102, DOI 10.1002/(SICI)1097-0177(199805)212:1<102::AID-AJA10>3.0.CO;2-9; Menezes R, 2010, BIRTH DEFECTS RES A, V88, P995, DOI 10.1002/bdra.20720; MINKOFF R, 1978, J EMBRYOL EXP MORPH, V46, P65; MINKOFF R, 1977, J EMBRYOL EXP MORPH, V40, P101; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Morosan-Puopolo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092679; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; PATTERSON SB, 1985, ANAT RECORD, V212, P90, DOI 10.1002/ar.1092120113; Pauws E, 2009, HUM MOL GENET, V18, P4171, DOI 10.1093/hmg/ddp368; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Plant MR, 2000, DEV BIOL, V222, P12, DOI 10.1006/dbio.2000.9706; RICHMAN JM, 1990, DEVELOPMENT, V109, P341; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Salahshourifar I, 2011, J HUM GENET, V56, P755, DOI 10.1038/jhg.2011.95; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Tadic T, 2002, J BONE MINER RES, V17, P1008, DOI 10.1359/jbmr.2002.17.6.1008; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WANG KY, 1995, J CRAN GENET DEV BIO, V15, P99; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	82	20	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24153	24167		10.1074/jbc.M113.522003	http://dx.doi.org/10.1074/jbc.M113.522003			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25008326	hybrid, Green Published			2022-12-25	WOS:000341505600014
J	Soki, FN; Koh, AJ; Jones, JD; Kim, YW; Dai, JL; Keller, ET; Pienta, KJ; Atabai, K; Roca, H; McCauley, LK				Soki, Fabiana N.; Koh, Amy J.; Jones, Jacqueline D.; Kim, Yeo Won; Dai, Jinlu; Keller, Evan T.; Pienta, Kenneth J.; Atabai, Kamran; Roca, Hernan; McCauley, Laurie K.			Polarization of Prostate Cancer-associated Macrophages Is Induced by Milk Fat Globule-EGF Factor 8 (MFG-E8)-mediated Efferocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone Marrow; Macrophage; Phagocytosis; Prostate Cancer; Alternative Activation; MFG-E8; Skeletal Metastasis; Tumor-associated Macrophages; Efferocytosis	PARATHYROID-HORMONE; APOPTOTIC CELLS; IN-VITRO; OSTEAL MACROPHAGES; TUMOR PROGRESSION; ANABOLIC ACTIONS; BONE; INFLAMMATION; ACTIVATION; MICROENVIRONMENT	Background: The growing body of data on tumor-associated macrophages largely neglects phagocytosis of apoptotic cells. Results: MFG-E8, induced during efferocytosis, contributes to macrophage polarization with STAT3/SOCS3 pathway involvement. Conclusion: Efferocytosis induces macrophage polarization into tumor-associated macrophages mediated by MFG-E8. Significance: A novel tumor-promoting mechanism for macrophage polarization through efferocytosis and MFG-E8 and its corresponding signaling pathway were identified. Tumor cells secrete factors that modulate macrophage activation and polarization into M2 type tumor-associated macrophages, which promote tumor growth, progression, and metastasis. The mechanisms that mediate this polarization are not clear. Macrophages are phagocytic cells that participate in the clearance of apoptotic cells, a process known as efferocytosis. Milk fat globule- EGF factor 8 (MFG-E8) is a bridge protein that facilitates efferocytosis and is associated with suppression of proinflammatory responses. This study investigated the hypothesis that MFG-E8-mediated efferocytosis promotes M2 polarization. Tissue and serum exosomes from prostate cancer patients presented higher levels of MFG-E8 compared with controls, a novel finding in human prostate cancer. Coculture of macrophages with apoptotic cancer cells increased efferocytosis, elevated MFG-E8 protein expression levels, and induced macrophage polarization into an alternatively activated M2 phenotype. Administration of antibody against MFG-E8 significantly attenuated the increase in M2 polarization. Inhibition of STAT3 phosphorylation using the inhibitor Stattic decreased efferocytosis and M2 macrophage polarization in vitro, with a correlating increase in SOCS3 protein expression. Moreover, MFG-E8 knockdown tumor cells cultured with wild-type or MFG-E8-deficient macrophages resulted in increased SOCS3 expression with decreased STAT3 activation. This suggests that SOCS3 and phospho-STAT3 act in an inversely dependent manner when stimulated by MFG-E8 and efferocytosis. These results uncover a unique role of efferocytosis via MFG-E8 as a mechanism for macrophage polarization into tumor-promoting M2 cells.	[Soki, Fabiana N.; Koh, Amy J.; Jones, Jacqueline D.; Kim, Yeo Won; Roca, Hernan; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Dai, Jinlu; Keller, Evan T.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Dai, Jinlu; Keller, Evan T.; McCauley, Laurie K.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD 21287 USA; [Atabai, Kamran] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCauley, LK (corresponding author), Univ Michigan, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu	Dai, Jin/GVT-2414-2022; Keller, Evan T/M-1446-2016	Dai, Jin/0000-0003-3063-746X; Keller, Evan T/0000-0002-7592-7535	Fund for Cancer Research; National Cancer Institute [P01-CA093900, F32 CA 168269]; American Cancer Society [U01CA143055, U54CA143803]; NATIONAL CANCER INSTITUTE [F32CA168269, P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904] Funding Source: NIH RePORTER	Fund for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Fund for Cancer Research grants and by National Cancer Institute Grants P01-CA093900 (to L. K. M., K. J.P., and E. T. K.) and F32 CA 168269 (to F. S.).; Supported as an American Cancer Society Clinical Research Professor by Grants U01CA143055 and U54CA143803.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Aziz M, 2011, APOPTOSIS, V16, P1077, DOI 10.1007/s10495-011-0630-0; Brissette MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036368; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111; Cho SW, 2013, J BIOL CHEM, V288, P6814, DOI 10.1074/jbc.M112.393363; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Fujii T, 2013, PATHOBIOLOGY, V80, P119, DOI 10.1159/000342396; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hiwatashi K, 2011, CANCER LETT, V308, P172, DOI 10.1016/j.canlet.2011.04.024; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Koh AJ, 2011, ENDOCRINOLOGY, V152, P4525, DOI 10.1210/en.2011-1515; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Loberg RD, 2005, J CELL BIOCHEM, V96, P439, DOI 10.1002/jcb.20522; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Miksa M, 2008, INT J MOL MED, V22, P743, DOI 10.3892/ijmm_00000080; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Novince CM, 2012, J BONE MINER RES, V27, P11, DOI 10.1002/jbmr.508; Park SI, 2011, CANCER MICROENVIRON, V4, P237, DOI 10.1007/s12307-011-0081-8; Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Reiter I, 1999, J IMMUNOL, V163, P1730; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang XH, 2012, J BIOL CHEM, V287, P18376, DOI 10.1074/jbc.M112.355164; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009	54	109	113	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24560	24572		10.1074/jbc.M114.571620	http://dx.doi.org/10.1074/jbc.M114.571620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006249	Green Published, hybrid			2022-12-25	WOS:000341505600047
J	Khoury, E; Nikolajev, L; Simaan, M; Namkung, Y; Laporte, SA				Khoury, Etienne; Nikolajev, Ljiljana; Simaan, May; Namkung, Yoon; Laporte, Stephane A.			Differential Regulation of Endosomal GPCR/beta-Arrestin Complexes and Trafficking by MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Cell Signaling; G Protein-coupled Receptor (GPCR); Mitogen-activated Protein Kinase (MAPK); Trafficking; Bradykinin B2 Receptor	PROTEIN-COUPLED RECEPTORS; II TYPE-1 RECEPTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ADRENERGIC-RECEPTOR; VISUAL ARRESTIN; ERK ACTIVATION; HEART-FAILURE; BIASED LIGAND; BINDING STATE; PHOSPHORYLATION	Background: Regulation between GPCRs and -arrestins in endosomes has never been reported. Results: A novel ERK regulatory site in -arrestin-2 controls the binding to GPCRs in endosomes, and receptor trafficking and signaling. Conclusion: Differential MAPK-dependent regulation of endosomal complexes exists among -arrestin subtypes and species. Significance: Such divergent mode of regulation may help understanding the physiological role of the endosomal GPCR/-arrestins signaling axis. -Arrestins are signaling adaptors that bind to agonist-occupied G protein-coupled receptors (GPCRs) and target them for endocytosis; however, the mechanisms regulating receptor/-arrestin complexes and trafficking in endosomes, remain ill defined. Here we show, in live cells, differential dynamic regulation of endosomal bradykinin B2 receptor (B2R) complexes with either -arrestin-1 or -2. We find a novel role for MAPK in the B2R/-arrestin-2 complex formation, receptor trafficking and signaling mediated by an ERK1/2 regulatory motif in the hinge domain of the rat -arrestin-2 ((PETP)-P-178), but not rat -arrestin-1 ((PERP)-P-177). While the ERK1/2 regulatory motif is conserved between rat and mouse -arrestin-2, it is surprisingly not conserved in human -arrestin-2 ((PEKP)-P-178). However, mutation of lysine 178 to threonine is sufficient to confer MAPK sensitivity to the human -arrestin-2. Furthermore, substitution for a phosphomimetic residue in both the rat and the human -arrestin-2 (T/K178D) significantly stabilizes B2R/-arrestin complexes in endosomes, delays receptor recycling to the plasma membrane and maintains intracellular MAPK signaling. Similarly, the endosomal trafficking of 2-adrenergic, angiotensin II type 1 and vasopressin V2 receptors was altered by the -arrestin-2 T178D mutant. Our findings unveil a novel subtype specific mode of MAPK-dependent regulation of -arrestins in intracellular trafficking and signaling of GPCRs, and suggest differential endosomal receptor/-arrestin-2 signaling roles among species.	[Khoury, Etienne; Simaan, May; Namkung, Yoon; Laporte, Stephane A.] McGill Univ, McGill Univ Hlth Ctr Res Inst, Dept Med, Montreal, PQ H3A 2B2, Canada; [Nikolajev, Ljiljana; Laporte, Stephane A.] McGill Univ, McGill Univ Hlth Ctr Res Inst, Dept Pharmacol & Therapeut, Montreal, PQ H3A 2B2, Canada; [Laporte, Stephane A.] McGill Univ, McGill Univ Hlth Ctr Res Inst, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University; McGill University; McGill University	Laporte, SA (corresponding author), McGill Univ, Polypeptide Lab, Strathcona Anat & Dent Bldg,3640 Univ St, Montreal, PQ H3A 2B2, Canada.	stephane.laporte@mcgill.ca	Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; 	Canadian Institutes of Health Research (CIHR) [MOP-74603]; McGill Division of Endocrinology and Metabolism; "Le Fonds de recherche du Quebec - Sante" (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Division of Endocrinology and Metabolism; "Le Fonds de recherche du Quebec - Sante" (FRQS)	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grants (to S. A. L.) (MOP-74603).; Recipient of a studentship from the McGill Division of Endocrinology and Metabolism.; Recipient of a Chercheur Boursier Senior scholarship from "Le Fonds de recherche du Quebec - Sante" (FRQS). To whom correspondence should be addressed: Polypeptide Laboratory, McGill University, Strathcona Anatomy & Dentistry Bldg., 3640 University St., Room W315, Montreal, QC H3A 2B2, Canada. Tel.: 514-398-4487; Fax: 514-398-3923; E-mail: stephane.laporte@mcgill.ca.	Aguila B, 2011, METHODS MOL BIOL, V756, P371, DOI 10.1007/978-1-61779-160-4_23; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Chen YS, 2008, J VIROL, V82, P9345, DOI 10.1128/JVI.00656-08; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gousseva V, 2008, BIOPHYS J, V94, P679, DOI 10.1529/biophysj.107.115188; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Hagai T, 2012, MOL BIOSYST, V8, P1865, DOI 10.1039/c2mb25052g; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma P, 2002, NAT REV DRUG DISCOV, V1, P571, DOI 10.1038/nrd884; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Violin JD, 2010, J CARD FAIL, V16, pS72, DOI 10.1016/j.cardfail.2010.06.247; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	45	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23302	23317		10.1074/jbc.M114.568147	http://dx.doi.org/10.1074/jbc.M114.568147			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016018	hybrid, Green Published			2022-12-25	WOS:000341505000004
J	Fimognari, C; Turrini, E; Sestili, P; Calcabrini, C; Carulli, G; Fontanelli, G; Rousseau, M; Cantelli-Forti, G; Hrelia, P				Fimognari, Carmela; Turrini, Eleonora; Sestili, Piero; Calcabrini, Cinzia; Carulli, Giovanni; Fontanelli, Giulia; Rousseau, Martina; Cantelli-Forti, Giorgio; Hrelia, Patrizia			Antileukemic Activity of Sulforaphane in Primary Blasts from Patients Affected by Myelo- and Lympho-Proliferative Disorders and in Hypoxic Conditions	PLOS ONE			English	Article							CELL-CYCLE ARREST; FAST-HALO ASSAY; CRUCIFEROUS VEGETABLES; STRAND BREAKAGE; ACUTE-LEUKEMIA; CANCER CELLS; APOPTOSIS; GROWTH; ISOTHIOCYANATES; CONSUMPTION	Sulforaphane is a dietary isothiocyanate found in cruciferous vegetables showing antileukemic activity. With the purpose of extending the potential clinical impact of sulforaphane in the oncological field, we investigated the antileukemic effect of sulforaphane on blasts from patients affected by different types of leukemia and, taking into account the intrinsically hypoxic nature of bone marrow, on a leukemia cell line (REH) maintained in hypoxic conditions. In particular, we tested sulforaphane on patients with chronic lymphocytic leukemia, acute myeloid leukemia, T-cell acute lymphoblastic leukemia, B-cell acute lymphoblastic leukemia, and blastic NK cell leukemia. Sulforaphane caused a dose-dependent induction of apoptosis in blasts from patients diagnosed with acute lymphoblastic or myeloid leukemia. Moreover, it was able to cause apoptosis and to inhibit proliferation in hypoxic conditions on REH cells. As to its cytotoxic mechanism, we found that sulforaphane creates an oxidative cellular environment that induces DNA damage and Bax and p53 gene activation, which in turn helps trigger apoptosis. On the whole, our results raise hopes that sulforaphane might set the stage for a novel therapeutic principle complementing our growing armature against malignancies and advocate the exploration of sulforaphane in a broader population of leukemic patients.	[Fimognari, Carmela; Turrini, Eleonora; Cantelli-Forti, Giorgio] Univ Bologna, Alma Mater Studiorum, Dept Life Qual Studies, Rimini, Italy; [Sestili, Piero; Calcabrini, Cinzia] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Carulli, Giovanni; Fontanelli, Giulia; Rousseau, Martina] Univ Pisa, Dept Clin & Expt Med, Div Hematol, Pisa, Italy; [Hrelia, Patrizia] Univ Bologna, Alma Mater Studiorum, Dept Pharm & BioTechnol, Bologna, Italy	University of Bologna; University of Urbino; University of Pisa; University of Bologna	Fimognari, C (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Life Qual Studies, Rimini, Italy.	carmela.fimognari@unibo.it	Fimognari, Carmela/J-7678-2019; Turrini, Eleonora/I-3629-2019; Hrelia, Patrizia/AAC-2071-2020; Sestili, Piero/H-6082-2019	Fimognari, Carmela/0000-0002-2461-8214; Turrini, Eleonora/0000-0003-4743-1126; Sestili, Piero/0000-0001-9412-1660; HRELIA, Patrizia/0000-0002-8415-3711	Fondazione Cassa di Risparmio di Imola (Italy); Fondazione del Monte di Bologna e Ravenna (Italy)	Fondazione Cassa di Risparmio di Imola (Italy); Fondazione del Monte di Bologna e Ravenna (Italy)(Fondazione del Monte di Bologna e Ravenna)	This work was supported by Fondazione Cassa di Risparmio di Imola (Italy) and by Fondazione del Monte di Bologna e Ravenna (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Arcangeli A, 2012, CURR MED CHEM, V19, P683, DOI 10.2174/092986712798992093; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Bosanquet Andrew G, 2002, J Exp Ther Oncol, V2, P53, DOI 10.1046/j.1359-4117.2002.01007.x; Box AH, 2004, CARCINOGENESIS, V25, P2325, DOI 10.1093/carcin/bgh274; Bromidge TJ, 1998, LEUKEMIA, V12, P1230, DOI 10.1038/sj.leu.2401095; Dietrich S, 2012, CLIN CANCER RES, V18, P417, DOI 10.1158/1078-0432.CCR-11-1049; Fathi AT, 2009, CURR ONCOL REP, V11, P346, DOI 10.1007/s11912-009-0047-x; Filippi I, 2011, CURR MED CHEM, V18, P2885, DOI 10.2174/092986711796150540; Fimognari C, 2003, ANN NY ACAD SCI, V1010, P393, DOI 10.1196/annals.1299.072; Fimognari C, 2007, MUTAT RES-REV MUTAT, V635, P90, DOI 10.1016/j.mrrev.2006.10.004; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Fimognari C, 2009, ENVIRON MOL MUTAGEN, V50, P171, DOI 10.1002/em.20447; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Ghamlouch H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060370; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hsu YC, 2013, CELL BIOCHEM BIOPHYS, V66, P765, DOI 10.1007/s12013-013-9522-y; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Karp JE, 2003, CLIN CANCER RES, V9, P307; Liu YY, 2014, J NEUROCHEM, V129, P539, DOI 10.1111/jnc.12647; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodi A, 2011, ACS CHEM BIOL, V6, P169, DOI 10.1021/cb900300j; Mohr J, 2011, BLOOD, V117, P1622, DOI 10.1182/blood-2010-08-300160; Morabito F, 1998, BRIT J HAEMATOL, V102, P528, DOI 10.1046/j.1365-2141.1998.00813.x; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; OCONNOR R, 1991, BLOOD, V77, P1534; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Pham NA, 2004, MOL CANCER THER, V3, P1239; Probst-Hensch NM, 1998, CANCER EPIDEM BIOMAR, V7, P635; Sestili P, 2002, BIOCHEM J, V364, P121, DOI 10.1042/bj3640121; Sestili P, 2006, MUTAT RES-GEN TOX EN, V607, P205, DOI 10.1016/j.mrgentox.2006.04.018; Sestili P, 2010, MUTAT RES-FUND MOL M, V689, P65, DOI 10.1016/j.mrfmmm.2010.05.003; Sestili Piero, 2009, V521, P517, DOI [10.1007/978-1-60327-815-7_30, 10.1007/978-1-60327-817-5_30]; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; Suppipat K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051251; Tang L, 2008, CANCER EPIDEM BIOMAR, V17, P938, DOI 10.1158/1055-9965.EPI-07-2502; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Traka M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002568; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Veeranki OL, 2013, BRIT J NUTR, V109, P25, DOI 10.1017/S0007114512000657	46	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101991	10.1371/journal.pone.0101991	http://dx.doi.org/10.1371/journal.pone.0101991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019218	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600034
J	Salewski, V; Siebenrock, KH; Hochachka, WM; Woog, F; Fiedler, W				Salewski, Volker; Siebenrock, Karl-Heinz; Hochachka, Wesley M.; Woog, Friederike; Fiedler, Wolfgang			Morphological Change to Birds over 120 Years Is Not Explained by Thermal Adaptation to Climate Change	PLOS ONE			English	Article							BODY-SIZE; BERGMANNS RULE; MEASUREMENT ERROR; HOUSE SPARROW; EVOLUTION; NORTH; HERITABILITY; POPULATIONS; RESPONSES; GOSHAWKS	Changes in morphology have been postulated as one of the responses of animals to global warming, with increasing ambient temperatures leading to decreasing body size. However, the results of previous studies are inconsistent. Problems related to the analyses of trends in body size may be related to the short-term nature of data sets, to the selection of surrogates for body size, to the appropriate models for data analyses, and to the interpretation as morphology may change in response to ecological drivers other than climate and irrespective of size. Using generalized additive models, we analysed trends in three morphological traits of 4529 specimens of eleven bird species collected between 1889 and 2010 in southern Germany and adjacent areas. Changes and trends in morphology over time were not consistent when all species and traits were considered. Six of the eleven species displayed a significant association of tarsus length with time but the direction of the association varied. Wing length decreased in the majority of species but there were few significant trends in wing pointedness. Few of the traits were significantly associated with mean ambient temperatures. We argue that although there are significant changes in morphology over time there is no consistent trend for decreasing body size and therefore no support for the hypothesis of decreasing body size because of climate change. Non-consistent trends of change in surrogates for size within species indicate that fluctuations are influenced by factors other than temperature, and that not all surrogates may represent size appropriately. Future analyses should carefully select measures of body size and consider alternative hypotheses for change.	[Salewski, Volker] NABU, Michael Otto Inst, Bergenhusen, Germany; [Siebenrock, Karl-Heinz; Fiedler, Wolfgang] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Hochachka, Wesley M.] Cornell Univ, Ornithol Lab, Ithaca, NY USA; [Woog, Friederike] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany	Max Planck Society; Cornell University	Fiedler, W (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	fiedler@orn.mpg.de	Woog, Friederike/AAI-1055-2020; Fiedler, Wolfgang/AAG-4510-2021; Hochachka, Wesley M./J-9768-2012	Fiedler, Wolfgang/0000-0003-1082-4161; Hochachka, Wesley M./0000-0002-0595-7827; Siebenrock, Klaus Arno/0000-0003-3627-4313				ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BAKER AJ, 1980, EVOLUTION, V34, P638, DOI 10.1111/j.1558-5646.1980.tb04003.x; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Bauer H.G., 2005, KOMPENDIUM VOGEL MIT; DAYAN T, 1991, PALEOBIOLOGY, V17, P189, DOI 10.1017/S0094837300010484; Dayan T, 1998, MAMMAL REV, V28, P99, DOI 10.1046/j.1365-2907.1998.00029.x; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Eck S., 2011, MEASURING BIRDS; Fiedler W, 2003, AVIAN MIGRATION, P21; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Flinks H, 2012, J ORNITHOL, V153, P1053, DOI 10.1007/s10336-012-0834-2; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; FREEMAN S, 1990, AUK, V107, P69; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Goodman RE, 2012, GLOBAL CHANGE BIOL, V18, P63, DOI 10.1111/j.1365-2486.2011.02538.x; Gosler AG, 1998, BIRD STUDY, V45, P92, DOI 10.1080/00063659809461082; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Guillemain M, 2005, WILDLIFE BIOL, V11, P81, DOI 10.2981/0909-6396(2005)11[81:LCTABS]2.0.CO;2; Hill ME, 2008, QUATERNARY SCI REV, V27, P1752, DOI 10.1016/j.quascirev.2008.07.002; Husby A, 2011, AM NAT, V178, P202, DOI 10.1086/660834; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Jakober H, 2000, J ORNITHOL, V141, P408, DOI 10.1007/BF01651570; Jenni L., 1994, MOULT AGING EUROPEAN; JOHNSTON RF, 1973, AM NAT, V107, P373, DOI 10.1086/282841; Kipp F. A., 1958, Vogelwarte, V19, P233; Kipp F.A., 1959, VOGELWARTE, V20, P77; Koontz TL, 2001, J ARID ENVIRON, V49, P581, DOI 10.1006/jare.2001.0806; Leisler B., 1985, Current Ornithology, V3, P155; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; LOUGHEED SC, 1991, AUK, V108, P432; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2003, J BIOGEOGR, V30, P331, DOI 10.1046/j.1365-2699.2003.00837.x; Merila J, 1996, J HERED, V87, P199, DOI 10.1093/oxfordjournals.jhered.a022985; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Moreno-Rueda G, 2007, J ORNITHOL, V148, P489, DOI 10.1007/s10336-007-0184-7; MOSER TJ, 1988, J WILDLIFE MANAGE, V52, P202, DOI 10.2307/3801223; Pergams ORW, 2001, GENETICA, V112, P245, DOI 10.1023/A:1013343923155; Perktas U, 2010, ACTA ORNITHOL, V45, P161, DOI 10.3161/000164510X551309; PIERSMA T, 1991, AUK, V108, P441; R Development Core Team, 2010, R LANG ENV STAT COMP; RISING JD, 1989, AUK, V106, P666; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Salewski V, 2008, BERICHTE VOGELWARTE, V18, P63; Salewski V, 2010, OECOLOGIA, V162, P247, DOI 10.1007/s00442-009-1446-2; SCHOLANDER PF, 1955, EVOLUTION, V9, P15, DOI 10.1111/j.1558-5646.1955.tb01510.x; Senar JC, 1997, ARDEA, V85, P269; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith FA, 2006, J BIOGEOGR, V33, P2061, DOI 10.1111/j.1365-2699.2006.01631.x; SMITH TB, 1995, CONSERV BIOL, V9, P107, DOI 10.1046/j.1523-1739.1995.09010107.x; Svensson L., 1992, IDENTIFICATION GUIDE; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Tornberg R, 1999, OECOLOGIA, V121, P369, DOI 10.1007/s004420050941; Van Buskirk J, 2010, OIKOS, V119, P1047, DOI 10.1111/j.1600-0706.2009.18349.x; van Vliet J, 2009, BIRD STUDY, V56, P276, DOI 10.1080/00063650902792148; Vanhooydonck B, 2009, BIOL J LINN SOC, V98, P129, DOI 10.1111/j.1095-8312.2009.01269.x; VANNOORDWIJK AJ, 1988, GENET RES, V51, P149, DOI 10.1017/S0016672300024162; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; Winkler Hans, 2005, P79; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yom-Tov Y, 2006, OIKOS, V112, P91, DOI 10.1111/j.0030-1299.2006.14183.x; Yom-Tov Y, 2005, J ANIM ECOL, V74, P803, DOI 10.1111/j.1365-2656.2005.00976.x; Yom-Tov Y, 2001, P ROY SOC B-BIOL SCI, V268, P947, DOI 10.1098/rspb.2001.1592; Yom-Tov Y, 2006, J ORNITHOL, V147, P644, DOI 10.1007/s10336-006-0090-4; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x; YOMTOV Y, 1986, J ZOOL, V208, P583; Zuur Alain F., 2009, P1	73	24	24	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e101927	10.1371/journal.pone.0101927	http://dx.doi.org/10.1371/journal.pone.0101927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019159	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600033
J	Trakarnsanga, K; Wilson, MC; Griffiths, RE; Toye, AM; Carpenter, L; Heesom, KJ; Parsons, SF; Anstee, DJ; Frayne, J				Trakarnsanga, Kongtana; Wilson, Marieangela C.; Griffiths, Rebecca E.; Toye, Ashley M.; Carpenter, Lee; Heesom, Kate J.; Parsons, Steve F.; Anstee, David J.; Frayne, Jan			Qualitative and Quantitative Comparison of the Proteome of Erythroid Cells Differentiated from Human iPSCs and Adult Erythroid Cells by Multiplex TMT Labelling and NanoLC-MS/MS	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MEMBRANE; EXPRESSION; GENERATION; PROTEINS; CADHERIN; COMPLEX; ANEMIA	Induced pluripotent stem cells (iPSC) are an attractive progenitor source for the generation of in vitro blood products. However, before iPSC-derived erythroid cells can be considered for therapeutic use their similarity to adult erythroid cells must be confirmed. We have analysed the proteome of erythroid cells differentiated from the iPSC fibroblast derived line (C19) and showed they express hallmark RBC proteins, including all those of the ankyrin and 4.1R complex. We next compared the proteome of erythroid cells differentiated from three iPSC lines (C19, OCE1, OPM2) with that of adult and cord blood progenitors. Of the 1989 proteins quantified <3% differed in level by 2-fold or more between the different iPSC-derived erythroid cells. When compared to adult cells, 11% of proteins differed in level by 2-fold or more, falling to 1.9% if a 5-fold threshold was imposed to accommodate slight inter-cell line erythropoietic developmental variation. Notably, the level of >30 hallmark erythroid proteins was consistent between the iPSC lines and adult cells. In addition, a sub-population (10-15%) of iPSC erythroid cells in each of the iPSC lines completed enucleation. Aberrant expression of some cytoskeleton proteins may contribute to the failure of the majority of the cells to enucleate since we detected some alterations in cytoskeletal protein abundance. In conclusion, the proteome of erythroid cells differentiated from iPSC lines is very similar to that of normal adult erythroid cells, but further work to improve the induction of erythroid cells in existing iPSC lines or to generate novel erythroid cell lines is required before iPSC-derived red cells can be considered suitable for transfusion therapy.	[Trakarnsanga, Kongtana; Wilson, Marieangela C.; Toye, Ashley M.; Heesom, Kate J.; Frayne, Jan] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Trakarnsanga, Kongtana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Griffiths, Rebecca E.; Toye, Ashley M.; Parsons, Steve F.; Anstee, David J.] NHSBT, Bristol Inst Transfus Sci, Bristol, Avon, England; [Carpenter, Lee] John Radcliffe Hosp, Natl Hlth Serv Blood & Transplant, Blood Res Lab, Oxford OX3 9DU, England	University of Bristol; Mahidol University; NHS Blood & Transplant (NHSBT); University of Oxford	Frayne, J (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	Jan.Frayne@Bristol.ac.uk	Toye, Ashley Mark/AAV-7199-2021; Anstee, David/AAE-9231-2020; Griffiths, Rebecca E/C-6127-2017; Toye, Ashley Mark/AFO-2320-2022	Toye, Ashley Mark/0000-0003-4395-9396; Griffiths, Rebecca E/0000-0001-7461-0635; Toye, Ashley Mark/0000-0003-4395-9396; Frayne, Jan/0000-0002-1113-7761; Wilson, Marieangela/0000-0001-6218-3533	Department of Health (England); NHSBT RD; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	Department of Health (England); NHSBT RD; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Department of Health (England), NHSBT R&D and funding from Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee DJ, 2011, VOX SANG, V100, P140, DOI 10.1111/j.1423-0410.2010.01388.x; Bell AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060300; Bieker JJ, 2005, MT SINAI J MED, V72, P333; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Carpenter L, 2011, BLOOD, V117, P4008, DOI 10.1182/blood-2010-08-299941; Chang CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025761; CHASIS JA, 1993, J CLIN INVEST, V91, P329, DOI 10.1172/JCI116189; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Dias J, 2011, STEM CELLS DEV, V20, P1639, DOI 10.1089/scd.2011.0078; Drews K, 2012, J MOL MED, V90, P735, DOI 10.1007/s00109-012-0913-0; Flatt JF, 2011, BLOOD, V118, P5267, DOI 10.1182/blood-2010-12-326645; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HORNE WC, 1993, BLOOD, V82, P2558; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Peyrard T, 2011, TRANSFUS MED REV, V25, P206, DOI 10.1016/j.tmrv.2011.01.002; Ponnusamy S, 2012, J PROTEOMICS, V75, P5762, DOI 10.1016/j.jprot.2012.07.020; Rombouts K, 2012, AM J PHYSIOL-CELL PH, V303, pC357, DOI 10.1152/ajpcell.00093.2012; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Seifinejad A, 2010, BIOCHEM BIOPH RES CO, V391, P329, DOI 10.1016/j.bbrc.2009.11.058; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Toye AM, 2008, BLOOD, V111, P5380, DOI 10.1182/blood-2007-07-099473; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Viprakasit V., 2014, BLOOD; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557	41	40	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e100874	10.1371/journal.pone.0100874	http://dx.doi.org/10.1371/journal.pone.0100874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019302	Green Published, gold, Green Submitted			2022-12-25	WOS:000339618600008
J	Oppliger, LV; von Dassow, P; Bouchemousse, S; Robuchon, M; Valero, M; Correa, JA; Mauger, S; Destombe, C				Valeria Oppliger, Luz; von Dassow, Peter; Bouchemousse, Sarah; Robuchon, Marine; Valero, Myriam; Correa, Juan A.; Mauger, Stephane; Destombe, Christophe			Alteration of Sexual Reproduction and Genetic Diversity in the Kelp Species Laminaria digitata at the Southern Limit of Its Range	PLOS ONE			English	Article							PARTHENOGENESIS; HYBRIDIZATION; ORIGIN; POLYPLOIDIZATION; PHAEOPHYCEAE; CONSERVATION; POPULATIONS; ADAPTATION; HYPOTHESIS; MANAGEMENT	Adaptation to marginal habitats at species range-limits has often been associated with parthenogenetic reproduction in terrestrial animals and plants. Laboratory observations have shown that brown algae exhibit a high propensity for parthenogenesis by various mechanisms. The kelp Laminaria digitata is an important component of the ecosystem in Northern European rocky intertidal habitats. We studied four L. digitata populations for the effects of marginality on genetic diversity and sexual reproduction. Two populations were marginal: One (Locquirec, in Northern Brittany) was well within the geographic range, but was genetically isolated from other populations by large stretches of sandy beaches. Another population was at the range limits of the species (Quiberon, in Southern Brittany) and was exposed to much higher seasonal temperature changes. Microsatellite analyses confirmed that these populations showed decreased genetic and allelic diversity, consistent with marginality and genetic isolation. Sporophytes from both marginal populations showed greatly diminished spore-production compared to central populations, but only the southern-limit population (Quiberon) showed a high propensity for producing unreduced (2N) spores. Unreduced 2N spores formed phenotypically normal gametophytes with nuclear area consistent with >= 2N DNA contents, and microsatellite studies suggested these were produced at least in part by automixis. However, despite this being the dominant path of spore production in Quiberon sporophyte individuals, the genetic evidence indicated the population was maintained mostly by sexual reproduction. Thus, although spore production and development showed the expected tendency of geographical parthenogenesis in marginal populations, this appeared to be a consequence of maladaptation, rather than an adaptation to, life in a marginal habitat.	[Valeria Oppliger, Luz; von Dassow, Peter; Correa, Juan A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Valeria Oppliger, Luz; Bouchemousse, Sarah; Robuchon, Marine; Valero, Myriam; Mauger, Stephane; Destombe, Christophe] Univ Paris 06, Sorbonne Univ, Stn Biol Roscoff, UMR 7144, Roscoff, France; [Valeria Oppliger, Luz; Bouchemousse, Sarah; Robuchon, Marine; Valero, Myriam; Mauger, Stephane; Destombe, Christophe] CNRS, Stn Biol Roscoff, UMR 7144, Roscoff, France; [von Dassow, Peter] Pontificia Univ Catolica Chile, IMO, Santiago, Chile; [Robuchon, Marine] Museum Natl Hist Nat, Inst Systemat, UMR 7205, F-75231 Paris, France; [Valeria Oppliger, Luz; Correa, Juan A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Appl Ecol & Sustainabil, Santiago, Chile	Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile	Oppliger, LV (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Alameda 340, Santiago, Chile.	valeriaoppliger@gmail.com	von Dassow, Peter/A-5399-2012; Bouchemousse, Sarah/AAT-3655-2021; Robuchon, Marine/D-4019-2018; Valero, Myriam/C-7550-2011; Valero, Myriam/M-6052-2019	Bouchemousse, Sarah/0000-0001-5283-5112; Robuchon, Marine/0000-0001-5873-2915; Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; Mauger, Stephane/0000-0002-8779-1516; von Dassow, Peter/0000-0002-1858-1953; Destombe, Christophe/0000-0001-5656-9659	CONICYT-FRENCH EMBASSY Ph.D. grant; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme [PIIF-GA-2008-221812]; French Ministry of Foreign Affairs [FONDAP 1501-0001, ANR 06 BDIV 012]; Laboratoire International Associe "Dispersal and Adaptation of Marine Species (LIA DIAMS)	CONICYT-FRENCH EMBASSY Ph.D. grant; Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission); French Ministry of Foreign Affairs; Laboratoire International Associe "Dispersal and Adaptation of Marine Species (LIA DIAMS)	V. Oppliger was supported by a CONICYT-FRENCH EMBASSY Ph.D. grant. P. von Dassow was supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (Grant PIIF-GA-2008-221812). This study is part of the research programs FONDAP 1501-0001 Program 7, ANR ECOKELP (ANR 06 BDIV 012), "ARCUS'' of the French Ministry of Foreign Affairs, and the Laboratoire International Associe "Dispersal and Adaptation of Marine Species (LIA DIAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson S, 2010, EVOLUTION, V64, P986, DOI 10.1111/j.1558-5646.2009.00872.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Asensi A, 2001, J PHYCOL, V37, P411, DOI 10.1046/j.1529-8817.2001.037003411.x; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Bartsch I, 2013, J PHYCOL, V49, P1061, DOI 10.1111/jpy.12125; BEATON MJ, 1988, AM NAT, V132, P837, DOI 10.1086/284892; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Billot C, 1998, MOL ECOL, V7, P1778, DOI 10.1046/j.1365-294x.1998.00516.x; Billot C, 2003, MAR ECOL PROG SER, V253, P111, DOI 10.3354/meps253111; Bothwell JH, 2010, NEW PHYTOL, V188, P111, DOI 10.1111/j.1469-8137.2010.03357.x; Couceiro L, 2013, AQUAT LIVING RESOUR, V26, P197, DOI 10.1051/alr/2012027; CUELLAR O, 1974, AM NAT, V108, P625, DOI 10.1086/282940; DIECK IT, 1992, PHYCOLOGIA, V31, P147, DOI 10.2216/i0031-8884-31-2-147.1; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; FANG TC, 1984, HYDROBIOLOGIA, V116, P317, DOI 10.1007/BF00027693; Fang TC, 1983, SUMMARY GENETIC STUD, P123; Fierst JL, 2010, PHYCOLOGIA, V49, P274, DOI 10.2216/PH09-41.1; Gall EA, 1996, EUR J PHYCOL, V31, P369, DOI 10.1080/09670269600651601; Gallon R, 2014, J BIOGEOGRAPHY; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Haag CR, 2004, ANN ZOOL FENN, V41, P539; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Horandl E, 2006, NEW PHYTOL, V171, P525, DOI 10.1111/j.1469-8137.2006.01769.x; Kamiya M, 2008, J PHYCOL, V44, P977, DOI 10.1111/j.1529-8817.2008.00551.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kearney M, 2006, TRENDS ECOL EVOL, V21, P10, DOI 10.1016/j.tree.2005.10.013; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kearney MR, 2003, TRENDS ECOL EVOL, V18, P605, DOI 10.1016/j.tree.2003.09.021; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; LEE JA, 1986, J PHYCOL, V22, P276, DOI 10.1111/j.1529-8817.1986.tb00024.x; Lewis RJ, 1996, PHYCOLOGIA, V35, P19, DOI 10.2216/i0031-8884-35-1-19.1; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Lundmark M, 2006, TRENDS ECOL EVOL, V21, P9, DOI 10.1016/j.tree.2005.10.007; Luning K, 1990, SEAWEEDS THEIR ENV B; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; MARIE D, 2000, CURRENT PROTOCOLS CY, P1; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; Meleder V, 2010, MAR BIOL, V157, P1525, DOI 10.1007/s00227-010-1426-4; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NUNNEY L, 1989, EVOLUTION, V43, P245, DOI 10.1111/j.1558-5646.1989.tb04225.x; Oppliger LV, 2007, J PHYCOL, V43, P1295, DOI 10.1111/j.1529-8817.2007.00408.x; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; Raybaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066044; Robuchon M, 2014, MOL ECOL, V23, P2669, DOI 10.1111/mec.12774; Roze D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001321; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stenberg P, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P63, DOI 10.1007/978-90-481-2770-2_4; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Valero M, 2011, CAH BIOL MAR, V52, P467; van Dijk PJ, 2003, PHILOS T R SOC B, V358, P1113, DOI 10.1098/rstb.2003.1302; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; Wattier R, 1997, J PHYCOL, V33, P868, DOI 10.1111/j.0022-3646.1997.00868.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; West John A., 1999, Phycological Research, V47, P115, DOI 10.1111/j.1440-1835.1999.tb00292.x	64	32	32	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2014	9	7							e102518	10.1371/journal.pone.0102518	http://dx.doi.org/10.1371/journal.pone.0102518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1PC	25019953	gold, Green Published, Green Submitted			2022-12-25	WOS:000339618600090
J	Belcaid, Z; Phallen, JA; Zeng, J; See, AP; Mathios, D; Gottschalk, C; Nicholas, S; Kellett, M; Ruzevick, J; Jackson, C; Albesiano, E; Durham, NM; Ye, XB; Tran, PT; Tyler, B; Wong, JW; Brem, H; Pardoll, DM; Drake, CG; Lim, M				Belcaid, Zineb; Phallen, Jillian A.; Zeng, Jing; See, Alfred P.; Mathios, Dimitrios; Gottschalk, Chelsea; Nicholas, Sarah; Kellett, Meghan; Ruzevick, Jacob; Jackson, Christopher; Albesiano, Emilia; Durham, Nicholas M.; Ye, Xiaobu; Tran, Phuoc T.; Tyler, Betty; Wong, John W.; Brem, Henry; Pardoll, Drew M.; Drake, Charles G.; Lim, Michael			Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; ADJUVANT TEMOZOLOMIDE; IMMUNOTHERAPY; IPILIMUMAB; RADIOTHERAPY; MELANOMA; CONCOMITANT; GUIDANCE; IMMUNITY	Background: Glioblastoma (GBM) is the most common malignant brain tumor in adults and is associated with a poor prognosis. Cytotoxic T lymphocyte antigen-4 (CTLA-4) blocking antibodies have demonstrated an ability to generate robust antitumor immune responses against a variety of solid tumors. 4-1BB (CD137) is expressed by activated T lymphocytes and served as a co-stimulatory signal, which promotes cytotoxic function. Here, we evaluate a combination immunotherapy regimen involving 4-1BB activation, CTLA-4 blockade, and focal radiation therapy in an immune-competent intracranial GBM model. Methods: GL261-luciferace cells were stereotactically implanted in the striatum of C57BL/6 mice. Mice were treated with a triple therapy regimen consisted of 4-1BB agonist antibodies, CTLA-4 blocking antibodies, and focal radiation therapy using a small animal radiation research platform and mice were followed for survival. Numbers of brain-infiltrating lymphocytes were analyzed by FACS analysis. CD4 or CD8 depleting antibodies were administered to determine the relative contribution of T helper and cytotoxic T cells in this regimen. To evaluate the ability of this immunotherapy to generate an antigen-specific memory response, long-term survivors were re-challenged with GL261 glioma en B16 melanoma flank tumors. Results: Mice treated with triple therapy had increased survival compared to mice treated with focal radiation therapy and immunotherapy with 4-1BB activation and CTLA-4 blockade. Animals treated with triple therapy exhibited at least 50% long-term tumor free survival. Treatment with triple therapy resulted in a higher density of CD4(+) and CD8(+) tumor infiltrating lymphocytes. Mechanistically, depletion of CD4(+) T cells abrogated the antitumor efficacy of triple therapy, while depletion of CD8(+) T cells had no effect on the treatment response. Conclusion: Combination therapy with 4-1BB activation and CTLA-4 blockade in the setting of focal radiation therapy improves survival in an orthotopic mouse model of glioma by a CD4(+) T cell dependent mechanism and generates antigen-specific memory.	[Belcaid, Zineb; Phallen, Jillian A.; See, Alfred P.; Mathios, Dimitrios; Gottschalk, Chelsea; Nicholas, Sarah; Kellett, Meghan; Ruzevick, Jacob; Jackson, Christopher; Ye, Xiaobu; Tyler, Betty; Brem, Henry; Lim, Michael] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Zeng, Jing; Tran, Phuoc T.; Wong, John W.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21205 USA; [Albesiano, Emilia; Durham, Nicholas M.; Pardoll, Drew M.; Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol & Med, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lim, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	mlim3@jhmi.edu	See, Alfred/AAD-6766-2022; Tran, Phuoc/W-2084-2019	See, Alfred/0000-0003-3634-4692; Tran, Phuoc/0000-0002-0147-0376; Lim, Michael/0000-0003-0523-3076	Accuray; Bristol-Meyers Squibb; Celldex; Agenus; Aduro; Medarex; NATIONAL CANCER INSTITUTE [R01CA166348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	Accuray; Bristol-Meyers Squibb(Bristol-Myers Squibb); Celldex; Agenus; Aduro; Medarex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Michael Lim is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria. Michael Lim is also a speaker for Accuray and receives research funding from Accuray, Bristol-Meyers Squibb, Celldex and Agenus. Charles Drake is a consultant for Bristol-Meyers Squibb, Compugen, Dendreon, and Roche/Genentech and he is an advisor for Aduro and Bristol-Meyers Squibb. He receives research funding from Bristol-Meyers Squibb, Aduro and Medarex and has stock ownership of Compugen. Drew Pardoll is a consultant/advisor for Jounce Therapeutics, Bristol-Meyers Squibb, ImmuneXcite and Aduro and receives research funding from Bristol-Meyers Squibb. Jing Zeng, Michael Lim, Charles Drake and Drew Pardoll hold a patent for the work related to this study. The authors declare that they have a patent relating to material pertinent to this article; this international patent application PCT/US2012/043124 entitled "Use of Adjuvant Focused Radiation Including Stereotactic Radiosurgery for Augmenting Immune Based Therapies Against Neoplasms'' was filed 19 June 2012. This application was subsequently filed on the national stage in the United Stage, Europe, Canada, Australia, India and China. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agarwalla P, 2012, J IMMUNOTHER, V35, P385, DOI 10.1097/CJI.0b013e3182562d59; Albesiano E, 2010, NEUROSURG CLIN N AM, V21, P17, DOI 10.1016/j.nec.2009.08.008; Armour M, 2010, RADIAT RES, V173, P119, DOI 10.1667/RR1845.1; Callahan MK, 2010, SEMIN ONCOL, V37, P473, DOI 10.1053/j.seminoncol.2010.09.001; Chi DDJ, 1997, AM J PATHOL, V150, P2143; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; Fecci PE, 2007, CLIN CANCER RES, V13, P2158, DOI 10.1158/1078-0432.CCR-06-2070; Ferrara TA, 2009, CURR OPIN MOL THER, V11, P37; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Grossman SA, 2011, CLIN CANCER RES, V17, P5473, DOI 10.1158/1078-0432.CCR-11-0774; Hodge JW, 2008, ONCOLOGY-NY, V22, P1064; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jackson C, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/732413; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kuang YL, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/439235; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Margolin K, 2012, LANCET ONCOL, V13, P459, DOI 10.1016/S1470-2045(12)70090-6; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; POLLOK KE, 1993, J IMMUNOL, V150, P771; Prins RM, 2003, CANCER RES, V63, P8487; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Silk AW, 2013, CANCER MED-US, V2, P899, DOI 10.1002/cam4.140; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wada S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-89; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025	34	174	179	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101764	10.1371/journal.pone.0101764	http://dx.doi.org/10.1371/journal.pone.0101764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013914	Green Published, Green Submitted, gold			2022-12-25	WOS:000339378400036
J	Voon, V; Mole, TB; Banca, P; Porter, L; Morris, L; Mitchell, S; Lapa, TR; Karr, J; Harrison, NA; Potenza, MN; Irvine, M				Voon, Valerie; Mole, Thomas B.; Banca, Paula; Porter, Laura; Morris, Laurel; Mitchell, Simon; Lapa, Tatyana R.; Karr, Judy; Harrison, Neil A.; Potenza, Marc N.; Irvine, Michael			Neural Correlates of Sexual Cue Reactivity in Individuals with and without Compulsive Sexual Behaviours	PLOS ONE			English	Article							IMPULSE-CONTROL DISORDERS; CINGULATE CORTEX; PSYCHIATRIC-INPATIENTS; HYPERSEXUAL DISORDER; PARKINSONS-DISEASE; COGNITIVE CONTROL; BRAIN POTENTIALS; FRONTAL-CORTEX; COCAINE CUES; HUMAN MALES	Although compulsive sexual behaviour (CSB) has been conceptualized as a "behavioural" addiction and common or overlapping neural circuits may govern the processing of natural and drug rewards, little is known regarding the responses to sexually explicit materials in individuals with and without CSB. Here, the processing of cues of varying sexual content was assessed in individuals with and without CSB, focusing on neural regions identified in prior studies of drug-cue reactivity. 19 CSB subjects and 19 healthy volunteers were assessed using functional MRI comparing sexually explicit videos with nonsexual exciting videos. Ratings of sexual desire and liking were obtained. Relative to healthy volunteers, CSB subjects had greater desire but similar liking scores in response to the sexually explicit videos. Exposure to sexually explicit cues in CSB compared to non-CSB subjects was associated with activation of the dorsal anterior cingulate, ventral striatum and amygdala. Functional connectivity of the dorsal anterior cingulate-ventral striatum-amygdala network was associated with subjective sexual desire (but not liking) to a greater degree in CSB relative to non-CSB subjects. The dissociation between desire or wanting and liking is consistent with theories of incentive motivation underlying CSB as in drug addictions. Neural differences in the processing of sexual-cue reactivity were identified in CSB subjects in regions previously implicated in drug-cue reactivity studies. The greater engagement of corticostriatal limbic circuitry in CSB following exposure to sexual cues suggests neural mechanisms underlying CSB and potential biological targets for interventions.	[Voon, Valerie; Mole, Thomas B.; Banca, Paula; Porter, Laura; Morris, Laurel; Mitchell, Simon; Lapa, Tatyana R.; Irvine, Michael] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; [Voon, Valerie; Morris, Laurel] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 2QQ, England; [Voon, Valerie; Mole, Thomas B.; Mitchell, Simon] Cambridgeshire & Peterborough Fdn Trust, Cambridge, England; [Karr, Judy] British Assoc Counselling & Psychotherapy, London, England; [Harrison, Neil A.] Brighton & Sussex Med Sch, Dept Psychiat, Brighton, E Sussex, England; [Potenza, Marc N.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Brighton; University of Sussex; Yale University; Yale University; Yale University	Voon, V (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England.	vv247@cam.ac.uk	Morris, Laurel/AAS-4655-2021; Mole, Tom/P-7588-2015; Banca, Paula/G-8330-2017; Voon, Valerie/O-7038-2017	Mole, Tom/0000-0001-8732-8188; Banca, Paula/0000-0001-7617-3635; Voon, Valerie/0000-0001-6790-1776; Harrison, Neil/0000-0002-9584-3769; Morris, Laurel S./0000-0002-5862-6650	Wellcome Trust Intermediate Fellowship grant [093705/Z/10/Z]; National Institutes of Health [DA027844, R01 DA018647]; Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; Medical Research Council [G0001354B, G1000183B, G0001354] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA027844, R01DA018647] Funding Source: NIH RePORTER	Wellcome Trust Intermediate Fellowship grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut State Department of Mental Health and Addiction Services; Connecticut Mental Health Center; Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by Wellcome Trust Intermediate Fellowship grant (093705/Z/10/Z). Dr. Potenza was supported in part by grants P20 DA027844 and R01 DA018647 from the National Institutes of Health; the Connecticut State Department of Mental Health and Addiction Services; the Connecticut Mental Health Center; and a Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, DOI 10.1016/B978-0-12-809324-5.05530-9]; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bocher M, 2001, NEUROIMAGE, V14, P105, DOI 10.1006/nimg.2001.0794; Carnes P. J., 2001, SHADOWS NET BREAKING; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Childress A R, 1993, NIDA Res Monogr, V137, P73; Delmonico DL, 2003, SEXUAL RELATIONSHIP, V18; Dunning JP, 2011, EUR J NEUROSCI, V33, P1716, DOI 10.1111/j.1460-9568.2011.07663.x; Euser AS, 2012, NEUROSCI BIOBEHAV R, V36, P572, DOI 10.1016/j.neubiorev.2011.09.002; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Fong Timothy W, 2006, Psychiatry (Edgmont), V3, P51; Franken IHA, 2004, J PSYCHOPHARMACOL, V18, P544, DOI 10.1177/0269881104047282; Franken IHA, 2003, PSYCHOPHARMACOLOGY, V170, P205, DOI 10.1007/s00213-003-1542-7; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Grant JE, 2005, AM J PSYCHIAT, V162, P2184, DOI 10.1176/appi.ajp.162.11.2184; Grant JE, 2007, J CLIN PSYCHIAT, V68, P1584, DOI 10.4088/JCP.v68n1018; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Heinze M, 2007, CLIN NEUROPHYSIOL, V118, P856, DOI 10.1016/j.clinph.2006.12.003; Kafka MP, 2010, ARCH SEX BEHAV, V39, P377, DOI 10.1007/s10508-009-9574-7; Kataoka H, 2009, MOVEMENT DISORD, V24, P471, DOI 10.1002/mds.22373; Kor A, 2013, SEX ADDICT COMPULSIV, V20; Kuhn S, 2014, JAMA PSYCHIAT; Kuhn S, 2011, J SEX MED, V8, P2269, DOI 10.1111/j.1743-6109.2011.02322.x; Kuhn S, 2011, EUR J NEUROSCI, V33, P1318, DOI 10.1111/j.1460-9568.2010.07590.x; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Lubman DI, 2008, J PSYCHOPHARMACOL, V22, P836, DOI 10.1177/0269881107083846; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Miner MH, 2009, PSYCHIAT RES-NEUROIM, V174, P146, DOI 10.1016/j.pscychresns.2009.04.008; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nelson HE., 1982, NATL ADULT READING T; Odlaug B.L., 2010, PRIM CARE COMPANION, V12; Odlaug BL, 2013, ANN CLIN PSYCHIATRY, V25, P193; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Perry DC, 2014, BRAIN; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Politis M, 2013, BRAIN, V136, P400, DOI 10.1093/brain/aws326; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Reid RC, 2013, SEXUAL ADDICTION COM, V20, P14; Reid RC, 2012, J SEX MED, V9, P2868, DOI 10.1111/j.1743-6109.2012.02936.x; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sescousse G, 2013, NEUROSCI BIOBEHAV R, V37, P681, DOI 10.1016/j.neubiorev.2013.02.002; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smith DG, 2014, BIOL PSYCHIAT, V75, P124, DOI 10.1016/j.biopsych.2013.05.019; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steele VR, 2013, SOCIOAFFECTIVE NEURO, V3, DOI 10.3402/snp.v3i0.20770; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; van de Laar MC, 2004, PSYCHOPHARMACOLOGY, V177, P121, DOI 10.1007/s00213-004-1928-1; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Warren CA, 1999, CLIN NEUROPHYSIOL, V110, P1570, DOI 10.1016/S1388-2457(99)00089-9; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	68	204	205	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102419	10.1371/journal.pone.0102419	http://dx.doi.org/10.1371/journal.pone.0102419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25013940	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000339378400094
J	Wang, R; Wang, YW; Lin, WK; Zhang, YM; Liu, W; Huang, K; Terrar, DA; Solaro, RJ; Wang, X; Ke, YB; Lei, M				Wang, Rui; Wang, Yanwen; Lin, Wee K.; Zhang, Yanmin; Liu, Wei; Huang, Kai; Terrar, Derek A.; Solaro, R. John; Wang, Xin; Ke, Yunbo; Lei, Ming			Inhibition of Angiotensin II-Induced Cardiac Hypertrophy and Associated Ventricular Arrhythmias by a p21 Activated Kinase 1 Bioactive Peptide	PLOS ONE			English	Article							PAK1; MYOCYTES; ACTIVATION; KINASE-1; ACTIN; HEART	Cardiac hypertrophy increases the risk of morbidity and mortality of cardiovascular disease and thus inhibiting such hypertrophy is beneficial. In the present study, we explored the effect of a bioactive peptide (PAP) on angiotensin II (Ang II)-induced hypertrophy and associated ventricular arrhythmias in in vitro and in vivo models. PAP enhances p21 activated kinase 1 (Pak1) activity by increasing the level of phosphorylated Pak1 in cultured neonatal rat ventricular myocytes (NRVMs). Such PAP-induced Pak1 activation is associated with a significant reduction of Ang II-induced hypertrophy in NRVMs and C57BL/6 mice, in vitro and in vivo, respectively. Furthermore, PAP antagonizes ventricular arrhythmias associated with Ang II-induced hypertrophy in mice. Its antiarrhythmic effect is likely to be involved in multiple mechanisms to affect both substrate and trigger of ventricular arrhythmogenesis. Thus our results suggest that Pak1 activation achieved by specific bioactive peptide represents a potential novel therapeutic strategy for cardiac hypertrophy and associated ventricular arrhythmias.	[Wang, Rui; Huang, Kai; Lei, Ming] Huazhong Univ Sci & Technol, Union Hosp, Inst Cardiovasc Dis, Wuhan 430074, Peoples R China; [Wang, Yanwen; Zhang, Yanmin; Liu, Wei] Univ Manchester, Fac Med & Human Sci, Inst Cardiovasc Sci, Manchester, Lancs, England; [Wang, Yanwen; Lin, Wee K.; Terrar, Derek A.; Lei, Ming] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Solaro, R. John; Ke, Yunbo] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Dept Physiol & Biophys, Chicago, IL 60607 USA; [Wang, Xin] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Huazhong University of Science & Technology; University of Manchester; University of Oxford; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Manchester	Ke, YB (corresponding author), Univ Illinois, Coll Med, Cardiovasc Res Ctr, Dept Physiol & Biophys, Chicago, IL 60607 USA.	yke@uic.edu; ming.lei@pharm.ox.ac.uk	Lei, Ming/S-7209-2016; Wang, Yanwen/I-1654-2015	Lei, Ming/0000-0002-0928-341X; Wang, Yanwen/0000-0002-7986-4500; Liu, Wei/0000-0003-1592-6693; Terrar, Derek/0000-0001-9408-6594; Zhang, Yanmin/0000-0001-7307-9408	Chinese Nature Science Foundation [31171085]; British Heart Foundation [PG/12/21/29473]; Medical Research Council [G10002647]; Wellcome Trust [081809]; NIH/NHLBI [RO1 HL064035, PO1 HL062426, CCTS UL1RR029879]; MRC [G1002647] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064035, P01HL062426] Funding Source: NIH RePORTER; British Heart Foundation [PG/12/76/29852, PG/09/052/27833] Funding Source: researchfish; Medical Research Council [G1002647] Funding Source: researchfish	Chinese Nature Science Foundation; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by a Chinese Nature Science Foundation Grant (31171085: ML); British Heart Foundation (PG/12/21/29473: ML, XW); Medical Research Council (G10002647: ML, XW, RJS, YK); The Wellcome Trust (081809: ML); and NIH/NHLBI grants RO1 HL064035, PO1 HL062426 (RJS), CCTS UL1RR029879 (YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2011, CARDIOVASC RES, V92, P106, DOI 10.1093/cvr/cvr163; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Beeser A, 2005, METHODS, V37, P203, DOI 10.1016/j.ymeth.2005.05.017; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Emdad L, 2001, J MOL CELL CARDIOL, V33, P219, DOI 10.1006/jmcc.2000.1293; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; Ke YB, 2007, CIRC RES, V100, P1317, DOI 10.1161/01.RES.0000266742.51389.a4; Ke YB, 2008, PROG BIOPHYS MOL BIO, V98, P238, DOI 10.1016/j.pbiomolbio.2009.01.007; Liu W, 2011, CIRCULATION, V124, P2702, DOI 10.1161/CIRCULATIONAHA.111.048785; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Qu JX, 2009, CIRC RES, V104, P365, DOI 10.1161/CIRCRESAHA.108.184044; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Sheridan DJ, 1999, BRIT J CLIN PHARMACO, V47, P125; Taglieri DM, 2011, J MOL CELL CARDIOL, V51, P988, DOI 10.1016/j.yjmcc.2011.09.016; Thullberg M, 2007, ONCOGENE, V26, P1820, DOI 10.1038/sj.onc.1209983; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	18	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e101974	10.1371/journal.pone.0101974	http://dx.doi.org/10.1371/journal.pone.0101974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014109	gold, Green Published, Green Submitted			2022-12-25	WOS:000339378400049
J	Yang, Y; Liu, Y; Cao, FQ; Chen, XP; Cheng, LS; Romeis, J; Li, YH; Peng, YF				Yang, Yan; Liu, Yue; Cao, Fengqin; Chen, Xiuping; Cheng, Lisheng; Romeis, Joerg; Li, Yunhe; Peng, Yufa			Consumption of Bt Rice Pollen Containing Cry1C or Cry2A Protein Poses a Low to Negligible Risk to the Silkworm Bombyx mori (Lepidoptera: Bombyxidae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; EXPRESSION; TOXICITY; LARVAE; CROPS; CHINA; LINES	By consuming mulberry leaves covered with pollen from nearby genetically engineered, insect-resistant rice lines producing Cry proteins derived from Bacillus thuringiensis (Bt), larvae of the domestic silkworm, Bombyx mori (Linnaeus) (Lepidoptera: Bombyxidae), could be exposed to insecticidal proteins. Laboratory experiments were conducted to assess the potential effects of Cry1C- or Cry2A-producing transgenic rice (T1C-19, T2A-1) pollen on B. mori fitness. In a short-term assay, B. mori larvae were fed mulberry leaves covered with different densities of pollen from Bt rice lines or their corresponding near isoline (control) for the first 3 d and then were fed mulberry leaves without pollen. No effect was detected on any life table parameter, even at 1800 pollen grains/cm(2) leaf, which is much higher than the mean natural density of rice pollen on leaves of mulberry trees near paddy fields. In a long-term assay, the larvae were fed Bt and control pollen in the same way but for their entire larval stage (approximately 27 d). Bt pollen densities >= 150 grains/cm(2) leaf reduced 14-d larval weight, increased larval development time, and reduced adult eclosion rate. ELISA analyses showed that 72.6% of the Cry protein was still detected in the pollen grains excreted with the feces. The low exposure of silkworm larvae to Cry proteins when feeding Bt rice pollen may be the explanation for the relatively low toxicity detected in the current study. Although the results demonstrate that B. mori larvae are sensitive to Cry1C and Cry2A proteins, the exposure levels that harmed the larvae in the current study are far greater than natural exposure levels. We therefore conclude that consumption of Bt rice pollen will pose a low to negligible risk to B. mori.	[Yang, Yan; Liu, Yue; Cao, Fengqin] Hainan Univ, Coll Environm & Plant Protect, Haikou, Peoples R China; [Yang, Yan; Chen, Xiuping; Romeis, Joerg; Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Yang, Yan; Cheng, Lisheng] Qiongtai Teachers Coll, Haikou, Peoples R China; [Romeis, Joerg] Agroscope, Inst Sustainabil Sci, Zurich, Switzerland	Hainan University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope	Li, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yunhe.li@hotmail.com	peng, yu/GXW-2071-2022		National GMO New Variety Breeding Program of PRC [2014ZX08011-02B, 2014ZX08011-001]	National GMO New Variety Breeding Program of PRC	The study was supported by the National GMO New Variety Breeding Program of PRC (2014ZX08011-02B, 2014ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; [樊龙江 Fan Longjiang], 2003, [生态学报, Acta Ecologica Sinica], V23, P826; Food and Agriculture Organization of the Unites Nations United Nations University World Health Organization, 2001, FAO FOOD NUTR TECHN; GE AZ, 1989, P NATL ACAD SCI USA, V86, P4037, DOI 10.1073/pnas.86.11.4037; IHARA H, 1993, BIOSCI BIOTECH BIOCH, V57, P200, DOI 10.1271/bbb.57.200; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Lang A, 2006, BASIC APPL ECOL, V7, P296, DOI 10.1016/j.baae.2005.10.003; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2014, ENVIRON TOXICOL CHEM, V33, P1391, DOI 10.1002/etc.2567; Li YH, 2014, PLANT CELL REP, V33, P565, DOI 10.1007/s00299-014-1567-x; Li YH, 2014, BIOL CONTROL, V69, P45, DOI 10.1016/j.biocontrol.2013.10.017; Li YH, 2013, ECOTOXICOLOGY, V22, P1413, DOI 10.1007/s10646-013-1127-0; Li YH, 2010, J INSECT PHYSIOL, V56, P157, DOI 10.1016/j.jinsphys.2009.09.011; Liu YQ, 2010, J INSECT SCI, V10, P1, DOI 10.1673/031.010.14140; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; PUSZTAI M, 1991, BIOCHEM J, V273, P43, DOI 10.1042/bj2730043; Raybould A, 2011, J AGR FOOD CHEM, V59, P5877, DOI 10.1021/jf1042079; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2013, CHEMOSPHERE, V90, P901, DOI 10.1016/j.chemosphere.2012.09.035; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Wang YN, 2014, ENVIRON ENTOMOL, V43, P528, DOI 10.1603/EN13254; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wang ZhongHua, 2001, Hereditas (Beijing), V23, P463; Wang ZhongHua, 2002, Scientia Agricultura Sinica, V35, P714; Yao HW, 2008, ENVIRON ENTOMOL, V37, P825, DOI 10.1603/0046-225X(2008)37[825:TAOPFD]2.0.CO;2; Yao HW, 2006, APPL ENTOMOL ZOOL, V41, P339, DOI 10.1303/aez.2006.339; Yuan Z, 2006, B SERICULTURE, V3, P23; Zhang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085395; Zhang XiuFu, 2005, Research of Agricultural Modernization, V26, P85; Zhang YJ, 2011, ENVIRON ENTOMOL, V40, P1323, DOI 10.1603/EN11035	33	10	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2014	9	7							e102302	10.1371/journal.pone.0102302	http://dx.doi.org/10.1371/journal.pone.0102302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8HH	25014054	Green Published, gold, Green Submitted			2022-12-25	WOS:000339378400086
J	Deusch, O; O'Flynn, C; Colyer, A; Morris, P; Allaway, D; Jones, PG; Swanson, KS				Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Morris, Penelope; Allaway, David; Jones, Paul G.; Swanson, Kelly S.			Deep Illumina-Based Shotgun Sequencing Reveals Dietary Effects on the Structure and Function of the Fecal Microbiome of Growing Kittens	PLOS ONE			English	Article							MEGASPHAERA-ELSDENII; GUT MICROBIOTA; BACTERIAL; GENE; MUCIN; FERMENTATION; POPULATIONS; PCR; BIFIDOBACTERIA; HYBRIDIZATION	Background: Previously, we demonstrated that dietary protein: carbohydrate ratio dramatically affects the fecal microbial taxonomic structure of kittens using targeted 16S gene sequencing. The present study, using the same fecal samples, applied deep Illumina shotgun sequencing to identify the diet-associated functional potential and analyze taxonomic changes of the feline fecal microbiome. Methodology & Principal Findings: Fecal samples from kittens fed one of two diets differing in protein and carbohydrate content (high-protein, low-carbohydrate, HPLC; and moderate-protein, moderate-carbohydrate, MPMC) were collected at 8, 12 and 16 weeks of age (n = 6 per group). A total of 345.3 gigabases of sequence were generated from 36 samples, with 99.75% of annotated sequences identified as bacterial. At the genus level, 26% and 39% of reads were annotated for HPLC- and MPMC-fed kittens, with HPLC-fed cats showing greater species richness and microbial diversity. Two phyla, ten families and fifteen genera were responsible for more than 80% of the sequences at each taxonomic level for both diet groups, consistent with the previous taxonomic study. Significantly different abundances between diet groups were observed for 324 genera (56% of all genera identified) demonstrating widespread diet-induced changes in microbial taxonomic structure. Diversity was not affected over time. Functional analysis identified 2,013 putative enzyme function groups were different (p<0.000007) between the two dietary groups and were associated to 194 pathways, which formed five discrete clusters based on average relative abundance. Of those, ten contained more (p<0.022) enzyme functions with significant diet effects than expected by chance. Six pathways were related to amino acid biosynthesis and metabolism linking changes in dietary protein with functional differences of the gut microbiome. Conclusions: These data indicate that feline feces-derived microbiomes have large structural and functional differences relating to the dietary protein: carbohydrate ratio and highlight the impact of diet early in life.	[Deusch, Oliver; O'Flynn, Ciaran; Colyer, Alison; Morris, Penelope; Allaway, David; Jones, Paul G.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	Mars; WALTHAM Petcare Science Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Swanson, KS (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Swanson, Kelly/0000-0001-5518-3076; Deusch, Oliver/0000-0003-3378-6129; Allaway, David/0000-0003-4602-8933	Mars Petcare	Mars Petcare	Funding was provided by Mars Petcare. The funders had no role in study design, data collection, and decision to publish (was the role of KSS). KSS, OD, and CO were the primary individuals that analyzed the data and wrote the manuscript.	AAFCO, 2007, OFF PUBL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Bermingham EN, 2013, MICROBIOLOGYOPEN, V2, P173, DOI 10.1002/mbo3.60; Biagi G, 2013, AM J VET RES, V74, P90, DOI 10.2460/ajvr.74.1.90; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Chan CKK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-215; COUNOTTE GHM, 1981, APPL ENVIRON MICROB, V42, P649, DOI 10.1128/AEM.42.4.649-655.1981; Delzenne NM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S10; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Faith J.J., 2013, SCIENCE, V341; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Goehler LE, 2008, BRAIN BEHAV IMMUN, V22, P354, DOI 10.1016/j.bbi.2007.08.009; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hartemink R, 1999, J MICROBIOL METH, V36, P181, DOI 10.1016/S0167-7012(99)00031-7; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; HISHINUMA F, 1968, AGR BIOL CHEM TOKYO, V32, P1325, DOI 10.1080/00021369.1968.10859234; Hooda S, 2013, BRIT J NUTR, V109, P1637, DOI 10.1017/S0007114512003479; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; JENSEN BB, 1994, APPL ENVIRON MICROB, V60, P1897, DOI 10.1128/AEM.60.6.1897-1904.1994; Jiao DZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002981; Kanakupt K, 2011, J ANIM SCI, V89, P1376, DOI 10.2527/jas.2010-3201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu JM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks828; MACFARLANE GT, 1991, FEMS MICROBIOL LETT, V77, P289, DOI 10.1111/j.1574-6968.1991.tb04363.x; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meakins TS, 1996, CLIN SCI, V90, P215, DOI 10.1042/cs0900215; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedersen R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-30; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ricke SC, 1996, CRIT REV MICROBIOL, V22, P27, DOI 10.3109/10408419609106455; Ricke SC, 1996, APPL MICROBIOL BIOT, V46, P169, DOI 10.1007/s002530050800; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; ROBERTON AM, 1982, APPL ENVIRON MICROB, V43, P325, DOI 10.1128/AEM.43.2.325-330.1982; Rodriguez-Prado M, 2004, J DAIRY SCI, V87, P1413, DOI 10.3168/jds.S0022-0302(04)73290-7; Rosin FM, 2005, TRENDS PLANT SCI, V10, P516, DOI 10.1016/j.tplants.2005.09.002; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; RUSSELL JB, 1978, APPL ENVIRON MICROB, V36, P319, DOI 10.1128/AEM.36.2.319-329.1978; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selle K, 2013, FEMS MICROBIOL REV; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; TERADA A, 1993, J VET MED SCI, V55, P291, DOI 10.1292/jvms.55.291; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2011, GUT MICROBES, V2, P183, DOI 10.4161/gmic.2.3.16105; Vester BM, 2009, ARCH ANIM NUTR, V63, P254, DOI 10.1080/17450390902860000; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Warren YA, 2006, J CLIN MICROBIOL, V44, P2416, DOI 10.1128/JCM.00116-06; Wright DP, 2000, J BACTERIOL, V182, P3002, DOI 10.1128/JB.182.11.3002-3007.2000; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yoshida Y, 2009, ANIM SCI J, V80, P709, DOI 10.1111/j.1740-0929.2009.00692.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	34	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101021	10.1371/journal.pone.0101021	http://dx.doi.org/10.1371/journal.pone.0101021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010839	Green Published, gold, Green Submitted			2022-12-25	WOS:000338763800012
J	Privat, M; Radosevic-Robin, N; Aubel, C; Cayre, A; Penault-Llorca, F; Marceau, G; Sapin, V; Bignon, YJ; Morvan, D				Privat, Maud; Radosevic-Robin, Nina; Aubel, Corinne; Cayre, Anne; Penault-Llorca, Frederique; Marceau, Geoffroy; Sapin, Vincent; Bignon, Yves-Jean; Morvan, Daniel			BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; OXIDATIVE STRESS; TUMOR SUPPRESSORS; SDH MUTATIONS; PARAGANGLIOMA; METABOLOMICS; EXPRESSION; WARBURG; AKT; TUMORIGENESIS	The hypermetabolic nature of cancer cells and their increased reliance on "aerobic glycolysis'', as originally described by Otto Warburg and colleagues, are considered metabolic hallmarks of cancer cells. BRCA1 is a major tumor suppressor in breast cancer and it was implicated in numerous pathways resulting in anticarcinogenic functions. The objective of our study was to address specific contributions of BRCA1 to the metabolic features of cancer cells, including the so-called "Warburg effect''. To get a comprehensive approach of the role of BRCA1 in tumor cell metabolism, we performed a global transcriptional and metabolite profiling in a BRCA1-mutated breast cancer cell line transfected or not by wild-type BRCA1. This study revealed that BRCA1 induced numerous modifications of metabolism, including strong inhibition of glycolysis while TCA cycle and oxidative phosphorylation tended to be activated. Regulation of AKT by BRCA1 in both our cell model and BRCA1-mutated breast tumors was suggested to participate in the effect of BRCA1 on glycolysis. We could also show that BRCA1 induced a decrease of ketone bodies and free fatty acids, maybe consumed to supply Acetyl-CoA for TCA cycle. Finally increased activity of antioxidation pathways was observed in BRCA1-transfected cells, that could be a consequence of ROS production by activated oxidative phosphorylation. Our study suggests a new function for BRCA1 in cell metabolic regulation, globally resulting in reversion of the Warburg effect. This could represent a new mechanism by which BRCA1 may exert tumor suppressor function.	[Privat, Maud; Radosevic-Robin, Nina; Aubel, Corinne; Cayre, Anne; Penault-Llorca, Frederique; Bignon, Yves-Jean; Morvan, Daniel] Univ Auvergne, Jean Perrin Comprehens Canc Ctr, Clermont Ferrand, France; [Privat, Maud; Radosevic-Robin, Nina; Aubel, Corinne; Cayre, Anne; Penault-Llorca, Frederique; Bignon, Yves-Jean; Morvan, Daniel] Univ Auvergne, ERTICA Res Team EA4677, Clermont Ferrand, France; [Morvan, Daniel] UNH, UMR 1019, INRA, Clermont Ferrand, France; [Marceau, Geoffroy; Sapin, Vincent] CHU Clermont Ferrand, Ctr Biol, Lab Biochim Med, Clermont Ferrand, France	UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); INRAE; CHU Clermont Ferrand	Bignon, YJ (corresponding author), Univ Auvergne, Jean Perrin Comprehens Canc Ctr, Clermont Ferrand, France.	Yves-Jean.Bignon@cjp.fr	, bignon/Y-3243-2019; , Maud/ABB-9090-2021; aubel, corinne/Y-7143-2019; Aubel, Corinne/ABB-2346-2021	, Maud/0000-0002-9373-3902; Aubel, Corinne/0000-0003-4500-6505; CAYRE, Anne/0000-0002-2578-8557; MARCEAU, GEOFFROY/0000-0003-4713-7162	Centre Jean Perrin; University of Auvergne; hospital of Clermont-Ferrand; League against the cancer committee of Allier and of Puy de Dome	Centre Jean Perrin; University of Auvergne; hospital of Clermont-Ferrand; League against the cancer committee of Allier and of Puy de Dome	This work was supported by the Centre Jean Perrin, the University of Auvergne, and the hospital of Clermont-Ferrand. Grants were also obtained from the League against the cancer committee of Allier and of Puy de Dome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bayet-Robert M, 2010, MAGN RESON MED, V63, P1172, DOI 10.1002/mrm.22303; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao L, 2007, CARCINOGENESIS, V28, P1401, DOI 10.1093/carcin/bgm060; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan SJ, 2009, CANCER RES, V69, P6083, DOI 10.1158/0008-5472.CAN-08-3309; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Nam H, 2009, BIOINFORMATICS, V25, P3151, DOI 10.1093/bioinformatics/btp558; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasini B, 2009, J INTERN MED, V266, P19, DOI 10.1111/j.1365-2796.2009.02111.x; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Privat M, 2009, BIOCHEM BIOPH RES CO, V379, P785, DOI 10.1016/j.bbrc.2008.12.151; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Thompson CB, 2009, NEW ENGL J MED, V360, P813, DOI 10.1056/NEJMe0810213; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xiang T, 2011, ONCOGENE, V30, P2443, DOI 10.1038/onc.2010.603; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471	45	41	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102438	10.1371/journal.pone.0102438	http://dx.doi.org/10.1371/journal.pone.0102438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010005	Green Published, gold			2022-12-25	WOS:000338763800102
J	Temma, T; Hanaoka, H; Yonezawa, A; Kondo, N; Sano, K; Sakamoto, T; Seiki, M; Ono, M; Saji, H				Temma, Takashi; Hanaoka, Hirofumi; Yonezawa, Aki; Kondo, Naoya; Sano, Kohei; Sakamoto, Takeharu; Seiki, Motoharu; Ono, Masahiro; Saji, Hideo			Investigation of a MMP-2 Activity-Dependent Anchoring Probe for Nuclear Imaging of Cancer	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; PEPTIDES; FLUORESCENCE; INHIBITION; STRATEGY; THERAPY; TARGET; CELLS	Purpose: Since matrix metalloproteinase-2 (MMP-2) is an important marker of tumor malignancy, we developed an original drug design strategy, MMP-2 activity dependent anchoring probes (MDAP), for use in MMP-2 activity imaging, and evaluated the usefulness of this probe in in vitro and in vivo experiments. Methods: We designed and synthesized MDAP(1000), MDAP(3000), and MDAP(5000), which consist of 4 independent moieties: RI unit (111 In hydrophilic chelate), MMP-2 substrate unit (short peptide), anchoring unit (alkyl chain), and anchoring inhibition unit (polyethylene glycol (PEGn; where n represents the approximate molecular weight, n = 1000, 3000, and 5000). Probe cleavage was evaluated by chromatography after MMP-2 treatment. Cellular uptake of the probes was then measured. Radioactivity accumulation in tumor xenografts was evaluated after intravenous injection of the probes, and probe cleavage was evaluated in tumor homogenates. Results: MDAP(1000), MDAP(3000), and MDAP(5000) were cleaved by MMP-2 in a concentration-dependent manner. MDAP(3000) pretreated with MMP-2 showed higher accumulation in tumor cells, and was completely blocked by additional treatment with an MMP inhibitor. MDAP(3000) exhibited rapid blood clearance and a high tumor accumulation after intravenous injection in a rodent model. Furthermore, pharmacokinetic analysis revealed that MDAP(3000) exhibited a considerably slow washout rate from tumors to blood. A certain fraction of cleaved MDAP(3000) existed in tumor xenografts in vivo. Conclusions: The results indicate the possible usefulness of our MDAP strategy for tumor imaging.	[Temma, Takashi; Yonezawa, Aki; Kondo, Naoya; Sano, Kohei; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto, Japan; [Hanaoka, Hirofumi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chuo Ku, Chiba, Japan; [Sano, Kohei] Kyoto Univ, Fac Med, Kyoto Univ Hosp, Radioisotopes Res Lab,Sakyo Ku, Kyoto, Japan; [Sakamoto, Takeharu; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo, Japan	Kyoto University; Chiba University; Kyoto University; University of Tokyo	Saji, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto, Japan.	hsaji@pharm.kyoto-u.ac.jp	Hanaoka, Hirofumi/T-6261-2019; Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015; Temma, Takashi/AAG-6809-2019	Hanaoka, Hirofumi/0000-0003-2421-7397; Sakamoto, Takeharu/0000-0002-1225-1902; Temma, Takashi/0000-0002-7345-6004; Kondo, Naoya/0000-0002-8082-8849	JSPS KAKENHI [22791189]; New Energy and Industrial Technology Development Organization (NEDO), Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by JSPS KAKENHI Grant Number 22791189. Part of this study was supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balon HR, 2001, J NUCL MED, V42, P1134; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Chen C, 2011, EXPERT OPIN DRUG DEL, V8, P1221, DOI 10.1517/17425247.2011.602399; Chien MH, 2013, EXPERT OPIN THER TAR, V17, P203, DOI 10.1517/14728222.2013.740012; Chuang CH, 2012, CLIN CANCER RES, V18, P238, DOI 10.1158/1078-0432.CCR-11-0608; Cornelissen B, 2011, J NUCL MED, V52, P776, DOI 10.2967/jnumed.110.084392; Kato K, 2004, BIOTECHNOL PROGR, V20, P897, DOI 10.1021/bp0342093; Kondo N, 2013, CANCER SCI, V104, P495, DOI 10.1111/cas.12102; Leyton JV, 2011, J NUCL MED, V52, P1465, DOI 10.2967/jnumed.111.087668; Myochin T, 2012, J AM CHEM SOC, V134, P13730, DOI 10.1021/ja303931b; Nestor JJ, 2009, CURR MED CHEM, V16, P4399, DOI 10.2174/092986709789712907; Nishigori K, 2013, NUCL MED BIOL, V40, P97, DOI 10.1016/j.nucmedbio.2012.08.002; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Sakamoto T, 2014, MOL CELL BIOL, V34, P30, DOI 10.1128/MCB.01169-13; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; SELTZER JL, 1990, J BIOL CHEM, V265, P20409; Shimizu Y, 2011, CANCER SCI, V102, P1897, DOI 10.1111/j.1349-7006.2011.02020.x; Stabin MG, 2005, J NUCL MED, V46, P1023; van Duijnhoven SMJ, 2011, J NUCL MED, V52, P279, DOI 10.2967/jnumed.110.082503; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zhao T, 2010, J CONTROL RELEASE, V144, P109, DOI 10.1016/j.jconrel.2010.01.023	21	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e102180	10.1371/journal.pone.0102180	http://dx.doi.org/10.1371/journal.pone.0102180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25010662	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800076
J	Kovalenko, KE; Brady, VJ; Ciborowski, JJH; Ilyushkin, S; Johnson, LB				Kovalenko, Katya E.; Brady, Valerie J.; Ciborowski, Jan J. H.; Ilyushkin, Sergey; Johnson, Lucinda B.			Functional Changes in Littoral Macroinvertebrate Communities in Response to Watershed-Level Anthropogenic Stress	PLOS ONE			English	Article							MULTIPLE SPATIAL SCALES; GREAT-LAKES; SPECIES TRAITS; LAND-COVER; BIODIVERSITY; DIVERSITY; THRESHOLDS; INDICATORS; URBANIZATION; ASSEMBLAGES	Watershed-scale anthropogenic stressors have profound effects on aquatic communities. Although several functional traits of stream macroinvertebrates change predictably in response to land development and urbanization, little is known about macroinvertebrate functional responses in lakes. We assessed functional community structure, functional diversity (Rao's quadratic entropy) and voltinism in macroinvertebrate communities sampled across the full gradient of anthropogenic stress in Laurentian Great Lakes coastal wetlands. Functional diversity and voltinism significantly decreased with increasing development, whereas agriculture had smaller or non-significant effects. Functional community structure was affected by watershed-scale development, as demonstrated by an ordination analysis followed by regression. Because functional community structure affects energy flow and ecosystem function, and functional diversity is known to have important implications for ecosystem resilience to further environmental change, these results highlight the necessity of finding ways to remediate or at least ameliorate these effects.	[Kovalenko, Katya E.; Ciborowski, Jan J. H.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Kovalenko, Katya E.; Brady, Valerie J.; Johnson, Lucinda B.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55812 USA; [Ilyushkin, Sergey] Colorado Sch Mines, Golden, CO 80401 USA	University of Windsor; University of Minnesota System; University of Minnesota Duluth; Colorado School of Mines	Kovalenko, KE (corresponding author), Univ Windsor, Windsor, ON N9B 3P4, Canada.	philarctus@gmail.com	Ciborowski, Jan J.H./AAC-8247-2019	Ciborowski, Jan J.H./0000-0002-6588-0366; Brady, Valerie/0000-0002-2575-1017; Kovalenko, Katya/0000-0001-7363-212X	U.S. Environmental Protection Agency Science [R-8286750]; Protocols for Selection of Classification Systems and Reference Conditions project [R-828777]; U.S. Environmental Protection Agency Great Lakes National Program Office [GL-00E00623-0]; US EPA	U.S. Environmental Protection Agency Science(United States Environmental Protection Agency); Protocols for Selection of Classification Systems and Reference Conditions project; U.S. Environmental Protection Agency Great Lakes National Program Office(United States Environmental Protection Agency); US EPA(United States Environmental Protection Agency)	Data collection for this project was supported by grants from the U.S. Environmental Protection Agency Science to Achieve Results Estuarine and Great Lakes Program through the Great Lakes Environmental Indicators Project (R-8286750) to G.L. Niemi et al. and the Protocols for Selection of Classification Systems and Reference Conditions project (R-828777) to L.B. Johnson et al. Other parts of this project were supported by the second stage GLEI-II Indicator Testing and Refinement project funded by a Great Lakes Restoration Initiative grant from the U.S. Environmental Protection Agency Great Lakes National Program Office to L.B. Johnson et al. (GL-00E00623-0). Although the research described in this work has been partly funded by the US EPA, it has not been subjected to the agency's required review and, therefore, does not necessarily reflect the views of the agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Batzer DP, 2013, WETLANDS, V33, P1, DOI 10.1007/s13157-012-0360-2; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brazner JC, 2007, J GREAT LAKES RES, V33, P42, DOI 10.3394/0380-1330(2007)33[42:ROGLWI]2.0.CO;2; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Compin A, 2007, LANDSCAPE ECOL, V22, P1215, DOI 10.1007/s10980-007-9101-y; Courtney G.W., 2008, INTRO AQUATIC INSECT, P687; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Danz NP, 2005, ENVIRON MONIT ASSESS, V102, P41, DOI 10.1007/s10661-005-1594-8; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Doledec S, 2006, J N AM BENTHOL SOC, V25, P44, DOI 10.1899/0887-3593(2006)25[44:COSAFA]2.0.CO;2; Dunne JA, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P117; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gathman JP, 2011, WETLANDS, V31, P329, DOI 10.1007/s13157-010-0140-9; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Heino J, 2008, LIMNOL OCEANOGR, V53, P1446, DOI 10.4319/lo.2008.53.4.1446; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hilderbrand RH, 2010, J N AM BENTHOL SOC, V29, P1009, DOI 10.1899/09-138.1; Hollenhorst TP, 2011, AQUAT ECOSYST HEALTH, V14, P433, DOI 10.1080/14634988.2011.628242; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huryn AD, 2008, AQUATIC INSECTS N AM, P55; Kail J, 2012, ECOL INDIC, V18, P63, DOI 10.1016/j.ecolind.2011.09.038; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kovalenko KE, 2014, FRESHW SCI IN PRESS; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Larsen S, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1361; Larsen S, 2010, BIOL CONSERV, V143, P2638, DOI 10.1016/j.biocon.2010.07.006; Lindeman R., 1980, INTRO BIVARIATE MULT; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Merritt R.W, 2008, INTRO AQUATIC INSECT, VFourth; MERRITT RW, 1995, INTRO AQUATIC INSECT; Morse JC, 2008, INTRO AQUATIC INSECT, P481; Niemi GJ, 2007, J GREAT LAKES RES, V33, P1, DOI 10.3394/0380-1330(2007)33[1:EIFTCR]2.0.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Polhemus J.T., 2008, INTRO AQUATIC INSECT, P385; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Richards C, 1997, FRESHWATER BIOL, V37, P219, DOI 10.1046/j.1365-2427.1997.d01-540.x; SOLIS MA, 2008, INTRO AQUATIC INSECT, P553; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Stendera S, 2012, HYDROBIOLOGIA, V696, P1, DOI 10.1007/s10750-012-1183-0; Tennessen KJ, 2008, INTRO AQUATIC INSECT, P237; THORP JH, 2001, ECOLOGY CLASSIFICATI; Utz RM, 2011, J N AM BENTHOL SOC, V30, P25, DOI 10.1899/10-007.1; Uzarski D. G., 2004, Aquatic Ecosystem Health & Management, V7, P269, DOI 10.1080/14634980490461498; Verberk WCEP, 2013, FRESHW SCI, V32, P531, DOI 10.1899/12-092.1; WALTZ RD, 2008, INTRO AQUATIC INSECT, P181; Watson D., 1994, NNGRIDR IMPLEMENTATI; Weigel BM, 2003, FRESHWATER BIOL, V48, P1440, DOI 10.1046/j.1365-2427.2003.01076.x; White D.S., 2008, INTRO AQUATIC INSECT, P571	53	16	16	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101499	10.1371/journal.pone.0101499	http://dx.doi.org/10.1371/journal.pone.0101499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006811	Green Submitted, gold, Green Published			2022-12-25	WOS:000339040600040
J	Nephin, J; Juniper, SK; Archambault, P				Nephin, Jessica; Juniper, S. Kim; Archambault, Philippe			Diversity, Abundance and Community Structure of Benthic Macro- and Megafauna on the Beaufort Shelf and Slope	PLOS ONE			English	Article							BATHYMETRIC PATTERNS; MACROFAUNAL BIOMASS; SPECIES-DIVERSITY; CANADIAN SHELF; BARENTS SEA; BIODIVERSITY; SEDIMENT; DYNAMICS; FLUXES; CARBON	Diversity and community patterns of macro- and megafauna were compared on the Canadian Beaufort shelf and slope. Faunal sampling collected 247 taxa from 48 stations with box core and trawl gear over the summers of 2009-2011 between 50 and 1,000 m in depth. Of the 80 macrofaunal and 167 megafaunal taxa, 23% were uniques, present at only one station. Rare taxa were found to increase proportional to total taxa richness and differ between the shelf (< 100 m) where they tended to be sparse and the slope where they were relatively abundant. The macrofauna principally comprised polychaetes with nephtyid polychaetes dominant on the shelf and maldanid polychaetes (up to 92% in relative abundance/station) dominant on the slope. The megafauna principally comprised echinoderms with Ophiocten sp. (up to 90% in relative abundance/station) dominant on the shelf and Ophiopleura sp. dominant on the slope. Macro- and megafauna had divergent patterns of abundance, taxa richness (alpha diversity) and beta diversity. A greater degree of macrofaunal than megafaunal variation in abundance, richness and beta diversity was explained by confounding factors: location (east-west), sampling year and the timing of sampling with respect to sea-ice conditions. Change in megafaunal abundance, richness and beta diversity was greatest across the depth gradient, with total abundance and richness elevated on the shelf compared to the slope. We conclude that megafaunal slope taxa were differentiated from shelf taxa, as faunal replacement not nestedness appears to be the main driver of megafaunal beta diversity across the depth gradient.	[Nephin, Jessica; Juniper, S. Kim] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada	University of Victoria; University of Quebec	Nephin, J (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada.	jnephin@uvic.ca	Juniper, Kim/N-6769-2015	Juniper, Kim/0000-0002-7608-260X	ArcticNet - a Network of Centres of Excellence of Canada; Canadian Healthy Oceans Network (CHONe); Amundsen program; BP Exploration Operating Company Limited and Imperial Oil	ArcticNet - a Network of Centres of Excellence of Canada; Canadian Healthy Oceans Network (CHONe); Amundsen program; BP Exploration Operating Company Limited and Imperial Oil	This work was supported by ArcticNet - a Network of Centres of Excellence of Canada (http://www.arcticnet.ulaval.ca/) and by the Canadian Healthy Oceans Network (CHONe) (http://chone.marinebiodiversity.ca/). This study was also supported through a research collaboration between the Amundsen program, BP Exploration Operating Company Limited and Imperial Oil. BP and Imperial Oil had a role in the location of sampling only, as it occurred within their leased exploration areas on the Beaufort shelf. The funders had no role in sampling protocols, data collection, data analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bekryaev RV, 2010, J CLIMATE, V23, P3888, DOI 10.1175/2010JCLI3297.1; Berge J, 2005, MAR ECOL PROG SER, V303, P167, DOI 10.3354/meps303167; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Brault S, 2013, DEEP-SEA RES PT II, V92, P157, DOI 10.1016/j.dsr2.2013.01.018; Carmack EC, 2002, ARCTIC, V55, P29; Carmack EC, 2004, MAR ECOL PROG SER, V277, P37, DOI 10.3354/meps277037; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Carney RS, 1983, DEEP SEA BIOL, P371; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Cochrane SKJ, 2012, J MARINE SYST, V94, P204, DOI 10.1016/j.jmarsys.2011.12.001; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Conlan K, 2013, J MARINE SYST, V127, P76, DOI 10.1016/j.jmarsys.2013.07.013; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cusson M, 2007, MAR ECOL PROG SER, V331, P291, DOI 10.3354/meps331291; Ellingsen KE, 2007, J SEA RES, V58, P291, DOI 10.1016/j.seares.2007.10.001; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Forest A, 2013, BIOGEOSCIENCES, V10, P2833, DOI 10.5194/bg-10-2833-2013; Forest A, 2007, J MARINE SYST, V68, P39, DOI 10.1016/j.jmarsys.2006.10.008; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gaston K.J., 1994, RARITY, P1; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; GRAF G, 1992, OCEANOGR MAR BIOL, V30, P149; Grassle J.F., 1979, AMBIO SPECIAL REPORT, V6, P47; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hammerstrom KK, 2012, INTEGR ENVIRON ASSES, V8, P649, DOI 10.1002/ieam.78; Jerosch K, 2013, J MARINE SYST, V127, P5, DOI 10.1016/j.jmarsys.2012.02.013; Kaufman L., 2005, FINDING GROUPS DATA; LAMPITT RS, 1986, MAR BIOL, V93, P69, DOI 10.1007/BF00428656; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Link H, 2013, BIOGEOSCIENCES, V10, P5911, DOI 10.5194/bg-10-5911-2013; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; MACDONALD RW, 1989, J GEOPHYS RES-OCEANS, V94, P18057, DOI 10.1029/JC094iC12p18057; O'Brien MC, 2006, CONT SHELF RES, V26, P41, DOI 10.1016/j.csr.2005.09.007; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg D, 1996, MAR BIOL, V125, P321, DOI 10.1007/BF00346313; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Rex M.A., 1977, European Marine Biology Symposium, P521; Rex M. A, 2010, DEEP SEA BIODIVERSIT; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Robinson JPW, 2014, MAR POLICY, V48, P123, DOI 10.1016/j.marpol.2014.03.012; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rysgaard S., 2007, MEDDR GRONLAND BIOSC, V58, P206; Shin PKS, 2004, MAR ECOL PROG SER, V276, P25, DOI 10.3354/meps276025; Snelgrove PVR, 2012, FISHERIES, V37, P296, DOI 10.1080/03632415.2012.696002; Snelgrove PVR, 1998, BIODIVERS CONSERV, V7, P1123, DOI 10.1023/A:1008867313340; Soltwedel T, 2009, DEEP-SEA RES PT I, V56, P1856, DOI 10.1016/j.dsr.2009.05.012; Starmans A, 1999, MAR BIOL, V135, P269, DOI 10.1007/s002270050624; Stuart CT, 2009, MAR ECOL-EVOL PERSP, V30, P164, DOI 10.1111/j.1439-0485.2008.00269.x; Stuart CT, 2003, ECOSY WORLD, V28, P295; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; THIEL H, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P575; Thistle D, 2001, HYDROBIOLOGIA, V453, P255, DOI 10.1023/A:1013152909018; Tremblay JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048825; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Walker TR, 2008, J MARINE SYST, V74, P794, DOI 10.1016/j.jmarsys.2008.01.006; Warwick RM, 2001, CHANGE MARINE COMMUN; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Weslawski Jan Marcin, 2011, Marine Biodiversity, V41, P71, DOI 10.1007/s12526-010-0073-9; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Williams WJ, 2006, CONT SHELF RES, V26, P2352, DOI 10.1016/j.csr.2006.06.012; Williams WJ, 2008, J MAR RES, V66, P645, DOI 10.1357/002224008787536808; Wlodarska-Kowalczuk M, 2007, MAR ECOL PROG SER, V351, P53, DOI 10.3354/meps07127; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858; Yang JY, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005084	78	18	19	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101556	10.1371/journal.pone.0101556	http://dx.doi.org/10.1371/journal.pone.0101556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007347	Green Published, Green Submitted, gold			2022-12-25	WOS:000339040600045
J	Wei, YH; Huang, Y; Luo, L; Xiao, XC; Liu, L; Yang, ZC				Wei, Yuehong; Huang, Yong; Luo, Lei; Xiao, Xincai; Liu, Lan; Yang, Zhicong			Rapid Increase of Scrub Typhus: An Epidemiology and Spatial-Temporal Cluster Analysis in Guangzhou City, Southern China, 2006-2012	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; ORIENTIA-TSUTSUGAMUSHI; SURVEILLANCE; TAIWAN; LEPTOTROMBIDIUM; RICKETTSIOSES; PREVALENCE; INFECTION; THAILAND; MALAYSIA	Background: Scrub typhus has been increasingly reported in Southern China, and public health authorities are concerned about its increased incidence. Additionally, little evidence is available on the epidemiology of scrub typhus in Southern China. This study aims to analyze the epidemiological and geographic features of ST in Guangzhou City, Southern China, to guide the future prevention efforts. Methods: Scrub typhus surveillance data in Guangzhou City during 2006-2012 were obtained from the Chinese National Communicable Disease Surveillance Network. We first conducted a descriptive analysis to analyze the epidemiological features of scrub typhus. Then we used space-time scan statistic based on a discrete Poisson model to detect and evaluate high-risk spatial-temporal clusters of scrub typhus. Results: There were 4,001 cases of scrub typhus in Guangzhou City during the study period. The incidence of scrub typhus increased from 3.29 per 100,000 in 2006 to 9.85 per 100,000 in 2012. A summer peak was observed in June and July with a second peak in September and October except year 2009 and 2011. The majority of the cases (71.4%) were among persons aged >= 40 years, and female incidence was higher than male incidence in persons >= 50 years. In the space-time analysis, high-risk clusters were concentrated in rural areas in Guangzhou City. Over the past 7 years, Haizhu District, an urban area, was found to be a high-risk cluster for the first time in 2012. Conclusion: The resurgence of scrub typhus epidemics in Guangzhou population in 2012 necessitates more effective measures for minimizing future epidemics. Consideration of high-risk population and historical spatial-temporal clusters may help prevent scrub typhus. The risk of scrub typhus in urban areas should not be neglected and needs more attention from public health authorities.	[Wei, Yuehong; Huang, Yong; Luo, Lei; Xiao, Xincai; Liu, Lan; Yang, Zhicong] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China		Yang, ZC (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yangzc@gzcdc.org.cn			United States/NIAID NIH [HHS/AI/1R01AI083202-01A1]; National Natural Science Foundation of China [81273139, 81271880]; Guangzhou Medical Science Program [20121A011124]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083202] Funding Source: NIH RePORTER	United States/NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Medical Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by United States/NIAID NIH HHS/AI/1R01AI083202-01A1, the National Natural Science Foundation of China (Grant No. 81273139 and 81271880), and the Guangzhou Medical Science Program (Grant No. 20121A011124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CADIGAN FC, 1972, T ROY SOC TROP MED H, V66, P582, DOI 10.1016/0035-9203(72)90303-3; Chinese Center for Disease Control and Prevention (China CDC), 2009, SCRUB TYPH CONTR PRE; Frances SP, 1999, J MED ENTOMOL, V36, P869, DOI 10.1093/jmedent/36.6.869; Guangzhou Bureau of Statistics, 2011, GUANGZH STAT YB; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Hashimoto S, 2007, J EPIDEMIOL, V17, pS48, DOI 10.2188/jea.17.S48; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kuo CC, 2011, ACTA TROP, V120, P52, DOI 10.1016/j.actatropica.2011.05.018; Kweon SS, 2009, EMERG INFECT DIS, V15, P1127, DOI 10.3201/eid1507.080399; Lee YS, 2006, JPN J INFECT DIS, V59, P235; Li J.C., 2000, CHIN J PUBLIC HLTH, V16, P773; Liu YX, 2009, PEDIATR INFECT DIS J, V28, P1111, DOI 10.1097/INF.0b013e3181af8287; Mahajan SK, 2010, EMERG INFECT DIS, V16, P1641, DOI 10.3201/eid1610.100456; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; Silpapojakul Khachornsakdi, 1997, Annals Academy of Medicine Singapore, V26, P794; Strickland GT, 2000, HUNTERS TROPICAL MED; Suputtamongkol Y, 2009, ANN NY ACAD SCI, V1166, P172, DOI 10.1111/j.1749-6632.2009.04514.x; Tay ST, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002341; Vallee J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000909; WANG DQ, 1992, MED VET ENTOMOL, V6, P389, DOI 10.1111/j.1365-2915.1992.tb00639.x; Wang YC, 2013, VECTOR-BORNE ZOONOT, V13, P154, DOI 10.1089/vbz.2012.1059; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Wu G.H., 2000, CHIN J PUBLIC HLTH, V16, P777; Zhang M, 2012, AM J TROP MED HYG, V87, P1099, DOI 10.4269/ajtmh.2012.12-0306; Zhang Meng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P419; Zhang SY, 2010, J CLIN MICROBIOL, V48, P1241, DOI 10.1128/JCM.01784-09	33	29	35	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101976	10.1371/journal.pone.0101976	http://dx.doi.org/10.1371/journal.pone.0101976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25006820	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600084
J	Zhai, YL; Zhu, L; Shi, SF; Liu, LJ; Lv, JC; Zhang, H				Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong			Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; GROWTH-FACTOR VEGF; MALIGNANT HYPERTENSION; OXFORD CLASSIFICATION; ANTIBODIES; FLT-1	Background: Endothelial injury, which may present clinically as hypertension, proteinuria and increased von Willebrand Factor (vWF) level, is a common manifestation in IgA nephropathy (IgAN). However, causal factors for endothelial injury in IgAN are not completely understood. An imbalance of vascular endothelial growth factor/Soluble fms-like tyrosine kinase-1 (VEGF/sFlt-1) has been observed in many diseases with endothelial dysfunction, including pre-eclampsia and diabetic retinopathy, but whether it contributes to endothelial injury in IgAN requires further exploration. Methods: Initially, 96 IgAN patients and 22 healthy volunteers were enrolled as a discovery cohort. VEGF/sFlt-1, sFlt-1 and VEGF levels were compared between patients with IgAN and healthy volunteers to explore the underlying factors that contribute to endothelial injury in IgAN. The identified contributor (sFlt-1) was further confirmed in a replication cohort, which included 109 IgAN patients and 30 healthy volunteers. Correlations of sFlt-1 with hypertension, proteinuria, Oxford-E score and plasma vWF were further evaluated in the combined 205 patients with IgAN. Results: VEGF/sFlt-1 levels were significantly lower in IgAN patients than healthy volunteers (0.33 +/- 0.27 vs. 0.43 +/- 0.22, p = 0.02) in the discovery cohort. Within the ratio, plasma sFlt-1 levels were significantly elevated (101.18 +/- 25.19 vs. 79.73 +/- 18.85 pg/ml, p<0.001), but plasma VEGF levels showed no significant differences. Elevated sFlt-1 levels in the replication cohort were confirmed in IgAN patients (93.40 +/- 39.78 vs. 71.92 +/- 15.78 pg/ml, p<0.001). Plasma sFlt-1 levels in IgAN patients correlated with proteinuria (severe (>3.5 g/d) vs. moderate (1-3.5 g/d) vs. mild (<1 g/d) proteinuria: 115.95 +/- 39.09 vs. 99.89 +/- 28.55 vs. 83.24 +/- 33.92 pg/ml; severe vs. mild: p<0.001, moderate vs. mild p = 0.001, severe vs. moderate: p = 0.014), hypertension (with vs. without hypertension: 107.87 +/- 31.94 vs. 87.32 +/- 32.76 pg/ml, p = 0.015) and vWF levels (r = 0.161, p = 0.021). Conclusions: The present study found elevated sFlt-1 in IgAN patients and further identified its correlation with proteinuria, hypertension and vWF levels. These results suggested that elevated sFlt-1 contributes to endothelial injury in IgAN.	[Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China; [Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Zhai, Ya-Ling; Zhu, Li; Shi, Su-Fang; Liu, Li-Jun; Lv, Ji-Cheng; Zhang, Hong] Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhu, L (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.	funnyzhuli@bjmu.edu.cn			National Natural Science Foundation for Innovative Research Groups of China [81021004]; National Natural Science Foundation for Youths of China [81000297, 81200515]	National Natural Science Foundation for Innovative Research Groups of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Youths of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation for Innovative Research Groups of China ( Grant No. 81021004) and by the National Natural Science Foundation for Youths of China (Grants No. 81000297 and 81200515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Belgore FM, 2001, AM J CARDIOL, V87, P805, DOI 10.1016/S0002-9149(00)01512-5; Bertaglia G, 1997, NEPHROL DIAL TRANSPL, V12, P474, DOI 10.1093/ndt/12.3.474; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chen Y, 2005, KIDNEY BLOOD PRESS R, V28, P251, DOI 10.1159/000090058; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; DAMICO G, 1987, Q J MED, V64, P709; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; El Karoui K, 2012, J AM SOC NEPHROL, V23, P137, DOI 10.1681/ASN.2010111130; Hagmann H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085258; Hernandez E, 1997, AM J KIDNEY DIS, V30, P397, DOI 10.1016/S0272-6386(97)90285-7; Javanmard SH, 2012, J RES MED SCI, V17, P1124; Jiang L, 2008, NEPHROL DIAL TRANSPL, V23, P3921, DOI 10.1093/ndt/gfn371; Karalliedde J, 2011, DIABETES CARE, V34, pS291, DOI 10.2337/dc11-s241; Keedy VL, 2007, CANCER SCI, V98, P1825, DOI 10.1111/j.1349-7006.2007.00620.x; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Major HD, 2014, AM J OBSTET IN PRESS; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; WOO K T, 1988, Annals Academy of Medicine Singapore, V17, P583; Wu FTH, 2010, J CELL MOL MED, V14, P528, DOI 10.1111/j.1582-4934.2009.00941.x; Zhang JJ, 2008, NEPHROLOGY, V13, P712, DOI 10.1111/j.1440-1797.2008.00983.x	26	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2014	9	7							e101779	10.1371/journal.pone.0101779	http://dx.doi.org/10.1371/journal.pone.0101779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL3PK	25007257	gold, Green Submitted, Green Published			2022-12-25	WOS:000339040600067
J	He, N; Zheng, H; Li, P; Zhao, YR; Zhang, W; Song, FJ; Chen, KX				He, Na; Zheng, Hong; Li, Pei; Zhao, Yanrui; Zhang, Wei; Song, Fengju; Chen, Kexin			miR-485-5p Binding Site SNP rs8752 in HPGD Gene Is Associated with Breast Cancer Risk	PLOS ONE			English	Article							MICRORNA-RELATED GENES; SINGLE-NUCLEOTIDE POLYMORPHISMS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; TUMOR-SUPPRESSOR; TARGET SITES; VARIANTS; DATABASE; REGION; STAGE	Background: Single nucleotide polymorphisms (SNPs) that reside in microRNA target sites may play an important role in breast cancer development and progression. To reveal the association between microRNA target site SNPs and breast cancer risk, we performed a large case-control study in China. Methods: We performed a two-stage case-control study including 2744 breast cancer cases and 3125 controls. In Stage I, we genotyped 192 SNPs within microRNA binding sites identified from the "Patrocles'' database using custom Illumina GoldenGate VeraCode assays on the Illumina BeadXpress platform. In Stage II, genotyping was performed on SNPs potentially associated with breast cancer risk using the TaqMan platform in an independent replication set. Results: In stage I, 15 SNPs were identified to be significantly associated with breast cancer risk (P<0.05). In stage II, one SNP rs8752 was replicated at P<0.05. This SNP is located in the 3' untranslated region (UTR) of the 15-hydroxyprostaglandin dehydrogenase (HPGD) gene at 4q34-35, a miR-485-5p binding site. Compared with the GG genotype, the combined GA+AA genotypes has a significantly higher risk of breast cancer (OR = 1.18; 95% CI: 1.06-1.31, P = 0.002). Specifically, this SNP was associated with estrogen receptor (ER) positive breast cancer (P = 0.0007), but not with ER negative breast cancer (P = 0.23), though p for heterogeneity not significant. Conclusion: Through a systematic case-control study of microRNA binding site SNPs, we identified a new breast cancer risk variant rs8752 in HPGD in Chinese women. Further studies are warranted to investigate the underling mechanism for this association.	[He, Na; Zheng, Hong; Li, Pei; Zhao, Yanrui; Song, Fengju; Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Key Lab Canc Prevent & Therapy,Minist Educ, Dept Epidemiol & Biostat,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center	Song, FJ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Key Lab Breast Canc Prevent & Therapy, Key Lab Canc Prevent & Therapy,Minist Educ, Dept Epidemiol & Biostat,Natl Clin Res Ctr Canc, Tianjin, Peoples R China.	songfengju@163.com		Chen, Kexin/0000-0003-4248-7681	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) in China [IRT1076]; National Key Scientific and Technological Project [2011ZX09307-001-04]; National Natural Science Foundation of China [81172762]; Tianjin Cancer Institute and Hospital; U.S. National Foundation for Cancer Research	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) in China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Scientific and Technological Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Cancer Institute and Hospital; U.S. National Foundation for Cancer Research	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) in China (IRT1076), the National Key Scientific and Technological Project (2011ZX09307-001-04), and the National Natural Science Foundation of China (No. 81172762). The tissue bank is jointly supported by the Tianjin Cancer Institute and Hospital and the U.S. National Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Brendle A, 2008, CARCINOGENESIS, V29, P1394, DOI 10.1093/carcin/bgn126; Chen JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086319; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061008; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Gilam A, 2013, BREAST CANCER RES TR, V138, P753, DOI 10.1007/s10549-013-2502-5; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Huang GS, 2008, CANCER RES, V68, P5040, DOI 10.1158/0008-5472.CAN-07-6575; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jedlinski DJ, 2011, TWIN RES HUM GENET, V14, P417, DOI 10.1375/twin.14.5.417; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084532; Kang S, 2013, INT J ONCOL, V43, P1659, DOI 10.3892/ijo.2013.2094; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Li MN, 2008, CANCER INVEST, V26, P905, DOI 10.1080/07357900802146154; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031146; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Lin MB, 2012, CLIN CANCER RES, V18, P3982, DOI 10.1158/1078-0432.CCR-11-2951; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pham H, 2008, MOL CARCINOGEN, V47, P466, DOI 10.1002/mc.20404; Ryu YM, 2013, CANCER PREV RES, V6, P349, DOI 10.1158/1940-6207.CAPR-12-0389; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Tong M, 2004, ENDOCRINOLOGY, V145, P2141, DOI 10.1210/en.2003-1229; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zheng H, 2011, INT J ONCOL, V38, P1153, DOI 10.3892/ijo.2011.940	44	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e102093	10.1371/journal.pone.0102093	http://dx.doi.org/10.1371/journal.pone.0102093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003827	gold, Green Published, Green Submitted			2022-12-25	WOS:000339242700107
J	Pakeman, RJ				Pakeman, Robin J.			Leaf Dry Matter Content Predicts Herbivore Productivity, but Its Functional Diversity Is Positively Related to Resilience in Grasslands	PLOS ONE			English	Article							LAND-USE INTENSIFICATION; ECOSYSTEM SERVICES; RESPONSE DIVERSITY; TRAITS; COMMUNITIES; REDUNDANCY; MANAGEMENT; FERTILITY; LANDSCAPE; FRAMEWORK	This paper addresses whether the ecosystem service of animal production from grasslands depends upon plant functional identity, plant functional diversity or if the resilience of production is a function of this diversity. Using the results of nine grazing experiments the paper shows that productivity is highly dependent on one leaf trait, leaf dry matter content, as well as rainfall. Animal (secondary) productivity is not dependent on plant functional diversity, but the variability in productivity of grasslands is related to the functional diversity of leaf dry matter content. This and a range of independent studies have shown that functional diversity is reduced at high levels of grassland productivity, so it appears that there is a trade-off between productivity and the resilience of productivity in the face of environmental variation.	James Hutton Inst, Aberdeen, Scotland	James Hutton Institute	Pakeman, RJ (corresponding author), James Hutton Inst, Aberdeen, Scotland.	robin.pakeman@hutton.ac.uk	Pakeman, Robin Jeffrey/P-7338-2015	Pakeman, Robin Jeffrey/0000-0001-6248-4133	Scottish Government's Rural and Environmental Research and Analysis Services Division	Scottish Government's Rural and Environmental Research and Analysis Services Division	The research was supported by the Scottish Government's Rural and Environmental Research and Analysis Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; [Anonymous], 2010, R LANG ENV STAT COMP; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Carpenter SR, 2006, ECOL SOC, V11; Chanteloup P, 2013, BASIC APPL ECOL, V14, P208, DOI 10.1016/j.baae.2013.01.002; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Crawley MJ., 2007, R BOOK; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Duru M, 2008, AGRON J, V100, P1622, DOI 10.2134/agronj2008.0003; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Freckleton RP, 1999, AGR FOREST METEOROL, V93, P39, DOI 10.1016/S0168-1923(98)00106-3; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Grant SA, 1996, J APPL ECOL, V33, P1267, DOI 10.2307/2404769; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S., 2002, BIOLFLOR EINE DATENB; Klumpp K, 2009, GLOBAL CHANGE BIOL, V15, P2921, DOI 10.1111/j.1365-2486.2009.01905.x; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lavorel S, 2012, J ECOL, V100, P128, DOI 10.1111/j.1365-2745.2011.01914.x; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Marriott CA, 2009, AGR ECOSYST ENVIRON, V134, P190, DOI 10.1016/j.agee.2009.07.002; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Pakeman RJ, 2004, J ECOL, V92, P893, DOI 10.1111/j.0022-0477.2004.00928.x; Pakeman RJ, 2013, FOLIA GEOBOT, V48, P355, DOI 10.1007/s12224-013-9168-y; Pakeman RJ, 2011, ECOLOGY, V92, P1353, DOI 10.1890/10-1728.1; Pakeman RJ, 2009, J VEG SCI, V20, P148, DOI 10.1111/j.1654-1103.2009.05548.x; Perry M, 2005, INT J CLIMATOL, V25, P1041, DOI 10.1002/joc.1161; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Zuur AF, 2009, STAT BIOL HLTH, P269	44	17	20	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2014	9	7							e101876	10.1371/journal.pone.0101876	http://dx.doi.org/10.1371/journal.pone.0101876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL6KZ	25003997	gold, Green Submitted, Green Published			2022-12-25	WOS:000339242700081
J	Shinko, A; Agari, T; Kameda, M; Yasuhara, T; Kondo, A; Tayra, JT; Sato, K; Sasaki, T; Sasada, S; Takeuchi, H; Wakamori, T; Borlongan, CV; Date, I				Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Borlongan, Cesario V.; Date, Isao			Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson's Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; SUBTHALAMIC NUCLEUS STIMULATION; DORSAL COLUMN STIMULATION; ELECTRICAL-STIMULATION; SUBARACHNOID HEMORRHAGE; DOPAMINERGIC-NEURONS; RAT MODEL; IN-VITRO; PAIN	In clinical practice, deep brain stimulation (DBS) is effective for treatment of motor symptoms in Parkinson's disease (PD). However, the mechanisms have not been understood completely. There are some reports that electrical stimulation exerts neuroprotective effects on the central nervous system diseases including cerebral ischemia, head trauma, epilepsy and PD, although there are a few reports on neuroprotective effects of spinal cord stimulation (SCS). We investigated the neuroprotective effects of high cervical SCS on PD model of rats. Adult female Sprague-Dawley rats received hour-long SCS (2, 50 or 200 Hz) with an epidural electrode at C1-2 level for 16 consecutive days. At 2 days after initial SCS, 6-hydroxydopamine (6-OHDA) was injected into the right striatum of rats. Behavioral evaluations of PD symptoms were employed, including cylinder test and amphetamine-induced rotation test performed at 1 and 2 weeks after 6-OHDA injection. Animals were subsequently euthanized for immunohistochemical investigations. In order to explore neurotrophic and growth factor upregulation induced by SCS, another cohort of rats that received 50 Hz SCS was euthanized at 1 and 2 weeks after lesion for protein assays. Behavioral tests revealed that the number of amphetamine-induced rotations decreased in SCS groups. Immunohistochemically, tyrosine hydroxylase (TH)-positive fibers in the striatum were significantly preserved in SCS groups. TH-positive neurons in the substantia nigra pars compacta were significantly preserved in 50 Hz SCS group. The level of vascular endothelial growth factor (VEGF) was upregulated by SCS at 1 week after the lesion. These results suggest that high cervical SCS exerts neuroprotection in PD model of rats, at least partially by upregulation of VEGF. SCS is supposed to suppress or delay PD progression and might become a less invasive option for PD patients, although further preclinical and clinical investigations are needed to confirm the effectiveness and safety.	[Shinko, Aiko; Agari, Takashi; Kameda, Masahiro; Yasuhara, Takao; Kondo, Akihiko; Tayra, Judith Thomas; Sato, Kenichiro; Sasaki, Tatsuya; Sasada, Susumu; Takeuchi, Hayato; Wakamori, Takaaki; Date, Isao] Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan; [Borlongan, Cesario V.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA	Okayama University; State University System of Florida; University of South Florida	Agari, T (corresponding author), Okayama Univ, Grad Sch Med, Dept Neurol Surg, Okayama, Japan.	agarit@cc.okayama-u.ac.jp	Yasuhara, Takao/AEU-1075-2022; Borlongan, Cesar/I-5696-2012; Kondo, Akihiko/A-2130-2015; Sheshukova, Ekaterina/O-1365-2013	Borlongan, Cesar/0000-0002-2966-9782; Shindyapina, Anastasia/0000-0002-7336-3086; Sheshukova, Ekaterina/0000-0002-0934-3902				Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; CHANDLER MJ, 1993, EUR HEART J, V14, P96, DOI 10.1093/eurheartj/14.1.96; Cui JG, 1996, PAIN, V66, P287, DOI 10.1016/0304-3959(96)03069-2; Cui JG, 1997, PAIN, V73, P87, DOI 10.1016/S0304-3959(97)00077-8; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; EDVINSSON L, 1989, J CEREBR BLOOD F MET, V9, P212, DOI 10.1038/jcbfm.1989.31; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Goksel HM, 2001, ACTA NEUROCHIR, V143, P383, DOI 10.1007/s007010170094; Gurelik M, 2005, NEUROSCIENCE, V134, P827, DOI 10.1016/j.neuroscience.2005.04.062; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; HOSOBUCHI Y, 1991, PACE, V14, P122, DOI 10.1111/j.1540-8159.1991.tb04056.x; HOSOBUCHI Y, 1985, APPL NEUROPHYSIOL, V48, P372, DOI 10.1159/000101161; Isono M, 1995, STEREOT FUNCT NEUROS, V64, P40, DOI 10.1159/000098732; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kumar K, 2007, PAIN, V132, P179, DOI 10.1016/j.pain.2007.07.028; Lee JY, 2008, J NEUROSURG, V109, P1148, DOI 10.3171/JNS.2008.109.12.1148; LEVIN BE, 1980, NEUROLOGY, V30, P65, DOI 10.1212/WNL.30.1.65; LINDEROTH B, 1995, NEUROSURGERY, V37, P266, DOI 10.1227/00006123-199508000-00011; LINDEROTH B, 1992, NEUROSURGERY, V31, P289, DOI 10.1227/00006123-199208000-00014; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Maher J, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01237.x; Maher J, 2009, NEUROGASTROENT MOTIL, V21, pe633; MEGLIO M, 1991, PACE, V14, P127, DOI 10.1111/j.1540-8159.1991.tb04057.x; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Patel S, 2004, NEUROSURGERY, V55, P201, DOI 10.1227/01.NEU.0000126949.28912.71; Patel S, 2003, J NEUROSURG, V99, P754, DOI 10.3171/jns.2003.99.4.0754; Paxions G, 1998, RAT BRAIN STEREOTAXI; Pitzer MR, 2003, EXP NEUROL, V182, P435, DOI 10.1016/S0014-4886(03)00100-6; Rajput AH, 2004, PARKINSONISM RELAT D, V10, P221, DOI 10.1016/j.parkreldis.2004.01.004; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sagher O, 2003, J NEUROSURG, V99, P131, DOI 10.3171/jns.2003.99.1.0131; Sagher Oren, 2006, Neurosurg Focus, V21, pE2; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schechtmann G, 2008, PAIN, V139, P136, DOI 10.1016/j.pain.2008.03.023; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Song ZY, 2008, NEUROSCI LETT, V436, P7, DOI 10.1016/j.neulet.2008.02.044; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Stiller CO, 1996, NEUROSURGERY, V39, P367, DOI 10.1097/00006123-199608000-00026; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; Thevathasan W, 2010, NEUROLOGY, V74, P1325, DOI 10.1212/WNL.0b013e3181d9ed58; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P262, DOI 10.1159/000066729; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P269, DOI 10.1159/000066730; Visocchi M, 2001, ACTA NEUROCHIR, V143, P177; Yadav AP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03839; Yakhnitsa V, 1999, PAIN, V79, P223, DOI 10.1016/S0304-3959(98)00169-9; Yang X, 2008, NEUROSCIENCE, V152, P950, DOI 10.1016/j.neuroscience.2008.01.009; Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhong J, 2004, ACTA NEUROCHIR, V146, P1227, DOI 10.1007/s00701-004-0364-7	55	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101468	10.1371/journal.pone.0101468	http://dx.doi.org/10.1371/journal.pone.0101468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	25009993	Green Submitted, Green Published, gold			2022-12-25	WOS:000338763800025
J	Xu, MY; Xie, F; Wang, K				Xu, Min-Yun; Xie, Fan; Wang, Kun			Response of Vegetation and Soil Carbon and Nitrogen Storage to Grazing Intensity in Semi-Arid Grasslands in the Agro-Pastoral Zone of Northern China	PLOS ONE			English	Article							INNER-MONGOLIA; SPATIAL VARIABILITY; PHYSICAL-PROPERTIES; SHORTGRASS STEPPE; ORGANIC-CARBON; ROOT BIOMASS; BULK-DENSITY; MIXED-GRASS; LAND-USE; MANAGEMENT	Overgrazing has been the primary cause of grassland degradation in the semi-arid grasslands of the agro-pastoral transition zone in northern China. However, there has been little evidence regarding grazing intensity impacts on vegetation change and soil C and N dynamics in this region. This paper reports the effects of four grazing intensities namely un-grazed (UG), lightly grazed (LG), moderately grazed (MG) and heavily grazed (HG) on vegetation characteristics and soil properties of grasslands in the Guyuan county in the agro-pastoral transition region, Hebei province, northern China. Our study showed that the vegetation height, canopy cover, plant species abundance and aboveground biomass decreased significantly with increased grazing intensity. Similarly, soil organic carbon (SOC) and total nitrogen (STN) in the 0-50 cm were highest under UG (13.3 kg C m(-2) and 1.69 kg N m(-2)) and lowest under HG (9.8 kg C m(-2) and 1.22 kg N m(-2)). Soil available nitrogen (SAN) was significantly lower under HG (644 kg N hm(-2)) than under other treatments (725-731 kg N hm(-2)) in the 0-50 cm. Our results indicate that the pasture management of ''take half-leave half'' has potential benefits for primary production and livestock grazing in this region. However, grazing exclusion was perhaps the most effective choice for restoring degraded grasslands in this region. Therefore, flexible rangeland management should be adopted in this region.	[Xu, Min-Yun] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Xu, Min-Yun] Hebei Agr Univ, Coll Anim Sci & Technol, Baoding, Hebei Province, Peoples R China; [Xie, Fan] China Natl Light Ind Council, Dept Party Affairs, Beijing, Peoples R China; [Wang, Kun] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Peking University; Hebei Agricultural University; China Agricultural University	Xu, MY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	xuminyun@pku.edu.cn			Baoding Science and Technology Development Project [13zf063]	Baoding Science and Technology Development Project	This research was funded by Baoding Science and Technology Development Project (Grant No. 13zf063). The funder (URL: http://www. bdskjj.gov.cn/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BAUER A, 1987, SOIL SCI SOC AM J, V51, P176, DOI 10.2136/sssaj1987.03615995005100010037x; Chen Z., 2000, TYPICAL STEPPE ECOSY; Chen ZQ, 2001, J GEOGR SCI, V11, P433, DOI DOI 10.1007/BF02837971; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Ding HA, 2007, INT J SUST DEV WORLD, V14, P391; FRANK AB, 1995, J RANGE MANAGE, V48, P470, DOI 10.2307/4002255; Gan L, 2012, PEDOSPHERE, V22, P165, DOI 10.1016/S1002-0160(12)60003-4; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YH, 2007, POL J ECOL, V55, P469; Gill R, 1999, ECOSYSTEMS, V2, P226; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; Haynes RJ, 1999, BIOL FERT SOILS, V28, P253, DOI 10.1007/s003740050490; He NP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00017.1; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Hiernaux P, 1998, PLANT ECOL, V138, P191, DOI 10.1023/A:1009752606688; HOLLAND EA, 1992, AM NAT, V140, P685, DOI 10.1086/285435; HOLLAND EA, 1990, ECOLOGY, V71, P1040, DOI 10.2307/1937372; Huang D, 2007, J ARID ENVIRON, V70, P120, DOI 10.1016/j.jaridenv.2006.12.009; Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL PHYS CHEM AN; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Li Yong-Hong, 1993, Acta Botanica Sinica, V35, P877; [刘全友 Liu Quanyou], 2003, [生态学报, Acta Ecologica Sinica], V23, P1025; Liu TZ, 2011, NUTR CYCL AGROECOSYS, V91, P67, DOI 10.1007/s10705-011-9445-1; Liu Yingru, 2004, Yingyong Shengtai Xuebao, V15, P1604; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; McNaughton SJ, 1998, ECOLOGY, V79, P587, DOI 10.1890/0012-9658(1998)079[0587:RBAPIA]2.0.CO;2; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; NAETH MA, 1991, CAN J SOIL SCI, V71, P313, DOI 10.4141/cjss91-031; NAETH MA, 1995, J RANGE MANAGE, V48, P528, DOI 10.2307/4003065; Neff JC, 2005, ECOL APPL, V15, P87, DOI 10.1890/04-0268; Page A.L., 1983, METHODS SOIL ANAL 2; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Ren JZ, 1985, GRASSLAND SURVEY PLA; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Stavi I, 2008, CATENA, V75, P288, DOI 10.1016/j.catena.2008.07.007; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Su YZ, 2004, SOIL TILL RES, V75, P27, DOI 10.1016/S0167-1987(03)00157-0; Tracy BF, 1998, OECOLOGIA, V114, P556, DOI 10.1007/s004420050480; VANHAVEREN BP, 1983, J RANGE MANAGE, V36, P586; Wen L, 2013, PLANT SOIL, V368, P329, DOI 10.1007/s11104-012-1500-4; WILLMS WD, 1993, J RANGE MANAGE, V46, P320, DOI 10.2307/4002466; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Xu MY, 2011, AFR J BIOTECHNOL, V10, P4844; Zhao Y, 2007, ECOL MODEL, V205, P241, DOI 10.1016/j.ecolmodel.2007.02.019; Zhou ZC, 2010, CATENA, V82, P87, DOI 10.1016/j.catena.2010.05.005; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	50	24	28	8	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2014	9	5							e96604	10.1371/journal.pone.0096604	http://dx.doi.org/10.1371/journal.pone.0096604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZC	25003849	Green Published, Green Submitted, gold			2022-12-25	WOS:000336653300023
J	Ritze, Y; Bardos, G; Claus, A; Ehrmann, V; Bergheim, I; Schwiertz, A; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Schwiertz, Andreas; Bischoff, Stephan C.			Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CACO-2 CELL MONOLAYERS; GUT MICROBIOTA; INTESTINAL PERMEABILITY; HEPATIC STEATOSIS; PROBIOTICS; OBESITY; FRUCTOSE; BARRIER; FLORA	Objective: Experimental evidence revealed that obesity-associated non-alcoholic fatty liver disease (NAFLD) is linked to changes in intestinal permeability and translocation of bacterial products to the liver. Hitherto, no reliable therapy is available except for weight reduction. Within this study, we examined the possible effect of the probiotic bacterial strain Lactobacillus rhamnosus GG (LGG) as protective agent against experimental NAFLD in a mouse model. Methods: Experimental NAFLD was induced by a high-fructose diet over eight weeks in C57BL/J6 mice. Fructose was administered via the drinking water containing 30% fructose with or without LGG at a concentration resulting in approximately 5x10(7) colony forming units/g body weight. Mice were examined for changes in small intestinal microbiota, gut barrier function, lipopolysaccharide (LPS) concentrations in the portal vein, liver inflammation and fat accumulation in the liver. Results: LGG increased beneficial bacteria in the distal small intestine. Moreover, LGG reduced duodenal I kappa B protein levels and restored the duodenal tight junction protein concentration. Portal LPS (P <= 0.05) was reduced and tended to attenuate TNF-alpha, IL-8R and IL-1 beta mRNA expression in the liver feeding a high-fructose diet supplemented with LGG. Furthermore liver fat accumulation and portal alanine-aminotransferase concentrations (P <= 0.05) were attenuated in mice fed the high-fructose diet and LGG. Conclusions: We show for the first time that LGG protects mice from NAFLD induced by a high-fructose diet. The underlying mechanisms of protection likely involve an increase of beneficial bacteria, restoration of gut barrier function and subsequent attenuation of liver inflammation and steatosis.	[Ritze, Yvonne; Bardos, Gyoengyi; Claus, Anke; Ehrmann, Veronika; Bergheim, Ina; Bischoff, Stephan C.] Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany; [Bergheim, Ina] Univ Jena, Dept Nutr Sci, Jena, Germany; [Schwiertz, Andreas] MVZ Inst Microecol, Herborn, Germany	University Hohenheim; Friedrich Schiller University of Jena	Bischoff, SC (corresponding author), Univ Hohenheim, Dept Med Nutr, Stuttgart, Germany.	bischoff.stephan@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research [FKZ: 01GI0843]; Institute Danone	Competence Network of Obesity, group 'Obesity and GI tract'; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute Danone(Danone Nutricia)	This work was supported by grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843) to S. C. Bischoff and the Institute Danone research grant 2010 to Y. Ritze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Donato KA, 2010, MICROBIOL-SGM, V156, P3288, DOI 10.1099/mic.0.040139-0; Dukowicz Andrew C, 2007, Gastroenterol Hepatol (N Y), V3, P112; ELLWOOD KC, 1993, P SOC EXP BIOL MED, V202, P440, DOI 10.3181/00379727-202-43556; Gratz SW, 2010, WORLD J GASTROENTERO, V16, P403, DOI 10.3748/wjg.v16.i4.403; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Haub S, 2011, J PHARMACOL EXP THER, V339, P790, DOI 10.1124/jpet.111.181834; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Ji YS, 2012, BENEF MICROBES, V3, P13, DOI 10.3920/BM2011.0046; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Lambert D, 2007, CELL PHYSIOL BIOCHEM, V20, P495, DOI 10.1159/000107533; Le Roy T, 2012, GUT; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee Sang Kil, 2012, Korean J Gastroenterol, V60, P86; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; NANJI AA, 1994, P SOC EXP BIOL MED, V205, P243; Park SK, 2012, HEPATOLOGY; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Sheth SG, 1997, ANN INTERN MED, V126, P137, DOI 10.7326/0003-4819-126-2-199701150-00008; Solga SF, 2004, HEPATOLOGY, V39, P1197, DOI 10.1002/hep.20220; Spiller R, 2008, ALIMENT PHARM THER, V28, P385, DOI 10.1111/j.1365-2036.2008.03750.x; Spruss A, 2009, J NUTR BIOCHEM, V20, P657, DOI 10.1016/j.jnutbio.2009.05.006; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vieira LQ, 2008, J CLIN GASTROENTEROL, V42, pS168, DOI 10.1097/MCG.0b013e31818063d4; Wagnerberger S, 2012, J NUTR BIOCH; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Wood Natalie J, 2012, Nat Rev Gastroenterol Hepatol, V9, P123, DOI 10.1038/nrgastro.2012.21; Xu RY, 2012, J CLIN BIOCHEM NUTR, V50, P72, DOI 10.3164/jcbn.11-38; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zhang LY, 2006, J PEDIATR GASTR NUTR, V42, P545, DOI 10.1097/01.mpg.0000221905.68781.4a	50	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e80169	10.1371/journal.pone.0080169	http://dx.doi.org/10.1371/journal.pone.0080169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475018	Green Published, gold, Green Submitted			2022-12-25	WOS:000330507300004
J	Ritze, Y; Bardos, G; D'Haese, JG; Ernst, B; Thurnheer, M; Schultes, B; Bischoff, SC				Ritze, Yvonne; Bardos, Gyoengyi; D'Haese, Jan G.; Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd; Bischoff, Stephan C.			Effect of High Sugar Intake on Glucose Transporter and Weight Regulating Hormones in Mice and Humans	PLOS ONE			English	Article							FOOD-INTAKE; SWEETENED BEVERAGES; ENERGY-EXPENDITURE; FRUCTOSE; APPETITE; HEALTH; GLUT2; CHOLECYSTOKININ; ABSORPTION; SATIETY	Objective: Sugar consumption has increased dramatically over the last decades in Western societies. Especially the intake of sugar-sweetened beverages seems to be a major risk for the development of obesity. Thus, we compared liquid versus solid high-sugar diets with regard to dietary intake, intestinal uptake and metabolic parameters in mice and partly in humans. Methods: Five iso-caloric diets, enriched with liquid (in water 30% vol/vol) or solid (in diet 65% g/g) fructose or sucrose or a control diet were fed for eight weeks to C57bl/6 mice. Sugar, liquid and caloric intake, small intestinal sugar transporters (GLUT2/5) and weight regulating hormone mRNA expression, as well as hepatic fat accumulation were measured. In obese versus lean humans that underwent either bariatric surgery or small bowel resection, we analyzed small intestinal GLUT2, GLUT5, and cholecystokinin expression. Results: In mice, the liquid high-sucrose diet caused an enhancement of total caloric intake compared to the solid high-sucrose diet and the control diet. In addition, the liquid high-sucrose diet increased expression of GLUT2, GLUT5, and cholecystokinin expression in the ileum (P<0.001). Enhanced liver triglyceride accumulation was observed in mice being fed the liquid high-sucrose or -fructose, and the solid high-sucrose diet compared to controls. In obese, GLUT2 and GLUT5 mRNA expression was enhanced in comparison to lean individuals. Conclusions: We show that the form of sugar intake (liquid versus solid) is presumably more important than the type of sugar, with regard to feeding behavior, intestinal sugar uptake and liver fat accumulation in mice. Interestingly, in obese individuals, an intestinal sugar transporter modulation also occurred when compared to lean individuals.	[Ritze, Yvonne; Bardos, Gyoengyi; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany; [D'Haese, Jan G.] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany; [Ernst, Barbara; Thurnheer, Martin; Schultes, Bernd] Interdisciplinary Obes Ctr, Rorschach, Switzerland	University Hohenheim; Technical University of Munich	Ritze, Y (corresponding author), Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany.	yvonne.ritze@uni-hohenheim.de	Schwiertz, Andreas/ABA-9274-2020; Schwiertz, Andreas/AAG-6381-2019	Schwiertz, Andreas/0000-0002-2876-2352; D'Haese, Jan G./0000-0002-7827-8753	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research [FKZ: 01GI0843]	Competence Network of Obesity, group 'Obesity and GI tract' - Federal Ministry of Education and Research	This work was supported with grants from the Competence Network of Obesity, group 'Obesity and GI tract', funded by the Federal Ministry of Education and Research (FKZ: 01GI0843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Atwater WO, 1900, STATE CONNECTICUT 12, V1899, P73; Atwater WO, 1903, CONN STORRS AGR EXPT, P123; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Bellissimo N, 2003, J NUTR, V133, P2319, DOI 10.1093/jn/133.7.2319; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bielohuby M, 2010, BRIT J NUTR, V103, P1525, DOI 10.1017/S000711450999345X; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Chaput JP, 2014, CURR OBES REP, V3, P54, DOI 10.1007/s13679-013-0086-3; Coelho SB, 2006, NUTRITION, V22, P585, DOI 10.1016/j.nut.2006.03.012; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Daousi C, 2009, CLIN ENDOCRINOL, V71, P195, DOI 10.1111/j.1365-2265.2008.03451.x; Date Y, 2012, METHOD ENZYMOL, V514, P261, DOI 10.1016/B978-0-12-381272-8.00016-7; de Graaf C, 2004, AM J CLIN NUTR, V79, P946; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Dumoulin V, 1998, ENDOCRINOLOGY, V139, P3780, DOI 10.1210/en.139.9.3780; Dyer J, 2007, BIOCHEM SOC T, V35, P1191, DOI 10.1042/BST0351191; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; FLIPOT P, 1971, CAN J ANIM SCI, V51, P801, DOI 10.4141/cjas71-108; Ford CN, 2013, J ACAD NUTR DIET, V113, P35, DOI 10.1016/j.jand.2012.08.022; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Haub S, 2010, AM J PHYSIOL-GASTR L, V298, pG335, DOI 10.1152/ajpgi.00088.2009; Holmes AD, 1918, US DEP AGR B, V687, P1; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Melanson KJ, 2008, AM J CLIN NUTR, V88, p1738S, DOI 10.3945/ajcn.2008.25825E; Must A, 2009, INT J OBESITY, V33, P705, DOI 10.1038/ijo.2009.60; Pereira MA, 2006, INT J OBESITY, V30, pS28, DOI 10.1038/sj.ijo.0803489; Rizkalla SW, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-82; Rubner M, 1885, I Z BIOL, V21, P250; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shirazi-Beechey SP, 2011, P NUTR SOC, V70, P185, DOI 10.1017/S0029665111000103; Siervo M, 2013, PUBLIC HEALTH NUTR, P1; SOUTHGATE DA, 1970, BRIT J NUTR, V24, P517, DOI 10.1079/BJN19700050; Stolarczyk E, 2010, AM J PHYSIOL-ENDOC M, V298, pE1078, DOI 10.1152/ajpendo.00737.2009; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tobin V, 2008, DIABETES, V57, P555, DOI 10.2337/db07-0928; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weed DL, 2011, AM J CLIN NUTR, V94, P1340, DOI 10.3945/ajcn.111.015875; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003	51	195	208	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2014	9	7							e101702	10.1371/journal.pone.0101702	http://dx.doi.org/10.1371/journal.pone.0101702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK9RG	24475018	Green Submitted, gold, Green Published			2022-12-25	WOS:000338763800034
